381	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	24086012	12043006	8028670.667	6021503	4817202.4	4014335.333	3440858.857	3010751.5	2676223.556	2408601.2	2189637.455	2007167.667	1852770.154	1720429.429	1605734.133	1505375.75	1338111.778	1267684.842	1204300.6	1003583.833	963440.48	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
382	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	18506678	9253339	6168892.667	4626669.5	3701335.6	3084446.333	2643811.143	2313334.75	2056297.556	1850667.8	1682425.273	1542223.167	1423590.615	1321905.571	1233778.533	1156667.375	1028148.778	974035.6842	925333.9	771111.5833	740267.12	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
383	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	8511076	4255538	2837025.333	2127769	1702215.2	1418512.667	1215868	1063884.5	945675.1111	851107.6	773734.1818	709256.3333	654698.1538	607934	567405.0667	531942.25	472837.5556	447951.3684	425553.8	354628.1667	340443.04	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
384	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	981051	490525.5	327017	245262.75	196210.2	163508.5	140150.1429	122631.375	109005.6667	98105.1	89186.45455	81754.25	75465.46154	70075.07143	65403.4	61315.6875	54502.83333	51634.26316	49052.55	40877.125	39242.04	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
385	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	487168	243584	162389.3333	121792	97433.6	81194.66667	69595.42857	60896	54129.77778	48716.8	44288	40597.33333	37474.46154	34797.71429	32477.86667	30448	27064.88889	25640.42105	24358.4	20298.66667	19486.72	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
386	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
387	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	2836850	1418425	945616.6667	709212.5	567370	472808.3333	405264.2857	354606.25	315205.5556	283685	257895.4545	236404.1667	218219.2308	202632.1429	189123.3333	177303.125	157602.7778	149307.8947	141842.5	118202.0833	113474	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
388	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	2125156	1062578	708385.3333	531289	425031.2	354192.6667	303593.7143	265644.5	236128.4444	212515.6	193196	177096.3333	163473.5385	151796.8571	141677.0667	132822.25	118064.2222	111850.3158	106257.8	88548.16667	85006.24	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
389	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
390	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	1080268	540134	360089.3333	270067	216053.6	180044.6667	154324	135033.5	120029.7778	108026.8	98206.18182	90022.33333	83097.53846	77162	72017.86667	67516.75	60014.88889	56856.21053	54013.4	45011.16667	43210.72	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
391	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	885036	442518	295012	221259	177007.2	147506	126433.7143	110629.5	98337.33333	88503.6	80457.81818	73753	68079.69231	63216.85714	59002.4	55314.75	49168.66667	46580.84211	44251.8	36876.5	35401.44	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
392	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	359009	179504.5	119669.6667	89752.25	71801.8	59834.83333	51287	44876.125	39889.88889	35900.9	32637.18182	29917.41667	27616.07692	25643.5	23933.93333	22438.0625	19944.94444	18895.21053	17950.45	14958.70833	14360.36	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
393	CHOYP_1433G.2.2|m.63451	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
394	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
395	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
396	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
397	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	74229	37114.5	24743	18557.25	14845.8	12371.5	10604.14286	9278.625	8247.666667	7422.9	6748.090909	6185.75	5709.923077	5302.071429	4948.6	4639.3125	4123.833333	3906.789474	3711.45	3092.875	2969.16	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
398	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
399	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	473015	236507.5	157671.6667	118253.75	94603	78835.83333	67573.57143	59126.875	52557.22222	47301.5	43001.36364	39417.91667	36385.76923	33786.78571	31534.33333	29563.4375	26278.61111	24895.52632	23650.75	19708.95833	18920.6	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
400	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	236270	118135	78756.66667	59067.5	47254	39378.33333	33752.85714	29533.75	26252.22222	23627	21479.09091	19689.16667	18174.61538	16876.42857	15751.33333	14766.875	13126.11111	12435.26316	11813.5	9844.583333	9450.8	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
401	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	242779	121389.5	80926.33333	60694.75	48555.8	40463.16667	34682.71429	30347.375	26975.44444	24277.9	22070.81818	20231.58333	18675.30769	17341.35714	16185.26667	15173.6875	13487.72222	12777.84211	12138.95	10115.79167	9711.16	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
402	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
403	CHOYP_1433G.2.2|m.63451	GDDPYYDSYYSR	GDDPYYDSYYSR	23743	11871.5	7914.333333	5935.75	4748.6	3957.166667	3391.857143	2967.875	2638.111111	2374.3	2158.454545	1978.583333	1826.384615	1695.928571	1582.866667	1483.9375	1319.055556	1249.631579	1187.15	989.2916667	949.72	Q4R979	RNA-binding protein 4 (RNA-binding motif protein 4)	RBM4 QtsA-10585	"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0032055; GO:0035198; GO:0035278; GO:0036002; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
2685	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	300708192	150354096	100236064	75177048	60141638.4	50118032	42958313.14	37588524	33412021.33	30070819.2	27337108.36	25059016	23131399.38	21479156.57	20047212.8	18794262	16706010.67	15826746.95	15035409.6	12529508	12028327.68	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2686	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	246823456	123411728	82274485.33	61705864	49364691.2	41137242.67	35260493.71	30852932	27424828.44	24682345.6	22438496	20568621.33	18986419.69	17630246.86	16454897.07	15426466	13712414.22	12990708.21	12341172.8	10284310.67	9872938.24	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2687	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	115931744	57965872	38643914.67	28982936	23186348.8	19321957.33	16561677.71	14491468	12881304.89	11593174.4	10539249.45	9660978.667	8917826.462	8280838.857	7728782.933	7245734	6440652.444	6101670.737	5796587.2	4830489.333	4637269.76	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2688	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	40311896	20155948	13437298.67	10077974	8062379.2	6718649.333	5758842.286	5038987	4479099.556	4031189.6	3664717.818	3359324.667	3100915.077	2879421.143	2687459.733	2519493.5	2239549.778	2121678.737	2015594.8	1679662.333	1612475.84	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2689	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	8405495	4202747.5	2801831.667	2101373.75	1681099	1400915.833	1200785	1050686.875	933943.8889	840549.5	764135.9091	700457.9167	646576.5385	600392.5	560366.3333	525343.4375	466971.9444	442394.4737	420274.75	350228.9583	336219.8	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2690	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	10504275	5252137.5	3501425	2626068.75	2100855	1750712.5	1500610.714	1313034.375	1167141.667	1050427.5	954934.0909	875356.25	808021.1538	750305.3571	700285	656517.1875	583570.8333	552856.5789	525213.75	437678.125	420171	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2691	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	33600628	16800314	11200209.33	8400157	6720125.6	5600104.667	4800089.714	4200078.5	3733403.111	3360062.8	3054602.545	2800052.333	2584663.692	2400044.857	2240041.867	2100039.25	1866701.556	1768454.105	1680031.4	1400026.167	1344025.12	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2692	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	14306196	7153098	4768732	3576549	2861239.2	2384366	2043742.286	1788274.5	1589577.333	1430619.6	1300563.273	1192183	1100476.615	1021871.143	953746.4	894137.25	794788.6667	752957.6842	715309.8	596091.5	572247.84	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2693	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	10307352	5153676	3435784	2576838	2061470.4	1717892	1472478.857	1288419	1145261.333	1030735.2	937032	858946	792873.2308	736239.4286	687156.8	644209.5	572630.6667	542492.2105	515367.6	429473	412294.08	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2694	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	13681354	6840677	4560451.333	3420338.5	2736270.8	2280225.667	1954479.143	1710169.25	1520150.444	1368135.4	1243759.455	1140112.833	1052411.846	977239.5714	912090.2667	855084.625	760075.2222	720071.2632	684067.7	570056.4167	547254.16	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2695	CHOYP_ABCA1.2.3|m.11687	IFVGNLSWETSQK	IFVGNLSWETSQK	6797250	3398625	2265750	1699312.5	1359450	1132875	971035.7143	849656.25	755250	679725	617931.8182	566437.5	522865.3846	485517.8571	453150	424828.125	377625	357750	339862.5	283218.75	271890	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2696	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	134986464	67493232	44995488	33746616	26997292.8	22497744	19283780.57	16873308	14998496	13498646.4	12271496.73	11248872	10383574.15	9641890.286	8999097.6	8436654	7499248	7104550.737	6749323.2	5624436	5399458.56	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2697	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	89098352	44549176	29699450.67	22274588	17819670.4	14849725.33	12728336	11137294	9899816.889	8909835.2	8099850.182	7424862.667	6853719.385	6364168	5939890.133	5568647	4949908.444	4689386.947	4454917.6	3712431.333	3563934.08	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2698	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	31857708	15928854	10619236	7964427	6371541.6	5309618	4551101.143	3982213.5	3539745.333	3185770.8	2896155.273	2654809	2450592.923	2275550.571	2123847.2	1991106.75	1769872.667	1676721.474	1592885.4	1327404.5	1274308.32	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2699	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	14638319	7319159.5	4879439.667	3659579.75	2927663.8	2439719.833	2091188.429	1829789.875	1626479.889	1463831.9	1330756.273	1219859.917	1126024.538	1045594.214	975887.9333	914894.9375	813239.9444	770437.8421	731915.95	609929.9583	585532.76	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2700	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	9007061	4503530.5	3002353.667	2251765.25	1801412.2	1501176.833	1286723	1125882.625	1000784.556	900706.1	818823.7273	750588.4167	692850.8462	643361.5	600470.7333	562941.3125	500392.2778	474055.8421	450353.05	375294.2083	360282.44	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2701	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	10866675	5433337.5	3622225	2716668.75	2173335	1811112.5	1552382.143	1358334.375	1207408.333	1086667.5	987879.5455	905556.25	835898.0769	776191.0714	724445	679167.1875	603704.1667	571930.2632	543333.75	452778.125	434667	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2702	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	2462618	1231309	820872.6667	615654.5	492523.6	410436.3333	351802.5714	307827.25	273624.2222	246261.8	223874.3636	205218.1667	189432.1538	175901.2857	164174.5333	153913.625	136812.1111	129611.4737	123130.9	102609.0833	98504.72	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2703	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	2810108	1405054	936702.6667	702527	562021.6	468351.3333	401444	351263.5	312234.2222	281010.8	255464.3636	234175.6667	216162.1538	200722	187340.5333	175631.75	156117.1111	147900.4211	140505.4	117087.8333	112404.32	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2704	CHOYP_ABCA1.2.3|m.11687	VDPSLTEAEIK	VDPSLTEAEIK	804931	402465.5	268310.3333	201232.75	160986.2	134155.1667	114990.1429	100616.375	89436.77778	80493.1	73175.54545	67077.58333	61917.76923	57495.07143	53662.06667	50308.1875	44718.38889	42364.78947	40246.55	33538.79167	32197.24	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2705	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2706	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2707	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	13789097	6894548.5	4596365.667	3447274.25	2757819.4	2298182.833	1969871	1723637.125	1532121.889	1378909.7	1253554.273	1149091.417	1060699.769	984935.5	919273.1333	861818.5625	766060.9444	725741.9474	689454.85	574545.7083	551563.88	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2708	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	4483691	2241845.5	1494563.667	1120922.75	896738.2	747281.8333	640527.2857	560461.375	498187.8889	448369.1	407608.2727	373640.9167	344899.3077	320263.6429	298912.7333	280230.6875	249093.9444	235983.7368	224184.55	186820.4583	179347.64	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2709	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	5712419	2856209.5	1904139.667	1428104.75	1142483.8	952069.8333	816059.8571	714052.375	634713.2222	571241.9	519310.8182	476034.9167	439416.8462	408029.9286	380827.9333	357026.1875	317356.6111	300653.6316	285620.95	238017.4583	228496.76	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2710	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	2696962	1348481	898987.3333	674240.5	539392.4	449493.6667	385280.2857	337120.25	299662.4444	269696.2	245178.3636	224746.8333	207458.6154	192640.1429	179797.4667	168560.125	149831.2222	141945.3684	134848.1	112373.4167	107878.48	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2711	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	2388219	1194109.5	796073	597054.75	477643.8	398036.5	341174.1429	298527.375	265357.6667	238821.9	217110.8182	199018.25	183709.1538	170587.0714	159214.6	149263.6875	132678.8333	125695.7368	119410.95	99509.125	95528.76	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2712	CHOYP_ABCA1.2.3|m.11687	EYFETFGEVK	EYFETFGEVK	343584	171792	114528	85896	68716.8	57264	49083.42857	42948	38176	34358.4	31234.90909	28632	26429.53846	24541.71429	22905.6	21474	19088	18083.36842	17179.2	14316	13743.36	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2713	CHOYP_ABCA1.2.3|m.11687	ITDQAVHK	ITDQAVHK	58027660	29013830	19342553.33	14506915	11605532	9671276.667	8289665.714	7253457.5	6447517.778	5802766	5275241.818	4835638.333	4463666.154	4144832.857	3868510.667	3626728.75	3223758.889	3054087.368	2901383	2417819.167	2321106.4	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2714	CHOYP_ABCA1.2.3|m.11687	ITDQAVHK	ITDQAVHK	28425522	14212761	9475174	7106380.5	5685104.4	4737587	4060788.857	3553190.25	3158391.333	2842552.2	2584138.364	2368793.5	2186578.615	2030394.429	1895034.8	1776595.125	1579195.667	1496080.105	1421276.1	1184396.75	1137020.88	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2715	CHOYP_ABCA1.2.3|m.11687	ITDQAVHK	ITDQAVHK	8268888	4134444	2756296	2067222	1653777.6	1378148	1181269.714	1033611	918765.3333	826888.8	751717.0909	689074	636068.3077	590634.8571	551259.2	516805.5	459382.6667	435204.6316	413444.4	344537	330755.52	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2716	CHOYP_ABCA1.2.3|m.11687	ITDQAVHK	ITDQAVHK	2334283	1167141.5	778094.3333	583570.75	466856.6	389047.1667	333469	291785.375	259364.7778	233428.3	212207.5455	194523.5833	179560.2308	166734.5	155618.8667	145892.6875	129682.3889	122857	116714.15	97261.79167	93371.32	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2717	CHOYP_ABCA1.2.3|m.11687	ITDQAVHK	ITDQAVHK	1531463	765731.5	510487.6667	382865.75	306292.6	255243.8333	218780.4286	191432.875	170162.5556	153146.3	139223.9091	127621.9167	117804.8462	109390.2143	102097.5333	95716.4375	85081.27778	80603.31579	76573.15	63810.95833	61258.52	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
2718	CHOYP_ABCA1.2.3|m.11687	ITDQAVHK	ITDQAVHK	1281097	640548.5	427032.3333	320274.25	256219.4	213516.1667	183013.8571	160137.125	142344.1111	128109.7	116463.3636	106758.0833	98545.92308	91506.92857	85406.46667	80068.5625	71172.05556	67426.15789	64054.85	53379.04167	51243.88	P41233	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	"cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]"	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397
12290	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	2410709	1205354.5	803569.6667	602677.25	482141.8	401784.8333	344387	301338.625	267856.5556	241070.9	219155.3636	200892.4167	185439.1538	172193.5	160713.9333	150669.3125	133928.2778	126879.4211	120535.45	100446.2083	96428.36	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12291	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	1530272	765136	510090.6667	382568	306054.4	255045.3333	218610.2857	191284	170030.2222	153027.2	139115.6364	127522.6667	117713.2308	109305.1429	102018.1333	95642	85015.11111	80540.63158	76513.6	63761.33333	61210.88	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12292	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	166323	83161.5	55441	41580.75	33264.6	27720.5	23760.42857	20790.375	18480.33333	16632.3	15120.27273	13860.25	12794.07692	11880.21429	11088.2	10395.1875	9240.166667	8753.842105	8316.15	6930.125	6652.92	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12293	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	493773	246886.5	164591	123443.25	98754.6	82295.5	70539	61721.625	54863.66667	49377.3	44888.45455	41147.75	37982.53846	35269.5	32918.2	30860.8125	27431.83333	25988.05263	24688.65	20573.875	19750.92	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12294	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	401262	200631	133754	100315.5	80252.4	66877	57323.14286	50157.75	44584.66667	40126.2	36478.36364	33438.5	30866.30769	28661.57143	26750.8	25078.875	22292.33333	21119.05263	20063.1	16719.25	16050.48	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12295	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	171878	85939	57292.66667	42969.5	34375.6	28646.33333	24554	21484.75	19097.55556	17187.8	15625.27273	14323.16667	13221.38462	12277	11458.53333	10742.375	9548.777778	9046.210526	8593.9	7161.583333	6875.12	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12296	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12297	CHOYP_AKT1.1.2|m.23291	EEMYYGASTK	EEMYYGASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12298	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	27067092	13533546	9022364	6766773	5413418.4	4511182	3866727.429	3383386.5	3007454.667	2706709.2	2460644.727	2255591	2082084	1933363.714	1804472.8	1691693.25	1503727.333	1424583.789	1353354.6	1127795.5	1082683.68	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12299	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	15552334	7776167	5184111.333	3888083.5	3110466.8	2592055.667	2221762	1944041.75	1728037.111	1555233.4	1413848.545	1296027.833	1196333.385	1110881	1036822.267	972020.875	864018.5556	818543.8947	777616.7	648013.9167	622093.36	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12300	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	2602408	1301204	867469.3333	650602	520481.6	433734.6667	371772.5714	325301	289156.4444	260240.8	236582.5455	216867.3333	200185.2308	185886.2857	173493.8667	162650.5	144578.2222	136968.8421	130120.4	108433.6667	104096.32	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12301	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12302	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12303	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12304	CHOYP_AKT1.1.2|m.23291	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12305	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12306	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12307	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12308	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	352202	176101	117400.6667	88050.5	70440.4	58700.33333	50314.57143	44025.25	39133.55556	35220.2	32018.36364	29350.16667	27092.46154	25157.28571	23480.13333	22012.625	19566.77778	18536.94737	17610.1	14675.08333	14088.08	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12309	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	245058	122529	81686	61264.5	49011.6	40843	35008.28571	30632.25	27228.66667	24505.8	22278	20421.5	18850.61538	17504.14286	16337.2	15316.125	13614.33333	12897.78947	12252.9	10210.75	9802.32	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12310	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	250403	125201.5	83467.66667	62600.75	50080.6	41733.83333	35771.85714	31300.375	27822.55556	25040.3	22763.90909	20866.91667	19261.76923	17885.92857	16693.53333	15650.1875	13911.27778	13179.10526	12520.15	10433.45833	10016.12	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12311	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12312	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12313	CHOYP_AKT1.2.2|m.51125	VTEEEGGLLEK	VTEEEGGLLEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12314	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	2165438	1082719	721812.6667	541359.5	433087.6	360906.3333	309348.2857	270679.75	240604.2222	216543.8	196858	180453.1667	166572.1538	154674.1429	144362.5333	135339.875	120302.1111	113970.4211	108271.9	90226.58333	86617.52	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12315	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	1552479	776239.5	517493	388119.75	310495.8	258746.5	221782.7143	194059.875	172497.6667	155247.9	141134.4545	129373.25	119421.4615	110891.3571	103498.6	97029.9375	86248.83333	81709.42105	77623.95	64686.625	62099.16	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12316	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	1086951	543475.5	362317	271737.75	217390.2	181158.5	155278.7143	135868.875	120772.3333	108695.1	98813.72727	90579.25	83611.61538	77639.35714	72463.4	67934.4375	60386.16667	57207.94737	54347.55	45289.625	43478.04	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12317	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	218444	109222	72814.66667	54611	43688.8	36407.33333	31206.28571	27305.5	24271.55556	21844.4	19858.54545	18203.66667	16803.38462	15603.14286	14562.93333	13652.75	12135.77778	11497.05263	10922.2	9101.833333	8737.76	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12318	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	119380	59690	39793.33333	29845	23876	19896.66667	17054.28571	14922.5	13264.44444	11938	10852.72727	9948.333333	9183.076923	8527.142857	7958.666667	7461.25	6632.222222	6283.157895	5969	4974.166667	4775.2	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12319	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	17779	8889.5	5926.333333	4444.75	3555.8	2963.166667	2539.857143	2222.375	1975.444444	1777.9	1616.272727	1481.583333	1367.615385	1269.928571	1185.266667	1111.1875	987.7222222	935.7368421	888.95	740.7916667	711.16	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12320	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12321	CHOYP_AKT1.2.2|m.51125	VSLDDFEFLK	VSLDDFEFLK	42222	21111	14074	10555.5	8444.4	7037	6031.714286	5277.75	4691.333333	4222.2	3838.363636	3518.5	3247.846154	3015.857143	2814.8	2638.875	2345.666667	2222.210526	2111.1	1759.25	1688.88	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12322	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	2410709	1205354.5	803569.6667	602677.25	482141.8	401784.8333	344387	301338.625	267856.5556	241070.9	219155.3636	200892.4167	185439.1538	172193.5	160713.9333	150669.3125	133928.2778	126879.4211	120535.45	100446.2083	96428.36	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12323	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	1530272	765136	510090.6667	382568	306054.4	255045.3333	218610.2857	191284	170030.2222	153027.2	139115.6364	127522.6667	117713.2308	109305.1429	102018.1333	95642	85015.11111	80540.63158	76513.6	63761.33333	61210.88	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12324	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	166323	83161.5	55441	41580.75	33264.6	27720.5	23760.42857	20790.375	18480.33333	16632.3	15120.27273	13860.25	12794.07692	11880.21429	11088.2	10395.1875	9240.166667	8753.842105	8316.15	6930.125	6652.92	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12325	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	493773	246886.5	164591	123443.25	98754.6	82295.5	70539	61721.625	54863.66667	49377.3	44888.45455	41147.75	37982.53846	35269.5	32918.2	30860.8125	27431.83333	25988.05263	24688.65	20573.875	19750.92	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12326	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	401262	200631	133754	100315.5	80252.4	66877	57323.14286	50157.75	44584.66667	40126.2	36478.36364	33438.5	30866.30769	28661.57143	26750.8	25078.875	22292.33333	21119.05263	20063.1	16719.25	16050.48	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12327	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	171878	85939	57292.66667	42969.5	34375.6	28646.33333	24554	21484.75	19097.55556	17187.8	15625.27273	14323.16667	13221.38462	12277	11458.53333	10742.375	9548.777778	9046.210526	8593.9	7161.583333	6875.12	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12328	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12329	CHOYP_AKT1.2.2|m.51125	EEMYYGASTK	EEMYYGASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12330	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	27067092	13533546	9022364	6766773	5413418.4	4511182	3866727.429	3383386.5	3007454.667	2706709.2	2460644.727	2255591	2082084	1933363.714	1804472.8	1691693.25	1503727.333	1424583.789	1353354.6	1127795.5	1082683.68	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12331	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	15552334	7776167	5184111.333	3888083.5	3110466.8	2592055.667	2221762	1944041.75	1728037.111	1555233.4	1413848.545	1296027.833	1196333.385	1110881	1036822.267	972020.875	864018.5556	818543.8947	777616.7	648013.9167	622093.36	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12332	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	2602408	1301204	867469.3333	650602	520481.6	433734.6667	371772.5714	325301	289156.4444	260240.8	236582.5455	216867.3333	200185.2308	185886.2857	173493.8667	162650.5	144578.2222	136968.8421	130120.4	108433.6667	104096.32	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12333	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12334	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12335	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
12336	CHOYP_AKT1.2.2|m.51125	VIVAHPFFK	VIVAHPFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8INB9	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	"apoptotic process [GO:0006915]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]; regulation of glucose metabolic process [GO:0010906]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein import into nucleus [GO:0042306]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]"	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008286; GO:0008360; GO:0008361; GO:0008362; GO:0009986; GO:0010906; GO:0018105; GO:0019915; GO:0030307; GO:0031104; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042306; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046620; GO:0046622; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215
16668	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16669	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	45367320	22683660	15122440	11341830	9073464	7561220	6481045.714	5670915	5040813.333	4536732	4124301.818	3780610	3489793.846	3240522.857	3024488	2835457.5	2520406.667	2387753.684	2268366	1890305	1814692.8	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16670	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	14095442	7047721	4698480.667	3523860.5	2819088.4	2349240.333	2013634.571	1761930.25	1566160.222	1409544.2	1281403.818	1174620.167	1084264.769	1006817.286	939696.1333	880965.125	783080.1111	741865.3684	704772.1	587310.0833	563817.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16671	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	1261852	630926	420617.3333	315463	252370.4	210308.6667	180264.5714	157731.5	140205.7778	126185.2	114713.8182	105154.3333	97065.53846	90132.28571	84123.46667	78865.75	70102.88889	66413.26316	63092.6	52577.16667	50474.08	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16672	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	449337	224668.5	149779	112334.25	89867.4	74889.5	64191	56167.125	49926.33333	44933.7	40848.81818	37444.75	34564.38462	32095.5	29955.8	28083.5625	24963.16667	23649.31579	22466.85	18722.375	17973.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16673	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	414457	207228.5	138152.3333	103614.25	82891.4	69076.16667	59208.14286	51807.125	46050.77778	41445.7	37677.90909	34538.08333	31881.30769	29604.07143	27630.46667	25903.5625	23025.38889	21813.52632	20722.85	17269.04167	16578.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16674	CHOYP_ANXA4.2.2|m.57444	AIIDVLAHR	AIIDVLAHR	96184	48092	32061.33333	24046	19236.8	16030.66667	13740.57143	12023	10687.11111	9618.4	8744	8015.333333	7398.769231	6870.285714	6412.266667	6011.5	5343.555556	5062.315789	4809.2	4007.666667	3847.36	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16675	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16676	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16677	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16678	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	1315751	657875.5	438583.6667	328937.75	263150.2	219291.8333	187964.4286	164468.875	146194.5556	131575.1	119613.7273	109645.9167	101211.6154	93982.21429	87716.73333	82234.4375	73097.27778	69250.05263	65787.55	54822.95833	52630.04	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16679	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	523636	261818	174545.3333	130909	104727.2	87272.66667	74805.14286	65454.5	58181.77778	52363.6	47603.27273	43636.33333	40279.69231	37402.57143	34909.06667	32727.25	29090.88889	27559.78947	26181.8	21818.16667	20945.44	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16680	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	429354	214677	143118	107338.5	85870.8	71559	61336.28571	53669.25	47706	42935.4	39032.18182	35779.5	33027.23077	30668.14286	28623.6	26834.625	23853	22597.57895	21467.7	17889.75	17174.16	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16681	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	337302	168651	112434	84325.5	67460.4	56217	48186	42162.75	37478	33730.2	30663.81818	28108.5	25946.30769	24093	22486.8	21081.375	18739	17752.73684	16865.1	14054.25	13492.08	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16682	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	190770	95385	63590	47692.5	38154	31795	27252.85714	23846.25	21196.66667	19077	17342.72727	15897.5	14674.61538	13626.42857	12718	11923.125	10598.33333	10040.52632	9538.5	7948.75	7630.8	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16683	CHOYP_ANXA4.2.2|m.57444	DIESDTSGHFK	DIESDTSGHFK	146967	73483.5	48989	36741.75	29393.4	24494.5	20995.28571	18370.875	16329.66667	14696.7	13360.63636	12247.25	11305.15385	10497.64286	9797.8	9185.4375	8164.833333	7735.105263	7348.35	6123.625	5878.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16765	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	28757988	14378994	9585996	7189497	5751597.6	4792998	4108284	3594748.5	3195332	2875798.8	2614362.545	2396499	2212152.923	2054142	1917199.2	1797374.25	1597666	1513578.316	1437899.4	1198249.5	1150319.52	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16766	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	19945688	9972844	6648562.667	4986422	3989137.6	3324281.333	2849384	2493211	2216187.556	1994568.8	1813244.364	1662140.667	1534283.692	1424692	1329712.533	1246605.5	1108093.778	1049773.053	997284.4	831070.3333	797827.52	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16767	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	6036937	3018468.5	2012312.333	1509234.25	1207387.4	1006156.167	862419.5714	754617.125	670770.7778	603693.7	548812.4545	503078.0833	464379.7692	431209.7857	402462.4667	377308.5625	335385.3889	317733.5263	301846.85	251539.0417	241477.48	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16768	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	969710	484855	323236.6667	242427.5	193942	161618.3333	138530	121213.75	107745.5556	96971	88155.45455	80809.16667	74593.07692	69265	64647.33333	60606.875	53872.77778	51037.36842	48485.5	40404.58333	38788.4	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16769	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	3019345	1509672.5	1006448.333	754836.25	603869	503224.1667	431335	377418.125	335482.7778	301934.5	274485.9091	251612.0833	232257.3077	215667.5	201289.6667	188709.0625	167741.3889	158912.8947	150967.25	125806.0417	120773.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16770	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	3119762	1559881	1039920.667	779940.5	623952.4	519960.3333	445680.2857	389970.25	346640.2222	311976.2	283614.7273	259980.1667	239981.6923	222840.1429	207984.1333	194985.125	173320.1111	164198	155988.1	129990.0833	124790.48	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16771	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	1050714	525357	350238	262678.5	210142.8	175119	150102	131339.25	116746	105071.4	95519.45455	87559.5	80824.15385	75051	70047.6	65669.625	58373	55300.73684	52535.7	43779.75	42028.56	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16772	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16773	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	663967	331983.5	221322.3333	165991.75	132793.4	110661.1667	94852.42857	82995.875	73774.11111	66396.7	60360.63636	55330.58333	51074.38462	47426.21429	44264.46667	41497.9375	36887.05556	34945.63158	33198.35	27665.29167	26558.68	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16774	CHOYP_ANXA7.1.4|m.4514	AIIQVIGHTSNK	AIIQVIGHTSNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16775	CHOYP_ANXA7.1.4|m.4514	TELTDSQR	TELTDSQR	8804121	4402060.5	2934707	2201030.25	1760824.2	1467353.5	1257731.571	1100515.125	978235.6667	880412.1	800374.6364	733676.75	677240.0769	628865.7857	586941.4	550257.5625	489117.8333	463374.7895	440206.05	366838.375	352164.84	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16776	CHOYP_ANXA7.1.4|m.4514	TELTDSQR	TELTDSQR	3304364	1652182	1101454.667	826091	660872.8	550727.3333	472052	413045.5	367151.5556	330436.4	300396.7273	275363.6667	254181.8462	236026	220290.9333	206522.75	183575.7778	173913.8947	165218.2	137681.8333	132174.56	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16777	CHOYP_ANXA7.1.4|m.4514	TELTDSQR	TELTDSQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16778	CHOYP_ANXA7.1.4|m.4514	TELTDSQR	TELTDSQR	825110	412555	275036.6667	206277.5	165022	137518.3333	117872.8571	103138.75	91678.88889	82511	75010	68759.16667	63470	58936.42857	55007.33333	51569.375	45839.44444	43426.84211	41255.5	34379.58333	33004.4	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16779	CHOYP_ANXA7.1.4|m.4514	TELTDSQR	TELTDSQR	211565	105782.5	70521.66667	52891.25	42313	35260.83333	30223.57143	26445.625	23507.22222	21156.5	19233.18182	17630.41667	16274.23077	15111.78571	14104.33333	13222.8125	11753.61111	11135	10578.25	8815.208333	8462.6	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16780	CHOYP_ANXA7.1.4|m.4514	TELTDSQR	TELTDSQR	387408	193704	129136	96852	77481.6	64568	55344	48426	43045.33333	38740.8	35218.90909	32284	29800.61538	27672	25827.2	24213	21522.66667	20389.89474	19370.4	16142	15496.32	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16781	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	20202574	10101287	6734191.333	5050643.5	4040514.8	3367095.667	2886082	2525321.75	2244730.444	2020257.4	1836597.636	1683547.833	1554044.154	1443041	1346838.267	1262660.875	1122365.222	1063293.368	1010128.7	841773.9167	808102.96	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16782	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	13987903	6993951.5	4662634.333	3496975.75	2797580.6	2331317.167	1998271.857	1748487.875	1554211.444	1398790.3	1271627.545	1165658.583	1075992.538	999135.9286	932526.8667	874243.9375	777105.7222	736205.4211	699395.15	582829.2917	559516.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16783	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	6344799	3172399.5	2114933	1586199.75	1268959.8	1057466.5	906399.8571	793099.875	704977.6667	634479.9	576799.9091	528733.25	488061.4615	453199.9286	422986.6	396549.9375	352488.8333	333936.7895	317239.95	264366.625	253791.96	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16784	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	406713	203356.5	135571	101678.25	81342.6	67785.5	58101.85714	50839.125	45190.33333	40671.3	36973.90909	33892.75	31285.61538	29050.92857	27114.2	25419.5625	22595.16667	21405.94737	20335.65	16946.375	16268.52	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16785	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	2578601	1289300.5	859533.6667	644650.25	515720.2	429766.8333	368371.5714	322325.125	286511.2222	257860.1	234418.2727	214883.4167	198353.9231	184185.7857	171906.7333	161162.5625	143255.6111	135715.8421	128930.05	107441.7083	103144.04	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16786	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	2350171	1175085.5	783390.3333	587542.75	470034.2	391695.1667	335738.7143	293771.375	261130.1111	235017.1	213651.9091	195847.5833	180782.3846	167869.3571	156678.0667	146885.6875	130565.0556	123693.2105	117508.55	97923.79167	94006.84	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16787	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	1041803	520901.5	347267.6667	260450.75	208360.6	173633.8333	148829	130225.375	115755.8889	104180.3	94709.36364	86816.91667	80138.69231	74414.5	69453.53333	65112.6875	57877.94444	54831.73684	52090.15	43408.45833	41672.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16788	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	245795	122897.5	81931.66667	61448.75	49159	40965.83333	35113.57143	30724.375	27310.55556	24579.5	22345	20482.91667	18907.30769	17556.78571	16386.33333	15362.1875	13655.27778	12936.57895	12289.75	10241.45833	9831.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16789	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	527456	263728	175818.6667	131864	105491.2	87909.33333	75350.85714	65932	58606.22222	52745.6	47950.54545	43954.66667	40573.53846	37675.42857	35163.73333	32966	29303.11111	27760.84211	26372.8	21977.33333	21098.24	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16790	CHOYP_ANXA7.1.4|m.4514	ALAQQDAQTLYK	ALAQQDAQTLYK	307709	153854.5	102569.6667	76927.25	61541.8	51284.83333	43958.42857	38463.625	34189.88889	30770.9	27973.54545	25642.41667	23669.92308	21979.21429	20513.93333	19231.8125	17094.94444	16195.21053	15385.45	12821.20833	12308.36	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16791	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	1602853	801426.5	534284.3333	400713.25	320570.6	267142.1667	228979	200356.625	178094.7778	160285.3	145713.9091	133571.0833	123296.3846	114489.5	106856.8667	100178.3125	89047.38889	84360.68421	80142.65	66785.54167	64114.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16792	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16793	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	483070	241535	161023.3333	120767.5	96614	80511.66667	69010	60383.75	53674.44444	48307	43915.45455	40255.83333	37159.23077	34505	32204.66667	30191.875	26837.22222	25424.73684	24153.5	20127.91667	19322.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16794	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16795	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	28456	14228	9485.333333	7114	5691.2	4742.666667	4065.142857	3557	3161.777778	2845.6	2586.909091	2371.333333	2188.923077	2032.571429	1897.066667	1778.5	1580.888889	1497.684211	1422.8	1185.666667	1138.24	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16796	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16797	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16798	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	164348	82174	54782.66667	41087	32869.6	27391.33333	23478.28571	20543.5	18260.88889	16434.8	14940.72727	13695.66667	12642.15385	11739.14286	10956.53333	10271.75	9130.444444	8649.894737	8217.4	6847.833333	6573.92	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16799	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	209900	104950	69966.66667	52475	41980	34983.33333	29985.71429	26237.5	23322.22222	20990	19081.81818	17491.66667	16146.15385	14992.85714	13993.33333	13118.75	11661.11111	11047.36842	10495	8745.833333	8396	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16800	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	269125	134562.5	89708.33333	67281.25	53825	44854.16667	38446.42857	33640.625	29902.77778	26912.5	24465.90909	22427.08333	20701.92308	19223.21429	17941.66667	16820.3125	14951.38889	14164.47368	13456.25	11213.54167	10765	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16801	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16802	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	9627	4813.5	3209	2406.75	1925.4	1604.5	1375.285714	1203.375	1069.666667	962.7	875.1818182	802.25	740.5384615	687.6428571	641.8	601.6875	534.8333333	506.6842105	481.35	401.125	385.08	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16803	CHOYP_ANXA7.1.4|m.4514	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16804	CHOYP_ANXA7.1.4|m.4514	ATFEEYQK	ATFEEYQK	8176207	4088103.5	2725402.333	2044051.75	1635241.4	1362701.167	1168029.571	1022025.875	908467.4444	817620.7	743291.5455	681350.5833	628939	584014.7857	545080.4667	511012.9375	454233.7222	430326.6842	408810.35	340675.2917	327048.28	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16805	CHOYP_ANXA7.1.4|m.4514	ATFEEYQK	ATFEEYQK	4709754	2354877	1569918	1177438.5	941950.8	784959	672822	588719.25	523306	470975.4	428159.4545	392479.5	362288.7692	336411	313983.6	294359.625	261653	247881.7895	235487.7	196239.75	188390.16	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16806	CHOYP_ANXA7.1.4|m.4514	ATFEEYQK	ATFEEYQK	662203	331101.5	220734.3333	165550.75	132440.6	110367.1667	94600.42857	82775.375	73578.11111	66220.3	60200.27273	55183.58333	50938.69231	47300.21429	44146.86667	41387.6875	36789.05556	34852.78947	33110.15	27591.79167	26488.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16807	CHOYP_ANXA7.1.4|m.4514	ATFEEYQK	ATFEEYQK	1016964	508482	338988	254241	203392.8	169494	145280.5714	127120.5	112996	101696.4	92451.27273	84747	78228	72640.28571	67797.6	63560.25	56498	53524.42105	50848.2	42373.5	40678.56	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16808	CHOYP_ANXA7.1.4|m.4514	ATFEEYQK	ATFEEYQK	619494	309747	206498	154873.5	123898.8	103249	88499.14286	77436.75	68832.66667	61949.4	56317.63636	51624.5	47653.38462	44249.57143	41299.6	38718.375	34416.33333	32604.94737	30974.7	25812.25	24779.76	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16809	CHOYP_ANXA7.1.4|m.4514	ATFEEYQK	ATFEEYQK	308752	154376	102917.3333	77188	61750.4	51458.66667	44107.42857	38594	34305.77778	30875.2	28068.36364	25729.33333	23750.15385	22053.71429	20583.46667	19297	17152.88889	16250.10526	15437.6	12864.66667	12350.08	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16810	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16811	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16812	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16813	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16814	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16815	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16816	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16817	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16818	CHOYP_ANXA7.1.4|m.4514	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16819	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16820	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16821	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16822	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16823	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	52882	26441	17627.33333	13220.5	10576.4	8813.666667	7554.571429	6610.25	5875.777778	5288.2	4807.454545	4406.833333	4067.846154	3777.285714	3525.466667	3305.125	2937.888889	2783.263158	2644.1	2203.416667	2115.28	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16824	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16825	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16826	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16827	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16828	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16829	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16830	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	20295	10147.5	6765	5073.75	4059	3382.5	2899.285714	2536.875	2255	2029.5	1845	1691.25	1561.153846	1449.642857	1353	1268.4375	1127.5	1068.157895	1014.75	845.625	811.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16831	CHOYP_ANXA7.1.4|m.4514	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16856	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	3458168	1729084	1152722.667	864542	691633.6	576361.3333	494024	432271	384240.8889	345816.8	314378.9091	288180.6667	266012.9231	247012	230544.5333	216135.5	192120.4444	182008.8421	172908.4	144090.3333	138326.72	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16857	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16858	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	1389762	694881	463254	347440.5	277952.4	231627	198537.4286	173720.25	154418	138976.2	126342	115813.5	106904.7692	99268.71429	92650.8	86860.125	77209	73145.36842	69488.1	57906.75	55590.48	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16859	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16860	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	265769	132884.5	88589.66667	66442.25	53153.8	44294.83333	37967	33221.125	29529.88889	26576.9	24160.81818	22147.41667	20443.76923	18983.5	17717.93333	16610.5625	14764.94444	13987.84211	13288.45	11073.70833	10630.76	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16861	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16862	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	687216	343608	229072	171804	137443.2	114536	98173.71429	85902	76357.33333	68721.6	62474.18182	57268	52862.76923	49086.85714	45814.4	42951	38178.66667	36169.26316	34360.8	28634	27488.64	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16863	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	348166	174083	116055.3333	87041.5	69633.2	58027.66667	49738	43520.75	38685.11111	34816.6	31651.45455	29013.83333	26782	24869	23211.06667	21760.375	19342.55556	18324.52632	17408.3	14506.91667	13926.64	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16864	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	393979	196989.5	131326.3333	98494.75	78795.8	65663.16667	56282.71429	49247.375	43775.44444	39397.9	35816.27273	32831.58333	30306.07692	28141.35714	26265.26667	24623.6875	21887.72222	20735.73684	19698.95	16415.79167	15759.16	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16865	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	1151968	575984	383989.3333	287992	230393.6	191994.6667	164566.8571	143996	127996.4444	115196.8	104724.3636	95997.33333	88612.92308	82283.42857	76797.86667	71998	63998.22222	60629.89474	57598.4	47998.66667	46078.72	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16866	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	537832	268916	179277.3333	134458	107566.4	89638.66667	76833.14286	67229	59759.11111	53783.2	48893.81818	44819.33333	41371.69231	38416.57143	35855.46667	33614.5	29879.55556	28306.94737	26891.6	22409.66667	21513.28	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16867	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	245434	122717	81811.33333	61358.5	49086.8	40905.66667	35062	30679.25	27270.44444	24543.4	22312.18182	20452.83333	18879.53846	17531	16362.26667	15339.625	13635.22222	12917.57895	12271.7	10226.41667	9817.36	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16868	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	483443	241721.5	161147.6667	120860.75	96688.6	80573.83333	69063.28571	60430.375	53715.88889	48344.3	43949.36364	40286.91667	37187.92308	34531.64286	32229.53333	30215.1875	26857.94444	25444.36842	24172.15	20143.45833	19337.72	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16869	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	272444	136222	90814.66667	68111	54488.8	45407.33333	38920.57143	34055.5	30271.55556	27244.4	24767.63636	22703.66667	20957.23077	19460.28571	18162.93333	17027.75	15135.77778	14339.15789	13622.2	11351.83333	10897.76	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16870	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	5671163	2835581.5	1890387.667	1417790.75	1134232.6	945193.8333	810166.1429	708895.375	630129.2222	567116.3	515560.2727	472596.9167	436243.3077	405083.0714	378077.5333	354447.6875	315064.6111	298482.2632	283558.15	236298.4583	226846.52	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16871	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	4952775	2476387.5	1650925	1238193.75	990555	825462.5	707539.2857	619096.875	550308.3333	495277.5	450252.2727	412731.25	380982.6923	353769.6429	330185	309548.4375	275154.1667	260672.3684	247638.75	206365.625	198111	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16872	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16873	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16874	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16875	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16876	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16877	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	23298	11649	7766	5824.5	4659.6	3883	3328.285714	2912.25	2588.666667	2329.8	2118	1941.5	1792.153846	1664.142857	1553.2	1456.125	1294.333333	1226.210526	1164.9	970.75	931.92	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16878	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16879	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	673847	336923.5	224615.6667	168461.75	134769.4	112307.8333	96263.85714	84230.875	74871.88889	67384.7	61258.81818	56153.91667	51834.38462	48131.92857	44923.13333	42115.4375	37435.94444	35465.63158	33692.35	28076.95833	26953.88	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16880	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16881	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	269178	134589	89726	67294.5	53835.6	44863	38454	33647.25	29908.66667	26917.8	24470.72727	22431.5	20706	19227	17945.2	16823.625	14954.33333	14167.26316	13458.9	11215.75	10767.12	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16882	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	292691	146345.5	97563.66667	73172.75	58538.2	48781.83333	41813	36586.375	32521.22222	29269.1	26608.27273	24390.91667	22514.69231	20906.5	19512.73333	18293.1875	16260.61111	15404.78947	14634.55	12195.45833	11707.64	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16883	CHOYP_ANXA7.2.4|m.30574	GLGTNEDAITHVITTR	GLGTNEDAITHVITTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16884	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	22218928	11109464	7406309.333	5554732	4443785.6	3703154.667	3174132.571	2777366	2468769.778	2221892.8	2019902.545	1851577.333	1709148.308	1587066.286	1481261.867	1388683	1234384.889	1169417.263	1110946.4	925788.6667	888757.12	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16885	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16886	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	5613485	2806742.5	1871161.667	1403371.25	1122697	935580.8333	801926.4286	701685.625	623720.5556	561348.5	510316.8182	467790.4167	431806.5385	400963.2143	374232.3333	350842.8125	311860.2778	295446.5789	280674.25	233895.2083	224539.4	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16887	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	4921643	2460821.5	1640547.667	1230410.75	984328.6	820273.8333	703091.8571	615205.375	546849.2222	492164.3	447422.0909	410136.9167	378587.9231	351545.9286	328109.5333	307602.6875	273424.6111	259033.8421	246082.15	205068.4583	196865.72	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16888	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	2133237	1066618.5	711079	533309.25	426647.4	355539.5	304748.1429	266654.625	237026.3333	213323.7	193930.6364	177769.75	164095.1538	152374.0714	142215.8	133327.3125	118513.1667	112275.6316	106661.85	88884.875	85329.48	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16889	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	1115157	557578.5	371719	278789.25	223031.4	185859.5	159308.1429	139394.625	123906.3333	111515.7	101377.9091	92929.75	85781.30769	79654.07143	74343.8	69697.3125	61953.16667	58692.47368	55757.85	46464.875	44606.28	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16890	CHOYP_ANXA7.2.4|m.30574	AEIDMVQIK	AEIDMVQIK	892060	446030	297353.3333	223015	178412	148676.6667	127437.1429	111507.5	99117.77778	89206	81096.36364	74338.33333	68620	63718.57143	59470.66667	55753.75	49558.88889	46950.52632	44603	37169.16667	35682.4	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16891	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	28757988	14378994	9585996	7189497	5751597.6	4792998	4108284	3594748.5	3195332	2875798.8	2614362.545	2396499	2212152.923	2054142	1917199.2	1797374.25	1597666	1513578.316	1437899.4	1198249.5	1150319.52	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16892	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	19945688	9972844	6648562.667	4986422	3989137.6	3324281.333	2849384	2493211	2216187.556	1994568.8	1813244.364	1662140.667	1534283.692	1424692	1329712.533	1246605.5	1108093.778	1049773.053	997284.4	831070.3333	797827.52	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16893	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	6036937	3018468.5	2012312.333	1509234.25	1207387.4	1006156.167	862419.5714	754617.125	670770.7778	603693.7	548812.4545	503078.0833	464379.7692	431209.7857	402462.4667	377308.5625	335385.3889	317733.5263	301846.85	251539.0417	241477.48	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16894	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	969710	484855	323236.6667	242427.5	193942	161618.3333	138530	121213.75	107745.5556	96971	88155.45455	80809.16667	74593.07692	69265	64647.33333	60606.875	53872.77778	51037.36842	48485.5	40404.58333	38788.4	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16895	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	3019345	1509672.5	1006448.333	754836.25	603869	503224.1667	431335	377418.125	335482.7778	301934.5	274485.9091	251612.0833	232257.3077	215667.5	201289.6667	188709.0625	167741.3889	158912.8947	150967.25	125806.0417	120773.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16896	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	3119762	1559881	1039920.667	779940.5	623952.4	519960.3333	445680.2857	389970.25	346640.2222	311976.2	283614.7273	259980.1667	239981.6923	222840.1429	207984.1333	194985.125	173320.1111	164198	155988.1	129990.0833	124790.48	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16897	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	1050714	525357	350238	262678.5	210142.8	175119	150102	131339.25	116746	105071.4	95519.45455	87559.5	80824.15385	75051	70047.6	65669.625	58373	55300.73684	52535.7	43779.75	42028.56	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16898	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16899	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	663967	331983.5	221322.3333	165991.75	132793.4	110661.1667	94852.42857	82995.875	73774.11111	66396.7	60360.63636	55330.58333	51074.38462	47426.21429	44264.46667	41497.9375	36887.05556	34945.63158	33198.35	27665.29167	26558.68	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16900	CHOYP_ANXA7.3.4|m.48325	AIIQVIGHTSNK	AIIQVIGHTSNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16901	CHOYP_ANXA7.3.4|m.48325	TELTDSQR	TELTDSQR	8804121	4402060.5	2934707	2201030.25	1760824.2	1467353.5	1257731.571	1100515.125	978235.6667	880412.1	800374.6364	733676.75	677240.0769	628865.7857	586941.4	550257.5625	489117.8333	463374.7895	440206.05	366838.375	352164.84	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16902	CHOYP_ANXA7.3.4|m.48325	TELTDSQR	TELTDSQR	3304364	1652182	1101454.667	826091	660872.8	550727.3333	472052	413045.5	367151.5556	330436.4	300396.7273	275363.6667	254181.8462	236026	220290.9333	206522.75	183575.7778	173913.8947	165218.2	137681.8333	132174.56	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16903	CHOYP_ANXA7.3.4|m.48325	TELTDSQR	TELTDSQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16904	CHOYP_ANXA7.3.4|m.48325	TELTDSQR	TELTDSQR	825110	412555	275036.6667	206277.5	165022	137518.3333	117872.8571	103138.75	91678.88889	82511	75010	68759.16667	63470	58936.42857	55007.33333	51569.375	45839.44444	43426.84211	41255.5	34379.58333	33004.4	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16905	CHOYP_ANXA7.3.4|m.48325	TELTDSQR	TELTDSQR	211565	105782.5	70521.66667	52891.25	42313	35260.83333	30223.57143	26445.625	23507.22222	21156.5	19233.18182	17630.41667	16274.23077	15111.78571	14104.33333	13222.8125	11753.61111	11135	10578.25	8815.208333	8462.6	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16906	CHOYP_ANXA7.3.4|m.48325	TELTDSQR	TELTDSQR	387408	193704	129136	96852	77481.6	64568	55344	48426	43045.33333	38740.8	35218.90909	32284	29800.61538	27672	25827.2	24213	21522.66667	20389.89474	19370.4	16142	15496.32	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16907	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	20202574	10101287	6734191.333	5050643.5	4040514.8	3367095.667	2886082	2525321.75	2244730.444	2020257.4	1836597.636	1683547.833	1554044.154	1443041	1346838.267	1262660.875	1122365.222	1063293.368	1010128.7	841773.9167	808102.96	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16908	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	13987903	6993951.5	4662634.333	3496975.75	2797580.6	2331317.167	1998271.857	1748487.875	1554211.444	1398790.3	1271627.545	1165658.583	1075992.538	999135.9286	932526.8667	874243.9375	777105.7222	736205.4211	699395.15	582829.2917	559516.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16909	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	6344799	3172399.5	2114933	1586199.75	1268959.8	1057466.5	906399.8571	793099.875	704977.6667	634479.9	576799.9091	528733.25	488061.4615	453199.9286	422986.6	396549.9375	352488.8333	333936.7895	317239.95	264366.625	253791.96	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16910	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	406713	203356.5	135571	101678.25	81342.6	67785.5	58101.85714	50839.125	45190.33333	40671.3	36973.90909	33892.75	31285.61538	29050.92857	27114.2	25419.5625	22595.16667	21405.94737	20335.65	16946.375	16268.52	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16911	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	2578601	1289300.5	859533.6667	644650.25	515720.2	429766.8333	368371.5714	322325.125	286511.2222	257860.1	234418.2727	214883.4167	198353.9231	184185.7857	171906.7333	161162.5625	143255.6111	135715.8421	128930.05	107441.7083	103144.04	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16912	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	2350171	1175085.5	783390.3333	587542.75	470034.2	391695.1667	335738.7143	293771.375	261130.1111	235017.1	213651.9091	195847.5833	180782.3846	167869.3571	156678.0667	146885.6875	130565.0556	123693.2105	117508.55	97923.79167	94006.84	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16913	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	1041803	520901.5	347267.6667	260450.75	208360.6	173633.8333	148829	130225.375	115755.8889	104180.3	94709.36364	86816.91667	80138.69231	74414.5	69453.53333	65112.6875	57877.94444	54831.73684	52090.15	43408.45833	41672.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16914	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	245795	122897.5	81931.66667	61448.75	49159	40965.83333	35113.57143	30724.375	27310.55556	24579.5	22345	20482.91667	18907.30769	17556.78571	16386.33333	15362.1875	13655.27778	12936.57895	12289.75	10241.45833	9831.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16915	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	527456	263728	175818.6667	131864	105491.2	87909.33333	75350.85714	65932	58606.22222	52745.6	47950.54545	43954.66667	40573.53846	37675.42857	35163.73333	32966	29303.11111	27760.84211	26372.8	21977.33333	21098.24	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16916	CHOYP_ANXA7.3.4|m.48325	ALAQQDAQTLYK	ALAQQDAQTLYK	307709	153854.5	102569.6667	76927.25	61541.8	51284.83333	43958.42857	38463.625	34189.88889	30770.9	27973.54545	25642.41667	23669.92308	21979.21429	20513.93333	19231.8125	17094.94444	16195.21053	15385.45	12821.20833	12308.36	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16917	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	1602853	801426.5	534284.3333	400713.25	320570.6	267142.1667	228979	200356.625	178094.7778	160285.3	145713.9091	133571.0833	123296.3846	114489.5	106856.8667	100178.3125	89047.38889	84360.68421	80142.65	66785.54167	64114.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16918	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16919	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	483070	241535	161023.3333	120767.5	96614	80511.66667	69010	60383.75	53674.44444	48307	43915.45455	40255.83333	37159.23077	34505	32204.66667	30191.875	26837.22222	25424.73684	24153.5	20127.91667	19322.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16920	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16921	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	28456	14228	9485.333333	7114	5691.2	4742.666667	4065.142857	3557	3161.777778	2845.6	2586.909091	2371.333333	2188.923077	2032.571429	1897.066667	1778.5	1580.888889	1497.684211	1422.8	1185.666667	1138.24	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16922	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16923	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16924	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	164348	82174	54782.66667	41087	32869.6	27391.33333	23478.28571	20543.5	18260.88889	16434.8	14940.72727	13695.66667	12642.15385	11739.14286	10956.53333	10271.75	9130.444444	8649.894737	8217.4	6847.833333	6573.92	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16925	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	209900	104950	69966.66667	52475	41980	34983.33333	29985.71429	26237.5	23322.22222	20990	19081.81818	17491.66667	16146.15385	14992.85714	13993.33333	13118.75	11661.11111	11047.36842	10495	8745.833333	8396	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16926	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	269125	134562.5	89708.33333	67281.25	53825	44854.16667	38446.42857	33640.625	29902.77778	26912.5	24465.90909	22427.08333	20701.92308	19223.21429	17941.66667	16820.3125	14951.38889	14164.47368	13456.25	11213.54167	10765	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16927	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16928	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	9627	4813.5	3209	2406.75	1925.4	1604.5	1375.285714	1203.375	1069.666667	962.7	875.1818182	802.25	740.5384615	687.6428571	641.8	601.6875	534.8333333	506.6842105	481.35	401.125	385.08	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16929	CHOYP_ANXA7.3.4|m.48325	FGTDESAFLSVLSIR	FGTDESAFLSVLSIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16930	CHOYP_ANXA7.3.4|m.48325	ATFEEYQK	ATFEEYQK	8176207	4088103.5	2725402.333	2044051.75	1635241.4	1362701.167	1168029.571	1022025.875	908467.4444	817620.7	743291.5455	681350.5833	628939	584014.7857	545080.4667	511012.9375	454233.7222	430326.6842	408810.35	340675.2917	327048.28	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16931	CHOYP_ANXA7.3.4|m.48325	ATFEEYQK	ATFEEYQK	4709754	2354877	1569918	1177438.5	941950.8	784959	672822	588719.25	523306	470975.4	428159.4545	392479.5	362288.7692	336411	313983.6	294359.625	261653	247881.7895	235487.7	196239.75	188390.16	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16932	CHOYP_ANXA7.3.4|m.48325	ATFEEYQK	ATFEEYQK	662203	331101.5	220734.3333	165550.75	132440.6	110367.1667	94600.42857	82775.375	73578.11111	66220.3	60200.27273	55183.58333	50938.69231	47300.21429	44146.86667	41387.6875	36789.05556	34852.78947	33110.15	27591.79167	26488.12	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16933	CHOYP_ANXA7.3.4|m.48325	ATFEEYQK	ATFEEYQK	1016964	508482	338988	254241	203392.8	169494	145280.5714	127120.5	112996	101696.4	92451.27273	84747	78228	72640.28571	67797.6	63560.25	56498	53524.42105	50848.2	42373.5	40678.56	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16934	CHOYP_ANXA7.3.4|m.48325	ATFEEYQK	ATFEEYQK	619494	309747	206498	154873.5	123898.8	103249	88499.14286	77436.75	68832.66667	61949.4	56317.63636	51624.5	47653.38462	44249.57143	41299.6	38718.375	34416.33333	32604.94737	30974.7	25812.25	24779.76	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16935	CHOYP_ANXA7.3.4|m.48325	ATFEEYQK	ATFEEYQK	308752	154376	102917.3333	77188	61750.4	51458.66667	44107.42857	38594	34305.77778	30875.2	28068.36364	25729.33333	23750.15385	22053.71429	20583.46667	19297	17152.88889	16250.10526	15437.6	12864.66667	12350.08	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16936	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16937	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16938	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16939	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16940	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16941	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16942	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16943	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16944	CHOYP_ANXA7.3.4|m.48325	GMGTDDSTLIR	GMGTDDSTLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16945	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16946	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16947	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16948	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16949	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	52882	26441	17627.33333	13220.5	10576.4	8813.666667	7554.571429	6610.25	5875.777778	5288.2	4807.454545	4406.833333	4067.846154	3777.285714	3525.466667	3305.125	2937.888889	2783.263158	2644.1	2203.416667	2115.28	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16950	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16951	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16952	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16953	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16954	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16955	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16956	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	20295	10147.5	6765	5073.75	4059	3382.5	2899.285714	2536.875	2255	2029.5	1845	1691.25	1561.153846	1449.642857	1353	1268.4375	1127.5	1068.157895	1014.75	845.625	811.8	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16957	CHOYP_ANXA7.3.4|m.48325	SLNAAVSSETSGDYK	SLNAAVSSETSGDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q07076	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	Anxa7 Anx7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0031982; GO:0035176; GO:0042584; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
16958	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	28757988	14378994	9585996	7189497	5751597.6	4792998	4108284	3594748.5	3195332	2875798.8	2614362.545	2396499	2212152.923	2054142	1917199.2	1797374.25	1597666	1513578.316	1437899.4	1198249.5	1150319.52	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16959	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	19945688	9972844	6648562.667	4986422	3989137.6	3324281.333	2849384	2493211	2216187.556	1994568.8	1813244.364	1662140.667	1534283.692	1424692	1329712.533	1246605.5	1108093.778	1049773.053	997284.4	831070.3333	797827.52	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16960	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	6036937	3018468.5	2012312.333	1509234.25	1207387.4	1006156.167	862419.5714	754617.125	670770.7778	603693.7	548812.4545	503078.0833	464379.7692	431209.7857	402462.4667	377308.5625	335385.3889	317733.5263	301846.85	251539.0417	241477.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16961	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	969710	484855	323236.6667	242427.5	193942	161618.3333	138530	121213.75	107745.5556	96971	88155.45455	80809.16667	74593.07692	69265	64647.33333	60606.875	53872.77778	51037.36842	48485.5	40404.58333	38788.4	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16962	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	3019345	1509672.5	1006448.333	754836.25	603869	503224.1667	431335	377418.125	335482.7778	301934.5	274485.9091	251612.0833	232257.3077	215667.5	201289.6667	188709.0625	167741.3889	158912.8947	150967.25	125806.0417	120773.8	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16963	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	3119762	1559881	1039920.667	779940.5	623952.4	519960.3333	445680.2857	389970.25	346640.2222	311976.2	283614.7273	259980.1667	239981.6923	222840.1429	207984.1333	194985.125	173320.1111	164198	155988.1	129990.0833	124790.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16964	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	1050714	525357	350238	262678.5	210142.8	175119	150102	131339.25	116746	105071.4	95519.45455	87559.5	80824.15385	75051	70047.6	65669.625	58373	55300.73684	52535.7	43779.75	42028.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16965	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16966	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	663967	331983.5	221322.3333	165991.75	132793.4	110661.1667	94852.42857	82995.875	73774.11111	66396.7	60360.63636	55330.58333	51074.38462	47426.21429	44264.46667	41497.9375	36887.05556	34945.63158	33198.35	27665.29167	26558.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16967	CHOYP_ANXA7.4.4|m.50772	AIIQVIGHTSNK	AIIQVIGHTSNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16968	CHOYP_ANXA7.4.4|m.50772	TELTDSQR	TELTDSQR	8804121	4402060.5	2934707	2201030.25	1760824.2	1467353.5	1257731.571	1100515.125	978235.6667	880412.1	800374.6364	733676.75	677240.0769	628865.7857	586941.4	550257.5625	489117.8333	463374.7895	440206.05	366838.375	352164.84	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16969	CHOYP_ANXA7.4.4|m.50772	TELTDSQR	TELTDSQR	3304364	1652182	1101454.667	826091	660872.8	550727.3333	472052	413045.5	367151.5556	330436.4	300396.7273	275363.6667	254181.8462	236026	220290.9333	206522.75	183575.7778	173913.8947	165218.2	137681.8333	132174.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16970	CHOYP_ANXA7.4.4|m.50772	TELTDSQR	TELTDSQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16971	CHOYP_ANXA7.4.4|m.50772	TELTDSQR	TELTDSQR	825110	412555	275036.6667	206277.5	165022	137518.3333	117872.8571	103138.75	91678.88889	82511	75010	68759.16667	63470	58936.42857	55007.33333	51569.375	45839.44444	43426.84211	41255.5	34379.58333	33004.4	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16972	CHOYP_ANXA7.4.4|m.50772	TELTDSQR	TELTDSQR	211565	105782.5	70521.66667	52891.25	42313	35260.83333	30223.57143	26445.625	23507.22222	21156.5	19233.18182	17630.41667	16274.23077	15111.78571	14104.33333	13222.8125	11753.61111	11135	10578.25	8815.208333	8462.6	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16973	CHOYP_ANXA7.4.4|m.50772	TELTDSQR	TELTDSQR	387408	193704	129136	96852	77481.6	64568	55344	48426	43045.33333	38740.8	35218.90909	32284	29800.61538	27672	25827.2	24213	21522.66667	20389.89474	19370.4	16142	15496.32	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16974	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	20202574	10101287	6734191.333	5050643.5	4040514.8	3367095.667	2886082	2525321.75	2244730.444	2020257.4	1836597.636	1683547.833	1554044.154	1443041	1346838.267	1262660.875	1122365.222	1063293.368	1010128.7	841773.9167	808102.96	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16975	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	13987903	6993951.5	4662634.333	3496975.75	2797580.6	2331317.167	1998271.857	1748487.875	1554211.444	1398790.3	1271627.545	1165658.583	1075992.538	999135.9286	932526.8667	874243.9375	777105.7222	736205.4211	699395.15	582829.2917	559516.12	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16976	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	6344799	3172399.5	2114933	1586199.75	1268959.8	1057466.5	906399.8571	793099.875	704977.6667	634479.9	576799.9091	528733.25	488061.4615	453199.9286	422986.6	396549.9375	352488.8333	333936.7895	317239.95	264366.625	253791.96	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16977	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	406713	203356.5	135571	101678.25	81342.6	67785.5	58101.85714	50839.125	45190.33333	40671.3	36973.90909	33892.75	31285.61538	29050.92857	27114.2	25419.5625	22595.16667	21405.94737	20335.65	16946.375	16268.52	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16978	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	2578601	1289300.5	859533.6667	644650.25	515720.2	429766.8333	368371.5714	322325.125	286511.2222	257860.1	234418.2727	214883.4167	198353.9231	184185.7857	171906.7333	161162.5625	143255.6111	135715.8421	128930.05	107441.7083	103144.04	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16979	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	2350171	1175085.5	783390.3333	587542.75	470034.2	391695.1667	335738.7143	293771.375	261130.1111	235017.1	213651.9091	195847.5833	180782.3846	167869.3571	156678.0667	146885.6875	130565.0556	123693.2105	117508.55	97923.79167	94006.84	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16980	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	1041803	520901.5	347267.6667	260450.75	208360.6	173633.8333	148829	130225.375	115755.8889	104180.3	94709.36364	86816.91667	80138.69231	74414.5	69453.53333	65112.6875	57877.94444	54831.73684	52090.15	43408.45833	41672.12	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16981	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	245795	122897.5	81931.66667	61448.75	49159	40965.83333	35113.57143	30724.375	27310.55556	24579.5	22345	20482.91667	18907.30769	17556.78571	16386.33333	15362.1875	13655.27778	12936.57895	12289.75	10241.45833	9831.8	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16982	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	527456	263728	175818.6667	131864	105491.2	87909.33333	75350.85714	65932	58606.22222	52745.6	47950.54545	43954.66667	40573.53846	37675.42857	35163.73333	32966	29303.11111	27760.84211	26372.8	21977.33333	21098.24	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
16983	CHOYP_ANXA7.4.4|m.50772	ALAQQDAQTLYK	ALAQQDAQTLYK	307709	153854.5	102569.6667	76927.25	61541.8	51284.83333	43958.42857	38463.625	34189.88889	30770.9	27973.54545	25642.41667	23669.92308	21979.21429	20513.93333	19231.8125	17094.94444	16195.21053	15385.45	12821.20833	12308.36	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
18461	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	3208449	1604224.5	1069483	802112.25	641689.8	534741.5	458349.8571	401056.125	356494.3333	320844.9	291677.1818	267370.75	246803.7692	229174.9286	213896.6	200528.0625	178247.1667	168865.7368	160422.45	133685.375	128337.96	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18462	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	2383434	1191717	794478	595858.5	476686.8	397239	340490.5714	297929.25	264826	238343.4	216675.8182	198619.5	183341.0769	170245.2857	158895.6	148964.625	132413	125443.8947	119171.7	99309.75	95337.36	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18463	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	877784	438892	292594.6667	219446	175556.8	146297.3333	125397.7143	109723	97531.55556	87778.4	79798.54545	73148.66667	67521.84615	62698.85714	58518.93333	54861.5	48765.77778	46199.15789	43889.2	36574.33333	35111.36	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18464	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	701042	350521	233680.6667	175260.5	140208.4	116840.3333	100148.8571	87630.25	77893.55556	70104.2	63731.09091	58420.16667	53926.30769	50074.42857	46736.13333	43815.125	38946.77778	36896.94737	35052.1	29210.08333	28041.68	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18465	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	1263148	631574	421049.3333	315787	252629.6	210524.6667	180449.7143	157893.5	140349.7778	126314.8	114831.6364	105262.3333	97165.23077	90224.85714	84209.86667	78946.75	70174.88889	66481.47368	63157.4	52631.16667	50525.92	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18466	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	178272	89136	59424	44568	35654.4	29712	25467.42857	22284	19808	17827.2	16206.54545	14856	13713.23077	12733.71429	11884.8	11142	9904	9382.736842	8913.6	7428	7130.88	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18467	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	572818	286409	190939.3333	143204.5	114563.6	95469.66667	81831.14286	71602.25	63646.44444	57281.8	52074.36364	47734.83333	44062.92308	40915.57143	38187.86667	35801.125	31823.22222	30148.31579	28640.9	23867.41667	22912.72	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18468	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	331256	165628	110418.6667	82814	66251.2	55209.33333	47322.28571	41407	36806.22222	33125.6	30114.18182	27604.66667	25481.23077	23661.14286	22083.73333	20703.5	18403.11111	17434.52632	16562.8	13802.33333	13250.24	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18469	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18470	CHOYP_AQP1A.2.1.1|m.56818	LLAEGDMIAIPR	LLAEGDMIAIPR	107843	53921.5	35947.66667	26960.75	21568.6	17973.83333	15406.14286	13480.375	11982.55556	10784.3	9803.909091	8986.916667	8295.615385	7703.071429	7189.533333	6740.1875	5991.277778	5675.947368	5392.15	4493.458333	4313.72	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18471	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	1100745	550372.5	366915	275186.25	220149	183457.5	157249.2857	137593.125	122305	110074.5	100067.7273	91728.75	84672.69231	78624.64286	73383	68796.5625	61152.5	57933.94737	55037.25	45864.375	44029.8	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18472	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	621109	310554.5	207036.3333	155277.25	124221.8	103518.1667	88729.85714	77638.625	69012.11111	62110.9	56464.45455	51759.08333	47777.61538	44364.92857	41407.26667	38819.3125	34506.05556	32689.94737	31055.45	25879.54167	24844.36	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18473	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18474	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18475	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	268553	134276.5	89517.66667	67138.25	53710.6	44758.83333	38364.71429	33569.125	29839.22222	26855.3	24413.90909	22379.41667	20657.92308	19182.35714	17903.53333	16784.5625	14919.61111	14134.36842	13427.65	11189.70833	10742.12	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18476	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18477	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	20054	10027	6684.666667	5013.5	4010.8	3342.333333	2864.857143	2506.75	2228.222222	2005.4	1823.090909	1671.166667	1542.615385	1432.428571	1336.933333	1253.375	1114.111111	1055.473684	1002.7	835.5833333	802.16	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18478	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18479	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18480	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18481	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
18482	CHOYP_AQP1A.2.1.1|m.56818	DYFTGSSEASSNGK	DYFTGSSEASSNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P29972	Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)	AQP1 CHIP28	ammonium transport [GO:0015696]; bicarbonate transport [GO:0015701]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to stress [GO:0033554]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cell volume homeostasis [GO:0006884]; cerebrospinal fluid secretion [GO:0033326]; cGMP biosynthetic process [GO:0006182]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; glycerol transport [GO:0015793]; lateral ventricle development [GO:0021670]; maintenance of symbiont-containing vacuole by host [GO:0085018]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; response to drug [GO:0042493]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]	GO:0003091; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006182; GO:0006813; GO:0006833; GO:0006884; GO:0008519; GO:0009925; GO:0009992; GO:0015079; GO:0015168; GO:0015250; GO:0015254; GO:0015670; GO:0015696; GO:0015701; GO:0015793; GO:0016323; GO:0016324; GO:0019725; GO:0020003; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033554; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042383; GO:0042476; GO:0042493; GO:0043066; GO:0043154; GO:0045177; GO:0045766; GO:0046878; GO:0048146; GO:0050891; GO:0070062; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0085018
20667	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	14709054	7354527	4903018	3677263.5	2941810.8	2451509	2101293.429	1838631.75	1634339.333	1470905.4	1337186.727	1225754.5	1131465.692	1050646.714	980603.6	919315.875	817169.6667	774160.7368	735452.7	612877.25	588362.16	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20668	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20669	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20670	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	2334277	1167138.5	778092.3333	583569.25	466855.4	389046.1667	333468.1429	291784.625	259364.1111	233427.7	212207	194523.0833	179559.7692	166734.0714	155618.4667	145892.3125	129682.0556	122856.6842	116713.85	97261.54167	93371.08	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20671	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	955415	477707.5	318471.6667	238853.75	191083	159235.8333	136487.8571	119426.875	106157.2222	95541.5	86855.90909	79617.91667	73493.46154	68243.92857	63694.33333	59713.4375	53078.61111	50285	47770.75	39808.95833	38216.6	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20672	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	1315689	657844.5	438563	328922.25	263137.8	219281.5	187955.5714	164461.125	146187.6667	131568.9	119608.0909	109640.75	101206.8462	93977.78571	87712.6	82230.5625	73093.83333	69246.78947	65784.45	54820.375	52627.56	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20673	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	762909	381454.5	254303	190727.25	152581.8	127151.5	108987	95363.625	84767.66667	76290.9	69355.36364	63575.75	58685.30769	54493.5	50860.6	47681.8125	42383.83333	40153.10526	38145.45	31787.875	30516.36	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
20674	CHOYP_BAX.1.1|m.30787	VLLNQFIQDR	VLLNQFIQDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O02703	Apoptosis regulator BAX	BAX	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in patterning of blood vessels [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]	GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0015267; GO:0021854; GO:0021987; GO:0032091; GO:0032461; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034644; GO:0035234; GO:0042475; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051260; GO:0051281; GO:0051402; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060058; GO:0060068; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0071310; GO:0072332; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:0097296; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1990009; GO:1990117; GO:2001234; GO:2001241; GO:2001244
21004	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21005	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21006	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21007	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21008	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21009	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21010	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21011	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21012	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21013	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21014	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21015	CHOYP_BIG3.1.1|m.51448	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21016	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21017	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21018	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21019	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21020	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21021	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21022	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21023	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21024	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21025	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21026	CHOYP_BIG3.1.1|m.51448	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21027	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21028	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21029	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21030	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21031	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21032	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21033	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21034	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21035	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21036	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21037	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21038	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21039	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21040	CHOYP_BIG3.1.1|m.51448	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21041	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21042	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21043	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21044	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21045	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21046	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21047	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
21048	CHOYP_BIG3.1.1|m.51448	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
22457	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	614209	307104.5	204736.3333	153552.25	122841.8	102368.1667	87744.14286	76776.125	68245.44444	61420.9	55837.18182	51184.08333	47246.84615	43872.07143	40947.26667	38388.0625	34122.72222	32326.78947	30710.45	25592.04167	24568.36	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22458	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	1223281	611640.5	407760.3333	305820.25	244656.2	203880.1667	174754.4286	152910.125	135920.1111	122328.1	111207.3636	101940.0833	94098.53846	87377.21429	81552.06667	76455.0625	67960.05556	64383.21053	61164.05	50970.04167	48931.24	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22459	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	125284	62642	41761.33333	31321	25056.8	20880.66667	17897.71429	15660.5	13920.44444	12528.4	11389.45455	10440.33333	9637.230769	8948.857143	8352.266667	7830.25	6960.222222	6593.894737	6264.2	5220.166667	5011.36	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22460	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	66705	33352.5	22235	16676.25	13341	11117.5	9529.285714	8338.125	7411.666667	6670.5	6064.090909	5558.75	5131.153846	4764.642857	4447	4169.0625	3705.833333	3510.789474	3335.25	2779.375	2668.2	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22461	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	168695	84347.5	56231.66667	42173.75	33739	28115.83333	24099.28571	21086.875	18743.88889	16869.5	15335.90909	14057.91667	12976.53846	12049.64286	11246.33333	10543.4375	9371.944444	8878.684211	8434.75	7028.958333	6747.8	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22462	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22463	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22464	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22465	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	VLSLGIADLNK	VLSLGIADLNK	47852	23926	15950.66667	11963	9570.4	7975.333333	6836	5981.5	5316.888889	4785.2	4350.181818	3987.666667	3680.923077	3418	3190.133333	2990.75	2658.444444	2518.526316	2392.6	1993.833333	1914.08	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22466	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22467	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22468	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22469	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	145185	72592.5	48395	36296.25	29037	24197.5	20740.71429	18148.125	16131.66667	14518.5	13198.63636	12098.75	11168.07692	10370.35714	9679	9074.0625	8065.833333	7641.315789	7259.25	6049.375	5807.4	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22470	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	79142	39571	26380.66667	19785.5	15828.4	13190.33333	11306	9892.75	8793.555556	7914.2	7194.727273	6595.166667	6087.846154	5653	5276.133333	4946.375	4396.777778	4165.368421	3957.1	3297.583333	3165.68	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22471	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	172244	86122	57414.66667	43061	34448.8	28707.33333	24606.28571	21530.5	19138.22222	17224.4	15658.54545	14353.66667	13249.53846	12303.14286	11482.93333	10765.25	9569.111111	9065.473684	8612.2	7176.833333	6889.76	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22472	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	254374	127187	84791.33333	63593.5	50874.8	42395.66667	36339.14286	31796.75	28263.77778	25437.4	23124.90909	21197.83333	19567.23077	18169.57143	16958.26667	15898.375	14131.88889	13388.10526	12718.7	10598.91667	10174.96	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22473	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	96808	48404	32269.33333	24202	19361.6	16134.66667	13829.71429	12101	10756.44444	9680.8	8800.727273	8067.333333	7446.769231	6914.857143	6453.866667	6050.5	5378.222222	5095.157895	4840.4	4033.666667	3872.32	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
22474	CHOYP_BRAFLDRAFT_113892.1.1|m.44055	EQLEELYNWAK	EQLEELYNWAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P48508	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0050880; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:2001237
25763	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	41270132	20635066	13756710.67	10317533	8254026.4	6878355.333	5895733.143	5158766.5	4585570.222	4127013.2	3751830.182	3439177.667	3174625.538	2947866.571	2751342.133	2579383.25	2292785.111	2172112.211	2063506.6	1719588.833	1650805.28	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25764	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	22263472	11131736	7421157.333	5565868	4452694.4	3710578.667	3180496	2782934	2473719.111	2226347.2	2023952	1855289.333	1712574.769	1590248	1484231.467	1391467	1236859.556	1171761.684	1113173.6	927644.6667	890538.88	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25765	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	5981934	2990967	1993978	1495483.5	1196386.8	996989	854562	747741.75	664659.3333	598193.4	543812.1818	498494.5	460148.7692	427281	398795.6	373870.875	332329.6667	314838.6316	299096.7	249247.25	239277.36	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25766	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	5532595	2766297.5	1844198.333	1383148.75	1106519	922099.1667	790370.7143	691574.375	614732.7778	553259.5	502963.1818	461049.5833	425584.2308	395185.3571	368839.6667	345787.1875	307366.3889	291189.2105	276629.75	230524.7917	221303.8	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25767	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	3328580	1664290	1109526.667	832145	665716	554763.3333	475511.4286	416072.5	369842.2222	332858	302598.1818	277381.6667	256044.6154	237755.7143	221905.3333	208036.25	184921.1111	175188.4211	166429	138690.8333	133143.2	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25768	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	2523622	1261811	841207.3333	630905.5	504724.4	420603.6667	360517.4286	315452.75	280402.4444	252362.2	229420.1818	210301.8333	194124.7692	180258.7143	168241.4667	157726.375	140201.2222	132822.2105	126181.1	105150.9167	100944.88	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25769	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VPAVDLFEK	VPAVDLFEK	1197790	598895	399263.3333	299447.5	239558	199631.6667	171112.8571	149723.75	133087.7778	119779	108890	99815.83333	92137.69231	85556.42857	79852.66667	74861.875	66543.88889	63041.57895	59889.5	49907.91667	47911.6	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25770	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	123306440	61653220	41102146.67	30826610	24661288	20551073.33	17615205.71	15413305	13700715.56	12330644	11209676.36	10275536.67	9485110.769	8807602.857	8220429.333	7706652.5	6850357.778	6489812.632	6165322	5137768.333	4932257.6	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25771	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	63100332	31550166	21033444	15775083	12620066.4	10516722	9014333.143	7887541.5	7011148	6310033.2	5736393.818	5258361	4853871.692	4507166.571	4206688.8	3943770.75	3505574	3321070.105	3155016.6	2629180.5	2524013.28	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25772	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	18281850	9140925	6093950	4570462.5	3656370	3046975	2611692.857	2285231.25	2031316.667	1828185	1661986.364	1523487.5	1406296.154	1305846.429	1218790	1142615.625	1015658.333	962202.6316	914092.5	761743.75	731274	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25773	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	5177845	2588922.5	1725948.333	1294461.25	1035569	862974.1667	739692.1429	647230.625	575316.1111	517784.5	470713.1818	431487.0833	398295.7692	369846.0714	345189.6667	323615.3125	287658.0556	272518.1579	258892.25	215743.5417	207113.8	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25774	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	1722754	861377	574251.3333	430688.5	344550.8	287125.6667	246107.7143	215344.25	191417.1111	172275.4	156614	143562.8333	132519.5385	123053.8571	114850.2667	107672.125	95708.55556	90671.26316	86137.7	71781.41667	68910.16	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25775	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	4661605	2330802.5	1553868.333	1165401.25	932321	776934.1667	665943.5714	582700.625	517956.1111	466160.5	423782.2727	388467.0833	358585	332971.7857	310773.6667	291350.3125	258978.0556	245347.6316	233080.25	194233.5417	186464.2	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25776	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	VNSGELFGK	VNSGELFGK	9606376	4803188	3202125.333	2401594	1921275.2	1601062.667	1372339.429	1200797	1067375.111	960637.6	873306.9091	800531.3333	738952	686169.7143	640425.0667	600398.5	533687.5556	505598.7368	480318.8	400265.6667	384255.04	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25777	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25778	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25779	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25780	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25781	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25782	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	551078	275539	183692.6667	137769.5	110215.6	91846.33333	78725.42857	68884.75	61230.88889	55107.8	50098	45923.16667	42390.61538	39362.71429	36738.53333	34442.375	30615.44444	29004.10526	27553.9	22961.58333	22043.12	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25783	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	618898	309449	206299.3333	154724.5	123779.6	103149.6667	88414	77362.25	68766.44444	61889.8	56263.45455	51574.83333	47607.53846	44207	41259.86667	38681.125	34383.22222	32573.57895	30944.9	25787.41667	24755.92	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25784	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	141338	70669	47112.66667	35334.5	28267.6	23556.33333	20191.14286	17667.25	15704.22222	14133.8	12848.90909	11778.16667	10872.15385	10095.57143	9422.533333	8833.625	7852.111111	7438.842105	7066.9	5889.083333	5653.52	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25785	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25786	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25787	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	118188	59094	39396	29547	23637.6	19698	16884	14773.5	13132	11818.8	10744.36364	9849	9091.384615	8442	7879.2	7386.75	6566	6220.421053	5909.4	4924.5	4727.52	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25788	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	414011	207005.5	138003.6667	103502.75	82802.2	69001.83333	59144.42857	51751.375	46001.22222	41401.1	37637.36364	34500.91667	31847	29572.21429	27600.73333	25875.6875	23000.61111	21790.05263	20700.55	17250.45833	16560.44	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
25789	CHOYP_BRAFLDRAFT_119799.1.1|m.23765	AVDMELDATAILGNK	AVDMELDATAILGNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P30044	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)"	PRDX5 ACR1 SBBI10	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057
32387	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32388	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32389	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	539091	269545.5	179697	134772.75	107818.2	89848.5	77013	67386.375	59899	53909.1	49008.27273	44924.25	41468.53846	38506.5	35939.4	33693.1875	29949.5	28373.21053	26954.55	22462.125	21563.64	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32390	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	64716	32358	21572	16179	12943.2	10786	9245.142857	8089.5	7190.666667	6471.6	5883.272727	5393	4978.153846	4622.571429	4314.4	4044.75	3595.333333	3406.105263	3235.8	2696.5	2588.64	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32391	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	612102	306051	204034	153025.5	122420.4	102017	87443.14286	76512.75	68011.33333	61210.2	55645.63636	51008.5	47084.76923	43721.57143	40806.8	38256.375	34005.66667	32215.89474	30605.1	25504.25	24484.08	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32392	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	899133	449566.5	299711	224783.25	179826.6	149855.5	128447.5714	112391.625	99903.66667	89913.3	81739.36364	74927.75	69164.07692	64223.78571	59942.2	56195.8125	49951.83333	47322.78947	44956.65	37463.875	35965.32	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32393	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	825443	412721.5	275147.6667	206360.75	165088.6	137573.8333	117920.4286	103180.375	91715.88889	82544.3	75040.27273	68786.91667	63495.61538	58960.21429	55029.53333	51590.1875	45857.94444	43444.36842	41272.15	34393.45833	33017.72	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32394	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	43073	21536.5	14357.66667	10768.25	8614.6	7178.833333	6153.285714	5384.125	4785.888889	4307.3	3915.727273	3589.416667	3313.307692	3076.642857	2871.533333	2692.0625	2392.944444	2267	2153.65	1794.708333	1722.92	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32395	CHOYP_BRAFLDRAFT_203655.1.2|m.12	NNAQIVSLSSK	NNAQIVSLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32396	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	12531678	6265839	4177226	3132919.5	2506335.6	2088613	1790239.714	1566459.75	1392408.667	1253167.8	1139243.455	1044306.5	963975.2308	895119.8571	835445.2	783229.875	696204.3333	659562	626583.9	522153.25	501267.12	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32397	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	8734980	4367490	2911660	2183745	1746996	1455830	1247854.286	1091872.5	970553.3333	873498	794089.0909	727915	671921.5385	623927.1429	582332	545936.25	485276.6667	459735.7895	436749	363957.5	349399.2	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32398	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	3420872	1710436	1140290.667	855218	684174.4	570145.3333	488696	427609	380096.8889	342087.2	310988.3636	285072.6667	263144	244348	228058.1333	213804.5	190048.4444	180045.8947	171043.6	142536.3333	136834.88	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32399	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	406973	203486.5	135657.6667	101743.25	81394.6	67828.83333	58139	50871.625	45219.22222	40697.3	36997.54545	33914.41667	31305.61538	29069.5	27131.53333	25435.8125	22609.61111	21419.63158	20348.65	16957.20833	16278.92	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32400	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	1439478	719739	479826	359869.5	287895.6	239913	205639.7143	179934.75	159942	143947.8	130861.6364	119956.5	110729.0769	102819.8571	95965.2	89967.375	79971	75762	71973.9	59978.25	57579.12	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32401	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	6823553	3411776.5	2274517.667	1705888.25	1364710.6	1137258.833	974793.2857	852944.125	758172.5556	682355.3	620323	568629.4167	524888.6923	487396.6429	454903.5333	426472.0625	379086.2778	359134.3684	341177.65	284314.7083	272942.12	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32402	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	235165	117582.5	78388.33333	58791.25	47033	39194.16667	33595	29395.625	26129.44444	23516.5	21378.63636	19597.08333	18089.61538	16797.5	15677.66667	14697.8125	13064.72222	12377.10526	11758.25	9798.541667	9406.6	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32403	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	334361	167180.5	111453.6667	83590.25	66872.2	55726.83333	47765.85714	41795.125	37151.22222	33436.1	30396.45455	27863.41667	25720.07692	23882.92857	22290.73333	20897.5625	18575.61111	17597.94737	16718.05	13931.70833	13374.44	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32404	CHOYP_BRAFLDRAFT_203655.1.2|m.12	FYTVIPHDFGR	FYTVIPHDFGR	959216	479608	319738.6667	239804	191843.2	159869.3333	137030.8571	119902	106579.5556	95921.6	87201.45455	79934.66667	73785.84615	68515.42857	63947.73333	59951	53289.77778	50485.05263	47960.8	39967.33333	38368.64	P09874	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1)	PARP1 ADPRT PPOL	"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of SMAD protein import into nucleus [GO:0060391]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; protein sumoylation [GO:0016925]; regulation of cellular protein localization [GO:1903827]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription from RNA polymerase II promoter [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	GO:0000122; GO:0000715; GO:0000717; GO:0000724; GO:0000784; GO:0003677; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0016020; GO:0016540; GO:0016925; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0032042; GO:0032869; GO:0033683; GO:0034599; GO:0036211; GO:0042769; GO:0042802; GO:0043234; GO:0043504; GO:0044822; GO:0045944; GO:0047485; GO:0051103; GO:0051287; GO:0060391; GO:0070212; GO:0070911; GO:1903827; GO:1904357; GO:1990966; GO:2000679
32903	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32904	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	3294311	1647155.5	1098103.667	823577.75	658862.2	549051.8333	470615.8571	411788.875	366034.5556	329431.1	299482.8182	274525.9167	253408.5385	235307.9286	219620.7333	205894.4375	183017.2778	173384.7895	164715.55	137262.9583	131772.44	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32905	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	1703285	851642.5	567761.6667	425821.25	340657	283880.8333	243326.4286	212910.625	189253.8889	170328.5	154844.0909	141940.4167	131021.9231	121663.2143	113552.3333	106455.3125	94626.94444	89646.57895	85164.25	70970.20833	68131.4	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32906	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32907	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32908	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32909	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32910	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32911	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32912	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32913	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	224033	112016.5	74677.66667	56008.25	44806.6	37338.83333	32004.71429	28004.125	24892.55556	22403.3	20366.63636	18669.41667	17233.30769	16002.35714	14935.53333	14002.0625	12446.27778	11791.21053	11201.65	9334.708333	8961.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32914	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	165389	82694.5	55129.66667	41347.25	33077.8	27564.83333	23627	20673.625	18376.55556	16538.9	15035.36364	13782.41667	12722.23077	11813.5	11025.93333	10336.8125	9188.277778	8704.684211	8269.45	6891.208333	6615.56	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32915	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	1293644	646822	431214.6667	323411	258728.8	215607.3333	184806.2857	161705.5	143738.2222	129364.4	117604	107803.6667	99511.07692	92403.14286	86242.93333	80852.75	71869.11111	68086.52632	64682.2	53901.83333	51745.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32916	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	197074	98537	65691.33333	49268.5	39414.8	32845.66667	28153.42857	24634.25	21897.11111	19707.4	17915.81818	16422.83333	15159.53846	14076.71429	13138.26667	12317.125	10948.55556	10372.31579	9853.7	8211.416667	7882.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32917	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	473131	236565.5	157710.3333	118282.75	94626.2	78855.16667	67590.14286	59141.375	52570.11111	47313.1	43011.90909	39427.58333	36394.69231	33795.07143	31542.06667	29570.6875	26285.05556	24901.63158	23656.55	19713.79167	18925.24	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32918	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32919	CHOYP_BRAFLDRAFT_207882.1.1|m.351	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
32920	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32921	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32922	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	295699	147849.5	98566.33333	73924.75	59139.8	49283.16667	42242.71429	36962.375	32855.44444	29569.9	26881.72727	24641.58333	22746.07692	21121.35714	19713.26667	18481.1875	16427.72222	15563.10526	14784.95	12320.79167	11827.96	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32923	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32924	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32925	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32926	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32927	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32928	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32929	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32930	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32931	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	112397	56198.5	37465.66667	28099.25	22479.4	18732.83333	16056.71429	14049.625	12488.55556	11239.7	10217.90909	9366.416667	8645.923077	8028.357143	7493.133333	7024.8125	6244.277778	5915.631579	5619.85	4683.208333	4495.88	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32932	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32933	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32934	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32935	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32936	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32937	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32938	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	AAGFDPMNQAGPAPPLEPKPEESPEEK	AAGFDPMNQAGPAPPLEPKPEESPEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32939	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32940	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32941	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32942	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	72875	36437.5	24291.66667	18218.75	14575	12145.83333	10410.71429	9109.375	8097.222222	7287.5	6625	6072.916667	5605.769231	5205.357143	4858.333333	4554.6875	4048.611111	3835.526316	3643.75	3036.458333	2915	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32943	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	180419	90209.5	60139.66667	45104.75	36083.8	30069.83333	25774.14286	22552.375	20046.55556	18041.9	16401.72727	15034.91667	13878.38462	12887.07143	12027.93333	11276.1875	10023.27778	9495.736842	9020.95	7517.458333	7216.76	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32944	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	54979	27489.5	18326.33333	13744.75	10995.8	9163.166667	7854.142857	6872.375	6108.777778	5497.9	4998.090909	4581.583333	4229.153846	3927.071429	3665.266667	3436.1875	3054.388889	2893.631579	2748.95	2290.791667	2199.16	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32945	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32946	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	DFTQAIETLK	DFTQAIETLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32947	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	1144083	572041.5	381361	286020.75	228816.6	190680.5	163440.4286	143010.375	127120.3333	114408.3	104007.5455	95340.25	88006.38462	81720.21429	76272.2	71505.1875	63560.16667	60214.89474	57204.15	47670.125	45763.32	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32948	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	637260	318630	212420	159315	127452	106210	91037.14286	79657.5	70806.66667	63726	57932.72727	53105	49020	45518.57143	42484	39828.75	35403.33333	33540	31863	26552.5	25490.4	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32949	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	349626	174813	116542	87406.5	69925.2	58271	49946.57143	43703.25	38847.33333	34962.6	31784.18182	29135.5	26894.30769	24973.28571	23308.4	21851.625	19423.66667	18401.36842	17481.3	14567.75	13985.04	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32950	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	129474	64737	43158	32368.5	25894.8	21579	18496.28571	16184.25	14386	12947.4	11770.36364	10789.5	9959.538462	9248.142857	8631.6	8092.125	7193	6814.421053	6473.7	5394.75	5178.96	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32951	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	283561	141780.5	94520.33333	70890.25	56712.2	47260.16667	40508.71429	35445.125	31506.77778	28356.1	25778.27273	23630.08333	21812.38462	20254.35714	18904.06667	17722.5625	15753.38889	14924.26316	14178.05	11815.04167	11342.44	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32952	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	17882	8941	5960.666667	4470.5	3576.4	2980.333333	2554.571429	2235.25	1986.888889	1788.2	1625.636364	1490.166667	1375.538462	1277.285714	1192.133333	1117.625	993.4444444	941.1578947	894.1	745.0833333	715.28	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32953	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32954	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32955	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	TGEIYDNEGDK	TGEIYDNEGDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32956	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	1052756	526378	350918.6667	263189	210551.2	175459.3333	150393.7143	131594.5	116972.8889	105275.6	95705.09091	87729.66667	80981.23077	75196.85714	70183.73333	65797.25	58486.44444	55408.21053	52637.8	43864.83333	42110.24	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32957	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	607657	303828.5	202552.3333	151914.25	121531.4	101276.1667	86808.14286	75957.125	67517.44444	60765.7	55241.54545	50638.08333	46742.84615	43404.07143	40510.46667	37978.5625	33758.72222	31981.94737	30382.85	25319.04167	24306.28	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32958	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32959	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	151178	75589	50392.66667	37794.5	30235.6	25196.33333	21596.85714	18897.25	16797.55556	15117.8	13743.45455	12598.16667	11629.07692	10798.42857	10078.53333	9448.625	8398.777778	7956.736842	7558.9	6299.083333	6047.12	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32960	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	416726	208363	138908.6667	104181.5	83345.2	69454.33333	59532.28571	52090.75	46302.88889	41672.6	37884.18182	34727.16667	32055.84615	29766.14286	27781.73333	26045.375	23151.44444	21932.94737	20836.3	17363.58333	16669.04	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32961	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	153695	76847.5	51231.66667	38423.75	30739	25615.83333	21956.42857	19211.875	17077.22222	15369.5	13972.27273	12807.91667	11822.69231	10978.21429	10246.33333	9605.9375	8538.611111	8089.210526	7684.75	6403.958333	6147.8	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32962	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	125597	62798.5	41865.66667	31399.25	25119.4	20932.83333	17942.42857	15699.625	13955.22222	12559.7	11417.90909	10466.41667	9661.307692	8971.214286	8373.133333	7849.8125	6977.611111	6610.368421	6279.85	5233.208333	5023.88	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32963	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	12457	6228.5	4152.333333	3114.25	2491.4	2076.166667	1779.571429	1557.125	1384.111111	1245.7	1132.454545	1038.083333	958.2307692	889.7857143	830.4666667	778.5625	692.0555556	655.6315789	622.85	519.0416667	498.28	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32964	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	16186	8093	5395.333333	4046.5	3237.2	2697.666667	2312.285714	2023.25	1798.444444	1618.6	1471.454545	1348.833333	1245.076923	1156.142857	1079.066667	1011.625	899.2222222	851.8947368	809.3	674.4166667	647.44	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
32965	CHOYP_BRAFLDRAFT_208090.1.1|m.45354	SQAFQYYYDSYR	SQAFQYYYDSYR	69934	34967	23311.33333	17483.5	13986.8	11655.66667	9990.571429	8741.75	7770.444444	6993.4	6357.636364	5827.833333	5379.538462	4995.285714	4662.266667	4370.875	3885.222222	3680.736842	3496.7	2913.916667	2797.36	Q61371	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0042384]; cilium morphogenesis [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; nonmotile primary cilium assembly [GO:0035058]; Notch signaling pathway [GO:0007219]; organ morphogenesis [GO:0009887]; palate development [GO:0060021]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	GO:0001654; GO:0001822; GO:0001889; GO:0002080; GO:0002081; GO:0003382; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0008589; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031512; GO:0032391; GO:0034405; GO:0035058; GO:0036064; GO:0036334; GO:0042384; GO:0042487; GO:0042733; GO:0043568; GO:0045177; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060021; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0072372; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:1902017; GO:2000785
34829	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	1171817	585908.5	390605.6667	292954.25	234363.4	195302.8333	167402.4286	146477.125	130201.8889	117181.7	106528.8182	97651.41667	90139.76923	83701.21429	78121.13333	73238.5625	65100.94444	61674.57895	58590.85	48825.70833	46872.68	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34830	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	1812871	906435.5	604290.3333	453217.75	362574.2	302145.1667	258981.5714	226608.875	201430.1111	181287.1	164806.4545	151072.5833	139451.6154	129490.7857	120858.0667	113304.4375	100715.0556	95414.26316	90643.55	75536.29167	72514.84	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34831	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34832	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	138709	69354.5	46236.33333	34677.25	27741.8	23118.16667	19815.57143	17338.625	15412.11111	13870.9	12609.90909	11559.08333	10669.92308	9907.785714	9247.266667	8669.3125	7706.055556	7300.473684	6935.45	5779.541667	5548.36	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34833	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	22298	11149	7432.666667	5574.5	4459.6	3716.333333	3185.428571	2787.25	2477.555556	2229.8	2027.090909	1858.166667	1715.230769	1592.714286	1486.533333	1393.625	1238.777778	1173.578947	1114.9	929.0833333	891.92	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34834	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	1464792	732396	488264	366198	292958.4	244132	209256	183099	162754.6667	146479.2	133162.9091	122066	112676.3077	104628	97652.8	91549.5	81377.33333	77094.31579	73239.6	61033	58591.68	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34835	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	23387	11693.5	7795.666667	5846.75	4677.4	3897.833333	3341	2923.375	2598.555556	2338.7	2126.090909	1948.916667	1799	1670.5	1559.133333	1461.6875	1299.277778	1230.894737	1169.35	974.4583333	935.48	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34836	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	116994	58497	38998	29248.5	23398.8	19499	16713.42857	14624.25	12999.33333	11699.4	10635.81818	9749.5	8999.538462	8356.714286	7799.6	7312.125	6499.666667	6157.578947	5849.7	4874.75	4679.76	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
34837	CHOYP_BRAFLDRAFT_223429.1.2|m.30136	AFAFVTFADHR	AFAFVTFADHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
39044	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39045	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	5789494	2894747	1929831.333	1447373.5	1157898.8	964915.6667	827070.5714	723686.75	643277.1111	578949.4	526317.6364	482457.8333	445345.6923	413535.2857	385966.2667	361843.375	321638.5556	304710.2105	289474.7	241228.9167	231579.76	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39046	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39047	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	109800	54900	36600	27450	21960	18300	15685.71429	13725	12200	10980	9981.818182	9150	8446.153846	7842.857143	7320	6862.5	6100	5778.947368	5490	4575	4392	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39048	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	408978	204489	136326	102244.5	81795.6	68163	58425.42857	51122.25	45442	40897.8	37179.81818	34081.5	31459.84615	29212.71429	27265.2	25561.125	22721	21525.15789	20448.9	17040.75	16359.12	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39049	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39050	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	366701	183350.5	122233.6667	91675.25	73340.2	61116.83333	52385.85714	45837.625	40744.55556	36670.1	33336.45455	30558.41667	28207.76923	26192.92857	24446.73333	22918.8125	20372.27778	19300.05263	18335.05	15279.20833	14668.04	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39051	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39052	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	61949	30974.5	20649.66667	15487.25	12389.8	10324.83333	8849.857143	7743.625	6883.222222	6194.9	5631.727273	5162.416667	4765.307692	4424.928571	4129.933333	3871.8125	3441.611111	3260.473684	3097.45	2581.208333	2477.96	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39053	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39054	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39055	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39056	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	VGVVDVTENPGLSGR	VGVVDVTENPGLSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39057	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39058	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	900594	450297	300198	225148.5	180118.8	150099	128656.2857	112574.25	100066	90059.4	81872.18182	75049.5	69276.46154	64328.14286	60039.6	56287.125	50033	47399.68421	45029.7	37524.75	36023.76	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39059	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39060	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39061	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39062	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	384789	192394.5	128263	96197.25	76957.8	64131.5	54969.85714	48098.625	42754.33333	38478.9	34980.81818	32065.75	29599.15385	27484.92857	25652.6	24049.3125	21377.16667	20252.05263	19239.45	16032.875	15391.56	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39063	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	38415	19207.5	12805	9603.75	7683	6402.5	5487.857143	4801.875	4268.333333	3841.5	3492.272727	3201.25	2955	2743.928571	2561	2400.9375	2134.166667	2021.842105	1920.75	1600.625	1536.6	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39064	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	28594	14297	9531.333333	7148.5	5718.8	4765.666667	4084.857143	3574.25	3177.111111	2859.4	2599.454545	2382.833333	2199.538462	2042.428571	1906.266667	1787.125	1588.555556	1504.947368	1429.7	1191.416667	1143.76	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
39065	CHOYP_BRAFLDRAFT_275793.1.1|m.9519	ETELVSFVDDK	ETELVSFVDDK	172398	86199	57466	43099.5	34479.6	28733	24628.28571	21549.75	19155.33333	17239.8	15672.54545	14366.5	13261.38462	12314.14286	11493.2	10774.875	9577.666667	9073.578947	8619.9	7183.25	6895.92	Q9H3N1	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005730; GO:0005783; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454
42643	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	15195473	7597736.5	5065157.667	3798868.25	3039094.6	2532578.833	2170781.857	1899434.125	1688385.889	1519547.3	1381406.636	1266289.417	1168882.538	1085390.929	1013031.533	949717.0625	844192.9444	799761.7368	759773.65	633144.7083	607818.92	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42644	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42645	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42646	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	1562843	781421.5	520947.6667	390710.75	312568.6	260473.8333	223263.2857	195355.375	173649.2222	156284.3	142076.6364	130236.9167	120218.6923	111631.6429	104189.5333	97677.6875	86824.61111	82254.89474	78142.15	65118.45833	62513.72	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42647	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	1091234	545617	363744.6667	272808.5	218246.8	181872.3333	155890.5714	136404.25	121248.2222	109123.4	99203.09091	90936.16667	83941.07692	77945.28571	72748.93333	68202.125	60624.11111	57433.36842	54561.7	45468.08333	43649.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42648	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	5628412	2814206	1876137.333	1407103	1125682.4	938068.6667	804058.8571	703551.5	625379.1111	562841.2	511673.8182	469034.3333	432954.7692	402029.4286	375227.4667	351775.75	312689.5556	296232.2105	281420.6	234517.1667	225136.48	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42649	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	425469	212734.5	141823	106367.25	85093.8	70911.5	60781.28571	53183.625	47274.33333	42546.9	38679	35455.75	32728.38462	30390.64286	28364.6	26591.8125	23637.16667	22393.10526	21273.45	17727.875	17018.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42650	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	576781	288390.5	192260.3333	144195.25	115356.2	96130.16667	82397.28571	72097.625	64086.77778	57678.1	52434.63636	48065.08333	44367.76923	41198.64286	38452.06667	36048.8125	32043.38889	30356.89474	28839.05	24032.54167	23071.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42651	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	950588	475294	316862.6667	237647	190117.6	158431.3333	135798.2857	118823.5	105620.8889	95058.8	86417.09091	79215.66667	73122.15385	67899.14286	63372.53333	59411.75	52810.44444	50030.94737	47529.4	39607.83333	38023.52	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42652	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	ATMDAPQIYVER	ATMDAPQIYVER	50586	25293	16862	12646.5	10117.2	8431	7226.571429	6323.25	5620.666667	5058.6	4598.727273	4215.5	3891.230769	3613.285714	3372.4	3161.625	2810.333333	2662.421053	2529.3	2107.75	2023.44	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42653	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	13806587	6903293.5	4602195.667	3451646.75	2761317.4	2301097.833	1972369.571	1725823.375	1534065.222	1380658.7	1255144.273	1150548.917	1062045.154	986184.7857	920439.1333	862911.6875	767032.6111	726662.4737	690329.35	575274.4583	552263.48	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42654	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	7467500	3733750	2489166.667	1866875	1493500	1244583.333	1066785.714	933437.5	829722.2222	746750	678863.6364	622291.6667	574423.0769	533392.8571	497833.3333	466718.75	414861.1111	393026.3158	373375	311145.8333	298700	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42655	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	9956258	4978129	3318752.667	2489064.5	1991251.6	1659376.333	1422322.571	1244532.25	1106250.889	995625.8	905114.3636	829688.1667	765866	711161.2857	663750.5333	622266.125	553125.4444	524013.5789	497812.9	414844.0833	398250.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42656	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	2651857	1325928.5	883952.3333	662964.25	530371.4	441976.1667	378836.7143	331482.125	294650.7778	265185.7	241077.9091	220988.0833	203989	189418.3571	176790.4667	165741.0625	147325.3889	139571.4211	132592.85	110494.0417	106074.28	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42657	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	4303631	2151815.5	1434543.667	1075907.75	860726.2	717271.8333	614804.4286	537953.875	478181.2222	430363.1	391239.1818	358635.9167	331048.5385	307402.2143	286908.7333	268976.9375	239090.6111	226506.8947	215181.55	179317.9583	172145.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42658	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	1724601	862300.5	574867	431150.25	344920.2	287433.5	246371.5714	215575.125	191622.3333	172460.1	156781.9091	143716.75	132661.6154	123185.7857	114973.4	107787.5625	95811.16667	90768.47368	86230.05	71858.375	68984.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42659	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	1440158	720079	480052.6667	360039.5	288031.6	240026.3333	205736.8571	180019.75	160017.5556	144015.8	130923.4545	120013.1667	110781.3846	102868.4286	96010.53333	90009.875	80008.77778	75797.78947	72007.9	60006.58333	57606.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42660	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	SEEIEDIILR	SEEIEDIILR	747769	373884.5	249256.3333	186942.25	149553.8	124628.1667	106824.1429	93471.125	83085.44444	74776.9	67979	62314.08333	57520.69231	53412.07143	49851.26667	46735.5625	41542.72222	39356.26316	37388.45	31157.04167	29910.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42661	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42662	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	12991744	6495872	4330581.333	3247936	2598348.8	2165290.667	1855963.429	1623968	1443527.111	1299174.4	1181067.636	1082645.333	999364.9231	927981.7143	866116.2667	811984	721763.5556	683776	649587.2	541322.6667	519669.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42663	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	7557351	3778675.5	2519117	1889337.75	1511470.2	1259558.5	1079621.571	944668.875	839705.6667	755735.1	687031.9091	629779.25	581334.6923	539810.7857	503823.4	472334.4375	419852.8333	397755.3158	377867.55	314889.625	302294.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42664	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42665	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42666	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42667	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	36950	18475	12316.66667	9237.5	7390	6158.333333	5278.571429	4618.75	4105.555556	3695	3359.090909	3079.166667	2842.307692	2639.285714	2463.333333	2309.375	2052.777778	1944.736842	1847.5	1539.583333	1478	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42668	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	491934	245967	163978	122983.5	98386.8	81989	70276.28571	61491.75	54659.33333	49193.4	44721.27273	40994.5	37841.07692	35138.14286	32795.6	30745.875	27329.66667	25891.26316	24596.7	20497.25	19677.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42669	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	962980	481490	320993.3333	240745	192596	160496.6667	137568.5714	120372.5	106997.7778	96298	87543.63636	80248.33333	74075.38462	68784.28571	64198.66667	60186.25	53498.88889	50683.15789	48149	40124.16667	38519.2	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42670	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	670977	335488.5	223659	167744.25	134195.4	111829.5	95853.85714	83872.125	74553	67097.7	60997.90909	55914.75	51613.61538	47926.92857	44731.8	41936.0625	37276.5	35314.57895	33548.85	27957.375	26839.08	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42671	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	894550	447275	298183.3333	223637.5	178910	149091.6667	127792.8571	111818.75	99394.44444	89455	81322.72727	74545.83333	68811.53846	63896.42857	59636.66667	55909.375	49697.22222	47081.57895	44727.5	37272.91667	35782	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42672	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	1793480	896740	597826.6667	448370	358696	298913.3333	256211.4286	224185	199275.5556	179348	163043.6364	149456.6667	137960	128105.7143	119565.3333	112092.5	99637.77778	94393.68421	89674	74728.33333	71739.2	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42673	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	442986	221493	147662	110746.5	88597.2	73831	63283.71429	55373.25	49220.66667	44298.6	40271.45455	36915.5	34075.84615	31641.85714	29532.4	27686.625	24610.33333	23315.05263	22149.3	18457.75	17719.44	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42674	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	944522	472261	314840.6667	236130.5	188904.4	157420.3333	134931.7143	118065.25	104946.8889	94452.2	85865.63636	78710.16667	72655.53846	67465.85714	62968.13333	59032.625	52473.44444	49711.68421	47226.1	39355.08333	37780.88	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42675	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42676	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	911176	455588	303725.3333	227794	182235.2	151862.6667	130168	113897	101241.7778	91117.6	82834.18182	75931.33333	70090.46154	65084	60745.06667	56948.5	50620.88889	47956.63158	45558.8	37965.66667	36447.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42677	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	DQAISYWR	DQAISYWR	12979491	6489745.5	4326497	3244872.75	2595898.2	2163248.5	1854213	1622436.375	1442165.667	1297949.1	1179953.727	1081624.25	998422.3846	927106.5	865299.4	811218.1875	721082.8333	683131.1053	648974.55	540812.125	519179.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42678	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	DQAISYWR	DQAISYWR	5480131	2740065.5	1826710.333	1370032.75	1096026.2	913355.1667	782875.8571	685016.375	608903.4444	548013.1	498193.7273	456677.5833	421548.5385	391437.9286	365342.0667	342508.1875	304451.7222	288427.9474	274006.55	228338.7917	219205.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42679	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	DQAISYWR	DQAISYWR	2366350	1183175	788783.3333	591587.5	473270	394391.6667	338050	295793.75	262927.7778	236635	215122.7273	197195.8333	182026.9231	169025	157756.6667	147896.875	131463.8889	124544.7368	118317.5	98597.91667	94654	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42680	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	DQAISYWR	DQAISYWR	2559791	1279895.5	853263.6667	639947.75	511958.2	426631.8333	365684.4286	319973.875	284421.2222	255979.1	232708.2727	213315.9167	196907	182842.2143	170652.7333	159986.9375	142210.6111	134725.8421	127989.55	106657.9583	102391.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42681	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	DQAISYWR	DQAISYWR	3674450	1837225	1224816.667	918612.5	734890	612408.3333	524921.4286	459306.25	408272.2222	367445	334040.9091	306204.1667	282650	262460.7143	244963.3333	229653.125	204136.1111	193392.1053	183722.5	153102.0833	146978	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42682	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	DQAISYWR	DQAISYWR	527649	263824.5	175883	131912.25	105529.8	87941.5	75378.42857	65956.125	58627.66667	52764.9	47968.09091	43970.75	40588.38462	37689.21429	35176.6	32978.0625	29313.83333	27771	26382.45	21985.375	21105.96	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42683	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	8670531	4335265.5	2890177	2167632.75	1734106.2	1445088.5	1238647.286	1083816.375	963392.3333	867053.1	788230.0909	722544.25	666963.9231	619323.6429	578035.4	541908.1875	481696.1667	456343.7368	433526.55	361272.125	346821.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42684	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	4178259	2089129.5	1392753	1044564.75	835651.8	696376.5	596894.1429	522282.375	464251	417825.9	379841.7273	348188.25	321404.5385	298447.0714	278550.6	261141.1875	232125.5	219908.3684	208912.95	174094.125	167130.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42685	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	877757	438878.5	292585.6667	219439.25	175551.4	146292.8333	125393.8571	109719.625	97528.55556	87775.7	79796.09091	73146.41667	67519.76923	62696.92857	58517.13333	54859.8125	48764.27778	46197.73684	43887.85	36573.20833	35110.28	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42686	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	1886009	943004.5	628669.6667	471502.25	377201.8	314334.8333	269429.8571	235751.125	209556.5556	188600.9	171455.3636	157167.4167	145077.6154	134714.9286	125733.9333	117875.5625	104778.2778	99263.63158	94300.45	78583.70833	75440.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42687	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	583018	291509	194339.3333	145754.5	116603.6	97169.66667	83288.28571	72877.25	64779.77778	58301.8	53001.63636	48584.83333	44847.53846	41644.14286	38867.86667	36438.625	32389.88889	30685.15789	29150.9	24292.41667	23320.72	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42688	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	101158	50579	33719.33333	25289.5	20231.6	16859.66667	14451.14286	12644.75	11239.77778	10115.8	9196.181818	8429.833333	7781.384615	7225.571429	6743.866667	6322.375	5619.888889	5324.105263	5057.9	4214.916667	4046.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42689	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	AVYGTDDQR	AVYGTDDQR	278738	139369	92912.66667	69684.5	55747.6	46456.33333	39819.71429	34842.25	30970.88889	27873.8	25339.81818	23228.16667	21441.38462	19909.85714	18582.53333	17421.125	15485.44444	14670.42105	13936.9	11614.08333	11149.52	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42690	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	8076040	4038020	2692013.333	2019010	1615208	1346006.667	1153720	1009505	897337.7778	807604	734185.4545	673003.3333	621233.8462	576860	538402.6667	504752.5	448668.8889	425054.7368	403802	336501.6667	323041.6	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42691	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	6854456	3427228	2284818.667	1713614	1370891.2	1142409.333	979208	856807	761606.2222	685445.6	623132.3636	571204.6667	527265.8462	489604	456963.7333	428403.5	380803.1111	360760.8421	342722.8	285602.3333	274178.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42692	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	3010249	1505124.5	1003416.333	752562.25	602049.8	501708.1667	430035.5714	376281.125	334472.1111	301024.9	273659	250854.0833	231557.6154	215017.7857	200683.2667	188140.5625	167236.0556	158434.1579	150512.45	125427.0417	120409.96	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42693	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	579833	289916.5	193277.6667	144958.25	115966.6	96638.83333	82833.28571	72479.125	64425.88889	57983.3	52712.09091	48319.41667	44602.53846	41416.64286	38655.53333	36239.5625	32212.94444	30517.52632	28991.65	24159.70833	23193.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42694	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	976953	488476.5	325651	244238.25	195390.6	162825.5	139564.7143	122119.125	108550.3333	97695.3	88813.90909	81412.75	75150.23077	69782.35714	65130.2	61059.5625	54275.16667	51418.57895	48847.65	40706.375	39078.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42695	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	158514	79257	52838	39628.5	31702.8	26419	22644.85714	19814.25	17612.66667	15851.4	14410.36364	13209.5	12193.38462	11322.42857	10567.6	9907.125	8806.333333	8342.842105	7925.7	6604.75	6340.56	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42696	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	64978	32489	21659.33333	16244.5	12995.6	10829.66667	9282.571429	8122.25	7219.777778	6497.8	5907.090909	5414.833333	4998.307692	4641.285714	4331.866667	4061.125	3609.888889	3419.894737	3248.9	2707.416667	2599.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42697	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	153589	76794.5	51196.33333	38397.25	30717.8	25598.16667	21941.28571	19198.625	17065.44444	15358.9	13962.63636	12799.08333	11814.53846	10970.64286	10239.26667	9599.3125	8532.722222	8083.631579	7679.45	6399.541667	6143.56	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42698	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42699	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42700	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42701	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	NALHGSDSFSSSEK	NALHGSDSFSSSEK	74478	37239	24826	18619.5	14895.6	12413	10639.71429	9309.75	8275.333333	7447.8	6770.727273	6206.5	5729.076923	5319.857143	4965.2	4654.875	4137.666667	3919.894737	3723.9	3103.25	2979.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42702	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	2871827	1435913.5	957275.6667	717956.75	574365.4	478637.8333	410261	358978.375	319091.8889	287182.7	261075.1818	239318.9167	220909.7692	205130.5	191455.1333	179489.1875	159545.9444	151148.7895	143591.35	119659.4583	114873.08	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42703	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42704	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	1167873	583936.5	389291	291968.25	233574.6	194645.5	166839	145984.125	129763.6667	116787.3	106170.2727	97322.75	89836.38462	83419.5	77858.2	72992.0625	64881.83333	61467	58393.65	48661.375	46714.92	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42705	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	254571	127285.5	84857	63642.75	50914.2	42428.5	36367.28571	31821.375	28285.66667	25457.1	23142.81818	21214.25	19582.38462	18183.64286	16971.4	15910.6875	14142.83333	13398.47368	12728.55	10607.125	10182.84	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42706	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	143465	71732.5	47821.66667	35866.25	28693	23910.83333	20495	17933.125	15940.55556	14346.5	13042.27273	11955.41667	11035.76923	10247.5	9564.333333	8966.5625	7970.277778	7550.789474	7173.25	5977.708333	5738.6	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42707	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	139241	69620.5	46413.66667	34810.25	27848.2	23206.83333	19891.57143	17405.125	15471.22222	13924.1	12658.27273	11603.41667	10710.84615	9945.785714	9282.733333	8702.5625	7735.611111	7328.473684	6962.05	5801.708333	5569.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42708	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
42709	CHOYP_BRAFLDRAFT_61845.1.1|m.37831	VVAYDTSVSR	VVAYDTSVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
46493	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	24086012	12043006	8028670.667	6021503	4817202.4	4014335.333	3440858.857	3010751.5	2676223.556	2408601.2	2189637.455	2007167.667	1852770.154	1720429.429	1605734.133	1505375.75	1338111.778	1267684.842	1204300.6	1003583.833	963440.48	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46494	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	18506678	9253339	6168892.667	4626669.5	3701335.6	3084446.333	2643811.143	2313334.75	2056297.556	1850667.8	1682425.273	1542223.167	1423590.615	1321905.571	1233778.533	1156667.375	1028148.778	974035.6842	925333.9	771111.5833	740267.12	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46495	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	8511076	4255538	2837025.333	2127769	1702215.2	1418512.667	1215868	1063884.5	945675.1111	851107.6	773734.1818	709256.3333	654698.1538	607934	567405.0667	531942.25	472837.5556	447951.3684	425553.8	354628.1667	340443.04	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46496	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	981051	490525.5	327017	245262.75	196210.2	163508.5	140150.1429	122631.375	109005.6667	98105.1	89186.45455	81754.25	75465.46154	70075.07143	65403.4	61315.6875	54502.83333	51634.26316	49052.55	40877.125	39242.04	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46497	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	487168	243584	162389.3333	121792	97433.6	81194.66667	69595.42857	60896	54129.77778	48716.8	44288	40597.33333	37474.46154	34797.71429	32477.86667	30448	27064.88889	25640.42105	24358.4	20298.66667	19486.72	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46498	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46499	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	2836850	1418425	945616.6667	709212.5	567370	472808.3333	405264.2857	354606.25	315205.5556	283685	257895.4545	236404.1667	218219.2308	202632.1429	189123.3333	177303.125	157602.7778	149307.8947	141842.5	118202.0833	113474	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46500	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	2125156	1062578	708385.3333	531289	425031.2	354192.6667	303593.7143	265644.5	236128.4444	212515.6	193196	177096.3333	163473.5385	151796.8571	141677.0667	132822.25	118064.2222	111850.3158	106257.8	88548.16667	85006.24	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46501	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46502	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	1080268	540134	360089.3333	270067	216053.6	180044.6667	154324	135033.5	120029.7778	108026.8	98206.18182	90022.33333	83097.53846	77162	72017.86667	67516.75	60014.88889	56856.21053	54013.4	45011.16667	43210.72	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46503	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	885036	442518	295012	221259	177007.2	147506	126433.7143	110629.5	98337.33333	88503.6	80457.81818	73753	68079.69231	63216.85714	59002.4	55314.75	49168.66667	46580.84211	44251.8	36876.5	35401.44	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46504	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	359009	179504.5	119669.6667	89752.25	71801.8	59834.83333	51287	44876.125	39889.88889	35900.9	32637.18182	29917.41667	27616.07692	25643.5	23933.93333	22438.0625	19944.94444	18895.21053	17950.45	14958.70833	14360.36	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46505	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	MAQANLDGVDFEGVK	MAQANLDGVDFEGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46506	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46507	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46508	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46509	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	74229	37114.5	24743	18557.25	14845.8	12371.5	10604.14286	9278.625	8247.666667	7422.9	6748.090909	6185.75	5709.923077	5302.071429	4948.6	4639.3125	4123.833333	3906.789474	3711.45	3092.875	2969.16	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46510	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46511	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	473015	236507.5	157671.6667	118253.75	94603	78835.83333	67573.57143	59126.875	52557.22222	47301.5	43001.36364	39417.91667	36385.76923	33786.78571	31534.33333	29563.4375	26278.61111	24895.52632	23650.75	19708.95833	18920.6	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46512	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	236270	118135	78756.66667	59067.5	47254	39378.33333	33752.85714	29533.75	26252.22222	23627	21479.09091	19689.16667	18174.61538	16876.42857	15751.33333	14766.875	13126.11111	12435.26316	11813.5	9844.583333	9450.8	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46513	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	242779	121389.5	80926.33333	60694.75	48555.8	40463.16667	34682.71429	30347.375	26975.44444	24277.9	22070.81818	20231.58333	18675.30769	17341.35714	16185.26667	15173.6875	13487.72222	12777.84211	12138.95	10115.79167	9711.16	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46514	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
46515	CHOYP_BRAFLDRAFT_83361.1.1|m.59005	GDDPYYDSYYSR	GDDPYYDSYYSR	23743	11871.5	7914.333333	5935.75	4748.6	3957.166667	3391.857143	2967.875	2638.111111	2374.3	2158.454545	1978.583333	1826.384615	1695.928571	1582.866667	1483.9375	1319.055556	1249.631579	1187.15	989.2916667	949.72	Q8C7Q4	RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)	Rbm4 Rbm4a	"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380]; stress-activated MAPK cascade [GO:0051403]"	GO:0000166; GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0044822; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0051403; GO:0097157; GO:0097158; GO:0097167
54008	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	3179558	1589779	1059852.667	794889.5	635911.6	529926.3333	454222.5714	397444.75	353284.2222	317955.8	289050.7273	264963.1667	244581.3846	227111.2857	211970.5333	198722.375	176642.1111	167345.1579	158977.9	132481.5833	127182.32	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54009	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	1136783	568391.5	378927.6667	284195.75	227356.6	189463.8333	162397.5714	142097.875	126309.2222	113678.3	103343.9091	94731.91667	87444.84615	81198.78571	75785.53333	71048.9375	63154.61111	59830.68421	56839.15	47365.95833	45471.32	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54010	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	267830	133915	89276.66667	66957.5	53566	44638.33333	38261.42857	33478.75	29758.88889	26783	24348.18182	22319.16667	20602.30769	19130.71429	17855.33333	16739.375	14879.44444	14096.31579	13391.5	11159.58333	10713.2	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54011	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	548837	274418.5	182945.6667	137209.25	109767.4	91472.83333	78405.28571	68604.625	60981.88889	54883.7	49894.27273	45736.41667	42218.23077	39202.64286	36589.13333	34302.3125	30490.94444	28886.15789	27441.85	22868.20833	21953.48	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54012	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	162115	81057.5	54038.33333	40528.75	32423	27019.16667	23159.28571	20264.375	18012.77778	16211.5	14737.72727	13509.58333	12470.38462	11579.64286	10807.66667	10132.1875	9006.388889	8532.368421	8105.75	6754.791667	6484.6	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54013	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	119544	59772	39848	29886	23908.8	19924	17077.71429	14943	13282.66667	11954.4	10867.63636	9962	9195.692308	8538.857143	7969.6	7471.5	6641.333333	6291.789474	5977.2	4981	4781.76	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54014	CHOYP_CASP3.2.3|m.24896	IDINEIILR	IDINEIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54015	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	1115836	557918	371945.3333	278959	223167.2	185972.6667	159405.1429	139479.5	123981.7778	111583.6	101439.6364	92986.33333	85833.53846	79702.57143	74389.06667	69739.75	61990.88889	58728.21053	55791.8	46493.16667	44633.44	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54016	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54017	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54018	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54019	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	82856	41428	27618.66667	20714	16571.2	13809.33333	11836.57143	10357	9206.222222	8285.6	7532.363636	6904.666667	6373.538462	5918.285714	5523.733333	5178.5	4603.111111	4360.842105	4142.8	3452.333333	3314.24	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54020	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	204620	102310	68206.66667	51155	40924	34103.33333	29231.42857	25577.5	22735.55556	20462	18601.81818	17051.66667	15740	14615.71429	13641.33333	12788.75	11367.77778	10769.47368	10231	8525.833333	8184.8	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54021	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	196699	98349.5	65566.33333	49174.75	39339.8	32783.16667	28099.85714	24587.375	21855.44444	19669.9	17881.72727	16391.58333	15130.69231	14049.92857	13113.26667	12293.6875	10927.72222	10352.57895	9834.95	8195.791667	7867.96	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54022	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54023	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54024	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54025	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54026	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54027	CHOYP_CASP3.2.3|m.24896	MNWDLQDESWSSGPR	MNWDLQDESWSSGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P70677	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	Casp3 Cpp32	apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	GO:0001666; GO:0001782; GO:0004190; GO:0004197; GO:0004252; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0042060; GO:0042493; GO:0042542; GO:0043029; GO:0043066; GO:0043200; GO:0043525; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051384; GO:0051402; GO:0070059; GO:0071310; GO:0071407; GO:0097153; GO:0097192; GO:0097194; GO:0097200
54373	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54374	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54375	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54376	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54377	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	1284991	642495.5	428330.3333	321247.75	256998.2	214165.1667	183570.1429	160623.875	142776.7778	128499.1	116817.3636	107082.5833	98845.46154	91785.07143	85666.06667	80311.9375	71388.38889	67631.10526	64249.55	53541.29167	51399.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54378	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	5721289	2860644.5	1907096.333	1430322.25	1144257.8	953548.1667	817327	715161.125	635698.7778	572128.9	520117.1818	476774.0833	440099.1538	408663.5	381419.2667	357580.5625	317849.3889	301120.4737	286064.45	238387.0417	228851.56	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54379	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54380	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	1440183	720091.5	480061	360045.75	288036.6	240030.5	205740.4286	180022.875	160020.3333	144018.3	130925.7273	120015.25	110783.3077	102870.2143	96012.2	90011.4375	80010.16667	75799.10526	72009.15	60007.625	57607.32	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54381	CHOYP_CATA.1.3|m.11120	LSAEDPDYAIR	LSAEDPDYAIR	232215	116107.5	77405	58053.75	46443	38702.5	33173.57143	29026.875	25801.66667	23221.5	21110.45455	19351.25	17862.69231	16586.78571	15481	14513.4375	12900.83333	12221.84211	11610.75	9675.625	9288.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54382	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	73393400	36696700	24464466.67	18348350	14678680	12232233.33	10484771.43	9174175	8154822.222	7339340	6672127.273	6116116.667	5645646.154	5242385.714	4892893.333	4587087.5	4077411.111	3862810.526	3669670	3058058.333	2935736	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54383	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	44792544	22396272	14930848	11198136	8958508.8	7465424	6398934.857	5599068	4976949.333	4479254.4	4072049.455	3732712	3445580.308	3199467.429	2986169.6	2799534	2488474.667	2357502.316	2239627.2	1866356	1791701.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54384	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	23912600	11956300	7970866.667	5978150	4782520	3985433.333	3416085.714	2989075	2656955.556	2391260	2173872.727	1992716.667	1839430.769	1708042.857	1594173.333	1494537.5	1328477.778	1258557.895	1195630	996358.3333	956504	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54385	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	10508771	5254385.5	3502923.667	2627192.75	2101754.2	1751461.833	1501253	1313596.375	1167641.222	1050877.1	955342.8182	875730.9167	808367	750626.5	700584.7333	656798.1875	583820.6111	553093.2105	525438.55	437865.4583	420350.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54386	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	7291400	3645700	2430466.667	1822850	1458280	1215233.333	1041628.571	911425	810155.5556	729140	662854.5455	607616.6667	560876.9231	520814.2857	486093.3333	455712.5	405077.7778	383757.8947	364570	303808.3333	291656	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54387	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	17465868	8732934	5821956	4366467	3493173.6	2910978	2495124	2183233.5	1940652	1746586.8	1587806.182	1455489	1343528.308	1247562	1164391.2	1091616.75	970326	919256.2105	873293.4	727744.5	698634.72	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54388	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	692691	346345.5	230897	173172.75	138538.2	115448.5	98955.85714	86586.375	76965.66667	69269.1	62971.90909	57724.25	53283.92308	49477.92857	46179.4	43293.1875	38482.83333	36457.42105	34634.55	28862.125	27707.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54389	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	2313186	1156593	771062	578296.5	462637.2	385531	330455.1429	289148.25	257020.6667	231318.6	210289.6364	192765.5	177937.3846	165227.5714	154212.4	144574.125	128510.3333	121746.6316	115659.3	96382.75	92527.44	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54390	CHOYP_CATA.1.3|m.11120	IQIMTPEQAEK	IQIMTPEQAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54391	CHOYP_CATA.1.3|m.11120	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54392	CHOYP_CATA.1.3|m.11120	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54393	CHOYP_CATA.1.3|m.11120	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54394	CHOYP_CATA.1.3|m.11120	WNPFDVTK	WNPFDVTK	293038	146519	97679.33333	73259.5	58607.6	48839.66667	41862.57143	36629.75	32559.77778	29303.8	26639.81818	24419.83333	22541.38462	20931.28571	19535.86667	18314.875	16279.88889	15423.05263	14651.9	12209.91667	11721.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54395	CHOYP_CATA.1.3|m.11120	WNPFDVTK	WNPFDVTK	532114	266057	177371.3333	133028.5	106422.8	88685.66667	76016.28571	66514.25	59123.77778	53211.4	48374	44342.83333	40931.84615	38008.14286	35474.26667	33257.125	29561.88889	28006	26605.7	22171.41667	21284.56	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54396	CHOYP_CATA.1.3|m.11120	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54397	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	56192312	28096156	18730770.67	14048078	11238462.4	9365385.333	8027473.143	7024039	6243590.222	5619231.2	5108392	4682692.667	4322485.538	4013736.571	3746154.133	3512019.5	3121795.111	2957490.105	2809615.6	2341346.333	2247692.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54398	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	34771544	17385772	11590514.67	8692886	6954308.8	5795257.333	4967363.429	4346443	3863504.889	3477154.4	3161049.455	2897628.667	2674734.154	2483681.714	2318102.933	2173221.5	1931752.444	1830081.263	1738577.2	1448814.333	1390861.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54399	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	8811298	4405649	2937099.333	2202824.5	1762259.6	1468549.667	1258756.857	1101412.25	979033.1111	881129.8	801027.0909	734274.8333	677792.1538	629378.4286	587419.8667	550706.125	489516.5556	463752.5263	440564.9	367137.4167	352451.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54400	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	4241265	2120632.5	1413755	1060316.25	848253	706877.5	605895	530158.125	471251.6667	424126.5	385569.5455	353438.75	326251.1538	302947.5	282751	265079.0625	235625.8333	223224.4737	212063.25	176719.375	169650.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54401	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	4756225	2378112.5	1585408.333	1189056.25	951245	792704.1667	679460.7143	594528.125	528469.4444	475622.5	432384.0909	396352.0833	365863.4615	339730.3571	317081.6667	297264.0625	264234.7222	250327.6316	237811.25	198176.0417	190249	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54402	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	826594	413297	275531.3333	206648.5	165318.8	137765.6667	118084.8571	103324.25	91843.77778	82659.4	75144.90909	68882.83333	63584.15385	59042.42857	55106.26667	51662.125	45921.88889	43504.94737	41329.7	34441.41667	33063.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54403	CHOYP_CATA.1.3|m.11120	LFSYSDTHR	LFSYSDTHR	2735738	1367869	911912.6667	683934.5	547147.6	455956.3333	390819.7143	341967.25	303970.8889	273573.8	248703.4545	227978.1667	210441.3846	195409.8571	182382.5333	170983.625	151985.4444	143986.2105	136786.9	113989.0833	109429.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54404	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	27497600	13748800	9165866.667	6874400	5499520	4582933.333	3928228.571	3437200	3055288.889	2749760	2499781.818	2291466.667	2115200	1964114.286	1833173.333	1718600	1527644.444	1447242.105	1374880	1145733.333	1099904	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54405	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	26081526	13040763	8693842	6520381.5	5216305.2	4346921	3725932.286	3260190.75	2897947.333	2608152.6	2371047.818	2173460.5	2006271.231	1862966.143	1738768.4	1630095.375	1448973.667	1372711.895	1304076.3	1086730.25	1043261.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54406	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	9157644	4578822	3052548	2289411	1831528.8	1526274	1308234.857	1144705.5	1017516	915764.4	832513.0909	763137	704434.1538	654117.4286	610509.6	572352.75	508758	481981.2632	457882.2	381568.5	366305.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54407	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	950924	475462	316974.6667	237731	190184.8	158487.3333	135846.2857	118865.5	105658.2222	95092.4	86447.63636	79243.66667	73148	67923.14286	63394.93333	59432.75	52829.11111	50048.63158	47546.2	39621.83333	38036.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54408	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	793412	396706	264470.6667	198353	158682.4	132235.3333	113344.5714	99176.5	88156.88889	79341.2	72128.36364	66117.66667	61031.69231	56672.28571	52894.13333	49588.25	44078.44444	41758.52632	39670.6	33058.83333	31736.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54409	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	4239965	2119982.5	1413321.667	1059991.25	847993	706660.8333	605709.2857	529995.625	471107.2222	423996.5	385451.3636	353330.4167	326151.1538	302854.6429	282664.3333	264997.8125	235553.6111	223156.0526	211998.25	176665.2083	169598.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54410	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	400184	200092	133394.6667	100046	80036.8	66697.33333	57169.14286	50023	44464.88889	40018.4	36380.36364	33348.66667	30783.38462	28584.57143	26678.93333	25011.5	22232.44444	21062.31579	20009.2	16674.33333	16007.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54411	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	1150106	575053	383368.6667	287526.5	230021.2	191684.3333	164300.8571	143763.25	127789.5556	115010.6	104555.0909	95842.16667	88469.69231	82150.42857	76673.73333	71881.625	63894.77778	60531.89474	57505.3	47921.08333	46004.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54412	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	577115	288557.5	192371.6667	144278.75	115423	96185.83333	82445	72139.375	64123.88889	57711.5	52465	48092.91667	44393.46154	41222.5	38474.33333	36069.6875	32061.94444	30374.47368	28855.75	24046.45833	23084.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54413	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	1376200	688100	458733.3333	344050	275240	229366.6667	196600	172025	152911.1111	137620	125109.0909	114683.3333	105861.5385	98300	91746.66667	86012.5	76455.55556	72431.57895	68810	57341.66667	55048	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54414	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	1833123	916561.5	611041	458280.75	366624.6	305520.5	261874.7143	229140.375	203680.3333	183312.3	166647.5455	152760.25	141009.4615	130937.3571	122208.2	114570.1875	101840.1667	96480.15789	91656.15	76380.125	73324.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54415	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	566701	283350.5	188900.3333	141675.25	113340.2	94450.16667	80957.28571	70837.625	62966.77778	56670.1	51518.27273	47225.08333	43592.38462	40478.64286	37780.06667	35418.8125	31483.38889	29826.36842	28335.05	23612.54167	22668.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54416	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	20487092	10243546	6829030.667	5121773	4097418.4	3414515.333	2926727.429	2560886.5	2276343.556	2048709.2	1862462.909	1707257.667	1575930.154	1463363.714	1365806.133	1280443.25	1138171.778	1078268	1024354.6	853628.8333	819483.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54417	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	16546984	8273492	5515661.333	4136746	3309396.8	2757830.667	2363854.857	2068373	1838553.778	1654698.4	1504271.273	1378915.333	1272844.923	1181927.429	1103132.267	1034186.5	919276.8889	870893.8947	827349.2	689457.6667	661879.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54418	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	8295566	4147783	2765188.667	2073891.5	1659113.2	1382594.333	1185080.857	1036945.75	921729.5556	829556.6	754142.3636	691297.1667	638120.4615	592540.4286	553037.7333	518472.875	460864.7778	436608.7368	414778.3	345648.5833	331822.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54419	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54420	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54421	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	1251551	625775.5	417183.6667	312887.75	250310.2	208591.8333	178793	156443.875	139061.2222	125155.1	113777.3636	104295.9167	96273.15385	89396.5	83436.73333	78221.9375	69530.61111	65871.10526	62577.55	52147.95833	50062.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54422	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54423	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	99106	49553	33035.33333	24776.5	19821.2	16517.66667	14158	12388.25	11011.77778	9910.6	9009.636364	8258.833333	7623.538462	7079	6607.066667	6194.125	5505.888889	5216.105263	4955.3	4129.416667	3964.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54424	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	470612	235306	156870.6667	117653	94122.4	78435.33333	67230.28571	58826.5	52290.22222	47061.2	42782.90909	39217.66667	36200.92308	33615.14286	31374.13333	29413.25	26145.11111	24769.05263	23530.6	19608.83333	18824.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54425	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	829709	414854.5	276569.6667	207427.25	165941.8	138284.8333	118529.8571	103713.625	92189.88889	82970.9	75428.09091	69142.41667	63823.76923	59264.92857	55313.93333	51856.8125	46094.94444	43668.89474	41485.45	34571.20833	33188.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54426	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	912092	456046	304030.6667	228023	182418.4	152015.3333	130298.8571	114011.5	101343.5556	91209.2	82917.45455	76007.66667	70160.92308	65149.42857	60806.13333	57005.75	50671.77778	48004.84211	45604.6	38003.83333	36483.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54427	CHOYP_CATA.1.3|m.11120	LVENIGNHLINTQK	LVENIGNHLINTQK	370873	185436.5	123624.3333	92718.25	74174.6	61812.16667	52981.85714	46359.125	41208.11111	37087.3	33715.72727	30906.08333	28528.69231	26490.92857	24724.86667	23179.5625	20604.05556	19519.63158	18543.65	15453.04167	14834.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54428	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	16095708	8047854	5365236	4023927	3219141.6	2682618	2299386.857	2011963.5	1788412	1609570.8	1463246.182	1341309	1238131.385	1149693.429	1073047.2	1005981.75	894206	847142.5263	804785.4	670654.5	643828.32	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54429	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54430	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	4158250	2079125	1386083.333	1039562.5	831650	693041.6667	594035.7143	519781.25	462027.7778	415825	378022.7273	346520.8333	319865.3846	297017.8571	277216.6667	259890.625	231013.8889	218855.2632	207912.5	173260.4167	166330	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54431	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	324946	162473	108315.3333	81236.5	64989.2	54157.66667	46420.85714	40618.25	36105.11111	32494.6	29540.54545	27078.83333	24995.84615	23210.42857	21663.06667	20309.125	18052.55556	17102.42105	16247.3	13539.41667	12997.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54432	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	636065	318032.5	212021.6667	159016.25	127213	106010.8333	90866.42857	79508.125	70673.88889	63606.5	57824.09091	53005.41667	48928.07692	45433.21429	42404.33333	39754.0625	35336.94444	33477.10526	31803.25	26502.70833	25442.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54433	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	388880	194440	129626.6667	97220	77776	64813.33333	55554.28571	48610	43208.88889	38888	35352.72727	32406.66667	29913.84615	27777.14286	25925.33333	24305	21604.44444	20467.36842	19444	16203.33333	15555.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54434	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	6052780	3026390	2017593.333	1513195	1210556	1008796.667	864682.8571	756597.5	672531.1111	605278	550252.7273	504398.3333	465598.4615	432341.4286	403518.6667	378298.75	336265.5556	318567.3684	302639	252199.1667	242111.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54435	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	80048	40024	26682.66667	20012	16009.6	13341.33333	11435.42857	10006	8894.222222	8004.8	7277.090909	6670.666667	6157.538462	5717.714286	5336.533333	5003	4447.111111	4213.052632	4002.4	3335.333333	3201.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54436	CHOYP_CATA.1.3|m.11120	NFGQADPEFGR	NFGQADPEFGR	644174	322087	214724.6667	161043.5	128834.8	107362.3333	92024.85714	80521.75	71574.88889	64417.4	58561.27273	53681.16667	49551.84615	46012.42857	42944.93333	40260.875	35787.44444	33903.89474	32208.7	26840.58333	25766.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54437	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	41958916	20979458	13986305.33	10489729	8391783.2	6993152.667	5994130.857	5244864.5	4662101.778	4195891.6	3814446.909	3496576.333	3227608.923	2997065.429	2797261.067	2622432.25	2331050.889	2208364	2097945.8	1748288.167	1678356.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54438	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	29921946	14960973	9973982	7480486.5	5984389.2	4986991	4274563.714	3740243.25	3324660.667	2992194.6	2720176.909	2493495.5	2301688.154	2137281.857	1994796.4	1870121.625	1662330.333	1574839.263	1496097.3	1246747.75	1196877.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54439	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	11830915	5915457.5	3943638.333	2957728.75	2366183	1971819.167	1690130.714	1478864.375	1314546.111	1183091.5	1075537.727	985909.5833	910070.3846	845065.3571	788727.6667	739432.1875	657273.0556	622679.7368	591545.75	492954.7917	473236.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54440	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1271898	635949	423966	317974.5	254379.6	211983	181699.7143	158987.25	141322	127189.8	115627.0909	105991.5	97838.30769	90849.85714	84793.2	79493.625	70661	66942	63594.9	52995.75	50875.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54441	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	2951116	1475558	983705.3333	737779	590223.2	491852.6667	421588	368889.5	327901.7778	295111.6	268283.2727	245926.3333	227008.9231	210794	196741.0667	184444.75	163950.8889	155321.8947	147555.8	122963.1667	118044.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54442	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	2761340	1380670	920446.6667	690335	552268	460223.3333	394477.1429	345167.5	306815.5556	276134	251030.9091	230111.6667	212410.7692	197238.5714	184089.3333	172583.75	153407.7778	145333.6842	138067	115055.8333	110453.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54443	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1011286	505643	337095.3333	252821.5	202257.2	168547.6667	144469.4286	126410.75	112365.1111	101128.6	91935.09091	84273.83333	77791.23077	72234.71429	67419.06667	63205.375	56182.55556	53225.57895	50564.3	42136.91667	40451.44	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54444	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54445	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1206901	603450.5	402300.3333	301725.25	241380.2	201150.1667	172414.4286	150862.625	134100.1111	120690.1	109718.2727	100575.0833	92838.53846	86207.21429	80460.06667	75431.3125	67050.05556	63521.10526	60345.05	50287.54167	48276.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54446	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	109581	54790.5	36527	27395.25	21916.2	18263.5	15654.42857	13697.625	12175.66667	10958.1	9961.909091	9131.75	8429.307692	7827.214286	7305.4	6848.8125	6087.833333	5767.421053	5479.05	4565.875	4383.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54447	CHOYP_CATA.1.3|m.11120	LQAHLDSVSNVSK	LQAHLDSVSNVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54448	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	31649338	15824669	10549779.33	7912334.5	6329867.6	5274889.667	4521334	3956167.25	3516593.111	3164933.8	2877212.545	2637444.833	2434564.462	2260667	2109955.867	1978083.625	1758296.556	1665754.632	1582466.9	1318722.417	1265973.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54449	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	18922978	9461489	6307659.333	4730744.5	3784595.6	3153829.667	2703282.571	2365372.25	2102553.111	1892297.8	1720270.727	1576914.833	1455613.692	1351641.286	1261531.867	1182686.125	1051276.556	995946.2105	946148.9	788457.4167	756919.12	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54450	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	3625712	1812856	1208570.667	906428	725142.4	604285.3333	517958.8571	453214	402856.8889	362571.2	329610.1818	302142.6667	278900.9231	258979.4286	241714.1333	226607	201428.4444	190826.9474	181285.6	151071.3333	145028.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54451	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	4431710	2215855	1477236.667	1107927.5	886342	738618.3333	633101.4286	553963.75	492412.2222	443171	402882.7273	369309.1667	340900.7692	316550.7143	295447.3333	276981.875	246206.1111	233247.8947	221585.5	184654.5833	177268.4	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54452	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	4396362	2198181	1465454	1099090.5	879272.4	732727	628051.7143	549545.25	488484.6667	439636.2	399669.2727	366363.5	338181.6923	314025.8571	293090.8	274772.625	244242.3333	231387.4737	219818.1	183181.75	175854.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54453	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	1679318	839659	559772.6667	419829.5	335863.6	279886.3333	239902.5714	209914.75	186590.8889	167931.8	152665.2727	139943.1667	129178.3077	119951.2857	111954.5333	104957.375	93295.44444	88385.15789	83965.9	69971.58333	67172.72	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54454	CHOYP_CATA.1.3|m.11120	INVVLNGVK	INVVLNGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54528	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	27497600	13748800	9165866.667	6874400	5499520	4582933.333	3928228.571	3437200	3055288.889	2749760	2499781.818	2291466.667	2115200	1964114.286	1833173.333	1718600	1527644.444	1447242.105	1374880	1145733.333	1099904	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54529	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	26081526	13040763	8693842	6520381.5	5216305.2	4346921	3725932.286	3260190.75	2897947.333	2608152.6	2371047.818	2173460.5	2006271.231	1862966.143	1738768.4	1630095.375	1448973.667	1372711.895	1304076.3	1086730.25	1043261.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54530	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	9157644	4578822	3052548	2289411	1831528.8	1526274	1308234.857	1144705.5	1017516	915764.4	832513.0909	763137	704434.1538	654117.4286	610509.6	572352.75	508758	481981.2632	457882.2	381568.5	366305.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54531	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	950924	475462	316974.6667	237731	190184.8	158487.3333	135846.2857	118865.5	105658.2222	95092.4	86447.63636	79243.66667	73148	67923.14286	63394.93333	59432.75	52829.11111	50048.63158	47546.2	39621.83333	38036.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54532	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	793412	396706	264470.6667	198353	158682.4	132235.3333	113344.5714	99176.5	88156.88889	79341.2	72128.36364	66117.66667	61031.69231	56672.28571	52894.13333	49588.25	44078.44444	41758.52632	39670.6	33058.83333	31736.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54533	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	4239965	2119982.5	1413321.667	1059991.25	847993	706660.8333	605709.2857	529995.625	471107.2222	423996.5	385451.3636	353330.4167	326151.1538	302854.6429	282664.3333	264997.8125	235553.6111	223156.0526	211998.25	176665.2083	169598.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54534	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	400184	200092	133394.6667	100046	80036.8	66697.33333	57169.14286	50023	44464.88889	40018.4	36380.36364	33348.66667	30783.38462	28584.57143	26678.93333	25011.5	22232.44444	21062.31579	20009.2	16674.33333	16007.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54535	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	1150106	575053	383368.6667	287526.5	230021.2	191684.3333	164300.8571	143763.25	127789.5556	115010.6	104555.0909	95842.16667	88469.69231	82150.42857	76673.73333	71881.625	63894.77778	60531.89474	57505.3	47921.08333	46004.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54536	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	577115	288557.5	192371.6667	144278.75	115423	96185.83333	82445	72139.375	64123.88889	57711.5	52465	48092.91667	44393.46154	41222.5	38474.33333	36069.6875	32061.94444	30374.47368	28855.75	24046.45833	23084.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54537	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	1376200	688100	458733.3333	344050	275240	229366.6667	196600	172025	152911.1111	137620	125109.0909	114683.3333	105861.5385	98300	91746.66667	86012.5	76455.55556	72431.57895	68810	57341.66667	55048	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54538	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	1833123	916561.5	611041	458280.75	366624.6	305520.5	261874.7143	229140.375	203680.3333	183312.3	166647.5455	152760.25	141009.4615	130937.3571	122208.2	114570.1875	101840.1667	96480.15789	91656.15	76380.125	73324.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54539	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	566701	283350.5	188900.3333	141675.25	113340.2	94450.16667	80957.28571	70837.625	62966.77778	56670.1	51518.27273	47225.08333	43592.38462	40478.64286	37780.06667	35418.8125	31483.38889	29826.36842	28335.05	23612.54167	22668.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54540	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	20487092	10243546	6829030.667	5121773	4097418.4	3414515.333	2926727.429	2560886.5	2276343.556	2048709.2	1862462.909	1707257.667	1575930.154	1463363.714	1365806.133	1280443.25	1138171.778	1078268	1024354.6	853628.8333	819483.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54541	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	16546984	8273492	5515661.333	4136746	3309396.8	2757830.667	2363854.857	2068373	1838553.778	1654698.4	1504271.273	1378915.333	1272844.923	1181927.429	1103132.267	1034186.5	919276.8889	870893.8947	827349.2	689457.6667	661879.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54542	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	8295566	4147783	2765188.667	2073891.5	1659113.2	1382594.333	1185080.857	1036945.75	921729.5556	829556.6	754142.3636	691297.1667	638120.4615	592540.4286	553037.7333	518472.875	460864.7778	436608.7368	414778.3	345648.5833	331822.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54543	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54544	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54545	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	1251551	625775.5	417183.6667	312887.75	250310.2	208591.8333	178793	156443.875	139061.2222	125155.1	113777.3636	104295.9167	96273.15385	89396.5	83436.73333	78221.9375	69530.61111	65871.10526	62577.55	52147.95833	50062.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54546	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54547	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	99106	49553	33035.33333	24776.5	19821.2	16517.66667	14158	12388.25	11011.77778	9910.6	9009.636364	8258.833333	7623.538462	7079	6607.066667	6194.125	5505.888889	5216.105263	4955.3	4129.416667	3964.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54548	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	470612	235306	156870.6667	117653	94122.4	78435.33333	67230.28571	58826.5	52290.22222	47061.2	42782.90909	39217.66667	36200.92308	33615.14286	31374.13333	29413.25	26145.11111	24769.05263	23530.6	19608.83333	18824.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54549	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	829709	414854.5	276569.6667	207427.25	165941.8	138284.8333	118529.8571	103713.625	92189.88889	82970.9	75428.09091	69142.41667	63823.76923	59264.92857	55313.93333	51856.8125	46094.94444	43668.89474	41485.45	34571.20833	33188.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54550	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	912092	456046	304030.6667	228023	182418.4	152015.3333	130298.8571	114011.5	101343.5556	91209.2	82917.45455	76007.66667	70160.92308	65149.42857	60806.13333	57005.75	50671.77778	48004.84211	45604.6	38003.83333	36483.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54551	CHOYP_CATA.2.3|m.18456	LVENIGNHLINTQK	LVENIGNHLINTQK	370873	185436.5	123624.3333	92718.25	74174.6	61812.16667	52981.85714	46359.125	41208.11111	37087.3	33715.72727	30906.08333	28528.69231	26490.92857	24724.86667	23179.5625	20604.05556	19519.63158	18543.65	15453.04167	14834.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54552	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	16095708	8047854	5365236	4023927	3219141.6	2682618	2299386.857	2011963.5	1788412	1609570.8	1463246.182	1341309	1238131.385	1149693.429	1073047.2	1005981.75	894206	847142.5263	804785.4	670654.5	643828.32	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54553	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54554	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	4158250	2079125	1386083.333	1039562.5	831650	693041.6667	594035.7143	519781.25	462027.7778	415825	378022.7273	346520.8333	319865.3846	297017.8571	277216.6667	259890.625	231013.8889	218855.2632	207912.5	173260.4167	166330	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54555	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	324946	162473	108315.3333	81236.5	64989.2	54157.66667	46420.85714	40618.25	36105.11111	32494.6	29540.54545	27078.83333	24995.84615	23210.42857	21663.06667	20309.125	18052.55556	17102.42105	16247.3	13539.41667	12997.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54556	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	636065	318032.5	212021.6667	159016.25	127213	106010.8333	90866.42857	79508.125	70673.88889	63606.5	57824.09091	53005.41667	48928.07692	45433.21429	42404.33333	39754.0625	35336.94444	33477.10526	31803.25	26502.70833	25442.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54557	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	388880	194440	129626.6667	97220	77776	64813.33333	55554.28571	48610	43208.88889	38888	35352.72727	32406.66667	29913.84615	27777.14286	25925.33333	24305	21604.44444	20467.36842	19444	16203.33333	15555.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54558	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	6052780	3026390	2017593.333	1513195	1210556	1008796.667	864682.8571	756597.5	672531.1111	605278	550252.7273	504398.3333	465598.4615	432341.4286	403518.6667	378298.75	336265.5556	318567.3684	302639	252199.1667	242111.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54559	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	80048	40024	26682.66667	20012	16009.6	13341.33333	11435.42857	10006	8894.222222	8004.8	7277.090909	6670.666667	6157.538462	5717.714286	5336.533333	5003	4447.111111	4213.052632	4002.4	3335.333333	3201.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54560	CHOYP_CATA.2.3|m.18456	NFGQADPEFGR	NFGQADPEFGR	644174	322087	214724.6667	161043.5	128834.8	107362.3333	92024.85714	80521.75	71574.88889	64417.4	58561.27273	53681.16667	49551.84615	46012.42857	42944.93333	40260.875	35787.44444	33903.89474	32208.7	26840.58333	25766.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54561	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	41958916	20979458	13986305.33	10489729	8391783.2	6993152.667	5994130.857	5244864.5	4662101.778	4195891.6	3814446.909	3496576.333	3227608.923	2997065.429	2797261.067	2622432.25	2331050.889	2208364	2097945.8	1748288.167	1678356.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54562	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	29921946	14960973	9973982	7480486.5	5984389.2	4986991	4274563.714	3740243.25	3324660.667	2992194.6	2720176.909	2493495.5	2301688.154	2137281.857	1994796.4	1870121.625	1662330.333	1574839.263	1496097.3	1246747.75	1196877.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54563	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	11830915	5915457.5	3943638.333	2957728.75	2366183	1971819.167	1690130.714	1478864.375	1314546.111	1183091.5	1075537.727	985909.5833	910070.3846	845065.3571	788727.6667	739432.1875	657273.0556	622679.7368	591545.75	492954.7917	473236.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54564	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1271898	635949	423966	317974.5	254379.6	211983	181699.7143	158987.25	141322	127189.8	115627.0909	105991.5	97838.30769	90849.85714	84793.2	79493.625	70661	66942	63594.9	52995.75	50875.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54565	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	2951116	1475558	983705.3333	737779	590223.2	491852.6667	421588	368889.5	327901.7778	295111.6	268283.2727	245926.3333	227008.9231	210794	196741.0667	184444.75	163950.8889	155321.8947	147555.8	122963.1667	118044.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54566	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	2761340	1380670	920446.6667	690335	552268	460223.3333	394477.1429	345167.5	306815.5556	276134	251030.9091	230111.6667	212410.7692	197238.5714	184089.3333	172583.75	153407.7778	145333.6842	138067	115055.8333	110453.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54567	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1011286	505643	337095.3333	252821.5	202257.2	168547.6667	144469.4286	126410.75	112365.1111	101128.6	91935.09091	84273.83333	77791.23077	72234.71429	67419.06667	63205.375	56182.55556	53225.57895	50564.3	42136.91667	40451.44	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54568	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54569	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1206901	603450.5	402300.3333	301725.25	241380.2	201150.1667	172414.4286	150862.625	134100.1111	120690.1	109718.2727	100575.0833	92838.53846	86207.21429	80460.06667	75431.3125	67050.05556	63521.10526	60345.05	50287.54167	48276.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54570	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	109581	54790.5	36527	27395.25	21916.2	18263.5	15654.42857	13697.625	12175.66667	10958.1	9961.909091	9131.75	8429.307692	7827.214286	7305.4	6848.8125	6087.833333	5767.421053	5479.05	4565.875	4383.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54571	CHOYP_CATA.2.3|m.18456	LQAHLDSVSNVSK	LQAHLDSVSNVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54572	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	31649338	15824669	10549779.33	7912334.5	6329867.6	5274889.667	4521334	3956167.25	3516593.111	3164933.8	2877212.545	2637444.833	2434564.462	2260667	2109955.867	1978083.625	1758296.556	1665754.632	1582466.9	1318722.417	1265973.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54573	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	18922978	9461489	6307659.333	4730744.5	3784595.6	3153829.667	2703282.571	2365372.25	2102553.111	1892297.8	1720270.727	1576914.833	1455613.692	1351641.286	1261531.867	1182686.125	1051276.556	995946.2105	946148.9	788457.4167	756919.12	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54574	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	3625712	1812856	1208570.667	906428	725142.4	604285.3333	517958.8571	453214	402856.8889	362571.2	329610.1818	302142.6667	278900.9231	258979.4286	241714.1333	226607	201428.4444	190826.9474	181285.6	151071.3333	145028.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54575	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	4431710	2215855	1477236.667	1107927.5	886342	738618.3333	633101.4286	553963.75	492412.2222	443171	402882.7273	369309.1667	340900.7692	316550.7143	295447.3333	276981.875	246206.1111	233247.8947	221585.5	184654.5833	177268.4	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54576	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	4396362	2198181	1465454	1099090.5	879272.4	732727	628051.7143	549545.25	488484.6667	439636.2	399669.2727	366363.5	338181.6923	314025.8571	293090.8	274772.625	244242.3333	231387.4737	219818.1	183181.75	175854.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54577	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	1679318	839659	559772.6667	419829.5	335863.6	279886.3333	239902.5714	209914.75	186590.8889	167931.8	152665.2727	139943.1667	129178.3077	119951.2857	111954.5333	104957.375	93295.44444	88385.15789	83965.9	69971.58333	67172.72	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54578	CHOYP_CATA.2.3|m.18456	INVVLNGVK	INVVLNGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54579	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	63109332	31554666	21036444	15777333	12621866.4	10518222	9015618.857	7888666.5	7012148	6310933.2	5737212	5259111	4854564	4507809.429	4207288.8	3944333.25	3506074	3321543.789	3155466.6	2629555.5	2524373.28	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54580	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	34268172	17134086	11422724	8567043	6853634.4	5711362	4895453.143	4283521.5	3807574.667	3426817.2	3115288.364	2855681	2636013.231	2447726.571	2284544.8	2141760.75	1903787.333	1803588	1713408.6	1427840.5	1370726.88	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54581	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	10915545	5457772.5	3638515	2728886.25	2183109	1819257.5	1559363.571	1364443.125	1212838.333	1091554.5	992322.2727	909628.75	839657.3077	779681.7857	727703	682221.5625	606419.1667	574502.3684	545777.25	454814.375	436621.8	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54582	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54583	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54584	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54585	CHOYP_CATA.3.3|m.21642	ATEQLNEFK	ATEQLNEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54586	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	18358698	9179349	6119566	4589674.5	3671739.6	3059783	2622671.143	2294837.25	2039855.333	1835869.8	1668972.545	1529891.5	1412207.538	1311335.571	1223913.2	1147418.625	1019927.667	966247.2632	917934.9	764945.75	734347.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54587	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	10550499	5275249.5	3516833	2637624.75	2110099.8	1758416.5	1507214.143	1318812.375	1172277.667	1055049.9	959136.2727	879208.25	811576.8462	753607.0714	703366.6	659406.1875	586138.8333	555289.4211	527524.95	439604.125	422019.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54588	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54589	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54590	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54591	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54592	CHOYP_CATA.3.3|m.21642	AKPFESVGK	AKPFESVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54593	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	9365530	4682765	3121843.333	2341382.5	1873106	1560921.667	1337932.857	1170691.25	1040614.444	936553	851411.8182	780460.8333	720425.3846	668966.4286	624368.6667	585345.625	520307.2222	492922.6316	468276.5	390230.4167	374621.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54594	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	7403798	3701899	2467932.667	1850949.5	1480759.6	1233966.333	1057685.429	925474.75	822644.2222	740379.8	673072.5455	616983.1667	569522.9231	528842.7143	493586.5333	462737.375	411322.1111	389673.5789	370189.9	308491.5833	296151.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54595	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	2445440	1222720	815146.6667	611360	489088	407573.3333	349348.5714	305680	271715.5556	244544	222312.7273	203786.6667	188110.7692	174674.2857	163029.3333	152840	135857.7778	128707.3684	122272	101893.3333	97817.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54596	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	495930	247965	165310	123982.5	99186	82655	70847.14286	61991.25	55103.33333	49593	45084.54545	41327.5	38148.46154	35423.57143	33062	30995.625	27551.66667	26101.57895	24796.5	20663.75	19837.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54597	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	3119455	1559727.5	1039818.333	779863.75	623891	519909.1667	445636.4286	389931.875	346606.1111	311945.5	283586.8182	259954.5833	239958.0769	222818.2143	207963.6667	194965.9375	173303.0556	164181.8421	155972.75	129977.2917	124778.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54598	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	855909	427954.5	285303	213977.25	171181.8	142651.5	122272.7143	106988.625	95101	85590.9	77809.90909	71325.75	65839.15385	61136.35714	57060.6	53494.3125	47550.5	45047.84211	42795.45	35662.875	34236.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54599	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	216878	108439	72292.66667	54219.5	43375.6	36146.33333	30982.57143	27109.75	24097.55556	21687.8	19716.18182	18073.16667	16682.92308	15491.28571	14458.53333	13554.875	12048.77778	11414.63158	10843.9	9036.583333	8675.12	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54600	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	979584	489792	326528	244896	195916.8	163264	139940.5714	122448	108842.6667	97958.4	89053.09091	81632	75352.61538	69970.28571	65305.6	61224	54421.33333	51557.05263	48979.2	40816	39183.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54601	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	289514	144757	96504.66667	72378.5	57902.8	48252.33333	41359.14286	36189.25	32168.22222	28951.4	26319.45455	24126.16667	22270.30769	20679.57143	19300.93333	18094.625	16084.11111	15237.57895	14475.7	12063.08333	11580.56	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54602	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	92208	46104	30736	23052	18441.6	15368	13172.57143	11526	10245.33333	9220.8	8382.545455	7684	7092.923077	6586.285714	6147.2	5763	5122.666667	4853.052632	4610.4	3842	3688.32	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54603	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54604	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54605	CHOYP_CATA.3.3|m.21642	FSTVGGESGSADTAR	FSTVGGESGSADTAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54606	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	40790016	20395008	13596672	10197504	8158003.2	6798336	5827145.143	5098752	4532224	4079001.6	3708183.273	3399168	3137693.538	2913572.571	2719334.4	2549376	2266112	2146842.947	2039500.8	1699584	1631600.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54607	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	27920540	13960270	9306846.667	6980135	5584108	4653423.333	3988648.571	3490067.5	3102282.222	2792054	2538230.909	2326711.667	2147733.846	1994324.286	1861369.333	1745033.75	1551141.111	1469502.105	1396027	1163355.833	1116821.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54608	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	10060896	5030448	3353632	2515224	2012179.2	1676816	1437270.857	1257612	1117877.333	1006089.6	914626.9091	838408	773915.0769	718635.4286	670726.4	628806	558938.6667	529520.8421	503044.8	419204	402435.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54609	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	909165	454582.5	303055	227291.25	181833	151527.5	129880.7143	113645.625	101018.3333	90916.5	82651.36364	75763.75	69935.76923	64940.35714	60611	56822.8125	50509.16667	47850.78947	45458.25	37881.875	36366.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54610	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	2977988	1488994	992662.6667	744497	595597.6	496331.3333	425426.8571	372248.5	330887.5556	297798.8	270726.1818	248165.6667	229076	212713.4286	198532.5333	186124.25	165443.7778	156736.2105	148899.4	124082.8333	119119.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54611	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	546600	273300	182200	136650	109320	91100	78085.71429	68325	60733.33333	54660	49690.90909	45550	42046.15385	39042.85714	36440	34162.5	30366.66667	28768.42105	27330	22775	21864	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54612	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	640621	320310.5	213540.3333	160155.25	128124.2	106770.1667	91517.28571	80077.625	71180.11111	64062.1	58238.27273	53385.08333	49278.53846	45758.64286	42708.06667	40038.8125	35590.05556	33716.89474	32031.05	26692.54167	25624.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54613	CHOYP_CATA.3.3|m.21642	MNGYGSHTFK	MNGYGSHTFK	735534	367767	245178	183883.5	147106.8	122589	105076.2857	91941.75	81726	73553.4	66866.72727	61294.5	56579.53846	52538.14286	49035.6	45970.875	40863	38712.31579	36776.7	30647.25	29421.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54614	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	112987280	56493640	37662426.67	28246820	22597456	18831213.33	16141040	14123410	12554142.22	11298728	10271570.91	9415606.667	8691329.231	8070520	7532485.333	7061705	6277071.111	5946698.947	5649364	4707803.333	4519491.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54615	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	86867680	43433840	28955893.33	21716920	17373536	14477946.67	12409668.57	10858460	9651964.444	8686768	7897061.818	7238973.333	6682129.231	6204834.286	5791178.667	5429230	4825982.222	4571983.158	4343384	3619486.667	3474707.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54616	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	34445828	17222914	11481942.67	8611457	6889165.6	5740971.333	4920832.571	4305728.5	3827314.222	3444582.8	3131438.909	2870485.667	2649679.077	2460416.286	2296388.533	2152864.25	1913657.111	1812938.316	1722291.4	1435242.833	1377833.12	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54617	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	8599285	4299642.5	2866428.333	2149821.25	1719857	1433214.167	1228469.286	1074910.625	955476.1111	859928.5	781753.1818	716607.0833	661483.4615	614234.6429	573285.6667	537455.3125	477738.0556	452593.9474	429964.25	358303.5417	343971.4	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54618	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	2976530	1488265	992176.6667	744132.5	595306	496088.3333	425218.5714	372066.25	330725.5556	297653	270593.6364	248044.1667	228963.8462	212609.2857	198435.3333	186033.125	165362.7778	156659.4737	148826.5	124022.0833	119061.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54619	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	22240184	11120092	7413394.667	5560046	4448036.8	3706697.333	3177169.143	2780023	2471131.556	2224018.4	2021834.909	1853348.667	1710783.385	1588584.571	1482678.933	1390011.5	1235565.778	1170536	1112009.2	926674.3333	889607.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54620	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	14220461	7110230.5	4740153.667	3555115.25	2844092.2	2370076.833	2031494.429	1777557.625	1580051.222	1422046.1	1292769.182	1185038.417	1093881.615	1015747.214	948030.7333	888778.8125	790025.6111	748445.3158	711023.05	592519.2083	568818.44	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54621	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	7578997	3789498.5	2526332.333	1894749.25	1515799.4	1263166.167	1082713.857	947374.625	842110.7778	757899.7	688999.7273	631583.0833	582999.7692	541356.9286	505266.4667	473687.3125	421055.3889	398894.5789	378949.85	315791.5417	303159.88	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54622	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	18644674	9322337	6214891.333	4661168.5	3728934.8	3107445.667	2663524.857	2330584.25	2071630.444	1864467.4	1694970.364	1553722.833	1434205.692	1331762.429	1242978.267	1165292.125	1035815.222	981298.6316	932233.7	776861.4167	745786.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54623	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	5938909	2969454.5	1979636.333	1484727.25	1187781.8	989818.1667	848415.5714	742363.625	659878.7778	593890.9	539900.8182	494909.0833	456839.1538	424207.7857	395927.2667	371181.8125	329939.3889	312574.1579	296945.45	247454.5417	237556.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54624	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	4701717	2350858.5	1567239	1175429.25	940343.4	783619.5	671673.8571	587714.625	522413	470171.7	427428.8182	391809.75	361670.5385	335836.9286	313447.8	293857.3125	261206.5	247458.7895	235085.85	195904.875	188068.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54625	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	3147435	1573717.5	1049145	786858.75	629487	524572.5	449633.5714	393429.375	349715	314743.5	286130.4545	262286.25	242110.3846	224816.7857	209829	196714.6875	174857.5	165654.4737	157371.75	131143.125	125897.4	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54626	CHOYP_CATA.3.3|m.21642	TDQGIQNLSAAEANR	TDQGIQNLSAAEANR	4065324	2032662	1355108	1016331	813064.8	677554	580760.5714	508165.5	451702.6667	406532.4	369574.9091	338777	312717.2308	290380.2857	271021.6	254082.75	225851.3333	213964.4211	203266.2	169388.5	162612.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54627	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54628	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54629	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54630	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54631	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	1284991	642495.5	428330.3333	321247.75	256998.2	214165.1667	183570.1429	160623.875	142776.7778	128499.1	116817.3636	107082.5833	98845.46154	91785.07143	85666.06667	80311.9375	71388.38889	67631.10526	64249.55	53541.29167	51399.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54632	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	5721289	2860644.5	1907096.333	1430322.25	1144257.8	953548.1667	817327	715161.125	635698.7778	572128.9	520117.1818	476774.0833	440099.1538	408663.5	381419.2667	357580.5625	317849.3889	301120.4737	286064.45	238387.0417	228851.56	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54633	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54634	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	1440183	720091.5	480061	360045.75	288036.6	240030.5	205740.4286	180022.875	160020.3333	144018.3	130925.7273	120015.25	110783.3077	102870.2143	96012.2	90011.4375	80010.16667	75799.10526	72009.15	60007.625	57607.32	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54635	CHOYP_CATA.3.3|m.21642	LSAEDPDYAIR	LSAEDPDYAIR	232215	116107.5	77405	58053.75	46443	38702.5	33173.57143	29026.875	25801.66667	23221.5	21110.45455	19351.25	17862.69231	16586.78571	15481	14513.4375	12900.83333	12221.84211	11610.75	9675.625	9288.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54636	CHOYP_CATA.3.3|m.21642	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54637	CHOYP_CATA.3.3|m.21642	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54638	CHOYP_CATA.3.3|m.21642	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54639	CHOYP_CATA.3.3|m.21642	WNPFDVTK	WNPFDVTK	293038	146519	97679.33333	73259.5	58607.6	48839.66667	41862.57143	36629.75	32559.77778	29303.8	26639.81818	24419.83333	22541.38462	20931.28571	19535.86667	18314.875	16279.88889	15423.05263	14651.9	12209.91667	11721.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54640	CHOYP_CATA.3.3|m.21642	WNPFDVTK	WNPFDVTK	532114	266057	177371.3333	133028.5	106422.8	88685.66667	76016.28571	66514.25	59123.77778	53211.4	48374	44342.83333	40931.84615	38008.14286	35474.26667	33257.125	29561.88889	28006	26605.7	22171.41667	21284.56	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54641	CHOYP_CATA.3.3|m.21642	WNPFDVTK	WNPFDVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54642	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	56192312	28096156	18730770.67	14048078	11238462.4	9365385.333	8027473.143	7024039	6243590.222	5619231.2	5108392	4682692.667	4322485.538	4013736.571	3746154.133	3512019.5	3121795.111	2957490.105	2809615.6	2341346.333	2247692.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54643	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	34771544	17385772	11590514.67	8692886	6954308.8	5795257.333	4967363.429	4346443	3863504.889	3477154.4	3161049.455	2897628.667	2674734.154	2483681.714	2318102.933	2173221.5	1931752.444	1830081.263	1738577.2	1448814.333	1390861.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54644	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	8811298	4405649	2937099.333	2202824.5	1762259.6	1468549.667	1258756.857	1101412.25	979033.1111	881129.8	801027.0909	734274.8333	677792.1538	629378.4286	587419.8667	550706.125	489516.5556	463752.5263	440564.9	367137.4167	352451.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54645	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	4241265	2120632.5	1413755	1060316.25	848253	706877.5	605895	530158.125	471251.6667	424126.5	385569.5455	353438.75	326251.1538	302947.5	282751	265079.0625	235625.8333	223224.4737	212063.25	176719.375	169650.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54646	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	4756225	2378112.5	1585408.333	1189056.25	951245	792704.1667	679460.7143	594528.125	528469.4444	475622.5	432384.0909	396352.0833	365863.4615	339730.3571	317081.6667	297264.0625	264234.7222	250327.6316	237811.25	198176.0417	190249	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54647	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	826594	413297	275531.3333	206648.5	165318.8	137765.6667	118084.8571	103324.25	91843.77778	82659.4	75144.90909	68882.83333	63584.15385	59042.42857	55106.26667	51662.125	45921.88889	43504.94737	41329.7	34441.41667	33063.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54648	CHOYP_CATA.3.3|m.21642	LFSYSDTHR	LFSYSDTHR	2735738	1367869	911912.6667	683934.5	547147.6	455956.3333	390819.7143	341967.25	303970.8889	273573.8	248703.4545	227978.1667	210441.3846	195409.8571	182382.5333	170983.625	151985.4444	143986.2105	136786.9	113989.0833	109429.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54649	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	27497600	13748800	9165866.667	6874400	5499520	4582933.333	3928228.571	3437200	3055288.889	2749760	2499781.818	2291466.667	2115200	1964114.286	1833173.333	1718600	1527644.444	1447242.105	1374880	1145733.333	1099904	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54650	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	26081526	13040763	8693842	6520381.5	5216305.2	4346921	3725932.286	3260190.75	2897947.333	2608152.6	2371047.818	2173460.5	2006271.231	1862966.143	1738768.4	1630095.375	1448973.667	1372711.895	1304076.3	1086730.25	1043261.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54651	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	9157644	4578822	3052548	2289411	1831528.8	1526274	1308234.857	1144705.5	1017516	915764.4	832513.0909	763137	704434.1538	654117.4286	610509.6	572352.75	508758	481981.2632	457882.2	381568.5	366305.76	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54652	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	950924	475462	316974.6667	237731	190184.8	158487.3333	135846.2857	118865.5	105658.2222	95092.4	86447.63636	79243.66667	73148	67923.14286	63394.93333	59432.75	52829.11111	50048.63158	47546.2	39621.83333	38036.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54653	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	793412	396706	264470.6667	198353	158682.4	132235.3333	113344.5714	99176.5	88156.88889	79341.2	72128.36364	66117.66667	61031.69231	56672.28571	52894.13333	49588.25	44078.44444	41758.52632	39670.6	33058.83333	31736.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54654	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	4239965	2119982.5	1413321.667	1059991.25	847993	706660.8333	605709.2857	529995.625	471107.2222	423996.5	385451.3636	353330.4167	326151.1538	302854.6429	282664.3333	264997.8125	235553.6111	223156.0526	211998.25	176665.2083	169598.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54655	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	400184	200092	133394.6667	100046	80036.8	66697.33333	57169.14286	50023	44464.88889	40018.4	36380.36364	33348.66667	30783.38462	28584.57143	26678.93333	25011.5	22232.44444	21062.31579	20009.2	16674.33333	16007.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54656	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	1150106	575053	383368.6667	287526.5	230021.2	191684.3333	164300.8571	143763.25	127789.5556	115010.6	104555.0909	95842.16667	88469.69231	82150.42857	76673.73333	71881.625	63894.77778	60531.89474	57505.3	47921.08333	46004.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54657	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	577115	288557.5	192371.6667	144278.75	115423	96185.83333	82445	72139.375	64123.88889	57711.5	52465	48092.91667	44393.46154	41222.5	38474.33333	36069.6875	32061.94444	30374.47368	28855.75	24046.45833	23084.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54658	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	1376200	688100	458733.3333	344050	275240	229366.6667	196600	172025	152911.1111	137620	125109.0909	114683.3333	105861.5385	98300	91746.66667	86012.5	76455.55556	72431.57895	68810	57341.66667	55048	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54659	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	1833123	916561.5	611041	458280.75	366624.6	305520.5	261874.7143	229140.375	203680.3333	183312.3	166647.5455	152760.25	141009.4615	130937.3571	122208.2	114570.1875	101840.1667	96480.15789	91656.15	76380.125	73324.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54660	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	566701	283350.5	188900.3333	141675.25	113340.2	94450.16667	80957.28571	70837.625	62966.77778	56670.1	51518.27273	47225.08333	43592.38462	40478.64286	37780.06667	35418.8125	31483.38889	29826.36842	28335.05	23612.54167	22668.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54661	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	20487092	10243546	6829030.667	5121773	4097418.4	3414515.333	2926727.429	2560886.5	2276343.556	2048709.2	1862462.909	1707257.667	1575930.154	1463363.714	1365806.133	1280443.25	1138171.778	1078268	1024354.6	853628.8333	819483.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54662	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	16546984	8273492	5515661.333	4136746	3309396.8	2757830.667	2363854.857	2068373	1838553.778	1654698.4	1504271.273	1378915.333	1272844.923	1181927.429	1103132.267	1034186.5	919276.8889	870893.8947	827349.2	689457.6667	661879.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54663	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	8295566	4147783	2765188.667	2073891.5	1659113.2	1382594.333	1185080.857	1036945.75	921729.5556	829556.6	754142.3636	691297.1667	638120.4615	592540.4286	553037.7333	518472.875	460864.7778	436608.7368	414778.3	345648.5833	331822.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54664	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54665	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54666	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	1251551	625775.5	417183.6667	312887.75	250310.2	208591.8333	178793	156443.875	139061.2222	125155.1	113777.3636	104295.9167	96273.15385	89396.5	83436.73333	78221.9375	69530.61111	65871.10526	62577.55	52147.95833	50062.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54667	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54668	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	99106	49553	33035.33333	24776.5	19821.2	16517.66667	14158	12388.25	11011.77778	9910.6	9009.636364	8258.833333	7623.538462	7079	6607.066667	6194.125	5505.888889	5216.105263	4955.3	4129.416667	3964.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54669	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	470612	235306	156870.6667	117653	94122.4	78435.33333	67230.28571	58826.5	52290.22222	47061.2	42782.90909	39217.66667	36200.92308	33615.14286	31374.13333	29413.25	26145.11111	24769.05263	23530.6	19608.83333	18824.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54670	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	829709	414854.5	276569.6667	207427.25	165941.8	138284.8333	118529.8571	103713.625	92189.88889	82970.9	75428.09091	69142.41667	63823.76923	59264.92857	55313.93333	51856.8125	46094.94444	43668.89474	41485.45	34571.20833	33188.36	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54671	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	912092	456046	304030.6667	228023	182418.4	152015.3333	130298.8571	114011.5	101343.5556	91209.2	82917.45455	76007.66667	70160.92308	65149.42857	60806.13333	57005.75	50671.77778	48004.84211	45604.6	38003.83333	36483.68	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54672	CHOYP_CATA.3.3|m.21642	LVENIGNHLINTQK	LVENIGNHLINTQK	370873	185436.5	123624.3333	92718.25	74174.6	61812.16667	52981.85714	46359.125	41208.11111	37087.3	33715.72727	30906.08333	28528.69231	26490.92857	24724.86667	23179.5625	20604.05556	19519.63158	18543.65	15453.04167	14834.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54673	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	16095708	8047854	5365236	4023927	3219141.6	2682618	2299386.857	2011963.5	1788412	1609570.8	1463246.182	1341309	1238131.385	1149693.429	1073047.2	1005981.75	894206	847142.5263	804785.4	670654.5	643828.32	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54674	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54675	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	4158250	2079125	1386083.333	1039562.5	831650	693041.6667	594035.7143	519781.25	462027.7778	415825	378022.7273	346520.8333	319865.3846	297017.8571	277216.6667	259890.625	231013.8889	218855.2632	207912.5	173260.4167	166330	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54676	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	324946	162473	108315.3333	81236.5	64989.2	54157.66667	46420.85714	40618.25	36105.11111	32494.6	29540.54545	27078.83333	24995.84615	23210.42857	21663.06667	20309.125	18052.55556	17102.42105	16247.3	13539.41667	12997.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54677	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	636065	318032.5	212021.6667	159016.25	127213	106010.8333	90866.42857	79508.125	70673.88889	63606.5	57824.09091	53005.41667	48928.07692	45433.21429	42404.33333	39754.0625	35336.94444	33477.10526	31803.25	26502.70833	25442.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54678	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	388880	194440	129626.6667	97220	77776	64813.33333	55554.28571	48610	43208.88889	38888	35352.72727	32406.66667	29913.84615	27777.14286	25925.33333	24305	21604.44444	20467.36842	19444	16203.33333	15555.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54679	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	6052780	3026390	2017593.333	1513195	1210556	1008796.667	864682.8571	756597.5	672531.1111	605278	550252.7273	504398.3333	465598.4615	432341.4286	403518.6667	378298.75	336265.5556	318567.3684	302639	252199.1667	242111.2	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54680	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	80048	40024	26682.66667	20012	16009.6	13341.33333	11435.42857	10006	8894.222222	8004.8	7277.090909	6670.666667	6157.538462	5717.714286	5336.533333	5003	4447.111111	4213.052632	4002.4	3335.333333	3201.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54681	CHOYP_CATA.3.3|m.21642	NFGQADPEFGR	NFGQADPEFGR	644174	322087	214724.6667	161043.5	128834.8	107362.3333	92024.85714	80521.75	71574.88889	64417.4	58561.27273	53681.16667	49551.84615	46012.42857	42944.93333	40260.875	35787.44444	33903.89474	32208.7	26840.58333	25766.96	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54682	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	41958916	20979458	13986305.33	10489729	8391783.2	6993152.667	5994130.857	5244864.5	4662101.778	4195891.6	3814446.909	3496576.333	3227608.923	2997065.429	2797261.067	2622432.25	2331050.889	2208364	2097945.8	1748288.167	1678356.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54683	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	29921946	14960973	9973982	7480486.5	5984389.2	4986991	4274563.714	3740243.25	3324660.667	2992194.6	2720176.909	2493495.5	2301688.154	2137281.857	1994796.4	1870121.625	1662330.333	1574839.263	1496097.3	1246747.75	1196877.84	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54684	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	11830915	5915457.5	3943638.333	2957728.75	2366183	1971819.167	1690130.714	1478864.375	1314546.111	1183091.5	1075537.727	985909.5833	910070.3846	845065.3571	788727.6667	739432.1875	657273.0556	622679.7368	591545.75	492954.7917	473236.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54685	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1271898	635949	423966	317974.5	254379.6	211983	181699.7143	158987.25	141322	127189.8	115627.0909	105991.5	97838.30769	90849.85714	84793.2	79493.625	70661	66942	63594.9	52995.75	50875.92	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54686	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	2951116	1475558	983705.3333	737779	590223.2	491852.6667	421588	368889.5	327901.7778	295111.6	268283.2727	245926.3333	227008.9231	210794	196741.0667	184444.75	163950.8889	155321.8947	147555.8	122963.1667	118044.64	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54687	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	2761340	1380670	920446.6667	690335	552268	460223.3333	394477.1429	345167.5	306815.5556	276134	251030.9091	230111.6667	212410.7692	197238.5714	184089.3333	172583.75	153407.7778	145333.6842	138067	115055.8333	110453.6	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54688	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1011286	505643	337095.3333	252821.5	202257.2	168547.6667	144469.4286	126410.75	112365.1111	101128.6	91935.09091	84273.83333	77791.23077	72234.71429	67419.06667	63205.375	56182.55556	53225.57895	50564.3	42136.91667	40451.44	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54689	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54690	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	1206901	603450.5	402300.3333	301725.25	241380.2	201150.1667	172414.4286	150862.625	134100.1111	120690.1	109718.2727	100575.0833	92838.53846	86207.21429	80460.06667	75431.3125	67050.05556	63521.10526	60345.05	50287.54167	48276.04	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54691	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	109581	54790.5	36527	27395.25	21916.2	18263.5	15654.42857	13697.625	12175.66667	10958.1	9961.909091	9131.75	8429.307692	7827.214286	7305.4	6848.8125	6087.833333	5767.421053	5479.05	4565.875	4383.24	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54692	CHOYP_CATA.3.3|m.21642	LQAHLDSVSNVSK	LQAHLDSVSNVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54693	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	31649338	15824669	10549779.33	7912334.5	6329867.6	5274889.667	4521334	3956167.25	3516593.111	3164933.8	2877212.545	2637444.833	2434564.462	2260667	2109955.867	1978083.625	1758296.556	1665754.632	1582466.9	1318722.417	1265973.52	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54694	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	18922978	9461489	6307659.333	4730744.5	3784595.6	3153829.667	2703282.571	2365372.25	2102553.111	1892297.8	1720270.727	1576914.833	1455613.692	1351641.286	1261531.867	1182686.125	1051276.556	995946.2105	946148.9	788457.4167	756919.12	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54695	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	3625712	1812856	1208570.667	906428	725142.4	604285.3333	517958.8571	453214	402856.8889	362571.2	329610.1818	302142.6667	278900.9231	258979.4286	241714.1333	226607	201428.4444	190826.9474	181285.6	151071.3333	145028.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54696	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	4431710	2215855	1477236.667	1107927.5	886342	738618.3333	633101.4286	553963.75	492412.2222	443171	402882.7273	369309.1667	340900.7692	316550.7143	295447.3333	276981.875	246206.1111	233247.8947	221585.5	184654.5833	177268.4	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54697	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	4396362	2198181	1465454	1099090.5	879272.4	732727	628051.7143	549545.25	488484.6667	439636.2	399669.2727	366363.5	338181.6923	314025.8571	293090.8	274772.625	244242.3333	231387.4737	219818.1	183181.75	175854.48	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54698	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	1679318	839659	559772.6667	419829.5	335863.6	279886.3333	239902.5714	209914.75	186590.8889	167931.8	152665.2727	139943.1667	129178.3077	119951.2857	111954.5333	104957.375	93295.44444	88385.15789	83965.9	69971.58333	67172.72	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
54699	CHOYP_CATA.3.3|m.21642	INVVLNGVK	INVVLNGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9PWF7	Catalase (EC 1.11.1.6)	cat	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872
57875	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	9814874	4907437	3271624.667	2453718.5	1962974.8	1635812.333	1402124.857	1226859.25	1090541.556	981487.4	892261.2727	817906.1667	754990.3077	701062.4286	654324.9333	613429.625	545270.7778	516572.3158	490743.7	408953.0833	392594.96	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57876	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	6265224	3132612	2088408	1566306	1253044.8	1044204	895032	783153	696136	626522.4	569565.8182	522102	481940.3077	447516	417681.6	391576.5	348068	329748.6316	313261.2	261051	250608.96	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57877	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	1750694	875347	583564.6667	437673.5	350138.8	291782.3333	250099.1429	218836.75	194521.5556	175069.4	159154	145891.1667	134668.7692	125049.5714	116712.9333	109418.375	97260.77778	92141.78947	87534.7	72945.58333	70027.76	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57878	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	897894	448947	299298	224473.5	179578.8	149649	128270.5714	112236.75	99766	89789.4	81626.72727	74824.5	69068.76923	64135.28571	59859.6	56118.375	49883	47257.57895	44894.7	37412.25	35915.76	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57879	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	372952	186476	124317.3333	93238	74590.4	62158.66667	53278.85714	46619	41439.11111	37295.2	33904.72727	31079.33333	28688.61538	26639.42857	24863.46667	23309.5	20719.55556	19629.05263	18647.6	15539.66667	14918.08	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57880	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	506653	253326.5	168884.3333	126663.25	101330.6	84442.16667	72379	63331.625	56294.77778	50665.3	46059.36364	42221.08333	38973.30769	36189.5	33776.86667	31665.8125	28147.38889	26665.94737	25332.65	21110.54167	20266.12	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57881	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	570863	285431.5	190287.6667	142715.75	114172.6	95143.83333	81551.85714	71357.875	63429.22222	57086.3	51896.63636	47571.91667	43912.53846	40775.92857	38057.53333	35678.9375	31714.61111	30045.42105	28543.15	23785.95833	22834.52	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57882	CHOYP_CNA1.1.1|m.65403	LSMNEVFDAK	LSMNEVFDAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57883	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	9961590	4980795	3320530	2490397.5	1992318	1660265	1423084.286	1245198.75	1106843.333	996159	905599.0909	830132.5	766276.1538	711542.1429	664106	622599.375	553421.6667	524294.2105	498079.5	415066.25	398463.6	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57884	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	3799516	1899758	1266505.333	949879	759903.2	633252.6667	542788	474939.5	422168.4444	379951.6	345410.5455	316626.3333	292270.4615	271394	253301.0667	237469.75	211084.2222	199974.5263	189975.8	158313.1667	151980.64	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57885	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	1937047	968523.5	645682.3333	484261.75	387409.4	322841.1667	276721	242130.875	215227.4444	193704.7	176095.1818	161420.5833	149003.6154	138360.5	129136.4667	121065.4375	107613.7222	101949.8421	96852.35	80710.29167	77481.88	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57886	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	468569	234284.5	156189.6667	117142.25	93713.8	78094.83333	66938.42857	58571.125	52063.22222	46856.9	42597.18182	39047.41667	36043.76923	33469.21429	31237.93333	29285.5625	26031.61111	24661.52632	23428.45	19523.70833	18742.76	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57887	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	1183619	591809.5	394539.6667	295904.75	236723.8	197269.8333	169088.4286	147952.375	131513.2222	118361.9	107601.7273	98634.91667	91047.61538	84544.21429	78907.93333	73976.1875	65756.61111	62295.73684	59180.95	49317.45833	47344.76	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57888	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	82839	41419.5	27613	20709.75	16567.8	13806.5	11834.14286	10354.875	9204.333333	8283.9	7530.818182	6903.25	6372.230769	5917.071429	5522.6	5177.4375	4602.166667	4359.947368	4141.95	3451.625	3313.56	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57889	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	128953	64476.5	42984.33333	32238.25	25790.6	21492.16667	18421.85714	16119.125	14328.11111	12895.3	11723	10746.08333	9919.461538	9210.928571	8596.866667	8059.5625	7164.055556	6787	6447.65	5373.041667	5158.12	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57890	CHOYP_CNA1.1.1|m.65403	LINEGAALLR	LINEGAALLR	63698	31849	21232.66667	15924.5	12739.6	10616.33333	9099.714286	7962.25	7077.555556	6369.8	5790.727273	5308.166667	4899.846154	4549.857143	4246.533333	3981.125	3538.777778	3352.526316	3184.9	2654.083333	2547.92	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57891	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57892	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57893	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57894	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	1198813	599406.5	399604.3333	299703.25	239762.6	199802.1667	171259	149851.625	133201.4444	119881.3	108983	99901.08333	92216.38462	85629.5	79920.86667	74925.8125	66600.72222	63095.42105	59940.65	49950.54167	47952.52	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57895	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	2887238	1443619	962412.6667	721809.5	577447.6	481206.3333	412462.5714	360904.75	320804.2222	288723.8	262476.1818	240603.1667	222095.2308	206231.2857	192482.5333	180452.375	160402.1111	151959.8947	144361.9	120301.5833	115489.52	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57896	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57897	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	860026	430013	286675.3333	215006.5	172005.2	143337.6667	122860.8571	107503.25	95558.44444	86002.6	78184.18182	71668.83333	66155.84615	61430.42857	57335.06667	53751.625	47779.22222	45264.52632	43001.3	35834.41667	34401.04	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57898	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57899	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57900	CHOYP_CNA1.1.1|m.65403	LFEVGGPPSTTR	LFEVGGPPSTTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57901	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57902	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57903	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57904	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57905	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	21882	10941	7294	5470.5	4376.4	3647	3126	2735.25	2431.333333	2188.2	1989.272727	1823.5	1683.230769	1563	1458.8	1367.625	1215.666667	1151.684211	1094.1	911.75	875.28	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57906	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57907	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57908	CHOYP_CNA1.1.1|m.65403	YLFLGDYVDR	YLFLGDYVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57909	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	4940366	2470183	1646788.667	1235091.5	988073.2	823394.3333	705766.5714	617545.75	548929.5556	494036.6	449124.1818	411697.1667	380028.1538	352883.2857	329357.7333	308772.875	274464.7778	260019.2632	247018.3	205848.5833	197614.64	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57910	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	4137723	2068861.5	1379241	1034430.75	827544.6	689620.5	591103.2857	517215.375	459747	413772.3	376156.6364	344810.25	318286.3846	295551.6429	275848.2	258607.6875	229873.5	217774.8947	206886.15	172405.125	165508.92	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57911	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	2244507	1122253.5	748169	561126.75	448901.4	374084.5	320643.8571	280563.375	249389.6667	224450.7	204046.0909	187042.25	172654.3846	160321.9286	149633.8	140281.6875	124694.8333	118131.9474	112225.35	93521.125	89780.28	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57912	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	3043086	1521543	1014362	760771.5	608617.2	507181	434726.5714	380385.75	338120.6667	304308.6	276644.1818	253590.5	234083.5385	217363.2857	202872.4	190192.875	169060.3333	160162.4211	152154.3	126795.25	121723.44	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57913	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	118834	59417	39611.33333	29708.5	23766.8	19805.66667	16976.28571	14854.25	13203.77778	11883.4	10803.09091	9902.833333	9141.076923	8488.142857	7922.266667	7427.125	6601.888889	6254.421053	5941.7	4951.416667	4753.36	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57914	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57915	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57916	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57917	CHOYP_CNA1.1.1|m.65403	ILHPTTFFLLR	ILHPTTFFLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57918	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	994848	497424	331616	248712	198969.6	165808	142121.1429	124356	110538.6667	99484.8	90440.72727	82904	76526.76923	71060.57143	66323.2	62178	55269.33333	52360.42105	49742.4	41452	39793.92	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57919	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57920	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57921	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57922	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57923	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57924	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57925	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57926	CHOYP_CNA1.1.1|m.65403	TSEHFTHNSVR	TSEHFTHNSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57927	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57928	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57929	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57930	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	363187	181593.5	121062.3333	90796.75	72637.4	60531.16667	51883.85714	45398.375	40354.11111	36318.7	33017	30265.58333	27937.46154	25941.92857	24212.46667	22699.1875	20177.05556	19115.10526	18159.35	15132.79167	14527.48	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57931	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	47917	23958.5	15972.33333	11979.25	9583.4	7986.166667	6845.285714	5989.625	5324.111111	4791.7	4356.090909	3993.083333	3685.923077	3422.642857	3194.466667	2994.8125	2662.055556	2521.947368	2395.85	1996.541667	1916.68	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57932	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	19743	9871.5	6581	4935.75	3948.6	3290.5	2820.428571	2467.875	2193.666667	1974.3	1794.818182	1645.25	1518.692308	1410.214286	1316.2	1233.9375	1096.833333	1039.105263	987.15	822.625	789.72	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57933	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	203727	101863.5	67909	50931.75	40745.4	33954.5	29103.85714	25465.875	22636.33333	20372.7	18520.63636	16977.25	15671.30769	14551.92857	13581.8	12732.9375	11318.16667	10722.47368	10186.35	8488.625	8149.08	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57934	CHOYP_CNA1.1.1|m.65403	AHEAQDAGYR	AHEAQDAGYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57935	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57936	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57937	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57938	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57939	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	170096	85048	56698.66667	42524	34019.2	28349.33333	24299.42857	21262	18899.55556	17009.6	15463.27273	14174.66667	13084.30769	12149.71429	11339.73333	10631	9449.777778	8952.421053	8504.8	7087.333333	6803.84	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57940	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57941	CHOYP_CNA1.1.1|m.65403	YENNVMNIR	YENNVMNIR	161985	80992.5	53995	40496.25	32397	26997.5	23140.71429	20248.125	17998.33333	16198.5	14725.90909	13498.75	12460.38462	11570.35714	10799	10124.0625	8999.166667	8525.526316	8099.25	6749.375	6479.4	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57942	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	13613460	6806730	4537820	3403365	2722692	2268910	1944780	1701682.5	1512606.667	1361346	1237587.273	1134455	1047189.231	972390	907564	850841.25	756303.3333	716497.8947	680673	567227.5	544538.4	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57943	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	12279511	6139755.5	4093170.333	3069877.75	2455902.2	2046585.167	1754215.857	1534938.875	1364390.111	1227951.1	1116319.182	1023292.583	944577.7692	877107.9286	818634.0667	767469.4375	682195.0556	646290.0526	613975.55	511646.2917	491180.44	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57944	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	4979595	2489797.5	1659865	1244898.75	995919	829932.5	711370.7143	622449.375	553288.3333	497959.5	452690.4545	414966.25	383045.7692	355685.3571	331973	311224.6875	276644.1667	262083.9474	248979.75	207483.125	199183.8	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57945	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	777870	388935	259290	194467.5	155574	129645	111124.2857	97233.75	86430	77787	70715.45455	64822.5	59836.15385	55562.14286	51858	48616.875	43215	40940.52632	38893.5	32411.25	31114.8	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57946	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	301265	150632.5	100421.6667	75316.25	60253	50210.83333	43037.85714	37658.125	33473.88889	30126.5	27387.72727	25105.41667	23174.23077	21518.92857	20084.33333	18829.0625	16736.94444	15856.05263	15063.25	12552.70833	12050.6	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57947	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57948	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	141190	70595	47063.33333	35297.5	28238	23531.66667	20170	17648.75	15687.77778	14119	12835.45455	11765.83333	10860.76923	10085	9412.666667	8824.375	7843.888889	7431.052632	7059.5	5882.916667	5647.6	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57949	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	1993847	996923.5	664615.6667	498461.75	398769.4	332307.8333	284835.2857	249230.875	221538.5556	199384.7	181258.8182	166153.9167	153372.8462	142417.6429	132923.1333	124615.4375	110769.2778	104939.3158	99692.35	83076.95833	79753.88	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57950	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	8006541	4003270.5	2668847	2001635.25	1601308.2	1334423.5	1143791.571	1000817.625	889615.6667	800654.1	727867.3636	667211.75	615887.7692	571895.7857	533769.4	500408.8125	444807.8333	421396.8947	400327.05	333605.875	320261.64	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57951	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57952	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	815592	407796	271864	203898	163118.4	135932	116513.1429	101949	90621.33333	81559.2	74144.72727	67966	62737.84615	58256.57143	54372.8	50974.5	45310.66667	42925.89474	40779.6	33983	32623.68	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57953	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57954	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	406021	203010.5	135340.3333	101505.25	81204.2	67670.16667	58003	50752.625	45113.44444	40602.1	36911	33835.08333	31232.38462	29001.5	27068.06667	25376.3125	22556.72222	21369.52632	20301.05	16917.54167	16240.84	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57955	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57956	CHOYP_CNA1.1.1|m.65403	GLTPNGLLPLGALSGGK	GLTPNGLLPLGALSGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57957	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	5984564	2992282	1994854.667	1496141	1196912.8	997427.3333	854937.7143	748070.5	664951.5556	598456.4	544051.2727	498713.6667	460351.0769	427468.8571	398970.9333	374035.25	332475.7778	314977.0526	299228.2	249356.8333	239382.56	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57958	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57959	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57960	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	587276	293638	195758.6667	146819	117455.2	97879.33333	83896.57143	73409.5	65252.88889	58727.6	53388.72727	48939.66667	45175.07692	41948.28571	39151.73333	36704.75	32626.44444	30909.26316	29363.8	24469.83333	23491.04	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57961	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	437113	218556.5	145704.3333	109278.25	87422.6	72852.16667	62444.71429	54639.125	48568.11111	43711.3	39737.54545	36426.08333	33624.07692	31222.35714	29140.86667	27319.5625	24284.05556	23005.94737	21855.65	18213.04167	17484.52	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57962	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	1295488	647744	431829.3333	323872	259097.6	215914.6667	185069.7143	161936	143943.1111	129548.8	117771.6364	107957.3333	99652.92308	92534.85714	86365.86667	80968	71971.55556	68183.57895	64774.4	53978.66667	51819.52	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57963	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	1403897	701948.5	467965.6667	350974.25	280779.4	233982.8333	200556.7143	175487.125	155988.5556	140389.7	127627	116991.4167	107992.0769	100278.3571	93593.13333	87743.5625	77994.27778	73889.31579	70194.85	58495.70833	56155.88	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57964	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	2129715	1064857.5	709905	532428.75	425943	354952.5	304245	266214.375	236635	212971.5	193610.4545	177476.25	163824.2308	152122.5	141981	133107.1875	118317.5	112090.2632	106485.75	88738.125	85188.6	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57965	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57966	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	31006	15503	10335.33333	7751.5	6201.2	5167.666667	4429.428571	3875.75	3445.111111	3100.6	2818.727273	2583.833333	2385.076923	2214.714286	2067.066667	1937.875	1722.555556	1631.894737	1550.3	1291.916667	1240.24	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57967	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	433486	216743	144495.3333	108371.5	86697.2	72247.66667	61926.57143	54185.75	48165.11111	43348.6	39407.81818	36123.83333	33345.07692	30963.28571	28899.06667	27092.875	24082.55556	22815.05263	21674.3	18061.91667	17339.44	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57968	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	853435	426717.5	284478.3333	213358.75	170687	142239.1667	121919.2857	106679.375	94826.11111	85343.5	77585	71119.58333	65648.84615	60959.64286	56895.66667	53339.6875	47413.05556	44917.63158	42671.75	35559.79167	34137.4	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57969	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57970	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57971	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57972	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57973	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57974	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57975	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57976	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57977	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57978	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57979	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57980	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	16846	8423	5615.333333	4211.5	3369.2	2807.666667	2406.571429	2105.75	1871.777778	1684.6	1531.454545	1403.833333	1295.846154	1203.285714	1123.066667	1052.875	935.8888889	886.6315789	842.3	701.9166667	673.84	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57981	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	37395	18697.5	12465	9348.75	7479	6232.5	5342.142857	4674.375	4155	3739.5	3399.545455	3116.25	2876.538462	2671.071429	2493	2337.1875	2077.5	1968.157895	1869.75	1558.125	1495.8	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
57982	CHOYP_CNA1.1.1|m.65403	ETLSTALSGFSPTHK	ETLSTALSGFSPTHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P63329	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	Ppp3ca Calna	calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of NFAT protein import into nucleus [GO:0051533]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008144; GO:0014883; GO:0014898; GO:0016020; GO:0030018; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0042383; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0046982; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051533; GO:0051592; GO:0060079; GO:0071333; GO:0098794; GO:1903244
62395	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	46850780	23425390	15616926.67	11712695	9370156	7808463.333	6692968.571	5856347.5	5205642.222	4685078	4259161.818	3904231.667	3603906.154	3346484.286	3123385.333	2928173.75	2602821.111	2465830.526	2342539	1952115.833	1874031.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62396	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	29077112	14538556	9692370.667	7269278	5815422.4	4846185.333	4153873.143	3634639	3230790.222	2907711.2	2643373.818	2423092.667	2236700.923	2076936.571	1938474.133	1817319.5	1615395.111	1530374.316	1453855.6	1211546.333	1163084.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62397	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	12124320	6062160	4041440	3031080	2424864	2020720	1732045.714	1515540	1347146.667	1212432	1102210.909	1010360	932640	866022.8571	808288	757770	673573.3333	638122.1053	606216	505180	484972.8	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62398	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	280900	140450	93633.33333	70225	56180	46816.66667	40128.57143	35112.5	31211.11111	28090	25536.36364	23408.33333	21607.69231	20064.28571	18726.66667	17556.25	15605.55556	14784.21053	14045	11704.16667	11236	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62399	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	2438919	1219459.5	812973	609729.75	487783.8	406486.5	348417	304864.875	270991	243891.9	221719.9091	203243.25	187609.1538	174208.5	162594.6	152432.4375	135495.5	128364.1579	121945.95	101621.625	97556.76	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62400	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	8162578	4081289	2720859.333	2040644.5	1632515.6	1360429.667	1166082.571	1020322.25	906953.1111	816257.8	742052.5455	680214.8333	627890.6154	583041.2857	544171.8667	510161.125	453476.5556	429609.3684	408128.9	340107.4167	326503.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62401	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62402	CHOYP_CRYAB.2.5|m.23200	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62403	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	88675256	44337628	29558418.67	22168814	17735051.2	14779209.33	12667893.71	11084407	9852806.222	8867525.6	8061386.909	7389604.667	6821173.538	6333946.857	5911683.733	5542203.5	4926403.111	4667118.737	4433762.8	3694802.333	3547010.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62404	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	42837028	21418514	14279009.33	10709257	8567405.6	7139504.667	6119575.429	5354628.5	4759669.778	4283702.8	3894275.273	3569752.333	3295156	3059787.714	2855801.867	2677314.25	2379834.889	2254580.421	2141851.4	1784876.167	1713481.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62405	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	13505777	6752888.5	4501925.667	3376444.25	2701155.4	2250962.833	1929396.714	1688222.125	1500641.889	1350577.7	1227797.909	1125481.417	1038905.923	964698.3571	900385.1333	844111.0625	750320.9444	710830.3684	675288.85	562740.7083	540231.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62406	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	17586380	8793190	5862126.667	4396595	3517276	2931063.333	2512340	2198297.5	1954042.222	1758638	1598761.818	1465531.667	1352798.462	1256170	1172425.333	1099148.75	977021.1111	925598.9474	879319	732765.8333	703455.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62407	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	4105488	2052744	1368496	1026372	821097.6	684248	586498.2857	513186	456165.3333	410548.8	373226.1818	342124	315806.7692	293249.1429	273699.2	256593	228082.6667	216078.3158	205274.4	171062	164219.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62408	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	9652707	4826353.5	3217569	2413176.75	1930541.4	1608784.5	1378958.143	1206588.375	1072523	965270.7	877518.8182	804392.25	742515.9231	689479.0714	643513.8	603294.1875	536261.5	508037.2105	482635.35	402196.125	386108.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62409	CHOYP_CRYAB.2.5|m.23200	VSVSDGMVR	VSVSDGMVR	213204	106602	71068	53301	42640.8	35534	30457.71429	26650.5	23689.33333	21320.4	19382.18182	17767	16400.30769	15228.85714	14213.6	13325.25	11844.66667	11221.26316	10660.2	8883.5	8528.16	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62410	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62411	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62412	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62413	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62414	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62415	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62416	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62417	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62418	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62419	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62420	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62421	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62422	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62423	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62424	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62425	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62426	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62427	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62428	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62429	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62430	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62431	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62432	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62433	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62434	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62435	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62436	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62437	CHOYP_CRYAB.2.5|m.23200	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62438	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62439	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62440	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62441	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62442	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62443	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62444	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62445	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62446	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62447	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62448	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62449	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62450	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62451	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62452	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62453	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62454	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62455	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62456	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62457	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62458	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62459	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62460	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62461	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62462	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62463	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62464	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62465	CHOYP_CRYAB.2.5|m.23201	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62466	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	170090	85045	56696.66667	42522.5	34018	28348.33333	24298.57143	21261.25	18898.88889	17009	15462.72727	14174.16667	13083.84615	12149.28571	11339.33333	10630.625	9449.444444	8952.105263	8504.5	7087.083333	6803.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62467	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	567582	283791	189194	141895.5	113516.4	94597	81083.14286	70947.75	63064.66667	56758.2	51598.36364	47298.5	43660.15385	40541.57143	37838.8	35473.875	31532.33333	29872.73684	28379.1	23649.25	22703.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62468	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62469	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62470	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	75461	37730.5	25153.66667	18865.25	15092.2	12576.83333	10780.14286	9432.625	8384.555556	7546.1	6860.090909	6288.416667	5804.692308	5390.071429	5030.733333	4716.3125	4192.277778	3971.631579	3773.05	3144.208333	3018.44	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62471	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62472	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62473	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62474	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
62475	CHOYP_CRYAB.2.5|m.23201	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
69882	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	2614414	1307207	871471.3333	653603.5	522882.8	435735.6667	373487.7143	326801.75	290490.4444	261441.4	237674	217867.8333	201108.7692	186743.8571	174294.2667	163400.875	145245.2222	137600.7368	130720.7	108933.9167	104576.56	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69883	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	2645169	1322584.5	881723	661292.25	529033.8	440861.5	377881.2857	330646.125	293907.6667	264516.9	240469.9091	220430.75	203474.5385	188940.6429	176344.6	165323.0625	146953.8333	139219.4211	132258.45	110215.375	105806.76	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69884	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	323131	161565.5	107710.3333	80782.75	64626.2	53855.16667	46161.57143	40391.375	35903.44444	32313.1	29375.54545	26927.58333	24856.23077	23080.78571	21542.06667	20195.6875	17951.72222	17006.89474	16156.55	13463.79167	12925.24	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69885	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	185355	92677.5	61785	46338.75	37071	30892.5	26479.28571	23169.375	20595	18535.5	16850.45455	15446.25	14258.07692	13239.64286	12357	11584.6875	10297.5	9755.526316	9267.75	7723.125	7414.2	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69886	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	676988	338494	225662.6667	169247	135397.6	112831.3333	96712.57143	84623.5	75220.88889	67698.8	61544.36364	56415.66667	52076	48356.28571	45132.53333	42311.75	37610.44444	35630.94737	33849.4	28207.83333	27079.52	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69887	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	2617568	1308784	872522.6667	654392	523513.6	436261.3333	373938.2857	327196	290840.8889	261756.8	237960.7273	218130.6667	201351.3846	186969.1429	174504.5333	163598	145420.4444	137766.7368	130878.4	109065.3333	104702.72	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69888	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69889	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	258996	129498	86332	64749	51799.2	43166	36999.42857	32374.5	28777.33333	25899.6	23545.09091	21583	19922.76923	18499.71429	17266.4	16187.25	14388.66667	13631.36842	12949.8	10791.5	10359.84	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69890	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69891	CHOYP_DNJC3.1.1|m.52309	VIELKPDFTAAR	VIELKPDFTAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69892	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69893	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	1413565	706782.5	471188.3333	353391.25	282713	235594.1667	201937.8571	176695.625	157062.7778	141356.5	128505.9091	117797.0833	108735.7692	100968.9286	94237.66667	88347.8125	78531.38889	74398.15789	70678.25	58898.54167	56542.6	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69894	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69895	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	200316	100158	66772	50079	40063.2	33386	28616.57143	25039.5	22257.33333	20031.6	18210.54545	16693	15408.92308	14308.28571	13354.4	12519.75	11128.66667	10542.94737	10015.8	8346.5	8012.64	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69896	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69897	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69898	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	81068	40534	27022.66667	20267	16213.6	13511.33333	11581.14286	10133.5	9007.555556	8106.8	7369.818182	6755.666667	6236	5790.571429	5404.533333	5066.75	4503.777778	4266.736842	4053.4	3377.833333	3242.72	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69899	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69900	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69901	CHOYP_DNJC3.1.1|m.52309	LGEAEESLIQIR	LGEAEESLIQIR	62171	31085.5	20723.66667	15542.75	12434.2	10361.83333	8881.571429	7771.375	6907.888889	6217.1	5651.909091	5180.916667	4782.384615	4440.785714	4144.733333	3885.6875	3453.944444	3272.157895	3108.55	2590.458333	2486.84	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69902	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69903	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69904	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69905	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	117219	58609.5	39073	29304.75	23443.8	19536.5	16745.57143	14652.375	13024.33333	11721.9	10656.27273	9768.25	9016.846154	8372.785714	7814.6	7326.1875	6512.166667	6169.421053	5860.95	4884.125	4688.76	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69906	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69907	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	40583	20291.5	13527.66667	10145.75	8116.6	6763.833333	5797.571429	5072.875	4509.222222	4058.3	3689.363636	3381.916667	3121.769231	2898.785714	2705.533333	2536.4375	2254.611111	2135.947368	2029.15	1690.958333	1623.32	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
69908	CHOYP_DNJC3.1.1|m.52309	MFIDIAAAK	MFIDIAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q27968	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912
70165	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70166	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70167	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70168	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70169	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70170	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70171	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70172	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70173	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70174	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70175	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70176	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70177	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70178	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70179	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70180	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70181	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70182	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70183	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70184	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70185	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70186	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70187	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70188	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70189	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70190	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70191	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70192	CHOYP_DPER_GL22446.1.1|m.52315	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70193	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	170090	85045	56696.66667	42522.5	34018	28348.33333	24298.57143	21261.25	18898.88889	17009	15462.72727	14174.16667	13083.84615	12149.28571	11339.33333	10630.625	9449.444444	8952.105263	8504.5	7087.083333	6803.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70194	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	567582	283791	189194	141895.5	113516.4	94597	81083.14286	70947.75	63064.66667	56758.2	51598.36364	47298.5	43660.15385	40541.57143	37838.8	35473.875	31532.33333	29872.73684	28379.1	23649.25	22703.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70195	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70196	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70197	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	75461	37730.5	25153.66667	18865.25	15092.2	12576.83333	10780.14286	9432.625	8384.555556	7546.1	6860.090909	6288.416667	5804.692308	5390.071429	5030.733333	4716.3125	4192.277778	3971.631579	3773.05	3144.208333	3018.44	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70198	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70199	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70200	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70201	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
70202	CHOYP_DPER_GL22446.1.1|m.52315	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
71409	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71410	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71411	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71412	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	77370	38685	25790	19342.5	15474	12895	11052.85714	9671.25	8596.666667	7737	7033.636364	6447.5	5951.538462	5526.428571	5158	4835.625	4298.333333	4072.105263	3868.5	3223.75	3094.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71413	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71414	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71415	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71416	CHOYP_DUOX1.1.4|m.14285	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71417	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	3597570	1798785	1199190	899392.5	719514	599595	513938.5714	449696.25	399730	359757	327051.8182	299797.5	276736.1538	256969.2857	239838	224848.125	199865	189345.7895	179878.5	149898.75	143902.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71418	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71419	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	26215	13107.5	8738.333333	6553.75	5243	4369.166667	3745	3276.875	2912.777778	2621.5	2383.181818	2184.583333	2016.538462	1872.5	1747.666667	1638.4375	1456.388889	1379.736842	1310.75	1092.291667	1048.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71420	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	1039502	519751	346500.6667	259875.5	207900.4	173250.3333	148500.2857	129937.75	115500.2222	103950.2	94500.18182	86625.16667	79961.69231	74250.14286	69300.13333	64968.875	57750.11111	54710.63158	51975.1	43312.58333	41580.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71421	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	714676	357338	238225.3333	178669	142935.2	119112.6667	102096.5714	89334.5	79408.44444	71467.6	64970.54545	59556.33333	54975.07692	51048.28571	47645.06667	44667.25	39704.22222	37614.52632	35733.8	29778.16667	28587.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71422	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	1496479	748239.5	498826.3333	374119.75	299295.8	249413.1667	213782.7143	187059.875	166275.4444	149647.9	136043.5455	124706.5833	115113.7692	106891.3571	99765.26667	93529.9375	83137.72222	78762.05263	74823.95	62353.29167	59859.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71423	CHOYP_DUOX1.1.4|m.14285	IVMYDWLPR	IVMYDWLPR	76480	38240	25493.33333	19120	15296	12746.66667	10925.71429	9560	8497.777778	7648	6952.727273	6373.333333	5883.076923	5462.857143	5098.666667	4780	4248.888889	4025.263158	3824	3186.666667	3059.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71424	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71425	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71426	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71427	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71428	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	963679	481839.5	321226.3333	240919.75	192735.8	160613.1667	137668.4286	120459.875	107075.4444	96367.9	87607.18182	80306.58333	74129.15385	68834.21429	64245.26667	60229.9375	53537.72222	50719.94737	48183.95	40153.29167	38547.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71429	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	689019	344509.5	229673	172254.75	137803.8	114836.5	98431.28571	86127.375	76557.66667	68901.9	62638.09091	57418.25	53001.46154	49215.64286	45934.6	43063.6875	38278.83333	36264.15789	34450.95	28709.125	27560.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71430	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71431	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	645831	322915.5	215277	161457.75	129166.2	107638.5	92261.57143	80728.875	71759	64583.1	58711.90909	53819.25	49679.30769	46130.78571	43055.4	40364.4375	35879.5	33991.10526	32291.55	26909.625	25833.24	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71432	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71433	CHOYP_DUOX1.1.4|m.14285	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71434	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71435	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71436	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71437	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71438	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	791773	395886.5	263924.3333	197943.25	158354.6	131962.1667	113110.4286	98971.625	87974.77778	79177.3	71979.36364	65981.08333	60905.61538	56555.21429	52784.86667	49485.8125	43987.38889	41672.26316	39588.65	32990.54167	31670.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71439	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71440	CHOYP_DUOX1.1.4|m.14285	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71441	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	7899817	3949908.5	2633272.333	1974954.25	1579963.4	1316636.167	1128545.286	987477.125	877757.4444	789981.7	718165.1818	658318.0833	607678.2308	564272.6429	526654.4667	493738.5625	438878.7222	415779.8421	394990.85	329159.0417	315992.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71442	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	4718094	2359047	1572698	1179523.5	943618.8	786349	674013.4286	589761.75	524232.6667	471809.4	428917.6364	393174.5	362930.3077	337006.7143	314539.6	294880.875	262116.3333	248320.7368	235904.7	196587.25	188723.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71443	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	12421159	6210579.5	4140386.333	3105289.75	2484231.8	2070193.167	1774451.286	1552644.875	1380128.778	1242115.9	1129196.273	1035096.583	955473.7692	887225.6429	828077.2667	776322.4375	690064.3889	653745.2105	621057.95	517548.2917	496846.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71444	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	152817	76408.5	50939	38204.25	30563.4	25469.5	21831	19102.125	16979.66667	15281.7	13892.45455	12734.75	11755.15385	10915.5	10187.8	9551.0625	8489.833333	8043	7640.85	6367.375	6112.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71445	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	2206576	1103288	735525.3333	551644	441315.2	367762.6667	315225.1429	275822	245175.1111	220657.6	200597.8182	183881.3333	169736.6154	157612.5714	147105.0667	137911	122587.5556	116135.5789	110328.8	91940.66667	88263.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71446	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	172088	86044	57362.66667	43022	34417.6	28681.33333	24584	21511	19120.88889	17208.8	15644.36364	14340.66667	13237.53846	12292	11472.53333	10755.5	9560.444444	9057.263158	8604.4	7170.333333	6883.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71447	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	535490	267745	178496.6667	133872.5	107098	89248.33333	76498.57143	66936.25	59498.88889	53549	48680.90909	44624.16667	41191.53846	38249.28571	35699.33333	33468.125	29749.44444	28183.68421	26774.5	22312.08333	21419.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71448	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	404428	202214	134809.3333	101107	80885.6	67404.66667	57775.42857	50553.5	44936.44444	40442.8	36766.18182	33702.33333	31109.84615	28887.71429	26961.86667	25276.75	22468.22222	21285.68421	20221.4	16851.16667	16177.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71449	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	24397	12198.5	8132.333333	6099.25	4879.4	4066.166667	3485.285714	3049.625	2710.777778	2439.7	2217.909091	2033.083333	1876.692308	1742.642857	1626.466667	1524.8125	1355.388889	1284.052632	1219.85	1016.541667	975.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71450	CHOYP_DUOX1.1.4|m.14285	LNSWGEINTQNR	LNSWGEINTQNR	69116	34558	23038.66667	17279	13823.2	11519.33333	9873.714286	8639.5	7679.555556	6911.6	6283.272727	5759.666667	5316.615385	4936.857143	4607.733333	4319.75	3839.777778	3637.684211	3455.8	2879.833333	2764.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71451	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71452	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71453	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	2251357	1125678.5	750452.3333	562839.25	450271.4	375226.1667	321622.4286	281419.625	250150.7778	225135.7	204668.8182	187613.0833	173181.3077	160811.2143	150090.4667	140709.8125	125075.3889	118492.4737	112567.85	93806.54167	90054.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71454	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	24402	12201	8134	6100.5	4880.4	4067	3486	3050.25	2711.333333	2440.2	2218.363636	2033.5	1877.076923	1743	1626.8	1525.125	1355.666667	1284.315789	1220.1	1016.75	976.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71455	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	23554	11777	7851.333333	5888.5	4710.8	3925.666667	3364.857143	2944.25	2617.111111	2355.4	2141.272727	1962.833333	1811.846154	1682.428571	1570.266667	1472.125	1308.555556	1239.684211	1177.7	981.4166667	942.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71456	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71457	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	629832	314916	209944	157458	125966.4	104972	89976	78729	69981.33333	62983.2	57257.45455	52486	48448.61538	44988	41988.8	39364.5	34990.66667	33149.05263	31491.6	26243	25193.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71458	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71459	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	180496	90248	60165.33333	45124	36099.2	30082.66667	25785.14286	22562	20055.11111	18049.6	16408.72727	15041.33333	13884.30769	12892.57143	12033.06667	11281	10027.55556	9499.789474	9024.8	7520.666667	7219.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71460	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	66348	33174	22116	16587	13269.6	11058	9478.285714	8293.5	7372	6634.8	6031.636364	5529	5103.692308	4739.142857	4423.2	4146.75	3686	3492	3317.4	2764.5	2653.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71461	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	81753	40876.5	27251	20438.25	16350.6	13625.5	11679	10219.125	9083.666667	8175.3	7432.090909	6812.75	6288.692308	5839.5	5450.2	5109.5625	4541.833333	4302.789474	4087.65	3406.375	3270.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71462	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71463	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	30370	15185	10123.33333	7592.5	6074	5061.666667	4338.571429	3796.25	3374.444444	3037	2760.909091	2530.833333	2336.153846	2169.285714	2024.666667	1898.125	1687.222222	1598.421053	1518.5	1265.416667	1214.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71464	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	29406	14703	9802	7351.5	5881.2	4901	4200.857143	3675.75	3267.333333	2940.6	2673.272727	2450.5	2262	2100.428571	1960.4	1837.875	1633.666667	1547.684211	1470.3	1225.25	1176.24	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71465	CHOYP_DUOX1.1.4|m.14285	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	32907	16453.5	10969	8226.75	6581.4	5484.5	4701	4113.375	3656.333333	3290.7	2991.545455	2742.25	2531.307692	2350.5	2193.8	2056.6875	1828.166667	1731.947368	1645.35	1371.125	1316.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71466	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	3239234	1619617	1079744.667	809808.5	647846.8	539872.3333	462747.7143	404904.25	359914.8889	323923.4	294475.8182	269936.1667	249171.8462	231373.8571	215948.9333	202452.125	179957.4444	170486	161961.7	134968.0833	129569.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71467	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	1458464	729232	486154.6667	364616	291692.8	243077.3333	208352	182308	162051.5556	145846.4	132587.6364	121538.6667	112189.5385	104176	97230.93333	91154	81025.77778	76761.26316	72923.2	60769.33333	58338.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71468	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	2696826	1348413	898942	674206.5	539365.2	449471	385260.8571	337103.25	299647.3333	269682.6	245166	224735.5	207448.1538	192630.4286	179788.4	168551.625	149823.6667	141938.2105	134841.3	112367.75	107873.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71469	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	761320	380660	253773.3333	190330	152264	126886.6667	108760	95165	84591.11111	76132	69210.90909	63443.33333	58563.07692	54380	50754.66667	47582.5	42295.55556	40069.47368	38066	31721.66667	30452.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71470	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	1647263	823631.5	549087.6667	411815.75	329452.6	274543.8333	235323.2857	205907.875	183029.2222	164726.3	149751.1818	137271.9167	126712.5385	117661.6429	109817.5333	102953.9375	91514.61111	86698.05263	82363.15	68635.95833	65890.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71471	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	451472	225736	150490.6667	112868	90294.4	75245.33333	64496	56434	50163.55556	45147.2	41042.90909	37622.66667	34728.61538	32248	30098.13333	28217	25081.77778	23761.68421	22573.6	18811.33333	18058.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71472	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	29336	14668	9778.666667	7334	5867.2	4889.333333	4190.857143	3667	3259.555556	2933.6	2666.909091	2444.666667	2256.615385	2095.428571	1955.733333	1833.5	1629.777778	1544	1466.8	1222.333333	1173.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71473	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71474	CHOYP_DUOX1.1.4|m.14285	AELILNNASTK	AELILNNASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71475	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	5717443	2858721.5	1905814.333	1429360.75	1143488.6	952907.1667	816777.5714	714680.375	635271.4444	571744.3	519767.5455	476453.5833	439803.3077	408388.7857	381162.8667	357340.1875	317635.7222	300918.0526	285872.15	238226.7917	228697.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71476	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	3398854	1699427	1132951.333	849713.5	679770.8	566475.6667	485550.5714	424856.75	377650.4444	339885.4	308986.7273	283237.8333	261450.3077	242775.2857	226590.2667	212428.375	188825.2222	178887.0526	169942.7	141618.9167	135954.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71477	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	1586136	793068	528712	396534	317227.2	264356	226590.8571	198267	176237.3333	158613.6	144194.1818	132178	122010.4615	113295.4286	105742.4	99133.5	88118.66667	83480.84211	79306.8	66089	63445.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71478	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	52605	26302.5	17535	13151.25	10521	8767.5	7515	6575.625	5845	5260.5	4782.272727	4383.75	4046.538462	3757.5	3507	3287.8125	2922.5	2768.684211	2630.25	2191.875	2104.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71479	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	203723	101861.5	67907.66667	50930.75	40744.6	33953.83333	29103.28571	25465.375	22635.88889	20372.3	18520.27273	16976.91667	15671	14551.64286	13581.53333	12732.6875	11317.94444	10722.26316	10186.15	8488.458333	8148.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71480	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	383434	191717	127811.3333	95858.5	76686.8	63905.66667	54776.28571	47929.25	42603.77778	38343.4	34857.63636	31952.83333	29494.92308	27388.14286	25562.26667	23964.625	21301.88889	20180.73684	19171.7	15976.41667	15337.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71481	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	108102	54051	36034	27025.5	21620.4	18017	15443.14286	13512.75	12011.33333	10810.2	9827.454545	9008.5	8315.538462	7721.571429	7206.8	6756.375	6005.666667	5689.578947	5405.1	4504.25	4324.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71482	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	190969	95484.5	63656.33333	47742.25	38193.8	31828.16667	27281.28571	23871.125	21218.77778	19096.9	17360.81818	15914.08333	14689.92308	13640.64286	12731.26667	11935.5625	10609.38889	10051	9548.45	7957.041667	7638.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71483	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	215277	107638.5	71759	53819.25	43055.4	35879.5	30753.85714	26909.625	23919.66667	21527.7	19570.63636	17939.75	16559.76923	15376.92857	14351.8	13454.8125	11959.83333	11330.36842	10763.85	8969.875	8611.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71484	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	34043	17021.5	11347.66667	8510.75	6808.6	5673.833333	4863.285714	4255.375	3782.555556	3404.3	3094.818182	2836.916667	2618.692308	2431.642857	2269.533333	2127.6875	1891.277778	1791.736842	1702.15	1418.458333	1361.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71485	CHOYP_DUOX1.1.4|m.14285	ELDLENLDHDTAK	ELDLENLDHDTAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71486	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	3536050	1768025	1178683.333	884012.5	707210	589341.6667	505150	442006.25	392894.4444	353605	321459.0909	294670.8333	272003.8462	252575	235736.6667	221003.125	196447.2222	186107.8947	176802.5	147335.4167	141442	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71487	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	2951577	1475788.5	983859	737894.25	590315.4	491929.5	421653.8571	368947.125	327953	295157.7	268325.1818	245964.75	227044.3846	210826.9286	196771.8	184473.5625	163976.5	155346.1579	147578.85	122982.375	118063.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71488	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	2000610	1000305	666870	500152.5	400122	333435	285801.4286	250076.25	222290	200061	181873.6364	166717.5	153893.0769	142900.7143	133374	125038.125	111145	105295.2632	100030.5	83358.75	80024.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71489	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71490	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71491	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71492	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	34428	17214	11476	8607	6885.6	5738	4918.285714	4303.5	3825.333333	3442.8	3129.818182	2869	2648.307692	2459.142857	2295.2	2151.75	1912.666667	1812	1721.4	1434.5	1377.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71493	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	309197	154598.5	103065.6667	77299.25	61839.4	51532.83333	44171	38649.625	34355.22222	30919.7	28108.81818	25766.41667	23784.38462	22085.5	20613.13333	19324.8125	17177.61111	16273.52632	15459.85	12883.20833	12367.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71494	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71495	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	47057	23528.5	15685.66667	11764.25	9411.4	7842.833333	6722.428571	5882.125	5228.555556	4705.7	4277.909091	3921.416667	3619.769231	3361.214286	3137.133333	2941.0625	2614.277778	2476.684211	2352.85	1960.708333	1882.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71496	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	847538	423769	282512.6667	211884.5	169507.6	141256.3333	121076.8571	105942.25	94170.88889	84753.8	77048.90909	70628.16667	65195.23077	60538.42857	56502.53333	52971.125	47085.44444	44607.26316	42376.9	35314.08333	33901.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71497	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71498	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71499	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71500	CHOYP_DUOX1.1.4|m.14285	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71501	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	481905	240952.5	160635	120476.25	96381	80317.5	68843.57143	60238.125	53545	48190.5	43809.54545	40158.75	37069.61538	34421.78571	32127	30119.0625	26772.5	25363.42105	24095.25	20079.375	19276.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71502	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71503	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	472792	236396	157597.3333	118198	94558.4	78798.66667	67541.71429	59099	52532.44444	47279.2	42981.09091	39399.33333	36368.61538	33770.85714	31519.46667	29549.5	26266.22222	24883.78947	23639.6	19699.66667	18911.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71504	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71505	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	309505	154752.5	103168.3333	77376.25	61901	51584.16667	44215	38688.125	34389.44444	30950.5	28136.81818	25792.08333	23808.07692	22107.5	20633.66667	19344.0625	17194.72222	16289.73684	15475.25	12896.04167	12380.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71506	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71507	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71508	CHOYP_DUOX1.1.4|m.14285	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71509	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	3009778	1504889	1003259.333	752444.5	601955.6	501629.6667	429968.2857	376222.25	334419.7778	300977.8	273616.1818	250814.8333	231521.3846	214984.1429	200651.8667	188111.125	167209.8889	158409.3684	150488.9	125407.4167	120391.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71510	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	2537643	1268821.5	845881	634410.75	507528.6	422940.5	362520.4286	317205.375	281960.3333	253764.3	230694.8182	211470.25	195203.3077	181260.2143	169176.2	158602.6875	140980.1667	133560.1579	126882.15	105735.125	101505.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71511	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	1045837	522918.5	348612.3333	261459.25	209167.4	174306.1667	149405.2857	130729.625	116204.1111	104583.7	95076.09091	87153.08333	80449	74702.64286	69722.46667	65364.8125	58102.05556	55044.05263	52291.85	43576.54167	41833.48	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71512	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	241784	120892	80594.66667	60446	48356.8	40297.33333	34540.57143	30223	26864.88889	24178.4	21980.36364	20148.66667	18598.76923	17270.28571	16118.93333	15111.5	13432.44444	12725.47368	12089.2	10074.33333	9671.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71513	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	444122	222061	148040.6667	111030.5	88824.4	74020.33333	63446	55515.25	49346.88889	44412.2	40374.72727	37010.16667	34163.23077	31723	29608.13333	27757.625	24673.44444	23374.84211	22206.1	18505.08333	17764.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71514	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	424911	212455.5	141637	106227.75	84982.2	70818.5	60701.57143	53113.875	47212.33333	42491.1	38628.27273	35409.25	32685.46154	30350.78571	28327.4	26556.9375	23606.16667	22363.73684	21245.55	17704.625	16996.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71515	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71516	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71517	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	24699	12349.5	8233	6174.75	4939.8	4116.5	3528.428571	3087.375	2744.333333	2469.9	2245.363636	2058.25	1899.923077	1764.214286	1646.6	1543.6875	1372.166667	1299.947368	1234.95	1029.125	987.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71518	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71519	CHOYP_DUOX1.1.4|m.14285	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71520	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	13063340	6531670	4354446.667	3265835	2612668	2177223.333	1866191.429	1632917.5	1451482.222	1306334	1187576.364	1088611.667	1004872.308	933095.7143	870889.3333	816458.75	725741.1111	687544.2105	653167	544305.8333	522533.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71521	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	7129513	3564756.5	2376504.333	1782378.25	1425902.6	1188252.167	1018501.857	891189.125	792168.1111	712951.3	648137.5455	594126.0833	548424.0769	509250.9286	475300.8667	445594.5625	396084.0556	375237.5263	356475.65	297063.0417	285180.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71522	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	2909174	1454587	969724.6667	727293.5	581834.8	484862.3333	415596.2857	363646.75	323241.5556	290917.4	264470.3636	242431.1667	223782.6154	207798.1429	193944.9333	181823.375	161620.7778	153114.4211	145458.7	121215.5833	116366.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71523	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	99950	49975	33316.66667	24987.5	19990	16658.33333	14278.57143	12493.75	11105.55556	9995	9086.363636	8329.166667	7688.461538	7139.285714	6663.333333	6246.875	5552.777778	5260.526316	4997.5	4164.583333	3998	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71524	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	475789	237894.5	158596.3333	118947.25	95157.8	79298.16667	67969.85714	59473.625	52865.44444	47578.9	43253.54545	39649.08333	36599.15385	33984.92857	31719.26667	29736.8125	26432.72222	25041.52632	23789.45	19824.54167	19031.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71525	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	259365	129682.5	86455	64841.25	51873	43227.5	37052.14286	32420.625	28818.33333	25936.5	23578.63636	21613.75	19951.15385	18526.07143	17291	16210.3125	14409.16667	13650.78947	12968.25	10806.875	10374.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71526	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	224835	112417.5	74945	56208.75	44967	37472.5	32119.28571	28104.375	24981.66667	22483.5	20439.54545	18736.25	17295	16059.64286	14989	14052.1875	12490.83333	11833.42105	11241.75	9368.125	8993.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71527	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	361923	180961.5	120641	90480.75	72384.6	60320.5	51703.28571	45240.375	40213.66667	36192.3	32902.09091	30160.25	27840.23077	25851.64286	24128.2	22620.1875	20106.83333	19048.57895	18096.15	15080.125	14476.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71528	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	512616	256308	170872	128154	102523.2	85436	73230.85714	64077	56957.33333	51261.6	46601.45455	42718	39432	36615.42857	34174.4	32038.5	28478.66667	26979.78947	25630.8	21359	20504.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71529	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	6866	3433	2288.666667	1716.5	1373.2	1144.333333	980.8571429	858.25	762.8888889	686.6	624.1818182	572.1666667	528.1538462	490.4285714	457.7333333	429.125	381.4444444	361.3684211	343.3	286.0833333	274.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71530	CHOYP_DUOX1.1.4|m.14285	IFASDEYAGTLQK	IFASDEYAGTLQK	126428	63214	42142.66667	31607	25285.6	21071.33333	18061.14286	15803.5	14047.55556	12642.8	11493.45455	10535.66667	9725.230769	9030.571429	8428.533333	7901.75	7023.777778	6654.105263	6321.4	5267.833333	5057.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71531	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	2634419	1317209.5	878139.6667	658604.75	526883.8	439069.8333	376345.5714	329302.375	292713.2222	263441.9	239492.6364	219534.9167	202647.6154	188172.7857	175627.9333	164651.1875	146356.6111	138653.6316	131720.95	109767.4583	105376.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71532	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71533	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	915023	457511.5	305007.6667	228755.75	183004.6	152503.8333	130717.5714	114377.875	101669.2222	91502.3	83183.90909	76251.91667	70386.38462	65358.78571	61001.53333	57188.9375	50834.61111	48159.10526	45751.15	38125.95833	36600.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71534	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71535	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	54157	27078.5	18052.33333	13539.25	10831.4	9026.166667	7736.714286	6769.625	6017.444444	5415.7	4923.363636	4513.083333	4165.923077	3868.357143	3610.466667	3384.8125	3008.722222	2850.368421	2707.85	2256.541667	2166.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71536	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	433957	216978.5	144652.3333	108489.25	86791.4	72326.16667	61993.85714	54244.625	48217.44444	43395.7	39450.63636	36163.08333	33381.30769	30996.92857	28930.46667	27122.3125	24108.72222	22839.84211	21697.85	18081.54167	17358.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71537	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	333860	166930	111286.6667	83465	66772	55643.33333	47694.28571	41732.5	37095.55556	33386	30350.90909	27821.66667	25681.53846	23847.14286	22257.33333	20866.25	18547.77778	17571.57895	16693	13910.83333	13354.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71538	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71539	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	1238546	619273	412848.6667	309636.5	247709.2	206424.3333	176935.1429	154818.25	137616.2222	123854.6	112595.0909	103212.1667	95272.76923	88467.57143	82569.73333	77409.125	68808.11111	65186.63158	61927.3	51606.08333	49541.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71540	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	13680	6840	4560	3420	2736	2280	1954.285714	1710	1520	1368	1243.636364	1140	1052.307692	977.1428571	912	855	760	720	684	570	547.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71541	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	259092	129546	86364	64773	51818.4	43182	37013.14286	32386.5	28788	25909.2	23553.81818	21591	19930.15385	18506.57143	17272.8	16193.25	14394	13636.42105	12954.6	10795.5	10363.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71542	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	111721	55860.5	37240.33333	27930.25	22344.2	18620.16667	15960.14286	13965.125	12413.44444	11172.1	10156.45455	9310.083333	8593.923077	7980.071429	7448.066667	6982.5625	6206.722222	5880.052632	5586.05	4655.041667	4468.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71543	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71544	CHOYP_DUOX1.1.4|m.14285	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71545	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	3027734	1513867	1009244.667	756933.5	605546.8	504622.3333	432533.4286	378466.75	336414.8889	302773.4	275248.5455	252311.1667	232902.6154	216266.7143	201848.9333	189233.375	168207.4444	159354.4211	151386.7	126155.5833	121109.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71546	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	2903053	1451526.5	967684.3333	725763.25	580610.6	483842.1667	414721.8571	362881.625	322561.4444	290305.3	263913.9091	241921.0833	223311.7692	207360.9286	193536.8667	181440.8125	161280.7222	152792.2632	145152.65	120960.5417	116122.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71547	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	404182	202091	134727.3333	101045.5	80836.4	67363.66667	57740.28571	50522.75	44909.11111	40418.2	36743.81818	33681.83333	31090.92308	28870.14286	26945.46667	25261.375	22454.55556	21272.73684	20209.1	16840.91667	16167.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71548	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	174884	87442	58294.66667	43721	34976.8	29147.33333	24983.42857	21860.5	19431.55556	17488.4	15898.54545	14573.66667	13452.61538	12491.71429	11658.93333	10930.25	9715.777778	9204.421053	8744.2	7286.833333	6995.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71549	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	1568924	784462	522974.6667	392231	313784.8	261487.3333	224132	196115.5	174324.8889	156892.4	142629.4545	130743.6667	120686.4615	112066	104594.9333	98057.75	87162.44444	82574.94737	78446.2	65371.83333	62756.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71550	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	129252	64626	43084	32313	25850.4	21542	18464.57143	16156.5	14361.33333	12925.2	11750.18182	10771	9942.461538	9232.285714	8616.8	8078.25	7180.666667	6802.736842	6462.6	5385.5	5170.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71551	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71552	CHOYP_DUOX1.1.4|m.14285	IAGYGVTVTR	IAGYGVTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71553	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71554	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71555	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71556	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71557	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71558	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71559	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	123770	61885	41256.66667	30942.5	24754	20628.33333	17681.42857	15471.25	13752.22222	12377	11251.81818	10314.16667	9520.769231	8840.714286	8251.333333	7735.625	6876.111111	6514.210526	6188.5	5157.083333	4950.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71560	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	48033	24016.5	16011	12008.25	9606.6	8005.5	6861.857143	6004.125	5337	4803.3	4366.636364	4002.75	3694.846154	3430.928571	3202.2	3002.0625	2668.5	2528.052632	2401.65	2001.375	1921.32	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71561	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	147531	73765.5	49177	36882.75	29506.2	24588.5	21075.85714	18441.375	16392.33333	14753.1	13411.90909	12294.25	11348.53846	10537.92857	9835.4	9220.6875	8196.166667	7764.789474	7376.55	6147.125	5901.24	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71562	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	207430	103715	69143.33333	51857.5	41486	34571.66667	29632.85714	25928.75	23047.77778	20743	18857.27273	17285.83333	15956.15385	14816.42857	13828.66667	12964.375	11523.88889	10917.36842	10371.5	8642.916667	8297.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71563	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	356788	178394	118929.3333	89197	71357.6	59464.66667	50969.71429	44598.5	39643.11111	35678.8	32435.27273	29732.33333	27445.23077	25484.85714	23785.86667	22299.25	19821.55556	18778.31579	17839.4	14866.16667	14271.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71564	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	11536	5768	3845.333333	2884	2307.2	1922.666667	1648	1442	1281.777778	1153.6	1048.727273	961.3333333	887.3846154	824	769.0666667	721	640.8888889	607.1578947	576.8	480.6666667	461.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71565	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	14926	7463	4975.333333	3731.5	2985.2	2487.666667	2132.285714	1865.75	1658.444444	1492.6	1356.909091	1243.833333	1148.153846	1066.142857	995.0666667	932.875	829.2222222	785.5789474	746.3	621.9166667	597.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71566	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71567	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71568	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71569	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	27557	13778.5	9185.666667	6889.25	5511.4	4592.833333	3936.714286	3444.625	3061.888889	2755.7	2505.181818	2296.416667	2119.769231	1968.357143	1837.133333	1722.3125	1530.944444	1450.368421	1377.85	1148.208333	1102.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71570	CHOYP_DUOX1.1.4|m.14285	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	11480	5740	3826.666667	2870	2296	1913.333333	1640	1435	1275.555556	1148	1043.636364	956.6666667	883.0769231	820	765.3333333	717.5	637.7777778	604.2105263	574	478.3333333	459.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71571	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71572	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	3617592	1808796	1205864	904398	723518.4	602932	516798.8571	452199	401954.6667	361759.2	328872	301466	278276.3077	258399.4286	241172.8	226099.5	200977.3333	190399.5789	180879.6	150733	144703.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71573	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71574	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	708318	354159	236106	177079.5	141663.6	118053	101188.2857	88539.75	78702	70831.8	64392.54545	59026.5	54486	50594.14286	47221.2	44269.875	39351	37279.89474	35415.9	29513.25	28332.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71575	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	901695	450847.5	300565	225423.75	180339	150282.5	128813.5714	112711.875	100188.3333	90169.5	81972.27273	75141.25	69361.15385	64406.78571	60113	56355.9375	50094.16667	47457.63158	45084.75	37570.625	36067.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71576	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	1232799	616399.5	410933	308199.75	246559.8	205466.5	176114.1429	154099.875	136977.6667	123279.9	112072.6364	102733.25	94830.69231	88057.07143	82186.6	77049.9375	68488.83333	64884.15789	61639.95	51366.625	49311.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71577	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	552478	276239	184159.3333	138119.5	110495.6	92079.66667	78925.42857	69059.75	61386.44444	55247.8	50225.27273	46039.83333	42498.30769	39462.71429	36831.86667	34529.875	30693.22222	29077.78947	27623.9	23019.91667	22099.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71578	CHOYP_DUOX1.1.4|m.14285	AVGPWTYNLR	AVGPWTYNLR	78353	39176.5	26117.66667	19588.25	15670.6	13058.83333	11193.28571	9794.125	8705.888889	7835.3	7123	6529.416667	6027.153846	5596.642857	5223.533333	4897.0625	4352.944444	4123.842105	3917.65	3264.708333	3134.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71579	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71580	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71581	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	2817934	1408967	939311.3333	704483.5	563586.8	469655.6667	402562	352241.75	313103.7778	281793.4	256175.8182	234827.8333	216764.1538	201281	187862.2667	176120.875	156551.8889	148312.3158	140896.7	117413.9167	112717.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71582	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	740717	370358.5	246905.6667	185179.25	148143.4	123452.8333	105816.7143	92589.625	82301.88889	74071.7	67337.90909	61726.41667	56978.23077	52908.35714	49381.13333	46294.8125	41150.94444	38985.10526	37035.85	30863.20833	29628.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71583	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	3243090	1621545	1081030	810772.5	648618	540515	463298.5714	405386.25	360343.3333	324309	294826.3636	270257.5	249468.4615	231649.2857	216206	202693.125	180171.6667	170688.9474	162154.5	135128.75	129723.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71584	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71585	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71586	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71587	CHOYP_DUOX1.1.4|m.14285	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71588	CHOYP_DUOX1.1.4|m.14285	VYFLWVTR	VYFLWVTR	2932702	1466351	977567.3333	733175.5	586540.4	488783.6667	418957.4286	366587.75	325855.7778	293270.2	266609.2727	244391.8333	225592.4615	209478.7143	195513.4667	183293.875	162927.8889	154352.7368	146635.1	122195.9167	117308.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71589	CHOYP_DUOX1.1.4|m.14285	VYFLWVTR	VYFLWVTR	2528441	1264220.5	842813.6667	632110.25	505688.2	421406.8333	361205.8571	316055.125	280937.8889	252844.1	229858.2727	210703.4167	194495.4615	180602.9286	168562.7333	158027.5625	140468.9444	133075.8421	126422.05	105351.7083	101137.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71590	CHOYP_DUOX1.1.4|m.14285	VYFLWVTR	VYFLWVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71591	CHOYP_DUOX1.1.4|m.14285	VYFLWVTR	VYFLWVTR	673196	336598	224398.6667	168299	134639.2	112199.3333	96170.85714	84149.5	74799.55556	67319.6	61199.63636	56099.66667	51784.30769	48085.42857	44879.73333	42074.75	37399.77778	35431.36842	33659.8	28049.83333	26927.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71592	CHOYP_DUOX1.1.4|m.14285	VYFLWVTR	VYFLWVTR	843964	421982	281321.3333	210991	168792.8	140660.6667	120566.2857	105495.5	93773.77778	84396.4	76724	70330.33333	64920.30769	60283.14286	56264.26667	52747.75	46886.88889	44419.15789	42198.2	35165.16667	33758.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71593	CHOYP_DUOX1.1.4|m.14285	VYFLWVTR	VYFLWVTR	56828	28414	18942.66667	14207	11365.6	9471.333333	8118.285714	7103.5	6314.222222	5682.8	5166.181818	4735.666667	4371.384615	4059.142857	3788.533333	3551.75	3157.111111	2990.947368	2841.4	2367.833333	2273.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71594	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	1444702	722351	481567.3333	361175.5	288940.4	240783.6667	206386	180587.75	160522.4444	144470.2	131336.5455	120391.8333	111130.9231	103193	96313.46667	90293.875	80261.22222	76036.94737	72235.1	60195.91667	57788.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71595	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	1501775	750887.5	500591.6667	375443.75	300355	250295.8333	214539.2857	187721.875	166863.8889	150177.5	136525	125147.9167	115521.1538	107269.6429	100118.3333	93860.9375	83431.94444	79040.78947	75088.75	62573.95833	60071	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71596	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	532485	266242.5	177495	133121.25	106497	88747.5	76069.28571	66560.625	59165	53248.5	48407.72727	44373.75	40960.38462	38034.64286	35499	33280.3125	29582.5	28025.52632	26624.25	22186.875	21299.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71597	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	351768	175884	117256	87942	70353.6	58628	50252.57143	43971	39085.33333	35176.8	31978.90909	29314	27059.07692	25126.28571	23451.2	21985.5	19542.66667	18514.10526	17588.4	14657	14070.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71598	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	443360	221680	147786.6667	110840	88672	73893.33333	63337.14286	55420	49262.22222	44336	40305.45455	36946.66667	34104.61538	31668.57143	29557.33333	27710	24631.11111	23334.73684	22168	18473.33333	17734.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71599	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	449515	224757.5	149838.3333	112378.75	89903	74919.16667	64216.42857	56189.375	49946.11111	44951.5	40865	37459.58333	34578.07692	32108.21429	29967.66667	28094.6875	24973.05556	23658.68421	22475.75	18729.79167	17980.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71600	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71601	CHOYP_DUOX1.1.4|m.14285	QFEWMTDIIR	QFEWMTDIIR	64007	32003.5	21335.66667	16001.75	12801.4	10667.83333	9143.857143	8000.875	7111.888889	6400.7	5818.818182	5333.916667	4923.615385	4571.928571	4267.133333	4000.4375	3555.944444	3368.789474	3200.35	2666.958333	2560.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71602	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	3597570	1798785	1199190	899392.5	719514	599595	513938.5714	449696.25	399730	359757	327051.8182	299797.5	276736.1538	256969.2857	239838	224848.125	199865	189345.7895	179878.5	149898.75	143902.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71603	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71604	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	26215	13107.5	8738.333333	6553.75	5243	4369.166667	3745	3276.875	2912.777778	2621.5	2383.181818	2184.583333	2016.538462	1872.5	1747.666667	1638.4375	1456.388889	1379.736842	1310.75	1092.291667	1048.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71605	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	1039502	519751	346500.6667	259875.5	207900.4	173250.3333	148500.2857	129937.75	115500.2222	103950.2	94500.18182	86625.16667	79961.69231	74250.14286	69300.13333	64968.875	57750.11111	54710.63158	51975.1	43312.58333	41580.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71606	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	714676	357338	238225.3333	178669	142935.2	119112.6667	102096.5714	89334.5	79408.44444	71467.6	64970.54545	59556.33333	54975.07692	51048.28571	47645.06667	44667.25	39704.22222	37614.52632	35733.8	29778.16667	28587.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71607	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	1496479	748239.5	498826.3333	374119.75	299295.8	249413.1667	213782.7143	187059.875	166275.4444	149647.9	136043.5455	124706.5833	115113.7692	106891.3571	99765.26667	93529.9375	83137.72222	78762.05263	74823.95	62353.29167	59859.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71608	CHOYP_DUOX1.2.4|m.33964	IVMYDWLPR	IVMYDWLPR	76480	38240	25493.33333	19120	15296	12746.66667	10925.71429	9560	8497.777778	7648	6952.727273	6373.333333	5883.076923	5462.857143	5098.666667	4780	4248.888889	4025.263158	3824	3186.666667	3059.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71609	CHOYP_DUOX1.2.4|m.33964	ILLDQFMR	ILLDQFMR	7989644	3994822	2663214.667	1997411	1597928.8	1331607.333	1141377.714	998705.5	887738.2222	798964.4	726331.2727	665803.6667	614588	570688.8571	532642.9333	499352.75	443869.1111	420507.5789	399482.2	332901.8333	319585.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71610	CHOYP_DUOX1.2.4|m.33964	ILLDQFMR	ILLDQFMR	4670177	2335088.5	1556725.667	1167544.25	934035.4	778362.8333	667168.1429	583772.125	518908.5556	467017.7	424561.5455	389181.4167	359244.3846	333584.0714	311345.1333	291886.0625	259454.2778	245798.7895	233508.85	194590.7083	186807.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71611	CHOYP_DUOX1.2.4|m.33964	ILLDQFMR	ILLDQFMR	1929627	964813.5	643209	482406.75	385925.4	321604.5	275661	241203.375	214403	192962.7	175420.6364	160802.25	148432.8462	137830.5	128641.8	120601.6875	107201.5	101559.3158	96481.35	80401.125	77185.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71612	CHOYP_DUOX1.2.4|m.33964	ILLDQFMR	ILLDQFMR	1490679	745339.5	496893	372669.75	298135.8	248446.5	212954.1429	186334.875	165631	149067.9	135516.2727	124223.25	114667.6154	106477.0714	99378.6	93167.4375	82815.5	78456.78947	74533.95	62111.625	59627.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71613	CHOYP_DUOX1.2.4|m.33964	ILLDQFMR	ILLDQFMR	1164222	582111	388074	291055.5	232844.4	194037	166317.4286	145527.75	129358	116422.2	105838.3636	97018.5	89555.53846	83158.71429	77614.8	72763.875	64679	61274.84211	58211.1	48509.25	46568.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71614	CHOYP_DUOX1.2.4|m.33964	ILLDQFMR	ILLDQFMR	15995	7997.5	5331.666667	3998.75	3199	2665.833333	2285	1999.375	1777.222222	1599.5	1454.090909	1332.916667	1230.384615	1142.5	1066.333333	999.6875	888.6111111	841.8421053	799.75	666.4583333	639.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71615	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	2584840	1292420	861613.3333	646210	516968	430806.6667	369262.8571	323105	287204.4444	258484	234985.4545	215403.3333	198833.8462	184631.4286	172322.6667	161552.5	143602.2222	136044.2105	129242	107701.6667	103393.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71616	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	1787867	893933.5	595955.6667	446966.75	357573.4	297977.8333	255409.5714	223483.375	198651.8889	178786.7	162533.3636	148988.9167	137528.2308	127704.7857	119191.1333	111741.6875	99325.94444	94098.26316	89393.35	74494.45833	71514.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71617	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	1293438	646719	431146	323359.5	258687.6	215573	184776.8571	161679.75	143715.3333	129343.8	117585.2727	107786.5	99495.23077	92388.42857	86229.2	80839.875	71857.66667	68075.68421	64671.9	53893.25	51737.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71618	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71619	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	119490	59745	39830	29872.5	23898	19915	17070	14936.25	13276.66667	11949	10862.72727	9957.5	9191.538462	8535	7966	7468.125	6638.333333	6288.947368	5974.5	4978.75	4779.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71620	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71621	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	322565	161282.5	107521.6667	80641.25	64513	53760.83333	46080.71429	40320.625	35840.55556	32256.5	29324.09091	26880.41667	24812.69231	23040.35714	21504.33333	20160.3125	17920.27778	16977.10526	16128.25	13440.20833	12902.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71622	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	380300	190150	126766.6667	95075	76060	63383.33333	54328.57143	47537.5	42255.55556	38030	34572.72727	31691.66667	29253.84615	27164.28571	25353.33333	23768.75	21127.77778	20015.78947	19015	15845.83333	15212	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71623	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71624	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	157142	78571	52380.66667	39285.5	31428.4	26190.33333	22448.85714	19642.75	17460.22222	15714.2	14285.63636	13095.16667	12087.84615	11224.42857	10476.13333	9821.375	8730.111111	8270.631579	7857.1	6547.583333	6285.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71625	CHOYP_DUOX1.2.4|m.33964	LSSDGLQNIIAIR	LSSDGLQNIIAIR	233893	116946.5	77964.33333	58473.25	46778.6	38982.16667	33413.28571	29236.625	25988.11111	23389.3	21263	19491.08333	17991.76923	16706.64286	15592.86667	14618.3125	12994.05556	12310.15789	11694.65	9745.541667	9355.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71626	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71627	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71628	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71629	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71630	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71631	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71632	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71633	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71634	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71635	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71636	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71637	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71638	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71639	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	44998	22499	14999.33333	11249.5	8999.6	7499.666667	6428.285714	5624.75	4999.777778	4499.8	4090.727273	3749.833333	3461.384615	3214.142857	2999.866667	2812.375	2499.888889	2368.315789	2249.9	1874.916667	1799.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71640	CHOYP_DUOX1.2.4|m.33964	TAGLPQNADIDFESFAK	TAGLPQNADIDFESFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71641	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	710916	355458	236972	177729	142183.2	118486	101559.4286	88864.5	78990.66667	71091.6	64628.72727	59243	54685.84615	50779.71429	47394.4	44432.25	39495.33333	37416.63158	35545.8	29621.5	28436.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71642	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	552263	276131.5	184087.6667	138065.75	110452.6	92043.83333	78894.71429	69032.875	61362.55556	55226.3	50205.72727	46021.91667	42481.76923	39447.35714	36817.53333	34516.4375	30681.27778	29066.47368	27613.15	23010.95833	22090.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71643	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71644	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	126213	63106.5	42071	31553.25	25242.6	21035.5	18030.42857	15776.625	14023.66667	12621.3	11473.90909	10517.75	9708.692308	9015.214286	8414.2	7888.3125	7011.833333	6642.789474	6310.65	5258.875	5048.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71645	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71646	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71647	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71648	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71649	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71650	CHOYP_DUOX1.2.4|m.33964	IFASDEYESTLK	IFASDEYESTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71651	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	3027734	1513867	1009244.667	756933.5	605546.8	504622.3333	432533.4286	378466.75	336414.8889	302773.4	275248.5455	252311.1667	232902.6154	216266.7143	201848.9333	189233.375	168207.4444	159354.4211	151386.7	126155.5833	121109.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71652	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	2903053	1451526.5	967684.3333	725763.25	580610.6	483842.1667	414721.8571	362881.625	322561.4444	290305.3	263913.9091	241921.0833	223311.7692	207360.9286	193536.8667	181440.8125	161280.7222	152792.2632	145152.65	120960.5417	116122.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71653	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	404182	202091	134727.3333	101045.5	80836.4	67363.66667	57740.28571	50522.75	44909.11111	40418.2	36743.81818	33681.83333	31090.92308	28870.14286	26945.46667	25261.375	22454.55556	21272.73684	20209.1	16840.91667	16167.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71654	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	174884	87442	58294.66667	43721	34976.8	29147.33333	24983.42857	21860.5	19431.55556	17488.4	15898.54545	14573.66667	13452.61538	12491.71429	11658.93333	10930.25	9715.777778	9204.421053	8744.2	7286.833333	6995.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71655	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	1568924	784462	522974.6667	392231	313784.8	261487.3333	224132	196115.5	174324.8889	156892.4	142629.4545	130743.6667	120686.4615	112066	104594.9333	98057.75	87162.44444	82574.94737	78446.2	65371.83333	62756.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71656	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	129252	64626	43084	32313	25850.4	21542	18464.57143	16156.5	14361.33333	12925.2	11750.18182	10771	9942.461538	9232.285714	8616.8	8078.25	7180.666667	6802.736842	6462.6	5385.5	5170.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71657	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71658	CHOYP_DUOX1.2.4|m.33964	IAGYGVTVTR	IAGYGVTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71659	CHOYP_DUOX1.2.4|m.33964	VYFLWVTR	VYFLWVTR	2932702	1466351	977567.3333	733175.5	586540.4	488783.6667	418957.4286	366587.75	325855.7778	293270.2	266609.2727	244391.8333	225592.4615	209478.7143	195513.4667	183293.875	162927.8889	154352.7368	146635.1	122195.9167	117308.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71660	CHOYP_DUOX1.2.4|m.33964	VYFLWVTR	VYFLWVTR	2528441	1264220.5	842813.6667	632110.25	505688.2	421406.8333	361205.8571	316055.125	280937.8889	252844.1	229858.2727	210703.4167	194495.4615	180602.9286	168562.7333	158027.5625	140468.9444	133075.8421	126422.05	105351.7083	101137.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71661	CHOYP_DUOX1.2.4|m.33964	VYFLWVTR	VYFLWVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71662	CHOYP_DUOX1.2.4|m.33964	VYFLWVTR	VYFLWVTR	673196	336598	224398.6667	168299	134639.2	112199.3333	96170.85714	84149.5	74799.55556	67319.6	61199.63636	56099.66667	51784.30769	48085.42857	44879.73333	42074.75	37399.77778	35431.36842	33659.8	28049.83333	26927.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71663	CHOYP_DUOX1.2.4|m.33964	VYFLWVTR	VYFLWVTR	843964	421982	281321.3333	210991	168792.8	140660.6667	120566.2857	105495.5	93773.77778	84396.4	76724	70330.33333	64920.30769	60283.14286	56264.26667	52747.75	46886.88889	44419.15789	42198.2	35165.16667	33758.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71664	CHOYP_DUOX1.2.4|m.33964	VYFLWVTR	VYFLWVTR	56828	28414	18942.66667	14207	11365.6	9471.333333	8118.285714	7103.5	6314.222222	5682.8	5166.181818	4735.666667	4371.384615	4059.142857	3788.533333	3551.75	3157.111111	2990.947368	2841.4	2367.833333	2273.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71684	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71685	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71686	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71687	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	2306542	1153271	768847.3333	576635.5	461308.4	384423.6667	329506	288317.75	256282.4444	230654.2	209685.6364	192211.8333	177426.3077	164753	153769.4667	144158.875	128141.2222	121396.9474	115327.1	96105.91667	92261.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71688	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	1303780	651890	434593.3333	325945	260756	217296.6667	186254.2857	162972.5	144864.4444	130378	118525.4545	108648.3333	100290.7692	93127.14286	86918.66667	81486.25	72432.22222	68620	65189	54324.16667	52151.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71689	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	698007	349003.5	232669	174501.75	139601.4	116334.5	99715.28571	87250.875	77556.33333	69800.7	63455.18182	58167.25	53692.84615	49857.64286	46533.8	43625.4375	38778.16667	36737.21053	34900.35	29083.625	27920.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71690	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	38855	19427.5	12951.66667	9713.75	7771	6475.833333	5550.714286	4856.875	4317.222222	3885.5	3532.272727	3237.916667	2988.846154	2775.357143	2590.333333	2428.4375	2158.611111	2045	1942.75	1618.958333	1554.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71691	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71692	CHOYP_DUOX1.4.4|m.44612	SNIAASLGSVR	SNIAASLGSVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71693	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71694	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71695	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71696	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	77370	38685	25790	19342.5	15474	12895	11052.85714	9671.25	8596.666667	7737	7033.636364	6447.5	5951.538462	5526.428571	5158	4835.625	4298.333333	4072.105263	3868.5	3223.75	3094.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71697	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71698	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71699	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71700	CHOYP_DUOX1.4.4|m.44612	LPFANPPNPR	LPFANPPNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71701	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	3597570	1798785	1199190	899392.5	719514	599595	513938.5714	449696.25	399730	359757	327051.8182	299797.5	276736.1538	256969.2857	239838	224848.125	199865	189345.7895	179878.5	149898.75	143902.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71702	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71703	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	26215	13107.5	8738.333333	6553.75	5243	4369.166667	3745	3276.875	2912.777778	2621.5	2383.181818	2184.583333	2016.538462	1872.5	1747.666667	1638.4375	1456.388889	1379.736842	1310.75	1092.291667	1048.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71704	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	1039502	519751	346500.6667	259875.5	207900.4	173250.3333	148500.2857	129937.75	115500.2222	103950.2	94500.18182	86625.16667	79961.69231	74250.14286	69300.13333	64968.875	57750.11111	54710.63158	51975.1	43312.58333	41580.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71705	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	714676	357338	238225.3333	178669	142935.2	119112.6667	102096.5714	89334.5	79408.44444	71467.6	64970.54545	59556.33333	54975.07692	51048.28571	47645.06667	44667.25	39704.22222	37614.52632	35733.8	29778.16667	28587.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71706	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	1496479	748239.5	498826.3333	374119.75	299295.8	249413.1667	213782.7143	187059.875	166275.4444	149647.9	136043.5455	124706.5833	115113.7692	106891.3571	99765.26667	93529.9375	83137.72222	78762.05263	74823.95	62353.29167	59859.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71707	CHOYP_DUOX1.4.4|m.44612	IVMYDWLPR	IVMYDWLPR	76480	38240	25493.33333	19120	15296	12746.66667	10925.71429	9560	8497.777778	7648	6952.727273	6373.333333	5883.076923	5462.857143	5098.666667	4780	4248.888889	4025.263158	3824	3186.666667	3059.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71708	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71709	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71710	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71711	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71712	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	963679	481839.5	321226.3333	240919.75	192735.8	160613.1667	137668.4286	120459.875	107075.4444	96367.9	87607.18182	80306.58333	74129.15385	68834.21429	64245.26667	60229.9375	53537.72222	50719.94737	48183.95	40153.29167	38547.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71713	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	689019	344509.5	229673	172254.75	137803.8	114836.5	98431.28571	86127.375	76557.66667	68901.9	62638.09091	57418.25	53001.46154	49215.64286	45934.6	43063.6875	38278.83333	36264.15789	34450.95	28709.125	27560.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71714	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71715	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	645831	322915.5	215277	161457.75	129166.2	107638.5	92261.57143	80728.875	71759	64583.1	58711.90909	53819.25	49679.30769	46130.78571	43055.4	40364.4375	35879.5	33991.10526	32291.55	26909.625	25833.24	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71716	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71717	CHOYP_DUOX1.4.4|m.44612	YGHTLVTPGLWR	YGHTLVTPGLWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71718	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71719	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71720	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71721	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71722	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	791773	395886.5	263924.3333	197943.25	158354.6	131962.1667	113110.4286	98971.625	87974.77778	79177.3	71979.36364	65981.08333	60905.61538	56555.21429	52784.86667	49485.8125	43987.38889	41672.26316	39588.65	32990.54167	31670.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71723	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71724	CHOYP_DUOX1.4.4|m.44612	DLAALNIQR	DLAALNIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71725	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	7899817	3949908.5	2633272.333	1974954.25	1579963.4	1316636.167	1128545.286	987477.125	877757.4444	789981.7	718165.1818	658318.0833	607678.2308	564272.6429	526654.4667	493738.5625	438878.7222	415779.8421	394990.85	329159.0417	315992.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71726	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	4718094	2359047	1572698	1179523.5	943618.8	786349	674013.4286	589761.75	524232.6667	471809.4	428917.6364	393174.5	362930.3077	337006.7143	314539.6	294880.875	262116.3333	248320.7368	235904.7	196587.25	188723.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71727	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	12421159	6210579.5	4140386.333	3105289.75	2484231.8	2070193.167	1774451.286	1552644.875	1380128.778	1242115.9	1129196.273	1035096.583	955473.7692	887225.6429	828077.2667	776322.4375	690064.3889	653745.2105	621057.95	517548.2917	496846.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71728	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	152817	76408.5	50939	38204.25	30563.4	25469.5	21831	19102.125	16979.66667	15281.7	13892.45455	12734.75	11755.15385	10915.5	10187.8	9551.0625	8489.833333	8043	7640.85	6367.375	6112.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71729	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	2206576	1103288	735525.3333	551644	441315.2	367762.6667	315225.1429	275822	245175.1111	220657.6	200597.8182	183881.3333	169736.6154	157612.5714	147105.0667	137911	122587.5556	116135.5789	110328.8	91940.66667	88263.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71730	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	172088	86044	57362.66667	43022	34417.6	28681.33333	24584	21511	19120.88889	17208.8	15644.36364	14340.66667	13237.53846	12292	11472.53333	10755.5	9560.444444	9057.263158	8604.4	7170.333333	6883.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71731	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	535490	267745	178496.6667	133872.5	107098	89248.33333	76498.57143	66936.25	59498.88889	53549	48680.90909	44624.16667	41191.53846	38249.28571	35699.33333	33468.125	29749.44444	28183.68421	26774.5	22312.08333	21419.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71732	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	404428	202214	134809.3333	101107	80885.6	67404.66667	57775.42857	50553.5	44936.44444	40442.8	36766.18182	33702.33333	31109.84615	28887.71429	26961.86667	25276.75	22468.22222	21285.68421	20221.4	16851.16667	16177.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71733	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	24397	12198.5	8132.333333	6099.25	4879.4	4066.166667	3485.285714	3049.625	2710.777778	2439.7	2217.909091	2033.083333	1876.692308	1742.642857	1626.466667	1524.8125	1355.388889	1284.052632	1219.85	1016.541667	975.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71734	CHOYP_DUOX1.4.4|m.44612	LNSWGEINTQNR	LNSWGEINTQNR	69116	34558	23038.66667	17279	13823.2	11519.33333	9873.714286	8639.5	7679.555556	6911.6	6283.272727	5759.666667	5316.615385	4936.857143	4607.733333	4319.75	3839.777778	3637.684211	3455.8	2879.833333	2764.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71735	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71736	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71737	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	2251357	1125678.5	750452.3333	562839.25	450271.4	375226.1667	321622.4286	281419.625	250150.7778	225135.7	204668.8182	187613.0833	173181.3077	160811.2143	150090.4667	140709.8125	125075.3889	118492.4737	112567.85	93806.54167	90054.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71738	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	24402	12201	8134	6100.5	4880.4	4067	3486	3050.25	2711.333333	2440.2	2218.363636	2033.5	1877.076923	1743	1626.8	1525.125	1355.666667	1284.315789	1220.1	1016.75	976.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71739	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	23554	11777	7851.333333	5888.5	4710.8	3925.666667	3364.857143	2944.25	2617.111111	2355.4	2141.272727	1962.833333	1811.846154	1682.428571	1570.266667	1472.125	1308.555556	1239.684211	1177.7	981.4166667	942.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71740	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71741	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	629832	314916	209944	157458	125966.4	104972	89976	78729	69981.33333	62983.2	57257.45455	52486	48448.61538	44988	41988.8	39364.5	34990.66667	33149.05263	31491.6	26243	25193.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71742	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71743	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	180496	90248	60165.33333	45124	36099.2	30082.66667	25785.14286	22562	20055.11111	18049.6	16408.72727	15041.33333	13884.30769	12892.57143	12033.06667	11281	10027.55556	9499.789474	9024.8	7520.666667	7219.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71744	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	66348	33174	22116	16587	13269.6	11058	9478.285714	8293.5	7372	6634.8	6031.636364	5529	5103.692308	4739.142857	4423.2	4146.75	3686	3492	3317.4	2764.5	2653.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71745	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	81753	40876.5	27251	20438.25	16350.6	13625.5	11679	10219.125	9083.666667	8175.3	7432.090909	6812.75	6288.692308	5839.5	5450.2	5109.5625	4541.833333	4302.789474	4087.65	3406.375	3270.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71746	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71747	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	30370	15185	10123.33333	7592.5	6074	5061.666667	4338.571429	3796.25	3374.444444	3037	2760.909091	2530.833333	2336.153846	2169.285714	2024.666667	1898.125	1687.222222	1598.421053	1518.5	1265.416667	1214.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71748	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	29406	14703	9802	7351.5	5881.2	4901	4200.857143	3675.75	3267.333333	2940.6	2673.272727	2450.5	2262	2100.428571	1960.4	1837.875	1633.666667	1547.684211	1470.3	1225.25	1176.24	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71749	CHOYP_DUOX1.4.4|m.44612	NFAEGIGASFSTNNFGK	NFAEGIGASFSTNNFGK	32907	16453.5	10969	8226.75	6581.4	5484.5	4701	4113.375	3656.333333	3290.7	2991.545455	2742.25	2531.307692	2350.5	2193.8	2056.6875	1828.166667	1731.947368	1645.35	1371.125	1316.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71750	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	3239234	1619617	1079744.667	809808.5	647846.8	539872.3333	462747.7143	404904.25	359914.8889	323923.4	294475.8182	269936.1667	249171.8462	231373.8571	215948.9333	202452.125	179957.4444	170486	161961.7	134968.0833	129569.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71751	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	1458464	729232	486154.6667	364616	291692.8	243077.3333	208352	182308	162051.5556	145846.4	132587.6364	121538.6667	112189.5385	104176	97230.93333	91154	81025.77778	76761.26316	72923.2	60769.33333	58338.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71752	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	2696826	1348413	898942	674206.5	539365.2	449471	385260.8571	337103.25	299647.3333	269682.6	245166	224735.5	207448.1538	192630.4286	179788.4	168551.625	149823.6667	141938.2105	134841.3	112367.75	107873.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71753	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	761320	380660	253773.3333	190330	152264	126886.6667	108760	95165	84591.11111	76132	69210.90909	63443.33333	58563.07692	54380	50754.66667	47582.5	42295.55556	40069.47368	38066	31721.66667	30452.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71754	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	1647263	823631.5	549087.6667	411815.75	329452.6	274543.8333	235323.2857	205907.875	183029.2222	164726.3	149751.1818	137271.9167	126712.5385	117661.6429	109817.5333	102953.9375	91514.61111	86698.05263	82363.15	68635.95833	65890.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71755	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	451472	225736	150490.6667	112868	90294.4	75245.33333	64496	56434	50163.55556	45147.2	41042.90909	37622.66667	34728.61538	32248	30098.13333	28217	25081.77778	23761.68421	22573.6	18811.33333	18058.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71756	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	29336	14668	9778.666667	7334	5867.2	4889.333333	4190.857143	3667	3259.555556	2933.6	2666.909091	2444.666667	2256.615385	2095.428571	1955.733333	1833.5	1629.777778	1544	1466.8	1222.333333	1173.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71757	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71758	CHOYP_DUOX1.4.4|m.44612	AELILNNASTK	AELILNNASTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71759	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	5717443	2858721.5	1905814.333	1429360.75	1143488.6	952907.1667	816777.5714	714680.375	635271.4444	571744.3	519767.5455	476453.5833	439803.3077	408388.7857	381162.8667	357340.1875	317635.7222	300918.0526	285872.15	238226.7917	228697.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71760	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	3398854	1699427	1132951.333	849713.5	679770.8	566475.6667	485550.5714	424856.75	377650.4444	339885.4	308986.7273	283237.8333	261450.3077	242775.2857	226590.2667	212428.375	188825.2222	178887.0526	169942.7	141618.9167	135954.16	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71761	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	1586136	793068	528712	396534	317227.2	264356	226590.8571	198267	176237.3333	158613.6	144194.1818	132178	122010.4615	113295.4286	105742.4	99133.5	88118.66667	83480.84211	79306.8	66089	63445.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71762	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	52605	26302.5	17535	13151.25	10521	8767.5	7515	6575.625	5845	5260.5	4782.272727	4383.75	4046.538462	3757.5	3507	3287.8125	2922.5	2768.684211	2630.25	2191.875	2104.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71763	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	203723	101861.5	67907.66667	50930.75	40744.6	33953.83333	29103.28571	25465.375	22635.88889	20372.3	18520.27273	16976.91667	15671	14551.64286	13581.53333	12732.6875	11317.94444	10722.26316	10186.15	8488.458333	8148.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71764	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	383434	191717	127811.3333	95858.5	76686.8	63905.66667	54776.28571	47929.25	42603.77778	38343.4	34857.63636	31952.83333	29494.92308	27388.14286	25562.26667	23964.625	21301.88889	20180.73684	19171.7	15976.41667	15337.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71765	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	108102	54051	36034	27025.5	21620.4	18017	15443.14286	13512.75	12011.33333	10810.2	9827.454545	9008.5	8315.538462	7721.571429	7206.8	6756.375	6005.666667	5689.578947	5405.1	4504.25	4324.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71766	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	190969	95484.5	63656.33333	47742.25	38193.8	31828.16667	27281.28571	23871.125	21218.77778	19096.9	17360.81818	15914.08333	14689.92308	13640.64286	12731.26667	11935.5625	10609.38889	10051	9548.45	7957.041667	7638.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71767	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	215277	107638.5	71759	53819.25	43055.4	35879.5	30753.85714	26909.625	23919.66667	21527.7	19570.63636	17939.75	16559.76923	15376.92857	14351.8	13454.8125	11959.83333	11330.36842	10763.85	8969.875	8611.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71768	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	34043	17021.5	11347.66667	8510.75	6808.6	5673.833333	4863.285714	4255.375	3782.555556	3404.3	3094.818182	2836.916667	2618.692308	2431.642857	2269.533333	2127.6875	1891.277778	1791.736842	1702.15	1418.458333	1361.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71769	CHOYP_DUOX1.4.4|m.44612	ELDLENLDHDTAK	ELDLENLDHDTAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71770	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	3536050	1768025	1178683.333	884012.5	707210	589341.6667	505150	442006.25	392894.4444	353605	321459.0909	294670.8333	272003.8462	252575	235736.6667	221003.125	196447.2222	186107.8947	176802.5	147335.4167	141442	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71771	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	2951577	1475788.5	983859	737894.25	590315.4	491929.5	421653.8571	368947.125	327953	295157.7	268325.1818	245964.75	227044.3846	210826.9286	196771.8	184473.5625	163976.5	155346.1579	147578.85	122982.375	118063.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71772	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	2000610	1000305	666870	500152.5	400122	333435	285801.4286	250076.25	222290	200061	181873.6364	166717.5	153893.0769	142900.7143	133374	125038.125	111145	105295.2632	100030.5	83358.75	80024.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71773	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71774	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71775	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71776	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	34428	17214	11476	8607	6885.6	5738	4918.285714	4303.5	3825.333333	3442.8	3129.818182	2869	2648.307692	2459.142857	2295.2	2151.75	1912.666667	1812	1721.4	1434.5	1377.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71777	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	309197	154598.5	103065.6667	77299.25	61839.4	51532.83333	44171	38649.625	34355.22222	30919.7	28108.81818	25766.41667	23784.38462	22085.5	20613.13333	19324.8125	17177.61111	16273.52632	15459.85	12883.20833	12367.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71778	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71779	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	47057	23528.5	15685.66667	11764.25	9411.4	7842.833333	6722.428571	5882.125	5228.555556	4705.7	4277.909091	3921.416667	3619.769231	3361.214286	3137.133333	2941.0625	2614.277778	2476.684211	2352.85	1960.708333	1882.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71780	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	847538	423769	282512.6667	211884.5	169507.6	141256.3333	121076.8571	105942.25	94170.88889	84753.8	77048.90909	70628.16667	65195.23077	60538.42857	56502.53333	52971.125	47085.44444	44607.26316	42376.9	35314.08333	33901.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71781	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71782	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71783	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71784	CHOYP_DUOX1.4.4|m.44612	TEFAEALGLKPTSIFVR	TEFAEALGLKPTSIFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71785	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	481905	240952.5	160635	120476.25	96381	80317.5	68843.57143	60238.125	53545	48190.5	43809.54545	40158.75	37069.61538	34421.78571	32127	30119.0625	26772.5	25363.42105	24095.25	20079.375	19276.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71786	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71787	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	472792	236396	157597.3333	118198	94558.4	78798.66667	67541.71429	59099	52532.44444	47279.2	42981.09091	39399.33333	36368.61538	33770.85714	31519.46667	29549.5	26266.22222	24883.78947	23639.6	19699.66667	18911.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71788	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71789	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	309505	154752.5	103168.3333	77376.25	61901	51584.16667	44215	38688.125	34389.44444	30950.5	28136.81818	25792.08333	23808.07692	22107.5	20633.66667	19344.0625	17194.72222	16289.73684	15475.25	12896.04167	12380.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71790	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71791	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71792	CHOYP_DUOX1.4.4|m.44612	NMFLLVDSDR	NMFLLVDSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71793	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	3009778	1504889	1003259.333	752444.5	601955.6	501629.6667	429968.2857	376222.25	334419.7778	300977.8	273616.1818	250814.8333	231521.3846	214984.1429	200651.8667	188111.125	167209.8889	158409.3684	150488.9	125407.4167	120391.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71794	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	2537643	1268821.5	845881	634410.75	507528.6	422940.5	362520.4286	317205.375	281960.3333	253764.3	230694.8182	211470.25	195203.3077	181260.2143	169176.2	158602.6875	140980.1667	133560.1579	126882.15	105735.125	101505.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71795	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	1045837	522918.5	348612.3333	261459.25	209167.4	174306.1667	149405.2857	130729.625	116204.1111	104583.7	95076.09091	87153.08333	80449	74702.64286	69722.46667	65364.8125	58102.05556	55044.05263	52291.85	43576.54167	41833.48	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71796	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	241784	120892	80594.66667	60446	48356.8	40297.33333	34540.57143	30223	26864.88889	24178.4	21980.36364	20148.66667	18598.76923	17270.28571	16118.93333	15111.5	13432.44444	12725.47368	12089.2	10074.33333	9671.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71797	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	444122	222061	148040.6667	111030.5	88824.4	74020.33333	63446	55515.25	49346.88889	44412.2	40374.72727	37010.16667	34163.23077	31723	29608.13333	27757.625	24673.44444	23374.84211	22206.1	18505.08333	17764.88	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71798	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	424911	212455.5	141637	106227.75	84982.2	70818.5	60701.57143	53113.875	47212.33333	42491.1	38628.27273	35409.25	32685.46154	30350.78571	28327.4	26556.9375	23606.16667	22363.73684	21245.55	17704.625	16996.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71799	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71800	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71801	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	24699	12349.5	8233	6174.75	4939.8	4116.5	3528.428571	3087.375	2744.333333	2469.9	2245.363636	2058.25	1899.923077	1764.214286	1646.6	1543.6875	1372.166667	1299.947368	1234.95	1029.125	987.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71802	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71803	CHOYP_DUOX1.4.4|m.44612	SLLDLSDSTLDDK	SLLDLSDSTLDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71804	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	13063340	6531670	4354446.667	3265835	2612668	2177223.333	1866191.429	1632917.5	1451482.222	1306334	1187576.364	1088611.667	1004872.308	933095.7143	870889.3333	816458.75	725741.1111	687544.2105	653167	544305.8333	522533.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71805	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	7129513	3564756.5	2376504.333	1782378.25	1425902.6	1188252.167	1018501.857	891189.125	792168.1111	712951.3	648137.5455	594126.0833	548424.0769	509250.9286	475300.8667	445594.5625	396084.0556	375237.5263	356475.65	297063.0417	285180.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71806	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	2909174	1454587	969724.6667	727293.5	581834.8	484862.3333	415596.2857	363646.75	323241.5556	290917.4	264470.3636	242431.1667	223782.6154	207798.1429	193944.9333	181823.375	161620.7778	153114.4211	145458.7	121215.5833	116366.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71807	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	99950	49975	33316.66667	24987.5	19990	16658.33333	14278.57143	12493.75	11105.55556	9995	9086.363636	8329.166667	7688.461538	7139.285714	6663.333333	6246.875	5552.777778	5260.526316	4997.5	4164.583333	3998	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71808	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	475789	237894.5	158596.3333	118947.25	95157.8	79298.16667	67969.85714	59473.625	52865.44444	47578.9	43253.54545	39649.08333	36599.15385	33984.92857	31719.26667	29736.8125	26432.72222	25041.52632	23789.45	19824.54167	19031.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71809	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	259365	129682.5	86455	64841.25	51873	43227.5	37052.14286	32420.625	28818.33333	25936.5	23578.63636	21613.75	19951.15385	18526.07143	17291	16210.3125	14409.16667	13650.78947	12968.25	10806.875	10374.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71810	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	224835	112417.5	74945	56208.75	44967	37472.5	32119.28571	28104.375	24981.66667	22483.5	20439.54545	18736.25	17295	16059.64286	14989	14052.1875	12490.83333	11833.42105	11241.75	9368.125	8993.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71811	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	361923	180961.5	120641	90480.75	72384.6	60320.5	51703.28571	45240.375	40213.66667	36192.3	32902.09091	30160.25	27840.23077	25851.64286	24128.2	22620.1875	20106.83333	19048.57895	18096.15	15080.125	14476.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71812	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	512616	256308	170872	128154	102523.2	85436	73230.85714	64077	56957.33333	51261.6	46601.45455	42718	39432	36615.42857	34174.4	32038.5	28478.66667	26979.78947	25630.8	21359	20504.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71813	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	6866	3433	2288.666667	1716.5	1373.2	1144.333333	980.8571429	858.25	762.8888889	686.6	624.1818182	572.1666667	528.1538462	490.4285714	457.7333333	429.125	381.4444444	361.3684211	343.3	286.0833333	274.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71814	CHOYP_DUOX1.4.4|m.44612	IFASDEYAGTLQK	IFASDEYAGTLQK	126428	63214	42142.66667	31607	25285.6	21071.33333	18061.14286	15803.5	14047.55556	12642.8	11493.45455	10535.66667	9725.230769	9030.571429	8428.533333	7901.75	7023.777778	6654.105263	6321.4	5267.833333	5057.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71815	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	2634419	1317209.5	878139.6667	658604.75	526883.8	439069.8333	376345.5714	329302.375	292713.2222	263441.9	239492.6364	219534.9167	202647.6154	188172.7857	175627.9333	164651.1875	146356.6111	138653.6316	131720.95	109767.4583	105376.76	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71816	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71817	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	915023	457511.5	305007.6667	228755.75	183004.6	152503.8333	130717.5714	114377.875	101669.2222	91502.3	83183.90909	76251.91667	70386.38462	65358.78571	61001.53333	57188.9375	50834.61111	48159.10526	45751.15	38125.95833	36600.92	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71818	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71819	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	54157	27078.5	18052.33333	13539.25	10831.4	9026.166667	7736.714286	6769.625	6017.444444	5415.7	4923.363636	4513.083333	4165.923077	3868.357143	3610.466667	3384.8125	3008.722222	2850.368421	2707.85	2256.541667	2166.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71820	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	433957	216978.5	144652.3333	108489.25	86791.4	72326.16667	61993.85714	54244.625	48217.44444	43395.7	39450.63636	36163.08333	33381.30769	30996.92857	28930.46667	27122.3125	24108.72222	22839.84211	21697.85	18081.54167	17358.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71821	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	333860	166930	111286.6667	83465	66772	55643.33333	47694.28571	41732.5	37095.55556	33386	30350.90909	27821.66667	25681.53846	23847.14286	22257.33333	20866.25	18547.77778	17571.57895	16693	13910.83333	13354.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71822	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71823	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	1238546	619273	412848.6667	309636.5	247709.2	206424.3333	176935.1429	154818.25	137616.2222	123854.6	112595.0909	103212.1667	95272.76923	88467.57143	82569.73333	77409.125	68808.11111	65186.63158	61927.3	51606.08333	49541.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71824	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	13680	6840	4560	3420	2736	2280	1954.285714	1710	1520	1368	1243.636364	1140	1052.307692	977.1428571	912	855	760	720	684	570	547.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71825	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	259092	129546	86364	64773	51818.4	43182	37013.14286	32386.5	28788	25909.2	23553.81818	21591	19930.15385	18506.57143	17272.8	16193.25	14394	13636.42105	12954.6	10795.5	10363.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71826	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	111721	55860.5	37240.33333	27930.25	22344.2	18620.16667	15960.14286	13965.125	12413.44444	11172.1	10156.45455	9310.083333	8593.923077	7980.071429	7448.066667	6982.5625	6206.722222	5880.052632	5586.05	4655.041667	4468.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71827	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71828	CHOYP_DUOX1.4.4|m.44612	ATLNLDAIGDIGQPVK	ATLNLDAIGDIGQPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71829	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	3027734	1513867	1009244.667	756933.5	605546.8	504622.3333	432533.4286	378466.75	336414.8889	302773.4	275248.5455	252311.1667	232902.6154	216266.7143	201848.9333	189233.375	168207.4444	159354.4211	151386.7	126155.5833	121109.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71830	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	2903053	1451526.5	967684.3333	725763.25	580610.6	483842.1667	414721.8571	362881.625	322561.4444	290305.3	263913.9091	241921.0833	223311.7692	207360.9286	193536.8667	181440.8125	161280.7222	152792.2632	145152.65	120960.5417	116122.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71831	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	404182	202091	134727.3333	101045.5	80836.4	67363.66667	57740.28571	50522.75	44909.11111	40418.2	36743.81818	33681.83333	31090.92308	28870.14286	26945.46667	25261.375	22454.55556	21272.73684	20209.1	16840.91667	16167.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71832	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	174884	87442	58294.66667	43721	34976.8	29147.33333	24983.42857	21860.5	19431.55556	17488.4	15898.54545	14573.66667	13452.61538	12491.71429	11658.93333	10930.25	9715.777778	9204.421053	8744.2	7286.833333	6995.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71833	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	1568924	784462	522974.6667	392231	313784.8	261487.3333	224132	196115.5	174324.8889	156892.4	142629.4545	130743.6667	120686.4615	112066	104594.9333	98057.75	87162.44444	82574.94737	78446.2	65371.83333	62756.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71834	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	129252	64626	43084	32313	25850.4	21542	18464.57143	16156.5	14361.33333	12925.2	11750.18182	10771	9942.461538	9232.285714	8616.8	8078.25	7180.666667	6802.736842	6462.6	5385.5	5170.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71835	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71836	CHOYP_DUOX1.4.4|m.44612	IAGYGVTVTR	IAGYGVTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71837	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71838	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71839	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71840	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71841	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71842	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71843	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	123770	61885	41256.66667	30942.5	24754	20628.33333	17681.42857	15471.25	13752.22222	12377	11251.81818	10314.16667	9520.769231	8840.714286	8251.333333	7735.625	6876.111111	6514.210526	6188.5	5157.083333	4950.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71844	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	48033	24016.5	16011	12008.25	9606.6	8005.5	6861.857143	6004.125	5337	4803.3	4366.636364	4002.75	3694.846154	3430.928571	3202.2	3002.0625	2668.5	2528.052632	2401.65	2001.375	1921.32	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71845	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	147531	73765.5	49177	36882.75	29506.2	24588.5	21075.85714	18441.375	16392.33333	14753.1	13411.90909	12294.25	11348.53846	10537.92857	9835.4	9220.6875	8196.166667	7764.789474	7376.55	6147.125	5901.24	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71846	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	207430	103715	69143.33333	51857.5	41486	34571.66667	29632.85714	25928.75	23047.77778	20743	18857.27273	17285.83333	15956.15385	14816.42857	13828.66667	12964.375	11523.88889	10917.36842	10371.5	8642.916667	8297.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71847	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	356788	178394	118929.3333	89197	71357.6	59464.66667	50969.71429	44598.5	39643.11111	35678.8	32435.27273	29732.33333	27445.23077	25484.85714	23785.86667	22299.25	19821.55556	18778.31579	17839.4	14866.16667	14271.52	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71848	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	11536	5768	3845.333333	2884	2307.2	1922.666667	1648	1442	1281.777778	1153.6	1048.727273	961.3333333	887.3846154	824	769.0666667	721	640.8888889	607.1578947	576.8	480.6666667	461.44	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71849	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	14926	7463	4975.333333	3731.5	2985.2	2487.666667	2132.285714	1865.75	1658.444444	1492.6	1356.909091	1243.833333	1148.153846	1066.142857	995.0666667	932.875	829.2222222	785.5789474	746.3	621.9166667	597.04	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71850	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71851	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71852	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71853	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	27557	13778.5	9185.666667	6889.25	5511.4	4592.833333	3936.714286	3444.625	3061.888889	2755.7	2505.181818	2296.416667	2119.769231	1968.357143	1837.133333	1722.3125	1530.944444	1450.368421	1377.85	1148.208333	1102.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71854	CHOYP_DUOX1.4.4|m.44612	AELLPSDVTALVFQRPTTFDYK	AELLPSDVTALVFQRPTTFDYK	11480	5740	3826.666667	2870	2296	1913.333333	1640	1435	1275.555556	1148	1043.636364	956.6666667	883.0769231	820	765.3333333	717.5	637.7777778	604.2105263	574	478.3333333	459.2	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71855	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71856	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	3617592	1808796	1205864	904398	723518.4	602932	516798.8571	452199	401954.6667	361759.2	328872	301466	278276.3077	258399.4286	241172.8	226099.5	200977.3333	190399.5789	180879.6	150733	144703.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71857	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71858	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	708318	354159	236106	177079.5	141663.6	118053	101188.2857	88539.75	78702	70831.8	64392.54545	59026.5	54486	50594.14286	47221.2	44269.875	39351	37279.89474	35415.9	29513.25	28332.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71859	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	901695	450847.5	300565	225423.75	180339	150282.5	128813.5714	112711.875	100188.3333	90169.5	81972.27273	75141.25	69361.15385	64406.78571	60113	56355.9375	50094.16667	47457.63158	45084.75	37570.625	36067.8	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71860	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	1232799	616399.5	410933	308199.75	246559.8	205466.5	176114.1429	154099.875	136977.6667	123279.9	112072.6364	102733.25	94830.69231	88057.07143	82186.6	77049.9375	68488.83333	64884.15789	61639.95	51366.625	49311.96	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71861	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	552478	276239	184159.3333	138119.5	110495.6	92079.66667	78925.42857	69059.75	61386.44444	55247.8	50225.27273	46039.83333	42498.30769	39462.71429	36831.86667	34529.875	30693.22222	29077.78947	27623.9	23019.91667	22099.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71862	CHOYP_DUOX1.4.4|m.44612	AVGPWTYNLR	AVGPWTYNLR	78353	39176.5	26117.66667	19588.25	15670.6	13058.83333	11193.28571	9794.125	8705.888889	7835.3	7123	6529.416667	6027.153846	5596.642857	5223.533333	4897.0625	4352.944444	4123.842105	3917.65	3264.708333	3134.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71863	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71864	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71865	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	2817934	1408967	939311.3333	704483.5	563586.8	469655.6667	402562	352241.75	313103.7778	281793.4	256175.8182	234827.8333	216764.1538	201281	187862.2667	176120.875	156551.8889	148312.3158	140896.7	117413.9167	112717.36	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71866	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	740717	370358.5	246905.6667	185179.25	148143.4	123452.8333	105816.7143	92589.625	82301.88889	74071.7	67337.90909	61726.41667	56978.23077	52908.35714	49381.13333	46294.8125	41150.94444	38985.10526	37035.85	30863.20833	29628.68	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71867	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	3243090	1621545	1081030	810772.5	648618	540515	463298.5714	405386.25	360343.3333	324309	294826.3636	270257.5	249468.4615	231649.2857	216206	202693.125	180171.6667	170688.9474	162154.5	135128.75	129723.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71868	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71869	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71870	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71871	CHOYP_DUOX1.4.4|m.44612	NLYDPDNLEGK	NLYDPDNLEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71872	CHOYP_DUOX1.4.4|m.44612	VYFLWVTR	VYFLWVTR	2932702	1466351	977567.3333	733175.5	586540.4	488783.6667	418957.4286	366587.75	325855.7778	293270.2	266609.2727	244391.8333	225592.4615	209478.7143	195513.4667	183293.875	162927.8889	154352.7368	146635.1	122195.9167	117308.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71873	CHOYP_DUOX1.4.4|m.44612	VYFLWVTR	VYFLWVTR	2528441	1264220.5	842813.6667	632110.25	505688.2	421406.8333	361205.8571	316055.125	280937.8889	252844.1	229858.2727	210703.4167	194495.4615	180602.9286	168562.7333	158027.5625	140468.9444	133075.8421	126422.05	105351.7083	101137.64	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71874	CHOYP_DUOX1.4.4|m.44612	VYFLWVTR	VYFLWVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71875	CHOYP_DUOX1.4.4|m.44612	VYFLWVTR	VYFLWVTR	673196	336598	224398.6667	168299	134639.2	112199.3333	96170.85714	84149.5	74799.55556	67319.6	61199.63636	56099.66667	51784.30769	48085.42857	44879.73333	42074.75	37399.77778	35431.36842	33659.8	28049.83333	26927.84	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71876	CHOYP_DUOX1.4.4|m.44612	VYFLWVTR	VYFLWVTR	843964	421982	281321.3333	210991	168792.8	140660.6667	120566.2857	105495.5	93773.77778	84396.4	76724	70330.33333	64920.30769	60283.14286	56264.26667	52747.75	46886.88889	44419.15789	42198.2	35165.16667	33758.56	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71877	CHOYP_DUOX1.4.4|m.44612	VYFLWVTR	VYFLWVTR	56828	28414	18942.66667	14207	11365.6	9471.333333	8118.285714	7103.5	6314.222222	5682.8	5166.181818	4735.666667	4371.384615	4059.142857	3788.533333	3551.75	3157.111111	2990.947368	2841.4	2367.833333	2273.12	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71878	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	1444702	722351	481567.3333	361175.5	288940.4	240783.6667	206386	180587.75	160522.4444	144470.2	131336.5455	120391.8333	111130.9231	103193	96313.46667	90293.875	80261.22222	76036.94737	72235.1	60195.91667	57788.08	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71879	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	1501775	750887.5	500591.6667	375443.75	300355	250295.8333	214539.2857	187721.875	166863.8889	150177.5	136525	125147.9167	115521.1538	107269.6429	100118.3333	93860.9375	83431.94444	79040.78947	75088.75	62573.95833	60071	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71880	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	532485	266242.5	177495	133121.25	106497	88747.5	76069.28571	66560.625	59165	53248.5	48407.72727	44373.75	40960.38462	38034.64286	35499	33280.3125	29582.5	28025.52632	26624.25	22186.875	21299.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71881	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	351768	175884	117256	87942	70353.6	58628	50252.57143	43971	39085.33333	35176.8	31978.90909	29314	27059.07692	25126.28571	23451.2	21985.5	19542.66667	18514.10526	17588.4	14657	14070.72	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71882	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	443360	221680	147786.6667	110840	88672	73893.33333	63337.14286	55420	49262.22222	44336	40305.45455	36946.66667	34104.61538	31668.57143	29557.33333	27710	24631.11111	23334.73684	22168	18473.33333	17734.4	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71883	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	449515	224757.5	149838.3333	112378.75	89903	74919.16667	64216.42857	56189.375	49946.11111	44951.5	40865	37459.58333	34578.07692	32108.21429	29967.66667	28094.6875	24973.05556	23658.68421	22475.75	18729.79167	17980.6	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71884	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71885	CHOYP_DUOX1.4.4|m.44612	QFEWMTDIIR	QFEWMTDIIR	64007	32003.5	21335.66667	16001.75	12801.4	10667.83333	9143.857143	8000.875	7111.888889	6400.7	5818.818182	5333.916667	4923.615385	4571.928571	4267.133333	4000.4375	3555.944444	3368.789474	3200.35	2666.958333	2560.28	Q8HZK2	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591; GO:0055114
71886	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71887	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	1310781	655390.5	436927	327695.25	262156.2	218463.5	187254.4286	163847.625	145642.3333	131078.1	119161.9091	109231.75	100829.3077	93627.21429	87385.4	81923.8125	72821.16667	68988.47368	65539.05	54615.875	52431.24	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71888	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71889	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71890	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71891	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	313076	156538	104358.6667	78269	62615.2	52179.33333	44725.14286	39134.5	34786.22222	31307.6	28461.45455	26089.66667	24082.76923	22362.57143	20871.73333	19567.25	17393.11111	16477.68421	15653.8	13044.83333	12523.04	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71892	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	265532	132766	88510.66667	66383	53106.4	44255.33333	37933.14286	33191.5	29503.55556	26553.2	24139.27273	22127.66667	20425.53846	18966.57143	17702.13333	16595.75	14751.77778	13975.36842	13276.6	11063.83333	10621.28	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71893	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	201995	100997.5	67331.66667	50498.75	40399	33665.83333	28856.42857	25249.375	22443.88889	20199.5	18363.18182	16832.91667	15538.07692	14428.21429	13466.33333	12624.6875	11221.94444	10631.31579	10099.75	8416.458333	8079.8	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71894	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	613792	306896	204597.3333	153448	122758.4	102298.6667	87684.57143	76724	68199.11111	61379.2	55799.27273	51149.33333	47214.76923	43842.28571	40919.46667	38362	34099.55556	32304.84211	30689.6	25574.66667	24551.68	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71895	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71896	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	159720	79860	53240	39930	31944	26620	22817.14286	19965	17746.66667	15972	14520	13310	12286.15385	11408.57143	10648	9982.5	8873.333333	8406.315789	7986	6655	6388.8	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71897	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	123232	61616	41077.33333	30808	24646.4	20538.66667	17604.57143	15404	13692.44444	12323.2	11202.90909	10269.33333	9479.384615	8802.285714	8215.466667	7702	6846.222222	6485.894737	6161.6	5134.666667	4929.28	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71898	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	72073	36036.5	24024.33333	18018.25	14414.6	12012.16667	10296.14286	9009.125	8008.111111	7207.3	6552.090909	6006.083333	5544.076923	5148.071429	4804.866667	4504.5625	4004.055556	3793.315789	3603.65	3003.041667	2882.92	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71899	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	82395	41197.5	27465	20598.75	16479	13732.5	11770.71429	10299.375	9155	8239.5	7490.454545	6866.25	6338.076923	5885.357143	5493	5149.6875	4577.5	4336.578947	4119.75	3433.125	3295.8	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71900	CHOYP_DVIR_GJ11008.1.1|m.11917	GNPLEEDIASETSGSLK	GNPLEEDIASETSGSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71901	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71902	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71903	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71904	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	279394	139697	93131.33333	69848.5	55878.8	46565.66667	39913.42857	34924.25	31043.77778	27939.4	25399.45455	23282.83333	21491.84615	19956.71429	18626.26667	17462.125	15521.88889	14704.94737	13969.7	11641.41667	11175.76	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71905	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	537658	268829	179219.3333	134414.5	107531.6	89609.66667	76808.28571	67207.25	59739.77778	53765.8	48878	44804.83333	41358.30769	38404.14286	35843.86667	33603.625	29869.88889	28297.78947	26882.9	22402.41667	21506.32	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71906	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	211344	105672	70448	52836	42268.8	35224	30192	26418	23482.66667	21134.4	19213.09091	17612	16257.23077	15096	14089.6	13209	11741.33333	11123.36842	10567.2	8806	8453.76	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71907	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	323331	161665.5	107777	80832.75	64666.2	53888.5	46190.14286	40416.375	35925.66667	32333.1	29393.72727	26944.25	24871.61538	23095.07143	21555.4	20208.1875	17962.83333	17017.42105	16166.55	13472.125	12933.24	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71908	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71909	CHOYP_DVIR_GJ11008.1.1|m.11917	DGFLAIVEVAR	DGFLAIVEVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71910	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	1281289	640644.5	427096.3333	320322.25	256257.8	213548.1667	183041.2857	160161.125	142365.4444	128128.9	116480.8182	106774.0833	98560.69231	91520.64286	85419.26667	80080.5625	71182.72222	67436.26316	64064.45	53387.04167	51251.56	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71911	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71912	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	2047645	1023822.5	682548.3333	511911.25	409529	341274.1667	292520.7143	255955.625	227516.1111	204764.5	186149.5455	170637.0833	157511.1538	146260.3571	136509.6667	127977.8125	113758.0556	107770.7895	102382.25	85318.54167	81905.8	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71913	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71914	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71915	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	29245	14622.5	9748.333333	7311.25	5849	4874.166667	4177.857143	3655.625	3249.444444	2924.5	2658.636364	2437.083333	2249.615385	2088.928571	1949.666667	1827.8125	1624.722222	1539.210526	1462.25	1218.541667	1169.8	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71916	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71917	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71918	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	68695	34347.5	22898.33333	17173.75	13739	11449.16667	9813.571429	8586.875	7632.777778	6869.5	6245	5724.583333	5284.230769	4906.785714	4579.666667	4293.4375	3816.388889	3615.526316	3434.75	2862.291667	2747.8	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71919	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71920	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71921	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71922	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71923	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71924	CHOYP_DVIR_GJ11008.1.1|m.11917	LHDAMAGLGTSDDDLIR	LHDAMAGLGTSDDDLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20073	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0035176; GO:0044822; GO:0048306; GO:0051592; GO:0061025; GO:0070062
71938	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71939	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71940	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71941	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	24987	12493.5	8329	6246.75	4997.4	4164.5	3569.571429	3123.375	2776.333333	2498.7	2271.545455	2082.25	1922.076923	1784.785714	1665.8	1561.6875	1388.166667	1315.105263	1249.35	1041.125	999.48	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71942	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71943	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	889156	444578	296385.3333	222289	177831.2	148192.6667	127022.2857	111144.5	98795.11111	88915.6	80832.36364	74096.33333	68396.61538	63511.14286	59277.06667	55572.25	49397.55556	46797.68421	44457.8	37048.16667	35566.24	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71944	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	219141	109570.5	73047	54785.25	43828.2	36523.5	31305.85714	27392.625	24349	21914.1	19921.90909	18261.75	16857	15652.92857	14609.4	13696.3125	12174.5	11533.73684	10957.05	9130.875	8765.64	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71945	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	423781	211890.5	141260.3333	105945.25	84756.2	70630.16667	60540.14286	52972.625	47086.77778	42378.1	38525.54545	35315.08333	32598.53846	30270.07143	28252.06667	26486.3125	23543.38889	22304.26316	21189.05	17657.54167	16951.24	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71946	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	406607	203303.5	135535.6667	101651.75	81321.4	67767.83333	58086.71429	50825.875	45178.55556	40660.7	36964.27273	33883.91667	31277.46154	29043.35714	27107.13333	25412.9375	22589.27778	21400.36842	20330.35	16941.95833	16264.28	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71947	CHOYP_DVIR_GJ19769.1.1|m.46852	YNQATPTFHQWR	YNQATPTFHQWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71948	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	1717881	858940.5	572627	429470.25	343576.2	286313.5	245411.5714	214735.125	190875.6667	171788.1	156171	143156.75	132144.6923	122705.7857	114525.4	107367.5625	95437.83333	90414.78947	85894.05	71578.375	68715.24	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71949	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	1227522	613761	409174	306880.5	245504.4	204587	175360.2857	153440.25	136391.3333	122752.2	111592.9091	102293.5	94424.76923	87680.14286	81834.8	76720.125	68195.66667	64606.42105	61376.1	51146.75	49100.88	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71950	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	844430	422215	281476.6667	211107.5	168886	140738.3333	120632.8571	105553.75	93825.55556	84443	76766.36364	70369.16667	64956.15385	60316.42857	56295.33333	52776.875	46912.77778	44443.68421	42221.5	35184.58333	33777.2	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71951	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71952	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71953	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	88065	44032.5	29355	22016.25	17613	14677.5	12580.71429	11008.125	9785	8806.5	8005.909091	7338.75	6774.230769	6290.357143	5871	5504.0625	4892.5	4635	4403.25	3669.375	3522.6	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71954	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71955	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71956	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71957	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71958	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71959	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71960	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71961	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	452488	226244	150829.3333	113122	90497.6	75414.66667	64641.14286	56561	50276.44444	45248.8	41135.27273	37707.33333	34806.76923	32320.57143	30165.86667	28280.5	25138.22222	23815.15789	22624.4	18853.66667	18099.52	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71962	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71963	CHOYP_DVIR_GJ19769.1.1|m.46852	ASQNESPSNEGSTPPEDR	ASQNESPSNEGSTPPEDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71964	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	299320	149660	99773.33333	74830	59864	49886.66667	42760	37415	33257.77778	29932	27210.90909	24943.33333	23024.61538	21380	19954.66667	18707.5	16628.88889	15753.68421	14966	12471.66667	11972.8	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71965	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	383459	191729.5	127819.6667	95864.75	76691.8	63909.83333	54779.85714	47932.375	42606.55556	38345.9	34859.90909	31954.91667	29496.84615	27389.92857	25563.93333	23966.1875	21303.27778	20182.05263	19172.95	15977.45833	15338.36	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71966	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71967	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71968	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71969	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	45398	22699	15132.66667	11349.5	9079.6	7566.333333	6485.428571	5674.75	5044.222222	4539.8	4127.090909	3783.166667	3492.153846	3242.714286	3026.533333	2837.375	2522.111111	2389.368421	2269.9	1891.583333	1815.92	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71970	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	19243	9621.5	6414.333333	4810.75	3848.6	3207.166667	2749	2405.375	2138.111111	1924.3	1749.363636	1603.583333	1480.230769	1374.5	1282.866667	1202.6875	1069.055556	1012.789474	962.15	801.7916667	769.72	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71971	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71972	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	24123	12061.5	8041	6030.75	4824.6	4020.5	3446.142857	3015.375	2680.333333	2412.3	2193	2010.25	1855.615385	1723.071429	1608.2	1507.6875	1340.166667	1269.631579	1206.15	1005.125	964.92	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71973	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
71974	CHOYP_DVIR_GJ19769.1.1|m.46852	IVNGTTNSPTPAR	IVNGTTNSPTPAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5R896	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL	actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	GO:0005737; GO:0005856; GO:0005925; GO:0008154; GO:0010633; GO:0016020; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028
73609	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73610	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73611	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73612	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73613	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73614	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73615	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73616	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73617	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73618	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73619	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73620	CHOYP_DYHC1.1.1|m.2432	FLGDPQIPVLLIQR	FLGDPQIPVLLIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73621	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73622	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73623	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73624	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73625	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73626	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	3821089	1910544.5	1273696.333	955272.25	764217.8	636848.1667	545869.8571	477636.125	424565.4444	382108.9	347371.7273	318424.0833	293929.9231	272934.9286	254739.2667	238818.0625	212282.7222	201109.9474	191054.45	159212.0417	152843.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73627	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73628	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73629	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73630	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73631	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73632	CHOYP_DYHC1.1.1|m.2432	QAMATVNDYNQLMK	QAMATVNDYNQLMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73633	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	1840807	920403.5	613602.3333	460201.75	368161.4	306801.1667	262972.4286	230100.875	204534.1111	184080.7	167346.0909	153400.5833	141600.5385	131486.2143	122720.4667	115050.4375	102267.0556	96884.57895	92040.35	76700.29167	73632.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73634	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73635	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73636	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73637	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73638	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	327187	163593.5	109062.3333	81796.75	65437.4	54531.16667	46741	40898.375	36354.11111	32718.7	29744.27273	27265.58333	25168.23077	23370.5	21812.46667	20449.1875	18177.05556	17220.36842	16359.35	13632.79167	13087.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73639	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	499441	249720.5	166480.3333	124860.25	99888.2	83240.16667	71348.71429	62430.125	55493.44444	49944.1	45403.72727	41620.08333	38418.53846	35674.35714	33296.06667	31215.0625	27746.72222	26286.36842	24972.05	20810.04167	19977.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73640	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	216337	108168.5	72112.33333	54084.25	43267.4	36056.16667	30905.28571	27042.125	24037.44444	21633.7	19667	18028.08333	16641.30769	15452.64286	14422.46667	13521.0625	12018.72222	11386.15789	10816.85	9014.041667	8653.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73641	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	156896	78448	52298.66667	39224	31379.2	26149.33333	22413.71429	19612	17432.88889	15689.6	14263.27273	13074.66667	12068.92308	11206.85714	10459.73333	9806	8716.444444	8257.684211	7844.8	6537.333333	6275.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73642	CHOYP_DYHC1.1.1|m.2432	LNTQELFEDWQR	LNTQELFEDWQR	193902	96951	64634	48475.5	38780.4	32317	27700.28571	24237.75	21544.66667	19390.2	17627.45455	16158.5	14915.53846	13850.14286	12926.8	12118.875	10772.33333	10205.36842	9695.1	8079.25	7756.08	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73643	CHOYP_DYHC1.1.1|m.2432	IFSVQSFK	IFSVQSFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73644	CHOYP_DYHC1.1.1|m.2432	IFSVQSFK	IFSVQSFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73645	CHOYP_DYHC1.1.1|m.2432	IFSVQSFK	IFSVQSFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73646	CHOYP_DYHC1.1.1|m.2432	IFSVQSFK	IFSVQSFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73647	CHOYP_DYHC1.1.1|m.2432	IFSVQSFK	IFSVQSFK	26683	13341.5	8894.333333	6670.75	5336.6	4447.166667	3811.857143	3335.375	2964.777778	2668.3	2425.727273	2223.583333	2052.538462	1905.928571	1778.866667	1667.6875	1482.388889	1404.368421	1334.15	1111.791667	1067.32	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73648	CHOYP_DYHC1.1.1|m.2432	IFSVQSFK	IFSVQSFK	139204	69602	46401.33333	34801	27840.8	23200.66667	19886.28571	17400.5	15467.11111	13920.4	12654.90909	11600.33333	10708	9943.142857	9280.266667	8700.25	7733.555556	7326.526316	6960.2	5800.166667	5568.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73649	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73650	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73651	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73652	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	45955	22977.5	15318.33333	11488.75	9191	7659.166667	6565	5744.375	5106.111111	4595.5	4177.727273	3829.583333	3535	3282.5	3063.666667	2872.1875	2553.055556	2418.684211	2297.75	1914.791667	1838.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73653	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73654	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	52745	26372.5	17581.66667	13186.25	10549	8790.833333	7535	6593.125	5860.555556	5274.5	4795	4395.416667	4057.307692	3767.5	3516.333333	3296.5625	2930.277778	2776.052632	2637.25	2197.708333	2109.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73655	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73656	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73657	CHOYP_DYHC1.1.1|m.2432	LADTENNFQEK	LADTENNFQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73658	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73659	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73660	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73661	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73662	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73663	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	47887	23943.5	15962.33333	11971.75	9577.4	7981.166667	6841	5985.875	5320.777778	4788.7	4353.363636	3990.583333	3683.615385	3420.5	3192.466667	2992.9375	2660.388889	2520.368421	2394.35	1995.291667	1915.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73664	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	72791	36395.5	24263.66667	18197.75	14558.2	12131.83333	10398.71429	9098.875	8087.888889	7279.1	6617.363636	6065.916667	5599.307692	5199.357143	4852.733333	4549.4375	4043.944444	3831.105263	3639.55	3032.958333	2911.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73665	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73666	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	115734	57867	38578	28933.5	23146.8	19289	16533.42857	14466.75	12859.33333	11573.4	10521.27273	9644.5	8902.615385	8266.714286	7715.6	7233.375	6429.666667	6091.263158	5786.7	4822.25	4629.36	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73667	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	63150	31575	21050	15787.5	12630	10525	9021.428571	7893.75	7016.666667	6315	5740.909091	5262.5	4857.692308	4510.714286	4210	3946.875	3508.333333	3323.684211	3157.5	2631.25	2526	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73668	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73669	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73670	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73671	CHOYP_DYHC1.1.1|m.2432	ITNQLIYVNPPVEESR	ITNQLIYVNPPVEESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73672	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73673	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73674	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	467896	233948	155965.3333	116974	93579.2	77982.66667	66842.28571	58487	51988.44444	46789.6	42536	38991.33333	35992	33421.14286	31193.06667	29243.5	25994.22222	24626.10526	23394.8	19495.66667	18715.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73675	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73676	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73677	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	169348	84674	56449.33333	42337	33869.6	28224.66667	24192.57143	21168.5	18816.44444	16934.8	15395.27273	14112.33333	13026.76923	12096.28571	11289.86667	10584.25	9408.222222	8913.052632	8467.4	7056.166667	6773.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73678	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	108728	54364	36242.66667	27182	21745.6	18121.33333	15532.57143	13591	12080.88889	10872.8	9884.363636	9060.666667	8363.692308	7766.285714	7248.533333	6795.5	6040.444444	5722.526316	5436.4	4530.333333	4349.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73679	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73680	CHOYP_DYHC1.1.1|m.2432	EIGPIIVQFGK	EIGPIIVQFGK	80017	40008.5	26672.33333	20004.25	16003.4	13336.16667	11431	10002.125	8890.777778	8001.7	7274.272727	6668.083333	6155.153846	5715.5	5334.466667	5001.0625	4445.388889	4211.421053	4000.85	3334.041667	3200.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73681	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	4357977	2178988.5	1452659	1089494.25	871595.4	726329.5	622568.1429	544747.125	484219.6667	435797.7	396179.7273	363164.75	335229	311284.0714	290531.8	272373.5625	242109.8333	229367.2105	217898.85	181582.375	174319.08	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73682	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	2578819	1289409.5	859606.3333	644704.75	515763.8	429803.1667	368402.7143	322352.375	286535.4444	257881.9	234438.0909	214901.5833	198370.6923	184201.3571	171921.2667	161176.1875	143267.7222	135727.3158	128940.95	107450.7917	103152.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73683	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73684	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	261692	130846	87230.66667	65423	52338.4	43615.33333	37384.57143	32711.5	29076.88889	26169.2	23790.18182	21807.66667	20130.15385	18692.28571	17446.13333	16355.75	14538.44444	13773.26316	13084.6	10903.83333	10467.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73685	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	674424	337212	224808	168606	134884.8	112404	96346.28571	84303	74936	67442.4	61311.27273	56202	51878.76923	48173.14286	44961.6	42151.5	37468	35496	33721.2	28101	26976.96	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73686	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	617095	308547.5	205698.3333	154273.75	123419	102849.1667	88156.42857	77136.875	68566.11111	61709.5	56099.54545	51424.58333	47468.84615	44078.21429	41139.66667	38568.4375	34283.05556	32478.68421	30854.75	25712.29167	24683.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73687	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73688	CHOYP_DYHC1.1.1|m.2432	TGDLLADWDK	TGDLLADWDK	388717	194358.5	129572.3333	97179.25	77743.4	64786.16667	55531	48589.625	43190.77778	38871.7	35337.90909	32393.08333	29901.30769	27765.5	25914.46667	24294.8125	21595.38889	20458.78947	19435.85	16196.54167	15548.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73689	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	4560105	2280052.5	1520035	1140026.25	912021	760017.5	651443.5714	570013.125	506678.3333	456010.5	414555	380008.75	350777.3077	325721.7857	304007	285006.5625	253339.1667	240005.5263	228005.25	190004.375	182404.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73690	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	3291576	1645788	1097192	822894	658315.2	548596	470225.1429	411447	365730.6667	329157.6	299234.1818	274298	253198.1538	235112.5714	219438.4	205723.5	182865.3333	173240.8421	164578.8	137149	131663.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73691	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73692	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73693	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	171119	85559.5	57039.66667	42779.75	34223.8	28519.83333	24445.57143	21389.875	19013.22222	17111.9	15556.27273	14259.91667	13163	12222.78571	11407.93333	10694.9375	9506.611111	9006.263158	8555.95	7129.958333	6844.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73694	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	518615	259307.5	172871.6667	129653.75	103723	86435.83333	74087.85714	64826.875	57623.88889	51861.5	47146.81818	43217.91667	39893.46154	37043.92857	34574.33333	32413.4375	28811.94444	27295.52632	25930.75	21608.95833	20744.6	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73695	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	302163	151081.5	100721	75540.75	60432.6	50360.5	43166.14286	37770.375	33573.66667	30216.3	27469.36364	25180.25	23243.30769	21583.07143	20144.2	18885.1875	16786.83333	15903.31579	15108.15	12590.125	12086.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73696	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	2600617	1300308.5	866872.3333	650154.25	520123.4	433436.1667	371516.7143	325077.125	288957.4444	260061.7	236419.7273	216718.0833	200047.4615	185758.3571	173374.4667	162538.5625	144478.7222	136874.5789	130030.85	108359.0417	104024.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73697	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73698	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73699	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	181844	90922	60614.66667	45461	36368.8	30307.33333	25977.71429	22730.5	20204.88889	18184.4	16531.27273	15153.66667	13988	12988.85714	12122.93333	11365.25	10102.44444	9570.736842	9092.2	7576.833333	7273.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73700	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	144051	72025.5	48017	36012.75	28810.2	24008.5	20578.71429	18006.375	16005.66667	14405.1	13095.54545	12004.25	11080.84615	10289.35714	9603.4	9003.1875	8002.833333	7581.631579	7202.55	6002.125	5762.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73701	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73702	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73703	CHOYP_DYHC1.1.1|m.2432	EALELSEPGQLSASEER	EALELSEPGQLSASEER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73704	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73705	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73706	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73707	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	39622	19811	13207.33333	9905.5	7924.4	6603.666667	5660.285714	4952.75	4402.444444	3962.2	3602	3301.833333	3047.846154	2830.142857	2641.466667	2476.375	2201.222222	2085.368421	1981.1	1650.916667	1584.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73708	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73709	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	53842	26921	17947.33333	13460.5	10768.4	8973.666667	7691.714286	6730.25	5982.444444	5384.2	4894.727273	4486.833333	4141.692308	3845.857143	3589.466667	3365.125	2991.222222	2833.789474	2692.1	2243.416667	2153.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73710	CHOYP_DYHC1.1.1|m.2432	IWEQIDELK	IWEQIDELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73711	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	4079657	2039828.5	1359885.667	1019914.25	815931.4	679942.8333	582808.1429	509957.125	453295.2222	407965.7	370877.9091	339971.4167	313819.7692	291404.0714	271977.1333	254978.5625	226647.6111	214718.7895	203982.85	169985.7083	163186.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73712	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	4634352	2317176	1544784	1158588	926870.4	772392	662050.2857	579294	514928	463435.2	421304.7273	386196	356488.6154	331025.1429	308956.8	289647	257464	243913.2632	231717.6	193098	185374.08	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73713	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	6980778	3490389	2326926	1745194.5	1396155.6	1163463	997254	872597.25	775642	698077.8	634616.1818	581731.5	536982.9231	498627	465385.2	436298.625	387821	367409.3684	349038.9	290865.75	279231.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73714	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	841488	420744	280496	210372	168297.6	140248	120212.5714	105186	93498.66667	84148.8	76498.90909	70124	64729.84615	60106.28571	56099.2	52593	46749.33333	44288.84211	42074.4	35062	33659.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73715	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	1509901	754950.5	503300.3333	377475.25	301980.2	251650.1667	215700.1429	188737.625	167766.7778	150990.1	137263.7273	125825.0833	116146.2308	107850.0714	100660.0667	94368.8125	83883.38889	79468.47368	75495.05	62912.54167	60396.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73716	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	994175	497087.5	331391.6667	248543.75	198835	165695.8333	142025	124271.875	110463.8889	99417.5	90379.54545	82847.91667	76475	71012.5	66278.33333	62135.9375	55231.94444	52325	49708.75	41423.95833	39767	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73717	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	140447	70223.5	46815.66667	35111.75	28089.4	23407.83333	20063.85714	17555.875	15605.22222	14044.7	12767.90909	11703.91667	10803.61538	10031.92857	9363.133333	8777.9375	7802.611111	7391.947368	7022.35	5851.958333	5617.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73718	CHOYP_DYHC1.1.1|m.2432	EKPWLSVQPR	EKPWLSVQPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73719	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	2851770	1425885	950590	712942.5	570354	475295	407395.7143	356471.25	316863.3333	285177	259251.8182	237647.5	219366.9231	203697.8571	190118	178235.625	158431.6667	150093.1579	142588.5	118823.75	114070.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73720	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	294553	147276.5	98184.33333	73638.25	58910.6	49092.16667	42079	36819.125	32728.11111	29455.3	26777.54545	24546.08333	22657.92308	21039.5	19636.86667	18409.5625	16364.05556	15502.78947	14727.65	12273.04167	11782.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73721	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73722	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	72765	36382.5	24255	18191.25	14553	12127.5	10395	9095.625	8085	7276.5	6615	6063.75	5597.307692	5197.5	4851	4547.8125	4042.5	3829.736842	3638.25	3031.875	2910.6	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73723	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73724	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73725	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	327622	163811	109207.3333	81905.5	65524.4	54603.66667	46803.14286	40952.75	36402.44444	32762.2	29783.81818	27301.83333	25201.69231	23401.57143	21841.46667	20476.375	18201.22222	17243.26316	16381.1	13650.91667	13104.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73726	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	177072	88536	59024	44268	35414.4	29512	25296	22134	19674.66667	17707.2	16097.45455	14756	13620.92308	12648	11804.8	11067	9837.333333	9319.578947	8853.6	7378	7082.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73727	CHOYP_DYHC1.1.1|m.2432	QSIDALLNQLK	QSIDALLNQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73728	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73729	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	1957867	978933.5	652622.3333	489466.75	391573.4	326311.1667	279695.2857	244733.375	217540.7778	195786.7	177987.9091	163155.5833	150605.1538	139847.6429	130524.4667	122366.6875	108770.3889	103045.6316	97893.35	81577.79167	78314.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73730	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73731	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73732	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	326217	163108.5	108739	81554.25	65243.4	54369.5	46602.42857	40777.125	36246.33333	32621.7	29656.09091	27184.75	25093.61538	23301.21429	21747.8	20388.5625	18123.16667	17169.31579	16310.85	13592.375	13048.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73733	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	33157	16578.5	11052.33333	8289.25	6631.4	5526.166667	4736.714286	4144.625	3684.111111	3315.7	3014.272727	2763.083333	2550.538462	2368.357143	2210.466667	2072.3125	1842.055556	1745.105263	1657.85	1381.541667	1326.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73734	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	10455	5227.5	3485	2613.75	2091	1742.5	1493.571429	1306.875	1161.666667	1045.5	950.4545455	871.25	804.2307692	746.7857143	697	653.4375	580.8333333	550.2631579	522.75	435.625	418.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73735	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73736	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73737	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73738	CHOYP_DYHC1.1.1|m.2432	FQGVSTEFLALMK	FQGVSTEFLALMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73739	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73740	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	2547852	1273926	849284	636963	509570.4	424642	363978.8571	318481.5	283094.6667	254785.2	231622.9091	212321	195988.6154	181989.4286	169856.8	159240.75	141547.3333	134097.4737	127392.6	106160.5	101914.08	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73741	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	1538118	769059	512706	384529.5	307623.6	256353	219731.1429	192264.75	170902	153811.8	139828.9091	128176.5	118316.7692	109865.5714	102541.2	96132.375	85451	80953.57895	76905.9	64088.25	61524.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73742	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	289310	144655	96436.66667	72327.5	57862	48218.33333	41330	36163.75	32145.55556	28931	26300.90909	24109.16667	22254.61538	20665	19287.33333	18081.875	16072.77778	15226.84211	14465.5	12054.58333	11572.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73743	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73744	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73745	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73746	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	408308	204154	136102.6667	102077	81661.6	68051.33333	58329.71429	51038.5	45367.55556	40830.8	37118.90909	34025.66667	31408.30769	29164.85714	27220.53333	25519.25	22683.77778	21489.89474	20415.4	17012.83333	16332.32	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73747	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	289467	144733.5	96489	72366.75	57893.4	48244.5	41352.42857	36183.375	32163	28946.7	26315.18182	24122.25	22266.69231	20676.21429	19297.8	18091.6875	16081.5	15235.10526	14473.35	12061.125	11578.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73748	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73749	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	328284	164142	109428	82071	65656.8	54714	46897.71429	41035.5	36476	32828.4	29844	27357	25252.61538	23448.85714	21885.6	20517.75	18238	17278.10526	16414.2	13678.5	13131.36	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73750	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	263463	131731.5	87821	65865.75	52692.6	43910.5	37637.57143	32932.875	29273.66667	26346.3	23951.18182	21955.25	20266.38462	18818.78571	17564.2	16466.4375	14636.83333	13866.47368	13173.15	10977.625	10538.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73751	CHOYP_DYHC1.1.1|m.2432	SPLVMDVVNIANVQK	SPLVMDVVNIANVQK	23862	11931	7954	5965.5	4772.4	3977	3408.857143	2982.75	2651.333333	2386.2	2169.272727	1988.5	1835.538462	1704.428571	1590.8	1491.375	1325.666667	1255.894737	1193.1	994.25	954.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73752	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73753	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73754	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73755	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73756	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73757	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73758	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73759	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	85806	42903	28602	21451.5	17161.2	14301	12258	10725.75	9534	8580.6	7800.545455	7150.5	6600.461538	6129	5720.4	5362.875	4767	4516.105263	4290.3	3575.25	3432.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73760	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73761	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73762	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73763	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73764	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73765	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73766	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73767	CHOYP_DYHC1.1.1|m.2432	EGEEVVFATPVSIAANPK	EGEEVVFATPVSIAANPK	10170	5085	3390	2542.5	2034	1695	1452.857143	1271.25	1130	1017	924.5454545	847.5	782.3076923	726.4285714	678	635.625	565	535.2631579	508.5	423.75	406.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73768	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73769	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73770	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73771	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73772	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73773	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73774	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73775	CHOYP_DYHC1.1.1|m.2432	INEWLTLTEK	INEWLTLTEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73776	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	3088860	1544430	1029620	772215	617772	514810	441265.7143	386107.5	343206.6667	308886	280805.4545	257405	237604.6154	220632.8571	205924	193053.75	171603.3333	162571.5789	154443	128702.5	123554.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73777	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	3290850	1645425	1096950	822712.5	658170	548475	470121.4286	411356.25	365650	329085	299168.1818	274237.5	253142.3077	235060.7143	219390	205678.125	182825	173202.6316	164542.5	137118.75	131634	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73778	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	1446081	723040.5	482027	361520.25	289216.2	241013.5	206583	180760.125	160675.6667	144608.1	131461.9091	120506.75	111237	103291.5	96405.4	90380.0625	80337.83333	76109.52632	72304.05	60253.375	57843.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73779	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73780	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73781	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	29566	14783	9855.333333	7391.5	5913.2	4927.666667	4223.714286	3695.75	3285.111111	2956.6	2687.818182	2463.833333	2274.307692	2111.857143	1971.066667	1847.875	1642.555556	1556.105263	1478.3	1231.916667	1182.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73782	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	144936	72468	48312	36234	28987.2	24156	20705.14286	18117	16104	14493.6	13176	12078	11148.92308	10352.57143	9662.4	9058.5	8052	7628.210526	7246.8	6039	5797.44	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73783	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	177061	88530.5	59020.33333	44265.25	35412.2	29510.16667	25294.42857	22132.625	19673.44444	17706.1	16096.45455	14755.08333	13620.07692	12647.21429	11804.06667	11066.3125	9836.722222	9319	8853.05	7377.541667	7082.44	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73784	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	309025	154512.5	103008.3333	77256.25	61805	51504.16667	44146.42857	38628.125	34336.11111	30902.5	28093.18182	25752.08333	23771.15385	22073.21429	20601.66667	19314.0625	17168.05556	16264.47368	15451.25	12876.04167	12361	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73785	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73786	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	128616	64308	42872	32154	25723.2	21436	18373.71429	16077	14290.66667	12861.6	11692.36364	10718	9893.538462	9186.857143	8574.4	8038.5	7145.333333	6769.263158	6430.8	5359	5144.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73787	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	24901	12450.5	8300.333333	6225.25	4980.2	4150.166667	3557.285714	3112.625	2766.777778	2490.1	2263.727273	2075.083333	1915.461538	1778.642857	1660.066667	1556.3125	1383.388889	1310.578947	1245.05	1037.541667	996.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73788	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	130293	65146.5	43431	32573.25	26058.6	21715.5	18613.28571	16286.625	14477	13029.3	11844.81818	10857.75	10022.53846	9306.642857	8686.2	8143.3125	7238.5	6857.526316	6514.65	5428.875	5211.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73789	CHOYP_DYHC1.1.1|m.2432	NSDVLQQLSIQMANAK	NSDVLQQLSIQMANAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73790	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73791	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	3807073	1903536.5	1269024.333	951768.25	761414.6	634512.1667	543867.5714	475884.125	423008.1111	380707.3	346097.5455	317256.0833	292851.7692	271933.7857	253804.8667	237942.0625	211504.0556	200372.2632	190353.65	158628.0417	152282.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73792	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	7745375	3872687.5	2581791.667	1936343.75	1549075	1290895.833	1106482.143	968171.875	860597.2222	774537.5	704125	645447.9167	595798.0769	553241.0714	516358.3333	484085.9375	430298.6111	407651.3158	387268.75	322723.9583	309815	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73793	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	601487	300743.5	200495.6667	150371.75	120297.4	100247.8333	85926.71429	75185.875	66831.88889	60148.7	54680.63636	50123.91667	46268.23077	42963.35714	40099.13333	37592.9375	33415.94444	31657.21053	30074.35	25061.95833	24059.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73794	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	176015	88007.5	58671.66667	44003.75	35203	29335.83333	25145	22001.875	19557.22222	17601.5	16001.36364	14667.91667	13539.61538	12572.5	11734.33333	11000.9375	9778.611111	9263.947368	8800.75	7333.958333	7040.6	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73795	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	340985	170492.5	113661.6667	85246.25	68197	56830.83333	48712.14286	42623.125	37887.22222	34098.5	30998.63636	28415.41667	26229.61538	24356.07143	22732.33333	21311.5625	18943.61111	17946.57895	17049.25	14207.70833	13639.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73796	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	183637	91818.5	61212.33333	45909.25	36727.4	30606.16667	26233.85714	22954.625	20404.11111	18363.7	16694.27273	15303.08333	14125.92308	13116.92857	12242.46667	11477.3125	10202.05556	9665.105263	9181.85	7651.541667	7345.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73797	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	226681	113340.5	75560.33333	56670.25	45336.2	37780.16667	32383	28335.125	25186.77778	22668.1	20607.36364	18890.08333	17437	16191.5	15112.06667	14167.5625	12593.38889	11930.57895	11334.05	9445.041667	9067.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73798	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	403374	201687	134458	100843.5	80674.8	67229	57624.85714	50421.75	44819.33333	40337.4	36670.36364	33614.5	31028.76923	28812.42857	26891.6	25210.875	22409.66667	21230.21053	20168.7	16807.25	16134.96	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73799	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	31116	15558	10372	7779	6223.2	5186	4445.142857	3889.5	3457.333333	3111.6	2828.727273	2593	2393.538462	2222.571429	2074.4	1944.75	1728.666667	1637.684211	1555.8	1296.5	1244.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73800	CHOYP_DYHC1.1.1|m.2432	FNYGFEYLGVQDK	FNYGFEYLGVQDK	52598	26299	17532.66667	13149.5	10519.6	8766.333333	7514	6574.75	5844.222222	5259.8	4781.636364	4383.166667	4046	3757	3506.533333	3287.375	2922.111111	2768.315789	2629.9	2191.583333	2103.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73801	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	2985179	1492589.5	995059.6667	746294.75	597035.8	497529.8333	426454.1429	373147.375	331686.5556	298517.9	271379.9091	248764.9167	229629.1538	213227.0714	199011.9333	186573.6875	165843.2778	157114.6842	149258.95	124382.4583	119407.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73802	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	4142360	2071180	1380786.667	1035590	828472	690393.3333	591765.7143	517795	460262.2222	414236	376578.1818	345196.6667	318643.0769	295882.8571	276157.3333	258897.5	230131.1111	218018.9474	207118	172598.3333	165694.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73803	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	1196487	598243.5	398829	299121.75	239297.4	199414.5	170926.7143	149560.875	132943	119648.7	108771.5455	99707.25	92037.46154	85463.35714	79765.8	74780.4375	66471.5	62973	59824.35	49853.625	47859.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73804	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	214685	107342.5	71561.66667	53671.25	42937	35780.83333	30669.28571	26835.625	23853.88889	21468.5	19516.81818	17890.41667	16514.23077	15334.64286	14312.33333	13417.8125	11926.94444	11299.21053	10734.25	8945.208333	8587.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73805	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	2012751	1006375.5	670917	503187.75	402550.2	335458.5	287535.8571	251593.875	223639	201275.1	182977.3636	167729.25	154827	143767.9286	134183.4	125796.9375	111819.5	105934.2632	100637.55	83864.625	80510.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73806	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	439793	219896.5	146597.6667	109948.25	87958.6	73298.83333	62827.57143	54974.125	48865.88889	43979.3	39981.18182	36649.41667	33830.23077	31413.78571	29319.53333	27487.0625	24432.94444	23147	21989.65	18324.70833	17591.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73807	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	339049	169524.5	113016.3333	84762.25	67809.8	56508.16667	48435.57143	42381.125	37672.11111	33904.9	30822.63636	28254.08333	26080.69231	24217.78571	22603.26667	21190.5625	18836.05556	17844.68421	16952.45	14127.04167	13561.96	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73808	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	276906	138453	92302	69226.5	55381.2	46151	39558	34613.25	30767.33333	27690.6	25173.27273	23075.5	21300.46154	19779	18460.4	17306.625	15383.66667	14574	13845.3	11537.75	11076.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73809	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73810	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	26164	13082	8721.333333	6541	5232.8	4360.666667	3737.714286	3270.5	2907.111111	2616.4	2378.545455	2180.333333	2012.615385	1868.857143	1744.266667	1635.25	1453.555556	1377.052632	1308.2	1090.166667	1046.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73811	CHOYP_DYHC1.1.1|m.2432	LGGSPFGPAGTGK	LGGSPFGPAGTGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73812	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	3694068	1847034	1231356	923517	738813.6	615678	527724	461758.5	410452	369406.8	335824.3636	307839	284159.0769	263862	246271.2	230879.25	205226	194424.6316	184703.4	153919.5	147762.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73813	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	3844555	1922277.5	1281518.333	961138.75	768911	640759.1667	549222.1429	480569.375	427172.7778	384455.5	349505	320379.5833	295735	274611.0714	256303.6667	240284.6875	213586.3889	202345	192227.75	160189.7917	153782.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73814	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	3506893	1753446.5	1168964.333	876723.25	701378.6	584482.1667	500984.7143	438361.625	389654.7778	350689.3	318808.4545	292241.0833	269761	250492.3571	233792.8667	219180.8125	194827.3889	184573.3158	175344.65	146120.5417	140275.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73815	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73816	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	10544	5272	3514.666667	2636	2108.8	1757.333333	1506.285714	1318	1171.555556	1054.4	958.5454545	878.6666667	811.0769231	753.1428571	702.9333333	659	585.7777778	554.9473684	527.2	439.3333333	421.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73817	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	155867	77933.5	51955.66667	38966.75	31173.4	25977.83333	22266.71429	19483.375	17318.55556	15586.7	14169.72727	12988.91667	11989.76923	11133.35714	10391.13333	9741.6875	8659.277778	8203.526316	7793.35	6494.458333	6234.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73818	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	12254	6127	4084.666667	3063.5	2450.8	2042.333333	1750.571429	1531.75	1361.555556	1225.4	1114	1021.166667	942.6153846	875.2857143	816.9333333	765.875	680.7777778	644.9473684	612.7	510.5833333	490.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73819	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	62658	31329	20886	15664.5	12531.6	10443	8951.142857	7832.25	6962	6265.8	5696.181818	5221.5	4819.846154	4475.571429	4177.2	3916.125	3481	3297.789474	3132.9	2610.75	2506.32	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73820	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	125948	62974	41982.66667	31487	25189.6	20991.33333	17992.57143	15743.5	13994.22222	12594.8	11449.81818	10495.66667	9688.307692	8996.285714	8396.533333	7871.75	6997.111111	6628.842105	6297.4	5247.833333	5037.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73821	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	139964	69982	46654.66667	34991	27992.8	23327.33333	19994.85714	17495.5	15551.55556	13996.4	12724	11663.66667	10766.46154	9997.428571	9330.933333	8747.75	7775.777778	7366.526316	6998.2	5831.833333	5598.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73822	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	141301	70650.5	47100.33333	35325.25	28260.2	23550.16667	20185.85714	17662.625	15700.11111	14130.1	12845.54545	11775.08333	10869.30769	10092.92857	9420.066667	8831.3125	7850.055556	7436.894737	7065.05	5887.541667	5652.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73823	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	43217	21608.5	14405.66667	10804.25	8643.4	7202.833333	6173.857143	5402.125	4801.888889	4321.7	3928.818182	3601.416667	3324.384615	3086.928571	2881.133333	2701.0625	2400.944444	2274.578947	2160.85	1800.708333	1728.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73824	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	185983	92991.5	61994.33333	46495.75	37196.6	30997.16667	26569	23247.875	20664.77778	18598.3	16907.54545	15498.58333	14306.38462	13284.5	12398.86667	11623.9375	10332.38889	9788.578947	9299.15	7749.291667	7439.32	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73825	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73826	CHOYP_DYHC1.1.1|m.2432	MLSAVSQQIQTIQEALK	MLSAVSQQIQTIQEALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73827	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73828	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73829	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73830	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73831	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73832	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73833	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73834	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73835	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73836	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73837	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	25517	12758.5	8505.666667	6379.25	5103.4	4252.833333	3645.285714	3189.625	2835.222222	2551.7	2319.727273	2126.416667	1962.846154	1822.642857	1701.133333	1594.8125	1417.611111	1343	1275.85	1063.208333	1020.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73838	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73839	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73840	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73841	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73842	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73843	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73844	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73845	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73846	CHOYP_DYHC1.1.1|m.2432	VLQLFQITNLHHGLMMVGPSGSGK	VLQLFQITNLHHGLMMVGPSGSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73847	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	6999013	3499506.5	2333004.333	1749753.25	1399802.6	1166502.167	999859	874876.625	777668.1111	699901.3	636273.9091	583251.0833	538385.6154	499929.5	466600.8667	437438.3125	388834.0556	368369.1053	349950.65	291625.5417	279960.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73848	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	2749245	1374622.5	916415	687311.25	549849	458207.5	392749.2857	343655.625	305471.6667	274924.5	249931.3636	229103.75	211480.3846	196374.6429	183283	171827.8125	152735.8333	144697.1053	137462.25	114551.875	109969.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73849	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	2835369	1417684.5	945123	708842.25	567073.8	472561.5	405052.7143	354421.125	315041	283536.9	257760.8182	236280.75	218105.3077	202526.3571	189024.6	177210.5625	157520.5	149229.9474	141768.45	118140.375	113414.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73850	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	687438	343719	229146	171859.5	137487.6	114573	98205.42857	85929.75	76382	68743.8	62494.36364	57286.5	52879.84615	49102.71429	45829.2	42964.875	38191	36180.94737	34371.9	28643.25	27497.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73851	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	909972	454986	303324	227493	181994.4	151662	129996	113746.5	101108	90997.2	82724.72727	75831	69997.84615	64998	60664.8	56873.25	50554	47893.26316	45498.6	37915.5	36398.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73852	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	45775	22887.5	15258.33333	11443.75	9155	7629.166667	6539.285714	5721.875	5086.111111	4577.5	4161.363636	3814.583333	3521.153846	3269.642857	3051.666667	2860.9375	2543.055556	2409.210526	2288.75	1907.291667	1831	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73853	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73854	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	57697	28848.5	19232.33333	14424.25	11539.4	9616.166667	8242.428571	7212.125	6410.777778	5769.7	5245.181818	4808.083333	4438.230769	4121.214286	3846.466667	3606.0625	3205.388889	3036.684211	2884.85	2404.041667	2307.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73855	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	2172169	1086084.5	724056.3333	543042.25	434433.8	362028.1667	310309.8571	271521.125	241352.1111	217216.9	197469.9091	181014.0833	167089.9231	155154.9286	144811.2667	135760.5625	120676.0556	114324.6842	108608.45	90507.04167	86886.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73856	CHOYP_DYHC1.1.1|m.2432	EALYGTLDPNTR	EALYGTLDPNTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73857	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	943723	471861.5	314574.3333	235930.75	188744.6	157287.1667	134817.5714	117965.375	104858.1111	94372.3	85793	78643.58333	72594.07692	67408.78571	62914.86667	58982.6875	52429.05556	49669.63158	47186.15	39321.79167	37748.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73858	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	1335430	667715	445143.3333	333857.5	267086	222571.6667	190775.7143	166928.75	148381.1111	133543	121402.7273	111285.8333	102725.3846	95387.85714	89028.66667	83464.375	74190.55556	70285.78947	66771.5	55642.91667	53417.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73859	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	767538	383769	255846	191884.5	153507.6	127923	109648.2857	95942.25	85282	76753.8	69776.18182	63961.5	59041.38462	54824.14286	51169.2	47971.125	42641	40396.73684	38376.9	31980.75	30701.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73860	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73861	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73862	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73863	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73864	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73865	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73866	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73867	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	1067251	533625.5	355750.3333	266812.75	213450.2	177875.1667	152464.4286	133406.375	118583.4444	106725.1	97022.81818	88937.58333	82096.23077	76232.21429	71150.06667	66703.1875	59291.72222	56171.10526	53362.55	44468.79167	42690.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73868	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73869	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73870	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73871	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73872	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73873	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	144029	72014.5	48009.66667	36007.25	28805.8	24004.83333	20575.57143	18003.625	16003.22222	14402.9	13093.54545	12002.41667	11079.15385	10287.78571	9601.933333	9001.8125	8001.611111	7580.473684	7201.45	6001.208333	5761.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73874	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	64196	32098	21398.66667	16049	12839.2	10699.33333	9170.857143	8024.5	7132.888889	6419.6	5836	5349.666667	4938.153846	4585.428571	4279.733333	4012.25	3566.444444	3378.736842	3209.8	2674.833333	2567.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73875	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	87078	43539	29026	21769.5	17415.6	14513	12439.71429	10884.75	9675.333333	8707.8	7916.181818	7256.5	6698.307692	6219.857143	5805.2	5442.375	4837.666667	4583.052632	4353.9	3628.25	3483.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73876	CHOYP_DYHC1.1.1|m.2432	EWTDGLFTHILR	EWTDGLFTHILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73877	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	2636953	1318476.5	878984.3333	659238.25	527390.6	439492.1667	376707.5714	329619.125	292994.7778	263695.3	239723	219746.0833	202842.5385	188353.7857	175796.8667	164809.5625	146497.3889	138787	131847.65	109873.0417	105478.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73878	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73879	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73880	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	196347	98173.5	65449	49086.75	39269.4	32724.5	28049.57143	24543.375	21816.33333	19634.7	17849.72727	16362.25	15103.61538	14024.78571	13089.8	12271.6875	10908.16667	10334.05263	9817.35	8181.125	7853.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73881	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	179853	89926.5	59951	44963.25	35970.6	29975.5	25693.28571	22481.625	19983.66667	17985.3	16350.27273	14987.75	13834.84615	12846.64286	11990.2	11240.8125	9991.833333	9465.947368	8992.65	7493.875	7194.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73882	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	57051	28525.5	19017	14262.75	11410.2	9508.5	8150.142857	7131.375	6339	5705.1	5186.454545	4754.25	4388.538462	4075.071429	3803.4	3565.6875	3169.5	3002.684211	2852.55	2377.125	2282.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73883	CHOYP_DYHC1.1.1|m.2432	IMFEVQDLK	IMFEVQDLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73884	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	1139617	569808.5	379872.3333	284904.25	227923.4	189936.1667	162802.4286	142452.125	126624.1111	113961.7	103601.5455	94968.08333	87662.84615	81401.21429	75974.46667	71226.0625	63312.05556	59979.84211	56980.85	47484.04167	45584.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73885	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	992453	496226.5	330817.6667	248113.25	198490.6	165408.8333	141779	124056.625	110272.5556	99245.3	90223	82704.41667	76342.53846	70889.5	66163.53333	62028.3125	55136.27778	52234.36842	49622.65	41352.20833	39698.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73886	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73887	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	53981	26990.5	17993.66667	13495.25	10796.2	8996.833333	7711.571429	6747.625	5997.888889	5398.1	4907.363636	4498.416667	4152.384615	3855.785714	3598.733333	3373.8125	2998.944444	2841.105263	2699.05	2249.208333	2159.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73888	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73889	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	164905	82452.5	54968.33333	41226.25	32981	27484.16667	23557.85714	20613.125	18322.77778	16490.5	14991.36364	13742.08333	12685	11778.92857	10993.66667	10306.5625	9161.388889	8679.210526	8245.25	6871.041667	6596.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73890	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73891	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	76789	38394.5	25596.33333	19197.25	15357.8	12798.16667	10969.85714	9598.625	8532.111111	7678.9	6980.818182	6399.083333	5906.846154	5484.928571	5119.266667	4799.3125	4266.055556	4041.526316	3839.45	3199.541667	3071.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73892	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	118581	59290.5	39527	29645.25	23716.2	19763.5	16940.14286	14822.625	13175.66667	11858.1	10780.09091	9881.75	9121.615385	8470.071429	7905.4	7411.3125	6587.833333	6241.105263	5929.05	4940.875	4743.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73893	CHOYP_DYHC1.1.1|m.2432	TLGGENEETLSK	TLGGENEETLSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73894	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73895	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73896	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	130284	65142	43428	32571	26056.8	21714	18612	16285.5	14476	13028.4	11844	10857	10021.84615	9306	8685.6	8142.75	7238	6857.052632	6514.2	5428.5	5211.36	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73897	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73898	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73899	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73900	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73901	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73902	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73903	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73904	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	9347	4673.5	3115.666667	2336.75	1869.4	1557.833333	1335.285714	1168.375	1038.555556	934.7	849.7272727	778.9166667	719	667.6428571	623.1333333	584.1875	519.2777778	491.9473684	467.35	389.4583333	373.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73905	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73906	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73907	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73908	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	668173	334086.5	222724.3333	167043.25	133634.6	111362.1667	95453.28571	83521.625	74241.44444	66817.3	60743	55681.08333	51397.92308	47726.64286	44544.86667	41760.8125	37120.72222	35167	33408.65	27840.54167	26726.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73909	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73910	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73911	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73912	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73913	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73914	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73915	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73916	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73917	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73918	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73919	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73920	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73921	CHOYP_DYHC1.1.1|m.2432	ALEYAVSLDHIMDFTR	ALEYAVSLDHIMDFTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73922	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	4738832	2369416	1579610.667	1184708	947766.4	789805.3333	676976	592354	526536.8889	473883.2	430802.9091	394902.6667	364525.5385	338488	315922.1333	296177	263268.4444	249412.2105	236941.6	197451.3333	189553.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73923	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	3674403	1837201.5	1224801	918600.75	734880.6	612400.5	524914.7143	459300.375	408267	367440.3	334036.6364	306200.25	282646.3846	262457.3571	244960.2	229650.1875	204133.5	193389.6316	183720.15	153100.125	146976.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73924	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	2083207	1041603.5	694402.3333	520801.75	416641.4	347201.1667	297601	260400.875	231467.4444	208320.7	189382.4545	173600.5833	160246.6923	148800.5	138880.4667	130200.4375	115733.7222	109642.4737	104160.35	86800.29167	83328.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73925	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	176356	88178	58785.33333	44089	35271.2	29392.66667	25193.71429	22044.5	19595.11111	17635.6	16032.36364	14696.33333	13565.84615	12596.85714	11757.06667	11022.25	9797.555556	9281.894737	8817.8	7348.166667	7054.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73926	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73927	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	728721	364360.5	242907	182180.25	145744.2	121453.5	104103	91090.125	80969	72872.1	66247.36364	60726.75	56055.46154	52051.5	48581.4	45545.0625	40484.5	38353.73684	36436.05	30363.375	29148.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73928	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	913487	456743.5	304495.6667	228371.75	182697.4	152247.8333	130498.1429	114185.875	101498.5556	91348.7	83044.27273	76123.91667	70268.23077	65249.07143	60899.13333	57092.9375	50749.27778	48078.26316	45674.35	38061.95833	36539.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73929	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	148128	74064	49376	37032	29625.6	24688	21161.14286	18516	16458.66667	14812.8	13466.18182	12344	11394.46154	10580.57143	9875.2	9258	8229.333333	7796.210526	7406.4	6172	5925.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73930	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	52973	26486.5	17657.66667	13243.25	10594.6	8828.833333	7567.571429	6621.625	5885.888889	5297.3	4815.727273	4414.416667	4074.846154	3783.785714	3531.533333	3310.8125	2942.944444	2788.052632	2648.65	2207.208333	2118.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73931	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	32710	16355	10903.33333	8177.5	6542	5451.666667	4672.857143	4088.75	3634.444444	3271	2973.636364	2725.833333	2516.153846	2336.428571	2180.666667	2044.375	1817.222222	1721.578947	1635.5	1362.916667	1308.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73932	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	140706	70353	46902	35176.5	28141.2	23451	20100.85714	17588.25	15634	14070.6	12791.45455	11725.5	10823.53846	10050.42857	9380.4	8794.125	7817	7405.578947	7035.3	5862.75	5628.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73933	CHOYP_DYHC1.1.1|m.2432	ALSSLFSMINQGVR	ALSSLFSMINQGVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73934	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	3587277	1793638.5	1195759	896819.25	717455.4	597879.5	512468.1429	448409.625	398586.3333	358727.7	326116.0909	298939.75	275944.3846	256234.0714	239151.8	224204.8125	199293.1667	188804.0526	179363.85	149469.875	143491.08	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73935	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73936	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73937	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73938	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73939	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73940	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73941	CHOYP_DYHC1.1.1|m.2432	VPVVEVETHK	VPVVEVETHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73942	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	2375371	1187685.5	791790.3333	593842.75	475074.2	395895.1667	339338.7143	296921.375	263930.1111	237537.1	215942.8182	197947.5833	182720.8462	169669.3571	158358.0667	148460.6875	131965.0556	125019.5263	118768.55	98973.79167	95014.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73943	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	1091989	545994.5	363996.3333	272997.25	218397.8	181998.1667	155998.4286	136498.625	121332.1111	109198.9	99271.72727	90999.08333	83999.15385	77999.21429	72799.26667	68249.3125	60666.05556	57473.10526	54599.45	45499.54167	43679.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73944	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73945	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	236773	118386.5	78924.33333	59193.25	47354.6	39462.16667	33824.71429	29596.625	26308.11111	23677.3	21524.81818	19731.08333	18213.30769	16912.35714	15784.86667	14798.3125	13154.05556	12461.73684	11838.65	9865.541667	9470.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73946	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	1311492	655746	437164	327873	262298.4	218582	187356	163936.5	145721.3333	131149.2	119226.5455	109291	100884	93678	87432.8	81968.25	72860.66667	69025.89474	65574.6	54645.5	52459.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73947	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	461770	230885	153923.3333	115442.5	92354	76961.66667	65967.14286	57721.25	51307.77778	46177	41979.09091	38480.83333	35520.76923	32983.57143	30784.66667	28860.625	25653.88889	24303.68421	23088.5	19240.41667	18470.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73948	CHOYP_DYHC1.1.1|m.2432	TMTLFSALR	TMTLFSALR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73949	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73950	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73951	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73952	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73953	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	24075	12037.5	8025	6018.75	4815	4012.5	3439.285714	3009.375	2675	2407.5	2188.636364	2006.25	1851.923077	1719.642857	1605	1504.6875	1337.5	1267.105263	1203.75	1003.125	963	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73954	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73955	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	827324	413662	275774.6667	206831	165464.8	137887.3333	118189.1429	103415.5	91924.88889	82732.4	75211.27273	68943.66667	63640.30769	59094.57143	55154.93333	51707.75	45962.44444	43543.36842	41366.2	34471.83333	33092.96	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73956	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	14153	7076.5	4717.666667	3538.25	2830.6	2358.833333	2021.857143	1769.125	1572.555556	1415.3	1286.636364	1179.416667	1088.692308	1010.928571	943.5333333	884.5625	786.2777778	744.8947368	707.65	589.7083333	566.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73957	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73958	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	30875	15437.5	10291.66667	7718.75	6175	5145.833333	4410.714286	3859.375	3430.555556	3087.5	2806.818182	2572.916667	2375	2205.357143	2058.333333	1929.6875	1715.277778	1625	1543.75	1286.458333	1235	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73959	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73960	CHOYP_DYHC1.1.1|m.2432	FTQDMQPHYVYSPR	FTQDMQPHYVYSPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73961	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	9139554	4569777	3046518	2284888.5	1827910.8	1523259	1305650.571	1142444.25	1015506	913955.4	830868.5455	761629.5	703042.6154	652825.2857	609303.6	571222.125	507753	481029.1579	456977.7	380814.75	365582.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73962	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	22786658	11393329	7595552.667	5696664.5	4557331.6	3797776.333	3255236.857	2848332.25	2531850.889	2278665.8	2071514.364	1898888.167	1752819.846	1627618.429	1519110.533	1424166.125	1265925.444	1199297.789	1139332.9	949444.0833	911466.32	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73963	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	31698370	15849185	10566123.33	7924592.5	6339674	5283061.667	4528338.571	3962296.25	3522041.111	3169837	2881670	2641530.833	2438336.154	2264169.286	2113224.667	1981148.125	1761020.556	1668335.263	1584918.5	1320765.417	1267934.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73964	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73965	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73966	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73967	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73968	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73969	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73970	CHOYP_DYHC1.1.1|m.2432	WTDENVDAVAQK	WTDENVDAVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73971	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73972	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73973	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	770271	385135.5	256757	192567.75	154054.2	128378.5	110038.7143	96283.875	85585.66667	77027.1	70024.63636	64189.25	59251.61538	55019.35714	51351.4	48141.9375	42792.83333	40540.57895	38513.55	32094.625	30810.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73974	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	32073	16036.5	10691	8018.25	6414.6	5345.5	4581.857143	4009.125	3563.666667	3207.3	2915.727273	2672.75	2467.153846	2290.928571	2138.2	2004.5625	1781.833333	1688.052632	1603.65	1336.375	1282.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73975	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	210787	105393.5	70262.33333	52696.75	42157.4	35131.16667	30112.42857	26348.375	23420.77778	21078.7	19162.45455	17565.58333	16214.38462	15056.21429	14052.46667	13174.1875	11710.38889	11094.05263	10539.35	8782.791667	8431.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73976	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	334685	167342.5	111561.6667	83671.25	66937	55780.83333	47812.14286	41835.625	37187.22222	33468.5	30425.90909	27890.41667	25745	23906.07143	22312.33333	20917.8125	18593.61111	17615	16734.25	13945.20833	13387.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73977	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73978	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73979	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73980	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73981	CHOYP_DYHC1.1.1|m.2432	EGLMLDSGEELYK	EGLMLDSGEELYK	129519	64759.5	43173	32379.75	25903.8	21586.5	18502.71429	16189.875	14391	12951.9	11774.45455	10793.25	9963	9251.357143	8634.6	8094.9375	7195.5	6816.789474	6475.95	5396.625	5180.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73982	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73983	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	2555703	1277851.5	851901	638925.75	511140.6	425950.5	365100.4286	319462.875	283967	255570.3	232336.6364	212975.25	196592.5385	182550.2143	170380.2	159731.4375	141983.5	134510.6842	127785.15	106487.625	102228.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73984	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	1922054	961027	640684.6667	480513.5	384410.8	320342.3333	274579.1429	240256.75	213561.5556	192205.4	174732.1818	160171.1667	147850.3077	137289.5714	128136.9333	120128.375	106780.7778	101160.7368	96102.7	80085.58333	76882.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73985	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	218262	109131	72754	54565.5	43652.4	36377	31180.28571	27282.75	24251.33333	21826.2	19842	18188.5	16789.38462	15590.14286	14550.8	13641.375	12125.66667	11487.47368	10913.1	9094.25	8730.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73986	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	1934929	967464.5	644976.3333	483732.25	386985.8	322488.1667	276418.4286	241866.125	214992.1111	193492.9	175902.6364	161244.0833	148840.6923	138209.2143	128995.2667	120933.0625	107496.0556	101838.3684	96746.45	80622.04167	77397.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73987	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	91007	45503.5	30335.66667	22751.75	18201.4	15167.83333	13001	11375.875	10111.88889	9100.7	8273.363636	7583.916667	7000.538462	6500.5	6067.133333	5687.9375	5055.944444	4789.842105	4550.35	3791.958333	3640.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73988	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	405739	202869.5	135246.3333	101434.75	81147.8	67623.16667	57962.71429	50717.375	45082.11111	40573.9	36885.36364	33811.58333	31210.69231	28981.35714	27049.26667	25358.6875	22541.05556	21354.68421	20286.95	16905.79167	16229.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73989	CHOYP_DYHC1.1.1|m.2432	ASTSPALFNR	ASTSPALFNR	172096	86048	57365.33333	43024	34419.2	28682.66667	24585.14286	21512	19121.77778	17209.6	15645.09091	14341.33333	13238.15385	12292.57143	11473.06667	10756	9560.888889	9057.684211	8604.8	7170.666667	6883.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73990	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	1861047	930523.5	620349	465261.75	372209.4	310174.5	265863.8571	232630.875	206783	186104.7	169186.0909	155087.25	143157.4615	132931.9286	124069.8	116315.4375	103391.5	97949.84211	93052.35	77543.625	74441.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73991	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73992	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	554661	277330.5	184887	138665.25	110932.2	92443.5	79237.28571	69332.625	61629	55466.1	50423.72727	46221.75	42666.23077	39618.64286	36977.4	34666.3125	30814.5	29192.68421	27733.05	23110.875	22186.44	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73993	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73994	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	47522	23761	15840.66667	11880.5	9504.4	7920.333333	6788.857143	5940.25	5280.222222	4752.2	4320.181818	3960.166667	3655.538462	3394.428571	3168.133333	2970.125	2640.111111	2501.157895	2376.1	1980.083333	1900.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73995	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73996	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73997	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73998	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	88528	44264	29509.33333	22132	17705.6	14754.66667	12646.85714	11066	9836.444444	8852.8	8048	7377.333333	6809.846154	6323.428571	5901.866667	5533	4918.222222	4659.368421	4426.4	3688.666667	3541.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
73999	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74000	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	69000	34500	23000	17250	13800	11500	9857.142857	8625	7666.666667	6900	6272.727273	5750	5307.692308	4928.571429	4600	4312.5	3833.333333	3631.578947	3450	2875	2760	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74001	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74002	CHOYP_DYHC1.1.1|m.2432	VMSQDIQTALMEQTK	VMSQDIQTALMEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74003	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74004	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74005	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74006	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74007	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	374695	187347.5	124898.3333	93673.75	74939	62449.16667	53527.85714	46836.875	41632.77778	37469.5	34063.18182	31224.58333	28822.69231	26763.92857	24979.66667	23418.4375	20816.38889	19720.78947	18734.75	15612.29167	14987.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74008	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74009	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74010	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	45618	22809	15206	11404.5	9123.6	7603	6516.857143	5702.25	5068.666667	4561.8	4147.090909	3801.5	3509.076923	3258.428571	3041.2	2851.125	2534.333333	2400.947368	2280.9	1900.75	1824.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74011	CHOYP_DYHC1.1.1|m.2432	YLSNPDYNYEK	YLSNPDYNYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74012	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74013	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	606556	303278	202185.3333	151639	121311.2	101092.6667	86650.85714	75819.5	67395.11111	60655.6	55141.45455	50546.33333	46658.15385	43325.42857	40437.06667	37909.75	33697.55556	31924	30327.8	25273.16667	24262.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74014	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74015	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	77434	38717	25811.33333	19358.5	15486.8	12905.66667	11062	9679.25	8603.777778	7743.4	7039.454545	6452.833333	5956.461538	5531	5162.266667	4839.625	4301.888889	4075.473684	3871.7	3226.416667	3097.36	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74016	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74017	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74018	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	30642	15321	10214	7660.5	6128.4	5107	4377.428571	3830.25	3404.666667	3064.2	2785.636364	2553.5	2357.076923	2188.714286	2042.8	1915.125	1702.333333	1612.736842	1532.1	1276.75	1225.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74019	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	9743	4871.5	3247.666667	2435.75	1948.6	1623.833333	1391.857143	1217.875	1082.555556	974.3	885.7272727	811.9166667	749.4615385	695.9285714	649.5333333	608.9375	541.2777778	512.7894737	487.15	405.9583333	389.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74020	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74021	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74022	CHOYP_DYHC1.1.1|m.2432	WAIAQINYADMLK	WAIAQINYADMLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74023	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	225746	112873	75248.66667	56436.5	45149.2	37624.33333	32249.42857	28218.25	25082.88889	22574.6	20522.36364	18812.16667	17365.07692	16124.71429	15049.73333	14109.125	12541.44444	11881.36842	11287.3	9406.083333	9029.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74024	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74025	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74026	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74027	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74028	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	26613	13306.5	8871	6653.25	5322.6	4435.5	3801.857143	3326.625	2957	2661.3	2419.363636	2217.75	2047.153846	1900.928571	1774.2	1663.3125	1478.5	1400.684211	1330.65	1108.875	1064.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74029	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74030	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74031	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74032	CHOYP_DYHC1.1.1|m.2432	DLETQAQENQQK	DLETQAQENQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74033	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74034	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74035	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74036	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	12101	6050.5	4033.666667	3025.25	2420.2	2016.833333	1728.714286	1512.625	1344.555556	1210.1	1100.090909	1008.416667	930.8461538	864.3571429	806.7333333	756.3125	672.2777778	636.8947368	605.05	504.2083333	484.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74037	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74038	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74039	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74040	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74041	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74042	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74043	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74044	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	22455	11227.5	7485	5613.75	4491	3742.5	3207.857143	2806.875	2495	2245.5	2041.363636	1871.25	1727.307692	1603.928571	1497	1403.4375	1247.5	1181.842105	1122.75	935.625	898.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74045	CHOYP_DYHC1.1.1|m.2432	ILITLGDQEIDFFPK	ILITLGDQEIDFFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74046	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	2273649	1136824.5	757883	568412.25	454729.8	378941.5	324807	284206.125	252627.6667	227364.9	206695.3636	189470.75	174896.0769	162403.5	151576.6	142103.0625	126313.8333	119665.7368	113682.45	94735.375	90945.96	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74047	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	1331037	665518.5	443679	332759.25	266207.4	221839.5	190148.1429	166379.625	147893	133103.7	121003.3636	110919.75	102387.4615	95074.07143	88735.8	83189.8125	73946.5	70054.57895	66551.85	55459.875	53241.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74048	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	233480	116740	77826.66667	58370	46696	38913.33333	33354.28571	29185	25942.22222	23348	21225.45455	19456.66667	17960	16677.14286	15565.33333	14592.5	12971.11111	12288.42105	11674	9728.333333	9339.2	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74049	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	388357	194178.5	129452.3333	97089.25	77671.4	64726.16667	55479.57143	48544.625	43150.77778	38835.7	35305.18182	32363.08333	29873.61538	27739.78571	25890.46667	24272.3125	21575.38889	20439.84211	19417.85	16181.54167	15534.28	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74050	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	839018	419509	279672.6667	209754.5	167803.6	139836.3333	119859.7143	104877.25	93224.22222	83901.8	76274.36364	69918.16667	64539.84615	59929.85714	55934.53333	52438.625	46612.11111	44158.84211	41950.9	34959.08333	33560.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74051	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	98438	49219	32812.66667	24609.5	19687.6	16406.33333	14062.57143	12304.75	10937.55556	9843.8	8948.909091	8203.166667	7572.153846	7031.285714	6562.533333	6152.375	5468.777778	5180.947368	4921.9	4101.583333	3937.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74052	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	69342	34671	23114	17335.5	13868.4	11557	9906	8667.75	7704.666667	6934.2	6303.818182	5778.5	5334	4953	4622.8	4333.875	3852.333333	3649.578947	3467.1	2889.25	2773.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74053	CHOYP_DYHC1.1.1|m.2432	VTFVNFTVTR	VTFVNFTVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74054	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	4488947	2244473.5	1496315.667	1122236.75	897789.4	748157.8333	641278.1429	561118.375	498771.8889	448894.7	408086.0909	374078.9167	345303.6154	320639.0714	299263.1333	280559.1875	249385.9444	236260.3684	224447.35	187039.4583	179557.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74055	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	2283717	1141858.5	761239	570929.25	456743.4	380619.5	326245.2857	285464.625	253746.3333	228371.7	207610.6364	190309.75	175670.5385	163122.6429	152247.8	142732.3125	126873.1667	120195.6316	114185.85	95154.875	91348.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74056	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	876345	438172.5	292115	219086.25	175269	146057.5	125192.1429	109543.125	97371.66667	87634.5	79667.72727	73028.75	67411.15385	62596.07143	58423	54771.5625	48685.83333	46123.42105	43817.25	36514.375	35053.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74057	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	579894	289947	193298	144973.5	115978.8	96649	82842	72486.75	64432.66667	57989.4	52717.63636	48324.5	44607.23077	41421	38659.6	36243.375	32216.33333	30520.73684	28994.7	24162.25	23195.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74058	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	614309	307154.5	204769.6667	153577.25	122861.8	102384.8333	87758.42857	76788.625	68256.55556	61430.9	55846.27273	51192.41667	47254.53846	43879.21429	40953.93333	38394.3125	34128.27778	32332.05263	30715.45	25596.20833	24572.36	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74059	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	205265	102632.5	68421.66667	51316.25	41053	34210.83333	29323.57143	25658.125	22807.22222	20526.5	18660.45455	17105.41667	15789.61538	14661.78571	13684.33333	12829.0625	11403.61111	10803.42105	10263.25	8552.708333	8210.6	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74060	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	149700	74850	49900	37425	29940	24950	21385.71429	18712.5	16633.33333	14970	13609.09091	12475	11515.38462	10692.85714	9980	9356.25	8316.666667	7878.947368	7485	6237.5	5988	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74061	CHOYP_DYHC1.1.1|m.2432	SLLQALNASK	SLLQALNASK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74062	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	730104	365052	243368	182526	146020.8	121684	104300.5714	91263	81122.66667	73010.4	66373.09091	60842	56161.84615	52150.28571	48673.6	45631.5	40561.33333	38426.52632	36505.2	30421	29204.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74063	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	695851	347925.5	231950.3333	173962.75	139170.2	115975.1667	99407.28571	86981.375	77316.77778	69585.1	63259.18182	57987.58333	53527	49703.64286	46390.06667	43490.6875	38658.38889	36623.73684	34792.55	28993.79167	27834.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74064	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74065	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	24690	12345	8230	6172.5	4938	4115	3527.142857	3086.25	2743.333333	2469	2244.545455	2057.5	1899.230769	1763.571429	1646	1543.125	1371.666667	1299.473684	1234.5	1028.75	987.6	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74066	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	470306	235153	156768.6667	117576.5	94061.2	78384.33333	67186.57143	58788.25	52256.22222	47030.6	42755.09091	39192.16667	36177.38462	33593.28571	31353.73333	29394.125	26128.11111	24752.94737	23515.3	19596.08333	18812.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74067	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	127239	63619.5	42413	31809.75	25447.8	21206.5	18177	15904.875	14137.66667	12723.9	11567.18182	10603.25	9787.615385	9088.5	8482.6	7952.4375	7068.833333	6696.789474	6361.95	5301.625	5089.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74068	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	91244	45622	30414.66667	22811	18248.8	15207.33333	13034.85714	11405.5	10138.22222	9124.4	8294.909091	7603.666667	7018.769231	6517.428571	6082.933333	5702.75	5069.111111	4802.315789	4562.2	3801.833333	3649.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74069	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	36811	18405.5	12270.33333	9202.75	7362.2	6135.166667	5258.714286	4601.375	4090.111111	3681.1	3346.454545	3067.583333	2831.615385	2629.357143	2454.066667	2300.6875	2045.055556	1937.421053	1840.55	1533.791667	1472.44	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74070	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	238511	119255.5	79503.66667	59627.75	47702.2	39751.83333	34073	29813.875	26501.22222	23851.1	21682.81818	19875.91667	18347	17036.5	15900.73333	14906.9375	13250.61111	12553.21053	11925.55	9937.958333	9540.44	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74071	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	89646	44823	29882	22411.5	17929.2	14941	12806.57143	11205.75	9960.666667	8964.6	8149.636364	7470.5	6895.846154	6403.285714	5976.4	5602.875	4980.333333	4718.210526	4482.3	3735.25	3585.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74072	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74073	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	17117	8558.5	5705.666667	4279.25	3423.4	2852.833333	2445.285714	2139.625	1901.888889	1711.7	1556.090909	1426.416667	1316.692308	1222.642857	1141.133333	1069.8125	950.9444444	900.8947368	855.85	713.2083333	684.68	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74074	CHOYP_DYHC1.1.1|m.2432	LSIITNELFQETYNR	LSIITNELFQETYNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74075	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74076	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	1742291	871145.5	580763.6667	435572.75	348458.2	290381.8333	248898.7143	217786.375	193587.8889	174229.1	158390.0909	145190.9167	134022.3846	124449.3571	116152.7333	108893.1875	96793.94444	91699.52632	87114.55	72595.45833	69691.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74077	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74078	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	159193	79596.5	53064.33333	39798.25	31838.6	26532.16667	22741.85714	19899.125	17688.11111	15919.3	14472.09091	13266.08333	12245.61538	11370.92857	10612.86667	9949.5625	8844.055556	8378.578947	7959.65	6633.041667	6367.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74079	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	480261	240130.5	160087	120065.25	96052.2	80043.5	68608.71429	60032.625	53362.33333	48026.1	43660.09091	40021.75	36943.15385	34304.35714	32017.4	30016.3125	26681.16667	25276.89474	24013.05	20010.875	19210.44	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74080	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	235803	117901.5	78601	58950.75	47160.6	39300.5	33686.14286	29475.375	26200.33333	23580.3	21436.63636	19650.25	18138.69231	16843.07143	15720.2	14737.6875	13100.16667	12410.68421	11790.15	9825.125	9432.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74081	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74082	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	202773	101386.5	67591	50693.25	40554.6	33795.5	28967.57143	25346.625	22530.33333	20277.3	18433.90909	16897.75	15597.92308	14483.78571	13518.2	12673.3125	11265.16667	10672.26316	10138.65	8448.875	8110.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74083	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74084	CHOYP_DYHC1.1.1|m.2432	GLSPQQQSAMMR	GLSPQQQSAMMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74085	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	6574073	3287036.5	2191357.667	1643518.25	1314814.6	1095678.833	939153.2857	821759.125	730452.5556	657407.3	597643	547839.4167	505697.9231	469576.6429	438271.5333	410879.5625	365226.2778	346003.8421	328703.65	273919.7083	262962.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74086	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	3379637	1689818.5	1126545.667	844909.25	675927.4	563272.8333	482805.2857	422454.625	375515.2222	337963.7	307239.7273	281636.4167	259972.0769	241402.6429	225309.1333	211227.3125	187757.6111	177875.6316	168981.85	140818.2083	135185.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74087	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	2357460	1178730	785820	589365	471492	392910	336780	294682.5	261940	235746	214314.5455	196455	181343.0769	168390	157164	147341.25	130970	124076.8421	117873	98227.5	94298.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74088	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	26025	13012.5	8675	6506.25	5205	4337.5	3717.857143	3253.125	2891.666667	2602.5	2365.909091	2168.75	2001.923077	1858.928571	1735	1626.5625	1445.833333	1369.736842	1301.25	1084.375	1041	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74089	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	280621	140310.5	93540.33333	70155.25	56124.2	46770.16667	40088.71429	35077.625	31180.11111	28062.1	25511	23385.08333	21586.23077	20044.35714	18708.06667	17538.8125	15590.05556	14769.52632	14031.05	11692.54167	11224.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74090	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	198046	99023	66015.33333	49511.5	39609.2	33007.66667	28292.28571	24755.75	22005.11111	19804.6	18004.18182	16503.83333	15234.30769	14146.14286	13203.06667	12377.875	11002.55556	10423.47368	9902.3	8251.916667	7921.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74091	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	355994	177997	118664.6667	88998.5	71198.8	59332.33333	50856.28571	44499.25	39554.88889	35599.4	32363.09091	29666.16667	27384.15385	25428.14286	23732.93333	22249.625	19777.44444	18736.52632	17799.7	14833.08333	14239.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74092	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	420544	210272	140181.3333	105136	84108.8	70090.66667	60077.71429	52568	46727.11111	42054.4	38231.27273	35045.33333	32349.53846	30038.85714	28036.26667	26284	23363.55556	22133.89474	21027.2	17522.66667	16821.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74093	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	250345	125172.5	83448.33333	62586.25	50069	41724.16667	35763.57143	31293.125	27816.11111	25034.5	22758.63636	20862.08333	19257.30769	17881.78571	16689.66667	15646.5625	13908.05556	13176.05263	12517.25	10431.04167	10013.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74094	CHOYP_DYHC1.1.1|m.2432	VLGNTFLHTAEK	VLGNTFLHTAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74095	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	879073	439536.5	293024.3333	219768.25	175814.6	146512.1667	125581.8571	109884.125	97674.77778	87907.3	79915.72727	73256.08333	67621	62790.92857	58604.86667	54942.0625	48837.38889	46267	43953.65	36628.04167	35162.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74096	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74097	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74098	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74099	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	396268	198134	132089.3333	99067	79253.6	66044.66667	56609.71429	49533.5	44029.77778	39626.8	36024.36364	33022.33333	30482.15385	28304.85714	26417.86667	24766.75	22014.88889	20856.21053	19813.4	16511.16667	15850.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74100	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	139791	69895.5	46597	34947.75	27958.2	23298.5	19970.14286	17473.875	15532.33333	13979.1	12708.27273	11649.25	10753.15385	9985.071429	9319.4	8736.9375	7766.166667	7357.421053	6989.55	5824.625	5591.64	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74101	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	70595	35297.5	23531.66667	17648.75	14119	11765.83333	10085	8824.375	7843.888889	7059.5	6417.727273	5882.916667	5430.384615	5042.5	4706.333333	4412.1875	3921.944444	3715.526316	3529.75	2941.458333	2823.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74102	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74103	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	98278	49139	32759.33333	24569.5	19655.6	16379.66667	14039.71429	12284.75	10919.77778	9827.8	8934.363636	8189.833333	7559.846154	7019.857143	6551.866667	6142.375	5459.888889	5172.526316	4913.9	4094.916667	3931.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74104	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	107799	53899.5	35933	26949.75	21559.8	17966.5	15399.85714	13474.875	11977.66667	10779.9	9799.909091	8983.25	8292.230769	7699.928571	7186.6	6737.4375	5988.833333	5673.631579	5389.95	4491.625	4311.96	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74105	CHOYP_DYHC1.1.1|m.2432	ELQLSSIVENEIK	ELQLSSIVENEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74106	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74107	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74108	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74109	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74110	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74111	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	372938	186469	124312.6667	93234.5	74587.6	62156.33333	53276.85714	46617.25	41437.55556	37293.8	33903.45455	31078.16667	28687.53846	26638.42857	24862.53333	23308.625	20718.77778	19628.31579	18646.9	15539.08333	14917.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74112	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	336918	168459	112306	84229.5	67383.6	56153	48131.14286	42114.75	37435.33333	33691.8	30628.90909	28076.5	25916.76923	24065.57143	22461.2	21057.375	18717.66667	17732.52632	16845.9	14038.25	13476.72	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74113	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	679847	339923.5	226615.6667	169961.75	135969.4	113307.8333	97121	84980.875	75538.55556	67984.7	61804.27273	56653.91667	52295.92308	48560.5	45323.13333	42490.4375	37769.27778	35781.42105	33992.35	28326.95833	27193.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74114	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	132496	66248	44165.33333	33124	26499.2	22082.66667	18928	16562	14721.77778	13249.6	12045.09091	11041.33333	10192	9464	8833.066667	8281	7360.888889	6973.473684	6624.8	5520.666667	5299.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74115	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	101260	50630	33753.33333	25315	20252	16876.66667	14465.71429	12657.5	11251.11111	10126	9205.454545	8438.333333	7789.230769	7232.857143	6750.666667	6328.75	5625.555556	5329.473684	5063	4219.166667	4050.4	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74116	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	121139	60569.5	40379.66667	30284.75	24227.8	20189.83333	17305.57143	15142.375	13459.88889	12113.9	11012.63636	10094.91667	9318.384615	8652.785714	8075.933333	7571.1875	6729.944444	6375.736842	6056.95	5047.458333	4845.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74117	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	189551	94775.5	63183.66667	47387.75	37910.2	31591.83333	27078.71429	23693.875	21061.22222	18955.1	17231.90909	15795.91667	14580.84615	13539.35714	12636.73333	11846.9375	10530.61111	9976.368421	9477.55	7897.958333	7582.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74118	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74119	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	147128	73564	49042.66667	36782	29425.6	24521.33333	21018.28571	18391	16347.55556	14712.8	13375.27273	12260.66667	11317.53846	10509.14286	9808.533333	9195.5	8173.777778	7743.578947	7356.4	6130.333333	5885.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74120	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	37063	18531.5	12354.33333	9265.75	7412.6	6177.166667	5294.714286	4632.875	4118.111111	3706.3	3369.363636	3088.583333	2851	2647.357143	2470.866667	2316.4375	2059.055556	1950.684211	1853.15	1544.291667	1482.52	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74121	CHOYP_DYHC1.1.1|m.2432	QLTSIAIGSAEGFTQADK	QLTSIAIGSAEGFTQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74122	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74123	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74124	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74125	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	108570	54285	36190	27142.5	21714	18095	15510	13571.25	12063.33333	10857	9870	9047.5	8351.538462	7755	7238	6785.625	6031.666667	5714.210526	5428.5	4523.75	4342.8	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74126	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74127	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	3066790	1533395	1022263.333	766697.5	613358	511131.6667	438112.8571	383348.75	340754.4444	306679	278799.0909	255565.8333	235906.9231	219056.4286	204452.6667	191674.375	170377.2222	161410	153339.5	127782.9167	122671.6	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74128	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74129	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	324956	162478	108318.6667	81239	64991.2	54159.33333	46422.28571	40619.5	36106.22222	32495.6	29541.45455	27079.66667	24996.61538	23211.14286	21663.73333	20309.75	18053.11111	17102.94737	16247.8	13539.83333	12998.24	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74130	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74131	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74132	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74133	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	18753	9376.5	6251	4688.25	3750.6	3125.5	2679	2344.125	2083.666667	1875.3	1704.818182	1562.75	1442.538462	1339.5	1250.2	1172.0625	1041.833333	987	937.65	781.375	750.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74134	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74135	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74136	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	600612	300306	200204	150153	120122.4	100102	85801.71429	75076.5	66734.66667	60061.2	54601.09091	50051	46200.92308	42900.85714	40040.8	37538.25	33367.33333	31611.15789	30030.6	25025.5	24024.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74137	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74138	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74139	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74140	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74141	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74142	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74143	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74144	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74145	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74146	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74147	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74148	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74149	CHOYP_DYHC1.1.1|m.2432	IFVFEPPPGVSANLSR	IFVFEPPPGVSANLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74150	CHOYP_DYHC1.1.1|m.2432	LLTTFIEK	LLTTFIEK	7625122	3812561	2541707.333	1906280.5	1525024.4	1270853.667	1089303.143	953140.25	847235.7778	762512.2	693192.9091	635426.8333	586547.8462	544651.5714	508341.4667	476570.125	423617.8889	401322.2105	381256.1	317713.4167	305004.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74151	CHOYP_DYHC1.1.1|m.2432	LLTTFIEK	LLTTFIEK	4738076	2369038	1579358.667	1184519	947615.2	789679.3333	676868	592259.5	526452.8889	473807.6	430734.1818	394839.6667	364467.3846	338434	315871.7333	296129.75	263226.4444	249372.4211	236903.8	197419.8333	189523.04	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74152	CHOYP_DYHC1.1.1|m.2432	LLTTFIEK	LLTTFIEK	1237796	618898	412598.6667	309449	247559.2	206299.3333	176828	154724.5	137532.8889	123779.6	112526.9091	103149.6667	95215.07692	88414	82519.73333	77362.25	68766.44444	65147.15789	61889.8	51574.83333	49511.84	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74153	CHOYP_DYHC1.1.1|m.2432	LLTTFIEK	LLTTFIEK	256008	128004	85336	64002	51201.6	42668	36572.57143	32001	28445.33333	25600.8	23273.45455	21334	19692.92308	18286.28571	17067.2	16000.5	14222.66667	13474.10526	12800.4	10667	10240.32	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74154	CHOYP_DYHC1.1.1|m.2432	LLTTFIEK	LLTTFIEK	360379	180189.5	120126.3333	90094.75	72075.8	60063.16667	51482.71429	45047.375	40042.11111	36037.9	32761.72727	30031.58333	27721.46154	25741.35714	24025.26667	22523.6875	20021.05556	18967.31579	18018.95	15015.79167	14415.16	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74155	CHOYP_DYHC1.1.1|m.2432	LLTTFIEK	LLTTFIEK	310528	155264	103509.3333	77632	62105.6	51754.66667	44361.14286	38816	34503.11111	31052.8	28229.81818	25877.33333	23886.76923	22180.57143	20701.86667	19408	17251.55556	16343.57895	15526.4	12938.66667	12421.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74156	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74157	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	2215409	1107704.5	738469.6667	553852.25	443081.8	369234.8333	316487	276926.125	246156.5556	221540.9	201400.8182	184617.4167	170416.0769	158243.5	147693.9333	138463.0625	123078.2778	116600.4737	110770.45	92308.70833	88616.36	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74158	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74159	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	10147	5073.5	3382.333333	2536.75	2029.4	1691.166667	1449.571429	1268.375	1127.444444	1014.7	922.4545455	845.5833333	780.5384615	724.7857143	676.4666667	634.1875	563.7222222	534.0526316	507.35	422.7916667	405.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74160	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74161	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	547223	273611.5	182407.6667	136805.75	109444.6	91203.83333	78174.71429	68402.875	60802.55556	54722.3	49747.54545	45601.91667	42094.07692	39087.35714	36481.53333	34201.4375	30401.27778	28801.21053	27361.15	22800.95833	21888.92	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74162	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74163	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	72069	36034.5	24023	18017.25	14413.8	12011.5	10295.57143	9008.625	8007.666667	7206.9	6551.727273	6005.75	5543.769231	5147.785714	4804.6	4504.3125	4003.833333	3793.105263	3603.45	3002.875	2882.76	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74164	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74165	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74166	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74167	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74168	CHOYP_DYHC1.1.1|m.2432	QLQAIVQTTQQGGTK	QLQAIVQTTQQGGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74169	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	4013178	2006589	1337726	1003294.5	802635.6	668863	573311.1429	501647.25	445908.6667	401317.8	364834.3636	334431.5	308706	286655.5714	267545.2	250823.625	222954.3333	211219.8947	200658.9	167215.75	160527.12	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74170	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	2062889	1031444.5	687629.6667	515722.25	412577.8	343814.8333	294698.4286	257861.125	229209.8889	206288.9	187535.3636	171907.4167	158683.7692	147349.2143	137525.9333	128930.5625	114604.9444	108573.1053	103144.45	85953.70833	82515.56	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74171	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	1569747	784873.5	523249	392436.75	313949.4	261624.5	224249.5714	196218.375	174416.3333	156974.7	142704.2727	130812.25	120749.7692	112124.7857	104649.8	98109.1875	87208.16667	82618.26316	78487.35	65406.125	62789.88	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74172	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	1601150	800575	533716.6667	400287.5	320230	266858.3333	228735.7143	200143.75	177905.5556	160115	145559.0909	133429.1667	123165.3846	114367.8571	106743.3333	100071.875	88952.77778	84271.05263	80057.5	66714.58333	64046	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74173	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74174	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	709087	354543.5	236362.3333	177271.75	141817.4	118181.1667	101298.1429	88635.875	78787.44444	70908.7	64462.45455	59090.58333	54545.15385	50649.07143	47272.46667	44317.9375	39393.72222	37320.36842	35454.35	29545.29167	28363.48	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74175	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74176	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
74177	CHOYP_DYHC1.1.1|m.2432	VTLPVYLNATR	VTLPVYLNATR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q14204	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cytoplasmic mRNA processing body assembly [GO:0033962]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; stress granule assembly [GO:0034063]	GO:0000086; GO:0003777; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0016020; GO:0016887; GO:0019886; GO:0030175; GO:0031012; GO:0033962; GO:0034063; GO:0044822; GO:0051293; GO:0051959; GO:0070062
83372	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83373	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	10754264	5377132	3584754.667	2688566	2150852.8	1792377.333	1536323.429	1344283	1194918.222	1075426.4	977660.3636	896188.6667	827251.0769	768161.7143	716950.9333	672141.5	597459.1111	566013.8947	537713.2	448094.3333	430170.56	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83374	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	6432991	3216495.5	2144330.333	1608247.75	1286598.2	1072165.167	918998.7143	804123.875	714776.7778	643299.1	584817.3636	536082.5833	494845.4615	459499.3571	428866.0667	402061.9375	357388.3889	338578.4737	321649.55	268041.2917	257319.64	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83375	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	263216	131608	87738.66667	65804	52643.2	43869.33333	37602.28571	32902	29246.22222	26321.6	23928.72727	21934.66667	20247.38462	18801.14286	17547.73333	16451	14623.11111	13853.47368	13160.8	10967.33333	10528.64	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83376	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	1483422	741711	494474	370855.5	296684.4	247237	211917.4286	185427.75	164824.6667	148342.2	134856.5455	123618.5	114109.3846	105958.7143	98894.8	92713.875	82412.33333	78074.84211	74171.1	61809.25	59336.88	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83377	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83378	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	2988643	1494321.5	996214.3333	747160.75	597728.6	498107.1667	426949	373580.375	332071.4444	298864.3	271694.8182	249053.5833	229895.6154	213474.5	199242.8667	186790.1875	166035.7222	157297	149432.15	124526.7917	119545.72	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83379	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83380	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	546031	273015.5	182010.3333	136507.75	109206.2	91005.16667	78004.42857	68253.875	60670.11111	54603.1	49639.18182	45502.58333	42002.38462	39002.21429	36402.06667	34126.9375	30335.05556	28738.47368	27301.55	22751.29167	21841.24	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83381	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	116851	58425.5	38950.33333	29212.75	23370.2	19475.16667	16693	14606.375	12983.44444	11685.1	10622.81818	9737.583333	8988.538462	8346.5	7790.066667	7303.1875	6491.722222	6150.052632	5842.55	4868.791667	4674.04	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83382	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	291989	145994.5	97329.66667	72997.25	58397.8	48664.83333	41712.71429	36498.625	32443.22222	29198.9	26544.45455	24332.41667	22460.69231	20856.35714	19465.93333	18249.3125	16221.61111	15367.84211	14599.45	12166.20833	11679.56	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83383	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83384	CHOYP_ERP44.1.1|m.3853	FSQILTPVFEEASNK	FSQILTPVFEEASNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83385	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83386	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83387	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83388	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	163928	81964	54642.66667	40982	32785.6	27321.33333	23418.28571	20491	18214.22222	16392.8	14902.54545	13660.66667	12609.84615	11709.14286	10928.53333	10245.5	9107.111111	8627.789474	8196.4	6830.333333	6557.12	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83389	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	114633	57316.5	38211	28658.25	22926.6	19105.5	16376.14286	14329.125	12737	11463.3	10421.18182	9552.75	8817.923077	8188.071429	7642.2	7164.5625	6368.5	6033.315789	5731.65	4776.375	4585.32	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83390	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	271561	135780.5	90520.33333	67890.25	54312.2	45260.16667	38794.42857	33945.125	30173.44444	27156.1	24687.36364	22630.08333	20889.30769	19397.21429	18104.06667	16972.5625	15086.72222	14292.68421	13578.05	11315.04167	10862.44	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83391	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	133152	66576	44384	33288	26630.4	22192	19021.71429	16644	14794.66667	13315.2	12104.72727	11096	10242.46154	9510.857143	8876.8	8322	7397.333333	7008	6657.6	5548	5326.08	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83392	CHOYP_ERP44.1.1|m.3853	SVDALVQFVK	SVDALVQFVK	134938	67469	44979.33333	33734.5	26987.6	22489.66667	19276.85714	16867.25	14993.11111	13493.8	12267.09091	11244.83333	10379.84615	9638.428571	8995.866667	8433.625	7496.555556	7102	6746.9	5622.416667	5397.52	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83393	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83394	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83395	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83396	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83397	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	85048	42524	28349.33333	21262	17009.6	14174.66667	12149.71429	10631	9449.777778	8504.8	7731.636364	7087.333333	6542.153846	6074.857143	5669.866667	5315.5	4724.888889	4476.210526	4252.4	3543.666667	3401.92	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83398	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	134768	67384	44922.66667	33692	26953.6	22461.33333	19252.57143	16846	14974.22222	13476.8	12251.63636	11230.66667	10366.76923	9626.285714	8984.533333	8423	7487.111111	7093.052632	6738.4	5615.333333	5390.72	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83399	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	187348	93674	62449.33333	46837	37469.6	31224.66667	26764	23418.5	20816.44444	18734.8	17031.63636	15612.33333	14411.38462	13382	12489.86667	11709.25	10408.22222	9860.421053	9367.4	7806.166667	7493.92	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83400	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83401	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83402	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83403	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83404	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83405	CHOYP_ERP44.1.1|m.3853	HIIGYFADVNSDAYR	HIIGYFADVNSDAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83406	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	13127439	6563719.5	4375813	3281859.75	2625487.8	2187906.5	1875348.429	1640929.875	1458604.333	1312743.9	1193403.545	1093953.25	1009803	937674.2143	875162.6	820464.9375	729302.1667	690917.8421	656371.95	546976.625	525097.56	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83407	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	10086107	5043053.5	3362035.667	2521526.75	2017221.4	1681017.833	1440872.429	1260763.375	1120678.556	1008610.7	916918.8182	840508.9167	775854.3846	720436.2143	672407.1333	630381.6875	560339.2778	530847.7368	504305.35	420254.4583	403444.28	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83408	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	6462413	3231206.5	2154137.667	1615603.25	1292482.6	1077068.833	923201.8571	807801.625	718045.8889	646241.3	587492.0909	538534.4167	497108.6923	461600.9286	430827.5333	403900.8125	359022.9444	340127	323120.65	269267.2083	258496.52	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83409	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	198813	99406.5	66271	49703.25	39762.6	33135.5	28401.85714	24851.625	22090.33333	19881.3	18073.90909	16567.75	15293.30769	14200.92857	13254.2	12425.8125	11045.16667	10463.84211	9940.65	8283.875	7952.52	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83410	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	1688462	844231	562820.6667	422115.5	337692.4	281410.3333	241208.8571	211057.75	187606.8889	168846.2	153496.5455	140705.1667	129881.6923	120604.4286	112564.1333	105528.875	93803.44444	88866.42105	84423.1	70352.58333	67538.48	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83411	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	1448564	724282	482854.6667	362141	289712.8	241427.3333	206937.7143	181070.5	160951.5556	144856.4	131687.6364	120713.6667	111428	103468.8571	96570.93333	90535.25	80475.77778	76240.21053	72428.2	60356.83333	57942.56	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83412	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	679868	339934	226622.6667	169967	135973.6	113311.3333	97124	84983.5	75540.88889	67986.8	61806.18182	56655.66667	52297.53846	48562	45324.53333	42491.75	37770.44444	35782.52632	33993.4	28327.83333	27194.72	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83413	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83414	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83415	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	341822	170911	113940.6667	85455.5	68364.4	56970.33333	48831.71429	42727.75	37980.22222	34182.2	31074.72727	28485.16667	26294	24415.85714	22788.13333	21363.875	18990.11111	17990.63158	17091.1	14242.58333	13672.88	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83416	CHOYP_ERP44.1.1|m.3853	FATVVQQQLMSEK	FATVVQQQLMSEK	220744	110372	73581.33333	55186	44148.8	36790.66667	31534.85714	27593	24527.11111	22074.4	20067.63636	18395.33333	16980.30769	15767.42857	14716.26667	13796.5	12263.55556	11618.10526	11037.2	9197.666667	8829.76	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83417	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	13337322	6668661	4445774	3334330.5	2667464.4	2222887	1905331.714	1667165.25	1481924.667	1333732.2	1212483.818	1111443.5	1025947.846	952665.8571	889154.8	833582.625	740962.3333	701964.3158	666866.1	555721.75	533492.88	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83418	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	8318474	4159237	2772824.667	2079618.5	1663694.8	1386412.333	1188353.429	1039809.25	924274.8889	831847.4	756224.9091	693206.1667	639882.6154	594176.7143	554564.9333	519904.625	462137.4444	437814.4211	415923.7	346603.0833	332738.96	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83419	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83420	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	1996911	998455.5	665637	499227.75	399382.2	332818.5	285273	249613.875	221879	199691.1	181537.3636	166409.25	153608.5385	142636.5	133127.4	124806.9375	110939.5	105100.5789	99845.55	83204.625	79876.44	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83421	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	1289691	644845.5	429897	322422.75	257938.2	214948.5	184241.5714	161211.375	143299	128969.1	117244.6364	107474.25	99207	92120.78571	85979.4	80605.6875	71649.5	67878.47368	64484.55	53737.125	51587.64	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83422	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	2066180	1033090	688726.6667	516545	413236	344363.3333	295168.5714	258272.5	229575.5556	206618	187834.5455	172181.6667	158936.9231	147584.2857	137745.3333	129136.25	114787.7778	108746.3158	103309	86090.83333	82647.2	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83423	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	1945889	972944.5	648629.6667	486472.25	389177.8	324314.8333	277984.1429	243236.125	216209.8889	194588.9	176899	162157.4167	149683.7692	138992.0714	129725.9333	121618.0625	108104.9444	102415.2105	97294.45	81078.70833	77835.56	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83424	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	594525	297262.5	198175	148631.25	118905	99087.5	84932.14286	74315.625	66058.33333	59452.5	54047.72727	49543.75	45732.69231	42466.07143	39635	37157.8125	33029.16667	31290.78947	29726.25	24771.875	23781	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83425	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83426	CHOYP_ERP44.1.1|m.3853	SSVNFLTADGLK	SSVNFLTADGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83427	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83428	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83429	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83430	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	133321	66660.5	44440.33333	33330.25	26664.2	22220.16667	19045.85714	16665.125	14813.44444	13332.1	12120.09091	11110.08333	10255.46154	9522.928571	8888.066667	8332.5625	7406.722222	7016.894737	6666.05	5555.041667	5332.84	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83431	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83432	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83433	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	402700	201350	134233.3333	100675	80540	67116.66667	57528.57143	50337.5	44744.44444	40270	36609.09091	33558.33333	30976.92308	28764.28571	26846.66667	25168.75	22372.22222	21194.73684	20135	16779.16667	16108	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83434	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	895597	447798.5	298532.3333	223899.25	179119.4	149266.1667	127942.4286	111949.625	99510.77778	89559.7	81417.90909	74633.08333	68892.07692	63971.21429	59706.46667	55974.8125	49755.38889	47136.68421	44779.85	37316.54167	35823.88	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83435	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83436	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	261454	130727	87151.33333	65363.5	52290.8	43575.66667	37350.57143	32681.75	29050.44444	26145.4	23768.54545	21787.83333	20111.84615	18675.28571	17430.26667	16340.875	14525.22222	13760.73684	13072.7	10893.91667	10458.16	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83437	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	31733	15866.5	10577.66667	7933.25	6346.6	5288.833333	4533.285714	3966.625	3525.888889	3173.3	2884.818182	2644.416667	2441	2266.642857	2115.533333	1983.3125	1762.944444	1670.157895	1586.65	1322.208333	1269.32	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83438	CHOYP_ERP44.1.1|m.3853	SENDLPVLAIDSFR	SENDLPVLAIDSFR	890776	445388	296925.3333	222694	178155.2	148462.6667	127253.7143	111347	98975.11111	89077.6	80979.63636	74231.33333	68521.23077	63626.85714	59385.06667	55673.5	49487.55556	46882.94737	44538.8	37115.66667	35631.04	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83439	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83440	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83441	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	463024	231512	154341.3333	115756	92604.8	77170.66667	66146.28571	57878	51447.11111	46302.4	42093.09091	38585.33333	35617.23077	33073.14286	30868.26667	28939	25723.55556	24369.68421	23151.2	19292.66667	18520.96	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83442	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83443	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83444	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	312015	156007.5	104005	78003.75	62403	52002.5	44573.57143	39001.875	34668.33333	31201.5	28365	26001.25	24001.15385	22286.78571	20801	19500.9375	17334.16667	16421.84211	15600.75	13000.625	12480.6	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83445	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	22658	11329	7552.666667	5664.5	4531.6	3776.333333	3236.857143	2832.25	2517.555556	2265.8	2059.818182	1888.166667	1742.923077	1618.428571	1510.533333	1416.125	1258.777778	1192.526316	1132.9	944.0833333	906.32	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83446	CHOYP_ERP44.1.1|m.3853	HMYLFPHNVK	HMYLFPHNVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83447	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83448	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83449	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83450	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83451	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83452	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83453	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83454	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83455	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83456	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83457	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83458	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83459	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83460	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83461	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83462	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83463	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83464	CHOYP_ERP44.1.1|m.3853	TDLETPGLLSQFIADLHSGK	TDLETPGLLSQFIADLHSGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q3T0L2	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 TXNDC4	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454; GO:0070062
83497	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	8380282	4190141	2793427.333	2095070.5	1676056.4	1396713.667	1197183.143	1047535.25	931142.4444	838028.2	761843.8182	698356.8333	644637.0769	598591.5714	558685.4667	523767.625	465571.2222	441067.4737	419014.1	349178.4167	335211.28	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83498	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	5313788	2656894	1771262.667	1328447	1062757.6	885631.3333	759112.5714	664223.5	590420.8889	531378.8	483071.6364	442815.6667	408752.9231	379556.2857	354252.5333	332111.75	295210.4444	279673.0526	265689.4	221407.8333	212551.52	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83499	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	2141002	1070501	713667.3333	535250.5	428200.4	356833.6667	305857.4286	267625.25	237889.1111	214100.2	194636.5455	178416.8333	164692.4615	152928.7143	142733.4667	133812.625	118944.5556	112684.3158	107050.1	89208.41667	85640.08	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83500	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	520180	260090	173393.3333	130045	104036	86696.66667	74311.42857	65022.5	57797.77778	52018	47289.09091	43348.33333	40013.84615	37155.71429	34678.66667	32511.25	28898.88889	27377.89474	26009	21674.16667	20807.2	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83501	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	1011429	505714.5	337143	252857.25	202285.8	168571.5	144489.8571	126428.625	112381	101142.9	91948.09091	84285.75	77802.23077	72244.92857	67428.6	63214.3125	56190.5	53233.10526	50571.45	42142.875	40457.16	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83502	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	2012665	1006332.5	670888.3333	503166.25	402533	335444.1667	287523.5714	251583.125	223629.4444	201266.5	182969.5455	167722.0833	154820.3846	143761.7857	134177.6667	125791.5625	111814.7222	105929.7368	100633.25	83861.04167	80506.6	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83503	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	2828763	1414381.5	942921	707190.75	565752.6	471460.5	404109	353595.375	314307	282876.3	257160.2727	235730.25	217597.1538	202054.5	188584.2	176797.6875	157153.5	148882.2632	141438.15	117865.125	113150.52	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83504	CHOYP_ETFD.1.1|m.6881	SLEELFPNWR	SLEELFPNWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83505	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	2216228	1108114	738742.6667	554057	443245.6	369371.3333	316604	277028.5	246247.5556	221622.8	201475.2727	184685.6667	170479.0769	158302	147748.5333	138514.25	123123.7778	116643.5789	110811.4	92342.83333	88649.12	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83506	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	1234850	617425	411616.6667	308712.5	246970	205808.3333	176407.1429	154356.25	137205.5556	123485	112259.0909	102904.1667	94988.46154	88203.57143	82323.33333	77178.125	68602.77778	64992.10526	61742.5	51452.08333	49394	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83507	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	404791	202395.5	134930.3333	101197.75	80958.2	67465.16667	57827.28571	50598.875	44976.77778	40479.1	36799.18182	33732.58333	31137.76923	28913.64286	26986.06667	25299.4375	22488.38889	21304.78947	20239.55	16866.29167	16191.64	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83508	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83509	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	175813	87906.5	58604.33333	43953.25	35162.6	29302.16667	25116.14286	21976.625	19534.77778	17581.3	15983	14651.08333	13524.07692	12558.07143	11720.86667	10988.3125	9767.388889	9253.315789	8790.65	7325.541667	7032.52	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83510	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83511	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	48867	24433.5	16289	12216.75	9773.4	8144.5	6981	6108.375	5429.666667	4886.7	4442.454545	4072.25	3759	3490.5	3257.8	3054.1875	2714.833333	2571.947368	2443.35	2036.125	1954.68	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83512	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	83475	41737.5	27825	20868.75	16695	13912.5	11925	10434.375	9275	8347.5	7588.636364	6956.25	6421.153846	5962.5	5565	5217.1875	4637.5	4393.421053	4173.75	3478.125	3339	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
83513	CHOYP_ETFD.1.1|m.6881	GIATNDVGIHK	GIATNDVGIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921G7	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051539
84222	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	11251128	5625564	3750376	2812782	2250225.6	1875188	1607304	1406391	1250125.333	1125112.8	1022829.818	937594	865471.3846	803652	750075.2	703195.5	625062.6667	592164.6316	562556.4	468797	450045.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84223	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	6762770	3381385	2254256.667	1690692.5	1352554	1127128.333	966110	845346.25	751418.8889	676277	614797.2727	563564.1667	520213.0769	483055	450851.3333	422673.125	375709.4444	355935.2632	338138.5	281782.0833	270510.8	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84224	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	2387351	1193675.5	795783.6667	596837.75	477470.2	397891.8333	341050.1429	298418.875	265261.2222	238735.1	217031.9091	198945.9167	183642.3846	170525.0714	159156.7333	149209.4375	132630.6111	125650.0526	119367.55	99472.95833	95494.04	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84225	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	2519317	1259658.5	839772.3333	629829.25	503863.4	419886.1667	359902.4286	314914.625	279924.1111	251931.7	229028.8182	209943.0833	193793.6154	179951.2143	167954.4667	157457.3125	139962.0556	132595.6316	125965.85	104971.5417	100772.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84226	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	376709	188354.5	125569.6667	94177.25	75341.8	62784.83333	53815.57143	47088.625	41856.55556	37670.9	34246.27273	31392.41667	28977.61538	26907.78571	25113.93333	23544.3125	20928.27778	19826.78947	18835.45	15696.20833	15068.36	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84227	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84228	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	172393	86196.5	57464.33333	43098.25	34478.6	28732.16667	24627.57143	21549.125	19154.77778	17239.3	15672.09091	14366.08333	13261	12313.78571	11492.86667	10774.5625	9577.388889	9073.315789	8619.65	7183.041667	6895.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84229	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	126278	63139	42092.66667	31569.5	25255.6	21046.33333	18039.71429	15784.75	14030.88889	12627.8	11479.81818	10523.16667	9713.692308	9019.857143	8418.533333	7892.375	7015.444444	6646.210526	6313.9	5261.583333	5051.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84230	CHOYP_FAS2.1.1|m.41201	NTAGGEQDNLK	NTAGGEQDNLK	159804	79902	53268	39951	31960.8	26634	22829.14286	19975.5	17756	15980.4	14527.63636	13317	12292.61538	11414.57143	10653.6	9987.75	8878	8410.736842	7990.2	6658.5	6392.16	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84231	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84232	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84233	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84234	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	561172	280586	187057.3333	140293	112234.4	93528.66667	80167.42857	70146.5	62352.44444	56117.2	51015.63636	46764.33333	43167.07692	40083.71429	37411.46667	35073.25	31176.22222	29535.36842	28058.6	23382.16667	22446.88	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84235	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	1134486	567243	378162	283621.5	226897.2	189081	162069.4286	141810.75	126054	113448.6	103135.0909	94540.5	87268.15385	81034.71429	75632.4	70905.375	63027	59709.78947	56724.3	47270.25	45379.44	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84236	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	288039	144019.5	96013	72009.75	57607.8	48006.5	41148.42857	36004.875	32004.33333	28803.9	26185.36364	24003.25	22156.84615	20574.21429	19202.6	18002.4375	16002.16667	15159.94737	14401.95	12001.625	11521.56	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84237	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84238	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	646401	323200.5	215467	161600.25	129280.2	107733.5	92343	80800.125	71822.33333	64640.1	58763.72727	53866.75	49723.15385	46171.5	43093.4	40400.0625	35911.16667	34021.10526	32320.05	26933.375	25856.04	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84239	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84240	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	229635	114817.5	76545	57408.75	45927	38272.5	32805	28704.375	25515	22963.5	20875.90909	19136.25	17664.23077	16402.5	15309	14352.1875	12757.5	12086.05263	11481.75	9568.125	9185.4	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84241	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	292133	146066.5	97377.66667	73033.25	58426.6	48688.83333	41733.28571	36516.625	32459.22222	29213.3	26557.54545	24344.41667	22471.76923	20866.64286	19475.53333	18258.3125	16229.61111	15375.42105	14606.65	12172.20833	11685.32	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84242	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	438353	219176.5	146117.6667	109588.25	87670.6	73058.83333	62621.85714	54794.125	48705.88889	43835.3	39850.27273	36529.41667	33719.46154	31310.92857	29223.53333	27397.0625	24352.94444	23071.21053	21917.65	18264.70833	17534.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84243	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	466639	233319.5	155546.3333	116659.75	93327.8	77773.16667	66662.71429	58329.875	51848.77778	46663.9	42421.72727	38886.58333	35895.30769	33331.35714	31109.26667	29164.9375	25924.38889	24559.94737	23331.95	19443.29167	18665.56	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84244	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84245	CHOYP_FAS2.1.1|m.41201	ITTPPSAGQAVVGEQYR	ITTPPSAGQAVVGEQYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84246	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	654918	327459	218306	163729.5	130983.6	109153	93559.71429	81864.75	72768.66667	65491.8	59538	54576.5	50378.30769	46779.85714	43661.2	40932.375	36384.33333	34469.36842	32745.9	27288.25	26196.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84247	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84248	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84249	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84250	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84251	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84252	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84253	CHOYP_FAS2.1.1|m.41201	AYGDPIPTIK	AYGDPIPTIK	8260	4130	2753.333333	2065	1652	1376.666667	1180	1032.5	917.7777778	826	750.9090909	688.3333333	635.3846154	590	550.6666667	516.25	458.8888889	434.7368421	413	344.1666667	330.4	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84254	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	35999300	17999650	11999766.67	8999825	7199860	5999883.333	5142757.143	4499912.5	3999922.222	3599930	3272663.636	2999941.667	2769176.923	2571378.571	2399953.333	2249956.25	1999961.111	1894700	1799965	1499970.833	1439972	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84255	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	26362796	13181398	8787598.667	6590699	5272559.2	4393799.333	3766113.714	3295349.5	2929199.556	2636279.6	2396617.818	2196899.667	2027907.385	1883056.857	1757519.733	1647674.75	1464599.778	1387515.579	1318139.8	1098449.833	1054511.84	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84256	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	13969843	6984921.5	4656614.333	3492460.75	2793968.6	2328307.167	1995691.857	1746230.375	1552204.778	1396984.3	1269985.727	1164153.583	1074603.308	997845.9286	931322.8667	873115.1875	776102.3889	735254.8947	698492.15	582076.7917	558793.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84257	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	1788080	894040	596026.6667	447020	357616	298013.3333	255440	223510	198675.5556	178808	162552.7273	149006.6667	137544.6154	127720	119205.3333	111755	99337.77778	94109.47368	89404	74503.33333	71523.2	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84258	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	1158769	579384.5	386256.3333	289692.25	231753.8	193128.1667	165538.4286	144846.125	128752.1111	115876.9	105342.6364	96564.08333	89136.07692	82769.21429	77251.26667	72423.0625	64376.05556	60987.84211	57938.45	48282.04167	46350.76	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84259	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	2187565	1093782.5	729188.3333	546891.25	437513	364594.1667	312509.2857	273445.625	243062.7778	218756.5	198869.5455	182297.0833	168274.2308	156254.6429	145837.6667	136722.8125	121531.3889	115135	109378.25	91148.54167	87502.6	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84260	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	1947923	973961.5	649307.6667	486980.75	389584.6	324653.8333	278274.7143	243490.375	216435.8889	194792.3	177083.9091	162326.9167	149840.2308	139137.3571	129861.5333	121745.1875	108217.9444	102522.2632	97396.15	81163.45833	77916.92	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84261	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	2060743	1030371.5	686914.3333	515185.75	412148.6	343457.1667	294391.8571	257592.875	228971.4444	206074.3	187340.2727	171728.5833	158518.6923	147195.9286	137382.8667	128796.4375	114485.7222	108460.1579	103037.15	85864.29167	82429.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84262	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	590298	295149	196766	147574.5	118059.6	98383	84328.28571	73787.25	65588.66667	59029.8	53663.45455	49191.5	45407.53846	42164.14286	39353.2	36893.625	32794.33333	31068.31579	29514.9	24595.75	23611.92	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84263	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	852024	426012	284008	213006	170404.8	142004	121717.7143	106503	94669.33333	85202.4	77456.72727	71002	65540.30769	60858.85714	56801.6	53251.5	47334.66667	44843.36842	42601.2	35501	34080.96	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84264	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	901042	450521	300347.3333	225260.5	180208.4	150173.6667	128720.2857	112630.25	100115.7778	90104.2	81912.90909	75086.83333	69310.92308	64360.14286	60069.46667	56315.125	50057.88889	47423.26316	45052.1	37543.41667	36041.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84265	CHOYP_FAS2.1.1|m.41201	VIQDATATQDINEK	VIQDATATQDINEK	1278350	639175	426116.6667	319587.5	255670	213058.3333	182621.4286	159793.75	142038.8889	127835	116213.6364	106529.1667	98334.61538	91310.71429	85223.33333	79896.875	71019.44444	67281.57895	63917.5	53264.58333	51134	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84266	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	20236462	10118231	6745487.333	5059115.5	4047292.4	3372743.667	2890923.143	2529557.75	2248495.778	2023646.2	1839678.364	1686371.833	1556650.923	1445461.571	1349097.467	1264778.875	1124247.889	1065076.947	1011823.1	843185.9167	809458.48	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84267	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	14806934	7403467	4935644.667	3701733.5	2961386.8	2467822.333	2115276.286	1850866.75	1645214.889	1480693.4	1346084.909	1233911.167	1138994.923	1057638.143	987128.9333	925433.375	822607.4444	779312.3158	740346.7	616955.5833	592277.36	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84268	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	4326203	2163101.5	1442067.667	1081550.75	865240.6	721033.8333	618029	540775.375	480689.2222	432620.3	393291.1818	360516.9167	332784.8462	309014.5	288413.5333	270387.6875	240344.6111	227694.8947	216310.15	180258.4583	173048.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84269	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	3817326	1908663	1272442	954331.5	763465.2	636221	545332.2857	477165.75	424147.3333	381732.6	347029.6364	318110.5	293640.4615	272666.1429	254488.4	238582.875	212073.6667	200911.8947	190866.3	159055.25	152693.04	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84270	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	1007548	503774	335849.3333	251887	201509.6	167924.6667	143935.4286	125943.5	111949.7778	100754.8	91595.27273	83962.33333	77503.69231	71967.71429	67169.86667	62971.75	55974.88889	53028.84211	50377.4	41981.16667	40301.92	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84271	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	649928	324964	216642.6667	162482	129985.6	108321.3333	92846.85714	81241	72214.22222	64992.8	59084.36364	54160.66667	49994.46154	46423.42857	43328.53333	40620.5	36107.11111	34206.73684	32496.4	27080.33333	25997.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84272	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	1718624	859312	572874.6667	429656	343724.8	286437.3333	245517.7143	214828	190958.2222	171862.4	156238.5455	143218.6667	132201.8462	122758.8571	114574.9333	107414	95479.11111	90453.89474	85931.2	71609.33333	68744.96	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84273	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	701443	350721.5	233814.3333	175360.75	140288.6	116907.1667	100206.1429	87680.375	77938.11111	70144.3	63767.54545	58453.58333	53957.15385	50103.07143	46762.86667	43840.1875	38969.05556	36918.05263	35072.15	29226.79167	28057.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84274	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	1310053	655026.5	436684.3333	327513.25	262010.6	218342.1667	187150.4286	163756.625	145561.4444	131005.3	119095.7273	109171.0833	100773.3077	93575.21429	87336.86667	81878.3125	72780.72222	68950.15789	65502.65	54585.54167	52402.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84275	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	715885	357942.5	238628.3333	178971.25	143177	119314.1667	102269.2857	89485.625	79542.77778	71588.5	65080.45455	59657.08333	55068.07692	51134.64286	47725.66667	44742.8125	39771.38889	37678.15789	35794.25	29828.54167	28635.4	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84276	CHOYP_FAS2.1.1|m.41201	TVVSSLTITSLTK	TVVSSLTITSLTK	152297	76148.5	50765.66667	38074.25	30459.4	25382.83333	21756.71429	19037.125	16921.88889	15229.7	13845.18182	12691.41667	11715.15385	10878.35714	10153.13333	9518.5625	8460.944444	8015.631579	7614.85	6345.708333	6091.88	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84277	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	742439	371219.5	247479.6667	185609.75	148487.8	123739.8333	106062.7143	92804.875	82493.22222	74243.9	67494.45455	61869.91667	57110.69231	53031.35714	49495.93333	46402.4375	41246.61111	39075.73684	37121.95	30934.95833	29697.56	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84278	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	1943358	971679	647786	485839.5	388671.6	323893	277622.5714	242919.75	215928.6667	194335.8	176668.9091	161946.5	149489.0769	138811.2857	129557.2	121459.875	107964.3333	102282	97167.9	80973.25	77734.32	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84279	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84280	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	101166	50583	33722	25291.5	20233.2	16861	14452.28571	12645.75	11240.66667	10116.6	9196.909091	8430.5	7782	7226.142857	6744.4	6322.875	5620.333333	5324.526316	5058.3	4215.25	4046.64	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84281	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	146542	73271	48847.33333	36635.5	29308.4	24423.66667	20934.57143	18317.75	16282.44444	14654.2	13322	12211.83333	11272.46154	10467.28571	9769.466667	9158.875	8141.222222	7712.736842	7327.1	6105.916667	5861.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84282	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84283	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84284	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	30509	15254.5	10169.66667	7627.25	6101.8	5084.833333	4358.428571	3813.625	3389.888889	3050.9	2773.545455	2542.416667	2346.846154	2179.214286	2033.933333	1906.8125	1694.944444	1605.736842	1525.45	1271.208333	1220.36	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84285	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84286	CHOYP_FAS2.1.1|m.41201	IEEESFYSISTK	IEEESFYSISTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84287	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	15200093	7600046.5	5066697.667	3800023.25	3040018.6	2533348.833	2171441.857	1900011.625	1688899.222	1520009.3	1381826.636	1266674.417	1169237.923	1085720.929	1013339.533	950005.8125	844449.6111	800004.8947	760004.65	633337.2083	608003.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84288	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	12370913	6185456.5	4123637.667	3092728.25	2474182.6	2061818.833	1767273.286	1546364.125	1374545.889	1237091.3	1124628.455	1030909.417	951608.6923	883636.6429	824727.5333	773182.0625	687272.9444	651100.6842	618545.65	515454.7083	494836.52	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84289	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	3660192	1830096	1220064	915048	732038.4	610032	522884.5714	457524	406688	366019.2	332744.7273	305016	281553.2308	261442.2857	244012.8	228762	203344	192641.6842	183009.6	152508	146407.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84290	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	1341372	670686	447124	335343	268274.4	223562	191624.5714	167671.5	149041.3333	134137.2	121942.9091	111781	103182.4615	95812.28571	89424.8	83835.75	74520.66667	70598.52632	67068.6	55890.5	53654.88	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84291	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	1925212	962606	641737.3333	481303	385042.4	320868.6667	275030.2857	240651.5	213912.4444	192521.2	175019.2727	160434.3333	148093.2308	137515.1429	128347.4667	120325.75	106956.2222	101326.9474	96260.6	80217.16667	77008.48	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84292	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	1336171	668085.5	445390.3333	334042.75	267234.2	222695.1667	190881.5714	167021.375	148463.4444	133617.1	121470.0909	111347.5833	102782.3846	95440.78571	89078.06667	83510.6875	74231.72222	70324.78947	66808.55	55673.79167	53446.84	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84293	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	1206527	603263.5	402175.6667	301631.75	241305.4	201087.8333	172361	150815.875	134058.5556	120652.7	109684.2727	100543.9167	92809.76923	86180.5	80435.13333	75407.9375	67029.27778	63501.42105	60326.35	50271.95833	48261.08	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84294	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	1374005	687002.5	458001.6667	343501.25	274801	229000.8333	196286.4286	171750.625	152667.2222	137400.5	124909.5455	114500.4167	105692.6923	98143.21429	91600.33333	85875.3125	76333.61111	72316.05263	68700.25	57250.20833	54960.2	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84295	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	593439	296719.5	197813	148359.75	118687.8	98906.5	84777	74179.875	65937.66667	59343.9	53949	49453.25	45649.15385	42388.5	39562.6	37089.9375	32968.83333	31233.63158	29671.95	24726.625	23737.56	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84296	CHOYP_FAS2.1.1|m.41201	YIDANTVQSILR	YIDANTVQSILR	118006	59003	39335.33333	29501.5	23601.2	19667.66667	16858	14750.75	13111.77778	11800.6	10727.81818	9833.833333	9077.384615	8429	7867.066667	7375.375	6555.888889	6210.842105	5900.3	4916.916667	4720.24	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84297	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84298	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84299	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84300	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84301	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	90382	45191	30127.33333	22595.5	18076.4	15063.66667	12911.71429	11297.75	10042.44444	9038.2	8216.545455	7531.833333	6952.461538	6455.857143	6025.466667	5648.875	5021.222222	4756.947368	4519.1	3765.916667	3615.28	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84302	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84303	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84304	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84305	CHOYP_FAS2.1.1|m.41201	FSSVSNAPPPK	FSSVSNAPPPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84306	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	19410422	9705211	6470140.667	4852605.5	3882084.4	3235070.333	2772917.429	2426302.75	2156713.556	1941042.2	1764583.818	1617535.167	1493109.385	1386458.714	1294028.133	1213151.375	1078356.778	1021601.158	970521.1	808767.5833	776416.88	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84307	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	17273234	8636617	5757744.667	4318308.5	3454646.8	2878872.333	2467604.857	2159154.25	1919248.222	1727323.4	1570294	1439436.167	1328710.308	1233802.429	1151548.933	1079577.125	959624.1111	909117.5789	863661.7	719718.0833	690929.36	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84308	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	8095742	4047871	2698580.667	2023935.5	1619148.4	1349290.333	1156534.571	1011967.75	899526.8889	809574.2	735976.5455	674645.1667	622749.3846	578267.2857	539716.1333	505983.875	449763.4444	426091.6842	404787.1	337322.5833	323829.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84309	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	1934721	967360.5	644907	483680.25	386944.2	322453.5	276388.7143	241840.125	214969	193472.1	175883.7273	161226.75	148824.6923	138194.3571	128981.4	120920.0625	107484.5	101827.4211	96736.05	80613.375	77388.84	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84310	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	2543756	1271878	847918.6667	635939	508751.2	423959.3333	363393.7143	317969.5	282639.5556	254375.6	231250.5455	211979.6667	195673.5385	181696.8571	169583.7333	158984.75	141319.7778	133881.8947	127187.8	105989.8333	101750.24	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84311	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	1595574	797787	531858	398893.5	319114.8	265929	227939.1429	199446.75	177286	159557.4	145052.1818	132964.5	122736.4615	113969.5714	106371.6	99723.375	88643	83977.57895	79778.7	66482.25	63822.96	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84312	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	5343939	2671969.5	1781313	1335984.75	1068787.8	890656.5	763419.8571	667992.375	593771	534393.9	485812.6364	445328.25	411072.2308	381709.9286	356262.6	333996.1875	296885.5	281259.9474	267196.95	222664.125	213757.56	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84313	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	413256	206628	137752	103314	82651.2	68876	59036.57143	51657	45917.33333	41325.6	37568.72727	34438	31788.92308	29518.28571	27550.4	25828.5	22958.66667	21750.31579	20662.8	17219	16530.24	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84314	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	1291512	645756	430504	322878	258302.4	215252	184501.7143	161439	143501.3333	129151.2	117410.1818	107626	99347.07692	92250.85714	86100.8	80719.5	71750.66667	67974.31579	64575.6	53813	51660.48	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84315	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	733351	366675.5	244450.3333	183337.75	146670.2	122225.1667	104764.4286	91668.875	81483.44444	73335.1	66668.27273	61112.58333	56411.61538	52382.21429	48890.06667	45834.4375	40741.72222	38597.42105	36667.55	30556.29167	29334.04	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84316	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84317	CHOYP_FAS2.1.1|m.41201	IQYFTVGVVNGRPK	IQYFTVGVVNGRPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84318	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	24943574	12471787	8314524.667	6235893.5	4988714.8	4157262.333	3563367.714	3117946.75	2771508.222	2494357.4	2267597.636	2078631.167	1918736.462	1781683.857	1662904.933	1558973.375	1385754.111	1312819.684	1247178.7	1039315.583	997742.96	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84319	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	20204712	10102356	6734904	5051178	4040942.4	3367452	2886387.429	2525589	2244968	2020471.2	1836792	1683726	1554208.615	1443193.714	1346980.8	1262794.5	1122484	1063405.895	1010235.6	841863	808188.48	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84320	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	10263438	5131719	3421146	2565859.5	2052687.6	1710573	1466205.429	1282929.75	1140382	1026343.8	933039.8182	855286.5	789495.2308	733102.7143	684229.2	641464.875	570191	540180.9474	513171.9	427643.25	410537.52	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84321	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	2350390	1175195	783463.3333	587597.5	470078	391731.6667	335770	293798.75	261154.4444	235039	213671.8182	195865.8333	180799.2308	167885	156692.6667	146899.375	130577.2222	123704.7368	117519.5	97932.91667	94015.6	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84322	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	2205166	1102583	735055.3333	551291.5	441033.2	367527.6667	315023.7143	275645.75	245018.4444	220516.6	200469.6364	183763.8333	169628.1538	157511.8571	147011.0667	137822.875	122509.2222	116061.3684	110258.3	91881.91667	88206.64	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84323	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	227970	113985	75990	56992.5	45594	37995	32567.14286	28496.25	25330	22797	20724.54545	18997.5	17536.15385	16283.57143	15198	14248.125	12665	11998.42105	11398.5	9498.75	9118.8	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84324	CHOYP_FAS2.1.1|m.41201	YLLEWETPK	YLLEWETPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84325	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	15547032	7773516	5182344	3886758	3109406.4	2591172	2221004.571	1943379	1727448	1554703.2	1413366.545	1295586	1195925.538	1110502.286	1036468.8	971689.5	863724	818264.8421	777351.6	647793	621881.28	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84326	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	18145012	9072506	6048337.333	4536253	3629002.4	3024168.667	2592144.571	2268126.5	2016112.444	1814501.2	1649546.545	1512084.333	1395770.154	1296072.286	1209667.467	1134063.25	1008056.222	955000.6316	907250.6	756042.1667	725800.48	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84327	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	10175856	5087928	3391952	2543964	2035171.2	1695976	1453693.714	1271982	1130650.667	1017585.6	925077.8182	847988	782758.1538	726846.8571	678390.4	635991	565325.3333	535571.3684	508792.8	423994	407034.24	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84328	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	549295	274647.5	183098.3333	137323.75	109859	91549.16667	78470.71429	68661.875	61032.77778	54929.5	49935.90909	45774.58333	42253.46154	39235.35714	36619.66667	34330.9375	30516.38889	28910.26316	27464.75	22887.29167	21971.8	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84329	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	1308667	654333.5	436222.3333	327166.75	261733.4	218111.1667	186952.4286	163583.375	145407.4444	130866.7	118969.7273	109055.5833	100666.6923	93476.21429	87244.46667	81791.6875	72703.72222	68877.21053	65433.35	54527.79167	52346.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84330	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	1501668	750834	500556	375417	300333.6	250278	214524	187708.5	166852	150166.8	136515.2727	125139	115512.9231	107262	100111.2	93854.25	83426	79035.15789	75083.4	62569.5	60066.72	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84331	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	306106	153053	102035.3333	76526.5	61221.2	51017.66667	43729.42857	38263.25	34011.77778	30610.6	27827.81818	25508.83333	23546.61538	21864.71429	20407.06667	19131.625	17005.88889	16110.84211	15305.3	12754.41667	12244.24	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84332	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	1820128	910064	606709.3333	455032	364025.6	303354.6667	260018.2857	227516	202236.4444	182012.8	165466.1818	151677.3333	140009.8462	130009.1429	121341.8667	113758	101118.2222	95796.21053	91006.4	75838.66667	72805.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84333	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	3334558	1667279	1111519.333	833639.5	666911.6	555759.6667	476365.4286	416819.75	370506.4444	333455.8	303141.6364	277879.8333	256504.4615	238182.7143	222303.8667	208409.875	185253.2222	175503.0526	166727.9	138939.9167	133382.32	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84334	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84335	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	273217	136608.5	91072.33333	68304.25	54643.4	45536.16667	39031	34152.125	30357.44444	27321.7	24837.90909	22768.08333	21016.69231	19515.5	18214.46667	17076.0625	15178.72222	14379.84211	13660.85	11384.04167	10928.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84336	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	326489	163244.5	108829.6667	81622.25	65297.8	54414.83333	46641.28571	40811.125	36276.55556	32648.9	29680.81818	27207.41667	25114.53846	23320.64286	21765.93333	20405.5625	18138.27778	17183.63158	16324.45	13603.70833	13059.56	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84337	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	847601	423800.5	282533.6667	211900.25	169520.2	141266.8333	121085.8571	105950.125	94177.88889	84760.1	77054.63636	70633.41667	65200.07692	60542.92857	56506.73333	52975.0625	47088.94444	44610.57895	42380.05	35316.70833	33904.04	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84338	CHOYP_FAS2.1.1|m.41201	VQVLADQSPNNEYQFK	VQVLADQSPNNEYQFK	278507	139253.5	92835.66667	69626.75	55701.4	46417.83333	39786.71429	34813.375	30945.22222	27850.7	25318.81818	23208.91667	21423.61538	19893.35714	18567.13333	17406.6875	15472.61111	14658.26316	13925.35	11604.45833	11140.28	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84339	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	7475815	3737907.5	2491938.333	1868953.75	1495163	1245969.167	1067973.571	934476.875	830646.1111	747581.5	679619.5455	622984.5833	575062.6923	533986.7857	498387.6667	467238.4375	415323.0556	393463.9474	373790.75	311492.2917	299032.6	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84340	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	6321750	3160875	2107250	1580437.5	1264350	1053625	903107.1429	790218.75	702416.6667	632175	574704.5455	526812.5	486288.4615	451553.5714	421450	395109.375	351208.3333	332723.6842	316087.5	263406.25	252870	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84341	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	3109402	1554701	1036467.333	777350.5	621880.4	518233.6667	444200.2857	388675.25	345489.1111	310940.2	282672.9091	259116.8333	239184.7692	222100.1429	207293.4667	194337.625	172744.5556	163652.7368	155470.1	129558.4167	124376.08	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84342	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84343	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	491169	245584.5	163723	122792.25	98233.8	81861.5	70167	61396.125	54574.33333	49116.9	44651.72727	40930.75	37782.23077	35083.5	32744.6	30698.0625	27287.16667	25851	24558.45	20465.375	19646.76	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84344	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	737641	368820.5	245880.3333	184410.25	147528.2	122940.1667	105377.2857	92205.125	81960.11111	73764.1	67058.27273	61470.08333	56741.61538	52688.64286	49176.06667	46102.5625	40980.05556	38823.21053	36882.05	30735.04167	29505.64	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84345	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	72854	36427	24284.66667	18213.5	14570.8	12142.33333	10407.71429	9106.75	8094.888889	7285.4	6623.090909	6071.166667	5604.153846	5203.857143	4856.933333	4553.375	4047.444444	3834.421053	3642.7	3035.583333	2914.16	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84346	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	358342	179171	119447.3333	89585.5	71668.4	59723.66667	51191.71429	44792.75	39815.77778	35834.2	32576.54545	29861.83333	27564.76923	25595.85714	23889.46667	22396.375	19907.88889	18860.10526	17917.1	14930.91667	14333.68	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84347	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	52952	26476	17650.66667	13238	10590.4	8825.333333	7564.571429	6619	5883.555556	5295.2	4813.818182	4412.666667	4073.230769	3782.285714	3530.133333	3309.5	2941.777778	2786.947368	2647.6	2206.333333	2118.08	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84348	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84349	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84350	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84351	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	299128	149564	99709.33333	74782	59825.6	49854.66667	42732.57143	37391	33236.44444	29912.8	27193.45455	24927.33333	23009.84615	21366.28571	19941.86667	18695.5	16618.22222	15743.57895	14956.4	12463.66667	11965.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84352	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	342128	171064	114042.6667	85532	68425.6	57021.33333	48875.42857	42766	38014.22222	34212.8	31102.54545	28510.66667	26317.53846	24437.71429	22808.53333	21383	19007.11111	18006.73684	17106.4	14255.33333	13685.12	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84353	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	9803136	4901568	3267712	2450784	1960627.2	1633856	1400448	1225392	1089237.333	980313.6	891194.1818	816928	754087.3846	700224	653542.4	612696	544618.6667	515954.5263	490156.8	408464	392125.44	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84354	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	8141057	4070528.5	2713685.667	2035264.25	1628211.4	1356842.833	1163008.143	1017632.125	904561.8889	814105.7	740096.0909	678421.4167	626235.1538	581504.0714	542737.1333	508816.0625	452280.9444	428476.6842	407052.85	339210.7083	325642.28	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84355	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	4449162	2224581	1483054	1112290.5	889832.4	741527	635594.5714	556145.25	494351.3333	444916.2	404469.2727	370763.5	342243.2308	317797.2857	296610.8	278072.625	247175.6667	234166.4211	222458.1	185381.75	177966.48	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84356	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84357	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84358	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84359	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84360	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84361	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84362	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84363	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84364	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84365	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	427310	213655	142436.6667	106827.5	85462	71218.33333	61044.28571	53413.75	47478.88889	42731	38846.36364	35609.16667	32870	30522.14286	28487.33333	26706.875	23739.44444	22490	21365.5	17804.58333	17092.4	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84366	CHOYP_FAS2.1.1|m.41201	ANNVHGLSESSLYIFK	ANNVHGLSESSLYIFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84367	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84368	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84369	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84370	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84371	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84372	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84373	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84374	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84375	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84376	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84377	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84378	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84379	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84380	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84381	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
84382	CHOYP_FAS2.1.1|m.41201	SPTIENAEEAKPAPESPK	SPTIENAEEAKPAPESPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13596	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	Ncam1 Ncam	aging [GO:0007568]; axon guidance [GO:0007411]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; organ regeneration [GO:0031100]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]	GO:0005104; GO:0005886; GO:0007155; GO:0007411; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0016021; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048167; GO:0048666; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241
92226	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	3818130	1909065	1272710	954532.5	763626	636355	545447.1429	477266.25	424236.6667	381813	347102.7273	318177.5	293702.3077	272723.5714	254542	238633.125	212118.3333	200954.2105	190906.5	159088.75	152725.2	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92227	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92228	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	2105971	1052985.5	701990.3333	526492.75	421194.2	350995.1667	300853	263246.375	233996.7778	210597.1	191451.9091	175497.5833	161997.7692	150426.5	140398.0667	131623.1875	116998.3889	110840.5789	105298.55	87748.79167	84238.84	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92229	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	277904	138952	92634.66667	69476	55580.8	46317.33333	39700.57143	34738	30878.22222	27790.4	25264	23158.66667	21377.23077	19850.28571	18526.93333	17369	15439.11111	14626.52632	13895.2	11579.33333	11116.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92230	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	571170	285585	190390	142792.5	114234	95195	81595.71429	71396.25	63463.33333	57117	51924.54545	47597.5	43936.15385	40797.85714	38078	35698.125	31731.66667	30061.57895	28558.5	23798.75	22846.8	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92231	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	273863	136931.5	91287.66667	68465.75	54772.6	45643.83333	39123.28571	34232.875	30429.22222	27386.3	24896.63636	22821.91667	21066.38462	19561.64286	18257.53333	17116.4375	15214.61111	14413.84211	13693.15	11410.95833	10954.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92232	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	126396	63198	42132	31599	25279.2	21066	18056.57143	15799.5	14044	12639.6	11490.54545	10533	9722.769231	9028.285714	8426.4	7899.75	7022	6652.421053	6319.8	5266.5	5055.84	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92233	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	93548	46774	31182.66667	23387	18709.6	15591.33333	13364	11693.5	10394.22222	9354.8	8504.363636	7795.666667	7196	6682	6236.533333	5846.75	5197.111111	4923.578947	4677.4	3897.833333	3741.92	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92234	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	736643	368321.5	245547.6667	184160.75	147328.6	122773.8333	105234.7143	92080.375	81849.22222	73664.3	66967.54545	61386.91667	56664.84615	52617.35714	49109.53333	46040.1875	40924.61111	38770.68421	36832.15	30693.45833	29465.72	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92235	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92236	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	455927	227963.5	151975.6667	113981.75	91185.4	75987.83333	65132.42857	56990.875	50658.55556	45592.7	41447.90909	37993.91667	35071.30769	32566.21429	30395.13333	28495.4375	25329.27778	23996.15789	22796.35	18996.95833	18237.08	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92237	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	142915	71457.5	47638.33333	35728.75	28583	23819.16667	20416.42857	17864.375	15879.44444	14291.5	12992.27273	11909.58333	10993.46154	10208.21429	9527.666667	8932.1875	7939.722222	7521.842105	7145.75	5954.791667	5716.6	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92238	CHOYP_FYNA.1.1|m.63901	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	145020	72510	48340	36255	29004	24170	20717.14286	18127.5	16113.33333	14502	13183.63636	12085	11155.38462	10358.57143	9668	9063.75	8056.666667	7632.631579	7251	6042.5	5800.8	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92239	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	16791866	8395933	5597288.667	4197966.5	3358373.2	2798644.333	2398838	2098983.25	1865762.889	1679186.6	1526533.273	1399322.167	1291682	1199419	1119457.733	1049491.625	932881.4444	883782.4211	839593.3	699661.0833	671674.64	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92240	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	14983379	7491689.5	4994459.667	3745844.75	2996675.8	2497229.833	2140482.714	1872922.375	1664819.889	1498337.9	1362125.364	1248614.917	1152567.615	1070241.357	998891.9333	936461.1875	832409.9444	788598.8947	749168.95	624307.4583	599335.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92241	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	7375975	3687987.5	2458658.333	1843993.75	1475195	1229329.167	1053710.714	921996.875	819552.7778	737597.5	670543.1818	614664.5833	567382.6923	526855.3571	491731.6667	460998.4375	409776.3889	388209.2105	368798.75	307332.2917	295039	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92242	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	2526694	1263347	842231.3333	631673.5	505338.8	421115.6667	360956.2857	315836.75	280743.7778	252669.4	229699.4545	210557.8333	194361.0769	180478.1429	168446.2667	157918.375	140371.8889	132983.8947	126334.7	105278.9167	101067.76	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92243	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	6210586	3105293	2070195.333	1552646.5	1242117.2	1035097.667	887226.5714	776323.25	690065.1111	621058.6	564598.7273	517548.8333	477737.3846	443613.2857	414039.0667	388161.625	345032.5556	326872.9474	310529.3	258774.4167	248423.44	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92244	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92245	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	843923	421961.5	281307.6667	210980.75	168784.6	140653.8333	120560.4286	105490.375	93769.22222	84392.3	76720.27273	70326.91667	64917.15385	60280.21429	56261.53333	52745.1875	46884.61111	44417	42196.15	35163.45833	33756.92	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92246	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92247	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92248	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	1410185	705092.5	470061.6667	352546.25	282037	235030.8333	201455	176273.125	156687.2222	141018.5	128198.6364	117515.4167	108475.7692	100727.5	94012.33333	88136.5625	78343.61111	74220.26316	70509.25	58757.70833	56407.4	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92249	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92250	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92251	CHOYP_FYNA.1.1|m.63901	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92252	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	13409713	6704856.5	4469904.333	3352428.25	2681942.6	2234952.167	1915673.286	1676214.125	1489968.111	1340971.3	1219064.818	1117476.083	1031516.385	957836.6429	893980.8667	838107.0625	744984.0556	705774.3684	670485.65	558738.0417	536388.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92253	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	7865183	3932591.5	2621727.667	1966295.75	1573036.6	1310863.833	1123597.571	983147.875	873909.2222	786518.3	715016.6364	655431.9167	605014.0769	561798.7857	524345.5333	491573.9375	436954.6111	413957	393259.15	327715.9583	314607.32	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92254	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	4411136	2205568	1470378.667	1102784	882227.2	735189.3333	630162.2857	551392	490126.2222	441113.6	401012.3636	367594.6667	339318.1538	315081.1429	294075.7333	275696	245063.1111	232165.0526	220556.8	183797.3333	176445.44	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92255	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	1382207	691103.5	460735.6667	345551.75	276441.4	230367.8333	197458.1429	172775.875	153578.5556	138220.7	125655.1818	115183.9167	106323.6154	98729.07143	92147.13333	86387.9375	76789.27778	72747.73684	69110.35	57591.95833	55288.28	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92256	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	275672	137836	91890.66667	68918	55134.4	45945.33333	39381.71429	34459	30630.22222	27567.2	25061.09091	22972.66667	21205.53846	19690.85714	18378.13333	17229.5	15315.11111	14509.05263	13783.6	11486.33333	11026.88	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92257	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	3095413	1547706.5	1031804.333	773853.25	619082.6	515902.1667	442201.8571	386926.625	343934.7778	309541.3	281401.1818	257951.0833	238108.6923	221100.9286	206360.8667	193463.3125	171967.3889	162916.4737	154770.65	128975.5417	123816.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92258	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	2119336	1059668	706445.3333	529834	423867.2	353222.6667	302762.2857	264917	235481.7778	211933.6	192666.9091	176611.3333	163025.8462	151381.1429	141289.0667	132458.5	117740.8889	111544	105966.8	88305.66667	84773.44	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92259	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	99977	49988.5	33325.66667	24994.25	19995.4	16662.83333	14282.42857	12497.125	11108.55556	9997.7	9088.818182	8331.416667	7690.538462	7141.214286	6665.133333	6248.5625	5554.277778	5261.947368	4998.85	4165.708333	3999.08	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92260	CHOYP_FYNA.1.1|m.63901	LGAGQFGEVWR	LGAGQFGEVWR	555857	277928.5	185285.6667	138964.25	111171.4	92642.83333	79408.14286	69482.125	61761.88889	55585.7	50532.45455	46321.41667	42758.23077	39704.07143	37057.13333	34741.0625	30880.94444	29255.63158	27792.85	23160.70833	22234.28	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92261	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	3821325	1910662.5	1273775	955331.25	764265	636887.5	545903.5714	477665.625	424591.6667	382132.5	347393.1818	318443.75	293948.0769	272951.7857	254755	238832.8125	212295.8333	201122.3684	191066.25	159221.875	152853	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92262	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92263	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92264	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	274310	137155	91436.66667	68577.5	54862	45718.33333	39187.14286	34288.75	30478.88889	27431	24937.27273	22859.16667	21100.76923	19593.57143	18287.33333	17144.375	15239.44444	14437.36842	13715.5	11429.58333	10972.4	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92265	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92266	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	11713	5856.5	3904.333333	2928.25	2342.6	1952.166667	1673.285714	1464.125	1301.444444	1171.3	1064.818182	976.0833333	901	836.6428571	780.8666667	732.0625	650.7222222	616.4736842	585.65	488.0416667	468.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92267	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92268	CHOYP_FYNA.1.1|m.63901	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92269	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92270	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	7984054	3992027	2661351.333	1996013.5	1596810.8	1330675.667	1140579.143	998006.75	887117.1111	798405.4	725823.0909	665337.8333	614158	570289.5714	532270.2667	499003.375	443558.5556	420213.3684	399202.7	332668.9167	319362.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92271	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	1592849	796424.5	530949.6667	398212.25	318569.8	265474.8333	227549.8571	199106.125	176983.2222	159284.9	144804.4545	132737.4167	122526.8462	113774.9286	106189.9333	99553.0625	88491.61111	83834.15789	79642.45	66368.70833	63713.96	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92272	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	3177979	1588989.5	1059326.333	794494.75	635595.8	529663.1667	453997	397247.375	353108.7778	317797.9	288907.1818	264831.5833	244459.9231	226998.5	211865.2667	198623.6875	176554.3889	167262.0526	158898.95	132415.7917	127119.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92273	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	441002	220501	147000.6667	110250.5	88200.4	73500.33333	63000.28571	55125.25	49000.22222	44100.2	40091.09091	36750.16667	33923.23077	31500.14286	29400.13333	27562.625	24500.11111	23210.63158	22050.1	18375.08333	17640.08	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92274	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	723731	361865.5	241243.6667	180932.75	144746.2	120621.8333	103390.1429	90466.375	80414.55556	72373.1	65793.72727	60310.91667	55671.61538	51695.07143	48248.73333	45233.1875	40207.27778	38091.10526	36186.55	30155.45833	28949.24	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92275	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	134021	67010.5	44673.66667	33505.25	26804.2	22336.83333	19145.85714	16752.625	14891.22222	13402.1	12183.72727	11168.41667	10309.30769	9572.928571	8934.733333	8376.3125	7445.611111	7053.736842	6701.05	5584.208333	5360.84	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92276	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	169674	84837	56558	42418.5	33934.8	28279	24239.14286	21209.25	18852.66667	16967.4	15424.90909	14139.5	13051.84615	12119.57143	11311.6	10604.625	9426.333333	8930.210526	8483.7	7069.75	6786.96	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92277	CHOYP_FYNA.1.1|m.63901	WTAPEAALYGR	WTAPEAALYGR	144413	72206.5	48137.66667	36103.25	28882.6	24068.83333	20630.42857	18051.625	16045.88889	14441.3	13128.45455	12034.41667	11108.69231	10315.21429	9627.533333	9025.8125	8022.944444	7600.684211	7220.65	6017.208333	5776.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92278	CHOYP_FYNA.1.1|m.63901	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92279	CHOYP_FYNA.1.1|m.63901	EVLEQVDR	EVLEQVDR	4296180	2148090	1432060	1074045	859236	716030	613740	537022.5	477353.3333	429618	390561.8182	358015	330475.3846	306870	286412	268511.25	238676.6667	226114.7368	214809	179007.5	171847.2	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92280	CHOYP_FYNA.1.1|m.63901	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92281	CHOYP_FYNA.1.1|m.63901	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92282	CHOYP_FYNA.1.1|m.63901	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92283	CHOYP_FYNA.1.1|m.63901	EVLEQVDR	EVLEQVDR	172591	86295.5	57530.33333	43147.75	34518.2	28765.16667	24655.85714	21573.875	19176.77778	17259.1	15690.09091	14382.58333	13276.23077	12327.92857	11506.06667	10786.9375	9588.388889	9083.736842	8629.55	7191.291667	6903.64	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
92284	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92285	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92286	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92287	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	260157	130078.5	86719	65039.25	52031.4	43359.5	37165.28571	32519.625	28906.33333	26015.7	23650.63636	21679.75	20012.07692	18582.64286	17343.8	16259.8125	14453.16667	13692.47368	13007.85	10839.875	10406.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92288	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	373020	186510	124340	93255	74604	62170	53288.57143	46627.5	41446.66667	37302	33910.90909	31085	28693.84615	26644.28571	24868	23313.75	20723.33333	19632.63158	18651	15542.5	14920.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92289	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	535114	267557	178371.3333	133778.5	107022.8	89185.66667	76444.85714	66889.25	59457.11111	53511.4	48646.72727	44592.83333	41162.61538	38222.42857	35674.26667	33444.625	29728.55556	28163.89474	26755.7	22296.41667	21404.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92290	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	501176	250588	167058.6667	125294	100235.2	83529.33333	71596.57143	62647	55686.22222	50117.6	45561.45455	41764.66667	38552	35798.28571	33411.73333	31323.5	27843.11111	26377.68421	25058.8	20882.33333	20047.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92291	CHOYP_G6PD.1.2|m.38380	IYPTLWWLYR	IYPTLWWLYR	8150	4075	2716.666667	2037.5	1630	1358.333333	1164.285714	1018.75	905.5555556	815	740.9090909	679.1666667	626.9230769	582.1428571	543.3333333	509.375	452.7777778	428.9473684	407.5	339.5833333	326	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92292	CHOYP_G6PD.1.2|m.38380	TYFIGYAR	TYFIGYAR	15355960	7677980	5118653.333	3838990	3071192	2559326.667	2193708.571	1919495	1706217.778	1535596	1395996.364	1279663.333	1181227.692	1096854.286	1023730.667	959747.5	853108.8889	808208.4211	767798	639831.6667	614238.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92293	CHOYP_G6PD.1.2|m.38380	TYFIGYAR	TYFIGYAR	7525460	3762730	2508486.667	1881365	1505092	1254243.333	1075065.714	940682.5	836162.2222	752546	684132.7273	627121.6667	578881.5385	537532.8571	501697.3333	470341.25	418081.1111	396076.8421	376273	313560.8333	301018.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92294	CHOYP_G6PD.1.2|m.38380	TYFIGYAR	TYFIGYAR	2259418	1129709	753139.3333	564854.5	451883.6	376569.6667	322774	282427.25	251046.4444	225941.8	205401.6364	188284.8333	173801.3846	161387	150627.8667	141213.625	125523.2222	118916.7368	112970.9	94142.41667	90376.72	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92295	CHOYP_G6PD.1.2|m.38380	TYFIGYAR	TYFIGYAR	2606764	1303382	868921.3333	651691	521352.8	434460.6667	372394.8571	325845.5	289640.4444	260676.4	236978.5455	217230.3333	200520.3077	186197.4286	173784.2667	162922.75	144820.2222	137198.1053	130338.2	108615.1667	104270.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92296	CHOYP_G6PD.1.2|m.38380	TYFIGYAR	TYFIGYAR	2935247	1467623.5	978415.6667	733811.75	587049.4	489207.8333	419321	366905.875	326138.5556	293524.7	266840.6364	244603.9167	225788.2308	209660.5	195683.1333	183452.9375	163069.2778	154486.6842	146762.35	122301.9583	117409.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92297	CHOYP_G6PD.1.2|m.38380	TYFIGYAR	TYFIGYAR	58211	29105.5	19403.66667	14552.75	11642.2	9701.833333	8315.857143	7276.375	6467.888889	5821.1	5291.909091	4850.916667	4477.769231	4157.928571	3880.733333	3638.1875	3233.944444	3063.736842	2910.55	2425.458333	2328.44	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92298	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92299	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	14468781	7234390.5	4822927	3617195.25	2893756.2	2411463.5	2066968.714	1808597.625	1607642.333	1446878.1	1315343.727	1205731.75	1112983.154	1033484.357	964585.4	904298.8125	803821.1667	761514.7895	723439.05	602865.875	578751.24	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92300	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	7143648	3571824	2381216	1785912	1428729.6	1190608	1020521.143	892956	793738.6667	714364.8	649422.5455	595304	549511.3846	510260.5714	476243.2	446478	396869.3333	375981.4737	357182.4	297652	285745.92	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92301	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	100424	50212	33474.66667	25106	20084.8	16737.33333	14346.28571	12553	11158.22222	10042.4	9129.454545	8368.666667	7724.923077	7173.142857	6694.933333	6276.5	5579.111111	5285.473684	5021.2	4184.333333	4016.96	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92302	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	615279	307639.5	205093	153819.75	123055.8	102546.5	87897	76909.875	68364.33333	61527.9	55934.45455	51273.25	47329.15385	43948.5	41018.6	38454.9375	34182.16667	32383.10526	30763.95	25636.625	24611.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92303	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	1955784	977892	651928	488946	391156.8	325964	279397.7143	244473	217309.3333	195578.4	177798.5455	162982	150444.9231	139698.8571	130385.6	122236.5	108654.6667	102936	97789.2	81491	78231.36	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92304	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	1396722	698361	465574	349180.5	279344.4	232787	199531.7143	174590.25	155191.3333	139672.2	126974.7273	116393.5	107440.1538	99765.85714	93114.8	87295.125	77595.66667	73511.68421	69836.1	58196.75	55868.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92305	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	356375	178187.5	118791.6667	89093.75	71275	59395.83333	50910.71429	44546.875	39597.22222	35637.5	32397.72727	29697.91667	27413.46154	25455.35714	23758.33333	22273.4375	19798.61111	18756.57895	17818.75	14848.95833	14255	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92306	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	177744	88872	59248	44436	35548.8	29624	25392	22218	19749.33333	17774.4	16158.54545	14812	13672.61538	12696	11849.6	11109	9874.666667	9354.947368	8887.2	7406	7109.76	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92307	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	210800	105400	70266.66667	52700	42160	35133.33333	30114.28571	26350	23422.22222	21080	19163.63636	17566.66667	16215.38462	15057.14286	14053.33333	13175	11711.11111	11094.73684	10540	8783.333333	8432	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92308	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	789528	394764	263176	197382	157905.6	131588	112789.7143	98691	87725.33333	78952.8	71775.27273	65794	60732.92308	56394.85714	52635.2	49345.5	43862.66667	41554.10526	39476.4	32897	31581.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92309	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	1698179	849089.5	566059.6667	424544.75	339635.8	283029.8333	242597	212272.375	188686.5556	169817.9	154379.9091	141514.9167	130629.1538	121298.5	113211.9333	106136.1875	94343.27778	89377.84211	84908.95	70757.45833	67927.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92310	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92311	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	530404	265202	176801.3333	132601	106080.8	88400.66667	75772	66300.5	58933.77778	53040.4	48218.54545	44200.33333	40800.30769	37886	35360.26667	33150.25	29466.88889	27916	26520.2	22100.16667	21216.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92312	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92313	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	11382051	5691025.5	3794017	2845512.75	2276410.2	1897008.5	1626007.286	1422756.375	1264672.333	1138205.1	1034731.909	948504.25	875542.3846	813003.6429	758803.4	711378.1875	632336.1667	599055.3158	569102.55	474252.125	455282.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92314	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	12212910	6106455	4070970	3053227.5	2442582	2035485	1744701.429	1526613.75	1356990	1221291	1110264.545	1017742.5	939454.6154	872350.7143	814194	763306.875	678495	642784.7368	610645.5	508871.25	488516.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92315	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	6954289	3477144.5	2318096.333	1738572.25	1390857.8	1159048.167	993469.8571	869286.125	772698.7778	695428.9	632208.0909	579524.0833	534945.3077	496734.9286	463619.2667	434643.0625	386349.3889	366015.2105	347714.45	289762.0417	278171.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92316	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92317	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	46861	23430.5	15620.33333	11715.25	9372.2	7810.166667	6694.428571	5857.625	5206.777778	4686.1	4260.090909	3905.083333	3604.692308	3347.214286	3124.066667	2928.8125	2603.388889	2466.368421	2343.05	1952.541667	1874.44	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92318	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	557462	278731	185820.6667	139365.5	111492.4	92910.33333	79637.42857	69682.75	61940.22222	55746.2	50678.36364	46455.16667	42881.69231	39818.71429	37164.13333	34841.375	30970.11111	29340.10526	27873.1	23227.58333	22298.48	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92319	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	336813	168406.5	112271	84203.25	67362.6	56135.5	48116.14286	42101.625	37423.66667	33681.3	30619.36364	28067.75	25908.69231	24058.07143	22454.2	21050.8125	18711.83333	17727	16840.65	14033.875	13472.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92320	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	113626	56813	37875.33333	28406.5	22725.2	18937.66667	16232.28571	14203.25	12625.11111	11362.6	10329.63636	9468.833333	8740.461538	8116.142857	7575.066667	7101.625	6312.555556	5980.315789	5681.3	4734.416667	4545.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92321	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	185069	92534.5	61689.66667	46267.25	37013.8	30844.83333	26438.42857	23133.625	20563.22222	18506.9	16824.45455	15422.41667	14236.07692	13219.21429	12337.93333	11566.8125	10281.61111	9740.473684	9253.45	7711.208333	7402.76	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92322	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92323	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	471246	235623	157082	117811.5	94249.2	78541	67320.85714	58905.75	52360.66667	47124.6	42840.54545	39270.5	36249.69231	33660.42857	31416.4	29452.875	26180.33333	24802.42105	23562.3	19635.25	18849.84	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92324	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	681212	340606	227070.6667	170303	136242.4	113535.3333	97316	85151.5	75690.22222	68121.2	61928.36364	56767.66667	52400.92308	48658	45414.13333	42575.75	37845.11111	35853.26316	34060.6	28383.83333	27248.48	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92325	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	46141	23070.5	15380.33333	11535.25	9228.2	7690.166667	6591.571429	5767.625	5126.777778	4614.1	4194.636364	3845.083333	3549.307692	3295.785714	3076.066667	2883.8125	2563.388889	2428.473684	2307.05	1922.541667	1845.64	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92326	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	308267	154133.5	102755.6667	77066.75	61653.4	51377.83333	44038.14286	38533.375	34251.88889	30826.7	28024.27273	25688.91667	23712.84615	22019.07143	20551.13333	19266.6875	17125.94444	16224.57895	15413.35	12844.45833	12330.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92327	CHOYP_G6PD.1.2|m.38380	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92328	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	14080745	7040372.5	4693581.667	3520186.25	2816149	2346790.833	2011535	1760093.125	1564527.222	1408074.5	1280067.727	1173395.417	1083134.231	1005767.5	938716.3333	880046.5625	782263.6111	741091.8421	704037.25	586697.7083	563229.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92329	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	7294497	3647248.5	2431499	1823624.25	1458899.4	1215749.5	1042071	911812.125	810499.6667	729449.7	663136.0909	607874.75	561115.1538	521035.5	486299.8	455906.0625	405249.8333	383920.8947	364724.85	303937.375	291779.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92330	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92331	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92332	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	349830	174915	116610	87457.5	69966	58305	49975.71429	43728.75	38870	34983	31802.72727	29152.5	26910	24987.85714	23322	21864.375	19435	18412.10526	17491.5	14576.25	13993.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92333	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	2156135	1078067.5	718711.6667	539033.75	431227	359355.8333	308019.2857	269516.875	239570.5556	215613.5	196012.2727	179677.9167	165856.5385	154009.6429	143742.3333	134758.4375	119785.2778	113480.7895	107806.75	89838.95833	86245.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92334	CHOYP_G6PD.1.2|m.38380	IVVEKPFGK	IVVEKPFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92335	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92336	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92337	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92338	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	4165688	2082844	1388562.667	1041422	833137.6	694281.3333	595098.2857	520711	462854.2222	416568.8	378698.9091	347140.6667	320437.5385	297549.1429	277712.5333	260355.5	231427.1111	219246.7368	208284.4	173570.3333	166627.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92339	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	3890426	1945213	1296808.667	972606.5	778085.2	648404.3333	555775.1429	486303.25	432269.5556	389042.6	353675.0909	324202.1667	299263.5385	277887.5714	259361.7333	243151.625	216134.7778	204759.2632	194521.3	162101.0833	155617.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92340	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	1274710	637355	424903.3333	318677.5	254942	212451.6667	182101.4286	159338.75	141634.4444	127471	115882.7273	106225.8333	98054.61538	91050.71429	84980.66667	79669.375	70817.22222	67090	63735.5	53112.91667	50988.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92341	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	1554471	777235.5	518157	388617.75	310894.2	259078.5	222067.2857	194308.875	172719	155447.1	141315.5455	129539.25	119574.6923	111033.6429	103631.4	97154.4375	86359.5	81814.26316	77723.55	64769.625	62178.84	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92342	CHOYP_G6PD.1.2|m.38380	EMVQNLMVLR	EMVQNLMVLR	851688	425844	283896	212922	170337.6	141948	121669.7143	106461	94632	85168.8	77426.18182	70974	65514.46154	60834.85714	56779.2	53230.5	47316	44825.68421	42584.4	35487	34067.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92343	CHOYP_G6PD.1.2|m.38380	IFSPVWNR	IFSPVWNR	15551430	7775715	5183810	3887857.5	3110286	2591905	2221632.857	1943928.75	1727936.667	1555143	1413766.364	1295952.5	1196263.846	1110816.429	1036762	971964.375	863968.3333	818496.3158	777571.5	647976.25	622057.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92344	CHOYP_G6PD.1.2|m.38380	IFSPVWNR	IFSPVWNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92345	CHOYP_G6PD.1.2|m.38380	IFSPVWNR	IFSPVWNR	3457825	1728912.5	1152608.333	864456.25	691565	576304.1667	493975	432228.125	384202.7778	345782.5	314347.7273	288152.0833	265986.5385	246987.5	230521.6667	216114.0625	192101.3889	181990.7895	172891.25	144076.0417	138313	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92346	CHOYP_G6PD.1.2|m.38380	IFSPVWNR	IFSPVWNR	2112647	1056323.5	704215.6667	528161.75	422529.4	352107.8333	301806.7143	264080.875	234738.5556	211264.7	192058.8182	176053.9167	162511.3077	150903.3571	140843.1333	132040.4375	117369.2778	111191.9474	105632.35	88026.95833	84505.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92347	CHOYP_G6PD.1.2|m.38380	IFSPVWNR	IFSPVWNR	914962	457481	304987.3333	228740.5	182992.4	152493.6667	130708.8571	114370.25	101662.4444	91496.2	83178.36364	76246.83333	70381.69231	65354.42857	60997.46667	57185.125	50831.22222	48155.89474	45748.1	38123.41667	36598.48	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92348	CHOYP_G6PD.1.2|m.38380	IFSPVWNR	IFSPVWNR	1081605	540802.5	360535	270401.25	216321	180267.5	154515	135200.625	120178.3333	108160.5	98327.72727	90133.75	83200.38462	77257.5	72107	67600.3125	60089.16667	56926.57895	54080.25	45066.875	43264.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92349	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	7862078	3931039	2620692.667	1965519.5	1572415.6	1310346.333	1123154	982759.75	873564.2222	786207.8	714734.3636	655173.1667	604775.2308	561577	524138.5333	491379.875	436782.1111	413793.5789	393103.9	327586.5833	314483.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92350	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	6234665	3117332.5	2078221.667	1558666.25	1246933	1039110.833	890666.4286	779333.125	692740.5556	623466.5	566787.7273	519555.4167	479589.6154	445333.2143	415644.3333	389666.5625	346370.2778	328140.2632	311733.25	259777.7083	249386.6	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92351	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92352	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	1069795	534897.5	356598.3333	267448.75	213959	178299.1667	152827.8571	133724.375	118866.1111	106979.5	97254.09091	89149.58333	82291.92308	76413.92857	71319.66667	66862.1875	59433.05556	56305	53489.75	44574.79167	42791.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92353	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	1828847	914423.5	609615.6667	457211.75	365769.4	304807.8333	261263.8571	228605.875	203205.2222	182884.7	166258.8182	152403.9167	140680.5385	130631.9286	121923.1333	114302.9375	101602.6111	96255.10526	91442.35	76201.95833	73153.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92354	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	781757	390878.5	260585.6667	195439.25	156351.4	130292.8333	111679.5714	97719.625	86861.88889	78175.7	71068.81818	65146.41667	60135.15385	55839.78571	52117.13333	48859.8125	43430.94444	41145.10526	39087.85	32573.20833	31270.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92355	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	763582	381791	254527.3333	190895.5	152716.4	127263.6667	109083.1429	95447.75	84842.44444	76358.2	69416.54545	63631.83333	58737.07692	54541.57143	50905.46667	47723.875	42421.22222	40188.52632	38179.1	31815.91667	30543.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92356	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	525439	262719.5	175146.3333	131359.75	105087.8	87573.16667	75062.71429	65679.875	58382.11111	52543.9	47767.18182	43786.58333	40418.38462	37531.35714	35029.26667	32839.9375	29191.05556	27654.68421	26271.95	21893.29167	21017.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92357	CHOYP_G6PD.1.2|m.38380	GGYFDEFGIIR	GGYFDEFGIIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92358	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	4059576	2029788	1353192	1014894	811915.2	676596	579939.4286	507447	451064	405957.6	369052.3636	338298	312275.0769	289969.7143	270638.4	253723.5	225532	213661.8947	202978.8	169149	162383.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92359	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	1863320	931660	621106.6667	465830	372664	310553.3333	266188.5714	232915	207035.5556	186332	169392.7273	155276.6667	143332.3077	133094.2857	124221.3333	116457.5	103517.7778	98069.47368	93166	77638.33333	74532.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92360	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	416455	208227.5	138818.3333	104113.75	83291	69409.16667	59493.57143	52056.875	46272.77778	41645.5	37859.54545	34704.58333	32035	29746.78571	27763.66667	26028.4375	23136.38889	21918.68421	20822.75	17352.29167	16658.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92361	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	182422	91211	60807.33333	45605.5	36484.4	30403.66667	26060.28571	22802.75	20269.11111	18242.2	16583.81818	15201.83333	14032.46154	13030.14286	12161.46667	11401.375	10134.55556	9601.157895	9121.1	7600.916667	7296.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92362	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	399558	199779	133186	99889.5	79911.6	66593	57079.71429	49944.75	44395.33333	39955.8	36323.45455	33296.5	30735.23077	28539.85714	26637.2	24972.375	22197.66667	21029.36842	19977.9	16648.25	15982.32	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92363	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	309590	154795	103196.6667	77397.5	61918	51598.33333	44227.14286	38698.75	34398.88889	30959	28144.54545	25799.16667	23814.61538	22113.57143	20639.33333	19349.375	17199.44444	16294.21053	15479.5	12899.58333	12383.6	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92364	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	896501	448250.5	298833.6667	224125.25	179300.2	149416.8333	128071.5714	112062.625	99611.22222	89650.1	81500.09091	74708.41667	68961.61538	64035.78571	59766.73333	56031.3125	49805.61111	47184.26316	44825.05	37354.20833	35860.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92365	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92366	CHOYP_G6PD.1.2|m.38380	QGYLDDPTVPK	QGYLDDPTVPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92367	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92368	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	5953342	2976671	1984447.333	1488335.5	1190668.4	992223.6667	850477.4286	744167.75	661482.4444	595334.2	541212.9091	496111.8333	457949.3846	425238.7143	396889.4667	372083.875	330741.2222	313333.7895	297667.1	248055.9167	238133.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92369	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	3272811	1636405.5	1090937	818202.75	654562.2	545468.5	467544.4286	409101.375	363645.6667	327281.1	297528.2727	272734.25	251754.6923	233772.2143	218187.4	204550.6875	181822.8333	172253.2105	163640.55	136367.125	130912.44	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92370	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92371	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92372	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92373	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92374	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92375	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92376	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92377	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92378	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92379	CHOYP_G6PD.1.2|m.38380	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92380	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92381	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92382	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92383	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	67217	33608.5	22405.66667	16804.25	13443.4	11202.83333	9602.428571	8402.125	7468.555556	6721.7	6110.636364	5601.416667	5170.538462	4801.214286	4481.133333	4201.0625	3734.277778	3537.736842	3360.85	2800.708333	2688.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92384	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	827905	413952.5	275968.3333	206976.25	165581	137984.1667	118272.1429	103488.125	91989.44444	82790.5	75264.09091	68992.08333	63685	59136.07143	55193.66667	51744.0625	45994.72222	43573.94737	41395.25	34496.04167	33116.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92385	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92386	CHOYP_G6PD.1.2|m.38380	WEGVPFILR	WEGVPFILR	15839	7919.5	5279.666667	3959.75	3167.8	2639.833333	2262.714286	1979.875	1759.888889	1583.9	1439.909091	1319.916667	1218.384615	1131.357143	1055.933333	989.9375	879.9444444	833.6315789	791.95	659.9583333	633.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92387	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	14124353	7062176.5	4708117.667	3531088.25	2824870.6	2354058.833	2017764.714	1765544.125	1569372.556	1412435.3	1284032.091	1177029.417	1086488.692	1008882.357	941623.5333	882772.0625	784686.2778	743387	706217.65	588514.7083	564974.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92388	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	7641167	3820583.5	2547055.667	1910291.75	1528233.4	1273527.833	1091595.286	955145.875	849018.5556	764116.7	694651.5455	636763.9167	587782.0769	545797.6429	509411.1333	477572.9375	424509.2778	402166.6842	382058.35	318381.9583	305646.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92389	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	3889905	1944952.5	1296635	972476.25	777981	648317.5	555700.7143	486238.125	432211.6667	388990.5	353627.7273	324158.75	299223.4615	277850.3571	259327	243119.0625	216105.8333	204731.8421	194495.25	162079.375	155596.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92390	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92391	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92392	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	63395	31697.5	21131.66667	15848.75	12679	10565.83333	9056.428571	7924.375	7043.888889	6339.5	5763.181818	5282.916667	4876.538462	4528.214286	4226.333333	3962.1875	3521.944444	3336.578947	3169.75	2641.458333	2535.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92393	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	1037720	518860	345906.6667	259430	207544	172953.3333	148245.7143	129715	115302.2222	103772	94338.18182	86476.66667	79824.61538	74122.85714	69181.33333	64857.5	57651.11111	54616.84211	51886	43238.33333	41508.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92394	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	2155820	1077910	718606.6667	538955	431164	359303.3333	307974.2857	269477.5	239535.5556	215582	195983.6364	179651.6667	165832.3077	153987.1429	143721.3333	134738.75	119767.7778	113464.2105	107791	89825.83333	86232.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92395	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92396	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92397	CHOYP_G6PD.1.2|m.38380	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92398	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	8745956	4372978	2915318.667	2186489	1749191.2	1457659.333	1249422.286	1093244.5	971772.8889	874595.6	795086.9091	728829.6667	672765.8462	624711.1429	583063.7333	546622.25	485886.4444	460313.4737	437297.8	364414.8333	349838.24	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92399	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	7319303	3659651.5	2439767.667	1829825.75	1463860.6	1219883.833	1045614.714	914912.875	813255.8889	731930.3	665391.1818	609941.9167	563023.3077	522807.3571	487953.5333	457456.4375	406627.9444	385226.4737	365965.15	304970.9583	292772.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92400	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92401	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92402	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	175378	87689	58459.33333	43844.5	35075.6	29229.66667	25054	21922.25	19486.44444	17537.8	15943.45455	14614.83333	13490.61538	12527	11691.86667	10961.125	9743.222222	9230.421053	8768.9	7307.416667	7015.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92403	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	108749	54374.5	36249.66667	27187.25	21749.8	18124.83333	15535.57143	13593.625	12083.22222	10874.9	9886.272727	9062.416667	8365.307692	7767.785714	7249.933333	6796.8125	6041.611111	5723.631579	5437.45	4531.208333	4349.96	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92404	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	106316	53158	35438.66667	26579	21263.2	17719.33333	15188	13289.5	11812.88889	10631.6	9665.090909	8859.666667	8178.153846	7594	7087.733333	6644.75	5906.444444	5595.578947	5315.8	4429.833333	4252.64	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92405	CHOYP_G6PD.1.2|m.38380	VQPDEAVYLK	VQPDEAVYLK	588577	294288.5	196192.3333	147144.25	117715.4	98096.16667	84082.42857	73572.125	65397.44444	58857.7	53507	49048.08333	45275.15385	42041.21429	39238.46667	36786.0625	32698.72222	30977.73684	29428.85	24524.04167	23543.08	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92406	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92407	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92408	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92409	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92410	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92411	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92412	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92413	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92414	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92415	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92416	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92417	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92418	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92419	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92420	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92421	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92422	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92423	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92424	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92425	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	9007	4503.5	3002.333333	2251.75	1801.4	1501.166667	1286.714286	1125.875	1000.777778	900.7	818.8181818	750.5833333	692.8461538	643.3571429	600.4666667	562.9375	500.3888889	474.0526316	450.35	375.2916667	360.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92426	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	8984	4492	2994.666667	2246	1796.8	1497.333333	1283.428571	1123	998.2222222	898.4	816.7272727	748.6666667	691.0769231	641.7142857	598.9333333	561.5	499.1111111	472.8421053	449.2	374.3333333	359.36	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92427	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92428	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92429	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92430	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92431	CHOYP_G6PD.1.2|m.38380	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92432	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	11938731	5969365.5	3979577	2984682.75	2387746.2	1989788.5	1705533	1492341.375	1326525.667	1193873.1	1085339.182	994894.25	918363.9231	852766.5	795915.4	746170.6875	663262.8333	628354.2632	596936.55	497447.125	477549.24	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92433	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	21114666	10557333	7038222	5278666.5	4222933.2	3519111	3016380.857	2639333.25	2346074	2111466.6	1919515.091	1759555.5	1624205.077	1508190.429	1407644.4	1319666.625	1173037	1111298.211	1055733.3	879777.75	844586.64	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92434	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	2706879	1353439.5	902293	676719.75	541375.8	451146.5	386697	338359.875	300764.3333	270687.9	246079.9091	225573.25	208221.4615	193348.5	180458.6	169179.9375	150382.1667	142467.3158	135343.95	112786.625	108275.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92435	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	1886370	943185	628790	471592.5	377274	314395	269481.4286	235796.25	209596.6667	188637	171488.1818	157197.5	145105.3846	134740.7143	125758	117898.125	104798.3333	99282.63158	94318.5	78598.75	75454.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92436	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	4430034	2215017	1476678	1107508.5	886006.8	738339	632862	553754.25	492226	443003.4	402730.3636	369169.5	340771.8462	316431	295335.6	276877.125	246113	233159.6842	221501.7	184584.75	177201.36	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92437	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	1732417	866208.5	577472.3333	433104.25	346483.4	288736.1667	247488.1429	216552.125	192490.7778	173241.7	157492.4545	144368.0833	133262.8462	123744.0714	115494.4667	108276.0625	96245.38889	91179.84211	86620.85	72184.04167	69296.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92438	CHOYP_G6PD.1.2|m.38380	SDELYEAWR	SDELYEAWR	904047	452023.5	301349	226011.75	180809.4	150674.5	129149.5714	113005.875	100449.6667	90404.7	82186.09091	75337.25	69542.07692	64574.78571	60269.8	56502.9375	50224.83333	47581.42105	45202.35	37668.625	36161.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92439	CHOYP_G6PD.1.2|m.38380	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92440	CHOYP_G6PD.1.2|m.38380	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92441	CHOYP_G6PD.1.2|m.38380	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92442	CHOYP_G6PD.1.2|m.38380	IFTPLLHK	IFTPLLHK	901227	450613.5	300409	225306.75	180245.4	150204.5	128746.7143	112653.375	100136.3333	90122.7	81929.72727	75102.25	69325.15385	64373.35714	60081.8	56326.6875	50068.16667	47433	45061.35	37551.125	36049.08	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92443	CHOYP_G6PD.1.2|m.38380	IFTPLLHK	IFTPLLHK	75818	37909	25272.66667	18954.5	15163.6	12636.33333	10831.14286	9477.25	8424.222222	7581.8	6892.545455	6318.166667	5832.153846	5415.571429	5054.533333	4738.625	4212.111111	3990.421053	3790.9	3159.083333	3032.72	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92444	CHOYP_G6PD.1.2|m.38380	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92445	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92446	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92447	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92448	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	260157	130078.5	86719	65039.25	52031.4	43359.5	37165.28571	32519.625	28906.33333	26015.7	23650.63636	21679.75	20012.07692	18582.64286	17343.8	16259.8125	14453.16667	13692.47368	13007.85	10839.875	10406.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92449	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	373020	186510	124340	93255	74604	62170	53288.57143	46627.5	41446.66667	37302	33910.90909	31085	28693.84615	26644.28571	24868	23313.75	20723.33333	19632.63158	18651	15542.5	14920.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92450	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	535114	267557	178371.3333	133778.5	107022.8	89185.66667	76444.85714	66889.25	59457.11111	53511.4	48646.72727	44592.83333	41162.61538	38222.42857	35674.26667	33444.625	29728.55556	28163.89474	26755.7	22296.41667	21404.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92451	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	501176	250588	167058.6667	125294	100235.2	83529.33333	71596.57143	62647	55686.22222	50117.6	45561.45455	41764.66667	38552	35798.28571	33411.73333	31323.5	27843.11111	26377.68421	25058.8	20882.33333	20047.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92452	CHOYP_G6PD.2.2|m.46923	IYPTLWWLYR	IYPTLWWLYR	8150	4075	2716.666667	2037.5	1630	1358.333333	1164.285714	1018.75	905.5555556	815	740.9090909	679.1666667	626.9230769	582.1428571	543.3333333	509.375	452.7777778	428.9473684	407.5	339.5833333	326	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92453	CHOYP_G6PD.2.2|m.46923	TYFIGYAR	TYFIGYAR	15355960	7677980	5118653.333	3838990	3071192	2559326.667	2193708.571	1919495	1706217.778	1535596	1395996.364	1279663.333	1181227.692	1096854.286	1023730.667	959747.5	853108.8889	808208.4211	767798	639831.6667	614238.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92454	CHOYP_G6PD.2.2|m.46923	TYFIGYAR	TYFIGYAR	7525460	3762730	2508486.667	1881365	1505092	1254243.333	1075065.714	940682.5	836162.2222	752546	684132.7273	627121.6667	578881.5385	537532.8571	501697.3333	470341.25	418081.1111	396076.8421	376273	313560.8333	301018.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92455	CHOYP_G6PD.2.2|m.46923	TYFIGYAR	TYFIGYAR	2259418	1129709	753139.3333	564854.5	451883.6	376569.6667	322774	282427.25	251046.4444	225941.8	205401.6364	188284.8333	173801.3846	161387	150627.8667	141213.625	125523.2222	118916.7368	112970.9	94142.41667	90376.72	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92456	CHOYP_G6PD.2.2|m.46923	TYFIGYAR	TYFIGYAR	2606764	1303382	868921.3333	651691	521352.8	434460.6667	372394.8571	325845.5	289640.4444	260676.4	236978.5455	217230.3333	200520.3077	186197.4286	173784.2667	162922.75	144820.2222	137198.1053	130338.2	108615.1667	104270.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92457	CHOYP_G6PD.2.2|m.46923	TYFIGYAR	TYFIGYAR	2935247	1467623.5	978415.6667	733811.75	587049.4	489207.8333	419321	366905.875	326138.5556	293524.7	266840.6364	244603.9167	225788.2308	209660.5	195683.1333	183452.9375	163069.2778	154486.6842	146762.35	122301.9583	117409.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92458	CHOYP_G6PD.2.2|m.46923	TYFIGYAR	TYFIGYAR	58211	29105.5	19403.66667	14552.75	11642.2	9701.833333	8315.857143	7276.375	6467.888889	5821.1	5291.909091	4850.916667	4477.769231	4157.928571	3880.733333	3638.1875	3233.944444	3063.736842	2910.55	2425.458333	2328.44	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92459	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92460	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	14468781	7234390.5	4822927	3617195.25	2893756.2	2411463.5	2066968.714	1808597.625	1607642.333	1446878.1	1315343.727	1205731.75	1112983.154	1033484.357	964585.4	904298.8125	803821.1667	761514.7895	723439.05	602865.875	578751.24	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92461	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	7143648	3571824	2381216	1785912	1428729.6	1190608	1020521.143	892956	793738.6667	714364.8	649422.5455	595304	549511.3846	510260.5714	476243.2	446478	396869.3333	375981.4737	357182.4	297652	285745.92	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92462	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	100424	50212	33474.66667	25106	20084.8	16737.33333	14346.28571	12553	11158.22222	10042.4	9129.454545	8368.666667	7724.923077	7173.142857	6694.933333	6276.5	5579.111111	5285.473684	5021.2	4184.333333	4016.96	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92463	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	615279	307639.5	205093	153819.75	123055.8	102546.5	87897	76909.875	68364.33333	61527.9	55934.45455	51273.25	47329.15385	43948.5	41018.6	38454.9375	34182.16667	32383.10526	30763.95	25636.625	24611.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92464	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	1955784	977892	651928	488946	391156.8	325964	279397.7143	244473	217309.3333	195578.4	177798.5455	162982	150444.9231	139698.8571	130385.6	122236.5	108654.6667	102936	97789.2	81491	78231.36	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92465	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	1396722	698361	465574	349180.5	279344.4	232787	199531.7143	174590.25	155191.3333	139672.2	126974.7273	116393.5	107440.1538	99765.85714	93114.8	87295.125	77595.66667	73511.68421	69836.1	58196.75	55868.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92466	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	356375	178187.5	118791.6667	89093.75	71275	59395.83333	50910.71429	44546.875	39597.22222	35637.5	32397.72727	29697.91667	27413.46154	25455.35714	23758.33333	22273.4375	19798.61111	18756.57895	17818.75	14848.95833	14255	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92467	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	177744	88872	59248	44436	35548.8	29624	25392	22218	19749.33333	17774.4	16158.54545	14812	13672.61538	12696	11849.6	11109	9874.666667	9354.947368	8887.2	7406	7109.76	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92468	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	210800	105400	70266.66667	52700	42160	35133.33333	30114.28571	26350	23422.22222	21080	19163.63636	17566.66667	16215.38462	15057.14286	14053.33333	13175	11711.11111	11094.73684	10540	8783.333333	8432	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92469	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	789528	394764	263176	197382	157905.6	131588	112789.7143	98691	87725.33333	78952.8	71775.27273	65794	60732.92308	56394.85714	52635.2	49345.5	43862.66667	41554.10526	39476.4	32897	31581.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92470	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	1698179	849089.5	566059.6667	424544.75	339635.8	283029.8333	242597	212272.375	188686.5556	169817.9	154379.9091	141514.9167	130629.1538	121298.5	113211.9333	106136.1875	94343.27778	89377.84211	84908.95	70757.45833	67927.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92471	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92472	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	530404	265202	176801.3333	132601	106080.8	88400.66667	75772	66300.5	58933.77778	53040.4	48218.54545	44200.33333	40800.30769	37886	35360.26667	33150.25	29466.88889	27916	26520.2	22100.16667	21216.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92473	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92474	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	11382051	5691025.5	3794017	2845512.75	2276410.2	1897008.5	1626007.286	1422756.375	1264672.333	1138205.1	1034731.909	948504.25	875542.3846	813003.6429	758803.4	711378.1875	632336.1667	599055.3158	569102.55	474252.125	455282.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92475	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	12212910	6106455	4070970	3053227.5	2442582	2035485	1744701.429	1526613.75	1356990	1221291	1110264.545	1017742.5	939454.6154	872350.7143	814194	763306.875	678495	642784.7368	610645.5	508871.25	488516.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92476	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	6954289	3477144.5	2318096.333	1738572.25	1390857.8	1159048.167	993469.8571	869286.125	772698.7778	695428.9	632208.0909	579524.0833	534945.3077	496734.9286	463619.2667	434643.0625	386349.3889	366015.2105	347714.45	289762.0417	278171.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92477	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92478	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	46861	23430.5	15620.33333	11715.25	9372.2	7810.166667	6694.428571	5857.625	5206.777778	4686.1	4260.090909	3905.083333	3604.692308	3347.214286	3124.066667	2928.8125	2603.388889	2466.368421	2343.05	1952.541667	1874.44	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92479	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	557462	278731	185820.6667	139365.5	111492.4	92910.33333	79637.42857	69682.75	61940.22222	55746.2	50678.36364	46455.16667	42881.69231	39818.71429	37164.13333	34841.375	30970.11111	29340.10526	27873.1	23227.58333	22298.48	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92480	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	336813	168406.5	112271	84203.25	67362.6	56135.5	48116.14286	42101.625	37423.66667	33681.3	30619.36364	28067.75	25908.69231	24058.07143	22454.2	21050.8125	18711.83333	17727	16840.65	14033.875	13472.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92481	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	113626	56813	37875.33333	28406.5	22725.2	18937.66667	16232.28571	14203.25	12625.11111	11362.6	10329.63636	9468.833333	8740.461538	8116.142857	7575.066667	7101.625	6312.555556	5980.315789	5681.3	4734.416667	4545.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92482	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	185069	92534.5	61689.66667	46267.25	37013.8	30844.83333	26438.42857	23133.625	20563.22222	18506.9	16824.45455	15422.41667	14236.07692	13219.21429	12337.93333	11566.8125	10281.61111	9740.473684	9253.45	7711.208333	7402.76	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92483	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92484	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	471246	235623	157082	117811.5	94249.2	78541	67320.85714	58905.75	52360.66667	47124.6	42840.54545	39270.5	36249.69231	33660.42857	31416.4	29452.875	26180.33333	24802.42105	23562.3	19635.25	18849.84	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92485	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	681212	340606	227070.6667	170303	136242.4	113535.3333	97316	85151.5	75690.22222	68121.2	61928.36364	56767.66667	52400.92308	48658	45414.13333	42575.75	37845.11111	35853.26316	34060.6	28383.83333	27248.48	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92486	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	46141	23070.5	15380.33333	11535.25	9228.2	7690.166667	6591.571429	5767.625	5126.777778	4614.1	4194.636364	3845.083333	3549.307692	3295.785714	3076.066667	2883.8125	2563.388889	2428.473684	2307.05	1922.541667	1845.64	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92487	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	308267	154133.5	102755.6667	77066.75	61653.4	51377.83333	44038.14286	38533.375	34251.88889	30826.7	28024.27273	25688.91667	23712.84615	22019.07143	20551.13333	19266.6875	17125.94444	16224.57895	15413.35	12844.45833	12330.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92488	CHOYP_G6PD.2.2|m.46923	VNEYIAGSYDKPDGFAK	VNEYIAGSYDKPDGFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92489	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	14080745	7040372.5	4693581.667	3520186.25	2816149	2346790.833	2011535	1760093.125	1564527.222	1408074.5	1280067.727	1173395.417	1083134.231	1005767.5	938716.3333	880046.5625	782263.6111	741091.8421	704037.25	586697.7083	563229.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92490	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	7294497	3647248.5	2431499	1823624.25	1458899.4	1215749.5	1042071	911812.125	810499.6667	729449.7	663136.0909	607874.75	561115.1538	521035.5	486299.8	455906.0625	405249.8333	383920.8947	364724.85	303937.375	291779.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92491	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92492	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92493	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	349830	174915	116610	87457.5	69966	58305	49975.71429	43728.75	38870	34983	31802.72727	29152.5	26910	24987.85714	23322	21864.375	19435	18412.10526	17491.5	14576.25	13993.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92494	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	2156135	1078067.5	718711.6667	539033.75	431227	359355.8333	308019.2857	269516.875	239570.5556	215613.5	196012.2727	179677.9167	165856.5385	154009.6429	143742.3333	134758.4375	119785.2778	113480.7895	107806.75	89838.95833	86245.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92495	CHOYP_G6PD.2.2|m.46923	IVVEKPFGK	IVVEKPFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92496	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92497	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92498	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92499	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	4165688	2082844	1388562.667	1041422	833137.6	694281.3333	595098.2857	520711	462854.2222	416568.8	378698.9091	347140.6667	320437.5385	297549.1429	277712.5333	260355.5	231427.1111	219246.7368	208284.4	173570.3333	166627.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92500	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	3890426	1945213	1296808.667	972606.5	778085.2	648404.3333	555775.1429	486303.25	432269.5556	389042.6	353675.0909	324202.1667	299263.5385	277887.5714	259361.7333	243151.625	216134.7778	204759.2632	194521.3	162101.0833	155617.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92501	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	1274710	637355	424903.3333	318677.5	254942	212451.6667	182101.4286	159338.75	141634.4444	127471	115882.7273	106225.8333	98054.61538	91050.71429	84980.66667	79669.375	70817.22222	67090	63735.5	53112.91667	50988.4	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92502	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	1554471	777235.5	518157	388617.75	310894.2	259078.5	222067.2857	194308.875	172719	155447.1	141315.5455	129539.25	119574.6923	111033.6429	103631.4	97154.4375	86359.5	81814.26316	77723.55	64769.625	62178.84	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92503	CHOYP_G6PD.2.2|m.46923	EMVQNLMVLR	EMVQNLMVLR	851688	425844	283896	212922	170337.6	141948	121669.7143	106461	94632	85168.8	77426.18182	70974	65514.46154	60834.85714	56779.2	53230.5	47316	44825.68421	42584.4	35487	34067.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92504	CHOYP_G6PD.2.2|m.46923	IFSPVWNR	IFSPVWNR	15551430	7775715	5183810	3887857.5	3110286	2591905	2221632.857	1943928.75	1727936.667	1555143	1413766.364	1295952.5	1196263.846	1110816.429	1036762	971964.375	863968.3333	818496.3158	777571.5	647976.25	622057.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92505	CHOYP_G6PD.2.2|m.46923	IFSPVWNR	IFSPVWNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92506	CHOYP_G6PD.2.2|m.46923	IFSPVWNR	IFSPVWNR	3457825	1728912.5	1152608.333	864456.25	691565	576304.1667	493975	432228.125	384202.7778	345782.5	314347.7273	288152.0833	265986.5385	246987.5	230521.6667	216114.0625	192101.3889	181990.7895	172891.25	144076.0417	138313	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92507	CHOYP_G6PD.2.2|m.46923	IFSPVWNR	IFSPVWNR	2112647	1056323.5	704215.6667	528161.75	422529.4	352107.8333	301806.7143	264080.875	234738.5556	211264.7	192058.8182	176053.9167	162511.3077	150903.3571	140843.1333	132040.4375	117369.2778	111191.9474	105632.35	88026.95833	84505.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92508	CHOYP_G6PD.2.2|m.46923	IFSPVWNR	IFSPVWNR	914962	457481	304987.3333	228740.5	182992.4	152493.6667	130708.8571	114370.25	101662.4444	91496.2	83178.36364	76246.83333	70381.69231	65354.42857	60997.46667	57185.125	50831.22222	48155.89474	45748.1	38123.41667	36598.48	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92509	CHOYP_G6PD.2.2|m.46923	IFSPVWNR	IFSPVWNR	1081605	540802.5	360535	270401.25	216321	180267.5	154515	135200.625	120178.3333	108160.5	98327.72727	90133.75	83200.38462	77257.5	72107	67600.3125	60089.16667	56926.57895	54080.25	45066.875	43264.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92510	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	7862078	3931039	2620692.667	1965519.5	1572415.6	1310346.333	1123154	982759.75	873564.2222	786207.8	714734.3636	655173.1667	604775.2308	561577	524138.5333	491379.875	436782.1111	413793.5789	393103.9	327586.5833	314483.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92511	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	6234665	3117332.5	2078221.667	1558666.25	1246933	1039110.833	890666.4286	779333.125	692740.5556	623466.5	566787.7273	519555.4167	479589.6154	445333.2143	415644.3333	389666.5625	346370.2778	328140.2632	311733.25	259777.7083	249386.6	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92512	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92513	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	1069795	534897.5	356598.3333	267448.75	213959	178299.1667	152827.8571	133724.375	118866.1111	106979.5	97254.09091	89149.58333	82291.92308	76413.92857	71319.66667	66862.1875	59433.05556	56305	53489.75	44574.79167	42791.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92514	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	1828847	914423.5	609615.6667	457211.75	365769.4	304807.8333	261263.8571	228605.875	203205.2222	182884.7	166258.8182	152403.9167	140680.5385	130631.9286	121923.1333	114302.9375	101602.6111	96255.10526	91442.35	76201.95833	73153.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92515	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	781757	390878.5	260585.6667	195439.25	156351.4	130292.8333	111679.5714	97719.625	86861.88889	78175.7	71068.81818	65146.41667	60135.15385	55839.78571	52117.13333	48859.8125	43430.94444	41145.10526	39087.85	32573.20833	31270.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92516	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	763582	381791	254527.3333	190895.5	152716.4	127263.6667	109083.1429	95447.75	84842.44444	76358.2	69416.54545	63631.83333	58737.07692	54541.57143	50905.46667	47723.875	42421.22222	40188.52632	38179.1	31815.91667	30543.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92517	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	525439	262719.5	175146.3333	131359.75	105087.8	87573.16667	75062.71429	65679.875	58382.11111	52543.9	47767.18182	43786.58333	40418.38462	37531.35714	35029.26667	32839.9375	29191.05556	27654.68421	26271.95	21893.29167	21017.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92518	CHOYP_G6PD.2.2|m.46923	GGYFDEFGIIR	GGYFDEFGIIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92519	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	4059576	2029788	1353192	1014894	811915.2	676596	579939.4286	507447	451064	405957.6	369052.3636	338298	312275.0769	289969.7143	270638.4	253723.5	225532	213661.8947	202978.8	169149	162383.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92520	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	1863320	931660	621106.6667	465830	372664	310553.3333	266188.5714	232915	207035.5556	186332	169392.7273	155276.6667	143332.3077	133094.2857	124221.3333	116457.5	103517.7778	98069.47368	93166	77638.33333	74532.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92521	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	416455	208227.5	138818.3333	104113.75	83291	69409.16667	59493.57143	52056.875	46272.77778	41645.5	37859.54545	34704.58333	32035	29746.78571	27763.66667	26028.4375	23136.38889	21918.68421	20822.75	17352.29167	16658.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92522	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	182422	91211	60807.33333	45605.5	36484.4	30403.66667	26060.28571	22802.75	20269.11111	18242.2	16583.81818	15201.83333	14032.46154	13030.14286	12161.46667	11401.375	10134.55556	9601.157895	9121.1	7600.916667	7296.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92523	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	399558	199779	133186	99889.5	79911.6	66593	57079.71429	49944.75	44395.33333	39955.8	36323.45455	33296.5	30735.23077	28539.85714	26637.2	24972.375	22197.66667	21029.36842	19977.9	16648.25	15982.32	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92524	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	309590	154795	103196.6667	77397.5	61918	51598.33333	44227.14286	38698.75	34398.88889	30959	28144.54545	25799.16667	23814.61538	22113.57143	20639.33333	19349.375	17199.44444	16294.21053	15479.5	12899.58333	12383.6	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92525	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	896501	448250.5	298833.6667	224125.25	179300.2	149416.8333	128071.5714	112062.625	99611.22222	89650.1	81500.09091	74708.41667	68961.61538	64035.78571	59766.73333	56031.3125	49805.61111	47184.26316	44825.05	37354.20833	35860.04	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92526	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92527	CHOYP_G6PD.2.2|m.46923	QGYLDDPTVPK	QGYLDDPTVPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92528	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92529	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	5953342	2976671	1984447.333	1488335.5	1190668.4	992223.6667	850477.4286	744167.75	661482.4444	595334.2	541212.9091	496111.8333	457949.3846	425238.7143	396889.4667	372083.875	330741.2222	313333.7895	297667.1	248055.9167	238133.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92530	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	3272811	1636405.5	1090937	818202.75	654562.2	545468.5	467544.4286	409101.375	363645.6667	327281.1	297528.2727	272734.25	251754.6923	233772.2143	218187.4	204550.6875	181822.8333	172253.2105	163640.55	136367.125	130912.44	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92531	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92532	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92533	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92534	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92535	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92536	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92537	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92538	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92539	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92540	CHOYP_G6PD.2.2|m.46923	GSATPTFVTAVLMVK	GSATPTFVTAVLMVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92541	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92542	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92543	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92544	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	67217	33608.5	22405.66667	16804.25	13443.4	11202.83333	9602.428571	8402.125	7468.555556	6721.7	6110.636364	5601.416667	5170.538462	4801.214286	4481.133333	4201.0625	3734.277778	3537.736842	3360.85	2800.708333	2688.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92545	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	827905	413952.5	275968.3333	206976.25	165581	137984.1667	118272.1429	103488.125	91989.44444	82790.5	75264.09091	68992.08333	63685	59136.07143	55193.66667	51744.0625	45994.72222	43573.94737	41395.25	34496.04167	33116.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92546	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92547	CHOYP_G6PD.2.2|m.46923	WEGVPFILR	WEGVPFILR	15839	7919.5	5279.666667	3959.75	3167.8	2639.833333	2262.714286	1979.875	1759.888889	1583.9	1439.909091	1319.916667	1218.384615	1131.357143	1055.933333	989.9375	879.9444444	833.6315789	791.95	659.9583333	633.56	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92548	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	14124353	7062176.5	4708117.667	3531088.25	2824870.6	2354058.833	2017764.714	1765544.125	1569372.556	1412435.3	1284032.091	1177029.417	1086488.692	1008882.357	941623.5333	882772.0625	784686.2778	743387	706217.65	588514.7083	564974.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92549	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	7641167	3820583.5	2547055.667	1910291.75	1528233.4	1273527.833	1091595.286	955145.875	849018.5556	764116.7	694651.5455	636763.9167	587782.0769	545797.6429	509411.1333	477572.9375	424509.2778	402166.6842	382058.35	318381.9583	305646.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92550	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	3889905	1944952.5	1296635	972476.25	777981	648317.5	555700.7143	486238.125	432211.6667	388990.5	353627.7273	324158.75	299223.4615	277850.3571	259327	243119.0625	216105.8333	204731.8421	194495.25	162079.375	155596.2	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92551	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92552	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92553	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	63395	31697.5	21131.66667	15848.75	12679	10565.83333	9056.428571	7924.375	7043.888889	6339.5	5763.181818	5282.916667	4876.538462	4528.214286	4226.333333	3962.1875	3521.944444	3336.578947	3169.75	2641.458333	2535.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92554	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	1037720	518860	345906.6667	259430	207544	172953.3333	148245.7143	129715	115302.2222	103772	94338.18182	86476.66667	79824.61538	74122.85714	69181.33333	64857.5	57651.11111	54616.84211	51886	43238.33333	41508.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92555	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	2155820	1077910	718606.6667	538955	431164	359303.3333	307974.2857	269477.5	239535.5556	215582	195983.6364	179651.6667	165832.3077	153987.1429	143721.3333	134738.75	119767.7778	113464.2105	107791	89825.83333	86232.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92556	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92557	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92558	CHOYP_G6PD.2.2|m.46923	DVAGDIFPAGEVK	DVAGDIFPAGEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92559	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	8745956	4372978	2915318.667	2186489	1749191.2	1457659.333	1249422.286	1093244.5	971772.8889	874595.6	795086.9091	728829.6667	672765.8462	624711.1429	583063.7333	546622.25	485886.4444	460313.4737	437297.8	364414.8333	349838.24	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92560	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	7319303	3659651.5	2439767.667	1829825.75	1463860.6	1219883.833	1045614.714	914912.875	813255.8889	731930.3	665391.1818	609941.9167	563023.3077	522807.3571	487953.5333	457456.4375	406627.9444	385226.4737	365965.15	304970.9583	292772.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92561	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92562	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92563	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	175378	87689	58459.33333	43844.5	35075.6	29229.66667	25054	21922.25	19486.44444	17537.8	15943.45455	14614.83333	13490.61538	12527	11691.86667	10961.125	9743.222222	9230.421053	8768.9	7307.416667	7015.12	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92564	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	108749	54374.5	36249.66667	27187.25	21749.8	18124.83333	15535.57143	13593.625	12083.22222	10874.9	9886.272727	9062.416667	8365.307692	7767.785714	7249.933333	6796.8125	6041.611111	5723.631579	5437.45	4531.208333	4349.96	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92565	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	106316	53158	35438.66667	26579	21263.2	17719.33333	15188	13289.5	11812.88889	10631.6	9665.090909	8859.666667	8178.153846	7594	7087.733333	6644.75	5906.444444	5595.578947	5315.8	4429.833333	4252.64	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92566	CHOYP_G6PD.2.2|m.46923	VQPDEAVYLK	VQPDEAVYLK	588577	294288.5	196192.3333	147144.25	117715.4	98096.16667	84082.42857	73572.125	65397.44444	58857.7	53507	49048.08333	45275.15385	42041.21429	39238.46667	36786.0625	32698.72222	30977.73684	29428.85	24524.04167	23543.08	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92567	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92568	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92569	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92570	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92571	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92572	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92573	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92574	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92575	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92576	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92577	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92578	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92579	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92580	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92581	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92582	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92583	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92584	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92585	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92586	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	9007	4503.5	3002.333333	2251.75	1801.4	1501.166667	1286.714286	1125.875	1000.777778	900.7	818.8181818	750.5833333	692.8461538	643.3571429	600.4666667	562.9375	500.3888889	474.0526316	450.35	375.2916667	360.28	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92587	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	8984	4492	2994.666667	2246	1796.8	1497.333333	1283.428571	1123	998.2222222	898.4	816.7272727	748.6666667	691.0769231	641.7142857	598.9333333	561.5	499.1111111	472.8421053	449.2	374.3333333	359.36	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92588	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92589	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92590	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92591	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92592	CHOYP_G6PD.2.2|m.46923	LILDVFTGSQIHFVR	LILDVFTGSQIHFVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92593	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	11938731	5969365.5	3979577	2984682.75	2387746.2	1989788.5	1705533	1492341.375	1326525.667	1193873.1	1085339.182	994894.25	918363.9231	852766.5	795915.4	746170.6875	663262.8333	628354.2632	596936.55	497447.125	477549.24	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92594	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	21114666	10557333	7038222	5278666.5	4222933.2	3519111	3016380.857	2639333.25	2346074	2111466.6	1919515.091	1759555.5	1624205.077	1508190.429	1407644.4	1319666.625	1173037	1111298.211	1055733.3	879777.75	844586.64	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92595	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	2706879	1353439.5	902293	676719.75	541375.8	451146.5	386697	338359.875	300764.3333	270687.9	246079.9091	225573.25	208221.4615	193348.5	180458.6	169179.9375	150382.1667	142467.3158	135343.95	112786.625	108275.16	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92596	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	1886370	943185	628790	471592.5	377274	314395	269481.4286	235796.25	209596.6667	188637	171488.1818	157197.5	145105.3846	134740.7143	125758	117898.125	104798.3333	99282.63158	94318.5	78598.75	75454.8	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92597	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	4430034	2215017	1476678	1107508.5	886006.8	738339	632862	553754.25	492226	443003.4	402730.3636	369169.5	340771.8462	316431	295335.6	276877.125	246113	233159.6842	221501.7	184584.75	177201.36	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92598	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	1732417	866208.5	577472.3333	433104.25	346483.4	288736.1667	247488.1429	216552.125	192490.7778	173241.7	157492.4545	144368.0833	133262.8462	123744.0714	115494.4667	108276.0625	96245.38889	91179.84211	86620.85	72184.04167	69296.68	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92599	CHOYP_G6PD.2.2|m.46923	SDELYEAWR	SDELYEAWR	904047	452023.5	301349	226011.75	180809.4	150674.5	129149.5714	113005.875	100449.6667	90404.7	82186.09091	75337.25	69542.07692	64574.78571	60269.8	56502.9375	50224.83333	47581.42105	45202.35	37668.625	36161.88	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92600	CHOYP_G6PD.2.2|m.46923	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92601	CHOYP_G6PD.2.2|m.46923	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92602	CHOYP_G6PD.2.2|m.46923	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92603	CHOYP_G6PD.2.2|m.46923	IFTPLLHK	IFTPLLHK	901227	450613.5	300409	225306.75	180245.4	150204.5	128746.7143	112653.375	100136.3333	90122.7	81929.72727	75102.25	69325.15385	64373.35714	60081.8	56326.6875	50068.16667	47433	45061.35	37551.125	36049.08	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92604	CHOYP_G6PD.2.2|m.46923	IFTPLLHK	IFTPLLHK	75818	37909	25272.66667	18954.5	15163.6	12636.33333	10831.14286	9477.25	8424.222222	7581.8	6892.545455	6318.166667	5832.153846	5415.571429	5054.533333	4738.625	4212.111111	3990.421053	3790.9	3159.083333	3032.72	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92605	CHOYP_G6PD.2.2|m.46923	IFTPLLHK	IFTPLLHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92606	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	102138	51069	34046	25534.5	20427.6	17023	14591.14286	12767.25	11348.66667	10213.8	9285.272727	8511.5	7856.769231	7295.571429	6809.2	6383.625	5674.333333	5375.684211	5106.9	4255.75	4085.52	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92607	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92608	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92609	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92610	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	118349	59174.5	39449.66667	29587.25	23669.8	19724.83333	16907	14793.625	13149.88889	11834.9	10759	9862.416667	9103.769231	8453.5	7889.933333	7396.8125	6574.944444	6228.894737	5917.45	4931.208333	4733.96	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92611	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
92612	CHOYP_G6PD.2.2|m.46923	EKPKPIPYK	EKPKPIPYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P05370	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	G6pdx G6pd	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378
93255	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93256	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93257	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93258	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93259	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93260	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	74560	37280	24853.33333	18640	14912	12426.66667	10651.42857	9320	8284.444444	7456	6778.181818	6213.333333	5735.384615	5325.714286	4970.666667	4660	4142.222222	3924.210526	3728	3106.666667	2982.4	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93261	CHOYP_GCN1L.1.1|m.1352	YIAPVILAR	YIAPVILAR	59682	29841	19894	14920.5	11936.4	9947	8526	7460.25	6631.333333	5968.2	5425.636364	4973.5	4590.923077	4263	3978.8	3730.125	3315.666667	3141.157895	2984.1	2486.75	2387.28	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93262	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	2754604	1377302	918201.3333	688651	550920.8	459100.6667	393514.8571	344325.5	306067.1111	275460.4	250418.5455	229550.3333	211892.6154	196757.4286	183640.2667	172162.75	153033.5556	144979.1579	137730.2	114775.1667	110184.16	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93263	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	1004903	502451.5	334967.6667	251225.75	200980.6	167483.8333	143557.5714	125612.875	111655.8889	100490.3	91354.81818	83741.91667	77300.23077	71778.78571	66993.53333	62806.4375	55827.94444	52889.63158	50245.15	41870.95833	40196.12	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93264	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	4582771	2291385.5	1527590.333	1145692.75	916554.2	763795.1667	654681.5714	572846.375	509196.7778	458277.1	416615.5455	381897.5833	352520.8462	327340.7857	305518.0667	286423.1875	254598.3889	241198.4737	229138.55	190948.7917	183310.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93265	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	209378	104689	69792.66667	52344.5	41875.6	34896.33333	29911.14286	26172.25	23264.22222	20937.8	19034.36364	17448.16667	16106	14955.57143	13958.53333	13086.125	11632.11111	11019.89474	10468.9	8724.083333	8375.12	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93266	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93267	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	613758	306879	204586	153439.5	122751.6	102293	87679.71429	76719.75	68195.33333	61375.8	55796.18182	51146.5	47212.15385	43839.85714	40917.2	38359.875	34097.66667	32303.05263	30687.9	25573.25	24550.32	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93268	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93269	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	45796	22898	15265.33333	11449	9159.2	7632.666667	6542.285714	5724.5	5088.444444	4579.6	4163.272727	3816.333333	3522.769231	3271.142857	3053.066667	2862.25	2544.222222	2410.315789	2289.8	1908.166667	1831.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93270	CHOYP_GCN1L.1.1|m.1352	DAETIAMATVR	DAETIAMATVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93271	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	375812	187906	125270.6667	93953	75162.4	62635.33333	53687.42857	46976.5	41756.88889	37581.2	34164.72727	31317.66667	28908.61538	26843.71429	25054.13333	23488.25	20878.44444	19779.57895	18790.6	15658.83333	15032.48	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93272	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93273	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93274	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93275	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93276	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93277	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	108264	54132	36088	27066	21652.8	18044	15466.28571	13533	12029.33333	10826.4	9842.181818	9022	8328	7733.142857	7217.6	6766.5	6014.666667	5698.105263	5413.2	4511	4330.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93278	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93279	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93280	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93281	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93282	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93283	CHOYP_GCN1L.1.1|m.1352	QLDENTQNALSTFAR	QLDENTQNALSTFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93284	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93285	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93286	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93287	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93288	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93289	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93290	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93291	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93292	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93293	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93294	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93295	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93296	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93297	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93298	CHOYP_GCN1L.1.1|m.1352	VFLSLGQAVFEDNMLGK	VFLSLGQAVFEDNMLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93299	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	2288021	1144010.5	762673.6667	572005.25	457604.2	381336.8333	326860.1429	286002.625	254224.5556	228802.1	208001.9091	190668.4167	176001.6154	163430.0714	152534.7333	143001.3125	127112.2778	120422.1579	114401.05	95334.20833	91520.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93300	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	815232	407616	271744	203808	163046.4	135872	116461.7143	101904	90581.33333	81523.2	74112	67936	62710.15385	58230.85714	54348.8	50952	45290.66667	42906.94737	40761.6	33968	32609.28	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93301	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93302	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	450158	225079	150052.6667	112539.5	90031.6	75026.33333	64308.28571	56269.75	50017.55556	45015.8	40923.45455	37513.16667	34627.53846	32154.14286	30010.53333	28134.875	25008.77778	23692.52632	22507.9	18756.58333	18006.32	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93303	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	861021	430510.5	287007	215255.25	172204.2	143503.5	123003	107627.625	95669	86102.1	78274.63636	71751.75	66232.38462	61501.5	57401.4	53813.8125	47834.5	45316.89474	43051.05	35875.875	34440.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93304	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	444443	222221.5	148147.6667	111110.75	88888.6	74073.83333	63491.85714	55555.375	49382.55556	44444.3	40403.90909	37036.91667	34187.92308	31745.92857	29629.53333	27777.6875	24691.27778	23391.73684	22222.15	18518.45833	17777.72	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93305	CHOYP_GCN1L.1.1|m.1352	DSALQALLR	DSALQALLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93306	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93307	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93308	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93309	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	269689	134844.5	89896.33333	67422.25	53937.8	44948.16667	38527	33711.125	29965.44444	26968.9	24517.18182	22474.08333	20745.30769	19263.5	17979.26667	16855.5625	14982.72222	14194.15789	13484.45	11237.04167	10787.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93310	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93311	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93312	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93313	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	18651	9325.5	6217	4662.75	3730.2	3108.5	2664.428571	2331.375	2072.333333	1865.1	1695.545455	1554.25	1434.692308	1332.214286	1243.4	1165.6875	1036.166667	981.6315789	932.55	777.125	746.04	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93314	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93315	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	32054	16027	10684.66667	8013.5	6410.8	5342.333333	4579.142857	4006.75	3561.555556	3205.4	2914	2671.166667	2465.692308	2289.571429	2136.933333	2003.375	1780.777778	1687.052632	1602.7	1335.583333	1282.16	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93316	CHOYP_GCN1L.1.1|m.1352	LFMPPPILDSFGR	LFMPPPILDSFGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93317	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	3498221	1749110.5	1166073.667	874555.25	699644.2	583036.8333	499745.8571	437277.625	388691.2222	349822.1	318020.0909	291518.4167	269093.9231	249872.9286	233214.7333	218638.8125	194345.6111	184116.8947	174911.05	145759.2083	139928.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93318	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	1863502	931751	621167.3333	465875.5	372700.4	310583.6667	266214.5714	232937.75	207055.7778	186350.2	169409.2727	155291.8333	143346.3077	133107.2857	124233.4667	116468.875	103527.8889	98079.05263	93175.1	77645.91667	74540.08	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93319	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	480112	240056	160037.3333	120028	96022.4	80018.66667	68587.42857	60014	53345.77778	48011.2	43646.54545	40009.33333	36931.69231	34293.71429	32007.46667	30007	26672.88889	25269.05263	24005.6	20004.66667	19204.48	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93320	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	57483	28741.5	19161	14370.75	11496.6	9580.5	8211.857143	7185.375	6387	5748.3	5225.727273	4790.25	4421.769231	4105.928571	3832.2	3592.6875	3193.5	3025.421053	2874.15	2395.125	2299.32	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93321	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	870375	435187.5	290125	217593.75	174075	145062.5	124339.2857	108796.875	96708.33333	87037.5	79125	72531.25	66951.92308	62169.64286	58025	54398.4375	48354.16667	45809.21053	43518.75	36265.625	34815	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93322	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	442961	221480.5	147653.6667	110740.25	88592.2	73826.83333	63280.14286	55370.125	49217.88889	44296.1	40269.18182	36913.41667	34073.92308	31640.07143	29530.73333	27685.0625	24608.94444	23313.73684	22148.05	18456.70833	17718.44	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93323	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93324	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	54965	27482.5	18321.66667	13741.25	10993	9160.833333	7852.142857	6870.625	6107.222222	5496.5	4996.818182	4580.416667	4228.076923	3926.071429	3664.333333	3435.3125	3053.611111	2892.894737	2748.25	2290.208333	2198.6	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93325	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93326	CHOYP_GCN1L.1.1|m.1352	DAALATVTAHGK	DAALATVTAHGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93327	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93328	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93329	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93330	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	160098	80049	53366	40024.5	32019.6	26683	22871.14286	20012.25	17788.66667	16009.8	14554.36364	13341.5	12315.23077	11435.57143	10673.2	10006.125	8894.333333	8426.210526	8004.9	6670.75	6403.92	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93331	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93332	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93333	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93334	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93335	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93336	CHOYP_GCN1L.1.1|m.1352	AVMSMLTAHGVK	AVMSMLTAHGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93337	CHOYP_GCN1L.1.1|m.1352	LVLPSLLR	LVLPSLLR	3912597	1956298.5	1304199	978149.25	782519.4	652099.5	558942.4286	489074.625	434733	391259.7	355690.6364	326049.75	300969	279471.2143	260839.8	244537.3125	217366.5	205926.1579	195629.85	163024.875	156503.88	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93338	CHOYP_GCN1L.1.1|m.1352	LVLPSLLR	LVLPSLLR	1468289	734144.5	489429.6667	367072.25	293657.8	244714.8333	209755.5714	183536.125	163143.2222	146828.9	133480.8182	122357.4167	112945.3077	104877.7857	97885.93333	91768.0625	81571.61111	77278.36842	73414.45	61178.70833	58731.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93339	CHOYP_GCN1L.1.1|m.1352	LVLPSLLR	LVLPSLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93340	CHOYP_GCN1L.1.1|m.1352	LVLPSLLR	LVLPSLLR	2259693	1129846.5	753231	564923.25	451938.6	376615.5	322813.2857	282461.625	251077	225969.3	205426.6364	188307.75	173822.5385	161406.6429	150646.2	141230.8125	125538.5	118931.2105	112984.65	94153.875	90387.72	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93341	CHOYP_GCN1L.1.1|m.1352	LVLPSLLR	LVLPSLLR	233234	116617	77744.66667	58308.5	46646.8	38872.33333	33319.14286	29154.25	25914.88889	23323.4	21203.09091	19436.16667	17941.07692	16659.57143	15548.93333	14577.125	12957.44444	12275.47368	11661.7	9718.083333	9329.36	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93342	CHOYP_GCN1L.1.1|m.1352	LVLPSLLR	LVLPSLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93343	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93344	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	1084820	542410	361606.6667	271205	216964	180803.3333	154974.2857	135602.5	120535.5556	108482	98620	90401.66667	83447.69231	77487.14286	72321.33333	67801.25	60267.77778	57095.78947	54241	45200.83333	43392.8	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93345	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93346	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93347	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93348	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93349	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93350	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93351	CHOYP_GCN1L.1.1|m.1352	ISEVLTDSHAK	ISEVLTDSHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93352	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	959051	479525.5	319683.6667	239762.75	191810.2	159841.8333	137007.2857	119881.375	106561.2222	95905.1	87186.45455	79920.91667	73773.15385	68503.64286	63936.73333	59940.6875	53280.61111	50476.36842	47952.55	39960.45833	38362.04	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93353	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93354	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93355	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93356	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93357	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93358	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93359	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	91385	45692.5	30461.66667	22846.25	18277	15230.83333	13055	11423.125	10153.88889	9138.5	8307.727273	7615.416667	7029.615385	6527.5	6092.333333	5711.5625	5076.944444	4809.736842	4569.25	3807.708333	3655.4	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93360	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	24142	12071	8047.333333	6035.5	4828.4	4023.666667	3448.857143	3017.75	2682.444444	2414.2	2194.727273	2011.833333	1857.076923	1724.428571	1609.466667	1508.875	1341.222222	1270.631579	1207.1	1005.916667	965.68	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93361	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93362	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93363	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93364	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93365	CHOYP_GCN1L.1.1|m.1352	MAAQIIGNMYSLTDQK	MAAQIIGNMYSLTDQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93366	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	6327080	3163540	2109026.667	1581770	1265416	1054513.333	903868.5714	790885	703008.8889	632708	575189.0909	527256.6667	486698.4615	451934.2857	421805.3333	395442.5	351504.4444	333004.2105	316354	263628.3333	253083.2	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93367	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	4921711	2460855.5	1640570.333	1230427.75	984342.2	820285.1667	703101.5714	615213.875	546856.7778	492171.1	447428.2727	410142.5833	378593.1538	351550.7857	328114.0667	307606.9375	273428.3889	259037.4211	246085.55	205071.2917	196868.44	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93368	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93369	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93370	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93371	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93372	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93373	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93374	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93375	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	24374	12187	8124.666667	6093.5	4874.8	4062.333333	3482	3046.75	2708.222222	2437.4	2215.818182	2031.166667	1874.923077	1741	1624.933333	1523.375	1354.111111	1282.842105	1218.7	1015.583333	974.96	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93376	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	181846	90923	60615.33333	45461.5	36369.2	30307.66667	25978	22730.75	20205.11111	18184.6	16531.45455	15153.83333	13988.15385	12989	12123.06667	11365.375	10102.55556	9570.842105	9092.3	7576.916667	7273.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93377	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	879614	439807	293204.6667	219903.5	175922.8	146602.3333	125659.1429	109951.75	97734.88889	87961.4	79964.90909	73301.16667	67662.61538	62829.57143	58640.93333	54975.875	48867.44444	46295.47368	43980.7	36650.58333	35184.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93378	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	502419	251209.5	167473	125604.75	100483.8	83736.5	71774.14286	62802.375	55824.33333	50241.9	45674.45455	41868.25	38647.61538	35887.07143	33494.6	31401.1875	27912.16667	26443.10526	25120.95	20934.125	20096.76	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93379	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93380	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	547966	273983	182655.3333	136991.5	109593.2	91327.66667	78280.85714	68495.75	60885.11111	54796.6	49815.09091	45663.83333	42151.23077	39140.42857	36531.06667	34247.875	30442.55556	28840.31579	27398.3	22831.91667	21918.64	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93381	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	84682	42341	28227.33333	21170.5	16936.4	14113.66667	12097.42857	10585.25	9409.111111	8468.2	7698.363636	7056.833333	6514	6048.714286	5645.466667	5292.625	4704.555556	4456.947368	4234.1	3528.416667	3387.28	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93382	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	142941	71470.5	47647	35735.25	28588.2	23823.5	20420.14286	17867.625	15882.33333	14294.1	12994.63636	11911.75	10995.46154	10210.07143	9529.4	8933.8125	7941.166667	7523.210526	7147.05	5955.875	5717.64	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93383	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	39087	19543.5	13029	9771.75	7817.4	6514.5	5583.857143	4885.875	4343	3908.7	3553.363636	3257.25	3006.692308	2791.928571	2605.8	2442.9375	2171.5	2057.210526	1954.35	1628.625	1563.48	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93384	CHOYP_GCN1L.1.1|m.1352	SGAAQGLSEVIGGLGVQELHR	SGAAQGLSEVIGGLGVQELHR	38721	19360.5	12907	9680.25	7744.2	6453.5	5531.571429	4840.125	4302.333333	3872.1	3520.090909	3226.75	2978.538462	2765.785714	2581.4	2420.0625	2151.166667	2037.947368	1936.05	1613.375	1548.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93385	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93386	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	1857529	928764.5	619176.3333	464382.25	371505.8	309588.1667	265361.2857	232191.125	206392.1111	185752.9	168866.2727	154794.0833	142886.8462	132680.6429	123835.2667	116095.5625	103196.0556	97764.68421	92876.45	77397.04167	74301.16	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93387	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	689240	344620	229746.6667	172310	137848	114873.3333	98462.85714	86155	76582.22222	68924	62658.18182	57436.66667	53018.46154	49231.42857	45949.33333	43077.5	38291.11111	36275.78947	34462	28718.33333	27569.6	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93388	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93389	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93390	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93391	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93392	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93393	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93394	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93395	CHOYP_GCN1L.1.1|m.1352	YSSVQLLGDLLYK	YSSVQLLGDLLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93396	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	4728659	2364329.5	1576219.667	1182164.75	945731.8	788109.8333	675522.7143	591082.375	525406.5556	472865.9	429878.0909	394054.9167	363743	337761.3571	315243.9333	295541.1875	262703.2778	248876.7895	236432.95	197027.4583	189146.36	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93397	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	3480118	1740059	1160039.333	870029.5	696023.6	580019.6667	497159.7143	435014.75	386679.7778	348011.8	316374.3636	290009.8333	267701.3846	248579.8571	232007.8667	217507.375	193339.8889	183164.1053	174005.9	145004.9167	139204.72	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93398	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	473922	236961	157974	118480.5	94784.4	78987	67703.14286	59240.25	52658	47392.2	43083.81818	39493.5	36455.53846	33851.57143	31594.8	29620.125	26329	24943.26316	23696.1	19746.75	18956.88	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93399	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	312351	156175.5	104117	78087.75	62470.2	52058.5	44621.57143	39043.875	34705.66667	31235.1	28395.54545	26029.25	24027	22310.78571	20823.4	19521.9375	17352.83333	16439.52632	15617.55	13014.625	12494.04	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93400	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	666406	333203	222135.3333	166601.5	133281.2	111067.6667	95200.85714	83300.75	74045.11111	66640.6	60582.36364	55533.83333	51262	47600.42857	44427.06667	41650.375	37022.55556	35074	33320.3	27766.91667	26656.24	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93401	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	420221	210110.5	140073.6667	105055.25	84044.2	70036.83333	60031.57143	52527.625	46691.22222	42022.1	38201.90909	35018.41667	32324.69231	30015.78571	28014.73333	26263.8125	23345.61111	22116.89474	21011.05	17509.20833	16808.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93402	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	1558858	779429	519619.3333	389714.5	311771.6	259809.6667	222694	194857.25	173206.4444	155885.8	141714.3636	129904.8333	119912.1538	111347	103923.8667	97428.625	86603.22222	82045.15789	77942.9	64952.41667	62354.32	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93403	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93404	CHOYP_GCN1L.1.1|m.1352	VLPEIIPILEK	VLPEIIPILEK	80529	40264.5	26843	20132.25	16105.8	13421.5	11504.14286	10066.125	8947.666667	8052.9	7320.818182	6710.75	6194.538462	5752.071429	5368.6	5033.0625	4473.833333	4238.368421	4026.45	3355.375	3221.16	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93405	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	1166840	583420	388946.6667	291710	233368	194473.3333	166691.4286	145855	129648.8889	116684	106076.3636	97236.66667	89756.92308	83345.71429	77789.33333	72927.5	64824.44444	61412.63158	58342	48618.33333	46673.6	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93406	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	220827	110413.5	73609	55206.75	44165.4	36804.5	31546.71429	27603.375	24536.33333	22082.7	20075.18182	18402.25	16986.69231	15773.35714	14721.8	13801.6875	12268.16667	11622.47368	11041.35	9201.125	8833.08	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93407	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93408	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93409	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	24445	12222.5	8148.333333	6111.25	4889	4074.166667	3492.142857	3055.625	2716.111111	2444.5	2222.272727	2037.083333	1880.384615	1746.071429	1629.666667	1527.8125	1358.055556	1286.578947	1222.25	1018.541667	977.8	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93410	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	51214	25607	17071.33333	12803.5	10242.8	8535.666667	7316.285714	6401.75	5690.444444	5121.4	4655.818182	4267.833333	3939.538462	3658.142857	3414.266667	3200.875	2845.222222	2695.473684	2560.7	2133.916667	2048.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93411	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	51690	25845	17230	12922.5	10338	8615	7384.285714	6461.25	5743.333333	5169	4699.090909	4307.5	3976.153846	3692.142857	3446	3230.625	2871.666667	2720.526316	2584.5	2153.75	2067.6	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93412	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	77946	38973	25982	19486.5	15589.2	12991	11135.14286	9743.25	8660.666667	7794.6	7086	6495.5	5995.846154	5567.571429	5196.4	4871.625	4330.333333	4102.421053	3897.3	3247.75	3117.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93413	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	46416	23208	15472	11604	9283.2	7736	6630.857143	5802	5157.333333	4641.6	4219.636364	3868	3570.461538	3315.428571	3094.4	2901	2578.666667	2442.947368	2320.8	1934	1856.64	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93414	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93415	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93416	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	84389	42194.5	28129.66667	21097.25	16877.8	14064.83333	12055.57143	10548.625	9376.555556	8438.9	7671.727273	7032.416667	6491.461538	6027.785714	5625.933333	5274.3125	4688.277778	4441.526316	4219.45	3516.208333	3375.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93417	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93418	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93419	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	34508	17254	11502.66667	8627	6901.6	5751.333333	4929.714286	4313.5	3834.222222	3450.8	3137.090909	2875.666667	2654.461538	2464.857143	2300.533333	2156.75	1917.111111	1816.210526	1725.4	1437.833333	1380.32	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93420	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	250394	125197	83464.66667	62598.5	50078.8	41732.33333	35770.57143	31299.25	27821.55556	25039.4	22763.09091	20866.16667	19261.07692	17885.28571	16692.93333	15649.625	13910.77778	13178.63158	12519.7	10433.08333	10015.76	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93421	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93422	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	439612	219806	146537.3333	109903	87922.4	73268.66667	62801.71429	54951.5	48845.77778	43961.2	39964.72727	36634.33333	33816.30769	31400.85714	29307.46667	27475.75	24422.88889	23137.47368	21980.6	18317.16667	17584.48	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93423	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93424	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93425	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93426	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93427	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	14351	7175.5	4783.666667	3587.75	2870.2	2391.833333	2050.142857	1793.875	1594.555556	1435.1	1304.636364	1195.916667	1103.923077	1025.071429	956.7333333	896.9375	797.2777778	755.3157895	717.55	597.9583333	574.04	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93428	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93429	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93430	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	127268	63634	42422.66667	31817	25453.6	21211.33333	18181.14286	15908.5	14140.88889	12726.8	11569.81818	10605.66667	9789.846154	9090.571429	8484.533333	7954.25	7070.444444	6698.315789	6363.4	5302.833333	5090.72	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93431	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	65991	32995.5	21997	16497.75	13198.2	10998.5	9427.285714	8248.875	7332.333333	6599.1	5999.181818	5499.25	5076.230769	4713.642857	4399.4	4124.4375	3666.166667	3473.210526	3299.55	2749.625	2639.64	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93432	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	55615	27807.5	18538.33333	13903.75	11123	9269.166667	7945	6951.875	6179.444444	5561.5	5055.909091	4634.583333	4278.076923	3972.5	3707.666667	3475.9375	3089.722222	2927.105263	2780.75	2317.291667	2224.6	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93433	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93434	CHOYP_GCN1L.1.1|m.1352	EAAAETFDNLHSNIGQR	EAAAETFDNLHSNIGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93435	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93436	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93437	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93438	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93439	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93440	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93441	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93442	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93443	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93444	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93445	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93446	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93447	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93448	CHOYP_GCN1L.1.1|m.1352	QLDDDEFAESALDGLK	QLDDDEFAESALDGLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93449	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93450	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	1372695	686347.5	457565	343173.75	274539	228782.5	196099.2857	171586.875	152521.6667	137269.5	124790.4545	114391.25	105591.9231	98049.64286	91513	85793.4375	76260.83333	72247.10526	68634.75	57195.625	54907.8	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93451	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93452	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93453	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	42250	21125	14083.33333	10562.5	8450	7041.666667	6035.714286	5281.25	4694.444444	4225	3840.909091	3520.833333	3250	3017.857143	2816.666667	2640.625	2347.222222	2223.684211	2112.5	1760.416667	1690	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93454	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	360404	180202	120134.6667	90101	72080.8	60067.33333	51486.28571	45050.5	40044.88889	36040.4	32764	30033.66667	27723.38462	25743.14286	24026.93333	22525.25	20022.44444	18968.63158	18020.2	15016.83333	14416.16	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93455	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93456	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93457	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	196489	98244.5	65496.33333	49122.25	39297.8	32748.16667	28069.85714	24561.125	21832.11111	19648.9	17862.63636	16374.08333	15114.53846	14034.92857	13099.26667	12280.5625	10916.05556	10341.52632	9824.45	8187.041667	7859.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93458	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	108194	54097	36064.66667	27048.5	21638.8	18032.33333	15456.28571	13524.25	12021.55556	10819.4	9835.818182	9016.166667	8322.615385	7728.142857	7212.933333	6762.125	6010.777778	5694.421053	5409.7	4508.083333	4327.76	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93459	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93460	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93461	CHOYP_GCN1L.1.1|m.1352	ALSFLSSVAGDALTK	ALSFLSSVAGDALTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93462	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	243799	121899.5	81266.33333	60949.75	48759.8	40633.16667	34828.42857	30474.875	27088.77778	24379.9	22163.54545	20316.58333	18753.76923	17414.21429	16253.26667	15237.4375	13544.38889	12831.52632	12189.95	10158.29167	9751.96	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93463	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	410839	205419.5	136946.3333	102709.75	82167.8	68473.16667	58691.28571	51354.875	45648.77778	41083.9	37349	34236.58333	31603	29345.64286	27389.26667	25677.4375	22824.38889	21623.10526	20541.95	17118.29167	16433.56	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93464	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	164218	82109	54739.33333	41054.5	32843.6	27369.66667	23459.71429	20527.25	18246.44444	16421.8	14928.90909	13684.83333	12632.15385	11729.85714	10947.86667	10263.625	9123.222222	8643.052632	8210.9	6842.416667	6568.72	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93465	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93466	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93467	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	100605	50302.5	33535	25151.25	20121	16767.5	14372.14286	12575.625	11178.33333	10060.5	9145.909091	8383.75	7738.846154	7186.071429	6707	6287.8125	5589.166667	5295	5030.25	4191.875	4024.2	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93468	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	108968	54484	36322.66667	27242	21793.6	18161.33333	15566.85714	13621	12107.55556	10896.8	9906.181818	9080.666667	8382.153846	7783.428571	7264.533333	6810.5	6053.777778	5735.157895	5448.4	4540.333333	4358.72	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93469	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93470	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93471	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	210971	105485.5	70323.66667	52742.75	42194.2	35161.83333	30138.71429	26371.375	23441.22222	21097.1	19179.18182	17580.91667	16228.53846	15069.35714	14064.73333	13185.6875	11720.61111	11103.73684	10548.55	8790.458333	8438.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93472	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93473	CHOYP_GCN1L.1.1|m.1352	TSADYADYLPQLFR	TSADYADYLPQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93474	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93475	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	854986	427493	284995.3333	213746.5	170997.2	142497.6667	122140.8571	106873.25	94998.44444	85498.6	77726	71248.83333	65768.15385	61070.42857	56999.06667	53436.625	47499.22222	44999.26316	42749.3	35624.41667	34199.44	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93476	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	814271	407135.5	271423.6667	203567.75	162854.2	135711.8333	116324.4286	101783.875	90474.55556	81427.1	74024.63636	67855.91667	62636.23077	58162.21429	54284.73333	50891.9375	45237.27778	42856.36842	40713.55	33927.95833	32570.84	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93477	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93478	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	355355	177677.5	118451.6667	88838.75	71071	59225.83333	50765	44419.375	39483.88889	35535.5	32305	29612.91667	27335	25382.5	23690.33333	22209.6875	19741.94444	18702.89474	17767.75	14806.45833	14214.2	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93479	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	163459	81729.5	54486.33333	40864.75	32691.8	27243.16667	23351.28571	20432.375	18162.11111	16345.9	14859.90909	13621.58333	12573.76923	11675.64286	10897.26667	10216.1875	9081.055556	8603.105263	8172.95	6810.791667	6538.36	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93480	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	23369	11684.5	7789.666667	5842.25	4673.8	3894.833333	3338.428571	2921.125	2596.555556	2336.9	2124.454545	1947.416667	1797.615385	1669.214286	1557.933333	1460.5625	1298.277778	1229.947368	1168.45	973.7083333	934.76	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93481	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93482	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93483	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93484	CHOYP_GCN1L.1.1|m.1352	VDPLFTELHSAVK	VDPLFTELHSAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93485	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	5678742	2839371	1892914	1419685.5	1135748.4	946457	811248.8571	709842.75	630971.3333	567874.2	516249.2727	473228.5	436826.3077	405624.4286	378582.8	354921.375	315485.6667	298881.1579	283937.1	236614.25	227149.68	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93486	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	3866870	1933435	1288956.667	966717.5	773374	644478.3333	552410	483358.75	429652.2222	386687	351533.6364	322239.1667	297451.5385	276205	257791.3333	241679.375	214826.1111	203519.4737	193343.5	161119.5833	154674.8	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93487	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	771254	385627	257084.6667	192813.5	154250.8	128542.3333	110179.1429	96406.75	85694.88889	77125.4	70114	64271.16667	59327.23077	55089.57143	51416.93333	48203.375	42847.44444	40592.31579	38562.7	32135.58333	30850.16	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93488	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	2808445	1404222.5	936148.3333	702111.25	561689	468074.1667	401206.4286	351055.625	312049.4444	280844.5	255313.1818	234037.0833	216034.2308	200603.2143	187229.6667	175527.8125	156024.7222	147812.8947	140422.25	117018.5417	112337.8	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93489	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93490	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	55834	27917	18611.33333	13958.5	11166.8	9305.666667	7976.285714	6979.25	6203.777778	5583.4	5075.818182	4652.833333	4294.923077	3988.142857	3722.266667	3489.625	3101.888889	2938.631579	2791.7	2326.416667	2233.36	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93491	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93492	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	315491	157745.5	105163.6667	78872.75	63098.2	52581.83333	45070.14286	39436.375	35054.55556	31549.1	28681	26290.91667	24268.53846	22535.07143	21032.73333	19718.1875	17527.27778	16604.78947	15774.55	13145.45833	12619.64	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93493	CHOYP_GCN1L.1.1|m.1352	ILIPALVMGTK	ILIPALVMGTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93494	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93495	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	4199756	2099878	1399918.667	1049939	839951.2	699959.3333	599965.1429	524969.5	466639.5556	419975.6	381796	349979.6667	323058.1538	299982.5714	279983.7333	262484.75	233319.7778	221039.7895	209987.8	174989.8333	167990.24	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93496	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93497	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93498	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	102508	51254	34169.33333	25627	20501.6	17084.66667	14644	12813.5	11389.77778	10250.8	9318.909091	8542.333333	7885.230769	7322	6833.866667	6406.75	5694.888889	5395.157895	5125.4	4271.166667	4100.32	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93499	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	56799	28399.5	18933	14199.75	11359.8	9466.5	8114.142857	7099.875	6311	5679.9	5163.545455	4733.25	4369.153846	4057.071429	3786.6	3549.9375	3155.5	2989.421053	2839.95	2366.625	2271.96	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93500	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93501	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93502	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
93503	CHOYP_GCN1L.1.1|m.1352	SSSEYAIISVLK	SSSEYAIISVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	E9PVA8	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	GO:0005737; GO:0005844; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0044822; GO:1990253
95862	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	611678	305839	203892.6667	152919.5	122335.6	101946.3333	87382.57143	76459.75	67964.22222	61167.8	55607.09091	50973.16667	47052.15385	43691.28571	40778.53333	38229.875	33982.11111	32193.57895	30583.9	25486.58333	24467.12	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95863	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	1437452	718726	479150.6667	359363	287490.4	239575.3333	205350.2857	179681.5	159716.8889	143745.2	130677.4545	119787.6667	110573.2308	102675.1429	95830.13333	89840.75	79858.44444	75655.36842	71872.6	59893.83333	57498.08	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95864	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95865	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95866	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95867	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95868	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95869	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95870	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95871	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95872	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95873	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95874	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95875	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95876	CHOYP_GSH1.1.1|m.8927	SPYLDDFEALGDDGEAR	SPYLDDFEALGDDGEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95877	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	2676359	1338179.5	892119.6667	669089.75	535271.8	446059.8333	382337	334544.875	297373.2222	267635.9	243305.3636	223029.9167	205873.7692	191168.5	178423.9333	167272.4375	148686.6111	140861	133817.95	111514.9583	107054.36	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95878	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	2960409	1480204.5	986803	740102.25	592081.8	493401.5	422915.5714	370051.125	328934.3333	296040.9	269128.0909	246700.75	227723.7692	211457.7857	197360.6	185025.5625	164467.1667	155811	148020.45	123350.375	118416.36	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95879	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	790893	395446.5	263631	197723.25	158178.6	131815.5	112984.7143	98861.625	87877	79089.3	71899.36364	65907.75	60837.92308	56492.35714	52726.2	49430.8125	43938.5	41625.94737	39544.65	32953.875	31635.72	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95880	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	44487	22243.5	14829	11121.75	8897.4	7414.5	6355.285714	5560.875	4943	4448.7	4044.272727	3707.25	3422.076923	3177.642857	2965.8	2780.4375	2471.5	2341.421053	2224.35	1853.625	1779.48	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95881	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95882	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	349636	174818	116545.3333	87409	69927.2	58272.66667	49948	43704.5	38848.44444	34963.6	31785.09091	29136.33333	26895.07692	24974	23309.06667	21852.25	19424.22222	18401.89474	17481.8	14568.16667	13985.44	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95883	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	10942	5471	3647.333333	2735.5	2188.4	1823.666667	1563.142857	1367.75	1215.777778	1094.2	994.7272727	911.8333333	841.6923077	781.5714286	729.4666667	683.875	607.8888889	575.8947368	547.1	455.9166667	437.68	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95884	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	170542	85271	56847.33333	42635.5	34108.4	28423.66667	24363.14286	21317.75	18949.11111	17054.2	15503.81818	14211.83333	13118.61538	12181.57143	11369.46667	10658.875	9474.555556	8975.894737	8527.1	7105.916667	6821.68	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95885	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	96103	48051.5	32034.33333	24025.75	19220.6	16017.16667	13729	12012.875	10678.11111	9610.3	8736.636364	8008.583333	7392.538462	6864.5	6406.866667	6006.4375	5339.055556	5058.052632	4805.15	4004.291667	3844.12	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95886	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	359239	179619.5	119746.3333	89809.75	71847.8	59873.16667	51319.85714	44904.875	39915.44444	35923.9	32658.09091	29936.58333	27633.76923	25659.92857	23949.26667	22452.4375	19957.72222	18907.31579	17961.95	14968.29167	14369.56	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95887	CHOYP_GSH1.1.1|m.8927	ELIAANVDEPLSK	ELIAANVDEPLSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P19468	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237
95888	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	2837707	1418853.5	945902.3333	709426.75	567541.4	472951.1667	405386.7143	354713.375	315300.7778	283770.7	257973.3636	236475.5833	218285.1538	202693.3571	189180.4667	177356.6875	157650.3889	149353	141885.35	118237.7917	113508.28	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95889	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95890	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95891	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	116754	58377	38918	29188.5	23350.8	19459	16679.14286	14594.25	12972.66667	11675.4	10614	9729.5	8981.076923	8339.571429	7783.6	7297.125	6486.333333	6144.947368	5837.7	4864.75	4670.16	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95892	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	51491	25745.5	17163.66667	12872.75	10298.2	8581.833333	7355.857143	6436.375	5721.222222	5149.1	4681	4290.916667	3960.846154	3677.928571	3432.733333	3218.1875	2860.611111	2710.052632	2574.55	2145.458333	2059.64	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95893	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	544505	272252.5	181501.6667	136126.25	108901	90750.83333	77786.42857	68063.125	60500.55556	54450.5	49500.45455	45375.41667	41885	38893.21429	36300.33333	34031.5625	30250.27778	28658.15789	27225.25	22687.70833	21780.2	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95894	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	664810	332405	221603.3333	166202.5	132962	110801.6667	94972.85714	83101.25	73867.77778	66481	60437.27273	55400.83333	51139.23077	47486.42857	44320.66667	41550.625	36933.88889	34990	33240.5	27700.41667	26592.4	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95895	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	360014	180007	120004.6667	90003.5	72002.8	60002.33333	51430.57143	45001.75	40001.55556	36001.4	32728.54545	30001.16667	27693.38462	25715.28571	24000.93333	22500.875	20000.77778	18948.10526	18000.7	15000.58333	14400.56	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95896	CHOYP_GSK3B.1.1|m.62139	SGSNAQFGGMR	SGSNAQFGGMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95897	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95898	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95899	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95900	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95901	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	878968	439484	292989.3333	219742	175793.6	146494.6667	125566.8571	109871	97663.11111	87896.8	79906.18182	73247.33333	67612.92308	62783.42857	58597.86667	54935.5	48831.55556	46261.47368	43948.4	36623.66667	35158.72	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95902	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	1218342	609171	406114	304585.5	243668.4	203057	174048.8571	152292.75	135371.3333	121834.2	110758.3636	101528.5	93718.61538	87024.42857	81222.8	76146.375	67685.66667	64123.26316	60917.1	50764.25	48733.68	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95903	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	638730	319365	212910	159682.5	127746	106455	91247.14286	79841.25	70970	63873	58066.36364	53227.5	49133.07692	45623.57143	42582	39920.625	35485	33617.36842	31936.5	26613.75	25549.2	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95904	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	251150	125575	83716.66667	62787.5	50230	41858.33333	35878.57143	31393.75	27905.55556	25115	22831.81818	20929.16667	19319.23077	17939.28571	16743.33333	15696.875	13952.77778	13218.42105	12557.5	10464.58333	10046	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95905	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	403384	201692	134461.3333	100846	80676.8	67230.66667	57626.28571	50423	44820.44444	40338.4	36671.27273	33615.33333	31029.53846	28813.14286	26892.26667	25211.5	22410.22222	21230.73684	20169.2	16807.66667	16135.36	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95906	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95907	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95908	CHOYP_GSK3B.1.1|m.62139	ITTVLATAGSGSDR	ITTVLATAGSGSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95909	CHOYP_GSK3B.1.1|m.62139	LYMYQLFR	LYMYQLFR	1248170	624085	416056.6667	312042.5	249634	208028.3333	178310	156021.25	138685.5556	124817	113470	104014.1667	96013.07692	89155	83211.33333	78010.625	69342.77778	65693.15789	62408.5	52007.08333	49926.8	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95910	CHOYP_GSK3B.1.1|m.62139	LYMYQLFR	LYMYQLFR	234798	117399	78266	58699.5	46959.6	39133	33542.57143	29349.75	26088.66667	23479.8	21345.27273	19566.5	18061.38462	16771.28571	15653.2	14674.875	13044.33333	12357.78947	11739.9	9783.25	9391.92	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95911	CHOYP_GSK3B.1.1|m.62139	LYMYQLFR	LYMYQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95912	CHOYP_GSK3B.1.1|m.62139	LYMYQLFR	LYMYQLFR	271757	135878.5	90585.66667	67939.25	54351.4	45292.83333	38822.42857	33969.625	30195.22222	27175.7	24705.18182	22646.41667	20904.38462	19411.21429	18117.13333	16984.8125	15097.61111	14303	13587.85	11323.20833	10870.28	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95913	CHOYP_GSK3B.1.1|m.62139	LYMYQLFR	LYMYQLFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
95914	CHOYP_GSK3B.1.1|m.62139	LYMYQLFR	LYMYQLFR	27202	13601	9067.333333	6800.5	5440.4	4533.666667	3886	3400.25	3022.444444	2720.2	2472.909091	2266.833333	2092.461538	1943	1813.466667	1700.125	1511.222222	1431.684211	1360.1	1133.416667	1088.08	Q9WV60	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	Gsk3b	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223
97576	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	3236324	1618162	1078774.667	809081	647264.8	539387.3333	462332	404540.5	359591.5556	323632.4	294211.2727	269693.6667	248948	231166	215754.9333	202270.25	179795.7778	170332.8421	161816.2	134846.8333	129452.96	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97577	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	3752459	1876229.5	1250819.667	938114.75	750491.8	625409.8333	536065.5714	469057.375	416939.8889	375245.9	341132.6364	312704.9167	288650.6923	268032.7857	250163.9333	234528.6875	208469.9444	197497.8421	187622.95	156352.4583	150098.36	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97578	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97579	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97580	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97581	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	107486	53743	35828.66667	26871.5	21497.2	17914.33333	15355.14286	13435.75	11942.88889	10748.6	9771.454545	8957.166667	8268.153846	7677.571429	7165.733333	6717.875	5971.444444	5657.157895	5374.3	4478.583333	4299.44	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97582	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	311834	155917	103944.6667	77958.5	62366.8	51972.33333	44547.71429	38979.25	34648.22222	31183.4	28348.54545	25986.16667	23987.23077	22273.85714	20788.93333	19489.625	17324.11111	16412.31579	15591.7	12993.08333	12473.36	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97583	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	286423	143211.5	95474.33333	71605.75	57284.6	47737.16667	40917.57143	35802.875	31824.77778	28642.3	26038.45455	23868.58333	22032.53846	20458.78571	19094.86667	17901.4375	15912.38889	15074.89474	14321.15	11934.29167	11456.92	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97584	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	1448348	724174	482782.6667	362087	289669.6	241391.3333	206906.8571	181043.5	160927.5556	144834.8	131668	120695.6667	111411.3846	103453.4286	96556.53333	90521.75	80463.77778	76228.84211	72417.4	60347.83333	57933.92	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97585	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	38322	19161	12774	9580.5	7664.4	6387	5474.571429	4790.25	4258	3832.2	3483.818182	3193.5	2947.846154	2737.285714	2554.8	2395.125	2129	2016.947368	1916.1	1596.75	1532.88	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97586	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97587	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	368722	184361	122907.3333	92180.5	73744.4	61453.66667	52674.57143	46090.25	40969.11111	36872.2	33520.18182	30726.83333	28363.23077	26337.28571	24581.46667	23045.125	20484.55556	19406.42105	18436.1	15363.41667	14748.88	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97588	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97589	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	120063	60031.5	40021	30015.75	24012.6	20010.5	17151.85714	15007.875	13340.33333	12006.3	10914.81818	10005.25	9235.615385	8575.928571	8004.2	7503.9375	6670.166667	6319.105263	6003.15	5002.625	4802.52	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97590	CHOYP_HMCN1.44.44|m.67044	YSNGDINNPSLTINNAR	YSNGDINNPSLTINNAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97591	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	1091293	545646.5	363764.3333	272823.25	218258.6	181882.1667	155899	136411.625	121254.7778	109129.3	99208.45455	90941.08333	83945.61538	77949.5	72752.86667	68205.8125	60627.38889	57436.47368	54564.65	45470.54167	43651.72	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97592	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97593	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	4001842	2000921	1333947.333	1000460.5	800368.4	666973.6667	571691.7143	500230.25	444649.1111	400184.2	363803.8182	333486.8333	307834	285845.8571	266789.4667	250115.125	222324.5556	210623.2632	200092.1	166743.4167	160073.68	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97594	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97595	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	591227	295613.5	197075.6667	147806.75	118245.4	98537.83333	84461	73903.375	65691.88889	59122.7	53747.90909	49268.91667	45479	42230.5	39415.13333	36951.6875	32845.94444	31117.21053	29561.35	24634.45833	23649.08	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97596	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	212207	106103.5	70735.66667	53051.75	42441.4	35367.83333	30315.28571	26525.875	23578.55556	21220.7	19291.54545	17683.91667	16323.61538	15157.64286	14147.13333	13262.9375	11789.27778	11168.78947	10610.35	8841.958333	8488.28	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97597	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97598	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97599	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97600	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	305223	152611.5	101741	76305.75	61044.6	50870.5	43603.28571	38152.875	33913.66667	30522.3	27747.54545	25435.25	23478.69231	21801.64286	20348.2	19076.4375	16956.83333	16064.36842	15261.15	12717.625	12208.92	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97601	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97602	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97603	CHOYP_HMCN1.44.44|m.67044	YSLATSTTASSLTVR	YSLATSTTASSLTVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97604	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97605	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97606	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97607	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97608	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97609	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97610	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97611	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97612	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97613	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97614	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	161459	80729.5	53819.66667	40364.75	32291.8	26909.83333	23065.57143	20182.375	17939.88889	16145.9	14678.09091	13454.91667	12419.92308	11532.78571	10763.93333	10091.1875	8969.944444	8497.842105	8072.95	6727.458333	6458.36	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97615	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97616	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97617	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97618	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
97619	CHOYP_HMCN1.44.44|m.67044	ANQGDSGTIISVDGNPTK	ANQGDSGTIISVDGNPTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A4IGL7	Peroxidasin (EC 1.11.1.7)	pxdn pxn	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872
100094	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100095	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100096	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	6052065	3026032.5	2017355	1513016.25	1210413	1008677.5	864580.7143	756508.125	672451.6667	605206.5	550187.7273	504338.75	465543.4615	432290.3571	403471	378254.0625	336225.8333	318529.7368	302603.25	252169.375	242082.6	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100097	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	87170	43585	29056.66667	21792.5	17434	14528.33333	12452.85714	10896.25	9685.555556	8717	7924.545455	7264.166667	6705.384615	6226.428571	5811.333333	5448.125	4842.777778	4587.894737	4358.5	3632.083333	3486.8	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100098	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	1493568	746784	497856	373392	298713.6	248928	213366.8571	186696	165952	149356.8	135778.9091	124464	114889.8462	106683.4286	99571.2	93348	82976	78608.84211	74678.4	62232	59742.72	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100099	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100100	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	842712	421356	280904	210678	168542.4	140452	120387.4286	105339	93634.66667	84271.2	76610.18182	70226	64824	60193.71429	56180.8	52669.5	46817.33333	44353.26316	42135.6	35113	33708.48	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100101	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	2452231	1226115.5	817410.3333	613057.75	490446.2	408705.1667	350318.7143	306528.875	272470.1111	245223.1	222930.0909	204352.5833	188633.1538	175159.3571	163482.0667	153264.4375	136235.0556	129064.7895	122611.55	102176.2917	98089.24	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100102	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	440330	220165	146776.6667	110082.5	88066	73388.33333	62904.28571	55041.25	48925.55556	44033	40030	36694.16667	33871.53846	31452.14286	29355.33333	27520.625	24462.77778	23175.26316	22016.5	18347.08333	17613.2	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100103	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100104	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	682453	341226.5	227484.3333	170613.25	136490.6	113742.1667	97493.28571	85306.625	75828.11111	68245.3	62041.18182	56871.08333	52496.38462	48746.64286	45496.86667	42653.3125	37914.05556	35918.57895	34122.65	28435.54167	27298.12	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100105	CHOYP_HS74L.1.1|m.24610	TGGIETIANEYSDR	TGGIETIANEYSDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100106	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	2488915	1244457.5	829638.3333	622228.75	497783	414819.1667	355559.2857	311114.375	276546.1111	248891.5	226265	207409.5833	191455	177779.6429	165927.6667	155557.1875	138273.0556	130995.5263	124445.75	103704.7917	99556.6	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100107	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	3824078	1912039	1274692.667	956019.5	764815.6	637346.3333	546296.8571	478009.75	424897.5556	382407.8	347643.4545	318673.1667	294159.8462	273148.4286	254938.5333	239004.875	212448.7778	201267.2632	191203.9	159336.5833	152963.12	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100108	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	2179347	1089673.5	726449	544836.75	435869.4	363224.5	311335.2857	272418.375	242149.6667	217934.7	198122.4545	181612.25	167642.0769	155667.6429	145289.8	136209.1875	121074.8333	114702.4737	108967.35	90806.125	87173.88	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100109	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100110	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100111	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100112	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	152965	76482.5	50988.33333	38241.25	30593	25494.16667	21852.14286	19120.625	16996.11111	15296.5	13905.90909	12747.08333	11766.53846	10926.07143	10197.66667	9560.3125	8498.055556	8050.789474	7648.25	6373.541667	6118.6	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100113	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	43740	21870	14580	10935	8748	7290	6248.571429	5467.5	4860	4374	3976.363636	3645	3364.615385	3124.285714	2916	2733.75	2430	2302.105263	2187	1822.5	1749.6	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100114	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	169019	84509.5	56339.66667	42254.75	33803.8	28169.83333	24145.57143	21127.375	18779.88889	16901.9	15365.36364	14084.91667	13001.46154	12072.78571	11267.93333	10563.6875	9389.944444	8895.736842	8450.95	7042.458333	6760.76	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100115	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	65338	32669	21779.33333	16334.5	13067.6	10889.66667	9334	8167.25	7259.777778	6533.8	5939.818182	5444.833333	5026	4667	4355.866667	4083.625	3629.888889	3438.842105	3266.9	2722.416667	2613.52	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100116	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100117	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	159627	79813.5	53209	39906.75	31925.4	26604.5	22803.85714	19953.375	17736.33333	15962.7	14511.54545	13302.25	12279	11401.92857	10641.8	9976.6875	8868.166667	8401.421053	7981.35	6651.125	6385.08	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100118	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	108758	54379	36252.66667	27189.5	21751.6	18126.33333	15536.85714	13594.75	12084.22222	10875.8	9887.090909	9063.166667	8366	7768.428571	7250.533333	6797.375	6042.111111	5724.105263	5437.9	4531.583333	4350.32	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100119	CHOYP_HS74L.1.1|m.24610	LMNDSTAVSLAYGIYK	LMNDSTAVSLAYGIYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100120	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	20793666	10396833	6931222	5198416.5	4158733.2	3465611	2970523.714	2599208.25	2310407.333	2079366.6	1890333.273	1732805.5	1599512.769	1485261.857	1386244.4	1299604.125	1155203.667	1094403.474	1039683.3	866402.75	831746.64	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100121	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	17300426	8650213	5766808.667	4325106.5	3460085.2	2883404.333	2471489.429	2162553.25	1922269.556	1730042.6	1572766	1441702.167	1330802	1235744.714	1153361.733	1081276.625	961134.7778	910548.7368	865021.3	720851.0833	692017.04	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100122	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	6905144	3452572	2301714.667	1726286	1381028.8	1150857.333	986449.1429	863143	767238.2222	690514.4	627740.3636	575428.6667	531164.9231	493224.5714	460342.9333	431571.5	383619.1111	363428.6316	345257.2	287714.3333	276205.76	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100123	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	3083335	1541667.5	1027778.333	770833.75	616667	513889.1667	440476.4286	385416.875	342592.7778	308333.5	280303.1818	256944.5833	237179.6154	220238.2143	205555.6667	192708.4375	171296.3889	162280.7895	154166.75	128472.2917	123333.4	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100124	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	1958000	979000	652666.6667	489500	391600	326333.3333	279714.2857	244750	217555.5556	195800	178000	163166.6667	150615.3846	139857.1429	130533.3333	122375	108777.7778	103052.6316	97900	81583.33333	78320	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100125	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	1925601	962800.5	641867	481400.25	385120.2	320933.5	275085.8571	240700.125	213955.6667	192560.1	175054.6364	160466.75	148123.1538	137542.9286	128373.4	120350.0625	106977.8333	101347.4211	96280.05	80233.375	77024.04	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100126	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	1647387	823693.5	549129	411846.75	329477.4	274564.5	235341	205923.375	183043	164738.7	149762.4545	137282.25	126722.0769	117670.5	109825.8	102961.6875	91521.5	86704.57895	82369.35	68641.125	65895.48	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100127	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	1666868	833434	555622.6667	416717	333373.6	277811.3333	238124	208358.5	185207.5556	166686.8	151533.4545	138905.6667	128220.6154	119062	111124.5333	104179.25	92603.77778	87729.89474	83343.4	69452.83333	66674.72	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100128	CHOYP_HS74L.1.1|m.24610	VLVDYFVDDFK	VLVDYFVDDFK	1068824	534412	356274.6667	267206	213764.8	178137.3333	152689.1429	133603	118758.2222	106882.4	97165.81818	89068.66667	82217.23077	76344.57143	71254.93333	66801.5	59379.11111	56253.89474	53441.2	44534.33333	42752.96	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100129	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100130	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100131	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100132	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100133	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100134	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	92486	46243	30828.66667	23121.5	18497.2	15414.33333	13212.28571	11560.75	10276.22222	9248.6	8407.818182	7707.166667	7114.307692	6606.142857	6165.733333	5780.375	5138.111111	4867.684211	4624.3	3853.583333	3699.44	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100135	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	275259	137629.5	91753	68814.75	55051.8	45876.5	39322.71429	34407.375	30584.33333	27525.9	25023.54545	22938.25	21173.76923	19661.35714	18350.6	17203.6875	15292.16667	14487.31579	13762.95	11469.125	11010.36	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100136	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100137	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100138	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100139	CHOYP_HS74L.1.1|m.24610	DVYSVEIVGGSSR	DVYSVEIVGGSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100140	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	2034785	1017392.5	678261.6667	508696.25	406957	339130.8333	290683.5714	254348.125	226087.2222	203478.5	184980.4545	169565.4167	156521.9231	145341.7857	135652.3333	127174.0625	113043.6111	107093.9474	101739.25	84782.70833	81391.4	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100141	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	2531532	1265766	843844	632883	506306.4	421922	361647.4286	316441.5	281281.3333	253153.2	230139.2727	210961	194733.2308	180823.7143	168768.8	158220.75	140640.6667	133238.5263	126576.6	105480.5	101261.28	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100142	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	808878	404439	269626	202219.5	161775.6	134813	115554	101109.75	89875.33333	80887.8	73534.36364	67406.5	62221.38462	57777	53925.2	50554.875	44937.66667	42572.52632	40443.9	33703.25	32355.12	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100143	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	260218	130109	86739.33333	65054.5	52043.6	43369.66667	37174	32527.25	28913.11111	26021.8	23656.18182	21684.83333	20016.76923	18587	17347.86667	16263.625	14456.55556	13695.68421	13010.9	10842.41667	10408.72	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100144	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100145	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100146	CHOYP_HS74L.1.1|m.24610	NMVTEIFGK	NMVTEIFGK	156328	78164	52109.33333	39082	31265.6	26054.66667	22332.57143	19541	17369.77778	15632.8	14211.63636	13027.33333	12025.23077	11166.28571	10421.86667	9770.5	8684.888889	8227.789474	7816.4	6513.666667	6253.12	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100147	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100148	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100149	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100150	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100151	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100152	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100153	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	296077	148038.5	98692.33333	74019.25	59215.4	49346.16667	42296.71429	37009.625	32897.44444	29607.7	26916.09091	24673.08333	22775.15385	21148.35714	19738.46667	18504.8125	16448.72222	15583	14803.85	12336.54167	11843.08	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100154	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	784929	392464.5	261643	196232.25	156985.8	130821.5	112132.7143	98116.125	87214.33333	78492.9	71357.18182	65410.75	60379.15385	56066.35714	52328.6	49058.0625	43607.16667	41312.05263	39246.45	32705.375	31397.16	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100155	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100156	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100157	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100158	CHOYP_HS74L.1.1|m.24610	EPSTTLNADEAVAR	EPSTTLNADEAVAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100159	CHOYP_HS74L.1.1|m.24610	FHQIPFSK	FHQIPFSK	18581922	9290961	6193974	4645480.5	3716384.4	3096987	2654560.286	2322740.25	2064658	1858192.2	1689265.636	1548493.5	1429378.615	1327280.143	1238794.8	1161370.125	1032329	977995.8947	929096.1	774246.75	743276.88	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100160	CHOYP_HS74L.1.1|m.24610	FHQIPFSK	FHQIPFSK	9387158	4693579	3129052.667	2346789.5	1877431.6	1564526.333	1341022.571	1173394.75	1043017.556	938715.8	853378	782263.1667	722089.0769	670511.2857	625810.5333	586697.375	521508.7778	494060.9474	469357.9	391131.5833	375486.32	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100161	CHOYP_HS74L.1.1|m.24610	FHQIPFSK	FHQIPFSK	4275170	2137585	1425056.667	1068792.5	855034	712528.3333	610738.5714	534396.25	475018.8889	427517	388651.8182	356264.1667	328859.2308	305369.2857	285011.3333	267198.125	237509.4444	225008.9474	213758.5	178132.0833	171006.8	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100162	CHOYP_HS74L.1.1|m.24610	FHQIPFSK	FHQIPFSK	406910	203455	135636.6667	101727.5	81382	67818.33333	58130	50863.75	45212.22222	40691	36991.81818	33909.16667	31300.76923	29065	27127.33333	25431.875	22606.11111	21416.31579	20345.5	16954.58333	16276.4	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100163	CHOYP_HS74L.1.1|m.24610	FHQIPFSK	FHQIPFSK	3867083	1933541.5	1289027.667	966770.75	773416.6	644513.8333	552440.4286	483385.375	429675.8889	386708.3	351553	322256.9167	297467.9231	276220.2143	257805.5333	241692.6875	214837.9444	203530.6842	193354.15	161128.4583	154683.32	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100164	CHOYP_HS74L.1.1|m.24610	FHQIPFSK	FHQIPFSK	444245	222122.5	148081.6667	111061.25	88849	74040.83333	63463.57143	55530.625	49360.55556	44424.5	40385.90909	37020.41667	34172.69231	31731.78571	29616.33333	27765.3125	24680.27778	23381.31579	22212.25	18510.20833	17769.8	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100165	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100166	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	2338775	1169387.5	779591.6667	584693.75	467755	389795.8333	334110.7143	292346.875	259863.8889	233877.5	212615.9091	194897.9167	179905.7692	167055.3571	155918.3333	146173.4375	129931.9444	123093.4211	116938.75	97448.95833	93551	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100167	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100168	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100169	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	79394	39697	26464.66667	19848.5	15878.8	13232.33333	11342	9924.25	8821.555556	7939.4	7217.636364	6616.166667	6107.230769	5671	5292.933333	4962.125	4410.777778	4178.631579	3969.7	3308.083333	3175.76	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100170	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	57732	28866	19244	14433	11546.4	9622	8247.428571	7216.5	6414.666667	5773.2	5248.363636	4811	4440.923077	4123.714286	3848.8	3608.25	3207.333333	3038.526316	2886.6	2405.5	2309.28	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100171	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	124193	62096.5	41397.66667	31048.25	24838.6	20698.83333	17741.85714	15524.125	13799.22222	12419.3	11290.27273	10349.41667	9553.307692	8870.928571	8279.533333	7762.0625	6899.611111	6536.473684	6209.65	5174.708333	4967.72	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100172	CHOYP_HS74L.1.1|m.24610	YTSPEIVPHK	YTSPEIVPHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100173	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100174	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100175	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100176	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	205013	102506.5	68337.66667	51253.25	41002.6	34168.83333	29287.57143	25626.625	22779.22222	20501.3	18637.54545	17084.41667	15770.23077	14643.78571	13667.53333	12813.3125	11389.61111	10790.15789	10250.65	8542.208333	8200.52	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100177	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	215227	107613.5	71742.33333	53806.75	43045.4	35871.16667	30746.71429	26903.375	23914.11111	21522.7	19566.09091	17935.58333	16555.92308	15373.35714	14348.46667	13451.6875	11957.05556	11327.73684	10761.35	8967.791667	8609.08	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100178	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	49538	24769	16512.66667	12384.5	9907.6	8256.333333	7076.857143	6192.25	5504.222222	4953.8	4503.454545	4128.166667	3810.615385	3538.428571	3302.533333	3096.125	2752.111111	2607.263158	2476.9	2064.083333	1981.52	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100179	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100180	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100181	CHOYP_HS74L.1.1|m.24610	VTPAANGESAK	VTPAANGESAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100182	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	5217774	2608887	1739258	1304443.5	1043554.8	869629	745396.2857	652221.75	579752.6667	521777.4	474343.0909	434814.5	401367.2308	372698.1429	347851.6	326110.875	289876.3333	274619.6842	260888.7	217407.25	208710.96	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100183	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	5168287	2584143.5	1722762.333	1292071.75	1033657.4	861381.1667	738326.7143	646035.875	574254.1111	516828.7	469844.2727	430690.5833	397560.5385	369163.3571	344552.4667	323017.9375	287127.0556	272015.1053	258414.35	215345.2917	206731.48	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100184	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	3452880	1726440	1150960	863220	690576	575480	493268.5714	431610	383653.3333	345288	313898.1818	287740	265606.1538	246634.2857	230192	215805	191826.6667	181730.5263	172644	143870	138115.2	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100185	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	2117062	1058531	705687.3333	529265.5	423412.4	352843.6667	302437.4286	264632.75	235229.1111	211706.2	192460.1818	176421.8333	162850.9231	151218.7143	141137.4667	132316.375	117614.5556	111424.3158	105853.1	88210.91667	84682.48	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100186	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	325673	162836.5	108557.6667	81418.25	65134.6	54278.83333	46524.71429	40709.125	36185.88889	32567.3	29606.63636	27139.41667	25051.76923	23262.35714	21711.53333	20354.5625	18092.94444	17140.68421	16283.65	13569.70833	13026.92	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100187	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	584533	292266.5	194844.3333	146133.25	116906.6	97422.16667	83504.71429	73066.625	64948.11111	58453.3	53139.36364	48711.08333	44964.07692	41752.35714	38968.86667	36533.3125	32474.05556	30764.89474	29226.65	24355.54167	23381.32	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100188	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	112963	56481.5	37654.33333	28240.75	22592.6	18827.16667	16137.57143	14120.375	12551.44444	11296.3	10269.36364	9413.583333	8689.461538	8068.785714	7530.866667	7060.1875	6275.722222	5945.421053	5648.15	4706.791667	4518.52	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100189	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	416931	208465.5	138977	104232.75	83386.2	69488.5	59561.57143	52116.375	46325.66667	41693.1	37902.81818	34744.25	32071.61538	29780.78571	27795.4	26058.1875	23162.83333	21943.73684	20846.55	17372.125	16677.24	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100190	CHOYP_HS74L.1.1|m.24610	NAVEEYVYEMR	NAVEEYVYEMR	62830	31415	20943.33333	15707.5	12566	10471.66667	8975.714286	7853.75	6981.111111	6283	5711.818182	5235.833333	4833.076923	4487.857143	4188.666667	3926.875	3490.555556	3306.842105	3141.5	2617.916667	2513.2	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100191	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100192	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100193	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100194	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100195	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	15855	7927.5	5285	3963.75	3171	2642.5	2265	1981.875	1761.666667	1585.5	1441.363636	1321.25	1219.615385	1132.5	1057	990.9375	880.8333333	834.4736842	792.75	660.625	634.2	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100196	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100197	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100198	CHOYP_HS74L.1.1|m.24610	IANVLAQFIK	IANVLAQFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100199	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	5312148	2656074	1770716	1328037	1062429.6	885358	758878.2857	664018.5	590238.6667	531214.8	482922.5455	442679	408626.7692	379439.1429	354143.2	332009.25	295119.3333	279586.7368	265607.4	221339.5	212485.92	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100200	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100201	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100202	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	67445	33722.5	22481.66667	16861.25	13489	11240.83333	9635	8430.625	7493.888889	6744.5	6131.363636	5620.416667	5188.076923	4817.5	4496.333333	4215.3125	3746.944444	3549.736842	3372.25	2810.208333	2697.8	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100203	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	1198262	599131	399420.6667	299565.5	239652.4	199710.3333	171180.2857	149782.75	133140.2222	119826.2	108932.9091	99855.16667	92174	85590.14286	79884.13333	74891.375	66570.11111	63066.42105	59913.1	49927.58333	47930.48	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100204	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	147455	73727.5	49151.66667	36863.75	29491	24575.83333	21065	18431.875	16383.88889	14745.5	13405	12287.91667	11342.69231	10532.5	9830.333333	9215.9375	8191.944444	7760.789474	7372.75	6143.958333	5898.2	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100205	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	252026	126013	84008.66667	63006.5	50405.2	42004.33333	36003.71429	31503.25	28002.88889	25202.6	22911.45455	21002.16667	19386.61538	18001.85714	16801.73333	15751.625	14001.44444	13264.52632	12601.3	10501.08333	10081.04	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100206	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	1698150	849075	566050	424537.5	339630	283025	242592.8571	212268.75	188683.3333	169815	154377.2727	141512.5	130626.9231	121296.4286	113210	106134.375	94341.66667	89376.31579	84907.5	70756.25	67926	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100207	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	1034658	517329	344886	258664.5	206931.6	172443	147808.2857	129332.25	114962	103465.8	94059.81818	86221.5	79589.07692	73904.14286	68977.2	64666.125	57481	54455.68421	51732.9	43110.75	41386.32	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100208	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	583322	291661	194440.6667	145830.5	116664.4	97220.33333	83331.71429	72915.25	64813.55556	58332.2	53029.27273	48610.16667	44870.92308	41665.85714	38888.13333	36457.625	32406.77778	30701.15789	29166.1	24305.08333	23332.88	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100209	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	130133	65066.5	43377.66667	32533.25	26026.6	21688.83333	18590.42857	16266.625	14459.22222	13013.3	11830.27273	10844.41667	10010.23077	9295.214286	8675.533333	8133.3125	7229.611111	6849.105263	6506.65	5422.208333	5205.32	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100210	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	92307	46153.5	30769	23076.75	18461.4	15384.5	13186.71429	11538.375	10256.33333	9230.7	8391.545455	7692.25	7100.538462	6593.357143	6153.8	5769.1875	5128.166667	4858.263158	4615.35	3846.125	3692.28	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100211	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	284684	142342	94894.66667	71171	56936.8	47447.33333	40669.14286	35585.5	31631.55556	28468.4	25880.36364	23723.66667	21898.76923	20334.57143	18978.93333	17792.75	15815.77778	14983.36842	14234.2	11861.83333	11387.36	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100212	CHOYP_HS74L.1.1|m.24610	LFENPTVLASQIMSTK	LFENPTVLASQIMSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100213	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100214	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100215	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	146657	73328.5	48885.66667	36664.25	29331.4	24442.83333	20951	18332.125	16295.22222	14665.7	13332.45455	12221.41667	11281.30769	10475.5	9777.133333	9166.0625	8147.611111	7718.789474	7332.85	6110.708333	5866.28	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100216	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100217	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100218	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100219	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100220	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100221	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100222	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100223	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100224	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100225	CHOYP_HS74L.1.1|m.24610	SANNSAESEAKPESK	SANNSAESEAKPESK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O95757	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	HSPA4L APG1 OSP94	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986
100226	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100227	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100228	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100229	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100230	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	575470	287735	191823.3333	143867.5	115094	95911.66667	82210	71933.75	63941.11111	57547	52315.45455	47955.83333	44266.92308	41105	38364.66667	35966.875	31970.55556	30287.89474	28773.5	23977.91667	23018.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100231	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	416278	208139	138759.3333	104069.5	83255.6	69379.66667	59468.28571	52034.75	46253.11111	41627.8	37843.45455	34689.83333	32021.38462	29734.14286	27751.86667	26017.375	23126.55556	21909.36842	20813.9	17344.91667	16651.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100232	CHOYP_HS90A.1.3|m.7724	YTEDEELNK	YTEDEELNK	639696	319848	213232	159924	127939.2	106616	91385.14286	79962	71077.33333	63969.6	58154.18182	53308	49207.38462	45692.57143	42646.4	39981	35538.66667	33668.21053	31984.8	26654	25587.84	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100233	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100234	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100235	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100236	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100237	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	316978	158489	105659.3333	79244.5	63395.6	52829.66667	45282.57143	39622.25	35219.77778	31697.8	28816.18182	26414.83333	24382.92308	22641.28571	21131.86667	19811.125	17609.88889	16683.05263	15848.9	13207.41667	12679.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100238	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	2581021	1290510.5	860340.3333	645255.25	516204.2	430170.1667	368717.2857	322627.625	286780.1111	258102.1	234638.2727	215085.0833	198540.0769	184358.6429	172068.0667	161313.8125	143390.0556	135843.2105	129051.05	107542.5417	103240.84	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100239	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	730238	365119	243412.6667	182559.5	146047.6	121706.3333	104319.7143	91279.75	81137.55556	73023.8	66385.27273	60853.16667	56172.15385	52159.85714	48682.53333	45639.875	40568.77778	38433.57895	36511.9	30426.58333	29209.52	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100240	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	821856	410928	273952	205464	164371.2	136976	117408	102732	91317.33333	82185.6	74714.18182	68488	63219.69231	58704	54790.4	51366	45658.66667	43255.57895	41092.8	34244	32874.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100241	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100242	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	824836	412418	274945.3333	206209	164967.2	137472.6667	117833.7143	103104.5	91648.44444	82483.6	74985.09091	68736.33333	63448.92308	58916.85714	54989.06667	51552.25	45824.22222	43412.42105	41241.8	34368.16667	32993.44	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100243	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	801313	400656.5	267104.3333	200328.25	160262.6	133552.1667	114473.2857	100164.125	89034.77778	80131.3	72846.63636	66776.08333	61639.46154	57236.64286	53420.86667	50082.0625	44517.38889	42174.36842	40065.65	33388.04167	32052.52	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100244	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	185516	92758	61838.66667	46379	37103.2	30919.33333	26502.28571	23189.5	20612.88889	18551.6	16865.09091	15459.66667	14270.46154	13251.14286	12367.73333	11594.75	10306.44444	9764	9275.8	7729.833333	7420.64	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100245	CHOYP_HS90A.1.3|m.7724	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	443256	221628	147752	110814	88651.2	73876	63322.28571	55407	49250.66667	44325.6	40296	36938	34096.61538	31661.14286	29550.4	27703.5	24625.33333	23329.26316	22162.8	18469	17730.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100246	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	47715980	23857990	15905326.67	11928995	9543196	7952663.333	6816568.571	5964497.5	5301775.556	4771598	4337816.364	3976331.667	3670460	3408284.286	3181065.333	2982248.75	2650887.778	2511367.368	2385799	1988165.833	1908639.2	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100247	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	38412468	19206234	12804156	9603117	7682493.6	6402078	5487495.429	4801558.5	4268052	3841246.8	3492042.545	3201039	2954805.231	2743747.714	2560831.2	2400779.25	2134026	2021708.842	1920623.4	1600519.5	1536498.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100248	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	16823500	8411750	5607833.333	4205875	3364700	2803916.667	2403357.143	2102937.5	1869277.778	1682350	1529409.091	1401958.333	1294115.385	1201678.571	1121566.667	1051468.75	934638.8889	885447.3684	841175	700979.1667	672940	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100249	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	2572090	1286045	857363.3333	643022.5	514418	428681.6667	367441.4286	321511.25	285787.7778	257209	233826.3636	214340.8333	197853.0769	183720.7143	171472.6667	160755.625	142893.8889	135373.1579	128604.5	107170.4167	102883.6	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100250	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	2815414	1407707	938471.3333	703853.5	563082.8	469235.6667	402202	351926.75	312823.7778	281541.4	255946.7273	234617.8333	216570.3077	201101	187694.2667	175963.375	156411.8889	148179.6842	140770.7	117308.9167	112616.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100251	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	3773561	1886780.5	1257853.667	943390.25	754712.2	628926.8333	539080.1429	471695.125	419284.5556	377356.1	343051	314463.4167	290273.9231	269540.0714	251570.7333	235847.5625	209642.2778	198608.4737	188678.05	157231.7083	150942.44	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100252	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	3425087	1712543.5	1141695.667	856271.75	685017.4	570847.8333	489298.1429	428135.875	380565.2222	342508.7	311371.5455	285423.9167	263468.2308	244649.0714	228339.1333	214067.9375	190282.6111	180267.7368	171254.35	142711.9583	137003.48	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100253	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	796420	398210	265473.3333	199105	159284	132736.6667	113774.2857	99552.5	88491.11111	79642	72401.81818	66368.33333	61263.07692	56887.14286	53094.66667	49776.25	44245.55556	41916.84211	39821	33184.16667	31856.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100254	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	1816225	908112.5	605408.3333	454056.25	363245	302704.1667	259460.7143	227028.125	201802.7778	181622.5	165111.3636	151352.0833	139709.6154	129730.3571	121081.6667	113514.0625	100901.3889	95590.78947	90811.25	75676.04167	72649	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100255	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	1121453	560726.5	373817.6667	280363.25	224290.6	186908.8333	160207.5714	140181.625	124605.8889	112145.3	101950.2727	93454.41667	86265.61538	80103.78571	74763.53333	70090.8125	62302.94444	59023.84211	56072.65	46727.20833	44858.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100256	CHOYP_HS90A.1.3|m.7724	SLTNDWEDHLAVK	SLTNDWEDHLAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100257	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	17864282	8932141	5954760.667	4466070.5	3572856.4	2977380.333	2552040.286	2233035.25	1984920.222	1786428.2	1624025.636	1488690.167	1374175.538	1276020.143	1190952.133	1116517.625	992460.1111	940225.3684	893214.1	744345.0833	714571.28	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100258	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	10012658	5006329	3337552.667	2503164.5	2002531.6	1668776.333	1430379.714	1251582.25	1112517.556	1001265.8	910241.6364	834388.1667	770204.4615	715189.8571	667510.5333	625791.125	556258.7778	526982	500632.9	417194.0833	400506.32	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100259	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	3771518	1885759	1257172.667	942879.5	754303.6	628586.3333	538788.2857	471439.75	419057.5556	377151.8	342865.2727	314293.1667	290116.7692	269394.1429	251434.5333	235719.875	209528.7778	198500.9474	188575.9	157146.5833	150860.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100260	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100261	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	1472569	736284.5	490856.3333	368142.25	294513.8	245428.1667	210367	184071.125	163618.7778	147256.9	133869.9091	122714.0833	113274.5385	105183.5	98171.26667	92035.5625	81809.38889	77503.63158	73628.45	61357.04167	58902.76	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100262	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	1270680	635340	423560	317670	254136	211780	181525.7143	158835	141186.6667	127068	115516.3636	105890	97744.61538	90762.85714	84712	79417.5	70593.33333	66877.89474	63534	52945	50827.2	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100263	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	36472	18236	12157.33333	9118	7294.4	6078.666667	5210.285714	4559	4052.444444	3647.2	3315.636364	3039.333333	2805.538462	2605.142857	2431.466667	2279.5	2026.222222	1919.578947	1823.6	1519.666667	1458.88	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100264	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	84868	42434	28289.33333	21217	16973.6	14144.66667	12124	10608.5	9429.777778	8486.8	7715.272727	7072.333333	6528.307692	6062	5657.866667	5304.25	4714.888889	4466.736842	4243.4	3536.166667	3394.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100265	CHOYP_HS90A.1.3|m.7724	HFSVEGQLEFR	HFSVEGQLEFR	18270	9135	6090	4567.5	3654	3045	2610	2283.75	2030	1827	1660.909091	1522.5	1405.384615	1305	1218	1141.875	1015	961.5789474	913.5	761.25	730.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100266	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	3757289	1878644.5	1252429.667	939322.25	751457.8	626214.8333	536755.5714	469661.125	417476.5556	375728.9	341571.7273	313107.4167	289022.2308	268377.7857	250485.9333	234830.5625	208738.2778	197752.0526	187864.45	156553.7083	150291.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100267	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	1527880	763940	509293.3333	381970	305576	254646.6667	218268.5714	190985	169764.4444	152788	138898.1818	127323.3333	117529.2308	109134.2857	101858.6667	95492.5	84882.22222	80414.73684	76394	63661.66667	61115.2	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100268	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	1712242	856121	570747.3333	428060.5	342448.4	285373.6667	244606	214030.25	190249.1111	171224.2	155658.3636	142686.8333	131710.9231	122303	114149.4667	107015.125	95124.55556	90118	85612.1	71343.41667	68489.68	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100269	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	351275	175637.5	117091.6667	87818.75	70255	58545.83333	50182.14286	43909.375	39030.55556	35127.5	31934.09091	29272.91667	27021.15385	25091.07143	23418.33333	21954.6875	19515.27778	18488.15789	17563.75	14636.45833	14051	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100270	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	157520	78760	52506.66667	39380	31504	26253.33333	22502.85714	19690	17502.22222	15752	14320	13126.66667	12116.92308	11251.42857	10501.33333	9845	8751.111111	8290.526316	7876	6563.333333	6300.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100271	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	82842	41421	27614	20710.5	16568.4	13807	11834.57143	10355.25	9204.666667	8284.2	7531.090909	6903.5	6372.461538	5917.285714	5522.8	5177.625	4602.333333	4360.105263	4142.1	3451.75	3313.68	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100272	CHOYP_HS90A.1.3|m.7724	APFDLFENK	APFDLFENK	17114	8557	5704.666667	4278.5	3422.8	2852.333333	2444.857143	2139.25	1901.555556	1711.4	1555.818182	1426.166667	1316.461538	1222.428571	1140.933333	1069.625	950.7777778	900.7368421	855.7	713.0833333	684.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100273	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100274	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100275	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100276	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4393975	2196987.5	1464658.333	1098493.75	878795	732329.1667	627710.7143	549246.875	488219.4444	439397.5	399452.2727	366164.5833	337998.0769	313855.3571	292931.6667	274623.4375	244109.7222	231261.8421	219698.75	183082.2917	175759	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100277	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4337723	2168861.5	1445907.667	1084430.75	867544.6	722953.8333	619674.7143	542215.375	481969.2222	433772.3	394338.4545	361476.9167	333671	309837.3571	289181.5333	271107.6875	240984.6111	228301.2105	216886.15	180738.4583	173508.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100278	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1902385	951192.5	634128.3333	475596.25	380477	317064.1667	271769.2857	237798.125	211376.1111	190238.5	172944.0909	158532.0833	146337.3077	135884.6429	126825.6667	118899.0625	105688.0556	100125.5263	95119.25	79266.04167	76095.4	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100279	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4885845	2442922.5	1628615	1221461.25	977169	814307.5	697977.8571	610730.625	542871.6667	488584.5	444167.7273	407153.75	375834.2308	348988.9286	325723	305365.3125	271435.8333	257149.7368	244292.25	203576.875	195433.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100280	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	5748341	2874170.5	1916113.667	1437085.25	1149668.2	958056.8333	821191.5714	718542.625	638704.5556	574834.1	522576.4545	479028.4167	442180.0769	410595.7857	383222.7333	359271.3125	319352.2778	302544.2632	287417.05	239514.2083	229933.64	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100281	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	15453536	7726768	5151178.667	3863384	3090707.2	2575589.333	2207648	1931692	1717059.556	1545353.6	1404866.909	1287794.667	1188733.538	1103824	1030235.733	965846	858529.7778	813344	772676.8	643897.3333	618141.44	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100282	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	585205	292602.5	195068.3333	146301.25	117041	97534.16667	83600.71429	73150.625	65022.77778	58520.5	53200.45455	48767.08333	45015.76923	41800.35714	39013.66667	36575.3125	32511.38889	30800.26316	29260.25	24383.54167	23408.2	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100283	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1079081	539540.5	359693.6667	269770.25	215816.2	179846.8333	154154.4286	134885.125	119897.8889	107908.1	98098.27273	89923.41667	83006.23077	77077.21429	71938.73333	67442.5625	59948.94444	56793.73684	53954.05	44961.70833	43163.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100284	CHOYP_HS90A.1.3|m.7724	GVVDSEDLPLNISR	GVVDSEDLPLNISR	819544	409772	273181.3333	204886	163908.8	136590.6667	117077.7143	102443	91060.44444	81954.4	74504	68295.33333	63041.84615	58538.85714	54636.26667	51221.5	45530.22222	43133.89474	40977.2	34147.66667	32781.76	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100285	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	25262710	12631355	8420903.333	6315677.5	5052542	4210451.667	3608958.571	3157838.75	2806967.778	2526271	2296610	2105225.833	1943285.385	1804479.286	1684180.667	1578919.375	1403483.889	1329616.316	1263135.5	1052612.917	1010508.4	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100286	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	12922148	6461074	4307382.667	3230537	2584429.6	2153691.333	1846021.143	1615268.5	1435794.222	1292214.8	1174740.727	1076845.667	994011.3846	923010.5714	861476.5333	807634.25	717897.1111	680113.0526	646107.4	538422.8333	516885.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100287	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	7798479	3899239.5	2599493	1949619.75	1559695.8	1299746.5	1114068.429	974809.875	866497.6667	779847.9	708952.6364	649873.25	599883	557034.2143	519898.6	487404.9375	433248.8333	410446.2632	389923.95	324936.625	311939.16	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100288	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	2521297	1260648.5	840432.3333	630324.25	504259.4	420216.1667	360185.2857	315162.125	280144.1111	252129.7	229208.8182	210108.0833	193945.9231	180092.6429	168086.4667	157581.0625	140072.0556	132699.8421	126064.85	105054.0417	100851.88	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100289	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	4679675	2339837.5	1559891.667	1169918.75	935935	779945.8333	668525	584959.375	519963.8889	467967.5	425425	389972.9167	359975	334262.5	311978.3333	292479.6875	259981.9444	246298.6842	233983.75	194986.4583	187187	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100290	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	2229400	1114700	743133.3333	557350	445880	371566.6667	318485.7143	278675	247711.1111	222940	202672.7273	185783.3333	171492.3077	159242.8571	148626.6667	139337.5	123855.5556	117336.8421	111470	92891.66667	89176	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100291	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	1824289	912144.5	608096.3333	456072.25	364857.8	304048.1667	260612.7143	228036.125	202698.7778	182428.9	165844.4545	152024.0833	140329.9231	130306.3571	121619.2667	114018.0625	101349.3889	96015.21053	91214.45	76012.04167	72971.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100292	CHOYP_HS90A.1.3|m.7724	LGLHEDSTNR	LGLHEDSTNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100293	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100294	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100295	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100296	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100297	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100298	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	1272731	636365.5	424243.6667	318182.75	254546.2	212121.8333	181818.7143	159091.375	141414.5556	127273.1	115702.8182	106060.9167	97902.38462	90909.35714	84848.73333	79545.6875	70707.27778	66985.84211	63636.55	53030.45833	50909.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100299	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100300	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100301	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	227146	113573	75715.33333	56786.5	45429.2	37857.66667	32449.42857	28393.25	25238.44444	22714.6	20649.63636	18928.83333	17472.76923	16224.71429	15143.06667	14196.625	12619.22222	11955.05263	11357.3	9464.416667	9085.84	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100302	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	104115	52057.5	34705	26028.75	20823	17352.5	14873.57143	13014.375	11568.33333	10411.5	9465	8676.25	8008.846154	7436.785714	6941	6507.1875	5784.166667	5479.736842	5205.75	4338.125	4164.6	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100303	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100304	CHOYP_HS90A.1.3|m.7724	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100305	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	89922672	44961336	29974224	22480668	17984534.4	14987112	12846096	11240334	9991408	8992267.2	8174788.364	7493556	6917128.615	6423048	5994844.8	5620167	4995704	4732772.211	4496133.6	3746778	3596906.88	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100306	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	56376732	28188366	18792244	14094183	11275346.4	9396122	8053818.857	7047091.5	6264081.333	5637673.2	5125157.455	4698061	4336671.692	4026909.429	3758448.8	3523545.75	3132040.667	2967196.421	2818836.6	2349030.5	2255069.28	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100307	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	17493822	8746911	5831274	4373455.5	3498764.4	2915637	2499117.429	2186727.75	1943758	1749382.2	1590347.455	1457818.5	1345678.615	1249558.714	1166254.8	1093363.875	971879	920727.4737	874691.1	728909.25	699752.88	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100308	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	9596298	4798149	3198766	2399074.5	1919259.6	1599383	1370899.714	1199537.25	1066255.333	959629.8	872390.7273	799691.5	738176.7692	685449.8571	639753.2	599768.625	533127.6667	505068.3158	479814.9	399845.75	383851.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100309	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	10079618	5039809	3359872.667	2519904.5	2015923.6	1679936.333	1439945.429	1259952.25	1119957.556	1007961.8	916328.9091	839968.1667	775355.2308	719972.7143	671974.5333	629976.125	559978.7778	530506.2105	503980.9	419984.0833	403184.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100310	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	8583982	4291991	2861327.333	2145995.5	1716796.4	1430663.667	1226283.143	1072997.75	953775.7778	858398.2	780362	715331.8333	660306.3077	613141.5714	572265.4667	536498.875	476887.8889	451788.5263	429199.1	357665.9167	343359.28	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100311	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	2949375	1474687.5	983125	737343.75	589875	491562.5	421339.2857	368671.875	327708.3333	294937.5	268125	245781.25	226875	210669.6429	196625	184335.9375	163854.1667	155230.2632	147468.75	122890.625	117975	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100312	CHOYP_HS90A.1.3|m.7724	SIYYITGESR	SIYYITGESR	324964	162482	108321.3333	81241	64992.8	54160.66667	46423.42857	40620.5	36107.11111	32496.4	29542.18182	27080.33333	24997.23077	23211.71429	21664.26667	20310.25	18053.55556	17103.36842	16248.2	13540.16667	12998.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100313	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	106232720	53116360	35410906.67	26558180	21246544	17705453.33	15176102.86	13279090	11803635.56	10623272	9657520	8852726.667	8171747.692	7588051.429	7082181.333	6639545	5901817.778	5591195.789	5311636	4426363.333	4249308.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100314	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	72286568	36143284	24095522.67	18071642	14457313.6	12047761.33	10326652.57	9035821	8031840.889	7228656.8	6571506.182	6023880.667	5560505.231	5163326.286	4819104.533	4517910.5	4015920.444	3804556.211	3614328.4	3011940.333	2891462.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100315	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	27068290	13534145	9022763.333	6767072.5	5413658	4511381.667	3866898.571	3383536.25	3007587.778	2706829	2460753.636	2255690.833	2082176.154	1933449.286	1804552.667	1691768.125	1503793.889	1424646.842	1353414.5	1127845.417	1082731.6	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100316	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	22171104	11085552	7390368	5542776	4434220.8	3695184	3167300.571	2771388	2463456	2217110.4	2015554.909	1847592	1705469.538	1583650.286	1478073.6	1385694	1231728	1166900.211	1108555.2	923796	886844.16	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100317	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	30104462	15052231	10034820.67	7526115.5	6020892.4	5017410.333	4300637.429	3763057.75	3344940.222	3010446.2	2736769.273	2508705.167	2315727.846	2150318.714	2006964.133	1881528.875	1672470.111	1584445.368	1505223.1	1254352.583	1204178.48	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100318	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	10070523	5035261.5	3356841	2517630.75	2014104.6	1678420.5	1438646.143	1258815.375	1118947	1007052.3	915502.0909	839210.25	774655.6154	719323.0714	671368.2	629407.6875	559473.5	530027.5263	503526.15	419605.125	402820.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100319	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	4609245	2304622.5	1536415	1152311.25	921849	768207.5	658463.5714	576155.625	512138.3333	460924.5	419022.2727	384103.75	354557.3077	329231.7857	307283	288077.8125	256069.1667	242591.8421	230462.25	192051.875	184369.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100320	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	4759845	2379922.5	1586615	1189961.25	951969	793307.5	679977.8571	594980.625	528871.6667	475984.5	432713.1818	396653.75	366141.9231	339988.9286	317323	297490.3125	264435.8333	250518.1579	237992.25	198326.875	190393.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100321	CHOYP_HS90A.1.3|m.7724	EVVQSSAFVER	EVVQSSAFVER	2809118	1404559	936372.6667	702279.5	561823.6	468186.3333	401302.5714	351139.75	312124.2222	280911.8	255374.3636	234093.1667	216086	200651.2857	187274.5333	175569.875	156062.1111	147848.3158	140455.9	117046.5833	112364.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100322	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	1919803	959901.5	639934.3333	479950.75	383960.6	319967.1667	274257.5714	239975.375	213311.4444	191980.3	174527.5455	159983.5833	147677.1538	137128.7857	127986.8667	119987.6875	106655.7222	101042.2632	95990.15	79991.79167	76792.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100323	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100324	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100325	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100326	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100327	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100328	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100329	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100330	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100331	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100332	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100333	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100334	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100335	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100336	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100337	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100338	CHOYP_HS90A.1.3|m.7724	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100339	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	75562496	37781248	25187498.67	18890624	15112499.2	12593749.33	10794642.29	9445312	8395832.889	7556249.6	6869317.818	6296874.667	5812499.692	5397321.143	5037499.733	4722656	4197916.444	3976973.474	3778124.8	3148437.333	3022499.84	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100340	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	55542052	27771026	18514017.33	13885513	11108410.4	9257008.667	7934578.857	6942756.5	6171339.111	5554205.2	5049277.455	4628504.333	4272465.538	3967289.429	3702803.467	3471378.25	3085669.556	2923265.895	2777102.6	2314252.167	2221682.08	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100341	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	25342870	12671435	8447623.333	6335717.5	5068574	4223811.667	3620410	3167858.75	2815874.444	2534287	2303897.273	2111905.833	1949451.538	1810205	1689524.667	1583929.375	1407937.222	1333835.263	1267143.5	1055952.917	1013714.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100342	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	1635356	817678	545118.6667	408839	327071.2	272559.3333	233622.2857	204419.5	181706.2222	163535.6	148668.7273	136279.6667	125796.6154	116811.1429	109023.7333	102209.75	90853.11111	86071.36842	81767.8	68139.83333	65414.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100343	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100344	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	22193678	11096839	7397892.667	5548419.5	4438735.6	3698946.333	3170525.429	2774209.75	2465964.222	2219367.8	2017607.091	1849473.167	1707206	1585262.714	1479578.533	1387104.875	1232982.111	1168088.316	1109683.9	924736.5833	887747.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100345	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100346	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	2146120	1073060	715373.3333	536530	429224	357686.6667	306588.5714	268265	238457.7778	214612	195101.8182	178843.3333	165086.1538	153294.2857	143074.6667	134132.5	119228.8889	112953.6842	107306	89421.66667	85844.8	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100347	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	2670466	1335233	890155.3333	667616.5	534093.2	445077.6667	381495.1429	333808.25	296718.4444	267046.6	242769.6364	222538.8333	205420.4615	190747.5714	178031.0667	166904.125	148359.2222	140550.8421	133523.3	111269.4167	106818.64	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100348	CHOYP_HS90A.1.3|m.7724	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100349	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	61842912	30921456	20614304	15460728	12368582.4	10307152	8834701.714	7730364	6871434.667	6184291.2	5622082.909	5153576	4757147.077	4417350.857	4122860.8	3865182	3435717.333	3254890.105	3092145.6	2576788	2473716.48	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100350	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100351	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	20161494	10080747	6720498	5040373.5	4032298.8	3360249	2880213.429	2520186.75	2240166	2016149.4	1832863.091	1680124.5	1550884.154	1440106.714	1344099.6	1260093.375	1120083	1061131.263	1008074.7	840062.25	806459.76	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100352	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	1593393	796696.5	531131	398348.25	318678.6	265565.5	227627.5714	199174.125	177043.6667	159339.3	144853.9091	132782.75	122568.6923	113813.7857	106226.2	99587.0625	88521.83333	83862.78947	79669.65	66391.375	63735.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100353	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	3507490	1753745	1169163.333	876872.5	701498	584581.6667	501070	438436.25	389721.1111	350749	318862.7273	292290.8333	269806.9231	250535	233832.6667	219218.125	194860.5556	184604.7368	175374.5	146145.4167	140299.6	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100354	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	16273881	8136940.5	5424627	4068470.25	3254776.2	2712313.5	2324840.143	2034235.125	1808209	1627388.1	1479443.727	1356156.75	1251837	1162420.071	1084925.4	1017117.563	904104.5	856520.0526	813694.05	678078.375	650955.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100355	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	690731	345365.5	230243.6667	172682.75	138146.2	115121.8333	98675.85714	86341.375	76747.88889	69073.1	62793.72727	57560.91667	53133.15385	49337.92857	46048.73333	43170.6875	38373.94444	36354.26316	34536.55	28780.45833	27629.24	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100356	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	896022	448011	298674	224005.5	179204.4	149337	128003.1429	112002.75	99558	89602.2	81456.54545	74668.5	68924.76923	64001.57143	59734.8	56001.375	49779	47159.05263	44801.1	37334.25	35840.88	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100357	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	1017388	508694	339129.3333	254347	203477.6	169564.6667	145341.1429	127173.5	113043.1111	101738.8	92489.81818	84782.33333	78260.61538	72670.57143	67825.86667	63586.75	56521.55556	53546.73684	50869.4	42391.16667	40695.52	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100358	CHOYP_HS90A.1.3|m.7724	EGLELPEDEEEK	EGLELPEDEEEK	446453	223226.5	148817.6667	111613.25	89290.6	74408.83333	63779	55806.625	49605.88889	44645.3	40586.63636	37204.41667	34342.53846	31889.5	29763.53333	27903.3125	24802.94444	23497.52632	22322.65	18602.20833	17858.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100359	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	62637692	31318846	20879230.67	15659423	12527538.4	10439615.33	8948241.714	7829711.5	6959743.556	6263769.2	5694335.636	5219807.667	4818284	4474120.857	4175846.133	3914855.75	3479871.778	3296720.632	3131884.6	2609903.833	2505507.68	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100360	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	35214484	17607242	11738161.33	8803621	7042896.8	5869080.667	5030640.571	4401810.5	3912720.444	3521448.4	3201316.727	2934540.333	2708806.462	2515320.286	2347632.267	2200905.25	1956360.222	1853393.895	1760724.2	1467270.167	1408579.36	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100361	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	15686494	7843247	5228831.333	3921623.5	3137298.8	2614415.667	2240927.714	1960811.75	1742943.778	1568649.4	1426044.909	1307207.833	1206653.385	1120463.857	1045766.267	980405.875	871471.8889	825604.9474	784324.7	653603.9167	627459.76	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100362	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	2429248	1214624	809749.3333	607312	485849.6	404874.6667	347035.4286	303656	269916.4444	242924.8	220840.7273	202437.3333	186865.2308	173517.7143	161949.8667	151828	134958.2222	127855.1579	121462.4	101218.6667	97169.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100363	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	4712405	2356202.5	1570801.667	1178101.25	942481	785400.8333	673200.7143	589050.625	523600.5556	471240.5	428400.4545	392700.4167	362492.6923	336600.3571	314160.3333	294525.3125	261800.2778	248021.3158	235620.25	196350.2083	188496.2	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100364	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	7045932	3522966	2348644	1761483	1409186.4	1174322	1006561.714	880741.5	782881.3333	704593.2	640539.2727	587161	541994.7692	503280.8571	469728.8	440370.75	391440.6667	370838.5263	352296.6	293580.5	281837.28	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100365	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	607062	303531	202354	151765.5	121412.4	101177	86723.14286	75882.75	67451.33333	60706.2	55187.45455	50588.5	46697.07692	43361.57143	40470.8	37941.375	33725.66667	31950.63158	30353.1	25294.25	24282.48	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100366	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	1594104	797052	531368	398526	318820.8	265684	227729.1429	199263	177122.6667	159410.4	144918.5455	132842	122623.3846	113864.5714	106273.6	99631.5	88561.33333	83900.21053	79705.2	66421	63764.16	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100367	CHOYP_HS90A.1.3|m.7724	DSSTMGYMAAK	DSSTMGYMAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100368	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	48885548	24442774	16295182.67	12221387	9777109.6	8147591.333	6983649.714	6110693.5	5431727.556	4888554.8	4444140.727	4073795.667	3760426.769	3491824.857	3259036.533	3055346.75	2715863.778	2572923.579	2444277.4	2036897.833	1955421.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100369	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100370	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100371	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	325035	162517.5	108345	81258.75	65007	54172.5	46433.57143	40629.375	36115	32503.5	29548.63636	27086.25	25002.69231	23216.78571	21669	20314.6875	18057.5	17107.10526	16251.75	13543.125	13001.4	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100372	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	248489	124244.5	82829.66667	62122.25	49697.8	41414.83333	35498.42857	31061.125	27609.88889	24848.9	22589.90909	20707.41667	19114.53846	17749.21429	16565.93333	15530.5625	13804.94444	13078.36842	12424.45	10353.70833	9939.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100373	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	469774	234887	156591.3333	117443.5	93954.8	78295.66667	67110.57143	58721.75	52197.11111	46977.4	42706.72727	39147.83333	36136.46154	33555.28571	31318.26667	29360.875	26098.55556	24724.94737	23488.7	19573.91667	18790.96	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100374	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100375	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100376	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100377	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	35439	17719.5	11813	8859.75	7087.8	5906.5	5062.714286	4429.875	3937.666667	3543.9	3221.727273	2953.25	2726.076923	2531.357143	2362.6	2214.9375	1968.833333	1865.210526	1771.95	1476.625	1417.56	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100378	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	82435536	41217768	27478512	20608884	16487107.2	13739256	11776505.14	10304442	9159504	8243553.6	7494139.636	6869628	6341195.077	5888252.571	5495702.4	5152221	4579752	4338712.421	4121776.8	3434814	3297421.44	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100379	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	70036504	35018252	23345501.33	17509126	14007300.8	11672750.67	10005214.86	8754563	7781833.778	7003650.4	6366954.909	5836375.333	5387423.385	5002607.429	4669100.267	4377281.5	3890916.889	3686131.789	3501825.2	2918187.667	2801460.16	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100380	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	21081204	10540602	7027068	5270301	4216240.8	3513534	3011600.571	2635150.5	2342356	2108120.4	1916473.091	1756767	1621631.077	1505800.286	1405413.6	1317575.25	1171178	1109537.053	1054060.2	878383.5	843248.16	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100381	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	66096	33048	22032	16524	13219.2	11016	9442.285714	8262	7344	6609.6	6008.727273	5508	5084.307692	4721.142857	4406.4	4131	3672	3478.736842	3304.8	2754	2643.84	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100382	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	309625	154812.5	103208.3333	77406.25	61925	51604.16667	44232.14286	38703.125	34402.77778	30962.5	28147.72727	25802.08333	23817.30769	22116.07143	20641.66667	19351.5625	17201.38889	16296.05263	15481.25	12901.04167	12385	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100383	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	2461248	1230624	820416	615312	492249.6	410208	351606.8571	307656	273472	246124.8	223749.8182	205104	189326.7692	175803.4286	164083.2	153828	136736	129539.3684	123062.4	102552	98449.92	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100384	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	932861	466430.5	310953.6667	233215.25	186572.2	155476.8333	133265.8571	116607.625	103651.2222	93286.1	84805.54545	77738.41667	71758.53846	66632.92857	62190.73333	58303.8125	51825.61111	49097.94737	46643.05	38869.20833	37314.44	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100385	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	2820722	1410361	940240.6667	705180.5	564144.4	470120.3333	402960.2857	352590.25	313413.5556	282072.2	256429.2727	235060.1667	216978.6154	201480.1429	188048.1333	176295.125	156706.7778	148459.0526	141036.1	117530.0833	112828.88	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100386	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	1440018	720009	480006	360004.5	288003.6	240003	205716.8571	180002.25	160002	144001.8	130910.7273	120001.5	110770.6154	102858.4286	96001.2	90001.125	80001	75790.42105	72000.9	60000.75	57600.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100387	CHOYP_HS90A.1.3|m.7724	HLEINPDHSIIK	HLEINPDHSIIK	375855	187927.5	125285	93963.75	75171	62642.5	53693.57143	46981.875	41761.66667	37585.5	34168.63636	31321.25	28911.92308	26846.78571	25057	23490.9375	20880.83333	19781.84211	18792.75	15660.625	15034.2	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100388	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	27152228	13576114	9050742.667	6788057	5430445.6	4525371.333	3878889.714	3394028.5	3016914.222	2715222.8	2468384.364	2262685.667	2088632.923	1939444.857	1810148.533	1697014.25	1508457.111	1429064.632	1357611.4	1131342.833	1086089.12	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100389	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	17048176	8524088	5682725.333	4262044	3409635.2	2841362.667	2435453.714	2131022	1894241.778	1704817.6	1549834.182	1420681.333	1311398.154	1217726.857	1136545.067	1065511	947120.8889	897272.4211	852408.8	710340.6667	681927.04	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100390	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	5072476	2536238	1690825.333	1268119	1014495.2	845412.6667	724639.4286	634059.5	563608.4444	507247.6	461134.1818	422706.3333	390190.4615	362319.7143	338165.0667	317029.75	281804.2222	266972.4211	253623.8	211353.1667	202899.04	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100391	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	2997074	1498537	999024.6667	749268.5	599414.8	499512.3333	428153.4286	374634.25	333008.2222	299707.4	272461.2727	249756.1667	230544.1538	214076.7143	199804.9333	187317.125	166504.1111	157740.7368	149853.7	124878.0833	119882.96	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100392	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	1956867	978433.5	652289	489216.75	391373.4	326144.5	279552.4286	244608.375	217429.6667	195686.7	177897	163072.25	150528.2308	139776.2143	130457.8	122304.1875	108714.8333	102993	97843.35	81536.125	78274.68	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100393	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	5803571	2901785.5	1934523.667	1450892.75	1160714.2	967261.8333	829081.5714	725446.375	644841.2222	580357.1	527597.3636	483630.9167	446428.5385	414540.7857	386904.7333	362723.1875	322420.6111	305451.1053	290178.55	241815.4583	232142.84	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100394	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	2451618	1225809	817206	612904.5	490323.6	408603	350231.1429	306452.25	272402	245161.8	222874.3636	204301.5	188586	175115.5714	163441.2	153226.125	136201	129032.5263	122580.9	102150.75	98064.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100395	CHOYP_HS90A.1.3|m.7724	EDQTEYLEER	EDQTEYLEER	2012588	1006294	670862.6667	503147	402517.6	335431.3333	287512.5714	251573.5	223620.8889	201258.8	182962.5455	167715.6667	154814.4615	143756.2857	134172.5333	125786.75	111810.4444	105925.6842	100629.4	83857.83333	80503.52	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100396	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100397	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100398	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	19473618	9736809	6491206	4868404.5	3894723.6	3245603	2781945.429	2434202.25	2163735.333	1947361.8	1770328.909	1622801.5	1497970.615	1390972.714	1298241.2	1217101.125	1081867.667	1024927.263	973680.9	811400.75	778944.72	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100399	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100400	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100401	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100402	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100403	CHOYP_HS90A.1.3|m.7724	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04809	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950
100404	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	137200672	68600336	45733557.33	34300168	27440134.4	22866778.67	19600096	17150084	15244519.11	13720067.2	12472788.36	11433389.33	10553897.85	9800048	9146711.467	8575042	7622259.556	7221088	6860033.6	5716694.667	5488026.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100405	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	90965872	45482936	30321957.33	22741468	18193174.4	15160978.67	12995124.57	11370734	10107319.11	9096587.2	8269624.727	7580489.333	6997374.769	6497562.286	6064391.467	5685367	5053659.556	4787677.474	4548293.6	3790244.667	3638634.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100406	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	30774828	15387414	10258276	7693707	6154965.6	5129138	4396404	3846853.5	3419425.333	3077482.8	2797711.636	2564569	2367294.462	2198202	2051655.2	1923426.75	1709712.667	1619727.789	1538741.4	1282284.5	1230993.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100407	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	12594760	6297380	4198253.333	3148690	2518952	2099126.667	1799251.429	1574345	1399417.778	1259476	1144978.182	1049563.333	968827.6923	899625.7143	839650.6667	787172.5	699708.8889	662882.1053	629738	524781.6667	503790.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100408	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	29448114	14724057	9816038	7362028.5	5889622.8	4908019	4206873.429	3681014.25	3272012.667	2944811.4	2677101.273	2454009.5	2265239.538	2103436.714	1963207.6	1840507.125	1636006.333	1549900.737	1472405.7	1227004.75	1177924.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100409	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	5789118	2894559	1929706	1447279.5	1157823.6	964853	827016.8571	723639.75	643235.3333	578911.8	526283.4545	482426.5	445316.7692	413508.4286	385941.2	361819.875	321617.6667	304690.4211	289455.9	241213.25	231564.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100410	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	4633562	2316781	1544520.667	1158390.5	926712.4	772260.3333	661937.4286	579195.25	514840.2222	463356.2	421232.9091	386130.1667	356427.8462	330968.7143	308904.1333	289597.625	257420.1111	243871.6842	231678.1	193065.0833	185342.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100411	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	8718910	4359455	2906303.333	2179727.5	1743782	1453151.667	1245558.571	1089863.75	968767.7778	871891	792628.1818	726575.8333	670685.3846	622779.2857	581260.6667	544931.875	484383.8889	458890	435945.5	363287.9167	348756.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100412	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	2203171	1101585.5	734390.3333	550792.75	440634.2	367195.1667	314738.7143	275396.375	244796.7778	220317.1	200288.2727	183597.5833	169474.6923	157369.3571	146878.0667	137698.1875	122398.3889	115956.3684	110158.55	91798.79167	88126.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100413	CHOYP_HS90A.2.3|m.21992	ADLVNNLGTIAK	ADLVNNLGTIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100414	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	17864282	8932141	5954760.667	4466070.5	3572856.4	2977380.333	2552040.286	2233035.25	1984920.222	1786428.2	1624025.636	1488690.167	1374175.538	1276020.143	1190952.133	1116517.625	992460.1111	940225.3684	893214.1	744345.0833	714571.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100415	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	10012658	5006329	3337552.667	2503164.5	2002531.6	1668776.333	1430379.714	1251582.25	1112517.556	1001265.8	910241.6364	834388.1667	770204.4615	715189.8571	667510.5333	625791.125	556258.7778	526982	500632.9	417194.0833	400506.32	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100416	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	3771518	1885759	1257172.667	942879.5	754303.6	628586.3333	538788.2857	471439.75	419057.5556	377151.8	342865.2727	314293.1667	290116.7692	269394.1429	251434.5333	235719.875	209528.7778	198500.9474	188575.9	157146.5833	150860.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100417	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100418	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	1472569	736284.5	490856.3333	368142.25	294513.8	245428.1667	210367	184071.125	163618.7778	147256.9	133869.9091	122714.0833	113274.5385	105183.5	98171.26667	92035.5625	81809.38889	77503.63158	73628.45	61357.04167	58902.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100419	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	1270680	635340	423560	317670	254136	211780	181525.7143	158835	141186.6667	127068	115516.3636	105890	97744.61538	90762.85714	84712	79417.5	70593.33333	66877.89474	63534	52945	50827.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100420	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	36472	18236	12157.33333	9118	7294.4	6078.666667	5210.285714	4559	4052.444444	3647.2	3315.636364	3039.333333	2805.538462	2605.142857	2431.466667	2279.5	2026.222222	1919.578947	1823.6	1519.666667	1458.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100421	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	84868	42434	28289.33333	21217	16973.6	14144.66667	12124	10608.5	9429.777778	8486.8	7715.272727	7072.333333	6528.307692	6062	5657.866667	5304.25	4714.888889	4466.736842	4243.4	3536.166667	3394.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100422	CHOYP_HS90A.2.3|m.21992	HFSVEGQLEFR	HFSVEGQLEFR	18270	9135	6090	4567.5	3654	3045	2610	2283.75	2030	1827	1660.909091	1522.5	1405.384615	1305	1218	1141.875	1015	961.5789474	913.5	761.25	730.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100423	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	3757289	1878644.5	1252429.667	939322.25	751457.8	626214.8333	536755.5714	469661.125	417476.5556	375728.9	341571.7273	313107.4167	289022.2308	268377.7857	250485.9333	234830.5625	208738.2778	197752.0526	187864.45	156553.7083	150291.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100424	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	1527880	763940	509293.3333	381970	305576	254646.6667	218268.5714	190985	169764.4444	152788	138898.1818	127323.3333	117529.2308	109134.2857	101858.6667	95492.5	84882.22222	80414.73684	76394	63661.66667	61115.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100425	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	1712242	856121	570747.3333	428060.5	342448.4	285373.6667	244606	214030.25	190249.1111	171224.2	155658.3636	142686.8333	131710.9231	122303	114149.4667	107015.125	95124.55556	90118	85612.1	71343.41667	68489.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100426	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	351275	175637.5	117091.6667	87818.75	70255	58545.83333	50182.14286	43909.375	39030.55556	35127.5	31934.09091	29272.91667	27021.15385	25091.07143	23418.33333	21954.6875	19515.27778	18488.15789	17563.75	14636.45833	14051	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100427	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	157520	78760	52506.66667	39380	31504	26253.33333	22502.85714	19690	17502.22222	15752	14320	13126.66667	12116.92308	11251.42857	10501.33333	9845	8751.111111	8290.526316	7876	6563.333333	6300.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100428	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	82842	41421	27614	20710.5	16568.4	13807	11834.57143	10355.25	9204.666667	8284.2	7531.090909	6903.5	6372.461538	5917.285714	5522.8	5177.625	4602.333333	4360.105263	4142.1	3451.75	3313.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100429	CHOYP_HS90A.2.3|m.21992	APFDLFENK	APFDLFENK	17114	8557	5704.666667	4278.5	3422.8	2852.333333	2444.857143	2139.25	1901.555556	1711.4	1555.818182	1426.166667	1316.461538	1222.428571	1140.933333	1069.625	950.7777778	900.7368421	855.7	713.0833333	684.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100430	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100431	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100432	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100433	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4393975	2196987.5	1464658.333	1098493.75	878795	732329.1667	627710.7143	549246.875	488219.4444	439397.5	399452.2727	366164.5833	337998.0769	313855.3571	292931.6667	274623.4375	244109.7222	231261.8421	219698.75	183082.2917	175759	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100434	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4337723	2168861.5	1445907.667	1084430.75	867544.6	722953.8333	619674.7143	542215.375	481969.2222	433772.3	394338.4545	361476.9167	333671	309837.3571	289181.5333	271107.6875	240984.6111	228301.2105	216886.15	180738.4583	173508.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100435	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1902385	951192.5	634128.3333	475596.25	380477	317064.1667	271769.2857	237798.125	211376.1111	190238.5	172944.0909	158532.0833	146337.3077	135884.6429	126825.6667	118899.0625	105688.0556	100125.5263	95119.25	79266.04167	76095.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100436	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4885845	2442922.5	1628615	1221461.25	977169	814307.5	697977.8571	610730.625	542871.6667	488584.5	444167.7273	407153.75	375834.2308	348988.9286	325723	305365.3125	271435.8333	257149.7368	244292.25	203576.875	195433.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100437	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	5748341	2874170.5	1916113.667	1437085.25	1149668.2	958056.8333	821191.5714	718542.625	638704.5556	574834.1	522576.4545	479028.4167	442180.0769	410595.7857	383222.7333	359271.3125	319352.2778	302544.2632	287417.05	239514.2083	229933.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100438	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	15453536	7726768	5151178.667	3863384	3090707.2	2575589.333	2207648	1931692	1717059.556	1545353.6	1404866.909	1287794.667	1188733.538	1103824	1030235.733	965846	858529.7778	813344	772676.8	643897.3333	618141.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100439	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	585205	292602.5	195068.3333	146301.25	117041	97534.16667	83600.71429	73150.625	65022.77778	58520.5	53200.45455	48767.08333	45015.76923	41800.35714	39013.66667	36575.3125	32511.38889	30800.26316	29260.25	24383.54167	23408.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100440	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1079081	539540.5	359693.6667	269770.25	215816.2	179846.8333	154154.4286	134885.125	119897.8889	107908.1	98098.27273	89923.41667	83006.23077	77077.21429	71938.73333	67442.5625	59948.94444	56793.73684	53954.05	44961.70833	43163.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100441	CHOYP_HS90A.2.3|m.21992	GVVDSEDLPLNISR	GVVDSEDLPLNISR	819544	409772	273181.3333	204886	163908.8	136590.6667	117077.7143	102443	91060.44444	81954.4	74504	68295.33333	63041.84615	58538.85714	54636.26667	51221.5	45530.22222	43133.89474	40977.2	34147.66667	32781.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100477	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	137200672	68600336	45733557.33	34300168	27440134.4	22866778.67	19600096	17150084	15244519.11	13720067.2	12472788.36	11433389.33	10553897.85	9800048	9146711.467	8575042	7622259.556	7221088	6860033.6	5716694.667	5488026.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100478	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	90965872	45482936	30321957.33	22741468	18193174.4	15160978.67	12995124.57	11370734	10107319.11	9096587.2	8269624.727	7580489.333	6997374.769	6497562.286	6064391.467	5685367	5053659.556	4787677.474	4548293.6	3790244.667	3638634.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100479	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	30774828	15387414	10258276	7693707	6154965.6	5129138	4396404	3846853.5	3419425.333	3077482.8	2797711.636	2564569	2367294.462	2198202	2051655.2	1923426.75	1709712.667	1619727.789	1538741.4	1282284.5	1230993.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100480	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	12594760	6297380	4198253.333	3148690	2518952	2099126.667	1799251.429	1574345	1399417.778	1259476	1144978.182	1049563.333	968827.6923	899625.7143	839650.6667	787172.5	699708.8889	662882.1053	629738	524781.6667	503790.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100481	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	29448114	14724057	9816038	7362028.5	5889622.8	4908019	4206873.429	3681014.25	3272012.667	2944811.4	2677101.273	2454009.5	2265239.538	2103436.714	1963207.6	1840507.125	1636006.333	1549900.737	1472405.7	1227004.75	1177924.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100482	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	5789118	2894559	1929706	1447279.5	1157823.6	964853	827016.8571	723639.75	643235.3333	578911.8	526283.4545	482426.5	445316.7692	413508.4286	385941.2	361819.875	321617.6667	304690.4211	289455.9	241213.25	231564.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100483	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	4633562	2316781	1544520.667	1158390.5	926712.4	772260.3333	661937.4286	579195.25	514840.2222	463356.2	421232.9091	386130.1667	356427.8462	330968.7143	308904.1333	289597.625	257420.1111	243871.6842	231678.1	193065.0833	185342.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100484	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	8718910	4359455	2906303.333	2179727.5	1743782	1453151.667	1245558.571	1089863.75	968767.7778	871891	792628.1818	726575.8333	670685.3846	622779.2857	581260.6667	544931.875	484383.8889	458890	435945.5	363287.9167	348756.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100485	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	2203171	1101585.5	734390.3333	550792.75	440634.2	367195.1667	314738.7143	275396.375	244796.7778	220317.1	200288.2727	183597.5833	169474.6923	157369.3571	146878.0667	137698.1875	122398.3889	115956.3684	110158.55	91798.79167	88126.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100486	CHOYP_HS90A.3.3|m.28299	ADLVNNLGTIAK	ADLVNNLGTIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100487	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	27152228	13576114	9050742.667	6788057	5430445.6	4525371.333	3878889.714	3394028.5	3016914.222	2715222.8	2468384.364	2262685.667	2088632.923	1939444.857	1810148.533	1697014.25	1508457.111	1429064.632	1357611.4	1131342.833	1086089.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100488	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	17048176	8524088	5682725.333	4262044	3409635.2	2841362.667	2435453.714	2131022	1894241.778	1704817.6	1549834.182	1420681.333	1311398.154	1217726.857	1136545.067	1065511	947120.8889	897272.4211	852408.8	710340.6667	681927.04	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100489	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	5072476	2536238	1690825.333	1268119	1014495.2	845412.6667	724639.4286	634059.5	563608.4444	507247.6	461134.1818	422706.3333	390190.4615	362319.7143	338165.0667	317029.75	281804.2222	266972.4211	253623.8	211353.1667	202899.04	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100490	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	2997074	1498537	999024.6667	749268.5	599414.8	499512.3333	428153.4286	374634.25	333008.2222	299707.4	272461.2727	249756.1667	230544.1538	214076.7143	199804.9333	187317.125	166504.1111	157740.7368	149853.7	124878.0833	119882.96	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100491	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	1956867	978433.5	652289	489216.75	391373.4	326144.5	279552.4286	244608.375	217429.6667	195686.7	177897	163072.25	150528.2308	139776.2143	130457.8	122304.1875	108714.8333	102993	97843.35	81536.125	78274.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100492	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	5803571	2901785.5	1934523.667	1450892.75	1160714.2	967261.8333	829081.5714	725446.375	644841.2222	580357.1	527597.3636	483630.9167	446428.5385	414540.7857	386904.7333	362723.1875	322420.6111	305451.1053	290178.55	241815.4583	232142.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100493	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	2451618	1225809	817206	612904.5	490323.6	408603	350231.1429	306452.25	272402	245161.8	222874.3636	204301.5	188586	175115.5714	163441.2	153226.125	136201	129032.5263	122580.9	102150.75	98064.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100494	CHOYP_HS90A.3.3|m.28299	EDQTEYLEER	EDQTEYLEER	2012588	1006294	670862.6667	503147	402517.6	335431.3333	287512.5714	251573.5	223620.8889	201258.8	182962.5455	167715.6667	154814.4615	143756.2857	134172.5333	125786.75	111810.4444	105925.6842	100629.4	83857.83333	80503.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100495	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100496	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100497	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	19473618	9736809	6491206	4868404.5	3894723.6	3245603	2781945.429	2434202.25	2163735.333	1947361.8	1770328.909	1622801.5	1497970.615	1390972.714	1298241.2	1217101.125	1081867.667	1024927.263	973680.9	811400.75	778944.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100498	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100499	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100500	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100501	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100502	CHOYP_HS90A.3.3|m.28299	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100503	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100504	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100505	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100506	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100507	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	575470	287735	191823.3333	143867.5	115094	95911.66667	82210	71933.75	63941.11111	57547	52315.45455	47955.83333	44266.92308	41105	38364.66667	35966.875	31970.55556	30287.89474	28773.5	23977.91667	23018.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100508	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	416278	208139	138759.3333	104069.5	83255.6	69379.66667	59468.28571	52034.75	46253.11111	41627.8	37843.45455	34689.83333	32021.38462	29734.14286	27751.86667	26017.375	23126.55556	21909.36842	20813.9	17344.91667	16651.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100509	CHOYP_HS90A.3.3|m.28299	YTEDEELNK	YTEDEELNK	639696	319848	213232	159924	127939.2	106616	91385.14286	79962	71077.33333	63969.6	58154.18182	53308	49207.38462	45692.57143	42646.4	39981	35538.66667	33668.21053	31984.8	26654	25587.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100510	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100511	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100512	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100513	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100514	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	316978	158489	105659.3333	79244.5	63395.6	52829.66667	45282.57143	39622.25	35219.77778	31697.8	28816.18182	26414.83333	24382.92308	22641.28571	21131.86667	19811.125	17609.88889	16683.05263	15848.9	13207.41667	12679.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100515	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	2581021	1290510.5	860340.3333	645255.25	516204.2	430170.1667	368717.2857	322627.625	286780.1111	258102.1	234638.2727	215085.0833	198540.0769	184358.6429	172068.0667	161313.8125	143390.0556	135843.2105	129051.05	107542.5417	103240.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100516	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	730238	365119	243412.6667	182559.5	146047.6	121706.3333	104319.7143	91279.75	81137.55556	73023.8	66385.27273	60853.16667	56172.15385	52159.85714	48682.53333	45639.875	40568.77778	38433.57895	36511.9	30426.58333	29209.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100517	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	821856	410928	273952	205464	164371.2	136976	117408	102732	91317.33333	82185.6	74714.18182	68488	63219.69231	58704	54790.4	51366	45658.66667	43255.57895	41092.8	34244	32874.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100518	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100519	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	824836	412418	274945.3333	206209	164967.2	137472.6667	117833.7143	103104.5	91648.44444	82483.6	74985.09091	68736.33333	63448.92308	58916.85714	54989.06667	51552.25	45824.22222	43412.42105	41241.8	34368.16667	32993.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100520	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	801313	400656.5	267104.3333	200328.25	160262.6	133552.1667	114473.2857	100164.125	89034.77778	80131.3	72846.63636	66776.08333	61639.46154	57236.64286	53420.86667	50082.0625	44517.38889	42174.36842	40065.65	33388.04167	32052.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100521	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	185516	92758	61838.66667	46379	37103.2	30919.33333	26502.28571	23189.5	20612.88889	18551.6	16865.09091	15459.66667	14270.46154	13251.14286	12367.73333	11594.75	10306.44444	9764	9275.8	7729.833333	7420.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100522	CHOYP_HS90A.3.3|m.28299	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	443256	221628	147752	110814	88651.2	73876	63322.28571	55407	49250.66667	44325.6	40296	36938	34096.61538	31661.14286	29550.4	27703.5	24625.33333	23329.26316	22162.8	18469	17730.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100523	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	47715980	23857990	15905326.67	11928995	9543196	7952663.333	6816568.571	5964497.5	5301775.556	4771598	4337816.364	3976331.667	3670460	3408284.286	3181065.333	2982248.75	2650887.778	2511367.368	2385799	1988165.833	1908639.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100524	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	38412468	19206234	12804156	9603117	7682493.6	6402078	5487495.429	4801558.5	4268052	3841246.8	3492042.545	3201039	2954805.231	2743747.714	2560831.2	2400779.25	2134026	2021708.842	1920623.4	1600519.5	1536498.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100525	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	16823500	8411750	5607833.333	4205875	3364700	2803916.667	2403357.143	2102937.5	1869277.778	1682350	1529409.091	1401958.333	1294115.385	1201678.571	1121566.667	1051468.75	934638.8889	885447.3684	841175	700979.1667	672940	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100526	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	2572090	1286045	857363.3333	643022.5	514418	428681.6667	367441.4286	321511.25	285787.7778	257209	233826.3636	214340.8333	197853.0769	183720.7143	171472.6667	160755.625	142893.8889	135373.1579	128604.5	107170.4167	102883.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100527	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	2815414	1407707	938471.3333	703853.5	563082.8	469235.6667	402202	351926.75	312823.7778	281541.4	255946.7273	234617.8333	216570.3077	201101	187694.2667	175963.375	156411.8889	148179.6842	140770.7	117308.9167	112616.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100528	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	3773561	1886780.5	1257853.667	943390.25	754712.2	628926.8333	539080.1429	471695.125	419284.5556	377356.1	343051	314463.4167	290273.9231	269540.0714	251570.7333	235847.5625	209642.2778	198608.4737	188678.05	157231.7083	150942.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100529	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	3425087	1712543.5	1141695.667	856271.75	685017.4	570847.8333	489298.1429	428135.875	380565.2222	342508.7	311371.5455	285423.9167	263468.2308	244649.0714	228339.1333	214067.9375	190282.6111	180267.7368	171254.35	142711.9583	137003.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100530	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	796420	398210	265473.3333	199105	159284	132736.6667	113774.2857	99552.5	88491.11111	79642	72401.81818	66368.33333	61263.07692	56887.14286	53094.66667	49776.25	44245.55556	41916.84211	39821	33184.16667	31856.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100531	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	1816225	908112.5	605408.3333	454056.25	363245	302704.1667	259460.7143	227028.125	201802.7778	181622.5	165111.3636	151352.0833	139709.6154	129730.3571	121081.6667	113514.0625	100901.3889	95590.78947	90811.25	75676.04167	72649	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100532	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	1121453	560726.5	373817.6667	280363.25	224290.6	186908.8333	160207.5714	140181.625	124605.8889	112145.3	101950.2727	93454.41667	86265.61538	80103.78571	74763.53333	70090.8125	62302.94444	59023.84211	56072.65	46727.20833	44858.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100533	CHOYP_HS90A.3.3|m.28299	SLTNDWEDHLAVK	SLTNDWEDHLAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100534	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	17864282	8932141	5954760.667	4466070.5	3572856.4	2977380.333	2552040.286	2233035.25	1984920.222	1786428.2	1624025.636	1488690.167	1374175.538	1276020.143	1190952.133	1116517.625	992460.1111	940225.3684	893214.1	744345.0833	714571.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100535	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	10012658	5006329	3337552.667	2503164.5	2002531.6	1668776.333	1430379.714	1251582.25	1112517.556	1001265.8	910241.6364	834388.1667	770204.4615	715189.8571	667510.5333	625791.125	556258.7778	526982	500632.9	417194.0833	400506.32	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100536	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	3771518	1885759	1257172.667	942879.5	754303.6	628586.3333	538788.2857	471439.75	419057.5556	377151.8	342865.2727	314293.1667	290116.7692	269394.1429	251434.5333	235719.875	209528.7778	198500.9474	188575.9	157146.5833	150860.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100537	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100538	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	1472569	736284.5	490856.3333	368142.25	294513.8	245428.1667	210367	184071.125	163618.7778	147256.9	133869.9091	122714.0833	113274.5385	105183.5	98171.26667	92035.5625	81809.38889	77503.63158	73628.45	61357.04167	58902.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100539	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	1270680	635340	423560	317670	254136	211780	181525.7143	158835	141186.6667	127068	115516.3636	105890	97744.61538	90762.85714	84712	79417.5	70593.33333	66877.89474	63534	52945	50827.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100540	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	36472	18236	12157.33333	9118	7294.4	6078.666667	5210.285714	4559	4052.444444	3647.2	3315.636364	3039.333333	2805.538462	2605.142857	2431.466667	2279.5	2026.222222	1919.578947	1823.6	1519.666667	1458.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100541	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	84868	42434	28289.33333	21217	16973.6	14144.66667	12124	10608.5	9429.777778	8486.8	7715.272727	7072.333333	6528.307692	6062	5657.866667	5304.25	4714.888889	4466.736842	4243.4	3536.166667	3394.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100542	CHOYP_HS90A.3.3|m.28299	HFSVEGQLEFR	HFSVEGQLEFR	18270	9135	6090	4567.5	3654	3045	2610	2283.75	2030	1827	1660.909091	1522.5	1405.384615	1305	1218	1141.875	1015	961.5789474	913.5	761.25	730.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100543	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	3757289	1878644.5	1252429.667	939322.25	751457.8	626214.8333	536755.5714	469661.125	417476.5556	375728.9	341571.7273	313107.4167	289022.2308	268377.7857	250485.9333	234830.5625	208738.2778	197752.0526	187864.45	156553.7083	150291.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100544	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	1527880	763940	509293.3333	381970	305576	254646.6667	218268.5714	190985	169764.4444	152788	138898.1818	127323.3333	117529.2308	109134.2857	101858.6667	95492.5	84882.22222	80414.73684	76394	63661.66667	61115.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100545	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	1712242	856121	570747.3333	428060.5	342448.4	285373.6667	244606	214030.25	190249.1111	171224.2	155658.3636	142686.8333	131710.9231	122303	114149.4667	107015.125	95124.55556	90118	85612.1	71343.41667	68489.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100546	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	351275	175637.5	117091.6667	87818.75	70255	58545.83333	50182.14286	43909.375	39030.55556	35127.5	31934.09091	29272.91667	27021.15385	25091.07143	23418.33333	21954.6875	19515.27778	18488.15789	17563.75	14636.45833	14051	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100547	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	157520	78760	52506.66667	39380	31504	26253.33333	22502.85714	19690	17502.22222	15752	14320	13126.66667	12116.92308	11251.42857	10501.33333	9845	8751.111111	8290.526316	7876	6563.333333	6300.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100548	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	82842	41421	27614	20710.5	16568.4	13807	11834.57143	10355.25	9204.666667	8284.2	7531.090909	6903.5	6372.461538	5917.285714	5522.8	5177.625	4602.333333	4360.105263	4142.1	3451.75	3313.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100549	CHOYP_HS90A.3.3|m.28299	APFDLFENK	APFDLFENK	17114	8557	5704.666667	4278.5	3422.8	2852.333333	2444.857143	2139.25	1901.555556	1711.4	1555.818182	1426.166667	1316.461538	1222.428571	1140.933333	1069.625	950.7777778	900.7368421	855.7	713.0833333	684.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100550	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100551	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100552	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100553	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4393975	2196987.5	1464658.333	1098493.75	878795	732329.1667	627710.7143	549246.875	488219.4444	439397.5	399452.2727	366164.5833	337998.0769	313855.3571	292931.6667	274623.4375	244109.7222	231261.8421	219698.75	183082.2917	175759	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100554	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4337723	2168861.5	1445907.667	1084430.75	867544.6	722953.8333	619674.7143	542215.375	481969.2222	433772.3	394338.4545	361476.9167	333671	309837.3571	289181.5333	271107.6875	240984.6111	228301.2105	216886.15	180738.4583	173508.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100555	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1902385	951192.5	634128.3333	475596.25	380477	317064.1667	271769.2857	237798.125	211376.1111	190238.5	172944.0909	158532.0833	146337.3077	135884.6429	126825.6667	118899.0625	105688.0556	100125.5263	95119.25	79266.04167	76095.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100556	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4885845	2442922.5	1628615	1221461.25	977169	814307.5	697977.8571	610730.625	542871.6667	488584.5	444167.7273	407153.75	375834.2308	348988.9286	325723	305365.3125	271435.8333	257149.7368	244292.25	203576.875	195433.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100557	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	5748341	2874170.5	1916113.667	1437085.25	1149668.2	958056.8333	821191.5714	718542.625	638704.5556	574834.1	522576.4545	479028.4167	442180.0769	410595.7857	383222.7333	359271.3125	319352.2778	302544.2632	287417.05	239514.2083	229933.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100558	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	15453536	7726768	5151178.667	3863384	3090707.2	2575589.333	2207648	1931692	1717059.556	1545353.6	1404866.909	1287794.667	1188733.538	1103824	1030235.733	965846	858529.7778	813344	772676.8	643897.3333	618141.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100559	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	585205	292602.5	195068.3333	146301.25	117041	97534.16667	83600.71429	73150.625	65022.77778	58520.5	53200.45455	48767.08333	45015.76923	41800.35714	39013.66667	36575.3125	32511.38889	30800.26316	29260.25	24383.54167	23408.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100560	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1079081	539540.5	359693.6667	269770.25	215816.2	179846.8333	154154.4286	134885.125	119897.8889	107908.1	98098.27273	89923.41667	83006.23077	77077.21429	71938.73333	67442.5625	59948.94444	56793.73684	53954.05	44961.70833	43163.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100561	CHOYP_HS90A.3.3|m.28299	GVVDSEDLPLNISR	GVVDSEDLPLNISR	819544	409772	273181.3333	204886	163908.8	136590.6667	117077.7143	102443	91060.44444	81954.4	74504	68295.33333	63041.84615	58538.85714	54636.26667	51221.5	45530.22222	43133.89474	40977.2	34147.66667	32781.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100562	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	25262710	12631355	8420903.333	6315677.5	5052542	4210451.667	3608958.571	3157838.75	2806967.778	2526271	2296610	2105225.833	1943285.385	1804479.286	1684180.667	1578919.375	1403483.889	1329616.316	1263135.5	1052612.917	1010508.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100563	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	12922148	6461074	4307382.667	3230537	2584429.6	2153691.333	1846021.143	1615268.5	1435794.222	1292214.8	1174740.727	1076845.667	994011.3846	923010.5714	861476.5333	807634.25	717897.1111	680113.0526	646107.4	538422.8333	516885.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100564	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	7798479	3899239.5	2599493	1949619.75	1559695.8	1299746.5	1114068.429	974809.875	866497.6667	779847.9	708952.6364	649873.25	599883	557034.2143	519898.6	487404.9375	433248.8333	410446.2632	389923.95	324936.625	311939.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100565	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	2521297	1260648.5	840432.3333	630324.25	504259.4	420216.1667	360185.2857	315162.125	280144.1111	252129.7	229208.8182	210108.0833	193945.9231	180092.6429	168086.4667	157581.0625	140072.0556	132699.8421	126064.85	105054.0417	100851.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100566	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	4679675	2339837.5	1559891.667	1169918.75	935935	779945.8333	668525	584959.375	519963.8889	467967.5	425425	389972.9167	359975	334262.5	311978.3333	292479.6875	259981.9444	246298.6842	233983.75	194986.4583	187187	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100567	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	2229400	1114700	743133.3333	557350	445880	371566.6667	318485.7143	278675	247711.1111	222940	202672.7273	185783.3333	171492.3077	159242.8571	148626.6667	139337.5	123855.5556	117336.8421	111470	92891.66667	89176	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100568	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	1824289	912144.5	608096.3333	456072.25	364857.8	304048.1667	260612.7143	228036.125	202698.7778	182428.9	165844.4545	152024.0833	140329.9231	130306.3571	121619.2667	114018.0625	101349.3889	96015.21053	91214.45	76012.04167	72971.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100569	CHOYP_HS90A.3.3|m.28299	LGIHEDSTNR	LGIHEDSTNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100570	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100571	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100572	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100573	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100574	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100575	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	1272731	636365.5	424243.6667	318182.75	254546.2	212121.8333	181818.7143	159091.375	141414.5556	127273.1	115702.8182	106060.9167	97902.38462	90909.35714	84848.73333	79545.6875	70707.27778	66985.84211	63636.55	53030.45833	50909.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100576	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100577	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100578	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	227146	113573	75715.33333	56786.5	45429.2	37857.66667	32449.42857	28393.25	25238.44444	22714.6	20649.63636	18928.83333	17472.76923	16224.71429	15143.06667	14196.625	12619.22222	11955.05263	11357.3	9464.416667	9085.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100579	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	104115	52057.5	34705	26028.75	20823	17352.5	14873.57143	13014.375	11568.33333	10411.5	9465	8676.25	8008.846154	7436.785714	6941	6507.1875	5784.166667	5479.736842	5205.75	4338.125	4164.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100580	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100581	CHOYP_HS90A.3.3|m.28299	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100582	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	89922672	44961336	29974224	22480668	17984534.4	14987112	12846096	11240334	9991408	8992267.2	8174788.364	7493556	6917128.615	6423048	5994844.8	5620167	4995704	4732772.211	4496133.6	3746778	3596906.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100583	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	56376732	28188366	18792244	14094183	11275346.4	9396122	8053818.857	7047091.5	6264081.333	5637673.2	5125157.455	4698061	4336671.692	4026909.429	3758448.8	3523545.75	3132040.667	2967196.421	2818836.6	2349030.5	2255069.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100584	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	17493822	8746911	5831274	4373455.5	3498764.4	2915637	2499117.429	2186727.75	1943758	1749382.2	1590347.455	1457818.5	1345678.615	1249558.714	1166254.8	1093363.875	971879	920727.4737	874691.1	728909.25	699752.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100585	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	9596298	4798149	3198766	2399074.5	1919259.6	1599383	1370899.714	1199537.25	1066255.333	959629.8	872390.7273	799691.5	738176.7692	685449.8571	639753.2	599768.625	533127.6667	505068.3158	479814.9	399845.75	383851.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100586	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	10079618	5039809	3359872.667	2519904.5	2015923.6	1679936.333	1439945.429	1259952.25	1119957.556	1007961.8	916328.9091	839968.1667	775355.2308	719972.7143	671974.5333	629976.125	559978.7778	530506.2105	503980.9	419984.0833	403184.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100587	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	8583982	4291991	2861327.333	2145995.5	1716796.4	1430663.667	1226283.143	1072997.75	953775.7778	858398.2	780362	715331.8333	660306.3077	613141.5714	572265.4667	536498.875	476887.8889	451788.5263	429199.1	357665.9167	343359.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100588	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	2949375	1474687.5	983125	737343.75	589875	491562.5	421339.2857	368671.875	327708.3333	294937.5	268125	245781.25	226875	210669.6429	196625	184335.9375	163854.1667	155230.2632	147468.75	122890.625	117975	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100589	CHOYP_HS90A.3.3|m.28299	SIYYITGESR	SIYYITGESR	324964	162482	108321.3333	81241	64992.8	54160.66667	46423.42857	40620.5	36107.11111	32496.4	29542.18182	27080.33333	24997.23077	23211.71429	21664.26667	20310.25	18053.55556	17103.36842	16248.2	13540.16667	12998.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100590	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	106232720	53116360	35410906.67	26558180	21246544	17705453.33	15176102.86	13279090	11803635.56	10623272	9657520	8852726.667	8171747.692	7588051.429	7082181.333	6639545	5901817.778	5591195.789	5311636	4426363.333	4249308.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100591	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	72286568	36143284	24095522.67	18071642	14457313.6	12047761.33	10326652.57	9035821	8031840.889	7228656.8	6571506.182	6023880.667	5560505.231	5163326.286	4819104.533	4517910.5	4015920.444	3804556.211	3614328.4	3011940.333	2891462.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100592	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	27068290	13534145	9022763.333	6767072.5	5413658	4511381.667	3866898.571	3383536.25	3007587.778	2706829	2460753.636	2255690.833	2082176.154	1933449.286	1804552.667	1691768.125	1503793.889	1424646.842	1353414.5	1127845.417	1082731.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100593	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	22171104	11085552	7390368	5542776	4434220.8	3695184	3167300.571	2771388	2463456	2217110.4	2015554.909	1847592	1705469.538	1583650.286	1478073.6	1385694	1231728	1166900.211	1108555.2	923796	886844.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100594	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	30104462	15052231	10034820.67	7526115.5	6020892.4	5017410.333	4300637.429	3763057.75	3344940.222	3010446.2	2736769.273	2508705.167	2315727.846	2150318.714	2006964.133	1881528.875	1672470.111	1584445.368	1505223.1	1254352.583	1204178.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100595	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	10070523	5035261.5	3356841	2517630.75	2014104.6	1678420.5	1438646.143	1258815.375	1118947	1007052.3	915502.0909	839210.25	774655.6154	719323.0714	671368.2	629407.6875	559473.5	530027.5263	503526.15	419605.125	402820.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100596	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	4609245	2304622.5	1536415	1152311.25	921849	768207.5	658463.5714	576155.625	512138.3333	460924.5	419022.2727	384103.75	354557.3077	329231.7857	307283	288077.8125	256069.1667	242591.8421	230462.25	192051.875	184369.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100597	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	4759845	2379922.5	1586615	1189961.25	951969	793307.5	679977.8571	594980.625	528871.6667	475984.5	432713.1818	396653.75	366141.9231	339988.9286	317323	297490.3125	264435.8333	250518.1579	237992.25	198326.875	190393.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100598	CHOYP_HS90A.3.3|m.28299	EVVQSSAFVER	EVVQSSAFVER	2809118	1404559	936372.6667	702279.5	561823.6	468186.3333	401302.5714	351139.75	312124.2222	280911.8	255374.3636	234093.1667	216086	200651.2857	187274.5333	175569.875	156062.1111	147848.3158	140455.9	117046.5833	112364.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100599	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	1919803	959901.5	639934.3333	479950.75	383960.6	319967.1667	274257.5714	239975.375	213311.4444	191980.3	174527.5455	159983.5833	147677.1538	137128.7857	127986.8667	119987.6875	106655.7222	101042.2632	95990.15	79991.79167	76792.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100600	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100601	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100602	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100603	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100604	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100605	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100606	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100607	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100608	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100609	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100610	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100611	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100612	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100613	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100614	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100615	CHOYP_HS90A.3.3|m.28299	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100616	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	75562496	37781248	25187498.67	18890624	15112499.2	12593749.33	10794642.29	9445312	8395832.889	7556249.6	6869317.818	6296874.667	5812499.692	5397321.143	5037499.733	4722656	4197916.444	3976973.474	3778124.8	3148437.333	3022499.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100617	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	55542052	27771026	18514017.33	13885513	11108410.4	9257008.667	7934578.857	6942756.5	6171339.111	5554205.2	5049277.455	4628504.333	4272465.538	3967289.429	3702803.467	3471378.25	3085669.556	2923265.895	2777102.6	2314252.167	2221682.08	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100618	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	25342870	12671435	8447623.333	6335717.5	5068574	4223811.667	3620410	3167858.75	2815874.444	2534287	2303897.273	2111905.833	1949451.538	1810205	1689524.667	1583929.375	1407937.222	1333835.263	1267143.5	1055952.917	1013714.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100619	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	1635356	817678	545118.6667	408839	327071.2	272559.3333	233622.2857	204419.5	181706.2222	163535.6	148668.7273	136279.6667	125796.6154	116811.1429	109023.7333	102209.75	90853.11111	86071.36842	81767.8	68139.83333	65414.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100620	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100621	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	22193678	11096839	7397892.667	5548419.5	4438735.6	3698946.333	3170525.429	2774209.75	2465964.222	2219367.8	2017607.091	1849473.167	1707206	1585262.714	1479578.533	1387104.875	1232982.111	1168088.316	1109683.9	924736.5833	887747.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100622	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100623	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	2146120	1073060	715373.3333	536530	429224	357686.6667	306588.5714	268265	238457.7778	214612	195101.8182	178843.3333	165086.1538	153294.2857	143074.6667	134132.5	119228.8889	112953.6842	107306	89421.66667	85844.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100624	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	2670466	1335233	890155.3333	667616.5	534093.2	445077.6667	381495.1429	333808.25	296718.4444	267046.6	242769.6364	222538.8333	205420.4615	190747.5714	178031.0667	166904.125	148359.2222	140550.8421	133523.3	111269.4167	106818.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100625	CHOYP_HS90A.3.3|m.28299	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100626	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	61842912	30921456	20614304	15460728	12368582.4	10307152	8834701.714	7730364	6871434.667	6184291.2	5622082.909	5153576	4757147.077	4417350.857	4122860.8	3865182	3435717.333	3254890.105	3092145.6	2576788	2473716.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100627	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100628	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	20161494	10080747	6720498	5040373.5	4032298.8	3360249	2880213.429	2520186.75	2240166	2016149.4	1832863.091	1680124.5	1550884.154	1440106.714	1344099.6	1260093.375	1120083	1061131.263	1008074.7	840062.25	806459.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100629	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	1593393	796696.5	531131	398348.25	318678.6	265565.5	227627.5714	199174.125	177043.6667	159339.3	144853.9091	132782.75	122568.6923	113813.7857	106226.2	99587.0625	88521.83333	83862.78947	79669.65	66391.375	63735.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100630	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	3507490	1753745	1169163.333	876872.5	701498	584581.6667	501070	438436.25	389721.1111	350749	318862.7273	292290.8333	269806.9231	250535	233832.6667	219218.125	194860.5556	184604.7368	175374.5	146145.4167	140299.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100631	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	16273881	8136940.5	5424627	4068470.25	3254776.2	2712313.5	2324840.143	2034235.125	1808209	1627388.1	1479443.727	1356156.75	1251837	1162420.071	1084925.4	1017117.563	904104.5	856520.0526	813694.05	678078.375	650955.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100632	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	690731	345365.5	230243.6667	172682.75	138146.2	115121.8333	98675.85714	86341.375	76747.88889	69073.1	62793.72727	57560.91667	53133.15385	49337.92857	46048.73333	43170.6875	38373.94444	36354.26316	34536.55	28780.45833	27629.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100633	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	896022	448011	298674	224005.5	179204.4	149337	128003.1429	112002.75	99558	89602.2	81456.54545	74668.5	68924.76923	64001.57143	59734.8	56001.375	49779	47159.05263	44801.1	37334.25	35840.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100634	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	1017388	508694	339129.3333	254347	203477.6	169564.6667	145341.1429	127173.5	113043.1111	101738.8	92489.81818	84782.33333	78260.61538	72670.57143	67825.86667	63586.75	56521.55556	53546.73684	50869.4	42391.16667	40695.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100635	CHOYP_HS90A.3.3|m.28299	EGLELPEDEEEK	EGLELPEDEEEK	446453	223226.5	148817.6667	111613.25	89290.6	74408.83333	63779	55806.625	49605.88889	44645.3	40586.63636	37204.41667	34342.53846	31889.5	29763.53333	27903.3125	24802.94444	23497.52632	22322.65	18602.20833	17858.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100636	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	62637692	31318846	20879230.67	15659423	12527538.4	10439615.33	8948241.714	7829711.5	6959743.556	6263769.2	5694335.636	5219807.667	4818284	4474120.857	4175846.133	3914855.75	3479871.778	3296720.632	3131884.6	2609903.833	2505507.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100637	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	35214484	17607242	11738161.33	8803621	7042896.8	5869080.667	5030640.571	4401810.5	3912720.444	3521448.4	3201316.727	2934540.333	2708806.462	2515320.286	2347632.267	2200905.25	1956360.222	1853393.895	1760724.2	1467270.167	1408579.36	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100638	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	15686494	7843247	5228831.333	3921623.5	3137298.8	2614415.667	2240927.714	1960811.75	1742943.778	1568649.4	1426044.909	1307207.833	1206653.385	1120463.857	1045766.267	980405.875	871471.8889	825604.9474	784324.7	653603.9167	627459.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100639	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	2429248	1214624	809749.3333	607312	485849.6	404874.6667	347035.4286	303656	269916.4444	242924.8	220840.7273	202437.3333	186865.2308	173517.7143	161949.8667	151828	134958.2222	127855.1579	121462.4	101218.6667	97169.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100640	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	4712405	2356202.5	1570801.667	1178101.25	942481	785400.8333	673200.7143	589050.625	523600.5556	471240.5	428400.4545	392700.4167	362492.6923	336600.3571	314160.3333	294525.3125	261800.2778	248021.3158	235620.25	196350.2083	188496.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100641	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	7045932	3522966	2348644	1761483	1409186.4	1174322	1006561.714	880741.5	782881.3333	704593.2	640539.2727	587161	541994.7692	503280.8571	469728.8	440370.75	391440.6667	370838.5263	352296.6	293580.5	281837.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100642	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	607062	303531	202354	151765.5	121412.4	101177	86723.14286	75882.75	67451.33333	60706.2	55187.45455	50588.5	46697.07692	43361.57143	40470.8	37941.375	33725.66667	31950.63158	30353.1	25294.25	24282.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100643	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	1594104	797052	531368	398526	318820.8	265684	227729.1429	199263	177122.6667	159410.4	144918.5455	132842	122623.3846	113864.5714	106273.6	99631.5	88561.33333	83900.21053	79705.2	66421	63764.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100644	CHOYP_HS90A.3.3|m.28299	DSSTMGYMAAK	DSSTMGYMAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100645	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	48885548	24442774	16295182.67	12221387	9777109.6	8147591.333	6983649.714	6110693.5	5431727.556	4888554.8	4444140.727	4073795.667	3760426.769	3491824.857	3259036.533	3055346.75	2715863.778	2572923.579	2444277.4	2036897.833	1955421.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100646	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100647	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100648	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	325035	162517.5	108345	81258.75	65007	54172.5	46433.57143	40629.375	36115	32503.5	29548.63636	27086.25	25002.69231	23216.78571	21669	20314.6875	18057.5	17107.10526	16251.75	13543.125	13001.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100649	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	248489	124244.5	82829.66667	62122.25	49697.8	41414.83333	35498.42857	31061.125	27609.88889	24848.9	22589.90909	20707.41667	19114.53846	17749.21429	16565.93333	15530.5625	13804.94444	13078.36842	12424.45	10353.70833	9939.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100650	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	469774	234887	156591.3333	117443.5	93954.8	78295.66667	67110.57143	58721.75	52197.11111	46977.4	42706.72727	39147.83333	36136.46154	33555.28571	31318.26667	29360.875	26098.55556	24724.94737	23488.7	19573.91667	18790.96	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100651	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100652	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100653	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100654	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	35439	17719.5	11813	8859.75	7087.8	5906.5	5062.714286	4429.875	3937.666667	3543.9	3221.727273	2953.25	2726.076923	2531.357143	2362.6	2214.9375	1968.833333	1865.210526	1771.95	1476.625	1417.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100655	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	82435536	41217768	27478512	20608884	16487107.2	13739256	11776505.14	10304442	9159504	8243553.6	7494139.636	6869628	6341195.077	5888252.571	5495702.4	5152221	4579752	4338712.421	4121776.8	3434814	3297421.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100656	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	70036504	35018252	23345501.33	17509126	14007300.8	11672750.67	10005214.86	8754563	7781833.778	7003650.4	6366954.909	5836375.333	5387423.385	5002607.429	4669100.267	4377281.5	3890916.889	3686131.789	3501825.2	2918187.667	2801460.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100657	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	21081204	10540602	7027068	5270301	4216240.8	3513534	3011600.571	2635150.5	2342356	2108120.4	1916473.091	1756767	1621631.077	1505800.286	1405413.6	1317575.25	1171178	1109537.053	1054060.2	878383.5	843248.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100658	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	66096	33048	22032	16524	13219.2	11016	9442.285714	8262	7344	6609.6	6008.727273	5508	5084.307692	4721.142857	4406.4	4131	3672	3478.736842	3304.8	2754	2643.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100659	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	309625	154812.5	103208.3333	77406.25	61925	51604.16667	44232.14286	38703.125	34402.77778	30962.5	28147.72727	25802.08333	23817.30769	22116.07143	20641.66667	19351.5625	17201.38889	16296.05263	15481.25	12901.04167	12385	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100660	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	2461248	1230624	820416	615312	492249.6	410208	351606.8571	307656	273472	246124.8	223749.8182	205104	189326.7692	175803.4286	164083.2	153828	136736	129539.3684	123062.4	102552	98449.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100661	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	932861	466430.5	310953.6667	233215.25	186572.2	155476.8333	133265.8571	116607.625	103651.2222	93286.1	84805.54545	77738.41667	71758.53846	66632.92857	62190.73333	58303.8125	51825.61111	49097.94737	46643.05	38869.20833	37314.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100662	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	2820722	1410361	940240.6667	705180.5	564144.4	470120.3333	402960.2857	352590.25	313413.5556	282072.2	256429.2727	235060.1667	216978.6154	201480.1429	188048.1333	176295.125	156706.7778	148459.0526	141036.1	117530.0833	112828.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100663	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	1440018	720009	480006	360004.5	288003.6	240003	205716.8571	180002.25	160002	144001.8	130910.7273	120001.5	110770.6154	102858.4286	96001.2	90001.125	80001	75790.42105	72000.9	60000.75	57600.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
100664	CHOYP_HS90A.3.3|m.28299	HLEINPDHSIIK	HLEINPDHSIIK	375855	187927.5	125285	93963.75	75171	62642.5	53693.57143	46981.875	41761.66667	37585.5	34168.63636	31321.25	28911.92308	26846.78571	25057	23490.9375	20880.83333	19781.84211	18792.75	15660.625	15034.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101490	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	175233232	87616616	58411077.33	43808308	35046646.4	29205538.67	25033318.86	21904154	19470359.11	17523323.2	15930293.82	14602769.33	13479479.38	12516659.43	11682215.47	10952077	9735179.556	9222801.684	8761661.6	7301384.667	7009329.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101491	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	118595480	59297740	39531826.67	29648870	23719096	19765913.33	16942211.43	14824435	13177275.56	11859548	10781407.27	9882956.667	9122729.231	8471105.714	7906365.333	7412217.5	6588637.778	6241867.368	5929774	4941478.333	4743819.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101492	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	36064504	18032252	12021501.33	9016126	7212900.8	6010750.667	5152072	4508063	4007167.111	3606450.4	3278591.273	3005375.333	2774192.615	2576036	2404300.267	2254031.5	2003583.556	1898131.789	1803225.2	1502687.667	1442580.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101493	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	42787900	21393950	14262633.33	10696975	8557580	7131316.667	6112557.143	5348487.5	4754211.111	4278790	3889809.091	3565658.333	3291376.923	3056278.571	2852526.667	2674243.75	2377105.556	2251994.737	2139395	1782829.167	1711516	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101494	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	12233905	6116952.5	4077968.333	3058476.25	2446781	2038984.167	1747700.714	1529238.125	1359322.778	1223390.5	1112173.182	1019492.083	941069.6154	873850.3571	815593.6667	764619.0625	679661.3889	643889.7368	611695.25	509746.0417	489356.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101495	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	11395052	5697526	3798350.667	2848763	2279010.4	1899175.333	1627864.571	1424381.5	1266116.889	1139505.2	1035913.818	949587.6667	876542.4615	813932.2857	759670.1333	712190.75	633058.4444	599739.5789	569752.6	474793.8333	455802.08	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101496	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	11230616	5615308	3743538.667	2807654	2246123.2	1871769.333	1604373.714	1403827	1247846.222	1123061.6	1020965.091	935884.6667	863893.5385	802186.8571	748707.7333	701913.5	623923.1111	591085.0526	561530.8	467942.3333	449224.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101497	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	4041484	2020742	1347161.333	1010371	808296.8	673580.6667	577354.8571	505185.5	449053.7778	404148.4	367407.6364	336790.3333	310883.3846	288677.4286	269432.2667	252592.75	224526.8889	212709.6842	202074.2	168395.1667	161659.36	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101498	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	7189765	3594882.5	2396588.333	1797441.25	1437953	1198294.167	1027109.286	898720.625	798862.7778	718976.5	653615	599147.0833	553058.8462	513554.6429	479317.6667	449360.3125	399431.3889	378408.6842	359488.25	299573.5417	287590.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101499	CHOYP_HSP90AA1.1.1|m.14867	ELISNASDALDK	ELISNASDALDK	3935852	1967926	1311950.667	983963	787170.4	655975.3333	562264.5714	491981.5	437316.8889	393585.2	357804.7273	327987.6667	302757.8462	281132.2857	262390.1333	245990.75	218658.4444	207150.1053	196792.6	163993.8333	157434.08	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101500	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101501	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101502	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101503	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	2046743	1023371.5	682247.6667	511685.75	409348.6	341123.8333	292391.8571	255842.875	227415.8889	204674.3	186067.5455	170561.9167	157441.7692	146195.9286	136449.5333	127921.4375	113707.9444	107723.3158	102337.15	85280.95833	81869.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101504	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	6452310	3226155	2150770	1613077.5	1290462	1075385	921758.5714	806538.75	716923.3333	645231	586573.6364	537692.5	496331.5385	460879.2857	430154	403269.375	358461.6667	339595.2632	322615.5	268846.25	258092.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101505	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	3144876	1572438	1048292	786219	628975.2	524146	449268	393109.5	349430.6667	314487.6	285897.8182	262073	241913.5385	224634	209658.4	196554.75	174715.3333	165519.7895	157243.8	131036.5	125795.04	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101506	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	2536644	1268322	845548	634161	507328.8	422774	362377.7143	317080.5	281849.3333	253664.4	230604	211387	195126.4615	181188.8571	169109.6	158540.25	140924.6667	133507.5789	126832.2	105693.5	101465.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101507	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	1360937	680468.5	453645.6667	340234.25	272187.4	226822.8333	194419.5714	170117.125	151215.2222	136093.7	123721.5455	113411.4167	104687.4615	97209.78571	90729.13333	85058.5625	75607.61111	71628.26316	68046.85	56705.70833	54437.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101508	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	498112	249056	166037.3333	124528	99622.4	83018.66667	71158.85714	62264	55345.77778	49811.2	45282.90909	41509.33333	38316.30769	35579.42857	33207.46667	31132	27672.88889	26216.42105	24905.6	20754.66667	19924.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101509	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	2828777	1414388.5	942925.6667	707194.25	565755.4	471462.8333	404111	353597.125	314308.5556	282877.7	257161.5455	235731.4167	217598.2308	202055.5	188585.1333	176798.5625	157154.2778	148883	141438.85	117865.7083	113151.08	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101510	CHOYP_HSP90AA1.1.1|m.14867	TLTIMDTGIGMTK	TLTIMDTGIGMTK	464867	232433.5	154955.6667	116216.75	92973.4	77477.83333	66409.57143	58108.375	51651.88889	46486.7	42260.63636	38738.91667	35759	33204.78571	30991.13333	29054.1875	25825.94444	24466.68421	23243.35	19369.45833	18594.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101511	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	137200672	68600336	45733557.33	34300168	27440134.4	22866778.67	19600096	17150084	15244519.11	13720067.2	12472788.36	11433389.33	10553897.85	9800048	9146711.467	8575042	7622259.556	7221088	6860033.6	5716694.667	5488026.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101512	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	90965872	45482936	30321957.33	22741468	18193174.4	15160978.67	12995124.57	11370734	10107319.11	9096587.2	8269624.727	7580489.333	6997374.769	6497562.286	6064391.467	5685367	5053659.556	4787677.474	4548293.6	3790244.667	3638634.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101513	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	30774828	15387414	10258276	7693707	6154965.6	5129138	4396404	3846853.5	3419425.333	3077482.8	2797711.636	2564569	2367294.462	2198202	2051655.2	1923426.75	1709712.667	1619727.789	1538741.4	1282284.5	1230993.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101514	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	12594760	6297380	4198253.333	3148690	2518952	2099126.667	1799251.429	1574345	1399417.778	1259476	1144978.182	1049563.333	968827.6923	899625.7143	839650.6667	787172.5	699708.8889	662882.1053	629738	524781.6667	503790.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101515	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	29448114	14724057	9816038	7362028.5	5889622.8	4908019	4206873.429	3681014.25	3272012.667	2944811.4	2677101.273	2454009.5	2265239.538	2103436.714	1963207.6	1840507.125	1636006.333	1549900.737	1472405.7	1227004.75	1177924.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101516	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	5789118	2894559	1929706	1447279.5	1157823.6	964853	827016.8571	723639.75	643235.3333	578911.8	526283.4545	482426.5	445316.7692	413508.4286	385941.2	361819.875	321617.6667	304690.4211	289455.9	241213.25	231564.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101517	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	4633562	2316781	1544520.667	1158390.5	926712.4	772260.3333	661937.4286	579195.25	514840.2222	463356.2	421232.9091	386130.1667	356427.8462	330968.7143	308904.1333	289597.625	257420.1111	243871.6842	231678.1	193065.0833	185342.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101518	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	8718910	4359455	2906303.333	2179727.5	1743782	1453151.667	1245558.571	1089863.75	968767.7778	871891	792628.1818	726575.8333	670685.3846	622779.2857	581260.6667	544931.875	484383.8889	458890	435945.5	363287.9167	348756.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101519	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	2203171	1101585.5	734390.3333	550792.75	440634.2	367195.1667	314738.7143	275396.375	244796.7778	220317.1	200288.2727	183597.5833	169474.6923	157369.3571	146878.0667	137698.1875	122398.3889	115956.3684	110158.55	91798.79167	88126.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101520	CHOYP_HSP90AA1.1.1|m.14867	ADLVNNLGTIAK	ADLVNNLGTIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101521	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	27152228	13576114	9050742.667	6788057	5430445.6	4525371.333	3878889.714	3394028.5	3016914.222	2715222.8	2468384.364	2262685.667	2088632.923	1939444.857	1810148.533	1697014.25	1508457.111	1429064.632	1357611.4	1131342.833	1086089.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101522	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	17048176	8524088	5682725.333	4262044	3409635.2	2841362.667	2435453.714	2131022	1894241.778	1704817.6	1549834.182	1420681.333	1311398.154	1217726.857	1136545.067	1065511	947120.8889	897272.4211	852408.8	710340.6667	681927.04	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101523	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	5072476	2536238	1690825.333	1268119	1014495.2	845412.6667	724639.4286	634059.5	563608.4444	507247.6	461134.1818	422706.3333	390190.4615	362319.7143	338165.0667	317029.75	281804.2222	266972.4211	253623.8	211353.1667	202899.04	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101524	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	2997074	1498537	999024.6667	749268.5	599414.8	499512.3333	428153.4286	374634.25	333008.2222	299707.4	272461.2727	249756.1667	230544.1538	214076.7143	199804.9333	187317.125	166504.1111	157740.7368	149853.7	124878.0833	119882.96	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101525	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	1956867	978433.5	652289	489216.75	391373.4	326144.5	279552.4286	244608.375	217429.6667	195686.7	177897	163072.25	150528.2308	139776.2143	130457.8	122304.1875	108714.8333	102993	97843.35	81536.125	78274.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101526	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	5803571	2901785.5	1934523.667	1450892.75	1160714.2	967261.8333	829081.5714	725446.375	644841.2222	580357.1	527597.3636	483630.9167	446428.5385	414540.7857	386904.7333	362723.1875	322420.6111	305451.1053	290178.55	241815.4583	232142.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101527	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	2451618	1225809	817206	612904.5	490323.6	408603	350231.1429	306452.25	272402	245161.8	222874.3636	204301.5	188586	175115.5714	163441.2	153226.125	136201	129032.5263	122580.9	102150.75	98064.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101528	CHOYP_HSP90AA1.1.1|m.14867	EDQTEYLEER	EDQTEYLEER	2012588	1006294	670862.6667	503147	402517.6	335431.3333	287512.5714	251573.5	223620.8889	201258.8	182962.5455	167715.6667	154814.4615	143756.2857	134172.5333	125786.75	111810.4444	105925.6842	100629.4	83857.83333	80503.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101529	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101530	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101531	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	19473618	9736809	6491206	4868404.5	3894723.6	3245603	2781945.429	2434202.25	2163735.333	1947361.8	1770328.909	1622801.5	1497970.615	1390972.714	1298241.2	1217101.125	1081867.667	1024927.263	973680.9	811400.75	778944.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101532	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101533	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101534	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101535	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101536	CHOYP_HSP90AA1.1.1|m.14867	HSQFIGYPIK	HSQFIGYPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101537	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	8980857	4490428.5	2993619	2245214.25	1796171.4	1496809.5	1282979.571	1122607.125	997873	898085.7	816441.5455	748404.75	690835.1538	641489.7857	598723.8	561303.5625	498936.5	472676.6842	449042.85	374202.375	359234.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101538	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	7254082	3627041	2418027.333	1813520.5	1450816.4	1209013.667	1036297.429	906760.25	806009.1111	725408.2	659462	604506.8333	558006.3077	518148.7143	483605.4667	453380.125	403004.5556	381793.7895	362704.1	302253.4167	290163.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101539	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	3070175	1535087.5	1023391.667	767543.75	614035	511695.8333	438596.4286	383771.875	341130.5556	307017.5	279106.8182	255847.9167	236167.3077	219298.2143	204678.3333	191885.9375	170565.2778	161588.1579	153508.75	127923.9583	122807	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101540	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	159313	79656.5	53104.33333	39828.25	31862.6	26552.16667	22759	19914.125	17701.44444	15931.3	14483	13276.08333	12254.84615	11379.5	10620.86667	9957.0625	8850.722222	8384.894737	7965.65	6638.041667	6372.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101541	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	825727	412863.5	275242.3333	206431.75	165145.4	137621.1667	117961	103215.875	91747.44444	82572.7	75066.09091	68810.58333	63517.46154	58980.5	55048.46667	51607.9375	45873.72222	43459.31579	41286.35	34405.29167	33029.08	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101542	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	334751	167375.5	111583.6667	83687.75	66950.2	55791.83333	47821.57143	41843.875	37194.55556	33475.1	30431.90909	27895.91667	25750.07692	23910.78571	22316.73333	20921.9375	18597.27778	17618.47368	16737.55	13947.95833	13390.04	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101543	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	327239	163619.5	109079.6667	81809.75	65447.8	54539.83333	46748.42857	40904.875	36359.88889	32723.9	29749	27269.91667	25172.23077	23374.21429	21815.93333	20452.4375	18179.94444	17223.10526	16361.95	13634.95833	13089.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101544	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	209067	104533.5	69689	52266.75	41813.4	34844.5	29866.71429	26133.375	23229.66667	20906.7	19006.09091	17422.25	16082.07692	14933.35714	13937.8	13066.6875	11614.83333	11003.52632	10453.35	8711.125	8362.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101545	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	203057	101528.5	67685.66667	50764.25	40611.4	33842.83333	29008.14286	25382.125	22561.88889	20305.7	18459.72727	16921.41667	15619.76923	14504.07143	13537.13333	12691.0625	11280.94444	10687.21053	10152.85	8460.708333	8122.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101546	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	236020	118010	78673.33333	59005	47204	39336.66667	33717.14286	29502.5	26224.44444	23602	21456.36364	19668.33333	18155.38462	16858.57143	15734.66667	14751.25	13112.22222	12422.10526	11801	9834.166667	9440.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101547	CHOYP_HSP90AA1.1.1|m.14867	VEDLDEDEEDDSK	VEDLDEDEEDDSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101548	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101549	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101550	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101551	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101552	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	575470	287735	191823.3333	143867.5	115094	95911.66667	82210	71933.75	63941.11111	57547	52315.45455	47955.83333	44266.92308	41105	38364.66667	35966.875	31970.55556	30287.89474	28773.5	23977.91667	23018.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101553	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	416278	208139	138759.3333	104069.5	83255.6	69379.66667	59468.28571	52034.75	46253.11111	41627.8	37843.45455	34689.83333	32021.38462	29734.14286	27751.86667	26017.375	23126.55556	21909.36842	20813.9	17344.91667	16651.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101554	CHOYP_HSP90AA1.1.1|m.14867	YTEDEELNK	YTEDEELNK	639696	319848	213232	159924	127939.2	106616	91385.14286	79962	71077.33333	63969.6	58154.18182	53308	49207.38462	45692.57143	42646.4	39981	35538.66667	33668.21053	31984.8	26654	25587.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101555	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101556	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101557	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101558	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101559	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	316978	158489	105659.3333	79244.5	63395.6	52829.66667	45282.57143	39622.25	35219.77778	31697.8	28816.18182	26414.83333	24382.92308	22641.28571	21131.86667	19811.125	17609.88889	16683.05263	15848.9	13207.41667	12679.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101560	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	2581021	1290510.5	860340.3333	645255.25	516204.2	430170.1667	368717.2857	322627.625	286780.1111	258102.1	234638.2727	215085.0833	198540.0769	184358.6429	172068.0667	161313.8125	143390.0556	135843.2105	129051.05	107542.5417	103240.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101561	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	730238	365119	243412.6667	182559.5	146047.6	121706.3333	104319.7143	91279.75	81137.55556	73023.8	66385.27273	60853.16667	56172.15385	52159.85714	48682.53333	45639.875	40568.77778	38433.57895	36511.9	30426.58333	29209.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101562	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	821856	410928	273952	205464	164371.2	136976	117408	102732	91317.33333	82185.6	74714.18182	68488	63219.69231	58704	54790.4	51366	45658.66667	43255.57895	41092.8	34244	32874.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101563	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101564	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	824836	412418	274945.3333	206209	164967.2	137472.6667	117833.7143	103104.5	91648.44444	82483.6	74985.09091	68736.33333	63448.92308	58916.85714	54989.06667	51552.25	45824.22222	43412.42105	41241.8	34368.16667	32993.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101565	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	801313	400656.5	267104.3333	200328.25	160262.6	133552.1667	114473.2857	100164.125	89034.77778	80131.3	72846.63636	66776.08333	61639.46154	57236.64286	53420.86667	50082.0625	44517.38889	42174.36842	40065.65	33388.04167	32052.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101566	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	185516	92758	61838.66667	46379	37103.2	30919.33333	26502.28571	23189.5	20612.88889	18551.6	16865.09091	15459.66667	14270.46154	13251.14286	12367.73333	11594.75	10306.44444	9764	9275.8	7729.833333	7420.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101567	CHOYP_HSP90AA1.1.1|m.14867	NPDDITQEEYGEFYK	NPDDITQEEYGEFYK	443256	221628	147752	110814	88651.2	73876	63322.28571	55407	49250.66667	44325.6	40296	36938	34096.61538	31661.14286	29550.4	27703.5	24625.33333	23329.26316	22162.8	18469	17730.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101568	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	47715980	23857990	15905326.67	11928995	9543196	7952663.333	6816568.571	5964497.5	5301775.556	4771598	4337816.364	3976331.667	3670460	3408284.286	3181065.333	2982248.75	2650887.778	2511367.368	2385799	1988165.833	1908639.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101569	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	38412468	19206234	12804156	9603117	7682493.6	6402078	5487495.429	4801558.5	4268052	3841246.8	3492042.545	3201039	2954805.231	2743747.714	2560831.2	2400779.25	2134026	2021708.842	1920623.4	1600519.5	1536498.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101570	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	16823500	8411750	5607833.333	4205875	3364700	2803916.667	2403357.143	2102937.5	1869277.778	1682350	1529409.091	1401958.333	1294115.385	1201678.571	1121566.667	1051468.75	934638.8889	885447.3684	841175	700979.1667	672940	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101571	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	2572090	1286045	857363.3333	643022.5	514418	428681.6667	367441.4286	321511.25	285787.7778	257209	233826.3636	214340.8333	197853.0769	183720.7143	171472.6667	160755.625	142893.8889	135373.1579	128604.5	107170.4167	102883.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101572	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	2815414	1407707	938471.3333	703853.5	563082.8	469235.6667	402202	351926.75	312823.7778	281541.4	255946.7273	234617.8333	216570.3077	201101	187694.2667	175963.375	156411.8889	148179.6842	140770.7	117308.9167	112616.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101573	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	3773561	1886780.5	1257853.667	943390.25	754712.2	628926.8333	539080.1429	471695.125	419284.5556	377356.1	343051	314463.4167	290273.9231	269540.0714	251570.7333	235847.5625	209642.2778	198608.4737	188678.05	157231.7083	150942.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101574	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	3425087	1712543.5	1141695.667	856271.75	685017.4	570847.8333	489298.1429	428135.875	380565.2222	342508.7	311371.5455	285423.9167	263468.2308	244649.0714	228339.1333	214067.9375	190282.6111	180267.7368	171254.35	142711.9583	137003.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101575	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	796420	398210	265473.3333	199105	159284	132736.6667	113774.2857	99552.5	88491.11111	79642	72401.81818	66368.33333	61263.07692	56887.14286	53094.66667	49776.25	44245.55556	41916.84211	39821	33184.16667	31856.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101576	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	1816225	908112.5	605408.3333	454056.25	363245	302704.1667	259460.7143	227028.125	201802.7778	181622.5	165111.3636	151352.0833	139709.6154	129730.3571	121081.6667	113514.0625	100901.3889	95590.78947	90811.25	75676.04167	72649	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101577	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	1121453	560726.5	373817.6667	280363.25	224290.6	186908.8333	160207.5714	140181.625	124605.8889	112145.3	101950.2727	93454.41667	86265.61538	80103.78571	74763.53333	70090.8125	62302.94444	59023.84211	56072.65	46727.20833	44858.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101578	CHOYP_HSP90AA1.1.1|m.14867	SLTNDWEDHLAVK	SLTNDWEDHLAVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101579	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	17864282	8932141	5954760.667	4466070.5	3572856.4	2977380.333	2552040.286	2233035.25	1984920.222	1786428.2	1624025.636	1488690.167	1374175.538	1276020.143	1190952.133	1116517.625	992460.1111	940225.3684	893214.1	744345.0833	714571.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101580	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	10012658	5006329	3337552.667	2503164.5	2002531.6	1668776.333	1430379.714	1251582.25	1112517.556	1001265.8	910241.6364	834388.1667	770204.4615	715189.8571	667510.5333	625791.125	556258.7778	526982	500632.9	417194.0833	400506.32	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101581	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	3771518	1885759	1257172.667	942879.5	754303.6	628586.3333	538788.2857	471439.75	419057.5556	377151.8	342865.2727	314293.1667	290116.7692	269394.1429	251434.5333	235719.875	209528.7778	198500.9474	188575.9	157146.5833	150860.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101582	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101583	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	1472569	736284.5	490856.3333	368142.25	294513.8	245428.1667	210367	184071.125	163618.7778	147256.9	133869.9091	122714.0833	113274.5385	105183.5	98171.26667	92035.5625	81809.38889	77503.63158	73628.45	61357.04167	58902.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101584	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	1270680	635340	423560	317670	254136	211780	181525.7143	158835	141186.6667	127068	115516.3636	105890	97744.61538	90762.85714	84712	79417.5	70593.33333	66877.89474	63534	52945	50827.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101585	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	36472	18236	12157.33333	9118	7294.4	6078.666667	5210.285714	4559	4052.444444	3647.2	3315.636364	3039.333333	2805.538462	2605.142857	2431.466667	2279.5	2026.222222	1919.578947	1823.6	1519.666667	1458.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101586	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	84868	42434	28289.33333	21217	16973.6	14144.66667	12124	10608.5	9429.777778	8486.8	7715.272727	7072.333333	6528.307692	6062	5657.866667	5304.25	4714.888889	4466.736842	4243.4	3536.166667	3394.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101587	CHOYP_HSP90AA1.1.1|m.14867	HFSVEGQLEFR	HFSVEGQLEFR	18270	9135	6090	4567.5	3654	3045	2610	2283.75	2030	1827	1660.909091	1522.5	1405.384615	1305	1218	1141.875	1015	961.5789474	913.5	761.25	730.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101588	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	3757289	1878644.5	1252429.667	939322.25	751457.8	626214.8333	536755.5714	469661.125	417476.5556	375728.9	341571.7273	313107.4167	289022.2308	268377.7857	250485.9333	234830.5625	208738.2778	197752.0526	187864.45	156553.7083	150291.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101589	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	1527880	763940	509293.3333	381970	305576	254646.6667	218268.5714	190985	169764.4444	152788	138898.1818	127323.3333	117529.2308	109134.2857	101858.6667	95492.5	84882.22222	80414.73684	76394	63661.66667	61115.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101590	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	1712242	856121	570747.3333	428060.5	342448.4	285373.6667	244606	214030.25	190249.1111	171224.2	155658.3636	142686.8333	131710.9231	122303	114149.4667	107015.125	95124.55556	90118	85612.1	71343.41667	68489.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101591	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	351275	175637.5	117091.6667	87818.75	70255	58545.83333	50182.14286	43909.375	39030.55556	35127.5	31934.09091	29272.91667	27021.15385	25091.07143	23418.33333	21954.6875	19515.27778	18488.15789	17563.75	14636.45833	14051	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101592	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	157520	78760	52506.66667	39380	31504	26253.33333	22502.85714	19690	17502.22222	15752	14320	13126.66667	12116.92308	11251.42857	10501.33333	9845	8751.111111	8290.526316	7876	6563.333333	6300.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101593	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	82842	41421	27614	20710.5	16568.4	13807	11834.57143	10355.25	9204.666667	8284.2	7531.090909	6903.5	6372.461538	5917.285714	5522.8	5177.625	4602.333333	4360.105263	4142.1	3451.75	3313.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101594	CHOYP_HSP90AA1.1.1|m.14867	APFDLFENK	APFDLFENK	17114	8557	5704.666667	4278.5	3422.8	2852.333333	2444.857143	2139.25	1901.555556	1711.4	1555.818182	1426.166667	1316.461538	1222.428571	1140.933333	1069.625	950.7777778	900.7368421	855.7	713.0833333	684.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101595	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101596	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101597	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101598	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4393975	2196987.5	1464658.333	1098493.75	878795	732329.1667	627710.7143	549246.875	488219.4444	439397.5	399452.2727	366164.5833	337998.0769	313855.3571	292931.6667	274623.4375	244109.7222	231261.8421	219698.75	183082.2917	175759	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101599	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4337723	2168861.5	1445907.667	1084430.75	867544.6	722953.8333	619674.7143	542215.375	481969.2222	433772.3	394338.4545	361476.9167	333671	309837.3571	289181.5333	271107.6875	240984.6111	228301.2105	216886.15	180738.4583	173508.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101600	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1902385	951192.5	634128.3333	475596.25	380477	317064.1667	271769.2857	237798.125	211376.1111	190238.5	172944.0909	158532.0833	146337.3077	135884.6429	126825.6667	118899.0625	105688.0556	100125.5263	95119.25	79266.04167	76095.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101601	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	4885845	2442922.5	1628615	1221461.25	977169	814307.5	697977.8571	610730.625	542871.6667	488584.5	444167.7273	407153.75	375834.2308	348988.9286	325723	305365.3125	271435.8333	257149.7368	244292.25	203576.875	195433.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101602	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	5748341	2874170.5	1916113.667	1437085.25	1149668.2	958056.8333	821191.5714	718542.625	638704.5556	574834.1	522576.4545	479028.4167	442180.0769	410595.7857	383222.7333	359271.3125	319352.2778	302544.2632	287417.05	239514.2083	229933.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101603	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	15453536	7726768	5151178.667	3863384	3090707.2	2575589.333	2207648	1931692	1717059.556	1545353.6	1404866.909	1287794.667	1188733.538	1103824	1030235.733	965846	858529.7778	813344	772676.8	643897.3333	618141.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101604	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	585205	292602.5	195068.3333	146301.25	117041	97534.16667	83600.71429	73150.625	65022.77778	58520.5	53200.45455	48767.08333	45015.76923	41800.35714	39013.66667	36575.3125	32511.38889	30800.26316	29260.25	24383.54167	23408.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101605	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	1079081	539540.5	359693.6667	269770.25	215816.2	179846.8333	154154.4286	134885.125	119897.8889	107908.1	98098.27273	89923.41667	83006.23077	77077.21429	71938.73333	67442.5625	59948.94444	56793.73684	53954.05	44961.70833	43163.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101606	CHOYP_HSP90AA1.1.1|m.14867	GVVDSEDLPLNISR	GVVDSEDLPLNISR	819544	409772	273181.3333	204886	163908.8	136590.6667	117077.7143	102443	91060.44444	81954.4	74504	68295.33333	63041.84615	58538.85714	54636.26667	51221.5	45530.22222	43133.89474	40977.2	34147.66667	32781.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101607	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	25262710	12631355	8420903.333	6315677.5	5052542	4210451.667	3608958.571	3157838.75	2806967.778	2526271	2296610	2105225.833	1943285.385	1804479.286	1684180.667	1578919.375	1403483.889	1329616.316	1263135.5	1052612.917	1010508.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101608	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	12922148	6461074	4307382.667	3230537	2584429.6	2153691.333	1846021.143	1615268.5	1435794.222	1292214.8	1174740.727	1076845.667	994011.3846	923010.5714	861476.5333	807634.25	717897.1111	680113.0526	646107.4	538422.8333	516885.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101609	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	7798479	3899239.5	2599493	1949619.75	1559695.8	1299746.5	1114068.429	974809.875	866497.6667	779847.9	708952.6364	649873.25	599883	557034.2143	519898.6	487404.9375	433248.8333	410446.2632	389923.95	324936.625	311939.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101610	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	2521297	1260648.5	840432.3333	630324.25	504259.4	420216.1667	360185.2857	315162.125	280144.1111	252129.7	229208.8182	210108.0833	193945.9231	180092.6429	168086.4667	157581.0625	140072.0556	132699.8421	126064.85	105054.0417	100851.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101611	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	4679675	2339837.5	1559891.667	1169918.75	935935	779945.8333	668525	584959.375	519963.8889	467967.5	425425	389972.9167	359975	334262.5	311978.3333	292479.6875	259981.9444	246298.6842	233983.75	194986.4583	187187	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101612	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	2229400	1114700	743133.3333	557350	445880	371566.6667	318485.7143	278675	247711.1111	222940	202672.7273	185783.3333	171492.3077	159242.8571	148626.6667	139337.5	123855.5556	117336.8421	111470	92891.66667	89176	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101613	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	1824289	912144.5	608096.3333	456072.25	364857.8	304048.1667	260612.7143	228036.125	202698.7778	182428.9	165844.4545	152024.0833	140329.9231	130306.3571	121619.2667	114018.0625	101349.3889	96015.21053	91214.45	76012.04167	72971.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101614	CHOYP_HSP90AA1.1.1|m.14867	LGIHEDSTNR	LGIHEDSTNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101615	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101616	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101617	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101618	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101619	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101620	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	1272731	636365.5	424243.6667	318182.75	254546.2	212121.8333	181818.7143	159091.375	141414.5556	127273.1	115702.8182	106060.9167	97902.38462	90909.35714	84848.73333	79545.6875	70707.27778	66985.84211	63636.55	53030.45833	50909.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101621	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101622	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101623	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	227146	113573	75715.33333	56786.5	45429.2	37857.66667	32449.42857	28393.25	25238.44444	22714.6	20649.63636	18928.83333	17472.76923	16224.71429	15143.06667	14196.625	12619.22222	11955.05263	11357.3	9464.416667	9085.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101624	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	104115	52057.5	34705	26028.75	20823	17352.5	14873.57143	13014.375	11568.33333	10411.5	9465	8676.25	8008.846154	7436.785714	6941	6507.1875	5784.166667	5479.736842	5205.75	4338.125	4164.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101625	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101626	CHOYP_HSP90AA1.1.1|m.14867	YYSSQSGDEMTSLK	YYSSQSGDEMTSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101627	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	89922672	44961336	29974224	22480668	17984534.4	14987112	12846096	11240334	9991408	8992267.2	8174788.364	7493556	6917128.615	6423048	5994844.8	5620167	4995704	4732772.211	4496133.6	3746778	3596906.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101628	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	56376732	28188366	18792244	14094183	11275346.4	9396122	8053818.857	7047091.5	6264081.333	5637673.2	5125157.455	4698061	4336671.692	4026909.429	3758448.8	3523545.75	3132040.667	2967196.421	2818836.6	2349030.5	2255069.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101629	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	17493822	8746911	5831274	4373455.5	3498764.4	2915637	2499117.429	2186727.75	1943758	1749382.2	1590347.455	1457818.5	1345678.615	1249558.714	1166254.8	1093363.875	971879	920727.4737	874691.1	728909.25	699752.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101630	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	9596298	4798149	3198766	2399074.5	1919259.6	1599383	1370899.714	1199537.25	1066255.333	959629.8	872390.7273	799691.5	738176.7692	685449.8571	639753.2	599768.625	533127.6667	505068.3158	479814.9	399845.75	383851.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101631	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	10079618	5039809	3359872.667	2519904.5	2015923.6	1679936.333	1439945.429	1259952.25	1119957.556	1007961.8	916328.9091	839968.1667	775355.2308	719972.7143	671974.5333	629976.125	559978.7778	530506.2105	503980.9	419984.0833	403184.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101632	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	8583982	4291991	2861327.333	2145995.5	1716796.4	1430663.667	1226283.143	1072997.75	953775.7778	858398.2	780362	715331.8333	660306.3077	613141.5714	572265.4667	536498.875	476887.8889	451788.5263	429199.1	357665.9167	343359.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101633	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	2949375	1474687.5	983125	737343.75	589875	491562.5	421339.2857	368671.875	327708.3333	294937.5	268125	245781.25	226875	210669.6429	196625	184335.9375	163854.1667	155230.2632	147468.75	122890.625	117975	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101634	CHOYP_HSP90AA1.1.1|m.14867	SIYYITGESR	SIYYITGESR	324964	162482	108321.3333	81241	64992.8	54160.66667	46423.42857	40620.5	36107.11111	32496.4	29542.18182	27080.33333	24997.23077	23211.71429	21664.26667	20310.25	18053.55556	17103.36842	16248.2	13540.16667	12998.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101635	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	106232720	53116360	35410906.67	26558180	21246544	17705453.33	15176102.86	13279090	11803635.56	10623272	9657520	8852726.667	8171747.692	7588051.429	7082181.333	6639545	5901817.778	5591195.789	5311636	4426363.333	4249308.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101636	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	72286568	36143284	24095522.67	18071642	14457313.6	12047761.33	10326652.57	9035821	8031840.889	7228656.8	6571506.182	6023880.667	5560505.231	5163326.286	4819104.533	4517910.5	4015920.444	3804556.211	3614328.4	3011940.333	2891462.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101637	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	27068290	13534145	9022763.333	6767072.5	5413658	4511381.667	3866898.571	3383536.25	3007587.778	2706829	2460753.636	2255690.833	2082176.154	1933449.286	1804552.667	1691768.125	1503793.889	1424646.842	1353414.5	1127845.417	1082731.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101638	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	22171104	11085552	7390368	5542776	4434220.8	3695184	3167300.571	2771388	2463456	2217110.4	2015554.909	1847592	1705469.538	1583650.286	1478073.6	1385694	1231728	1166900.211	1108555.2	923796	886844.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101639	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	30104462	15052231	10034820.67	7526115.5	6020892.4	5017410.333	4300637.429	3763057.75	3344940.222	3010446.2	2736769.273	2508705.167	2315727.846	2150318.714	2006964.133	1881528.875	1672470.111	1584445.368	1505223.1	1254352.583	1204178.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101640	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	10070523	5035261.5	3356841	2517630.75	2014104.6	1678420.5	1438646.143	1258815.375	1118947	1007052.3	915502.0909	839210.25	774655.6154	719323.0714	671368.2	629407.6875	559473.5	530027.5263	503526.15	419605.125	402820.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101641	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	4609245	2304622.5	1536415	1152311.25	921849	768207.5	658463.5714	576155.625	512138.3333	460924.5	419022.2727	384103.75	354557.3077	329231.7857	307283	288077.8125	256069.1667	242591.8421	230462.25	192051.875	184369.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101642	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	4759845	2379922.5	1586615	1189961.25	951969	793307.5	679977.8571	594980.625	528871.6667	475984.5	432713.1818	396653.75	366141.9231	339988.9286	317323	297490.3125	264435.8333	250518.1579	237992.25	198326.875	190393.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101643	CHOYP_HSP90AA1.1.1|m.14867	EVVQSSAFVER	EVVQSSAFVER	2809118	1404559	936372.6667	702279.5	561823.6	468186.3333	401302.5714	351139.75	312124.2222	280911.8	255374.3636	234093.1667	216086	200651.2857	187274.5333	175569.875	156062.1111	147848.3158	140455.9	117046.5833	112364.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101644	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	1919803	959901.5	639934.3333	479950.75	383960.6	319967.1667	274257.5714	239975.375	213311.4444	191980.3	174527.5455	159983.5833	147677.1538	137128.7857	127986.8667	119987.6875	106655.7222	101042.2632	95990.15	79991.79167	76792.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101645	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101646	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101647	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101648	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101649	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101650	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101651	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101652	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101653	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101654	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101655	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101656	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101657	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101658	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101659	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101660	CHOYP_HSP90AA1.1.1|m.14867	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101661	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	75562496	37781248	25187498.67	18890624	15112499.2	12593749.33	10794642.29	9445312	8395832.889	7556249.6	6869317.818	6296874.667	5812499.692	5397321.143	5037499.733	4722656	4197916.444	3976973.474	3778124.8	3148437.333	3022499.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101662	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	55542052	27771026	18514017.33	13885513	11108410.4	9257008.667	7934578.857	6942756.5	6171339.111	5554205.2	5049277.455	4628504.333	4272465.538	3967289.429	3702803.467	3471378.25	3085669.556	2923265.895	2777102.6	2314252.167	2221682.08	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101663	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	25342870	12671435	8447623.333	6335717.5	5068574	4223811.667	3620410	3167858.75	2815874.444	2534287	2303897.273	2111905.833	1949451.538	1810205	1689524.667	1583929.375	1407937.222	1333835.263	1267143.5	1055952.917	1013714.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101664	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	1635356	817678	545118.6667	408839	327071.2	272559.3333	233622.2857	204419.5	181706.2222	163535.6	148668.7273	136279.6667	125796.6154	116811.1429	109023.7333	102209.75	90853.11111	86071.36842	81767.8	68139.83333	65414.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101665	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101666	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	22193678	11096839	7397892.667	5548419.5	4438735.6	3698946.333	3170525.429	2774209.75	2465964.222	2219367.8	2017607.091	1849473.167	1707206	1585262.714	1479578.533	1387104.875	1232982.111	1168088.316	1109683.9	924736.5833	887747.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101667	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101668	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	2146120	1073060	715373.3333	536530	429224	357686.6667	306588.5714	268265	238457.7778	214612	195101.8182	178843.3333	165086.1538	153294.2857	143074.6667	134132.5	119228.8889	112953.6842	107306	89421.66667	85844.8	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101669	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	2670466	1335233	890155.3333	667616.5	534093.2	445077.6667	381495.1429	333808.25	296718.4444	267046.6	242769.6364	222538.8333	205420.4615	190747.5714	178031.0667	166904.125	148359.2222	140550.8421	133523.3	111269.4167	106818.64	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101670	CHOYP_HSP90AA1.1.1|m.14867	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101671	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	61842912	30921456	20614304	15460728	12368582.4	10307152	8834701.714	7730364	6871434.667	6184291.2	5622082.909	5153576	4757147.077	4417350.857	4122860.8	3865182	3435717.333	3254890.105	3092145.6	2576788	2473716.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101672	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101673	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	20161494	10080747	6720498	5040373.5	4032298.8	3360249	2880213.429	2520186.75	2240166	2016149.4	1832863.091	1680124.5	1550884.154	1440106.714	1344099.6	1260093.375	1120083	1061131.263	1008074.7	840062.25	806459.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101674	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	1593393	796696.5	531131	398348.25	318678.6	265565.5	227627.5714	199174.125	177043.6667	159339.3	144853.9091	132782.75	122568.6923	113813.7857	106226.2	99587.0625	88521.83333	83862.78947	79669.65	66391.375	63735.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101675	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	3507490	1753745	1169163.333	876872.5	701498	584581.6667	501070	438436.25	389721.1111	350749	318862.7273	292290.8333	269806.9231	250535	233832.6667	219218.125	194860.5556	184604.7368	175374.5	146145.4167	140299.6	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101676	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	16273881	8136940.5	5424627	4068470.25	3254776.2	2712313.5	2324840.143	2034235.125	1808209	1627388.1	1479443.727	1356156.75	1251837	1162420.071	1084925.4	1017117.563	904104.5	856520.0526	813694.05	678078.375	650955.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101677	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	690731	345365.5	230243.6667	172682.75	138146.2	115121.8333	98675.85714	86341.375	76747.88889	69073.1	62793.72727	57560.91667	53133.15385	49337.92857	46048.73333	43170.6875	38373.94444	36354.26316	34536.55	28780.45833	27629.24	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101678	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	896022	448011	298674	224005.5	179204.4	149337	128003.1429	112002.75	99558	89602.2	81456.54545	74668.5	68924.76923	64001.57143	59734.8	56001.375	49779	47159.05263	44801.1	37334.25	35840.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101679	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	1017388	508694	339129.3333	254347	203477.6	169564.6667	145341.1429	127173.5	113043.1111	101738.8	92489.81818	84782.33333	78260.61538	72670.57143	67825.86667	63586.75	56521.55556	53546.73684	50869.4	42391.16667	40695.52	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101680	CHOYP_HSP90AA1.1.1|m.14867	EGLELPEDEEEK	EGLELPEDEEEK	446453	223226.5	148817.6667	111613.25	89290.6	74408.83333	63779	55806.625	49605.88889	44645.3	40586.63636	37204.41667	34342.53846	31889.5	29763.53333	27903.3125	24802.94444	23497.52632	22322.65	18602.20833	17858.12	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101681	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	62637692	31318846	20879230.67	15659423	12527538.4	10439615.33	8948241.714	7829711.5	6959743.556	6263769.2	5694335.636	5219807.667	4818284	4474120.857	4175846.133	3914855.75	3479871.778	3296720.632	3131884.6	2609903.833	2505507.68	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101682	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	35214484	17607242	11738161.33	8803621	7042896.8	5869080.667	5030640.571	4401810.5	3912720.444	3521448.4	3201316.727	2934540.333	2708806.462	2515320.286	2347632.267	2200905.25	1956360.222	1853393.895	1760724.2	1467270.167	1408579.36	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101683	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	15686494	7843247	5228831.333	3921623.5	3137298.8	2614415.667	2240927.714	1960811.75	1742943.778	1568649.4	1426044.909	1307207.833	1206653.385	1120463.857	1045766.267	980405.875	871471.8889	825604.9474	784324.7	653603.9167	627459.76	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101684	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	2429248	1214624	809749.3333	607312	485849.6	404874.6667	347035.4286	303656	269916.4444	242924.8	220840.7273	202437.3333	186865.2308	173517.7143	161949.8667	151828	134958.2222	127855.1579	121462.4	101218.6667	97169.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101685	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	4712405	2356202.5	1570801.667	1178101.25	942481	785400.8333	673200.7143	589050.625	523600.5556	471240.5	428400.4545	392700.4167	362492.6923	336600.3571	314160.3333	294525.3125	261800.2778	248021.3158	235620.25	196350.2083	188496.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101686	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	7045932	3522966	2348644	1761483	1409186.4	1174322	1006561.714	880741.5	782881.3333	704593.2	640539.2727	587161	541994.7692	503280.8571	469728.8	440370.75	391440.6667	370838.5263	352296.6	293580.5	281837.28	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101687	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	607062	303531	202354	151765.5	121412.4	101177	86723.14286	75882.75	67451.33333	60706.2	55187.45455	50588.5	46697.07692	43361.57143	40470.8	37941.375	33725.66667	31950.63158	30353.1	25294.25	24282.48	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101688	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	1594104	797052	531368	398526	318820.8	265684	227729.1429	199263	177122.6667	159410.4	144918.5455	132842	122623.3846	113864.5714	106273.6	99631.5	88561.33333	83900.21053	79705.2	66421	63764.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101689	CHOYP_HSP90AA1.1.1|m.14867	DSSTMGYMAAK	DSSTMGYMAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101690	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	48885548	24442774	16295182.67	12221387	9777109.6	8147591.333	6983649.714	6110693.5	5431727.556	4888554.8	4444140.727	4073795.667	3760426.769	3491824.857	3259036.533	3055346.75	2715863.778	2572923.579	2444277.4	2036897.833	1955421.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101691	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101692	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101693	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	325035	162517.5	108345	81258.75	65007	54172.5	46433.57143	40629.375	36115	32503.5	29548.63636	27086.25	25002.69231	23216.78571	21669	20314.6875	18057.5	17107.10526	16251.75	13543.125	13001.4	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101694	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	248489	124244.5	82829.66667	62122.25	49697.8	41414.83333	35498.42857	31061.125	27609.88889	24848.9	22589.90909	20707.41667	19114.53846	17749.21429	16565.93333	15530.5625	13804.94444	13078.36842	12424.45	10353.70833	9939.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101695	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	469774	234887	156591.3333	117443.5	93954.8	78295.66667	67110.57143	58721.75	52197.11111	46977.4	42706.72727	39147.83333	36136.46154	33555.28571	31318.26667	29360.875	26098.55556	24724.94737	23488.7	19573.91667	18790.96	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101696	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101697	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101698	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101699	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	35439	17719.5	11813	8859.75	7087.8	5906.5	5062.714286	4429.875	3937.666667	3543.9	3221.727273	2953.25	2726.076923	2531.357143	2362.6	2214.9375	1968.833333	1865.210526	1771.95	1476.625	1417.56	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101700	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	82435536	41217768	27478512	20608884	16487107.2	13739256	11776505.14	10304442	9159504	8243553.6	7494139.636	6869628	6341195.077	5888252.571	5495702.4	5152221	4579752	4338712.421	4121776.8	3434814	3297421.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101701	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	70036504	35018252	23345501.33	17509126	14007300.8	11672750.67	10005214.86	8754563	7781833.778	7003650.4	6366954.909	5836375.333	5387423.385	5002607.429	4669100.267	4377281.5	3890916.889	3686131.789	3501825.2	2918187.667	2801460.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101702	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	21081204	10540602	7027068	5270301	4216240.8	3513534	3011600.571	2635150.5	2342356	2108120.4	1916473.091	1756767	1621631.077	1505800.286	1405413.6	1317575.25	1171178	1109537.053	1054060.2	878383.5	843248.16	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101703	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	66096	33048	22032	16524	13219.2	11016	9442.285714	8262	7344	6609.6	6008.727273	5508	5084.307692	4721.142857	4406.4	4131	3672	3478.736842	3304.8	2754	2643.84	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101704	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	309625	154812.5	103208.3333	77406.25	61925	51604.16667	44232.14286	38703.125	34402.77778	30962.5	28147.72727	25802.08333	23817.30769	22116.07143	20641.66667	19351.5625	17201.38889	16296.05263	15481.25	12901.04167	12385	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101705	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	2461248	1230624	820416	615312	492249.6	410208	351606.8571	307656	273472	246124.8	223749.8182	205104	189326.7692	175803.4286	164083.2	153828	136736	129539.3684	123062.4	102552	98449.92	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101706	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	932861	466430.5	310953.6667	233215.25	186572.2	155476.8333	133265.8571	116607.625	103651.2222	93286.1	84805.54545	77738.41667	71758.53846	66632.92857	62190.73333	58303.8125	51825.61111	49097.94737	46643.05	38869.20833	37314.44	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101707	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	2820722	1410361	940240.6667	705180.5	564144.4	470120.3333	402960.2857	352590.25	313413.5556	282072.2	256429.2727	235060.1667	216978.6154	201480.1429	188048.1333	176295.125	156706.7778	148459.0526	141036.1	117530.0833	112828.88	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101708	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	1440018	720009	480006	360004.5	288003.6	240003	205716.8571	180002.25	160002	144001.8	130910.7273	120001.5	110770.6154	102858.4286	96001.2	90001.125	80001	75790.42105	72000.9	60000.75	57600.72	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
101709	CHOYP_HSP90AA1.1.1|m.14867	HLEINPDHSIIK	HLEINPDHSIIK	375855	187927.5	125285	93963.75	75171	62642.5	53693.57143	46981.875	41761.66667	37585.5	34168.63636	31321.25	28911.92308	26846.78571	25057	23490.9375	20880.83333	19781.84211	18792.75	15660.625	15034.2	Q90474	Heat shock protein HSP 90-alpha 1	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688
103738	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103739	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	2028979	1014489.5	676326.3333	507244.75	405795.8	338163.1667	289854.1429	253622.375	225442.1111	202897.9	184452.6364	169081.5833	156075.3077	144927.0714	135265.2667	126811.1875	112721.0556	106788.3684	101448.95	84540.79167	81159.16	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103740	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103741	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103742	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	757931	378965.5	252643.6667	189482.75	151586.2	126321.8333	108275.8571	94741.375	84214.55556	75793.1	68902.81818	63160.91667	58302.38462	54137.92857	50528.73333	47370.6875	42107.27778	39891.10526	37896.55	31580.45833	30317.24	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103743	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	663752	331876	221250.6667	165938	132750.4	110625.3333	94821.71429	82969	73750.22222	66375.2	60341.09091	55312.66667	51057.84615	47410.85714	44250.13333	41484.5	36875.11111	34934.31579	33187.6	27656.33333	26550.08	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103744	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103745	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103746	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103747	CHOYP_HYOU1.3.3|m.28442	DQNITPLTEKPK	DQNITPLTEKPK	52212	26106	17404	13053	10442.4	8702	7458.857143	6526.5	5801.333333	5221.2	4746.545455	4351	4016.307692	3729.428571	3480.8	3263.25	2900.666667	2748	2610.6	2175.5	2088.48	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103748	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103749	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103750	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103751	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	418095	209047.5	139365	104523.75	83619	69682.5	59727.85714	52261.875	46455	41809.5	38008.63636	34841.25	32161.15385	29863.92857	27873	26130.9375	23227.5	22005	20904.75	17420.625	16723.8	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103752	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	174575	87287.5	58191.66667	43643.75	34915	29095.83333	24939.28571	21821.875	19397.22222	17457.5	15870.45455	14547.91667	13428.84615	12469.64286	11638.33333	10910.9375	9698.611111	9188.157895	8728.75	7273.958333	6983	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103753	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	87897	43948.5	29299	21974.25	17579.4	14649.5	12556.71429	10987.125	9766.333333	8789.7	7990.636364	7324.75	6761.307692	6278.357143	5859.8	5493.5625	4883.166667	4626.157895	4394.85	3662.375	3515.88	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103754	CHOYP_HYOU1.3.3|m.28442	LLVDDIAMK	LLVDDIAMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103755	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	617139	308569.5	205713	154284.75	123427.8	102856.5	88162.71429	77142.375	68571	61713.9	56103.54545	51428.25	47472.23077	44081.35714	41142.6	38571.1875	34285.5	32481	30856.95	25714.125	24685.56	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103756	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103757	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103758	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103759	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103760	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103761	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103762	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103763	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103764	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	189674	94837	63224.66667	47418.5	37934.8	31612.33333	27096.28571	23709.25	21074.88889	18967.4	17243.09091	15806.16667	14590.30769	13548.14286	12644.93333	11854.625	10537.44444	9982.842105	9483.7	7903.083333	7586.96	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103765	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	39800	19900	13266.66667	9950	7960	6633.333333	5685.714286	4975	4422.222222	3980	3618.181818	3316.666667	3061.538462	2842.857143	2653.333333	2487.5	2211.111111	2094.736842	1990	1658.333333	1592	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103766	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	676765	338382.5	225588.3333	169191.25	135353	112794.1667	96680.71429	84595.625	75196.11111	67676.5	61524.09091	56397.08333	52058.84615	48340.35714	45117.66667	42297.8125	37598.05556	35619.21053	33838.25	28198.54167	27070.6	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103767	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103768	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	14271	7135.5	4757	3567.75	2854.2	2378.5	2038.714286	1783.875	1585.666667	1427.1	1297.363636	1189.25	1097.769231	1019.357143	951.4	891.9375	792.8333333	751.1052632	713.55	594.625	570.84	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
103769	CHOYP_HYOU1.3.3|m.28442	SGTDEGPQLDVPETETK	SGTDEGPQLDVPETETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y4L1	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	HYOU1 GRP170 ORP150	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382
104102	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	2779255	1389627.5	926418.3333	694813.75	555851	463209.1667	397036.4286	347406.875	308806.1111	277925.5	252659.5455	231604.5833	213788.8462	198518.2143	185283.6667	173703.4375	154403.0556	146276.5789	138962.75	115802.2917	111170.2	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104103	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	2297470	1148735	765823.3333	574367.5	459494	382911.6667	328210	287183.75	255274.4444	229747	208860.9091	191455.8333	176728.4615	164105	153164.6667	143591.875	127637.2222	120919.4737	114873.5	95727.91667	91898.8	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104104	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	1035567	517783.5	345189	258891.75	207113.4	172594.5	147938.1429	129445.875	115063	103556.7	94142.45455	86297.25	79659	73969.07143	69037.8	64722.9375	57531.5	54503.52632	51778.35	43148.625	41422.68	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104105	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104106	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	30538	15269	10179.33333	7634.5	6107.6	5089.666667	4362.571429	3817.25	3393.111111	3053.8	2776.181818	2544.833333	2349.076923	2181.285714	2035.866667	1908.625	1696.555556	1607.263158	1526.9	1272.416667	1221.52	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104107	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104108	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104109	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	40859	20429.5	13619.66667	10214.75	8171.8	6809.833333	5837	5107.375	4539.888889	4085.9	3714.454545	3404.916667	3143	2918.5	2723.933333	2553.6875	2269.944444	2150.473684	2042.95	1702.458333	1634.36	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104110	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104111	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	37587	18793.5	12529	9396.75	7517.4	6264.5	5369.571429	4698.375	4176.333333	3758.7	3417	3132.25	2891.307692	2684.785714	2505.8	2349.1875	2088.166667	1978.263158	1879.35	1566.125	1503.48	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104112	CHOYP_IF2A.1.1|m.13279	FHSDEQMEELYTK	FHSDEQMEELYTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104113	CHOYP_IF2A.1.1|m.13279	TAWFFDDK	TAWFFDDK	5574025	2787012.5	1858008.333	1393506.25	1114805	929004.1667	796289.2857	696753.125	619336.1111	557402.5	506729.5455	464502.0833	428771.1538	398144.6429	371601.6667	348376.5625	309668.0556	293369.7368	278701.25	232251.0417	222961	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104114	CHOYP_IF2A.1.1|m.13279	TAWFFDDK	TAWFFDDK	2604077	1302038.5	868025.6667	651019.25	520815.4	434012.8333	372011	325509.625	289341.8889	260407.7	236734.2727	217006.4167	200313.6154	186005.5	173605.1333	162754.8125	144670.9444	137056.6842	130203.85	108503.2083	104163.08	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104115	CHOYP_IF2A.1.1|m.13279	TAWFFDDK	TAWFFDDK	913494	456747	304498	228373.5	182698.8	152249	130499.1429	114186.75	101499.3333	91349.4	83044.90909	76124.5	70268.76923	65249.57143	60899.6	57093.375	50749.66667	48078.63158	45674.7	38062.25	36539.76	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104116	CHOYP_IF2A.1.1|m.13279	TAWFFDDK	TAWFFDDK	942310	471155	314103.3333	235577.5	188462	157051.6667	134615.7143	117788.75	104701.1111	94231	85664.54545	78525.83333	72485.38462	67307.85714	62820.66667	58894.375	52350.55556	49595.26316	47115.5	39262.91667	37692.4	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104117	CHOYP_IF2A.1.1|m.13279	TAWFFDDK	TAWFFDDK	232273	116136.5	77424.33333	58068.25	46454.6	38712.16667	33181.85714	29034.125	25808.11111	23227.3	21115.72727	19356.08333	17867.15385	16590.92857	15484.86667	14517.0625	12904.05556	12224.89474	11613.65	9678.041667	9290.92	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104118	CHOYP_IF2A.1.1|m.13279	TAWFFDDK	TAWFFDDK	196578	98289	65526	49144.5	39315.6	32763	28082.57143	24572.25	21842	19657.8	17870.72727	16381.5	15121.38462	14041.28571	13105.2	12286.125	10921	10346.21053	9828.9	8190.75	7863.12	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104119	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104120	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104121	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104122	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104123	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104124	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104125	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104126	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104127	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104128	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104129	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104130	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	51130	25565	17043.33333	12782.5	10226	8521.666667	7304.285714	6391.25	5681.111111	5113	4648.181818	4260.833333	3933.076923	3652.142857	3408.666667	3195.625	2840.555556	2691.052632	2556.5	2130.416667	2045.2	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104131	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104132	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104133	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	32265	16132.5	10755	8066.25	6453	5377.5	4609.285714	4033.125	3585	3226.5	2933.181818	2688.75	2481.923077	2304.642857	2151	2016.5625	1792.5	1698.157895	1613.25	1344.375	1290.6	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104134	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	43195	21597.5	14398.33333	10798.75	8639	7199.166667	6170.714286	5399.375	4799.444444	4319.5	3926.818182	3599.583333	3322.692308	3085.357143	2879.666667	2699.6875	2399.722222	2273.421053	2159.75	1799.791667	1727.8	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104135	CHOYP_IF2A.1.1|m.13279	HAVTNPEILDELDIDEETK	HAVTNPEILDELDIDEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104136	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	3672628	1836314	1224209.333	918157	734525.6	612104.6667	524661.1429	459078.5	408069.7778	367262.8	333875.2727	306052.3333	282509.8462	262330.5714	244841.8667	229539.25	204034.8889	193296.2105	183631.4	153026.1667	146905.12	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104137	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	11163632	5581816	3721210.667	2790908	2232726.4	1860605.333	1594804.571	1395454	1240403.556	1116363.2	1014875.636	930302.6667	858740.9231	797402.2857	744242.1333	697727	620201.7778	587559.5789	558181.6	465151.3333	446545.28	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104138	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104139	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	367500	183750	122500	91875	73500	61250	52500	45937.5	40833.33333	36750	33409.09091	30625	28269.23077	26250	24500	22968.75	20416.66667	19342.10526	18375	15312.5	14700	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104140	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	1035914	517957	345304.6667	258978.5	207182.8	172652.3333	147987.7143	129489.25	115101.5556	103591.4	94174	86326.16667	79685.69231	73993.85714	69060.93333	64744.625	57550.77778	54521.78947	51795.7	43163.08333	41436.56	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104141	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	388303	194151.5	129434.3333	97075.75	77660.6	64717.16667	55471.85714	48537.875	43144.77778	38830.3	35300.27273	32358.58333	29869.46154	27735.92857	25886.86667	24268.9375	21572.38889	20437	19415.15	16179.29167	15532.12	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104142	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	28800	14400	9600	7200	5760	4800	4114.285714	3600	3200	2880	2618.181818	2400	2215.384615	2057.142857	1920	1800	1600	1515.789474	1440	1200	1152	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104143	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	39705	19852.5	13235	9926.25	7941	6617.5	5672.142857	4963.125	4411.666667	3970.5	3609.545455	3308.75	3054.230769	2836.071429	2647	2481.5625	2205.833333	2089.736842	1985.25	1654.375	1588.2	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104144	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	31180	15590	10393.33333	7795	6236	5196.666667	4454.285714	3897.5	3464.444444	3118	2834.545455	2598.333333	2398.461538	2227.142857	2078.666667	1948.75	1732.222222	1641.052632	1559	1299.166667	1247.2	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104145	CHOYP_IF2A.1.1|m.13279	GLELSTESMPIK	GLELSTESMPIK	933970	466985	311323.3333	233492.5	186794	155661.6667	133424.2857	116746.25	103774.4444	93397	84906.36364	77830.83333	71843.84615	66712.14286	62264.66667	58373.125	51887.22222	49156.31579	46698.5	38915.41667	37358.8	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104146	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104147	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	2473071	1236535.5	824357	618267.75	494614.2	412178.5	353295.8571	309133.875	274785.6667	247307.1	224824.6364	206089.25	190236.2308	176647.9286	164871.4	154566.9375	137392.8333	130161.6316	123653.55	103044.625	98922.84	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104148	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	920302	460151	306767.3333	230075.5	184060.4	153383.6667	131471.7143	115037.75	102255.7778	92030.2	83663.81818	76691.83333	70792.46154	65735.85714	61353.46667	57518.875	51127.88889	48436.94737	46015.1	38345.91667	36812.08	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104149	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	314103	157051.5	104701	78525.75	62820.6	52350.5	44871.85714	39262.875	34900.33333	31410.3	28554.81818	26175.25	24161.76923	22435.92857	20940.2	19631.4375	17450.16667	16531.73684	15705.15	13087.625	12564.12	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104150	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	192572	96286	64190.66667	48143	38514.4	32095.33333	27510.28571	24071.5	21396.88889	19257.2	17506.54545	16047.66667	14813.23077	13755.14286	12838.13333	12035.75	10698.44444	10135.36842	9628.6	8023.833333	7702.88	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104151	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	316872	158436	105624	79218	63374.4	52812	45267.42857	39609	35208	31687.2	28806.54545	26406	24374.76923	22633.71429	21124.8	19804.5	17604	16677.47368	15843.6	13203	12674.88	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104152	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	550332	275166	183444	137583	110066.4	91722	78618.85714	68791.5	61148	55033.2	50030.18182	45861	42333.23077	39309.42857	36688.8	34395.75	30574	28964.84211	27516.6	22930.5	22013.28	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104153	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	96189	48094.5	32063	24047.25	19237.8	16031.5	13741.28571	12023.625	10687.66667	9618.9	8744.454545	8015.75	7399.153846	6870.642857	6412.6	6011.8125	5343.833333	5062.578947	4809.45	4007.875	3847.56	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104154	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104155	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104156	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104157	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104158	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104159	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104160	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104161	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104162	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104163	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104164	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104165	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104166	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104167	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	15901	7950.5	5300.333333	3975.25	3180.2	2650.166667	2271.571429	1987.625	1766.777778	1590.1	1445.545455	1325.083333	1223.153846	1135.785714	1060.066667	993.8125	883.3888889	836.8947368	795.05	662.5416667	636.04	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104168	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104169	CHOYP_IF2A.1.1|m.13279	LTIEEAGGIFNIHK	LTIEEAGGIFNIHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104170	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104171	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104172	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	13606413	6803206.5	4535471	3401603.25	2721282.6	2267735.5	1943773.286	1700801.625	1511823.667	1360641.3	1236946.636	1133867.75	1046647.154	971886.6429	907094.2	850400.8125	755911.8333	716127	680320.65	566933.875	544256.52	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104173	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	356396	178198	118798.6667	89099	71279.2	59399.33333	50913.71429	44549.5	39599.55556	35639.6	32399.63636	29699.66667	27415.07692	25456.85714	23759.73333	22274.75	19799.77778	18757.68421	17819.8	14849.83333	14255.84	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104174	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	250846	125423	83615.33333	62711.5	50169.2	41807.66667	35835.14286	31355.75	27871.77778	25084.6	22804.18182	20903.83333	19295.84615	17917.57143	16723.06667	15677.875	13935.88889	13202.42105	12542.3	10451.91667	10033.84	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104175	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	1315396	657698	438465.3333	328849	263079.2	219232.6667	187913.7143	164424.5	146155.1111	131539.6	119581.4545	109616.3333	101184.3077	93956.85714	87693.06667	82212.25	73077.55556	69231.36842	65769.8	54808.16667	52615.84	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104176	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	236682	118341	78894	59170.5	47336.4	39447	33811.71429	29585.25	26298	23668.2	21516.54545	19723.5	18206.30769	16905.85714	15778.8	14792.625	13149	12456.94737	11834.1	9861.75	9467.28	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104177	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104178	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	385600	192800	128533.3333	96400	77120	64266.66667	55085.71429	48200	42844.44444	38560	35054.54545	32133.33333	29661.53846	27542.85714	25706.66667	24100	21422.22222	20294.73684	19280	16066.66667	15424	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104179	CHOYP_IF2A.1.1|m.13279	VVSDIDEIELEK	VVSDIDEIELEK	317298	158649	105766	79324.5	63459.6	52883	45328.28571	39662.25	35255.33333	31729.8	28845.27273	26441.5	24407.53846	22664.14286	21153.2	19831.125	17627.66667	16699.89474	15864.9	13220.75	12691.92	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104180	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104181	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104182	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104183	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	849182	424591	283060.6667	212295.5	169836.4	141530.3333	121311.7143	106147.75	94353.55556	84918.2	77198.36364	70765.16667	65321.69231	60655.85714	56612.13333	53073.875	47176.77778	44693.78947	42459.1	35382.58333	33967.28	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104184	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	602968	301484	200989.3333	150742	120593.6	100494.6667	86138.28571	75371	66996.44444	60296.8	54815.27273	50247.33333	46382.15385	43069.14286	40197.86667	37685.5	33498.22222	31735.15789	30148.4	25123.66667	24118.72	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104185	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	143066	71533	47688.66667	35766.5	28613.2	23844.33333	20438	17883.25	15896.22222	14306.6	13006	11922.16667	11005.07692	10219	9537.733333	8941.625	7948.111111	7529.789474	7153.3	5961.083333	5722.64	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104186	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	171163	85581.5	57054.33333	42790.75	34232.6	28527.16667	24451.85714	21395.375	19018.11111	17116.3	15560.27273	14263.58333	13166.38462	12225.92857	11410.86667	10697.6875	9509.055556	9008.578947	8558.15	7131.791667	6846.52	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
104187	CHOYP_IF2A.1.1|m.13279	QLQQLEAENR	QLQQLEAENR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P68101	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	Eif2s1 Eif2a	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; mitophagy in response to mitochondrial depolarization [GO:0098779]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; translational initiation [GO:0006413]; xenophagy [GO:0098792]	GO:0002230; GO:0003743; GO:0005634; GO:0005737; GO:0005840; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034198; GO:0034605; GO:0034644; GO:0034976; GO:0043022; GO:0043614; GO:0044207; GO:0044822; GO:0046777; GO:0070062; GO:0097451; GO:0098779; GO:0098792; GO:1901216; GO:1905098; GO:1990737; GO:2000676
105388	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	23265982	11632991	7755327.333	5816495.5	4653196.4	3877663.667	3323711.714	2908247.75	2585109.111	2326598.2	2115089.273	1938831.833	1789690.923	1661855.857	1551065.467	1454123.875	1292554.556	1224525.368	1163299.1	969415.9167	930639.28	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105389	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	18383254	9191627	6127751.333	4595813.5	3676650.8	3063875.667	2626179.143	2297906.75	2042583.778	1838325.4	1671204.909	1531937.833	1414096.462	1313089.571	1225550.267	1148953.375	1021291.889	967539.6842	919162.7	765968.9167	735330.16	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105390	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105391	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	966363	483181.5	322121	241590.75	193272.6	161060.5	138051.8571	120795.375	107373.6667	96636.3	87851.18182	80530.25	74335.61538	69025.92857	64424.2	60397.6875	53686.83333	50861.21053	48318.15	40265.125	38654.52	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105392	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	1554129	777064.5	518043	388532.25	310825.8	259021.5	222018.4286	194266.125	172681	155412.9	141284.4545	129510.75	119548.3846	111009.2143	103608.6	97133.0625	86340.5	81796.26316	77706.45	64755.375	62165.16	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105393	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	3762446	1881223	1254148.667	940611.5	752489.2	627074.3333	537492.2857	470305.75	418049.5556	376244.6	342040.5455	313537.1667	289418.9231	268746.1429	250829.7333	235152.875	209024.7778	198023.4737	188122.3	156768.5833	150497.84	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105394	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	10498298	5249149	3499432.667	2624574.5	2099659.6	1749716.333	1499756.857	1312287.25	1166477.556	1049829.8	954390.7273	874858.1667	807561.3846	749878.4286	699886.5333	656143.625	583238.7778	552542	524914.9	437429.0833	419931.92	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105395	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	399891	199945.5	133297	99972.75	79978.2	66648.5	57127.28571	49986.375	44432.33333	39989.1	36353.72727	33324.25	30760.84615	28563.64286	26659.4	24993.1875	22216.16667	21046.89474	19994.55	16662.125	15995.64	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105396	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	379052	189526	126350.6667	94763	75810.4	63175.33333	54150.28571	47381.5	42116.88889	37905.2	34459.27273	31587.66667	29157.84615	27075.14286	25270.13333	23690.75	21058.44444	19950.10526	18952.6	15793.83333	15162.08	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105397	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	688290	344145	229430	172072.5	137658	114715	98327.14286	86036.25	76476.66667	68829	62571.81818	57357.5	52945.38462	49163.57143	45886	43018.125	38238.33333	36225.78947	34414.5	28678.75	27531.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105398	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	796199	398099.5	265399.6667	199049.75	159239.8	132699.8333	113742.7143	99524.875	88466.55556	79619.9	72381.72727	66349.91667	61246.07692	56871.35714	53079.93333	49762.4375	44233.27778	41905.21053	39809.95	33174.95833	31847.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105399	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105400	CHOYP_ISCW_ISCW000704.1.1|m.38250	ADQAANPEAVINSLR	ADQAANPEAVINSLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105401	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105402	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105403	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105404	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	209749	104874.5	69916.33333	52437.25	41949.8	34958.16667	29964.14286	26218.625	23305.44444	20974.9	19068.09091	17479.08333	16134.53846	14982.07143	13983.26667	13109.3125	11652.72222	11039.42105	10487.45	8739.541667	8389.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105405	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	86018	43009	28672.66667	21504.5	17203.6	14336.33333	12288.28571	10752.25	9557.555556	8601.8	7819.818182	7168.166667	6616.769231	6144.142857	5734.533333	5376.125	4778.777778	4527.263158	4300.9	3584.083333	3440.72	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105406	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	63890	31945	21296.66667	15972.5	12778	10648.33333	9127.142857	7986.25	7098.888889	6389	5808.181818	5324.166667	4914.615385	4563.571429	4259.333333	3993.125	3549.444444	3362.631579	3194.5	2662.083333	2555.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105407	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	112825	56412.5	37608.33333	28206.25	22565	18804.16667	16117.85714	14103.125	12536.11111	11282.5	10256.81818	9402.083333	8678.846154	8058.928571	7521.666667	7051.5625	6268.055556	5938.157895	5641.25	4701.041667	4513	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105408	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105409	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105410	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105411	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105412	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	9449	4724.5	3149.666667	2362.25	1889.8	1574.833333	1349.857143	1181.125	1049.888889	944.9	859	787.4166667	726.8461538	674.9285714	629.9333333	590.5625	524.9444444	497.3157895	472.45	393.7083333	377.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105413	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105414	CHOYP_ISCW_ISCW000704.1.1|m.38250	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105415	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105416	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105417	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105418	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105419	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	743394	371697	247798	185848.5	148678.8	123899	106199.1429	92924.25	82599.33333	74339.4	67581.27273	61949.5	57184.15385	53099.57143	49559.6	46462.125	41299.66667	39126	37169.7	30974.75	29735.76	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105420	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	964189	482094.5	321396.3333	241047.25	192837.8	160698.1667	137741.2857	120523.625	107132.1111	96418.9	87653.54545	80349.08333	74168.38462	68870.64286	64279.26667	60261.8125	53566.05556	50746.78947	48209.45	40174.54167	38567.56	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105421	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105422	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	1045265	522632.5	348421.6667	261316.25	209053	174210.8333	149323.5714	130658.125	116140.5556	104526.5	95024.09091	87105.41667	80405	74661.78571	69684.33333	65329.0625	58070.27778	55013.94737	52263.25	43552.70833	41810.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105423	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	216449	108224.5	72149.66667	54112.25	43289.8	36074.83333	30921.28571	27056.125	24049.88889	21644.9	19677.18182	18037.41667	16649.92308	15460.64286	14429.93333	13528.0625	12024.94444	11392.05263	10822.45	9018.708333	8657.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105424	CHOYP_ISCW_ISCW000704.1.1|m.38250	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105425	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	5542344	2771172	1847448	1385586	1108468.8	923724	791763.4286	692793	615816	554234.4	503849.4545	461862	426334.1538	395881.7143	369489.6	346396.5	307908	291702.3158	277117.2	230931	221693.76	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105426	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	1823518	911759	607839.3333	455879.5	364703.6	303919.6667	260502.5714	227939.75	202613.1111	182351.8	165774.3636	151959.8333	140270.6154	130251.2857	121567.8667	113969.875	101306.5556	95974.63158	91175.9	75979.91667	72940.72	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105427	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	788285	394142.5	262761.6667	197071.25	157657	131380.8333	112612.1429	98535.625	87587.22222	78828.5	71662.27273	65690.41667	60637.30769	56306.07143	52552.33333	49267.8125	43793.61111	41488.68421	39414.25	32845.20833	31531.4	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105428	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105429	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105430	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105431	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105432	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105433	CHOYP_ISCW_ISCW000704.1.1|m.38250	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105434	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	3962201	1981100.5	1320733.667	990550.25	792440.2	660366.8333	566028.7143	495275.125	440244.5556	396220.1	360200.0909	330183.4167	304784.6923	283014.3571	264146.7333	247637.5625	220122.2778	208536.8947	198110.05	165091.7083	158488.04	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105435	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	2531581	1265790.5	843860.3333	632895.25	506316.2	421930.1667	361654.4286	316447.625	281286.7778	253158.1	230143.7273	210965.0833	194737	180827.2143	168772.0667	158223.8125	140643.3889	133241.1053	126579.05	105482.5417	101263.24	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105436	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	811993	405996.5	270664.3333	202998.25	162398.6	135332.1667	115999	101499.125	90221.44444	81199.3	73817.54545	67666.08333	62461	57999.5	54132.86667	50749.5625	45110.72222	42736.47368	40599.65	33833.04167	32479.72	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105437	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	351885	175942.5	117295	87971.25	70377	58647.5	50269.28571	43985.625	39098.33333	35188.5	31989.54545	29323.75	27068.07692	25134.64286	23459	21992.8125	19549.16667	18520.26316	17594.25	14661.875	14075.4	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105438	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	1226839	613419.5	408946.3333	306709.75	245367.8	204473.1667	175262.7143	153354.875	136315.4444	122683.9	111530.8182	102236.5833	94372.23077	87631.35714	81789.26667	76677.4375	68157.72222	64570.47368	61341.95	51118.29167	49073.56	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105439	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	119047	59523.5	39682.33333	29761.75	23809.4	19841.16667	17006.71429	14880.875	13227.44444	11904.7	10822.45455	9920.583333	9157.461538	8503.357143	7936.466667	7440.4375	6613.722222	6265.631579	5952.35	4960.291667	4761.88	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105440	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	40587	20293.5	13529	10146.75	8117.4	6764.5	5798.142857	5073.375	4509.666667	4058.7	3689.727273	3382.25	3122.076923	2899.071429	2705.8	2536.6875	2254.833333	2136.157895	2029.35	1691.125	1623.48	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105441	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	90521	45260.5	30173.66667	22630.25	18104.2	15086.83333	12931.57143	11315.125	10057.88889	9052.1	8229.181818	7543.416667	6963.153846	6465.785714	6034.733333	5657.5625	5028.944444	4764.263158	4526.05	3771.708333	3620.84	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
105442	CHOYP_ISCW_ISCW000704.1.1|m.38250	ELLITEIEVMK	ELLITEIEVMK	86865	43432.5	28955	21716.25	17373	14477.5	12409.28571	10858.125	9651.666667	8686.5	7896.818182	7238.75	6681.923077	6204.642857	5791	5429.0625	4825.833333	4571.842105	4343.25	3619.375	3474.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
106686	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	22987048	11493524	7662349.333	5746762	4597409.6	3831174.667	3283864	2873381	2554116.444	2298704.8	2089731.636	1915587.333	1768234.462	1641932	1532469.867	1436690.5	1277058.222	1209844.632	1149352.4	957793.6667	919481.92	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106687	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	12377584	6188792	4125861.333	3094396	2475516.8	2062930.667	1768226.286	1547198	1375287.111	1237758.4	1125234.909	1031465.333	952121.8462	884113.1429	825172.2667	773599	687643.5556	651451.7895	618879.2	515732.6667	495103.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106688	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	2906477	1453238.5	968825.6667	726619.25	581295.4	484412.8333	415211	363309.625	322941.8889	290647.7	264225.1818	242206.4167	223575.1538	207605.5	193765.1333	181654.8125	161470.9444	152972.4737	145323.85	121103.2083	116259.08	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106689	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	708692	354346	236230.6667	177173	141738.4	118115.3333	101241.7143	88586.5	78743.55556	70869.2	64426.54545	59057.66667	54514.76923	50620.85714	47246.13333	44293.25	39371.77778	37299.57895	35434.6	29528.83333	28347.68	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106690	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	4011231	2005615.5	1337077	1002807.75	802246.2	668538.5	573033	501403.875	445692.3333	401123.1	364657.3636	334269.25	308556.2308	286516.5	267415.4	250701.9375	222846.1667	211117.4211	200561.55	167134.625	160449.24	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106691	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106692	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	367154	183577	122384.6667	91788.5	73430.8	61192.33333	52450.57143	45894.25	40794.88889	36715.4	33377.63636	30596.16667	28242.61538	26225.28571	24476.93333	22947.125	20397.44444	19323.89474	18357.7	15298.08333	14686.16	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106693	CHOYP_ISCW_ISCW008219.1.2|m.46822	EHGAPEDTER	EHGAPEDTER	922556	461278	307518.6667	230639	184511.2	153759.3333	131793.7143	115319.5	102506.2222	92255.6	83868.72727	76879.66667	70965.84615	65896.85714	61503.73333	57659.75	51253.11111	48555.57895	46127.8	38439.83333	36902.24	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106694	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	68740312	34370156	22913437.33	17185078	13748062.4	11456718.67	9820044.571	8592539	7637812.444	6874031.2	6249119.273	5728359.333	5287716.308	4910022.286	4582687.467	4296269.5	3818906.222	3617911.158	3437015.6	2864179.667	2749612.48	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106695	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	56999808	28499904	18999936	14249952	11399961.6	9499968	8142829.714	7124976	6333312	5699980.8	5181800.727	4749984	4384600.615	4071414.857	3799987.2	3562488	3166656	2999989.895	2849990.4	2374992	2279992.32	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106696	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	27510230	13755115	9170076.667	6877557.5	5502046	4585038.333	3930032.857	3438778.75	3056692.222	2751023	2500930	2292519.167	2116171.538	1965016.429	1834015.333	1719389.375	1528346.111	1447906.842	1375511.5	1146259.583	1100409.2	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106697	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	431487	215743.5	143829	107871.75	86297.4	71914.5	61641	53935.875	47943	43148.7	39226.09091	35957.25	33191.30769	30820.5	28765.8	26967.9375	23971.5	22709.84211	21574.35	17978.625	17259.48	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106698	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2127935	1063967.5	709311.6667	531983.75	425587	354655.8333	303990.7143	265991.875	236437.2222	212793.5	193448.6364	177327.9167	163687.3077	151995.3571	141862.3333	132995.9375	118218.6111	111996.5789	106396.75	88663.95833	85117.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106699	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2894744	1447372	964914.6667	723686	578948.8	482457.3333	413534.8571	361843	321638.2222	289474.4	263158.5455	241228.6667	222672.6154	206767.4286	192982.9333	180921.5	160819.1111	152354.9474	144737.2	120614.3333	115789.76	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106700	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	589184	294592	196394.6667	147296	117836.8	98197.33333	84169.14286	73648	65464.88889	58918.4	53562.18182	49098.66667	45321.84615	42084.57143	39278.93333	36824	32732.44444	31009.68421	29459.2	24549.33333	23567.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106701	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	1614769	807384.5	538256.3333	403692.25	322953.8	269128.1667	230681.2857	201846.125	179418.7778	161476.9	146797.1818	134564.0833	124213	115340.6429	107651.2667	100923.0625	89709.38889	84987.84211	80738.45	67282.04167	64590.76	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106702	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	3824584	1912292	1274861.333	956146	764916.8	637430.6667	546369.1429	478073	424953.7778	382458.4	347689.4545	318715.3333	294198.7692	273184.5714	254972.2667	239036.5	212476.8889	201293.8947	191229.2	159357.6667	152983.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106703	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2145111	1072555.5	715037	536277.75	429022.2	357518.5	306444.4286	268138.875	238345.6667	214511.1	195010.0909	178759.25	165008.5385	153222.2143	143007.4	134069.4375	119172.8333	112900.5789	107255.55	89379.625	85804.44	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106704	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2944142	1472071	981380.6667	736035.5	588828.4	490690.3333	420591.7143	368017.75	327126.8889	294414.2	267649.2727	245345.1667	226472.4615	210295.8571	196276.1333	184008.875	163563.4444	154954.8421	147207.1	122672.5833	117765.68	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106705	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	407580	203790	135860	101895	81516	67930	58225.71429	50947.5	45286.66667	40758	37052.72727	33965	31352.30769	29112.85714	27172	25473.75	22643.33333	21451.57895	20379	16982.5	16303.2	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106706	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	1542699	771349.5	514233	385674.75	308539.8	257116.5	220385.5714	192837.375	171411	154269.9	140245.3636	128558.25	118669.1538	110192.7857	102846.6	96418.6875	85705.5	81194.68421	77134.95	64279.125	61707.96	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106707	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	3442165	1721082.5	1147388.333	860541.25	688433	573694.1667	491737.8571	430270.625	382462.7778	344216.5	312924.0909	286847.0833	264781.9231	245868.9286	229477.6667	215135.3125	191231.3889	181166.5789	172108.25	143423.5417	137686.6	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106708	CHOYP_ISCW_ISCW008219.1.2|m.46822	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106709	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	106463160	53231580	35487720	26615790	21292632	17743860	15209022.86	13307895	11829240	10646316	9678469.091	8871930	8189473.846	7604511.429	7097544	6653947.5	5914620	5603324.211	5323158	4435965	4258526.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106710	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	81388416	40694208	27129472	20347104	16277683.2	13564736	11626916.57	10173552	9043157.333	8138841.6	7398946.909	6782368	6260647.385	5813458.286	5425894.4	5086776	4521578.667	4283600.842	4069420.8	3391184	3255536.64	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106711	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	36224888	18112444	12074962.67	9056222	7244977.6	6037481.333	5174984	4528111	4024987.556	3622488.8	3293171.636	3018740.667	2786529.846	2587492	2414992.533	2264055.5	2012493.778	1906573.053	1811244.4	1509370.333	1448995.52	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106712	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	7729345	3864672.5	2576448.333	1932336.25	1545869	1288224.167	1104192.143	966168.125	858816.1111	772934.5	702667.7273	644112.0833	594565	552096.0714	515289.6667	483084.0625	429408.0556	406807.6316	386467.25	322056.0417	309173.8	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106713	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	27045550	13522775	9015183.333	6761387.5	5409110	4507591.667	3863650	3380693.75	3005061.111	2704555	2458686.364	2253795.833	2080426.923	1931825	1803036.667	1690346.875	1502530.556	1423450	1352277.5	1126897.917	1081822	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106714	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	39330688	19665344	13110229.33	9832672	7866137.6	6555114.667	5618669.714	4916336	4370076.444	3933068.8	3575517.091	3277557.333	3025437.538	2809334.857	2622045.867	2458168	2185038.222	2070036.211	1966534.4	1638778.667	1573227.52	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106715	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	13893073	6946536.5	4631024.333	3473268.25	2778614.6	2315512.167	1984724.714	1736634.125	1543674.778	1389307.3	1263006.636	1157756.083	1068697.923	992362.3571	926204.8667	868317.0625	771837.3889	731214.3684	694653.65	578878.0417	555722.92	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106716	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	569309	284654.5	189769.6667	142327.25	113861.8	94884.83333	81329.85714	71163.625	63256.55556	56930.9	51755.36364	47442.41667	43793	40664.92857	37953.93333	35581.8125	31628.27778	29963.63158	28465.45	23721.20833	22772.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106717	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	2668196	1334098	889398.6667	667049	533639.2	444699.3333	381170.8571	333524.5	296466.2222	266819.6	242563.2727	222349.6667	205245.8462	190585.4286	177879.7333	166762.25	148233.1111	140431.3684	133409.8	111174.8333	106727.84	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106718	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	1028187	514093.5	342729	257046.75	205637.4	171364.5	146883.8571	128523.375	114243	102818.7	93471.54545	85682.25	79091.30769	73441.92857	68545.8	64261.6875	57121.5	54115.10526	51409.35	42841.125	41127.48	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106719	CHOYP_ISCW_ISCW008219.1.2|m.46822	MIDLAGPQSIIGR	MIDLAGPQSIIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106720	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	37520364	18760182	12506788	9380091	7504072.8	6253394	5360052	4690045.5	4168929.333	3752036.4	3410942.182	3126697	2886181.846	2680026	2501357.6	2345022.75	2084464.667	1974756	1876018.2	1563348.5	1500814.56	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106721	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	27841696	13920848	9280565.333	6960424	5568339.2	4640282.667	3977385.143	3480212	3093521.778	2784169.6	2531063.273	2320141.333	2141668.923	1988692.571	1856113.067	1740106	1546760.889	1465352.421	1392084.8	1160070.667	1113667.84	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106722	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	10262977	5131488.5	3420992.333	2565744.25	2052595.4	1710496.167	1466139.571	1282872.125	1140330.778	1026297.7	932997.9091	855248.0833	789459.7692	733069.7857	684198.4667	641436.0625	570165.3889	540156.6842	513148.85	427624.0417	410519.08	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106723	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	1687560	843780	562520	421890	337512	281260	241080	210945	187506.6667	168756	153414.5455	140630	129812.3077	120540	112504	105472.5	93753.33333	88818.94737	84378	70315	67502.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106724	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	4264769	2132384.5	1421589.667	1066192.25	852953.8	710794.8333	609252.7143	533096.125	473863.2222	426476.9	387706.2727	355397.4167	328059.1538	304626.3571	284317.9333	266548.0625	236931.6111	224461.5263	213238.45	177698.7083	170590.76	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106725	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	3298880	1649440	1099626.667	824720	659776	549813.3333	471268.5714	412360	366542.2222	329888	299898.1818	274906.6667	253760	235634.2857	219925.3333	206180	183271.1111	173625.2632	164944	137453.3333	131955.2	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106726	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	1067432	533716	355810.6667	266858	213486.4	177905.3333	152490.2857	133429	118603.5556	106743.2	97039.27273	88952.66667	82110.15385	76245.14286	71162.13333	66714.5	59301.77778	56180.63158	53371.6	44476.33333	42697.28	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106727	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	1129360	564680	376453.3333	282340	225872	188226.6667	161337.1429	141170	125484.4444	112936	102669.0909	94113.33333	86873.84615	80668.57143	75290.66667	70585	62742.22222	59440	56468	47056.66667	45174.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106728	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	440725	220362.5	146908.3333	110181.25	88145	73454.16667	62960.71429	55090.625	48969.44444	44072.5	40065.90909	36727.08333	33901.92308	31480.35714	29381.66667	27545.3125	24484.72222	23196.05263	22036.25	18363.54167	17629	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106729	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	686400	343200	228800	171600	137280	114400	98057.14286	85800	76266.66667	68640	62400	57200	52800	49028.57143	45760	42900	38133.33333	36126.31579	34320	28600	27456	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106730	CHOYP_ISCW_ISCW008219.1.2|m.46822	TVVIHADVDDLGK	TVVIHADVDDLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106731	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	22987048	11493524	7662349.333	5746762	4597409.6	3831174.667	3283864	2873381	2554116.444	2298704.8	2089731.636	1915587.333	1768234.462	1641932	1532469.867	1436690.5	1277058.222	1209844.632	1149352.4	957793.6667	919481.92	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106732	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	12377584	6188792	4125861.333	3094396	2475516.8	2062930.667	1768226.286	1547198	1375287.111	1237758.4	1125234.909	1031465.333	952121.8462	884113.1429	825172.2667	773599	687643.5556	651451.7895	618879.2	515732.6667	495103.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106733	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	2906477	1453238.5	968825.6667	726619.25	581295.4	484412.8333	415211	363309.625	322941.8889	290647.7	264225.1818	242206.4167	223575.1538	207605.5	193765.1333	181654.8125	161470.9444	152972.4737	145323.85	121103.2083	116259.08	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106734	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	708692	354346	236230.6667	177173	141738.4	118115.3333	101241.7143	88586.5	78743.55556	70869.2	64426.54545	59057.66667	54514.76923	50620.85714	47246.13333	44293.25	39371.77778	37299.57895	35434.6	29528.83333	28347.68	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106735	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	4011231	2005615.5	1337077	1002807.75	802246.2	668538.5	573033	501403.875	445692.3333	401123.1	364657.3636	334269.25	308556.2308	286516.5	267415.4	250701.9375	222846.1667	211117.4211	200561.55	167134.625	160449.24	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106736	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106737	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	367154	183577	122384.6667	91788.5	73430.8	61192.33333	52450.57143	45894.25	40794.88889	36715.4	33377.63636	30596.16667	28242.61538	26225.28571	24476.93333	22947.125	20397.44444	19323.89474	18357.7	15298.08333	14686.16	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106738	CHOYP_ISCW_ISCW008219.2.2|m.63442	EHGAPEDTER	EHGAPEDTER	922556	461278	307518.6667	230639	184511.2	153759.3333	131793.7143	115319.5	102506.2222	92255.6	83868.72727	76879.66667	70965.84615	65896.85714	61503.73333	57659.75	51253.11111	48555.57895	46127.8	38439.83333	36902.24	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106739	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	68740312	34370156	22913437.33	17185078	13748062.4	11456718.67	9820044.571	8592539	7637812.444	6874031.2	6249119.273	5728359.333	5287716.308	4910022.286	4582687.467	4296269.5	3818906.222	3617911.158	3437015.6	2864179.667	2749612.48	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106740	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	56999808	28499904	18999936	14249952	11399961.6	9499968	8142829.714	7124976	6333312	5699980.8	5181800.727	4749984	4384600.615	4071414.857	3799987.2	3562488	3166656	2999989.895	2849990.4	2374992	2279992.32	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106741	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	27510230	13755115	9170076.667	6877557.5	5502046	4585038.333	3930032.857	3438778.75	3056692.222	2751023	2500930	2292519.167	2116171.538	1965016.429	1834015.333	1719389.375	1528346.111	1447906.842	1375511.5	1146259.583	1100409.2	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106742	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	431487	215743.5	143829	107871.75	86297.4	71914.5	61641	53935.875	47943	43148.7	39226.09091	35957.25	33191.30769	30820.5	28765.8	26967.9375	23971.5	22709.84211	21574.35	17978.625	17259.48	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106743	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2127935	1063967.5	709311.6667	531983.75	425587	354655.8333	303990.7143	265991.875	236437.2222	212793.5	193448.6364	177327.9167	163687.3077	151995.3571	141862.3333	132995.9375	118218.6111	111996.5789	106396.75	88663.95833	85117.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106744	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2894744	1447372	964914.6667	723686	578948.8	482457.3333	413534.8571	361843	321638.2222	289474.4	263158.5455	241228.6667	222672.6154	206767.4286	192982.9333	180921.5	160819.1111	152354.9474	144737.2	120614.3333	115789.76	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106745	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	589184	294592	196394.6667	147296	117836.8	98197.33333	84169.14286	73648	65464.88889	58918.4	53562.18182	49098.66667	45321.84615	42084.57143	39278.93333	36824	32732.44444	31009.68421	29459.2	24549.33333	23567.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106746	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	1614769	807384.5	538256.3333	403692.25	322953.8	269128.1667	230681.2857	201846.125	179418.7778	161476.9	146797.1818	134564.0833	124213	115340.6429	107651.2667	100923.0625	89709.38889	84987.84211	80738.45	67282.04167	64590.76	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106747	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	3824584	1912292	1274861.333	956146	764916.8	637430.6667	546369.1429	478073	424953.7778	382458.4	347689.4545	318715.3333	294198.7692	273184.5714	254972.2667	239036.5	212476.8889	201293.8947	191229.2	159357.6667	152983.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106748	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2145111	1072555.5	715037	536277.75	429022.2	357518.5	306444.4286	268138.875	238345.6667	214511.1	195010.0909	178759.25	165008.5385	153222.2143	143007.4	134069.4375	119172.8333	112900.5789	107255.55	89379.625	85804.44	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106749	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	2944142	1472071	981380.6667	736035.5	588828.4	490690.3333	420591.7143	368017.75	327126.8889	294414.2	267649.2727	245345.1667	226472.4615	210295.8571	196276.1333	184008.875	163563.4444	154954.8421	147207.1	122672.5833	117765.68	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106750	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	407580	203790	135860	101895	81516	67930	58225.71429	50947.5	45286.66667	40758	37052.72727	33965	31352.30769	29112.85714	27172	25473.75	22643.33333	21451.57895	20379	16982.5	16303.2	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106751	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	1542699	771349.5	514233	385674.75	308539.8	257116.5	220385.5714	192837.375	171411	154269.9	140245.3636	128558.25	118669.1538	110192.7857	102846.6	96418.6875	85705.5	81194.68421	77134.95	64279.125	61707.96	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106752	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	3442165	1721082.5	1147388.333	860541.25	688433	573694.1667	491737.8571	430270.625	382462.7778	344216.5	312924.0909	286847.0833	264781.9231	245868.9286	229477.6667	215135.3125	191231.3889	181166.5789	172108.25	143423.5417	137686.6	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106753	CHOYP_ISCW_ISCW008219.2.2|m.63442	HVGDLGNVTAGEDGVAK	HVGDLGNVTAGEDGVAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106754	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	106463160	53231580	35487720	26615790	21292632	17743860	15209022.86	13307895	11829240	10646316	9678469.091	8871930	8189473.846	7604511.429	7097544	6653947.5	5914620	5603324.211	5323158	4435965	4258526.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106755	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	81388416	40694208	27129472	20347104	16277683.2	13564736	11626916.57	10173552	9043157.333	8138841.6	7398946.909	6782368	6260647.385	5813458.286	5425894.4	5086776	4521578.667	4283600.842	4069420.8	3391184	3255536.64	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106756	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	36224888	18112444	12074962.67	9056222	7244977.6	6037481.333	5174984	4528111	4024987.556	3622488.8	3293171.636	3018740.667	2786529.846	2587492	2414992.533	2264055.5	2012493.778	1906573.053	1811244.4	1509370.333	1448995.52	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106757	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	7729345	3864672.5	2576448.333	1932336.25	1545869	1288224.167	1104192.143	966168.125	858816.1111	772934.5	702667.7273	644112.0833	594565	552096.0714	515289.6667	483084.0625	429408.0556	406807.6316	386467.25	322056.0417	309173.8	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106758	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	27045550	13522775	9015183.333	6761387.5	5409110	4507591.667	3863650	3380693.75	3005061.111	2704555	2458686.364	2253795.833	2080426.923	1931825	1803036.667	1690346.875	1502530.556	1423450	1352277.5	1126897.917	1081822	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106759	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	39330688	19665344	13110229.33	9832672	7866137.6	6555114.667	5618669.714	4916336	4370076.444	3933068.8	3575517.091	3277557.333	3025437.538	2809334.857	2622045.867	2458168	2185038.222	2070036.211	1966534.4	1638778.667	1573227.52	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106760	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	13893073	6946536.5	4631024.333	3473268.25	2778614.6	2315512.167	1984724.714	1736634.125	1543674.778	1389307.3	1263006.636	1157756.083	1068697.923	992362.3571	926204.8667	868317.0625	771837.3889	731214.3684	694653.65	578878.0417	555722.92	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106761	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	569309	284654.5	189769.6667	142327.25	113861.8	94884.83333	81329.85714	71163.625	63256.55556	56930.9	51755.36364	47442.41667	43793	40664.92857	37953.93333	35581.8125	31628.27778	29963.63158	28465.45	23721.20833	22772.36	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106762	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	2668196	1334098	889398.6667	667049	533639.2	444699.3333	381170.8571	333524.5	296466.2222	266819.6	242563.2727	222349.6667	205245.8462	190585.4286	177879.7333	166762.25	148233.1111	140431.3684	133409.8	111174.8333	106727.84	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106763	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	1028187	514093.5	342729	257046.75	205637.4	171364.5	146883.8571	128523.375	114243	102818.7	93471.54545	85682.25	79091.30769	73441.92857	68545.8	64261.6875	57121.5	54115.10526	51409.35	42841.125	41127.48	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106764	CHOYP_ISCW_ISCW008219.2.2|m.63442	MIDLAGPQSIIGR	MIDLAGPQSIIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106765	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	37520364	18760182	12506788	9380091	7504072.8	6253394	5360052	4690045.5	4168929.333	3752036.4	3410942.182	3126697	2886181.846	2680026	2501357.6	2345022.75	2084464.667	1974756	1876018.2	1563348.5	1500814.56	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106766	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	27841696	13920848	9280565.333	6960424	5568339.2	4640282.667	3977385.143	3480212	3093521.778	2784169.6	2531063.273	2320141.333	2141668.923	1988692.571	1856113.067	1740106	1546760.889	1465352.421	1392084.8	1160070.667	1113667.84	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106767	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	10262977	5131488.5	3420992.333	2565744.25	2052595.4	1710496.167	1466139.571	1282872.125	1140330.778	1026297.7	932997.9091	855248.0833	789459.7692	733069.7857	684198.4667	641436.0625	570165.3889	540156.6842	513148.85	427624.0417	410519.08	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106768	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	1687560	843780	562520	421890	337512	281260	241080	210945	187506.6667	168756	153414.5455	140630	129812.3077	120540	112504	105472.5	93753.33333	88818.94737	84378	70315	67502.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106769	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	4264769	2132384.5	1421589.667	1066192.25	852953.8	710794.8333	609252.7143	533096.125	473863.2222	426476.9	387706.2727	355397.4167	328059.1538	304626.3571	284317.9333	266548.0625	236931.6111	224461.5263	213238.45	177698.7083	170590.76	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106770	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	3298880	1649440	1099626.667	824720	659776	549813.3333	471268.5714	412360	366542.2222	329888	299898.1818	274906.6667	253760	235634.2857	219925.3333	206180	183271.1111	173625.2632	164944	137453.3333	131955.2	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106771	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	1067432	533716	355810.6667	266858	213486.4	177905.3333	152490.2857	133429	118603.5556	106743.2	97039.27273	88952.66667	82110.15385	76245.14286	71162.13333	66714.5	59301.77778	56180.63158	53371.6	44476.33333	42697.28	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106772	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	1129360	564680	376453.3333	282340	225872	188226.6667	161337.1429	141170	125484.4444	112936	102669.0909	94113.33333	86873.84615	80668.57143	75290.66667	70585	62742.22222	59440	56468	47056.66667	45174.4	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106773	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	440725	220362.5	146908.3333	110181.25	88145	73454.16667	62960.71429	55090.625	48969.44444	44072.5	40065.90909	36727.08333	33901.92308	31480.35714	29381.66667	27545.3125	24484.72222	23196.05263	22036.25	18363.54167	17629	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106774	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	686400	343200	228800	171600	137280	114400	98057.14286	85800	76266.66667	68640	62400	57200	52800	49028.57143	45760	42900	38133.33333	36126.31579	34320	28600	27456	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106775	CHOYP_ISCW_ISCW008219.2.2|m.63442	TVVIHADVDDLGK	TVVIHADVDDLGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P08228	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115
106876	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106877	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106878	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	2367459	1183729.5	789153	591864.75	473491.8	394576.5	338208.4286	295932.375	263051	236745.9	215223.5455	197288.25	182112.2308	169104.2143	157830.6	147966.1875	131525.5	124603.1053	118372.95	98644.125	94698.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106879	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106880	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	82711	41355.5	27570.33333	20677.75	16542.2	13785.16667	11815.85714	10338.875	9190.111111	8271.1	7519.181818	6892.583333	6362.384615	5907.928571	5514.066667	5169.4375	4595.055556	4353.210526	4135.55	3446.291667	3308.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106881	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	823927	411963.5	274642.3333	205981.75	164785.4	137321.1667	117703.8571	102990.875	91547.44444	82392.7	74902.45455	68660.58333	63379	58851.92857	54928.46667	51495.4375	45773.72222	43364.57895	41196.35	34330.29167	32957.08	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106882	CHOYP_ISCW_ISCW010532.1.4|m.11493	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106883	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	62316376	31158188	20772125.33	15579094	12463275.2	10386062.67	8902339.429	7789547	6924041.778	6231637.6	5665125.091	5193031.333	4793567.385	4451169.714	4154425.067	3894773.5	3462020.889	3279809.263	3115818.8	2596515.667	2492655.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106884	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	30288212	15144106	10096070.67	7572053	6057642.4	5048035.333	4326887.429	3786026.5	3365356.889	3028821.2	2753473.818	2524017.667	2329862.462	2163443.714	2019214.133	1893013.25	1682678.444	1594116.421	1514410.6	1262008.833	1211528.48	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106885	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	30715424	15357712	10238474.67	7678856	6143084.8	5119237.333	4387917.714	3839428	3412824.889	3071542.4	2792311.273	2559618.667	2362724.923	2193958.857	2047694.933	1919714	1706412.444	1616601.263	1535771.2	1279809.333	1228616.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106886	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	6397053	3198526.5	2132351	1599263.25	1279410.6	1066175.5	913864.7143	799631.625	710783.6667	639705.3	581550.2727	533087.75	492081	456932.3571	426470.2	399815.8125	355391.8333	336687	319852.65	266543.875	255882.12	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106887	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	6145369	3072684.5	2048456.333	1536342.25	1229073.8	1024228.167	877909.8571	768171.125	682818.7778	614536.9	558669.9091	512114.0833	472720.6923	438954.9286	409691.2667	384085.5625	341409.3889	323440.4737	307268.45	256057.0417	245814.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106888	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	4644988	2322494	1548329.333	1161247	928997.6	774164.6667	663569.7143	580623.5	516109.7778	464498.8	422271.6364	387082.3333	357306.7692	331784.8571	309665.8667	290311.75	258054.8889	244473.0526	232249.4	193541.1667	185799.52	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106889	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	4268880	2134440	1422960	1067220	853776	711480	609840	533610	474320	426888	388080	355740	328375.3846	304920	284592	266805	237160	224677.8947	213444	177870	170755.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106890	CHOYP_ISCW_ISCW010532.1.4|m.11493	GQAVVDGEFK	GQAVVDGEFK	265221	132610.5	88407	66305.25	53044.2	44203.5	37888.71429	33152.625	29469	26522.1	24111	22101.75	20401.61538	18944.35714	17681.4	16576.3125	14734.5	13959	13261.05	11050.875	10608.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106891	CHOYP_ISCW_ISCW010532.1.4|m.11493	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106892	CHOYP_ISCW_ISCW010532.1.4|m.11493	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106893	CHOYP_ISCW_ISCW010532.1.4|m.11493	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106894	CHOYP_ISCW_ISCW010532.1.4|m.11493	DISLANYK	DISLANYK	114084	57042	38028	28521	22816.8	19014	16297.71429	14260.5	12676	11408.4	10371.27273	9507	8775.692308	8148.857143	7605.6	7130.25	6338	6004.421053	5704.2	4753.5	4563.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106895	CHOYP_ISCW_ISCW010532.1.4|m.11493	DISLANYK	DISLANYK	290769	145384.5	96923	72692.25	58153.8	48461.5	41538.42857	36346.125	32307.66667	29076.9	26433.54545	24230.75	22366.84615	20769.21429	19384.6	18173.0625	16153.83333	15303.63158	14538.45	12115.375	11630.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106896	CHOYP_ISCW_ISCW010532.1.4|m.11493	DISLANYK	DISLANYK	110821	55410.5	36940.33333	27705.25	22164.2	18470.16667	15831.57143	13852.625	12313.44444	11082.1	10074.63636	9235.083333	8524.692308	7915.785714	7388.066667	6926.3125	6156.722222	5832.684211	5541.05	4617.541667	4432.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106897	CHOYP_ISCW_ISCW010532.1.4|m.11493	EDDGISFR	EDDGISFR	17640324	8820162	5880108	4410081	3528064.8	2940054	2520046.286	2205040.5	1960036	1764032.4	1603665.818	1470027	1356948	1260023.143	1176021.6	1102520.25	980018	928438.1053	882016.2	735013.5	705612.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106898	CHOYP_ISCW_ISCW010532.1.4|m.11493	EDDGISFR	EDDGISFR	2886319	1443159.5	962106.3333	721579.75	577263.8	481053.1667	412331.2857	360789.875	320702.1111	288631.9	262392.6364	240526.5833	222024.5385	206165.6429	192421.2667	180394.9375	160351.0556	151911.5263	144315.95	120263.2917	115452.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106899	CHOYP_ISCW_ISCW010532.1.4|m.11493	EDDGISFR	EDDGISFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106900	CHOYP_ISCW_ISCW010532.1.4|m.11493	EDDGISFR	EDDGISFR	1905510	952755	635170	476377.5	381102	317585	272215.7143	238188.75	211723.3333	190551	173228.1818	158792.5	146577.6923	136107.8571	127034	119094.375	105861.6667	100290	95275.5	79396.25	76220.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106901	CHOYP_ISCW_ISCW010532.1.4|m.11493	EDDGISFR	EDDGISFR	451586	225793	150528.6667	112896.5	90317.2	75264.33333	64512.28571	56448.25	50176.22222	45158.6	41053.27273	37632.16667	34737.38462	32256.14286	30105.73333	28224.125	25088.11111	23767.68421	22579.3	18816.08333	18063.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106902	CHOYP_ISCW_ISCW010532.1.4|m.11493	EDDGISFR	EDDGISFR	6374681	3187340.5	2124893.667	1593670.25	1274936.2	1062446.833	910668.7143	796835.125	708297.8889	637468.1	579516.4545	531223.4167	490360.0769	455334.3571	424978.7333	398417.5625	354148.9444	335509.5263	318734.05	265611.7083	254987.24	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106903	CHOYP_ISCW_ISCW010532.1.4|m.11493	GLFIIDDK	GLFIIDDK	18495340	9247670	6165113.333	4623835	3699068	3082556.667	2642191.429	2311917.5	2055037.778	1849534	1681394.545	1541278.333	1422718.462	1321095.714	1233022.667	1155958.75	1027518.889	973438.9474	924767	770639.1667	739813.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106904	CHOYP_ISCW_ISCW010532.1.4|m.11493	GLFIIDDK	GLFIIDDK	8675401	4337700.5	2891800.333	2168850.25	1735080.2	1445900.167	1239343	1084425.125	963933.4444	867540.1	788672.8182	722950.0833	667338.5385	619671.5	578360.0667	542212.5625	481966.7222	456600.0526	433770.05	361475.0417	347016.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106905	CHOYP_ISCW_ISCW010532.1.4|m.11493	GLFIIDDK	GLFIIDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106906	CHOYP_ISCW_ISCW010532.1.4|m.11493	GLFIIDDK	GLFIIDDK	1921098	960549	640366	480274.5	384219.6	320183	274442.5714	240137.25	213455.3333	192109.8	174645.2727	160091.5	147776.7692	137221.2857	128073.2	120068.625	106727.6667	101110.4211	96054.9	80045.75	76843.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106907	CHOYP_ISCW_ISCW010532.1.4|m.11493	GLFIIDDK	GLFIIDDK	3030290	1515145	1010096.667	757572.5	606058	505048.3333	432898.5714	378786.25	336698.8889	303029	275480.9091	252524.1667	233099.2308	216449.2857	202019.3333	189393.125	168349.4444	159488.9474	151514.5	126262.0833	121211.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106908	CHOYP_ISCW_ISCW010532.1.4|m.11493	GLFIIDDK	GLFIIDDK	1753883	876941.5	584627.6667	438470.75	350776.6	292313.8333	250554.7143	219235.375	194875.8889	175388.3	159443.9091	146156.9167	134914.0769	125277.3571	116925.5333	109617.6875	97437.94444	92309.63158	87694.15	73078.45833	70155.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106909	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	81968008	40984004	27322669.33	20492002	16393601.6	13661334.67	11709715.43	10246001	9107556.444	8196800.8	7451637.091	6830667.333	6305231.385	5854857.714	5464533.867	5123000.5	4553778.222	4314105.684	4098400.4	3415333.667	3278720.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106910	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	52031592	26015796	17343864	13007898	10406318.4	8671932	7433084.571	6503949	5781288	5203159.2	4730144.727	4335966	4002430.154	3716542.286	3468772.8	3251974.5	2890644	2738504.842	2601579.6	2167983	2081263.68	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106911	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	20562410	10281205	6854136.667	5140602.5	4112482	3427068.333	2937487.143	2570301.25	2284712.222	2056241	1869310	1713534.167	1581723.846	1468743.571	1370827.333	1285150.625	1142356.111	1082232.105	1028120.5	856767.0833	822496.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106912	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	6314790	3157395	2104930	1578697.5	1262958	1052465	902112.8571	789348.75	701643.3333	631479	574071.8182	526232.5	485753.0769	451056.4286	420986	394674.375	350821.6667	332357.3684	315739.5	263116.25	252591.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106913	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	9972505	4986252.5	3324168.333	2493126.25	1994501	1662084.167	1424643.571	1246563.125	1108056.111	997250.5	906591.3636	831042.0833	767115.7692	712321.7857	664833.6667	623281.5625	554028.0556	524868.6842	498625.25	415521.0417	398900.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106914	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	4445414	2222707	1481804.667	1111353.5	889082.8	740902.3333	635059.1429	555676.75	493934.8889	444541.4	404128.5455	370451.1667	341954.9231	317529.5714	296360.9333	277838.375	246967.4444	233969.1579	222270.7	185225.5833	177816.56	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106915	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	11395068	5697534	3798356	2848767	2279013.6	1899178	1627866.857	1424383.5	1266118.667	1139506.8	1035915.273	949589	876543.6923	813933.4286	759671.2	712191.75	633059.3333	599740.4211	569753.4	474794.5	455802.72	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106916	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	12560279	6280139.5	4186759.667	3140069.75	2512055.8	2093379.833	1794325.571	1570034.875	1395586.556	1256027.9	1141843.545	1046689.917	966175.3077	897162.7857	837351.9333	785017.4375	697793.2778	661067.3158	628013.95	523344.9583	502411.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106917	CHOYP_ISCW_ISCW010532.1.4|m.11493	QITMNDLPVGR	QITMNDLPVGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106918	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	91304096	45652048	30434698.67	22826024	18260819.2	15217349.33	13043442.29	11413012	10144899.56	9130409.6	8300372.364	7608674.667	7023392	6521721.143	6086939.733	5706506	5072449.778	4805478.737	4565204.8	3804337.333	3652163.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106919	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	64869784	32434892	21623261.33	16217446	12973956.8	10811630.67	9267112	8108723	7207753.778	6486978.4	5897253.091	5405815.333	4989983.385	4633556	4324652.267	4054361.5	3603876.889	3414199.158	3243489.2	2702907.667	2594791.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106920	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	33955748	16977874	11318582.67	8488937	6791149.6	5659291.333	4850821.143	4244468.5	3772860.889	3395574.8	3086886.182	2829645.667	2611980.615	2425410.571	2263716.533	2122234.25	1886430.444	1787144.632	1697787.4	1414822.833	1358229.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106921	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	10869148	5434574	3623049.333	2717287	2173829.6	1811524.667	1552735.429	1358643.5	1207683.111	1086914.8	988104.3636	905762.3333	836088.3077	776367.7143	724609.8667	679321.75	603841.5556	572060.4211	543457.4	452881.1667	434765.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106922	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	7606276	3803138	2535425.333	1901569	1521255.2	1267712.667	1086610.857	950784.5	845141.7778	760627.6	691479.6364	633856.3333	585098.1538	543305.4286	507085.0667	475392.25	422570.8889	400330.3158	380313.8	316928.1667	304251.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106923	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	3192332	1596166	1064110.667	798083	638466.4	532055.3333	456047.4286	399041.5	354703.5556	319233.2	290212	266027.6667	245564	228023.7143	212822.1333	199520.75	177351.7778	168017.4737	159616.6	133013.8333	127693.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106924	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	6568554	3284277	2189518	1642138.5	1313710.8	1094759	938364.8571	821069.25	729839.3333	656855.4	597141.2727	547379.5	505273.3846	469182.4286	437903.6	410534.625	364919.6667	345713.3684	328427.7	273689.75	262742.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106925	CHOYP_ISCW_ISCW010532.1.4|m.11493	LVQAFQFTDK	LVQAFQFTDK	3393157	1696578.5	1131052.333	848289.25	678631.4	565526.1667	484736.7143	424144.625	377017.4444	339315.7	308468.8182	282763.0833	261012.0769	242368.3571	226210.4667	212072.3125	188508.7222	178587.2105	169657.85	141381.5417	135726.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106926	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106927	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106928	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	2367459	1183729.5	789153	591864.75	473491.8	394576.5	338208.4286	295932.375	263051	236745.9	215223.5455	197288.25	182112.2308	169104.2143	157830.6	147966.1875	131525.5	124603.1053	118372.95	98644.125	94698.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106929	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106930	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	82711	41355.5	27570.33333	20677.75	16542.2	13785.16667	11815.85714	10338.875	9190.111111	8271.1	7519.181818	6892.583333	6362.384615	5907.928571	5514.066667	5169.4375	4595.055556	4353.210526	4135.55	3446.291667	3308.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106931	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	823927	411963.5	274642.3333	205981.75	164785.4	137321.1667	117703.8571	102990.875	91547.44444	82392.7	74902.45455	68660.58333	63379	58851.92857	54928.46667	51495.4375	45773.72222	43364.57895	41196.35	34330.29167	32957.08	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106932	CHOYP_ISCW_ISCW010532.2.4|m.35454	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106933	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	62316376	31158188	20772125.33	15579094	12463275.2	10386062.67	8902339.429	7789547	6924041.778	6231637.6	5665125.091	5193031.333	4793567.385	4451169.714	4154425.067	3894773.5	3462020.889	3279809.263	3115818.8	2596515.667	2492655.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106934	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	30288212	15144106	10096070.67	7572053	6057642.4	5048035.333	4326887.429	3786026.5	3365356.889	3028821.2	2753473.818	2524017.667	2329862.462	2163443.714	2019214.133	1893013.25	1682678.444	1594116.421	1514410.6	1262008.833	1211528.48	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106935	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	30715424	15357712	10238474.67	7678856	6143084.8	5119237.333	4387917.714	3839428	3412824.889	3071542.4	2792311.273	2559618.667	2362724.923	2193958.857	2047694.933	1919714	1706412.444	1616601.263	1535771.2	1279809.333	1228616.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106936	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	6397053	3198526.5	2132351	1599263.25	1279410.6	1066175.5	913864.7143	799631.625	710783.6667	639705.3	581550.2727	533087.75	492081	456932.3571	426470.2	399815.8125	355391.8333	336687	319852.65	266543.875	255882.12	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106937	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	6145369	3072684.5	2048456.333	1536342.25	1229073.8	1024228.167	877909.8571	768171.125	682818.7778	614536.9	558669.9091	512114.0833	472720.6923	438954.9286	409691.2667	384085.5625	341409.3889	323440.4737	307268.45	256057.0417	245814.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106938	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	4644988	2322494	1548329.333	1161247	928997.6	774164.6667	663569.7143	580623.5	516109.7778	464498.8	422271.6364	387082.3333	357306.7692	331784.8571	309665.8667	290311.75	258054.8889	244473.0526	232249.4	193541.1667	185799.52	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106939	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	4268880	2134440	1422960	1067220	853776	711480	609840	533610	474320	426888	388080	355740	328375.3846	304920	284592	266805	237160	224677.8947	213444	177870	170755.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106940	CHOYP_ISCW_ISCW010532.2.4|m.35454	GQAVVDGEFK	GQAVVDGEFK	265221	132610.5	88407	66305.25	53044.2	44203.5	37888.71429	33152.625	29469	26522.1	24111	22101.75	20401.61538	18944.35714	17681.4	16576.3125	14734.5	13959	13261.05	11050.875	10608.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106941	CHOYP_ISCW_ISCW010532.2.4|m.35454	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106942	CHOYP_ISCW_ISCW010532.2.4|m.35454	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106943	CHOYP_ISCW_ISCW010532.2.4|m.35454	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106944	CHOYP_ISCW_ISCW010532.2.4|m.35454	DISLANYK	DISLANYK	114084	57042	38028	28521	22816.8	19014	16297.71429	14260.5	12676	11408.4	10371.27273	9507	8775.692308	8148.857143	7605.6	7130.25	6338	6004.421053	5704.2	4753.5	4563.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106945	CHOYP_ISCW_ISCW010532.2.4|m.35454	DISLANYK	DISLANYK	290769	145384.5	96923	72692.25	58153.8	48461.5	41538.42857	36346.125	32307.66667	29076.9	26433.54545	24230.75	22366.84615	20769.21429	19384.6	18173.0625	16153.83333	15303.63158	14538.45	12115.375	11630.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106946	CHOYP_ISCW_ISCW010532.2.4|m.35454	DISLANYK	DISLANYK	110821	55410.5	36940.33333	27705.25	22164.2	18470.16667	15831.57143	13852.625	12313.44444	11082.1	10074.63636	9235.083333	8524.692308	7915.785714	7388.066667	6926.3125	6156.722222	5832.684211	5541.05	4617.541667	4432.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106947	CHOYP_ISCW_ISCW010532.2.4|m.35454	EDDGISFR	EDDGISFR	17640324	8820162	5880108	4410081	3528064.8	2940054	2520046.286	2205040.5	1960036	1764032.4	1603665.818	1470027	1356948	1260023.143	1176021.6	1102520.25	980018	928438.1053	882016.2	735013.5	705612.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106948	CHOYP_ISCW_ISCW010532.2.4|m.35454	EDDGISFR	EDDGISFR	2886319	1443159.5	962106.3333	721579.75	577263.8	481053.1667	412331.2857	360789.875	320702.1111	288631.9	262392.6364	240526.5833	222024.5385	206165.6429	192421.2667	180394.9375	160351.0556	151911.5263	144315.95	120263.2917	115452.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106949	CHOYP_ISCW_ISCW010532.2.4|m.35454	EDDGISFR	EDDGISFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106950	CHOYP_ISCW_ISCW010532.2.4|m.35454	EDDGISFR	EDDGISFR	1905510	952755	635170	476377.5	381102	317585	272215.7143	238188.75	211723.3333	190551	173228.1818	158792.5	146577.6923	136107.8571	127034	119094.375	105861.6667	100290	95275.5	79396.25	76220.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106951	CHOYP_ISCW_ISCW010532.2.4|m.35454	EDDGISFR	EDDGISFR	451586	225793	150528.6667	112896.5	90317.2	75264.33333	64512.28571	56448.25	50176.22222	45158.6	41053.27273	37632.16667	34737.38462	32256.14286	30105.73333	28224.125	25088.11111	23767.68421	22579.3	18816.08333	18063.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106952	CHOYP_ISCW_ISCW010532.2.4|m.35454	EDDGISFR	EDDGISFR	6374681	3187340.5	2124893.667	1593670.25	1274936.2	1062446.833	910668.7143	796835.125	708297.8889	637468.1	579516.4545	531223.4167	490360.0769	455334.3571	424978.7333	398417.5625	354148.9444	335509.5263	318734.05	265611.7083	254987.24	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106953	CHOYP_ISCW_ISCW010532.2.4|m.35454	GLFIIDDK	GLFIIDDK	18495340	9247670	6165113.333	4623835	3699068	3082556.667	2642191.429	2311917.5	2055037.778	1849534	1681394.545	1541278.333	1422718.462	1321095.714	1233022.667	1155958.75	1027518.889	973438.9474	924767	770639.1667	739813.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106954	CHOYP_ISCW_ISCW010532.2.4|m.35454	GLFIIDDK	GLFIIDDK	8675401	4337700.5	2891800.333	2168850.25	1735080.2	1445900.167	1239343	1084425.125	963933.4444	867540.1	788672.8182	722950.0833	667338.5385	619671.5	578360.0667	542212.5625	481966.7222	456600.0526	433770.05	361475.0417	347016.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106955	CHOYP_ISCW_ISCW010532.2.4|m.35454	GLFIIDDK	GLFIIDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106956	CHOYP_ISCW_ISCW010532.2.4|m.35454	GLFIIDDK	GLFIIDDK	1921098	960549	640366	480274.5	384219.6	320183	274442.5714	240137.25	213455.3333	192109.8	174645.2727	160091.5	147776.7692	137221.2857	128073.2	120068.625	106727.6667	101110.4211	96054.9	80045.75	76843.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106957	CHOYP_ISCW_ISCW010532.2.4|m.35454	GLFIIDDK	GLFIIDDK	3030290	1515145	1010096.667	757572.5	606058	505048.3333	432898.5714	378786.25	336698.8889	303029	275480.9091	252524.1667	233099.2308	216449.2857	202019.3333	189393.125	168349.4444	159488.9474	151514.5	126262.0833	121211.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106958	CHOYP_ISCW_ISCW010532.2.4|m.35454	GLFIIDDK	GLFIIDDK	1753883	876941.5	584627.6667	438470.75	350776.6	292313.8333	250554.7143	219235.375	194875.8889	175388.3	159443.9091	146156.9167	134914.0769	125277.3571	116925.5333	109617.6875	97437.94444	92309.63158	87694.15	73078.45833	70155.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106959	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	81968008	40984004	27322669.33	20492002	16393601.6	13661334.67	11709715.43	10246001	9107556.444	8196800.8	7451637.091	6830667.333	6305231.385	5854857.714	5464533.867	5123000.5	4553778.222	4314105.684	4098400.4	3415333.667	3278720.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106960	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	52031592	26015796	17343864	13007898	10406318.4	8671932	7433084.571	6503949	5781288	5203159.2	4730144.727	4335966	4002430.154	3716542.286	3468772.8	3251974.5	2890644	2738504.842	2601579.6	2167983	2081263.68	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106961	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	20562410	10281205	6854136.667	5140602.5	4112482	3427068.333	2937487.143	2570301.25	2284712.222	2056241	1869310	1713534.167	1581723.846	1468743.571	1370827.333	1285150.625	1142356.111	1082232.105	1028120.5	856767.0833	822496.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106962	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	6314790	3157395	2104930	1578697.5	1262958	1052465	902112.8571	789348.75	701643.3333	631479	574071.8182	526232.5	485753.0769	451056.4286	420986	394674.375	350821.6667	332357.3684	315739.5	263116.25	252591.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106963	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	9972505	4986252.5	3324168.333	2493126.25	1994501	1662084.167	1424643.571	1246563.125	1108056.111	997250.5	906591.3636	831042.0833	767115.7692	712321.7857	664833.6667	623281.5625	554028.0556	524868.6842	498625.25	415521.0417	398900.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106964	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	4445414	2222707	1481804.667	1111353.5	889082.8	740902.3333	635059.1429	555676.75	493934.8889	444541.4	404128.5455	370451.1667	341954.9231	317529.5714	296360.9333	277838.375	246967.4444	233969.1579	222270.7	185225.5833	177816.56	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106965	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	11395068	5697534	3798356	2848767	2279013.6	1899178	1627866.857	1424383.5	1266118.667	1139506.8	1035915.273	949589	876543.6923	813933.4286	759671.2	712191.75	633059.3333	599740.4211	569753.4	474794.5	455802.72	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106966	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	12560279	6280139.5	4186759.667	3140069.75	2512055.8	2093379.833	1794325.571	1570034.875	1395586.556	1256027.9	1141843.545	1046689.917	966175.3077	897162.7857	837351.9333	785017.4375	697793.2778	661067.3158	628013.95	523344.9583	502411.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106967	CHOYP_ISCW_ISCW010532.2.4|m.35454	QITMNDLPVGR	QITMNDLPVGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106968	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	91304096	45652048	30434698.67	22826024	18260819.2	15217349.33	13043442.29	11413012	10144899.56	9130409.6	8300372.364	7608674.667	7023392	6521721.143	6086939.733	5706506	5072449.778	4805478.737	4565204.8	3804337.333	3652163.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106969	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	64869784	32434892	21623261.33	16217446	12973956.8	10811630.67	9267112	8108723	7207753.778	6486978.4	5897253.091	5405815.333	4989983.385	4633556	4324652.267	4054361.5	3603876.889	3414199.158	3243489.2	2702907.667	2594791.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106970	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	33955748	16977874	11318582.67	8488937	6791149.6	5659291.333	4850821.143	4244468.5	3772860.889	3395574.8	3086886.182	2829645.667	2611980.615	2425410.571	2263716.533	2122234.25	1886430.444	1787144.632	1697787.4	1414822.833	1358229.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106971	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	10869148	5434574	3623049.333	2717287	2173829.6	1811524.667	1552735.429	1358643.5	1207683.111	1086914.8	988104.3636	905762.3333	836088.3077	776367.7143	724609.8667	679321.75	603841.5556	572060.4211	543457.4	452881.1667	434765.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106972	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	7606276	3803138	2535425.333	1901569	1521255.2	1267712.667	1086610.857	950784.5	845141.7778	760627.6	691479.6364	633856.3333	585098.1538	543305.4286	507085.0667	475392.25	422570.8889	400330.3158	380313.8	316928.1667	304251.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106973	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	3192332	1596166	1064110.667	798083	638466.4	532055.3333	456047.4286	399041.5	354703.5556	319233.2	290212	266027.6667	245564	228023.7143	212822.1333	199520.75	177351.7778	168017.4737	159616.6	133013.8333	127693.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106974	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	6568554	3284277	2189518	1642138.5	1313710.8	1094759	938364.8571	821069.25	729839.3333	656855.4	597141.2727	547379.5	505273.3846	469182.4286	437903.6	410534.625	364919.6667	345713.3684	328427.7	273689.75	262742.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106975	CHOYP_ISCW_ISCW010532.2.4|m.35454	LVQAFQFTDK	LVQAFQFTDK	3393157	1696578.5	1131052.333	848289.25	678631.4	565526.1667	484736.7143	424144.625	377017.4444	339315.7	308468.8182	282763.0833	261012.0769	242368.3571	226210.4667	212072.3125	188508.7222	178587.2105	169657.85	141381.5417	135726.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106976	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106977	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106978	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	2367459	1183729.5	789153	591864.75	473491.8	394576.5	338208.4286	295932.375	263051	236745.9	215223.5455	197288.25	182112.2308	169104.2143	157830.6	147966.1875	131525.5	124603.1053	118372.95	98644.125	94698.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106979	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106980	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	82711	41355.5	27570.33333	20677.75	16542.2	13785.16667	11815.85714	10338.875	9190.111111	8271.1	7519.181818	6892.583333	6362.384615	5907.928571	5514.066667	5169.4375	4595.055556	4353.210526	4135.55	3446.291667	3308.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106981	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	823927	411963.5	274642.3333	205981.75	164785.4	137321.1667	117703.8571	102990.875	91547.44444	82392.7	74902.45455	68660.58333	63379	58851.92857	54928.46667	51495.4375	45773.72222	43364.57895	41196.35	34330.29167	32957.08	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106982	CHOYP_ISCW_ISCW010532.3.4|m.56458	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106983	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	62316376	31158188	20772125.33	15579094	12463275.2	10386062.67	8902339.429	7789547	6924041.778	6231637.6	5665125.091	5193031.333	4793567.385	4451169.714	4154425.067	3894773.5	3462020.889	3279809.263	3115818.8	2596515.667	2492655.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106984	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	30288212	15144106	10096070.67	7572053	6057642.4	5048035.333	4326887.429	3786026.5	3365356.889	3028821.2	2753473.818	2524017.667	2329862.462	2163443.714	2019214.133	1893013.25	1682678.444	1594116.421	1514410.6	1262008.833	1211528.48	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106985	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	30715424	15357712	10238474.67	7678856	6143084.8	5119237.333	4387917.714	3839428	3412824.889	3071542.4	2792311.273	2559618.667	2362724.923	2193958.857	2047694.933	1919714	1706412.444	1616601.263	1535771.2	1279809.333	1228616.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106986	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	6397053	3198526.5	2132351	1599263.25	1279410.6	1066175.5	913864.7143	799631.625	710783.6667	639705.3	581550.2727	533087.75	492081	456932.3571	426470.2	399815.8125	355391.8333	336687	319852.65	266543.875	255882.12	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106987	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	6145369	3072684.5	2048456.333	1536342.25	1229073.8	1024228.167	877909.8571	768171.125	682818.7778	614536.9	558669.9091	512114.0833	472720.6923	438954.9286	409691.2667	384085.5625	341409.3889	323440.4737	307268.45	256057.0417	245814.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106988	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	4644988	2322494	1548329.333	1161247	928997.6	774164.6667	663569.7143	580623.5	516109.7778	464498.8	422271.6364	387082.3333	357306.7692	331784.8571	309665.8667	290311.75	258054.8889	244473.0526	232249.4	193541.1667	185799.52	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106989	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	4268880	2134440	1422960	1067220	853776	711480	609840	533610	474320	426888	388080	355740	328375.3846	304920	284592	266805	237160	224677.8947	213444	177870	170755.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106990	CHOYP_ISCW_ISCW010532.3.4|m.56458	GQAVVDGEFK	GQAVVDGEFK	265221	132610.5	88407	66305.25	53044.2	44203.5	37888.71429	33152.625	29469	26522.1	24111	22101.75	20401.61538	18944.35714	17681.4	16576.3125	14734.5	13959	13261.05	11050.875	10608.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106991	CHOYP_ISCW_ISCW010532.3.4|m.56458	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106992	CHOYP_ISCW_ISCW010532.3.4|m.56458	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106993	CHOYP_ISCW_ISCW010532.3.4|m.56458	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106994	CHOYP_ISCW_ISCW010532.3.4|m.56458	DISLANYK	DISLANYK	114084	57042	38028	28521	22816.8	19014	16297.71429	14260.5	12676	11408.4	10371.27273	9507	8775.692308	8148.857143	7605.6	7130.25	6338	6004.421053	5704.2	4753.5	4563.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106995	CHOYP_ISCW_ISCW010532.3.4|m.56458	DISLANYK	DISLANYK	290769	145384.5	96923	72692.25	58153.8	48461.5	41538.42857	36346.125	32307.66667	29076.9	26433.54545	24230.75	22366.84615	20769.21429	19384.6	18173.0625	16153.83333	15303.63158	14538.45	12115.375	11630.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106996	CHOYP_ISCW_ISCW010532.3.4|m.56458	DISLANYK	DISLANYK	110821	55410.5	36940.33333	27705.25	22164.2	18470.16667	15831.57143	13852.625	12313.44444	11082.1	10074.63636	9235.083333	8524.692308	7915.785714	7388.066667	6926.3125	6156.722222	5832.684211	5541.05	4617.541667	4432.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106997	CHOYP_ISCW_ISCW010532.3.4|m.56458	EDDGISFR	EDDGISFR	17640324	8820162	5880108	4410081	3528064.8	2940054	2520046.286	2205040.5	1960036	1764032.4	1603665.818	1470027	1356948	1260023.143	1176021.6	1102520.25	980018	928438.1053	882016.2	735013.5	705612.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106998	CHOYP_ISCW_ISCW010532.3.4|m.56458	EDDGISFR	EDDGISFR	2886319	1443159.5	962106.3333	721579.75	577263.8	481053.1667	412331.2857	360789.875	320702.1111	288631.9	262392.6364	240526.5833	222024.5385	206165.6429	192421.2667	180394.9375	160351.0556	151911.5263	144315.95	120263.2917	115452.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
106999	CHOYP_ISCW_ISCW010532.3.4|m.56458	EDDGISFR	EDDGISFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107000	CHOYP_ISCW_ISCW010532.3.4|m.56458	EDDGISFR	EDDGISFR	1905510	952755	635170	476377.5	381102	317585	272215.7143	238188.75	211723.3333	190551	173228.1818	158792.5	146577.6923	136107.8571	127034	119094.375	105861.6667	100290	95275.5	79396.25	76220.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107001	CHOYP_ISCW_ISCW010532.3.4|m.56458	EDDGISFR	EDDGISFR	451586	225793	150528.6667	112896.5	90317.2	75264.33333	64512.28571	56448.25	50176.22222	45158.6	41053.27273	37632.16667	34737.38462	32256.14286	30105.73333	28224.125	25088.11111	23767.68421	22579.3	18816.08333	18063.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107002	CHOYP_ISCW_ISCW010532.3.4|m.56458	EDDGISFR	EDDGISFR	6374681	3187340.5	2124893.667	1593670.25	1274936.2	1062446.833	910668.7143	796835.125	708297.8889	637468.1	579516.4545	531223.4167	490360.0769	455334.3571	424978.7333	398417.5625	354148.9444	335509.5263	318734.05	265611.7083	254987.24	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107003	CHOYP_ISCW_ISCW010532.3.4|m.56458	GLFIIDDK	GLFIIDDK	18495340	9247670	6165113.333	4623835	3699068	3082556.667	2642191.429	2311917.5	2055037.778	1849534	1681394.545	1541278.333	1422718.462	1321095.714	1233022.667	1155958.75	1027518.889	973438.9474	924767	770639.1667	739813.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107004	CHOYP_ISCW_ISCW010532.3.4|m.56458	GLFIIDDK	GLFIIDDK	8675401	4337700.5	2891800.333	2168850.25	1735080.2	1445900.167	1239343	1084425.125	963933.4444	867540.1	788672.8182	722950.0833	667338.5385	619671.5	578360.0667	542212.5625	481966.7222	456600.0526	433770.05	361475.0417	347016.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107005	CHOYP_ISCW_ISCW010532.3.4|m.56458	GLFIIDDK	GLFIIDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107006	CHOYP_ISCW_ISCW010532.3.4|m.56458	GLFIIDDK	GLFIIDDK	1921098	960549	640366	480274.5	384219.6	320183	274442.5714	240137.25	213455.3333	192109.8	174645.2727	160091.5	147776.7692	137221.2857	128073.2	120068.625	106727.6667	101110.4211	96054.9	80045.75	76843.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107007	CHOYP_ISCW_ISCW010532.3.4|m.56458	GLFIIDDK	GLFIIDDK	3030290	1515145	1010096.667	757572.5	606058	505048.3333	432898.5714	378786.25	336698.8889	303029	275480.9091	252524.1667	233099.2308	216449.2857	202019.3333	189393.125	168349.4444	159488.9474	151514.5	126262.0833	121211.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107008	CHOYP_ISCW_ISCW010532.3.4|m.56458	GLFIIDDK	GLFIIDDK	1753883	876941.5	584627.6667	438470.75	350776.6	292313.8333	250554.7143	219235.375	194875.8889	175388.3	159443.9091	146156.9167	134914.0769	125277.3571	116925.5333	109617.6875	97437.94444	92309.63158	87694.15	73078.45833	70155.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107009	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	81968008	40984004	27322669.33	20492002	16393601.6	13661334.67	11709715.43	10246001	9107556.444	8196800.8	7451637.091	6830667.333	6305231.385	5854857.714	5464533.867	5123000.5	4553778.222	4314105.684	4098400.4	3415333.667	3278720.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107010	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	52031592	26015796	17343864	13007898	10406318.4	8671932	7433084.571	6503949	5781288	5203159.2	4730144.727	4335966	4002430.154	3716542.286	3468772.8	3251974.5	2890644	2738504.842	2601579.6	2167983	2081263.68	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107011	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	20562410	10281205	6854136.667	5140602.5	4112482	3427068.333	2937487.143	2570301.25	2284712.222	2056241	1869310	1713534.167	1581723.846	1468743.571	1370827.333	1285150.625	1142356.111	1082232.105	1028120.5	856767.0833	822496.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107012	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	6314790	3157395	2104930	1578697.5	1262958	1052465	902112.8571	789348.75	701643.3333	631479	574071.8182	526232.5	485753.0769	451056.4286	420986	394674.375	350821.6667	332357.3684	315739.5	263116.25	252591.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107013	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	9972505	4986252.5	3324168.333	2493126.25	1994501	1662084.167	1424643.571	1246563.125	1108056.111	997250.5	906591.3636	831042.0833	767115.7692	712321.7857	664833.6667	623281.5625	554028.0556	524868.6842	498625.25	415521.0417	398900.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107014	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	4445414	2222707	1481804.667	1111353.5	889082.8	740902.3333	635059.1429	555676.75	493934.8889	444541.4	404128.5455	370451.1667	341954.9231	317529.5714	296360.9333	277838.375	246967.4444	233969.1579	222270.7	185225.5833	177816.56	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107015	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	11395068	5697534	3798356	2848767	2279013.6	1899178	1627866.857	1424383.5	1266118.667	1139506.8	1035915.273	949589	876543.6923	813933.4286	759671.2	712191.75	633059.3333	599740.4211	569753.4	474794.5	455802.72	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107016	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	12560279	6280139.5	4186759.667	3140069.75	2512055.8	2093379.833	1794325.571	1570034.875	1395586.556	1256027.9	1141843.545	1046689.917	966175.3077	897162.7857	837351.9333	785017.4375	697793.2778	661067.3158	628013.95	523344.9583	502411.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107017	CHOYP_ISCW_ISCW010532.3.4|m.56458	QITMNDLPVGR	QITMNDLPVGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107018	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	91304096	45652048	30434698.67	22826024	18260819.2	15217349.33	13043442.29	11413012	10144899.56	9130409.6	8300372.364	7608674.667	7023392	6521721.143	6086939.733	5706506	5072449.778	4805478.737	4565204.8	3804337.333	3652163.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107019	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	64869784	32434892	21623261.33	16217446	12973956.8	10811630.67	9267112	8108723	7207753.778	6486978.4	5897253.091	5405815.333	4989983.385	4633556	4324652.267	4054361.5	3603876.889	3414199.158	3243489.2	2702907.667	2594791.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107020	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	33955748	16977874	11318582.67	8488937	6791149.6	5659291.333	4850821.143	4244468.5	3772860.889	3395574.8	3086886.182	2829645.667	2611980.615	2425410.571	2263716.533	2122234.25	1886430.444	1787144.632	1697787.4	1414822.833	1358229.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107021	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	10869148	5434574	3623049.333	2717287	2173829.6	1811524.667	1552735.429	1358643.5	1207683.111	1086914.8	988104.3636	905762.3333	836088.3077	776367.7143	724609.8667	679321.75	603841.5556	572060.4211	543457.4	452881.1667	434765.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107022	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	7606276	3803138	2535425.333	1901569	1521255.2	1267712.667	1086610.857	950784.5	845141.7778	760627.6	691479.6364	633856.3333	585098.1538	543305.4286	507085.0667	475392.25	422570.8889	400330.3158	380313.8	316928.1667	304251.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107023	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	3192332	1596166	1064110.667	798083	638466.4	532055.3333	456047.4286	399041.5	354703.5556	319233.2	290212	266027.6667	245564	228023.7143	212822.1333	199520.75	177351.7778	168017.4737	159616.6	133013.8333	127693.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107024	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	6568554	3284277	2189518	1642138.5	1313710.8	1094759	938364.8571	821069.25	729839.3333	656855.4	597141.2727	547379.5	505273.3846	469182.4286	437903.6	410534.625	364919.6667	345713.3684	328427.7	273689.75	262742.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107025	CHOYP_ISCW_ISCW010532.3.4|m.56458	LVQAFQFTDK	LVQAFQFTDK	3393157	1696578.5	1131052.333	848289.25	678631.4	565526.1667	484736.7143	424144.625	377017.4444	339315.7	308468.8182	282763.0833	261012.0769	242368.3571	226210.4667	212072.3125	188508.7222	178587.2105	169657.85	141381.5417	135726.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107026	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107027	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107028	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	2367459	1183729.5	789153	591864.75	473491.8	394576.5	338208.4286	295932.375	263051	236745.9	215223.5455	197288.25	182112.2308	169104.2143	157830.6	147966.1875	131525.5	124603.1053	118372.95	98644.125	94698.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107029	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107030	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	82711	41355.5	27570.33333	20677.75	16542.2	13785.16667	11815.85714	10338.875	9190.111111	8271.1	7519.181818	6892.583333	6362.384615	5907.928571	5514.066667	5169.4375	4595.055556	4353.210526	4135.55	3446.291667	3308.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107031	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	823927	411963.5	274642.3333	205981.75	164785.4	137321.1667	117703.8571	102990.875	91547.44444	82392.7	74902.45455	68660.58333	63379	58851.92857	54928.46667	51495.4375	45773.72222	43364.57895	41196.35	34330.29167	32957.08	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107032	CHOYP_ISCW_ISCW010532.4.4|m.62265	LTKPAPEFK	LTKPAPEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107033	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	62316376	31158188	20772125.33	15579094	12463275.2	10386062.67	8902339.429	7789547	6924041.778	6231637.6	5665125.091	5193031.333	4793567.385	4451169.714	4154425.067	3894773.5	3462020.889	3279809.263	3115818.8	2596515.667	2492655.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107034	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	30288212	15144106	10096070.67	7572053	6057642.4	5048035.333	4326887.429	3786026.5	3365356.889	3028821.2	2753473.818	2524017.667	2329862.462	2163443.714	2019214.133	1893013.25	1682678.444	1594116.421	1514410.6	1262008.833	1211528.48	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107035	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	30715424	15357712	10238474.67	7678856	6143084.8	5119237.333	4387917.714	3839428	3412824.889	3071542.4	2792311.273	2559618.667	2362724.923	2193958.857	2047694.933	1919714	1706412.444	1616601.263	1535771.2	1279809.333	1228616.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107036	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	6397053	3198526.5	2132351	1599263.25	1279410.6	1066175.5	913864.7143	799631.625	710783.6667	639705.3	581550.2727	533087.75	492081	456932.3571	426470.2	399815.8125	355391.8333	336687	319852.65	266543.875	255882.12	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107037	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	6145369	3072684.5	2048456.333	1536342.25	1229073.8	1024228.167	877909.8571	768171.125	682818.7778	614536.9	558669.9091	512114.0833	472720.6923	438954.9286	409691.2667	384085.5625	341409.3889	323440.4737	307268.45	256057.0417	245814.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107038	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	4644988	2322494	1548329.333	1161247	928997.6	774164.6667	663569.7143	580623.5	516109.7778	464498.8	422271.6364	387082.3333	357306.7692	331784.8571	309665.8667	290311.75	258054.8889	244473.0526	232249.4	193541.1667	185799.52	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107039	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	4268880	2134440	1422960	1067220	853776	711480	609840	533610	474320	426888	388080	355740	328375.3846	304920	284592	266805	237160	224677.8947	213444	177870	170755.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107040	CHOYP_ISCW_ISCW010532.4.4|m.62265	GQAVVDGEFK	GQAVVDGEFK	265221	132610.5	88407	66305.25	53044.2	44203.5	37888.71429	33152.625	29469	26522.1	24111	22101.75	20401.61538	18944.35714	17681.4	16576.3125	14734.5	13959	13261.05	11050.875	10608.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107041	CHOYP_ISCW_ISCW010532.4.4|m.62265	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107042	CHOYP_ISCW_ISCW010532.4.4|m.62265	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107043	CHOYP_ISCW_ISCW010532.4.4|m.62265	DISLANYK	DISLANYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107044	CHOYP_ISCW_ISCW010532.4.4|m.62265	DISLANYK	DISLANYK	114084	57042	38028	28521	22816.8	19014	16297.71429	14260.5	12676	11408.4	10371.27273	9507	8775.692308	8148.857143	7605.6	7130.25	6338	6004.421053	5704.2	4753.5	4563.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107045	CHOYP_ISCW_ISCW010532.4.4|m.62265	DISLANYK	DISLANYK	290769	145384.5	96923	72692.25	58153.8	48461.5	41538.42857	36346.125	32307.66667	29076.9	26433.54545	24230.75	22366.84615	20769.21429	19384.6	18173.0625	16153.83333	15303.63158	14538.45	12115.375	11630.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107046	CHOYP_ISCW_ISCW010532.4.4|m.62265	DISLANYK	DISLANYK	110821	55410.5	36940.33333	27705.25	22164.2	18470.16667	15831.57143	13852.625	12313.44444	11082.1	10074.63636	9235.083333	8524.692308	7915.785714	7388.066667	6926.3125	6156.722222	5832.684211	5541.05	4617.541667	4432.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107047	CHOYP_ISCW_ISCW010532.4.4|m.62265	EDDGISFR	EDDGISFR	17640324	8820162	5880108	4410081	3528064.8	2940054	2520046.286	2205040.5	1960036	1764032.4	1603665.818	1470027	1356948	1260023.143	1176021.6	1102520.25	980018	928438.1053	882016.2	735013.5	705612.96	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107048	CHOYP_ISCW_ISCW010532.4.4|m.62265	EDDGISFR	EDDGISFR	2886319	1443159.5	962106.3333	721579.75	577263.8	481053.1667	412331.2857	360789.875	320702.1111	288631.9	262392.6364	240526.5833	222024.5385	206165.6429	192421.2667	180394.9375	160351.0556	151911.5263	144315.95	120263.2917	115452.76	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107049	CHOYP_ISCW_ISCW010532.4.4|m.62265	EDDGISFR	EDDGISFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107050	CHOYP_ISCW_ISCW010532.4.4|m.62265	EDDGISFR	EDDGISFR	1905510	952755	635170	476377.5	381102	317585	272215.7143	238188.75	211723.3333	190551	173228.1818	158792.5	146577.6923	136107.8571	127034	119094.375	105861.6667	100290	95275.5	79396.25	76220.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107051	CHOYP_ISCW_ISCW010532.4.4|m.62265	EDDGISFR	EDDGISFR	451586	225793	150528.6667	112896.5	90317.2	75264.33333	64512.28571	56448.25	50176.22222	45158.6	41053.27273	37632.16667	34737.38462	32256.14286	30105.73333	28224.125	25088.11111	23767.68421	22579.3	18816.08333	18063.44	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107052	CHOYP_ISCW_ISCW010532.4.4|m.62265	EDDGISFR	EDDGISFR	6374681	3187340.5	2124893.667	1593670.25	1274936.2	1062446.833	910668.7143	796835.125	708297.8889	637468.1	579516.4545	531223.4167	490360.0769	455334.3571	424978.7333	398417.5625	354148.9444	335509.5263	318734.05	265611.7083	254987.24	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107053	CHOYP_ISCW_ISCW010532.4.4|m.62265	GLFIIDDK	GLFIIDDK	18495340	9247670	6165113.333	4623835	3699068	3082556.667	2642191.429	2311917.5	2055037.778	1849534	1681394.545	1541278.333	1422718.462	1321095.714	1233022.667	1155958.75	1027518.889	973438.9474	924767	770639.1667	739813.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107054	CHOYP_ISCW_ISCW010532.4.4|m.62265	GLFIIDDK	GLFIIDDK	8675401	4337700.5	2891800.333	2168850.25	1735080.2	1445900.167	1239343	1084425.125	963933.4444	867540.1	788672.8182	722950.0833	667338.5385	619671.5	578360.0667	542212.5625	481966.7222	456600.0526	433770.05	361475.0417	347016.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107055	CHOYP_ISCW_ISCW010532.4.4|m.62265	GLFIIDDK	GLFIIDDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107056	CHOYP_ISCW_ISCW010532.4.4|m.62265	GLFIIDDK	GLFIIDDK	1921098	960549	640366	480274.5	384219.6	320183	274442.5714	240137.25	213455.3333	192109.8	174645.2727	160091.5	147776.7692	137221.2857	128073.2	120068.625	106727.6667	101110.4211	96054.9	80045.75	76843.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107057	CHOYP_ISCW_ISCW010532.4.4|m.62265	GLFIIDDK	GLFIIDDK	3030290	1515145	1010096.667	757572.5	606058	505048.3333	432898.5714	378786.25	336698.8889	303029	275480.9091	252524.1667	233099.2308	216449.2857	202019.3333	189393.125	168349.4444	159488.9474	151514.5	126262.0833	121211.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107058	CHOYP_ISCW_ISCW010532.4.4|m.62265	GLFIIDDK	GLFIIDDK	1753883	876941.5	584627.6667	438470.75	350776.6	292313.8333	250554.7143	219235.375	194875.8889	175388.3	159443.9091	146156.9167	134914.0769	125277.3571	116925.5333	109617.6875	97437.94444	92309.63158	87694.15	73078.45833	70155.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107059	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	81968008	40984004	27322669.33	20492002	16393601.6	13661334.67	11709715.43	10246001	9107556.444	8196800.8	7451637.091	6830667.333	6305231.385	5854857.714	5464533.867	5123000.5	4553778.222	4314105.684	4098400.4	3415333.667	3278720.32	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107060	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	52031592	26015796	17343864	13007898	10406318.4	8671932	7433084.571	6503949	5781288	5203159.2	4730144.727	4335966	4002430.154	3716542.286	3468772.8	3251974.5	2890644	2738504.842	2601579.6	2167983	2081263.68	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107061	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	20562410	10281205	6854136.667	5140602.5	4112482	3427068.333	2937487.143	2570301.25	2284712.222	2056241	1869310	1713534.167	1581723.846	1468743.571	1370827.333	1285150.625	1142356.111	1082232.105	1028120.5	856767.0833	822496.4	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107062	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	6314790	3157395	2104930	1578697.5	1262958	1052465	902112.8571	789348.75	701643.3333	631479	574071.8182	526232.5	485753.0769	451056.4286	420986	394674.375	350821.6667	332357.3684	315739.5	263116.25	252591.6	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107063	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	9972505	4986252.5	3324168.333	2493126.25	1994501	1662084.167	1424643.571	1246563.125	1108056.111	997250.5	906591.3636	831042.0833	767115.7692	712321.7857	664833.6667	623281.5625	554028.0556	524868.6842	498625.25	415521.0417	398900.2	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107064	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	4445414	2222707	1481804.667	1111353.5	889082.8	740902.3333	635059.1429	555676.75	493934.8889	444541.4	404128.5455	370451.1667	341954.9231	317529.5714	296360.9333	277838.375	246967.4444	233969.1579	222270.7	185225.5833	177816.56	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107065	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	11395068	5697534	3798356	2848767	2279013.6	1899178	1627866.857	1424383.5	1266118.667	1139506.8	1035915.273	949589	876543.6923	813933.4286	759671.2	712191.75	633059.3333	599740.4211	569753.4	474794.5	455802.72	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107066	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	12560279	6280139.5	4186759.667	3140069.75	2512055.8	2093379.833	1794325.571	1570034.875	1395586.556	1256027.9	1141843.545	1046689.917	966175.3077	897162.7857	837351.9333	785017.4375	697793.2778	661067.3158	628013.95	523344.9583	502411.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107067	CHOYP_ISCW_ISCW010532.4.4|m.62265	QITMNDLPVGR	QITMNDLPVGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107068	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	91304096	45652048	30434698.67	22826024	18260819.2	15217349.33	13043442.29	11413012	10144899.56	9130409.6	8300372.364	7608674.667	7023392	6521721.143	6086939.733	5706506	5072449.778	4805478.737	4565204.8	3804337.333	3652163.84	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107069	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	64869784	32434892	21623261.33	16217446	12973956.8	10811630.67	9267112	8108723	7207753.778	6486978.4	5897253.091	5405815.333	4989983.385	4633556	4324652.267	4054361.5	3603876.889	3414199.158	3243489.2	2702907.667	2594791.36	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107070	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	33955748	16977874	11318582.67	8488937	6791149.6	5659291.333	4850821.143	4244468.5	3772860.889	3395574.8	3086886.182	2829645.667	2611980.615	2425410.571	2263716.533	2122234.25	1886430.444	1787144.632	1697787.4	1414822.833	1358229.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107071	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	10869148	5434574	3623049.333	2717287	2173829.6	1811524.667	1552735.429	1358643.5	1207683.111	1086914.8	988104.3636	905762.3333	836088.3077	776367.7143	724609.8667	679321.75	603841.5556	572060.4211	543457.4	452881.1667	434765.92	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107072	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	7606276	3803138	2535425.333	1901569	1521255.2	1267712.667	1086610.857	950784.5	845141.7778	760627.6	691479.6364	633856.3333	585098.1538	543305.4286	507085.0667	475392.25	422570.8889	400330.3158	380313.8	316928.1667	304251.04	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107073	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	3192332	1596166	1064110.667	798083	638466.4	532055.3333	456047.4286	399041.5	354703.5556	319233.2	290212	266027.6667	245564	228023.7143	212822.1333	199520.75	177351.7778	168017.4737	159616.6	133013.8333	127693.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107074	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	6568554	3284277	2189518	1642138.5	1313710.8	1094759	938364.8571	821069.25	729839.3333	656855.4	597141.2727	547379.5	505273.3846	469182.4286	437903.6	410534.625	364919.6667	345713.3684	328427.7	273689.75	262742.16	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
107075	CHOYP_ISCW_ISCW010532.4.4|m.62265	LVQAFQFTDK	LVQAFQFTDK	3393157	1696578.5	1131052.333	848289.25	678631.4	565526.1667	484736.7143	424144.625	377017.4444	339315.7	308468.8182	282763.0833	261012.0769	242368.3571	226210.4667	212072.3125	188508.7222	178587.2105	169657.85	141381.5417	135726.28	Q9NL98	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	0	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454
108379	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	4421699	2210849.5	1473899.667	1105424.75	884339.8	736949.8333	631671.2857	552712.375	491299.8889	442169.9	401972.6364	368474.9167	340130.6923	315835.6429	294779.9333	276356.1875	245649.9444	232721	221084.95	184237.4583	176867.96	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108380	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	2198150	1099075	732716.6667	549537.5	439630	366358.3333	314021.4286	274768.75	244238.8889	219815	199831.8182	183179.1667	169088.4615	157010.7143	146543.3333	137384.375	122119.4444	115692.1053	109907.5	91589.58333	87926	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108381	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108382	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108383	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108384	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108385	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108386	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108387	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108388	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108389	CHOYP_ISCW_ISCW018425.1.1|m.35608	LVETPSFVDTEIK	LVETPSFVDTEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108390	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	2215557	1107778.5	738519	553889.25	443111.4	369259.5	316508.1429	276944.625	246173	221555.7	201414.2727	184629.75	170427.4615	158254.0714	147703.8	138472.3125	123086.5	116608.2632	110777.85	92314.875	88622.28	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108391	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108392	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108393	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	823465	411732.5	274488.3333	205866.25	164693	137244.1667	117637.8571	102933.125	91496.11111	82346.5	74860.45455	68622.08333	63343.46154	58818.92857	54897.66667	51466.5625	45748.05556	43340.26316	41173.25	34311.04167	32938.6	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108394	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	1034472	517236	344824	258618	206894.4	172412	147781.7143	129309	114941.3333	103447.2	94042.90909	86206	79574.76923	73890.85714	68964.8	64654.5	57470.66667	54445.89474	51723.6	43103	41378.88	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108395	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	241907	120953.5	80635.66667	60476.75	48381.4	40317.83333	34558.14286	30238.375	26878.55556	24190.7	21991.54545	20158.91667	18608.23077	17279.07143	16127.13333	15119.1875	13439.27778	12731.94737	12095.35	10079.45833	9676.28	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108396	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108397	CHOYP_ISCW_ISCW018425.1.1|m.35608	LNILTSFQMR	LNILTSFQMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P81623	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235
108931	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108932	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108933	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108934	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	657589	328794.5	219196.3333	164397.25	131517.8	109598.1667	93941.28571	82198.625	73065.44444	65758.9	59780.81818	54799.08333	50583.76923	46970.64286	43839.26667	41099.3125	36532.72222	34609.94737	32879.45	27399.54167	26303.56	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108935	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	2205860	1102930	735286.6667	551465	441172	367643.3333	315122.8571	275732.5	245095.5556	220586	200532.7273	183821.6667	169681.5385	157561.4286	147057.3333	137866.25	122547.7778	116097.8947	110293	91910.83333	88234.4	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108936	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	323600	161800	107866.6667	80900	64720	53933.33333	46228.57143	40450	35955.55556	32360	29418.18182	26966.66667	24892.30769	23114.28571	21573.33333	20225	17977.77778	17031.57895	16180	13483.33333	12944	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108937	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108938	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108939	CHOYP_ISCW_ISCW020302.1.1|m.37564	LAAQTLLGAAK	LAAQTLLGAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108940	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108941	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108942	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108943	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	822766	411383	274255.3333	205691.5	164553.2	137127.6667	117538	102845.75	91418.44444	82276.6	74796.90909	68563.83333	63289.69231	58769	54851.06667	51422.875	45709.22222	43303.47368	41138.3	34281.91667	32910.64	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108944	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	3806789	1903394.5	1268929.667	951697.25	761357.8	634464.8333	543827	475848.625	422976.5556	380678.9	346071.7273	317232.4167	292829.9231	271913.5	253785.9333	237924.3125	211488.2778	200357.3158	190339.45	158616.2083	152271.56	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108945	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	1660771	830385.5	553590.3333	415192.75	332154.2	276795.1667	237253	207596.375	184530.1111	166077.1	150979.1818	138397.5833	127751.6154	118626.5	110718.0667	103798.1875	92265.05556	87409	83038.55	69198.79167	66430.84	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108946	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	1687812	843906	562604	421953	337562.4	281302	241116	210976.5	187534.6667	168781.2	153437.4545	140651	129831.6923	120558	112520.8	105488.25	93767.33333	88832.21053	84390.6	70325.5	67512.48	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108947	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	1312390	656195	437463.3333	328097.5	262478	218731.6667	187484.2857	164048.75	145821.1111	131239	119308.1818	109365.8333	100953.0769	93742.14286	87492.66667	82024.375	72910.55556	69073.15789	65619.5	54682.91667	52495.6	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108948	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	240646	120323	80215.33333	60161.5	48129.2	40107.66667	34378	30080.75	26738.44444	24064.6	21876.90909	20053.83333	18511.23077	17189	16043.06667	15040.375	13369.22222	12665.57895	12032.3	10026.91667	9625.84	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108949	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	260842	130421	86947.33333	65210.5	52168.4	43473.66667	37263.14286	32605.25	28982.44444	26084.2	23712.90909	21736.83333	20064.76923	18631.57143	17389.46667	16302.625	14491.22222	13728.52632	13042.1	10868.41667	10433.68	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
108950	CHOYP_ISCW_ISCW020302.1.1|m.37564	SSLITAVETATNR	SSLITAVETATNR	119567	59783.5	39855.66667	29891.75	23913.4	19927.83333	17081	14945.875	13285.22222	11956.7	10869.72727	9963.916667	9197.461538	8540.5	7971.133333	7472.9375	6642.611111	6293	5978.35	4981.958333	4782.68	Q17QJ7	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129
109413	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	2800214	1400107	933404.6667	700053.5	560042.8	466702.3333	400030.5714	350026.75	311134.8889	280021.4	254564.9091	233351.1667	215401.0769	200015.2857	186680.9333	175013.375	155567.4444	147379.6842	140010.7	116675.5833	112008.56	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109414	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	2388132	1194066	796044	597033	477626.4	398022	341161.7143	298516.5	265348	238813.2	217102.9091	199011	183702.4615	170580.8571	159208.8	149258.25	132674	125691.1579	119406.6	99505.5	95525.28	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109415	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	1082630	541315	360876.6667	270657.5	216526	180438.3333	154661.4286	135328.75	120292.2222	108263	98420.90909	90219.16667	83279.23077	77330.71429	72175.33333	67664.375	60146.11111	56980.52632	54131.5	45109.58333	43305.2	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109416	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	745780	372890	248593.3333	186445	149156	124296.6667	106540	93222.5	82864.44444	74578	67798.18182	62148.33333	57367.69231	53270	49718.66667	46611.25	41432.22222	39251.57895	37289	31074.16667	29831.2	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109417	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	350703	175351.5	116901	87675.75	70140.6	58450.5	50100.42857	43837.875	38967	35070.3	31882.09091	29225.25	26977.15385	25050.21429	23380.2	21918.9375	19483.5	18458.05263	17535.15	14612.625	14028.12	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109418	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	76317	38158.5	25439	19079.25	15263.4	12719.5	10902.42857	9539.625	8479.666667	7631.7	6937.909091	6359.75	5870.538462	5451.214286	5087.8	4769.8125	4239.833333	4016.684211	3815.85	3179.875	3052.68	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109419	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	65695	32847.5	21898.33333	16423.75	13139	10949.16667	9385	8211.875	7299.444444	6569.5	5972.272727	5474.583333	5053.461538	4692.5	4379.666667	4105.9375	3649.722222	3457.631579	3284.75	2737.291667	2627.8	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109420	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109421	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109422	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	103040	51520	34346.66667	25760	20608	17173.33333	14720	12880	11448.88889	10304	9367.272727	8586.666667	7926.153846	7360	6869.333333	6440	5724.444444	5423.157895	5152	4293.333333	4121.6	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109423	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	31481	15740.5	10493.66667	7870.25	6296.2	5246.833333	4497.285714	3935.125	3497.888889	3148.1	2861.909091	2623.416667	2421.615385	2248.642857	2098.733333	1967.5625	1748.944444	1656.894737	1574.05	1311.708333	1259.24	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109424	CHOYP_ISCW_ISCW022925.1.2|m.61535	NGVMDEASIATVLK	NGVMDEASIATVLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109425	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109426	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109427	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109428	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	1976802	988401	658934	494200.5	395360.4	329467	282400.2857	247100.25	219644.6667	197680.2	179709.2727	164733.5	152061.6923	141200.1429	131786.8	123550.125	109822.3333	104042.2105	98840.1	82366.75	79072.08	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109429	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	385446	192723	128482	96361.5	77089.2	64241	55063.71429	48180.75	42827.33333	38544.6	35040.54545	32120.5	29649.69231	27531.85714	25696.4	24090.375	21413.66667	20286.63158	19272.3	16060.25	15417.84	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109430	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	1007927	503963.5	335975.6667	251981.75	201585.4	167987.8333	143989.5714	125990.875	111991.8889	100792.7	91629.72727	83993.91667	77532.84615	71994.78571	67195.13333	62995.4375	55995.94444	53048.78947	50396.35	41996.95833	40317.08	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109431	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109432	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109433	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109434	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	374776	187388	124925.3333	93694	74955.2	62462.66667	53539.42857	46847	41641.77778	37477.6	34070.54545	31231.33333	28828.92308	26769.71429	24985.06667	23423.5	20820.88889	19725.05263	18738.8	15615.66667	14991.04	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109435	CHOYP_ISCW_ISCW022925.1.2|m.61535	SLISEGVSVKPQK	SLISEGVSVKPQK	1089971	544985.5	363323.6667	272492.75	217994.2	181661.8333	155710.1429	136246.375	121107.8889	108997.1	99088.27273	90830.91667	83843.92308	77855.07143	72664.73333	68123.1875	60553.94444	57366.89474	54498.55	45415.45833	43598.84	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109436	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109437	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	1770956	885478	590318.6667	442739	354191.2	295159.3333	252993.7143	221369.5	196772.8889	177095.6	160996	147579.6667	136227.3846	126496.8571	118063.7333	110684.75	98386.44444	93208.21053	88547.8	73789.83333	70838.24	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109438	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109439	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109440	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	523011	261505.5	174337	130752.75	104602.2	87168.5	74715.85714	65376.375	58112.33333	52301.1	47546.45455	43584.25	40231.61538	37357.92857	34867.4	32688.1875	29056.16667	27526.89474	26150.55	21792.125	20920.44	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109441	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	460439	230219.5	153479.6667	115109.75	92087.8	76739.83333	65777	57554.875	51159.88889	46043.9	41858.09091	38369.91667	35418.38462	32888.5	30695.93333	28777.4375	25579.94444	24233.63158	23021.95	19184.95833	18417.56	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109442	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109443	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	258628	129314	86209.33333	64657	51725.6	43104.66667	36946.85714	32328.5	28736.44444	25862.8	23511.63636	21552.33333	19894.46154	18473.42857	17241.86667	16164.25	14368.22222	13612	12931.4	10776.16667	10345.12	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
109444	CHOYP_ISCW_ISCW022925.1.2|m.61535	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
110089	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	13943991	6971995.5	4647997	3485997.75	2788798.2	2323998.5	1991998.714	1742998.875	1549332.333	1394399.1	1267635.545	1161999.25	1072614.692	995999.3571	929599.4	871499.4375	774666.1667	733894.2632	697199.55	580999.625	557759.64	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110090	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	9125427	4562713.5	3041809	2281356.75	1825085.4	1520904.5	1303632.429	1140678.375	1013936.333	912542.7	829584.2727	760452.25	701955.9231	651816.2143	608361.8	570339.1875	506968.1667	480285.6316	456271.35	380226.125	365017.08	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110091	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	4427301	2213650.5	1475767	1106825.25	885460.2	737883.5	632471.5714	553412.625	491922.3333	442730.1	402481.9091	368941.75	340561.6154	316235.7857	295153.4	276706.3125	245961.1667	233015.8421	221365.05	184470.875	177092.04	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110092	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	2412889	1206444.5	804296.3333	603222.25	482577.8	402148.1667	344698.4286	301611.125	268098.7778	241288.9	219353.5455	201074.0833	185606.8462	172349.2143	160859.2667	150805.5625	134049.3889	126994.1579	120644.45	100537.0417	96515.56	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110093	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	652307	326153.5	217435.6667	163076.75	130461.4	108717.8333	93186.71429	81538.375	72478.55556	65230.7	59300.63636	54358.91667	50177.46154	46593.35714	43487.13333	40769.1875	36239.27778	34331.94737	32615.35	27179.45833	26092.28	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110094	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	589640	294820	196546.6667	147410	117928	98273.33333	84234.28571	73705	65515.55556	58964	53603.63636	49136.66667	45356.92308	42117.14286	39309.33333	36852.5	32757.77778	31033.68421	29482	24568.33333	23585.6	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110095	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	898158	449079	299386	224539.5	179631.6	149693	128308.2857	112269.75	99795.33333	89815.8	81650.72727	74846.5	69089.07692	64154.14286	59877.2	56134.875	49897.66667	47271.47368	44907.9	37423.25	35926.32	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110096	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	1343291	671645.5	447763.6667	335822.75	268658.2	223881.8333	191898.7143	167911.375	149254.5556	134329.1	122117.3636	111940.9167	103330.0769	95949.35714	89552.73333	83955.6875	74627.27778	70699.52632	67164.55	55970.45833	53731.64	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110097	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	948029	474014.5	316009.6667	237007.25	189605.8	158004.8333	135432.7143	118503.625	105336.5556	94802.9	86184.45455	79002.41667	72925.30769	67716.35714	63201.93333	59251.8125	52668.27778	49896.26316	47401.45	39501.20833	37921.16	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110098	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	415896	207948	138632	103974	83179.2	69316	59413.71429	51987	46210.66667	41589.6	37808.72727	34658	31992	29706.85714	27726.4	25993.5	23105.33333	21889.26316	20794.8	17329	16635.84	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110099	CHOYP_ITB1.3.4|m.28565	VIVGNDIVQFIGR	VIVGNDIVQFIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110100	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110101	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	734657	367328.5	244885.6667	183664.25	146931.4	122442.8333	104951	91832.125	81628.55556	73465.7	66787	61221.41667	56512.07692	52475.5	48977.13333	45916.0625	40814.27778	38666.15789	36732.85	30610.70833	29386.28	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110102	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110103	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110104	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	10126	5063	3375.333333	2531.5	2025.2	1687.666667	1446.571429	1265.75	1125.111111	1012.6	920.5454545	843.8333333	778.9230769	723.2857143	675.0666667	632.875	562.5555556	532.9473684	506.3	421.9166667	405.04	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110105	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110106	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	64743	32371.5	21581	16185.75	12948.6	10790.5	9249	8092.875	7193.666667	6474.3	5885.727273	5395.25	4980.230769	4624.5	4316.2	4046.4375	3596.833333	3407.526316	3237.15	2697.625	2589.72	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110107	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	213158	106579	71052.66667	53289.5	42631.6	35526.33333	30451.14286	26644.75	23684.22222	21315.8	19378	17763.16667	16396.76923	15225.57143	14210.53333	13322.375	11842.11111	11218.84211	10657.9	8881.583333	8526.32	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110108	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110109	CHOYP_ITB1.3.4|m.28565	VTAVFILPNMGK	VTAVFILPNMGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P11584	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; epithelial cell migration, open tracheal system [GO:0007427]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; tracheal outgrowth, open tracheal system [GO:0007426]; visual perception [GO:0007601]"	GO:0003344; GO:0004872; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007155; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007426; GO:0007427; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0043034; GO:0045214; GO:0046982; GO:0048803; GO:0050839; GO:0051492
110403	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110404	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	1938263	969131.5	646087.6667	484565.75	387652.6	323043.8333	276894.7143	242282.875	215362.5556	193826.3	176205.7273	161521.9167	149097.1538	138447.3571	129217.5333	121141.4375	107681.2778	102013.8421	96913.15	80760.95833	77530.52	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110405	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	714670	357335	238223.3333	178667.5	142934	119111.6667	102095.7143	89333.75	79407.77778	71467	64970	59555.83333	54974.61538	51047.85714	47644.66667	44666.875	39703.88889	37614.21053	35733.5	29777.91667	28586.8	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110406	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	349610	174805	116536.6667	87402.5	69922	58268.33333	49944.28571	43701.25	38845.55556	34961	31782.72727	29134.16667	26893.07692	24972.14286	23307.33333	21850.625	19422.77778	18400.52632	17480.5	14567.08333	13984.4	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110407	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110408	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	66459	33229.5	22153	16614.75	13291.8	11076.5	9494.142857	8307.375	7384.333333	6645.9	6041.727273	5538.25	5112.230769	4747.071429	4430.6	4153.6875	3692.166667	3497.842105	3322.95	2769.125	2658.36	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110409	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	143631	71815.5	47877	35907.75	28726.2	23938.5	20518.71429	17953.875	15959	14363.1	13057.36364	11969.25	11048.53846	10259.35714	9575.4	8976.9375	7979.5	7559.526316	7181.55	5984.625	5745.24	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110410	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110411	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110412	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	111057	55528.5	37019	27764.25	22211.4	18509.5	15865.28571	13882.125	12339.66667	11105.7	10096.09091	9254.75	8542.846154	7932.642857	7403.8	6941.0625	6169.833333	5845.105263	5552.85	4627.375	4442.28	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110413	CHOYP_JNK.1.1|m.1540	NIIGLLNAFTPQK	NIIGLLNAFTPQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110414	CHOYP_JNK.1.1|m.1540	ILDFGLAR	ILDFGLAR	15178574	7589287	5059524.667	3794643.5	3035714.8	2529762.333	2168367.714	1897321.75	1686508.222	1517857.4	1379870.364	1264881.167	1167582.615	1084183.857	1011904.933	948660.875	843254.1111	798872.3158	758928.7	632440.5833	607142.96	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110415	CHOYP_JNK.1.1|m.1540	ILDFGLAR	ILDFGLAR	8195234	4097617	2731744.667	2048808.5	1639046.8	1365872.333	1170747.714	1024404.25	910581.5556	819523.4	745021.2727	682936.1667	630402.6154	585373.8571	546348.9333	512202.125	455290.7778	431328.1053	409761.7	341468.0833	327809.36	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110416	CHOYP_JNK.1.1|m.1540	ILDFGLAR	ILDFGLAR	2429885	1214942.5	809961.6667	607471.25	485977	404980.8333	347126.4286	303735.625	269987.2222	242988.5	220898.6364	202490.4167	186914.2308	173563.2143	161992.3333	151867.8125	134993.6111	127888.6842	121494.25	101245.2083	97195.4	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110417	CHOYP_JNK.1.1|m.1540	ILDFGLAR	ILDFGLAR	5411319	2705659.5	1803773	1352829.75	1082263.8	901886.5	773045.5714	676414.875	601257.6667	541131.9	491938.0909	450943.25	416255.3077	386522.7857	360754.6	338207.4375	300628.8333	284806.2632	270565.95	225471.625	216452.76	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110418	CHOYP_JNK.1.1|m.1540	ILDFGLAR	ILDFGLAR	1696320	848160	565440	424080	339264	282720	242331.4286	212040	188480	169632	154210.9091	141360	130486.1538	121165.7143	113088	106020	94240	89280	84816	70680	67852.8	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110419	CHOYP_JNK.1.1|m.1540	ILDFGLAR	ILDFGLAR	74240	37120	24746.66667	18560	14848	12373.33333	10605.71429	9280	8248.888889	7424	6749.090909	6186.666667	5710.769231	5302.857143	4949.333333	4640	4124.444444	3907.368421	3712	3093.333333	2969.6	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110420	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110421	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110422	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110423	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110424	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	244888	122444	81629.33333	61222	48977.6	40814.66667	34984	30611	27209.77778	24488.8	22262.54545	20407.33333	18837.53846	17492	16325.86667	15305.5	13604.88889	12888.84211	12244.4	10203.66667	9795.52	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110425	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	24092	12046	8030.666667	6023	4818.4	4015.333333	3441.714286	3011.5	2676.888889	2409.2	2190.181818	2007.666667	1853.230769	1720.857143	1606.133333	1505.75	1338.444444	1268	1204.6	1003.833333	963.68	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110426	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	536188	268094	178729.3333	134047	107237.6	89364.66667	76598.28571	67023.5	59576.44444	53618.8	48744.36364	44682.33333	41245.23077	38299.14286	35745.86667	33511.75	29788.22222	28220.42105	26809.4	22341.16667	21447.52	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110427	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	1640203	820101.5	546734.3333	410050.75	328040.6	273367.1667	234314.7143	205025.375	182244.7778	164020.3	149109.3636	136683.5833	126169.4615	117157.3571	109346.8667	102512.6875	91122.38889	86326.47368	82010.15	68341.79167	65608.12	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110428	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110429	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	418634	209317	139544.6667	104658.5	83726.8	69772.33333	59804.85714	52329.25	46514.88889	41863.4	38057.63636	34886.16667	32202.61538	29902.42857	27908.93333	26164.625	23257.44444	22033.36842	20931.7	17443.08333	16745.36	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110430	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110431	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110432	CHOYP_JNK.1.1|m.1540	TQGTGFMMTPYVVTR	TQGTGFMMTPYVVTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110433	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	2640428	1320214	880142.6667	660107	528085.6	440071.3333	377204	330053.5	293380.8889	264042.8	240038.9091	220035.6667	203109.8462	188602	176028.5333	165026.75	146690.4444	138969.8947	132021.4	110017.8333	105617.12	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110434	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110435	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110436	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110437	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110438	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110439	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110440	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110441	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110442	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110443	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110444	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110445	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110446	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110447	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110448	CHOYP_JNK.1.1|m.1540	LFPDVIFPQDSQEHAGLR	LFPDVIFPQDSQEHAGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110449	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110450	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110451	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110452	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	337444	168722	112481.3333	84361	67488.8	56240.66667	48206.28571	42180.5	37493.77778	33744.4	30676.72727	28120.33333	25957.23077	24103.14286	22496.26667	21090.25	18746.88889	17760.21053	16872.2	14060.16667	13497.76	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110453	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110454	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
110455	CHOYP_JNK.1.1|m.1540	MLVIDPTQR	MLVIDPTQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P92208	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; micropyle formation [GO:0046844]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007298; GO:0007391; GO:0007411; GO:0007616; GO:0009408; GO:0010508; GO:0016055; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801
113391	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	5845919	2922959.5	1948639.667	1461479.75	1169183.8	974319.8333	835131.2857	730739.875	649546.5556	584591.9	531447.1818	487159.9167	449686.0769	417565.6429	389727.9333	365369.9375	324773.2778	307679.9474	292295.95	243579.9583	233836.76	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113392	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	5368597	2684298.5	1789532.333	1342149.25	1073719.4	894766.1667	766942.4286	671074.625	596510.7778	536859.7	488054.2727	447383.0833	412969	383471.2143	357906.4667	335537.3125	298255.3889	282557.7368	268429.85	223691.5417	214743.88	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113393	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	2692712	1346356	897570.6667	673178	538542.4	448785.3333	384673.1429	336589	299190.2222	269271.2	244792	224392.6667	207131.6923	192336.5714	179514.1333	168294.5	149595.1111	141721.6842	134635.6	112196.3333	107708.48	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113394	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	1261134	630567	420378	315283.5	252226.8	210189	180162	157641.75	140126	126113.4	114648.5455	105094.5	97010.30769	90081	84075.6	78820.875	70063	66375.47368	63056.7	52547.25	50445.36	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113395	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	950595	475297.5	316865	237648.75	190119	158432.5	135799.2857	118824.375	105621.6667	95059.5	86417.72727	79216.25	73122.69231	67899.64286	63373	59412.1875	52810.83333	50031.31579	47529.75	39608.125	38023.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113396	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	329716	164858	109905.3333	82429	65943.2	54952.66667	47102.28571	41214.5	36635.11111	32971.6	29974.18182	27476.33333	25362.76923	23551.14286	21981.06667	20607.25	18317.55556	17353.47368	16485.8	13738.16667	13188.64	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113397	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	359547	179773.5	119849	89886.75	71909.4	59924.5	51363.85714	44943.375	39949.66667	35954.7	32686.09091	29962.25	27657.46154	25681.92857	23969.8	22471.6875	19974.83333	18923.52632	17977.35	14981.125	14381.88	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113398	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	355008	177504	118336	88752	71001.6	59168	50715.42857	44376	39445.33333	35500.8	32273.45455	29584	27308.30769	25357.71429	23667.2	22188	19722.66667	18684.63158	17750.4	14792	14200.32	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113399	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	1470485	735242.5	490161.6667	367621.25	294097	245080.8333	210069.2857	183810.625	163387.2222	147048.5	133680.4545	122540.4167	113114.2308	105034.6429	98032.33333	91905.3125	81693.61111	77393.94737	73524.25	61270.20833	58819.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113400	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113401	CHOYP_KS6A1.1.1|m.38386	DILADVNHPFIVK	DILADVNHPFIVK	92132	46066	30710.66667	23033	18426.4	15355.33333	13161.71429	11516.5	10236.88889	9213.2	8375.636364	7677.666667	7087.076923	6580.857143	6142.133333	5758.25	5118.444444	4849.052632	4606.6	3838.833333	3685.28	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113402	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113403	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113404	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	811560	405780	270520	202890	162312	135260	115937.1429	101445	90173.33333	81156	73778.18182	67630	62427.69231	57968.57143	54104	50722.5	45086.66667	42713.68421	40578	33815	32462.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113405	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113406	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	725747	362873.5	241915.6667	181436.75	145149.4	120957.8333	103678.1429	90718.375	80638.55556	72574.7	65977	60478.91667	55826.69231	51839.07143	48383.13333	45359.1875	40319.27778	38197.21053	36287.35	30239.45833	29029.88	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113407	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	124595	62297.5	41531.66667	31148.75	24919	20765.83333	17799.28571	15574.375	13843.88889	12459.5	11326.81818	10382.91667	9584.230769	8899.642857	8306.333333	7787.1875	6921.944444	6557.631579	6229.75	5191.458333	4983.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113408	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	7935	3967.5	2645	1983.75	1587	1322.5	1133.571429	991.875	881.6666667	793.5	721.3636364	661.25	610.3846154	566.7857143	529	495.9375	440.8333333	417.6315789	396.75	330.625	317.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113409	CHOYP_KS6A1.1.1|m.38386	EVMFTEEDVK	EVMFTEEDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113410	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113411	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113412	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113413	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113414	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113415	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113416	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113417	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113418	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	26437	13218.5	8812.333333	6609.25	5287.4	4406.166667	3776.714286	3304.625	2937.444444	2643.7	2403.363636	2203.083333	2033.615385	1888.357143	1762.466667	1652.3125	1468.722222	1391.421053	1321.85	1101.541667	1057.48	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113419	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113420	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	10309	5154.5	3436.333333	2577.25	2061.8	1718.166667	1472.714286	1288.625	1145.444444	1030.9	937.1818182	859.0833333	793	736.3571429	687.2666667	644.3125	572.7222222	542.5789474	515.45	429.5416667	412.36	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113421	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113422	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113423	CHOYP_KS6A1.1.1|m.38386	DLKPENILLDHEGHIK	DLKPENILLDHEGHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113424	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	19974270	9987135	6658090	4993567.5	3994854	3329045	2853467.143	2496783.75	2219363.333	1997427	1815842.727	1664522.5	1536482.308	1426733.571	1331618	1248391.875	1109681.667	1051277.368	998713.5	832261.25	798970.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113425	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	13787079	6893539.5	4595693	3446769.75	2757415.8	2297846.5	1969582.714	1723384.875	1531897.667	1378707.9	1253370.818	1148923.25	1060544.538	984791.3571	919138.6	861692.4375	765948.8333	725635.7368	689353.95	574461.625	551483.16	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113426	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113427	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	594010	297005	198003.3333	148502.5	118802	99001.66667	84858.57143	74251.25	66001.11111	59401	54000.90909	49500.83333	45693.07692	42429.28571	39600.66667	37125.625	33000.55556	31263.68421	29700.5	24750.41667	23760.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113428	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	425999	212999.5	141999.6667	106499.75	85199.8	70999.83333	60857	53249.875	47333.22222	42599.9	38727.18182	35499.91667	32769.15385	30428.5	28399.93333	26624.9375	23666.61111	22421	21299.95	17749.95833	17039.96	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113429	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	2862743	1431371.5	954247.6667	715685.75	572548.6	477123.8333	408963.2857	357842.875	318082.5556	286274.3	260249.3636	238561.9167	220211	204481.6429	190849.5333	178921.4375	159041.2778	150670.6842	143137.15	119280.9583	114509.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113430	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	3334946	1667473	1111648.667	833736.5	666989.2	555824.3333	476420.8571	416868.25	370549.5556	333494.6	303176.9091	277912.1667	256534.3077	238210.4286	222329.7333	208434.125	185274.7778	175523.4737	166747.3	138956.0833	133397.84	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113431	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	6314341	3157170.5	2104780.333	1578585.25	1262868.2	1052390.167	902048.7143	789292.625	701593.4444	631434.1	574031	526195.0833	485718.5385	451024.3571	420956.0667	394646.3125	350796.7222	332333.7368	315717.05	263097.5417	252573.64	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113432	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	5841534	2920767	1947178	1460383.5	1168306.8	973589	834504.8571	730191.75	649059.3333	584153.4	531048.5455	486794.5	449348.7692	417252.4286	389435.6	365095.875	324529.6667	307449.1579	292076.7	243397.25	233661.36	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113433	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113434	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	357898	178949	119299.3333	89474.5	71579.6	59649.66667	51128.28571	44737.25	39766.44444	35789.8	32536.18182	29824.83333	27530.61538	25564.14286	23859.86667	22368.625	19883.22222	18836.73684	17894.9	14912.41667	14315.92	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113435	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113436	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113437	CHOYP_KS6A1.1.1|m.38386	LGMPQFLSPEAQQLLR	LGMPQFLSPEAQQLLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113438	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113439	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113440	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113441	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	84434	42217	28144.66667	21108.5	16886.8	14072.33333	12062	10554.25	9381.555556	8443.4	7675.818182	7036.166667	6494.923077	6031	5628.933333	5277.125	4690.777778	4443.894737	4221.7	3518.083333	3377.36	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113442	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	148924	74462	49641.33333	37231	29784.8	24820.66667	21274.85714	18615.5	16547.11111	14892.4	13538.54545	12410.33333	11455.69231	10637.42857	9928.266667	9307.75	8273.555556	7838.105263	7446.2	6205.166667	5956.96	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113443	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	66243	33121.5	22081	16560.75	13248.6	11040.5	9463.285714	8280.375	7360.333333	6624.3	6022.090909	5520.25	5095.615385	4731.642857	4416.2	4140.1875	3680.166667	3486.473684	3312.15	2760.125	2649.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113444	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	141254	70627	47084.66667	35313.5	28250.8	23542.33333	20179.14286	17656.75	15694.88889	14125.4	12841.27273	11771.16667	10865.69231	10089.57143	9416.933333	8828.375	7847.444444	7434.421053	7062.7	5885.583333	5650.16	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113445	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113446	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113447	CHOYP_KS6A1.1.1|m.38386	LGSGPNGIEDIK	LGSGPNGIEDIK	12641	6320.5	4213.666667	3160.25	2528.2	2106.833333	1805.857143	1580.125	1404.555556	1264.1	1149.181818	1053.416667	972.3846154	902.9285714	842.7333333	790.0625	702.2777778	665.3157895	632.05	526.7083333	505.64	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113448	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	18241456	9120728	6080485.333	4560364	3648291.2	3040242.667	2605922.286	2280182	2026828.444	1824145.6	1658314.182	1520121.333	1403188.923	1302961.143	1216097.067	1140091	1013414.222	960076.6316	912072.8	760060.6667	729658.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113449	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113450	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	7732320	3866160	2577440	1933080	1546464	1288720	1104617.143	966540	859146.6667	773232	702938.1818	644360	594793.8462	552308.5714	515488	483270	429573.3333	406964.2105	386616	322180	309292.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113451	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	655231	327615.5	218410.3333	163807.75	131046.2	109205.1667	93604.42857	81903.875	72803.44444	65523.1	59566.45455	54602.58333	50402.38462	46802.21429	43682.06667	40951.9375	36401.72222	34485.84211	32761.55	27301.29167	26209.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113452	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	1505649	752824.5	501883	376412.25	301129.8	250941.5	215092.7143	188206.125	167294.3333	150564.9	136877.1818	125470.75	115819.1538	107546.3571	100376.6	94103.0625	83647.16667	79244.68421	75282.45	62735.375	60225.96	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113453	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	963581	481790.5	321193.6667	240895.25	192716.2	160596.8333	137654.4286	120447.625	107064.5556	96358.1	87598.27273	80298.41667	74121.61538	68827.21429	64238.73333	60223.8125	53532.27778	50714.78947	48179.05	40149.20833	38543.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113454	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	602895	301447.5	200965	150723.75	120579	100482.5	86127.85714	75361.875	66988.33333	60289.5	54808.63636	50241.25	46376.53846	43063.92857	40193	37680.9375	33494.16667	31731.31579	30144.75	25120.625	24115.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113455	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	328316	164158	109438.6667	82079	65663.2	54719.33333	46902.28571	41039.5	36479.55556	32831.6	29846.90909	27359.66667	25255.07692	23451.14286	21887.73333	20519.75	18239.77778	17279.78947	16415.8	13679.83333	13132.64	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113456	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	726744	363372	242248	181686	145348.8	121124	103820.5714	90843	80749.33333	72674.4	66067.63636	60562	55903.38462	51910.28571	48449.6	45421.5	40374.66667	38249.68421	36337.2	30281	29069.76	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113457	CHOYP_KS6A1.1.1|m.38386	TQPFFNTIDFDK	TQPFFNTIDFDK	291951	145975.5	97317	72987.75	58390.2	48658.5	41707.28571	36493.875	32439	29195.1	26541	24329.25	22457.76923	20853.64286	19463.4	18246.9375	16219.5	15365.84211	14597.55	12164.625	11678.04	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113458	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113459	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	296863	148431.5	98954.33333	74215.75	59372.6	49477.16667	42409	37107.875	32984.77778	29686.3	26987.54545	24738.58333	22835.61538	21204.5	19790.86667	18553.9375	16492.38889	15624.36842	14843.15	12369.29167	11874.52	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113460	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113461	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113462	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113463	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113464	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113465	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	49718	24859	16572.66667	12429.5	9943.6	8286.333333	7102.571429	6214.75	5524.222222	4971.8	4519.818182	4143.166667	3824.461538	3551.285714	3314.533333	3107.375	2762.111111	2616.736842	2485.9	2071.583333	1988.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113466	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113467	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113468	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113469	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113470	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113471	CHOYP_KS6A1.1.1|m.38386	DSPGIPPSATAHELFR	DSPGIPPSATAHELFR	8042	4021	2680.666667	2010.5	1608.4	1340.333333	1148.857143	1005.25	893.5555556	804.2	731.0909091	670.1666667	618.6153846	574.4285714	536.1333333	502.625	446.7777778	423.2631579	402.1	335.0833333	321.68	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113472	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	3611627	1805813.5	1203875.667	902906.75	722325.4	601937.8333	515946.7143	451453.375	401291.8889	361162.7	328329.7273	300968.9167	277817.4615	257973.3571	240775.1333	225726.6875	200645.9444	190085.6316	180581.35	150484.4583	144465.08	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113473	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	8144993	4072496.5	2714997.667	2036248.25	1628998.6	1357498.833	1163570.429	1018124.125	904999.2222	814499.3	740453.9091	678749.4167	626537.9231	581785.2143	542999.5333	509062.0625	452499.6111	428683.8421	407249.65	339374.7083	325799.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113474	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	5618806	2809403	1872935.333	1404701.5	1123761.2	936467.6667	802686.5714	702350.75	624311.7778	561880.6	510800.5455	468233.8333	432215.8462	401343.2857	374587.0667	351175.375	312155.8889	295726.6316	280940.3	234116.9167	224752.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113475	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	311217	155608.5	103739	77804.25	62243.4	51869.5	44459.57143	38902.125	34579.66667	31121.7	28292.45455	25934.75	23939.76923	22229.78571	20747.8	19451.0625	17289.83333	16379.84211	15560.85	12967.375	12448.68	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113476	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	1169701	584850.5	389900.3333	292425.25	233940.2	194950.1667	167100.1429	146212.625	129966.7778	116970.1	106336.4545	97475.08333	89977	83550.07143	77980.06667	73106.3125	64983.38889	61563.21053	58485.05	48737.54167	46788.04	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113477	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	264989	132494.5	88329.66667	66247.25	52997.8	44164.83333	37855.57143	33123.625	29443.22222	26498.9	24089.90909	22082.41667	20383.76923	18927.78571	17665.93333	16561.8125	14721.61111	13946.78947	13249.45	11041.20833	10599.56	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113478	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	577582	288791	192527.3333	144395.5	115516.4	96263.66667	82511.71429	72197.75	64175.77778	57758.2	52507.45455	48131.83333	44429.38462	41255.85714	38505.46667	36098.875	32087.88889	30399.05263	28879.1	24065.91667	23103.28	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113479	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	993585	496792.5	331195	248396.25	198717	165597.5	141940.7143	124198.125	110398.3333	99358.5	90325.90909	82798.75	76429.61538	70970.35714	66239	62099.0625	55199.16667	52293.94737	49679.25	41399.375	39743.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113480	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	213352	106676	71117.33333	53338	42670.4	35558.66667	30478.85714	26669	23705.77778	21335.2	19395.63636	17779.33333	16411.69231	15239.42857	14223.46667	13334.5	11852.88889	11229.05263	10667.6	8889.666667	8534.08	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113481	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	729196	364598	243065.3333	182299	145839.2	121532.6667	104170.8571	91149.5	81021.77778	72919.6	66290.54545	60766.33333	56092	52085.42857	48613.06667	45574.75	40510.88889	38378.73684	36459.8	30383.16667	29167.84	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113482	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	271007	135503.5	90335.66667	67751.75	54201.4	45167.83333	38715.28571	33875.875	30111.88889	27100.7	24637	22583.91667	20846.69231	19357.64286	18067.13333	16937.9375	15055.94444	14263.52632	13550.35	11291.95833	10840.28	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113483	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	20858	10429	6952.666667	5214.5	4171.6	3476.333333	2979.714286	2607.25	2317.555556	2085.8	1896.181818	1738.166667	1604.461538	1489.857143	1390.533333	1303.625	1158.777778	1097.789474	1042.9	869.0833333	834.32	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113484	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	359097	179548.5	119699	89774.25	71819.4	59849.5	51299.57143	44887.125	39899.66667	35909.7	32645.18182	29924.75	27622.84615	25649.78571	23939.8	22443.5625	19949.83333	18899.84211	17954.85	14962.375	14363.88	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113485	CHOYP_KS6A1.1.1|m.38386	VYMVTELMQGGELLDK	VYMVTELMQGGELLDK	181712	90856	60570.66667	45428	36342.4	30285.33333	25958.85714	22714	20190.22222	18171.2	16519.27273	15142.66667	13977.84615	12979.42857	12114.13333	11357	10095.11111	9563.789474	9085.6	7571.333333	7268.48	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113486	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	8511162	4255581	2837054	2127790.5	1702232.4	1418527	1215880.286	1063895.25	945684.6667	851116.2	773742	709263.5	654704.7692	607940.1429	567410.8	531947.625	472842.3333	447955.8947	425558.1	354631.75	340446.48	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113487	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	9952285	4976142.5	3317428.333	2488071.25	1990457	1658714.167	1421755	1244035.625	1105809.444	995228.5	904753.1818	829357.0833	765560.3846	710877.5	663485.6667	622017.8125	552904.7222	523804.4737	497614.25	414678.5417	398091.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113488	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	2790856	1395428	930285.3333	697714	558171.2	465142.6667	398693.7143	348857	310095.1111	279085.6	253714.1818	232571.3333	214681.2308	199346.8571	186057.0667	174428.5	155047.5556	146887.1579	139542.8	116285.6667	111634.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113489	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113490	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	510938	255469	170312.6667	127734.5	102187.6	85156.33333	72991.14286	63867.25	56770.88889	51093.8	46448.90909	42578.16667	39302.92308	36495.57143	34062.53333	31933.625	28385.44444	26891.47368	25546.9	21289.08333	20437.52	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113491	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	1920204	960102	640068	480051	384040.8	320034	274314.8571	240025.5	213356	192020.4	174564	160017	147708	137157.4286	128013.6	120012.75	106678	101063.3684	96010.2	80008.5	76808.16	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113492	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	798719	399359.5	266239.6667	199679.75	159743.8	133119.8333	114102.7143	99839.875	88746.55556	79871.9	72610.81818	66559.91667	61439.92308	57051.35714	53247.93333	49919.9375	44373.27778	42037.84211	39935.95	33279.95833	31948.76	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113493	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	264810	132405	88270	66202.5	52962	44135	37830	33101.25	29423.33333	26481	24073.63636	22067.5	20370	18915	17654	16550.625	14711.66667	13937.36842	13240.5	11033.75	10592.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113494	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	29391	14695.5	9797	7347.75	5878.2	4898.5	4198.714286	3673.875	3265.666667	2939.1	2671.909091	2449.25	2260.846154	2099.357143	1959.4	1836.9375	1632.833333	1546.894737	1469.55	1224.625	1175.64	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113495	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113496	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	50153	25076.5	16717.66667	12538.25	10030.6	8358.833333	7164.714286	6269.125	5572.555556	5015.3	4559.363636	4179.416667	3857.923077	3582.357143	3343.533333	3134.5625	2786.277778	2639.631579	2507.65	2089.708333	2006.12	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113497	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	14419605	7209802.5	4806535	3604901.25	2883921	2403267.5	2059943.571	1802450.625	1602178.333	1441960.5	1310873.182	1201633.75	1109200.385	1029971.786	961307	901225.3125	801089.1667	758926.5789	720980.25	600816.875	576784.2	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113498	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	12996393	6498196.5	4332131	3249098.25	2599278.6	2166065.5	1856627.571	1624549.125	1444043.667	1299639.3	1181490.273	1083032.75	999722.5385	928313.7857	866426.2	812274.5625	722021.8333	684020.6842	649819.65	541516.375	519855.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113499	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	4066019	2033009.5	1355339.667	1016504.75	813203.8	677669.8333	580859.8571	508252.375	451779.8889	406601.9	369638.0909	338834.9167	312770.6923	290429.9286	271067.9333	254126.1875	225889.9444	214001	203300.95	169417.4583	162640.76	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113500	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113501	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	87206	43603	29068.66667	21801.5	17441.2	14534.33333	12458	10900.75	9689.555556	8720.6	7927.818182	7267.166667	6708.153846	6229	5813.733333	5450.375	4844.777778	4589.789474	4360.3	3633.583333	3488.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113502	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	769596	384798	256532	192399	153919.2	128266	109942.2857	96199.5	85510.66667	76959.6	69963.27273	64133	59199.69231	54971.14286	51306.4	48099.75	42755.33333	40505.05263	38479.8	32066.5	30783.84	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113503	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	1607417	803708.5	535805.6667	401854.25	321483.4	267902.8333	229631	200927.125	178601.8889	160741.7	146128.8182	133951.4167	123647.4615	114815.5	107161.1333	100463.5625	89300.94444	84600.89474	80370.85	66975.70833	64296.68	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113504	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	206210	103105	68736.66667	51552.5	41242	34368.33333	29458.57143	25776.25	22912.22222	20621	18746.36364	17184.16667	15862.30769	14729.28571	13747.33333	12888.125	11456.11111	10853.15789	10310.5	8592.083333	8248.4	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113505	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	187553	93776.5	62517.66667	46888.25	37510.6	31258.83333	26793.28571	23444.125	20839.22222	18755.3	17050.27273	15629.41667	14427.15385	13396.64286	12503.53333	11722.0625	10419.61111	9871.210526	9377.65	7814.708333	7502.12	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113506	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113507	CHOYP_KS6A1.1.1|m.38386	TVEYLHANGVVHR	TVEYLHANGVVHR	1882736	941368	627578.6667	470684	376547.2	313789.3333	268962.2857	235342	209192.8889	188273.6	171157.8182	156894.6667	144825.8462	134481.1429	125515.7333	117671	104596.4444	99091.36842	94136.8	78447.33333	75309.44	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113508	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113509	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113510	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113511	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	383234	191617	127744.6667	95808.5	76646.8	63872.33333	54747.71429	47904.25	42581.55556	38323.4	34839.45455	31936.16667	29479.53846	27373.85714	25548.93333	23952.125	21290.77778	20170.21053	19161.7	15968.08333	15329.36	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113512	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	698366	349183	232788.6667	174591.5	139673.2	116394.3333	99766.57143	87295.75	77596.22222	69836.6	63487.81818	58197.16667	53720.46154	49883.28571	46557.73333	43647.875	38798.11111	36756.10526	34918.3	29098.58333	27934.64	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113513	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	175373	87686.5	58457.66667	43843.25	35074.6	29228.83333	25053.28571	21921.625	19485.88889	17537.3	15943	14614.41667	13490.23077	12526.64286	11691.53333	10960.8125	9742.944444	9230.157895	8768.65	7307.208333	7014.92	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113514	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	47307	23653.5	15769	11826.75	9461.4	7884.5	6758.142857	5913.375	5256.333333	4730.7	4300.636364	3942.25	3639	3379.071429	3153.8	2956.6875	2628.166667	2489.842105	2365.35	1971.125	1892.28	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113515	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113516	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	230943	115471.5	76981	57735.75	46188.6	38490.5	32991.85714	28867.875	25660.33333	23094.3	20994.81818	19245.25	17764.84615	16495.92857	15396.2	14433.9375	12830.16667	12154.89474	11547.15	9622.625	9237.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113517	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113518	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	7706	3853	2568.666667	1926.5	1541.2	1284.333333	1100.857143	963.25	856.2222222	770.6	700.5454545	642.1666667	592.7692308	550.4285714	513.7333333	481.625	428.1111111	405.5789474	385.3	321.0833333	308.24	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113519	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113520	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113521	CHOYP_KS6A1.1.1|m.38386	FTLAGGNWDSVSAAAK	FTLAGGNWDSVSAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113522	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	10363102	5181551	3454367.333	2590775.5	2072620.4	1727183.667	1480443.143	1295387.75	1151455.778	1036310.2	942100.1818	863591.8333	797161.6923	740221.5714	690873.4667	647693.875	575727.8889	545426.4211	518155.1	431795.9167	414524.08	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113523	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	4667333	2333666.5	1555777.667	1166833.25	933466.6	777888.8333	666761.8571	583416.625	518592.5556	466733.3	424303	388944.4167	359025.6154	333380.9286	311155.5333	291708.3125	259296.2778	245649.1053	233366.65	194472.2083	186693.32	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113524	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	3371024	1685512	1123674.667	842756	674204.8	561837.3333	481574.8571	421378	374558.2222	337102.4	306456.7273	280918.6667	259309.5385	240787.4286	224734.9333	210689	187279.1111	177422.3158	168551.2	140459.3333	134840.96	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113525	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	897363	448681.5	299121	224340.75	179472.6	149560.5	128194.7143	112170.375	99707	89736.3	81578.45455	74780.25	69027.92308	64097.35714	59824.2	56085.1875	49853.5	47229.63158	44868.15	37390.125	35894.52	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113526	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	132567	66283.5	44189	33141.75	26513.4	22094.5	18938.14286	16570.875	14729.66667	13256.7	12051.54545	11047.25	10197.46154	9469.071429	8837.8	8285.4375	7364.833333	6977.210526	6628.35	5523.625	5302.68	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113527	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	6408050	3204025	2136016.667	1602012.5	1281610	1068008.333	915435.7143	801006.25	712005.5556	640805	582550	534004.1667	492926.9231	457717.8571	427203.3333	400503.125	356002.7778	337265.7895	320402.5	267002.0833	256322	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113528	CHOYP_KS6A1.1.1|m.38386	MLHVDPGSR	MLHVDPGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113529	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	12093682	6046841	4031227.333	3023420.5	2418736.4	2015613.667	1727668.857	1511710.25	1343742.444	1209368.2	1099425.636	1007806.833	930283.2308	863834.4286	806245.4667	755855.125	671871.2222	636509.5789	604684.1	503903.4167	483747.28	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113530	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	7261165	3630582.5	2420388.333	1815291.25	1452233	1210194.167	1037309.286	907645.625	806796.1111	726116.5	660105.9091	605097.0833	558551.1538	518654.6429	484077.6667	453822.8125	403398.0556	382166.5789	363058.25	302548.5417	290446.6	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113531	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	4582186	2291093	1527395.333	1145546.5	916437.2	763697.6667	654598	572773.25	509131.7778	458218.6	416562.3636	381848.8333	352475.8462	327299	305479.0667	286386.625	254565.8889	241167.6842	229109.3	190924.4167	183287.44	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113532	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113533	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	155464	77732	51821.33333	38866	31092.8	25910.66667	22209.14286	19433	17273.77778	15546.4	14133.09091	12955.33333	11958.76923	11104.57143	10364.26667	9716.5	8636.888889	8182.315789	7773.2	6477.666667	6218.56	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113534	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	596893	298446.5	198964.3333	149223.25	119378.6	99482.16667	85270.42857	74611.625	66321.44444	59689.3	54263	49741.08333	45914.84615	42635.21429	39792.86667	37305.8125	33160.72222	31415.42105	29844.65	24870.54167	23875.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113535	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	1573289	786644.5	524429.6667	393322.25	314657.8	262214.8333	224755.5714	196661.125	174809.8889	157328.9	143026.2727	131107.4167	121022.2308	112377.7857	104885.9333	98330.5625	87404.94444	82804.68421	78664.45	65553.70833	62931.56	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113536	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	1508886	754443	502962	377221.5	301777.2	251481	215555.1429	188610.75	167654	150888.6	137171.4545	125740.5	116068.1538	107777.5714	100592.4	94305.375	83827	79415.05263	75444.3	62870.25	60355.44	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113537	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	1250203	625101.5	416734.3333	312550.75	250040.6	208367.1667	178600.4286	156275.375	138911.4444	125020.3	113654.8182	104183.5833	96169.46154	89300.21429	83346.86667	78137.6875	69455.72222	65800.15789	62510.15	52091.79167	50008.12	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113538	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	3483938	1741969	1161312.667	870984.5	696787.6	580656.3333	497705.4286	435492.25	387104.2222	348393.8	316721.6364	290328.1667	267995.2308	248852.7143	232262.5333	217746.125	193552.1111	183365.1579	174196.9	145164.0833	139357.52	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113539	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	113125	56562.5	37708.33333	28281.25	22625	18854.16667	16160.71429	14140.625	12569.44444	11312.5	10284.09091	9427.083333	8701.923077	8080.357143	7541.666667	7070.3125	6284.722222	5953.947368	5656.25	4713.541667	4525	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113540	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113541	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	626154	313077	208718	156538.5	125230.8	104359	89450.57143	78269.25	69572.66667	62615.4	56923.09091	52179.5	48165.69231	44725.28571	41743.6	39134.625	34786.33333	32955.47368	31307.7	26089.75	25046.16	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113542	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	18577944	9288972	6192648	4644486	3715588.8	3096324	2653992	2322243	2064216	1857794.4	1688904	1548162	1429072.615	1326996	1238529.6	1161121.5	1032108	977786.5263	928897.2	774081	743117.76	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113543	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	18004036	9002018	6001345.333	4501009	3600807.2	3000672.667	2572005.143	2250504.5	2000448.444	1800403.6	1636730.545	1500336.333	1384925.846	1286002.571	1200269.067	1125252.25	1000224.222	947580.8421	900201.8	750168.1667	720161.44	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113544	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	8189158	4094579	2729719.333	2047289.5	1637831.6	1364859.667	1169879.714	1023644.75	909906.4444	818915.8	744468.9091	682429.8333	629935.2308	584939.8571	545943.8667	511822.375	454953.2222	431008.3158	409457.9	341214.9167	327566.32	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113545	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113546	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113547	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	202030	101015	67343.33333	50507.5	40406	33671.66667	28861.42857	25253.75	22447.77778	20203	18366.36364	16835.83333	15540.76923	14430.71429	13468.66667	12626.875	11223.88889	10633.15789	10101.5	8417.916667	8081.2	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113548	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	710695	355347.5	236898.3333	177673.75	142139	118449.1667	101527.8571	88836.875	78966.11111	71069.5	64608.63636	59224.58333	54668.84615	50763.92857	47379.66667	44418.4375	39483.05556	37405	35534.75	29612.29167	28427.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113549	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	1187583	593791.5	395861	296895.75	237516.6	197930.5	169654.7143	148447.875	131953.6667	118758.3	107962.0909	98965.25	91352.53846	84827.35714	79172.2	74223.9375	65976.83333	62504.36842	59379.15	49482.625	47503.32	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113550	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113551	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	3557477	1778738.5	1185825.667	889369.25	711495.4	592912.8333	508211	444684.625	395275.2222	355747.7	323407	296456.4167	273652.0769	254105.5	237165.1333	222342.3125	197637.6111	187235.6316	177873.85	148228.2083	142299.08	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113552	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	508867	254433.5	169622.3333	127216.75	101773.4	84811.16667	72695.28571	63608.375	56540.77778	50886.7	46260.63636	42405.58333	39143.61538	36347.64286	33924.46667	31804.1875	28270.38889	26782.47368	25443.35	21202.79167	20354.68	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113553	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	381421	190710.5	127140.3333	95355.25	76284.2	63570.16667	54488.71429	47677.625	42380.11111	38142.1	34674.63636	31785.08333	29340.07692	27244.35714	25428.06667	23838.8125	21190.05556	20074.78947	19071.05	15892.54167	15256.84	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113554	CHOYP_KS6A1.1.1|m.38386	LSATQVLNHPWVAQR	LSATQVLNHPWVAQR	385619	192809.5	128539.6667	96404.75	77123.8	64269.83333	55088.42857	48202.375	42846.55556	38561.9	35056.27273	32134.91667	29663	27544.21429	25707.93333	24101.1875	21423.27778	20295.73684	19280.95	16067.45833	15424.76	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113555	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	14406287	7203143.5	4802095.667	3601571.75	2881257.4	2401047.833	2058041	1800785.875	1600698.556	1440628.7	1309662.455	1200523.917	1108175.923	1029020.5	960419.1333	900392.9375	800349.2778	758225.6316	720314.35	600261.9583	576251.48	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113556	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	10381783	5190891.5	3460594.333	2595445.75	2076356.6	1730297.167	1483111.857	1297722.875	1153531.444	1038178.3	943798.4545	865148.5833	798598.6923	741555.9286	692118.8667	648861.4375	576765.7222	546409.6316	519089.15	432574.2917	415271.32	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113557	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	2986539	1493269.5	995513	746634.75	597307.8	497756.5	426648.4286	373317.375	331837.6667	298653.9	271503.5455	248878.25	229733.7692	213324.2143	199102.6	186658.6875	165918.8333	157186.2632	149326.95	124439.125	119461.56	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113558	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	1202901	601450.5	400967	300725.25	240580.2	200483.5	171843	150362.625	133655.6667	120290.1	109354.6364	100241.75	92530.84615	85921.5	80193.4	75181.3125	66827.83333	63310.57895	60145.05	50120.875	48116.04	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113559	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	1058593	529296.5	352864.3333	264648.25	211718.6	176432.1667	151227.5714	132324.125	117621.4444	105859.3	96235.72727	88216.08333	81430.23077	75613.78571	70572.86667	66162.0625	58810.72222	55715.42105	52929.65	44108.04167	42343.72	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113560	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	200530	100265	66843.33333	50132.5	40106	33421.66667	28647.14286	25066.25	22281.11111	20053	18230	16710.83333	15425.38462	14323.57143	13368.66667	12533.125	11140.55556	10554.21053	10026.5	8355.416667	8021.2	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113561	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	21336	10668	7112	5334	4267.2	3556	3048	2667	2370.666667	2133.6	1939.636364	1778	1641.230769	1524	1422.4	1333.5	1185.333333	1122.947368	1066.8	889	853.44	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113562	CHOYP_KS6A1.1.1|m.38386	LTLQDAQLVK	LTLQDAQLVK	158012	79006	52670.66667	39503	31602.4	26335.33333	22573.14286	19751.5	17556.88889	15801.2	14364.72727	13167.66667	12154.76923	11286.57143	10534.13333	9875.75	8778.444444	8316.421053	7900.6	6583.833333	6320.48	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113563	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	11079013	5539506.5	3693004.333	2769753.25	2215802.6	1846502.167	1582716.143	1384876.625	1231001.444	1107901.3	1007183	923251.0833	852231.7692	791358.0714	738600.8667	692438.3125	615500.7222	583105.9474	553950.65	461625.5417	443160.52	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113564	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	8147029	4073514.5	2715676.333	2036757.25	1629405.8	1357838.167	1163861.286	1018378.625	905225.4444	814702.9	740639	678919.0833	626694.5385	581930.6429	543135.2667	509189.3125	452612.7222	428791	407351.45	339459.5417	325881.16	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113565	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	3771079	1885539.5	1257026.333	942769.75	754215.8	628513.1667	538725.5714	471384.875	419008.7778	377107.9	342825.3636	314256.5833	290083	269362.7857	251405.2667	235692.4375	209504.3889	198477.8421	188553.95	157128.2917	150843.16	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113566	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	514830	257415	171610	128707.5	102966	85805	73547.14286	64353.75	57203.33333	51483	46802.72727	42902.5	39602.30769	36773.57143	34322	32176.875	28601.66667	27096.31579	25741.5	21451.25	20593.2	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113567	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	6866376	3433188	2288792	1716594	1373275.2	1144396	980910.8571	858297	762930.6667	686637.6	624216	572198	528182.7692	490455.4286	457758.4	429148.5	381465.3333	361388.2105	343318.8	286099	274655.04	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113568	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	495127	247563.5	165042.3333	123781.75	99025.4	82521.16667	70732.42857	61890.875	55014.11111	49512.7	45011.54545	41260.58333	38086.69231	35366.21429	33008.46667	30945.4375	27507.05556	26059.31579	24756.35	20630.29167	19805.08	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113569	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	2440311	1220155.5	813437	610077.75	488062.2	406718.5	348615.8571	305038.875	271145.6667	244031.1	221846.4545	203359.25	187716.2308	174307.9286	162687.4	152519.4375	135572.8333	128437.4211	122015.55	101679.625	97612.44	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113570	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113571	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	499047	249523.5	166349	124761.75	99809.4	83174.5	71292.42857	62380.875	55449.66667	49904.7	45367.90909	41587.25	38388.23077	35646.21429	33269.8	31190.4375	27724.83333	26265.63158	24952.35	20793.625	19961.88	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113572	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	93549	46774.5	31183	23387.25	18709.8	15591.5	13364.14286	11693.625	10394.33333	9354.9	8504.454545	7795.75	7196.076923	6682.071429	6236.6	5846.8125	5197.166667	4923.631579	4677.45	3897.875	3741.96	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113573	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
113574	CHOYP_KS6A1.1.1|m.38386	TTLEPVGASGLAQR	TTLEPVGASGLAQR	93295	46647.5	31098.33333	23323.75	18659	15549.16667	13327.85714	11661.875	10366.11111	9329.5	8481.363636	7774.583333	7176.538462	6663.928571	6219.666667	5830.9375	5183.055556	4910.263158	4664.75	3887.291667	3731.8	P51812	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944
115454	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115455	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	2174748	1087374	724916	543687	434949.6	362458	310678.2857	271843.5	241638.6667	217474.8	197704.3636	181229	167288.3077	155339.1429	144983.2	135921.75	120819.3333	114460.4211	108737.4	90614.5	86989.92	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115456	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	2635386	1317693	878462	658846.5	527077.2	439231	376483.7143	329423.25	292820.6667	263538.6	239580.5455	219615.5	202722	188241.8571	175692.4	164711.625	146410.3333	138704.5263	131769.3	109807.75	105415.44	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115457	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115458	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	162944	81472	54314.66667	40736	32588.8	27157.33333	23277.71429	20368	18104.88889	16294.4	14813.09091	13578.66667	12534.15385	11638.85714	10862.93333	10184	9052.444444	8576	8147.2	6789.333333	6517.76	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115459	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	372250	186125	124083.3333	93062.5	74450	62041.66667	53178.57143	46531.25	41361.11111	37225	33840.90909	31020.83333	28634.61538	26589.28571	24816.66667	23265.625	20680.55556	19592.10526	18612.5	15510.41667	14890	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115460	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115461	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	144519	72259.5	48173	36129.75	28903.8	24086.5	20645.57143	18064.875	16057.66667	14451.9	13138.09091	12043.25	11116.84615	10322.78571	9634.6	9032.4375	8028.833333	7606.263158	7225.95	6021.625	5780.76	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115462	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	58151	29075.5	19383.66667	14537.75	11630.2	9691.833333	8307.285714	7268.875	6461.222222	5815.1	5286.454545	4845.916667	4473.153846	4153.642857	3876.733333	3634.4375	3230.611111	3060.578947	2907.55	2422.958333	2326.04	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115463	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	110922	55461	36974	27730.5	22184.4	18487	15846	13865.25	12324.66667	11092.2	10083.81818	9243.5	8532.461538	7923	7394.8	6932.625	6162.333333	5838	5546.1	4621.75	4436.88	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115464	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	376858	188429	125619.3333	94214.5	75371.6	62809.66667	53836.85714	47107.25	41873.11111	37685.8	34259.81818	31404.83333	28989.07692	26918.42857	25123.86667	23553.625	20936.55556	19834.63158	18842.9	15702.41667	15074.32	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115465	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115466	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115467	CHOYP_LOC100024935.1.1|m.2615	FIGLQEDDAIDSFVEK	FIGLQEDDAIDSFVEK	70897	35448.5	23632.33333	17724.25	14179.4	11816.16667	10128.14286	8862.125	7877.444444	7089.7	6445.181818	5908.083333	5453.615385	5064.071429	4726.466667	4431.0625	3938.722222	3731.421053	3544.85	2954.041667	2835.88	Q95108	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0055114
115971	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	977096832	488548416	325698944	244274208	195419366.4	162849472	139585261.7	122137104	108566314.7	97709683.2	88826984.73	81424736	75161294.77	69792630.86	65139788.8	61068552	54283157.33	51426149.05	48854841.6	40712368	39083873.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115972	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	591583168	295791584	197194389.3	147895792	118316633.6	98597194.67	84511881.14	73947896	65731463.11	59158316.8	53780288	49298597.33	45506397.54	42255940.57	39438877.87	36973948	32865731.56	31135956.21	29579158.4	24649298.67	23663326.72	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115973	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	246532256	123266128	82177418.67	61633064	49306451.2	41088709.33	35218893.71	30816532	27392472.89	24653225.6	22412023.27	20544354.67	18964019.69	17609446.86	16435483.73	15408266	13696236.44	12975381.89	12326612.8	10272177.33	9861290.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115974	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	53643948	26821974	17881316	13410987	10728789.6	8940658	7663421.143	6705493.5	5960438.667	5364394.8	4876722.545	4470329	4126457.538	3831710.571	3576263.2	3352746.75	2980219.333	2823365.684	2682197.4	2235164.5	2145757.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115975	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	24872264	12436132	8290754.667	6218066	4974452.8	4145377.333	3553180.571	3109033	2763584.889	2487226.4	2261114.909	2072688.667	1913251.077	1776590.286	1658150.933	1554516.5	1381792.444	1309066.526	1243613.2	1036344.333	994890.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115976	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	32144684	16072342	10714894.67	8036171	6428936.8	5357447.333	4592097.714	4018085.5	3571631.556	3214468.4	2922244	2678723.667	2472668	2296048.857	2142978.933	2009042.75	1785815.778	1691825.474	1607234.2	1339361.833	1285787.36	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115977	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	30837662	15418831	10279220.67	7709415.5	6167532.4	5139610.333	4405380.286	3854707.75	3426406.889	3083766.2	2803423.818	2569805.167	2372127.846	2202690.143	2055844.133	1927353.875	1713203.444	1623034.842	1541883.1	1284902.583	1233506.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115978	CHOYP_LOC100083074.1.1|m.1592	VHGSIEMHQR	VHGSIEMHQR	11772739	5886369.5	3924246.333	2943184.75	2354547.8	1962123.167	1681819.857	1471592.375	1308082.111	1177273.9	1070249	981061.5833	905595.3077	840909.9286	784849.2667	735796.1875	654041.0556	619617.8421	588636.95	490530.7917	470909.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115979	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115980	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115981	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115982	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115983	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115984	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115985	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115986	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115987	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115988	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115989	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115990	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115991	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
115992	CHOYP_LOC100083074.1.1|m.1592	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
116069	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	10226000	5113000	3408666.667	2556500	2045200	1704333.333	1460857.143	1278250	1136222.222	1022600	929636.3636	852166.6667	786615.3846	730428.5714	681733.3333	639125	568111.1111	538210.5263	511300	426083.3333	409040	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116070	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	7796588	3898294	2598862.667	1949147	1559317.6	1299431.333	1113798.286	974573.5	866287.5556	779658.8	708780.7273	649715.6667	599737.5385	556899.1429	519772.5333	487286.75	433143.7778	410346.7368	389829.4	324857.8333	311863.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116071	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	3308631	1654315.5	1102877	827157.75	661726.2	551438.5	472661.5714	413578.875	367625.6667	330863.1	300784.6364	275719.25	254510.0769	236330.7857	220575.4	206789.4375	183812.8333	174138.4737	165431.55	137859.625	132345.24	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116072	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	1600010	800005	533336.6667	400002.5	320002	266668.3333	228572.8571	200001.25	177778.8889	160001	145455.4545	133334.1667	123077.6923	114286.4286	106667.3333	100000.625	88889.44444	84211.05263	80000.5	66667.08333	64000.4	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116073	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	224110	112055	74703.33333	56027.5	44822	37351.66667	32015.71429	28013.75	24901.11111	22411	20373.63636	18675.83333	17239.23077	16007.85714	14940.66667	14006.875	12450.55556	11795.26316	11205.5	9337.916667	8964.4	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116074	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	477384	238692	159128	119346	95476.8	79564	68197.71429	59673	53042.66667	47738.4	43398.54545	39782	36721.84615	34098.85714	31825.6	29836.5	26521.33333	25125.47368	23869.2	19891	19095.36	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116075	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	2030156	1015078	676718.6667	507539	406031.2	338359.3333	290022.2857	253769.5	225572.8889	203015.6	184559.6364	169179.6667	156165.8462	145011.1429	135343.7333	126884.75	112786.4444	106850.3158	101507.8	84589.83333	81206.24	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116076	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	735200	367600	245066.6667	183800	147040	122533.3333	105028.5714	91900	81688.88889	73520	66836.36364	61266.66667	56553.84615	52514.28571	49013.33333	45950	40844.44444	38694.73684	36760	30633.33333	29408	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116077	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	1087231	543615.5	362410.3333	271807.75	217446.2	181205.1667	155318.7143	135903.875	120803.4444	108723.1	98839.18182	90602.58333	83633.15385	77659.35714	72482.06667	67951.9375	60401.72222	57222.68421	54361.55	45301.29167	43489.24	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116078	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	586163	293081.5	195387.6667	146540.75	117232.6	97693.83333	83737.57143	73270.375	65129.22222	58616.3	53287.54545	48846.91667	45089.46154	41868.78571	39077.53333	36635.1875	32564.61111	30850.68421	29308.15	24423.45833	23446.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116079	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	871213	435606.5	290404.3333	217803.25	174242.6	145202.1667	124459	108901.625	96801.44444	87121.3	79201.18182	72601.08333	67016.38462	62229.5	58080.86667	54450.8125	48400.72222	45853.31579	43560.65	36300.54167	34848.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116080	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	887302	443651	295767.3333	221825.5	177460.4	147883.6667	126757.4286	110912.75	98589.11111	88730.2	80663.81818	73941.83333	68254	63378.71429	59153.46667	55456.375	49294.55556	46700.10526	44365.1	36970.91667	35492.08	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116081	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	320763	160381.5	106921	80190.75	64152.6	53460.5	45823.28571	40095.375	35640.33333	32076.3	29160.27273	26730.25	24674.07692	22911.64286	21384.2	20047.6875	17820.16667	16882.26316	16038.15	13365.125	12830.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116082	CHOYP_LOC100114171.1.1|m.50280	VYVGNLDQAVDEGTLR	VYVGNLDQAVDEGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116083	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116084	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116085	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116086	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	41665	20832.5	13888.33333	10416.25	8333	6944.166667	5952.142857	5208.125	4629.444444	4166.5	3787.727273	3472.083333	3205	2976.071429	2777.666667	2604.0625	2314.722222	2192.894737	2083.25	1736.041667	1666.6	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116087	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	194578	97289	64859.33333	48644.5	38915.6	32429.66667	27796.85714	24322.25	21619.77778	19457.8	17688.90909	16214.83333	14967.53846	13898.42857	12971.86667	12161.125	10809.88889	10240.94737	9728.9	8107.416667	7783.12	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116088	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	66464	33232	22154.66667	16616	13292.8	11077.33333	9494.857143	8308	7384.888889	6646.4	6042.181818	5538.666667	5112.615385	4747.428571	4430.933333	4154	3692.444444	3498.105263	3323.2	2769.333333	2658.56	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116089	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	438336	219168	146112	109584	87667.2	73056	62619.42857	54792	48704	43833.6	39848.72727	36528	33718.15385	31309.71429	29222.4	27396	24352	23070.31579	21916.8	18264	17533.44	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116090	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116091	CHOYP_LOC100114171.1.1|m.50280	IAIQNLPVHIK	IAIQNLPVHIK	75323	37661.5	25107.66667	18830.75	15064.6	12553.83333	10760.42857	9415.375	8369.222222	7532.3	6847.545455	6276.916667	5794.076923	5380.214286	5021.533333	4707.6875	4184.611111	3964.368421	3766.15	3138.458333	3012.92	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116092	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	2268549	1134274.5	756183	567137.25	453709.8	378091.5	324078.4286	283568.625	252061	226854.9	206231.7273	189045.75	174503.7692	162039.2143	151236.6	141784.3125	126030.5	119397.3158	113427.45	94522.875	90741.96	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116093	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116094	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116095	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	194788	97394	64929.33333	48697	38957.6	32464.66667	27826.85714	24348.5	21643.11111	19478.8	17708	16232.33333	14983.69231	13913.42857	12985.86667	12174.25	10821.55556	10252	9739.4	8116.166667	7791.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116096	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116097	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116098	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116099	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116100	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116101	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116102	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116103	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116104	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116105	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116106	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	1965483	982741.5	655161	491370.75	393096.6	327580.5	280783.2857	245685.375	218387	196548.3	178680.2727	163790.25	151191	140391.6429	131032.2	122842.6875	109193.5	103446.4737	98274.15	81895.125	78619.32	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116107	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	2312887	1156443.5	770962.3333	578221.75	462577.4	385481.1667	330412.4286	289110.875	256987.4444	231288.7	210262.4545	192740.5833	177914.3846	165206.2143	154192.4667	144555.4375	128493.7222	121730.8947	115644.35	96370.29167	92515.48	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116108	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	128380	64190	42793.33333	32095	25676	21396.66667	18340	16047.5	14264.44444	12838	11670.90909	10698.33333	9875.384615	9170	8558.666667	8023.75	7132.222222	6756.842105	6419	5349.166667	5135.2	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116109	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116110	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116111	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116112	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116113	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	267045	133522.5	89015	66761.25	53409	44507.5	38149.28571	33380.625	29671.66667	26704.5	24276.81818	22253.75	20541.92308	19074.64286	17803	16690.3125	14835.83333	14055	13352.25	11126.875	10681.8	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116114	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	378385	189192.5	126128.3333	94596.25	75677	63064.16667	54055	47298.125	42042.77778	37838.5	34398.63636	31532.08333	29106.53846	27027.5	25225.66667	23649.0625	21021.38889	19915	18919.25	15766.04167	15135.4	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116115	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	245620	122810	81873.33333	61405	49124	40936.66667	35088.57143	30702.5	27291.11111	24562	22329.09091	20468.33333	18893.84615	17544.28571	16374.66667	15351.25	13645.55556	12927.36842	12281	10234.16667	9824.8	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116116	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	56182	28091	18727.33333	14045.5	11236.4	9363.666667	8026	7022.75	6242.444444	5618.2	5107.454545	4681.833333	4321.692308	4013	3745.466667	3511.375	3121.222222	2956.947368	2809.1	2340.916667	2247.28	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116117	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116118	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116119	CHOYP_LOC100114171.1.1|m.50280	VEIAGGMGPGGGNKPR	VEIAGGMGPGGGNKPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116120	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	840827	420413.5	280275.6667	210206.75	168165.4	140137.8333	120118.1429	105103.375	93425.22222	84082.7	76438.81818	70068.91667	64679	60059.07143	56055.13333	52551.6875	46712.61111	44254.05263	42041.35	35034.45833	33633.08	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116121	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	480604	240302	160201.3333	120151	96120.8	80100.66667	68657.71429	60075.5	53400.44444	48060.4	43691.27273	40050.33333	36969.53846	34328.85714	32040.26667	30037.75	26700.22222	25294.94737	24030.2	20025.16667	19224.16	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116122	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	356968	178484	118989.3333	89242	71393.6	59494.66667	50995.42857	44621	39663.11111	35696.8	32451.63636	29747.33333	27459.07692	25497.71429	23797.86667	22310.5	19831.55556	18787.78947	17848.4	14873.66667	14278.72	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116123	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	19788	9894	6596	4947	3957.6	3298	2826.857143	2473.5	2198.666667	1978.8	1798.909091	1649	1522.153846	1413.428571	1319.2	1236.75	1099.333333	1041.473684	989.4	824.5	791.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116124	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	71101	35550.5	23700.33333	17775.25	14220.2	11850.16667	10157.28571	8887.625	7900.111111	7110.1	6463.727273	5925.083333	5469.307692	5078.642857	4740.066667	4443.8125	3950.055556	3742.157895	3555.05	2962.541667	2844.04	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116125	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116126	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	105284	52642	35094.66667	26321	21056.8	17547.33333	15040.57143	13160.5	11698.22222	10528.4	9571.272727	8773.666667	8098.769231	7520.285714	7018.933333	6580.25	5849.111111	5541.263158	5264.2	4386.833333	4211.36	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116127	CHOYP_LOC100114171.1.1|m.50280	INNQNQGMNR	INNQNQGMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116128	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	21035036	10517518	7011678.667	5258759	4207007.2	3505839.333	3005005.143	2629379.5	2337226.222	2103503.6	1912276	1752919.667	1618079.692	1502502.571	1402335.733	1314689.75	1168613.111	1107107.158	1051751.8	876459.8333	841401.44	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116129	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	16353973	8176986.5	5451324.333	4088493.25	3270794.6	2725662.167	2336281.857	2044246.625	1817108.111	1635397.3	1486724.818	1362831.083	1257997.923	1168140.929	1090264.867	1022123.313	908554.0556	860735.4211	817698.65	681415.5417	654158.92	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116130	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	6410530	3205265	2136843.333	1602632.5	1282106	1068421.667	915790	801316.25	712281.1111	641053	582775.4545	534210.8333	493117.6923	457895	427368.6667	400658.125	356140.5556	337396.3158	320526.5	267105.4167	256421.2	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116131	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	3168147	1584073.5	1056049	792036.75	633629.4	528024.5	452592.4286	396018.375	352016.3333	316814.7	288013.3636	264012.25	243703.6154	226296.2143	211209.8	198009.1875	176008.1667	166744.5789	158407.35	132006.125	126725.88	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116132	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	583821	291910.5	194607	145955.25	116764.2	97303.5	83403	72977.625	64869	58382.1	53074.63636	48651.75	44909.30769	41701.5	38921.4	36488.8125	32434.5	30727.42105	29191.05	24325.875	23352.84	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116133	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	354060	177030	118020	88515	70812	59010	50580	44257.5	39340	35406	32187.27273	29505	27235.38462	25290	23604	22128.75	19670	18634.73684	17703	14752.5	14162.4	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116134	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	967368	483684	322456	241842	193473.6	161228	138195.4286	120921	107485.3333	96736.8	87942.54545	80614	74412.92308	69097.71429	64491.2	60460.5	53742.66667	50914.10526	48368.4	40307	38694.72	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116135	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	892354	446177	297451.3333	223088.5	178470.8	148725.6667	127479.1429	111544.25	99150.44444	89235.4	81123.09091	74362.83333	68642.61538	63739.57143	59490.26667	55772.125	49575.22222	46966	44617.7	37181.41667	35694.16	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116136	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	1786095	893047.5	595365	446523.75	357219	297682.5	255156.4286	223261.875	198455	178609.5	162372.2727	148841.25	137391.9231	127578.2143	119073	111630.9375	99227.5	94005	89304.75	74420.625	71443.8	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116137	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	113592	56796	37864	28398	22718.4	18932	16227.42857	14199	12621.33333	11359.2	10326.54545	9466	8737.846154	8113.714286	7572.8	7099.5	6310.666667	5978.526316	5679.6	4733	4543.68	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116138	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	640300	320150	213433.3333	160075	128060	106716.6667	91471.42857	80037.5	71144.44444	64030	58209.09091	53358.33333	49253.84615	45735.71429	42686.66667	40018.75	35572.22222	33700	32015	26679.16667	25612	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116139	CHOYP_LOC100114171.1.1|m.50280	ILVGSEYVGAIIGK	ILVGSEYVGAIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116140	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	2618805	1309402.5	872935	654701.25	523761	436467.5	374115	327350.625	290978.3333	261880.5	238073.1818	218233.75	201446.5385	187057.5	174587	163675.3125	145489.1667	137831.8421	130940.25	109116.875	104752.2	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116141	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	1242170	621085	414056.6667	310542.5	248434	207028.3333	177452.8571	155271.25	138018.8889	124217	112924.5455	103514.1667	95551.53846	88726.42857	82811.33333	77635.625	69009.44444	65377.36842	62108.5	51757.08333	49686.8	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116142	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	667947	333973.5	222649	166986.75	133589.4	111324.5	95421	83493.375	74216.33333	66794.7	60722.45455	55662.25	51380.53846	47710.5	44529.8	41746.6875	37108.16667	35155.10526	33397.35	27831.125	26717.88	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116143	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	61958	30979	20652.66667	15489.5	12391.6	10326.33333	8851.142857	7744.75	6884.222222	6195.8	5632.545455	5163.166667	4766	4425.571429	4130.533333	3872.375	3442.111111	3260.947368	3097.9	2581.583333	2478.32	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116144	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	27839	13919.5	9279.666667	6959.75	5567.8	4639.833333	3977	3479.875	3093.222222	2783.9	2530.818182	2319.916667	2141.461538	1988.5	1855.933333	1739.9375	1546.611111	1465.210526	1391.95	1159.958333	1113.56	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116145	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	715890	357945	238630	178972.5	143178	119315	102270	89486.25	79543.33333	71589	65080.90909	59657.5	55068.46154	51135	47726	44743.125	39771.66667	37678.42105	35794.5	29828.75	28635.6	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116146	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	388552	194276	129517.3333	97138	77710.4	64758.66667	55507.42857	48569	43172.44444	38855.2	35322.90909	32379.33333	29888.61538	27753.71429	25903.46667	24284.5	21586.22222	20450.10526	19427.6	16189.66667	15542.08	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116147	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	60796	30398	20265.33333	15199	12159.2	10132.66667	8685.142857	7599.5	6755.111111	6079.6	5526.909091	5066.333333	4676.615385	4342.571429	4053.066667	3799.75	3377.555556	3199.789474	3039.8	2533.166667	2431.84	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116148	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	95182	47591	31727.33333	23795.5	19036.4	15863.66667	13597.42857	11897.75	10575.77778	9518.2	8652.909091	7931.833333	7321.692308	6798.714286	6345.466667	5948.875	5287.888889	5009.578947	4759.1	3965.916667	3807.28	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116149	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116150	CHOYP_LOC100114171.1.1|m.50280	QGQTIHNITSESR	QGQTIHNITSESR	33941	16970.5	11313.66667	8485.25	6788.2	5656.833333	4848.714286	4242.625	3771.222222	3394.1	3085.545455	2828.416667	2610.846154	2424.357143	2262.733333	2121.3125	1885.611111	1786.368421	1697.05	1414.208333	1357.64	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116151	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116152	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116153	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	204591	102295.5	68197	51147.75	40918.2	34098.5	29227.28571	25573.875	22732.33333	20459.1	18599.18182	17049.25	15737.76923	14613.64286	13639.4	12786.9375	11366.16667	10767.94737	10229.55	8524.625	8183.64	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116154	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	1086114	543057	362038	271528.5	217222.8	181019	155159.1429	135764.25	120679.3333	108611.4	98737.63636	90509.5	83547.23077	77579.57143	72407.6	67882.125	60339.66667	57163.89474	54305.7	45254.75	43444.56	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116155	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	211038	105519	70346	52759.5	42207.6	35173	30148.28571	26379.75	23448.66667	21103.8	19185.27273	17586.5	16233.69231	15074.14286	14069.2	13189.875	11724.33333	11107.26316	10551.9	8793.25	8441.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116156	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116157	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116158	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116159	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	97094	48547	32364.66667	24273.5	19418.8	16182.33333	13870.57143	12136.75	10788.22222	9709.4	8826.727273	8091.166667	7468.769231	6935.285714	6472.933333	6068.375	5394.111111	5110.210526	4854.7	4045.583333	3883.76	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116160	CHOYP_LOC100114171.1.1|m.50280	DGLSTDTLVTIK	DGLSTDTLVTIK	400816	200408	133605.3333	100204	80163.2	66802.66667	57259.42857	50102	44535.11111	40081.6	36437.81818	33401.33333	30832	28629.71429	26721.06667	25051	22267.55556	21095.57895	20040.8	16700.66667	16032.64	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116161	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116162	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116163	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116164	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	588294	294147	196098	147073.5	117658.8	98049	84042	73536.75	65366	58829.4	53481.27273	49024.5	45253.38462	42021	39219.6	36768.375	32683	30962.84211	29414.7	24512.25	23531.76	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116165	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	197762	98881	65920.66667	49440.5	39552.4	32960.33333	28251.71429	24720.25	21973.55556	19776.2	17978.36364	16480.16667	15212.46154	14125.85714	13184.13333	12360.125	10986.77778	10408.52632	9888.1	8240.083333	7910.48	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116166	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	30302	15151	10100.66667	7575.5	6060.4	5050.333333	4328.857143	3787.75	3366.888889	3030.2	2754.727273	2525.166667	2330.923077	2164.428571	2020.133333	1893.875	1683.444444	1594.842105	1515.1	1262.583333	1212.08	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116167	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116168	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	242375	121187.5	80791.66667	60593.75	48475	40395.83333	34625	30296.875	26930.55556	24237.5	22034.09091	20197.91667	18644.23077	17312.5	16158.33333	15148.4375	13465.27778	12756.57895	12118.75	10098.95833	9695	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116169	CHOYP_LOC100114171.1.1|m.50280	IVESEAQSLNK	IVESEAQSLNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116170	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116171	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116172	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116173	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116174	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116175	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116176	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116177	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	63091	31545.5	21030.33333	15772.75	12618.2	10515.16667	9013	7886.375	7010.111111	6309.1	5735.545455	5257.583333	4853.153846	4506.5	4206.066667	3943.1875	3505.055556	3320.578947	3154.55	2628.791667	2523.64	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116178	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116179	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116180	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	188580	94290	62860	47145	37716	31430	26940	23572.5	20953.33333	18858	17143.63636	15715	14506.15385	13470	12572	11786.25	10476.66667	9925.263158	9429	7857.5	7543.2	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116181	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	124457	62228.5	41485.66667	31114.25	24891.4	20742.83333	17779.57143	15557.125	13828.55556	12445.7	11314.27273	10371.41667	9573.615385	8889.785714	8297.133333	7778.5625	6914.277778	6550.368421	6222.85	5185.708333	4978.28	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116182	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	152838	76419	50946	38209.5	30567.6	25473	21834	19104.75	16982	15283.8	13894.36364	12736.5	11756.76923	10917	10189.2	9552.375	8491	8044.105263	7641.9	6368.25	6113.52	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116183	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	271040	135520	90346.66667	67760	54208	45173.33333	38720	33880	30115.55556	27104	24640	22586.66667	20849.23077	19360	18069.33333	16940	15057.77778	14265.26316	13552	11293.33333	10841.6	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116184	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116185	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116186	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	75028	37514	25009.33333	18757	15005.6	12504.66667	10718.28571	9378.5	8336.444444	7502.8	6820.727273	6252.333333	5771.384615	5359.142857	5001.866667	4689.25	4168.222222	3948.842105	3751.4	3126.166667	3001.12	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116187	CHOYP_LOC100114171.1.1|m.50280	SFMEQTGTHIVVSSATDMNNFFVDR	SFMEQTGTHIVVSSATDMNNFFVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116188	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	13993869	6996934.5	4664623	3498467.25	2798773.8	2332311.5	1999124.143	1749233.625	1554874.333	1399386.9	1272169.909	1166155.75	1076451.462	999562.0714	932924.6	874616.8125	777437.1667	736519.4211	699693.45	583077.875	559754.76	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116189	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	11630424	5815212	3876808	2907606	2326084.8	1938404	1661489.143	1453803	1292269.333	1163042.4	1057311.273	969202	894648	830744.5714	775361.6	726901.5	646134.6667	612127.5789	581521.2	484601	465216.96	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116190	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	3673733	1836866.5	1224577.667	918433.25	734746.6	612288.8333	524819	459216.625	408192.5556	367373.3	333975.7273	306144.4167	282594.8462	262409.5	244915.5333	229608.3125	204096.2778	193354.3684	183686.65	153072.2083	146949.32	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116191	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	648211	324105.5	216070.3333	162052.75	129642.2	108035.1667	92601.57143	81026.375	72023.44444	64821.1	58928.27273	54017.58333	49862.38462	46300.78571	43214.06667	40513.1875	36011.72222	34116.36842	32410.55	27008.79167	25928.44	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116192	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	3564358	1782179	1188119.333	891089.5	712871.6	594059.6667	509194	445544.75	396039.7778	356435.8	324032.5455	297029.8333	274181.3846	254597	237623.8667	222772.375	198019.8889	187597.7895	178217.9	148514.9167	142574.32	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116193	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	1963533	981766.5	654511	490883.25	392706.6	327255.5	280504.7143	245441.625	218170.3333	196353.3	178503	163627.75	151041	140252.3571	130902.2	122720.8125	109085.1667	103343.8421	98176.65	81813.875	78541.32	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116194	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	356464	178232	118821.3333	89116	71292.8	59410.66667	50923.42857	44558	39607.11111	35646.4	32405.81818	29705.33333	27420.30769	25461.71429	23764.26667	22279	19803.55556	18761.26316	17823.2	14852.66667	14258.56	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116195	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	881545	440772.5	293848.3333	220386.25	176309	146924.1667	125935	110193.125	97949.44444	88154.5	80140.45455	73462.08333	67811.15385	62967.5	58769.66667	55096.5625	48974.72222	46397.10526	44077.25	36731.04167	35261.8	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116196	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116197	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	257422	128711	85807.33333	64355.5	51484.4	42903.66667	36774.57143	32177.75	28602.44444	25742.2	23402	21451.83333	19801.69231	18387.28571	17161.46667	16088.875	14301.22222	13548.52632	12871.1	10725.91667	10296.88	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116198	CHOYP_LOC100114171.1.1|m.50280	VITITGSPENTSK	VITITGSPENTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116199	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116200	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116201	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116202	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116203	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	139865	69932.5	46621.66667	34966.25	27973	23310.83333	19980.71429	17483.125	15540.55556	13986.5	12715	11655.41667	10758.84615	9990.357143	9324.333333	8741.5625	7770.277778	7361.315789	6993.25	5827.708333	5594.6	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116204	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116205	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116206	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116207	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	10332	5166	3444	2583	2066.4	1722	1476	1291.5	1148	1033.2	939.2727273	861	794.7692308	738	688.8	645.75	574	543.7894737	516.6	430.5	413.28	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116208	CHOYP_LOC100114171.1.1|m.50280	VIITGTAEAQWK	VIITGTAEAQWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116209	CHOYP_LOC100114171.1.1|m.50280	AQFYVFDK	AQFYVFDK	8216903	4108451.5	2738967.667	2054225.75	1643380.6	1369483.833	1173843.286	1027112.875	912989.2222	821690.3	746991.1818	684741.9167	632069.4615	586921.6429	547793.5333	513556.4375	456494.6111	432468.5789	410845.15	342370.9583	328676.12	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116210	CHOYP_LOC100114171.1.1|m.50280	AQFYVFDK	AQFYVFDK	4561349	2280674.5	1520449.667	1140337.25	912269.8	760224.8333	651621.2857	570168.625	506816.5556	456134.9	414668.0909	380112.4167	350873	325810.6429	304089.9333	285084.3125	253408.2778	240071	228067.45	190056.2083	182453.96	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116211	CHOYP_LOC100114171.1.1|m.50280	AQFYVFDK	AQFYVFDK	1782752	891376	594250.6667	445688	356550.4	297125.3333	254678.8571	222844	198083.5556	178275.2	162068.3636	148562.6667	137134.7692	127339.4286	118850.1333	111422	99041.77778	93829.05263	89137.6	74281.33333	71310.08	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116212	CHOYP_LOC100114171.1.1|m.50280	AQFYVFDK	AQFYVFDK	289406	144703	96468.66667	72351.5	57881.2	48234.33333	41343.71429	36175.75	32156.22222	28940.6	26309.63636	24117.16667	22262	20671.85714	19293.73333	18087.875	16078.11111	15231.89474	14470.3	12058.58333	11576.24	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116213	CHOYP_LOC100114171.1.1|m.50280	AQFYVFDK	AQFYVFDK	776057	388028.5	258685.6667	194014.25	155211.4	129342.8333	110865.2857	97007.125	86228.55556	77605.7	70550.63636	64671.41667	59696.69231	55432.64286	51737.13333	48503.5625	43114.27778	40845.10526	38802.85	32335.70833	31042.28	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116214	CHOYP_LOC100114171.1.1|m.50280	AQFYVFDK	AQFYVFDK	1077745	538872.5	359248.3333	269436.25	215549	179624.1667	153963.5714	134718.125	119749.4444	107774.5	97976.81818	89812.08333	82903.46154	76981.78571	71849.66667	67359.0625	59874.72222	56723.42105	53887.25	44906.04167	43109.8	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116215	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116216	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	2928687	1464343.5	976229	732171.75	585737.4	488114.5	418383.8571	366085.875	325409.6667	292868.7	266244.2727	244057.25	225283.6154	209191.9286	195245.8	183042.9375	162704.8333	154141.4211	146434.35	122028.625	117147.48	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116217	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	1518939	759469.5	506313	379734.75	303787.8	253156.5	216991.2857	189867.375	168771	151893.9	138085.3636	126578.25	116841.4615	108495.6429	101262.6	94933.6875	84385.5	79944.15789	75946.95	63289.125	60757.56	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116218	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116219	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116220	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116221	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116222	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116223	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116224	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116225	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116226	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116227	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116228	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	113618	56809	37872.66667	28404.5	22723.6	18936.33333	16231.14286	14202.25	12624.22222	11361.8	10328.90909	9468.166667	8739.846154	8115.571429	7574.533333	7101.125	6312.111111	5979.894737	5680.9	4734.083333	4544.72	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116229	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116230	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
116231	CHOYP_LOC100114171.1.1|m.50280	SLVNPRPQQGPVLMPGQQR	SLVNPRPQQGPVLMPGQQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O42254	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150
117253	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117254	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117255	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	1055768	527884	351922.6667	263942	211153.6	175961.3333	150824	131971	117307.5556	105576.8	95978.90909	87980.66667	81212.92308	75412	70384.53333	65985.5	58653.77778	55566.73684	52788.4	43990.33333	42230.72	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117256	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	175523	87761.5	58507.66667	43880.75	35104.6	29253.83333	25074.71429	21940.375	19502.55556	17552.3	15956.63636	14626.91667	13501.76923	12537.35714	11701.53333	10970.1875	9751.277778	9238.052632	8776.15	7313.458333	7020.92	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117257	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	1197340	598670	399113.3333	299335	239468	199556.6667	171048.5714	149667.5	133037.7778	119734	108849.0909	99778.33333	92103.07692	85524.28571	79822.66667	74833.75	66518.88889	63017.89474	59867	49889.16667	47893.6	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117258	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	304089	152044.5	101363	76022.25	60817.8	50681.5	43441.28571	38011.125	33787.66667	30408.9	27644.45455	25340.75	23391.46154	21720.64286	20272.6	19005.5625	16893.83333	16004.68421	15204.45	12670.375	12163.56	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117259	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117260	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	28985	14492.5	9661.666667	7246.25	5797	4830.833333	4140.714286	3623.125	3220.555556	2898.5	2635	2415.416667	2229.615385	2070.357143	1932.333333	1811.5625	1610.277778	1525.526316	1449.25	1207.708333	1159.4	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117261	CHOYP_LOC100114636.1.1|m.11052	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117262	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117263	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117264	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117265	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117266	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117267	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117268	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117269	CHOYP_LOC100114636.1.1|m.11052	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117270	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117271	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	1184895	592447.5	394965	296223.75	236979	197482.5	169270.7143	148111.875	131655	118489.5	107717.7273	98741.25	91145.76923	84635.35714	78993	74055.9375	65827.5	62362.89474	59244.75	49370.625	47395.8	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117272	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117273	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117274	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	34037	17018.5	11345.66667	8509.25	6807.4	5672.833333	4862.428571	4254.625	3781.888889	3403.7	3094.272727	2836.416667	2618.230769	2431.214286	2269.133333	2127.3125	1890.944444	1791.421053	1701.85	1418.208333	1361.48	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117275	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117276	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117277	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	145382	72691	48460.66667	36345.5	29076.4	24230.33333	20768.85714	18172.75	16153.55556	14538.2	13216.54545	12115.16667	11183.23077	10384.42857	9692.133333	9086.375	8076.777778	7651.684211	7269.1	6057.583333	5815.28	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117278	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117279	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117280	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	18214	9107	6071.333333	4553.5	3642.8	3035.666667	2602	2276.75	2023.777778	1821.4	1655.818182	1517.833333	1401.076923	1301	1214.266667	1138.375	1011.888889	958.6315789	910.7	758.9166667	728.56	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117281	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117282	CHOYP_LOC100114636.1.1|m.11052	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117283	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	7734938	3867469	2578312.667	1933734.5	1546987.6	1289156.333	1104991.143	966867.25	859437.5556	773493.8	703176.1818	644578.1667	594995.2308	552495.5714	515662.5333	483433.625	429718.7778	407102	386746.9	322289.0833	309397.52	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117284	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	4301321	2150660.5	1433773.667	1075330.25	860264.2	716886.8333	614474.4286	537665.125	477924.5556	430132.1	391029.1818	358443.4167	330870.8462	307237.2143	286754.7333	268832.5625	238962.2778	226385.3158	215066.05	179221.7083	172052.84	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117285	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	1250681	625340.5	416893.6667	312670.25	250136.2	208446.8333	178668.7143	156335.125	138964.5556	125068.1	113698.2727	104223.4167	96206.23077	89334.35714	83378.73333	78167.5625	69482.27778	65825.31579	62534.05	52111.70833	50027.24	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117286	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	341066	170533	113688.6667	85266.5	68213.2	56844.33333	48723.71429	42633.25	37896.22222	34106.6	31006	28422.16667	26235.84615	24361.85714	22737.73333	21316.625	18948.11111	17950.84211	17053.3	14211.08333	13642.64	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117287	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	201368	100684	67122.66667	50342	40273.6	33561.33333	28766.85714	25171	22374.22222	20136.8	18306.18182	16780.66667	15489.84615	14383.42857	13424.53333	12585.5	11187.11111	10598.31579	10068.4	8390.333333	8054.72	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117288	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	128977	64488.5	42992.33333	32244.25	25795.4	21496.16667	18425.28571	16122.125	14330.77778	12897.7	11725.18182	10748.08333	9921.307692	9212.642857	8598.466667	8061.0625	7165.388889	6788.263158	6448.85	5374.041667	5159.08	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117289	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	65923	32961.5	21974.33333	16480.75	13184.6	10987.16667	9417.571429	8240.375	7324.777778	6592.3	5993	5493.583333	5071	4708.785714	4394.866667	4120.1875	3662.388889	3469.631579	3296.15	2746.791667	2636.92	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117290	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117291	CHOYP_LOC100114636.1.1|m.11052	GHMDLASMINK	GHMDLASMINK	216589	108294.5	72196.33333	54147.25	43317.8	36098.16667	30941.28571	27073.625	24065.44444	21658.9	19689.90909	18049.08333	16660.69231	15470.64286	14439.26667	13536.8125	12032.72222	11399.42105	10829.45	9024.541667	8663.56	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117292	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	5976879	2988439.5	1992293	1494219.75	1195375.8	996146.5	853839.8571	747109.875	664097.6667	597687.9	543352.6364	498073.25	459759.9231	426919.9286	398458.6	373554.9375	332048.8333	314572.5789	298843.95	249036.625	239075.16	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117293	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	3171413	1585706.5	1057137.667	792853.25	634282.6	528568.8333	453059	396426.625	352379.2222	317141.3	288310.2727	264284.4167	243954.8462	226529.5	211427.5333	198213.3125	176189.6111	166916.4737	158570.65	132142.2083	126856.52	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117294	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	1104538	552269	368179.3333	276134.5	220907.6	184089.6667	157791.1429	138067.25	122726.4444	110453.8	100412.5455	92044.83333	84964.46154	78895.57143	73635.86667	69033.625	61363.22222	58133.57895	55226.9	46022.41667	44181.52	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117295	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	1225882	612941	408627.3333	306470.5	245176.4	204313.6667	175126	153235.25	136209.1111	122588.2	111443.8182	102156.8333	94298.61538	87563	81725.46667	76617.625	68104.55556	64520.10526	61294.1	51078.41667	49035.28	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117296	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	163783	81891.5	54594.33333	40945.75	32756.6	27297.16667	23397.57143	20472.875	18198.11111	16378.3	14889.36364	13648.58333	12598.69231	11698.78571	10918.86667	10236.4375	9099.055556	8620.157895	8189.15	6824.291667	6551.32	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117297	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	78776	39388	26258.66667	19694	15755.2	13129.33333	11253.71429	9847	8752.888889	7877.6	7161.454545	6564.666667	6059.692308	5626.857143	5251.733333	4923.5	4376.444444	4146.105263	3938.8	3282.333333	3151.04	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117298	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
117299	CHOYP_LOC100114636.1.1|m.11052	LYAPEENGPK	LYAPEENGPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
118120	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118121	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118122	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118123	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118124	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118125	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118126	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118127	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118128	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118129	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118130	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118131	CHOYP_LOC100121999.1.4|m.23944	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118132	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118133	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118134	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118135	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118136	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118137	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118138	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118139	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118140	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118141	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118142	CHOYP_LOC100121999.1.4|m.23944	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118143	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118144	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118145	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118146	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118147	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118148	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118149	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118150	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118151	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118152	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118153	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118154	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118155	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118156	CHOYP_LOC100121999.1.4|m.23944	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118157	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118158	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118159	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118160	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118161	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118162	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118163	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118164	CHOYP_LOC100121999.1.4|m.23944	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
118165	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118166	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118167	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118168	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118169	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118170	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118171	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118172	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118173	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118174	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118175	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118176	CHOYP_LOC100121999.2.4|m.44520	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118177	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118178	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118179	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118180	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118181	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118182	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118183	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118184	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118185	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118186	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118187	CHOYP_LOC100121999.2.4|m.44520	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118188	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118189	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118190	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118191	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118192	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118193	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118194	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118195	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118196	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118197	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118198	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118199	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118200	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118201	CHOYP_LOC100121999.2.4|m.44520	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118202	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118203	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118204	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118205	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118206	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118207	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118208	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118209	CHOYP_LOC100121999.2.4|m.44520	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118210	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118211	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118212	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118213	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118214	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118215	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118216	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118217	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118218	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118219	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118220	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118221	CHOYP_LOC100121999.4.4|m.63100	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118222	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118223	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118224	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118225	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118226	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118227	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118228	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118229	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118230	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118231	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118232	CHOYP_LOC100121999.4.4|m.63100	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118233	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118234	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118235	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118236	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118237	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118238	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118239	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118240	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118241	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118242	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118243	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118244	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118245	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118246	CHOYP_LOC100121999.4.4|m.63100	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118247	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118248	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118249	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118250	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118251	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118252	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118253	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
118254	CHOYP_LOC100121999.4.4|m.63100	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119167	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119168	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119169	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119170	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119171	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119172	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119173	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119174	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119175	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119176	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119177	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119178	CHOYP_LOC100160839.1.1|m.53063	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119179	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119180	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119181	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119182	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119183	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119184	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119185	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119186	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119187	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119188	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119189	CHOYP_LOC100160839.1.1|m.53063	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119190	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119191	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119192	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119193	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119194	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119195	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119196	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119197	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119198	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119199	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119200	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119201	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119202	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119203	CHOYP_LOC100160839.1.1|m.53063	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119204	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119205	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119206	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119207	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119208	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119209	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119210	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
119211	CHOYP_LOC100160839.1.1|m.53063	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O00506	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	GO:0000139; GO:0004672; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
120254	CHOYP_LOC100169460.1.1|m.41302	ITLDTVFR	ITLDTVFR	3204084	1602042	1068028	801021	640816.8	534014	457726.2857	400510.5	356009.3333	320408.4	291280.3636	267007	246468	228863.1429	213605.6	200255.25	178004.6667	168636	160204.2	133503.5	128163.36	Q9UJZ1	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046
120255	CHOYP_LOC100169460.1.1|m.41302	ITLDTVFR	ITLDTVFR	1186230	593115	395410	296557.5	237246	197705	169461.4286	148278.75	131803.3333	118623	107839.0909	98852.5	91248.46154	84730.71429	79082	74139.375	65901.66667	62433.15789	59311.5	49426.25	47449.2	Q9UJZ1	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046
120256	CHOYP_LOC100169460.1.1|m.41302	ITLDTVFR	ITLDTVFR	207819	103909.5	69273	51954.75	41563.8	34636.5	29688.42857	25977.375	23091	20781.9	18892.63636	17318.25	15986.07692	14844.21429	13854.6	12988.6875	11545.5	10937.84211	10390.95	8659.125	8312.76	Q9UJZ1	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046
120257	CHOYP_LOC100169460.1.1|m.41302	ITLDTVFR	ITLDTVFR	717718	358859	239239.3333	179429.5	143543.6	119619.6667	102531.1429	89714.75	79746.44444	71771.8	65247.09091	59809.83333	55209.07692	51265.57143	47847.86667	44857.375	39873.22222	37774.63158	35885.9	29904.91667	28708.72	Q9UJZ1	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046
120258	CHOYP_LOC100169460.1.1|m.41302	ITLDTVFR	ITLDTVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UJZ1	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046
120259	CHOYP_LOC100169460.1.1|m.41302	ITLDTVFR	ITLDTVFR	165440	82720	55146.66667	41360	33088	27573.33333	23634.28571	20680	18382.22222	16544	15040	13786.66667	12726.15385	11817.14286	11029.33333	10340	9191.111111	8707.368421	8272	6893.333333	6617.6	Q9UJZ1	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046
120260	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120261	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120262	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120263	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	187951	93975.5	62650.33333	46987.75	37590.2	31325.16667	26850.14286	23493.875	20883.44444	18795.1	17086.45455	15662.58333	14457.76923	13425.07143	12530.06667	11746.9375	10441.72222	9892.157895	9397.55	7831.291667	7518.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120264	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120265	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	412539	206269.5	137513	103134.75	82507.8	68756.5	58934.14286	51567.375	45837.66667	41253.9	37503.54545	34378.25	31733.76923	29467.07143	27502.6	25783.6875	22918.83333	21712.57895	20626.95	17189.125	16501.56	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120266	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	458015	229007.5	152671.6667	114503.75	91603	76335.83333	65430.71429	57251.875	50890.55556	45801.5	41637.72727	38167.91667	35231.92308	32715.35714	30534.33333	28625.9375	25445.27778	24106.05263	22900.75	19083.95833	18320.6	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120267	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	24603	12301.5	8201	6150.75	4920.6	4100.5	3514.714286	3075.375	2733.666667	2460.3	2236.636364	2050.25	1892.538462	1757.357143	1640.2	1537.6875	1366.833333	1294.894737	1230.15	1025.125	984.12	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120268	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120269	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120270	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120271	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120272	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120273	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120274	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120275	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120276	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120277	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120278	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	10756	5378	3585.333333	2689	2151.2	1792.666667	1536.571429	1344.5	1195.111111	1075.6	977.8181818	896.3333333	827.3846154	768.2857143	717.0666667	672.25	597.5555556	566.1052632	537.8	448.1666667	430.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120279	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120280	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120281	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120282	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120283	CHOYP_LOC100174996.1.1|m.27300	VILLHVMENLINVK	VILLHVMENLINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120284	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	23902686	11951343	7967562	5975671.5	4780537.2	3983781	3414669.429	2987835.75	2655854	2390268.6	2172971.455	1991890.5	1838668.154	1707334.714	1593512.4	1493917.875	1327927	1258036.105	1195134.3	995945.25	956107.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120285	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	19269974	9634987	6423324.667	4817493.5	3853994.8	3211662.333	2752853.429	2408746.75	2141108.222	1926997.4	1751815.818	1605831.167	1482305.692	1376426.714	1284664.933	1204373.375	1070554.111	1014209.158	963498.7	802915.5833	770798.96	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120286	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	8040795	4020397.5	2680265	2010198.75	1608159	1340132.5	1148685	1005099.375	893421.6667	804079.5	730981.3636	670066.25	618522.6923	574342.5	536053	502549.6875	446710.8333	423199.7368	402039.75	335033.125	321631.8	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120287	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	716584	358292	238861.3333	179146	143316.8	119430.6667	102369.1429	89573	79620.44444	71658.4	65144	59715.33333	55121.84615	51184.57143	47772.26667	44786.5	39810.22222	37714.94737	35829.2	29857.66667	28663.36	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120288	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	7311684	3655842	2437228	1827921	1462336.8	1218614	1044526.286	913960.5	812409.3333	731168.4	664698.5455	609307	562437.2308	522263.1429	487445.6	456980.25	406204.6667	384825.4737	365584.2	304653.5	292467.36	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120289	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	7556731	3778365.5	2518910.333	1889182.75	1511346.2	1259455.167	1079533	944591.375	839636.7778	755673.1	686975.5455	629727.5833	581287	539766.5	503782.0667	472295.6875	419818.3889	397722.6842	377836.55	314863.7917	302269.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120290	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	6595952	3297976	2198650.667	1648988	1319190.4	1099325.333	942278.8571	824494	732883.5556	659595.2	599632	549662.6667	507380.9231	471139.4286	439730.1333	412247	366441.7778	347155.3684	329797.6	274831.3333	263838.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120291	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	3070444	1535222	1023481.333	767611	614088.8	511740.6667	438634.8571	383805.5	341160.4444	307044.4	279131.2727	255870.3333	236188	219317.4286	204696.2667	191902.75	170580.2222	161602.3158	153522.2	127935.1667	122817.76	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120292	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	2215357	1107678.5	738452.3333	553839.25	443071.4	369226.1667	316479.5714	276919.625	246150.7778	221535.7	201396.0909	184613.0833	170412.0769	158239.7857	147690.4667	138459.8125	123075.3889	116597.7368	110767.85	92306.54167	88614.28	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120293	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	373488	186744	124496	93372	74697.6	62248	53355.42857	46686	41498.66667	37348.8	33953.45455	31124	28729.84615	26677.71429	24899.2	23343	20749.33333	19657.26316	18674.4	15562	14939.52	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120294	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	1003825	501912.5	334608.3333	250956.25	200765	167304.1667	143403.5714	125478.125	111536.1111	100382.5	91256.81818	83652.08333	77217.30769	71701.78571	66921.66667	62739.0625	55768.05556	52832.89474	50191.25	41826.04167	40153	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120295	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	444898	222449	148299.3333	111224.5	88979.6	74149.66667	63556.85714	55612.25	49433.11111	44489.8	40445.27273	37074.83333	34222.92308	31778.42857	29659.86667	27806.125	24716.55556	23415.68421	22244.9	18537.41667	17795.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120296	CHOYP_LOC100174996.1.1|m.27300	FSALAASSGIQAEVR	FSALAASSGIQAEVR	125395	62697.5	41798.33333	31348.75	25079	20899.16667	17913.57143	15674.375	13932.77778	12539.5	11399.54545	10449.58333	9645.769231	8956.785714	8359.666667	7837.1875	6966.388889	6599.736842	6269.75	5224.791667	5015.8	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120297	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120298	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120299	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120300	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	431770	215885	143923.3333	107942.5	86354	71961.66667	61681.42857	53971.25	47974.44444	43177	39251.81818	35980.83333	33213.07692	30840.71429	28784.66667	26985.625	23987.22222	22724.73684	21588.5	17990.41667	17270.8	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120301	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120302	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120303	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	122327	61163.5	40775.66667	30581.75	24465.4	20387.83333	17475.28571	15290.875	13591.88889	12232.7	11120.63636	10193.91667	9409.769231	8737.642857	8155.133333	7645.4375	6795.944444	6438.263158	6116.35	5096.958333	4893.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120304	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120305	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	9134	4567	3044.666667	2283.5	1826.8	1522.333333	1304.857143	1141.75	1014.888889	913.4	830.3636364	761.1666667	702.6153846	652.4285714	608.9333333	570.875	507.4444444	480.7368421	456.7	380.5833333	365.36	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120306	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120307	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	126281	63140.5	42093.66667	31570.25	25256.2	21046.83333	18040.14286	15785.125	14031.22222	12628.1	11480.09091	10523.41667	9713.923077	9020.071429	8418.733333	7892.5625	7015.611111	6646.368421	6314.05	5261.708333	5051.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120308	CHOYP_LOC100174996.1.1|m.27300	AEKPSHGIVDIANK	AEKPSHGIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120790	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	204637456	102318728	68212485.33	51159364	40927491.2	34106242.67	29233922.29	25579682	22737495.11	20463745.6	18603405.09	17053121.33	15741342.77	14616961.14	13642497.07	12789841	11368747.56	10770392.42	10231872.8	8526560.667	8185498.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120791	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	143806432	71903216	47935477.33	35951608	28761286.4	23967738.67	20543776	17975804	15978492.44	14380643.2	13073312	11983869.33	11062033.23	10271888	9587095.467	8987902	7989246.222	7568759.579	7190321.6	5991934.667	5752257.28	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120792	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	56987864	28493932	18995954.67	14246966	11397572.8	9497977.333	8141123.429	7123483	6331984.889	5698786.4	5180714.909	4748988.667	4383681.846	4070561.714	3799190.933	3561741.5	3165992.444	2999361.263	2849393.2	2374494.333	2279514.56	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120793	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	14613856	7306928	4871285.333	3653464	2922771.2	2435642.667	2087693.714	1826732	1623761.778	1461385.6	1328532.364	1217821.333	1124142.769	1043846.857	974257.0667	913366	811880.8889	769150.3158	730692.8	608910.6667	584554.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120794	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	25225630	12612815	8408543.333	6306407.5	5045126	4204271.667	3603661.429	3153203.75	2802847.778	2522563	2293239.091	2102135.833	1940433.077	1801830.714	1681708.667	1576601.875	1401423.889	1327664.737	1261281.5	1051067.917	1009025.2	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120795	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	16020404	8010202	5340134.667	4005101	3204080.8	2670067.333	2288629.143	2002550.5	1780044.889	1602040.4	1456400.364	1335033.667	1232338.769	1144314.571	1068026.933	1001275.25	890022.4444	843179.1579	801020.2	667516.8333	640816.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120796	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	16468021	8234010.5	5489340.333	4117005.25	3293604.2	2744670.167	2352574.429	2058502.625	1829780.111	1646802.1	1497092.818	1372335.083	1266770.846	1176287.214	1097868.067	1029251.313	914890.0556	866737.9474	823401.05	686167.5417	658720.84	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120797	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	6867126	3433563	2289042	1716781.5	1373425.2	1144521	981018	858390.75	763014	686712.6	624284.1818	572260.5	528240.4615	490509	457808.4	429195.375	381507	361427.6842	343356.3	286130.25	274685.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120798	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120799	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	2229679	1114839.5	743226.3333	557419.75	445935.8	371613.1667	318525.5714	278709.875	247742.1111	222967.9	202698.0909	185806.5833	171513.7692	159262.7857	148645.2667	139354.9375	123871.0556	117351.5263	111483.95	92903.29167	89187.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120800	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	3557984	1778992	1185994.667	889496	711596.8	592997.3333	508283.4286	444748	395331.5556	355798.4	323453.0909	296498.6667	273691.0769	254141.7143	237198.9333	222374	197665.7778	187262.3158	177899.2	148249.3333	142319.36	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120801	CHOYP_LOC100180023.1.7|m.11060	VVVVAVDGSDQADK	VVVVAVDGSDQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120802	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	246668816	123334408	82222938.67	61667204	49333763.2	41111469.33	35238402.29	30833602	27407646.22	24666881.6	22424437.82	20555734.67	18974524.31	17619201.14	16444587.73	15416801	13703823.11	12982569.26	12333440.8	10277867.33	9866752.64	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120803	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	150274576	75137288	50091525.33	37568644	30054915.2	25045762.67	21467796.57	18784322	16697175.11	15027457.6	13661325.09	12522881.33	11559582.77	10733898.29	10018305.07	9392161	8348587.556	7909188.211	7513728.8	6261440.667	6010983.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120804	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	61997036	30998518	20665678.67	15499259	12399407.2	10332839.33	8856719.429	7749629.5	6888559.556	6199703.6	5636094.182	5166419.667	4769002.769	4428359.714	4133135.733	3874814.75	3444279.778	3263001.895	3099851.8	2583209.833	2479881.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120805	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	15423027	7711513.5	5141009	3855756.75	3084605.4	2570504.5	2203289.571	1927878.375	1713669.667	1542302.7	1402093.364	1285252.25	1186386.692	1101644.786	1028201.8	963939.1875	856834.8333	811738.2632	771151.35	642626.125	616921.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120806	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	159616752	79808376	53205584	39904188	31923350.4	26602792	22802393.14	19952094	17735194.67	15961675.2	14510613.82	13301396	12278211.69	11401196.57	10641116.8	9976047	8867597.333	8400881.684	7980837.6	6650698	6384670.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120807	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	16148372	8074186	5382790.667	4037093	3229674.4	2691395.333	2306910.286	2018546.5	1794263.556	1614837.2	1468033.818	1345697.667	1242182.462	1153455.143	1076558.133	1009273.25	897131.7778	849914.3158	807418.6	672848.8333	645934.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120808	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	4225073	2112536.5	1408357.667	1056268.25	845014.6	704178.8333	603581.8571	528134.125	469452.5556	422507.3	384097.5455	352089.4167	325005.6154	301790.9286	281671.5333	264067.0625	234726.2778	222372.2632	211253.65	176044.7083	169002.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120809	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	7755212	3877606	2585070.667	1938803	1551042.4	1292535.333	1107887.429	969401.5	861690.2222	775521.2	705019.2727	646267.6667	596554.7692	553943.7143	517014.1333	484700.75	430845.1111	408169.0526	387760.6	323133.8333	310208.48	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120810	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	8897772	4448886	2965924	2224443	1779554.4	1482962	1271110.286	1112221.5	988641.3333	889777.2	808888.3636	741481	684444	635555.1429	593184.8	556110.75	494320.6667	468303.7895	444888.6	370740.5	355910.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120811	CHOYP_LOC100180023.1.7|m.11060	VSFMPGQVSESR	VSFMPGQVSESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120812	CHOYP_LOC100180023.1.7|m.11060	EIQDEMSK	EIQDEMSK	75056528	37528264	25018842.67	18764132	15011305.6	12509421.33	10722361.14	9382066	8339614.222	7505652.8	6823320.727	6254710.667	5773579.077	5361180.571	5003768.533	4691033	4169807.111	3950343.579	3752826.4	3127355.333	3002261.12	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120813	CHOYP_LOC100180023.1.7|m.11060	EIQDEMSK	EIQDEMSK	34896300	17448150	11632100	8724075	6979260	5816050	4985185.714	4362037.5	3877366.667	3489630	3172390.909	2908025	2684330.769	2492592.857	2326420	2181018.75	1938683.333	1836647.368	1744815	1454012.5	1395852	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120814	CHOYP_LOC100180023.1.7|m.11060	EIQDEMSK	EIQDEMSK	12655740	6327870	4218580	3163935	2531148	2109290	1807962.857	1581967.5	1406193.333	1265574	1150521.818	1054645	973518.4615	903981.4286	843716	790983.75	703096.6667	666091.5789	632787	527322.5	506229.6	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120815	CHOYP_LOC100180023.1.7|m.11060	EIQDEMSK	EIQDEMSK	7093281	3546640.5	2364427	1773320.25	1418656.2	1182213.5	1013325.857	886660.125	788142.3333	709328.1	644843.7273	591106.75	545637	506662.9286	472885.4	443330.0625	394071.1667	373330.5789	354664.05	295553.375	283731.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120816	CHOYP_LOC100180023.1.7|m.11060	EIQDEMSK	EIQDEMSK	1441186	720593	480395.3333	360296.5	288237.2	240197.6667	205883.7143	180148.25	160131.7778	144118.6	131016.9091	120098.8333	110860.4615	102941.8571	96079.06667	90074.125	80065.88889	75851.89474	72059.3	60049.41667	57647.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120817	CHOYP_LOC100180023.1.7|m.11060	EIQDEMSK	EIQDEMSK	3364760	1682380	1121586.667	841190	672952	560793.3333	480680	420595	373862.2222	336476	305887.2727	280396.6667	258827.6923	240340	224317.3333	210297.5	186931.1111	177092.6316	168238	140198.3333	134590.4	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120818	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	45827836	22913918	15275945.33	11456959	9165567.2	7637972.667	6546833.714	5728479.5	5091981.778	4582783.6	4166166.909	3818986.333	3525218.154	3273416.857	3055189.067	2864239.75	2545990.889	2411991.368	2291391.8	1909493.167	1833113.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120819	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	21601506	10800753	7200502	5400376.5	4320301.2	3600251	3085929.429	2700188.25	2400167.333	2160150.6	1963773.273	1800125.5	1661654.308	1542964.714	1440100.4	1350094.125	1200083.667	1136921.368	1080075.3	900062.75	864060.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120820	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120821	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	1120342	560171	373447.3333	280085.5	224068.4	186723.6667	160048.8571	140042.75	124482.4444	112034.2	101849.2727	93361.83333	86180.15385	80024.42857	74689.46667	70021.375	62241.22222	58965.36842	56017.1	46680.91667	44813.68	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120822	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	704251	352125.5	234750.3333	176062.75	140850.2	117375.1667	100607.2857	88031.375	78250.11111	70425.1	64022.81818	58687.58333	54173.15385	50303.64286	46950.06667	44015.6875	39125.05556	37065.84211	35212.55	29343.79167	28170.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120823	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	433248	216624	144416	108312	86649.6	72208	61892.57143	54156	48138.66667	43324.8	39386.18182	36104	33326.76923	30946.28571	28883.2	27078	24069.33333	22802.52632	21662.4	18052	17329.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120824	CHOYP_LOC100180023.1.7|m.11060	KPEEAIISK	KPEEAIISK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120825	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120826	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120827	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120828	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	8523792	4261896	2841264	2130948	1704758.4	1420632	1217684.571	1065474	947088	852379.2	774890.1818	710316	655676.3077	608842.2857	568252.8	532737	473544	448620.6316	426189.6	355158	340951.68	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120829	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	16026205	8013102.5	5342068.333	4006551.25	3205241	2671034.167	2289457.857	2003275.625	1780689.444	1602620.5	1456927.727	1335517.083	1232785	1144728.929	1068413.667	1001637.813	890344.7222	843484.4737	801310.25	667758.5417	641048.2	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120830	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	5379175	2689587.5	1793058.333	1344793.75	1075835	896529.1667	768453.5714	672396.875	597686.1111	537917.5	489015.9091	448264.5833	413782.6923	384226.7857	358611.6667	336198.4375	298843.0556	283114.4737	268958.75	224132.2917	215167	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120831	CHOYP_LOC100180023.1.7|m.11060	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120832	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	135589248	67794624	45196416	33897312	27117849.6	22598208	19369892.57	16948656	15065472	13558924.8	12326295.27	11299104	10429942.15	9684946.286	9039283.2	8474328	7532736	7136276.211	6779462.4	5649552	5423569.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120833	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	173720272	86860136	57906757.33	43430068	34744054.4	28953378.67	24817181.71	21715034	19302252.44	17372027.2	15792752	14476689.33	13363097.85	12408590.86	11581351.47	10857517	9651126.222	9143172.211	8686013.6	7238344.667	6948810.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120834	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	125826448	62913224	41942149.33	31456612	25165289.6	20971074.67	17975206.86	15728306	13980716.44	12582644.8	11438768	10485537.33	9678957.538	8987603.429	8388429.867	7864153	6990358.222	6622444.632	6291322.4	5242768.667	5033057.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120835	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120836	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120837	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120838	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120839	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	437902	218951	145967.3333	109475.5	87580.4	72983.66667	62557.42857	54737.75	48655.77778	43790.2	39809.27273	36491.83333	33684.76923	31278.71429	29193.46667	27368.875	24327.88889	23047.47368	21895.1	18245.91667	17516.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120840	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1717354	858677	572451.3333	429338.5	343470.8	286225.6667	245336.2857	214669.25	190817.1111	171735.4	156123.0909	143112.8333	132104.1538	122668.1429	114490.2667	107334.625	95408.55556	90387.05263	85867.7	71556.41667	68694.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120841	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	8856555	4428277.5	2952185	2214138.75	1771311	1476092.5	1265222.143	1107069.375	984061.6667	885655.5	805141.3636	738046.25	681273.4615	632611.0714	590437	553534.6875	492030.8333	466134.4737	442827.75	369023.125	354262.2	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120842	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	19657926	9828963	6552642	4914481.5	3931585.2	3276321	2808275.143	2457240.75	2184214	1965792.6	1787084.182	1638160.5	1512148.154	1404137.571	1310528.4	1228620.375	1092107	1034627.684	982896.3	819080.25	786317.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120843	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	27262806	13631403	9087602	6815701.5	5452561.2	4543801	3894686.571	3407850.75	3029200.667	2726280.6	2478436.909	2271900.5	2097138.923	1947343.286	1817520.4	1703925.375	1514600.333	1434884.526	1363140.3	1135950.25	1090512.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120844	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	23171766	11585883	7723922	5792941.5	4634353.2	3861961	3310252.286	2896470.75	2574640.667	2317176.6	2106524.182	1930980.5	1782443.538	1655126.143	1544784.4	1448235.375	1287320.333	1219566.632	1158588.3	965490.25	926870.64	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120845	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	15035288	7517644	5011762.667	3758822	3007057.6	2505881.333	2147898.286	1879411	1670587.556	1503528.8	1366844.364	1252940.667	1156560.615	1073949.143	1002352.533	939705.5	835293.7778	791330.9474	751764.4	626470.3333	601411.52	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120846	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1494112	747056	498037.3333	373528	298822.4	249018.6667	213444.5714	186764	166012.4444	149411.2	135828.3636	124509.3333	114931.6923	106722.2857	99607.46667	93382	83006.22222	78637.47368	74705.6	62254.66667	59764.48	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120847	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	17401794	8700897	5800598	4350448.5	3480358.8	2900299	2485970.571	2175224.25	1933532.667	1740179.4	1581981.273	1450149.5	1338599.538	1242985.286	1160119.6	1087612.125	966766.3333	915883.8947	870089.7	725074.75	696071.76	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120848	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120849	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1533757	766878.5	511252.3333	383439.25	306751.4	255626.1667	219108.1429	191719.625	170417.4444	153375.7	139432.4545	127813.0833	117981.3077	109554.0714	102250.4667	95859.8125	85208.72222	80724.05263	76687.85	63906.54167	61350.28	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120850	CHOYP_LOC100180023.1.7|m.11060	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1554106	777053	518035.3333	388526.5	310821.2	259017.6667	222015.1429	194263.25	172678.4444	155410.6	141282.3636	129508.8333	119546.6154	111007.5714	103607.0667	97131.625	86339.22222	81795.05263	77705.3	64754.41667	62164.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120851	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	204637456	102318728	68212485.33	51159364	40927491.2	34106242.67	29233922.29	25579682	22737495.11	20463745.6	18603405.09	17053121.33	15741342.77	14616961.14	13642497.07	12789841	11368747.56	10770392.42	10231872.8	8526560.667	8185498.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120852	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	143806432	71903216	47935477.33	35951608	28761286.4	23967738.67	20543776	17975804	15978492.44	14380643.2	13073312	11983869.33	11062033.23	10271888	9587095.467	8987902	7989246.222	7568759.579	7190321.6	5991934.667	5752257.28	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120853	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	56987864	28493932	18995954.67	14246966	11397572.8	9497977.333	8141123.429	7123483	6331984.889	5698786.4	5180714.909	4748988.667	4383681.846	4070561.714	3799190.933	3561741.5	3165992.444	2999361.263	2849393.2	2374494.333	2279514.56	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120854	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	14613856	7306928	4871285.333	3653464	2922771.2	2435642.667	2087693.714	1826732	1623761.778	1461385.6	1328532.364	1217821.333	1124142.769	1043846.857	974257.0667	913366	811880.8889	769150.3158	730692.8	608910.6667	584554.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120855	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	25225630	12612815	8408543.333	6306407.5	5045126	4204271.667	3603661.429	3153203.75	2802847.778	2522563	2293239.091	2102135.833	1940433.077	1801830.714	1681708.667	1576601.875	1401423.889	1327664.737	1261281.5	1051067.917	1009025.2	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120856	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	16020404	8010202	5340134.667	4005101	3204080.8	2670067.333	2288629.143	2002550.5	1780044.889	1602040.4	1456400.364	1335033.667	1232338.769	1144314.571	1068026.933	1001275.25	890022.4444	843179.1579	801020.2	667516.8333	640816.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120857	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	16468021	8234010.5	5489340.333	4117005.25	3293604.2	2744670.167	2352574.429	2058502.625	1829780.111	1646802.1	1497092.818	1372335.083	1266770.846	1176287.214	1097868.067	1029251.313	914890.0556	866737.9474	823401.05	686167.5417	658720.84	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120858	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	6867126	3433563	2289042	1716781.5	1373425.2	1144521	981018	858390.75	763014	686712.6	624284.1818	572260.5	528240.4615	490509	457808.4	429195.375	381507	361427.6842	343356.3	286130.25	274685.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120859	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120860	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	2229679	1114839.5	743226.3333	557419.75	445935.8	371613.1667	318525.5714	278709.875	247742.1111	222967.9	202698.0909	185806.5833	171513.7692	159262.7857	148645.2667	139354.9375	123871.0556	117351.5263	111483.95	92903.29167	89187.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120861	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	3557984	1778992	1185994.667	889496	711596.8	592997.3333	508283.4286	444748	395331.5556	355798.4	323453.0909	296498.6667	273691.0769	254141.7143	237198.9333	222374	197665.7778	187262.3158	177899.2	148249.3333	142319.36	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120862	CHOYP_LOC100180023.2.7|m.28766	VVVVAVDGSDQADK	VVVVAVDGSDQADK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120863	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	246668816	123334408	82222938.67	61667204	49333763.2	41111469.33	35238402.29	30833602	27407646.22	24666881.6	22424437.82	20555734.67	18974524.31	17619201.14	16444587.73	15416801	13703823.11	12982569.26	12333440.8	10277867.33	9866752.64	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120864	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	150274576	75137288	50091525.33	37568644	30054915.2	25045762.67	21467796.57	18784322	16697175.11	15027457.6	13661325.09	12522881.33	11559582.77	10733898.29	10018305.07	9392161	8348587.556	7909188.211	7513728.8	6261440.667	6010983.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120865	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	61997036	30998518	20665678.67	15499259	12399407.2	10332839.33	8856719.429	7749629.5	6888559.556	6199703.6	5636094.182	5166419.667	4769002.769	4428359.714	4133135.733	3874814.75	3444279.778	3263001.895	3099851.8	2583209.833	2479881.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120866	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	15423027	7711513.5	5141009	3855756.75	3084605.4	2570504.5	2203289.571	1927878.375	1713669.667	1542302.7	1402093.364	1285252.25	1186386.692	1101644.786	1028201.8	963939.1875	856834.8333	811738.2632	771151.35	642626.125	616921.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120867	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	159616752	79808376	53205584	39904188	31923350.4	26602792	22802393.14	19952094	17735194.67	15961675.2	14510613.82	13301396	12278211.69	11401196.57	10641116.8	9976047	8867597.333	8400881.684	7980837.6	6650698	6384670.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120868	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	16148372	8074186	5382790.667	4037093	3229674.4	2691395.333	2306910.286	2018546.5	1794263.556	1614837.2	1468033.818	1345697.667	1242182.462	1153455.143	1076558.133	1009273.25	897131.7778	849914.3158	807418.6	672848.8333	645934.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120869	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	4225073	2112536.5	1408357.667	1056268.25	845014.6	704178.8333	603581.8571	528134.125	469452.5556	422507.3	384097.5455	352089.4167	325005.6154	301790.9286	281671.5333	264067.0625	234726.2778	222372.2632	211253.65	176044.7083	169002.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120870	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	7755212	3877606	2585070.667	1938803	1551042.4	1292535.333	1107887.429	969401.5	861690.2222	775521.2	705019.2727	646267.6667	596554.7692	553943.7143	517014.1333	484700.75	430845.1111	408169.0526	387760.6	323133.8333	310208.48	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120871	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	8897772	4448886	2965924	2224443	1779554.4	1482962	1271110.286	1112221.5	988641.3333	889777.2	808888.3636	741481	684444	635555.1429	593184.8	556110.75	494320.6667	468303.7895	444888.6	370740.5	355910.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120872	CHOYP_LOC100180023.2.7|m.28766	VSFMPGQVSESR	VSFMPGQVSESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120873	CHOYP_LOC100180023.2.7|m.28766	EIQDEMSK	EIQDEMSK	75056528	37528264	25018842.67	18764132	15011305.6	12509421.33	10722361.14	9382066	8339614.222	7505652.8	6823320.727	6254710.667	5773579.077	5361180.571	5003768.533	4691033	4169807.111	3950343.579	3752826.4	3127355.333	3002261.12	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120874	CHOYP_LOC100180023.2.7|m.28766	EIQDEMSK	EIQDEMSK	34896300	17448150	11632100	8724075	6979260	5816050	4985185.714	4362037.5	3877366.667	3489630	3172390.909	2908025	2684330.769	2492592.857	2326420	2181018.75	1938683.333	1836647.368	1744815	1454012.5	1395852	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120875	CHOYP_LOC100180023.2.7|m.28766	EIQDEMSK	EIQDEMSK	12655740	6327870	4218580	3163935	2531148	2109290	1807962.857	1581967.5	1406193.333	1265574	1150521.818	1054645	973518.4615	903981.4286	843716	790983.75	703096.6667	666091.5789	632787	527322.5	506229.6	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120876	CHOYP_LOC100180023.2.7|m.28766	EIQDEMSK	EIQDEMSK	7093281	3546640.5	2364427	1773320.25	1418656.2	1182213.5	1013325.857	886660.125	788142.3333	709328.1	644843.7273	591106.75	545637	506662.9286	472885.4	443330.0625	394071.1667	373330.5789	354664.05	295553.375	283731.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120877	CHOYP_LOC100180023.2.7|m.28766	EIQDEMSK	EIQDEMSK	1441186	720593	480395.3333	360296.5	288237.2	240197.6667	205883.7143	180148.25	160131.7778	144118.6	131016.9091	120098.8333	110860.4615	102941.8571	96079.06667	90074.125	80065.88889	75851.89474	72059.3	60049.41667	57647.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120878	CHOYP_LOC100180023.2.7|m.28766	EIQDEMSK	EIQDEMSK	3364760	1682380	1121586.667	841190	672952	560793.3333	480680	420595	373862.2222	336476	305887.2727	280396.6667	258827.6923	240340	224317.3333	210297.5	186931.1111	177092.6316	168238	140198.3333	134590.4	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120879	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	45827836	22913918	15275945.33	11456959	9165567.2	7637972.667	6546833.714	5728479.5	5091981.778	4582783.6	4166166.909	3818986.333	3525218.154	3273416.857	3055189.067	2864239.75	2545990.889	2411991.368	2291391.8	1909493.167	1833113.44	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120880	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	21601506	10800753	7200502	5400376.5	4320301.2	3600251	3085929.429	2700188.25	2400167.333	2160150.6	1963773.273	1800125.5	1661654.308	1542964.714	1440100.4	1350094.125	1200083.667	1136921.368	1080075.3	900062.75	864060.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120881	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120882	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	1120342	560171	373447.3333	280085.5	224068.4	186723.6667	160048.8571	140042.75	124482.4444	112034.2	101849.2727	93361.83333	86180.15385	80024.42857	74689.46667	70021.375	62241.22222	58965.36842	56017.1	46680.91667	44813.68	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120883	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	704251	352125.5	234750.3333	176062.75	140850.2	117375.1667	100607.2857	88031.375	78250.11111	70425.1	64022.81818	58687.58333	54173.15385	50303.64286	46950.06667	44015.6875	39125.05556	37065.84211	35212.55	29343.79167	28170.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120884	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	433248	216624	144416	108312	86649.6	72208	61892.57143	54156	48138.66667	43324.8	39386.18182	36104	33326.76923	30946.28571	28883.2	27078	24069.33333	22802.52632	21662.4	18052	17329.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120885	CHOYP_LOC100180023.2.7|m.28766	KPEEAIISK	KPEEAIISK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120886	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120887	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120888	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120889	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	8523792	4261896	2841264	2130948	1704758.4	1420632	1217684.571	1065474	947088	852379.2	774890.1818	710316	655676.3077	608842.2857	568252.8	532737	473544	448620.6316	426189.6	355158	340951.68	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120890	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	16026205	8013102.5	5342068.333	4006551.25	3205241	2671034.167	2289457.857	2003275.625	1780689.444	1602620.5	1456927.727	1335517.083	1232785	1144728.929	1068413.667	1001637.813	890344.7222	843484.4737	801310.25	667758.5417	641048.2	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120891	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	5379175	2689587.5	1793058.333	1344793.75	1075835	896529.1667	768453.5714	672396.875	597686.1111	537917.5	489015.9091	448264.5833	413782.6923	384226.7857	358611.6667	336198.4375	298843.0556	283114.4737	268958.75	224132.2917	215167	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120892	CHOYP_LOC100180023.2.7|m.28766	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120893	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	135589248	67794624	45196416	33897312	27117849.6	22598208	19369892.57	16948656	15065472	13558924.8	12326295.27	11299104	10429942.15	9684946.286	9039283.2	8474328	7532736	7136276.211	6779462.4	5649552	5423569.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120894	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	173720272	86860136	57906757.33	43430068	34744054.4	28953378.67	24817181.71	21715034	19302252.44	17372027.2	15792752	14476689.33	13363097.85	12408590.86	11581351.47	10857517	9651126.222	9143172.211	8686013.6	7238344.667	6948810.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120895	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	125826448	62913224	41942149.33	31456612	25165289.6	20971074.67	17975206.86	15728306	13980716.44	12582644.8	11438768	10485537.33	9678957.538	8987603.429	8388429.867	7864153	6990358.222	6622444.632	6291322.4	5242768.667	5033057.92	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120896	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120897	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120898	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120899	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120900	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	437902	218951	145967.3333	109475.5	87580.4	72983.66667	62557.42857	54737.75	48655.77778	43790.2	39809.27273	36491.83333	33684.76923	31278.71429	29193.46667	27368.875	24327.88889	23047.47368	21895.1	18245.91667	17516.08	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120901	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1717354	858677	572451.3333	429338.5	343470.8	286225.6667	245336.2857	214669.25	190817.1111	171735.4	156123.0909	143112.8333	132104.1538	122668.1429	114490.2667	107334.625	95408.55556	90387.05263	85867.7	71556.41667	68694.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120902	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	8856555	4428277.5	2952185	2214138.75	1771311	1476092.5	1265222.143	1107069.375	984061.6667	885655.5	805141.3636	738046.25	681273.4615	632611.0714	590437	553534.6875	492030.8333	466134.4737	442827.75	369023.125	354262.2	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120903	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	19657926	9828963	6552642	4914481.5	3931585.2	3276321	2808275.143	2457240.75	2184214	1965792.6	1787084.182	1638160.5	1512148.154	1404137.571	1310528.4	1228620.375	1092107	1034627.684	982896.3	819080.25	786317.04	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120904	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	27262806	13631403	9087602	6815701.5	5452561.2	4543801	3894686.571	3407850.75	3029200.667	2726280.6	2478436.909	2271900.5	2097138.923	1947343.286	1817520.4	1703925.375	1514600.333	1434884.526	1363140.3	1135950.25	1090512.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120905	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	23171766	11585883	7723922	5792941.5	4634353.2	3861961	3310252.286	2896470.75	2574640.667	2317176.6	2106524.182	1930980.5	1782443.538	1655126.143	1544784.4	1448235.375	1287320.333	1219566.632	1158588.3	965490.25	926870.64	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120906	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	15035288	7517644	5011762.667	3758822	3007057.6	2505881.333	2147898.286	1879411	1670587.556	1503528.8	1366844.364	1252940.667	1156560.615	1073949.143	1002352.533	939705.5	835293.7778	791330.9474	751764.4	626470.3333	601411.52	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120907	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1494112	747056	498037.3333	373528	298822.4	249018.6667	213444.5714	186764	166012.4444	149411.2	135828.3636	124509.3333	114931.6923	106722.2857	99607.46667	93382	83006.22222	78637.47368	74705.6	62254.66667	59764.48	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120908	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	17401794	8700897	5800598	4350448.5	3480358.8	2900299	2485970.571	2175224.25	1933532.667	1740179.4	1581981.273	1450149.5	1338599.538	1242985.286	1160119.6	1087612.125	966766.3333	915883.8947	870089.7	725074.75	696071.76	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120909	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120910	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1533757	766878.5	511252.3333	383439.25	306751.4	255626.1667	219108.1429	191719.625	170417.4444	153375.7	139432.4545	127813.0833	117981.3077	109554.0714	102250.4667	95859.8125	85208.72222	80724.05263	76687.85	63906.54167	61350.28	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120911	CHOYP_LOC100180023.2.7|m.28766	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1554106	777053	518035.3333	388526.5	310821.2	259017.6667	222015.1429	194263.25	172678.4444	155410.6	141282.3636	129508.8333	119546.6154	111007.5714	103607.0667	97131.625	86339.22222	81795.05263	77705.3	64754.41667	62164.24	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
120912	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120913	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120914	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120915	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	427663	213831.5	142554.3333	106915.75	85532.6	71277.16667	61094.71429	53457.875	47518.11111	42766.3	38878.45455	35638.58333	32897.15385	30547.35714	28510.86667	26728.9375	23759.05556	22508.57895	21383.15	17819.29167	17106.52	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120916	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120917	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	101586	50793	33862	25396.5	20317.2	16931	14512.28571	12698.25	11287.33333	10158.6	9235.090909	8465.5	7814.307692	7256.142857	6772.4	6349.125	5643.666667	5346.631579	5079.3	4232.75	4063.44	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120918	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120919	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	64131	32065.5	21377	16032.75	12826.2	10688.5	9161.571429	8016.375	7125.666667	6413.1	5830.090909	5344.25	4933.153846	4580.785714	4275.4	4008.1875	3562.833333	3375.315789	3206.55	2672.125	2565.24	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120920	CHOYP_LOC100180023.5.7|m.56825	SSFPSTMSPGR	SSFPSTMSPGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120921	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	9459660	4729830	3153220	2364915	1891932	1576610	1351380	1182457.5	1051073.333	945966	859969.0909	788305	727666.1538	675690	630644	591228.75	525536.6667	497876.8421	472983	394152.5	378386.4	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120922	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	8360693	4180346.5	2786897.667	2090173.25	1672138.6	1393448.833	1194384.714	1045086.625	928965.8889	836069.3	760063	696724.4167	643130.2308	597192.3571	557379.5333	522543.3125	464482.9444	440036.4737	418034.65	348362.2083	334427.72	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120923	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	3266522	1633261	1088840.667	816630.5	653304.4	544420.3333	466646	408315.25	362946.8889	326652.2	296956.5455	272210.1667	251270.9231	233323	217768.1333	204157.625	181473.4444	171922.2105	163326.1	136105.0833	130660.88	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120924	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120925	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	910143	455071.5	303381	227535.75	182028.6	151690.5	130020.4286	113767.875	101127	91014.3	82740.27273	75845.25	70011	65010.21429	60676.2	56883.9375	50563.5	47902.26316	45507.15	37922.625	36405.72	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120926	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120927	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120928	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120929	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120930	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120931	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	88595	44297.5	29531.66667	22148.75	17719	14765.83333	12656.42857	11074.375	9843.888889	8859.5	8054.090909	7382.916667	6815	6328.214286	5906.333333	5537.1875	4921.944444	4662.894737	4429.75	3691.458333	3543.8	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120932	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	193756	96878	64585.33333	48439	38751.2	32292.66667	27679.42857	24219.5	21528.44444	19375.6	17614.18182	16146.33333	14904.30769	13839.71429	12917.06667	12109.75	10764.22222	10197.68421	9687.8	8073.166667	7750.24	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120933	CHOYP_LOC100180023.5.7|m.56825	SDSKPEHTIVDIANK	SDSKPEHTIVDIANK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A0QZA1	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	MSMEG_3950 MSMEI_3859	response to stress [GO:0006950]	GO:0006950
120934	CHOYP_LOC100180023.6.7|m.63800	EIQDEMSK	EIQDEMSK	75056528	37528264	25018842.67	18764132	15011305.6	12509421.33	10722361.14	9382066	8339614.222	7505652.8	6823320.727	6254710.667	5773579.077	5361180.571	5003768.533	4691033	4169807.111	3950343.579	3752826.4	3127355.333	3002261.12	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120935	CHOYP_LOC100180023.6.7|m.63800	EIQDEMSK	EIQDEMSK	34896300	17448150	11632100	8724075	6979260	5816050	4985185.714	4362037.5	3877366.667	3489630	3172390.909	2908025	2684330.769	2492592.857	2326420	2181018.75	1938683.333	1836647.368	1744815	1454012.5	1395852	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120936	CHOYP_LOC100180023.6.7|m.63800	EIQDEMSK	EIQDEMSK	12655740	6327870	4218580	3163935	2531148	2109290	1807962.857	1581967.5	1406193.333	1265574	1150521.818	1054645	973518.4615	903981.4286	843716	790983.75	703096.6667	666091.5789	632787	527322.5	506229.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120937	CHOYP_LOC100180023.6.7|m.63800	EIQDEMSK	EIQDEMSK	7093281	3546640.5	2364427	1773320.25	1418656.2	1182213.5	1013325.857	886660.125	788142.3333	709328.1	644843.7273	591106.75	545637	506662.9286	472885.4	443330.0625	394071.1667	373330.5789	354664.05	295553.375	283731.24	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120938	CHOYP_LOC100180023.6.7|m.63800	EIQDEMSK	EIQDEMSK	1441186	720593	480395.3333	360296.5	288237.2	240197.6667	205883.7143	180148.25	160131.7778	144118.6	131016.9091	120098.8333	110860.4615	102941.8571	96079.06667	90074.125	80065.88889	75851.89474	72059.3	60049.41667	57647.44	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120939	CHOYP_LOC100180023.6.7|m.63800	EIQDEMSK	EIQDEMSK	3364760	1682380	1121586.667	841190	672952	560793.3333	480680	420595	373862.2222	336476	305887.2727	280396.6667	258827.6923	240340	224317.3333	210297.5	186931.1111	177092.6316	168238	140198.3333	134590.4	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120940	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	45827836	22913918	15275945.33	11456959	9165567.2	7637972.667	6546833.714	5728479.5	5091981.778	4582783.6	4166166.909	3818986.333	3525218.154	3273416.857	3055189.067	2864239.75	2545990.889	2411991.368	2291391.8	1909493.167	1833113.44	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120941	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	21601506	10800753	7200502	5400376.5	4320301.2	3600251	3085929.429	2700188.25	2400167.333	2160150.6	1963773.273	1800125.5	1661654.308	1542964.714	1440100.4	1350094.125	1200083.667	1136921.368	1080075.3	900062.75	864060.24	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120942	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120943	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	1120342	560171	373447.3333	280085.5	224068.4	186723.6667	160048.8571	140042.75	124482.4444	112034.2	101849.2727	93361.83333	86180.15385	80024.42857	74689.46667	70021.375	62241.22222	58965.36842	56017.1	46680.91667	44813.68	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120944	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	704251	352125.5	234750.3333	176062.75	140850.2	117375.1667	100607.2857	88031.375	78250.11111	70425.1	64022.81818	58687.58333	54173.15385	50303.64286	46950.06667	44015.6875	39125.05556	37065.84211	35212.55	29343.79167	28170.04	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120945	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	433248	216624	144416	108312	86649.6	72208	61892.57143	54156	48138.66667	43324.8	39386.18182	36104	33326.76923	30946.28571	28883.2	27078	24069.33333	22802.52632	21662.4	18052	17329.92	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120946	CHOYP_LOC100180023.6.7|m.63800	KPEEAIISK	KPEEAIISK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120947	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120948	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120949	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120950	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	8523792	4261896	2841264	2130948	1704758.4	1420632	1217684.571	1065474	947088	852379.2	774890.1818	710316	655676.3077	608842.2857	568252.8	532737	473544	448620.6316	426189.6	355158	340951.68	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120951	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	16026205	8013102.5	5342068.333	4006551.25	3205241	2671034.167	2289457.857	2003275.625	1780689.444	1602620.5	1456927.727	1335517.083	1232785	1144728.929	1068413.667	1001637.813	890344.7222	843484.4737	801310.25	667758.5417	641048.2	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120952	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	5379175	2689587.5	1793058.333	1344793.75	1075835	896529.1667	768453.5714	672396.875	597686.1111	537917.5	489015.9091	448264.5833	413782.6923	384226.7857	358611.6667	336198.4375	298843.0556	283114.4737	268958.75	224132.2917	215167	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120953	CHOYP_LOC100180023.6.7|m.63800	AAMIVMGTR	AAMIVMGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120954	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	135589248	67794624	45196416	33897312	27117849.6	22598208	19369892.57	16948656	15065472	13558924.8	12326295.27	11299104	10429942.15	9684946.286	9039283.2	8474328	7532736	7136276.211	6779462.4	5649552	5423569.92	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120955	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	173720272	86860136	57906757.33	43430068	34744054.4	28953378.67	24817181.71	21715034	19302252.44	17372027.2	15792752	14476689.33	13363097.85	12408590.86	11581351.47	10857517	9651126.222	9143172.211	8686013.6	7238344.667	6948810.88	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120956	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	125826448	62913224	41942149.33	31456612	25165289.6	20971074.67	17975206.86	15728306	13980716.44	12582644.8	11438768	10485537.33	9678957.538	8987603.429	8388429.867	7864153	6990358.222	6622444.632	6291322.4	5242768.667	5033057.92	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120957	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120958	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120959	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120960	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120961	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	437902	218951	145967.3333	109475.5	87580.4	72983.66667	62557.42857	54737.75	48655.77778	43790.2	39809.27273	36491.83333	33684.76923	31278.71429	29193.46667	27368.875	24327.88889	23047.47368	21895.1	18245.91667	17516.08	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120962	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1717354	858677	572451.3333	429338.5	343470.8	286225.6667	245336.2857	214669.25	190817.1111	171735.4	156123.0909	143112.8333	132104.1538	122668.1429	114490.2667	107334.625	95408.55556	90387.05263	85867.7	71556.41667	68694.16	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120963	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	8856555	4428277.5	2952185	2214138.75	1771311	1476092.5	1265222.143	1107069.375	984061.6667	885655.5	805141.3636	738046.25	681273.4615	632611.0714	590437	553534.6875	492030.8333	466134.4737	442827.75	369023.125	354262.2	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120964	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	19657926	9828963	6552642	4914481.5	3931585.2	3276321	2808275.143	2457240.75	2184214	1965792.6	1787084.182	1638160.5	1512148.154	1404137.571	1310528.4	1228620.375	1092107	1034627.684	982896.3	819080.25	786317.04	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120965	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	27262806	13631403	9087602	6815701.5	5452561.2	4543801	3894686.571	3407850.75	3029200.667	2726280.6	2478436.909	2271900.5	2097138.923	1947343.286	1817520.4	1703925.375	1514600.333	1434884.526	1363140.3	1135950.25	1090512.24	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120966	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	23171766	11585883	7723922	5792941.5	4634353.2	3861961	3310252.286	2896470.75	2574640.667	2317176.6	2106524.182	1930980.5	1782443.538	1655126.143	1544784.4	1448235.375	1287320.333	1219566.632	1158588.3	965490.25	926870.64	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120967	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	15035288	7517644	5011762.667	3758822	3007057.6	2505881.333	2147898.286	1879411	1670587.556	1503528.8	1366844.364	1252940.667	1156560.615	1073949.143	1002352.533	939705.5	835293.7778	791330.9474	751764.4	626470.3333	601411.52	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120968	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1494112	747056	498037.3333	373528	298822.4	249018.6667	213444.5714	186764	166012.4444	149411.2	135828.3636	124509.3333	114931.6923	106722.2857	99607.46667	93382	83006.22222	78637.47368	74705.6	62254.66667	59764.48	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120969	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	17401794	8700897	5800598	4350448.5	3480358.8	2900299	2485970.571	2175224.25	1933532.667	1740179.4	1581981.273	1450149.5	1338599.538	1242985.286	1160119.6	1087612.125	966766.3333	915883.8947	870089.7	725074.75	696071.76	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120970	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120971	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1533757	766878.5	511252.3333	383439.25	306751.4	255626.1667	219108.1429	191719.625	170417.4444	153375.7	139432.4545	127813.0833	117981.3077	109554.0714	102250.4667	95859.8125	85208.72222	80724.05263	76687.85	63906.54167	61350.28	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
120972	CHOYP_LOC100180023.6.7|m.63800	TLMGSVSDYVVHHAGIPVIVVR	TLMGSVSDYVVHHAGIPVIVVR	1554106	777053	518035.3333	388526.5	310821.2	259017.6667	222015.1429	194263.25	172678.4444	155410.6	141282.3636	129508.8333	119546.6154	111007.5714	103607.0667	97131.625	86339.22222	81795.05263	77705.3	64754.41667	62164.24	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
121028	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121029	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121030	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121031	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121032	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	939266	469633	313088.6667	234816.5	187853.2	156544.3333	134180.8571	117408.25	104362.8889	93926.6	85387.81818	78272.16667	72251.23077	67090.42857	62617.73333	58704.125	52181.44444	49435.05263	46963.3	39136.08333	37570.64	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121033	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	70796	35398	23598.66667	17699	14159.2	11799.33333	10113.71429	8849.5	7866.222222	7079.6	6436	5899.666667	5445.846154	5056.857143	4719.733333	4424.75	3933.111111	3726.105263	3539.8	2949.833333	2831.84	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121034	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	184194	92097	61398	46048.5	36838.8	30699	26313.42857	23024.25	20466	18419.4	16744.90909	15349.5	14168.76923	13156.71429	12279.6	11512.125	10233	9694.421053	9209.7	7674.75	7367.76	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121035	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	359290	179645	119763.3333	89822.5	71858	59881.66667	51327.14286	44911.25	39921.11111	35929	32662.72727	29940.83333	27637.69231	25663.57143	23952.66667	22455.625	19960.55556	18910	17964.5	14970.41667	14371.6	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121036	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	89377	44688.5	29792.33333	22344.25	17875.4	14896.16667	12768.14286	11172.125	9930.777778	8937.7	8125.181818	7448.083333	6875.153846	6384.071429	5958.466667	5586.0625	4965.388889	4704.052632	4468.85	3724.041667	3575.08	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121037	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	198125	99062.5	66041.66667	49531.25	39625	33020.83333	28303.57143	24765.625	22013.88889	19812.5	18011.36364	16510.41667	15240.38462	14151.78571	13208.33333	12382.8125	11006.94444	10427.63158	9906.25	8255.208333	7925	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121038	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	206329	103164.5	68776.33333	51582.25	41265.8	34388.16667	29475.57143	25791.125	22925.44444	20632.9	18757.18182	17194.08333	15871.46154	14737.78571	13755.26667	12895.5625	11462.72222	10859.42105	10316.45	8597.041667	8253.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121039	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	333029	166514.5	111009.6667	83257.25	66605.8	55504.83333	47575.57143	41628.625	37003.22222	33302.9	30275.36364	27752.41667	25617.61538	23787.78571	22201.93333	20814.3125	18501.61111	17527.84211	16651.45	13876.20833	13321.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121040	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121041	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	17387278	8693639	5795759.333	4346819.5	3477455.6	2897879.667	2483896.857	2173409.75	1931919.778	1738727.8	1580661.636	1448939.833	1337482.923	1241948.429	1159151.867	1086704.875	965959.8889	915119.8947	869363.9	724469.9167	695491.12	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121042	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121043	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	8145542	4072771	2715180.667	2036385.5	1629108.4	1357590.333	1163648.857	1018192.75	905060.2222	814554.2	740503.8182	678795.1667	626580.1538	581824.4286	543036.1333	509096.375	452530.1111	428712.7368	407277.1	339397.5833	325821.68	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121044	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121045	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	289606	144803	96535.33333	72401.5	57921.2	48267.66667	41372.28571	36200.75	32178.44444	28960.6	26327.81818	24133.83333	22277.38462	20686.14286	19307.06667	18100.375	16089.22222	15242.42105	14480.3	12066.91667	11584.24	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121046	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121047	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	131068	65534	43689.33333	32767	26213.6	21844.66667	18724	16383.5	14563.11111	13106.8	11915.27273	10922.33333	10082.15385	9362	8737.866667	8191.75	7281.555556	6898.315789	6553.4	5461.166667	5242.72	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121048	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121049	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	138364	69182	46121.33333	34591	27672.8	23060.66667	19766.28571	17295.5	15373.77778	13836.4	12578.54545	11530.33333	10643.38462	9883.142857	9224.266667	8647.75	7686.888889	7282.315789	6918.2	5765.166667	5534.56	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121050	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	1907594	953797	635864.6667	476898.5	381518.8	317932.3333	272513.4286	238449.25	211954.8889	190759.4	173417.6364	158966.1667	146738	136256.7143	127172.9333	119224.625	105977.4444	100399.6842	95379.7	79483.08333	76303.76	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121051	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	878074	439037	292691.3333	219518.5	175614.8	146345.6667	125439.1429	109759.25	97563.77778	87807.4	79824.90909	73172.83333	67544.15385	62719.57143	58538.26667	54879.625	48781.88889	46214.42105	43903.7	36586.41667	35122.96	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121052	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	460074	230037	153358	115018.5	92014.8	76679	65724.85714	57509.25	51119.33333	46007.4	41824.90909	38339.5	35390.30769	32862.42857	30671.6	28754.625	25559.66667	24214.42105	23003.7	19169.75	18402.96	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121053	CHOYP_LOC100180855.2.4|m.46097	TSDKPEHSIVDLAEK	TSDKPEHSIVDLAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121054	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	27335076	13667538	9111692	6833769	5467015.2	4555846	3905010.857	3416884.5	3037230.667	2733507.6	2485006.909	2277923	2102698.154	1952505.429	1822338.4	1708442.25	1518615.333	1438688.211	1366753.8	1138961.5	1093403.04	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121055	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	14908394	7454197	4969464.667	3727098.5	2981678.8	2484732.333	2129770.571	1863549.25	1656488.222	1490839.4	1355308.545	1242366.167	1146799.538	1064885.286	993892.9333	931774.625	828244.1111	784652.3158	745419.7	621183.0833	596335.76	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121056	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	4135784	2067892	1378594.667	1033946	827156.8	689297.3333	590826.2857	516973	459531.5556	413578.4	375980.3636	344648.6667	318137.2308	295413.1429	275718.9333	258486.5	229765.7778	217672.8421	206789.2	172324.3333	165431.36	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121057	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	3237356	1618678	1079118.667	809339	647471.2	539559.3333	462479.4286	404669.5	359706.2222	323735.6	294305.0909	269779.6667	249027.3846	231239.7143	215823.7333	202334.75	179853.1111	170387.1579	161867.8	134889.8333	129494.24	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121058	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	5395612	2697806	1798537.333	1348903	1079122.4	899268.6667	770801.7143	674451.5	599512.4444	539561.2	490510.1818	449634.3333	415047.0769	385400.8571	359707.4667	337225.75	299756.2222	283979.5789	269780.6	224817.1667	215824.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121059	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	1943798	971899	647932.6667	485949.5	388759.6	323966.3333	277685.4286	242974.75	215977.5556	194379.8	176708.9091	161983.1667	149522.9231	138842.7143	129586.5333	121487.375	107988.7778	102305.1579	97189.9	80991.58333	77751.92	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121060	CHOYP_LOC100180855.2.4|m.46097	VTYIVSGSR	VTYIVSGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121404	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	10158142	5079071	3386047.333	2539535.5	2031628.4	1693023.667	1451163.143	1269767.75	1128682.444	1015814.2	923467.4545	846511.8333	781395.5385	725581.5714	677209.4667	634883.875	564341.2222	534639.0526	507907.1	423255.9167	406325.68	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121405	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	8873502	4436751	2957834	2218375.5	1774700.4	1478917	1267643.143	1109187.75	985944.6667	887350.2	806682	739458.5	682577.0769	633821.5714	591566.8	554593.875	492972.3333	467026.4211	443675.1	369729.25	354940.08	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121406	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	6780592	3390296	2260197.333	1695148	1356118.4	1130098.667	968656	847574	753399.1111	678059.2	616417.4545	565049.3333	521584	484328	452039.4667	423787	376699.5556	356873.2632	339029.6	282524.6667	271223.68	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121407	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	168437	84218.5	56145.66667	42109.25	33687.4	28072.83333	24062.42857	21054.625	18715.22222	16843.7	15312.45455	14036.41667	12956.69231	12031.21429	11229.13333	10527.3125	9357.611111	8865.105263	8421.85	7018.208333	6737.48	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121408	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1382665	691332.5	460888.3333	345666.25	276533	230444.1667	197523.5714	172833.125	153629.4444	138266.5	125696.8182	115222.0833	106358.8462	98761.78571	92177.66667	86416.5625	76814.72222	72771.84211	69133.25	57611.04167	55306.6	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121409	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1964985	982492.5	654995	491246.25	392997	327497.5	280712.1429	245623.125	218331.6667	196498.5	178635	163748.75	151152.6923	140356.0714	130999	122811.5625	109165.8333	103420.2632	98249.25	81874.375	78599.4	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121410	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1613641	806820.5	537880.3333	403410.25	322728.2	268940.1667	230520.1429	201705.125	179293.4444	161364.1	146694.6364	134470.0833	124126.2308	115260.0714	107576.0667	100852.5625	89646.72222	84928.47368	80682.05	67235.04167	64545.64	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121411	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	2356256	1178128	785418.6667	589064	471251.2	392709.3333	336608	294532	261806.2222	235625.6	214205.0909	196354.6667	181250.4615	168304	157083.7333	147266	130903.1111	124013.4737	117812.8	98177.33333	94250.24	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121412	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1826883	913441.5	608961	456720.75	365376.6	304480.5	260983.2857	228360.375	202987	182688.3	166080.2727	152240.25	140529.4615	130491.6429	121792.2	114180.1875	101493.5	96151.73684	91344.15	76120.125	73075.32	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121413	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	743738	371869	247912.6667	185934.5	148747.6	123956.3333	106248.2857	92967.25	82637.55556	74373.8	67612.54545	61978.16667	57210.61538	53124.14286	49582.53333	46483.625	41318.77778	39144.10526	37186.9	30989.08333	29749.52	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121414	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	761472	380736	253824	190368	152294.4	126912	108781.7143	95184	84608	76147.2	69224.72727	63456	58574.76923	54390.85714	50764.8	47592	42304	40077.47368	38073.6	31728	30458.88	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121415	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	643039	321519.5	214346.3333	160759.75	128607.8	107173.1667	91862.71429	80379.875	71448.77778	64303.9	58458.09091	53586.58333	49464.53846	45931.35714	42869.26667	40189.9375	35724.38889	33844.15789	32151.95	26793.29167	25721.56	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121416	CHOYP_LOC100181607.1.2|m.36709	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121417	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121418	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121419	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	1595709	797854.5	531903	398927.25	319141.8	265951.5	227958.4286	199463.625	177301	159570.9	145064.4545	132975.75	122746.8462	113979.2143	106380.6	99731.8125	88650.5	83984.68421	79785.45	66487.875	63828.36	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121420	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121421	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121422	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121423	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121424	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121425	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121426	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121427	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121428	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121429	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121430	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121431	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121432	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121433	CHOYP_LOC100181607.1.2|m.36709	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121434	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	10158142	5079071	3386047.333	2539535.5	2031628.4	1693023.667	1451163.143	1269767.75	1128682.444	1015814.2	923467.4545	846511.8333	781395.5385	725581.5714	677209.4667	634883.875	564341.2222	534639.0526	507907.1	423255.9167	406325.68	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121435	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	8873502	4436751	2957834	2218375.5	1774700.4	1478917	1267643.143	1109187.75	985944.6667	887350.2	806682	739458.5	682577.0769	633821.5714	591566.8	554593.875	492972.3333	467026.4211	443675.1	369729.25	354940.08	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121436	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	6780592	3390296	2260197.333	1695148	1356118.4	1130098.667	968656	847574	753399.1111	678059.2	616417.4545	565049.3333	521584	484328	452039.4667	423787	376699.5556	356873.2632	339029.6	282524.6667	271223.68	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121437	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	168437	84218.5	56145.66667	42109.25	33687.4	28072.83333	24062.42857	21054.625	18715.22222	16843.7	15312.45455	14036.41667	12956.69231	12031.21429	11229.13333	10527.3125	9357.611111	8865.105263	8421.85	7018.208333	6737.48	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121438	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1382665	691332.5	460888.3333	345666.25	276533	230444.1667	197523.5714	172833.125	153629.4444	138266.5	125696.8182	115222.0833	106358.8462	98761.78571	92177.66667	86416.5625	76814.72222	72771.84211	69133.25	57611.04167	55306.6	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121439	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1964985	982492.5	654995	491246.25	392997	327497.5	280712.1429	245623.125	218331.6667	196498.5	178635	163748.75	151152.6923	140356.0714	130999	122811.5625	109165.8333	103420.2632	98249.25	81874.375	78599.4	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121440	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1613641	806820.5	537880.3333	403410.25	322728.2	268940.1667	230520.1429	201705.125	179293.4444	161364.1	146694.6364	134470.0833	124126.2308	115260.0714	107576.0667	100852.5625	89646.72222	84928.47368	80682.05	67235.04167	64545.64	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121441	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	2356256	1178128	785418.6667	589064	471251.2	392709.3333	336608	294532	261806.2222	235625.6	214205.0909	196354.6667	181250.4615	168304	157083.7333	147266	130903.1111	124013.4737	117812.8	98177.33333	94250.24	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121442	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	1826883	913441.5	608961	456720.75	365376.6	304480.5	260983.2857	228360.375	202987	182688.3	166080.2727	152240.25	140529.4615	130491.6429	121792.2	114180.1875	101493.5	96151.73684	91344.15	76120.125	73075.32	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121443	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	743738	371869	247912.6667	185934.5	148747.6	123956.3333	106248.2857	92967.25	82637.55556	74373.8	67612.54545	61978.16667	57210.61538	53124.14286	49582.53333	46483.625	41318.77778	39144.10526	37186.9	30989.08333	29749.52	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121444	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	761472	380736	253824	190368	152294.4	126912	108781.7143	95184	84608	76147.2	69224.72727	63456	58574.76923	54390.85714	50764.8	47592	42304	40077.47368	38073.6	31728	30458.88	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121445	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	643039	321519.5	214346.3333	160759.75	128607.8	107173.1667	91862.71429	80379.875	71448.77778	64303.9	58458.09091	53586.58333	49464.53846	45931.35714	42869.26667	40189.9375	35724.38889	33844.15789	32151.95	26793.29167	25721.56	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121446	CHOYP_LOC100181607.2.2|m.55285	LADEFNAAYIVTGTR	LADEFNAAYIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121447	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121448	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121449	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	1595709	797854.5	531903	398927.25	319141.8	265951.5	227958.4286	199463.625	177301	159570.9	145064.4545	132975.75	122746.8462	113979.2143	106380.6	99731.8125	88650.5	83984.68421	79785.45	66487.875	63828.36	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121450	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121451	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121452	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121453	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121454	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121455	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121456	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121457	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121458	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121459	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121460	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121461	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121462	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121463	CHOYP_LOC100181607.2.2|m.55285	TILGSVSDYVMHHSHVPVLIYR	TILGSVSDYVMHHSHVPVLIYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
121899	CHOYP_LOC100185549.1.6|m.31232	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121900	CHOYP_LOC100185549.1.6|m.31232	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121901	CHOYP_LOC100185549.1.6|m.31232	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121902	CHOYP_LOC100185549.1.6|m.31232	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121903	CHOYP_LOC100185549.1.6|m.31232	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121904	CHOYP_LOC100185549.1.6|m.31232	LGIEAEFR	LGIEAEFR	22733	11366.5	7577.666667	5683.25	4546.6	3788.833333	3247.571429	2841.625	2525.888889	2273.3	2066.636364	1894.416667	1748.692308	1623.785714	1515.533333	1420.8125	1262.944444	1196.473684	1136.65	947.2083333	909.32	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121905	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	12373778	6186889	4124592.667	3093444.5	2474755.6	2062296.333	1767682.571	1546722.25	1374864.222	1237377.8	1124888.909	1031148.167	951829.0769	883841.2857	824918.5333	773361.125	687432.1111	651251.4737	618688.9	515574.0833	494951.12	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121906	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	11666637	5833318.5	3888879	2916659.25	2333327.4	1944439.5	1666662.429	1458329.625	1296293	1166663.7	1060603.364	972219.75	897433.6154	833331.2143	777775.8	729164.8125	648146.5	614033.5263	583331.85	486109.875	466665.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121907	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	6203541	3101770.5	2067847	1550885.25	1240708.2	1033923.5	886220.1429	775442.625	689282.3333	620354.1	563958.2727	516961.75	477195.4615	443110.0714	413569.4	387721.3125	344641.1667	326502.1579	310177.05	258480.875	248141.64	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121908	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121909	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121910	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121911	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	709354	354677	236451.3333	177338.5	141870.8	118225.6667	101336.2857	88669.25	78817.11111	70935.4	64486.72727	59112.83333	54565.69231	50668.14286	47290.26667	44334.625	39408.55556	37334.42105	35467.7	29556.41667	28374.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121912	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121913	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121914	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	362605	181302.5	120868.3333	90651.25	72521	60434.16667	51800.71429	45325.625	40289.44444	36260.5	32964.09091	30217.08333	27892.69231	25900.35714	24173.66667	22662.8125	20144.72222	19084.47368	18130.25	15108.54167	14504.2	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121915	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	337834	168917	112611.3333	84458.5	67566.8	56305.66667	48262	42229.25	37537.11111	33783.4	30712.18182	28152.83333	25987.23077	24131	22522.26667	21114.625	18768.55556	17780.73684	16891.7	14076.41667	13513.36	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121916	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	664425	332212.5	221475	166106.25	132885	110737.5	94917.85714	83053.125	73825	66442.5	60402.27273	55368.75	51109.61538	47458.92857	44295	41526.5625	36912.5	34969.73684	33221.25	27684.375	26577	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121917	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121918	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	568352	284176	189450.6667	142088	113670.4	94725.33333	81193.14286	71044	63150.22222	56835.2	51668.36364	47362.66667	43719.38462	40596.57143	37890.13333	35522	31575.11111	29913.26316	28417.6	23681.33333	22734.08	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121919	CHOYP_LOC100185549.1.6|m.31232	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121920	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121921	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121922	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121923	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	4566145	2283072.5	1522048.333	1141536.25	913229	761024.1667	652306.4286	570768.125	507349.4444	456614.5	415104.0909	380512.0833	351241.9231	326153.2143	304409.6667	285384.0625	253674.7222	240323.4211	228307.25	190256.0417	182645.8	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121924	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	5617387	2808693.5	1872462.333	1404346.75	1123477.4	936231.1667	802483.8571	702173.375	624154.1111	561738.7	510671.5455	468115.5833	432106.6923	401241.9286	374492.4667	351086.6875	312077.0556	295651.9474	280869.35	234057.7917	224695.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121925	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	7129088	3564544	2376362.667	1782272	1425817.6	1188181.333	1018441.143	891136	792120.8889	712908.8	648098.9091	594090.6667	548391.3846	509220.5714	475272.5333	445568	396060.4444	375215.1579	356454.4	297045.3333	285163.52	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121926	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	5611423	2805711.5	1870474.333	1402855.75	1122284.6	935237.1667	801631.8571	701427.875	623491.4444	561142.3	510129.3636	467618.5833	431647.9231	400815.9286	374094.8667	350713.9375	311745.7222	295338.0526	280571.15	233809.2917	224456.92	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121927	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	2822657	1411328.5	940885.6667	705664.25	564531.4	470442.8333	403236.7143	352832.125	313628.5556	282265.7	256605.1818	235221.4167	217127.4615	201618.3571	188177.1333	176416.0625	156814.2778	148560.8947	141132.85	117610.7083	112906.28	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121928	CHOYP_LOC100185549.1.6|m.31232	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121929	CHOYP_LOC100185549.3.6|m.43515	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121930	CHOYP_LOC100185549.3.6|m.43515	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121931	CHOYP_LOC100185549.3.6|m.43515	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121932	CHOYP_LOC100185549.3.6|m.43515	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121933	CHOYP_LOC100185549.3.6|m.43515	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121934	CHOYP_LOC100185549.3.6|m.43515	LGIEAEFR	LGIEAEFR	22733	11366.5	7577.666667	5683.25	4546.6	3788.833333	3247.571429	2841.625	2525.888889	2273.3	2066.636364	1894.416667	1748.692308	1623.785714	1515.533333	1420.8125	1262.944444	1196.473684	1136.65	947.2083333	909.32	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121935	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	12373778	6186889	4124592.667	3093444.5	2474755.6	2062296.333	1767682.571	1546722.25	1374864.222	1237377.8	1124888.909	1031148.167	951829.0769	883841.2857	824918.5333	773361.125	687432.1111	651251.4737	618688.9	515574.0833	494951.12	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121936	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	11666637	5833318.5	3888879	2916659.25	2333327.4	1944439.5	1666662.429	1458329.625	1296293	1166663.7	1060603.364	972219.75	897433.6154	833331.2143	777775.8	729164.8125	648146.5	614033.5263	583331.85	486109.875	466665.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121937	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	6203541	3101770.5	2067847	1550885.25	1240708.2	1033923.5	886220.1429	775442.625	689282.3333	620354.1	563958.2727	516961.75	477195.4615	443110.0714	413569.4	387721.3125	344641.1667	326502.1579	310177.05	258480.875	248141.64	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121938	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121939	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121940	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121941	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	709354	354677	236451.3333	177338.5	141870.8	118225.6667	101336.2857	88669.25	78817.11111	70935.4	64486.72727	59112.83333	54565.69231	50668.14286	47290.26667	44334.625	39408.55556	37334.42105	35467.7	29556.41667	28374.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121942	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121943	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121944	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	362605	181302.5	120868.3333	90651.25	72521	60434.16667	51800.71429	45325.625	40289.44444	36260.5	32964.09091	30217.08333	27892.69231	25900.35714	24173.66667	22662.8125	20144.72222	19084.47368	18130.25	15108.54167	14504.2	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121945	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	337834	168917	112611.3333	84458.5	67566.8	56305.66667	48262	42229.25	37537.11111	33783.4	30712.18182	28152.83333	25987.23077	24131	22522.26667	21114.625	18768.55556	17780.73684	16891.7	14076.41667	13513.36	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121946	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	664425	332212.5	221475	166106.25	132885	110737.5	94917.85714	83053.125	73825	66442.5	60402.27273	55368.75	51109.61538	47458.92857	44295	41526.5625	36912.5	34969.73684	33221.25	27684.375	26577	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121947	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121948	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	568352	284176	189450.6667	142088	113670.4	94725.33333	81193.14286	71044	63150.22222	56835.2	51668.36364	47362.66667	43719.38462	40596.57143	37890.13333	35522	31575.11111	29913.26316	28417.6	23681.33333	22734.08	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121949	CHOYP_LOC100185549.3.6|m.43515	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121950	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121951	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121952	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121953	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	4566145	2283072.5	1522048.333	1141536.25	913229	761024.1667	652306.4286	570768.125	507349.4444	456614.5	415104.0909	380512.0833	351241.9231	326153.2143	304409.6667	285384.0625	253674.7222	240323.4211	228307.25	190256.0417	182645.8	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121954	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	5617387	2808693.5	1872462.333	1404346.75	1123477.4	936231.1667	802483.8571	702173.375	624154.1111	561738.7	510671.5455	468115.5833	432106.6923	401241.9286	374492.4667	351086.6875	312077.0556	295651.9474	280869.35	234057.7917	224695.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121955	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	7129088	3564544	2376362.667	1782272	1425817.6	1188181.333	1018441.143	891136	792120.8889	712908.8	648098.9091	594090.6667	548391.3846	509220.5714	475272.5333	445568	396060.4444	375215.1579	356454.4	297045.3333	285163.52	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121956	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	5611423	2805711.5	1870474.333	1402855.75	1122284.6	935237.1667	801631.8571	701427.875	623491.4444	561142.3	510129.3636	467618.5833	431647.9231	400815.9286	374094.8667	350713.9375	311745.7222	295338.0526	280571.15	233809.2917	224456.92	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121957	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	2822657	1411328.5	940885.6667	705664.25	564531.4	470442.8333	403236.7143	352832.125	313628.5556	282265.7	256605.1818	235221.4167	217127.4615	201618.3571	188177.1333	176416.0625	156814.2778	148560.8947	141132.85	117610.7083	112906.28	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121958	CHOYP_LOC100185549.3.6|m.43515	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121959	CHOYP_LOC100185549.4.6|m.57314	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121960	CHOYP_LOC100185549.4.6|m.57314	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121961	CHOYP_LOC100185549.4.6|m.57314	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121962	CHOYP_LOC100185549.4.6|m.57314	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121963	CHOYP_LOC100185549.4.6|m.57314	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121964	CHOYP_LOC100185549.4.6|m.57314	LGIEAEFR	LGIEAEFR	22733	11366.5	7577.666667	5683.25	4546.6	3788.833333	3247.571429	2841.625	2525.888889	2273.3	2066.636364	1894.416667	1748.692308	1623.785714	1515.533333	1420.8125	1262.944444	1196.473684	1136.65	947.2083333	909.32	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121965	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	12373778	6186889	4124592.667	3093444.5	2474755.6	2062296.333	1767682.571	1546722.25	1374864.222	1237377.8	1124888.909	1031148.167	951829.0769	883841.2857	824918.5333	773361.125	687432.1111	651251.4737	618688.9	515574.0833	494951.12	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121966	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	11666637	5833318.5	3888879	2916659.25	2333327.4	1944439.5	1666662.429	1458329.625	1296293	1166663.7	1060603.364	972219.75	897433.6154	833331.2143	777775.8	729164.8125	648146.5	614033.5263	583331.85	486109.875	466665.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121967	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	6203541	3101770.5	2067847	1550885.25	1240708.2	1033923.5	886220.1429	775442.625	689282.3333	620354.1	563958.2727	516961.75	477195.4615	443110.0714	413569.4	387721.3125	344641.1667	326502.1579	310177.05	258480.875	248141.64	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121968	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121969	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121970	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121971	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	709354	354677	236451.3333	177338.5	141870.8	118225.6667	101336.2857	88669.25	78817.11111	70935.4	64486.72727	59112.83333	54565.69231	50668.14286	47290.26667	44334.625	39408.55556	37334.42105	35467.7	29556.41667	28374.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121972	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121973	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121974	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	362605	181302.5	120868.3333	90651.25	72521	60434.16667	51800.71429	45325.625	40289.44444	36260.5	32964.09091	30217.08333	27892.69231	25900.35714	24173.66667	22662.8125	20144.72222	19084.47368	18130.25	15108.54167	14504.2	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121975	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	337834	168917	112611.3333	84458.5	67566.8	56305.66667	48262	42229.25	37537.11111	33783.4	30712.18182	28152.83333	25987.23077	24131	22522.26667	21114.625	18768.55556	17780.73684	16891.7	14076.41667	13513.36	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121976	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	664425	332212.5	221475	166106.25	132885	110737.5	94917.85714	83053.125	73825	66442.5	60402.27273	55368.75	51109.61538	47458.92857	44295	41526.5625	36912.5	34969.73684	33221.25	27684.375	26577	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121977	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121978	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	568352	284176	189450.6667	142088	113670.4	94725.33333	81193.14286	71044	63150.22222	56835.2	51668.36364	47362.66667	43719.38462	40596.57143	37890.13333	35522	31575.11111	29913.26316	28417.6	23681.33333	22734.08	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121979	CHOYP_LOC100185549.4.6|m.57314	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121980	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121981	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121982	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121983	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	4566145	2283072.5	1522048.333	1141536.25	913229	761024.1667	652306.4286	570768.125	507349.4444	456614.5	415104.0909	380512.0833	351241.9231	326153.2143	304409.6667	285384.0625	253674.7222	240323.4211	228307.25	190256.0417	182645.8	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121984	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	5617387	2808693.5	1872462.333	1404346.75	1123477.4	936231.1667	802483.8571	702173.375	624154.1111	561738.7	510671.5455	468115.5833	432106.6923	401241.9286	374492.4667	351086.6875	312077.0556	295651.9474	280869.35	234057.7917	224695.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121985	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	7129088	3564544	2376362.667	1782272	1425817.6	1188181.333	1018441.143	891136	792120.8889	712908.8	648098.9091	594090.6667	548391.3846	509220.5714	475272.5333	445568	396060.4444	375215.1579	356454.4	297045.3333	285163.52	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121986	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	5611423	2805711.5	1870474.333	1402855.75	1122284.6	935237.1667	801631.8571	701427.875	623491.4444	561142.3	510129.3636	467618.5833	431647.9231	400815.9286	374094.8667	350713.9375	311745.7222	295338.0526	280571.15	233809.2917	224456.92	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121987	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	2822657	1411328.5	940885.6667	705664.25	564531.4	470442.8333	403236.7143	352832.125	313628.5556	282265.7	256605.1818	235221.4167	217127.4615	201618.3571	188177.1333	176416.0625	156814.2778	148560.8947	141132.85	117610.7083	112906.28	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121988	CHOYP_LOC100185549.4.6|m.57314	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
121989	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	1839699	919849.5	613233	459924.75	367939.8	306616.5	262814.1429	229962.375	204411	183969.9	167245.3636	153308.25	141515.3077	131407.0714	122646.6	114981.1875	102205.5	96826.26316	91984.95	76654.125	73587.96	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121990	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	3769780	1884890	1256593.333	942445	753956	628296.6667	538540	471222.5	418864.4444	376978	342707.2727	314148.3333	289983.0769	269270	251318.6667	235611.25	209432.2222	198409.4737	188489	157074.1667	150791.2	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121991	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	1233260	616630	411086.6667	308315	246652	205543.3333	176180	154157.5	137028.8889	123326	112114.5455	102771.6667	94866.15385	88090	82217.33333	77078.75	68514.44444	64908.42105	61663	51385.83333	49330.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121992	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121993	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121994	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121995	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121996	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121997	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121998	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
121999	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122000	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122001	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	1839281	919640.5	613093.6667	459820.25	367856.2	306546.8333	262754.4286	229910.125	204364.5556	183928.1	167207.3636	153273.4167	141483.1538	131377.2143	122618.7333	114955.0625	102182.2778	96804.26316	91964.05	76636.70833	73571.24	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122002	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	1121360	560680	373786.6667	280340	224272	186893.3333	160194.2857	140170	124595.5556	112136	101941.8182	93446.66667	86258.46154	80097.14286	74757.33333	70085	62297.77778	59018.94737	56068	46723.33333	44854.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122003	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122004	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122005	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122006	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	188111	94055.5	62703.66667	47027.75	37622.2	31351.83333	26873	23513.875	20901.22222	18811.1	17101	15675.91667	14470.07692	13436.5	12540.73333	11756.9375	10450.61111	9900.578947	9405.55	7837.958333	7524.44	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122007	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	32262	16131	10754	8065.5	6452.4	5377	4608.857143	4032.75	3584.666667	3226.2	2932.909091	2688.5	2481.692308	2304.428571	2150.8	2016.375	1792.333333	1698	1613.1	1344.25	1290.48	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122008	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	565280	282640	188426.6667	141320	113056	94213.33333	80754.28571	70660	62808.88889	56528	51389.09091	47106.66667	43483.07692	40377.14286	37685.33333	35330	31404.44444	29751.57895	28264	23553.33333	22611.2	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122009	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122010	CHOYP_LOC100185549.5.6|m.62694	EDDVIILVHTPER	EDDVIILVHTPER	13383	6691.5	4461	3345.75	2676.6	2230.5	1911.857143	1672.875	1487	1338.3	1216.636364	1115.25	1029.461538	955.9285714	892.2	836.4375	743.5	704.3684211	669.15	557.625	535.32	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122011	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122012	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	19427318	9713659	6475772.667	4856829.5	3885463.6	3237886.333	2775331.143	2428414.75	2158590.889	1942731.8	1766119.818	1618943.167	1494409.077	1387665.571	1295154.533	1214207.375	1079295.444	1022490.421	971365.9	809471.5833	777092.72	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122013	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	7157529	3578764.5	2385843	1789382.25	1431505.8	1192921.5	1022504.143	894691.125	795281	715752.9	650684.4545	596460.75	550579.1538	511252.0714	477168.6	447345.5625	397640.5	376712.0526	357876.45	298230.375	286301.16	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122014	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	2021106	1010553	673702	505276.5	404221.2	336851	288729.4286	252638.25	224567.3333	202110.6	183736.9091	168425.5	155469.6923	144364.7143	134740.4	126319.125	112283.6667	106374	101055.3	84212.75	80844.24	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122015	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	3700342	1850171	1233447.333	925085.5	740068.4	616723.6667	528620.2857	462542.75	411149.1111	370034.2	336394.7273	308361.8333	284641.6923	264310.1429	246689.4667	231271.375	205574.5556	194754.8421	185017.1	154180.9167	148013.68	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122016	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122017	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	3152963	1576481.5	1050987.667	788240.75	630592.6	525493.8333	450423.2857	394120.375	350329.2222	315296.3	286633	262746.9167	242535.6154	225211.6429	210197.5333	197060.1875	175164.6111	165945.4211	157648.15	131373.4583	126118.52	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122018	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	2010379	1005189.5	670126.3333	502594.75	402075.8	335063.1667	287197	251297.375	223375.4444	201037.9	182761.7273	167531.5833	154644.5385	143598.5	134025.2667	125648.6875	111687.7222	105809.4211	100518.95	83765.79167	80415.16	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122019	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	2595806	1297903	865268.6667	648951.5	519161.2	432634.3333	370829.4286	324475.75	288422.8889	259580.6	235982.3636	216317.1667	199677.3846	185414.7143	173053.7333	162237.875	144211.4444	136621.3684	129790.3	108158.5833	103832.24	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122020	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	1407838	703919	469279.3333	351959.5	281567.6	234639.6667	201119.7143	175979.75	156426.4444	140783.8	127985.2727	117319.8333	108295.2308	100559.8571	93855.86667	87989.875	78213.22222	74096.73684	70391.9	58659.91667	56313.52	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122021	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	494290	247145	164763.3333	123572.5	98858	82381.66667	70612.85714	61786.25	54921.11111	49429	44935.45455	41190.83333	38022.30769	35306.42857	32952.66667	30893.125	27460.55556	26015.26316	24714.5	20595.41667	19771.6	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122022	CHOYP_LOC100185549.5.6|m.62694	EGEAGEAIVAIAER	EGEAGEAIVAIAER	683569	341784.5	227856.3333	170892.25	136713.8	113928.1667	97652.71429	85446.125	75952.11111	68356.9	62142.63636	56964.08333	52582.23077	48826.35714	45571.26667	42723.0625	37976.05556	35977.31579	34178.45	28482.04167	27342.76	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122023	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	92928312	46464156	30976104	23232078	18585662.4	15488052	13275473.14	11616039	10325368	9292831.2	8448028.364	7744026	7148331.692	6637736.571	6195220.8	5808019.5	5162684	4890963.789	4646415.6	3872013	3717132.48	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122024	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	41115940	20557970	13705313.33	10278985	8223188	6852656.667	5873705.714	5139492.5	4568437.778	4111594	3737812.727	3426328.333	3162764.615	2936852.857	2741062.667	2569746.25	2284218.889	2163996.842	2055797	1713164.167	1644637.6	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122025	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	10903497	5451748.5	3634499	2725874.25	2180699.4	1817249.5	1557642.429	1362937.125	1211499.667	1090349.7	991227	908624.75	838730.5385	778821.2143	726899.8	681468.5625	605749.8333	573868.2632	545174.85	454312.375	436139.88	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122026	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	15307842	7653921	5102614	3826960.5	3061568.4	2551307	2186834.571	1913480.25	1700871.333	1530784.2	1391622	1275653.5	1177526.308	1093417.286	1020522.8	956740.125	850435.6667	805675.8947	765392.1	637826.75	612313.68	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122027	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	29870092	14935046	9956697.333	7467523	5974018.4	4978348.667	4267156	3733761.5	3318899.111	2987009.2	2715462.909	2489174.333	2297699.385	2133578	1991339.467	1866880.75	1659449.556	1572110.105	1493504.6	1244587.167	1194803.68	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122028	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	8079043	4039521.5	2693014.333	2019760.75	1615808.6	1346507.167	1154149	1009880.375	897671.4444	807904.3	734458.4545	673253.5833	621464.8462	577074.5	538602.8667	504940.1875	448835.7222	425212.7895	403952.15	336626.7917	323161.72	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122029	CHOYP_LOC100185549.5.6|m.62694	ANLIVTGTR	ANLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122030	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	5924724	2962362	1974908	1481181	1184944.8	987454	846389.1429	740590.5	658302.6667	592472.4	538611.2727	493727	455748	423194.5714	394981.6	370295.25	329151.3333	311827.5789	296236.2	246863.5	236988.96	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122031	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122032	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	4138462	2069231	1379487.333	1034615.5	827692.4	689743.6667	591208.8571	517307.75	459829.1111	413846.2	376223.8182	344871.8333	318343.2308	295604.4286	275897.4667	258653.875	229914.5556	217813.7895	206923.1	172435.9167	165538.48	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122033	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	1759723	879861.5	586574.3333	439930.75	351944.6	293287.1667	251389	219965.375	195524.7778	175972.3	159974.8182	146643.5833	135363.3077	125694.5	117314.8667	109982.6875	97762.38889	92617	87986.15	73321.79167	70388.92	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122034	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	470760	235380	156920	117690	94152	78460	67251.42857	58845	52306.66667	47076	42796.36364	39230	36212.30769	33625.71429	31384	29422.5	26153.33333	24776.84211	23538	19615	18830.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122035	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	468063	234031.5	156021	117015.75	93612.6	78010.5	66866.14286	58507.875	52007	46806.3	42551.18182	39005.25	36004.84615	33433.07143	31204.2	29253.9375	26003.5	24634.89474	23403.15	19502.625	18722.52	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122036	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122037	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	417311	208655.5	139103.6667	104327.75	83462.2	69551.83333	59615.85714	52163.875	46367.88889	41731.1	37937.36364	34775.91667	32100.84615	29807.92857	27820.73333	26081.9375	23183.94444	21963.73684	20865.55	17387.95833	16692.44	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122038	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	616337	308168.5	205445.6667	154084.25	123267.4	102722.8333	88048.14286	77042.125	68481.88889	61633.7	56030.63636	51361.41667	47410.53846	44024.07143	41089.13333	38521.0625	34240.94444	32438.78947	30816.85	25680.70833	24653.48	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122039	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122040	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	656385	328192.5	218795	164096.25	131277	109397.5	93769.28571	82048.125	72931.66667	65638.5	59671.36364	54698.75	50491.15385	46884.64286	43759	41024.0625	36465.83333	34546.57895	32819.25	27349.375	26255.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122041	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	1089872	544936	363290.6667	272468	217974.4	181645.3333	155696	136234	121096.8889	108987.2	99079.27273	90822.66667	83836.30769	77848	72658.13333	68117	60548.44444	57361.68421	54493.6	45411.33333	43594.88	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122042	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122043	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122044	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122045	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122046	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	269454	134727	89818	67363.5	53890.8	44909	38493.42857	33681.75	29939.33333	26945.4	24495.81818	22454.5	20727.23077	19246.71429	17963.6	16840.875	14969.66667	14181.78947	13472.7	11227.25	10778.16	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122047	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122048	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122049	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	2584052	1292026	861350.6667	646013	516810.4	430675.3333	369150.2857	323006.5	287116.8889	258405.2	234913.8182	215337.6667	198773.2308	184575.1429	172270.1333	161503.25	143558.4444	136002.7368	129202.6	107668.8333	103362.08	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122050	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	794041	397020.5	264680.3333	198510.25	158808.2	132340.1667	113434.4286	99255.125	88226.77778	79404.1	72185.54545	66170.08333	61080.07692	56717.21429	52936.06667	49627.5625	44113.38889	41791.63158	39702.05	33085.04167	31761.64	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122051	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	939125	469562.5	313041.6667	234781.25	187825	156520.8333	134160.7143	117390.625	104347.2222	93912.5	85375	78260.41667	72240.38462	67080.35714	62608.33333	58695.3125	52173.61111	49427.63158	46956.25	39130.20833	37565	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122052	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	854152	427076	284717.3333	213538	170830.4	142358.6667	122021.7143	106769	94905.77778	85415.2	77650.18182	71179.33333	65704	61010.85714	56943.46667	53384.5	47452.88889	44955.36842	42707.6	35589.66667	34166.08	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122053	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	1293935	646967.5	431311.6667	323483.75	258787	215655.8333	184847.8571	161741.875	143770.5556	129393.5	117630.4545	107827.9167	99533.46154	92423.92857	86262.33333	80870.9375	71885.27778	68101.84211	64696.75	53913.95833	51757.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122054	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	1531218	765609	510406	382804.5	306243.6	255203	218745.4286	191402.25	170135.3333	153121.8	139201.6364	127601.5	117786	109372.7143	102081.2	95701.125	85067.66667	80590.42105	76560.9	63800.75	61248.72	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122055	CHOYP_LOC100185549.5.6|m.62694	TFLGSVSDYVIHHAK	TFLGSVSDYVIHHAK	1455202	727601	485067.3333	363800.5	291040.4	242533.6667	207886	181900.25	161689.1111	145520.2	132291.0909	121266.8333	111938.6154	103943	97013.46667	90950.125	80844.55556	76589.57895	72760.1	60633.41667	58208.08	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
122056	CHOYP_LOC100185549.6.6|m.63147	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122057	CHOYP_LOC100185549.6.6|m.63147	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122058	CHOYP_LOC100185549.6.6|m.63147	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122059	CHOYP_LOC100185549.6.6|m.63147	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122060	CHOYP_LOC100185549.6.6|m.63147	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122061	CHOYP_LOC100185549.6.6|m.63147	LGIEAEFR	LGIEAEFR	22733	11366.5	7577.666667	5683.25	4546.6	3788.833333	3247.571429	2841.625	2525.888889	2273.3	2066.636364	1894.416667	1748.692308	1623.785714	1515.533333	1420.8125	1262.944444	1196.473684	1136.65	947.2083333	909.32	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122062	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	12373778	6186889	4124592.667	3093444.5	2474755.6	2062296.333	1767682.571	1546722.25	1374864.222	1237377.8	1124888.909	1031148.167	951829.0769	883841.2857	824918.5333	773361.125	687432.1111	651251.4737	618688.9	515574.0833	494951.12	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122063	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	11666637	5833318.5	3888879	2916659.25	2333327.4	1944439.5	1666662.429	1458329.625	1296293	1166663.7	1060603.364	972219.75	897433.6154	833331.2143	777775.8	729164.8125	648146.5	614033.5263	583331.85	486109.875	466665.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122064	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	6203541	3101770.5	2067847	1550885.25	1240708.2	1033923.5	886220.1429	775442.625	689282.3333	620354.1	563958.2727	516961.75	477195.4615	443110.0714	413569.4	387721.3125	344641.1667	326502.1579	310177.05	258480.875	248141.64	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122065	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122066	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122067	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122068	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	709354	354677	236451.3333	177338.5	141870.8	118225.6667	101336.2857	88669.25	78817.11111	70935.4	64486.72727	59112.83333	54565.69231	50668.14286	47290.26667	44334.625	39408.55556	37334.42105	35467.7	29556.41667	28374.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122069	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122070	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122071	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	362605	181302.5	120868.3333	90651.25	72521	60434.16667	51800.71429	45325.625	40289.44444	36260.5	32964.09091	30217.08333	27892.69231	25900.35714	24173.66667	22662.8125	20144.72222	19084.47368	18130.25	15108.54167	14504.2	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122072	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	337834	168917	112611.3333	84458.5	67566.8	56305.66667	48262	42229.25	37537.11111	33783.4	30712.18182	28152.83333	25987.23077	24131	22522.26667	21114.625	18768.55556	17780.73684	16891.7	14076.41667	13513.36	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122073	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	664425	332212.5	221475	166106.25	132885	110737.5	94917.85714	83053.125	73825	66442.5	60402.27273	55368.75	51109.61538	47458.92857	44295	41526.5625	36912.5	34969.73684	33221.25	27684.375	26577	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122074	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122075	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	568352	284176	189450.6667	142088	113670.4	94725.33333	81193.14286	71044	63150.22222	56835.2	51668.36364	47362.66667	43719.38462	40596.57143	37890.13333	35522	31575.11111	29913.26316	28417.6	23681.33333	22734.08	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122076	CHOYP_LOC100185549.6.6|m.63147	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122077	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122078	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122079	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122080	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	4566145	2283072.5	1522048.333	1141536.25	913229	761024.1667	652306.4286	570768.125	507349.4444	456614.5	415104.0909	380512.0833	351241.9231	326153.2143	304409.6667	285384.0625	253674.7222	240323.4211	228307.25	190256.0417	182645.8	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122081	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	5617387	2808693.5	1872462.333	1404346.75	1123477.4	936231.1667	802483.8571	702173.375	624154.1111	561738.7	510671.5455	468115.5833	432106.6923	401241.9286	374492.4667	351086.6875	312077.0556	295651.9474	280869.35	234057.7917	224695.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122082	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	7129088	3564544	2376362.667	1782272	1425817.6	1188181.333	1018441.143	891136	792120.8889	712908.8	648098.9091	594090.6667	548391.3846	509220.5714	475272.5333	445568	396060.4444	375215.1579	356454.4	297045.3333	285163.52	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122083	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	5611423	2805711.5	1870474.333	1402855.75	1122284.6	935237.1667	801631.8571	701427.875	623491.4444	561142.3	510129.3636	467618.5833	431647.9231	400815.9286	374094.8667	350713.9375	311745.7222	295338.0526	280571.15	233809.2917	224456.92	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122084	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	2822657	1411328.5	940885.6667	705664.25	564531.4	470442.8333	403236.7143	352832.125	313628.5556	282265.7	256605.1818	235221.4167	217127.4615	201618.3571	188177.1333	176416.0625	156814.2778	148560.8947	141132.85	117610.7083	112906.28	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
122085	CHOYP_LOC100185549.6.6|m.63147	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
123943	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	46850780	23425390	15616926.67	11712695	9370156	7808463.333	6692968.571	5856347.5	5205642.222	4685078	4259161.818	3904231.667	3603906.154	3346484.286	3123385.333	2928173.75	2602821.111	2465830.526	2342539	1952115.833	1874031.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123944	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	29077112	14538556	9692370.667	7269278	5815422.4	4846185.333	4153873.143	3634639	3230790.222	2907711.2	2643373.818	2423092.667	2236700.923	2076936.571	1938474.133	1817319.5	1615395.111	1530374.316	1453855.6	1211546.333	1163084.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123945	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	12124320	6062160	4041440	3031080	2424864	2020720	1732045.714	1515540	1347146.667	1212432	1102210.909	1010360	932640	866022.8571	808288	757770	673573.3333	638122.1053	606216	505180	484972.8	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123946	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	280900	140450	93633.33333	70225	56180	46816.66667	40128.57143	35112.5	31211.11111	28090	25536.36364	23408.33333	21607.69231	20064.28571	18726.66667	17556.25	15605.55556	14784.21053	14045	11704.16667	11236	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123947	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	2438919	1219459.5	812973	609729.75	487783.8	406486.5	348417	304864.875	270991	243891.9	221719.9091	203243.25	187609.1538	174208.5	162594.6	152432.4375	135495.5	128364.1579	121945.95	101621.625	97556.76	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123948	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	8162578	4081289	2720859.333	2040644.5	1632515.6	1360429.667	1166082.571	1020322.25	906953.1111	816257.8	742052.5455	680214.8333	627890.6154	583041.2857	544171.8667	510161.125	453476.5556	429609.3684	408128.9	340107.4167	326503.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123949	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123950	CHOYP_LOC100211409.1.1|m.4742	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123951	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	88675256	44337628	29558418.67	22168814	17735051.2	14779209.33	12667893.71	11084407	9852806.222	8867525.6	8061386.909	7389604.667	6821173.538	6333946.857	5911683.733	5542203.5	4926403.111	4667118.737	4433762.8	3694802.333	3547010.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123952	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	42837028	21418514	14279009.33	10709257	8567405.6	7139504.667	6119575.429	5354628.5	4759669.778	4283702.8	3894275.273	3569752.333	3295156	3059787.714	2855801.867	2677314.25	2379834.889	2254580.421	2141851.4	1784876.167	1713481.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123953	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	13505777	6752888.5	4501925.667	3376444.25	2701155.4	2250962.833	1929396.714	1688222.125	1500641.889	1350577.7	1227797.909	1125481.417	1038905.923	964698.3571	900385.1333	844111.0625	750320.9444	710830.3684	675288.85	562740.7083	540231.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123954	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	17586380	8793190	5862126.667	4396595	3517276	2931063.333	2512340	2198297.5	1954042.222	1758638	1598761.818	1465531.667	1352798.462	1256170	1172425.333	1099148.75	977021.1111	925598.9474	879319	732765.8333	703455.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123955	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	4105488	2052744	1368496	1026372	821097.6	684248	586498.2857	513186	456165.3333	410548.8	373226.1818	342124	315806.7692	293249.1429	273699.2	256593	228082.6667	216078.3158	205274.4	171062	164219.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123956	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	9652707	4826353.5	3217569	2413176.75	1930541.4	1608784.5	1378958.143	1206588.375	1072523	965270.7	877518.8182	804392.25	742515.9231	689479.0714	643513.8	603294.1875	536261.5	508037.2105	482635.35	402196.125	386108.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123957	CHOYP_LOC100211409.1.1|m.4742	VSVSDGMVR	VSVSDGMVR	213204	106602	71068	53301	42640.8	35534	30457.71429	26650.5	23689.33333	21320.4	19382.18182	17767	16400.30769	15228.85714	14213.6	13325.25	11844.66667	11221.26316	10660.2	8883.5	8528.16	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123958	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123959	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123960	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123961	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123962	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123963	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123964	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123965	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123966	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123967	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123968	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123969	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123970	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123971	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123972	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123973	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123974	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123975	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123976	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123977	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123978	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123979	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123980	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123981	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123982	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123983	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123984	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123985	CHOYP_LOC100211409.1.1|m.4742	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123986	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	170090	85045	56696.66667	42522.5	34018	28348.33333	24298.57143	21261.25	18898.88889	17009	15462.72727	14174.16667	13083.84615	12149.28571	11339.33333	10630.625	9449.444444	8952.105263	8504.5	7087.083333	6803.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123987	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	567582	283791	189194	141895.5	113516.4	94597	81083.14286	70947.75	63064.66667	56758.2	51598.36364	47298.5	43660.15385	40541.57143	37838.8	35473.875	31532.33333	29872.73684	28379.1	23649.25	22703.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123988	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123989	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123990	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	75461	37730.5	25153.66667	18865.25	15092.2	12576.83333	10780.14286	9432.625	8384.555556	7546.1	6860.090909	6288.416667	5804.692308	5390.071429	5030.733333	4716.3125	4192.277778	3971.631579	3773.05	3144.208333	3018.44	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123991	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123992	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123993	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123994	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
123995	CHOYP_LOC100211409.1.1|m.4742	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
128452	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128453	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	45367320	22683660	15122440	11341830	9073464	7561220	6481045.714	5670915	5040813.333	4536732	4124301.818	3780610	3489793.846	3240522.857	3024488	2835457.5	2520406.667	2387753.684	2268366	1890305	1814692.8	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128454	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	14095442	7047721	4698480.667	3523860.5	2819088.4	2349240.333	2013634.571	1761930.25	1566160.222	1409544.2	1281403.818	1174620.167	1084264.769	1006817.286	939696.1333	880965.125	783080.1111	741865.3684	704772.1	587310.0833	563817.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128455	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	1261852	630926	420617.3333	315463	252370.4	210308.6667	180264.5714	157731.5	140205.7778	126185.2	114713.8182	105154.3333	97065.53846	90132.28571	84123.46667	78865.75	70102.88889	66413.26316	63092.6	52577.16667	50474.08	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128456	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	449337	224668.5	149779	112334.25	89867.4	74889.5	64191	56167.125	49926.33333	44933.7	40848.81818	37444.75	34564.38462	32095.5	29955.8	28083.5625	24963.16667	23649.31579	22466.85	18722.375	17973.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128457	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	414457	207228.5	138152.3333	103614.25	82891.4	69076.16667	59208.14286	51807.125	46050.77778	41445.7	37677.90909	34538.08333	31881.30769	29604.07143	27630.46667	25903.5625	23025.38889	21813.52632	20722.85	17269.04167	16578.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128458	CHOYP_LOC100367736.2.2|m.66862	AIIDVLAHR	AIIDVLAHR	96184	48092	32061.33333	24046	19236.8	16030.66667	13740.57143	12023	10687.11111	9618.4	8744	8015.333333	7398.769231	6870.285714	6412.266667	6011.5	5343.555556	5062.315789	4809.2	4007.666667	3847.36	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128459	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128460	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128461	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128462	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	1315751	657875.5	438583.6667	328937.75	263150.2	219291.8333	187964.4286	164468.875	146194.5556	131575.1	119613.7273	109645.9167	101211.6154	93982.21429	87716.73333	82234.4375	73097.27778	69250.05263	65787.55	54822.95833	52630.04	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128463	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	523636	261818	174545.3333	130909	104727.2	87272.66667	74805.14286	65454.5	58181.77778	52363.6	47603.27273	43636.33333	40279.69231	37402.57143	34909.06667	32727.25	29090.88889	27559.78947	26181.8	21818.16667	20945.44	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128464	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	429354	214677	143118	107338.5	85870.8	71559	61336.28571	53669.25	47706	42935.4	39032.18182	35779.5	33027.23077	30668.14286	28623.6	26834.625	23853	22597.57895	21467.7	17889.75	17174.16	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128465	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	337302	168651	112434	84325.5	67460.4	56217	48186	42162.75	37478	33730.2	30663.81818	28108.5	25946.30769	24093	22486.8	21081.375	18739	17752.73684	16865.1	14054.25	13492.08	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128466	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	190770	95385	63590	47692.5	38154	31795	27252.85714	23846.25	21196.66667	19077	17342.72727	15897.5	14674.61538	13626.42857	12718	11923.125	10598.33333	10040.52632	9538.5	7948.75	7630.8	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128467	CHOYP_LOC100367736.2.2|m.66862	DIESDTSGHFK	DIESDTSGHFK	146967	73483.5	48989	36741.75	29393.4	24494.5	20995.28571	18370.875	16329.66667	14696.7	13360.63636	12247.25	11305.15385	10497.64286	9797.8	9185.4375	8164.833333	7735.105263	7348.35	6123.625	5878.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128468	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	5546974	2773487	1848991.333	1386743.5	1109394.8	924495.6667	792424.8571	693371.75	616330.4444	554697.4	504270.3636	462247.8333	426690.3077	396212.4286	369798.2667	346685.875	308165.2222	291946	277348.7	231123.9167	221878.96	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128469	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	1122456	561228	374152	280614	224491.2	187076	160350.8571	140307	124717.3333	112245.6	102041.4545	93538	86342.76923	80175.42857	74830.4	70153.5	62358.66667	59076.63158	56122.8	46769	44898.24	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128470	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	1518067	759033.5	506022.3333	379516.75	303613.4	253011.1667	216866.7143	189758.375	168674.1111	151806.7	138006.0909	126505.5833	116774.3846	108433.3571	101204.4667	94879.1875	84337.05556	79898.26316	75903.35	63252.79167	60722.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128471	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	2238778	1119389	746259.3333	559694.5	447755.6	373129.6667	319825.4286	279847.25	248753.1111	223877.8	203525.2727	186564.8333	172213.6923	159912.7143	149251.8667	139923.625	124376.5556	117830.4211	111938.9	93282.41667	89551.12	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128472	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	232283	116141.5	77427.66667	58070.75	46456.6	38713.83333	33183.28571	29035.375	25809.22222	23228.3	21116.63636	19356.91667	17867.92308	16591.64286	15485.53333	14517.6875	12904.61111	12225.42105	11614.15	9678.458333	9291.32	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128473	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	1005803	502901.5	335267.6667	251450.75	201160.6	167633.8333	143686.1429	125725.375	111755.8889	100580.3	91436.63636	83816.91667	77369.46154	71843.07143	67053.53333	62862.6875	55877.94444	52937	50290.15	41908.45833	40232.12	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128474	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	406202	203101	135400.6667	101550.5	81240.4	67700.33333	58028.85714	50775.25	45133.55556	40620.2	36927.45455	33850.16667	31246.30769	29014.42857	27080.13333	25387.625	22566.77778	21379.05263	20310.1	16925.08333	16248.08	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128475	CHOYP_LOC100367736.2.2|m.66862	LMVSLASGGR	LMVSLASGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128476	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	21769394	10884697	7256464.667	5442348.5	4353878.8	3628232.333	3109913.429	2721174.25	2418821.556	2176939.4	1979035.818	1814116.167	1674568.769	1554956.714	1451292.933	1360587.125	1209410.778	1145757.579	1088469.7	907058.0833	870775.76	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128477	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128478	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128479	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128480	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	6547146	3273573	2182382	1636786.5	1309429.2	1091191	935306.5714	818393.25	727460.6667	654714.6	595195.0909	545595.5	503626.6154	467653.2857	436476.4	409196.625	363730.3333	344586.6316	327357.3	272797.75	261885.84	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128481	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128482	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	1389415	694707.5	463138.3333	347353.75	277883	231569.1667	198487.8571	173676.875	154379.4444	138941.5	126310.4545	115784.5833	106878.0769	99243.92857	92627.66667	86838.4375	77189.72222	73127.10526	69470.75	57892.29167	55576.6	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128483	CHOYP_LOC100367736.2.2|m.66862	MENQPVDMTK	MENQPVDMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128484	CHOYP_LOC100367736.2.2|m.66862	AVFDAYQK	AVFDAYQK	71252192	35626096	23750730.67	17813048	14250438.4	11875365.33	10178884.57	8906524	7916910.222	7125219.2	6477472	5937682.667	5480937.846	5089442.286	4750146.133	4453262	3958455.111	3750115.368	3562609.6	2968841.333	2850087.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128485	CHOYP_LOC100367736.2.2|m.66862	AVFDAYQK	AVFDAYQK	35622112	17811056	11874037.33	8905528	7124422.4	5937018.667	5088873.143	4452764	3958012.444	3562211.2	3238373.818	2968509.333	2740162.462	2544436.571	2374807.467	2226382	1979006.222	1874848	1781105.6	1484254.667	1424884.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128486	CHOYP_LOC100367736.2.2|m.66862	AVFDAYQK	AVFDAYQK	11104014	5552007	3701338	2776003.5	2220802.8	1850669	1586287.714	1388001.75	1233779.333	1110401.4	1009455.818	925334.5	854154.9231	793143.8571	740267.6	694000.875	616889.6667	584421.7895	555200.7	462667.25	444160.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128487	CHOYP_LOC100367736.2.2|m.66862	AVFDAYQK	AVFDAYQK	5185065	2592532.5	1728355	1296266.25	1037013	864177.5	740723.5714	648133.125	576118.3333	518506.5	471369.5455	432088.75	398851.1538	370361.7857	345671	324066.5625	288059.1667	272898.1579	259253.25	216044.375	207402.6	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128488	CHOYP_LOC100367736.2.2|m.66862	AVFDAYQK	AVFDAYQK	5411447	2705723.5	1803815.667	1352861.75	1082289.4	901907.8333	773063.8571	676430.875	601271.8889	541144.7	491949.7273	450953.9167	416265.1538	386531.9286	360763.1333	338215.4375	300635.9444	284813	270572.35	225476.9583	216457.88	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128489	CHOYP_LOC100367736.2.2|m.66862	AVFDAYQK	AVFDAYQK	2485235	1242617.5	828411.6667	621308.75	497047	414205.8333	355033.5714	310654.375	276137.2222	248523.5	225930.4545	207102.9167	191171.9231	177516.7857	165682.3333	155327.1875	138068.6111	130801.8421	124261.75	103551.4583	99409.4	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128490	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128491	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	15981338	7990669	5327112.667	3995334.5	3196267.6	2663556.333	2283048.286	1997667.25	1775704.222	1598133.8	1452848.909	1331778.167	1229333.692	1141524.143	1065422.533	998833.625	887852.1111	841123.0526	799066.9	665889.0833	639253.52	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128492	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128493	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	2446182	1223091	815394	611545.5	489236.4	407697	349454.5714	305772.75	271798	244618.2	222380.1818	203848.5	188167.8462	174727.2857	163078.8	152886.375	135899	128746.4211	122309.1	101924.25	97847.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128494	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	962039	481019.5	320679.6667	240509.75	192407.8	160339.8333	137434.1429	120254.875	106893.2222	96203.9	87458.09091	80169.91667	74003	68717.07143	64135.93333	60127.4375	53446.61111	50633.63158	48101.95	40084.95833	38481.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128495	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
128496	CHOYP_LOC100367736.2.2|m.66862	AEVDMVQVK	AEVDMVQVK	425847	212923.5	141949	106461.75	85169.4	70974.5	60835.28571	53230.875	47316.33333	42584.7	38713.36364	35487.25	32757.46154	30417.64286	28389.8	26615.4375	23658.16667	22413	21292.35	17743.625	17033.88	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
134904	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	3438587	1719293.5	1146195.667	859646.75	687717.4	573097.8333	491226.7143	429823.375	382065.2222	343858.7	312598.8182	286548.9167	264506.6923	245613.3571	229239.1333	214911.6875	191032.6111	180978.2632	171929.35	143274.4583	137543.48	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134905	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	1905725	952862.5	635241.6667	476431.25	381145	317620.8333	272246.4286	238215.625	211747.2222	190572.5	173247.7273	158810.4167	146594.2308	136123.2143	127048.3333	119107.8125	105873.6111	100301.3158	95286.25	79405.20833	76229	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134906	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134907	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134908	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	58342	29171	19447.33333	14585.5	11668.4	9723.666667	8334.571429	7292.75	6482.444444	5834.2	5303.818182	4861.833333	4487.846154	4167.285714	3889.466667	3646.375	3241.222222	3070.631579	2917.1	2430.916667	2333.68	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134909	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	437011	218505.5	145670.3333	109252.75	87402.2	72835.16667	62430.14286	54626.375	48556.77778	43701.1	39728.27273	36417.58333	33616.23077	31215.07143	29134.06667	27313.1875	24278.38889	23000.57895	21850.55	18208.79167	17480.44	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134910	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134911	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134912	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134913	CHOYP_LOC100370583.1.1|m.56859	VINMIVNEKPNR	VINMIVNEKPNR	53683	26841.5	17894.33333	13420.75	10736.6	8947.166667	7669	6710.375	5964.777778	5368.3	4880.272727	4473.583333	4129.461538	3834.5	3578.866667	3355.1875	2982.388889	2825.421053	2684.15	2236.791667	2147.32	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134914	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	5981936	2990968	1993978.667	1495484	1196387.2	996989.3333	854562.2857	747742	664659.5556	598193.6	543812.3636	498494.6667	460148.9231	427281.1429	398795.7333	373871	332329.7778	314838.7368	299096.8	249247.3333	239277.44	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134915	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134916	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	926798	463399	308932.6667	231699.5	185359.6	154466.3333	132399.7143	115849.75	102977.5556	92679.8	84254.36364	77233.16667	71292.15385	66199.85714	61786.53333	57924.875	51488.77778	48778.84211	46339.9	38616.58333	37071.92	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134917	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	1460859	730429.5	486953	365214.75	292171.8	243476.5	208694.1429	182607.375	162317.6667	146085.9	132805.3636	121738.25	112373.7692	104347.0714	97390.6	91303.6875	81158.83333	76887.31579	73042.95	60869.125	58434.36	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134918	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	1580827	790413.5	526942.3333	395206.75	316165.4	263471.1667	225832.4286	197603.375	175647.4444	158082.7	143711.5455	131735.5833	121602.0769	112916.2143	105388.4667	98801.6875	87823.72222	83201.42105	79041.35	65867.79167	63233.08	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134919	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	855382	427691	285127.3333	213845.5	171076.4	142563.6667	122197.4286	106922.75	95042.44444	85538.2	77762	71281.83333	65798.61538	61098.71429	57025.46667	53461.375	47521.22222	45020.10526	42769.1	35640.91667	34215.28	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134920	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	734710	367355	244903.3333	183677.5	146942	122451.6667	104958.5714	91838.75	81634.44444	73471	66791.81818	61225.83333	56516.15385	52479.28571	48980.66667	45919.375	40817.22222	38668.94737	36735.5	30612.91667	29388.4	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
134921	CHOYP_LOC100370583.1.1|m.56859	MLAEVLSEVR	MLAEVLSEVR	21221	10610.5	7073.666667	5305.25	4244.2	3536.833333	3031.571429	2652.625	2357.888889	2122.1	1929.181818	1768.416667	1632.384615	1515.785714	1414.733333	1326.3125	1178.944444	1116.894737	1061.05	884.2083333	848.84	Q05655	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	activation of phospholipase C activity [GO:0007202]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006921; GO:0007049; GO:0007165; GO:0007202; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235
137483	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	13806587	6903293.5	4602195.667	3451646.75	2761317.4	2301097.833	1972369.571	1725823.375	1534065.222	1380658.7	1255144.273	1150548.917	1062045.154	986184.7857	920439.1333	862911.6875	767032.6111	726662.4737	690329.35	575274.4583	552263.48	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137484	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	7467500	3733750	2489166.667	1866875	1493500	1244583.333	1066785.714	933437.5	829722.2222	746750	678863.6364	622291.6667	574423.0769	533392.8571	497833.3333	466718.75	414861.1111	393026.3158	373375	311145.8333	298700	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137485	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	9956258	4978129	3318752.667	2489064.5	1991251.6	1659376.333	1422322.571	1244532.25	1106250.889	995625.8	905114.3636	829688.1667	765866	711161.2857	663750.5333	622266.125	553125.4444	524013.5789	497812.9	414844.0833	398250.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137486	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	2651857	1325928.5	883952.3333	662964.25	530371.4	441976.1667	378836.7143	331482.125	294650.7778	265185.7	241077.9091	220988.0833	203989	189418.3571	176790.4667	165741.0625	147325.3889	139571.4211	132592.85	110494.0417	106074.28	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137487	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	4303631	2151815.5	1434543.667	1075907.75	860726.2	717271.8333	614804.4286	537953.875	478181.2222	430363.1	391239.1818	358635.9167	331048.5385	307402.2143	286908.7333	268976.9375	239090.6111	226506.8947	215181.55	179317.9583	172145.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137488	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	1724601	862300.5	574867	431150.25	344920.2	287433.5	246371.5714	215575.125	191622.3333	172460.1	156781.9091	143716.75	132661.6154	123185.7857	114973.4	107787.5625	95811.16667	90768.47368	86230.05	71858.375	68984.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137489	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	1440158	720079	480052.6667	360039.5	288031.6	240026.3333	205736.8571	180019.75	160017.5556	144015.8	130923.4545	120013.1667	110781.3846	102868.4286	96010.53333	90009.875	80008.77778	75797.78947	72007.9	60006.58333	57606.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137490	CHOYP_LOC100371808.1.2|m.15364	SEEIEDIILR	SEEIEDIILR	747769	373884.5	249256.3333	186942.25	149553.8	124628.1667	106824.1429	93471.125	83085.44444	74776.9	67979	62314.08333	57520.69231	53412.07143	49851.26667	46735.5625	41542.72222	39356.26316	37388.45	31157.04167	29910.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137491	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137492	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	12991744	6495872	4330581.333	3247936	2598348.8	2165290.667	1855963.429	1623968	1443527.111	1299174.4	1181067.636	1082645.333	999364.9231	927981.7143	866116.2667	811984	721763.5556	683776	649587.2	541322.6667	519669.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137493	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	7557351	3778675.5	2519117	1889337.75	1511470.2	1259558.5	1079621.571	944668.875	839705.6667	755735.1	687031.9091	629779.25	581334.6923	539810.7857	503823.4	472334.4375	419852.8333	397755.3158	377867.55	314889.625	302294.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137494	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137495	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137496	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137497	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	36950	18475	12316.66667	9237.5	7390	6158.333333	5278.571429	4618.75	4105.555556	3695	3359.090909	3079.166667	2842.307692	2639.285714	2463.333333	2309.375	2052.777778	1944.736842	1847.5	1539.583333	1478	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137498	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	491934	245967	163978	122983.5	98386.8	81989	70276.28571	61491.75	54659.33333	49193.4	44721.27273	40994.5	37841.07692	35138.14286	32795.6	30745.875	27329.66667	25891.26316	24596.7	20497.25	19677.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137499	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	962980	481490	320993.3333	240745	192596	160496.6667	137568.5714	120372.5	106997.7778	96298	87543.63636	80248.33333	74075.38462	68784.28571	64198.66667	60186.25	53498.88889	50683.15789	48149	40124.16667	38519.2	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137500	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	670977	335488.5	223659	167744.25	134195.4	111829.5	95853.85714	83872.125	74553	67097.7	60997.90909	55914.75	51613.61538	47926.92857	44731.8	41936.0625	37276.5	35314.57895	33548.85	27957.375	26839.08	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137501	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	894550	447275	298183.3333	223637.5	178910	149091.6667	127792.8571	111818.75	99394.44444	89455	81322.72727	74545.83333	68811.53846	63896.42857	59636.66667	55909.375	49697.22222	47081.57895	44727.5	37272.91667	35782	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137502	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	1793480	896740	597826.6667	448370	358696	298913.3333	256211.4286	224185	199275.5556	179348	163043.6364	149456.6667	137960	128105.7143	119565.3333	112092.5	99637.77778	94393.68421	89674	74728.33333	71739.2	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137503	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	442986	221493	147662	110746.5	88597.2	73831	63283.71429	55373.25	49220.66667	44298.6	40271.45455	36915.5	34075.84615	31641.85714	29532.4	27686.625	24610.33333	23315.05263	22149.3	18457.75	17719.44	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137504	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	944522	472261	314840.6667	236130.5	188904.4	157420.3333	134931.7143	118065.25	104946.8889	94452.2	85865.63636	78710.16667	72655.53846	67465.85714	62968.13333	59032.625	52473.44444	49711.68421	47226.1	39355.08333	37780.88	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137505	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137506	CHOYP_LOC100371808.1.2|m.15364	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	911176	455588	303725.3333	227794	182235.2	151862.6667	130168	113897	101241.7778	91117.6	82834.18182	75931.33333	70090.46154	65084	60745.06667	56948.5	50620.88889	47956.63158	45558.8	37965.66667	36447.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137507	CHOYP_LOC100371808.1.2|m.15364	DQAISYWR	DQAISYWR	12979491	6489745.5	4326497	3244872.75	2595898.2	2163248.5	1854213	1622436.375	1442165.667	1297949.1	1179953.727	1081624.25	998422.3846	927106.5	865299.4	811218.1875	721082.8333	683131.1053	648974.55	540812.125	519179.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137508	CHOYP_LOC100371808.1.2|m.15364	DQAISYWR	DQAISYWR	5480131	2740065.5	1826710.333	1370032.75	1096026.2	913355.1667	782875.8571	685016.375	608903.4444	548013.1	498193.7273	456677.5833	421548.5385	391437.9286	365342.0667	342508.1875	304451.7222	288427.9474	274006.55	228338.7917	219205.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137509	CHOYP_LOC100371808.1.2|m.15364	DQAISYWR	DQAISYWR	2366350	1183175	788783.3333	591587.5	473270	394391.6667	338050	295793.75	262927.7778	236635	215122.7273	197195.8333	182026.9231	169025	157756.6667	147896.875	131463.8889	124544.7368	118317.5	98597.91667	94654	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137510	CHOYP_LOC100371808.1.2|m.15364	DQAISYWR	DQAISYWR	2559791	1279895.5	853263.6667	639947.75	511958.2	426631.8333	365684.4286	319973.875	284421.2222	255979.1	232708.2727	213315.9167	196907	182842.2143	170652.7333	159986.9375	142210.6111	134725.8421	127989.55	106657.9583	102391.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137511	CHOYP_LOC100371808.1.2|m.15364	DQAISYWR	DQAISYWR	3674450	1837225	1224816.667	918612.5	734890	612408.3333	524921.4286	459306.25	408272.2222	367445	334040.9091	306204.1667	282650	262460.7143	244963.3333	229653.125	204136.1111	193392.1053	183722.5	153102.0833	146978	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137512	CHOYP_LOC100371808.1.2|m.15364	DQAISYWR	DQAISYWR	527649	263824.5	175883	131912.25	105529.8	87941.5	75378.42857	65956.125	58627.66667	52764.9	47968.09091	43970.75	40588.38462	37689.21429	35176.6	32978.0625	29313.83333	27771	26382.45	21985.375	21105.96	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137513	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	8670531	4335265.5	2890177	2167632.75	1734106.2	1445088.5	1238647.286	1083816.375	963392.3333	867053.1	788230.0909	722544.25	666963.9231	619323.6429	578035.4	541908.1875	481696.1667	456343.7368	433526.55	361272.125	346821.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137514	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	4178259	2089129.5	1392753	1044564.75	835651.8	696376.5	596894.1429	522282.375	464251	417825.9	379841.7273	348188.25	321404.5385	298447.0714	278550.6	261141.1875	232125.5	219908.3684	208912.95	174094.125	167130.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137515	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	877757	438878.5	292585.6667	219439.25	175551.4	146292.8333	125393.8571	109719.625	97528.55556	87775.7	79796.09091	73146.41667	67519.76923	62696.92857	58517.13333	54859.8125	48764.27778	46197.73684	43887.85	36573.20833	35110.28	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137516	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	1886009	943004.5	628669.6667	471502.25	377201.8	314334.8333	269429.8571	235751.125	209556.5556	188600.9	171455.3636	157167.4167	145077.6154	134714.9286	125733.9333	117875.5625	104778.2778	99263.63158	94300.45	78583.70833	75440.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137517	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	583018	291509	194339.3333	145754.5	116603.6	97169.66667	83288.28571	72877.25	64779.77778	58301.8	53001.63636	48584.83333	44847.53846	41644.14286	38867.86667	36438.625	32389.88889	30685.15789	29150.9	24292.41667	23320.72	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137518	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	101158	50579	33719.33333	25289.5	20231.6	16859.66667	14451.14286	12644.75	11239.77778	10115.8	9196.181818	8429.833333	7781.384615	7225.571429	6743.866667	6322.375	5619.888889	5324.105263	5057.9	4214.916667	4046.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137519	CHOYP_LOC100371808.1.2|m.15364	AVYGTDDQR	AVYGTDDQR	278738	139369	92912.66667	69684.5	55747.6	46456.33333	39819.71429	34842.25	30970.88889	27873.8	25339.81818	23228.16667	21441.38462	19909.85714	18582.53333	17421.125	15485.44444	14670.42105	13936.9	11614.08333	11149.52	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137520	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	8076040	4038020	2692013.333	2019010	1615208	1346006.667	1153720	1009505	897337.7778	807604	734185.4545	673003.3333	621233.8462	576860	538402.6667	504752.5	448668.8889	425054.7368	403802	336501.6667	323041.6	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137521	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	6854456	3427228	2284818.667	1713614	1370891.2	1142409.333	979208	856807	761606.2222	685445.6	623132.3636	571204.6667	527265.8462	489604	456963.7333	428403.5	380803.1111	360760.8421	342722.8	285602.3333	274178.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137522	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	3010249	1505124.5	1003416.333	752562.25	602049.8	501708.1667	430035.5714	376281.125	334472.1111	301024.9	273659	250854.0833	231557.6154	215017.7857	200683.2667	188140.5625	167236.0556	158434.1579	150512.45	125427.0417	120409.96	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137523	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	579833	289916.5	193277.6667	144958.25	115966.6	96638.83333	82833.28571	72479.125	64425.88889	57983.3	52712.09091	48319.41667	44602.53846	41416.64286	38655.53333	36239.5625	32212.94444	30517.52632	28991.65	24159.70833	23193.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137524	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	976953	488476.5	325651	244238.25	195390.6	162825.5	139564.7143	122119.125	108550.3333	97695.3	88813.90909	81412.75	75150.23077	69782.35714	65130.2	61059.5625	54275.16667	51418.57895	48847.65	40706.375	39078.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137525	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	158514	79257	52838	39628.5	31702.8	26419	22644.85714	19814.25	17612.66667	15851.4	14410.36364	13209.5	12193.38462	11322.42857	10567.6	9907.125	8806.333333	8342.842105	7925.7	6604.75	6340.56	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137526	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	64978	32489	21659.33333	16244.5	12995.6	10829.66667	9282.571429	8122.25	7219.777778	6497.8	5907.090909	5414.833333	4998.307692	4641.285714	4331.866667	4061.125	3609.888889	3419.894737	3248.9	2707.416667	2599.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137527	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	153589	76794.5	51196.33333	38397.25	30717.8	25598.16667	21941.28571	19198.625	17065.44444	15358.9	13962.63636	12799.08333	11814.53846	10970.64286	10239.26667	9599.3125	8532.722222	8083.631579	7679.45	6399.541667	6143.56	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137528	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137529	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137530	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137531	CHOYP_LOC100371808.1.2|m.15364	NALHGSDSFSSSEK	NALHGSDSFSSSEK	74478	37239	24826	18619.5	14895.6	12413	10639.71429	9309.75	8275.333333	7447.8	6770.727273	6206.5	5729.076923	5319.857143	4965.2	4654.875	4137.666667	3919.894737	3723.9	3103.25	2979.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137532	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	15195473	7597736.5	5065157.667	3798868.25	3039094.6	2532578.833	2170781.857	1899434.125	1688385.889	1519547.3	1381406.636	1266289.417	1168882.538	1085390.929	1013031.533	949717.0625	844192.9444	799761.7368	759773.65	633144.7083	607818.92	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137533	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137534	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137535	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	1562843	781421.5	520947.6667	390710.75	312568.6	260473.8333	223263.2857	195355.375	173649.2222	156284.3	142076.6364	130236.9167	120218.6923	111631.6429	104189.5333	97677.6875	86824.61111	82254.89474	78142.15	65118.45833	62513.72	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137536	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	1091234	545617	363744.6667	272808.5	218246.8	181872.3333	155890.5714	136404.25	121248.2222	109123.4	99203.09091	90936.16667	83941.07692	77945.28571	72748.93333	68202.125	60624.11111	57433.36842	54561.7	45468.08333	43649.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137537	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	5628412	2814206	1876137.333	1407103	1125682.4	938068.6667	804058.8571	703551.5	625379.1111	562841.2	511673.8182	469034.3333	432954.7692	402029.4286	375227.4667	351775.75	312689.5556	296232.2105	281420.6	234517.1667	225136.48	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137538	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	425469	212734.5	141823	106367.25	85093.8	70911.5	60781.28571	53183.625	47274.33333	42546.9	38679	35455.75	32728.38462	30390.64286	28364.6	26591.8125	23637.16667	22393.10526	21273.45	17727.875	17018.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137539	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	576781	288390.5	192260.3333	144195.25	115356.2	96130.16667	82397.28571	72097.625	64086.77778	57678.1	52434.63636	48065.08333	44367.76923	41198.64286	38452.06667	36048.8125	32043.38889	30356.89474	28839.05	24032.54167	23071.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137540	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	950588	475294	316862.6667	237647	190117.6	158431.3333	135798.2857	118823.5	105620.8889	95058.8	86417.09091	79215.66667	73122.15385	67899.14286	63372.53333	59411.75	52810.44444	50030.94737	47529.4	39607.83333	38023.52	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137541	CHOYP_LOC100371808.2.2|m.62772	ATMDAPQIYVER	ATMDAPQIYVER	50586	25293	16862	12646.5	10117.2	8431	7226.571429	6323.25	5620.666667	5058.6	4598.727273	4215.5	3891.230769	3613.285714	3372.4	3161.625	2810.333333	2662.421053	2529.3	2107.75	2023.44	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137542	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	13806587	6903293.5	4602195.667	3451646.75	2761317.4	2301097.833	1972369.571	1725823.375	1534065.222	1380658.7	1255144.273	1150548.917	1062045.154	986184.7857	920439.1333	862911.6875	767032.6111	726662.4737	690329.35	575274.4583	552263.48	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137543	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	7467500	3733750	2489166.667	1866875	1493500	1244583.333	1066785.714	933437.5	829722.2222	746750	678863.6364	622291.6667	574423.0769	533392.8571	497833.3333	466718.75	414861.1111	393026.3158	373375	311145.8333	298700	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137544	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	9956258	4978129	3318752.667	2489064.5	1991251.6	1659376.333	1422322.571	1244532.25	1106250.889	995625.8	905114.3636	829688.1667	765866	711161.2857	663750.5333	622266.125	553125.4444	524013.5789	497812.9	414844.0833	398250.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137545	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	2651857	1325928.5	883952.3333	662964.25	530371.4	441976.1667	378836.7143	331482.125	294650.7778	265185.7	241077.9091	220988.0833	203989	189418.3571	176790.4667	165741.0625	147325.3889	139571.4211	132592.85	110494.0417	106074.28	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137546	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	4303631	2151815.5	1434543.667	1075907.75	860726.2	717271.8333	614804.4286	537953.875	478181.2222	430363.1	391239.1818	358635.9167	331048.5385	307402.2143	286908.7333	268976.9375	239090.6111	226506.8947	215181.55	179317.9583	172145.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137547	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	1724601	862300.5	574867	431150.25	344920.2	287433.5	246371.5714	215575.125	191622.3333	172460.1	156781.9091	143716.75	132661.6154	123185.7857	114973.4	107787.5625	95811.16667	90768.47368	86230.05	71858.375	68984.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137548	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	1440158	720079	480052.6667	360039.5	288031.6	240026.3333	205736.8571	180019.75	160017.5556	144015.8	130923.4545	120013.1667	110781.3846	102868.4286	96010.53333	90009.875	80008.77778	75797.78947	72007.9	60006.58333	57606.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137549	CHOYP_LOC100371808.2.2|m.62772	SEEIEDIILR	SEEIEDIILR	747769	373884.5	249256.3333	186942.25	149553.8	124628.1667	106824.1429	93471.125	83085.44444	74776.9	67979	62314.08333	57520.69231	53412.07143	49851.26667	46735.5625	41542.72222	39356.26316	37388.45	31157.04167	29910.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137550	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137551	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	12991744	6495872	4330581.333	3247936	2598348.8	2165290.667	1855963.429	1623968	1443527.111	1299174.4	1181067.636	1082645.333	999364.9231	927981.7143	866116.2667	811984	721763.5556	683776	649587.2	541322.6667	519669.76	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137552	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	7557351	3778675.5	2519117	1889337.75	1511470.2	1259558.5	1079621.571	944668.875	839705.6667	755735.1	687031.9091	629779.25	581334.6923	539810.7857	503823.4	472334.4375	419852.8333	397755.3158	377867.55	314889.625	302294.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137553	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137554	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137555	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137556	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	36950	18475	12316.66667	9237.5	7390	6158.333333	5278.571429	4618.75	4105.555556	3695	3359.090909	3079.166667	2842.307692	2639.285714	2463.333333	2309.375	2052.777778	1944.736842	1847.5	1539.583333	1478	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137557	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	491934	245967	163978	122983.5	98386.8	81989	70276.28571	61491.75	54659.33333	49193.4	44721.27273	40994.5	37841.07692	35138.14286	32795.6	30745.875	27329.66667	25891.26316	24596.7	20497.25	19677.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137558	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	962980	481490	320993.3333	240745	192596	160496.6667	137568.5714	120372.5	106997.7778	96298	87543.63636	80248.33333	74075.38462	68784.28571	64198.66667	60186.25	53498.88889	50683.15789	48149	40124.16667	38519.2	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137559	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	670977	335488.5	223659	167744.25	134195.4	111829.5	95853.85714	83872.125	74553	67097.7	60997.90909	55914.75	51613.61538	47926.92857	44731.8	41936.0625	37276.5	35314.57895	33548.85	27957.375	26839.08	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137560	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	894550	447275	298183.3333	223637.5	178910	149091.6667	127792.8571	111818.75	99394.44444	89455	81322.72727	74545.83333	68811.53846	63896.42857	59636.66667	55909.375	49697.22222	47081.57895	44727.5	37272.91667	35782	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137561	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	1793480	896740	597826.6667	448370	358696	298913.3333	256211.4286	224185	199275.5556	179348	163043.6364	149456.6667	137960	128105.7143	119565.3333	112092.5	99637.77778	94393.68421	89674	74728.33333	71739.2	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137562	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	442986	221493	147662	110746.5	88597.2	73831	63283.71429	55373.25	49220.66667	44298.6	40271.45455	36915.5	34075.84615	31641.85714	29532.4	27686.625	24610.33333	23315.05263	22149.3	18457.75	17719.44	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137563	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	944522	472261	314840.6667	236130.5	188904.4	157420.3333	134931.7143	118065.25	104946.8889	94452.2	85865.63636	78710.16667	72655.53846	67465.85714	62968.13333	59032.625	52473.44444	49711.68421	47226.1	39355.08333	37780.88	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137564	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137565	CHOYP_LOC100371808.2.2|m.62772	VHLTPEQASDFYAEHYGK	VHLTPEQASDFYAEHYGK	911176	455588	303725.3333	227794	182235.2	151862.6667	130168	113897	101241.7778	91117.6	82834.18182	75931.33333	70090.46154	65084	60745.06667	56948.5	50620.88889	47956.63158	45558.8	37965.66667	36447.04	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137566	CHOYP_LOC100371808.2.2|m.62772	DQAISYWR	DQAISYWR	12979491	6489745.5	4326497	3244872.75	2595898.2	2163248.5	1854213	1622436.375	1442165.667	1297949.1	1179953.727	1081624.25	998422.3846	927106.5	865299.4	811218.1875	721082.8333	683131.1053	648974.55	540812.125	519179.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137567	CHOYP_LOC100371808.2.2|m.62772	DQAISYWR	DQAISYWR	5480131	2740065.5	1826710.333	1370032.75	1096026.2	913355.1667	782875.8571	685016.375	608903.4444	548013.1	498193.7273	456677.5833	421548.5385	391437.9286	365342.0667	342508.1875	304451.7222	288427.9474	274006.55	228338.7917	219205.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137568	CHOYP_LOC100371808.2.2|m.62772	DQAISYWR	DQAISYWR	2366350	1183175	788783.3333	591587.5	473270	394391.6667	338050	295793.75	262927.7778	236635	215122.7273	197195.8333	182026.9231	169025	157756.6667	147896.875	131463.8889	124544.7368	118317.5	98597.91667	94654	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137569	CHOYP_LOC100371808.2.2|m.62772	DQAISYWR	DQAISYWR	2559791	1279895.5	853263.6667	639947.75	511958.2	426631.8333	365684.4286	319973.875	284421.2222	255979.1	232708.2727	213315.9167	196907	182842.2143	170652.7333	159986.9375	142210.6111	134725.8421	127989.55	106657.9583	102391.64	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137570	CHOYP_LOC100371808.2.2|m.62772	DQAISYWR	DQAISYWR	3674450	1837225	1224816.667	918612.5	734890	612408.3333	524921.4286	459306.25	408272.2222	367445	334040.9091	306204.1667	282650	262460.7143	244963.3333	229653.125	204136.1111	193392.1053	183722.5	153102.0833	146978	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137571	CHOYP_LOC100371808.2.2|m.62772	DQAISYWR	DQAISYWR	527649	263824.5	175883	131912.25	105529.8	87941.5	75378.42857	65956.125	58627.66667	52764.9	47968.09091	43970.75	40588.38462	37689.21429	35176.6	32978.0625	29313.83333	27771	26382.45	21985.375	21105.96	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137572	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	8670531	4335265.5	2890177	2167632.75	1734106.2	1445088.5	1238647.286	1083816.375	963392.3333	867053.1	788230.0909	722544.25	666963.9231	619323.6429	578035.4	541908.1875	481696.1667	456343.7368	433526.55	361272.125	346821.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137573	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	4178259	2089129.5	1392753	1044564.75	835651.8	696376.5	596894.1429	522282.375	464251	417825.9	379841.7273	348188.25	321404.5385	298447.0714	278550.6	261141.1875	232125.5	219908.3684	208912.95	174094.125	167130.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137574	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	877757	438878.5	292585.6667	219439.25	175551.4	146292.8333	125393.8571	109719.625	97528.55556	87775.7	79796.09091	73146.41667	67519.76923	62696.92857	58517.13333	54859.8125	48764.27778	46197.73684	43887.85	36573.20833	35110.28	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137575	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	1886009	943004.5	628669.6667	471502.25	377201.8	314334.8333	269429.8571	235751.125	209556.5556	188600.9	171455.3636	157167.4167	145077.6154	134714.9286	125733.9333	117875.5625	104778.2778	99263.63158	94300.45	78583.70833	75440.36	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137576	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	583018	291509	194339.3333	145754.5	116603.6	97169.66667	83288.28571	72877.25	64779.77778	58301.8	53001.63636	48584.83333	44847.53846	41644.14286	38867.86667	36438.625	32389.88889	30685.15789	29150.9	24292.41667	23320.72	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137577	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	101158	50579	33719.33333	25289.5	20231.6	16859.66667	14451.14286	12644.75	11239.77778	10115.8	9196.181818	8429.833333	7781.384615	7225.571429	6743.866667	6322.375	5619.888889	5324.105263	5057.9	4214.916667	4046.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137578	CHOYP_LOC100371808.2.2|m.62772	AVYGTDDQR	AVYGTDDQR	278738	139369	92912.66667	69684.5	55747.6	46456.33333	39819.71429	34842.25	30970.88889	27873.8	25339.81818	23228.16667	21441.38462	19909.85714	18582.53333	17421.125	15485.44444	14670.42105	13936.9	11614.08333	11149.52	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137579	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	8076040	4038020	2692013.333	2019010	1615208	1346006.667	1153720	1009505	897337.7778	807604	734185.4545	673003.3333	621233.8462	576860	538402.6667	504752.5	448668.8889	425054.7368	403802	336501.6667	323041.6	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137580	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	6854456	3427228	2284818.667	1713614	1370891.2	1142409.333	979208	856807	761606.2222	685445.6	623132.3636	571204.6667	527265.8462	489604	456963.7333	428403.5	380803.1111	360760.8421	342722.8	285602.3333	274178.24	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137581	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	3010249	1505124.5	1003416.333	752562.25	602049.8	501708.1667	430035.5714	376281.125	334472.1111	301024.9	273659	250854.0833	231557.6154	215017.7857	200683.2667	188140.5625	167236.0556	158434.1579	150512.45	125427.0417	120409.96	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137582	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	579833	289916.5	193277.6667	144958.25	115966.6	96638.83333	82833.28571	72479.125	64425.88889	57983.3	52712.09091	48319.41667	44602.53846	41416.64286	38655.53333	36239.5625	32212.94444	30517.52632	28991.65	24159.70833	23193.32	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137583	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	976953	488476.5	325651	244238.25	195390.6	162825.5	139564.7143	122119.125	108550.3333	97695.3	88813.90909	81412.75	75150.23077	69782.35714	65130.2	61059.5625	54275.16667	51418.57895	48847.65	40706.375	39078.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137584	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	158514	79257	52838	39628.5	31702.8	26419	22644.85714	19814.25	17612.66667	15851.4	14410.36364	13209.5	12193.38462	11322.42857	10567.6	9907.125	8806.333333	8342.842105	7925.7	6604.75	6340.56	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137585	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	64978	32489	21659.33333	16244.5	12995.6	10829.66667	9282.571429	8122.25	7219.777778	6497.8	5907.090909	5414.833333	4998.307692	4641.285714	4331.866667	4061.125	3609.888889	3419.894737	3248.9	2707.416667	2599.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137586	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	153589	76794.5	51196.33333	38397.25	30717.8	25598.16667	21941.28571	19198.625	17065.44444	15358.9	13962.63636	12799.08333	11814.53846	10970.64286	10239.26667	9599.3125	8532.722222	8083.631579	7679.45	6399.541667	6143.56	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137587	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137588	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137589	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
137590	CHOYP_LOC100371808.2.2|m.62772	NALHGSDSFSSSEK	NALHGSDSFSSSEK	74478	37239	24826	18619.5	14895.6	12413	10639.71429	9309.75	8275.333333	7447.8	6770.727273	6206.5	5729.076923	5319.857143	4965.2	4654.875	4137.666667	3919.894737	3723.9	3103.25	2979.12	P56597	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	cilium assembly [GO:0042384]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	GO:0003351; GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0042384; GO:1902176
139194	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139195	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139196	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139197	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139198	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	10810	5405	3603.333333	2702.5	2162	1801.666667	1544.285714	1351.25	1201.111111	1081	982.7272727	900.8333333	831.5384615	772.1428571	720.6666667	675.625	600.5555556	568.9473684	540.5	450.4166667	432.4	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139199	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	29256	14628	9752	7314	5851.2	4876	4179.428571	3657	3250.666667	2925.6	2659.636364	2438	2250.461538	2089.714286	1950.4	1828.5	1625.333333	1539.789474	1462.8	1219	1170.24	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139200	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139201	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	60949	30474.5	20316.33333	15237.25	12189.8	10158.16667	8707	7618.625	6772.111111	6094.9	5540.818182	5079.083333	4688.384615	4353.5	4063.266667	3809.3125	3386.055556	3207.842105	3047.45	2539.541667	2437.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139202	CHOYP_LOC100372340.1.3|m.9116	TKPNVLVVFAK	TKPNVLVVFAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139203	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139204	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	3294311	1647155.5	1098103.667	823577.75	658862.2	549051.8333	470615.8571	411788.875	366034.5556	329431.1	299482.8182	274525.9167	253408.5385	235307.9286	219620.7333	205894.4375	183017.2778	173384.7895	164715.55	137262.9583	131772.44	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139205	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	1703285	851642.5	567761.6667	425821.25	340657	283880.8333	243326.4286	212910.625	189253.8889	170328.5	154844.0909	141940.4167	131021.9231	121663.2143	113552.3333	106455.3125	94626.94444	89646.57895	85164.25	70970.20833	68131.4	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139206	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139207	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139208	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139209	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139210	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139211	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139212	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139213	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	224033	112016.5	74677.66667	56008.25	44806.6	37338.83333	32004.71429	28004.125	24892.55556	22403.3	20366.63636	18669.41667	17233.30769	16002.35714	14935.53333	14002.0625	12446.27778	11791.21053	11201.65	9334.708333	8961.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139214	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	165389	82694.5	55129.66667	41347.25	33077.8	27564.83333	23627	20673.625	18376.55556	16538.9	15035.36364	13782.41667	12722.23077	11813.5	11025.93333	10336.8125	9188.277778	8704.684211	8269.45	6891.208333	6615.56	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139215	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	1293644	646822	431214.6667	323411	258728.8	215607.3333	184806.2857	161705.5	143738.2222	129364.4	117604	107803.6667	99511.07692	92403.14286	86242.93333	80852.75	71869.11111	68086.52632	64682.2	53901.83333	51745.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139216	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	197074	98537	65691.33333	49268.5	39414.8	32845.66667	28153.42857	24634.25	21897.11111	19707.4	17915.81818	16422.83333	15159.53846	14076.71429	13138.26667	12317.125	10948.55556	10372.31579	9853.7	8211.416667	7882.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139217	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	473131	236565.5	157710.3333	118282.75	94626.2	78855.16667	67590.14286	59141.375	52570.11111	47313.1	43011.90909	39427.58333	36394.69231	33795.07143	31542.06667	29570.6875	26285.05556	24901.63158	23656.55	19713.79167	18925.24	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139218	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139219	CHOYP_LOC100372340.1.3|m.9116	GQAILAGIDVDKPHQMELR	GQAILAGIDVDKPHQMELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139220	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	6747411	3373705.5	2249137	1686852.75	1349482.2	1124568.5	963915.8571	843426.375	749712.3333	674741.1	613401	562284.25	519031.6154	481957.9286	449827.4	421713.1875	374856.1667	355126.8947	337370.55	281142.125	269896.44	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139221	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	15645834	7822917	5215278	3911458.5	3129166.8	2607639	2235119.143	1955729.25	1738426	1564583.4	1422348.545	1303819.5	1203525.692	1117559.571	1043055.6	977864.625	869213	823464.9474	782291.7	651909.75	625833.36	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139222	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	12920694	6460347	4306898	3230173.5	2584138.8	2153449	1845813.429	1615086.75	1435632.667	1292069.4	1174608.545	1076724.5	993899.5385	922906.7143	861379.6	807543.375	717816.3333	680036.5263	646034.7	538362.25	516827.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139223	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	2339783	1169891.5	779927.6667	584945.75	467956.6	389963.8333	334254.7143	292472.875	259975.8889	233978.3	212707.5455	194981.9167	179983.3077	167127.3571	155985.5333	146236.4375	129987.9444	123146.4737	116989.15	97490.95833	93591.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139224	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	138922	69461	46307.33333	34730.5	27784.4	23153.66667	19846	17365.25	15435.77778	13892.2	12629.27273	11576.83333	10686.30769	9923	9261.466667	8682.625	7717.888889	7311.684211	6946.1	5788.416667	5556.88	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139225	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	851983	425991.5	283994.3333	212995.75	170396.6	141997.1667	121711.8571	106497.875	94664.77778	85198.3	77453	70998.58333	65537.15385	60855.92857	56798.86667	53248.9375	47332.38889	44841.21053	42599.15	35499.29167	34079.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139226	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	496142	248071	165380.6667	124035.5	99228.4	82690.33333	70877.42857	62017.75	55126.88889	49614.2	45103.81818	41345.16667	38164.76923	35438.71429	33076.13333	31008.875	27563.44444	26112.73684	24807.1	20672.58333	19845.68	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139227	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	274317	137158.5	91439	68579.25	54863.4	45719.5	39188.14286	34289.625	30479.66667	27431.7	24937.90909	22859.75	21101.30769	19594.07143	18287.8	17144.8125	15239.83333	14437.73684	13715.85	11429.875	10972.68	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139228	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	50508	25254	16836	12627	10101.6	8418	7215.428571	6313.5	5612	5050.8	4591.636364	4209	3885.230769	3607.714286	3367.2	3156.75	2806	2658.315789	2525.4	2104.5	2020.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139229	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	197429	98714.5	65809.66667	49357.25	39485.8	32904.83333	28204.14286	24678.625	21936.55556	19742.9	17948.09091	16452.41667	15186.84615	14102.07143	13161.93333	12339.3125	10968.27778	10391	9871.45	8226.208333	7897.16	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139230	CHOYP_LOC100372340.1.3|m.9116	NIDGVLAAVDATK	NIDGVLAAVDATK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139231	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139232	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139233	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139234	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139235	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	11031	5515.5	3677	2757.75	2206.2	1838.5	1575.857143	1378.875	1225.666667	1103.1	1002.818182	919.25	848.5384615	787.9285714	735.4	689.4375	612.8333333	580.5789474	551.55	459.625	441.24	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139236	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139237	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139238	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139239	CHOYP_LOC100372340.1.3|m.9116	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139240	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139241	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	2885499	1442749.5	961833	721374.75	577099.8	480916.5	412214.1429	360687.375	320611	288549.9	262318.0909	240458.25	221961.4615	206107.0714	192366.6	180343.6875	160305.5	151868.3684	144274.95	120229.125	115419.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139242	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139243	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139244	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	96846	48423	32282	24211.5	19369.2	16141	13835.14286	12105.75	10760.66667	9684.6	8804.181818	8070.5	7449.692308	6917.571429	6456.4	6052.875	5380.333333	5097.157895	4842.3	4035.25	3873.84	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139245	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139246	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139247	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	750023	375011.5	250007.6667	187505.75	150004.6	125003.8333	107146.1429	93752.875	83335.88889	75002.3	68183.90909	62501.91667	57694.07692	53573.07143	50001.53333	46876.4375	41667.94444	39474.89474	37501.15	31250.95833	30000.92	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139248	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	586390	293195	195463.3333	146597.5	117278	97731.66667	83770	73298.75	65154.44444	58639	53308.18182	48865.83333	45106.92308	41885	39092.66667	36649.375	32577.22222	30862.63158	29319.5	24432.91667	23455.6	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139249	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139250	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	213572	106786	71190.66667	53393	42714.4	35595.33333	30510.28571	26696.5	23730.22222	21357.2	19415.63636	17797.66667	16428.61538	15255.14286	14238.13333	13348.25	11865.11111	11240.63158	10678.6	8898.833333	8542.88	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139251	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139252	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139253	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139254	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139255	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139256	CHOYP_LOC100372340.1.3|m.9116	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139257	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139258	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	1699005	849502.5	566335	424751.25	339801	283167.5	242715	212375.625	188778.3333	169900.5	154455	141583.75	130692.6923	121357.5	113267	106187.8125	94389.16667	89421.31579	84950.25	70791.875	67960.2	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139259	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	434139	217069.5	144713	108534.75	86827.8	72356.5	62019.85714	54267.375	48237.66667	43413.9	39467.18182	36178.25	33395.30769	31009.92857	28942.6	27133.6875	24118.83333	22849.42105	21706.95	18089.125	17365.56	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139260	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139261	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	490863	245431.5	163621	122715.75	98172.6	81810.5	70123.28571	61357.875	54540.33333	49086.3	44623.90909	40905.25	37758.69231	35061.64286	32724.2	30678.9375	27270.16667	25834.89474	24543.15	20452.625	19634.52	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139262	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	550669	275334.5	183556.3333	137667.25	110133.8	91778.16667	78667	68833.625	61185.44444	55066.9	50060.81818	45889.08333	42359.15385	39333.5	36711.26667	34416.8125	30592.72222	28982.57895	27533.45	22944.54167	22026.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139263	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139264	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139265	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	39816	19908	13272	9954	7963.2	6636	5688	4977	4424	3981.6	3619.636364	3318	3062.769231	2844	2654.4	2488.5	2212	2095.578947	1990.8	1659	1592.64	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139266	CHOYP_LOC100372340.1.3|m.9116	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139267	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139268	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	2885499	1442749.5	961833	721374.75	577099.8	480916.5	412214.1429	360687.375	320611	288549.9	262318.0909	240458.25	221961.4615	206107.0714	192366.6	180343.6875	160305.5	151868.3684	144274.95	120229.125	115419.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139269	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139270	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139271	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	96846	48423	32282	24211.5	19369.2	16141	13835.14286	12105.75	10760.66667	9684.6	8804.181818	8070.5	7449.692308	6917.571429	6456.4	6052.875	5380.333333	5097.157895	4842.3	4035.25	3873.84	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139272	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139273	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139274	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	750023	375011.5	250007.6667	187505.75	150004.6	125003.8333	107146.1429	93752.875	83335.88889	75002.3	68183.90909	62501.91667	57694.07692	53573.07143	50001.53333	46876.4375	41667.94444	39474.89474	37501.15	31250.95833	30000.92	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139275	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	586390	293195	195463.3333	146597.5	117278	97731.66667	83770	73298.75	65154.44444	58639	53308.18182	48865.83333	45106.92308	41885	39092.66667	36649.375	32577.22222	30862.63158	29319.5	24432.91667	23455.6	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139276	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139277	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	213572	106786	71190.66667	53393	42714.4	35595.33333	30510.28571	26696.5	23730.22222	21357.2	19415.63636	17797.66667	16428.61538	15255.14286	14238.13333	13348.25	11865.11111	11240.63158	10678.6	8898.833333	8542.88	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139278	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139279	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139280	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139281	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139282	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139283	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139284	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139285	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	1699005	849502.5	566335	424751.25	339801	283167.5	242715	212375.625	188778.3333	169900.5	154455	141583.75	130692.6923	121357.5	113267	106187.8125	94389.16667	89421.31579	84950.25	70791.875	67960.2	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139286	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	434139	217069.5	144713	108534.75	86827.8	72356.5	62019.85714	54267.375	48237.66667	43413.9	39467.18182	36178.25	33395.30769	31009.92857	28942.6	27133.6875	24118.83333	22849.42105	21706.95	18089.125	17365.56	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139287	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139288	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	490863	245431.5	163621	122715.75	98172.6	81810.5	70123.28571	61357.875	54540.33333	49086.3	44623.90909	40905.25	37758.69231	35061.64286	32724.2	30678.9375	27270.16667	25834.89474	24543.15	20452.625	19634.52	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139289	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	550669	275334.5	183556.3333	137667.25	110133.8	91778.16667	78667	68833.625	61185.44444	55066.9	50060.81818	45889.08333	42359.15385	39333.5	36711.26667	34416.8125	30592.72222	28982.57895	27533.45	22944.54167	22026.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139290	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139291	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139292	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	39816	19908	13272	9954	7963.2	6636	5688	4977	4424	3981.6	3619.636364	3318	3062.769231	2844	2654.4	2488.5	2212	2095.578947	1990.8	1659	1592.64	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139293	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139294	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	6747411	3373705.5	2249137	1686852.75	1349482.2	1124568.5	963915.8571	843426.375	749712.3333	674741.1	613401	562284.25	519031.6154	481957.9286	449827.4	421713.1875	374856.1667	355126.8947	337370.55	281142.125	269896.44	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139295	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	15645834	7822917	5215278	3911458.5	3129166.8	2607639	2235119.143	1955729.25	1738426	1564583.4	1422348.545	1303819.5	1203525.692	1117559.571	1043055.6	977864.625	869213	823464.9474	782291.7	651909.75	625833.36	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139296	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	12920694	6460347	4306898	3230173.5	2584138.8	2153449	1845813.429	1615086.75	1435632.667	1292069.4	1174608.545	1076724.5	993899.5385	922906.7143	861379.6	807543.375	717816.3333	680036.5263	646034.7	538362.25	516827.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139297	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	2339783	1169891.5	779927.6667	584945.75	467956.6	389963.8333	334254.7143	292472.875	259975.8889	233978.3	212707.5455	194981.9167	179983.3077	167127.3571	155985.5333	146236.4375	129987.9444	123146.4737	116989.15	97490.95833	93591.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139298	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	138922	69461	46307.33333	34730.5	27784.4	23153.66667	19846	17365.25	15435.77778	13892.2	12629.27273	11576.83333	10686.30769	9923	9261.466667	8682.625	7717.888889	7311.684211	6946.1	5788.416667	5556.88	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139299	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	851983	425991.5	283994.3333	212995.75	170396.6	141997.1667	121711.8571	106497.875	94664.77778	85198.3	77453	70998.58333	65537.15385	60855.92857	56798.86667	53248.9375	47332.38889	44841.21053	42599.15	35499.29167	34079.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139300	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	496142	248071	165380.6667	124035.5	99228.4	82690.33333	70877.42857	62017.75	55126.88889	49614.2	45103.81818	41345.16667	38164.76923	35438.71429	33076.13333	31008.875	27563.44444	26112.73684	24807.1	20672.58333	19845.68	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139301	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	274317	137158.5	91439	68579.25	54863.4	45719.5	39188.14286	34289.625	30479.66667	27431.7	24937.90909	22859.75	21101.30769	19594.07143	18287.8	17144.8125	15239.83333	14437.73684	13715.85	11429.875	10972.68	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139302	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	50508	25254	16836	12627	10101.6	8418	7215.428571	6313.5	5612	5050.8	4591.636364	4209	3885.230769	3607.714286	3367.2	3156.75	2806	2658.315789	2525.4	2104.5	2020.32	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139303	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	197429	98714.5	65809.66667	49357.25	39485.8	32904.83333	28204.14286	24678.625	21936.55556	19742.9	17948.09091	16452.41667	15186.84615	14102.07143	13161.93333	12339.3125	10968.27778	10391	9871.45	8226.208333	7897.16	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139304	CHOYP_LOC100372340.2.3|m.43098	NIDGVLAAVDATK	NIDGVLAAVDATK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139305	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139306	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139307	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139308	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139309	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	11031	5515.5	3677	2757.75	2206.2	1838.5	1575.857143	1378.875	1225.666667	1103.1	1002.818182	919.25	848.5384615	787.9285714	735.4	689.4375	612.8333333	580.5789474	551.55	459.625	441.24	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139310	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139311	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139312	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139313	CHOYP_LOC100372340.2.3|m.43098	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139314	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139315	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	2885499	1442749.5	961833	721374.75	577099.8	480916.5	412214.1429	360687.375	320611	288549.9	262318.0909	240458.25	221961.4615	206107.0714	192366.6	180343.6875	160305.5	151868.3684	144274.95	120229.125	115419.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139316	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139317	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139318	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	96846	48423	32282	24211.5	19369.2	16141	13835.14286	12105.75	10760.66667	9684.6	8804.181818	8070.5	7449.692308	6917.571429	6456.4	6052.875	5380.333333	5097.157895	4842.3	4035.25	3873.84	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139319	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139320	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139321	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	750023	375011.5	250007.6667	187505.75	150004.6	125003.8333	107146.1429	93752.875	83335.88889	75002.3	68183.90909	62501.91667	57694.07692	53573.07143	50001.53333	46876.4375	41667.94444	39474.89474	37501.15	31250.95833	30000.92	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139322	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	586390	293195	195463.3333	146597.5	117278	97731.66667	83770	73298.75	65154.44444	58639	53308.18182	48865.83333	45106.92308	41885	39092.66667	36649.375	32577.22222	30862.63158	29319.5	24432.91667	23455.6	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139323	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139324	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	213572	106786	71190.66667	53393	42714.4	35595.33333	30510.28571	26696.5	23730.22222	21357.2	19415.63636	17797.66667	16428.61538	15255.14286	14238.13333	13348.25	11865.11111	11240.63158	10678.6	8898.833333	8542.88	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139325	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139326	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139327	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139328	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139329	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139330	CHOYP_LOC100372340.2.3|m.43098	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139331	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139332	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	1699005	849502.5	566335	424751.25	339801	283167.5	242715	212375.625	188778.3333	169900.5	154455	141583.75	130692.6923	121357.5	113267	106187.8125	94389.16667	89421.31579	84950.25	70791.875	67960.2	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139333	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	434139	217069.5	144713	108534.75	86827.8	72356.5	62019.85714	54267.375	48237.66667	43413.9	39467.18182	36178.25	33395.30769	31009.92857	28942.6	27133.6875	24118.83333	22849.42105	21706.95	18089.125	17365.56	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139334	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139335	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	490863	245431.5	163621	122715.75	98172.6	81810.5	70123.28571	61357.875	54540.33333	49086.3	44623.90909	40905.25	37758.69231	35061.64286	32724.2	30678.9375	27270.16667	25834.89474	24543.15	20452.625	19634.52	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139336	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	550669	275334.5	183556.3333	137667.25	110133.8	91778.16667	78667	68833.625	61185.44444	55066.9	50060.81818	45889.08333	42359.15385	39333.5	36711.26667	34416.8125	30592.72222	28982.57895	27533.45	22944.54167	22026.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139337	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139338	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139339	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	39816	19908	13272	9954	7963.2	6636	5688	4977	4424	3981.6	3619.636364	3318	3062.769231	2844	2654.4	2488.5	2212	2095.578947	1990.8	1659	1592.64	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139340	CHOYP_LOC100372340.2.3|m.43098	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139341	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139342	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139343	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139344	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139345	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	11031	5515.5	3677	2757.75	2206.2	1838.5	1575.857143	1378.875	1225.666667	1103.1	1002.818182	919.25	848.5384615	787.9285714	735.4	689.4375	612.8333333	580.5789474	551.55	459.625	441.24	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139346	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139347	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139348	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139349	CHOYP_LOC100372340.3.3|m.59986	AKPEFQNAAAK	AKPEFQNAAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139350	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139351	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	2885499	1442749.5	961833	721374.75	577099.8	480916.5	412214.1429	360687.375	320611	288549.9	262318.0909	240458.25	221961.4615	206107.0714	192366.6	180343.6875	160305.5	151868.3684	144274.95	120229.125	115419.96	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139352	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139353	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139354	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	96846	48423	32282	24211.5	19369.2	16141	13835.14286	12105.75	10760.66667	9684.6	8804.181818	8070.5	7449.692308	6917.571429	6456.4	6052.875	5380.333333	5097.157895	4842.3	4035.25	3873.84	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139355	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139356	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139357	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	750023	375011.5	250007.6667	187505.75	150004.6	125003.8333	107146.1429	93752.875	83335.88889	75002.3	68183.90909	62501.91667	57694.07692	53573.07143	50001.53333	46876.4375	41667.94444	39474.89474	37501.15	31250.95833	30000.92	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139358	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	586390	293195	195463.3333	146597.5	117278	97731.66667	83770	73298.75	65154.44444	58639	53308.18182	48865.83333	45106.92308	41885	39092.66667	36649.375	32577.22222	30862.63158	29319.5	24432.91667	23455.6	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139359	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139360	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	213572	106786	71190.66667	53393	42714.4	35595.33333	30510.28571	26696.5	23730.22222	21357.2	19415.63636	17797.66667	16428.61538	15255.14286	14238.13333	13348.25	11865.11111	11240.63158	10678.6	8898.833333	8542.88	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139361	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139362	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139363	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139364	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139365	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139366	CHOYP_LOC100372340.3.3|m.59986	IDGVLAAVDATAEQALGTR	IDGVLAAVDATAEQALGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139367	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139368	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	1699005	849502.5	566335	424751.25	339801	283167.5	242715	212375.625	188778.3333	169900.5	154455	141583.75	130692.6923	121357.5	113267	106187.8125	94389.16667	89421.31579	84950.25	70791.875	67960.2	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139369	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	434139	217069.5	144713	108534.75	86827.8	72356.5	62019.85714	54267.375	48237.66667	43413.9	39467.18182	36178.25	33395.30769	31009.92857	28942.6	27133.6875	24118.83333	22849.42105	21706.95	18089.125	17365.56	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139370	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139371	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	490863	245431.5	163621	122715.75	98172.6	81810.5	70123.28571	61357.875	54540.33333	49086.3	44623.90909	40905.25	37758.69231	35061.64286	32724.2	30678.9375	27270.16667	25834.89474	24543.15	20452.625	19634.52	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139372	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	550669	275334.5	183556.3333	137667.25	110133.8	91778.16667	78667	68833.625	61185.44444	55066.9	50060.81818	45889.08333	42359.15385	39333.5	36711.26667	34416.8125	30592.72222	28982.57895	27533.45	22944.54167	22026.76	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139373	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139374	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139375	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	39816	19908	13272	9954	7963.2	6636	5688	4977	4424	3981.6	3619.636364	3318	3062.769231	2844	2654.4	2488.5	2212	2095.578947	1990.8	1659	1592.64	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139376	CHOYP_LOC100372340.3.3|m.59986	NGQEAFDYQSGR	NGQEAFDYQSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q921X9	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0034976; GO:0045454
139492	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	2940910	1470455	980303.3333	735227.5	588182	490151.6667	420130	367613.75	326767.7778	294091	267355.4545	245075.8333	226223.8462	210065	196060.6667	183806.875	163383.8889	154784.7368	147045.5	122537.9167	117636.4	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139493	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	3182680	1591340	1060893.333	795670	636536	530446.6667	454668.5714	397835	353631.1111	318268	289334.5455	265223.3333	244821.5385	227334.2857	212178.6667	198917.5	176815.5556	167509.4737	159134	132611.6667	127307.2	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139494	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139495	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	180166	90083	60055.33333	45041.5	36033.2	30027.66667	25738	22520.75	20018.44444	18016.6	16378.72727	15013.83333	13858.92308	12869	12011.06667	11260.375	10009.22222	9482.421053	9008.3	7506.916667	7206.64	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139496	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	792057	396028.5	264019	198014.25	158411.4	132009.5	113151	99007.125	88006.33333	79205.7	72005.18182	66004.75	60927.46154	56575.5	52803.8	49503.5625	44003.16667	41687.21053	39602.85	33002.375	31682.28	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139497	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	612359	306179.5	204119.6667	153089.75	122471.8	102059.8333	87479.85714	76544.875	68039.88889	61235.9	55669	51029.91667	47104.53846	43739.92857	40823.93333	38272.4375	34019.94444	32229.42105	30617.95	25514.95833	24494.36	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139498	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	345099	172549.5	115033	86274.75	69019.8	57516.5	49299.85714	43137.375	38344.33333	34509.9	31372.63636	28758.25	26546.07692	24649.92857	23006.6	21568.6875	19172.16667	18163.10526	17254.95	14379.125	13803.96	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139499	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	67036	33518	22345.33333	16759	13407.2	11172.66667	9576.571429	8379.5	7448.444444	6703.6	6094.181818	5586.333333	5156.615385	4788.285714	4469.066667	4189.75	3724.222222	3528.210526	3351.8	2793.166667	2681.44	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139500	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	410580	205290	136860	102645	82116	68430	58654.28571	51322.5	45620	41058	37325.45455	34215	31583.07692	29327.14286	27372	25661.25	22810	21609.47368	20529	17107.5	16423.2	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
139501	CHOYP_LOC100372481.1.1|m.21010	SSLVELVDHYSR	SSLVELVDHYSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P23727	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; NFAT protein import into nucleus [GO:0051531]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	GO:0001678; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0042993; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0051492; GO:0051531; GO:0060396; GO:0090004; GO:1900103; GO:1990578; GO:2001275
145380	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145381	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	8651313	4325656.5	2883771	2162828.25	1730262.6	1441885.5	1235901.857	1081414.125	961257	865131.3	786483	720942.75	665485.6154	617950.9286	576754.2	540707.0625	480628.5	455332.2632	432565.65	360471.375	346052.52	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145382	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	1435625	717812.5	478541.6667	358906.25	287125	239270.8333	205089.2857	179453.125	159513.8889	143562.5	130511.3636	119635.4167	110432.6923	102544.6429	95708.33333	89726.5625	79756.94444	75559.21053	71781.25	59817.70833	57425	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145383	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145384	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	179592	89796	59864	44898	35918.4	29932	25656	22449	19954.66667	17959.2	16326.54545	14966	13814.76923	12828	11972.8	11224.5	9977.333333	9452.210526	8979.6	7483	7183.68	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145385	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145386	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	149812	74906	49937.33333	37453	29962.4	24968.66667	21401.71429	18726.5	16645.77778	14981.2	13619.27273	12484.33333	11524	10700.85714	9987.466667	9363.25	8322.888889	7884.842105	7490.6	6242.166667	5992.48	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145387	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	88503	44251.5	29501	22125.75	17700.6	14750.5	12643.28571	11062.875	9833.666667	8850.3	8045.727273	7375.25	6807.923077	6321.642857	5900.2	5531.4375	4916.833333	4658.052632	4425.15	3687.625	3540.12	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145388	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	62127	31063.5	20709	15531.75	12425.4	10354.5	8875.285714	7765.875	6903	6212.7	5647.909091	5177.25	4779	4437.642857	4141.8	3882.9375	3451.5	3269.842105	3106.35	2588.625	2485.08	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145389	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145390	CHOYP_LOC100374573.1.1|m.24523	MISQAYEVLSDPK	MISQAYEVLSDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145391	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145392	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145393	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145394	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145395	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	93601	46800.5	31200.33333	23400.25	18720.2	15600.16667	13371.57143	11700.125	10400.11111	9360.1	8509.181818	7800.083333	7200.076923	6685.785714	6240.066667	5850.0625	5200.055556	4926.368421	4680.05	3900.041667	3744.04	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145396	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145397	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145398	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145399	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145400	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	50264	25132	16754.66667	12566	10052.8	8377.333333	7180.571429	6283	5584.888889	5026.4	4569.454545	4188.666667	3866.461538	3590.285714	3350.933333	3141.5	2792.444444	2645.473684	2513.2	2094.333333	2010.56	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145401	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	315447	157723.5	105149	78861.75	63089.4	52574.5	45063.85714	39430.875	35049.66667	31544.7	28677	26287.25	24265.15385	22531.92857	21029.8	19715.4375	17524.83333	16602.47368	15772.35	13143.625	12617.88	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145402	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
145403	CHOYP_LOC100374573.1.1|m.24523	EAYEDDDEDMPGGQR	EAYEDDDEDMPGGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31689	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]"	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
153537	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	46850780	23425390	15616926.67	11712695	9370156	7808463.333	6692968.571	5856347.5	5205642.222	4685078	4259161.818	3904231.667	3603906.154	3346484.286	3123385.333	2928173.75	2602821.111	2465830.526	2342539	1952115.833	1874031.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153538	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	29077112	14538556	9692370.667	7269278	5815422.4	4846185.333	4153873.143	3634639	3230790.222	2907711.2	2643373.818	2423092.667	2236700.923	2076936.571	1938474.133	1817319.5	1615395.111	1530374.316	1453855.6	1211546.333	1163084.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153539	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	12124320	6062160	4041440	3031080	2424864	2020720	1732045.714	1515540	1347146.667	1212432	1102210.909	1010360	932640	866022.8571	808288	757770	673573.3333	638122.1053	606216	505180	484972.8	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153540	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	280900	140450	93633.33333	70225	56180	46816.66667	40128.57143	35112.5	31211.11111	28090	25536.36364	23408.33333	21607.69231	20064.28571	18726.66667	17556.25	15605.55556	14784.21053	14045	11704.16667	11236	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153541	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	2438919	1219459.5	812973	609729.75	487783.8	406486.5	348417	304864.875	270991	243891.9	221719.9091	203243.25	187609.1538	174208.5	162594.6	152432.4375	135495.5	128364.1579	121945.95	101621.625	97556.76	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153542	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	8162578	4081289	2720859.333	2040644.5	1632515.6	1360429.667	1166082.571	1020322.25	906953.1111	816257.8	742052.5455	680214.8333	627890.6154	583041.2857	544171.8667	510161.125	453476.5556	429609.3684	408128.9	340107.4167	326503.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153543	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153544	CHOYP_LOC100377173.1.2|m.37699	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153545	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	88675256	44337628	29558418.67	22168814	17735051.2	14779209.33	12667893.71	11084407	9852806.222	8867525.6	8061386.909	7389604.667	6821173.538	6333946.857	5911683.733	5542203.5	4926403.111	4667118.737	4433762.8	3694802.333	3547010.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153546	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	42837028	21418514	14279009.33	10709257	8567405.6	7139504.667	6119575.429	5354628.5	4759669.778	4283702.8	3894275.273	3569752.333	3295156	3059787.714	2855801.867	2677314.25	2379834.889	2254580.421	2141851.4	1784876.167	1713481.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153547	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	13505777	6752888.5	4501925.667	3376444.25	2701155.4	2250962.833	1929396.714	1688222.125	1500641.889	1350577.7	1227797.909	1125481.417	1038905.923	964698.3571	900385.1333	844111.0625	750320.9444	710830.3684	675288.85	562740.7083	540231.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153548	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	17586380	8793190	5862126.667	4396595	3517276	2931063.333	2512340	2198297.5	1954042.222	1758638	1598761.818	1465531.667	1352798.462	1256170	1172425.333	1099148.75	977021.1111	925598.9474	879319	732765.8333	703455.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153549	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	4105488	2052744	1368496	1026372	821097.6	684248	586498.2857	513186	456165.3333	410548.8	373226.1818	342124	315806.7692	293249.1429	273699.2	256593	228082.6667	216078.3158	205274.4	171062	164219.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153550	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	9652707	4826353.5	3217569	2413176.75	1930541.4	1608784.5	1378958.143	1206588.375	1072523	965270.7	877518.8182	804392.25	742515.9231	689479.0714	643513.8	603294.1875	536261.5	508037.2105	482635.35	402196.125	386108.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153551	CHOYP_LOC100377173.1.2|m.37699	VSVSDGMVR	VSVSDGMVR	213204	106602	71068	53301	42640.8	35534	30457.71429	26650.5	23689.33333	21320.4	19382.18182	17767	16400.30769	15228.85714	14213.6	13325.25	11844.66667	11221.26316	10660.2	8883.5	8528.16	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153552	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153553	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153554	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153555	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153556	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153557	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153558	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153559	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153560	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153561	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153562	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153563	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153564	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153565	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153566	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153567	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153568	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153569	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153570	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153571	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153572	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153573	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153574	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153575	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153576	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153577	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153578	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
153579	CHOYP_LOC100377173.1.2|m.37699	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
164932	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	4284618	2142309	1428206	1071154.5	856923.6	714103	612088.2857	535577.25	476068.6667	428461.8	389510.7273	357051.5	329586	306044.1429	285641.2	267788.625	238034.3333	225506.2105	214230.9	178525.75	171384.72	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164933	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	3769776	1884888	1256592	942444	753955.2	628296	538539.4286	471222	418864	376977.6	342706.9091	314148	289982.7692	269269.7143	251318.4	235611	209432	198409.2632	188488.8	157074	150791.04	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164934	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164935	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164936	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	596911	298455.5	198970.3333	149227.75	119382.2	99485.16667	85273	74613.875	66323.44444	59691.1	54264.63636	49742.58333	45916.23077	42636.5	39794.06667	37306.9375	33161.72222	31416.36842	29845.55	24871.29167	23876.44	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164937	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	367848	183924	122616	91962	73569.6	61308	52549.71429	45981	40872	36784.8	33440.72727	30654	28296	26274.85714	24523.2	22990.5	20436	19360.42105	18392.4	15327	14713.92	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164938	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	52649	26324.5	17549.66667	13162.25	10529.8	8774.833333	7521.285714	6581.125	5849.888889	5264.9	4786.272727	4387.416667	4049.923077	3760.642857	3509.933333	3290.5625	2924.944444	2771	2632.45	2193.708333	2105.96	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164939	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	489652	244826	163217.3333	122413	97930.4	81608.66667	69950.28571	61206.5	54405.77778	48965.2	44513.81818	40804.33333	37665.53846	34975.14286	32643.46667	30603.25	27202.88889	25771.15789	24482.6	20402.16667	19586.08	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164940	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164941	CHOYP_LOC100561894.1.1|m.45814	NFSAENDANILR	NFSAENDANILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164942	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164943	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	16525874	8262937	5508624.667	4131468.5	3305174.8	2754312.333	2360839.143	2065734.25	1836208.222	1652587.4	1502352.182	1377156.167	1271221.077	1180419.571	1101724.933	1032867.125	918104.1111	869782.8421	826293.7	688578.0833	661034.96	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164944	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	5916182	2958091	1972060.667	1479045.5	1183236.4	986030.3333	845168.8571	739522.75	657353.5556	591618.2	537834.7273	493015.1667	455090.9231	422584.4286	394412.1333	369761.375	328676.7778	311378	295809.1	246507.5833	236647.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164945	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	813482	406741	271160.6667	203370.5	162696.4	135580.3333	116211.7143	101685.25	90386.88889	81348.2	73952.90909	67790.16667	62575.53846	58105.85714	54232.13333	50842.625	45193.44444	42814.84211	40674.1	33895.08333	32539.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164946	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	303194	151597	101064.6667	75798.5	60638.8	50532.33333	43313.42857	37899.25	33688.22222	30319.4	27563.09091	25266.16667	23322.61538	21656.71429	20212.93333	18949.625	16844.11111	15957.57895	15159.7	12633.08333	12127.76	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164947	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	197169	98584.5	65723	49292.25	39433.8	32861.5	28167	24646.125	21907.66667	19716.9	17924.45455	16430.75	15166.84615	14083.5	13144.6	12323.0625	10953.83333	10377.31579	9858.45	8215.375	7886.76	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164948	CHOYP_LOC100561894.1.1|m.45814	AIVDVLAYR	AIVDVLAYR	120487	60243.5	40162.33333	30121.75	24097.4	20081.16667	17212.42857	15060.875	13387.44444	12048.7	10953.36364	10040.58333	9268.230769	8606.214286	8032.466667	7530.4375	6693.722222	6341.421053	6024.35	5020.291667	4819.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164949	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164950	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164951	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164952	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164953	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	2207307	1103653.5	735769	551826.75	441461.4	367884.5	315329.5714	275913.375	245256.3333	220730.7	200664.2727	183942.25	169792.8462	157664.7857	147153.8	137956.6875	122628.1667	116174.0526	110365.35	91971.125	88292.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164954	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164955	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	5236555	2618277.5	1745518.333	1309138.75	1047311	872759.1667	748079.2857	654569.375	581839.4444	523655.5	476050.4545	436379.5833	402811.9231	374039.6429	349103.6667	327284.6875	290919.7222	275608.1579	261827.75	218189.7917	209462.2	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164956	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	4718439	2359219.5	1572813	1179609.75	943687.8	786406.5	674062.7143	589804.875	524271	471843.9	428949	393203.25	362956.8462	337031.3571	314562.6	294902.4375	262135.5	248338.8947	235921.95	196601.625	188737.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164957	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164958	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	1365478	682739	455159.3333	341369.5	273095.6	227579.6667	195068.2857	170684.75	151719.7778	136547.8	124134.3636	113789.8333	105036.7692	97534.14286	91031.86667	85342.375	75859.88889	71867.26316	68273.9	56894.91667	54619.12	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164959	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	588343	294171.5	196114.3333	147085.75	117668.6	98057.16667	84049	73542.875	65371.44444	58834.3	53485.72727	49028.58333	45257.15385	42024.5	39222.86667	36771.4375	32685.72222	30965.42105	29417.15	24514.29167	23533.72	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164960	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	342090	171045	114030	85522.5	68418	57015	48870	42761.25	38010	34209	31099.09091	28507.5	26314.61538	24435	22806	21380.625	19005	18004.73684	17104.5	14253.75	13683.6	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164961	CHOYP_LOC100561894.1.1|m.45814	TLEQDIVSDTSGHFK	TLEQDIVSDTSGHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164962	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	8033712	4016856	2677904	2008428	1606742.4	1338952	1147673.143	1004214	892634.6667	803371.2	730337.4545	669476	617977.8462	573836.5714	535580.8	502107	446317.3333	422826.9474	401685.6	334738	321348.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164963	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164964	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164965	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	48147	24073.5	16049	12036.75	9629.4	8024.5	6878.142857	6018.375	5349.666667	4814.7	4377	4012.25	3703.615385	3439.071429	3209.8	3009.1875	2674.833333	2534.052632	2407.35	2006.125	1925.88	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164966	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	210122	105061	70040.66667	52530.5	42024.4	35020.33333	30017.42857	26265.25	23346.88889	21012.2	19102	17510.16667	16163.23077	15008.71429	14008.13333	13132.625	11673.44444	11059.05263	10506.1	8755.083333	8404.88	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164967	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	209098	104549	69699.33333	52274.5	41819.6	34849.66667	29871.14286	26137.25	23233.11111	20909.8	19008.90909	17424.83333	16084.46154	14935.57143	13939.86667	13068.625	11616.55556	11005.15789	10454.9	8712.416667	8363.92	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164968	CHOYP_LOC100561894.1.1|m.45814	MENQAVDMK	MENQAVDMK	216603	108301.5	72201	54150.75	43320.6	36100.5	30943.28571	27075.375	24067	21660.3	19691.18182	18050.25	16661.76923	15471.64286	14440.2	13537.6875	12033.5	11400.15789	10830.15	9025.125	8664.12	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164969	CHOYP_LOC100561894.1.1|m.45814	AVFDAYQK	AVFDAYQK	71252192	35626096	23750730.67	17813048	14250438.4	11875365.33	10178884.57	8906524	7916910.222	7125219.2	6477472	5937682.667	5480937.846	5089442.286	4750146.133	4453262	3958455.111	3750115.368	3562609.6	2968841.333	2850087.68	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164970	CHOYP_LOC100561894.1.1|m.45814	AVFDAYQK	AVFDAYQK	35622112	17811056	11874037.33	8905528	7124422.4	5937018.667	5088873.143	4452764	3958012.444	3562211.2	3238373.818	2968509.333	2740162.462	2544436.571	2374807.467	2226382	1979006.222	1874848	1781105.6	1484254.667	1424884.48	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164971	CHOYP_LOC100561894.1.1|m.45814	AVFDAYQK	AVFDAYQK	11104014	5552007	3701338	2776003.5	2220802.8	1850669	1586287.714	1388001.75	1233779.333	1110401.4	1009455.818	925334.5	854154.9231	793143.8571	740267.6	694000.875	616889.6667	584421.7895	555200.7	462667.25	444160.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164972	CHOYP_LOC100561894.1.1|m.45814	AVFDAYQK	AVFDAYQK	5185065	2592532.5	1728355	1296266.25	1037013	864177.5	740723.5714	648133.125	576118.3333	518506.5	471369.5455	432088.75	398851.1538	370361.7857	345671	324066.5625	288059.1667	272898.1579	259253.25	216044.375	207402.6	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164973	CHOYP_LOC100561894.1.1|m.45814	AVFDAYQK	AVFDAYQK	5411447	2705723.5	1803815.667	1352861.75	1082289.4	901907.8333	773063.8571	676430.875	601271.8889	541144.7	491949.7273	450953.9167	416265.1538	386531.9286	360763.1333	338215.4375	300635.9444	284813	270572.35	225476.9583	216457.88	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164974	CHOYP_LOC100561894.1.1|m.45814	AVFDAYQK	AVFDAYQK	2485235	1242617.5	828411.6667	621308.75	497047	414205.8333	355033.5714	310654.375	276137.2222	248523.5	225930.4545	207102.9167	191171.9231	177516.7857	165682.3333	155327.1875	138068.6111	130801.8421	124261.75	103551.4583	99409.4	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164975	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164976	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	15981338	7990669	5327112.667	3995334.5	3196267.6	2663556.333	2283048.286	1997667.25	1775704.222	1598133.8	1452848.909	1331778.167	1229333.692	1141524.143	1065422.533	998833.625	887852.1111	841123.0526	799066.9	665889.0833	639253.52	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164977	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164978	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	2446182	1223091	815394	611545.5	489236.4	407697	349454.5714	305772.75	271798	244618.2	222380.1818	203848.5	188167.8462	174727.2857	163078.8	152886.375	135899	128746.4211	122309.1	101924.25	97847.28	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164979	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	962039	481019.5	320679.6667	240509.75	192407.8	160339.8333	137434.1429	120254.875	106893.2222	96203.9	87458.09091	80169.91667	74003	68717.07143	64135.93333	60127.4375	53446.61111	50633.63158	48101.95	40084.95833	38481.56	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164980	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
164981	CHOYP_LOC100561894.1.1|m.45814	AEVDMVQVK	AEVDMVQVK	425847	212923.5	141949	106461.75	85169.4	70974.5	60835.28571	53230.875	47316.33333	42584.7	38713.36364	35487.25	32757.46154	30417.64286	28389.8	26615.4375	23658.16667	22413	21292.35	17743.625	17033.88	P20072	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]	GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0044822; GO:0048306; GO:0070062
165049	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	780506	390253	260168.6667	195126.5	156101.2	130084.3333	111500.8571	97563.25	86722.88889	78050.6	70955.09091	65042.16667	60038.92308	55750.42857	52033.73333	48781.625	43361.44444	41079.26316	39025.3	32521.08333	31220.24	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165050	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165051	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	328747	164373.5	109582.3333	82186.75	65749.4	54791.16667	46963.85714	41093.375	36527.44444	32874.7	29886.09091	27395.58333	25288.23077	23481.92857	21916.46667	20546.6875	18263.72222	17302.47368	16437.35	13697.79167	13149.88	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165052	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165053	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165054	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	108390	54195	36130	27097.5	21678	18065	15484.28571	13548.75	12043.33333	10839	9853.636364	9032.5	8337.692308	7742.142857	7226	6774.375	6021.666667	5704.736842	5419.5	4516.25	4335.6	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165055	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	145150	72575	48383.33333	36287.5	29030	24191.66667	20735.71429	18143.75	16127.77778	14515	13195.45455	12095.83333	11165.38462	10367.85714	9676.666667	9071.875	8063.888889	7639.473684	7257.5	6047.916667	5806	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165056	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	396783	198391.5	132261	99195.75	79356.6	66130.5	56683.28571	49597.875	44087	39678.3	36071.18182	33065.25	30521.76923	28341.64286	26452.2	24798.9375	22043.5	20883.31579	19839.15	16532.625	15871.32	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165057	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	57007	28503.5	19002.33333	14251.75	11401.4	9501.166667	8143.857143	7125.875	6334.111111	5700.7	5182.454545	4750.583333	4385.153846	4071.928571	3800.466667	3562.9375	3167.055556	3000.368421	2850.35	2375.291667	2280.28	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165058	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165059	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165060	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165061	CHOYP_LOC100562954.1.1|m.27429	LVPNMVLTDFQVSYK	LVPNMVLTDFQVSYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165062	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	4076452	2038226	1358817.333	1019113	815290.4	679408.6667	582350.2857	509556.5	452939.1111	407645.2	370586.5455	339704.3333	313573.2308	291175.1429	271763.4667	254778.25	226469.5556	214550.1053	203822.6	169852.1667	163058.08	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165063	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	3269180	1634590	1089726.667	817295	653836	544863.3333	467025.7143	408647.5	363242.2222	326918	297198.1818	272431.6667	251475.3846	233512.8571	217945.3333	204323.75	181621.1111	172062.1053	163459	136215.8333	130767.2	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165064	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165065	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	274793	137396.5	91597.66667	68698.25	54958.6	45798.83333	39256.14286	34349.125	30532.55556	27479.3	24981.18182	22899.41667	21137.92308	19628.07143	18319.53333	17174.5625	15266.27778	14462.78947	13739.65	11449.70833	10991.72	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165066	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165067	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	643791	321895.5	214597	160947.75	128758.2	107298.5	91970.14286	80473.875	71532.33333	64379.1	58526.45455	53649.25	49522.38462	45985.07143	42919.4	40236.9375	35766.16667	33883.73684	32189.55	26824.625	25751.64	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165068	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	228823	114411.5	76274.33333	57205.75	45764.6	38137.16667	32689	28602.875	25424.77778	22882.3	20802.09091	19068.58333	17601.76923	16344.5	15254.86667	14301.4375	12712.38889	12043.31579	11441.15	9534.291667	9152.92	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165069	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165070	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	131913	65956.5	43971	32978.25	26382.6	21985.5	18844.71429	16489.125	14657	13191.3	11992.09091	10992.75	10147.15385	9422.357143	8794.2	8244.5625	7328.5	6942.789474	6595.65	5496.375	5276.52	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165071	CHOYP_LOC100562954.1.1|m.27429	IEDFEAAVDDIR	IEDFEAAVDDIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165072	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	1651932	825966	550644	412983	330386.4	275322	235990.2857	206491.5	183548	165193.2	150175.6364	137661	127071.6923	117995.1429	110128.8	103245.75	91774	86943.78947	82596.6	68830.5	66077.28	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165073	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	1794690	897345	598230	448672.5	358938	299115	256384.2857	224336.25	199410	179469	163153.6364	149557.5	138053.0769	128192.1429	119646	112168.125	99705	94457.36842	89734.5	74778.75	71787.6	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165074	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	2452140	1226070	817380	613035	490428	408690	350305.7143	306517.5	272460	245214	222921.8182	204345	188626.1538	175152.8571	163476	153258.75	136230	129060	122607	102172.5	98085.6	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165075	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	186735	93367.5	62245	46683.75	37347	31122.5	26676.42857	23341.875	20748.33333	18673.5	16975.90909	15561.25	14364.23077	13338.21429	12449	11670.9375	10374.16667	9828.157895	9336.75	7780.625	7469.4	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165076	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	439910	219955	146636.6667	109977.5	87982	73318.33333	62844.28571	54988.75	48878.88889	43991	39991.81818	36659.16667	33839.23077	31422.14286	29327.33333	27494.375	24439.44444	23153.15789	21995.5	18329.58333	17596.4	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165077	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	141427	70713.5	47142.33333	35356.75	28285.4	23571.16667	20203.85714	17678.375	15714.11111	14142.7	12857	11785.58333	10879	10101.92857	9428.466667	8839.1875	7857.055556	7443.526316	7071.35	5892.791667	5657.08	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165078	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	87640	43820	29213.33333	21910	17528	14606.66667	12520	10955	9737.777778	8764	7967.272727	7303.333333	6741.538462	6260	5842.666667	5477.5	4868.888889	4612.631579	4382	3651.666667	3505.6	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165079	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	101312	50656	33770.66667	25328	20262.4	16885.33333	14473.14286	12664	11256.88889	10131.2	9210.181818	8442.666667	7793.230769	7236.571429	6754.133333	6332	5628.444444	5332.210526	5065.6	4221.333333	4052.48	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165080	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	201796	100898	67265.33333	50449	40359.2	33632.66667	28828	25224.5	22421.77778	20179.6	18345.09091	16816.33333	15522.76923	14414	13453.06667	12612.25	11210.88889	10620.84211	10089.8	8408.166667	8071.84	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165081	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165082	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	125063	62531.5	41687.66667	31265.75	25012.6	20843.83333	17866.14286	15632.875	13895.88889	12506.3	11369.36364	10421.91667	9620.230769	8933.071429	8337.533333	7816.4375	6947.944444	6582.263158	6253.15	5210.958333	5002.52	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165083	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	86067	43033.5	28689	21516.75	17213.4	14344.5	12295.28571	10758.375	9563	8606.7	7824.272727	7172.25	6620.538462	6147.642857	5737.8	5379.1875	4781.5	4529.842105	4303.35	3586.125	3442.68	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165084	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165085	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	31521	15760.5	10507	7880.25	6304.2	5253.5	4503	3940.125	3502.333333	3152.1	2865.545455	2626.75	2424.692308	2251.5	2101.4	1970.0625	1751.166667	1659	1576.05	1313.375	1260.84	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165086	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165087	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165088	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	3723010	1861505	1241003.333	930752.5	744602	620501.6667	531858.5714	465376.25	413667.7778	372301	338455.4545	310250.8333	286385.3846	265929.2857	248200.6667	232688.125	206833.8889	195947.8947	186150.5	155125.4167	148920.4	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165089	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	1656726	828363	552242	414181.5	331345.2	276121	236675.1429	207090.75	184080.6667	165672.6	150611.4545	138060.5	127440.4615	118337.5714	110448.4	103545.375	92040.33333	87196.10526	82836.3	69030.25	66269.04	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165090	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165091	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165092	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165093	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165094	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165095	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	160456	80228	53485.33333	40114	32091.2	26742.66667	22922.28571	20057	17828.44444	16045.6	14586.90909	13371.33333	12342.76923	11461.14286	10697.06667	10028.5	8914.222222	8445.052632	8022.8	6685.666667	6418.24	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165096	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165097	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	182001	91000.5	60667	45500.25	36400.2	30333.5	26000.14286	22750.125	20222.33333	18200.1	16545.54545	15166.75	14000.07692	13000.07143	12133.4	11375.0625	10111.16667	9579	9100.05	7583.375	7280.04	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165098	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165099	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	100106	50053	33368.66667	25026.5	20021.2	16684.33333	14300.85714	12513.25	11122.88889	10010.6	9100.545455	8342.166667	7700.461538	7150.428571	6673.733333	6256.625	5561.444444	5268.736842	5005.3	4171.083333	4004.24	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165100	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165101	CHOYP_LOC100562954.1.1|m.27429	MLLYASDINFHQAGDGR	MLLYASDINFHQAGDGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165102	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	638757	319378.5	212919	159689.25	127751.4	106459.5	91251	79844.625	70973	63875.7	58068.81818	53229.75	49135.15385	45625.5	42583.8	39922.3125	35486.5	33618.78947	31937.85	26614.875	25550.28	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165103	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	533348	266674	177782.6667	133337	106669.6	88891.33333	76192.57143	66668.5	59260.88889	53334.8	48486.18182	44445.66667	41026.76923	38096.28571	35556.53333	33334.25	29630.44444	28070.94737	26667.4	22222.83333	21333.92	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165104	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	112263	56131.5	37421	28065.75	22452.6	18710.5	16037.57143	14032.875	12473.66667	11226.3	10205.72727	9355.25	8635.615385	8018.785714	7484.2	7016.4375	6236.833333	5908.578947	5613.15	4677.625	4490.52	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165105	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	1024140	512070	341380	256035	204828	170690	146305.7143	128017.5	113793.3333	102414	93103.63636	85345	78780	73152.85714	68276	64008.75	56896.66667	53902.10526	51207	42672.5	40965.6	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165106	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	432572	216286	144190.6667	108143	86514.4	72095.33333	61796	54071.5	48063.55556	43257.2	39324.72727	36047.66667	33274.76923	30898	28838.13333	27035.75	24031.77778	22766.94737	21628.6	18023.83333	17302.88	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165107	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	731805	365902.5	243935	182951.25	146361	121967.5	104543.5714	91475.625	81311.66667	73180.5	66527.72727	60983.75	56292.69231	52271.78571	48787	45737.8125	40655.83333	38516.05263	36590.25	30491.875	29272.2	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165108	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165109	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	71421	35710.5	23807	17855.25	14284.2	11903.5	10203	8927.625	7935.666667	7142.1	6492.818182	5951.75	5493.923077	5101.5	4761.4	4463.8125	3967.833333	3759	3571.05	2975.875	2856.84	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165110	CHOYP_LOC100562954.1.1|m.27429	NILDIVSANYR	NILDIVSANYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165111	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165112	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165113	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	1844616	922308	614872	461154	368923.2	307436	263516.5714	230577	204957.3333	184461.6	167692.3636	153718	141893.5385	131758.2857	122974.4	115288.5	102478.6667	97085.05263	92230.8	76859	73784.64	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165114	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165115	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165116	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165117	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165118	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165119	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
165120	CHOYP_LOC100562954.1.1|m.27429	FESEIQNPAWER	FESEIQNPAWER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O70309	Integrin beta-5	Itgb5	cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0004872; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0031252; GO:0034684; GO:0043149; GO:0043235; GO:0070062; GO:0090136
170693	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	977096832	488548416	325698944	244274208	195419366.4	162849472	139585261.7	122137104	108566314.7	97709683.2	88826984.73	81424736	75161294.77	69792630.86	65139788.8	61068552	54283157.33	51426149.05	48854841.6	40712368	39083873.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170694	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	591583168	295791584	197194389.3	147895792	118316633.6	98597194.67	84511881.14	73947896	65731463.11	59158316.8	53780288	49298597.33	45506397.54	42255940.57	39438877.87	36973948	32865731.56	31135956.21	29579158.4	24649298.67	23663326.72	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170695	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	246532256	123266128	82177418.67	61633064	49306451.2	41088709.33	35218893.71	30816532	27392472.89	24653225.6	22412023.27	20544354.67	18964019.69	17609446.86	16435483.73	15408266	13696236.44	12975381.89	12326612.8	10272177.33	9861290.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170696	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	53643948	26821974	17881316	13410987	10728789.6	8940658	7663421.143	6705493.5	5960438.667	5364394.8	4876722.545	4470329	4126457.538	3831710.571	3576263.2	3352746.75	2980219.333	2823365.684	2682197.4	2235164.5	2145757.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170697	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	24872264	12436132	8290754.667	6218066	4974452.8	4145377.333	3553180.571	3109033	2763584.889	2487226.4	2261114.909	2072688.667	1913251.077	1776590.286	1658150.933	1554516.5	1381792.444	1309066.526	1243613.2	1036344.333	994890.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170698	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	32144684	16072342	10714894.67	8036171	6428936.8	5357447.333	4592097.714	4018085.5	3571631.556	3214468.4	2922244	2678723.667	2472668	2296048.857	2142978.933	2009042.75	1785815.778	1691825.474	1607234.2	1339361.833	1285787.36	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170699	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	30837662	15418831	10279220.67	7709415.5	6167532.4	5139610.333	4405380.286	3854707.75	3426406.889	3083766.2	2803423.818	2569805.167	2372127.846	2202690.143	2055844.133	1927353.875	1713203.444	1623034.842	1541883.1	1284902.583	1233506.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
170700	CHOYP_LOC100698842.1.1|m.40947	VHGSIEMHQR	VHGSIEMHQR	11772739	5886369.5	3924246.333	2943184.75	2354547.8	1962123.167	1681819.857	1471592.375	1308082.111	1177273.9	1070249	981061.5833	905595.3077	840909.9286	784849.2667	735796.1875	654041.0556	619617.8421	588636.95	490530.7917	470909.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
171588	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171589	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171590	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171591	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	643812	321906	214604	160953	128762.4	107302	91973.14286	80476.5	71534.66667	64381.2	58528.36364	53651	49524	45986.57143	42920.8	40238.25	35767.33333	33884.84211	32190.6	26825.5	25752.48	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171592	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171593	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	186392	93196	62130.66667	46598	37278.4	31065.33333	26627.42857	23299	20710.22222	18639.2	16944.72727	15532.66667	14337.84615	13313.71429	12426.13333	11649.5	10355.11111	9810.105263	9319.6	7766.333333	7455.68	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171594	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171595	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
171596	CHOYP_LOC100706287.1.1|m.44791	DNITDLGDTLK	DNITDLGDTLK	125505	62752.5	41835	31376.25	25101	20917.5	17929.28571	15688.125	13945	12550.5	11409.54545	10458.75	9654.230769	8964.642857	8367	7844.0625	6972.5	6605.526316	6275.25	5229.375	5020.2	P10758	Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP)	Reg1 Reg	calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]	GO:0001666; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030246; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0043234; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878
174144	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	3047870	1523935	1015956.667	761967.5	609574	507978.3333	435410	380983.75	338652.2222	304787	277079.0909	253989.1667	234451.5385	217705	203191.3333	190491.875	169326.1111	160414.2105	152393.5	126994.5833	121914.8	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174145	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	2092511	1046255.5	697503.6667	523127.75	418502.2	348751.8333	298930.1429	261563.875	232501.2222	209251.1	190228.2727	174375.9167	160962.3846	149465.0714	139500.7333	130781.9375	116250.6111	110132.1579	104625.55	87187.95833	83700.44	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174146	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174147	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174148	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	232830	116415	77610	58207.5	46566	38805	33261.42857	29103.75	25870	23283	21166.36364	19402.5	17910	16630.71429	15522	14551.875	12935	12254.21053	11641.5	9701.25	9313.2	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174149	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	1106374	553187	368791.3333	276593.5	221274.8	184395.6667	158053.4286	138296.75	122930.4444	110637.4	100579.4545	92197.83333	85105.69231	79026.71429	73758.26667	69148.375	61465.22222	58230.21053	55318.7	46098.91667	44254.96	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174150	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	35846	17923	11948.66667	8961.5	7169.2	5974.333333	5120.857143	4480.75	3982.888889	3584.6	3258.727273	2987.166667	2757.384615	2560.428571	2389.733333	2240.375	1991.444444	1886.631579	1792.3	1493.583333	1433.84	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174151	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	229990	114995	76663.33333	57497.5	45998	38331.66667	32855.71429	28748.75	25554.44444	22999	20908.18182	19165.83333	17691.53846	16427.85714	15332.66667	14374.375	12777.22222	12104.73684	11499.5	9582.916667	9199.6	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174152	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
174153	CHOYP_LOC100744089.1.1|m.58530	LADMLGWGDELR	LADMLGWGDELR	30461	15230.5	10153.66667	7615.25	6092.2	5076.833333	4351.571429	3807.625	3384.555556	3046.1	2769.181818	2538.416667	2343.153846	2175.785714	2030.733333	1903.8125	1692.277778	1603.210526	1523.05	1269.208333	1218.44	Q7ZVK3	NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium morphogenesis [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008270; GO:0008285; GO:0010507; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
176529	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176530	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176531	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176532	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176533	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176534	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176535	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176536	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176537	CHOYP_LOC100867381.1.8|m.2154	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176538	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176539	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176540	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176541	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176542	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176543	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176544	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176545	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176546	CHOYP_LOC100867381.1.8|m.2154	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176547	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176548	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176549	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176550	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176551	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176552	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176553	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176554	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176555	CHOYP_LOC100867381.2.8|m.14977	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176556	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176557	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176558	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176559	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176560	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176561	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176562	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176563	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176564	CHOYP_LOC100867381.2.8|m.14977	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176565	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176566	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176567	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176568	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176569	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176570	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176571	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176572	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176573	CHOYP_LOC100867381.3.8|m.15890	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176574	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176575	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176576	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176577	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176578	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176579	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176580	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176581	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176582	CHOYP_LOC100867381.3.8|m.15890	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176583	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176584	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176585	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176586	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176587	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176588	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176589	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176590	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176591	CHOYP_LOC100867381.4.8|m.28245	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176592	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176593	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176594	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176595	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176596	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176597	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176598	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176599	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176600	CHOYP_LOC100867381.4.8|m.28245	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176601	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176602	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176603	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176604	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176605	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176606	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176607	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176608	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176609	CHOYP_LOC100867381.5.8|m.37859	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176610	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176611	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176612	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176613	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176614	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176615	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176616	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176617	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176618	CHOYP_LOC100867381.5.8|m.37859	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176619	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176620	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176621	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176622	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176623	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176624	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176625	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176626	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176627	CHOYP_LOC100867381.6.8|m.44771	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176628	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176629	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176630	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176631	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176632	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176633	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176634	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176635	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176636	CHOYP_LOC100867381.6.8|m.44771	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176637	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176638	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176639	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176640	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176641	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176642	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176643	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176644	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176645	CHOYP_LOC100867381.7.8|m.50678	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176646	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176647	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176648	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176649	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176650	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176651	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176652	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176653	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176654	CHOYP_LOC100867381.7.8|m.50678	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9BX66	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	SORBS1 KIAA0894 KIAA1296 SH3D5	cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0015758; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176655	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176656	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176657	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176658	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176659	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176660	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176661	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176662	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176663	CHOYP_LOC100867381.8.8|m.53059	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176664	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176665	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176666	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176667	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176668	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176669	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176670	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176671	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
176672	CHOYP_LOC100867381.8.8|m.53059	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177338	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177339	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177340	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177341	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	109573	54786.5	36524.33333	27393.25	21914.6	18262.16667	15653.28571	13696.625	12174.77778	10957.3	9961.181818	9131.083333	8428.692308	7826.642857	7304.866667	6848.3125	6087.388889	5767	5478.65	4565.541667	4382.92	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177342	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	232654	116327	77551.33333	58163.5	46530.8	38775.66667	33236.28571	29081.75	25850.44444	23265.4	21150.36364	19387.83333	17896.46154	16618.14286	15510.26667	14540.875	12925.22222	12244.94737	11632.7	9693.916667	9306.16	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177343	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	96950	48475	32316.66667	24237.5	19390	16158.33333	13850	12118.75	10772.22222	9695	8813.636364	8079.166667	7457.692308	6925	6463.333333	6059.375	5386.111111	5102.631579	4847.5	4039.583333	3878	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177344	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	11395	5697.5	3798.333333	2848.75	2279	1899.166667	1627.857143	1424.375	1266.111111	1139.5	1035.909091	949.5833333	876.5384615	813.9285714	759.6666667	712.1875	633.0555556	599.7368421	569.75	474.7916667	455.8	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177345	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	205	102.5	68.33333333	51.25	41	34.16666667	29.28571429	25.625	22.77777778	20.5	18.63636364	17.08333333	15.76923077	14.64285714	13.66666667	12.8125	11.38888889	10.78947368	10.25	8.541666667	8.2	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177346	CHOYP_LOC100875671.1.1|m.57087	ILQEEADIEAR	ILQEEADIEAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177347	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	3568210	1784105	1189403.333	892052.5	713642	594701.6667	509744.2857	446026.25	396467.7778	356821	324382.7273	297350.8333	274477.6923	254872.1429	237880.6667	223013.125	198233.8889	187800.5263	178410.5	148675.4167	142728.4	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177348	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	2117424	1058712	705808	529356	423484.8	352904	302489.1429	264678	235269.3333	211742.4	192493.0909	176452	162878.7692	151244.5714	141161.6	132339	117634.6667	111443.3684	105871.2	88226	84696.96	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177349	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	226194	113097	75398	56548.5	45238.8	37699	32313.42857	28274.25	25132.66667	22619.4	20563.09091	18849.5	17399.53846	16156.71429	15079.6	14137.125	12566.33333	11904.94737	11309.7	9424.75	9047.76	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177350	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	429385	214692.5	143128.3333	107346.25	85877	71564.16667	61340.71429	53673.125	47709.44444	42938.5	39035	35782.08333	33029.61538	30670.35714	28625.66667	26836.5625	23854.72222	22599.21053	21469.25	17891.04167	17175.4	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177351	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	533357	266678.5	177785.6667	133339.25	106671.4	88892.83333	76193.85714	66669.625	59261.88889	53335.7	48487	44446.41667	41027.46154	38096.92857	35557.13333	33334.8125	29630.94444	28071.42105	26667.85	22223.20833	21334.28	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177352	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	341039	170519.5	113679.6667	85259.75	68207.8	56839.83333	48719.85714	42629.875	37893.22222	34103.9	31003.54545	28419.91667	26233.76923	24359.92857	22735.93333	21314.9375	18946.61111	17949.42105	17051.95	14209.95833	13641.56	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177353	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	77059	38529.5	25686.33333	19264.75	15411.8	12843.16667	11008.42857	9632.375	8562.111111	7705.9	7005.363636	6421.583333	5927.615385	5504.214286	5137.266667	4816.1875	4281.055556	4055.736842	3852.95	3210.791667	3082.36	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177354	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	81928	40964	27309.33333	20482	16385.6	13654.66667	11704	10241	9103.111111	8192.8	7448	6827.333333	6302.153846	5852	5461.866667	5120.5	4551.555556	4312	4096.4	3413.666667	3277.12	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
177355	CHOYP_LOC100875671.1.1|m.57087	ALYTFNAQNPR	ALYTFNAQNPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q62417	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; glucose transport [GO:0015758]; insulin receptor signaling pathway [GO:0008286]; positive regulation of establishment of protein localization to plasma membrane [GO:0090004]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; stress fiber assembly [GO:0043149]	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0015758; GO:0016020; GO:0016363; GO:0019901; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:0090004
179895	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179896	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179897	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179898	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	814472	407236	271490.6667	203618	162894.4	135745.3333	116353.1429	101809	90496.88889	81447.2	74042.90909	67872.66667	62651.69231	58176.57143	54298.13333	50904.5	45248.44444	42866.94737	40723.6	33936.33333	32578.88	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179899	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179900	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	210432	105216	70144	52608	42086.4	35072	30061.71429	26304	23381.33333	21043.2	19130.18182	17536	16187.07692	15030.85714	14028.8	13152	11690.66667	11075.36842	10521.6	8768	8417.28	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179901	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	24452	12226	8150.666667	6113	4890.4	4075.333333	3493.142857	3056.5	2716.888889	2445.2	2222.909091	2037.666667	1880.923077	1746.571429	1630.133333	1528.25	1358.444444	1286.947368	1222.6	1018.833333	978.08	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179902	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	49521	24760.5	16507	12380.25	9904.2	8253.5	7074.428571	6190.125	5502.333333	4952.1	4501.909091	4126.75	3809.307692	3537.214286	3301.4	3095.0625	2751.166667	2606.368421	2476.05	2063.375	1980.84	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179903	CHOYP_LOC100880757.1.2|m.19188	MFWGVTLDGGK	MFWGVTLDGGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179904	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	4865986	2432993	1621995.333	1216496.5	973197.2	810997.6667	695140.8571	608248.25	540665.1111	486598.6	442362.3636	405498.8333	374306.6154	347570.4286	324399.0667	304124.125	270332.5556	256104.5263	243299.3	202749.4167	194639.44	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179905	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	3872707	1936353.5	1290902.333	968176.75	774541.4	645451.1667	553243.8571	484088.375	430300.7778	387270.7	352064.2727	322725.5833	297900.5385	276621.9286	258180.4667	242044.1875	215150.3889	203826.6842	193635.35	161362.7917	154908.28	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179906	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	1417409	708704.5	472469.6667	354352.25	283481.8	236234.8333	202487	177176.125	157489.8889	141740.9	128855.3636	118117.4167	109031.4615	101243.5	94493.93333	88588.0625	78744.94444	74600.47368	70870.45	59058.70833	56696.36	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179907	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179908	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179909	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179910	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179911	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179912	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179913	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179914	CHOYP_LOC100880757.1.2|m.19188	TPQNAETPNTEGK	TPQNAETPNTEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179915	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179916	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	7061923	3530961.5	2353974.333	1765480.75	1412384.6	1176987.167	1008846.143	882740.375	784658.1111	706192.3	641993	588493.5833	543224.8462	504423.0714	470794.8667	441370.1875	392329.0556	371680.1579	353096.15	294246.7917	282476.92	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179917	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	3420985	1710492.5	1140328.333	855246.25	684197	570164.1667	488712.1429	427623.125	380109.4444	342098.5	310998.6364	285082.0833	263152.6923	244356.0714	228065.6667	213811.5625	190054.7222	180051.8421	171049.25	142541.0417	136839.4	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179918	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	1006347	503173.5	335449	251586.75	201269.4	167724.5	143763.8571	125793.375	111816.3333	100634.7	91486.09091	83862.25	77411.30769	71881.92857	67089.8	62896.6875	55908.16667	52965.63158	50317.35	41931.125	40253.88	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179919	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	245838	122919	81946	61459.5	49167.6	40973	35119.71429	30729.75	27315.33333	24583.8	22348.90909	20486.5	18910.61538	17559.85714	16389.2	15364.875	13657.66667	12938.84211	12291.9	10243.25	9833.52	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179920	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	26170	13085	8723.333333	6542.5	5234	4361.666667	3738.571429	3271.25	2907.777778	2617	2379.090909	2180.833333	2013.076923	1869.285714	1744.666667	1635.625	1453.888889	1377.368421	1308.5	1090.416667	1046.8	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179921	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	689651	344825.5	229883.6667	172412.75	137930.2	114941.8333	98521.57143	86206.375	76627.88889	68965.1	62695.54545	57470.91667	53050.07692	49260.78571	45976.73333	43103.1875	38313.94444	36297.42105	34482.55	28735.45833	27586.04	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179922	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	303477	151738.5	101159	75869.25	60695.4	50579.5	43353.85714	37934.625	33719.66667	30347.7	27588.81818	25289.75	23344.38462	21676.92857	20231.8	18967.3125	16859.83333	15972.47368	15173.85	12644.875	12139.08	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179923	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	234050	117025	78016.66667	58512.5	46810	39008.33333	33435.71429	29256.25	26005.55556	23405	21277.27273	19504.16667	18003.84615	16717.85714	15603.33333	14628.125	13002.77778	12318.42105	11702.5	9752.083333	9362	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
179924	CHOYP_LOC100880757.1.2|m.19188	VMAGGVVMEETK	VMAGGVVMEETK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P41777	Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)	Nolc1	"box H/ACA snoRNA metabolic process [GO:0033979]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; response to osmotic stress [GO:0006970]"	GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006970; GO:0008134; GO:0008139; GO:0008284; GO:0019904; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893
181393	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181394	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181395	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	1055768	527884	351922.6667	263942	211153.6	175961.3333	150824	131971	117307.5556	105576.8	95978.90909	87980.66667	81212.92308	75412	70384.53333	65985.5	58653.77778	55566.73684	52788.4	43990.33333	42230.72	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181396	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	175523	87761.5	58507.66667	43880.75	35104.6	29253.83333	25074.71429	21940.375	19502.55556	17552.3	15956.63636	14626.91667	13501.76923	12537.35714	11701.53333	10970.1875	9751.277778	9238.052632	8776.15	7313.458333	7020.92	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181397	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	1197340	598670	399113.3333	299335	239468	199556.6667	171048.5714	149667.5	133037.7778	119734	108849.0909	99778.33333	92103.07692	85524.28571	79822.66667	74833.75	66518.88889	63017.89474	59867	49889.16667	47893.6	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181398	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	304089	152044.5	101363	76022.25	60817.8	50681.5	43441.28571	38011.125	33787.66667	30408.9	27644.45455	25340.75	23391.46154	21720.64286	20272.6	19005.5625	16893.83333	16004.68421	15204.45	12670.375	12163.56	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181399	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181400	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	28985	14492.5	9661.666667	7246.25	5797	4830.833333	4140.714286	3623.125	3220.555556	2898.5	2635	2415.416667	2229.615385	2070.357143	1932.333333	1811.5625	1610.277778	1525.526316	1449.25	1207.708333	1159.4	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181401	CHOYP_LOC100893535.1.1|m.27958	IAPVYGELSLK	IAPVYGELSLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181402	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181403	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181404	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181405	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181406	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181407	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181408	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181409	CHOYP_LOC100893535.1.1|m.27958	GADAAALEEK	GADAAALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181410	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181411	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	1184895	592447.5	394965	296223.75	236979	197482.5	169270.7143	148111.875	131655	118489.5	107717.7273	98741.25	91145.76923	84635.35714	78993	74055.9375	65827.5	62362.89474	59244.75	49370.625	47395.8	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181412	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181413	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181414	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	34037	17018.5	11345.66667	8509.25	6807.4	5672.833333	4862.428571	4254.625	3781.888889	3403.7	3094.272727	2836.416667	2618.230769	2431.214286	2269.133333	2127.3125	1890.944444	1791.421053	1701.85	1418.208333	1361.48	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181415	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181416	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181417	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	145382	72691	48460.66667	36345.5	29076.4	24230.33333	20768.85714	18172.75	16153.55556	14538.2	13216.54545	12115.16667	11183.23077	10384.42857	9692.133333	9086.375	8076.777778	7651.684211	7269.1	6057.583333	5815.28	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181418	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181419	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181420	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	18214	9107	6071.333333	4553.5	3642.8	3035.666667	2602	2276.75	2023.777778	1821.4	1655.818182	1517.833333	1401.076923	1301	1214.266667	1138.375	1011.888889	958.6315789	910.7	758.9166667	728.56	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181421	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181422	CHOYP_LOC100893535.1.1|m.27958	LMGDGEEGADEVTVK	LMGDGEEGADEVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181423	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	7734938	3867469	2578312.667	1933734.5	1546987.6	1289156.333	1104991.143	966867.25	859437.5556	773493.8	703176.1818	644578.1667	594995.2308	552495.5714	515662.5333	483433.625	429718.7778	407102	386746.9	322289.0833	309397.52	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181424	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	4301321	2150660.5	1433773.667	1075330.25	860264.2	716886.8333	614474.4286	537665.125	477924.5556	430132.1	391029.1818	358443.4167	330870.8462	307237.2143	286754.7333	268832.5625	238962.2778	226385.3158	215066.05	179221.7083	172052.84	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181425	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	1250681	625340.5	416893.6667	312670.25	250136.2	208446.8333	178668.7143	156335.125	138964.5556	125068.1	113698.2727	104223.4167	96206.23077	89334.35714	83378.73333	78167.5625	69482.27778	65825.31579	62534.05	52111.70833	50027.24	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181426	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	341066	170533	113688.6667	85266.5	68213.2	56844.33333	48723.71429	42633.25	37896.22222	34106.6	31006	28422.16667	26235.84615	24361.85714	22737.73333	21316.625	18948.11111	17950.84211	17053.3	14211.08333	13642.64	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181427	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	201368	100684	67122.66667	50342	40273.6	33561.33333	28766.85714	25171	22374.22222	20136.8	18306.18182	16780.66667	15489.84615	14383.42857	13424.53333	12585.5	11187.11111	10598.31579	10068.4	8390.333333	8054.72	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181428	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	128977	64488.5	42992.33333	32244.25	25795.4	21496.16667	18425.28571	16122.125	14330.77778	12897.7	11725.18182	10748.08333	9921.307692	9212.642857	8598.466667	8061.0625	7165.388889	6788.263158	6448.85	5374.041667	5159.08	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181429	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	65923	32961.5	21974.33333	16480.75	13184.6	10987.16667	9417.571429	8240.375	7324.777778	6592.3	5993	5493.583333	5071	4708.785714	4394.866667	4120.1875	3662.388889	3469.631579	3296.15	2746.791667	2636.92	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181430	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181431	CHOYP_LOC100893535.1.1|m.27958	GHMDLASMINK	GHMDLASMINK	216589	108294.5	72196.33333	54147.25	43317.8	36098.16667	30941.28571	27073.625	24065.44444	21658.9	19689.90909	18049.08333	16660.69231	15470.64286	14439.26667	13536.8125	12032.72222	11399.42105	10829.45	9024.541667	8663.56	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181432	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	5976879	2988439.5	1992293	1494219.75	1195375.8	996146.5	853839.8571	747109.875	664097.6667	597687.9	543352.6364	498073.25	459759.9231	426919.9286	398458.6	373554.9375	332048.8333	314572.5789	298843.95	249036.625	239075.16	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181433	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	3171413	1585706.5	1057137.667	792853.25	634282.6	528568.8333	453059	396426.625	352379.2222	317141.3	288310.2727	264284.4167	243954.8462	226529.5	211427.5333	198213.3125	176189.6111	166916.4737	158570.65	132142.2083	126856.52	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181434	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	1104538	552269	368179.3333	276134.5	220907.6	184089.6667	157791.1429	138067.25	122726.4444	110453.8	100412.5455	92044.83333	84964.46154	78895.57143	73635.86667	69033.625	61363.22222	58133.57895	55226.9	46022.41667	44181.52	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181435	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	1225882	612941	408627.3333	306470.5	245176.4	204313.6667	175126	153235.25	136209.1111	122588.2	111443.8182	102156.8333	94298.61538	87563	81725.46667	76617.625	68104.55556	64520.10526	61294.1	51078.41667	49035.28	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181436	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	163783	81891.5	54594.33333	40945.75	32756.6	27297.16667	23397.57143	20472.875	18198.11111	16378.3	14889.36364	13648.58333	12598.69231	11698.78571	10918.86667	10236.4375	9099.055556	8620.157895	8189.15	6824.291667	6551.32	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181437	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	78776	39388	26258.66667	19694	15755.2	13129.33333	11253.71429	9847	8752.888889	7877.6	7161.454545	6564.666667	6059.692308	5626.857143	5251.733333	4923.5	4376.444444	4146.105263	3938.8	3282.333333	3151.04	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181438	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
181439	CHOYP_LOC100893535.1.1|m.27958	LYAPEENGPK	LYAPEENGPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O43396	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]; protein folding [GO:0006457]; sulfate assimilation [GO:0000103]	GO:0000103; GO:0000502; GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0006662; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0070062
184540	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	2565384	1282692	855128	641346	513076.8	427564	366483.4286	320673	285042.6667	256538.4	233216.7273	213782	197337.2308	183241.7143	171025.6	160336.5	142521.3333	135020.2105	128269.2	106891	102615.36	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184541	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	1516424	758212	505474.6667	379106	303284.8	252737.3333	216632	189553	168491.5556	151642.4	137856.7273	126368.6667	116648	108316	101094.9333	94776.5	84245.77778	79811.78947	75821.2	63184.33333	60656.96	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184542	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	679184	339592	226394.6667	169796	135836.8	113197.3333	97026.28571	84898	75464.88889	67918.4	61744	56598.66667	52244.92308	48513.14286	45278.93333	42449	37732.44444	35746.52632	33959.2	28299.33333	27167.36	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184543	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184544	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184545	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184546	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184547	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184548	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184549	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184550	CHOYP_LOC101070737.1.3|m.1746	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184551	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	12891938	6445969	4297312.667	3222984.5	2578387.6	2148656.333	1841705.429	1611492.25	1432437.556	1289193.8	1171994.364	1074328.167	991687.5385	920852.7143	859462.5333	805746.125	716218.7778	678523.0526	644596.9	537164.0833	515677.52	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184552	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	7595854	3797927	2531951.333	1898963.5	1519170.8	1265975.667	1085122	949481.75	843983.7778	759585.4	690532.1818	632987.8333	584296.4615	542561	506390.2667	474740.875	421991.8889	399781.7895	379792.7	316493.9167	303834.16	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184553	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184554	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184555	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184556	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184557	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184558	CHOYP_LOC101070737.1.3|m.1746	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184559	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	2565384	1282692	855128	641346	513076.8	427564	366483.4286	320673	285042.6667	256538.4	233216.7273	213782	197337.2308	183241.7143	171025.6	160336.5	142521.3333	135020.2105	128269.2	106891	102615.36	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184560	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	1516424	758212	505474.6667	379106	303284.8	252737.3333	216632	189553	168491.5556	151642.4	137856.7273	126368.6667	116648	108316	101094.9333	94776.5	84245.77778	79811.78947	75821.2	63184.33333	60656.96	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184561	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	679184	339592	226394.6667	169796	135836.8	113197.3333	97026.28571	84898	75464.88889	67918.4	61744	56598.66667	52244.92308	48513.14286	45278.93333	42449	37732.44444	35746.52632	33959.2	28299.33333	27167.36	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184562	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184563	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184564	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184565	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184566	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184567	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184568	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184569	CHOYP_LOC101070737.2.3|m.11531	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184570	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	12891938	6445969	4297312.667	3222984.5	2578387.6	2148656.333	1841705.429	1611492.25	1432437.556	1289193.8	1171994.364	1074328.167	991687.5385	920852.7143	859462.5333	805746.125	716218.7778	678523.0526	644596.9	537164.0833	515677.52	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184571	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	7595854	3797927	2531951.333	1898963.5	1519170.8	1265975.667	1085122	949481.75	843983.7778	759585.4	690532.1818	632987.8333	584296.4615	542561	506390.2667	474740.875	421991.8889	399781.7895	379792.7	316493.9167	303834.16	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184572	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184573	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184574	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184575	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184576	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184577	CHOYP_LOC101070737.2.3|m.11531	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184578	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	2565384	1282692	855128	641346	513076.8	427564	366483.4286	320673	285042.6667	256538.4	233216.7273	213782	197337.2308	183241.7143	171025.6	160336.5	142521.3333	135020.2105	128269.2	106891	102615.36	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184579	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	1516424	758212	505474.6667	379106	303284.8	252737.3333	216632	189553	168491.5556	151642.4	137856.7273	126368.6667	116648	108316	101094.9333	94776.5	84245.77778	79811.78947	75821.2	63184.33333	60656.96	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184580	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	679184	339592	226394.6667	169796	135836.8	113197.3333	97026.28571	84898	75464.88889	67918.4	61744	56598.66667	52244.92308	48513.14286	45278.93333	42449	37732.44444	35746.52632	33959.2	28299.33333	27167.36	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184581	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184582	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184583	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184584	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184585	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184586	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184587	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184588	CHOYP_LOC101070737.3.3|m.20342	AKPIMSANPSEAK	AKPIMSANPSEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184589	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	12891938	6445969	4297312.667	3222984.5	2578387.6	2148656.333	1841705.429	1611492.25	1432437.556	1289193.8	1171994.364	1074328.167	991687.5385	920852.7143	859462.5333	805746.125	716218.7778	678523.0526	644596.9	537164.0833	515677.52	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184590	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	7595854	3797927	2531951.333	1898963.5	1519170.8	1265975.667	1085122	949481.75	843983.7778	759585.4	690532.1818	632987.8333	584296.4615	542561	506390.2667	474740.875	421991.8889	399781.7895	379792.7	316493.9167	303834.16	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184591	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184592	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184593	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184594	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184595	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
184596	CHOYP_LOC101070737.3.3|m.20342	QIPQMVQLYK	QIPQMVQLYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9CQZ5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0055114
185859	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	164666672	82333336	54888890.67	41166668	32933334.4	27444445.33	23523810.29	20583334	18296296.89	16466667.2	14969697.45	13722222.67	12666667.08	11761905.14	10977778.13	10291667	9148148.444	8666666.947	8233333.6	6861111.333	6586666.88	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185860	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	142129024	71064512	47376341.33	35532256	28425804.8	23688170.67	20304146.29	17766128	15792113.78	14212902.4	12920820.36	11844085.33	10933001.85	10152073.14	9475268.267	8883064	7896056.889	7480474.947	7106451.2	5922042.667	5685160.96	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185861	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	66531356	33265678	22177118.67	16632839	13306271.2	11088559.33	9504479.429	8316419.5	7392372.889	6653135.6	6048305.091	5544279.667	5117796.615	4752239.714	4435423.733	4158209.75	3696186.444	3501650.316	3326567.8	2772139.833	2661254.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185862	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1573498	786749	524499.3333	393374.5	314699.6	262249.6667	224785.4286	196687.25	174833.1111	157349.8	143045.2727	131124.8333	121038.3077	112392.7143	104899.8667	98343.625	87416.55556	82815.68421	78674.9	65562.41667	62939.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185863	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	950382	475191	316794	237595.5	190076.4	158397	135768.8571	118797.75	105598	95038.2	86398.36364	79198.5	73106.30769	67884.42857	63358.8	59398.875	52799	50020.10526	47519.1	39599.25	38015.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185864	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	6095735	3047867.5	2031911.667	1523933.75	1219147	1015955.833	870819.2857	761966.875	677303.8889	609573.5	554157.7273	507977.9167	468902.6923	435409.6429	406382.3333	380983.4375	338651.9444	320828.1579	304786.75	253988.9583	243829.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185865	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	4495820	2247910	1498606.667	1123955	899164	749303.3333	642260	561977.5	499535.5556	449582	408710.9091	374651.6667	345832.3077	321130	299721.3333	280988.75	249767.7778	236622.1053	224791	187325.8333	179832.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185866	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1913259	956629.5	637753	478314.75	382651.8	318876.5	273322.7143	239157.375	212584.3333	191325.9	173932.6364	159438.25	147173.7692	136661.3571	127550.6	119578.6875	106292.1667	100697.8421	95662.95	79719.125	76530.36	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185867	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1441170	720585	480390	360292.5	288234	240195	205881.4286	180146.25	160130	144117	131015.4545	120097.5	110859.2308	102940.7143	96078	90073.125	80065	75851.05263	72058.5	60048.75	57646.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185868	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	778056	389028	259352	194514	155611.2	129676	111150.8571	97257	86450.66667	77805.6	70732.36364	64838	59850.46154	55575.42857	51870.4	48628.5	43225.33333	40950.31579	38902.8	32419	31122.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185869	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1656563	828281.5	552187.6667	414140.75	331312.6	276093.8333	236651.8571	207070.375	184062.5556	165656.3	150596.6364	138046.9167	127427.9231	118325.9286	110437.5333	103535.1875	92031.27778	87187.52632	82828.15	69023.45833	66262.52	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185870	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	961148	480574	320382.6667	240287	192229.6	160191.3333	137306.8571	120143.5	106794.2222	96114.8	87377.09091	80095.66667	73934.46154	68653.42857	64076.53333	60071.75	53397.11111	50586.73684	48057.4	40047.83333	38445.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185871	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	126238416	63119208	42079472	31559604	25247683.2	21039736	18034059.43	15779802	14026490.67	12623841.6	11476219.64	10519868	9710647.385	9017029.714	8415894.4	7889901	7013245.333	6644127.158	6311920.8	5259934	5049536.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185872	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	113649616	56824808	37883205.33	28412404	22729923.2	18941602.67	16235659.43	14206202	12627735.11	11364961.6	10331783.27	9470801.333	8742278.154	8117829.714	7576641.067	7103101	6313867.556	5981558.737	5682480.8	4735400.667	4545984.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185873	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	51343636	25671818	17114545.33	12835909	10268727.2	8557272.667	7334805.143	6417954.5	5704848.444	5134363.6	4667603.273	4278636.333	3949510.462	3667402.571	3422909.067	3208977.25	2852424.222	2702296.632	2567181.8	2139318.167	2053745.44	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185874	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	313072	156536	104357.3333	78268	62614.4	52178.66667	44724.57143	39134	34785.77778	31307.2	28461.09091	26089.33333	24082.46154	22362.28571	20871.46667	19567	17392.88889	16477.47368	15653.6	13044.66667	12522.88	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185875	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	427527	213763.5	142509	106881.75	85505.4	71254.5	61075.28571	53440.875	47503	42752.7	38866.09091	35627.25	32886.69231	30537.64286	28501.8	26720.4375	23751.5	22501.42105	21376.35	17813.625	17101.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185876	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	6700597	3350298.5	2233532.333	1675149.25	1340119.4	1116766.167	957228.1429	837574.625	744510.7778	670059.7	609145.1818	558383.0833	515430.5385	478614.0714	446706.4667	418787.3125	372255.3889	352663	335029.85	279191.5417	268023.88	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185877	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1993769	996884.5	664589.6667	498442.25	398753.8	332294.8333	284824.1429	249221.125	221529.8889	199376.9	181251.7273	166147.4167	153366.8462	142412.0714	132917.9333	124610.5625	110764.9444	104935.2105	99688.45	83073.70833	79750.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185878	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	4140928	2070464	1380309.333	1035232	828185.6	690154.6667	591561.1429	517616	460103.1111	414092.8	376448	345077.3333	318532.9231	295780.5714	276061.8667	258808	230051.5556	217943.5789	207046.4	172538.6667	165637.12	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185879	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1763046	881523	587682	440761.5	352609.2	293841	251863.7143	220380.75	195894	176304.6	160276.9091	146920.5	135618.9231	125931.8571	117536.4	110190.375	97947	92791.89474	88152.3	73460.25	70521.84	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185880	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	2330300	1165150	776766.6667	582575	466060	388383.3333	332900	291287.5	258922.2222	233030	211845.4545	194191.6667	179253.8462	166450	155353.3333	145643.75	129461.1111	122647.3684	116515	97095.83333	93212	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185881	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	3219638	1609819	1073212.667	804909.5	643927.6	536606.3333	459948.2857	402454.75	357737.5556	321963.8	292694.3636	268303.1667	247664.4615	229974.1429	214642.5333	201227.375	178868.7778	169454.6316	160981.9	134151.5833	128785.52	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185882	CHOYP_LOC101169658.1.3|m.18820	ADISHLQDEVNLLK	ADISHLQDEVNLLK	1595818	797909	531939.3333	398954.5	319163.6	265969.6667	227974	199477.25	177313.1111	159581.8	145074.3636	132984.8333	122755.2308	113987	106387.8667	99738.625	88656.55556	83990.42105	79790.9	66492.41667	63832.72	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185883	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185884	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	2369852	1184926	789950.6667	592463	473970.4	394975.3333	338550.2857	296231.5	263316.8889	236985.2	215441.0909	197487.6667	182296.3077	169275.1429	157990.1333	148115.75	131658.4444	124729.0526	118492.6	98743.83333	94794.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185885	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185886	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185887	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185888	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185889	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185890	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185891	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185892	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185893	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185894	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185895	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185896	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185897	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185898	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185899	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185900	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185901	CHOYP_LOC101169658.1.3|m.18820	LHEHDELLHVTTAAPHTGPIR	LHEHDELLHVTTAAPHTGPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185902	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185903	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185904	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185905	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185906	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185907	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185908	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185909	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185910	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185911	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185912	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185913	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	153440	76720	51146.66667	38360	30688	25573.33333	21920	19180	17048.88889	15344	13949.09091	12786.66667	11803.07692	10960	10229.33333	9590	8524.444444	8075.789474	7672	6393.333333	6137.6	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185914	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	10440	5220	3480	2610	2088	1740	1491.428571	1305	1160	1044	949.0909091	870	803.0769231	745.7142857	696	652.5	580	549.4736842	522	435	417.6	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185915	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	211006	105503	70335.33333	52751.5	42201.2	35167.66667	30143.71429	26375.75	23445.11111	21100.6	19182.36364	17583.83333	16231.23077	15071.85714	14067.06667	13187.875	11722.55556	11105.57895	10550.3	8791.916667	8440.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185916	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185917	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	28195	14097.5	9398.333333	7048.75	5639	4699.166667	4027.857143	3524.375	3132.777778	2819.5	2563.181818	2349.583333	2168.846154	2013.928571	1879.666667	1762.1875	1566.388889	1483.947368	1409.75	1174.791667	1127.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185918	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	11399	5699.5	3799.666667	2849.75	2279.8	1899.833333	1628.428571	1424.875	1266.555556	1139.9	1036.272727	949.9166667	876.8461538	814.2142857	759.9333333	712.4375	633.2777778	599.9473684	569.95	474.9583333	455.96	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185919	CHOYP_LOC101169658.1.3|m.18820	VHLDFFVDAEDTPEPVISVFR	VHLDFFVDAEDTPEPVISVFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185920	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185921	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185922	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185923	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185924	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	191283	95641.5	63761	47820.75	38256.6	31880.5	27326.14286	23910.375	21253.66667	19128.3	17389.36364	15940.25	14714.07692	13663.07143	12752.2	11955.1875	10626.83333	10067.52632	9564.15	7970.125	7651.32	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185925	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	855958	427979	285319.3333	213989.5	171191.6	142659.6667	122279.7143	106994.75	95106.44444	85595.8	77814.36364	71329.83333	65842.92308	61139.85714	57063.86667	53497.375	47553.22222	45050.42105	42797.9	35664.91667	34238.32	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185926	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	3937277	1968638.5	1312425.667	984319.25	787455.4	656212.8333	562468.1429	492159.625	437475.2222	393727.7	357934.2727	328106.4167	302867.4615	281234.0714	262485.1333	246079.8125	218737.6111	207225.1053	196863.85	164053.2083	157491.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185927	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	474992	237496	158330.6667	118748	94998.4	79165.33333	67856	59374	52776.88889	47499.2	43181.09091	39582.66667	36537.84615	33928	31666.13333	29687	26388.44444	24999.57895	23749.6	19791.33333	18999.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185928	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185929	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	301282	150641	100427.3333	75320.5	60256.4	50213.66667	43040.28571	37660.25	33475.77778	30128.2	27389.27273	25106.83333	23175.53846	21520.14286	20085.46667	18830.125	16737.88889	15856.94737	15064.1	12553.41667	12051.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185930	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	842539	421269.5	280846.3333	210634.75	168507.8	140423.1667	120362.7143	105317.375	93615.44444	84253.9	76594.45455	70211.58333	64810.69231	60181.35714	56169.26667	52658.6875	46807.72222	44344.15789	42126.95	35105.79167	33701.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185931	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185932	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185933	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	883853	441926.5	294617.6667	220963.25	176770.6	147308.8333	126264.7143	110481.625	98205.88889	88385.3	80350.27273	73654.41667	67988.69231	63132.35714	58923.53333	55240.8125	49102.94444	46518.57895	44192.65	36827.20833	35354.12	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185934	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185935	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	221192	110596	73730.66667	55298	44238.4	36865.33333	31598.85714	27649	24576.88889	22119.2	20108.36364	18432.66667	17014.76923	15799.42857	14746.13333	13824.5	12288.44444	11641.68421	11059.6	9216.333333	8847.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185936	CHOYP_LOC101169658.1.3|m.18820	SLVILQGDHNHPDSEQIACCVIGR	SLVILQGDHNHPDSEQIACCVIGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185937	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	977096832	488548416	325698944	244274208	195419366.4	162849472	139585261.7	122137104	108566314.7	97709683.2	88826984.73	81424736	75161294.77	69792630.86	65139788.8	61068552	54283157.33	51426149.05	48854841.6	40712368	39083873.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185938	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	591583168	295791584	197194389.3	147895792	118316633.6	98597194.67	84511881.14	73947896	65731463.11	59158316.8	53780288	49298597.33	45506397.54	42255940.57	39438877.87	36973948	32865731.56	31135956.21	29579158.4	24649298.67	23663326.72	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185939	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	246532256	123266128	82177418.67	61633064	49306451.2	41088709.33	35218893.71	30816532	27392472.89	24653225.6	22412023.27	20544354.67	18964019.69	17609446.86	16435483.73	15408266	13696236.44	12975381.89	12326612.8	10272177.33	9861290.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185940	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	53643948	26821974	17881316	13410987	10728789.6	8940658	7663421.143	6705493.5	5960438.667	5364394.8	4876722.545	4470329	4126457.538	3831710.571	3576263.2	3352746.75	2980219.333	2823365.684	2682197.4	2235164.5	2145757.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185941	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	24872264	12436132	8290754.667	6218066	4974452.8	4145377.333	3553180.571	3109033	2763584.889	2487226.4	2261114.909	2072688.667	1913251.077	1776590.286	1658150.933	1554516.5	1381792.444	1309066.526	1243613.2	1036344.333	994890.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185942	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	32144684	16072342	10714894.67	8036171	6428936.8	5357447.333	4592097.714	4018085.5	3571631.556	3214468.4	2922244	2678723.667	2472668	2296048.857	2142978.933	2009042.75	1785815.778	1691825.474	1607234.2	1339361.833	1285787.36	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185943	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	30837662	15418831	10279220.67	7709415.5	6167532.4	5139610.333	4405380.286	3854707.75	3426406.889	3083766.2	2803423.818	2569805.167	2372127.846	2202690.143	2055844.133	1927353.875	1713203.444	1623034.842	1541883.1	1284902.583	1233506.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185944	CHOYP_LOC101169658.2.3|m.20752	VHGSIEMHQR	VHGSIEMHQR	11772739	5886369.5	3924246.333	2943184.75	2354547.8	1962123.167	1681819.857	1471592.375	1308082.111	1177273.9	1070249	981061.5833	905595.3077	840909.9286	784849.2667	735796.1875	654041.0556	619617.8421	588636.95	490530.7917	470909.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185945	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185946	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185947	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185948	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185949	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185950	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185951	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185952	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185953	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185954	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185955	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185956	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185957	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185958	CHOYP_LOC101169658.2.3|m.20752	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185959	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185960	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185961	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185962	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185963	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185964	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185965	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185966	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185967	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185968	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185969	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185970	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185971	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
185972	CHOYP_LOC101169658.3.3|m.46969	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
193739	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193740	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	1194006	597003	398002	298501.5	238801.2	199001	170572.2857	149250.75	132667.3333	119400.6	108546	99500.5	91846.61538	85286.14286	79600.4	74625.375	66333.66667	62842.42105	59700.3	49750.25	47760.24	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193741	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193742	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	51158	25579	17052.66667	12789.5	10231.6	8526.333333	7308.285714	6394.75	5684.222222	5115.8	4650.727273	4263.166667	3935.230769	3654.142857	3410.533333	3197.375	2842.111111	2692.526316	2557.9	2131.583333	2046.32	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193743	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193744	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	181402	90701	60467.33333	45350.5	36280.4	30233.66667	25914.57143	22675.25	20155.77778	18140.2	16491.09091	15116.83333	13954	12957.28571	12093.46667	11337.625	10077.88889	9547.473684	9070.1	7558.416667	7256.08	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193745	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	31695	15847.5	10565	7923.75	6339	5282.5	4527.857143	3961.875	3521.666667	3169.5	2881.363636	2641.25	2438.076923	2263.928571	2113	1980.9375	1760.833333	1668.157895	1584.75	1320.625	1267.8	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193746	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193747	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	47102	23551	15700.66667	11775.5	9420.4	7850.333333	6728.857143	5887.75	5233.555556	4710.2	4282	3925.166667	3623.230769	3364.428571	3140.133333	2943.875	2616.777778	2479.052632	2355.1	1962.583333	1884.08	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
193748	CHOYP_LOC579737.1.1|m.14356	VSNLQMYDTVSR	VSNLQMYDTVSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q64350	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5 Eif2be	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cellular response to drug [GO:0035690]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; translational initiation [GO:0006413]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0035690; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708
197264	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	39115416	19557708	13038472	9778854	7823083.2	6519236	5587916.571	4889427	4346157.333	3911541.6	3555946.909	3259618	3008878.154	2793958.286	2607694.4	2444713.5	2173078.667	2058706.105	1955770.8	1629809	1564616.64	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197265	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	45428592	22714296	15142864	11357148	9085718.4	7571432	6489798.857	5678574	5047621.333	4542859.2	4129872	3785716	3494507.077	3244899.429	3028572.8	2839287	2523810.667	2390978.526	2271429.6	1892858	1817143.68	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197266	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197267	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	2469874	1234937	823291.3333	617468.5	493974.8	411645.6667	352839.1429	308734.25	274430.4444	246987.4	224534	205822.8333	189990.3077	176419.5714	164658.2667	154367.125	137215.2222	129993.3684	123493.7	102911.4167	98794.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197268	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	3940158	1970079	1313386	985039.5	788031.6	656693	562879.7143	492519.75	437795.3333	394015.8	358196.1818	328346.5	303089.0769	281439.8571	262677.2	246259.875	218897.6667	207376.7368	197007.9	164173.25	157606.32	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197269	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	5472779	2736389.5	1824259.667	1368194.75	1094555.8	912129.8333	781825.5714	684097.375	608086.5556	547277.9	497525.3636	456064.9167	420983	390912.7857	364851.9333	342048.6875	304043.2778	288041	273638.95	228032.4583	218911.16	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197270	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	6737810	3368905	2245936.667	1684452.5	1347562	1122968.333	962544.2857	842226.25	748645.5556	673781	612528.1818	561484.1667	518293.0769	481272.1429	449187.3333	421113.125	374322.7778	354621.5789	336890.5	280742.0833	269512.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197271	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	3926524	1963262	1308841.333	981631	785304.8	654420.6667	560932	490815.5	436280.4444	392652.4	356956.7273	327210.3333	302040.3077	280466	261768.2667	245407.75	218140.2222	206659.1579	196326.2	163605.1667	157060.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197272	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	2662560	1331280	887520	665640	532512	443760	380365.7143	332820	295840	266256	242050.9091	221880	204812.3077	190182.8571	177504	166410	147920	140134.7368	133128	110940	106502.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197273	CHOYP_LOC587133.1.1|m.61281	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
197991	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	643111	321555.5	214370.3333	160777.75	128622.2	107185.1667	91873	80388.875	71456.77778	64311.1	58464.63636	53592.58333	49470.07692	45936.5	42874.06667	40194.4375	35728.38889	33847.94737	32155.55	26796.29167	25724.44	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197992	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	830784	415392	276928	207696	166156.8	138464	118683.4286	103848	92309.33333	83078.4	75525.81818	69232	63906.46154	59341.71429	55385.6	51924	46154.66667	43725.47368	41539.2	34616	33231.36	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197993	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197994	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	38099	19049.5	12699.66667	9524.75	7619.8	6349.833333	5442.714286	4762.375	4233.222222	3809.9	3463.545455	3174.916667	2930.692308	2721.357143	2539.933333	2381.1875	2116.611111	2005.210526	1904.95	1587.458333	1523.96	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197995	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197996	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197997	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197998	CHOYP_LOC589012.1.1|m.26892	QSVSDFLIPR	QSVSDFLIPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
197999	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198000	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198001	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198002	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198003	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198004	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198005	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198006	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	23574	11787	7858	5893.5	4714.8	3929	3367.714286	2946.75	2619.333333	2357.4	2143.090909	1964.5	1813.384615	1683.857143	1571.6	1473.375	1309.666667	1240.736842	1178.7	982.25	942.96	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198007	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198008	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	19449	9724.5	6483	4862.25	3889.8	3241.5	2778.428571	2431.125	2161	1944.9	1768.090909	1620.75	1496.076923	1389.214286	1296.6	1215.5625	1080.5	1023.631579	972.45	810.375	777.96	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198009	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	25048	12524	8349.333333	6262	5009.6	4174.666667	3578.285714	3131	2783.111111	2504.8	2277.090909	2087.333333	1926.769231	1789.142857	1669.866667	1565.5	1391.555556	1318.315789	1252.4	1043.666667	1001.92	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198010	CHOYP_LOC589012.1.1|m.26892	GADSEEQNEVVAIK	GADSEEQNEVVAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198011	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198012	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	1095653	547826.5	365217.6667	273913.25	219130.6	182608.8333	156521.8571	136956.625	121739.2222	109565.3	99604.81818	91304.41667	84281	78260.92857	73043.53333	68478.3125	60869.61111	57665.94737	54782.65	45652.20833	43826.12	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198013	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	528510	264255	176170	132127.5	105702	88085	75501.42857	66063.75	58723.33333	52851	48046.36364	44042.5	40654.61538	37750.71429	35234	33031.875	29361.66667	27816.31579	26425.5	22021.25	21140.4	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198014	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198015	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198016	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	8724	4362	2908	2181	1744.8	1454	1246.285714	1090.5	969.3333333	872.4	793.0909091	727	671.0769231	623.1428571	581.6	545.25	484.6666667	459.1578947	436.2	363.5	348.96	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198017	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	77381	38690.5	25793.66667	19345.25	15476.2	12896.83333	11054.42857	9672.625	8597.888889	7738.1	7034.636364	6448.416667	5952.384615	5527.214286	5158.733333	4836.3125	4298.944444	4072.684211	3869.05	3224.208333	3095.24	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198018	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	79691	39845.5	26563.66667	19922.75	15938.2	13281.83333	11384.42857	9961.375	8854.555556	7969.1	7244.636364	6640.916667	6130.076923	5692.214286	5312.733333	4980.6875	4427.277778	4194.263158	3984.55	3320.458333	3187.64	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
198019	CHOYP_LOC589012.1.1|m.26892	WWAPEILDIEK	WWAPEILDIEK	7062	3531	2354	1765.5	1412.4	1177	1008.857143	882.75	784.6666667	706.2	642	588.5	543.2307692	504.4285714	470.8	441.375	392.3333333	371.6842105	353.1	294.25	282.48	P16056	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	Met	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028
199506	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	2585950	1292975	861983.3333	646487.5	517190	430991.6667	369421.4286	323243.75	287327.7778	258595	235086.3636	215495.8333	198919.2308	184710.7143	172396.6667	161621.875	143663.8889	136102.6316	129297.5	107747.9167	103438	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199507	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	2701862	1350931	900620.6667	675465.5	540372.4	450310.3333	385980.2857	337732.75	300206.8889	270186.2	245623.8182	225155.1667	207835.5385	192990.1429	180124.1333	168866.375	150103.4444	142203.2632	135093.1	112577.5833	108074.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199508	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199509	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199510	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199511	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199512	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199513	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199514	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199515	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199516	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199517	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199518	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199519	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199520	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199521	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199522	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199523	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199524	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199525	CHOYP_LOC593522.1.2|m.5381	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199526	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199527	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	15784552	7892276	5261517.333	3946138	3156910.4	2630758.667	2254936	1973069	1753839.111	1578455.2	1434959.273	1315379.333	1214196.308	1127468	1052303.467	986534.5	876919.5556	830765.8947	789227.6	657689.6667	631382.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199528	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199529	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1419877	709938.5	473292.3333	354969.25	283975.4	236646.1667	202839.5714	177484.625	157764.1111	141987.7	129079.7273	118323.0833	109221.3077	101419.7857	94658.46667	88742.3125	78882.05556	74730.36842	70993.85	59161.54167	56795.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199530	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	509221	254610.5	169740.3333	127305.25	101844.2	84870.16667	72745.85714	63652.625	56580.11111	50922.1	46292.81818	42435.08333	39170.84615	36372.92857	33948.06667	31826.3125	28290.05556	26801.10526	25461.05	21217.54167	20368.84	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199531	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	967088	483544	322362.6667	241772	193417.6	161181.3333	138155.4286	120886	107454.2222	96708.8	87917.09091	80590.66667	74391.38462	69077.71429	64472.53333	60443	53727.11111	50899.36842	48354.4	40295.33333	38683.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199532	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	3274028	1637014	1091342.667	818507	654805.6	545671.3333	467718.2857	409253.5	363780.8889	327402.8	297638.9091	272835.6667	251848.3077	233859.1429	218268.5333	204626.75	181890.4444	172317.2632	163701.4	136417.8333	130961.12	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199533	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1955514	977757	651838	488878.5	391102.8	325919	279359.1429	244439.25	217279.3333	195551.4	177774	162959.5	150424.1538	139679.5714	130367.6	122219.625	108639.6667	102921.7895	97775.7	81479.75	78220.56	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199534	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	441737	220868.5	147245.6667	110434.25	88347.4	73622.83333	63105.28571	55217.125	49081.88889	44173.7	40157.90909	36811.41667	33979.76923	31552.64286	29449.13333	27608.5625	24540.94444	23249.31579	22086.85	18405.70833	17669.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199535	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1193294	596647	397764.6667	298323.5	238658.8	198882.3333	170470.5714	149161.75	132588.2222	119329.4	108481.2727	99441.16667	91791.84615	85235.28571	79552.93333	74580.875	66294.11111	62804.94737	59664.7	49720.58333	47731.76	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199536	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	696827	348413.5	232275.6667	174206.75	139365.4	116137.8333	99546.71429	87103.375	77425.22222	69682.7	63347.90909	58068.91667	53602.07692	49773.35714	46455.13333	43551.6875	38712.61111	36675.10526	34841.35	29034.45833	27873.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199537	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	242454	121227	80818	60613.5	48490.8	40409	34636.28571	30306.75	26939.33333	24245.4	22041.27273	20204.5	18650.30769	17318.14286	16163.6	15153.375	13469.66667	12760.73684	12122.7	10102.25	9698.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199538	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	672612	336306	224204	168153	134522.4	112102	96087.42857	84076.5	74734.66667	67261.2	61146.54545	56051	51739.38462	48043.71429	44840.8	42038.25	37367.33333	35400.63158	33630.6	28025.5	26904.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199539	CHOYP_LOC593522.1.2|m.5381	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199540	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	18772410	9386205	6257470	4693102.5	3754482	3128735	2681772.857	2346551.25	2085823.333	1877241	1706582.727	1564367.5	1444031.538	1340886.429	1251494	1173275.625	1042911.667	988021.5789	938620.5	782183.75	750896.4	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199541	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	13851659	6925829.5	4617219.667	3462914.75	2770331.8	2308609.833	1978808.429	1731457.375	1539073.222	1385165.9	1259241.727	1154304.917	1065512.231	989404.2143	923443.9333	865728.6875	769536.6111	729034.6842	692582.95	577152.4583	554066.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199542	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	5117163	2558581.5	1705721	1279290.75	1023432.6	852860.5	731023.2857	639645.375	568573.6667	511716.3	465196.6364	426430.25	393627.9231	365511.6429	341144.2	319822.6875	284286.8333	269324.3684	255858.15	213215.125	204686.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199543	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	1186046	593023	395348.6667	296511.5	237209.2	197674.3333	169435.1429	148255.75	131782.8889	118604.6	107822.3636	98837.16667	91234.30769	84717.57143	79069.73333	74127.875	65891.44444	62423.47368	59302.3	49418.58333	47441.84	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199544	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	1469648	734824	489882.6667	367412	293929.6	244941.3333	209949.7143	183706	163294.2222	146964.8	133604.3636	122470.6667	113049.8462	104974.8571	97976.53333	91853	81647.11111	77349.89474	73482.4	61235.33333	58785.92	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199545	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	428104	214052	142701.3333	107026	85620.8	71350.66667	61157.71429	53513	47567.11111	42810.4	38918.54545	35675.33333	32931.07692	30578.85714	28540.26667	26756.5	23783.55556	22531.78947	21405.2	17837.66667	17124.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199546	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	1007842	503921	335947.3333	251960.5	201568.4	167973.6667	143977.4286	125980.25	111982.4444	100784.2	91622	83986.83333	77526.30769	71988.71429	67189.46667	62990.125	55991.22222	53044.31579	50392.1	41993.41667	40313.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199547	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	905817	452908.5	301939	226454.25	181163.4	150969.5	129402.4286	113227.125	100646.3333	90581.7	82347	75484.75	69678.23077	64701.21429	60387.8	56613.5625	50323.16667	47674.57895	45290.85	37742.375	36232.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199548	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	781125	390562.5	260375	195281.25	156225	130187.5	111589.2857	97640.625	86791.66667	78112.5	71011.36364	65093.75	60086.53846	55794.64286	52075	48820.3125	43395.83333	41111.84211	39056.25	32546.875	31245	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199549	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	906267	453133.5	302089	226566.75	181253.4	151044.5	129466.7143	113283.375	100696.3333	90626.7	82387.90909	75522.25	69712.84615	64733.35714	60417.8	56641.6875	50348.16667	47698.26316	45313.35	37761.125	36250.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199550	CHOYP_LOC593522.1.2|m.5381	FGETGEMFLNGSK	FGETGEMFLNGSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199551	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	3796991	1898495.5	1265663.667	949247.75	759398.2	632831.8333	542427.2857	474623.875	421887.8889	379699.1	345181	316415.9167	292076.2308	271213.6429	253132.7333	237311.9375	210943.9444	199841.6316	189849.55	158207.9583	151879.64	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199552	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	2573647	1286823.5	857882.3333	643411.75	514729.4	428941.1667	367663.8571	321705.875	285960.7778	257364.7	233967.9091	214470.5833	197972.8462	183831.9286	171576.4667	160852.9375	142980.3889	135455.1053	128682.35	107235.2917	102945.88	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199553	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199554	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	98920	49460	32973.33333	24730	19784	16486.66667	14131.42857	12365	10991.11111	9892	8992.727273	8243.333333	7609.230769	7065.714286	6594.666667	6182.5	5495.555556	5206.315789	4946	4121.666667	3956.8	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199555	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199556	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	34151	17075.5	11383.66667	8537.75	6830.2	5691.833333	4878.714286	4268.875	3794.555556	3415.1	3104.636364	2845.916667	2627	2439.357143	2276.733333	2134.4375	1897.277778	1797.421053	1707.55	1422.958333	1366.04	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199557	CHOYP_LOC593522.1.2|m.5381	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199558	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	16112286	8056143	5370762	4028071.5	3222457.2	2685381	2301755.143	2014035.75	1790254	1611228.6	1464753.273	1342690.5	1239406.615	1150877.571	1074152.4	1007017.875	895127	848015.0526	805614.3	671345.25	644491.44	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199559	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	8211049	4105524.5	2737016.333	2052762.25	1642209.8	1368508.167	1173007	1026381.125	912338.7778	821104.9	746459	684254.0833	631619.1538	586503.5	547403.2667	513190.5625	456169.3889	432160.4737	410552.45	342127.0417	328441.96	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199560	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199561	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	399029	199514.5	133009.6667	99757.25	79805.8	66504.83333	57004.14286	49878.625	44336.55556	39902.9	36275.36364	33252.41667	30694.53846	28502.07143	26601.93333	24939.3125	22168.27778	21001.52632	19951.45	16626.20833	15961.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199562	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	1969608	984804	656536	492402	393921.6	328268	281372.5714	246201	218845.3333	196960.8	179055.2727	164134	151508.3077	140686.2857	131307.2	123100.5	109422.6667	103663.5789	98480.4	82067	78784.32	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199563	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	355784	177892	118594.6667	88946	71156.8	59297.33333	50826.28571	44473	39531.55556	35578.4	32344	29648.66667	27368	25413.14286	23718.93333	22236.5	19765.77778	18725.47368	17789.2	14824.33333	14231.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199564	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	2113537	1056768.5	704512.3333	528384.25	422707.4	352256.1667	301933.8571	264192.125	234837.4444	211353.7	192139.7273	176128.0833	162579.7692	150966.9286	140902.4667	132096.0625	117418.7222	111238.7895	105676.85	88064.04167	84541.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199565	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	761542	380771	253847.3333	190385.5	152308.4	126923.6667	108791.7143	95192.75	84615.77778	76154.2	69231.09091	63461.83333	58580.15385	54395.85714	50769.46667	47596.375	42307.88889	40081.15789	38077.1	31730.91667	30461.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199566	CHOYP_LOC593522.1.2|m.5381	STGEGIVEFAR	STGEGIVEFAR	402040	201020	134013.3333	100510	80408	67006.66667	57434.28571	50255	44671.11111	40204	36549.09091	33503.33333	30926.15385	28717.14286	26802.66667	25127.5	22335.55556	21160	20102	16751.66667	16081.6	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199567	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199568	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199569	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	1528232	764116	509410.6667	382058	305646.4	254705.3333	218318.8571	191029	169803.5556	152823.2	138930.1818	127352.6667	117556.3077	109159.4286	101882.1333	95514.5	84901.77778	80433.26316	76411.6	63676.33333	61129.28	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199570	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199571	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199572	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199573	CHOYP_LOC593522.1.2|m.5381	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199574	CHOYP_LOC593522.1.2|m.5381	NQQYQAER	NQQYQAER	4562977	2281488.5	1520992.333	1140744.25	912595.4	760496.1667	651853.8571	570372.125	506997.4444	456297.7	414816.0909	380248.0833	350998.2308	325926.9286	304198.4667	285186.0625	253498.7222	240156.6842	228148.85	190124.0417	182519.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199575	CHOYP_LOC593522.1.2|m.5381	NQQYQAER	NQQYQAER	1555173	777586.5	518391	388793.25	311034.6	259195.5	222167.5714	194396.625	172797	155517.3	141379.3636	129597.75	119628.6923	111083.7857	103678.2	97198.3125	86398.5	81851.21053	77758.65	64798.875	62206.92	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199576	CHOYP_LOC593522.1.2|m.5381	NQQYQAER	NQQYQAER	1037068	518534	345689.3333	259267	207413.6	172844.6667	148152.5714	129633.5	115229.7778	103706.8	94278.90909	86422.33333	79774.46154	74076.28571	69137.86667	64816.75	57614.88889	54582.52632	51853.4	43211.16667	41482.72	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199577	CHOYP_LOC593522.1.2|m.5381	NQQYQAER	NQQYQAER	960788	480394	320262.6667	240197	192157.6	160131.3333	137255.4286	120098.5	106754.2222	96078.8	87344.36364	80065.66667	73906.76923	68627.71429	64052.53333	60049.25	53377.11111	50567.78947	48039.4	40032.83333	38431.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199578	CHOYP_LOC593522.1.2|m.5381	NQQYQAER	NQQYQAER	96959	48479.5	32319.66667	24239.75	19391.8	16159.83333	13851.28571	12119.875	10773.22222	9695.9	8814.454545	8079.916667	7458.384615	6925.642857	6463.933333	6059.9375	5386.611111	5103.105263	4847.95	4039.958333	3878.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199579	CHOYP_LOC593522.1.2|m.5381	NQQYQAER	NQQYQAER	308140	154070	102713.3333	77035	61628	51356.66667	44020	38517.5	34237.77778	30814	28012.72727	25678.33333	23703.07692	22010	20542.66667	19258.75	17118.88889	16217.89474	15407	12839.16667	12325.6	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199580	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199581	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199582	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	9208920	4604460	3069640	2302230	1841784	1534820	1315560	1151115	1023213.333	920892	837174.5455	767410	708378.4615	657780	613928	575557.5	511606.6667	484680	460446	383705	368356.8	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199583	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	7862484	3931242	2620828	1965621	1572496.8	1310414	1123212	982810.5	873609.3333	786248.4	714771.2727	655207	604806.4615	561606	524165.6	491405.25	436804.6667	413814.9474	393124.2	327603.5	314499.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199584	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	4079389	2039694.5	1359796.333	1019847.25	815877.8	679898.1667	582769.8571	509923.625	453265.4444	407938.9	370853.5455	339949.0833	313799.1538	291384.9286	271959.2667	254961.8125	226632.7222	214704.6842	203969.45	169974.5417	163175.56	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199585	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	413926	206963	137975.3333	103481.5	82785.2	68987.66667	59132.28571	51740.75	45991.77778	41392.6	37629.63636	34493.83333	31840.46154	29566.14286	27595.06667	25870.375	22995.88889	21785.57895	20696.3	17246.91667	16557.04	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199586	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199587	CHOYP_LOC593522.1.2|m.5381	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199588	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	2585950	1292975	861983.3333	646487.5	517190	430991.6667	369421.4286	323243.75	287327.7778	258595	235086.3636	215495.8333	198919.2308	184710.7143	172396.6667	161621.875	143663.8889	136102.6316	129297.5	107747.9167	103438	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199589	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	2701862	1350931	900620.6667	675465.5	540372.4	450310.3333	385980.2857	337732.75	300206.8889	270186.2	245623.8182	225155.1667	207835.5385	192990.1429	180124.1333	168866.375	150103.4444	142203.2632	135093.1	112577.5833	108074.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199590	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199591	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199592	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199593	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199594	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199595	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199596	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199597	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199598	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199599	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199600	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199601	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199602	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199603	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199604	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199605	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199606	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199607	CHOYP_LOC593522.2.2|m.33859	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199608	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199609	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	15784552	7892276	5261517.333	3946138	3156910.4	2630758.667	2254936	1973069	1753839.111	1578455.2	1434959.273	1315379.333	1214196.308	1127468	1052303.467	986534.5	876919.5556	830765.8947	789227.6	657689.6667	631382.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199610	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199611	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1419877	709938.5	473292.3333	354969.25	283975.4	236646.1667	202839.5714	177484.625	157764.1111	141987.7	129079.7273	118323.0833	109221.3077	101419.7857	94658.46667	88742.3125	78882.05556	74730.36842	70993.85	59161.54167	56795.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199612	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	509221	254610.5	169740.3333	127305.25	101844.2	84870.16667	72745.85714	63652.625	56580.11111	50922.1	46292.81818	42435.08333	39170.84615	36372.92857	33948.06667	31826.3125	28290.05556	26801.10526	25461.05	21217.54167	20368.84	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199613	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	967088	483544	322362.6667	241772	193417.6	161181.3333	138155.4286	120886	107454.2222	96708.8	87917.09091	80590.66667	74391.38462	69077.71429	64472.53333	60443	53727.11111	50899.36842	48354.4	40295.33333	38683.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199614	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	3274028	1637014	1091342.667	818507	654805.6	545671.3333	467718.2857	409253.5	363780.8889	327402.8	297638.9091	272835.6667	251848.3077	233859.1429	218268.5333	204626.75	181890.4444	172317.2632	163701.4	136417.8333	130961.12	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199615	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1955514	977757	651838	488878.5	391102.8	325919	279359.1429	244439.25	217279.3333	195551.4	177774	162959.5	150424.1538	139679.5714	130367.6	122219.625	108639.6667	102921.7895	97775.7	81479.75	78220.56	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199616	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	441737	220868.5	147245.6667	110434.25	88347.4	73622.83333	63105.28571	55217.125	49081.88889	44173.7	40157.90909	36811.41667	33979.76923	31552.64286	29449.13333	27608.5625	24540.94444	23249.31579	22086.85	18405.70833	17669.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199617	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1193294	596647	397764.6667	298323.5	238658.8	198882.3333	170470.5714	149161.75	132588.2222	119329.4	108481.2727	99441.16667	91791.84615	85235.28571	79552.93333	74580.875	66294.11111	62804.94737	59664.7	49720.58333	47731.76	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199618	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	696827	348413.5	232275.6667	174206.75	139365.4	116137.8333	99546.71429	87103.375	77425.22222	69682.7	63347.90909	58068.91667	53602.07692	49773.35714	46455.13333	43551.6875	38712.61111	36675.10526	34841.35	29034.45833	27873.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199619	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	242454	121227	80818	60613.5	48490.8	40409	34636.28571	30306.75	26939.33333	24245.4	22041.27273	20204.5	18650.30769	17318.14286	16163.6	15153.375	13469.66667	12760.73684	12122.7	10102.25	9698.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199620	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	672612	336306	224204	168153	134522.4	112102	96087.42857	84076.5	74734.66667	67261.2	61146.54545	56051	51739.38462	48043.71429	44840.8	42038.25	37367.33333	35400.63158	33630.6	28025.5	26904.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199621	CHOYP_LOC593522.2.2|m.33859	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199622	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	18772410	9386205	6257470	4693102.5	3754482	3128735	2681772.857	2346551.25	2085823.333	1877241	1706582.727	1564367.5	1444031.538	1340886.429	1251494	1173275.625	1042911.667	988021.5789	938620.5	782183.75	750896.4	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199623	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	13851659	6925829.5	4617219.667	3462914.75	2770331.8	2308609.833	1978808.429	1731457.375	1539073.222	1385165.9	1259241.727	1154304.917	1065512.231	989404.2143	923443.9333	865728.6875	769536.6111	729034.6842	692582.95	577152.4583	554066.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199624	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	5117163	2558581.5	1705721	1279290.75	1023432.6	852860.5	731023.2857	639645.375	568573.6667	511716.3	465196.6364	426430.25	393627.9231	365511.6429	341144.2	319822.6875	284286.8333	269324.3684	255858.15	213215.125	204686.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199625	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	1186046	593023	395348.6667	296511.5	237209.2	197674.3333	169435.1429	148255.75	131782.8889	118604.6	107822.3636	98837.16667	91234.30769	84717.57143	79069.73333	74127.875	65891.44444	62423.47368	59302.3	49418.58333	47441.84	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199626	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	1469648	734824	489882.6667	367412	293929.6	244941.3333	209949.7143	183706	163294.2222	146964.8	133604.3636	122470.6667	113049.8462	104974.8571	97976.53333	91853	81647.11111	77349.89474	73482.4	61235.33333	58785.92	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199627	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	428104	214052	142701.3333	107026	85620.8	71350.66667	61157.71429	53513	47567.11111	42810.4	38918.54545	35675.33333	32931.07692	30578.85714	28540.26667	26756.5	23783.55556	22531.78947	21405.2	17837.66667	17124.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199628	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	1007842	503921	335947.3333	251960.5	201568.4	167973.6667	143977.4286	125980.25	111982.4444	100784.2	91622	83986.83333	77526.30769	71988.71429	67189.46667	62990.125	55991.22222	53044.31579	50392.1	41993.41667	40313.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199629	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	905817	452908.5	301939	226454.25	181163.4	150969.5	129402.4286	113227.125	100646.3333	90581.7	82347	75484.75	69678.23077	64701.21429	60387.8	56613.5625	50323.16667	47674.57895	45290.85	37742.375	36232.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199630	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	781125	390562.5	260375	195281.25	156225	130187.5	111589.2857	97640.625	86791.66667	78112.5	71011.36364	65093.75	60086.53846	55794.64286	52075	48820.3125	43395.83333	41111.84211	39056.25	32546.875	31245	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199631	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	906267	453133.5	302089	226566.75	181253.4	151044.5	129466.7143	113283.375	100696.3333	90626.7	82387.90909	75522.25	69712.84615	64733.35714	60417.8	56641.6875	50348.16667	47698.26316	45313.35	37761.125	36250.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199632	CHOYP_LOC593522.2.2|m.33859	FGETGEMFLNGSK	FGETGEMFLNGSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199633	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	3796991	1898495.5	1265663.667	949247.75	759398.2	632831.8333	542427.2857	474623.875	421887.8889	379699.1	345181	316415.9167	292076.2308	271213.6429	253132.7333	237311.9375	210943.9444	199841.6316	189849.55	158207.9583	151879.64	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199634	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	2573647	1286823.5	857882.3333	643411.75	514729.4	428941.1667	367663.8571	321705.875	285960.7778	257364.7	233967.9091	214470.5833	197972.8462	183831.9286	171576.4667	160852.9375	142980.3889	135455.1053	128682.35	107235.2917	102945.88	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199635	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199636	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	98920	49460	32973.33333	24730	19784	16486.66667	14131.42857	12365	10991.11111	9892	8992.727273	8243.333333	7609.230769	7065.714286	6594.666667	6182.5	5495.555556	5206.315789	4946	4121.666667	3956.8	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199637	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199638	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	34151	17075.5	11383.66667	8537.75	6830.2	5691.833333	4878.714286	4268.875	3794.555556	3415.1	3104.636364	2845.916667	2627	2439.357143	2276.733333	2134.4375	1897.277778	1797.421053	1707.55	1422.958333	1366.04	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199639	CHOYP_LOC593522.2.2|m.33859	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199640	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	16112286	8056143	5370762	4028071.5	3222457.2	2685381	2301755.143	2014035.75	1790254	1611228.6	1464753.273	1342690.5	1239406.615	1150877.571	1074152.4	1007017.875	895127	848015.0526	805614.3	671345.25	644491.44	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199641	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	8211049	4105524.5	2737016.333	2052762.25	1642209.8	1368508.167	1173007	1026381.125	912338.7778	821104.9	746459	684254.0833	631619.1538	586503.5	547403.2667	513190.5625	456169.3889	432160.4737	410552.45	342127.0417	328441.96	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199642	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199643	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	399029	199514.5	133009.6667	99757.25	79805.8	66504.83333	57004.14286	49878.625	44336.55556	39902.9	36275.36364	33252.41667	30694.53846	28502.07143	26601.93333	24939.3125	22168.27778	21001.52632	19951.45	16626.20833	15961.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199644	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	1969608	984804	656536	492402	393921.6	328268	281372.5714	246201	218845.3333	196960.8	179055.2727	164134	151508.3077	140686.2857	131307.2	123100.5	109422.6667	103663.5789	98480.4	82067	78784.32	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199645	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	355784	177892	118594.6667	88946	71156.8	59297.33333	50826.28571	44473	39531.55556	35578.4	32344	29648.66667	27368	25413.14286	23718.93333	22236.5	19765.77778	18725.47368	17789.2	14824.33333	14231.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199646	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	2113537	1056768.5	704512.3333	528384.25	422707.4	352256.1667	301933.8571	264192.125	234837.4444	211353.7	192139.7273	176128.0833	162579.7692	150966.9286	140902.4667	132096.0625	117418.7222	111238.7895	105676.85	88064.04167	84541.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199647	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	761542	380771	253847.3333	190385.5	152308.4	126923.6667	108791.7143	95192.75	84615.77778	76154.2	69231.09091	63461.83333	58580.15385	54395.85714	50769.46667	47596.375	42307.88889	40081.15789	38077.1	31730.91667	30461.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199648	CHOYP_LOC593522.2.2|m.33859	STGEGIVEFAR	STGEGIVEFAR	402040	201020	134013.3333	100510	80408	67006.66667	57434.28571	50255	44671.11111	40204	36549.09091	33503.33333	30926.15385	28717.14286	26802.66667	25127.5	22335.55556	21160	20102	16751.66667	16081.6	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199649	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199650	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199651	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	1528232	764116	509410.6667	382058	305646.4	254705.3333	218318.8571	191029	169803.5556	152823.2	138930.1818	127352.6667	117556.3077	109159.4286	101882.1333	95514.5	84901.77778	80433.26316	76411.6	63676.33333	61129.28	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199652	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199653	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199654	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199655	CHOYP_LOC593522.2.2|m.33859	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199656	CHOYP_LOC593522.2.2|m.33859	NQQYQAER	NQQYQAER	4562977	2281488.5	1520992.333	1140744.25	912595.4	760496.1667	651853.8571	570372.125	506997.4444	456297.7	414816.0909	380248.0833	350998.2308	325926.9286	304198.4667	285186.0625	253498.7222	240156.6842	228148.85	190124.0417	182519.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199657	CHOYP_LOC593522.2.2|m.33859	NQQYQAER	NQQYQAER	1555173	777586.5	518391	388793.25	311034.6	259195.5	222167.5714	194396.625	172797	155517.3	141379.3636	129597.75	119628.6923	111083.7857	103678.2	97198.3125	86398.5	81851.21053	77758.65	64798.875	62206.92	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199658	CHOYP_LOC593522.2.2|m.33859	NQQYQAER	NQQYQAER	1037068	518534	345689.3333	259267	207413.6	172844.6667	148152.5714	129633.5	115229.7778	103706.8	94278.90909	86422.33333	79774.46154	74076.28571	69137.86667	64816.75	57614.88889	54582.52632	51853.4	43211.16667	41482.72	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199659	CHOYP_LOC593522.2.2|m.33859	NQQYQAER	NQQYQAER	960788	480394	320262.6667	240197	192157.6	160131.3333	137255.4286	120098.5	106754.2222	96078.8	87344.36364	80065.66667	73906.76923	68627.71429	64052.53333	60049.25	53377.11111	50567.78947	48039.4	40032.83333	38431.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199660	CHOYP_LOC593522.2.2|m.33859	NQQYQAER	NQQYQAER	96959	48479.5	32319.66667	24239.75	19391.8	16159.83333	13851.28571	12119.875	10773.22222	9695.9	8814.454545	8079.916667	7458.384615	6925.642857	6463.933333	6059.9375	5386.611111	5103.105263	4847.95	4039.958333	3878.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199661	CHOYP_LOC593522.2.2|m.33859	NQQYQAER	NQQYQAER	308140	154070	102713.3333	77035	61628	51356.66667	44020	38517.5	34237.77778	30814	28012.72727	25678.33333	23703.07692	22010	20542.66667	19258.75	17118.88889	16217.89474	15407	12839.16667	12325.6	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199662	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199663	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199664	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	9208920	4604460	3069640	2302230	1841784	1534820	1315560	1151115	1023213.333	920892	837174.5455	767410	708378.4615	657780	613928	575557.5	511606.6667	484680	460446	383705	368356.8	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199665	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	7862484	3931242	2620828	1965621	1572496.8	1310414	1123212	982810.5	873609.3333	786248.4	714771.2727	655207	604806.4615	561606	524165.6	491405.25	436804.6667	413814.9474	393124.2	327603.5	314499.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199666	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	4079389	2039694.5	1359796.333	1019847.25	815877.8	679898.1667	582769.8571	509923.625	453265.4444	407938.9	370853.5455	339949.0833	313799.1538	291384.9286	271959.2667	254961.8125	226632.7222	214704.6842	203969.45	169974.5417	163175.56	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199667	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	413926	206963	137975.3333	103481.5	82785.2	68987.66667	59132.28571	51740.75	45991.77778	41392.6	37629.63636	34493.83333	31840.46154	29566.14286	27595.06667	25870.375	22995.88889	21785.57895	20696.3	17246.91667	16557.04	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199668	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
199669	CHOYP_LOC593522.2.2|m.33859	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
200592	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200593	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200594	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200595	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200596	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	267399	133699.5	89133	66849.75	53479.8	44566.5	38199.85714	33424.875	29711	26739.9	24309	22283.25	20569.15385	19099.92857	17826.6	16712.4375	14855.5	14073.63158	13369.95	11141.625	10695.96	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200597	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	134458	67229	44819.33333	33614.5	26891.6	22409.66667	19208.28571	16807.25	14939.77778	13445.8	12223.45455	11204.83333	10342.92308	9604.142857	8963.866667	8403.625	7469.888889	7076.736842	6722.9	5602.416667	5378.32	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200598	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200599	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200600	CHOYP_LOC656201.1.1|m.8657	LYPPDIEWSNR	LYPPDIEWSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200601	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200602	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200603	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200604	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200605	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200606	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	180998	90499	60332.66667	45249.5	36199.6	30166.33333	25856.85714	22624.75	20110.88889	18099.8	16454.36364	15083.16667	13922.92308	12928.42857	12066.53333	11312.375	10055.44444	9526.210526	9049.9	7541.583333	7239.92	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200607	CHOYP_LOC656201.1.1|m.8657	EGAQQIMNR	EGAQQIMNR	229176	114588	76392	57294	45835.2	38196	32739.42857	28647	25464	22917.6	20834.18182	19098	17628.92308	16369.71429	15278.4	14323.5	12732	12061.89474	11458.8	9549	9167.04	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200608	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200609	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	2204136	1102068	734712	551034	440827.2	367356	314876.5714	275517	244904	220413.6	200376	183678	169548.9231	157438.2857	146942.4	137758.5	122452	116007.1579	110206.8	91839	88165.44	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200610	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	1114267	557133.5	371422.3333	278566.75	222853.4	185711.1667	159181	139283.375	123807.4444	111426.7	101297	92855.58333	85712.84615	79590.5	74284.46667	69641.6875	61903.72222	58645.63158	55713.35	46427.79167	44570.68	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200611	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200612	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	413518	206759	137839.3333	103379.5	82703.6	68919.66667	59074	51689.75	45946.44444	41351.8	37592.54545	34459.83333	31809.07692	29537	27567.86667	25844.875	22973.22222	21764.10526	20675.9	17229.91667	16540.72	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200613	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	119373	59686.5	39791	29843.25	23874.6	19895.5	17053.28571	14921.625	13263.66667	11937.3	10852.09091	9947.75	9182.538462	8526.642857	7958.2	7460.8125	6631.833333	6282.789474	5968.65	4973.875	4774.92	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200614	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200615	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	372231	186115.5	124077	93057.75	74446.2	62038.5	53175.85714	46528.875	41359	37223.1	33839.18182	31019.25	28633.15385	26587.92857	24815.4	23264.4375	20679.5	19591.10526	18611.55	15509.625	14889.24	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200616	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	34623	17311.5	11541	8655.75	6924.6	5770.5	4946.142857	4327.875	3847	3462.3	3147.545455	2885.25	2663.307692	2473.071429	2308.2	2163.9375	1923.5	1822.263158	1731.15	1442.625	1384.92	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200617	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	914883	457441.5	304961	228720.75	182976.6	152480.5	130697.5714	114360.375	101653.6667	91488.3	83171.18182	76240.25	70375.61538	65348.78571	60992.2	57180.1875	50826.83333	48151.73684	45744.15	38120.125	36595.32	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200618	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200619	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	106009	53004.5	35336.33333	26502.25	21201.8	17668.16667	15144.14286	13251.125	11778.77778	10600.9	9637.181818	8834.083333	8154.538462	7572.071429	7067.266667	6625.5625	5889.388889	5579.421053	5300.45	4417.041667	4240.36	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200620	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200621	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200622	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200623	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200624	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200625	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200626	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200627	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	49672	24836	16557.33333	12418	9934.4	8278.666667	7096	6209	5519.111111	4967.2	4515.636364	4139.333333	3820.923077	3548	3311.466667	3104.5	2759.555556	2614.315789	2483.6	2069.666667	1986.88	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200628	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200629	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	259916	129958	86638.66667	64979	51983.2	43319.33333	37130.85714	32489.5	28879.55556	25991.6	23628.72727	21659.66667	19993.53846	18565.42857	17327.73333	16244.75	14439.77778	13679.78947	12995.8	10829.83333	10396.64	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200630	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200631	CHOYP_LOC656201.1.1|m.8657	FGEVVDVFIPKPFR	FGEVVDVFIPKPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200632	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	947375	473687.5	315791.6667	236843.75	189475	157895.8333	135339.2857	118421.875	105263.8889	94737.5	86125	78947.91667	72875	67669.64286	63158.33333	59210.9375	52631.94444	49861.84211	47368.75	39473.95833	37895	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200633	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200634	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200635	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200636	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200637	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200638	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200639	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200640	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	63861	31930.5	21287	15965.25	12772.2	10643.5	9123	7982.625	7095.666667	6386.1	5805.545455	5321.75	4912.384615	4561.5	4257.4	3991.3125	3547.833333	3361.105263	3193.05	2660.875	2554.44	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200641	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200642	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200643	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200644	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	63482	31741	21160.66667	15870.5	12696.4	10580.33333	9068.857143	7935.25	7053.555556	6348.2	5771.090909	5290.166667	4883.230769	4534.428571	4232.133333	3967.625	3526.777778	3341.157895	3174.1	2645.083333	2539.28	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200645	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	134028	67014	44676	33507	26805.6	22338	19146.85714	16753.5	14892	13402.8	12184.36364	11169	10309.84615	9573.428571	8935.2	8376.75	7446	7054.105263	6701.4	5584.5	5361.12	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200646	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200647	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200648	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
200649	CHOYP_LOC656201.1.1|m.8657	STSPHQLGYTQAYPPNPWSQGPR	STSPHQLGYTQAYPPNPWSQGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q13148	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0000166; GO:0001205; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010629; GO:0016607; GO:0030264; GO:0032024; GO:0034976; GO:0035061; GO:0042802; GO:0043922; GO:0044822; GO:0051726; GO:0070935; GO:0071765
202322	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	4071751	2035875.5	1357250.333	1017937.75	814350.2	678625.1667	581678.7143	508968.875	452416.7778	407175.1	370159.1818	339312.5833	313211.6154	290839.3571	271450.0667	254484.4375	226208.3889	214302.6842	203587.55	169656.2917	162870.04	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202323	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202324	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	2163669	1081834.5	721223	540917.25	432733.8	360611.5	309095.5714	270458.625	240407.6667	216366.9	196697.1818	180305.75	166436.0769	154547.7857	144244.6	135229.3125	120203.8333	113877.3158	108183.45	90152.875	86546.76	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202325	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	334410	167205	111470	83602.5	66882	55735	47772.85714	41801.25	37156.66667	33441	30400.90909	27867.5	25723.84615	23886.42857	22294	20900.625	18578.33333	17600.52632	16720.5	13933.75	13376.4	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202326	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202327	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	406532	203266	135510.6667	101633	81306.4	67755.33333	58076	50816.5	45170.22222	40653.2	36957.45455	33877.66667	31271.69231	29038	27102.13333	25408.25	22585.11111	21396.42105	20326.6	16938.83333	16261.28	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202328	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	308332	154166	102777.3333	77083	61666.4	51388.66667	44047.42857	38541.5	34259.11111	30833.2	28030.18182	25694.33333	23717.84615	22023.71429	20555.46667	19270.75	17129.55556	16228	15416.6	12847.16667	12333.28	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202329	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202330	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202331	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202332	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	64077	32038.5	21359	16019.25	12815.4	10679.5	9153.857143	8009.625	7119.666667	6407.7	5825.181818	5339.75	4929	4576.928571	4271.8	4004.8125	3559.833333	3372.473684	3203.85	2669.875	2563.08	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202333	CHOYP_LOC660338.1.1|m.33595	LYNPLLDQTLIIGK	LYNPLLDQTLIIGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202334	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202335	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202336	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202337	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202338	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202339	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202340	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202341	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202342	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202343	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202344	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	121219	60609.5	40406.33333	30304.75	24243.8	20203.16667	17317	15152.375	13468.77778	12121.9	11019.90909	10101.58333	9324.538462	8658.5	8081.266667	7576.1875	6734.388889	6379.947368	6060.95	5050.791667	4848.76	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202345	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	21990	10995	7330	5497.5	4398	3665	3141.428571	2748.75	2443.333333	2199	1999.090909	1832.5	1691.538462	1570.714286	1466	1374.375	1221.666667	1157.368421	1099.5	916.25	879.6	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202346	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202347	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	118813	59406.5	39604.33333	29703.25	23762.6	19802.16667	16973.28571	14851.625	13201.44444	11881.3	10801.18182	9901.083333	9139.461538	8486.642857	7920.866667	7425.8125	6600.722222	6253.315789	5940.65	4950.541667	4752.52	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202348	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202349	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202350	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	292769	146384.5	97589.66667	73192.25	58553.8	48794.83333	41824.14286	36596.125	32529.88889	29276.9	26615.36364	24397.41667	22520.69231	20912.07143	19517.93333	18298.0625	16264.94444	15408.89474	14638.45	12198.70833	11710.76	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202351	CHOYP_LOC660338.1.1|m.33595	DIQSLNNFIEEQLSNSPEKPEAK	DIQSLNNFIEEQLSNSPEKPEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202352	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202353	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202354	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	809638	404819	269879.3333	202409.5	161927.6	134939.6667	115662.5714	101204.75	89959.77778	80963.8	73603.45455	67469.83333	62279.84615	57831.28571	53975.86667	50602.375	44979.88889	42612.52632	40481.9	33734.91667	32385.52	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202355	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	50292	25146	16764	12573	10058.4	8382	7184.571429	6286.5	5588	5029.2	4572	4191	3868.615385	3592.285714	3352.8	3143.25	2794	2646.947368	2514.6	2095.5	2011.68	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202356	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	76433	38216.5	25477.66667	19108.25	15286.6	12738.83333	10919	9554.125	8492.555556	7643.3	6948.454545	6369.416667	5879.461538	5459.5	5095.533333	4777.0625	4246.277778	4022.789474	3821.65	3184.708333	3057.32	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202357	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	14962	7481	4987.333333	3740.5	2992.4	2493.666667	2137.428571	1870.25	1662.444444	1496.2	1360.181818	1246.833333	1150.923077	1068.714286	997.4666667	935.125	831.2222222	787.4736842	748.1	623.4166667	598.48	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202358	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	747714	373857	249238	186928.5	149542.8	124619	106816.2857	93464.25	83079.33333	74771.4	67974	62309.5	57516.46154	53408.14286	49847.6	46732.125	41539.66667	39353.36842	37385.7	31154.75	29908.56	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202359	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	228029	114014.5	76009.66667	57007.25	45605.8	38004.83333	32575.57143	28503.625	25336.55556	22802.9	20729.90909	19002.41667	17540.69231	16287.78571	15201.93333	14251.8125	12668.27778	12001.52632	11401.45	9501.208333	9121.16	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202360	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202361	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	229754	114877	76584.66667	57438.5	45950.8	38292.33333	32822	28719.25	25528.22222	22975.4	20886.72727	19146.16667	17673.38462	16411	15316.93333	14359.625	12764.11111	12092.31579	11487.7	9573.083333	9190.16	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202362	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	31102	15551	10367.33333	7775.5	6220.4	5183.666667	4443.142857	3887.75	3455.777778	3110.2	2827.454545	2591.833333	2392.461538	2221.571429	2073.466667	1943.875	1727.888889	1636.947368	1555.1	1295.916667	1244.08	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202363	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	5254	2627	1751.333333	1313.5	1050.8	875.6666667	750.5714286	656.75	583.7777778	525.4	477.6363636	437.8333333	404.1538462	375.2857143	350.2666667	328.375	291.8888889	276.5263158	262.7	218.9166667	210.16	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202364	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	24274	12137	8091.333333	6068.5	4854.8	4045.666667	3467.714286	3034.25	2697.111111	2427.4	2206.727273	2022.833333	1867.230769	1733.857143	1618.266667	1517.125	1348.555556	1277.578947	1213.7	1011.416667	970.96	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202365	CHOYP_LOC660338.1.1|m.33595	VSTGGLFDLTDDSFPK	VSTGGLFDLTDDSFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202366	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202367	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202368	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202369	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	748756	374378	249585.3333	187189	149751.2	124792.6667	106965.1429	93594.5	83195.11111	74875.6	68068.72727	62396.33333	57596.61538	53482.57143	49917.06667	46797.25	41597.55556	39408.21053	37437.8	31198.16667	29950.24	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202370	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202371	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	512883	256441.5	170961	128220.75	102576.6	85480.5	73269	64110.375	56987	51288.3	46625.72727	42740.25	39452.53846	36634.5	34192.2	32055.1875	28493.5	26993.84211	25644.15	21370.125	20515.32	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202372	CHOYP_LOC660338.1.1|m.33595	SYPTLLFFR	SYPTLLFFR	172253	86126.5	57417.66667	43063.25	34450.6	28708.83333	24607.57143	21531.625	19139.22222	17225.3	15659.36364	14354.41667	13250.23077	12303.78571	11483.53333	10765.8125	9569.611111	9065.947368	8612.65	7177.208333	6890.12	Q91W90	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0034976; GO:0043277; GO:0045454; GO:0070062
202923	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	11855494	5927747	3951831.333	2963873.5	2371098.8	1975915.667	1693642	1481936.75	1317277.111	1185549.4	1077772.182	987957.8333	911961.0769	846821	790366.2667	740968.375	658638.5556	623973.3684	592774.7	493978.9167	474219.76	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202924	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	6457927	3228963.5	2152642.333	1614481.75	1291585.4	1076321.167	922561	807240.875	717547.4444	645792.7	587084.2727	538160.5833	496763.6154	461280.5	430528.4667	403620.4375	358773.7222	339890.8947	322896.35	269080.2917	258317.08	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202925	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	2227081	1113540.5	742360.3333	556770.25	445416.2	371180.1667	318154.4286	278385.125	247453.4444	222708.1	202461.9091	185590.0833	171313.9231	159077.2143	148472.0667	139192.5625	123726.7222	117214.7895	111354.05	92795.04167	89083.24	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202926	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	3202963	1601481.5	1067654.333	800740.75	640592.6	533827.1667	457566.1429	400370.375	355884.7778	320296.3	291178.4545	266913.5833	246381.7692	228783.0714	213530.8667	200185.1875	177942.3889	168577	160148.15	133456.7917	128118.52	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202927	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	1937156	968578	645718.6667	484289	387431.2	322859.3333	276736.5714	242144.5	215239.5556	193715.6	176105.0909	161429.6667	149012	138368.2857	129143.7333	121072.25	107619.7778	101955.5789	96857.8	80714.83333	77486.24	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202928	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	423976	211988	141325.3333	105994	84795.2	70662.66667	60568	52997	47108.44444	42397.6	38543.27273	35331.33333	32613.53846	30284	28265.06667	26498.5	23554.22222	22314.52632	21198.8	17665.66667	16959.04	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202929	CHOYP_LOC662357.1.1|m.64856	DTLFAILEK	DTLFAILEK	1216686	608343	405562	304171.5	243337.2	202781	173812.2857	152085.75	135187.3333	121668.6	110607.8182	101390.5	93591.23077	86906.14286	81112.4	76042.875	67593.66667	64036.10526	60834.3	50695.25	48667.44	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202930	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	24380386	12190193	8126795.333	6095096.5	4876077.2	4063397.667	3482912.286	3047548.25	2708931.778	2438038.6	2216398.727	2031698.833	1875414.308	1741456.143	1625359.067	1523774.125	1354465.889	1283178.211	1219019.3	1015849.417	975215.44	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202931	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	15886172	7943086	5295390.667	3971543	3177234.4	2647695.333	2269453.143	1985771.5	1765130.222	1588617.2	1444197.455	1323847.667	1222013.231	1134726.571	1059078.133	992885.75	882565.1111	836114.3158	794308.6	661923.8333	635446.88	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202932	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	4265746	2132873	1421915.333	1066436.5	853149.2	710957.6667	609392.2857	533218.25	473971.7778	426574.6	387795.0909	355478.8333	328134.3077	304696.1429	284383.0667	266609.125	236985.8889	224512.9474	213287.3	177739.4167	170629.84	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202933	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	4063621	2031810.5	1354540.333	1015905.25	812724.2	677270.1667	580517.2857	507952.625	451513.4444	406362.1	369420.0909	338635.0833	312586.2308	290258.6429	270908.0667	253976.3125	225756.7222	213874.7895	203181.05	169317.5417	162544.84	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202934	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	3220770	1610385	1073590	805192.5	644154	536795	460110	402596.25	357863.3333	322077	292797.2727	268397.5	247751.5385	230055	214718	201298.125	178931.6667	169514.2105	161038.5	134198.75	128830.8	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202935	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	1538804	769402	512934.6667	384701	307760.8	256467.3333	219829.1429	192350.5	170978.2222	153880.4	139891.2727	128233.6667	118369.5385	109914.5714	102586.9333	96175.25	85489.11111	80989.68421	76940.2	64116.83333	61552.16	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202936	CHOYP_LOC662357.1.1|m.64856	LEEFAQLLR	LEEFAQLLR	1146713	573356.5	382237.6667	286678.25	229342.6	191118.8333	163816.1429	143339.125	127412.5556	114671.3	104246.6364	95559.41667	88208.69231	81908.07143	76447.53333	71669.5625	63706.27778	60353.31579	57335.65	47779.70833	45868.52	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202937	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	6117402	3058701	2039134	1529350.5	1223480.4	1019567	873914.5714	764675.25	679711.3333	611740.2	556127.4545	509783.5	470569.3846	436957.2857	407826.8	382337.625	339855.6667	321968.5263	305870.1	254891.75	244696.08	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202938	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	10015351	5007675.5	3338450.333	2503837.75	2003070.2	1669225.167	1430764.429	1251918.875	1112816.778	1001535.1	910486.4545	834612.5833	770411.6154	715382.2143	667690.0667	625959.4375	556408.3889	527123.7368	500767.55	417306.2917	400614.04	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202939	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202940	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	765769	382884.5	255256.3333	191442.25	153153.8	127628.1667	109395.5714	95721.125	85085.44444	76576.9	69615.36364	63814.08333	58905.30769	54697.78571	51051.26667	47860.5625	42542.72222	40303.63158	38288.45	31907.04167	30630.76	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202941	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	1818477	909238.5	606159	454619.25	363695.4	303079.5	259782.4286	227309.625	202053	181847.7	165316.0909	151539.75	139882.8462	129891.2143	121231.8	113654.8125	101026.5	95709.31579	90923.85	75769.875	72739.08	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202942	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	976815	488407.5	325605	244203.75	195363	162802.5	139545	122101.875	108535	97681.5	88801.36364	81401.25	75139.61538	69772.5	65121	61050.9375	54267.5	51411.31579	48840.75	40700.625	39072.6	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202943	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	1479471	739735.5	493157	369867.75	295894.2	246578.5	211353	184933.875	164385.6667	147947.1	134497.3636	123289.25	113805.4615	105676.5	98631.4	92466.9375	82192.83333	77866.89474	73973.55	61644.625	59178.84	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202944	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	2033720	1016860	677906.6667	508430	406744	338953.3333	290531.4286	254215	225968.8889	203372	184883.6364	169476.6667	156440	145265.7143	135581.3333	127107.5	112984.4444	107037.8947	101686	84738.33333	81348.8	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202945	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	951185	475592.5	317061.6667	237796.25	190237	158530.8333	135883.5714	118898.125	105687.2222	95118.5	86471.36364	79265.41667	73168.07692	67941.78571	63412.33333	59449.0625	52843.61111	50062.36842	47559.25	39632.70833	38047.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
202946	CHOYP_LOC662357.1.1|m.64856	EVNADLIITGTR	EVNADLIITGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
203825	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203826	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203827	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203828	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203829	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203830	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203831	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203832	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203833	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203834	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203835	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203836	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203837	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203838	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	507467	253733.5	169155.6667	126866.75	101493.4	84577.83333	72495.28571	63433.375	56385.22222	50746.7	46133.36364	42288.91667	39035.92308	36247.64286	33831.13333	31716.6875	28192.61111	26708.78947	25373.35	21144.45833	20298.68	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203839	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203840	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203841	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203842	CHOYP_LOC732900.1.1|m.62814	VSNFTLNFGPQHPAAHGVLR	VSNFTLNFGPQHPAAHGVLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203843	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203844	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	3599785	1799892.5	1199928.333	899946.25	719957	599964.1667	514255	449973.125	399976.1111	359978.5	327253.1818	299982.0833	276906.5385	257127.5	239985.6667	224986.5625	199988.0556	189462.3684	179989.25	149991.0417	143991.4	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203845	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203846	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	372405	186202.5	124135	93101.25	74481	62067.5	53200.71429	46550.625	41378.33333	37240.5	33855	31033.75	28646.53846	26600.35714	24827	23275.3125	20689.16667	19600.26316	18620.25	15516.875	14896.2	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203847	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	114094	57047	38031.33333	28523.5	22818.8	19015.66667	16299.14286	14261.75	12677.11111	11409.4	10372.18182	9507.833333	8776.461538	8149.571429	7606.266667	7130.875	6338.555556	6004.947368	5704.7	4753.916667	4563.76	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203848	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203849	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203850	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203851	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203852	CHOYP_LOC732900.1.1|m.62814	LIATLQNETVVK	LIATLQNETVVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203853	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	15535409	7767704.5	5178469.667	3883852.25	3107081.8	2589234.833	2219344.143	1941926.125	1726156.556	1553540.9	1412309.909	1294617.417	1195031.462	1109672.071	1035693.933	970963.0625	863078.2778	817653.1053	776770.45	647308.7083	621416.36	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203854	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	8979163	4489581.5	2993054.333	2244790.75	1795832.6	1496527.167	1282737.571	1122395.375	997684.7778	897916.3	816287.5455	748263.5833	690704.8462	641368.7857	598610.8667	561197.6875	498842.3889	472587.5263	448958.15	374131.7917	359166.52	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203855	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203856	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	712415	356207.5	237471.6667	178103.75	142483	118735.8333	101773.5714	89051.875	79157.22222	71241.5	64765	59367.91667	54801.15385	50886.78571	47494.33333	44525.9375	39578.61111	37495.52632	35620.75	29683.95833	28496.6	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203857	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	3317957	1658978.5	1105985.667	829489.25	663591.4	552992.8333	473993.8571	414744.625	368661.8889	331795.7	301632.4545	276496.4167	255227.4615	236996.9286	221197.1333	207372.3125	184330.9444	174629.3158	165897.85	138248.2083	132718.28	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203858	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	3234411	1617205.5	1078137	808602.75	646882.2	539068.5	462058.7143	404301.375	359379	323441.1	294037.3636	269534.25	248800.8462	231029.3571	215627.4	202150.6875	179689.5	170232.1579	161720.55	134767.125	129376.44	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203859	CHOYP_LOC732900.1.1|m.62814	LLNIDVPIR	LLNIDVPIR	1307482	653741	435827.3333	326870.5	261496.4	217913.6667	186783.1429	163435.25	145275.7778	130748.2	118862	108956.8333	100575.5385	93391.57143	87165.46667	81717.625	72637.88889	68814.84211	65374.1	54478.41667	52299.28	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203860	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203861	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	3827242	1913621	1275747.333	956810.5	765448.4	637873.6667	546748.8571	478405.25	425249.1111	382724.2	347931.0909	318936.8333	294403.2308	273374.4286	255149.4667	239202.625	212624.5556	201433.7895	191362.1	159468.4167	153089.68	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203862	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	1117257	558628.5	372419	279314.25	223451.4	186209.5	159608.1429	139657.125	124139.6667	111725.7	101568.8182	93104.75	85942.84615	79804.07143	74483.8	69828.5625	62069.83333	58803	55862.85	46552.375	44690.28	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203863	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	113331	56665.5	37777	28332.75	22666.2	18888.5	16190.14286	14166.375	12592.33333	11333.1	10302.81818	9444.25	8717.769231	8095.071429	7555.4	7083.1875	6296.166667	5964.789474	5666.55	4722.125	4533.24	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203864	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	173066	86533	57688.66667	43266.5	34613.2	28844.33333	24723.71429	21633.25	19229.55556	17306.6	15733.27273	14422.16667	13312.76923	12361.85714	11537.73333	10816.625	9614.777778	9108.736842	8653.3	7211.083333	6922.64	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203865	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	155571	77785.5	51857	38892.75	31114.2	25928.5	22224.42857	19446.375	17285.66667	15557.1	14142.81818	12964.25	11967	11112.21429	10371.4	9723.1875	8642.833333	8187.947368	7778.55	6482.125	6222.84	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203866	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	51823	25911.5	17274.33333	12955.75	10364.6	8637.166667	7403.285714	6477.875	5758.111111	5182.3	4711.181818	4318.583333	3986.384615	3701.642857	3454.866667	3238.9375	2879.055556	2727.526316	2591.15	2159.291667	2072.92	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203867	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	305438	152719	101812.6667	76359.5	61087.6	50906.33333	43634	38179.75	33937.55556	30543.8	27767.09091	25453.16667	23495.23077	21817	20362.53333	19089.875	16968.77778	16075.68421	15271.9	12726.58333	12217.52	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203868	CHOYP_LOC732900.1.1|m.62814	ESMEALIHHFK	ESMEALIHHFK	176154	88077	58718	44038.5	35230.8	29359	25164.85714	22019.25	19572.66667	17615.4	16014	14679.5	13550.30769	12582.42857	11743.6	11009.625	9786.333333	9271.263158	8807.7	7339.75	7046.16	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203869	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	7153055	3576527.5	2384351.667	1788263.75	1430611	1192175.833	1021865	894131.875	794783.8889	715305.5	650277.7273	596087.9167	550235	510932.5	476870.3333	447065.9375	397391.9444	376476.5789	357652.75	298043.9583	286122.2	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203870	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	6844397	3422198.5	2281465.667	1711099.25	1368879.4	1140732.833	977771	855549.625	760488.5556	684439.7	622217.9091	570366.4167	526492.0769	488885.5	456293.1333	427774.8125	380244.2778	360231.4211	342219.85	285183.2083	273775.88	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203871	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	5431027	2715513.5	1810342.333	1357756.75	1086205.4	905171.1667	775861	678878.375	603447.4444	543102.7	493729.7273	452585.5833	417771.3077	387930.5	362068.4667	339439.1875	301723.7222	285843.5263	271551.35	226292.7917	217241.08	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203872	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	49390	24695	16463.33333	12347.5	9878	8231.666667	7055.714286	6173.75	5487.777778	4939	4490	4115.833333	3799.230769	3527.857143	3292.666667	3086.875	2743.888889	2599.473684	2469.5	2057.916667	1975.6	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203873	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203874	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	1876686	938343	625562	469171.5	375337.2	312781	268098	234585.75	208520.6667	187668.6	170607.8182	156390.5	144360.4615	134049	125112.4	117292.875	104260.3333	98772.94737	93834.3	78195.25	75067.44	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203875	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	1006234	503117	335411.3333	251558.5	201246.8	167705.6667	143747.7143	125779.25	111803.7778	100623.4	91475.81818	83852.83333	77402.61538	71873.85714	67082.26667	62889.625	55901.88889	52959.68421	50311.7	41926.41667	40249.36	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203876	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	1761235	880617.5	587078.3333	440308.75	352247	293539.1667	251605	220154.375	195692.7778	176123.5	160112.2727	146769.5833	135479.6154	125802.5	117415.6667	110077.1875	97846.38889	92696.57895	88061.75	73384.79167	70449.4	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203877	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	2238201	1119100.5	746067	559550.25	447640.2	373033.5	319743	279775.125	248689	223820.1	203472.8182	186516.75	172169.3077	159871.5	149213.4	139887.5625	124344.5	117800.0526	111910.05	93258.375	89528.04	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203878	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	1483631	741815.5	494543.6667	370907.75	296726.2	247271.8333	211947.2857	185453.875	164847.8889	148363.1	134875.5455	123635.9167	114125.4615	105973.6429	98908.73333	92726.9375	82423.94444	78085.84211	74181.55	61817.95833	59345.24	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203879	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	1235194	617597	411731.3333	308798.5	247038.8	205865.6667	176456.2857	154399.25	137243.7778	123519.4	112290.3636	102932.8333	95014.92308	88228.14286	82346.26667	77199.625	68621.88889	65010.21053	61759.7	51466.41667	49407.76	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203880	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203881	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203882	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203883	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	576200	288100	192066.6667	144050	115240	96033.33333	82314.28571	72025	64022.22222	57620	52381.81818	48016.66667	44323.07692	41157.14286	38413.33333	36012.5	32011.11111	30326.31579	28810	24008.33333	23048	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203884	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203885	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203886	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203887	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203888	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203889	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203890	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203891	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203892	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	94002	47001	31334	23500.5	18800.4	15667	13428.85714	11750.25	10444.66667	9400.2	8545.636364	7833.5	7230.923077	6714.428571	6266.8	5875.125	5222.333333	4947.473684	4700.1	3916.75	3760.08	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203893	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	11030	5515	3676.666667	2757.5	2206	1838.333333	1575.714286	1378.75	1225.555556	1103	1002.727273	919.1666667	848.4615385	787.8571429	735.3333333	689.375	612.7777778	580.5263158	551.5	459.5833333	441.2	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203894	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203895	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203896	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203897	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203898	CHOYP_LOC732900.1.1|m.62814	GEFGVYLVSDGTNKPYR	GEFGVYLVSDGTNKPYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203899	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	11390810	5695405	3796936.667	2847702.5	2278162	1898468.333	1627258.571	1423851.25	1265645.556	1139081	1035528.182	949234.1667	876216.1538	813629.2857	759387.3333	711925.625	632822.7778	599516.3158	569540.5	474617.0833	455632.4	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203900	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	11608535	5804267.5	3869511.667	2902133.75	2321707	1934755.833	1658362.143	1451066.875	1289837.222	1160853.5	1055321.364	967377.9167	892964.2308	829181.0714	773902.3333	725533.4375	644918.6111	610975.5263	580426.75	483688.9583	464341.4	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203901	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	6567432	3283716	2189144	1641858	1313486.4	1094572	938204.5714	820929	729714.6667	656743.2	597039.2727	547286	505187.0769	469102.2857	437828.8	410464.5	364857.3333	345654.3158	328371.6	273643	262697.28	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203902	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203903	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203904	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	17090	8545	5696.666667	4272.5	3418	2848.333333	2441.428571	2136.25	1898.888889	1709	1553.636364	1424.166667	1314.615385	1220.714286	1139.333333	1068.125	949.4444444	899.4736842	854.5	712.0833333	683.6	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203905	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	427823	213911.5	142607.6667	106955.75	85564.6	71303.83333	61117.57143	53477.875	47535.88889	42782.3	38893	35651.91667	32909.46154	30558.78571	28521.53333	26738.9375	23767.94444	22517	21391.15	17825.95833	17112.92	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203906	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	960891	480445.5	320297	240222.75	192178.2	160148.5	137270.1429	120111.375	106765.6667	96089.1	87353.72727	80074.25	73914.69231	68635.07143	64059.4	60055.6875	53382.83333	50573.21053	48044.55	40037.125	38435.64	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203907	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	265911	132955.5	88637	66477.75	53182.2	44318.5	37987.28571	33238.875	29545.66667	26591.1	24173.72727	22159.25	20454.69231	18993.64286	17727.4	16619.4375	14772.83333	13995.31579	13295.55	11079.625	10636.44	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203908	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	89541	44770.5	29847	22385.25	17908.2	14923.5	12791.57143	11192.625	9949	8954.1	8140.090909	7461.75	6887.769231	6395.785714	5969.4	5596.3125	4974.5	4712.684211	4477.05	3730.875	3581.64	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203909	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	63702	31851	21234	15925.5	12740.4	10617	9100.285714	7962.75	7078	6370.2	5791.090909	5308.5	4900.153846	4550.142857	4246.8	3981.375	3539	3352.736842	3185.1	2654.25	2548.08	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203910	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	269615	134807.5	89871.66667	67403.75	53923	44935.83333	38516.42857	33701.875	29957.22222	26961.5	24510.45455	22467.91667	20739.61538	19258.21429	17974.33333	16850.9375	14978.61111	14190.26316	13480.75	11233.95833	10784.6	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
203911	CHOYP_LOC732900.1.1|m.62814	APGFAHLAALDHIAK	APGFAHLAALDHIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q641Y2	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	response to oxidative stress [GO:0006979]	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539
204245	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	9985607	4992803.5	3328535.667	2496401.75	1997121.4	1664267.833	1426515.286	1248200.875	1109511.889	998560.7	907782.4545	832133.9167	768123.6154	713257.6429	665707.1333	624100.4375	554755.9444	525558.2632	499280.35	416066.9583	399424.28	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204246	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	10581681	5290840.5	3527227	2645420.25	2116336.2	1763613.5	1511668.714	1322710.125	1175742.333	1058168.1	961971	881806.75	813975.4615	755834.3571	705445.4	661355.0625	587871.1667	556930.5789	529084.05	440903.375	423267.24	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204247	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204248	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	33073	16536.5	11024.33333	8268.25	6614.6	5512.166667	4724.714286	4134.125	3674.777778	3307.3	3006.636364	2756.083333	2544.076923	2362.357143	2204.866667	2067.0625	1837.388889	1740.684211	1653.65	1378.041667	1322.92	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204249	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204250	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	456740	228370	152246.6667	114185	91348	76123.33333	65248.57143	57092.5	50748.88889	45674	41521.81818	38061.66667	35133.84615	32624.28571	30449.33333	28546.25	25374.44444	24038.94737	22837	19030.83333	18269.6	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204251	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1297472	648736	432490.6667	324368	259494.4	216245.3333	185353.1429	162184	144163.5556	129747.2	117952	108122.6667	99805.53846	92676.57143	86498.13333	81092	72081.77778	68288	64873.6	54061.33333	51898.88	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204252	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204253	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1304334	652167	434778	326083.5	260866.8	217389	186333.4286	163041.75	144926	130433.4	118575.8182	108694.5	100333.3846	93166.71429	86955.6	81520.875	72463	68649.15789	65216.7	54347.25	52173.36	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204254	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1663876	831938	554625.3333	415969	332775.2	277312.6667	237696.5714	207984.5	184875.1111	166387.6	151261.4545	138656.3333	127990.4615	118848.2857	110925.0667	103992.25	92437.55556	87572.42105	83193.8	69328.16667	66555.04	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204255	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1919015	959507.5	639671.6667	479753.75	383803	319835.8333	274145	239876.875	213223.8889	191901.5	174455.9091	159917.9167	147616.5385	137072.5	127934.3333	119938.4375	106611.9444	101000.7895	95950.75	79958.95833	76760.6	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
204256	CHOYP_LOC754102.1.1|m.57575	KPNDVVYIVHSLER	KPNDVVYIVHSLER	90811	45405.5	30270.33333	22702.75	18162.2	15135.16667	12973	11351.375	10090.11111	9081.1	8255.545455	7567.583333	6985.461538	6486.5	6054.066667	5675.6875	5045.055556	4779.526316	4540.55	3783.791667	3632.44	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
205258	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	10658416	5329208	3552805.333	2664604	2131683.2	1776402.667	1522630.857	1332302	1184268.444	1065841.6	968946.9091	888201.3333	819878.1538	761315.4286	710561.0667	666151	592134.2222	560969.2632	532920.8	444100.6667	426336.64	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205259	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	9302730	4651365	3100910	2325682.5	1860546	1550455	1328961.429	1162841.25	1033636.667	930273	845702.7273	775227.5	715594.6154	664480.7143	620182	581420.625	516818.3333	489617.3684	465136.5	387613.75	372109.2	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205260	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	4362693	2181346.5	1454231	1090673.25	872538.6	727115.5	623241.8571	545336.625	484743.6667	436269.3	396608.4545	363557.75	335591.7692	311620.9286	290846.2	272668.3125	242371.8333	229615.4211	218134.65	181778.875	174507.72	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205261	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	169265	84632.5	56421.66667	42316.25	33853	28210.83333	24180.71429	21158.125	18807.22222	16926.5	15387.72727	14105.41667	13020.38462	12090.35714	11284.33333	10579.0625	9403.611111	8908.684211	8463.25	7052.708333	6770.6	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205262	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	1115223	557611.5	371741	278805.75	223044.6	185870.5	159317.5714	139402.875	123913.6667	111522.3	101383.9091	92935.25	85786.38462	79658.78571	74348.2	69701.4375	61956.83333	58695.94737	55761.15	46467.625	44608.92	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205263	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	3878697	1939348.5	1292899	969674.25	775739.4	646449.5	554099.5714	484837.125	430966.3333	387869.7	352608.8182	323224.75	298361.3077	277049.7857	258579.8	242418.5625	215483.1667	204141.9474	193934.85	161612.375	155147.88	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205264	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	3722485	1861242.5	1240828.333	930621.25	744497	620414.1667	531783.5714	465310.625	413609.4444	372248.5	338407.7273	310207.0833	286345	265891.7857	248165.6667	232655.3125	206804.7222	195920.2632	186124.25	155103.5417	148899.4	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205265	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	1129643	564821.5	376547.6667	282410.75	225928.6	188273.8333	161377.5714	141205.375	125515.8889	112964.3	102694.8182	94136.91667	86895.61538	80688.78571	75309.53333	70602.6875	62757.94444	59454.89474	56482.15	47068.45833	45185.72	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205266	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	462539	231269.5	154179.6667	115634.75	92507.8	77089.83333	66077	57817.375	51393.22222	46253.9	42049	38544.91667	35579.92308	33038.5	30835.93333	28908.6875	25696.61111	24344.15789	23126.95	19272.45833	18501.56	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205267	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	359457	179728.5	119819	89864.25	71891.4	59909.5	51351	44932.125	39939.66667	35945.7	32677.90909	29954.75	27650.53846	25675.5	23963.8	22466.0625	19969.83333	18918.78947	17972.85	14977.375	14378.28	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205268	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	51891	25945.5	17297	12972.75	10378.2	8648.5	7413	6486.375	5765.666667	5189.1	4717.363636	4324.25	3991.615385	3706.5	3459.4	3243.1875	2882.833333	2731.105263	2594.55	2162.125	2075.64	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205269	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205270	CHOYP_LR16A.1.3|m.9037	LATAILSNSSSQLQR	LATAILSNSSSQLQR	41470	20735	13823.33333	10367.5	8294	6911.666667	5924.285714	5183.75	4607.777778	4147	3770	3455.833333	3190	2962.142857	2764.666667	2591.875	2303.888889	2182.631579	2073.5	1727.916667	1658.8	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205271	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205272	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205273	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205274	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205275	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205276	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205277	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	85859	42929.5	28619.66667	21464.75	17171.8	14309.83333	12265.57143	10732.375	9539.888889	8585.9	7805.363636	7154.916667	6604.538462	6132.785714	5723.933333	5366.1875	4769.944444	4518.894737	4292.95	3577.458333	3434.36	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205278	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205279	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	28803	14401.5	9601	7200.75	5760.6	4800.5	4114.714286	3600.375	3200.333333	2880.3	2618.454545	2400.25	2215.615385	2057.357143	1920.2	1800.1875	1600.166667	1515.947368	1440.15	1200.125	1152.12	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205280	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205281	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205282	CHOYP_LR16A.1.3|m.9037	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	74463	37231.5	24821	18615.75	14892.6	12410.5	10637.57143	9307.875	8273.666667	7446.3	6769.363636	6205.25	5727.923077	5318.785714	4964.2	4653.9375	4136.833333	3919.105263	3723.15	3102.625	2978.52	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205283	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	3586910	1793455	1195636.667	896727.5	717382	597818.3333	512415.7143	448363.75	398545.5556	358691	326082.7273	298909.1667	275916.1538	256207.8571	239127.3333	224181.875	199272.7778	188784.7368	179345.5	149454.5833	143476.4	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205284	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	3280030	1640015	1093343.333	820007.5	656006	546671.6667	468575.7143	410003.75	364447.7778	328003	298184.5455	273335.8333	252310	234287.8571	218668.6667	205001.875	182223.8889	172633.1579	164001.5	136667.9167	131201.2	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205285	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	2437718	1218859	812572.6667	609429.5	487543.6	406286.3333	348245.4286	304714.75	270857.5556	243771.8	221610.7273	203143.1667	187516.7692	174122.7143	162514.5333	152357.375	135428.7778	128300.9474	121885.9	101571.5833	97508.72	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205286	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	355678	177839	118559.3333	88919.5	71135.6	59279.66667	50811.14286	44459.75	39519.77778	35567.8	32334.36364	29639.83333	27359.84615	25405.57143	23711.86667	22229.875	19759.88889	18719.89474	17783.9	14819.91667	14227.12	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205287	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205288	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	651721	325860.5	217240.3333	162930.25	130344.2	108620.1667	93103	81465.125	72413.44444	65172.1	59247.36364	54310.08333	50132.38462	46551.5	43448.06667	40732.5625	36206.72222	34301.10526	32586.05	27155.04167	26068.84	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205289	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	890516	445258	296838.6667	222629	178103.2	148419.3333	127216.5714	111314.5	98946.22222	89051.6	80956	74209.66667	68501.23077	63608.28571	59367.73333	55657.25	49473.11111	46869.26316	44525.8	37104.83333	35620.64	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205290	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	1749407	874703.5	583135.6667	437351.75	349881.4	291567.8333	249915.2857	218675.875	194378.5556	174940.7	159037	145783.9167	134569.7692	124957.6429	116627.1333	109337.9375	97189.27778	92074.05263	87470.35	72891.95833	69976.28	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205291	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	404437	202218.5	134812.3333	101109.25	80887.4	67406.16667	57776.71429	50554.625	44937.44444	40443.7	36767	33703.08333	31110.53846	28888.35714	26962.46667	25277.3125	22468.72222	21286.15789	20221.85	16851.54167	16177.48	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205292	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	104922	52461	34974	26230.5	20984.4	17487	14988.85714	13115.25	11658	10492.2	9538.363636	8743.5	8070.923077	7494.428571	6994.8	6557.625	5829	5522.210526	5246.1	4371.75	4196.88	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205293	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205294	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205295	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	54199	27099.5	18066.33333	13549.75	10839.8	9033.166667	7742.714286	6774.875	6022.111111	5419.9	4927.181818	4516.583333	4169.153846	3871.357143	3613.266667	3387.4375	3011.055556	2852.578947	2709.95	2258.291667	2167.96	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205296	CHOYP_LR16A.1.3|m.9037	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205297	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205298	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	2046081	1023040.5	682027	511520.25	409216.2	341013.5	292297.2857	255760.125	227342.3333	204608.1	186007.3636	170506.75	157390.8462	146148.6429	136405.4	127880.0625	113671.1667	107688.4737	102304.05	85253.375	81843.24	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205299	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205300	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	134481	67240.5	44827	33620.25	26896.2	22413.5	19211.57143	16810.125	14942.33333	13448.1	12225.54545	11206.75	10344.69231	9605.785714	8965.4	8405.0625	7471.166667	7077.947368	6724.05	5603.375	5379.24	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205301	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205302	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	91438	45719	30479.33333	22859.5	18287.6	15239.66667	13062.57143	11429.75	10159.77778	9143.8	8312.545455	7619.833333	7033.692308	6531.285714	6095.866667	5714.875	5079.888889	4812.526316	4571.9	3809.916667	3657.52	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205303	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	70111	35055.5	23370.33333	17527.75	14022.2	11685.16667	10015.85714	8763.875	7790.111111	7011.1	6373.727273	5842.583333	5393.153846	5007.928571	4674.066667	4381.9375	3895.055556	3690.052632	3505.55	2921.291667	2804.44	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205304	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205305	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205306	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205307	CHOYP_LR16A.1.3|m.9037	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205308	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	8405986	4202993	2801995.333	2101496.5	1681197.2	1400997.667	1200855.143	1050748.25	933998.4444	840598.6	764180.5455	700498.8333	646614.3077	600427.5714	560399.0667	525374.125	466999.2222	442420.3158	420299.3	350249.4167	336239.44	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205309	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205310	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	2308003	1154001.5	769334.3333	577000.75	461600.6	384667.1667	329714.7143	288500.375	256444.7778	230800.3	209818.4545	192333.5833	177538.6923	164857.3571	153866.8667	144250.1875	128222.3889	121473.8421	115400.15	96166.79167	92320.12	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205311	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205312	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205313	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205314	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205315	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205316	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205317	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205318	CHOYP_LR16A.1.3|m.9037	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205319	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	1291223	645611.5	430407.6667	322805.75	258244.6	215203.8333	184460.4286	161402.875	143469.2222	129122.3	117383.9091	107601.9167	99324.84615	92230.21429	86081.53333	80701.4375	71734.61111	67959.10526	64561.15	53800.95833	51648.92	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205320	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	678538	339269	226179.3333	169634.5	135707.6	113089.6667	96934	84817.25	75393.11111	67853.8	61685.27273	56544.83333	52195.23077	48467	45235.86667	42408.625	37696.55556	35712.52632	33926.9	28272.41667	27141.52	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205321	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	42604	21302	14201.33333	10651	8520.8	7100.666667	6086.285714	5325.5	4733.777778	4260.4	3873.090909	3550.333333	3277.230769	3043.142857	2840.266667	2662.75	2366.888889	2242.315789	2130.2	1775.166667	1704.16	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205322	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205323	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205324	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	20954	10477	6984.666667	5238.5	4190.8	3492.333333	2993.428571	2619.25	2328.222222	2095.4	1904.909091	1746.166667	1611.846154	1496.714286	1396.933333	1309.625	1164.111111	1102.842105	1047.7	873.0833333	838.16	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205325	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	186477	93238.5	62159	46619.25	37295.4	31079.5	26639.57143	23309.625	20719.66667	18647.7	16952.45455	15539.75	14344.38462	13319.78571	12431.8	11654.8125	10359.83333	9814.578947	9323.85	7769.875	7459.08	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205326	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205327	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	36465	18232.5	12155	9116.25	7293	6077.5	5209.285714	4558.125	4051.666667	3646.5	3315	3038.75	2805	2604.642857	2431	2279.0625	2025.833333	1919.210526	1823.25	1519.375	1458.6	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205328	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	402931	201465.5	134310.3333	100732.75	80586.2	67155.16667	57561.57143	50366.375	44770.11111	40293.1	36630.09091	33577.58333	30994.69231	28780.78571	26862.06667	25183.1875	22385.05556	21206.89474	20146.55	16788.79167	16117.24	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205329	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205330	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205331	CHOYP_LR16A.1.3|m.9037	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6EDY6	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Lrrc16a Carmil Lrrc16	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005886; GO:0007163; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205332	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	4015521	2007760.5	1338507	1003880.25	803104.2	669253.5	573645.8571	501940.125	446169	401552.1	365047.3636	334626.75	308886.2308	286822.9286	267701.4	250970.0625	223084.5	211343.2105	200776.05	167313.375	160620.84	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205333	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	2508275	1254137.5	836091.6667	627068.75	501655	418045.8333	358325	313534.375	278697.2222	250827.5	228025	209022.9167	192944.2308	179162.5	167218.3333	156767.1875	139348.6111	132014.4737	125413.75	104511.4583	100331	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205334	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	3525527	1762763.5	1175175.667	881381.75	705105.4	587587.8333	503646.7143	440690.875	391725.2222	352552.7	320502.4545	293793.9167	271194.3846	251823.3571	235035.1333	220345.4375	195862.6111	185554.0526	176276.35	146896.9583	141021.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205335	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	386277	193138.5	128759	96569.25	77255.4	64379.5	55182.42857	48284.625	42919.66667	38627.7	35116.09091	32189.75	29713.61538	27591.21429	25751.8	24142.3125	21459.83333	20330.36842	19313.85	16094.875	15451.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205336	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	224769	112384.5	74923	56192.25	44953.8	37461.5	32109.85714	28096.125	24974.33333	22476.9	20433.54545	18730.75	17289.92308	16054.92857	14984.6	14048.0625	12487.16667	11829.94737	11238.45	9365.375	8990.76	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205337	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	487115	243557.5	162371.6667	121778.75	97423	81185.83333	69587.85714	60889.375	54123.88889	48711.5	44283.18182	40592.91667	37470.38462	34793.92857	32474.33333	30444.6875	27061.94444	25637.63158	24355.75	20296.45833	19484.6	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205338	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	132195	66097.5	44065	33048.75	26439	22032.5	18885	16524.375	14688.33333	13219.5	12017.72727	11016.25	10168.84615	9442.5	8813	8262.1875	7344.166667	6957.631579	6609.75	5508.125	5287.8	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205339	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205340	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	177075	88537.5	59025	44268.75	35415	29512.5	25296.42857	22134.375	19675	17707.5	16097.72727	14756.25	13621.15385	12648.21429	11805	11067.1875	9837.5	9319.736842	8853.75	7378.125	7083	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205341	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	8102	4051	2700.666667	2025.5	1620.4	1350.333333	1157.428571	1012.75	900.2222222	810.2	736.5454545	675.1666667	623.2307692	578.7142857	540.1333333	506.375	450.1111111	426.4210526	405.1	337.5833333	324.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205342	CHOYP_LR16A.2.3|m.41105	ELNLQDFDHLSSK	ELNLQDFDHLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205343	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	10658416	5329208	3552805.333	2664604	2131683.2	1776402.667	1522630.857	1332302	1184268.444	1065841.6	968946.9091	888201.3333	819878.1538	761315.4286	710561.0667	666151	592134.2222	560969.2632	532920.8	444100.6667	426336.64	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205344	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	9302730	4651365	3100910	2325682.5	1860546	1550455	1328961.429	1162841.25	1033636.667	930273	845702.7273	775227.5	715594.6154	664480.7143	620182	581420.625	516818.3333	489617.3684	465136.5	387613.75	372109.2	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205345	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	4362693	2181346.5	1454231	1090673.25	872538.6	727115.5	623241.8571	545336.625	484743.6667	436269.3	396608.4545	363557.75	335591.7692	311620.9286	290846.2	272668.3125	242371.8333	229615.4211	218134.65	181778.875	174507.72	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205346	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	169265	84632.5	56421.66667	42316.25	33853	28210.83333	24180.71429	21158.125	18807.22222	16926.5	15387.72727	14105.41667	13020.38462	12090.35714	11284.33333	10579.0625	9403.611111	8908.684211	8463.25	7052.708333	6770.6	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205347	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	1115223	557611.5	371741	278805.75	223044.6	185870.5	159317.5714	139402.875	123913.6667	111522.3	101383.9091	92935.25	85786.38462	79658.78571	74348.2	69701.4375	61956.83333	58695.94737	55761.15	46467.625	44608.92	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205348	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	3878697	1939348.5	1292899	969674.25	775739.4	646449.5	554099.5714	484837.125	430966.3333	387869.7	352608.8182	323224.75	298361.3077	277049.7857	258579.8	242418.5625	215483.1667	204141.9474	193934.85	161612.375	155147.88	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205349	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	3722485	1861242.5	1240828.333	930621.25	744497	620414.1667	531783.5714	465310.625	413609.4444	372248.5	338407.7273	310207.0833	286345	265891.7857	248165.6667	232655.3125	206804.7222	195920.2632	186124.25	155103.5417	148899.4	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205350	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	1129643	564821.5	376547.6667	282410.75	225928.6	188273.8333	161377.5714	141205.375	125515.8889	112964.3	102694.8182	94136.91667	86895.61538	80688.78571	75309.53333	70602.6875	62757.94444	59454.89474	56482.15	47068.45833	45185.72	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205351	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	462539	231269.5	154179.6667	115634.75	92507.8	77089.83333	66077	57817.375	51393.22222	46253.9	42049	38544.91667	35579.92308	33038.5	30835.93333	28908.6875	25696.61111	24344.15789	23126.95	19272.45833	18501.56	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205352	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	359457	179728.5	119819	89864.25	71891.4	59909.5	51351	44932.125	39939.66667	35945.7	32677.90909	29954.75	27650.53846	25675.5	23963.8	22466.0625	19969.83333	18918.78947	17972.85	14977.375	14378.28	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205353	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	51891	25945.5	17297	12972.75	10378.2	8648.5	7413	6486.375	5765.666667	5189.1	4717.363636	4324.25	3991.615385	3706.5	3459.4	3243.1875	2882.833333	2731.105263	2594.55	2162.125	2075.64	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205354	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205355	CHOYP_LR16A.2.3|m.41105	LATAILSNSSSQLQR	LATAILSNSSSQLQR	41470	20735	13823.33333	10367.5	8294	6911.666667	5924.285714	5183.75	4607.777778	4147	3770	3455.833333	3190	2962.142857	2764.666667	2591.875	2303.888889	2182.631579	2073.5	1727.916667	1658.8	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205356	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	4015521	2007760.5	1338507	1003880.25	803104.2	669253.5	573645.8571	501940.125	446169	401552.1	365047.3636	334626.75	308886.2308	286822.9286	267701.4	250970.0625	223084.5	211343.2105	200776.05	167313.375	160620.84	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205357	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	2508275	1254137.5	836091.6667	627068.75	501655	418045.8333	358325	313534.375	278697.2222	250827.5	228025	209022.9167	192944.2308	179162.5	167218.3333	156767.1875	139348.6111	132014.4737	125413.75	104511.4583	100331	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205358	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	3525527	1762763.5	1175175.667	881381.75	705105.4	587587.8333	503646.7143	440690.875	391725.2222	352552.7	320502.4545	293793.9167	271194.3846	251823.3571	235035.1333	220345.4375	195862.6111	185554.0526	176276.35	146896.9583	141021.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205359	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	386277	193138.5	128759	96569.25	77255.4	64379.5	55182.42857	48284.625	42919.66667	38627.7	35116.09091	32189.75	29713.61538	27591.21429	25751.8	24142.3125	21459.83333	20330.36842	19313.85	16094.875	15451.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205360	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	224769	112384.5	74923	56192.25	44953.8	37461.5	32109.85714	28096.125	24974.33333	22476.9	20433.54545	18730.75	17289.92308	16054.92857	14984.6	14048.0625	12487.16667	11829.94737	11238.45	9365.375	8990.76	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205361	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	487115	243557.5	162371.6667	121778.75	97423	81185.83333	69587.85714	60889.375	54123.88889	48711.5	44283.18182	40592.91667	37470.38462	34793.92857	32474.33333	30444.6875	27061.94444	25637.63158	24355.75	20296.45833	19484.6	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205362	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	132195	66097.5	44065	33048.75	26439	22032.5	18885	16524.375	14688.33333	13219.5	12017.72727	11016.25	10168.84615	9442.5	8813	8262.1875	7344.166667	6957.631579	6609.75	5508.125	5287.8	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205363	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205364	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	177075	88537.5	59025	44268.75	35415	29512.5	25296.42857	22134.375	19675	17707.5	16097.72727	14756.25	13621.15385	12648.21429	11805	11067.1875	9837.5	9319.736842	8853.75	7378.125	7083	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205365	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	8102	4051	2700.666667	2025.5	1620.4	1350.333333	1157.428571	1012.75	900.2222222	810.2	736.5454545	675.1666667	623.2307692	578.7142857	540.1333333	506.375	450.1111111	426.4210526	405.1	337.5833333	324.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205366	CHOYP_LR16A.3.3|m.59538	ELNLQDFDHLSSK	ELNLQDFDHLSSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205367	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	10658416	5329208	3552805.333	2664604	2131683.2	1776402.667	1522630.857	1332302	1184268.444	1065841.6	968946.9091	888201.3333	819878.1538	761315.4286	710561.0667	666151	592134.2222	560969.2632	532920.8	444100.6667	426336.64	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205368	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	9302730	4651365	3100910	2325682.5	1860546	1550455	1328961.429	1162841.25	1033636.667	930273	845702.7273	775227.5	715594.6154	664480.7143	620182	581420.625	516818.3333	489617.3684	465136.5	387613.75	372109.2	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205369	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	4362693	2181346.5	1454231	1090673.25	872538.6	727115.5	623241.8571	545336.625	484743.6667	436269.3	396608.4545	363557.75	335591.7692	311620.9286	290846.2	272668.3125	242371.8333	229615.4211	218134.65	181778.875	174507.72	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205370	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	169265	84632.5	56421.66667	42316.25	33853	28210.83333	24180.71429	21158.125	18807.22222	16926.5	15387.72727	14105.41667	13020.38462	12090.35714	11284.33333	10579.0625	9403.611111	8908.684211	8463.25	7052.708333	6770.6	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205371	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	1115223	557611.5	371741	278805.75	223044.6	185870.5	159317.5714	139402.875	123913.6667	111522.3	101383.9091	92935.25	85786.38462	79658.78571	74348.2	69701.4375	61956.83333	58695.94737	55761.15	46467.625	44608.92	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205372	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	3878697	1939348.5	1292899	969674.25	775739.4	646449.5	554099.5714	484837.125	430966.3333	387869.7	352608.8182	323224.75	298361.3077	277049.7857	258579.8	242418.5625	215483.1667	204141.9474	193934.85	161612.375	155147.88	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205373	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	3722485	1861242.5	1240828.333	930621.25	744497	620414.1667	531783.5714	465310.625	413609.4444	372248.5	338407.7273	310207.0833	286345	265891.7857	248165.6667	232655.3125	206804.7222	195920.2632	186124.25	155103.5417	148899.4	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205374	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	1129643	564821.5	376547.6667	282410.75	225928.6	188273.8333	161377.5714	141205.375	125515.8889	112964.3	102694.8182	94136.91667	86895.61538	80688.78571	75309.53333	70602.6875	62757.94444	59454.89474	56482.15	47068.45833	45185.72	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205375	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	462539	231269.5	154179.6667	115634.75	92507.8	77089.83333	66077	57817.375	51393.22222	46253.9	42049	38544.91667	35579.92308	33038.5	30835.93333	28908.6875	25696.61111	24344.15789	23126.95	19272.45833	18501.56	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205376	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	359457	179728.5	119819	89864.25	71891.4	59909.5	51351	44932.125	39939.66667	35945.7	32677.90909	29954.75	27650.53846	25675.5	23963.8	22466.0625	19969.83333	18918.78947	17972.85	14977.375	14378.28	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205377	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	51891	25945.5	17297	12972.75	10378.2	8648.5	7413	6486.375	5765.666667	5189.1	4717.363636	4324.25	3991.615385	3706.5	3459.4	3243.1875	2882.833333	2731.105263	2594.55	2162.125	2075.64	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205378	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205379	CHOYP_LR16A.3.3|m.59538	LATAILSNSSSQLQR	LATAILSNSSSQLQR	41470	20735	13823.33333	10367.5	8294	6911.666667	5924.285714	5183.75	4607.777778	4147	3770	3455.833333	3190	2962.142857	2764.666667	2591.875	2303.888889	2182.631579	2073.5	1727.916667	1658.8	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205380	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205381	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205382	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205383	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205384	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205385	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205386	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	85859	42929.5	28619.66667	21464.75	17171.8	14309.83333	12265.57143	10732.375	9539.888889	8585.9	7805.363636	7154.916667	6604.538462	6132.785714	5723.933333	5366.1875	4769.944444	4518.894737	4292.95	3577.458333	3434.36	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205387	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205388	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	28803	14401.5	9601	7200.75	5760.6	4800.5	4114.714286	3600.375	3200.333333	2880.3	2618.454545	2400.25	2215.615385	2057.357143	1920.2	1800.1875	1600.166667	1515.947368	1440.15	1200.125	1152.12	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205389	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205390	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205391	CHOYP_LR16A.3.3|m.59538	SLAIGQNFDNVKPK	SLAIGQNFDNVKPK	74463	37231.5	24821	18615.75	14892.6	12410.5	10637.57143	9307.875	8273.666667	7446.3	6769.363636	6205.25	5727.923077	5318.785714	4964.2	4653.9375	4136.833333	3919.105263	3723.15	3102.625	2978.52	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205392	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	3586910	1793455	1195636.667	896727.5	717382	597818.3333	512415.7143	448363.75	398545.5556	358691	326082.7273	298909.1667	275916.1538	256207.8571	239127.3333	224181.875	199272.7778	188784.7368	179345.5	149454.5833	143476.4	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205393	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	3280030	1640015	1093343.333	820007.5	656006	546671.6667	468575.7143	410003.75	364447.7778	328003	298184.5455	273335.8333	252310	234287.8571	218668.6667	205001.875	182223.8889	172633.1579	164001.5	136667.9167	131201.2	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205394	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	2437718	1218859	812572.6667	609429.5	487543.6	406286.3333	348245.4286	304714.75	270857.5556	243771.8	221610.7273	203143.1667	187516.7692	174122.7143	162514.5333	152357.375	135428.7778	128300.9474	121885.9	101571.5833	97508.72	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205395	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	355678	177839	118559.3333	88919.5	71135.6	59279.66667	50811.14286	44459.75	39519.77778	35567.8	32334.36364	29639.83333	27359.84615	25405.57143	23711.86667	22229.875	19759.88889	18719.89474	17783.9	14819.91667	14227.12	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205396	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205397	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	651721	325860.5	217240.3333	162930.25	130344.2	108620.1667	93103	81465.125	72413.44444	65172.1	59247.36364	54310.08333	50132.38462	46551.5	43448.06667	40732.5625	36206.72222	34301.10526	32586.05	27155.04167	26068.84	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205398	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	890516	445258	296838.6667	222629	178103.2	148419.3333	127216.5714	111314.5	98946.22222	89051.6	80956	74209.66667	68501.23077	63608.28571	59367.73333	55657.25	49473.11111	46869.26316	44525.8	37104.83333	35620.64	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205399	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	1749407	874703.5	583135.6667	437351.75	349881.4	291567.8333	249915.2857	218675.875	194378.5556	174940.7	159037	145783.9167	134569.7692	124957.6429	116627.1333	109337.9375	97189.27778	92074.05263	87470.35	72891.95833	69976.28	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205400	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	404437	202218.5	134812.3333	101109.25	80887.4	67406.16667	57776.71429	50554.625	44937.44444	40443.7	36767	33703.08333	31110.53846	28888.35714	26962.46667	25277.3125	22468.72222	21286.15789	20221.85	16851.54167	16177.48	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205401	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	104922	52461	34974	26230.5	20984.4	17487	14988.85714	13115.25	11658	10492.2	9538.363636	8743.5	8070.923077	7494.428571	6994.8	6557.625	5829	5522.210526	5246.1	4371.75	4196.88	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205402	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205403	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205404	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	54199	27099.5	18066.33333	13549.75	10839.8	9033.166667	7742.714286	6774.875	6022.111111	5419.9	4927.181818	4516.583333	4169.153846	3871.357143	3613.266667	3387.4375	3011.055556	2852.578947	2709.95	2258.291667	2167.96	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205405	CHOYP_LR16A.3.3|m.59538	LQQGFLISSTQQMVDR	LQQGFLISSTQQMVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205406	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205407	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	2046081	1023040.5	682027	511520.25	409216.2	341013.5	292297.2857	255760.125	227342.3333	204608.1	186007.3636	170506.75	157390.8462	146148.6429	136405.4	127880.0625	113671.1667	107688.4737	102304.05	85253.375	81843.24	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205408	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205409	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	134481	67240.5	44827	33620.25	26896.2	22413.5	19211.57143	16810.125	14942.33333	13448.1	12225.54545	11206.75	10344.69231	9605.785714	8965.4	8405.0625	7471.166667	7077.947368	6724.05	5603.375	5379.24	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205410	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205411	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	91438	45719	30479.33333	22859.5	18287.6	15239.66667	13062.57143	11429.75	10159.77778	9143.8	8312.545455	7619.833333	7033.692308	6531.285714	6095.866667	5714.875	5079.888889	4812.526316	4571.9	3809.916667	3657.52	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205412	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	70111	35055.5	23370.33333	17527.75	14022.2	11685.16667	10015.85714	8763.875	7790.111111	7011.1	6373.727273	5842.583333	5393.153846	5007.928571	4674.066667	4381.9375	3895.055556	3690.052632	3505.55	2921.291667	2804.44	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205413	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205414	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205415	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205416	CHOYP_LR16A.3.3|m.59538	SLNTGNMVETELK	SLNTGNMVETELK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205417	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	8405986	4202993	2801995.333	2101496.5	1681197.2	1400997.667	1200855.143	1050748.25	933998.4444	840598.6	764180.5455	700498.8333	646614.3077	600427.5714	560399.0667	525374.125	466999.2222	442420.3158	420299.3	350249.4167	336239.44	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205418	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205419	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	2308003	1154001.5	769334.3333	577000.75	461600.6	384667.1667	329714.7143	288500.375	256444.7778	230800.3	209818.4545	192333.5833	177538.6923	164857.3571	153866.8667	144250.1875	128222.3889	121473.8421	115400.15	96166.79167	92320.12	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205420	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205421	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205422	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205423	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205424	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205425	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205426	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205427	CHOYP_LR16A.3.3|m.59538	HLMDGVETDVYNK	HLMDGVETDVYNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205428	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	1291223	645611.5	430407.6667	322805.75	258244.6	215203.8333	184460.4286	161402.875	143469.2222	129122.3	117383.9091	107601.9167	99324.84615	92230.21429	86081.53333	80701.4375	71734.61111	67959.10526	64561.15	53800.95833	51648.92	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205429	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	678538	339269	226179.3333	169634.5	135707.6	113089.6667	96934	84817.25	75393.11111	67853.8	61685.27273	56544.83333	52195.23077	48467	45235.86667	42408.625	37696.55556	35712.52632	33926.9	28272.41667	27141.52	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205430	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	42604	21302	14201.33333	10651	8520.8	7100.666667	6086.285714	5325.5	4733.777778	4260.4	3873.090909	3550.333333	3277.230769	3043.142857	2840.266667	2662.75	2366.888889	2242.315789	2130.2	1775.166667	1704.16	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205431	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205432	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205433	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	20954	10477	6984.666667	5238.5	4190.8	3492.333333	2993.428571	2619.25	2328.222222	2095.4	1904.909091	1746.166667	1611.846154	1496.714286	1396.933333	1309.625	1164.111111	1102.842105	1047.7	873.0833333	838.16	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205434	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	186477	93238.5	62159	46619.25	37295.4	31079.5	26639.57143	23309.625	20719.66667	18647.7	16952.45455	15539.75	14344.38462	13319.78571	12431.8	11654.8125	10359.83333	9814.578947	9323.85	7769.875	7459.08	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205435	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205436	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	36465	18232.5	12155	9116.25	7293	6077.5	5209.285714	4558.125	4051.666667	3646.5	3315	3038.75	2805	2604.642857	2431	2279.0625	2025.833333	1919.210526	1823.25	1519.375	1458.6	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205437	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	402931	201465.5	134310.3333	100732.75	80586.2	67155.16667	57561.57143	50366.375	44770.11111	40293.1	36630.09091	33577.58333	30994.69231	28780.78571	26862.06667	25183.1875	22385.05556	21206.89474	20146.55	16788.79167	16117.24	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205438	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205439	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
205440	CHOYP_LR16A.3.3|m.59538	VELDSLGSLPDTSTK	VELDSLGSLPDTSTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5VZK9	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	LRRC16A CARMIL CARMIL1 LRRC16	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0032403; GO:0044351; GO:0044354; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813
211118	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	4488371	2244185.5	1496123.667	1122092.75	897674.2	748061.8333	641195.8571	561046.375	498707.8889	448837.1	408033.7273	374030.9167	345259.3077	320597.9286	299224.7333	280523.1875	249353.9444	236230.0526	224418.55	187015.4583	179534.84	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211119	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	3581065	1790532.5	1193688.333	895266.25	716213	596844.1667	511580.7143	447633.125	397896.1111	358106.5	325551.3636	298422.0833	275466.5385	255790.3571	238737.6667	223816.5625	198948.0556	188477.1053	179053.25	149211.0417	143242.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211120	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	2583026	1291513	861008.6667	645756.5	516605.2	430504.3333	369003.7143	322878.25	287002.8889	258302.6	234820.5455	215252.1667	198694.3077	184501.8571	172201.7333	161439.125	143501.4444	135948.7368	129151.3	107626.0833	103321.04	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211121	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	433054	216527	144351.3333	108263.5	86610.8	72175.66667	61864.85714	54131.75	48117.11111	43305.4	39368.54545	36087.83333	33311.84615	30932.42857	28870.26667	27065.875	24058.55556	22792.31579	21652.7	18043.91667	17322.16	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211122	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	889378	444689	296459.3333	222344.5	177875.6	148229.6667	127054	111172.25	98819.77778	88937.8	80852.54545	74114.83333	68413.69231	63527	59291.86667	55586.125	49409.88889	46809.36842	44468.9	37057.41667	35575.12	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211123	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	510464	255232	170154.6667	127616	102092.8	85077.33333	72923.42857	63808	56718.22222	51046.4	46405.81818	42538.66667	39266.46154	36461.71429	34030.93333	31904	28359.11111	26866.52632	25523.2	21269.33333	20418.56	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211124	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	491140	245570	163713.3333	122785	98228	81856.66667	70162.85714	61392.5	54571.11111	49114	44649.09091	40928.33333	37780	35081.42857	32742.66667	30696.25	27285.55556	25849.47368	24557	20464.16667	19645.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211125	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	1297656	648828	432552	324414	259531.2	216276	185379.4286	162207	144184	129765.6	117968.7273	108138	99819.69231	92689.71429	86510.4	81103.5	72092	68297.68421	64882.8	54069	51906.24	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211126	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	792088	396044	264029.3333	198022	158417.6	132014.6667	113155.4286	99011	88009.77778	79208.8	72008	66007.33333	60929.84615	56577.71429	52805.86667	49505.5	44004.88889	41688.84211	39604.4	33003.66667	31683.52	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211127	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	726589	363294.5	242196.3333	181647.25	145317.8	121098.1667	103798.4286	90823.625	80732.11111	72658.9	66053.54545	60549.08333	55891.46154	51899.21429	48439.26667	45411.8125	40366.05556	38241.52632	36329.45	30274.54167	29063.56	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211128	CHOYP_MRP1.10.10|m.64931	DLTEDDLFDLNPR	DLTEDDLFDLNPR	351719	175859.5	117239.6667	87929.75	70343.8	58619.83333	50245.57143	43964.875	39079.88889	35171.9	31974.45455	29309.91667	27055.30769	25122.78571	23447.93333	21982.4375	19539.94444	18511.52632	17585.95	14654.95833	14068.76	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211129	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211130	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211131	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211132	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	51315	25657.5	17105	12828.75	10263	8552.5	7330.714286	6414.375	5701.666667	5131.5	4665	4276.25	3947.307692	3665.357143	3421	3207.1875	2850.833333	2700.789474	2565.75	2138.125	2052.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211133	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	298261	149130.5	99420.33333	74565.25	59652.2	49710.16667	42608.71429	37282.625	33140.11111	29826.1	27114.63636	24855.08333	22943.15385	21304.35714	19884.06667	18641.3125	16570.05556	15697.94737	14913.05	12427.54167	11930.44	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211134	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211135	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211136	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211137	CHOYP_MRP1.10.10|m.64931	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211138	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	1934719	967359.5	644906.3333	483679.75	386943.8	322453.1667	276388.4286	241839.875	214968.7778	193471.9	175883.5455	161226.5833	148824.5385	138194.2143	128981.2667	120919.9375	107484.3889	101827.3158	96735.95	80613.29167	77388.76	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211139	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	2113186	1056593	704395.3333	528296.5	422637.2	352197.6667	301883.7143	264148.25	234798.4444	211318.6	192107.8182	176098.8333	162552.7692	150941.8571	140879.0667	132074.125	117399.2222	111220.3158	105659.3	88049.41667	84527.44	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211140	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211141	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	1220598	610299	406866	305149.5	244119.6	203433	174371.1429	152574.75	135622	122059.8	110963.4545	101716.5	93892.15385	87185.57143	81373.2	76287.375	67811	64242	61029.9	50858.25	48823.92	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211142	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	1151137	575568.5	383712.3333	287784.25	230227.4	191856.1667	164448.1429	143892.125	127904.1111	115113.7	104648.8182	95928.08333	88549	82224.07143	76742.46667	71946.0625	63952.05556	60586.15789	57556.85	47964.04167	46045.48	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211143	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211144	CHOYP_MRP1.10.10|m.64931	TPLVGTSSR	TPLVGTSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211145	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	4488371	2244185.5	1496123.667	1122092.75	897674.2	748061.8333	641195.8571	561046.375	498707.8889	448837.1	408033.7273	374030.9167	345259.3077	320597.9286	299224.7333	280523.1875	249353.9444	236230.0526	224418.55	187015.4583	179534.84	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211146	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	3581065	1790532.5	1193688.333	895266.25	716213	596844.1667	511580.7143	447633.125	397896.1111	358106.5	325551.3636	298422.0833	275466.5385	255790.3571	238737.6667	223816.5625	198948.0556	188477.1053	179053.25	149211.0417	143242.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211147	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	2583026	1291513	861008.6667	645756.5	516605.2	430504.3333	369003.7143	322878.25	287002.8889	258302.6	234820.5455	215252.1667	198694.3077	184501.8571	172201.7333	161439.125	143501.4444	135948.7368	129151.3	107626.0833	103321.04	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211148	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	433054	216527	144351.3333	108263.5	86610.8	72175.66667	61864.85714	54131.75	48117.11111	43305.4	39368.54545	36087.83333	33311.84615	30932.42857	28870.26667	27065.875	24058.55556	22792.31579	21652.7	18043.91667	17322.16	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211149	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	889378	444689	296459.3333	222344.5	177875.6	148229.6667	127054	111172.25	98819.77778	88937.8	80852.54545	74114.83333	68413.69231	63527	59291.86667	55586.125	49409.88889	46809.36842	44468.9	37057.41667	35575.12	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211150	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	510464	255232	170154.6667	127616	102092.8	85077.33333	72923.42857	63808	56718.22222	51046.4	46405.81818	42538.66667	39266.46154	36461.71429	34030.93333	31904	28359.11111	26866.52632	25523.2	21269.33333	20418.56	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211151	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	491140	245570	163713.3333	122785	98228	81856.66667	70162.85714	61392.5	54571.11111	49114	44649.09091	40928.33333	37780	35081.42857	32742.66667	30696.25	27285.55556	25849.47368	24557	20464.16667	19645.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211152	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	1297656	648828	432552	324414	259531.2	216276	185379.4286	162207	144184	129765.6	117968.7273	108138	99819.69231	92689.71429	86510.4	81103.5	72092	68297.68421	64882.8	54069	51906.24	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211153	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	792088	396044	264029.3333	198022	158417.6	132014.6667	113155.4286	99011	88009.77778	79208.8	72008	66007.33333	60929.84615	56577.71429	52805.86667	49505.5	44004.88889	41688.84211	39604.4	33003.66667	31683.52	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211154	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	726589	363294.5	242196.3333	181647.25	145317.8	121098.1667	103798.4286	90823.625	80732.11111	72658.9	66053.54545	60549.08333	55891.46154	51899.21429	48439.26667	45411.8125	40366.05556	38241.52632	36329.45	30274.54167	29063.56	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211155	CHOYP_MRP1.5.10|m.34368	DLTEDDLFDLNPR	DLTEDDLFDLNPR	351719	175859.5	117239.6667	87929.75	70343.8	58619.83333	50245.57143	43964.875	39079.88889	35171.9	31974.45455	29309.91667	27055.30769	25122.78571	23447.93333	21982.4375	19539.94444	18511.52632	17585.95	14654.95833	14068.76	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211156	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211157	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211158	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211159	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	51315	25657.5	17105	12828.75	10263	8552.5	7330.714286	6414.375	5701.666667	5131.5	4665	4276.25	3947.307692	3665.357143	3421	3207.1875	2850.833333	2700.789474	2565.75	2138.125	2052.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211160	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	298261	149130.5	99420.33333	74565.25	59652.2	49710.16667	42608.71429	37282.625	33140.11111	29826.1	27114.63636	24855.08333	22943.15385	21304.35714	19884.06667	18641.3125	16570.05556	15697.94737	14913.05	12427.54167	11930.44	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211161	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211162	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211163	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211164	CHOYP_MRP1.5.10|m.34368	VIPQFEEQWDK	VIPQFEEQWDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211165	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	1934719	967359.5	644906.3333	483679.75	386943.8	322453.1667	276388.4286	241839.875	214968.7778	193471.9	175883.5455	161226.5833	148824.5385	138194.2143	128981.2667	120919.9375	107484.3889	101827.3158	96735.95	80613.29167	77388.76	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211166	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	2113186	1056593	704395.3333	528296.5	422637.2	352197.6667	301883.7143	264148.25	234798.4444	211318.6	192107.8182	176098.8333	162552.7692	150941.8571	140879.0667	132074.125	117399.2222	111220.3158	105659.3	88049.41667	84527.44	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211167	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211168	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	1220598	610299	406866	305149.5	244119.6	203433	174371.1429	152574.75	135622	122059.8	110963.4545	101716.5	93892.15385	87185.57143	81373.2	76287.375	67811	64242	61029.9	50858.25	48823.92	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211169	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	1151137	575568.5	383712.3333	287784.25	230227.4	191856.1667	164448.1429	143892.125	127904.1111	115113.7	104648.8182	95928.08333	88549	82224.07143	76742.46667	71946.0625	63952.05556	60586.15789	57556.85	47964.04167	46045.48	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211170	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211171	CHOYP_MRP1.5.10|m.34368	TPLVGTSSR	TPLVGTSSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211172	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211173	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211174	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211175	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211176	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	111132	55566	37044	27783	22226.4	18522	15876	13891.5	12348	11113.2	10102.90909	9261	8548.615385	7938	7408.8	6945.75	6174	5849.052632	5556.6	4630.5	4445.28	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211177	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	275777	137888.5	91925.66667	68944.25	55155.4	45962.83333	39396.71429	34472.125	30641.88889	27577.7	25070.63636	22981.41667	21213.61538	19698.35714	18385.13333	17236.0625	15320.94444	14514.57895	13788.85	11490.70833	11031.08	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211178	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	206216	103108	68738.66667	51554	41243.2	34369.33333	29459.42857	25777	22912.88889	20621.6	18746.90909	17184.66667	15862.76923	14729.71429	13747.73333	12888.5	11456.44444	10853.47368	10310.8	8592.333333	8248.64	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211179	CHOYP_MRP1.5.10|m.34368	LMSEVLNGMK	LMSEVLNGMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211180	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	6033534	3016767	2011178	1508383.5	1206706.8	1005589	861933.4286	754191.75	670392.6667	603353.4	548503.0909	502794.5	464118	430966.7143	402235.6	377095.875	335196.3333	317554.4211	301676.7	251397.25	241341.36	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211181	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	4514828	2257414	1504942.667	1128707	902965.6	752471.3333	644975.4286	564353.5	501647.5556	451482.8	410438.9091	376235.6667	347294.4615	322487.7143	300988.5333	282176.75	250823.7778	237622.5263	225741.4	188117.8333	180593.12	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211182	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	2124046	1062023	708015.3333	531011.5	424809.2	354007.6667	303435.1429	265505.75	236005.1111	212404.6	193095.0909	177003.8333	163388.1538	151717.5714	141603.0667	132752.875	118002.5556	111791.8947	106202.3	88501.91667	84961.84	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211183	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	276907	138453.5	92302.33333	69226.75	55381.4	46151.16667	39558.14286	34613.375	30767.44444	27690.7	25173.36364	23075.58333	21300.53846	19779.07143	18460.46667	17306.6875	15383.72222	14574.05263	13845.35	11537.79167	11076.28	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211184	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	280701	140350.5	93567	70175.25	56140.2	46783.5	40100.14286	35087.625	31189	28070.1	25518.27273	23391.75	21592.38462	20050.07143	18713.4	17543.8125	15594.5	14773.73684	14035.05	11695.875	11228.04	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211185	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	2233762	1116881	744587.3333	558440.5	446752.4	372293.6667	319108.8571	279220.25	248195.7778	223376.2	203069.2727	186146.8333	171827.8462	159554.4286	148917.4667	139610.125	124097.8889	117566.4211	111688.1	93073.41667	89350.48	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211186	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	62727	31363.5	20909	15681.75	12545.4	10454.5	8961	7840.875	6969.666667	6272.7	5702.454545	5227.25	4825.153846	4480.5	4181.8	3920.4375	3484.833333	3301.421053	3136.35	2613.625	2509.08	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211187	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	87089	43544.5	29029.66667	21772.25	17417.8	14514.83333	12441.28571	10886.125	9676.555556	8708.9	7917.181818	7257.416667	6699.153846	6220.642857	5805.933333	5443.0625	4838.277778	4583.631579	4354.45	3628.708333	3483.56	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211188	CHOYP_MRP1.5.10|m.34368	LYAWEPSFQDK	LYAWEPSFQDK	25746	12873	8582	6436.5	5149.2	4291	3678	3218.25	2860.666667	2574.6	2340.545455	2145.5	1980.461538	1839	1716.4	1609.125	1430.333333	1355.052632	1287.3	1072.75	1029.84	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211189	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211190	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211191	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211192	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211193	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211194	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211195	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	247033	123516.5	82344.33333	61758.25	49406.6	41172.16667	35290.42857	30879.125	27448.11111	24703.3	22457.54545	20586.08333	19002.53846	17645.21429	16468.86667	15439.5625	13724.05556	13001.73684	12351.65	10293.04167	9881.32	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211196	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211197	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211198	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211199	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211200	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211201	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211202	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211203	CHOYP_MRP1.5.10|m.34368	TDLEILTGGDMTEIGEK	TDLEILTGGDMTEIGEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211204	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211205	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211206	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211207	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211208	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211209	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211210	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211211	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211212	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211213	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211214	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211215	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211216	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211217	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211218	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211219	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211220	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211221	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211222	CHOYP_MRP1.5.10|m.34368	AVYNNADIYMLDDPLSAVDSHVGK	AVYNNADIYMLDDPLSAVDSHVGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211223	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	409371	204685.5	136457	102342.75	81874.2	68228.5	58481.57143	51171.375	45485.66667	40937.1	37215.54545	34114.25	31490.07692	29240.78571	27291.4	25585.6875	22742.83333	21545.84211	20468.55	17057.125	16374.84	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211224	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211225	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211226	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211227	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211228	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	14495	7247.5	4831.666667	3623.75	2899	2415.833333	2070.714286	1811.875	1610.555556	1449.5	1317.727273	1207.916667	1115	1035.357143	966.3333333	905.9375	805.2777778	762.8947368	724.75	603.9583333	579.8	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211229	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211230	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211231	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211232	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211233	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211234	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211235	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211236	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211237	CHOYP_MRP1.5.10|m.34368	VESVTSDTGATSGEEGK	VESVTSDTGATSGEEGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211238	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	7935022	3967511	2645007.333	1983755.5	1587004.4	1322503.667	1133574.571	991877.75	881669.1111	793502.2	721365.6364	661251.8333	610386.3077	566787.2857	529001.4667	495938.875	440834.5556	417632.7368	396751.1	330625.9167	317400.88	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211239	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	4610635	2305317.5	1536878.333	1152658.75	922127	768439.1667	658662.1429	576329.375	512292.7778	461063.5	419148.6364	384219.5833	354664.2308	329331.0714	307375.6667	288164.6875	256146.3889	242665	230531.75	192109.7917	184425.4	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211240	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	2068641	1034320.5	689547	517160.25	413728.2	344773.5	295520.1429	258580.125	229849	206864.1	188058.2727	172386.75	159126.2308	147760.0714	137909.4	129290.0625	114924.5	108875.8421	103432.05	86193.375	82745.64	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211241	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	1110141	555070.5	370047	277535.25	222028.2	185023.5	158591.5714	138767.625	123349	111014.1	100921.9091	92511.75	85395.46154	79295.78571	74009.4	69383.8125	61674.5	58428.47368	55507.05	46255.875	44405.64	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211242	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	749116	374558	249705.3333	187279	149823.2	124852.6667	107016.5714	93639.5	83235.11111	74911.6	68101.45455	62426.33333	57624.30769	53508.28571	49941.06667	46819.75	41617.55556	39427.15789	37455.8	31213.16667	29964.64	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211243	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	869211	434605.5	289737	217302.75	173842.2	144868.5	124173	108651.375	96579	86921.1	79019.18182	72434.25	66862.38462	62086.5	57947.4	54325.6875	48289.5	45747.94737	43460.55	36217.125	34768.44	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211244	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	647650	323825	215883.3333	161912.5	129530	107941.6667	92521.42857	80956.25	71961.11111	64765	58877.27273	53970.83333	49819.23077	46260.71429	43176.66667	40478.125	35980.55556	34086.84211	32382.5	26985.41667	25906	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211245	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	616890	308445	205630	154222.5	123378	102815	88127.14286	77111.25	68543.33333	61689	56080.90909	51407.5	47453.07692	44063.57143	41126	38555.625	34271.66667	32467.89474	30844.5	25703.75	24675.6	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211246	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	171776	85888	57258.66667	42944	34355.2	28629.33333	24539.42857	21472	19086.22222	17177.6	15616	14314.66667	13213.53846	12269.71429	11451.73333	10736	9543.111111	9040.842105	8588.8	7157.333333	6871.04	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211247	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	385988	192994	128662.6667	96497	77197.6	64331.33333	55141.14286	48248.5	42887.55556	38598.8	35089.81818	32165.66667	29691.38462	27570.57143	25732.53333	24124.25	21443.77778	20315.15789	19299.4	16082.83333	15439.52	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211248	CHOYP_MRP1.5.10|m.34368	APMSFFDTTPSGR	APMSFFDTTPSGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211249	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211250	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211251	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211252	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211253	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211254	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	109728	54864	36576	27432	21945.6	18288	15675.42857	13716	12192	10972.8	9975.272727	9144	8440.615385	7837.714286	7315.2	6858	6096	5775.157895	5486.4	4572	4389.12	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211255	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211256	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211257	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211258	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211259	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211260	CHOYP_MRP1.5.10|m.34368	QTAELETNVVAVER	QTAELETNVVAVER	20370	10185	6790	5092.5	4074	3395	2910	2546.25	2263.333333	2037	1851.818182	1697.5	1566.923077	1455	1358	1273.125	1131.666667	1072.105263	1018.5	848.75	814.8	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211261	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211262	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211263	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211264	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211265	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211266	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211267	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211268	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211269	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211270	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211271	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211272	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211273	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211274	CHOYP_MRP1.5.10|m.34368	EYSEVETEAEWIRPFR	EYSEVETEAEWIRPFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211275	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	1353612	676806	451204	338403	270722.4	225602	193373.1429	169201.5	150401.3333	135361.2	123055.6364	112801	104124	96686.57143	90240.8	84600.75	75200.66667	71242.73684	67680.6	56400.5	54144.48	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211276	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	1080900	540450	360300	270225	216180	180150	154414.2857	135112.5	120100	108090	98263.63636	90075	83146.15385	77207.14286	72060	67556.25	60050	56889.47368	54045	45037.5	43236	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211277	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211278	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211279	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211280	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211281	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211282	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211283	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211284	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211285	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211286	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211287	CHOYP_MRP1.5.10|m.34368	LIESAGGQIVIDGQR	LIESAGGQIVIDGQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211288	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211289	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211290	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211291	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	80227	40113.5	26742.33333	20056.75	16045.4	13371.16667	11461	10028.375	8914.111111	8022.7	7293.363636	6685.583333	6171.307692	5730.5	5348.466667	5014.1875	4457.055556	4222.473684	4011.35	3342.791667	3209.08	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211292	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	1017317	508658.5	339105.6667	254329.25	203463.4	169552.8333	145331	127164.625	113035.2222	101731.7	92483.36364	84776.41667	78255.15385	72665.5	67821.13333	63582.3125	56517.61111	53543	50865.85	42388.20833	40692.68	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211293	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211294	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211295	CHOYP_MRP1.5.10|m.34368	ISDIGLHDLR	ISDIGLHDLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211296	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211297	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211298	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	1106250	553125	368750	276562.5	221250	184375	158035.7143	138281.25	122916.6667	110625	100568.1818	92187.5	85096.15385	79017.85714	73750	69140.625	61458.33333	58223.68421	55312.5	46093.75	44250	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211299	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211300	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211301	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211302	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	252042	126021	84014	63010.5	50408.4	42007	36006	31505.25	28004.66667	25204.2	22912.90909	21003.5	19387.84615	18003	16802.8	15752.625	14002.33333	13265.36842	12602.1	10501.75	10081.68	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211303	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211304	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211305	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	34324	17162	11441.33333	8581	6864.8	5720.666667	4903.428571	4290.5	3813.777778	3432.4	3120.363636	2860.333333	2640.307692	2451.714286	2288.266667	2145.25	1906.888889	1806.526316	1716.2	1430.166667	1372.96	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211306	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211307	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	48616	24308	16205.33333	12154	9723.2	8102.666667	6945.142857	6077	5401.777778	4861.6	4419.636364	4051.333333	3739.692308	3472.571429	3241.066667	3038.5	2700.888889	2558.736842	2430.8	2025.666667	1944.64	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211308	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211309	CHOYP_MRP1.5.10|m.34368	LTILPQDPVLFSGTLR	LTILPQDPVLFSGTLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211310	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	7964382	3982191	2654794	1991095.5	1592876.4	1327397	1137768.857	995547.75	884931.3333	796438.2	724034.7273	663698.5	612644.7692	568884.4286	530958.8	497773.875	442465.6667	419178	398219.1	331849.25	318575.28	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211311	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211312	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	1877384	938692	625794.6667	469346	375476.8	312897.3333	268197.7143	234673	208598.2222	187738.4	170671.2727	156448.6667	144414.1538	134098.8571	125158.9333	117336.5	104299.1111	98809.68421	93869.2	78224.33333	75095.36	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211313	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	533554	266777	177851.3333	133388.5	106710.8	88925.66667	76222	66694.25	59283.77778	53355.4	48504.90909	44462.83333	41042.61538	38111	35570.26667	33347.125	29641.88889	28081.78947	26677.7	22231.41667	21342.16	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211314	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	2289232	1144616	763077.3333	572308	457846.4	381538.6667	327033.1429	286154	254359.1111	228923.2	208112	190769.3333	176094.7692	163516.5714	152615.4667	143077	127179.5556	120485.8947	114461.6	95384.66667	91569.28	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211315	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	1729381	864690.5	576460.3333	432345.25	345876.2	288230.1667	247054.4286	216172.625	192153.4444	172938.1	157216.4545	144115.0833	133029.3077	123527.2143	115292.0667	108086.3125	96076.72222	91020.05263	86469.05	72057.54167	69175.24	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211316	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	330202	165101	110067.3333	82550.5	66040.4	55033.66667	47171.71429	41275.25	36689.11111	33020.2	30018.36364	27516.83333	25400.15385	23585.85714	22013.46667	20637.625	18344.55556	17379.05263	16510.1	13758.41667	13208.08	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211317	CHOYP_MRP1.5.10|m.34368	DSTVLTIAHR	DSTVLTIAHR	58699	29349.5	19566.33333	14674.75	11739.8	9783.166667	8385.571429	7337.375	6522.111111	5869.9	5336.272727	4891.583333	4515.307692	4192.785714	3913.266667	3668.6875	3261.055556	3089.421053	2934.95	2445.791667	2347.96	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211318	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	9699992	4849996	3233330.667	2424998	1939998.4	1616665.333	1385713.143	1212499	1077776.889	969999.2	881817.4545	808332.6667	746153.2308	692856.5714	646666.1333	606249.5	538888.4444	510525.8947	484999.6	404166.3333	387999.68	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211319	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	6039735	3019867.5	2013245	1509933.75	1207947	1006622.5	862819.2857	754966.875	671081.6667	603973.5	549066.8182	503311.25	464595	431409.6429	402649	377483.4375	335540.8333	317880.7895	301986.75	251655.625	241589.4	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211320	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	1971282	985641	657094	492820.5	394256.4	328547	281611.7143	246410.25	219031.3333	197128.2	179207.4545	164273.5	151637.0769	140805.8571	131418.8	123205.125	109515.6667	103751.6842	98564.1	82136.75	78851.28	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211321	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	2277316	1138658	759105.3333	569329	455463.2	379552.6667	325330.8571	284664.5	253035.1111	227731.6	207028.7273	189776.3333	175178.1538	162665.4286	151821.0667	142332.25	126517.5556	119858.7368	113865.8	94888.16667	91092.64	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211322	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	764353	382176.5	254784.3333	191088.25	152870.6	127392.1667	109193.2857	95544.125	84928.11111	76435.3	69486.63636	63696.08333	58796.38462	54596.64286	50956.86667	47772.0625	42464.05556	40229.10526	38217.65	31848.04167	30574.12	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211323	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211324	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	117369	58684.5	39123	29342.25	23473.8	19561.5	16767	14671.125	13041	11736.9	10669.90909	9780.75	9028.384615	8383.5	7824.6	7335.5625	6520.5	6177.315789	5868.45	4890.375	4694.76	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211325	CHOYP_MRP1.5.10|m.34368	VLVLDQGLVK	VLVLDQGLVK	344114	172057	114704.6667	86028.5	68822.8	57352.33333	49159.14286	43014.25	38234.88889	34411.4	31283.09091	28676.16667	26470.30769	24579.57143	22940.93333	21507.125	19117.44444	18111.26316	17205.7	14338.08333	13764.56	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211326	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211327	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211328	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211329	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211330	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	616984	308492	205661.3333	154246	123396.8	102830.6667	88140.57143	77123	68553.77778	61698.4	56089.45455	51415.33333	47460.30769	44070.28571	41132.26667	38561.5	34276.88889	32472.84211	30849.2	25707.66667	24679.36	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211331	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	333469	166734.5	111156.3333	83367.25	66693.8	55578.16667	47638.42857	41683.625	37052.11111	33346.9	30315.36364	27789.08333	25651.46154	23819.21429	22231.26667	20841.8125	18526.05556	17551	16673.45	13894.54167	13338.76	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
211332	CHOYP_MRP1.5.10|m.34368	TSVFYGMAK	TSVFYGMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8CG09	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Mrp1	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215
221630	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	1123317	561658.5	374439	280829.25	224663.4	187219.5	160473.8571	140414.625	124813	112331.7	102119.7273	93609.75	86409	80236.92857	74887.8	70207.3125	62406.5	59121.94737	56165.85	46804.875	44932.68	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221631	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221632	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	512939	256469.5	170979.6667	128234.75	102587.8	85489.83333	73277	64117.375	56993.22222	51293.9	46630.81818	42744.91667	39456.84615	36638.5	34195.93333	32058.6875	28496.61111	26996.78947	25646.95	21372.45833	20517.56	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221633	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221634	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	1016311	508155.5	338770.3333	254077.75	203262.2	169385.1667	145187.2857	127038.875	112923.4444	101631.1	92391.90909	84692.58333	78177.76923	72593.64286	67754.06667	63519.4375	56461.72222	53490.05263	50815.55	42346.29167	40652.44	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221635	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221636	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	142202	71101	47400.66667	35550.5	28440.4	23700.33333	20314.57143	17775.25	15800.22222	14220.2	12927.45455	11850.16667	10938.61538	10157.28571	9480.133333	8887.625	7900.111111	7484.315789	7110.1	5925.083333	5688.08	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221637	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221638	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	158276	79138	52758.66667	39569	31655.2	26379.33333	22610.85714	19784.5	17586.22222	15827.6	14388.72727	13189.66667	12175.07692	11305.42857	10551.73333	9892.25	8793.111111	8330.315789	7913.8	6594.833333	6331.04	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221639	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	146522	73261	48840.66667	36630.5	29304.4	24420.33333	20931.71429	18315.25	16280.22222	14652.2	13320.18182	12210.16667	11270.92308	10465.85714	9768.133333	9157.625	8140.111111	7711.684211	7326.1	6105.083333	5860.88	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221640	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	LQSQPLTLLSSDK	LQSQPLTLLSSDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221641	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	2632923	1316461.5	877641	658230.75	526584.6	438820.5	376131.8571	329115.375	292547	263292.3	239356.6364	219410.25	202532.5385	188065.9286	175528.2	164557.6875	146273.5	138574.8947	131646.15	109705.125	105316.92	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221642	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	2474243	1237121.5	824747.6667	618560.75	494848.6	412373.8333	353463.2857	309280.375	274915.8889	247424.3	224931.1818	206186.9167	190326.3846	176731.6429	164949.5333	154640.1875	137457.9444	130223.3158	123712.15	103093.4583	98969.72	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221643	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	1197165	598582.5	399055	299291.25	239433	199527.5	171023.5714	149645.625	133018.3333	119716.5	108833.1818	99763.75	92089.61538	85511.78571	79811	74822.8125	66509.16667	63008.68421	59858.25	49881.875	47886.6	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221644	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	274585	137292.5	91528.33333	68646.25	54917	45764.16667	39226.42857	34323.125	30509.44444	27458.5	24962.27273	22882.08333	21121.92308	19613.21429	18305.66667	17161.5625	15254.72222	14451.84211	13729.25	11441.04167	10983.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221645	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	169633	84816.5	56544.33333	42408.25	33926.6	28272.16667	24233.28571	21204.125	18848.11111	16963.3	15421.18182	14136.08333	13048.69231	12116.64286	11308.86667	10602.0625	9424.055556	8928.052632	8481.65	7068.041667	6785.32	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221646	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221647	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	188868	94434	62956	47217	37773.6	31478	26981.14286	23608.5	20985.33333	18886.8	17169.81818	15739	14528.30769	13490.57143	12591.2	11804.25	10492.66667	9940.421053	9443.4	7869.5	7554.72	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221648	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	244478	122239	81492.66667	61119.5	48895.6	40746.33333	34925.42857	30559.75	27164.22222	24447.8	22225.27273	20373.16667	18806	17462.71429	16298.53333	15279.875	13582.11111	12867.26316	12223.9	10186.58333	9779.12	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221649	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	191469	95734.5	63823	47867.25	38293.8	31911.5	27352.71429	23933.625	21274.33333	19146.9	17406.27273	15955.75	14728.38462	13676.35714	12764.6	11966.8125	10637.16667	10077.31579	9573.45	7977.875	7658.76	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221650	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	38834	19417	12944.66667	9708.5	7766.8	6472.333333	5547.714286	4854.25	4314.888889	3883.4	3530.363636	3236.166667	2987.230769	2773.857143	2588.933333	2427.125	2157.444444	2043.894737	1941.7	1618.083333	1553.36	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221651	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	29624	14812	9874.666667	7406	5924.8	4937.333333	4232	3703	3291.555556	2962.4	2693.090909	2468.666667	2278.769231	2116	1974.933333	1851.5	1645.777778	1559.157895	1481.2	1234.333333	1184.96	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221652	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	44225	22112.5	14741.66667	11056.25	8845	7370.833333	6317.857143	5528.125	4913.888889	4422.5	4020.454545	3685.416667	3401.923077	3158.928571	2948.333333	2764.0625	2456.944444	2327.631579	2211.25	1842.708333	1769	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221653	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	SLVTNFLDSEETSVK	SLVTNFLDSEETSVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221654	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221655	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221656	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221657	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221658	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	281039	140519.5	93679.66667	70259.75	56207.8	46839.83333	40148.42857	35129.875	31226.55556	28103.9	25549	23419.91667	21618.38462	20074.21429	18735.93333	17564.9375	15613.27778	14791.52632	14051.95	11709.95833	11241.56	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221659	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221660	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221661	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221662	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221663	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221664	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	104500	52250	34833.33333	26125	20900	17416.66667	14928.57143	13062.5	11611.11111	10450	9500	8708.333333	8038.461538	7464.285714	6966.666667	6531.25	5805.555556	5500	5225	4354.166667	4180	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221665	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221666	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221667	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221668	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	INGDPGPGLVEVSVNEK	INGDPGPGLVEVSVNEK	16488	8244	5496	4122	3297.6	2748	2355.428571	2061	1832	1648.8	1498.909091	1374	1268.307692	1177.714286	1099.2	1030.5	916	867.7894737	824.4	687	659.52	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221669	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221670	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221671	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221672	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	114626	57313	38208.66667	28656.5	22925.2	19104.33333	16375.14286	14328.25	12736.22222	11462.6	10420.54545	9552.166667	8817.384615	8187.571429	7641.733333	7164.125	6368.111111	6032.947368	5731.3	4776.083333	4585.04	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221673	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221674	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221675	CHOYP_NEMVEDRAFT_V1G236573.2.2|m.47233	AAMIVMGSR	AAMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
221699	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	39115416	19557708	13038472	9778854	7823083.2	6519236	5587916.571	4889427	4346157.333	3911541.6	3555946.909	3259618	3008878.154	2793958.286	2607694.4	2444713.5	2173078.667	2058706.105	1955770.8	1629809	1564616.64	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221700	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	45428592	22714296	15142864	11357148	9085718.4	7571432	6489798.857	5678574	5047621.333	4542859.2	4129872	3785716	3494507.077	3244899.429	3028572.8	2839287	2523810.667	2390978.526	2271429.6	1892858	1817143.68	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221701	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221702	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	2469874	1234937	823291.3333	617468.5	493974.8	411645.6667	352839.1429	308734.25	274430.4444	246987.4	224534	205822.8333	189990.3077	176419.5714	164658.2667	154367.125	137215.2222	129993.3684	123493.7	102911.4167	98794.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221703	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	3940158	1970079	1313386	985039.5	788031.6	656693	562879.7143	492519.75	437795.3333	394015.8	358196.1818	328346.5	303089.0769	281439.8571	262677.2	246259.875	218897.6667	207376.7368	197007.9	164173.25	157606.32	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221704	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	5472779	2736389.5	1824259.667	1368194.75	1094555.8	912129.8333	781825.5714	684097.375	608086.5556	547277.9	497525.3636	456064.9167	420983	390912.7857	364851.9333	342048.6875	304043.2778	288041	273638.95	228032.4583	218911.16	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221705	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	6737810	3368905	2245936.667	1684452.5	1347562	1122968.333	962544.2857	842226.25	748645.5556	673781	612528.1818	561484.1667	518293.0769	481272.1429	449187.3333	421113.125	374322.7778	354621.5789	336890.5	280742.0833	269512.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221706	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	3926524	1963262	1308841.333	981631	785304.8	654420.6667	560932	490815.5	436280.4444	392652.4	356956.7273	327210.3333	302040.3077	280466	261768.2667	245407.75	218140.2222	206659.1579	196326.2	163605.1667	157060.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221707	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	2662560	1331280	887520	665640	532512	443760	380365.7143	332820	295840	266256	242050.9091	221880	204812.3077	190182.8571	177504	166410	147920	140134.7368	133128	110940	106502.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221708	CHOYP_NEMVEDRAFT_V1G236658.1.6|m.1822	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221709	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	39115416	19557708	13038472	9778854	7823083.2	6519236	5587916.571	4889427	4346157.333	3911541.6	3555946.909	3259618	3008878.154	2793958.286	2607694.4	2444713.5	2173078.667	2058706.105	1955770.8	1629809	1564616.64	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221710	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	45428592	22714296	15142864	11357148	9085718.4	7571432	6489798.857	5678574	5047621.333	4542859.2	4129872	3785716	3494507.077	3244899.429	3028572.8	2839287	2523810.667	2390978.526	2271429.6	1892858	1817143.68	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221711	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221712	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	2469874	1234937	823291.3333	617468.5	493974.8	411645.6667	352839.1429	308734.25	274430.4444	246987.4	224534	205822.8333	189990.3077	176419.5714	164658.2667	154367.125	137215.2222	129993.3684	123493.7	102911.4167	98794.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221713	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	3940158	1970079	1313386	985039.5	788031.6	656693	562879.7143	492519.75	437795.3333	394015.8	358196.1818	328346.5	303089.0769	281439.8571	262677.2	246259.875	218897.6667	207376.7368	197007.9	164173.25	157606.32	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221714	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	5472779	2736389.5	1824259.667	1368194.75	1094555.8	912129.8333	781825.5714	684097.375	608086.5556	547277.9	497525.3636	456064.9167	420983	390912.7857	364851.9333	342048.6875	304043.2778	288041	273638.95	228032.4583	218911.16	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221715	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	6737810	3368905	2245936.667	1684452.5	1347562	1122968.333	962544.2857	842226.25	748645.5556	673781	612528.1818	561484.1667	518293.0769	481272.1429	449187.3333	421113.125	374322.7778	354621.5789	336890.5	280742.0833	269512.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221716	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	3926524	1963262	1308841.333	981631	785304.8	654420.6667	560932	490815.5	436280.4444	392652.4	356956.7273	327210.3333	302040.3077	280466	261768.2667	245407.75	218140.2222	206659.1579	196326.2	163605.1667	157060.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221717	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	2662560	1331280	887520	665640	532512	443760	380365.7143	332820	295840	266256	242050.9091	221880	204812.3077	190182.8571	177504	166410	147920	140134.7368	133128	110940	106502.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221718	CHOYP_NEMVEDRAFT_V1G236658.2.6|m.2257	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
221719	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	19375440	9687720	6458480	4843860	3875088	3229240	2767920	2421930	2152826.667	1937544	1761403.636	1614620	1490418.462	1383960	1291696	1210965	1076413.333	1019760	968772	807310	775017.6	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221720	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221721	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	3969427	1984713.5	1323142.333	992356.75	793885.4	661571.1667	567061	496178.375	441047.4444	396942.7	360857	330785.5833	305340.5385	283530.5	264628.4667	248089.1875	220523.7222	208917.2105	198471.35	165392.7917	158777.08	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221722	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	823971	411985.5	274657	205992.75	164794.2	137328.5	117710.1429	102996.375	91552.33333	82397.1	74906.45455	68664.25	63382.38462	58855.07143	54931.4	51498.1875	45776.16667	43366.89474	41198.55	34332.125	32958.84	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221723	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	976874	488437	325624.6667	244218.5	195374.8	162812.3333	139553.4286	122109.25	108541.5556	97687.4	88806.72727	81406.16667	75144.15385	69776.71429	65124.93333	61054.625	54270.77778	51414.42105	48843.7	40703.08333	39074.96	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221724	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	766522	383261	255507.3333	191630.5	153304.4	127753.6667	109503.1429	95815.25	85169.11111	76652.2	69683.81818	63876.83333	58963.23077	54751.57143	51101.46667	47907.625	42584.55556	40343.26316	38326.1	31938.41667	30660.88	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221725	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	1441720	720860	480573.3333	360430	288344	240286.6667	205960	180215	160191.1111	144172	131065.4545	120143.3333	110901.5385	102980	96114.66667	90107.5	80095.55556	75880	72086	60071.66667	57668.8	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221726	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	YANDAVTWFK	YANDAVTWFK	952299	476149.5	317433	238074.75	190459.8	158716.5	136042.7143	119037.375	105811	95229.9	86572.63636	79358.25	73253.76923	68021.35714	63486.6	59518.6875	52905.5	50121	47614.95	39679.125	38091.96	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221727	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	18304140	9152070	6101380	4576035	3660828	3050690	2614877.143	2288017.5	2033793.333	1830414	1664012.727	1525345	1408010.769	1307438.571	1220276	1144008.75	1016896.667	963375.7895	915207	762672.5	732165.6	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221728	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	11558970	5779485	3852990	2889742.5	2311794	1926495	1651281.429	1444871.25	1284330	1155897	1050815.455	963247.5	889151.5385	825640.7143	770598	722435.625	642165	608366.8421	577948.5	481623.75	462358.8	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221729	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221730	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	2606800	1303400	868933.3333	651700	521360	434466.6667	372400	325850	289644.4444	260680	236981.8182	217233.3333	200523.0769	186200	173786.6667	162925	144822.2222	137200	130340	108616.6667	104272	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221731	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	5584046	2792023	1861348.667	1396011.5	1116809.2	930674.3333	797720.8571	698005.75	620449.5556	558404.6	507640.5455	465337.1667	429542	398860.4286	372269.7333	349002.875	310224.7778	293897.1579	279202.3	232668.5833	223361.84	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221732	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	1523473	761736.5	507824.3333	380868.25	304694.6	253912.1667	217639	190434.125	169274.7778	152347.3	138497.5455	126956.0833	117190.2308	108819.5	101564.8667	95217.0625	84637.38889	80182.78947	76173.65	63478.04167	60938.92	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221733	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
221734	CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704	VLFVTAIDHR	VLFVTAIDHR	249777	124888.5	83259	62444.25	49955.4	41629.5	35682.42857	31222.125	27753	24977.7	22707	20814.75	19213.61538	17841.21429	16651.8	15611.0625	13876.5	13146.15789	12488.85	10407.375	9991.08	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
222100	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	1839699	919849.5	613233	459924.75	367939.8	306616.5	262814.1429	229962.375	204411	183969.9	167245.3636	153308.25	141515.3077	131407.0714	122646.6	114981.1875	102205.5	96826.26316	91984.95	76654.125	73587.96	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222101	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	3769780	1884890	1256593.333	942445	753956	628296.6667	538540	471222.5	418864.4444	376978	342707.2727	314148.3333	289983.0769	269270	251318.6667	235611.25	209432.2222	198409.4737	188489	157074.1667	150791.2	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222102	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	1233260	616630	411086.6667	308315	246652	205543.3333	176180	154157.5	137028.8889	123326	112114.5455	102771.6667	94866.15385	88090	82217.33333	77078.75	68514.44444	64908.42105	61663	51385.83333	49330.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222103	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222104	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222105	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222106	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222107	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222108	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222109	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222110	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222111	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222112	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	1839281	919640.5	613093.6667	459820.25	367856.2	306546.8333	262754.4286	229910.125	204364.5556	183928.1	167207.3636	153273.4167	141483.1538	131377.2143	122618.7333	114955.0625	102182.2778	96804.26316	91964.05	76636.70833	73571.24	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222113	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	1121360	560680	373786.6667	280340	224272	186893.3333	160194.2857	140170	124595.5556	112136	101941.8182	93446.66667	86258.46154	80097.14286	74757.33333	70085	62297.77778	59018.94737	56068	46723.33333	44854.4	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222114	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222115	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222116	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222117	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	188111	94055.5	62703.66667	47027.75	37622.2	31351.83333	26873	23513.875	20901.22222	18811.1	17101	15675.91667	14470.07692	13436.5	12540.73333	11756.9375	10450.61111	9900.578947	9405.55	7837.958333	7524.44	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222118	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	32262	16131	10754	8065.5	6452.4	5377	4608.857143	4032.75	3584.666667	3226.2	2932.909091	2688.5	2481.692308	2304.428571	2150.8	2016.375	1792.333333	1698	1613.1	1344.25	1290.48	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222119	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	565280	282640	188426.6667	141320	113056	94213.33333	80754.28571	70660	62808.88889	56528	51389.09091	47106.66667	43483.07692	40377.14286	37685.33333	35330	31404.44444	29751.57895	28264	23553.33333	22611.2	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222120	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222121	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	EDDVIILVHTPER	EDDVIILVHTPER	13383	6691.5	4461	3345.75	2676.6	2230.5	1911.857143	1672.875	1487	1338.3	1216.636364	1115.25	1029.461538	955.9285714	892.2	836.4375	743.5	704.3684211	669.15	557.625	535.32	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222122	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	1909339	954669.5	636446.3333	477334.75	381867.8	318223.1667	272762.7143	238667.375	212148.7778	190933.9	173576.2727	159111.5833	146872.2308	136381.3571	127289.2667	119333.6875	106074.3889	100491.5263	95466.95	79555.79167	76373.56	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222123	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	2360220	1180110	786740	590055	472044	393370	337174.2857	295027.5	262246.6667	236022	214565.4545	196685	181555.3846	168587.1429	157348	147513.75	131123.3333	124222.1053	118011	98342.5	94408.8	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222124	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	1424105	712052.5	474701.6667	356026.25	284821	237350.8333	203443.5714	178013.125	158233.8889	142410.5	129464.0909	118675.4167	109546.5385	101721.7857	94940.33333	89006.5625	79116.94444	74952.89474	71205.25	59337.70833	56964.2	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222125	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	352228	176114	117409.3333	88057	70445.6	58704.66667	50318.28571	44028.5	39136.44444	35222.8	32020.72727	29352.33333	27094.46154	25159.14286	23481.86667	22014.25	19568.22222	18538.31579	17611.4	14676.16667	14089.12	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222126	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	1078523	539261.5	359507.6667	269630.75	215704.6	179753.8333	154074.7143	134815.375	119835.8889	107852.3	98047.54545	89876.91667	82963.30769	77037.35714	71901.53333	67407.6875	59917.94444	56764.36842	53926.15	44938.45833	43140.92	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222127	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	487572	243786	162524	121893	97514.4	81262	69653.14286	60946.5	54174.66667	48757.2	44324.72727	40631	37505.53846	34826.57143	32504.8	30473.25	27087.33333	25661.68421	24378.6	20315.5	19502.88	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222128	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	161614	80807	53871.33333	40403.5	32322.8	26935.66667	23087.71429	20201.75	17957.11111	16161.4	14692.18182	13467.83333	12431.84615	11543.85714	10774.26667	10100.875	8978.555556	8506	8080.7	6733.916667	6464.56	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222129	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	340489	170244.5	113496.3333	85122.25	68097.8	56748.16667	48641.28571	42561.125	37832.11111	34048.9	30953.54545	28374.08333	26191.46154	24320.64286	22699.26667	21280.5625	18916.05556	17920.47368	17024.45	14187.04167	13619.56	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222130	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222131	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	YNFVDASPHVHR	YNFVDASPHVHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222132	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222133	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222134	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222135	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222136	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222137	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222138	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222139	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222140	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222141	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222142	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222143	CHOYP_NEMVEDRAFT_V1G242153.2.4|m.15572	HGDAGEAIIAVAEK	HGDAGEAIIAVAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q57951	Universal stress protein MJ0531 (USP MJ0531)	MJ0531	response to stress [GO:0006950]	GO:0006950
222144	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	9985607	4992803.5	3328535.667	2496401.75	1997121.4	1664267.833	1426515.286	1248200.875	1109511.889	998560.7	907782.4545	832133.9167	768123.6154	713257.6429	665707.1333	624100.4375	554755.9444	525558.2632	499280.35	416066.9583	399424.28	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222145	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	10581681	5290840.5	3527227	2645420.25	2116336.2	1763613.5	1511668.714	1322710.125	1175742.333	1058168.1	961971	881806.75	813975.4615	755834.3571	705445.4	661355.0625	587871.1667	556930.5789	529084.05	440903.375	423267.24	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222146	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222147	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	33073	16536.5	11024.33333	8268.25	6614.6	5512.166667	4724.714286	4134.125	3674.777778	3307.3	3006.636364	2756.083333	2544.076923	2362.357143	2204.866667	2067.0625	1837.388889	1740.684211	1653.65	1378.041667	1322.92	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222148	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222149	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	456740	228370	152246.6667	114185	91348	76123.33333	65248.57143	57092.5	50748.88889	45674	41521.81818	38061.66667	35133.84615	32624.28571	30449.33333	28546.25	25374.44444	24038.94737	22837	19030.83333	18269.6	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222150	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1297472	648736	432490.6667	324368	259494.4	216245.3333	185353.1429	162184	144163.5556	129747.2	117952	108122.6667	99805.53846	92676.57143	86498.13333	81092	72081.77778	68288	64873.6	54061.33333	51898.88	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222151	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222152	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1304334	652167	434778	326083.5	260866.8	217389	186333.4286	163041.75	144926	130433.4	118575.8182	108694.5	100333.3846	93166.71429	86955.6	81520.875	72463	68649.15789	65216.7	54347.25	52173.36	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222153	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1663876	831938	554625.3333	415969	332775.2	277312.6667	237696.5714	207984.5	184875.1111	166387.6	151261.4545	138656.3333	127990.4615	118848.2857	110925.0667	103992.25	92437.55556	87572.42105	83193.8	69328.16667	66555.04	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222154	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	1919015	959507.5	639671.6667	479753.75	383803	319835.8333	274145	239876.875	213223.8889	191901.5	174455.9091	159917.9167	147616.5385	137072.5	127934.3333	119938.4375	106611.9444	101000.7895	95950.75	79958.95833	76760.6	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222155	CHOYP_NEMVEDRAFT_V1G242153.3.4|m.17716	KPNDVVYIVHSLER	KPNDVVYIVHSLER	90811	45405.5	30270.33333	22702.75	18162.2	15135.16667	12973	11351.375	10090.11111	9081.1	8255.545455	7567.583333	6985.461538	6486.5	6054.066667	5675.6875	5045.055556	4779.526316	4540.55	3783.791667	3632.44	O07552	Stress response protein NhaX	nhaX yheK BSU09690	response to stress [GO:0006950]	GO:0006950
222156	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	3281420	1640710	1093806.667	820355	656284	546903.3333	468774.2857	410177.5	364602.2222	328142	298310.9091	273451.6667	252416.9231	234387.1429	218761.3333	205088.75	182301.1111	172706.3158	164071	136725.8333	131256.8	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222157	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	1535283	767641.5	511761	383820.75	307056.6	255880.5	219326.1429	191910.375	170587	153528.3	139571.1818	127940.25	118098.6923	109663.0714	102352.2	95955.1875	85293.5	80804.36842	76764.15	63970.125	61411.32	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222158	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	911536	455768	303845.3333	227884	182307.2	151922.6667	130219.4286	113942	101281.7778	91153.6	82866.90909	75961.33333	70118.15385	65109.71429	60769.06667	56971	50640.88889	47975.57895	45576.8	37980.66667	36461.44	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222159	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	487437	243718.5	162479	121859.25	97487.4	81239.5	69633.85714	60929.625	54159.66667	48743.7	44312.45455	40619.75	37495.15385	34816.92857	32495.8	30464.8125	27079.83333	25654.57895	24371.85	20309.875	19497.48	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222160	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	1503804	751902	501268	375951	300760.8	250634	214829.1429	187975.5	167089.3333	150380.4	136709.4545	125317	115677.2308	107414.5714	100253.6	93987.75	83544.66667	79147.57895	75190.2	62658.5	60152.16	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222161	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	376418	188209	125472.6667	94104.5	75283.6	62736.33333	53774	47052.25	41824.22222	37641.8	34219.81818	31368.16667	28955.23077	26887	25094.53333	23526.125	20912.11111	19811.47368	18820.9	15684.08333	15056.72	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222162	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	471527	235763.5	157175.6667	117881.75	94305.4	78587.83333	67361	58940.875	52391.88889	47152.7	42866.09091	39293.91667	36271.30769	33680.5	31435.13333	29470.4375	26195.94444	24817.21053	23576.35	19646.95833	18861.08	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222163	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	652529	326264.5	217509.6667	163132.25	130505.8	108754.8333	93218.42857	81566.125	72503.22222	65252.9	59320.81818	54377.41667	50194.53846	46609.21429	43501.93333	40783.0625	36251.61111	34343.63158	32626.45	27188.70833	26101.16	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222164	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222165	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	123057	61528.5	41019	30764.25	24611.4	20509.5	17579.57143	15382.125	13673	12305.7	11187	10254.75	9465.923077	8789.785714	8203.8	7691.0625	6836.5	6476.684211	6152.85	5127.375	4922.28	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222166	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	TVLIAIDGSEQAR	TVLIAIDGSEQAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222167	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	NAFDWYK	NAFDWYK	82846752	41423376	27615584	20711688	16569350.4	13807792	11835250.29	10355844	9205194.667	8284675.2	7531522.909	6903896	6372827.077	5917625.143	5523116.8	5177922	4602597.333	4360355.368	4142337.6	3451948	3313870.08	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222168	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	NAFDWYK	NAFDWYK	44883696	22441848	14961232	11220924	8976739.2	7480616	6411956.571	5610462	4987077.333	4488369.6	4080336	3740308	3452592	3205978.286	2992246.4	2805231	2493538.667	2362299.789	2244184.8	1870154	1795347.84	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222169	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	NAFDWYK	NAFDWYK	15112196	7556098	5037398.667	3778049	3022439.2	2518699.333	2158885.143	1889024.5	1679132.889	1511219.6	1373836	1259349.667	1162476.615	1079442.571	1007479.733	944512.25	839566.4444	795378.7368	755609.8	629674.8333	604487.84	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222170	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	NAFDWYK	NAFDWYK	10459913	5229956.5	3486637.667	2614978.25	2091982.6	1743318.833	1494273.286	1307489.125	1162212.556	1045991.3	950901.1818	871659.4167	804608.6923	747136.6429	697327.5333	653744.5625	581106.2778	550521.7368	522995.65	435829.7083	418396.52	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222171	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	NAFDWYK	NAFDWYK	930750	465375	310250	232687.5	186150	155125	132964.2857	116343.75	103416.6667	93075	84613.63636	77562.5	71596.15385	66482.14286	62050	58171.875	51708.33333	48986.84211	46537.5	38781.25	37230	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222172	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	11855494	5927747	3951831.333	2963873.5	2371098.8	1975915.667	1693642	1481936.75	1317277.111	1185549.4	1077772.182	987957.8333	911961.0769	846821	790366.2667	740968.375	658638.5556	623973.3684	592774.7	493978.9167	474219.76	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222173	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	6457927	3228963.5	2152642.333	1614481.75	1291585.4	1076321.167	922561	807240.875	717547.4444	645792.7	587084.2727	538160.5833	496763.6154	461280.5	430528.4667	403620.4375	358773.7222	339890.8947	322896.35	269080.2917	258317.08	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222174	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	2227081	1113540.5	742360.3333	556770.25	445416.2	371180.1667	318154.4286	278385.125	247453.4444	222708.1	202461.9091	185590.0833	171313.9231	159077.2143	148472.0667	139192.5625	123726.7222	117214.7895	111354.05	92795.04167	89083.24	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222175	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	3202963	1601481.5	1067654.333	800740.75	640592.6	533827.1667	457566.1429	400370.375	355884.7778	320296.3	291178.4545	266913.5833	246381.7692	228783.0714	213530.8667	200185.1875	177942.3889	168577	160148.15	133456.7917	128118.52	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222176	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	1937156	968578	645718.6667	484289	387431.2	322859.3333	276736.5714	242144.5	215239.5556	193715.6	176105.0909	161429.6667	149012	138368.2857	129143.7333	121072.25	107619.7778	101955.5789	96857.8	80714.83333	77486.24	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222177	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	423976	211988	141325.3333	105994	84795.2	70662.66667	60568	52997	47108.44444	42397.6	38543.27273	35331.33333	32613.53846	30284	28265.06667	26498.5	23554.22222	22314.52632	21198.8	17665.66667	16959.04	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222178	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	DTLFAILEK	DTLFAILEK	1216686	608343	405562	304171.5	243337.2	202781	173812.2857	152085.75	135187.3333	121668.6	110607.8182	101390.5	93591.23077	86906.14286	81112.4	76042.875	67593.66667	64036.10526	60834.3	50695.25	48667.44	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222179	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	24380386	12190193	8126795.333	6095096.5	4876077.2	4063397.667	3482912.286	3047548.25	2708931.778	2438038.6	2216398.727	2031698.833	1875414.308	1741456.143	1625359.067	1523774.125	1354465.889	1283178.211	1219019.3	1015849.417	975215.44	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222180	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	15886172	7943086	5295390.667	3971543	3177234.4	2647695.333	2269453.143	1985771.5	1765130.222	1588617.2	1444197.455	1323847.667	1222013.231	1134726.571	1059078.133	992885.75	882565.1111	836114.3158	794308.6	661923.8333	635446.88	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222181	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	4265746	2132873	1421915.333	1066436.5	853149.2	710957.6667	609392.2857	533218.25	473971.7778	426574.6	387795.0909	355478.8333	328134.3077	304696.1429	284383.0667	266609.125	236985.8889	224512.9474	213287.3	177739.4167	170629.84	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222182	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	4063621	2031810.5	1354540.333	1015905.25	812724.2	677270.1667	580517.2857	507952.625	451513.4444	406362.1	369420.0909	338635.0833	312586.2308	290258.6429	270908.0667	253976.3125	225756.7222	213874.7895	203181.05	169317.5417	162544.84	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222183	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	3220770	1610385	1073590	805192.5	644154	536795	460110	402596.25	357863.3333	322077	292797.2727	268397.5	247751.5385	230055	214718	201298.125	178931.6667	169514.2105	161038.5	134198.75	128830.8	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222184	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	1538804	769402	512934.6667	384701	307760.8	256467.3333	219829.1429	192350.5	170978.2222	153880.4	139891.2727	128233.6667	118369.5385	109914.5714	102586.9333	96175.25	85489.11111	80989.68421	76940.2	64116.83333	61552.16	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222185	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	LEEFAQLLR	LEEFAQLLR	1146713	573356.5	382237.6667	286678.25	229342.6	191118.8333	163816.1429	143339.125	127412.5556	114671.3	104246.6364	95559.41667	88208.69231	81908.07143	76447.53333	71669.5625	63706.27778	60353.31579	57335.65	47779.70833	45868.52	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222186	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	6117402	3058701	2039134	1529350.5	1223480.4	1019567	873914.5714	764675.25	679711.3333	611740.2	556127.4545	509783.5	470569.3846	436957.2857	407826.8	382337.625	339855.6667	321968.5263	305870.1	254891.75	244696.08	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222187	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	10015351	5007675.5	3338450.333	2503837.75	2003070.2	1669225.167	1430764.429	1251918.875	1112816.778	1001535.1	910486.4545	834612.5833	770411.6154	715382.2143	667690.0667	625959.4375	556408.3889	527123.7368	500767.55	417306.2917	400614.04	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222188	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222189	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	765769	382884.5	255256.3333	191442.25	153153.8	127628.1667	109395.5714	95721.125	85085.44444	76576.9	69615.36364	63814.08333	58905.30769	54697.78571	51051.26667	47860.5625	42542.72222	40303.63158	38288.45	31907.04167	30630.76	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222190	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	1818477	909238.5	606159	454619.25	363695.4	303079.5	259782.4286	227309.625	202053	181847.7	165316.0909	151539.75	139882.8462	129891.2143	121231.8	113654.8125	101026.5	95709.31579	90923.85	75769.875	72739.08	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222191	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	976815	488407.5	325605	244203.75	195363	162802.5	139545	122101.875	108535	97681.5	88801.36364	81401.25	75139.61538	69772.5	65121	61050.9375	54267.5	51411.31579	48840.75	40700.625	39072.6	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222192	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	1479471	739735.5	493157	369867.75	295894.2	246578.5	211353	184933.875	164385.6667	147947.1	134497.3636	123289.25	113805.4615	105676.5	98631.4	92466.9375	82192.83333	77866.89474	73973.55	61644.625	59178.84	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222193	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	2033720	1016860	677906.6667	508430	406744	338953.3333	290531.4286	254215	225968.8889	203372	184883.6364	169476.6667	156440	145265.7143	135581.3333	127107.5	112984.4444	107037.8947	101686	84738.33333	81348.8	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222194	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	951185	475592.5	317061.6667	237796.25	190237	158530.8333	135883.5714	118898.125	105687.2222	95118.5	86471.36364	79265.41667	73168.07692	67941.78571	63412.33333	59449.0625	52843.61111	50062.36842	47559.25	39632.70833	38047.4	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222195	CHOYP_NEMVEDRAFT_V1G242153.4.4|m.60071	EVNADLIITGTR	EVNADLIITGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q2FXL6	Putative universal stress protein SAOUHSC_01819	SAOUHSC_01819	response to stress [GO:0006950]	GO:0005737; GO:0006950
222249	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	39115416	19557708	13038472	9778854	7823083.2	6519236	5587916.571	4889427	4346157.333	3911541.6	3555946.909	3259618	3008878.154	2793958.286	2607694.4	2444713.5	2173078.667	2058706.105	1955770.8	1629809	1564616.64	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222250	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	45428592	22714296	15142864	11357148	9085718.4	7571432	6489798.857	5678574	5047621.333	4542859.2	4129872	3785716	3494507.077	3244899.429	3028572.8	2839287	2523810.667	2390978.526	2271429.6	1892858	1817143.68	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222251	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222252	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	2469874	1234937	823291.3333	617468.5	493974.8	411645.6667	352839.1429	308734.25	274430.4444	246987.4	224534	205822.8333	189990.3077	176419.5714	164658.2667	154367.125	137215.2222	129993.3684	123493.7	102911.4167	98794.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222253	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	3940158	1970079	1313386	985039.5	788031.6	656693	562879.7143	492519.75	437795.3333	394015.8	358196.1818	328346.5	303089.0769	281439.8571	262677.2	246259.875	218897.6667	207376.7368	197007.9	164173.25	157606.32	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222254	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	5472779	2736389.5	1824259.667	1368194.75	1094555.8	912129.8333	781825.5714	684097.375	608086.5556	547277.9	497525.3636	456064.9167	420983	390912.7857	364851.9333	342048.6875	304043.2778	288041	273638.95	228032.4583	218911.16	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222255	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	6737810	3368905	2245936.667	1684452.5	1347562	1122968.333	962544.2857	842226.25	748645.5556	673781	612528.1818	561484.1667	518293.0769	481272.1429	449187.3333	421113.125	374322.7778	354621.5789	336890.5	280742.0833	269512.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222256	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	3926524	1963262	1308841.333	981631	785304.8	654420.6667	560932	490815.5	436280.4444	392652.4	356956.7273	327210.3333	302040.3077	280466	261768.2667	245407.75	218140.2222	206659.1579	196326.2	163605.1667	157060.96	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222257	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	2662560	1331280	887520	665640	532512	443760	380365.7143	332820	295840	266256	242050.9091	221880	204812.3077	190182.8571	177504	166410	147920	140134.7368	133128	110940	106502.4	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
222258	CHOYP_NEMVEDRAFT_V1G244537.1.3|m.7917	DENAQLIVTGTR	DENAQLIVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P72745	Universal stress protein Slr1101 (USP Slr1101)	slr1101	response to stress [GO:0006950]	GO:0006950
227125	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	23265982	11632991	7755327.333	5816495.5	4653196.4	3877663.667	3323711.714	2908247.75	2585109.111	2326598.2	2115089.273	1938831.833	1789690.923	1661855.857	1551065.467	1454123.875	1292554.556	1224525.368	1163299.1	969415.9167	930639.28	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227126	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	18383254	9191627	6127751.333	4595813.5	3676650.8	3063875.667	2626179.143	2297906.75	2042583.778	1838325.4	1671204.909	1531937.833	1414096.462	1313089.571	1225550.267	1148953.375	1021291.889	967539.6842	919162.7	765968.9167	735330.16	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227127	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227128	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	966363	483181.5	322121	241590.75	193272.6	161060.5	138051.8571	120795.375	107373.6667	96636.3	87851.18182	80530.25	74335.61538	69025.92857	64424.2	60397.6875	53686.83333	50861.21053	48318.15	40265.125	38654.52	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227129	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	1554129	777064.5	518043	388532.25	310825.8	259021.5	222018.4286	194266.125	172681	155412.9	141284.4545	129510.75	119548.3846	111009.2143	103608.6	97133.0625	86340.5	81796.26316	77706.45	64755.375	62165.16	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227130	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	3762446	1881223	1254148.667	940611.5	752489.2	627074.3333	537492.2857	470305.75	418049.5556	376244.6	342040.5455	313537.1667	289418.9231	268746.1429	250829.7333	235152.875	209024.7778	198023.4737	188122.3	156768.5833	150497.84	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227131	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	10498298	5249149	3499432.667	2624574.5	2099659.6	1749716.333	1499756.857	1312287.25	1166477.556	1049829.8	954390.7273	874858.1667	807561.3846	749878.4286	699886.5333	656143.625	583238.7778	552542	524914.9	437429.0833	419931.92	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227132	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	399891	199945.5	133297	99972.75	79978.2	66648.5	57127.28571	49986.375	44432.33333	39989.1	36353.72727	33324.25	30760.84615	28563.64286	26659.4	24993.1875	22216.16667	21046.89474	19994.55	16662.125	15995.64	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227133	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	379052	189526	126350.6667	94763	75810.4	63175.33333	54150.28571	47381.5	42116.88889	37905.2	34459.27273	31587.66667	29157.84615	27075.14286	25270.13333	23690.75	21058.44444	19950.10526	18952.6	15793.83333	15162.08	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227134	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	688290	344145	229430	172072.5	137658	114715	98327.14286	86036.25	76476.66667	68829	62571.81818	57357.5	52945.38462	49163.57143	45886	43018.125	38238.33333	36225.78947	34414.5	28678.75	27531.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227135	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	796199	398099.5	265399.6667	199049.75	159239.8	132699.8333	113742.7143	99524.875	88466.55556	79619.9	72381.72727	66349.91667	61246.07692	56871.35714	53079.93333	49762.4375	44233.27778	41905.21053	39809.95	33174.95833	31847.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227136	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227137	CHOYP_PAK1.1.1|m.50796	ADQAANPEAVINSLR	ADQAANPEAVINSLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227138	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227139	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227140	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227141	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	209749	104874.5	69916.33333	52437.25	41949.8	34958.16667	29964.14286	26218.625	23305.44444	20974.9	19068.09091	17479.08333	16134.53846	14982.07143	13983.26667	13109.3125	11652.72222	11039.42105	10487.45	8739.541667	8389.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227142	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	86018	43009	28672.66667	21504.5	17203.6	14336.33333	12288.28571	10752.25	9557.555556	8601.8	7819.818182	7168.166667	6616.769231	6144.142857	5734.533333	5376.125	4778.777778	4527.263158	4300.9	3584.083333	3440.72	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227143	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	63890	31945	21296.66667	15972.5	12778	10648.33333	9127.142857	7986.25	7098.888889	6389	5808.181818	5324.166667	4914.615385	4563.571429	4259.333333	3993.125	3549.444444	3362.631579	3194.5	2662.083333	2555.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227144	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	112825	56412.5	37608.33333	28206.25	22565	18804.16667	16117.85714	14103.125	12536.11111	11282.5	10256.81818	9402.083333	8678.846154	8058.928571	7521.666667	7051.5625	6268.055556	5938.157895	5641.25	4701.041667	4513	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227145	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227146	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227147	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227148	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227149	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	9449	4724.5	3149.666667	2362.25	1889.8	1574.833333	1349.857143	1181.125	1049.888889	944.9	859	787.4166667	726.8461538	674.9285714	629.9333333	590.5625	524.9444444	497.3157895	472.45	393.7083333	377.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227150	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227151	CHOYP_PAK1.1.1|m.50796	ITIDNDNEPPAEAIQR	ITIDNDNEPPAEAIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227152	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227153	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227154	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227155	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227156	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	743394	371697	247798	185848.5	148678.8	123899	106199.1429	92924.25	82599.33333	74339.4	67581.27273	61949.5	57184.15385	53099.57143	49559.6	46462.125	41299.66667	39126	37169.7	30974.75	29735.76	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227157	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	964189	482094.5	321396.3333	241047.25	192837.8	160698.1667	137741.2857	120523.625	107132.1111	96418.9	87653.54545	80349.08333	74168.38462	68870.64286	64279.26667	60261.8125	53566.05556	50746.78947	48209.45	40174.54167	38567.56	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227158	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227159	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	1045265	522632.5	348421.6667	261316.25	209053	174210.8333	149323.5714	130658.125	116140.5556	104526.5	95024.09091	87105.41667	80405	74661.78571	69684.33333	65329.0625	58070.27778	55013.94737	52263.25	43552.70833	41810.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227160	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	216449	108224.5	72149.66667	54112.25	43289.8	36074.83333	30921.28571	27056.125	24049.88889	21644.9	19677.18182	18037.41667	16649.92308	15460.64286	14429.93333	13528.0625	12024.94444	11392.05263	10822.45	9018.708333	8657.96	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227161	CHOYP_PAK1.1.1|m.50796	NMTDEEINNGLR	NMTDEEINNGLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227162	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	5542344	2771172	1847448	1385586	1108468.8	923724	791763.4286	692793	615816	554234.4	503849.4545	461862	426334.1538	395881.7143	369489.6	346396.5	307908	291702.3158	277117.2	230931	221693.76	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227163	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	1823518	911759	607839.3333	455879.5	364703.6	303919.6667	260502.5714	227939.75	202613.1111	182351.8	165774.3636	151959.8333	140270.6154	130251.2857	121567.8667	113969.875	101306.5556	95974.63158	91175.9	75979.91667	72940.72	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227164	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	788285	394142.5	262761.6667	197071.25	157657	131380.8333	112612.1429	98535.625	87587.22222	78828.5	71662.27273	65690.41667	60637.30769	56306.07143	52552.33333	49267.8125	43793.61111	41488.68421	39414.25	32845.20833	31531.4	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227165	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227166	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227167	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227168	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227169	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227170	CHOYP_PAK1.1.1|m.50796	ALASPGDPTSK	ALASPGDPTSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227171	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	3962201	1981100.5	1320733.667	990550.25	792440.2	660366.8333	566028.7143	495275.125	440244.5556	396220.1	360200.0909	330183.4167	304784.6923	283014.3571	264146.7333	247637.5625	220122.2778	208536.8947	198110.05	165091.7083	158488.04	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227172	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	2531581	1265790.5	843860.3333	632895.25	506316.2	421930.1667	361654.4286	316447.625	281286.7778	253158.1	230143.7273	210965.0833	194737	180827.2143	168772.0667	158223.8125	140643.3889	133241.1053	126579.05	105482.5417	101263.24	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227173	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	811993	405996.5	270664.3333	202998.25	162398.6	135332.1667	115999	101499.125	90221.44444	81199.3	73817.54545	67666.08333	62461	57999.5	54132.86667	50749.5625	45110.72222	42736.47368	40599.65	33833.04167	32479.72	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227174	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	351885	175942.5	117295	87971.25	70377	58647.5	50269.28571	43985.625	39098.33333	35188.5	31989.54545	29323.75	27068.07692	25134.64286	23459	21992.8125	19549.16667	18520.26316	17594.25	14661.875	14075.4	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227175	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	1226839	613419.5	408946.3333	306709.75	245367.8	204473.1667	175262.7143	153354.875	136315.4444	122683.9	111530.8182	102236.5833	94372.23077	87631.35714	81789.26667	76677.4375	68157.72222	64570.47368	61341.95	51118.29167	49073.56	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227176	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	119047	59523.5	39682.33333	29761.75	23809.4	19841.16667	17006.71429	14880.875	13227.44444	11904.7	10822.45455	9920.583333	9157.461538	8503.357143	7936.466667	7440.4375	6613.722222	6265.631579	5952.35	4960.291667	4761.88	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227177	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	40587	20293.5	13529	10146.75	8117.4	6764.5	5798.142857	5073.375	4509.666667	4058.7	3689.727273	3382.25	3122.076923	2899.071429	2705.8	2536.6875	2254.833333	2136.157895	2029.35	1691.125	1623.48	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227178	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	90521	45260.5	30173.66667	22630.25	18104.2	15086.83333	12931.57143	11315.125	10057.88889	9052.1	8229.181818	7543.416667	6963.153846	6465.785714	6034.733333	5657.5625	5028.944444	4764.263158	4526.05	3771.708333	3620.84	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227179	CHOYP_PAK1.1.1|m.50796	ELLITEIEVMK	ELLITEIEVMK	86865	43432.5	28955	21716.25	17373	14477.5	12409.28571	10858.125	9651.666667	8686.5	7896.818182	7238.75	6681.923077	6204.642857	5791	5429.0625	4825.833333	4571.842105	4343.25	3619.375	3474.6	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227180	CHOYP_PAK1.1.1|m.50796	LLQNFIDR	LLQNFIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227181	CHOYP_PAK1.1.1|m.50796	LLQNFIDR	LLQNFIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227182	CHOYP_PAK1.1.1|m.50796	LLQNFIDR	LLQNFIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227183	CHOYP_PAK1.1.1|m.50796	LLQNFIDR	LLQNFIDR	1806366	903183	602122	451591.5	361273.2	301061	258052.2857	225795.75	200707.3333	180636.6	164215.0909	150530.5	138951.2308	129026.1429	120424.4	112897.875	100353.6667	95071.89474	90318.3	75265.25	72254.64	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227184	CHOYP_PAK1.1.1|m.50796	LLQNFIDR	LLQNFIDR	800738	400369	266912.6667	200184.5	160147.6	133456.3333	114391.1429	100092.25	88970.88889	80073.8	72794.36364	66728.16667	61595.23077	57195.57143	53382.53333	50046.125	44485.44444	42144.10526	40036.9	33364.08333	32029.52	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
227185	CHOYP_PAK1.1.1|m.50796	LLQNFIDR	LLQNFIDR	527681	263840.5	175893.6667	131920.25	105536.2	87946.83333	75383	65960.125	58631.22222	52768.1	47971	43973.41667	40590.84615	37691.5	35178.73333	32980.0625	29315.61111	27772.68421	26384.05	21986.70833	21107.24	Q08E52	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; exocytosis [GO:0006887]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]	GO:0001726; GO:0001934; GO:0004674; GO:0004702; GO:0005518; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0007409; GO:0030036; GO:0030335; GO:0031532; GO:0032587; GO:0033138; GO:0033148; GO:0042060; GO:0043234; GO:0043507; GO:0046777; GO:0048754; GO:0051496; GO:0060244; GO:0071437
228897	CHOYP_PDIA1.1.1|m.5297	SLAPEYEK	SLAPEYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228898	CHOYP_PDIA1.1.1|m.5297	SLAPEYEK	SLAPEYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228899	CHOYP_PDIA1.1.1|m.5297	SLAPEYEK	SLAPEYEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228900	CHOYP_PDIA1.1.1|m.5297	SLAPEYEK	SLAPEYEK	2807491	1403745.5	935830.3333	701872.75	561498.2	467915.1667	401070.1429	350936.375	311943.4444	280749.1	255226.4545	233957.5833	215960.8462	200535.0714	187166.0667	175468.1875	155971.7222	147762.6842	140374.55	116978.7917	112299.64	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228901	CHOYP_PDIA1.1.1|m.5297	SLAPEYEK	SLAPEYEK	459463	229731.5	153154.3333	114865.75	91892.6	76577.16667	65637.57143	57432.875	51051.44444	45946.3	41769.36364	38288.58333	35343.30769	32818.78571	30630.86667	28716.4375	25525.72222	24182.26316	22973.15	19144.29167	18378.52	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228902	CHOYP_PDIA1.1.1|m.5297	SLAPEYEK	SLAPEYEK	1189014	594507	396338	297253.5	237802.8	198169	169859.1429	148626.75	132112.6667	118901.4	108092.1818	99084.5	91462.61538	84929.57143	79267.6	74313.375	66056.33333	62579.68421	59450.7	49542.25	47560.56	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228903	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228904	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228905	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228906	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	2857084	1428542	952361.3333	714271	571416.8	476180.6667	408154.8571	357135.5	317453.7778	285708.4	259734.9091	238090.3333	219775.6923	204077.4286	190472.2667	178567.75	158726.8889	150372.8421	142854.2	119045.1667	114283.36	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228907	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	1797978	898989	599326	449494.5	359595.6	299663	256854	224747.25	199775.3333	179797.8	163452.5455	149831.5	138306	128427	119865.2	112373.625	99887.66667	94630.42105	89898.9	74915.75	71919.12	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228908	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	1200285	600142.5	400095	300071.25	240057	200047.5	171469.2857	150035.625	133365	120028.5	109116.8182	100023.75	92329.61538	85734.64286	80019	75017.8125	66682.5	63172.89474	60014.25	50011.875	48011.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228909	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	224939	112469.5	74979.66667	56234.75	44987.8	37489.83333	32134.14286	28117.375	24993.22222	22493.9	20449	18744.91667	17303	16067.07143	14995.93333	14058.6875	12496.61111	11838.89474	11246.95	9372.458333	8997.56	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228910	CHOYP_PDIA1.1.1|m.5297	ALADEGSEIK	ALADEGSEIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228911	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	152343616	76171808	50781205.33	38085904	30468723.2	25390602.67	21763373.71	19042952	16927068.44	15234361.6	13849419.64	12695301.33	11718739.69	10881686.86	10156241.07	9521476	8463534.222	8018085.053	7617180.8	6347650.667	6093744.64	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228912	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	103597464	51798732	34532488	25899366	20719492.8	17266244	14799637.71	12949683	11510829.33	10359746.4	9417951.273	8633122	7969035.692	7399818.857	6906497.6	6474841.5	5755414.667	5452498.105	5179873.2	4316561	4143898.56	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228913	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	31139290	15569645	10379763.33	7784822.5	6227858	5189881.667	4448470	3892411.25	3459921.111	3113929	2830844.545	2594940.833	2395330	2224235	2075952.667	1946205.625	1729960.556	1638910	1556964.5	1297470.417	1245571.6	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228914	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	24695512	12347756	8231837.333	6173878	4939102.4	4115918.667	3527930.286	3086939	2743945.778	2469551.2	2245046.545	2057959.333	1899654.769	1763965.143	1646367.467	1543469.5	1371972.889	1299763.789	1234775.6	1028979.667	987820.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228915	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	36154872	18077436	12051624	9038718	7230974.4	6025812	5164981.714	4519359	4017208	3615487.2	3286806.545	3012906	2781144	2582490.857	2410324.8	2259679.5	2008604	1902888	1807743.6	1506453	1446194.88	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228916	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	27508710	13754355	9169570	6877177.5	5501742	4584785	3929815.714	3438588.75	3056523.333	2750871	2500791.818	2292392.5	2116054.615	1964907.857	1833914	1719294.375	1528261.667	1447826.842	1375435.5	1146196.25	1100348.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228917	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	15028519	7514259.5	5009506.333	3757129.75	3005703.8	2504753.167	2146931.286	1878564.875	1669835.444	1502851.9	1366229	1252376.583	1156039.923	1073465.643	1001901.267	939282.4375	834917.7222	790974.6842	751425.95	626188.2917	601140.76	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228918	CHOYP_PDIA1.1.1|m.5297	TSPEIVNWLR	TSPEIVNWLR	3456951	1728475.5	1152317	864237.75	691390.2	576158.5	493850.1429	432118.875	384105.6667	345695.1	314268.2727	288079.25	265919.3077	246925.0714	230463.4	216059.4375	192052.8333	181944.7895	172847.55	144039.625	138278.04	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228919	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	1466406	733203	488802	366601.5	293281.2	244401	209486.5714	183300.75	162934	146640.6	133309.6364	122200.5	112800.4615	104743.2857	97760.4	91650.375	81467	77179.26316	73320.3	61100.25	58656.24	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228920	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228921	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	497589	248794.5	165863	124397.25	99517.8	82931.5	71084.14286	62198.625	55287.66667	49758.9	45235.36364	41465.75	38276.07692	35542.07143	33172.6	31099.3125	27643.83333	26188.89474	24879.45	20732.875	19903.56	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228922	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	92610	46305	30870	23152.5	18522	15435	13230	11576.25	10290	9261	8419.090909	7717.5	7123.846154	6615	6174	5788.125	5145	4874.210526	4630.5	3858.75	3704.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228923	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	157537	78768.5	52512.33333	39384.25	31507.4	26256.16667	22505.28571	19692.125	17504.11111	15753.7	14321.54545	13128.08333	12118.23077	11252.64286	10502.46667	9846.0625	8752.055556	8291.421053	7876.85	6564.041667	6301.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228924	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228925	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228926	CHOYP_PDIA1.1.1|m.5297	DDVVVIGFFK	DDVVVIGFFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228927	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	77397704	38698852	25799234.67	19349426	15479540.8	12899617.33	11056814.86	9674713	8599744.889	7739770.4	7036154.909	6449808.667	5953669.538	5528407.429	5159846.933	4837356.5	4299872.444	4073563.368	3869885.2	3224904.333	3095908.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228928	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	62478744	31239372	20826248	15619686	12495748.8	10413124	8925534.857	7809843	6942082.667	6247874.4	5679885.818	5206562	4806057.231	4462767.429	4165249.6	3904921.5	3471041.333	3288354.947	3123937.2	2603281	2499149.76	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228929	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	27567226	13783613	9189075.333	6891806.5	5513445.2	4594537.667	3938175.143	3445903.25	3063025.111	2756722.6	2506111.455	2297268.833	2120555.846	1969087.571	1837815.067	1722951.625	1531512.556	1450906.632	1378361.3	1148634.417	1102689.04	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228930	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	5400584	2700292	1800194.667	1350146	1080116.8	900097.3333	771512	675073	600064.8889	540058.4	490962.1818	450048.6667	415429.5385	385756	360038.9333	337536.5	300032.4444	284241.2632	270029.2	225024.3333	216023.36	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228931	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	10711562	5355781	3570520.667	2677890.5	2142312.4	1785260.333	1530223.143	1338945.25	1190173.556	1071156.2	973778.3636	892630.1667	823966.3077	765111.5714	714104.1333	669472.625	595086.7778	563766.4211	535578.1	446315.0833	428462.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228932	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	8003791	4001895.5	2667930.333	2000947.75	1600758.2	1333965.167	1143398.714	1000473.875	889310.1111	800379.1	727617.3636	666982.5833	615676.2308	571699.3571	533586.0667	500236.9375	444655.0556	421252.1579	400189.55	333491.2917	320151.64	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228933	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	2136555	1068277.5	712185	534138.75	427311	356092.5	305222.1429	267069.375	237395	213655.5	194232.2727	178046.25	164350.3846	152611.0714	142437	133534.6875	118697.5	112450.2632	106827.75	89023.125	85462.2	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228934	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	3547512	1773756	1182504	886878	709502.4	591252	506787.4286	443439	394168	354751.2	322501.0909	295626	272885.5385	253393.7143	236500.8	221719.5	197084	186711.1579	177375.6	147813	141900.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228935	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	141669	70834.5	47223	35417.25	28333.8	23611.5	20238.42857	17708.625	15741	14166.9	12879	11805.75	10897.61538	10119.21429	9444.6	8854.3125	7870.5	7456.263158	7083.45	5902.875	5666.76	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228936	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	4481354	2240677	1493784.667	1120338.5	896270.8	746892.3333	640193.4286	560169.25	497928.2222	448135.4	407395.8182	373446.1667	344719.5385	320096.7143	298756.9333	280084.625	248964.1111	235860.7368	224067.7	186723.0833	179254.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228937	CHOYP_PDIA1.1.1|m.5297	EYEVESDGIVLFK	EYEVESDGIVLFK	5300211	2650105.5	1766737	1325052.75	1060042.2	883368.5	757173	662526.375	588912.3333	530021.1	481837.3636	441684.25	407708.5385	378586.5	353347.4	331263.1875	294456.1667	278958.4737	265010.55	220842.125	212008.44	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228938	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	61584832	30792416	20528277.33	15396208	12316966.4	10264138.67	8797833.143	7698104	6842759.111	6158483.2	5598621.091	5132069.333	4737294.769	4398916.571	4105655.467	3849052	3421379.556	3241306.947	3079241.6	2566034.667	2463393.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228939	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	49374796	24687398	16458265.33	12343699	9874959.2	8229132.667	7053542.286	6171849.5	5486088.444	4937479.6	4488617.818	4114566.333	3798061.231	3526771.143	3291653.067	3085924.75	2743044.222	2598673.474	2468739.8	2057283.167	1974991.84	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228940	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	19866592	9933296	6622197.333	4966648	3973318.4	3311098.667	2838084.571	2483324	2207399.111	1986659.2	1806053.818	1655549.333	1528199.385	1419042.286	1324439.467	1241662	1103699.556	1045610.105	993329.6	827774.6667	794663.68	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228941	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	3452837	1726418.5	1150945.667	863209.25	690567.4	575472.8333	493262.4286	431604.625	383648.5556	345283.7	313894.2727	287736.4167	265602.8462	246631.2143	230189.1333	215802.3125	191824.2778	181728.2632	172641.85	143868.2083	138113.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228942	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	4252957	2126478.5	1417652.333	1063239.25	850591.4	708826.1667	607565.2857	531619.625	472550.7778	425295.7	386632.4545	354413.0833	327150.5385	303782.6429	283530.4667	265809.8125	236275.3889	223839.8421	212647.85	177206.5417	170118.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228943	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	1070712	535356	356904	267678	214142.4	178452	152958.8571	133839	118968	107071.2	97337.45455	89226	82362.46154	76479.42857	71380.8	66919.5	59484	56353.26316	53535.6	44613	42828.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228944	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	2302443	1151221.5	767481	575610.75	460488.6	383740.5	328920.4286	287805.375	255827	230244.3	209313	191870.25	177111	164460.2143	153496.2	143902.6875	127913.5	121181.2105	115122.15	95935.125	92097.72	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228945	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	2380356	1190178	793452	595089	476071.2	396726	340050.8571	297544.5	264484	238035.6	216396	198363	183104.3077	170025.4286	158690.4	148772.25	132242	125281.8947	119017.8	99181.5	95214.24	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228946	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	1076654	538327	358884.6667	269163.5	215330.8	179442.3333	153807.7143	134581.75	119628.2222	107665.4	97877.63636	89721.16667	82819.53846	76903.85714	71776.93333	67290.875	59814.11111	56666	53832.7	44860.58333	43066.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228947	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	878079	439039.5	292693	219519.75	175615.8	146346.5	125439.8571	109759.875	97564.33333	87807.9	79825.36364	73173.25	67544.53846	62719.92857	58538.6	54879.9375	48782.16667	46214.68421	43903.95	36586.625	35123.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228948	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	1013123	506561.5	337707.6667	253280.75	202624.6	168853.8333	144731.8571	126640.375	112569.2222	101312.3	92102.09091	84426.91667	77932.53846	72365.92857	67541.53333	63320.1875	56284.61111	53322.26316	50656.15	42213.45833	40524.92	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228949	CHOYP_PDIA1.1.1|m.5297	NNFEGAITAEAVSK	NNFEGAITAEAVSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228950	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228951	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228952	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228953	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	1470478	735239	490159.3333	367619.5	294095.6	245079.6667	210068.2857	183809.75	163386.4444	147047.8	133679.8182	122539.8333	113113.6923	105034.1429	98031.86667	91904.875	81693.22222	77393.57895	73523.9	61269.91667	58819.12	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228954	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	3094407	1547203.5	1031469	773601.75	618881.4	515734.5	442058.1429	386800.875	343823	309440.7	281309.7273	257867.25	238031.3077	221029.0714	206293.8	193400.4375	171911.5	162863.5263	154720.35	128933.625	123776.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228955	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	2573270	1286635	857756.6667	643317.5	514654	428878.3333	367610	321658.75	285918.8889	257327	233933.6364	214439.1667	197943.8462	183805	171551.3333	160829.375	142959.4444	135435.2632	128663.5	107219.5833	102930.8	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228956	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	1993750	996875	664583.3333	498437.5	398750	332291.6667	284821.4286	249218.75	221527.7778	199375	181250	166145.8333	153365.3846	142410.7143	132916.6667	124609.375	110763.8889	104934.2105	99687.5	83072.91667	79750	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228957	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	934825	467412.5	311608.3333	233706.25	186965	155804.1667	133546.4286	116853.125	103869.4444	93482.5	84984.09091	77902.08333	71909.61538	66773.21429	62321.66667	58426.5625	51934.72222	49201.31579	46741.25	38951.04167	37393	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228958	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	424260	212130	141420	106065	84852	70710	60608.57143	53032.5	47140	42426	38569.09091	35355	32635.38462	30304.28571	28284	26516.25	23570	22329.47368	21213	17677.5	16970.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228959	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	479977	239988.5	159992.3333	119994.25	95995.4	79996.16667	68568.14286	59997.125	53330.77778	47997.7	43634.27273	39998.08333	36921.30769	34284.07143	31998.46667	29998.5625	26665.38889	25261.94737	23998.85	19999.04167	19199.08	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228960	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	716146	358073	238715.3333	179036.5	143229.2	119357.6667	102306.5714	89518.25	79571.77778	71614.6	65104.18182	59678.83333	55088.15385	51153.28571	47743.06667	44759.125	39785.88889	37691.89474	35807.3	29839.41667	28645.84	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228961	CHOYP_PDIA1.1.1|m.5297	LPMVVEFTQESAQK	LPMVVEFTQESAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228962	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	183938224	91969112	61312741.33	45984556	36787644.8	30656370.67	26276889.14	22992278	20437580.44	18393822.4	16721656.73	15328185.33	14149094.15	13138444.57	12262548.27	11496139	10218790.22	9680959.158	9196911.2	7664092.667	7357528.96	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228963	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	107942264	53971132	35980754.67	26985566	21588452.8	17990377.33	15420323.43	13492783	11993584.89	10794226.4	9812933.091	8995188.667	8303251.077	7710161.714	7196150.933	6746391.5	5996792.444	5681171.789	5397113.2	4497594.333	4317690.56	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228964	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	43996804	21998402	14665601.33	10999201	8799360.8	7332800.667	6285257.714	5499600.5	4888533.778	4399680.4	3999709.455	3666400.333	3384369.538	3142628.857	2933120.267	2749800.25	2444266.889	2315621.263	2199840.2	1833200.167	1759872.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228965	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	14211469	7105734.5	4737156.333	3552867.25	2842293.8	2368578.167	2030209.857	1776433.625	1579052.111	1421146.9	1291951.727	1184289.083	1093189.923	1015104.929	947431.2667	888216.8125	789526.0556	747972.0526	710573.45	592144.5417	568458.76	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228966	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	32343054	16171527	10781018	8085763.5	6468610.8	5390509	4620436.286	4042881.75	3593672.667	3234305.4	2940277.636	2695254.5	2487927.231	2310218.143	2156203.6	2021440.875	1796836.333	1702266	1617152.7	1347627.25	1293722.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228967	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	2325630	1162815	775210	581407.5	465126	387605	332232.8571	290703.75	258403.3333	232563	211420.9091	193802.5	178894.6154	166116.4286	155042	145351.875	129201.6667	122401.5789	116281.5	96901.25	93025.2	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228968	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	6267763	3133881.5	2089254.333	1566940.75	1253552.6	1044627.167	895394.7143	783470.375	696418.1111	626776.3	569796.6364	522313.5833	482135.6154	447697.3571	417850.8667	391735.1875	348209.0556	329882.2632	313388.15	261156.7917	250710.52	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228969	CHOYP_PDIA1.1.1|m.5297	LITLGEDMTK	LITLGEDMTK	5772862	2886431	1924287.333	1443215.5	1154572.4	962143.6667	824694.5714	721607.75	641429.1111	577286.2	524805.6364	481071.8333	444066.3077	412347.2857	384857.4667	360803.875	320714.5556	303834.8421	288643.1	240535.9167	230914.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228970	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	64215840	32107920	21405280	16053960	12843168	10702640	9173691.429	8026980	7135093.333	6421584	5837803.636	5351320	4939680	4586845.714	4281056	4013490	3567546.667	3379781.053	3210792	2675660	2568633.6	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228971	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	56934528	28467264	18978176	14233632	11386905.6	9489088	8133504	7116816	6326058.667	5693452.8	5175866.182	4744544	4379579.077	4066752	3795635.2	3558408	3163029.333	2996554.105	2846726.4	2372272	2277381.12	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228972	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	25157756	12578878	8385918.667	6289439	5031551.2	4192959.333	3593965.143	3144719.5	2795306.222	2515775.6	2287068.727	2096479.667	1935212	1796982.571	1677183.733	1572359.75	1397653.111	1324092.421	1257887.8	1048239.833	1006310.24	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228973	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	3371596	1685798	1123865.333	842899	674319.2	561932.6667	481656.5714	421449.5	374621.7778	337159.6	306508.7273	280966.3333	259353.5385	240828.2857	224773.0667	210724.75	187310.8889	177452.4211	168579.8	140483.1667	134863.84	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228974	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	5674260	2837130	1891420	1418565	1134852	945710	810608.5714	709282.5	630473.3333	567426	515841.8182	472855	436481.5385	405304.2857	378284	354641.25	315236.6667	298645.2632	283713	236427.5	226970.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228975	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	2050565	1025282.5	683521.6667	512641.25	410113	341760.8333	292937.8571	256320.625	227840.5556	205056.5	186415	170880.4167	157735.7692	146468.9286	136704.3333	128160.3125	113920.2778	107924.4737	102528.25	85440.20833	82022.6	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228976	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	2064811	1032405.5	688270.3333	516202.75	412962.2	344135.1667	294973	258101.375	229423.4444	206481.1	187710.0909	172067.5833	158831.6154	147486.5	137654.0667	129050.6875	114711.7222	108674.2632	103240.55	86033.79167	82592.44	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228977	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	4771346	2385673	1590448.667	1192836.5	954269.2	795224.3333	681620.8571	596418.25	530149.5556	477134.6	433758.7273	397612.1667	367026.6154	340810.4286	318089.7333	298209.125	265074.7778	251123.4737	238567.3	198806.0833	190853.84	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228978	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	4576624	2288312	1525541.333	1144156	915324.8	762770.6667	653803.4286	572078	508513.7778	457662.4	416056.7273	381385.3333	352048	326901.7143	305108.2667	286039	254256.8889	240874.9474	228831.2	190692.6667	183064.96	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228979	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	1131110	565555	377036.6667	282777.5	226222	188518.3333	161587.1429	141388.75	125678.8889	113111	102828.1818	94259.16667	87008.46154	80793.57143	75407.33333	70694.375	62839.44444	59532.10526	56555.5	47129.58333	45244.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228980	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	616518	308259	205506	154129.5	123303.6	102753	88074	77064.75	68502	61651.8	56047.09091	51376.5	47424.46154	44037	41101.2	38532.375	34251	32448.31579	30825.9	25688.25	24660.72	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228981	CHOYP_PDIA1.1.1|m.5297	YKPDTNDLSTEAVR	YKPDTNDLSTEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228982	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	101495032	50747516	33831677.33	25373758	20299006.4	16915838.67	14499290.29	12686879	11277225.78	10149503.2	9226821.091	8457919.333	7807310.154	7249645.143	6766335.467	6343439.5	5638612.889	5341843.789	5074751.6	4228959.667	4059801.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228983	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	124455392	62227696	41485130.67	31113848	24891078.4	20742565.33	17779341.71	15556924	13828376.89	12445539.2	11314126.55	10371282.67	9573491.692	8889670.857	8297026.133	7778462	6914188.444	6550283.789	6222769.6	5185641.333	4978215.68	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228984	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	93365960	46682980	31121986.67	23341490	18673192	15560993.33	13337994.29	11670745	10373995.56	9336596	8487814.545	7780496.667	7181996.923	6668997.143	6224397.333	5835372.5	5186997.778	4913997.895	4668298	3890248.333	3734638.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228985	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228986	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228987	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228988	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228989	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228990	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	206371	103185.5	68790.33333	51592.75	41274.2	34395.16667	29481.57143	25796.375	22930.11111	20637.1	18761	17197.58333	15874.69231	14740.78571	13758.06667	12898.1875	11465.05556	10861.63158	10318.55	8598.791667	8254.84	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228991	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	17671830	8835915	5890610	4417957.5	3534366	2945305	2524547.143	2208978.75	1963536.667	1767183	1606530	1472652.5	1359371.538	1262273.571	1178122	1104489.375	981768.3333	930096.3158	883591.5	736326.25	706873.2	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228992	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	4871395	2435697.5	1623798.333	1217848.75	974279	811899.1667	695913.5714	608924.375	541266.1111	487139.5	442854.0909	405949.5833	374722.6923	347956.7857	324759.6667	304462.1875	270633.0556	256389.2105	243569.75	202974.7917	194855.8	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228993	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	7108134	3554067	2369378	1777033.5	1421626.8	1184689	1015447.714	888516.75	789792.6667	710813.4	646194	592344.5	546779.5385	507723.8571	473875.6	444258.375	394896.3333	374112.3158	355406.7	296172.25	284325.36	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228994	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	2973710	1486855	991236.6667	743427.5	594742	495618.3333	424815.7143	371713.75	330412.2222	297371	270337.2727	247809.1667	228746.9231	212407.8571	198247.3333	185856.875	165206.1111	156511.0526	148685.5	123904.5833	118948.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228995	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	3155347	1577673.5	1051782.333	788836.75	631069.4	525891.1667	450763.8571	394418.375	350594.1111	315534.7	286849.7273	262945.5833	242719	225381.9286	210356.4667	197209.1875	175297.0556	166070.8947	157767.35	131472.7917	126213.88	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228996	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	4394112	2197056	1464704	1098528	878822.4	732352	627730.2857	549264	488234.6667	439411.2	399464.7273	366176	338008.6154	313865.1429	292940.8	274632	244117.3333	231269.0526	219705.6	183088	175764.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228997	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	2259613	1129806.5	753204.3333	564903.25	451922.6	376602.1667	322801.8571	282451.625	251068.1111	225961.3	205419.3636	188301.0833	173816.3846	161400.9286	150640.8667	141225.8125	125534.0556	118927	112980.65	94150.54167	90384.52	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228998	CHOYP_PDIA1.1.1|m.5297	LKPHLMSEEVPEDWDAKPVK	LKPHLMSEEVPEDWDAKPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
228999	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	12724453	6362226.5	4241484.333	3181113.25	2544890.6	2120742.167	1817779	1590556.625	1413828.111	1272445.3	1156768.455	1060371.083	978804.0769	908889.5	848296.8667	795278.3125	706914.0556	669708.0526	636222.65	530185.5417	508978.12	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229000	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	6840957	3420478.5	2280319	1710239.25	1368191.4	1140159.5	977279.5714	855119.625	760106.3333	684095.7	621905.1818	570079.75	526227.4615	488639.7857	456063.8	427559.8125	380053.1667	360050.3684	342047.85	285039.875	273638.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229001	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	8032192	4016096	2677397.333	2008048	1606438.4	1338698.667	1147456	1004024	892465.7778	803219.2	730199.2727	669349.3333	617860.9231	573728	535479.4667	502012	446232.8889	422746.9474	401609.6	334674.6667	321287.68	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229002	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229003	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229004	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229005	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229006	CHOYP_PDIA1.1.1|m.5297	NFVEVALDEK	NFVEVALDEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229007	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	168803008	84401504	56267669.33	42200752	33760601.6	28133834.67	24114715.43	21100376	18755889.78	16880300.8	15345728	14066917.33	12984846.77	12057357.71	11253533.87	10550188	9377944.889	8884368.842	8440150.4	7033458.667	6752120.32	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229008	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	135290944	67645472	45096981.33	33822736	27058188.8	22548490.67	19327277.71	16911368	15032327.11	13529094.4	12299176.73	11274245.33	10406995.69	9663638.857	9019396.267	8455684	7516163.556	7120576	6764547.2	5637122.667	5411637.76	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229009	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	58928520	29464260	19642840	14732130	11785704	9821420	8418360	7366065	6547613.333	5892852	5357138.182	4910710	4532963.077	4209180	3928568	3683032.5	3273806.667	3101501.053	2946426	2455355	2357140.8	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229010	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	30874124	15437062	10291374.67	7718531	6174824.8	5145687.333	4410589.143	3859265.5	3430458.222	3087412.4	2806738.545	2572843.667	2374932.615	2205294.571	2058274.933	1929632.75	1715229.111	1624953.895	1543706.2	1286421.833	1234964.96	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229011	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	6665315	3332657.5	2221771.667	1666328.75	1333063	1110885.833	952187.8571	833164.375	740590.5556	666531.5	605937.7273	555442.9167	512716.5385	476093.9286	444354.3333	416582.1875	370295.2778	350806.0526	333265.75	277721.4583	266612.6	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229012	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	24811926	12405963	8270642	6202981.5	4962385.2	4135321	3544560.857	3101490.75	2756880.667	2481192.6	2255629.636	2067660.5	1908609.692	1772280.429	1654128.4	1550745.375	1378440.333	1305890.842	1240596.3	1033830.25	992477.04	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229013	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	9516761	4758380.5	3172253.667	2379190.25	1903352.2	1586126.833	1359537.286	1189595.125	1057417.889	951676.1	865160.0909	793063.4167	732058.5385	679768.6429	634450.7333	594797.5625	528708.9444	500882.1579	475838.05	396531.7083	380670.44	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229014	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	5739254	2869627	1913084.667	1434813.5	1147850.8	956542.3333	819893.4286	717406.75	637694.8889	573925.4	521750.3636	478271.1667	441481.0769	409946.7143	382616.9333	358703.375	318847.4444	302066	286962.7	239135.5833	229570.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229015	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	4414465	2207232.5	1471488.333	1103616.25	882893	735744.1667	630637.8571	551808.125	490496.1111	441446.5	401315	367872.0833	339574.2308	315318.9286	294297.6667	275904.0625	245248.0556	232340.2632	220723.25	183936.0417	176578.6	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229016	CHOYP_PDIA1.1.1|m.5297	QLAPIWDELAEK	QLAPIWDELAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229017	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	118123328	59061664	39374442.67	29530832	23624665.6	19687221.33	16874761.14	14765416	13124814.22	11812332.8	10738484.36	9843610.667	9086409.846	8437380.571	7874888.533	7382708	6562407.111	6217017.263	5906166.4	4921805.333	4724933.12	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229018	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229019	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229020	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	3238562	1619281	1079520.667	809640.5	647712.4	539760.3333	462651.7143	404820.25	359840.2222	323856.2	294414.7273	269880.1667	249120.1538	231325.8571	215904.1333	202410.125	179920.1111	170450.6316	161928.1	134940.0833	129542.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229021	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	8198106	4099053	2732702	2049526.5	1639621.2	1366351	1171158	1024763.25	910900.6667	819810.6	745282.3636	683175.5	630623.5385	585579	546540.4	512381.625	455450.3333	431479.2632	409905.3	341587.75	327924.24	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229022	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	9416057	4708028.5	3138685.667	2354014.25	1883211.4	1569342.833	1345151	1177007.125	1046228.556	941605.7	856005.1818	784671.4167	724312.0769	672575.5	627737.1333	588503.5625	523114.2778	495581.9474	470802.85	392335.7083	376642.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229023	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	3354761	1677380.5	1118253.667	838690.25	670952.2	559126.8333	479251.5714	419345.125	372751.2222	335476.1	304978.2727	279563.4167	258058.5385	239625.7857	223650.7333	209672.5625	186375.6111	176566.3684	167738.05	139781.7083	134190.44	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229024	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	4773307	2386653.5	1591102.333	1193326.75	954661.4	795551.1667	681901	596663.375	530367.4444	477330.7	433937	397775.5833	367177.4615	340950.5	318220.4667	298331.6875	265183.7222	251226.6842	238665.35	198887.7917	190932.28	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229025	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	5069844	2534922	1689948	1267461	1013968.8	844974	724263.4286	633730.5	563316	506984.4	460894.9091	422487	389988	362131.7143	337989.6	316865.25	281658	266833.8947	253492.2	211243.5	202793.76	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229026	CHOYP_PDIA1.1.1|m.5297	MDSTANEVEQVK	MDSTANEVEQVK	2172661	1086330.5	724220.3333	543165.25	434532.2	362110.1667	310380.1429	271582.625	241406.7778	217266.1	197514.6364	181055.0833	167127.7692	155190.0714	144844.0667	135791.3125	120703.3889	114350.5789	108633.05	90527.54167	86906.44	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229027	CHOYP_PDIA1.1.1|m.5297	VQSFPTLK	VQSFPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229028	CHOYP_PDIA1.1.1|m.5297	VQSFPTLK	VQSFPTLK	96241448	48120724	32080482.67	24060362	19248289.6	16040241.33	13748778.29	12030181	10693494.22	9624144.8	8749222.545	8020120.667	7403188.308	6874389.143	6416096.533	6015090.5	5346747.111	5065339.368	4812072.4	4010060.333	3849657.92	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229029	CHOYP_PDIA1.1.1|m.5297	VQSFPTLK	VQSFPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229030	CHOYP_PDIA1.1.1|m.5297	VQSFPTLK	VQSFPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229031	CHOYP_PDIA1.1.1|m.5297	VQSFPTLK	VQSFPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229032	CHOYP_PDIA1.1.1|m.5297	VQSFPTLK	VQSFPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229033	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	81150104	40575052	27050034.67	20287526	16230020.8	13525017.33	11592872	10143763	9016678.222	8115010.4	7377282.182	6762508.667	6242315.692	5796436	5410006.933	5071881.5	4508339.111	4271058.105	4057505.2	3381254.333	3246004.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229034	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	54850736	27425368	18283578.67	13712684	10970147.2	9141789.333	7835819.429	6856342	6094526.222	5485073.6	4986430.545	4570894.667	4219287.385	3917909.714	3656715.733	3428171	3047263.111	2886880.842	2742536.8	2285447.333	2194029.44	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229035	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	16219187	8109593.5	5406395.667	4054796.75	3243837.4	2703197.833	2317026.714	2027398.375	1802131.889	1621918.7	1474471.545	1351598.917	1247629.769	1158513.357	1081279.133	1013699.188	901065.9444	853641.4211	810959.35	675799.4583	648767.48	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229036	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	5845266	2922633	1948422	1461316.5	1169053.2	974211	835038	730658.25	649474	584526.6	531387.8182	487105.5	449635.8462	417519	389684.4	365329.125	324737	307645.5789	292263.3	243552.75	233810.64	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229037	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	12508848	6254424	4169616	3127212	2501769.6	2084808	1786978.286	1563606	1389872	1250884.8	1137168	1042404	962219.0769	893489.1429	833923.2	781803	694936	658360.4211	625442.4	521202	500353.92	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229038	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	23499592	11749796	7833197.333	5874898	4699918.4	3916598.667	3357084.571	2937449	2611065.778	2349959.2	2136326.545	1958299.333	1807660.923	1678542.286	1566639.467	1468724.5	1305532.889	1236820.632	1174979.6	979149.6667	939983.68	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229039	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	11668104	5834052	3889368	2917026	2333620.8	1944684	1666872	1458513	1296456	1166810.4	1060736.727	972342	897546.4615	833436	777873.6	729256.5	648228	614110.7368	583405.2	486171	466724.16	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229040	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	10071785	5035892.5	3357261.667	2517946.25	2014357	1678630.833	1438826.429	1258973.125	1119087.222	1007178.5	915616.8182	839315.4167	774752.6923	719413.2143	671452.3333	629486.5625	559543.6111	530093.9474	503589.25	419657.7083	402871.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229041	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	2313985	1156992.5	771328.3333	578496.25	462797	385664.1667	330569.2857	289248.125	257109.4444	231398.5	210362.2727	192832.0833	177998.8462	165284.6429	154265.6667	144624.0625	128554.7222	121788.6842	115699.25	96416.04167	92559.4	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229042	CHOYP_PDIA1.1.1|m.5297	GSQQVVDYNGER	GSQQVVDYNGER	1061868	530934	353956	265467	212373.6	176978	151695.4286	132733.5	117985.3333	106186.8	96533.45455	88489	81682.15385	75847.71429	70791.2	66366.75	58992.66667	55887.78947	53093.4	44244.5	42474.72	P04785	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta)	P4hb Pdia1	cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0016222; GO:0018401; GO:0019899; GO:0034663; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:1902175
229043	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229044	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	3457340	1728670	1152446.667	864335	691468	576223.3333	493905.7143	432167.5	384148.8889	345734	314303.6364	288111.6667	265949.2308	246952.8571	230489.3333	216083.75	192074.4444	181965.2632	172867	144055.8333	138293.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229045	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229046	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	5498060	2749030	1832686.667	1374515	1099612	916343.3333	785437.1429	687257.5	610895.5556	549806	499823.6364	458171.6667	422927.6923	392718.5714	366537.3333	343628.75	305447.7778	289371.5789	274903	229085.8333	219922.4	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229047	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	2222803	1111401.5	740934.3333	555700.75	444560.6	370467.1667	317543.2857	277850.375	246978.1111	222280.3	202073	185233.5833	170984.8462	158771.6429	148186.8667	138925.1875	123489.0556	116989.6316	111140.15	92616.79167	88912.12	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229048	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229049	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	2928381	1464190.5	976127	732095.25	585676.2	488063.5	418340.1429	366047.625	325375.6667	292838.1	266216.4545	244031.75	225260.0769	209170.0714	195225.4	183023.8125	162687.8333	154125.3158	146419.05	122015.875	117135.24	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229050	CHOYP_PDIA3.1.1|m.60223	DNDPPVPLAK	DNDPPVPLAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229051	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	35443500	17721750	11814500	8860875	7088700	5907250	5063357.143	4430437.5	3938166.667	3544350	3222136.364	2953625	2726423.077	2531678.571	2362900	2215218.75	1969083.333	1865447.368	1772175	1476812.5	1417740	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229052	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	21905912	10952956	7301970.667	5476478	4381182.4	3650985.333	3129416	2738239	2433990.222	2190591.2	1991446.545	1825492.667	1685070.154	1564708	1460394.133	1369119.5	1216995.111	1152942.737	1095295.6	912746.3333	876236.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229053	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	5579508	2789754	1859836	1394877	1115901.6	929918	797072.5714	697438.5	619945.3333	557950.8	507228	464959	429192.9231	398536.2857	371967.2	348719.25	309972.6667	293658.3158	278975.4	232479.5	223180.32	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229054	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	5065812	2532906	1688604	1266453	1013162.4	844302	723687.4286	633226.5	562868	506581.2	460528.3636	422151	389677.8462	361843.7143	337720.8	316613.25	281434	266621.6842	253290.6	211075.5	202632.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229055	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	1468658	734329	489552.6667	367164.5	293731.6	244776.3333	209808.2857	183582.25	163184.2222	146865.8	133514.3636	122388.1667	112973.6923	104904.1429	97910.53333	91791.125	81592.11111	77297.78947	73432.9	61194.08333	58746.32	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229056	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	351742	175871	117247.3333	87935.5	70348.4	58623.66667	50248.85714	43967.75	39082.44444	35174.2	31976.54545	29311.83333	27057.07692	25124.42857	23449.46667	21983.875	19541.22222	18512.73684	17587.1	14655.91667	14069.68	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229057	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	2831933	1415966.5	943977.6667	707983.25	566386.6	471988.8333	404561.8571	353991.625	314659.2222	283193.3	257448.4545	235994.4167	217841	202280.9286	188795.5333	176995.8125	157329.6111	149049.1053	141596.65	117997.2083	113277.32	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229058	CHOYP_PDIA3.1.1|m.60223	FGVSGYPTLK	FGVSGYPTLK	50948	25474	16982.66667	12737	10189.6	8491.333333	7278.285714	6368.5	5660.888889	5094.8	4631.636364	4245.666667	3919.076923	3639.142857	3396.533333	3184.25	2830.444444	2681.473684	2547.4	2122.833333	2037.92	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229059	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	93414896	46707448	31138298.67	23353724	18682979.2	15569149.33	13344985.14	11676862	10379432.89	9341489.6	8492263.273	7784574.667	7185761.231	6672492.571	6227659.733	5838431	5189716.444	4916573.474	4670744.8	3892287.333	3736595.84	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229060	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	84890720	42445360	28296906.67	21222680	16978144	14148453.33	12127245.71	10611340	9432302.222	8489072	7717338.182	7074226.667	6530055.385	6063622.857	5659381.333	5305670	4716151.111	4467932.632	4244536	3537113.333	3395628.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229061	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	40839476	20419738	13613158.67	10209869	8167895.2	6806579.333	5834210.857	5104934.5	4537719.556	4083947.6	3712679.636	3403289.667	3141498.154	2917105.429	2722631.733	2552467.25	2268859.778	2149446.105	2041973.8	1701644.833	1633579.04	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229062	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	13048420	6524210	4349473.333	3262105	2609684	2174736.667	1864060	1631052.5	1449824.444	1304842	1186220	1087368.333	1003724.615	932030	869894.6667	815526.25	724912.2222	686758.9474	652421	543684.1667	521936.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229063	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	29419364	14709682	9806454.667	7354841	5883872.8	4903227.333	4202766.286	3677420.5	3268818.222	2941936.4	2674487.636	2451613.667	2263028	2101383.143	1961290.933	1838710.25	1634409.111	1548387.579	1470968.2	1225806.833	1176774.56	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229064	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	11322973	5661486.5	3774324.333	2830743.25	2264594.6	1887162.167	1617567.571	1415371.625	1258108.111	1132297.3	1029361.182	943581.0833	870997.9231	808783.7857	754864.8667	707685.8125	629054.0556	595945.9474	566148.65	471790.5417	452918.92	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229065	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	9339469	4669734.5	3113156.333	2334867.25	1867893.8	1556578.167	1334209.857	1167433.625	1037718.778	933946.9	849042.6364	778289.0833	718420.6923	667104.9286	622631.2667	583716.8125	518859.3889	491551	466973.45	389144.5417	373578.76	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229066	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	8937988	4468994	2979329.333	2234497	1787597.6	1489664.667	1276855.429	1117248.5	993109.7778	893798.8	812544.3636	744832.3333	687537.5385	638427.7143	595865.8667	558624.25	496554.8889	470420.4211	446899.4	372416.1667	357519.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229067	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	5680003	2840001.5	1893334.333	1420000.75	1136000.6	946667.1667	811429	710000.375	631111.4444	568000.3	516363.9091	473333.5833	436923.3077	405714.5	378666.8667	355000.1875	315555.7222	298947.5263	284000.15	236666.7917	227200.12	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229068	CHOYP_PDIA3.1.1|m.60223	AGEFSEEYGGPR	AGEFSEEYGGPR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229069	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	56000628	28000314	18666876	14000157	11200125.6	9333438	8000089.714	7000078.5	6222292	5600062.8	5090966.182	4666719	4307740.615	4000044.857	3733375.2	3500039.25	3111146	2947401.474	2800031.4	2333359.5	2240025.12	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229070	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	31833606	15916803	10611202	7958401.5	6366721.2	5305601	4547658	3979200.75	3537067.333	3183360.6	2893964.182	2652800.5	2448738.923	2273829	2122240.4	1989600.375	1768533.667	1675452.947	1591680.3	1326400.25	1273344.24	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229071	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	15051579	7525789.5	5017193	3762894.75	3010315.8	2508596.5	2150225.571	1881447.375	1672397.667	1505157.9	1368325.364	1254298.25	1157813.769	1075112.786	1003438.6	940723.6875	836198.8333	792188.3684	752578.95	627149.125	602063.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229072	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	2311103	1155551.5	770367.6667	577775.75	462220.6	385183.8333	330157.5714	288887.875	256789.2222	231110.3	210100.2727	192591.9167	177777.1538	165078.7857	154073.5333	144443.9375	128394.6111	121637	115555.15	96295.95833	92444.12	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229073	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	2232212	1116106	744070.6667	558053	446442.4	372035.3333	318887.4286	279026.5	248023.5556	223221.2	202928.3636	186017.6667	171708.6154	159443.7143	148814.1333	139513.25	124011.7778	117484.8421	111610.6	93008.83333	89288.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229074	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	6173384	3086692	2057794.667	1543346	1234676.8	1028897.333	881912	771673	685931.5556	617338.4	561216.7273	514448.6667	474875.6923	440956	411558.9333	385836.5	342965.7778	324914.9474	308669.2	257224.3333	246935.36	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229075	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	2027375	1013687.5	675791.6667	506843.75	405475	337895.8333	289625	253421.875	225263.8889	202737.5	184306.8182	168947.9167	155951.9231	144812.5	135158.3333	126710.9375	112631.9444	106703.9474	101368.75	84473.95833	81095	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229076	CHOYP_PDIA3.1.1|m.60223	ELNNVADAEK	ELNNVADAEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229077	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	123359688	61679844	41119896	30839922	24671937.6	20559948	17622812.57	15419961	13706632	12335968.8	11214517.09	10279974	9489206.769	8811406.286	8223979.2	7709980.5	6853316	6492615.158	6167984.4	5139987	4934387.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229078	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	57900404	28950202	19300134.67	14475101	11580080.8	9650067.333	8271486.286	7237550.5	6433378.222	5790040.4	5263673.091	4825033.667	4453877.231	4135743.143	3860026.933	3618775.25	3216689.111	3047389.684	2895020.2	2412516.833	2316016.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229079	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	31493098	15746549	10497699.33	7873274.5	6298619.6	5248849.667	4499014	3936637.25	3499233.111	3149309.8	2863008.909	2624424.833	2422546	2249507	2099539.867	1968318.625	1749616.556	1657531.474	1574654.9	1312212.417	1259723.92	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229080	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	7169720	3584860	2389906.667	1792430	1433944	1194953.333	1024245.714	896215	796635.5556	716972	651792.7273	597476.6667	551516.9231	512122.8571	477981.3333	448107.5	398317.7778	377353.6842	358486	298738.3333	286788.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229081	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	8196446	4098223	2732148.667	2049111.5	1639289.2	1366074.333	1170920.857	1024555.75	910716.2222	819644.6	745131.4545	683037.1667	630495.8462	585460.4286	546429.7333	512277.875	455358.1111	431391.8947	409822.3	341518.5833	327857.84	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229082	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	8864853	4432426.5	2954951	2216213.25	1772970.6	1477475.5	1266407.571	1108106.625	984983.6667	886485.3	805895.7273	738737.75	681911.7692	633203.7857	590990.2	554053.3125	492491.8333	466571.2105	443242.65	369368.875	354594.12	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229083	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	2417140	1208570	805713.3333	604285	483428	402856.6667	345305.7143	302142.5	268571.1111	241714	219740	201428.3333	185933.8462	172652.8571	161142.6667	151071.25	134285.5556	127217.8947	120857	100714.1667	96685.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229084	CHOYP_PDIA3.1.1|m.60223	VADAMSTDLK	VADAMSTDLK	2535142	1267571	845047.3333	633785.5	507028.4	422523.6667	362163.1429	316892.75	281682.4444	253514.2	230467.4545	211261.8333	195010.9231	181081.5714	169009.4667	158446.375	140841.2222	133428.5263	126757.1	105630.9167	101405.68	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229085	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229086	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	15714947	7857473.5	5238315.667	3928736.75	3142989.4	2619157.833	2244992.429	1964368.375	1746105.222	1571494.7	1428631.545	1309578.917	1208842.077	1122496.214	1047663.133	982184.1875	873052.6111	827102.4737	785747.35	654789.4583	628597.88	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229087	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229088	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	5107000	2553500	1702333.333	1276750	1021400	851166.6667	729571.4286	638375	567444.4444	510700	464272.7273	425583.3333	392846.1538	364785.7143	340466.6667	319187.5	283722.2222	268789.4737	255350	212791.6667	204280	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229089	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	3368368	1684184	1122789.333	842092	673673.6	561394.6667	481195.4286	421046	374263.1111	336836.8	306215.2727	280697.3333	259105.2308	240597.7143	224557.8667	210523	187131.5556	177282.5263	168418.4	140348.6667	134734.72	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229090	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229091	CHOYP_PDIA3.1.1|m.60223	NDIVLYQPK	NDIVLYQPK	402530	201265	134176.6667	100632.5	80506	67088.33333	57504.28571	50316.25	44725.55556	40253	36593.63636	33544.16667	30963.84615	28752.14286	26835.33333	25158.125	22362.77778	21185.78947	20126.5	16772.08333	16101.2	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229092	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	36286988	18143494	12095662.67	9071747	7257397.6	6047831.333	5183855.429	4535873.5	4031887.556	3628698.8	3298817.091	3023915.667	2791306.769	2591927.714	2419132.533	2267936.75	2015943.778	1909841.474	1814349.4	1511957.833	1451479.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229093	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	20564836	10282418	6854945.333	5141209	4112967.2	3427472.667	2937833.714	2570604.5	2284981.778	2056483.6	1869530.545	1713736.333	1581910.462	1468916.857	1370989.067	1285302.25	1142490.889	1082359.789	1028241.8	856868.1667	822593.44	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229094	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	7089716	3544858	2363238.667	1772429	1417943.2	1181619.333	1012816.571	886214.5	787746.2222	708971.6	644519.6364	590809.6667	545362.7692	506408.2857	472647.7333	443107.25	393873.1111	373142.9474	354485.8	295404.8333	283588.64	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229095	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229096	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	1431075	715537.5	477025	357768.75	286215	238512.5	204439.2857	178884.375	159008.3333	143107.5	130097.7273	119256.25	110082.6923	102219.6429	95405	89442.1875	79504.16667	75319.73684	71553.75	59628.125	57243	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229097	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	837956	418978	279318.6667	209489	167591.2	139659.3333	119708	104744.5	93106.22222	83795.6	76177.81818	69829.66667	64458.15385	59854	55863.73333	52372.25	46553.11111	44102.94737	41897.8	34914.83333	33518.24	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229098	CHOYP_PDIA3.1.1|m.60223	YTDDATVYK	YTDDATVYK	930654	465327	310218	232663.5	186130.8	155109	132950.5714	116331.75	103406	93065.4	84604.90909	77554.5	71588.76923	66475.28571	62043.6	58165.875	51703	48981.78947	46532.7	38777.25	37226.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229099	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	5300838	2650419	1766946	1325209.5	1060167.6	883473	757262.5714	662604.75	588982	530083.8	481894.3636	441736.5	407756.7692	378631.2857	353389.2	331302.375	294491	278991.4737	265041.9	220868.25	212033.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229100	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	7608288	3804144	2536096	1902072	1521657.6	1268048	1086898.286	951036	845365.3333	760828.8	691662.5455	634024	585252.9231	543449.1429	507219.2	475518	422682.6667	400436.2105	380414.4	317012	304331.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229101	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229102	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229103	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229104	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229105	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229106	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229107	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229108	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229109	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229110	CHOYP_PDIA3.1.1|m.60223	KPLVVAFYDVDYVK	KPLVVAFYDVDYVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229111	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	71821608	35910804	23940536	17955402	14364321.6	11970268	10260229.71	8977701	7980178.667	7182160.8	6529237.091	5985134	5524739.077	5130114.857	4788107.2	4488850.5	3990089.333	3780084.632	3591080.4	2992567	2872864.32	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229112	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	39395212	19697606	13131737.33	9848803	7879042.4	6565868.667	5627887.429	4924401.5	4377245.778	3939521.2	3581382.909	3282934.333	3030400.923	2813943.714	2626347.467	2462200.75	2188622.889	2073432.211	1969760.6	1641467.167	1575808.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229113	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	13745369	6872684.5	4581789.667	3436342.25	2749073.8	2290894.833	1963624.143	1718171.125	1527263.222	1374536.9	1249579	1145447.417	1057336.077	981812.0714	916357.9333	859085.5625	763631.6111	723440.4737	687268.45	572723.7083	549814.76	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229114	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	8318433	4159216.5	2772811	2079608.25	1663686.6	1386405.5	1188347.571	1039804.125	924270.3333	831843.3	756221.1818	693202.75	639879.4615	594173.7857	554562.2	519902.0625	462135.1667	437812.2632	415921.65	346601.375	332737.32	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229115	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	5710473	2855236.5	1903491	1427618.25	1142094.6	951745.5	815781.8571	713809.125	634497	571047.3	519133.9091	475872.75	439267.1538	407890.9286	380698.2	356904.5625	317248.5	300551.2105	285523.65	237936.375	228418.92	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229116	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	6849187	3424593.5	2283062.333	1712296.75	1369837.4	1141531.167	978455.2857	856148.375	761020.7778	684918.7	622653.3636	570765.5833	526860.5385	489227.6429	456612.4667	428074.1875	380510.3889	360483.5263	342459.35	285382.7917	273967.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229117	CHOYP_PDIA3.1.1|m.60223	IFFAVSNSK	IFFAVSNSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229118	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	60932900	30466450	20310966.67	15233225	12186580	10155483.33	8704700	7616612.5	6770322.222	6093290	5539354.545	5077741.667	4687146.154	4352350	4062193.333	3808306.25	3385161.111	3206994.737	3046645	2538870.833	2437316	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229119	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	85029680	42514840	28343226.67	21257420	17005936	14171613.33	12147097.14	10628710	9447742.222	8502968	7729970.909	7085806.667	6540744.615	6073548.571	5668645.333	5314355	4723871.111	4475246.316	4251484	3542903.333	3401187.2	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229120	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	62178360	31089180	20726120	15544590	12435672	10363060	8882622.857	7772295	6908706.667	6217836	5652578.182	5181530	4782950.769	4441311.429	4145224	3886147.5	3454353.333	3272545.263	3108918	2590765	2487134.4	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229121	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229122	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229123	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229124	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	510038	255019	170012.6667	127509.5	102007.6	85006.33333	72862.57143	63754.75	56670.88889	51003.8	46367.09091	42503.16667	39233.69231	36431.28571	34002.53333	31877.375	28335.44444	26844.10526	25501.9	21251.58333	20401.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229125	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	3484462	1742231	1161487.333	871115.5	696892.4	580743.6667	497780.2857	435557.75	387162.4444	348446.2	316769.2727	290371.8333	268035.5385	248890.1429	232297.4667	217778.875	193581.2222	183392.7368	174223.1	145185.9167	139378.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229126	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	957434	478717	319144.6667	239358.5	191486.8	159572.3333	136776.2857	119679.25	106381.5556	95743.4	87039.45455	79786.16667	73648.76923	68388.14286	63828.93333	59839.625	53190.77778	50391.26316	47871.7	39893.08333	38297.36	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229127	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	9809519	4904759.5	3269839.667	2452379.75	1961903.8	1634919.833	1401359.857	1226189.875	1089946.556	980951.9	891774.4545	817459.9167	754578.3846	700679.9286	653967.9333	613094.9375	544973.2778	516290.4737	490475.95	408729.9583	392380.76	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229128	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	1458364	729182	486121.3333	364591	291672.8	243060.6667	208337.7143	182295.5	162040.4444	145836.4	132578.5455	121530.3333	112181.8462	104168.8571	97224.26667	91147.75	81020.22222	76756	72918.2	60765.16667	58334.56	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229129	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	5191979	2595989.5	1730659.667	1297994.75	1038395.8	865329.8333	741711.2857	648997.375	576886.5556	519197.9	471998.0909	432664.9167	399383	370855.6429	346131.9333	324498.6875	288443.2778	273262.0526	259598.95	216332.4583	207679.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229130	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	11747531	5873765.5	3915843.667	2936882.75	2349506.2	1957921.833	1678218.714	1468441.375	1305281.222	1174753.1	1067957.364	978960.9167	903656.2308	839109.3571	783168.7333	734220.6875	652640.6111	618291.1053	587376.55	489480.4583	469901.24	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229131	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	4016809	2008404.5	1338936.333	1004202.25	803361.8	669468.1667	573829.8571	502101.125	446312.1111	401680.9	365164.4545	334734.0833	308985.3077	286914.9286	267787.2667	251050.5625	223156.0556	211411	200840.45	167367.0417	160672.36	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229132	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229133	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	8252240	4126120	2750746.667	2063060	1650448	1375373.333	1178891.429	1031530	916915.5556	825224	750203.6364	687686.6667	634787.6923	589445.7143	550149.3333	515765	458457.7778	434328.4211	412612	343843.3333	330089.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229134	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	7423021	3711510.5	2474340.333	1855755.25	1484604.2	1237170.167	1060431.571	927877.625	824780.1111	742302.1	674820.0909	618585.0833	571001.6154	530215.7857	494868.0667	463938.8125	412390.0556	390685.3158	371151.05	309292.5417	296920.84	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229135	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229136	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	1148926	574463	382975.3333	287231.5	229785.2	191487.6667	164132.2857	143615.75	127658.4444	114892.6	104447.8182	95743.83333	88378.92308	82066.14286	76595.06667	71807.875	63829.22222	60469.78947	57446.3	47871.91667	45957.04	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229137	CHOYP_PDIA3.1.1|m.60223	DFSYELGEFGLGDVSGDKPVVAAR	DFSYELGEFGLGDVSGDKPVVAAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229138	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	38338388	19169194	12779462.67	9584597	7667677.6	6389731.333	5476912.571	4792298.5	4259820.889	3833838.8	3485308	3194865.667	2949106.769	2738456.286	2555892.533	2396149.25	2129910.444	2017809.895	1916919.4	1597432.833	1533535.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229139	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	34160056	17080028	11386685.33	8540014	6832011.2	5693342.667	4880008	4270007	3795561.778	3416005.6	3105459.636	2846671.333	2627696.615	2440004	2277337.067	2135003.5	1897780.889	1797897.684	1708002.8	1423335.667	1366402.24	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229140	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	18615502	9307751	6205167.333	4653875.5	3723100.4	3102583.667	2659357.429	2326937.75	2068389.111	1861550.2	1692318.364	1551291.833	1431961.692	1329678.714	1241033.467	1163468.875	1034194.556	979763.2632	930775.1	775645.9167	744620.08	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229141	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	3797625	1898812.5	1265875	949406.25	759525	632937.5	542517.8571	474703.125	421958.3333	379762.5	345238.6364	316468.75	292125	271258.9286	253175	237351.5625	210979.1667	199875	189881.25	158234.375	151905	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229142	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	2443063	1221531.5	814354.3333	610765.75	488612.6	407177.1667	349009	305382.875	271451.4444	244306.3	222096.6364	203588.5833	187927.9231	174504.5	162870.8667	152691.4375	135725.7222	128582.2632	122153.15	101794.2917	97722.52	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229143	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	1956097	978048.5	652032.3333	489024.25	391219.4	326016.1667	279442.4286	244512.125	217344.1111	195609.7	177827	163008.0833	150469	139721.2143	130406.4667	122256.0625	108672.0556	102952.4737	97804.85	81504.04167	78243.88	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229144	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	3413050	1706525	1137683.333	853262.5	682610	568841.6667	487578.5714	426631.25	379227.7778	341305	310277.2727	284420.8333	262542.3077	243789.2857	227536.6667	213315.625	189613.8889	179634.2105	170652.5	142210.4167	136522	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229145	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	4427212	2213606	1475737.333	1106803	885442.4	737868.6667	632458.8571	553401.5	491912.4444	442721.2	402473.8182	368934.3333	340554.7692	316229.4286	295147.4667	276700.75	245956.2222	233011.1579	221360.6	184467.1667	177088.48	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229146	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	1649140	824570	549713.3333	412285	329828	274856.6667	235591.4286	206142.5	183237.7778	164914	149921.8182	137428.3333	126856.9231	117795.7143	109942.6667	103071.25	91618.88889	86796.84211	82457	68714.16667	65965.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229147	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	2100986	1050493	700328.6667	525246.5	420197.2	350164.3333	300140.8571	262623.25	233442.8889	210098.6	190998.7273	175082.1667	161614.3077	150070.4286	140065.7333	131311.625	116721.4444	110578.2105	105049.3	87541.08333	84039.44	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229148	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	2573971	1286985.5	857990.3333	643492.75	514794.2	428995.1667	367710.1429	321746.375	285996.7778	257397.1	233997.3636	214497.5833	197997.7692	183855.0714	171598.0667	160873.1875	142998.3889	135472.1579	128698.55	107248.7917	102958.84	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229149	CHOYP_PDIA3.1.1|m.60223	YVMSDEFSMDNLEK	YVMSDEFSMDNLEK	727027	363513.5	242342.3333	181756.75	145405.4	121171.1667	103861	90878.375	80780.77778	72702.7	66093.36364	60585.58333	55925.15385	51930.5	48468.46667	45439.1875	40390.38889	38264.57895	36351.35	30292.79167	29081.08	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229150	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229151	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229152	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229153	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	497860	248930	165953.3333	124465	99572	82976.66667	71122.85714	62232.5	55317.77778	49786	45260	41488.33333	38296.92308	35561.42857	33190.66667	31116.25	27658.88889	26203.15789	24893	20744.16667	19914.4	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229154	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	11422429	5711214.5	3807476.333	2855607.25	2284485.8	1903738.167	1631775.571	1427803.625	1269158.778	1142242.9	1038402.636	951869.0833	878648.3846	815887.7857	761495.2667	713901.8125	634579.3889	601180.4737	571121.45	475934.5417	456897.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229155	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229156	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	1005461	502730.5	335153.6667	251365.25	201092.2	167576.8333	143637.2857	125682.625	111717.8889	100546.1	91405.54545	83788.41667	77343.15385	71818.64286	67030.73333	62841.3125	55858.94444	52919	50273.05	41894.20833	40218.44	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229157	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	134217	67108.5	44739	33554.25	26843.4	22369.5	19173.85714	16777.125	14913	13421.7	12201.54545	11184.75	10324.38462	9586.928571	8947.8	8388.5625	7456.5	7064.052632	6710.85	5592.375	5368.68	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229158	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229159	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	1519845	759922.5	506615	379961.25	303969	253307.5	217120.7143	189980.625	168871.6667	151984.5	138167.7273	126653.75	116911.1538	108560.3571	101323	94990.3125	84435.83333	79991.84211	75992.25	63326.875	60793.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229160	CHOYP_PDIA3.1.1|m.60223	SEPVPDNTDAPVK	SEPVPDNTDAPVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229161	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	1285793	642896.5	428597.6667	321448.25	257158.6	214298.8333	183684.7143	160724.125	142865.8889	128579.3	116890.2727	107149.4167	98907.15385	91842.35714	85719.53333	80362.0625	71432.94444	67673.31579	64289.65	53574.70833	51431.72	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229162	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229163	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229164	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	244448	122224	81482.66667	61112	48889.6	40741.33333	34921.14286	30556	27160.88889	24444.8	22222.54545	20370.66667	18803.69231	17460.57143	16296.53333	15278	13580.44444	12865.68421	12222.4	10185.33333	9777.92	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229165	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229166	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	338769	169384.5	112923	84692.25	67753.8	56461.5	48395.57143	42346.125	37641	33876.9	30797.18182	28230.75	26059.15385	24197.78571	22584.6	21173.0625	18820.5	17829.94737	16938.45	14115.375	13550.76	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229167	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229168	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229169	CHOYP_PDIA3.1.1|m.60223	NFDEIVNDSER	NFDEIVNDSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229170	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	98152944	49076472	32717648	24538236	19630588.8	16358824	14021849.14	12269118	10905882.67	9815294.4	8922994.909	8179412	7550226.462	7010924.571	6543529.6	6134559	5452941.333	5165944.421	4907647.2	4089706	3926117.76	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229171	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	49832024	24916012	16610674.67	12458006	9966404.8	8305337.333	7118860.571	6229003	5536891.556	4983202.4	4530184	4152668.667	3833232.615	3559430.286	3322134.933	3114501.5	2768445.778	2622738.105	2491601.2	2076334.333	1993280.96	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229172	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	14648317	7324158.5	4882772.333	3662079.25	2929663.4	2441386.167	2092616.714	1831039.625	1627590.778	1464831.7	1331665.182	1220693.083	1126793.615	1046308.357	976554.4667	915519.8125	813795.3889	770964.0526	732415.85	610346.5417	585932.68	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229173	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	6782386	3391193	2260795.333	1695596.5	1356477.2	1130397.667	968912.2857	847798.25	753598.4444	678238.6	616580.5455	565198.8333	521722	484456.1429	452159.0667	423899.125	376799.2222	356967.6842	339119.3	282599.4167	271295.44	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229174	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	5458470	2729235	1819490	1364617.5	1091694	909745	779781.4286	682308.75	606496.6667	545847	496224.5455	454872.5	419882.3077	389890.7143	363898	341154.375	303248.3333	287287.8947	272923.5	227436.25	218338.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229175	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	3423120	1711560	1141040	855780	684624	570520	489017.1429	427890	380346.6667	342312	311192.7273	285260	263316.9231	244508.5714	228208	213945	190173.3333	180164.2105	171156	142630	136924.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229176	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	559779	279889.5	186593	139944.75	111955.8	93296.5	79968.42857	69972.375	62197.66667	55977.9	50889	46648.25	43059.92308	39984.21429	37318.6	34986.1875	31098.83333	29462.05263	27988.95	23324.125	22391.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229177	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	5261922	2630961	1753974	1315480.5	1052384.4	876987	751703.1429	657740.25	584658	526192.2	478356.5455	438493.5	404763.2308	375851.5714	350794.8	328870.125	292329	276943.2632	263096.1	219246.75	210476.88	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229178	CHOYP_PDIA3.1.1|m.60223	LAEESGITIAK	LAEESGITIAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229179	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	65351224	32675612	21783741.33	16337806	13070244.8	10891870.67	9335889.143	8168903	7261247.111	6535122.4	5941020.364	5445935.333	5027017.231	4667944.571	4356748.267	4084451.5	3630623.556	3439538.105	3267561.2	2722967.667	2614048.96	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229180	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	87934176	43967088	29311392	21983544	17586835.2	14655696	12562025.14	10991772	9770464	8793417.6	7994016	7327848	6764167.385	6281012.571	5862278.4	5495886	4885232	4628114.526	4396708.8	3663924	3517367.04	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229181	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	70658264	35329132	23552754.67	17664566	14131652.8	11776377.33	10094037.71	8832283	7850918.222	7065826.4	6423478.545	5888188.667	5435251.077	5047018.857	4710550.933	4416141.5	3925459.111	3718856	3532913.2	2944094.333	2826330.56	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229182	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229183	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229184	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	2430072	1215036	810024	607518	486014.4	405012	347153.1429	303759	270008	243007.2	220915.6364	202506	186928.6154	173576.5714	162004.8	151879.5	135004	127898.5263	121503.6	101253	97202.88	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229185	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229186	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	311244	155622	103748	77811	62248.8	51874	44463.42857	38905.5	34582.66667	31124.4	28294.90909	25937	23941.84615	22231.71429	20749.6	19452.75	17291.33333	16381.26316	15562.2	12968.5	12449.76	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229187	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	600465	300232.5	200155	150116.25	120093	100077.5	85780.71429	75058.125	66718.33333	60046.5	54587.72727	50038.75	46189.61538	42890.35714	40031	37529.0625	33359.16667	31603.42105	30023.25	25019.375	24018.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229188	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	2366146	1183073	788715.3333	591536.5	473229.2	394357.6667	338020.8571	295768.25	262905.1111	236614.6	215104.1818	197178.8333	182011.2308	169010.4286	157743.0667	147884.125	131452.5556	124534	118307.3	98589.41667	94645.84	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229189	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	751440	375720	250480	187860	150288	125240	107348.5714	93930	83493.33333	75144	68312.72727	62620	57803.07692	53674.28571	50096	46965	41746.66667	39549.47368	37572	31310	30057.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229190	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	630573	315286.5	210191	157643.25	126114.6	105095.5	90081.85714	78821.625	70063.66667	63057.3	57324.81818	52547.75	48505.61538	45040.92857	42038.2	39410.8125	35031.83333	33188.05263	31528.65	26273.875	25222.92	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229191	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	5932974	2966487	1977658	1483243.5	1186594.8	988829	847567.7143	741621.75	659219.3333	593297.4	539361.2727	494414.5	456382.6154	423783.8571	395531.6	370810.875	329609.6667	312261.7895	296648.7	247207.25	237318.96	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229192	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	733324	366662	244441.3333	183331	146664.8	122220.6667	104760.5714	91665.5	81480.44444	73332.4	66665.81818	61110.33333	56409.53846	52380.28571	48888.26667	45832.75	40740.22222	38596	36666.2	30555.16667	29332.96	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229193	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	751461	375730.5	250487	187865.25	150292.2	125243.5	107351.5714	93932.625	83495.66667	75146.1	68314.63636	62621.75	57804.69231	53675.78571	50097.4	46966.3125	41747.83333	39550.57895	37573.05	31310.875	30058.44	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229194	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	2005479	1002739.5	668493	501369.75	401095.8	334246.5	286497	250684.875	222831	200547.9	182316.2727	167123.25	154267.6154	143248.5	133698.6	125342.4375	111415.5	105551.5263	100273.95	83561.625	80219.16	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229195	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	1290140	645070	430046.6667	322535	258028	215023.3333	184305.7143	161267.5	143348.8889	129014	117285.4545	107511.6667	99241.53846	92152.85714	86009.33333	80633.75	71674.44444	67902.10526	64507	53755.83333	51605.6	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229196	CHOYP_PDIA3.1.1|m.60223	MDATANDVAKPYEVSGFPTIYFAPK	MDATANDVAKPYEVSGFPTIYFAPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229197	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229198	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	3359680	1679840	1119893.333	839920	671936	559946.6667	479954.2857	419960	373297.7778	335968	305425.4545	279973.3333	258436.9231	239977.1429	223978.6667	209980	186648.8889	176825.2632	167984	139986.6667	134387.2	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229199	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	1247136	623568	415712	311784	249427.2	207856	178162.2857	155892	138570.6667	124713.6	113376	103928	95933.53846	89081.14286	83142.4	77946	69285.33333	65638.73684	62356.8	51964	49885.44	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229200	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229201	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	463541	231770.5	154513.6667	115885.25	92708.2	77256.83333	66220.14286	57942.625	51504.55556	46354.1	42140.09091	38628.41667	35657	33110.07143	30902.73333	28971.3125	25752.27778	24396.89474	23177.05	19314.20833	18541.64	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229202	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	1278270	639135	426090	319567.5	255654	213045	182610	159783.75	142030	127827	116206.3636	106522.5	98328.46154	91305	85218	79891.875	71015	67277.36842	63913.5	53261.25	51130.8	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229203	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	1820493	910246.5	606831	455123.25	364098.6	303415.5	260070.4286	227561.625	202277	182049.3	165499.3636	151707.75	140037.9231	130035.2143	121366.2	113780.8125	101138.5	95815.42105	91024.65	75853.875	72819.72	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229204	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229205	CHOYP_PDIA3.1.1|m.60223	EATNELSGFDR	EATNELSGFDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8JG64	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	cell redox homeostasis [GO:0045454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0034976; GO:0042470; GO:0043209; GO:0044822; GO:0045454; GO:0070062; GO:2001238
229206	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	5242218	2621109	1747406	1310554.5	1048443.6	873703	748888.2857	655277.25	582468.6667	524221.8	476565.2727	436851.5	403247.5385	374444.1429	349481.2	327638.625	291234.3333	275906.2105	262110.9	218425.75	209688.72	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229207	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229208	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	1457597	728798.5	485865.6667	364399.25	291519.4	242932.8333	208228.1429	182199.625	161955.2222	145759.7	132508.8182	121466.4167	112122.8462	104114.0714	97173.13333	91099.8125	80977.61111	76715.63158	72879.85	60733.20833	58303.88	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229209	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	802154	401077	267384.6667	200538.5	160430.8	133692.3333	114593.4286	100269.25	89128.22222	80215.4	72923.09091	66846.16667	61704.15385	57296.71429	53476.93333	50134.625	44564.11111	42218.63158	40107.7	33423.08333	32086.16	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229210	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	1343130	671565	447710	335782.5	268626	223855	191875.7143	167891.25	149236.6667	134313	122102.7273	111927.5	103317.6923	95937.85714	89542	83945.625	74618.33333	70691.05263	67156.5	55963.75	53725.2	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229211	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	1934767	967383.5	644922.3333	483691.75	386953.4	322461.1667	276395.2857	241845.875	214974.1111	193476.7	175887.9091	161230.5833	148828.2308	138197.6429	128984.4667	120922.9375	107487.0556	101829.8421	96738.35	80615.29167	77390.68	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229212	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229213	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	49887	24943.5	16629	12471.75	9977.4	8314.5	7126.714286	6235.875	5543	4988.7	4535.181818	4157.25	3837.461538	3563.357143	3325.8	3117.9375	2771.5	2625.631579	2494.35	2078.625	1995.48	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229214	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	314689	157344.5	104896.3333	78672.25	62937.8	52448.16667	44955.57143	39336.125	34965.44444	31468.9	28608.09091	26224.08333	24206.84615	22477.78571	20979.26667	19668.0625	17482.72222	16562.57895	15734.45	13112.04167	12587.56	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229215	CHOYP_PDIA4.1.1|m.54958	VDATIESDLASR	VDATIESDLASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229216	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	1261935	630967.5	420645	315483.75	252387	210322.5	180276.4286	157741.875	140215	126193.5	114721.3636	105161.25	97071.92308	90138.21429	84129	78870.9375	70107.5	66417.63158	63096.75	52580.625	50477.4	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229217	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	3339862	1669931	1113287.333	834965.5	667972.4	556643.6667	477123.1429	417482.75	371095.7778	333986.2	303623.8182	278321.8333	256912.4615	238561.5714	222657.4667	208741.375	185547.8889	175782.2105	166993.1	139160.9167	133594.48	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229218	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	663068	331534	221022.6667	165767	132613.6	110511.3333	94724	82883.5	73674.22222	66306.8	60278.90909	55255.66667	51005.23077	47362	44204.53333	41441.75	36837.11111	34898.31579	33153.4	27627.83333	26522.72	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229219	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	725162	362581	241720.6667	181290.5	145032.4	120860.3333	103594.5714	90645.25	80573.55556	72516.2	65923.81818	60430.16667	55781.69231	51797.28571	48344.13333	45322.625	40286.77778	38166.42105	36258.1	30215.08333	29006.48	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229220	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229221	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	17338	8669	5779.333333	4334.5	3467.6	2889.666667	2476.857143	2167.25	1926.444444	1733.8	1576.181818	1444.833333	1333.692308	1238.428571	1155.866667	1083.625	963.2222222	912.5263158	866.9	722.4166667	693.52	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229222	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	185463	92731.5	61821	46365.75	37092.6	30910.5	26494.71429	23182.875	20607	18546.3	16860.27273	15455.25	14266.38462	13247.35714	12364.2	11591.4375	10303.5	9761.210526	9273.15	7727.625	7418.52	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229223	CHOYP_PDIA4.1.1|m.54958	FDVSGYPTLK	FDVSGYPTLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229224	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	9152233	4576116.5	3050744.333	2288058.25	1830446.6	1525372.167	1307461.857	1144029.125	1016914.778	915223.3	832021.1818	762686.0833	704017.9231	653730.9286	610148.8667	572014.5625	508457.3889	481696.4737	457611.65	381343.0417	366089.32	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229225	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	6342142	3171071	2114047.333	1585535.5	1268428.4	1057023.667	906020.2857	792767.75	704682.4444	634214.2	576558.3636	528511.8333	487857.0769	453010.1429	422809.4667	396383.875	352341.2222	333796.9474	317107.1	264255.9167	253685.68	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229226	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229227	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	283996	141998	94665.33333	70999	56799.2	47332.66667	40570.85714	35499.5	31555.11111	28399.6	25817.81818	23666.33333	21845.84615	20285.42857	18933.06667	17749.75	15777.55556	14947.15789	14199.8	11833.16667	11359.84	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229228	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229229	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229230	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	1524954	762477	508318	381238.5	304990.8	254159	217850.5714	190619.25	169439.3333	152495.4	138632.1818	127079.5	117304.1538	108925.2857	101663.6	95309.625	84719.66667	80260.73684	76247.7	63539.75	60998.16	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229231	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229232	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	376389	188194.5	125463	94097.25	75277.8	62731.5	53769.85714	47048.625	41821	37638.9	34217.18182	31365.75	28953	26884.92857	25092.6	23524.3125	20910.5	19809.94737	18819.45	15682.875	15055.56	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229233	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	271445	135722.5	90481.66667	67861.25	54289	45240.83333	38777.85714	33930.625	30160.55556	27144.5	24676.81818	22620.41667	20880.38462	19388.92857	18096.33333	16965.3125	15080.27778	14286.57895	13572.25	11310.20833	10857.8	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229234	CHOYP_PDIA4.1.1|m.54958	TNPQTVLVFTPER	TNPQTVLVFTPER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229235	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229236	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	743420	371710	247806.6667	185855	148684	123903.3333	106202.8571	92927.5	82602.22222	74342	67583.63636	61951.66667	57186.15385	53101.42857	49561.33333	46463.75	41301.11111	39127.36842	37171	30975.83333	29736.8	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229237	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	543070	271535	181023.3333	135767.5	108614	90511.66667	77581.42857	67883.75	60341.11111	54307	49370	45255.83333	41774.61538	38790.71429	36204.66667	33941.875	30170.55556	28582.63158	27153.5	22627.91667	21722.8	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229238	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	39908	19954	13302.66667	9977	7981.6	6651.333333	5701.142857	4988.5	4434.222222	3990.8	3628	3325.666667	3069.846154	2850.571429	2660.533333	2494.25	2217.111111	2100.421053	1995.4	1662.833333	1596.32	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229239	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	195828	97914	65276	48957	39165.6	32638	27975.42857	24478.5	21758.66667	19582.8	17802.54545	16319	15063.69231	13987.71429	13055.2	12239.25	10879.33333	10306.73684	9791.4	8159.5	7833.12	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229240	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229241	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229242	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	15206	7603	5068.666667	3801.5	3041.2	2534.333333	2172.285714	1900.75	1689.555556	1520.6	1382.363636	1267.166667	1169.692308	1086.142857	1013.733333	950.375	844.7777778	800.3157895	760.3	633.5833333	608.24	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229243	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229244	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229245	CHOYP_PDIA4.1.1|m.54958	MDATANDVPEAFK	MDATANDVPEAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P13667	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0034976; GO:0042470; GO:0044822; GO:0045454; GO:0061077
229246	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	18852200	9426100	6284066.667	4713050	3770440	3142033.333	2693171.429	2356525	2094688.889	1885220	1713836.364	1571016.667	1450169.231	1346585.714	1256813.333	1178262.5	1047344.444	992221.0526	942610	785508.3333	754088	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229247	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	22677754	11338877	7559251.333	5669438.5	4535550.8	3779625.667	3239679.143	2834719.25	2519750.444	2267775.4	2061614	1889812.833	1744442.615	1619839.571	1511850.267	1417359.625	1259875.222	1193566	1133887.7	944906.4167	907110.16	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229248	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	24541190	12270595	8180396.667	6135297.5	4908238	4090198.333	3505884.286	3067648.75	2726798.889	2454119	2231017.273	2045099.167	1887783.846	1752942.143	1636079.333	1533824.375	1363399.444	1291641.579	1227059.5	1022549.583	981647.6	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229249	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229250	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229251	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229252	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229253	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229254	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229255	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229256	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229257	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229258	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229259	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229260	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229261	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229262	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229263	CHOYP_PDIA6.1.2|m.9012	IAAVNADEHQSLGGQYQIQGFPTIK	IAAVNADEHQSLGGQYQIQGFPTIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229264	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229265	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229266	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229267	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	424253	212126.5	141417.6667	106063.25	84850.6	70708.83333	60607.57143	53031.625	47139.22222	42425.3	38568.45455	35354.41667	32634.84615	30303.78571	28283.53333	26515.8125	23569.61111	22329.10526	21212.65	17677.20833	16970.12	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229268	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229269	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	249787	124893.5	83262.33333	62446.75	49957.4	41631.16667	35683.85714	31223.375	27754.11111	24978.7	22707.90909	20815.58333	19214.38462	17841.92857	16652.46667	15611.6875	13877.05556	13146.68421	12489.35	10407.79167	9991.48	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229270	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	95738	47869	31912.66667	23934.5	19147.6	15956.33333	13676.85714	11967.25	10637.55556	9573.8	8703.454545	7978.166667	7364.461538	6838.428571	6382.533333	5983.625	5318.777778	5038.842105	4786.9	3989.083333	3829.52	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229271	CHOYP_PDIA6.1.2|m.9012	NSPSDYQGGR	NSPSDYQGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229272	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	55469036	27734518	18489678.67	13867259	11093807.2	9244839.333	7924148	6933629.5	6163226.222	5546903.6	5042639.636	4622419.667	4266848.923	3962074	3697935.733	3466814.75	3081613.111	2919422.947	2773451.8	2311209.833	2218761.44	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229273	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	27265858	13632929	9088619.333	6816464.5	5453171.6	4544309.667	3895122.571	3408232.25	3029539.778	2726585.8	2478714.364	2272154.833	2097373.692	1947561.286	1817723.867	1704116.125	1514769.889	1435045.158	1363292.9	1136077.417	1090634.32	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229274	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229275	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	2223018	1111509	741006	555754.5	444603.6	370503	317574	277877.25	247002	222301.8	202092.5455	185251.5	171001.3846	158787	148201.2	138938.625	123501	117000.9474	111150.9	92625.75	88920.72	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229276	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	3176365	1588182.5	1058788.333	794091.25	635273	529394.1667	453766.4286	397045.625	352929.4444	317636.5	288760.4545	264697.0833	244335.7692	226883.2143	211757.6667	198522.8125	176464.7222	167177.1053	158818.25	132348.5417	127054.6	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229277	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	12520373	6260186.5	4173457.667	3130093.25	2504074.6	2086728.833	1788624.714	1565046.625	1391152.556	1252037.3	1138215.727	1043364.417	963105.6154	894312.3571	834691.5333	782523.3125	695576.2778	658967	626018.65	521682.2083	500814.92	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229278	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	3960522	1980261	1320174	990130.5	792104.4	660087	565788.8571	495065.25	440058	396052.2	360047.4545	330043.5	304655.5385	282894.4286	264034.8	247532.625	220029	208448.5263	198026.1	165021.75	158420.88	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229279	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	2397784	1198892	799261.3333	599446	479556.8	399630.6667	342540.5714	299723	266420.4444	239778.4	217980.3636	199815.3333	184444.9231	171270.2857	159852.2667	149861.5	133210.2222	126199.1579	119889.2	99907.66667	95911.36	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229280	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	1247086	623543	415695.3333	311771.5	249417.2	207847.6667	178155.1429	155885.75	138565.1111	124708.6	113371.4545	103923.8333	95929.69231	89077.57143	83139.06667	77942.875	69282.55556	65636.10526	62354.3	51961.91667	49883.44	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229281	CHOYP_PDIA6.1.2|m.9012	TADAIVDTALSK	TADAIVDTALSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229282	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	10454165	5227082.5	3484721.667	2613541.25	2090833	1742360.833	1493452.143	1306770.625	1161573.889	1045416.5	950378.6364	871180.4167	804166.5385	746726.0714	696944.3333	653385.3125	580786.9444	550219.2105	522708.25	435590.2083	418166.6	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229283	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	9850858	4925429	3283619.333	2462714.5	1970171.6	1641809.667	1407265.429	1231357.25	1094539.778	985085.8	895532.5455	820904.8333	757758.3077	703632.7143	656723.8667	615678.625	547269.8889	518466.2105	492542.9	410452.4167	394034.32	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229284	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	4739713	2369856.5	1579904.333	1184928.25	947942.6	789952.1667	677101.8571	592464.125	526634.7778	473971.3	430883	394976.0833	364593.3077	338550.9286	315980.8667	296232.0625	263317.3889	249458.5789	236985.65	197488.0417	189588.52	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229285	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	1773423	886711.5	591141	443355.75	354684.6	295570.5	253346.1429	221677.875	197047	177342.3	161220.2727	147785.25	136417.1538	126673.0714	118228.2	110838.9375	98523.5	93338.05263	88671.15	73892.625	70936.92	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229286	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	630276	315138	210092	157569	126055.2	105046	90039.42857	78784.5	70030.66667	63027.6	57297.81818	52523	48482.76923	45019.71429	42018.4	39392.25	35015.33333	33172.42105	31513.8	26261.5	25211.04	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229287	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	1934750	967375	644916.6667	483687.5	386950	322458.3333	276392.8571	241843.75	214972.2222	193475	175886.3636	161229.1667	148826.9231	138196.4286	128983.3333	120921.875	107486.1111	101828.9474	96737.5	80614.58333	77390	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229288	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	486084	243042	162028	121521	97216.8	81014	69440.57143	60760.5	54009.33333	48608.4	44189.45455	40507	37391.07692	34720.28571	32405.6	30380.25	27004.66667	25583.36842	24304.2	20253.5	19443.36	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229289	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	534641	267320.5	178213.6667	133660.25	106928.2	89106.83333	76377.28571	66830.125	59404.55556	53464.1	48603.72727	44553.41667	41126.23077	38188.64286	35642.73333	33415.0625	29702.27778	28139	26732.05	22276.70833	21385.64	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229290	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229291	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	271803	135901.5	90601	67950.75	54360.6	45300.5	38829	33975.375	30200.33333	27180.3	24709.36364	22650.25	20907.92308	19414.5	18120.2	16987.6875	15100.16667	14305.42105	13590.15	11325.125	10872.12	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229292	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	365606	182803	121868.6667	91401.5	73121.2	60934.33333	52229.42857	45700.75	40622.88889	36560.6	33236.90909	30467.16667	28123.53846	26114.71429	24373.73333	22850.375	20311.44444	19242.42105	18280.3	15233.58333	14624.24	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229293	CHOYP_PDIA6.1.2|m.9012	NLAPHWQSAASEMK	NLAPHWQSAASEMK	31241	15620.5	10413.66667	7810.25	6248.2	5206.833333	4463	3905.125	3471.222222	3124.1	2840.090909	2603.416667	2403.153846	2231.5	2082.733333	1952.5625	1735.611111	1644.263158	1562.05	1301.708333	1249.64	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229294	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	22487012	11243506	7495670.667	5621753	4497402.4	3747835.333	3212430.286	2810876.5	2498556.889	2248701.2	2044273.818	1873917.667	1729770.154	1606215.143	1499134.133	1405438.25	1249278.444	1183526.947	1124350.6	936958.8333	899480.48	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229295	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	24123562	12061781	8041187.333	6030890.5	4824712.4	4020593.667	3446223.143	3015445.25	2680395.778	2412356.2	2193051.091	2010296.833	1855658.615	1723111.571	1608237.467	1507722.625	1340197.889	1269661.158	1206178.1	1005148.417	964942.48	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229296	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	14241428	7120714	4747142.667	3560357	2848285.6	2373571.333	2034489.714	1780178.5	1582380.889	1424142.8	1294675.273	1186785.667	1095494.462	1017244.857	949428.5333	890089.25	791190.4444	749548.8421	712071.4	593392.8333	569657.12	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229297	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	394081	197040.5	131360.3333	98520.25	78816.2	65680.16667	56297.28571	49260.125	43786.77778	39408.1	35825.54545	32840.08333	30313.92308	28148.64286	26272.06667	24630.0625	21893.38889	20741.10526	19704.05	16420.04167	15763.24	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229298	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	4347210	2173605	1449070	1086802.5	869442	724535	621030	543401.25	483023.3333	434721	395200.9091	362267.5	334400.7692	310515	289814	271700.625	241511.6667	228800.5263	217360.5	181133.75	173888.4	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229299	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	2820117	1410058.5	940039	705029.25	564023.4	470019.5	402873.8571	352514.625	313346.3333	282011.7	256374.2727	235009.75	216932.0769	201436.9286	188007.8	176257.3125	156673.1667	148427.2105	141005.85	117504.875	112804.68	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229300	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	3673974	1836987	1224658	918493.5	734794.8	612329	524853.4286	459246.75	408219.3333	367397.4	333997.6364	306164.5	282613.3846	262426.7143	244931.6	229623.375	204109.6667	193367.0526	183698.7	153082.25	146958.96	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229301	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	3506820	1753410	1168940	876705	701364	584470	500974.2857	438352.5	389646.6667	350682	318801.8182	292235	269755.3846	250487.1429	233788	219176.25	194823.3333	184569.4737	175341	146117.5	140272.8	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229302	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	7252798	3626399	2417599.333	1813199.5	1450559.6	1208799.667	1036114	906599.75	805866.4444	725279.8	659345.2727	604399.8333	557907.5385	518057	483519.8667	453299.875	402933.2222	381726.2105	362639.9	302199.9167	290111.92	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229303	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	3837001	1918500.5	1279000.333	959250.25	767400.2	639500.1667	548143	479625.125	426333.4444	383700.1	348818.2727	319750.0833	295153.9231	274071.5	255800.0667	239812.5625	213166.7222	201947.4211	191850.05	159875.0417	153480.04	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229304	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	1159484	579742	386494.6667	289871	231896.8	193247.3333	165640.5714	144935.5	128831.5556	115948.4	105407.6364	96623.66667	89191.07692	82820.28571	77298.93333	72467.75	64415.77778	61025.47368	57974.2	48311.83333	46379.36	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229305	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	1231842	615921	410614	307960.5	246368.4	205307	175977.4286	153980.25	136871.3333	123184.2	111985.6364	102653.5	94757.07692	87988.71429	82122.8	76990.125	68435.66667	64833.78947	61592.1	51326.75	49273.68	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229306	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	592829	296414.5	197609.6667	148207.25	118565.8	98804.83333	84689.85714	74103.625	65869.88889	59282.9	53893.54545	49402.41667	45602.23077	42344.92857	39521.93333	37051.8125	32934.94444	31201.52632	29641.45	24701.20833	23713.16	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229307	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	16163232	8081616	5387744	4040808	3232646.4	2693872	2309033.143	2020404	1795914.667	1616323.2	1469384.727	1346936	1243325.538	1154516.571	1077548.8	1010202	897957.3333	850696.4211	808161.6	673468	646529.28	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229308	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	13045201	6522600.5	4348400.333	3261300.25	2609040.2	2174200.167	1863600.143	1630650.125	1449466.778	1304520.1	1185927.364	1087100.083	1003477	931800.0714	869680.0667	815325.0625	724733.3889	686589.5263	652260.05	543550.0417	521808.04	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229309	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	6626346	3313173	2208782	1656586.5	1325269.2	1104391	946620.8571	828293.25	736260.6667	662634.6	602395.0909	552195.5	509718.9231	473310.4286	441756.4	414146.625	368130.3333	348755.0526	331317.3	276097.75	265053.84	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229310	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229311	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	557170	278585	185723.3333	139292.5	111434	92861.66667	79595.71429	69646.25	61907.77778	55717	50651.81818	46430.83333	42859.23077	39797.85714	37144.66667	34823.125	30953.88889	29324.73684	27858.5	23215.41667	22286.8	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229312	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	427080	213540	142360	106770	85416	71180	61011.42857	53385	47453.33333	42708	38825.45455	35590	32852.30769	30505.71429	28472	26692.5	23726.66667	22477.89474	21354	17795	17083.2	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229313	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	778555	389277.5	259518.3333	194638.75	155711	129759.1667	111222.1429	97319.375	86506.11111	77855.5	70777.72727	64879.58333	59888.84615	55611.07143	51903.66667	48659.6875	43253.05556	40976.57895	38927.75	32439.79167	31142.2	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229314	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	1314702	657351	438234	328675.5	262940.4	219117	187814.5714	164337.75	146078	131470.2	119518.3636	109558.5	101130.9231	93907.28571	87646.8	82168.875	73039	69194.84211	65735.1	54779.25	52588.08	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229315	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	4102380	2051190	1367460	1025595	820476	683730	586054.2857	512797.5	455820	410238	372943.6364	341865	315567.6923	293027.1429	273492	256398.75	227910	215914.7368	205119	170932.5	164095.2	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229316	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	3391781	1695890.5	1130593.667	847945.25	678356.2	565296.8333	484540.1429	423972.625	376864.5556	339178.1	308343.7273	282648.4167	260906.2308	242270.0714	226118.7333	211986.3125	188432.2778	178514.7895	169589.05	141324.2083	135671.24	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229317	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	897054	448527	299018	224263.5	179410.8	149509	128150.5714	112131.75	99672.66667	89705.4	81550.36364	74754.5	69004.15385	64075.28571	59803.6	56065.875	49836.33333	47213.36842	44852.7	37377.25	35882.16	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229318	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	611860	305930	203953.3333	152965	122372	101976.6667	87408.57143	76482.5	67984.44444	61186	55623.63636	50988.33333	47066.15385	43704.28571	40790.66667	38241.25	33992.22222	32203.15789	30593	25494.16667	24474.4	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229319	CHOYP_PDIA6.1.2|m.9012	FGALDATVHSVMANR	FGALDATVHSVMANR	200306	100153	66768.66667	50076.5	40061.2	33384.33333	28615.14286	25038.25	22256.22222	20030.6	18209.63636	16692.16667	15408.15385	14307.57143	13353.73333	12519.125	11128.11111	10542.42105	10015.3	8346.083333	8012.24	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229320	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	5954818	2977409	1984939.333	1488704.5	1190963.6	992469.6667	850688.2857	744352.25	661646.4444	595481.8	541347.0909	496234.8333	458062.9231	425344.1429	396987.8667	372176.125	330823.2222	313411.4737	297740.9	248117.4167	238192.72	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229321	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229322	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	800376	400188	266792	200094	160075.2	133396	114339.4286	100047	88930.66667	80037.6	72761.45455	66698	61567.38462	57169.71429	53358.4	50023.5	44465.33333	42125.05263	40018.8	33349	32015.04	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229323	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	250598	125299	83532.66667	62649.5	50119.6	41766.33333	35799.71429	31324.75	27844.22222	25059.8	22781.63636	20883.16667	19276.76923	17899.85714	16706.53333	15662.375	13922.11111	13189.36842	12529.9	10441.58333	10023.92	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229324	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	815685	407842.5	271895	203921.25	163137	135947.5	116526.4286	101960.625	90631.66667	81568.5	74153.18182	67973.75	62745	58263.21429	54379	50980.3125	45315.83333	42930.78947	40784.25	33986.875	32627.4	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229325	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	1166108	583054	388702.6667	291527	233221.6	194351.3333	166586.8571	145763.5	129567.5556	116610.8	106009.8182	97175.66667	89700.61538	83293.42857	77740.53333	72881.75	64783.77778	61374.10526	58305.4	48587.83333	46644.32	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229326	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229327	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229328	CHOYP_PDIA6.1.2|m.9012	DGDAMEYDGGR	DGDAMEYDGGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229329	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	30834988	15417494	10278329.33	7708747	6166997.6	5139164.667	4404998.286	3854373.5	3426109.778	3083498.8	2803180.727	2569582.333	2371922.154	2202499.143	2055665.867	1927186.75	1713054.889	1622894.105	1541749.4	1284791.167	1233399.52	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229330	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	23201460	11600730	7733820	5800365	4640292	3866910	3314494.286	2900182.5	2577940	2320146	2109223.636	1933455	1784727.692	1657247.143	1546764	1450091.25	1288970	1221129.474	1160073	966727.5	928058.4	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229331	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	9938023	4969011.5	3312674.333	2484505.75	1987604.6	1656337.167	1419717.571	1242252.875	1104224.778	993802.3	903456.6364	828168.5833	764463.3077	709858.7857	662534.8667	621126.4375	552112.3889	523053.8421	496901.15	414084.2917	397520.92	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229332	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	648595	324297.5	216198.3333	162148.75	129719	108099.1667	92656.42857	81074.375	72066.11111	64859.5	58963.18182	54049.58333	49891.92308	46328.21429	43239.66667	40537.1875	36033.05556	34136.57895	32429.75	27024.79167	25943.8	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229333	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	1484174	742087	494724.6667	371043.5	296834.8	247362.3333	212024.8571	185521.75	164908.2222	148417.4	134924.9091	123681.1667	114167.2308	106012.4286	98944.93333	92760.875	82454.11111	78114.42105	74208.7	61840.58333	59366.96	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229334	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	5680289	2840144.5	1893429.667	1420072.25	1136057.8	946714.8333	811469.8571	710036.125	631143.2222	568028.9	516389.9091	473357.4167	436945.3077	405734.9286	378685.9333	355018.0625	315571.6111	298962.5789	284014.45	236678.7083	227211.56	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229335	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	4097376	2048688	1365792	1024344	819475.2	682896	585339.4286	512172	455264	409737.6	372488.7273	341448	315182.7692	292669.7143	273158.4	256086	227632	215651.3684	204868.8	170724	163895.04	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229336	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	1659021	829510.5	553007	414755.25	331804.2	276503.5	237003	207377.625	184335.6667	165902.1	150820.0909	138251.75	127617	118501.5	110601.4	103688.8125	92167.83333	87316.89474	82951.05	69125.875	66360.84	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229337	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	1578087	789043.5	526029	394521.75	315617.4	263014.5	225441	197260.875	175343	157808.7	143462.4545	131507.25	121391.3077	112720.5	105205.8	98630.4375	87671.5	83057.21053	78904.35	65753.625	63123.48	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
229338	CHOYP_PDIA6.1.2|m.9012	TSSDIVNWATEK	TSSDIVNWATEK	1565142	782571	521714	391285.5	313028.4	260857	223591.7143	195642.75	173904.6667	156514.2	142285.6364	130428.5	120395.5385	111795.8571	104342.8	97821.375	86952.33333	82375.89474	78257.1	65214.25	62605.68	Q922R8	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003756; GO:0005788; GO:0005793; GO:0005886; GO:0006457; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0043277; GO:0045454; GO:0070062; GO:0070527
231126	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231127	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231128	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231129	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231130	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231131	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231132	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231133	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231134	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231135	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231136	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231137	CHOYP_PHUM_PHUM071280.1.1|m.25507	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231138	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231139	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231140	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231141	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231142	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231143	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231144	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231145	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231146	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231147	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231148	CHOYP_PHUM_PHUM071280.1.1|m.25507	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231149	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231150	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231151	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231152	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231153	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231154	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231155	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231156	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231157	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231158	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231159	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231160	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231161	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231162	CHOYP_PHUM_PHUM071280.1.1|m.25507	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231163	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231164	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231165	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231166	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231167	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231168	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231169	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
231170	CHOYP_PHUM_PHUM071280.1.1|m.25507	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Y6E0	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mitotic cell cycle [GO:0000278]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	GO:0000278; GO:0004672; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005913; GO:0006468; GO:0006921; GO:0007165; GO:0008631; GO:0016020; GO:0030336; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194; GO:0098641
235771	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235772	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235773	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235774	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	208133	104066.5	69377.66667	52033.25	41626.6	34688.83333	29733.28571	26016.625	23125.88889	20813.3	18921.18182	17344.41667	16010.23077	14866.64286	13875.53333	13008.3125	11562.94444	10954.36842	10406.65	8672.208333	8325.32	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235775	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235776	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235777	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235778	CHOYP_PNCB.1.1|m.57201	FSVSDINYLK	FSVSDINYLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235779	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	2222605	1111302.5	740868.3333	555651.25	444521	370434.1667	317515	277825.625	246956.1111	222260.5	202055	185217.0833	170969.6154	158757.5	148173.6667	138912.8125	123478.0556	116979.2105	111130.25	92608.54167	88904.2	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235780	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	2024380	1012190	674793.3333	506095	404876	337396.6667	289197.1429	253047.5	224931.1111	202438	184034.5455	168698.3333	155721.5385	144598.5714	134958.6667	126523.75	112465.5556	106546.3158	101219	84349.16667	80975.2	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235781	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	1632995	816497.5	544331.6667	408248.75	326599	272165.8333	233285	204124.375	181443.8889	163299.5	148454.0909	136082.9167	125615	116642.5	108866.3333	102062.1875	90721.94444	85947.10526	81649.75	68041.45833	65319.8	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235782	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	178445	89222.5	59481.66667	44611.25	35689	29740.83333	25492.14286	22305.625	19827.22222	17844.5	16222.27273	14870.41667	13726.53846	12746.07143	11896.33333	11152.8125	9913.611111	9391.842105	8922.25	7435.208333	7137.8	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235783	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	186322	93161	62107.33333	46580.5	37264.4	31053.66667	26617.42857	23290.25	20702.44444	18632.2	16938.36364	15526.83333	14332.46154	13308.71429	12421.46667	11645.125	10351.22222	9806.421053	9316.1	7763.416667	7452.88	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235784	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	47755	23877.5	15918.33333	11938.75	9551	7959.166667	6822.142857	5969.375	5306.111111	4775.5	4341.363636	3979.583333	3673.461538	3411.071429	3183.666667	2984.6875	2653.055556	2513.421053	2387.75	1989.791667	1910.2	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235785	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235786	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235787	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235788	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235789	CHOYP_PNCB.1.1|m.57201	LIAIDEGMVVFPK	LIAIDEGMVVFPK	225937	112968.5	75312.33333	56484.25	45187.4	37656.16667	32276.71429	28242.125	25104.11111	22593.7	20539.72727	18828.08333	17379.76923	16138.35714	15062.46667	14121.0625	12552.05556	11891.42105	11296.85	9414.041667	9037.48	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235790	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235791	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235792	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235793	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	59673	29836.5	19891	14918.25	11934.6	9945.5	8524.714286	7459.125	6630.333333	5967.3	5424.818182	4972.75	4590.230769	4262.357143	3978.2	3729.5625	3315.166667	3140.684211	2983.65	2486.375	2386.92	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235794	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	23424	11712	7808	5856	4684.8	3904	3346.285714	2928	2602.666667	2342.4	2129.454545	1952	1801.846154	1673.142857	1561.6	1464	1301.333333	1232.842105	1171.2	976	936.96	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235795	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	126864	63432	42288	31716	25372.8	21144	18123.42857	15858	14096	12686.4	11533.09091	10572	9758.769231	9061.714286	8457.6	7929	7048	6677.052632	6343.2	5286	5074.56	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235796	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	217584	108792	72528	54396	43516.8	36264	31083.42857	27198	24176	21758.4	19780.36364	18132	16737.23077	15541.71429	14505.6	13599	12088	11451.78947	10879.2	9066	8703.36	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235797	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	29103	14551.5	9701	7275.75	5820.6	4850.5	4157.571429	3637.875	3233.666667	2910.3	2645.727273	2425.25	2238.692308	2078.785714	1940.2	1818.9375	1616.833333	1531.736842	1455.15	1212.625	1164.12	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235798	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	25956	12978	8652	6489	5191.2	4326	3708	3244.5	2884	2595.6	2359.636364	2163	1996.615385	1854	1730.4	1622.25	1442	1366.105263	1297.8	1081.5	1038.24	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235799	CHOYP_PNCB.1.1|m.57201	AQGPDGALSASR	AQGPDGALSASR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235800	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	5221699	2610849.5	1740566.333	1305424.75	1044339.8	870283.1667	745957	652712.375	580188.7778	522169.9	474699.9091	435141.5833	401669.1538	372978.5	348113.2667	326356.1875	290094.3889	274826.2632	261084.95	217570.7917	208867.96	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235801	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	2774962	1387481	924987.3333	693740.5	554992.4	462493.6667	396423.1429	346870.25	308329.1111	277496.2	252269.2727	231246.8333	213458.6154	198211.5714	184997.4667	173435.125	154164.5556	146050.6316	138748.1	115623.4167	110998.48	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235802	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	1179923	589961.5	393307.6667	294980.75	235984.6	196653.8333	168560.4286	147490.375	131102.5556	117992.3	107265.7273	98326.91667	90763.30769	84280.21429	78661.53333	73745.1875	65551.27778	62101.21053	58996.15	49163.45833	47196.92	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235803	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	122280	61140	40760	30570	24456	20380	17468.57143	15285	13586.66667	12228	11116.36364	10190	9406.153846	8734.285714	8152	7642.5	6793.333333	6435.789474	6114	5095	4891.2	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235804	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235805	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	25924	12962	8641.333333	6481	5184.8	4320.666667	3703.428571	3240.5	2880.444444	2592.4	2356.727273	2160.333333	1994.153846	1851.714286	1728.266667	1620.25	1440.222222	1364.421053	1296.2	1080.166667	1036.96	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235806	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	904814	452407	301604.6667	226203.5	180962.8	150802.3333	129259.1429	113101.75	100534.8889	90481.4	82255.81818	75401.16667	69601.07692	64629.57143	60320.93333	56550.875	50267.44444	47621.78947	45240.7	37700.58333	36192.56	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235807	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	1396681	698340.5	465560.3333	349170.25	279336.2	232780.1667	199525.8571	174585.125	155186.7778	139668.1	126971	116390.0833	107437	99762.92857	93112.06667	87292.5625	77593.38889	73509.52632	69834.05	58195.04167	55867.24	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235808	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	482147	241073.5	160715.6667	120536.75	96429.4	80357.83333	68878.14286	60268.375	53571.88889	48214.7	43831.54545	40178.91667	37088.23077	34439.07143	32143.13333	30134.1875	26785.94444	25376.15789	24107.35	20089.45833	19285.88	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235809	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	309481	154740.5	103160.3333	77370.25	61896.2	51580.16667	44211.57143	38685.125	34386.77778	30948.1	28134.63636	25790.08333	23806.23077	22105.78571	20632.06667	19342.5625	17193.38889	16288.47368	15474.05	12895.04167	12379.24	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235810	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
235811	CHOYP_PNCB.1.1|m.57201	LDSGDLAYLSTVVR	LDSGDLAYLSTVVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9VQX4	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	CG3714	NAD biosynthetic process [GO:0009435]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0016874; GO:0019358
238919	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	1508586	754293	502862	377146.5	301717.2	251431	215512.2857	188573.25	167620.6667	150858.6	137144.1818	125715.5	116045.0769	107756.1429	100572.4	94286.625	83810.33333	79399.26316	75429.3	62857.75	60343.44	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238920	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238921	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	639479	319739.5	213159.6667	159869.75	127895.8	106579.8333	91354.14286	79934.875	71053.22222	63947.9	58134.45455	53289.91667	49190.69231	45677.07143	42631.93333	39967.4375	35526.61111	33656.78947	31973.95	26644.95833	25579.16	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238922	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238923	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	372701	186350.5	124233.6667	93175.25	74540.2	62116.83333	53243	46587.625	41411.22222	37270.1	33881.90909	31058.41667	28669.30769	26621.5	24846.73333	23293.8125	20705.61111	19615.84211	18635.05	15529.20833	14908.04	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238924	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	285480	142740	95160	71370	57096	47580	40782.85714	35685	31720	28548	25952.72727	23790	21960	20391.42857	19032	17842.5	15860	15025.26316	14274	11895	11419.2	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238925	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	83099	41549.5	27699.66667	20774.75	16619.8	13849.83333	11871.28571	10387.375	9233.222222	8309.9	7554.454545	6924.916667	6392.230769	5935.642857	5539.933333	5193.6875	4616.611111	4373.631579	4154.95	3462.458333	3323.96	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238926	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238927	CHOYP_PTEN.1.1|m.5408	MADVVNFLDER	MADVVNFLDER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238928	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238929	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238930	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238931	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238932	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238933	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238934	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238935	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238936	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	92566	46283	30855.33333	23141.5	18513.2	15427.66667	13223.71429	11570.75	10285.11111	9256.6	8415.090909	7713.833333	7120.461538	6611.857143	6171.066667	5785.375	5142.555556	4871.894737	4628.3	3856.916667	3702.64	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238937	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238938	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238939	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238940	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
238941	CHOYP_PTEN.1.1|m.5408	STTNENLTSISTSGVK	STTNENLTSISTSGVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P60484	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1 TEP1	"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031658]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell receptor signaling pathway [GO:0050852]"	GO:0000079; GO:0000287; GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008283; GO:0008284; GO:0008285; GO:0008289; GO:0009749; GO:0009898; GO:0010043; GO:0010975; GO:0010997; GO:0014067; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0031658; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035749; GO:0042493; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0043647; GO:0045211; GO:0045471; GO:0045475; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048015; GO:0048679; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0050852; GO:0051091; GO:0051717; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903984; GO:1904668; GO:2000060; GO:2000134; GO:2000463; GO:2000808
240463	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	7759022	3879511	2586340.667	1939755.5	1551804.4	1293170.333	1108431.714	969877.75	862113.5556	775902.2	705365.6364	646585.1667	596847.8462	554215.8571	517268.1333	484938.875	431056.7778	408369.5789	387951.1	323292.5833	310360.88	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240464	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	5652415	2826207.5	1884138.333	1413103.75	1130483	942069.1667	807487.8571	706551.875	628046.1111	565241.5	513855.9091	471034.5833	434801.1538	403743.9286	376827.6667	353275.9375	314023.0556	297495.5263	282620.75	235517.2917	226096.6	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240465	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	1059450	529725	353150	264862.5	211890	176575	151350	132431.25	117716.6667	105945	96313.63636	88287.5	81496.15385	75675	70630	66215.625	58858.33333	55760.52632	52972.5	44143.75	42378	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240466	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240467	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	1212433	606216.5	404144.3333	303108.25	242486.6	202072.1667	173204.7143	151554.125	134714.7778	121243.3	110221.1818	101036.0833	93264.07692	86602.35714	80828.86667	75777.0625	67357.38889	63812.26316	60621.65	50518.04167	48497.32	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240468	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	666889	333444.5	222296.3333	166722.25	133377.8	111148.1667	95269.85714	83361.125	74098.77778	66688.9	60626.27273	55574.08333	51299.15385	47634.92857	44459.26667	41680.5625	37049.38889	35099.42105	33344.45	27787.04167	26675.56	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240469	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	2659542	1329771	886514	664885.5	531908.4	443257	379934.5714	332442.75	295504.6667	265954.2	241776.5455	221628.5	204580.1538	189967.2857	177302.8	166221.375	147752.3333	139975.8947	132977.1	110814.25	106381.68	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240470	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240471	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	77572	38786	25857.33333	19393	15514.4	12928.66667	11081.71429	9696.5	8619.111111	7757.2	7052	6464.333333	5967.076923	5540.857143	5171.466667	4848.25	4309.555556	4082.736842	3878.6	3232.166667	3102.88	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240472	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240473	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	62090	31045	20696.66667	15522.5	12418	10348.33333	8870	7761.25	6898.888889	6209	5644.545455	5174.166667	4776.153846	4435	4139.333333	3880.625	3449.444444	3267.894737	3104.5	2587.083333	2483.6	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240474	CHOYP_RAC1.1.3|m.20871	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240475	CHOYP_RAC1.1.3|m.20871	NVFDEAIR	NVFDEAIR	11782354	5891177	3927451.333	2945588.5	2356470.8	1963725.667	1683193.429	1472794.25	1309150.444	1178235.4	1071123.091	981862.8333	906334.9231	841596.7143	785490.2667	736397.125	654575.2222	620123.8947	589117.7	490931.4167	471294.16	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240476	CHOYP_RAC1.1.3|m.20871	NVFDEAIR	NVFDEAIR	5640929	2820464.5	1880309.667	1410232.25	1128185.8	940154.8333	805847	705116.125	626769.8889	564092.9	512811.7273	470077.4167	433917.6154	402923.5	376061.9333	352558.0625	313384.9444	296891	282046.45	235038.7083	225637.16	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240477	CHOYP_RAC1.1.3|m.20871	NVFDEAIR	NVFDEAIR	1286548	643274	428849.3333	321637	257309.6	214424.6667	183792.5714	160818.5	142949.7778	128654.8	116958.9091	107212.3333	98965.23077	91896.28571	85769.86667	80409.25	71474.88889	67713.05263	64327.4	53606.16667	51461.92	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240478	CHOYP_RAC1.1.3|m.20871	NVFDEAIR	NVFDEAIR	1540930	770465	513643.3333	385232.5	308186	256821.6667	220132.8571	192616.25	171214.4444	154093	140084.5455	128410.8333	118533.0769	110066.4286	102728.6667	96308.125	85607.22222	81101.57895	77046.5	64205.41667	61637.2	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240479	CHOYP_RAC1.1.3|m.20871	NVFDEAIR	NVFDEAIR	1342404	671202	447468	335601	268480.8	223734	191772	167800.5	149156	134240.4	122036.7273	111867	103261.8462	95886	89493.6	83900.25	74578	70652.84211	67120.2	55933.5	53696.16	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240480	CHOYP_RAC1.1.3|m.20871	NVFDEAIR	NVFDEAIR	492186	246093	164062	123046.5	98437.2	82031	70312.28571	61523.25	54687.33333	49218.6	44744.18182	41015.5	37860.46154	35156.14286	32812.4	30761.625	27343.66667	25904.52632	24609.3	20507.75	19687.44	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240529	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	15215573	7607786.5	5071857.667	3803893.25	3043114.6	2535928.833	2173653.286	1901946.625	1690619.222	1521557.3	1383233.909	1267964.417	1170428.692	1086826.643	1014371.533	950973.3125	845309.6111	800819.6316	760778.65	633982.2083	608622.92	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240530	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	8757348	4378674	2919116	2189337	1751469.6	1459558	1251049.714	1094668.5	973038.6667	875734.8	796122.5455	729779	673642.1538	625524.8571	583823.2	547334.25	486519.3333	460913.0526	437867.4	364889.5	350293.92	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240531	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	5917105	2958552.5	1972368.333	1479276.25	1183421	986184.1667	845300.7143	739638.125	657456.1111	591710.5	537918.6364	493092.0833	455161.9231	422650.3571	394473.6667	369819.0625	328728.0556	311426.5789	295855.25	246546.0417	236684.2	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240532	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	63700	31850	21233.33333	15925	12740	10616.66667	9100	7962.5	7077.777778	6370	5790.909091	5308.333333	4900	4550	4246.666667	3981.25	3538.888889	3352.631579	3185	2654.166667	2548	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240533	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	2258206	1129103	752735.3333	564551.5	451641.2	376367.6667	322600.8571	282275.75	250911.7778	225820.6	205291.4545	188183.8333	173708.1538	161300.4286	150547.0667	141137.875	125455.8889	118852.9474	112910.3	94091.91667	90328.24	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240534	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	752332	376166	250777.3333	188083	150466.4	125388.6667	107476	94041.5	83592.44444	75233.2	68393.81818	62694.33333	57871.69231	53738	50155.46667	47020.75	41796.22222	39596.42105	37616.6	31347.16667	30093.28	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240535	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	3235123	1617561.5	1078374.333	808780.75	647024.6	539187.1667	462160.4286	404390.375	359458.1111	323512.3	294102.0909	269593.5833	248855.6154	231080.2143	215674.8667	202195.1875	179729.0556	170269.6316	161756.15	134796.7917	129404.92	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240536	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240537	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	94668	47334	31556	23667	18933.6	15778	13524	11833.5	10518.66667	9466.8	8606.181818	7889	7282.153846	6762	6311.2	5916.75	5259.333333	4982.526316	4733.4	3944.5	3786.72	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240538	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240539	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	63818	31909	21272.66667	15954.5	12763.6	10636.33333	9116.857143	7977.25	7090.888889	6381.8	5801.636364	5318.166667	4909.076923	4558.428571	4254.533333	3988.625	3545.444444	3358.842105	3190.9	2659.083333	2552.72	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240540	CHOYP_RAC1.2.3|m.23406	LSPITYPQGLALAK	LSPITYPQGLALAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240541	CHOYP_RAC1.2.3|m.23406	MVFDEAIR	MVFDEAIR	16267998	8133999	5422666	4066999.5	3253599.6	2711333	2323999.714	2033499.75	1807555.333	1626799.8	1478908.909	1355666.5	1251384.462	1161999.857	1084533.2	1016749.875	903777.6667	856210.4211	813399.9	677833.25	650719.92	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240542	CHOYP_RAC1.2.3|m.23406	MVFDEAIR	MVFDEAIR	7779184	3889592	2593061.333	1944796	1555836.8	1296530.667	1111312	972398	864353.7778	777918.4	707198.5455	648265.3333	598398.7692	555656	518612.2667	486199	432176.8889	409430.7368	388959.2	324132.6667	311167.36	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240543	CHOYP_RAC1.2.3|m.23406	MVFDEAIR	MVFDEAIR	1313021	656510.5	437673.6667	328255.25	262604.2	218836.8333	187574.4286	164127.625	145891.2222	131302.1	119365.5455	109418.4167	101001.6154	93787.21429	87534.73333	82063.8125	72945.61111	69106.36842	65651.05	54709.20833	52520.84	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240544	CHOYP_RAC1.2.3|m.23406	MVFDEAIR	MVFDEAIR	1917595	958797.5	639198.3333	479398.75	383519	319599.1667	273942.1429	239699.375	213066.1111	191759.5	174326.8182	159799.5833	147507.3077	136971.0714	127839.6667	119849.6875	106533.0556	100926.0526	95879.75	79899.79167	76703.8	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240545	CHOYP_RAC1.2.3|m.23406	MVFDEAIR	MVFDEAIR	2142609	1071304.5	714203	535652.25	428521.8	357101.5	306087	267826.125	238067.6667	214260.9	194782.6364	178550.75	164816.0769	153043.5	142840.6	133913.0625	119033.8333	112768.8947	107130.45	89275.375	85704.36	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240546	CHOYP_RAC1.2.3|m.23406	MVFDEAIR	MVFDEAIR	523969	261984.5	174656.3333	130992.25	104793.8	87328.16667	74852.71429	65496.125	58218.77778	52396.9	47633.54545	43664.08333	40305.30769	37426.35714	34931.26667	32748.0625	29109.38889	27577.31579	26198.45	21832.04167	20958.76	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240547	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	7759022	3879511	2586340.667	1939755.5	1551804.4	1293170.333	1108431.714	969877.75	862113.5556	775902.2	705365.6364	646585.1667	596847.8462	554215.8571	517268.1333	484938.875	431056.7778	408369.5789	387951.1	323292.5833	310360.88	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240548	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	5652415	2826207.5	1884138.333	1413103.75	1130483	942069.1667	807487.8571	706551.875	628046.1111	565241.5	513855.9091	471034.5833	434801.1538	403743.9286	376827.6667	353275.9375	314023.0556	297495.5263	282620.75	235517.2917	226096.6	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240549	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	1059450	529725	353150	264862.5	211890	176575	151350	132431.25	117716.6667	105945	96313.63636	88287.5	81496.15385	75675	70630	66215.625	58858.33333	55760.52632	52972.5	44143.75	42378	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240550	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240551	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	1212433	606216.5	404144.3333	303108.25	242486.6	202072.1667	173204.7143	151554.125	134714.7778	121243.3	110221.1818	101036.0833	93264.07692	86602.35714	80828.86667	75777.0625	67357.38889	63812.26316	60621.65	50518.04167	48497.32	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240552	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	666889	333444.5	222296.3333	166722.25	133377.8	111148.1667	95269.85714	83361.125	74098.77778	66688.9	60626.27273	55574.08333	51299.15385	47634.92857	44459.26667	41680.5625	37049.38889	35099.42105	33344.45	27787.04167	26675.56	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240553	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	2659542	1329771	886514	664885.5	531908.4	443257	379934.5714	332442.75	295504.6667	265954.2	241776.5455	221628.5	204580.1538	189967.2857	177302.8	166221.375	147752.3333	139975.8947	132977.1	110814.25	106381.68	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240554	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240555	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	77572	38786	25857.33333	19393	15514.4	12928.66667	11081.71429	9696.5	8619.111111	7757.2	7052	6464.333333	5967.076923	5540.857143	5171.466667	4848.25	4309.555556	4082.736842	3878.6	3232.166667	3102.88	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240556	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240557	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	62090	31045	20696.66667	15522.5	12418	10348.33333	8870	7761.25	6898.888889	6209	5644.545455	5174.166667	4776.153846	4435	4139.333333	3880.625	3449.444444	3267.894737	3104.5	2587.083333	2483.6	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240558	CHOYP_RAC1.3.3|m.57018	LAPITYPQGLAMAK	LAPITYPQGLAMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240559	CHOYP_RAC1.3.3|m.57018	NVFDEAIR	NVFDEAIR	11782354	5891177	3927451.333	2945588.5	2356470.8	1963725.667	1683193.429	1472794.25	1309150.444	1178235.4	1071123.091	981862.8333	906334.9231	841596.7143	785490.2667	736397.125	654575.2222	620123.8947	589117.7	490931.4167	471294.16	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240560	CHOYP_RAC1.3.3|m.57018	NVFDEAIR	NVFDEAIR	5640929	2820464.5	1880309.667	1410232.25	1128185.8	940154.8333	805847	705116.125	626769.8889	564092.9	512811.7273	470077.4167	433917.6154	402923.5	376061.9333	352558.0625	313384.9444	296891	282046.45	235038.7083	225637.16	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240561	CHOYP_RAC1.3.3|m.57018	NVFDEAIR	NVFDEAIR	1286548	643274	428849.3333	321637	257309.6	214424.6667	183792.5714	160818.5	142949.7778	128654.8	116958.9091	107212.3333	98965.23077	91896.28571	85769.86667	80409.25	71474.88889	67713.05263	64327.4	53606.16667	51461.92	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240562	CHOYP_RAC1.3.3|m.57018	NVFDEAIR	NVFDEAIR	1540930	770465	513643.3333	385232.5	308186	256821.6667	220132.8571	192616.25	171214.4444	154093	140084.5455	128410.8333	118533.0769	110066.4286	102728.6667	96308.125	85607.22222	81101.57895	77046.5	64205.41667	61637.2	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240563	CHOYP_RAC1.3.3|m.57018	NVFDEAIR	NVFDEAIR	1342404	671202	447468	335601	268480.8	223734	191772	167800.5	149156	134240.4	122036.7273	111867	103261.8462	95886	89493.6	83900.25	74578	70652.84211	67120.2	55933.5	53696.16	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
240564	CHOYP_RAC1.3.3|m.57018	NVFDEAIR	NVFDEAIR	492186	246093	164062	123046.5	98437.2	82031	70312.28571	61523.25	54687.33333	49218.6	44744.18182	41015.5	37860.46154	35156.14286	32812.4	30761.625	27343.66667	25904.52632	24609.3	20507.75	19687.44	Q6RUV5	Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)	Rac1	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell-cell junction organization [GO:0045216]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; G-protein coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of fibroblast migration [GO:0010762]; regulation of neuron maturation [GO:0014041]; regulation of respiratory burst [GO:0060263]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0000139; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003382; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005925; GO:0006935; GO:0006972; GO:0007015; GO:0007186; GO:0007411; GO:0008283; GO:0008361; GO:0010592; GO:0010762; GO:0014041; GO:0016020; GO:0016601; GO:0017137; GO:0019897; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030838; GO:0031410; GO:0031901; GO:0032587; GO:0032707; GO:0034446; GO:0036464; GO:0042470; GO:0042826; GO:0043552; GO:0043652; GO:0045216; GO:0045453; GO:0045740; GO:0048532; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0090023; GO:0090103; GO:0097178; GO:1900026
241103	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	4849074	2424537	1616358	1212268.5	969814.8	808179	692724.8571	606134.25	538786	484907.4	440824.9091	404089.5	373005.6923	346362.4286	323271.6	303067.125	269393	255214.4211	242453.7	202044.75	193962.96	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241104	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	3622185	1811092.5	1207395	905546.25	724437	603697.5	517455	452773.125	402465	362218.5	329289.5455	301848.75	278629.6154	258727.5	241479	226386.5625	201232.5	190641.3158	181109.25	150924.375	144887.4	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241105	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	1552035	776017.5	517345	388008.75	310407	258672.5	221719.2857	194004.375	172448.3333	155203.5	141094.0909	129336.25	119387.3077	110859.6429	103469	97002.1875	86224.16667	81686.05263	77601.75	64668.125	62081.4	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241106	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	20356	10178	6785.333333	5089	4071.2	3392.666667	2908	2544.5	2261.777778	2035.6	1850.545455	1696.333333	1565.846154	1454	1357.066667	1272.25	1130.888889	1071.368421	1017.8	848.1666667	814.24	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241107	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	161800	80900	53933.33333	40450	32360	26966.66667	23114.28571	20225	17977.77778	16180	14709.09091	13483.33333	12446.15385	11557.14286	10786.66667	10112.5	8988.888889	8515.789474	8090	6741.666667	6472	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241108	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	125094	62547	41698	31273.5	25018.8	20849	17870.57143	15636.75	13899.33333	12509.4	11372.18182	10424.5	9622.615385	8935.285714	8339.6	7818.375	6949.666667	6583.894737	6254.7	5212.25	5003.76	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241109	CHOYP_RAN.1.3|m.3468	GWGDDIEWK	GWGDDIEWK	132308	66154	44102.66667	33077	26461.6	22051.33333	18901.14286	16538.5	14700.88889	13230.8	12028	11025.66667	10177.53846	9450.571429	8820.533333	8269.25	7350.444444	6963.578947	6615.4	5512.833333	5292.32	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241110	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	5853318	2926659	1951106	1463329.5	1170663.6	975553	836188.2857	731664.75	650368.6667	585331.8	532119.8182	487776.5	450255.2308	418094.1429	390221.2	365832.375	325184.3333	308069.3684	292665.9	243888.25	234132.72	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241111	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241112	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	2156646	1078323	718882	539161.5	431329.2	359441	308092.2857	269580.75	239627.3333	215664.6	196058.7273	179720.5	165895.8462	154046.1429	143776.4	134790.375	119813.6667	113507.6842	107832.3	89860.25	86265.84	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241113	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	572271	286135.5	190757	143067.75	114454.2	95378.5	81753	71533.875	63585.66667	57227.1	52024.63636	47689.25	44020.84615	40876.5	38151.4	35766.9375	31792.83333	30119.52632	28613.55	23844.625	22890.84	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241114	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241115	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	1394913	697456.5	464971	348728.25	278982.6	232485.5	199273.2857	174364.125	154990.3333	139491.3	126810.2727	116242.75	107301	99636.64286	92994.2	87182.0625	77495.16667	73416.47368	69745.65	58121.375	55796.52	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241116	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241117	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241118	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	59312	29656	19770.66667	14828	11862.4	9885.333333	8473.142857	7414	6590.222222	5931.2	5392	4942.666667	4562.461538	4236.571429	3954.133333	3707	3295.111111	3121.684211	2965.6	2471.333333	2372.48	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241119	CHOYP_RAN.1.3|m.3468	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241120	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241121	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241122	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241123	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241124	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	275583	137791.5	91861	68895.75	55116.6	45930.5	39369	34447.875	30620.33333	27558.3	25053	22965.25	21198.69231	19684.5	18372.2	17223.9375	15310.16667	14504.36842	13779.15	11482.625	11023.32	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241125	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	279054	139527	93018	69763.5	55810.8	46509	39864.85714	34881.75	31006	27905.4	25368.54545	23254.5	21465.69231	19932.42857	18603.6	17440.875	15503	14687.05263	13952.7	11627.25	11162.16	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241126	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241127	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241128	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	89633	44816.5	29877.66667	22408.25	17926.6	14938.83333	12804.71429	11204.125	9959.222222	8963.3	8148.454545	7469.416667	6894.846154	6402.357143	5975.533333	5602.0625	4979.611111	4717.526316	4481.65	3734.708333	3585.32	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241129	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	358891	179445.5	119630.3333	89722.75	71778.2	59815.16667	51270.14286	44861.375	39876.77778	35889.1	32626.45455	29907.58333	27607	25635.07143	23926.06667	22430.6875	19938.38889	18889	17944.55	14953.79167	14355.64	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241130	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	84368	42184	28122.66667	21092	16873.6	14061.33333	12052.57143	10546	9374.222222	8436.8	7669.818182	7030.666667	6489.846154	6026.285714	5624.533333	5273	4687.111111	4440.421053	4218.4	3515.333333	3374.72	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
241131	CHOYP_RAN.1.3|m.3468	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
244907	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	14602823	7301411.5	4867607.667	3650705.75	2920564.6	2433803.833	2086117.571	1825352.875	1622535.889	1460282.3	1327529.364	1216901.917	1123294.077	1043058.786	973521.5333	912676.4375	811267.9444	768569.6316	730141.15	608450.9583	584112.92	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244908	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244909	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	10013054	5006527	3337684.667	2503263.5	2002610.8	1668842.333	1430436.286	1251631.75	1112561.556	1001305.4	910277.6364	834421.1667	770234.9231	715218.1429	667536.9333	625815.875	556280.7778	527002.8421	500652.7	417210.5833	400522.16	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244910	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244911	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	557521	278760.5	185840.3333	139380.25	111504.2	92920.16667	79645.85714	69690.125	61946.77778	55752.1	50683.72727	46460.08333	42886.23077	39822.92857	37168.06667	34845.0625	30973.38889	29343.21053	27876.05	23230.04167	22300.84	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244912	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	1539058	769529	513019.3333	384764.5	307811.6	256509.6667	219865.4286	192382.25	171006.4444	153905.8	139914.3636	128254.8333	118389.0769	109932.7143	102603.8667	96191.125	85503.22222	81003.05263	76952.9	64127.41667	61562.32	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244913	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	2855030	1427515	951676.6667	713757.5	571006	475838.3333	407861.4286	356878.75	317225.5556	285503	259548.1818	237919.1667	219617.6923	203930.7143	190335.3333	178439.375	158612.7778	150264.7368	142751.5	118959.5833	114201.2	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244914	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	1081423	540711.5	360474.3333	270355.75	216284.6	180237.1667	154489	135177.875	120158.1111	108142.3	98311.18182	90118.58333	83186.38462	77244.5	72094.86667	67588.9375	60079.05556	56917	54071.15	45059.29167	43256.92	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244915	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	1704959	852479.5	568319.6667	426239.75	340991.8	284159.8333	243565.5714	213119.875	189439.8889	170495.9	154996.2727	142079.9167	131150.6923	121782.7857	113663.9333	106559.9375	94719.94444	89734.68421	85247.95	71039.95833	68198.36	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244916	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	1880402	940201	626800.6667	470100.5	376080.4	313400.3333	268628.8571	235050.25	208933.5556	188040.2	170945.6364	156700.1667	144646.3077	134314.4286	125360.1333	117525.125	104466.7778	98968.52632	94020.1	78350.08333	75216.08	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244917	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	1223788	611894	407929.3333	305947	244757.6	203964.6667	174826.8571	152973.5	135976.4444	122378.8	111253.4545	101982.3333	94137.53846	87413.42857	81585.86667	76486.75	67988.22222	64409.89474	61189.4	50991.16667	48951.52	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244918	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	326116	163058	108705.3333	81529	65223.2	54352.66667	46588	40764.5	36235.11111	32611.6	29646.90909	27176.33333	25085.84615	23294	21741.06667	20382.25	18117.55556	17164	16305.8	13588.16667	13044.64	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244919	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244920	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	9652548	4826274	3217516	2413137	1930509.6	1608758	1378935.429	1206568.5	1072505.333	965254.8	877504.3636	804379	742503.6923	689467.7143	643503.2	603284.25	536252.6667	508028.8421	482627.4	402189.5	386101.92	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244921	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	7692804	3846402	2564268	1923201	1538560.8	1282134	1098972	961600.5	854756	769280.4	699345.8182	641067	591754.1538	549486	512853.6	480800.25	427378	404884.4211	384640.2	320533.5	307712.16	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244922	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	4288185	2144092.5	1429395	1072046.25	857637	714697.5	612597.8571	536023.125	476465	428818.5	389835	357348.75	329860.3846	306298.9286	285879	268011.5625	238232.5	225693.9474	214409.25	178674.375	171527.4	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244923	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244924	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244925	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	97571	48785.5	32523.66667	24392.75	19514.2	16261.83333	13938.71429	12196.375	10841.22222	9757.1	8870.090909	8130.916667	7505.461538	6969.357143	6504.733333	6098.1875	5420.611111	5135.315789	4878.55	4065.458333	3902.84	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244926	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	696009	348004.5	232003	174002.25	139201.8	116001.5	99429.85714	87001.125	77334.33333	69600.9	63273.54545	58000.75	53539.15385	49714.92857	46400.6	43500.5625	38667.16667	36632.05263	34800.45	29000.375	27840.36	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244927	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244928	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244929	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	308793	154396.5	102931	77198.25	61758.6	51465.5	44113.28571	38599.125	34310.33333	30879.3	28072.09091	25732.75	23753.30769	22056.64286	20586.2	19299.5625	17155.16667	16252.26316	15439.65	12866.375	12351.72	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244930	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	322175	161087.5	107391.6667	80543.75	64435	53695.83333	46025	40271.875	35797.22222	32217.5	29288.63636	26847.91667	24782.69231	23012.5	21478.33333	20135.9375	17898.61111	16956.57895	16108.75	13423.95833	12887	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244931	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	63913	31956.5	21304.33333	15978.25	12782.6	10652.16667	9130.428571	7989.125	7101.444444	6391.3	5810.272727	5326.083333	4916.384615	4565.214286	4260.866667	3994.5625	3550.722222	3363.842105	3195.65	2663.041667	2556.52	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244932	CHOYP_RL40.1.7|m.3623	MDGDYLTVVHSFEAK	MDGDYLTVVHSFEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244933	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	22587330	11293665	7529110	5646832.5	4517466	3764555	3226761.429	2823416.25	2509703.333	2258733	2053393.636	1882277.5	1737486.923	1613380.714	1505822	1411708.125	1254851.667	1188806.842	1129366.5	941138.75	903493.2	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244934	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	25178330	12589165	8392776.667	6294582.5	5035666	4196388.333	3596904.286	3147291.25	2797592.222	2517833	2288939.091	2098194.167	1936794.615	1798452.143	1678555.333	1573645.625	1398796.111	1325175.263	1258916.5	1049097.083	1007133.2	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244935	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	5213122	2606561	1737707.333	1303280.5	1042624.4	868853.6667	744731.7143	651640.25	579235.7778	521312.2	473920.1818	434426.8333	401009.3846	372365.8571	347541.4667	325820.125	289617.8889	274374.8421	260656.1	217213.4167	208524.88	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244936	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	250358	125179	83452.66667	62589.5	50071.6	41726.33333	35765.42857	31294.75	27817.55556	25035.8	22759.81818	20863.16667	19258.30769	17882.71429	16690.53333	15647.375	13908.77778	13176.73684	12517.9	10431.58333	10014.32	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244937	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	2477684	1238842	825894.6667	619421	495536.8	412947.3333	353954.8571	309710.5	275298.2222	247768.4	225244	206473.6667	190591.0769	176977.4286	165178.9333	154855.25	137649.1111	130404.4211	123884.2	103236.8333	99107.36	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244938	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	1753340	876670	584446.6667	438335	350668	292223.3333	250477.1429	219167.5	194815.5556	175334	159394.5455	146111.6667	134872.3077	125238.5714	116889.3333	109583.75	97407.77778	92281.05263	87667	73055.83333	70133.6	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244939	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	748279	374139.5	249426.3333	187069.75	149655.8	124713.1667	106897	93534.875	83142.11111	74827.9	68025.36364	62356.58333	57559.92308	53448.5	49885.26667	46767.4375	41571.05556	39383.10526	37413.95	31178.29167	29931.16	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244940	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	725269	362634.5	241756.3333	181317.25	145053.8	120878.1667	103609.8571	90658.625	80585.44444	72526.9	65933.54545	60439.08333	55789.92308	51804.92857	48351.26667	45329.3125	40292.72222	38172.05263	36263.45	30219.54167	29010.76	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244941	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	80238	40119	26746	20059.5	16047.6	13373	11462.57143	10029.75	8915.333333	8023.8	7294.363636	6686.5	6172.153846	5731.285714	5349.2	5014.875	4457.666667	4223.052632	4011.9	3343.25	3209.52	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244942	CHOYP_RL40.1.7|m.3623	SISHAALGSDVK	SISHAALGSDVK	46164	23082	15388	11541	9232.8	7694	6594.857143	5770.5	5129.333333	4616.4	4196.727273	3847	3551.076923	3297.428571	3077.6	2885.25	2564.666667	2429.684211	2308.2	1923.5	1846.56	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244943	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	83034480	41517240	27678160	20758620	16606896	13839080	11862068.57	10379310	9226053.333	8303448	7548589.091	6919540	6387267.692	5931034.286	5535632	5189655	4613026.667	4370235.789	4151724	3459770	3321379.2	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244944	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	50384292	25192146	16794764	12596073	10076858.4	8397382	7197756	6298036.5	5598254.667	5038429.2	4580390.182	4198691	3875714.769	3598878	3358952.8	3149018.25	2799127.333	2651804.842	2519214.6	2099345.5	2015371.68	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244945	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	14939578	7469789	4979859.333	3734894.5	2987915.6	2489929.667	2134225.429	1867447.25	1659953.111	1493957.8	1358143.455	1244964.833	1149198.308	1067112.714	995971.8667	933723.625	829976.5556	786293.5789	746978.9	622482.4167	597583.12	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244946	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	900031	450015.5	300010.3333	225007.75	180006.2	150005.1667	128575.8571	112503.875	100003.4444	90003.1	81821	75002.58333	69233.15385	64287.92857	60002.06667	56251.9375	50001.72222	47370.05263	45001.55	37501.29167	36001.24	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244947	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	3788687	1894343.5	1262895.667	947171.75	757737.4	631447.8333	541241	473585.875	420965.2222	378868.7	344426.0909	315723.9167	291437.4615	270620.5	252579.1333	236792.9375	210482.6111	199404.5789	189434.35	157861.9583	151547.48	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244948	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	11550321	5775160.5	3850107	2887580.25	2310064.2	1925053.5	1650045.857	1443790.125	1283369	1155032.1	1050029.182	962526.75	888486.2308	825022.9286	770021.4	721895.0625	641684.5	607911.6316	577516.05	481263.375	462012.84	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244949	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	4662161	2331080.5	1554053.667	1165540.25	932432.2	777026.8333	666023	582770.125	518017.8889	466216.1	423832.8182	388513.4167	358627.7692	333011.5	310810.7333	291385.0625	259008.9444	245376.8947	233108.05	194256.7083	186486.44	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244950	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	3316129	1658064.5	1105376.333	829032.25	663225.8	552688.1667	473732.7143	414516.125	368458.7778	331612.9	301466.2727	276344.0833	255086.8462	236866.3571	221075.2667	207258.0625	184229.3889	174533.1053	165806.45	138172.0417	132645.16	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
244951	CHOYP_RL40.1.7|m.3623	ALGNVLEEEAK	ALGNVLEEEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74148	Universal stress protein Sll1388 (USP Sll1388)	sll1388	response to stress [GO:0006950]	GO:0006950
247356	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	46850780	23425390	15616926.67	11712695	9370156	7808463.333	6692968.571	5856347.5	5205642.222	4685078	4259161.818	3904231.667	3603906.154	3346484.286	3123385.333	2928173.75	2602821.111	2465830.526	2342539	1952115.833	1874031.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247357	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	29077112	14538556	9692370.667	7269278	5815422.4	4846185.333	4153873.143	3634639	3230790.222	2907711.2	2643373.818	2423092.667	2236700.923	2076936.571	1938474.133	1817319.5	1615395.111	1530374.316	1453855.6	1211546.333	1163084.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247358	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	12124320	6062160	4041440	3031080	2424864	2020720	1732045.714	1515540	1347146.667	1212432	1102210.909	1010360	932640	866022.8571	808288	757770	673573.3333	638122.1053	606216	505180	484972.8	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247359	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	280900	140450	93633.33333	70225	56180	46816.66667	40128.57143	35112.5	31211.11111	28090	25536.36364	23408.33333	21607.69231	20064.28571	18726.66667	17556.25	15605.55556	14784.21053	14045	11704.16667	11236	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247360	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	2438919	1219459.5	812973	609729.75	487783.8	406486.5	348417	304864.875	270991	243891.9	221719.9091	203243.25	187609.1538	174208.5	162594.6	152432.4375	135495.5	128364.1579	121945.95	101621.625	97556.76	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247361	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	8162578	4081289	2720859.333	2040644.5	1632515.6	1360429.667	1166082.571	1020322.25	906953.1111	816257.8	742052.5455	680214.8333	627890.6154	583041.2857	544171.8667	510161.125	453476.5556	429609.3684	408128.9	340107.4167	326503.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247362	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247363	CHOYP_RNP1B.1.1|m.59889	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247364	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	88675256	44337628	29558418.67	22168814	17735051.2	14779209.33	12667893.71	11084407	9852806.222	8867525.6	8061386.909	7389604.667	6821173.538	6333946.857	5911683.733	5542203.5	4926403.111	4667118.737	4433762.8	3694802.333	3547010.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247365	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	42837028	21418514	14279009.33	10709257	8567405.6	7139504.667	6119575.429	5354628.5	4759669.778	4283702.8	3894275.273	3569752.333	3295156	3059787.714	2855801.867	2677314.25	2379834.889	2254580.421	2141851.4	1784876.167	1713481.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247366	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	13505777	6752888.5	4501925.667	3376444.25	2701155.4	2250962.833	1929396.714	1688222.125	1500641.889	1350577.7	1227797.909	1125481.417	1038905.923	964698.3571	900385.1333	844111.0625	750320.9444	710830.3684	675288.85	562740.7083	540231.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247367	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	17586380	8793190	5862126.667	4396595	3517276	2931063.333	2512340	2198297.5	1954042.222	1758638	1598761.818	1465531.667	1352798.462	1256170	1172425.333	1099148.75	977021.1111	925598.9474	879319	732765.8333	703455.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247368	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	4105488	2052744	1368496	1026372	821097.6	684248	586498.2857	513186	456165.3333	410548.8	373226.1818	342124	315806.7692	293249.1429	273699.2	256593	228082.6667	216078.3158	205274.4	171062	164219.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247369	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	9652707	4826353.5	3217569	2413176.75	1930541.4	1608784.5	1378958.143	1206588.375	1072523	965270.7	877518.8182	804392.25	742515.9231	689479.0714	643513.8	603294.1875	536261.5	508037.2105	482635.35	402196.125	386108.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247370	CHOYP_RNP1B.1.1|m.59889	VSVSDGMVR	VSVSDGMVR	213204	106602	71068	53301	42640.8	35534	30457.71429	26650.5	23689.33333	21320.4	19382.18182	17767	16400.30769	15228.85714	14213.6	13325.25	11844.66667	11221.26316	10660.2	8883.5	8528.16	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247371	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247372	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247373	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247374	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247375	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247376	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247377	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247378	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247379	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247380	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247381	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247382	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247383	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247384	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247385	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247386	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247387	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247388	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247389	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247390	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247391	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247392	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247393	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247394	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247395	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247396	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247397	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247398	CHOYP_RNP1B.1.1|m.59893	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247399	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	170090	85045	56696.66667	42522.5	34018	28348.33333	24298.57143	21261.25	18898.88889	17009	15462.72727	14174.16667	13083.84615	12149.28571	11339.33333	10630.625	9449.444444	8952.105263	8504.5	7087.083333	6803.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247400	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	567582	283791	189194	141895.5	113516.4	94597	81083.14286	70947.75	63064.66667	56758.2	51598.36364	47298.5	43660.15385	40541.57143	37838.8	35473.875	31532.33333	29872.73684	28379.1	23649.25	22703.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247401	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247402	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247403	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	75461	37730.5	25153.66667	18865.25	15092.2	12576.83333	10780.14286	9432.625	8384.555556	7546.1	6860.090909	6288.416667	5804.692308	5390.071429	5030.733333	4716.3125	4192.277778	3971.631579	3773.05	3144.208333	3018.44	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247404	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247405	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247406	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247407	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
247408	CHOYP_RNP1B.1.1|m.59893	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
250773	CHOYP_RS21.1.4|m.13400	SEFDSTIK	SEFDSTIK	87165568	43582784	29055189.33	21791392	17433113.6	14527594.67	12452224	10895696	9685063.111	8716556.8	7924142.545	7263797.333	6705043.692	6226112	5811037.867	5447848	4842531.556	4587661.474	4358278.4	3631898.667	3486622.72	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250774	CHOYP_RS21.1.4|m.13400	SEFDSTIK	SEFDSTIK	40266908	20133454	13422302.67	10066727	8053381.6	6711151.333	5752415.429	5033363.5	4474100.889	4026690.8	3660628	3355575.667	3097454.462	2876207.714	2684460.533	2516681.75	2237050.444	2119310.947	2013345.4	1677787.833	1610676.32	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250775	CHOYP_RS21.1.4|m.13400	SEFDSTIK	SEFDSTIK	12134360	6067180	4044786.667	3033590	2426872	2022393.333	1733480	1516795	1348262.222	1213436	1103123.636	1011196.667	933412.3077	866740	808957.3333	758397.5	674131.1111	638650.5263	606718	505598.3333	485374.4	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250776	CHOYP_RS21.1.4|m.13400	SEFDSTIK	SEFDSTIK	6467057	3233528.5	2155685.667	1616764.25	1293411.4	1077842.833	923865.2857	808382.125	718561.8889	646705.7	587914.2727	538921.4167	497465.9231	461932.6429	431137.1333	404191.0625	359280.9444	340371.4211	323352.85	269460.7083	258682.28	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250777	CHOYP_RS21.1.4|m.13400	SEFDSTIK	SEFDSTIK	6108834	3054417	2036278	1527208.5	1221766.8	1018139	872690.5714	763604.25	678759.3333	610883.4	555348.5455	509069.5	469910.3077	436345.2857	407255.6	381802.125	339379.6667	321517.5789	305441.7	254534.75	244353.36	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250778	CHOYP_RS21.1.4|m.13400	SEFDSTIK	SEFDSTIK	1459291	729645.5	486430.3333	364822.75	291858.2	243215.1667	208470.1429	182411.375	162143.4444	145929.1	132662.8182	121607.5833	112253.1538	104235.0714	97286.06667	91205.6875	81071.72222	76804.78947	72964.55	60803.79167	58371.64	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250779	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250780	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250781	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250782	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	3579000	1789500	1193000	894750	715800	596500	511285.7143	447375	397666.6667	357900	325363.6364	298250	275307.6923	255642.8571	238600	223687.5	198833.3333	188368.4211	178950	149125	143160	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250783	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250784	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	5770885	2885442.5	1923628.333	1442721.25	1154177	961814.1667	824412.1429	721360.625	641209.4444	577088.5	524625.9091	480907.0833	443914.2308	412206.0714	384725.6667	360680.3125	320604.7222	303730.7895	288544.25	240453.5417	230835.4	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250785	CHOYP_RS21.1.4|m.13400	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250786	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	49446776	24723388	16482258.67	12361694	9889355.2	8241129.333	7063825.143	6180847	5494086.222	4944677.6	4495161.455	4120564.667	3803598.154	3531912.571	3296451.733	3090423.5	2747043.111	2602461.895	2472338.8	2060282.333	1977871.04	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250787	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	25666204	12833102	8555401.333	6416551	5133240.8	4277700.667	3666600.571	3208275.5	2851800.444	2566620.4	2333291.273	2138850.333	1974323.385	1833300.286	1711080.267	1604137.75	1425900.222	1350852.842	1283310.2	1069425.167	1026648.16	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250788	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	13801096	6900548	4600365.333	3450274	2760219.2	2300182.667	1971585.143	1725137	1533455.111	1380109.6	1254645.091	1150091.333	1061622.769	985792.5714	920073.0667	862568.5	766727.5556	726373.4737	690054.8	575045.6667	552043.84	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250789	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	4354904	2177452	1451634.667	1088726	870980.8	725817.3333	622129.1429	544363	483878.2222	435490.4	395900.3636	362908.6667	334992.6154	311064.5714	290326.9333	272181.5	241939.1111	229205.4737	217745.2	181454.3333	174196.16	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250790	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	9834097	4917048.5	3278032.333	2458524.25	1966819.4	1639016.167	1404871	1229262.125	1092677.444	983409.7	894008.8182	819508.0833	756469	702435.5	655606.4667	614631.0625	546338.7222	517584.0526	491704.85	409754.0417	393363.88	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250791	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	9525735	4762867.5	3175245	2381433.75	1905147	1587622.5	1360819.286	1190716.875	1058415	952573.5	865975.9091	793811.25	732748.8462	680409.6429	635049	595358.4375	529207.5	501354.4737	476286.75	396905.625	381029.4	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250792	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	1259526	629763	419842	314881.5	251905.2	209921	179932.2857	157440.75	139947.3333	125952.6	114502.3636	104960.5	96886.61538	89966.14286	83968.4	78720.375	69973.66667	66290.84211	62976.3	52480.25	50381.04	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
250793	CHOYP_RS21.1.4|m.13400	VGEVVGANEK	VGEVVGANEK	1894323	947161.5	631441	473580.75	378864.6	315720.5	270617.5714	236790.375	210480.3333	189432.3	172211.1818	157860.25	145717.1538	135308.7857	126288.2	118395.1875	105240.1667	99701.21053	94716.15	78930.125	75772.92	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254536	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	46850780	23425390	15616926.67	11712695	9370156	7808463.333	6692968.571	5856347.5	5205642.222	4685078	4259161.818	3904231.667	3603906.154	3346484.286	3123385.333	2928173.75	2602821.111	2465830.526	2342539	1952115.833	1874031.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254537	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	29077112	14538556	9692370.667	7269278	5815422.4	4846185.333	4153873.143	3634639	3230790.222	2907711.2	2643373.818	2423092.667	2236700.923	2076936.571	1938474.133	1817319.5	1615395.111	1530374.316	1453855.6	1211546.333	1163084.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254538	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	12124320	6062160	4041440	3031080	2424864	2020720	1732045.714	1515540	1347146.667	1212432	1102210.909	1010360	932640	866022.8571	808288	757770	673573.3333	638122.1053	606216	505180	484972.8	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254539	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	280900	140450	93633.33333	70225	56180	46816.66667	40128.57143	35112.5	31211.11111	28090	25536.36364	23408.33333	21607.69231	20064.28571	18726.66667	17556.25	15605.55556	14784.21053	14045	11704.16667	11236	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254540	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	2438919	1219459.5	812973	609729.75	487783.8	406486.5	348417	304864.875	270991	243891.9	221719.9091	203243.25	187609.1538	174208.5	162594.6	152432.4375	135495.5	128364.1579	121945.95	101621.625	97556.76	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254541	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	8162578	4081289	2720859.333	2040644.5	1632515.6	1360429.667	1166082.571	1020322.25	906953.1111	816257.8	742052.5455	680214.8333	627890.6154	583041.2857	544171.8667	510161.125	453476.5556	429609.3684	408128.9	340107.4167	326503.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254542	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254543	CHOYP_RSMB.2.2|m.37626	LDGFHPDEVK	LDGFHPDEVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254544	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	88675256	44337628	29558418.67	22168814	17735051.2	14779209.33	12667893.71	11084407	9852806.222	8867525.6	8061386.909	7389604.667	6821173.538	6333946.857	5911683.733	5542203.5	4926403.111	4667118.737	4433762.8	3694802.333	3547010.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254545	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	42837028	21418514	14279009.33	10709257	8567405.6	7139504.667	6119575.429	5354628.5	4759669.778	4283702.8	3894275.273	3569752.333	3295156	3059787.714	2855801.867	2677314.25	2379834.889	2254580.421	2141851.4	1784876.167	1713481.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254546	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	13505777	6752888.5	4501925.667	3376444.25	2701155.4	2250962.833	1929396.714	1688222.125	1500641.889	1350577.7	1227797.909	1125481.417	1038905.923	964698.3571	900385.1333	844111.0625	750320.9444	710830.3684	675288.85	562740.7083	540231.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254547	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	17586380	8793190	5862126.667	4396595	3517276	2931063.333	2512340	2198297.5	1954042.222	1758638	1598761.818	1465531.667	1352798.462	1256170	1172425.333	1099148.75	977021.1111	925598.9474	879319	732765.8333	703455.2	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254548	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	4105488	2052744	1368496	1026372	821097.6	684248	586498.2857	513186	456165.3333	410548.8	373226.1818	342124	315806.7692	293249.1429	273699.2	256593	228082.6667	216078.3158	205274.4	171062	164219.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254549	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	9652707	4826353.5	3217569	2413176.75	1930541.4	1608784.5	1378958.143	1206588.375	1072523	965270.7	877518.8182	804392.25	742515.9231	689479.0714	643513.8	603294.1875	536261.5	508037.2105	482635.35	402196.125	386108.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254550	CHOYP_RSMB.2.2|m.37626	VSVSDGMVR	VSVSDGMVR	213204	106602	71068	53301	42640.8	35534	30457.71429	26650.5	23689.33333	21320.4	19382.18182	17767	16400.30769	15228.85714	14213.6	13325.25	11844.66667	11221.26316	10660.2	8883.5	8528.16	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254551	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	60122472	30061236	20040824	15030618	12024494.4	10020412	8588924.571	7515309	6680274.667	6012247.2	5465679.273	5010206	4624805.538	4294462.286	4008164.8	3757654.5	3340137.333	3164340.632	3006123.6	2505103	2404898.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254552	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	54476568	27238284	18158856	13619142	10895313.6	9079428	7782366.857	6809571	6052952	5447656.8	4952415.273	4539714	4190505.231	3891183.429	3631771.2	3404785.5	3026476	2867187.789	2723828.4	2269857	2179062.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254553	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	32369490	16184745	10789830	8092372.5	6473898	5394915	4624212.857	4046186.25	3596610	3236949	2942680.909	2697457.5	2489960.769	2312106.429	2157966	2023093.125	1798305	1703657.368	1618474.5	1348728.75	1294779.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254554	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	908809	454404.5	302936.3333	227202.25	181761.8	151468.1667	129829.8571	113601.125	100978.7778	90880.9	82619	75734.08333	69908.38462	64914.92857	60587.26667	56800.5625	50489.38889	47832.05263	45440.45	37867.04167	36352.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254555	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254556	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	8313272	4156636	2771090.667	2078318	1662654.4	1385545.333	1187610.286	1039159	923696.8889	831327.2	755752	692772.6667	639482.4615	593805.1429	554218.1333	519579.5	461848.4444	437540.6316	415663.6	346386.3333	332530.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254557	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	4440393	2220196.5	1480131	1110098.25	888078.6	740065.5	634341.8571	555049.125	493377	444039.3	403672.0909	370032.75	341568.6923	317170.9286	296026.2	277524.5625	246688.5	233704.8947	222019.65	185016.375	177615.72	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254558	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10063587	5031793.5	3354529	2515896.75	2012717.4	1677264.5	1437655.286	1257948.375	1118176.333	1006358.7	914871.5455	838632.25	774122.0769	718827.6429	670905.8	628974.1875	559088.1667	529662.4737	503179.35	419316.125	402543.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254559	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	3157631	1578815.5	1052543.667	789407.75	631526.2	526271.8333	451090.1429	394703.875	350847.8889	315763.1	287057.3636	263135.9167	242894.6923	225545.0714	210508.7333	197351.9375	175423.9444	166191.1053	157881.55	131567.9583	126305.24	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254560	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	10566971	5283485.5	3522323.667	2641742.75	2113394.2	1761161.833	1509567.286	1320871.375	1174107.889	1056697.1	960633.7273	880580.9167	812843.9231	754783.6429	704464.7333	660435.6875	587053.9444	556156.3684	528348.55	440290.4583	422678.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254561	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254562	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254563	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1149352	574676	383117.3333	287338	229870.4	191558.6667	164193.1429	143669	127705.7778	114935.2	104486.5455	95779.33333	88411.69231	82096.57143	76623.46667	71834.5	63852.88889	60492.21053	57467.6	47889.66667	45974.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254564	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1697209	848604.5	565736.3333	424302.25	339441.8	282868.1667	242458.4286	212151.125	188578.7778	169720.9	154291.7273	141434.0833	130554.5385	121229.2143	113147.2667	106075.5625	94289.38889	89326.78947	84860.45	70717.04167	67888.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254565	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	30774116	15387058	10258038.67	7693529	6154823.2	5129019.333	4396302.286	3846764.5	3419346.222	3077411.6	2797646.909	2564509.667	2367239.692	2198151.143	2051607.733	1923382.25	1709673.111	1619690.316	1538705.8	1282254.833	1230964.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254566	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	29549296	14774648	9849765.333	7387324	5909859.2	4924882.667	4221328	3693662	3283255.111	2954929.6	2686299.636	2462441.333	2273022.769	2110664	1969953.067	1846831	1641627.556	1555226.105	1477464.8	1231220.667	1181971.84	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254567	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	17856150	8928075	5952050	4464037.5	3571230	2976025	2550878.571	2232018.75	1984016.667	1785615	1623286.364	1488012.5	1373550	1275439.286	1190410	1116009.375	992008.3333	939797.3684	892807.5	744006.25	714246	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254568	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254569	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254570	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	228572	114286	76190.66667	57143	45714.4	38095.33333	32653.14286	28571.5	25396.88889	22857.2	20779.27273	19047.66667	17582.46154	16326.57143	15238.13333	14285.75	12698.44444	12030.10526	11428.6	9523.833333	9142.88	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254571	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	93753	46876.5	31251	23438.25	18750.6	15625.5	13393.28571	11719.125	10417	9375.3	8523	7812.75	7211.769231	6696.642857	6250.2	5859.5625	5208.5	4934.368421	4687.65	3906.375	3750.12	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254572	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	2694649	1347324.5	898216.3333	673662.25	538929.8	449108.1667	384949.8571	336831.125	299405.4444	269464.9	244968.0909	224554.0833	207280.6923	192474.9286	179643.2667	168415.5625	149702.7222	141823.6316	134732.45	112277.0417	107785.96	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254573	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	1388912	694456	462970.6667	347228	277782.4	231485.3333	198416	173614	154323.5556	138891.2	126264.7273	115742.6667	106839.3846	99208	92594.13333	86807	77161.77778	73100.63158	69445.6	57871.33333	55556.48	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254574	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	6833709	3416854.5	2277903	1708427.25	1366741.8	1138951.5	976244.1429	854213.625	759301	683370.9	621246.2727	569475.75	525669.9231	488122.0714	455580.6	427106.8125	379650.5	359668.8947	341685.45	284737.875	273348.36	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254575	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	289891	144945.5	96630.33333	72472.75	57978.2	48315.16667	41413	36236.375	32210.11111	28989.1	26353.72727	24157.58333	22299.30769	20706.5	19326.06667	18118.1875	16105.05556	15257.42105	14494.55	12078.79167	11595.64	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254576	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	366202	183101	122067.3333	91550.5	73240.4	61033.66667	52314.57143	45775.25	40689.11111	36620.2	33291.09091	30516.83333	28169.38462	26157.28571	24413.46667	22887.625	20344.55556	19273.78947	18310.1	15258.41667	14648.08	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254577	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	555023	277511.5	185007.6667	138755.75	111004.6	92503.83333	79289	69377.875	61669.22222	55502.3	50456.63636	46251.91667	42694.07692	39644.5	37001.53333	34688.9375	30834.61111	29211.73684	27751.15	23125.95833	22200.92	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254578	CHOYP_RSMB.2.2|m.37626	ESLDLSVFEPDHINVK	ESLDLSVFEPDHINVK	604738	302369	201579.3333	151184.5	120947.6	100789.6667	86391.14286	75592.25	67193.11111	60473.8	54976.18182	50394.83333	46518.30769	43195.57143	40315.86667	37796.125	33596.55556	31828.31579	30236.9	25197.41667	24189.52	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254579	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	170090	85045	56696.66667	42522.5	34018	28348.33333	24298.57143	21261.25	18898.88889	17009	15462.72727	14174.16667	13083.84615	12149.28571	11339.33333	10630.625	9449.444444	8952.105263	8504.5	7087.083333	6803.6	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254580	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	567582	283791	189194	141895.5	113516.4	94597	81083.14286	70947.75	63064.66667	56758.2	51598.36364	47298.5	43660.15385	40541.57143	37838.8	35473.875	31532.33333	29872.73684	28379.1	23649.25	22703.28	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254581	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254582	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254583	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	75461	37730.5	25153.66667	18865.25	15092.2	12576.83333	10780.14286	9432.625	8384.555556	7546.1	6860.090909	6288.416667	5804.692308	5390.071429	5030.733333	4716.3125	4192.277778	3971.631579	3773.05	3144.208333	3018.44	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254584	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254585	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254586	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254587	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254588	CHOYP_RSMB.2.2|m.37626	GNIISVSADHDK	GNIISVSADHDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04792	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	HSPB1 HSP27 HSP28	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028
254933	CHOYP_RTJK.3.3|m.35968	SEFDSTIK	SEFDSTIK	87165568	43582784	29055189.33	21791392	17433113.6	14527594.67	12452224	10895696	9685063.111	8716556.8	7924142.545	7263797.333	6705043.692	6226112	5811037.867	5447848	4842531.556	4587661.474	4358278.4	3631898.667	3486622.72	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254934	CHOYP_RTJK.3.3|m.35968	SEFDSTIK	SEFDSTIK	40266908	20133454	13422302.67	10066727	8053381.6	6711151.333	5752415.429	5033363.5	4474100.889	4026690.8	3660628	3355575.667	3097454.462	2876207.714	2684460.533	2516681.75	2237050.444	2119310.947	2013345.4	1677787.833	1610676.32	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254935	CHOYP_RTJK.3.3|m.35968	SEFDSTIK	SEFDSTIK	12134360	6067180	4044786.667	3033590	2426872	2022393.333	1733480	1516795	1348262.222	1213436	1103123.636	1011196.667	933412.3077	866740	808957.3333	758397.5	674131.1111	638650.5263	606718	505598.3333	485374.4	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254936	CHOYP_RTJK.3.3|m.35968	SEFDSTIK	SEFDSTIK	6467057	3233528.5	2155685.667	1616764.25	1293411.4	1077842.833	923865.2857	808382.125	718561.8889	646705.7	587914.2727	538921.4167	497465.9231	461932.6429	431137.1333	404191.0625	359280.9444	340371.4211	323352.85	269460.7083	258682.28	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254937	CHOYP_RTJK.3.3|m.35968	SEFDSTIK	SEFDSTIK	6108834	3054417	2036278	1527208.5	1221766.8	1018139	872690.5714	763604.25	678759.3333	610883.4	555348.5455	509069.5	469910.3077	436345.2857	407255.6	381802.125	339379.6667	321517.5789	305441.7	254534.75	244353.36	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254938	CHOYP_RTJK.3.3|m.35968	SEFDSTIK	SEFDSTIK	1459291	729645.5	486430.3333	364822.75	291858.2	243215.1667	208470.1429	182411.375	162143.4444	145929.1	132662.8182	121607.5833	112253.1538	104235.0714	97286.06667	91205.6875	81071.72222	76804.78947	72964.55	60803.79167	58371.64	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254939	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254940	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254941	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254942	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	3579000	1789500	1193000	894750	715800	596500	511285.7143	447375	397666.6667	357900	325363.6364	298250	275307.6923	255642.8571	238600	223687.5	198833.3333	188368.4211	178950	149125	143160	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254943	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254944	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	5770885	2885442.5	1923628.333	1442721.25	1154177	961814.1667	824412.1429	721360.625	641209.4444	577088.5	524625.9091	480907.0833	443914.2308	412206.0714	384725.6667	360680.3125	320604.7222	303730.7895	288544.25	240453.5417	230835.4	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254945	CHOYP_RTJK.3.3|m.35968	EYSGVVFIK	EYSGVVFIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254946	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	49446776	24723388	16482258.67	12361694	9889355.2	8241129.333	7063825.143	6180847	5494086.222	4944677.6	4495161.455	4120564.667	3803598.154	3531912.571	3296451.733	3090423.5	2747043.111	2602461.895	2472338.8	2060282.333	1977871.04	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254947	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	25666204	12833102	8555401.333	6416551	5133240.8	4277700.667	3666600.571	3208275.5	2851800.444	2566620.4	2333291.273	2138850.333	1974323.385	1833300.286	1711080.267	1604137.75	1425900.222	1350852.842	1283310.2	1069425.167	1026648.16	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254948	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	13801096	6900548	4600365.333	3450274	2760219.2	2300182.667	1971585.143	1725137	1533455.111	1380109.6	1254645.091	1150091.333	1061622.769	985792.5714	920073.0667	862568.5	766727.5556	726373.4737	690054.8	575045.6667	552043.84	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254949	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	4354904	2177452	1451634.667	1088726	870980.8	725817.3333	622129.1429	544363	483878.2222	435490.4	395900.3636	362908.6667	334992.6154	311064.5714	290326.9333	272181.5	241939.1111	229205.4737	217745.2	181454.3333	174196.16	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254950	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	9834097	4917048.5	3278032.333	2458524.25	1966819.4	1639016.167	1404871	1229262.125	1092677.444	983409.7	894008.8182	819508.0833	756469	702435.5	655606.4667	614631.0625	546338.7222	517584.0526	491704.85	409754.0417	393363.88	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254951	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	9525735	4762867.5	3175245	2381433.75	1905147	1587622.5	1360819.286	1190716.875	1058415	952573.5	865975.9091	793811.25	732748.8462	680409.6429	635049	595358.4375	529207.5	501354.4737	476286.75	396905.625	381029.4	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254952	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	1259526	629763	419842	314881.5	251905.2	209921	179932.2857	157440.75	139947.3333	125952.6	114502.3636	104960.5	96886.61538	89966.14286	83968.4	78720.375	69973.66667	66290.84211	62976.3	52480.25	50381.04	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
254953	CHOYP_RTJK.3.3|m.35968	VGEVVGANEK	VGEVVGANEK	1894323	947161.5	631441	473580.75	378864.6	315720.5	270617.5714	236790.375	210480.3333	189432.3	172211.1818	157860.25	145717.1538	135308.7857	126288.2	118395.1875	105240.1667	99701.21053	94716.15	78930.125	75772.92	O14463	Thioredoxin-1 (TR-1) (Trx-1)	trx1 trx2 SPAC7D4.07c	"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine biosynthetic process from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; protein folding [GO:0006457]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]"	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006662; GO:0015035; GO:0016209; GO:0016671; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:1900409; GO:1990355
256441	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	89922672	44961336	29974224	22480668	17984534.4	14987112	12846096	11240334	9991408	8992267.2	8174788.364	7493556	6917128.615	6423048	5994844.8	5620167	4995704	4732772.211	4496133.6	3746778	3596906.88	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256442	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	56376732	28188366	18792244	14094183	11275346.4	9396122	8053818.857	7047091.5	6264081.333	5637673.2	5125157.455	4698061	4336671.692	4026909.429	3758448.8	3523545.75	3132040.667	2967196.421	2818836.6	2349030.5	2255069.28	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256443	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	17493822	8746911	5831274	4373455.5	3498764.4	2915637	2499117.429	2186727.75	1943758	1749382.2	1590347.455	1457818.5	1345678.615	1249558.714	1166254.8	1093363.875	971879	920727.4737	874691.1	728909.25	699752.88	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256444	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	9596298	4798149	3198766	2399074.5	1919259.6	1599383	1370899.714	1199537.25	1066255.333	959629.8	872390.7273	799691.5	738176.7692	685449.8571	639753.2	599768.625	533127.6667	505068.3158	479814.9	399845.75	383851.92	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256445	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	10079618	5039809	3359872.667	2519904.5	2015923.6	1679936.333	1439945.429	1259952.25	1119957.556	1007961.8	916328.9091	839968.1667	775355.2308	719972.7143	671974.5333	629976.125	559978.7778	530506.2105	503980.9	419984.0833	403184.72	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256446	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	8583982	4291991	2861327.333	2145995.5	1716796.4	1430663.667	1226283.143	1072997.75	953775.7778	858398.2	780362	715331.8333	660306.3077	613141.5714	572265.4667	536498.875	476887.8889	451788.5263	429199.1	357665.9167	343359.28	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256447	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	2949375	1474687.5	983125	737343.75	589875	491562.5	421339.2857	368671.875	327708.3333	294937.5	268125	245781.25	226875	210669.6429	196625	184335.9375	163854.1667	155230.2632	147468.75	122890.625	117975	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256448	CHOYP_SC31A.1.2|m.8241	SIYYITGESR	SIYYITGESR	324964	162482	108321.3333	81241	64992.8	54160.66667	46423.42857	40620.5	36107.11111	32496.4	29542.18182	27080.33333	24997.23077	23211.71429	21664.26667	20310.25	18053.55556	17103.36842	16248.2	13540.16667	12998.56	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256449	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	106232720	53116360	35410906.67	26558180	21246544	17705453.33	15176102.86	13279090	11803635.56	10623272	9657520	8852726.667	8171747.692	7588051.429	7082181.333	6639545	5901817.778	5591195.789	5311636	4426363.333	4249308.8	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256450	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	72286568	36143284	24095522.67	18071642	14457313.6	12047761.33	10326652.57	9035821	8031840.889	7228656.8	6571506.182	6023880.667	5560505.231	5163326.286	4819104.533	4517910.5	4015920.444	3804556.211	3614328.4	3011940.333	2891462.72	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256451	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	27068290	13534145	9022763.333	6767072.5	5413658	4511381.667	3866898.571	3383536.25	3007587.778	2706829	2460753.636	2255690.833	2082176.154	1933449.286	1804552.667	1691768.125	1503793.889	1424646.842	1353414.5	1127845.417	1082731.6	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256452	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	22171104	11085552	7390368	5542776	4434220.8	3695184	3167300.571	2771388	2463456	2217110.4	2015554.909	1847592	1705469.538	1583650.286	1478073.6	1385694	1231728	1166900.211	1108555.2	923796	886844.16	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256453	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	30104462	15052231	10034820.67	7526115.5	6020892.4	5017410.333	4300637.429	3763057.75	3344940.222	3010446.2	2736769.273	2508705.167	2315727.846	2150318.714	2006964.133	1881528.875	1672470.111	1584445.368	1505223.1	1254352.583	1204178.48	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256454	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	10070523	5035261.5	3356841	2517630.75	2014104.6	1678420.5	1438646.143	1258815.375	1118947	1007052.3	915502.0909	839210.25	774655.6154	719323.0714	671368.2	629407.6875	559473.5	530027.5263	503526.15	419605.125	402820.92	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256455	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	4609245	2304622.5	1536415	1152311.25	921849	768207.5	658463.5714	576155.625	512138.3333	460924.5	419022.2727	384103.75	354557.3077	329231.7857	307283	288077.8125	256069.1667	242591.8421	230462.25	192051.875	184369.8	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256456	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	4759845	2379922.5	1586615	1189961.25	951969	793307.5	679977.8571	594980.625	528871.6667	475984.5	432713.1818	396653.75	366141.9231	339988.9286	317323	297490.3125	264435.8333	250518.1579	237992.25	198326.875	190393.8	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256457	CHOYP_SC31A.1.2|m.8241	EVVQSSAFVER	EVVQSSAFVER	2809118	1404559	936372.6667	702279.5	561823.6	468186.3333	401302.5714	351139.75	312124.2222	280911.8	255374.3636	234093.1667	216086	200651.2857	187274.5333	175569.875	156062.1111	147848.3158	140455.9	117046.5833	112364.72	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256458	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	1919803	959901.5	639934.3333	479950.75	383960.6	319967.1667	274257.5714	239975.375	213311.4444	191980.3	174527.5455	159983.5833	147677.1538	137128.7857	127986.8667	119987.6875	106655.7222	101042.2632	95990.15	79991.79167	76792.12	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256459	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256460	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256461	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256462	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256463	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256464	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256465	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256466	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256467	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256468	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256469	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256470	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256471	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256472	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256473	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256474	CHOYP_SC31A.1.2|m.8241	GMEVIYMVDPIDEYAVQQLK	GMEVIYMVDPIDEYAVQQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256475	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	75562496	37781248	25187498.67	18890624	15112499.2	12593749.33	10794642.29	9445312	8395832.889	7556249.6	6869317.818	6296874.667	5812499.692	5397321.143	5037499.733	4722656	4197916.444	3976973.474	3778124.8	3148437.333	3022499.84	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256476	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	55542052	27771026	18514017.33	13885513	11108410.4	9257008.667	7934578.857	6942756.5	6171339.111	5554205.2	5049277.455	4628504.333	4272465.538	3967289.429	3702803.467	3471378.25	3085669.556	2923265.895	2777102.6	2314252.167	2221682.08	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256477	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	25342870	12671435	8447623.333	6335717.5	5068574	4223811.667	3620410	3167858.75	2815874.444	2534287	2303897.273	2111905.833	1949451.538	1810205	1689524.667	1583929.375	1407937.222	1333835.263	1267143.5	1055952.917	1013714.8	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256478	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	1635356	817678	545118.6667	408839	327071.2	272559.3333	233622.2857	204419.5	181706.2222	163535.6	148668.7273	136279.6667	125796.6154	116811.1429	109023.7333	102209.75	90853.11111	86071.36842	81767.8	68139.83333	65414.24	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256479	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256480	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	22193678	11096839	7397892.667	5548419.5	4438735.6	3698946.333	3170525.429	2774209.75	2465964.222	2219367.8	2017607.091	1849473.167	1707206	1585262.714	1479578.533	1387104.875	1232982.111	1168088.316	1109683.9	924736.5833	887747.12	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256481	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256482	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	2146120	1073060	715373.3333	536530	429224	357686.6667	306588.5714	268265	238457.7778	214612	195101.8182	178843.3333	165086.1538	153294.2857	143074.6667	134132.5	119228.8889	112953.6842	107306	89421.66667	85844.8	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256483	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	2670466	1335233	890155.3333	667616.5	534093.2	445077.6667	381495.1429	333808.25	296718.4444	267046.6	242769.6364	222538.8333	205420.4615	190747.5714	178031.0667	166904.125	148359.2222	140550.8421	133523.3	111269.4167	106818.64	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256484	CHOYP_SC31A.1.2|m.8241	EYDGKPLVNVTK	EYDGKPLVNVTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256485	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	61842912	30921456	20614304	15460728	12368582.4	10307152	8834701.714	7730364	6871434.667	6184291.2	5622082.909	5153576	4757147.077	4417350.857	4122860.8	3865182	3435717.333	3254890.105	3092145.6	2576788	2473716.48	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256486	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256487	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	20161494	10080747	6720498	5040373.5	4032298.8	3360249	2880213.429	2520186.75	2240166	2016149.4	1832863.091	1680124.5	1550884.154	1440106.714	1344099.6	1260093.375	1120083	1061131.263	1008074.7	840062.25	806459.76	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256488	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	1593393	796696.5	531131	398348.25	318678.6	265565.5	227627.5714	199174.125	177043.6667	159339.3	144853.9091	132782.75	122568.6923	113813.7857	106226.2	99587.0625	88521.83333	83862.78947	79669.65	66391.375	63735.72	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256489	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	3507490	1753745	1169163.333	876872.5	701498	584581.6667	501070	438436.25	389721.1111	350749	318862.7273	292290.8333	269806.9231	250535	233832.6667	219218.125	194860.5556	184604.7368	175374.5	146145.4167	140299.6	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256490	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	16273881	8136940.5	5424627	4068470.25	3254776.2	2712313.5	2324840.143	2034235.125	1808209	1627388.1	1479443.727	1356156.75	1251837	1162420.071	1084925.4	1017117.563	904104.5	856520.0526	813694.05	678078.375	650955.24	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256491	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	690731	345365.5	230243.6667	172682.75	138146.2	115121.8333	98675.85714	86341.375	76747.88889	69073.1	62793.72727	57560.91667	53133.15385	49337.92857	46048.73333	43170.6875	38373.94444	36354.26316	34536.55	28780.45833	27629.24	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256492	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	896022	448011	298674	224005.5	179204.4	149337	128003.1429	112002.75	99558	89602.2	81456.54545	74668.5	68924.76923	64001.57143	59734.8	56001.375	49779	47159.05263	44801.1	37334.25	35840.88	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256493	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	1017388	508694	339129.3333	254347	203477.6	169564.6667	145341.1429	127173.5	113043.1111	101738.8	92489.81818	84782.33333	78260.61538	72670.57143	67825.86667	63586.75	56521.55556	53546.73684	50869.4	42391.16667	40695.52	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256494	CHOYP_SC31A.1.2|m.8241	EGLELPEDEEEK	EGLELPEDEEEK	446453	223226.5	148817.6667	111613.25	89290.6	74408.83333	63779	55806.625	49605.88889	44645.3	40586.63636	37204.41667	34342.53846	31889.5	29763.53333	27903.3125	24802.94444	23497.52632	22322.65	18602.20833	17858.12	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256495	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	62637692	31318846	20879230.67	15659423	12527538.4	10439615.33	8948241.714	7829711.5	6959743.556	6263769.2	5694335.636	5219807.667	4818284	4474120.857	4175846.133	3914855.75	3479871.778	3296720.632	3131884.6	2609903.833	2505507.68	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256496	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	35214484	17607242	11738161.33	8803621	7042896.8	5869080.667	5030640.571	4401810.5	3912720.444	3521448.4	3201316.727	2934540.333	2708806.462	2515320.286	2347632.267	2200905.25	1956360.222	1853393.895	1760724.2	1467270.167	1408579.36	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256497	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	15686494	7843247	5228831.333	3921623.5	3137298.8	2614415.667	2240927.714	1960811.75	1742943.778	1568649.4	1426044.909	1307207.833	1206653.385	1120463.857	1045766.267	980405.875	871471.8889	825604.9474	784324.7	653603.9167	627459.76	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256498	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	2429248	1214624	809749.3333	607312	485849.6	404874.6667	347035.4286	303656	269916.4444	242924.8	220840.7273	202437.3333	186865.2308	173517.7143	161949.8667	151828	134958.2222	127855.1579	121462.4	101218.6667	97169.92	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256499	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	4712405	2356202.5	1570801.667	1178101.25	942481	785400.8333	673200.7143	589050.625	523600.5556	471240.5	428400.4545	392700.4167	362492.6923	336600.3571	314160.3333	294525.3125	261800.2778	248021.3158	235620.25	196350.2083	188496.2	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256500	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	7045932	3522966	2348644	1761483	1409186.4	1174322	1006561.714	880741.5	782881.3333	704593.2	640539.2727	587161	541994.7692	503280.8571	469728.8	440370.75	391440.6667	370838.5263	352296.6	293580.5	281837.28	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256501	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	607062	303531	202354	151765.5	121412.4	101177	86723.14286	75882.75	67451.33333	60706.2	55187.45455	50588.5	46697.07692	43361.57143	40470.8	37941.375	33725.66667	31950.63158	30353.1	25294.25	24282.48	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256502	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	1594104	797052	531368	398526	318820.8	265684	227729.1429	199263	177122.6667	159410.4	144918.5455	132842	122623.3846	113864.5714	106273.6	99631.5	88561.33333	83900.21053	79705.2	66421	63764.16	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256503	CHOYP_SC31A.1.2|m.8241	DSSTMGYMAAK	DSSTMGYMAAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256504	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	48885548	24442774	16295182.67	12221387	9777109.6	8147591.333	6983649.714	6110693.5	5431727.556	4888554.8	4444140.727	4073795.667	3760426.769	3491824.857	3259036.533	3055346.75	2715863.778	2572923.579	2444277.4	2036897.833	1955421.92	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256505	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256506	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256507	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	325035	162517.5	108345	81258.75	65007	54172.5	46433.57143	40629.375	36115	32503.5	29548.63636	27086.25	25002.69231	23216.78571	21669	20314.6875	18057.5	17107.10526	16251.75	13543.125	13001.4	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256508	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	248489	124244.5	82829.66667	62122.25	49697.8	41414.83333	35498.42857	31061.125	27609.88889	24848.9	22589.90909	20707.41667	19114.53846	17749.21429	16565.93333	15530.5625	13804.94444	13078.36842	12424.45	10353.70833	9939.56	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256509	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	469774	234887	156591.3333	117443.5	93954.8	78295.66667	67110.57143	58721.75	52197.11111	46977.4	42706.72727	39147.83333	36136.46154	33555.28571	31318.26667	29360.875	26098.55556	24724.94737	23488.7	19573.91667	18790.96	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256510	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256511	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256512	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256513	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	35439	17719.5	11813	8859.75	7087.8	5906.5	5062.714286	4429.875	3937.666667	3543.9	3221.727273	2953.25	2726.076923	2531.357143	2362.6	2214.9375	1968.833333	1865.210526	1771.95	1476.625	1417.56	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256514	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	82435536	41217768	27478512	20608884	16487107.2	13739256	11776505.14	10304442	9159504	8243553.6	7494139.636	6869628	6341195.077	5888252.571	5495702.4	5152221	4579752	4338712.421	4121776.8	3434814	3297421.44	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256515	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	70036504	35018252	23345501.33	17509126	14007300.8	11672750.67	10005214.86	8754563	7781833.778	7003650.4	6366954.909	5836375.333	5387423.385	5002607.429	4669100.267	4377281.5	3890916.889	3686131.789	3501825.2	2918187.667	2801460.16	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256516	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	21081204	10540602	7027068	5270301	4216240.8	3513534	3011600.571	2635150.5	2342356	2108120.4	1916473.091	1756767	1621631.077	1505800.286	1405413.6	1317575.25	1171178	1109537.053	1054060.2	878383.5	843248.16	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256517	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	66096	33048	22032	16524	13219.2	11016	9442.285714	8262	7344	6609.6	6008.727273	5508	5084.307692	4721.142857	4406.4	4131	3672	3478.736842	3304.8	2754	2643.84	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256518	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	309625	154812.5	103208.3333	77406.25	61925	51604.16667	44232.14286	38703.125	34402.77778	30962.5	28147.72727	25802.08333	23817.30769	22116.07143	20641.66667	19351.5625	17201.38889	16296.05263	15481.25	12901.04167	12385	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256519	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	2461248	1230624	820416	615312	492249.6	410208	351606.8571	307656	273472	246124.8	223749.8182	205104	189326.7692	175803.4286	164083.2	153828	136736	129539.3684	123062.4	102552	98449.92	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256520	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	932861	466430.5	310953.6667	233215.25	186572.2	155476.8333	133265.8571	116607.625	103651.2222	93286.1	84805.54545	77738.41667	71758.53846	66632.92857	62190.73333	58303.8125	51825.61111	49097.94737	46643.05	38869.20833	37314.44	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256521	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	2820722	1410361	940240.6667	705180.5	564144.4	470120.3333	402960.2857	352590.25	313413.5556	282072.2	256429.2727	235060.1667	216978.6154	201480.1429	188048.1333	176295.125	156706.7778	148459.0526	141036.1	117530.0833	112828.88	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256522	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	1440018	720009	480006	360004.5	288003.6	240003	205716.8571	180002.25	160002	144001.8	130910.7273	120001.5	110770.6154	102858.4286	96001.2	90001.125	80001	75790.42105	72000.9	60000.75	57600.72	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
256523	CHOYP_SC31A.1.2|m.8241	HLEINPDHSIIK	HLEINPDHSIIK	375855	187927.5	125285	93963.75	75171	62642.5	53693.57143	46981.875	41761.66667	37585.5	34168.63636	31321.25	28911.92308	26846.78571	25057	23490.9375	20880.83333	19781.84211	18792.75	15660.625	15034.2	O57521	Heat shock protein HSP 90-beta	hsp90ab1 hsp90b	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900
257262	CHOYP_SDHC.1.1|m.31277	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257263	CHOYP_SDHC.1.1|m.31277	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257264	CHOYP_SDHC.1.1|m.31277	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257265	CHOYP_SDHC.1.1|m.31277	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257266	CHOYP_SDHC.1.1|m.31277	LGIEAEFR	LGIEAEFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257267	CHOYP_SDHC.1.1|m.31277	LGIEAEFR	LGIEAEFR	22733	11366.5	7577.666667	5683.25	4546.6	3788.833333	3247.571429	2841.625	2525.888889	2273.3	2066.636364	1894.416667	1748.692308	1623.785714	1515.533333	1420.8125	1262.944444	1196.473684	1136.65	947.2083333	909.32	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257268	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	12373778	6186889	4124592.667	3093444.5	2474755.6	2062296.333	1767682.571	1546722.25	1374864.222	1237377.8	1124888.909	1031148.167	951829.0769	883841.2857	824918.5333	773361.125	687432.1111	651251.4737	618688.9	515574.0833	494951.12	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257269	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	11666637	5833318.5	3888879	2916659.25	2333327.4	1944439.5	1666662.429	1458329.625	1296293	1166663.7	1060603.364	972219.75	897433.6154	833331.2143	777775.8	729164.8125	648146.5	614033.5263	583331.85	486109.875	466665.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257270	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	6203541	3101770.5	2067847	1550885.25	1240708.2	1033923.5	886220.1429	775442.625	689282.3333	620354.1	563958.2727	516961.75	477195.4615	443110.0714	413569.4	387721.3125	344641.1667	326502.1579	310177.05	258480.875	248141.64	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257271	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257272	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257273	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257274	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	709354	354677	236451.3333	177338.5	141870.8	118225.6667	101336.2857	88669.25	78817.11111	70935.4	64486.72727	59112.83333	54565.69231	50668.14286	47290.26667	44334.625	39408.55556	37334.42105	35467.7	29556.41667	28374.16	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257275	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257276	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257277	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	362605	181302.5	120868.3333	90651.25	72521	60434.16667	51800.71429	45325.625	40289.44444	36260.5	32964.09091	30217.08333	27892.69231	25900.35714	24173.66667	22662.8125	20144.72222	19084.47368	18130.25	15108.54167	14504.2	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257278	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	337834	168917	112611.3333	84458.5	67566.8	56305.66667	48262	42229.25	37537.11111	33783.4	30712.18182	28152.83333	25987.23077	24131	22522.26667	21114.625	18768.55556	17780.73684	16891.7	14076.41667	13513.36	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257279	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	664425	332212.5	221475	166106.25	132885	110737.5	94917.85714	83053.125	73825	66442.5	60402.27273	55368.75	51109.61538	47458.92857	44295	41526.5625	36912.5	34969.73684	33221.25	27684.375	26577	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257280	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257281	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	568352	284176	189450.6667	142088	113670.4	94725.33333	81193.14286	71044	63150.22222	56835.2	51668.36364	47362.66667	43719.38462	40596.57143	37890.13333	35522	31575.11111	29913.26316	28417.6	23681.33333	22734.08	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257282	CHOYP_SDHC.1.1|m.31277	VENADKPGHAIVDVAQK	VENADKPGHAIVDVAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257283	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257284	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257285	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257286	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	4566145	2283072.5	1522048.333	1141536.25	913229	761024.1667	652306.4286	570768.125	507349.4444	456614.5	415104.0909	380512.0833	351241.9231	326153.2143	304409.6667	285384.0625	253674.7222	240323.4211	228307.25	190256.0417	182645.8	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257287	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	5617387	2808693.5	1872462.333	1404346.75	1123477.4	936231.1667	802483.8571	702173.375	624154.1111	561738.7	510671.5455	468115.5833	432106.6923	401241.9286	374492.4667	351086.6875	312077.0556	295651.9474	280869.35	234057.7917	224695.48	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257288	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	7129088	3564544	2376362.667	1782272	1425817.6	1188181.333	1018441.143	891136	792120.8889	712908.8	648098.9091	594090.6667	548391.3846	509220.5714	475272.5333	445568	396060.4444	375215.1579	356454.4	297045.3333	285163.52	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257289	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	5611423	2805711.5	1870474.333	1402855.75	1122284.6	935237.1667	801631.8571	701427.875	623491.4444	561142.3	510129.3636	467618.5833	431647.9231	400815.9286	374094.8667	350713.9375	311745.7222	295338.0526	280571.15	233809.2917	224456.92	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257290	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	2822657	1411328.5	940885.6667	705664.25	564531.4	470442.8333	403236.7143	352832.125	313628.5556	282265.7	256605.1818	235221.4167	217127.4615	201618.3571	188177.1333	176416.0625	156814.2778	148560.8947	141132.85	117610.7083	112906.28	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
257291	CHOYP_SDHC.1.1|m.31277	ENATFVVTGTR	ENATFVVTGTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8LGG8	Universal stress protein A-like protein	At3g01520 F4P13.7	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208
258862	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	2585950	1292975	861983.3333	646487.5	517190	430991.6667	369421.4286	323243.75	287327.7778	258595	235086.3636	215495.8333	198919.2308	184710.7143	172396.6667	161621.875	143663.8889	136102.6316	129297.5	107747.9167	103438	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258863	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	2701862	1350931	900620.6667	675465.5	540372.4	450310.3333	385980.2857	337732.75	300206.8889	270186.2	245623.8182	225155.1667	207835.5385	192990.1429	180124.1333	168866.375	150103.4444	142203.2632	135093.1	112577.5833	108074.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258864	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258865	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258866	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258867	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258868	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258869	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258870	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258871	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258872	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258873	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258874	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258875	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258876	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258877	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258878	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258879	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258880	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258881	CHOYP_SFPQ.1.1|m.15746	GNQGQQQNQGQHGQGGGGGNFR	GNQGQQQNQGQHGQGGGGGNFR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258882	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258883	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	15784552	7892276	5261517.333	3946138	3156910.4	2630758.667	2254936	1973069	1753839.111	1578455.2	1434959.273	1315379.333	1214196.308	1127468	1052303.467	986534.5	876919.5556	830765.8947	789227.6	657689.6667	631382.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258884	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258885	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1419877	709938.5	473292.3333	354969.25	283975.4	236646.1667	202839.5714	177484.625	157764.1111	141987.7	129079.7273	118323.0833	109221.3077	101419.7857	94658.46667	88742.3125	78882.05556	74730.36842	70993.85	59161.54167	56795.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258886	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	509221	254610.5	169740.3333	127305.25	101844.2	84870.16667	72745.85714	63652.625	56580.11111	50922.1	46292.81818	42435.08333	39170.84615	36372.92857	33948.06667	31826.3125	28290.05556	26801.10526	25461.05	21217.54167	20368.84	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258887	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	967088	483544	322362.6667	241772	193417.6	161181.3333	138155.4286	120886	107454.2222	96708.8	87917.09091	80590.66667	74391.38462	69077.71429	64472.53333	60443	53727.11111	50899.36842	48354.4	40295.33333	38683.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258888	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	3274028	1637014	1091342.667	818507	654805.6	545671.3333	467718.2857	409253.5	363780.8889	327402.8	297638.9091	272835.6667	251848.3077	233859.1429	218268.5333	204626.75	181890.4444	172317.2632	163701.4	136417.8333	130961.12	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258889	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1955514	977757	651838	488878.5	391102.8	325919	279359.1429	244439.25	217279.3333	195551.4	177774	162959.5	150424.1538	139679.5714	130367.6	122219.625	108639.6667	102921.7895	97775.7	81479.75	78220.56	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258890	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	441737	220868.5	147245.6667	110434.25	88347.4	73622.83333	63105.28571	55217.125	49081.88889	44173.7	40157.90909	36811.41667	33979.76923	31552.64286	29449.13333	27608.5625	24540.94444	23249.31579	22086.85	18405.70833	17669.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258891	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	1193294	596647	397764.6667	298323.5	238658.8	198882.3333	170470.5714	149161.75	132588.2222	119329.4	108481.2727	99441.16667	91791.84615	85235.28571	79552.93333	74580.875	66294.11111	62804.94737	59664.7	49720.58333	47731.76	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258892	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	696827	348413.5	232275.6667	174206.75	139365.4	116137.8333	99546.71429	87103.375	77425.22222	69682.7	63347.90909	58068.91667	53602.07692	49773.35714	46455.13333	43551.6875	38712.61111	36675.10526	34841.35	29034.45833	27873.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258893	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	242454	121227	80818	60613.5	48490.8	40409	34636.28571	30306.75	26939.33333	24245.4	22041.27273	20204.5	18650.30769	17318.14286	16163.6	15153.375	13469.66667	12760.73684	12122.7	10102.25	9698.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258894	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	672612	336306	224204	168153	134522.4	112102	96087.42857	84076.5	74734.66667	67261.2	61146.54545	56051	51739.38462	48043.71429	44840.8	42038.25	37367.33333	35400.63158	33630.6	28025.5	26904.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258895	CHOYP_SFPQ.1.1|m.15746	LFVGNVTSETSDEEFK	LFVGNVTSETSDEEFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258896	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	18772410	9386205	6257470	4693102.5	3754482	3128735	2681772.857	2346551.25	2085823.333	1877241	1706582.727	1564367.5	1444031.538	1340886.429	1251494	1173275.625	1042911.667	988021.5789	938620.5	782183.75	750896.4	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258897	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	13851659	6925829.5	4617219.667	3462914.75	2770331.8	2308609.833	1978808.429	1731457.375	1539073.222	1385165.9	1259241.727	1154304.917	1065512.231	989404.2143	923443.9333	865728.6875	769536.6111	729034.6842	692582.95	577152.4583	554066.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258898	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	5117163	2558581.5	1705721	1279290.75	1023432.6	852860.5	731023.2857	639645.375	568573.6667	511716.3	465196.6364	426430.25	393627.9231	365511.6429	341144.2	319822.6875	284286.8333	269324.3684	255858.15	213215.125	204686.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258899	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	1186046	593023	395348.6667	296511.5	237209.2	197674.3333	169435.1429	148255.75	131782.8889	118604.6	107822.3636	98837.16667	91234.30769	84717.57143	79069.73333	74127.875	65891.44444	62423.47368	59302.3	49418.58333	47441.84	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258900	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	1469648	734824	489882.6667	367412	293929.6	244941.3333	209949.7143	183706	163294.2222	146964.8	133604.3636	122470.6667	113049.8462	104974.8571	97976.53333	91853	81647.11111	77349.89474	73482.4	61235.33333	58785.92	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258901	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	428104	214052	142701.3333	107026	85620.8	71350.66667	61157.71429	53513	47567.11111	42810.4	38918.54545	35675.33333	32931.07692	30578.85714	28540.26667	26756.5	23783.55556	22531.78947	21405.2	17837.66667	17124.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258902	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	1007842	503921	335947.3333	251960.5	201568.4	167973.6667	143977.4286	125980.25	111982.4444	100784.2	91622	83986.83333	77526.30769	71988.71429	67189.46667	62990.125	55991.22222	53044.31579	50392.1	41993.41667	40313.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258903	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	905817	452908.5	301939	226454.25	181163.4	150969.5	129402.4286	113227.125	100646.3333	90581.7	82347	75484.75	69678.23077	64701.21429	60387.8	56613.5625	50323.16667	47674.57895	45290.85	37742.375	36232.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258904	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	781125	390562.5	260375	195281.25	156225	130187.5	111589.2857	97640.625	86791.66667	78112.5	71011.36364	65093.75	60086.53846	55794.64286	52075	48820.3125	43395.83333	41111.84211	39056.25	32546.875	31245	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258905	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	906267	453133.5	302089	226566.75	181253.4	151044.5	129466.7143	113283.375	100696.3333	90626.7	82387.90909	75522.25	69712.84615	64733.35714	60417.8	56641.6875	50348.16667	47698.26316	45313.35	37761.125	36250.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258906	CHOYP_SFPQ.1.1|m.15746	FGETGEMFLNGSK	FGETGEMFLNGSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258907	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	3796991	1898495.5	1265663.667	949247.75	759398.2	632831.8333	542427.2857	474623.875	421887.8889	379699.1	345181	316415.9167	292076.2308	271213.6429	253132.7333	237311.9375	210943.9444	199841.6316	189849.55	158207.9583	151879.64	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258908	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	2573647	1286823.5	857882.3333	643411.75	514729.4	428941.1667	367663.8571	321705.875	285960.7778	257364.7	233967.9091	214470.5833	197972.8462	183831.9286	171576.4667	160852.9375	142980.3889	135455.1053	128682.35	107235.2917	102945.88	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258909	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258910	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	98920	49460	32973.33333	24730	19784	16486.66667	14131.42857	12365	10991.11111	9892	8992.727273	8243.333333	7609.230769	7065.714286	6594.666667	6182.5	5495.555556	5206.315789	4946	4121.666667	3956.8	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258911	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258912	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	34151	17075.5	11383.66667	8537.75	6830.2	5691.833333	4878.714286	4268.875	3794.555556	3415.1	3104.636364	2845.916667	2627	2439.357143	2276.733333	2134.4375	1897.277778	1797.421053	1707.55	1422.958333	1366.04	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258913	CHOYP_SFPQ.1.1|m.15746	FSNQGSAIK	FSNQGSAIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258914	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	16112286	8056143	5370762	4028071.5	3222457.2	2685381	2301755.143	2014035.75	1790254	1611228.6	1464753.273	1342690.5	1239406.615	1150877.571	1074152.4	1007017.875	895127	848015.0526	805614.3	671345.25	644491.44	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258915	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	8211049	4105524.5	2737016.333	2052762.25	1642209.8	1368508.167	1173007	1026381.125	912338.7778	821104.9	746459	684254.0833	631619.1538	586503.5	547403.2667	513190.5625	456169.3889	432160.4737	410552.45	342127.0417	328441.96	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258916	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258917	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	399029	199514.5	133009.6667	99757.25	79805.8	66504.83333	57004.14286	49878.625	44336.55556	39902.9	36275.36364	33252.41667	30694.53846	28502.07143	26601.93333	24939.3125	22168.27778	21001.52632	19951.45	16626.20833	15961.16	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258918	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	1969608	984804	656536	492402	393921.6	328268	281372.5714	246201	218845.3333	196960.8	179055.2727	164134	151508.3077	140686.2857	131307.2	123100.5	109422.6667	103663.5789	98480.4	82067	78784.32	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258919	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	355784	177892	118594.6667	88946	71156.8	59297.33333	50826.28571	44473	39531.55556	35578.4	32344	29648.66667	27368	25413.14286	23718.93333	22236.5	19765.77778	18725.47368	17789.2	14824.33333	14231.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258920	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	2113537	1056768.5	704512.3333	528384.25	422707.4	352256.1667	301933.8571	264192.125	234837.4444	211353.7	192139.7273	176128.0833	162579.7692	150966.9286	140902.4667	132096.0625	117418.7222	111238.7895	105676.85	88064.04167	84541.48	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258921	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	761542	380771	253847.3333	190385.5	152308.4	126923.6667	108791.7143	95192.75	84615.77778	76154.2	69231.09091	63461.83333	58580.15385	54395.85714	50769.46667	47596.375	42307.88889	40081.15789	38077.1	31730.91667	30461.68	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258922	CHOYP_SFPQ.1.1|m.15746	STGEGIVEFAR	STGEGIVEFAR	402040	201020	134013.3333	100510	80408	67006.66667	57434.28571	50255	44671.11111	40204	36549.09091	33503.33333	30926.15385	28717.14286	26802.66667	25127.5	22335.55556	21160	20102	16751.66667	16081.6	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258923	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258924	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258925	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	1528232	764116	509410.6667	382058	305646.4	254705.3333	218318.8571	191029	169803.5556	152823.2	138930.1818	127352.6667	117556.3077	109159.4286	101882.1333	95514.5	84901.77778	80433.26316	76411.6	63676.33333	61129.28	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258926	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258927	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258928	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258929	CHOYP_SFPQ.1.1|m.15746	KPGAQQALK	KPGAQQALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258930	CHOYP_SFPQ.1.1|m.15746	NQQYQAER	NQQYQAER	4562977	2281488.5	1520992.333	1140744.25	912595.4	760496.1667	651853.8571	570372.125	506997.4444	456297.7	414816.0909	380248.0833	350998.2308	325926.9286	304198.4667	285186.0625	253498.7222	240156.6842	228148.85	190124.0417	182519.08	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258931	CHOYP_SFPQ.1.1|m.15746	NQQYQAER	NQQYQAER	1555173	777586.5	518391	388793.25	311034.6	259195.5	222167.5714	194396.625	172797	155517.3	141379.3636	129597.75	119628.6923	111083.7857	103678.2	97198.3125	86398.5	81851.21053	77758.65	64798.875	62206.92	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258932	CHOYP_SFPQ.1.1|m.15746	NQQYQAER	NQQYQAER	1037068	518534	345689.3333	259267	207413.6	172844.6667	148152.5714	129633.5	115229.7778	103706.8	94278.90909	86422.33333	79774.46154	74076.28571	69137.86667	64816.75	57614.88889	54582.52632	51853.4	43211.16667	41482.72	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258933	CHOYP_SFPQ.1.1|m.15746	NQQYQAER	NQQYQAER	960788	480394	320262.6667	240197	192157.6	160131.3333	137255.4286	120098.5	106754.2222	96078.8	87344.36364	80065.66667	73906.76923	68627.71429	64052.53333	60049.25	53377.11111	50567.78947	48039.4	40032.83333	38431.52	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258934	CHOYP_SFPQ.1.1|m.15746	NQQYQAER	NQQYQAER	96959	48479.5	32319.66667	24239.75	19391.8	16159.83333	13851.28571	12119.875	10773.22222	9695.9	8814.454545	8079.916667	7458.384615	6925.642857	6463.933333	6059.9375	5386.611111	5103.105263	4847.95	4039.958333	3878.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258935	CHOYP_SFPQ.1.1|m.15746	NQQYQAER	NQQYQAER	308140	154070	102713.3333	77035	61628	51356.66667	44020	38517.5	34237.77778	30814	28012.72727	25678.33333	23703.07692	22010	20542.66667	19258.75	17118.88889	16217.89474	15407	12839.16667	12325.6	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258936	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258937	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258938	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	9208920	4604460	3069640	2302230	1841784	1534820	1315560	1151115	1023213.333	920892	837174.5455	767410	708378.4615	657780	613928	575557.5	511606.6667	484680	460446	383705	368356.8	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258939	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	7862484	3931242	2620828	1965621	1572496.8	1310414	1123212	982810.5	873609.3333	786248.4	714771.2727	655207	604806.4615	561606	524165.6	491405.25	436804.6667	413814.9474	393124.2	327603.5	314499.36	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258940	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	4079389	2039694.5	1359796.333	1019847.25	815877.8	679898.1667	582769.8571	509923.625	453265.4444	407938.9	370853.5455	339949.0833	313799.1538	291384.9286	271959.2667	254961.8125	226632.7222	214704.6842	203969.45	169974.5417	163175.56	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258941	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	413926	206963	137975.3333	103481.5	82785.2	68987.66667	59132.28571	51740.75	45991.77778	41392.6	37629.63636	34493.83333	31840.46154	29566.14286	27595.06667	25870.375	22995.88889	21785.57895	20696.3	17246.91667	16557.04	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258942	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
258943	CHOYP_SFPQ.1.1|m.15746	FAPPGSFEYR	FAPPGSFEYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8VIJ6	"Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	Sfpq Psf	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]"	GO:0000122; GO:0000166; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0000980; GO:0001047; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006974; GO:0016363; GO:0042382; GO:0042752; GO:0042754; GO:0042826; GO:0044212; GO:0044822; GO:0045876; GO:0045892; GO:0048511; GO:0051276; GO:0051726; GO:0070932; GO:0090575; GO:1902177
262637	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	3818130	1909065	1272710	954532.5	763626	636355	545447.1429	477266.25	424236.6667	381813	347102.7273	318177.5	293702.3077	272723.5714	254542	238633.125	212118.3333	200954.2105	190906.5	159088.75	152725.2	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262638	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262639	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	2105971	1052985.5	701990.3333	526492.75	421194.2	350995.1667	300853	263246.375	233996.7778	210597.1	191451.9091	175497.5833	161997.7692	150426.5	140398.0667	131623.1875	116998.3889	110840.5789	105298.55	87748.79167	84238.84	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262640	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	277904	138952	92634.66667	69476	55580.8	46317.33333	39700.57143	34738	30878.22222	27790.4	25264	23158.66667	21377.23077	19850.28571	18526.93333	17369	15439.11111	14626.52632	13895.2	11579.33333	11116.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262641	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	571170	285585	190390	142792.5	114234	95195	81595.71429	71396.25	63463.33333	57117	51924.54545	47597.5	43936.15385	40797.85714	38078	35698.125	31731.66667	30061.57895	28558.5	23798.75	22846.8	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262642	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	273863	136931.5	91287.66667	68465.75	54772.6	45643.83333	39123.28571	34232.875	30429.22222	27386.3	24896.63636	22821.91667	21066.38462	19561.64286	18257.53333	17116.4375	15214.61111	14413.84211	13693.15	11410.95833	10954.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262643	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	126396	63198	42132	31599	25279.2	21066	18056.57143	15799.5	14044	12639.6	11490.54545	10533	9722.769231	9028.285714	8426.4	7899.75	7022	6652.421053	6319.8	5266.5	5055.84	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262644	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	93548	46774	31182.66667	23387	18709.6	15591.33333	13364	11693.5	10394.22222	9354.8	8504.363636	7795.666667	7196	6682	6236.533333	5846.75	5197.111111	4923.578947	4677.4	3897.833333	3741.92	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262645	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	736643	368321.5	245547.6667	184160.75	147328.6	122773.8333	105234.7143	92080.375	81849.22222	73664.3	66967.54545	61386.91667	56664.84615	52617.35714	49109.53333	46040.1875	40924.61111	38770.68421	36832.15	30693.45833	29465.72	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262646	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262647	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	455927	227963.5	151975.6667	113981.75	91185.4	75987.83333	65132.42857	56990.875	50658.55556	45592.7	41447.90909	37993.91667	35071.30769	32566.21429	30395.13333	28495.4375	25329.27778	23996.15789	22796.35	18996.95833	18237.08	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262648	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	142915	71457.5	47638.33333	35728.75	28583	23819.16667	20416.42857	17864.375	15879.44444	14291.5	12992.27273	11909.58333	10993.46154	10208.21429	9527.666667	8932.1875	7939.722222	7521.842105	7145.75	5954.791667	5716.6	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262649	CHOYP_SMUF2.1.1|m.14325	LTLLDDSNPDWWFAR	LTLLDDSNPDWWFAR	145020	72510	48340	36255	29004	24170	20717.14286	18127.5	16113.33333	14502	13183.63636	12085	11155.38462	10358.57143	9668	9063.75	8056.666667	7632.631579	7251	6042.5	5800.8	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262650	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	16791866	8395933	5597288.667	4197966.5	3358373.2	2798644.333	2398838	2098983.25	1865762.889	1679186.6	1526533.273	1399322.167	1291682	1199419	1119457.733	1049491.625	932881.4444	883782.4211	839593.3	699661.0833	671674.64	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262651	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	14983379	7491689.5	4994459.667	3745844.75	2996675.8	2497229.833	2140482.714	1872922.375	1664819.889	1498337.9	1362125.364	1248614.917	1152567.615	1070241.357	998891.9333	936461.1875	832409.9444	788598.8947	749168.95	624307.4583	599335.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262652	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	7375975	3687987.5	2458658.333	1843993.75	1475195	1229329.167	1053710.714	921996.875	819552.7778	737597.5	670543.1818	614664.5833	567382.6923	526855.3571	491731.6667	460998.4375	409776.3889	388209.2105	368798.75	307332.2917	295039	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262653	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	2526694	1263347	842231.3333	631673.5	505338.8	421115.6667	360956.2857	315836.75	280743.7778	252669.4	229699.4545	210557.8333	194361.0769	180478.1429	168446.2667	157918.375	140371.8889	132983.8947	126334.7	105278.9167	101067.76	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262654	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	6210586	3105293	2070195.333	1552646.5	1242117.2	1035097.667	887226.5714	776323.25	690065.1111	621058.6	564598.7273	517548.8333	477737.3846	443613.2857	414039.0667	388161.625	345032.5556	326872.9474	310529.3	258774.4167	248423.44	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262655	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262656	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	843923	421961.5	281307.6667	210980.75	168784.6	140653.8333	120560.4286	105490.375	93769.22222	84392.3	76720.27273	70326.91667	64917.15385	60280.21429	56261.53333	52745.1875	46884.61111	44417	42196.15	35163.45833	33756.92	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262657	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262658	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262659	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	1410185	705092.5	470061.6667	352546.25	282037	235030.8333	201455	176273.125	156687.2222	141018.5	128198.6364	117515.4167	108475.7692	100727.5	94012.33333	88136.5625	78343.61111	74220.26316	70509.25	58757.70833	56407.4	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262660	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262661	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262662	CHOYP_SMUF2.1.1|m.14325	QLLSPENALGSYLIR	QLLSPENALGSYLIR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262663	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	13409713	6704856.5	4469904.333	3352428.25	2681942.6	2234952.167	1915673.286	1676214.125	1489968.111	1340971.3	1219064.818	1117476.083	1031516.385	957836.6429	893980.8667	838107.0625	744984.0556	705774.3684	670485.65	558738.0417	536388.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262664	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	7865183	3932591.5	2621727.667	1966295.75	1573036.6	1310863.833	1123597.571	983147.875	873909.2222	786518.3	715016.6364	655431.9167	605014.0769	561798.7857	524345.5333	491573.9375	436954.6111	413957	393259.15	327715.9583	314607.32	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262665	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	4411136	2205568	1470378.667	1102784	882227.2	735189.3333	630162.2857	551392	490126.2222	441113.6	401012.3636	367594.6667	339318.1538	315081.1429	294075.7333	275696	245063.1111	232165.0526	220556.8	183797.3333	176445.44	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262666	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	1382207	691103.5	460735.6667	345551.75	276441.4	230367.8333	197458.1429	172775.875	153578.5556	138220.7	125655.1818	115183.9167	106323.6154	98729.07143	92147.13333	86387.9375	76789.27778	72747.73684	69110.35	57591.95833	55288.28	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262667	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	275672	137836	91890.66667	68918	55134.4	45945.33333	39381.71429	34459	30630.22222	27567.2	25061.09091	22972.66667	21205.53846	19690.85714	18378.13333	17229.5	15315.11111	14509.05263	13783.6	11486.33333	11026.88	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262668	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	3095413	1547706.5	1031804.333	773853.25	619082.6	515902.1667	442201.8571	386926.625	343934.7778	309541.3	281401.1818	257951.0833	238108.6923	221100.9286	206360.8667	193463.3125	171967.3889	162916.4737	154770.65	128975.5417	123816.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262669	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	2119336	1059668	706445.3333	529834	423867.2	353222.6667	302762.2857	264917	235481.7778	211933.6	192666.9091	176611.3333	163025.8462	151381.1429	141289.0667	132458.5	117740.8889	111544	105966.8	88305.66667	84773.44	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262670	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	99977	49988.5	33325.66667	24994.25	19995.4	16662.83333	14282.42857	12497.125	11108.55556	9997.7	9088.818182	8331.416667	7690.538462	7141.214286	6665.133333	6248.5625	5554.277778	5261.947368	4998.85	4165.708333	3999.08	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262671	CHOYP_SMUF2.1.1|m.14325	LGAGQFGEVWR	LGAGQFGEVWR	555857	277928.5	185285.6667	138964.25	111171.4	92642.83333	79408.14286	69482.125	61761.88889	55585.7	50532.45455	46321.41667	42758.23077	39704.07143	37057.13333	34741.0625	30880.94444	29255.63158	27792.85	23160.70833	22234.28	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262672	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	3821325	1910662.5	1273775	955331.25	764265	636887.5	545903.5714	477665.625	424591.6667	382132.5	347393.1818	318443.75	293948.0769	272951.7857	254755	238832.8125	212295.8333	201122.3684	191066.25	159221.875	152853	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262673	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262674	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262675	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	274310	137155	91436.66667	68577.5	54862	45718.33333	39187.14286	34288.75	30478.88889	27431	24937.27273	22859.16667	21100.76923	19593.57143	18287.33333	17144.375	15239.44444	14437.36842	13715.5	11429.58333	10972.4	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262676	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262677	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	11713	5856.5	3904.333333	2928.25	2342.6	1952.166667	1673.285714	1464.125	1301.444444	1171.3	1064.818182	976.0833333	901	836.6428571	780.8666667	732.0625	650.7222222	616.4736842	585.65	488.0416667	468.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262678	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262679	CHOYP_SMUF2.1.1|m.14325	LIEDDEYTPK	LIEDDEYTPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262680	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262681	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	7984054	3992027	2661351.333	1996013.5	1596810.8	1330675.667	1140579.143	998006.75	887117.1111	798405.4	725823.0909	665337.8333	614158	570289.5714	532270.2667	499003.375	443558.5556	420213.3684	399202.7	332668.9167	319362.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262682	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	1592849	796424.5	530949.6667	398212.25	318569.8	265474.8333	227549.8571	199106.125	176983.2222	159284.9	144804.4545	132737.4167	122526.8462	113774.9286	106189.9333	99553.0625	88491.61111	83834.15789	79642.45	66368.70833	63713.96	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262683	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	3177979	1588989.5	1059326.333	794494.75	635595.8	529663.1667	453997	397247.375	353108.7778	317797.9	288907.1818	264831.5833	244459.9231	226998.5	211865.2667	198623.6875	176554.3889	167262.0526	158898.95	132415.7917	127119.16	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262684	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	441002	220501	147000.6667	110250.5	88200.4	73500.33333	63000.28571	55125.25	49000.22222	44100.2	40091.09091	36750.16667	33923.23077	31500.14286	29400.13333	27562.625	24500.11111	23210.63158	22050.1	18375.08333	17640.08	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262685	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	723731	361865.5	241243.6667	180932.75	144746.2	120621.8333	103390.1429	90466.375	80414.55556	72373.1	65793.72727	60310.91667	55671.61538	51695.07143	48248.73333	45233.1875	40207.27778	38091.10526	36186.55	30155.45833	28949.24	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262686	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	134021	67010.5	44673.66667	33505.25	26804.2	22336.83333	19145.85714	16752.625	14891.22222	13402.1	12183.72727	11168.41667	10309.30769	9572.928571	8934.733333	8376.3125	7445.611111	7053.736842	6701.05	5584.208333	5360.84	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262687	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	169674	84837	56558	42418.5	33934.8	28279	24239.14286	21209.25	18852.66667	16967.4	15424.90909	14139.5	13051.84615	12119.57143	11311.6	10604.625	9426.333333	8930.210526	8483.7	7069.75	6786.96	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262688	CHOYP_SMUF2.1.1|m.14325	WTAPEAALYGR	WTAPEAALYGR	144413	72206.5	48137.66667	36103.25	28882.6	24068.83333	20630.42857	18051.625	16045.88889	14441.3	13128.45455	12034.41667	11108.69231	10315.21429	9627.533333	9025.8125	8022.944444	7600.684211	7220.65	6017.208333	5776.52	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262689	CHOYP_SMUF2.1.1|m.14325	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262690	CHOYP_SMUF2.1.1|m.14325	EVLEQVDR	EVLEQVDR	4296180	2148090	1432060	1074045	859236	716030	613740	537022.5	477353.3333	429618	390561.8182	358015	330475.3846	306870	286412	268511.25	238676.6667	226114.7368	214809	179007.5	171847.2	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262691	CHOYP_SMUF2.1.1|m.14325	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262692	CHOYP_SMUF2.1.1|m.14325	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262693	CHOYP_SMUF2.1.1|m.14325	EVLEQVDR	EVLEQVDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262694	CHOYP_SMUF2.1.1|m.14325	EVLEQVDR	EVLEQVDR	172591	86295.5	57530.33333	43147.75	34518.2	28765.16667	24655.85714	21573.875	19176.77778	17259.1	15690.09091	14382.58333	13276.23077	12327.92857	11506.06667	10786.9375	9588.388889	9083.736842	8629.55	7191.291667	6903.64	P00523	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC	angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to fluid shear stress [GO:0071498]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to reactive oxygen species [GO:0034614]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular signal transduction [GO:0035556]; negative regulation of anoikis [GO:2000811]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; progesterone receptor signaling pathway [GO:0050847]; protein destabilization [GO:0031648]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell cycle [GO:0051726]; regulation of cell projection assembly [GO:0060491]; regulation of cell proliferation [GO:0042127]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of podosome assembly [GO:0071801]; regulation of protein binding [GO:0043393]; response to interleukin-1 [GO:0070555]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]	GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005901; GO:0007049; GO:0007155; GO:0007173; GO:0007179; GO:0007229; GO:0007417; GO:0010008; GO:0010634; GO:0016477; GO:0019903; GO:0020037; GO:0022407; GO:0030520; GO:0030900; GO:0031234; GO:0031648; GO:0032211; GO:0032463; GO:0032587; GO:0033146; GO:0034446; GO:0034614; GO:0035556; GO:0036035; GO:0036120; GO:0038083; GO:0042127; GO:0043149; GO:0043154; GO:0043393; GO:0045087; GO:0045453; GO:0048008; GO:0048013; GO:0048471; GO:0048477; GO:0050847; GO:0051427; GO:0051726; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060491; GO:0070062; GO:0070374; GO:0070555; GO:0070851; GO:0071498; GO:0071801; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:2000394; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286
262859	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	8038368	4019184	2679456	2009592	1607673.6	1339728	1148338.286	1004796	893152	803836.8	730760.7273	669864	618336	574169.1429	535891.2	502398	446576	423072	401918.4	334932	321534.72	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262860	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262861	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	4433963	2216981.5	1477987.667	1108490.75	886792.6	738993.8333	633423.2857	554245.375	492662.5556	443396.3	403087.5455	369496.9167	341074.0769	316711.6429	295597.5333	277122.6875	246331.2778	233366.4737	221698.15	184748.4583	177358.52	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262862	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	739428	369714	246476	184857	147885.6	123238	105632.5714	92428.5	82158.66667	73942.8	67220.72727	61619	56879.07692	52816.28571	49295.2	46214.25	41079.33333	38917.26316	36971.4	30809.5	29577.12	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262863	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	266898	133449	88966	66724.5	53379.6	44483	38128.28571	33362.25	29655.33333	26689.8	24263.45455	22241.5	20530.61538	19064.14286	17793.2	16681.125	14827.66667	14047.26316	13344.9	11120.75	10675.92	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262864	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	325225	162612.5	108408.3333	81306.25	65045	54204.16667	46460.71429	40653.125	36136.11111	32522.5	29565.90909	27102.08333	25017.30769	23230.35714	21681.66667	20326.5625	18068.05556	17117.10526	16261.25	13551.04167	13009	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262865	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	453515	226757.5	151171.6667	113378.75	90703	75585.83333	64787.85714	56689.375	50390.55556	45351.5	41228.63636	37792.91667	34885.76923	32393.92857	30234.33333	28344.6875	25195.27778	23869.21053	22675.75	18896.45833	18140.6	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262866	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	44178	22089	14726	11044.5	8835.6	7363	6311.142857	5522.25	4908.666667	4417.8	4016.181818	3681.5	3398.307692	3155.571429	2945.2	2761.125	2454.333333	2325.157895	2208.9	1840.75	1767.12	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262867	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262868	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	731941	365970.5	243980.3333	182985.25	146388.2	121990.1667	104563	91492.625	81326.77778	73194.1	66540.09091	60995.08333	56303.15385	52281.5	48796.06667	45746.3125	40663.38889	38523.21053	36597.05	30497.54167	29277.64	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262869	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	334561	167280.5	111520.3333	83640.25	66912.2	55760.16667	47794.42857	41820.125	37173.44444	33456.1	30414.63636	27880.08333	25735.46154	23897.21429	22304.06667	20910.0625	18586.72222	17608.47368	16728.05	13940.04167	13382.44	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262870	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	1154369	577184.5	384789.6667	288592.25	230873.8	192394.8333	164909.8571	144296.125	128263.2222	115436.9	104942.6364	96197.41667	88797.61538	82454.92857	76957.93333	72148.0625	64131.61111	60756.26316	57718.45	48098.70833	46174.76	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262871	CHOYP_SODM.1.2|m.45531	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	330187	165093.5	110062.3333	82546.75	66037.4	55031.16667	47169.57143	41273.375	36687.44444	33018.7	30017	27515.58333	25399	23584.78571	22012.46667	20636.6875	18343.72222	17378.26316	16509.35	13757.79167	13207.48	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262872	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	16844802	8422401	5614934	4211200.5	3368960.4	2807467	2406400.286	2105600.25	1871644.667	1684480.2	1531345.636	1403733.5	1295754	1203200.143	1122986.8	1052800.125	935822.3333	886568.5263	842240.1	701866.75	673792.08	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262873	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	9577870	4788935	3192623.333	2394467.5	1915574	1596311.667	1368267.143	1197233.75	1064207.778	957787	870715.4545	798155.8333	736759.2308	684133.5714	638524.6667	598616.875	532103.8889	504098.4211	478893.5	399077.9167	383114.8	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262874	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	2469855	1234927.5	823285	617463.75	493971	411642.5	352836.4286	308731.875	274428.3333	246985.5	224532.2727	205821.25	189988.8462	176418.2143	164657	154365.9375	137214.1667	129992.3684	123492.75	102910.625	98794.2	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262875	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	3889258	1944629	1296419.333	972314.5	777851.6	648209.6667	555608.2857	486157.25	432139.7778	388925.8	353568.9091	324104.8333	299173.6923	277804.1429	259283.8667	243078.625	216069.8889	204697.7895	194462.9	162052.4167	155570.32	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262876	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	2241474	1120737	747158	560368.5	448294.8	373579	320210.5714	280184.25	249052.6667	224147.4	203770.3636	186789.5	172421.0769	160105.2857	149431.6	140092.125	124526.3333	117972.3158	112073.7	93394.75	89658.96	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262877	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	1187721	593860.5	395907	296930.25	237544.2	197953.5	169674.4286	148465.125	131969	118772.1	107974.6364	98976.75	91363.15385	84837.21429	79181.4	74232.5625	65984.5	62511.63158	59386.05	49488.375	47508.84	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262878	CHOYP_SODM.1.2|m.45531	IIQLQAAIR	IIQLQAAIR	406529	203264.5	135509.6667	101632.25	81305.8	67754.83333	58075.57143	50816.125	45169.88889	40652.9	36957.18182	33877.41667	31271.46154	29037.78571	27101.93333	25408.0625	22584.94444	21396.26316	20326.45	16938.70833	16261.16	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262879	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	1151867	575933.5	383955.6667	287966.75	230373.4	191977.8333	164552.4286	143983.375	127985.2222	115186.7	104715.1818	95988.91667	88605.15385	82276.21429	76791.13333	71991.6875	63992.61111	60624.57895	57593.35	47994.45833	46074.68	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262880	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	1014686	507343	338228.6667	253671.5	202937.2	169114.3333	144955.1429	126835.75	112742.8889	101468.6	92244.18182	84557.16667	78052.76923	72477.57143	67645.73333	63417.875	56371.44444	53404.52632	50734.3	42278.58333	40587.44	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262881	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	1213097	606548.5	404365.6667	303274.25	242619.4	202182.8333	173299.5714	151637.125	134788.5556	121309.7	110281.5455	101091.4167	93315.15385	86649.78571	80873.13333	75818.5625	67394.27778	63847.21053	60654.85	50545.70833	48523.88	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262882	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262883	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262884	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262885	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262886	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262887	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262888	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262889	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262890	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262891	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262892	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262893	CHOYP_SODM.1.2|m.45531	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262903	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	8038368	4019184	2679456	2009592	1607673.6	1339728	1148338.286	1004796	893152	803836.8	730760.7273	669864	618336	574169.1429	535891.2	502398	446576	423072	401918.4	334932	321534.72	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262904	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262905	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	4433963	2216981.5	1477987.667	1108490.75	886792.6	738993.8333	633423.2857	554245.375	492662.5556	443396.3	403087.5455	369496.9167	341074.0769	316711.6429	295597.5333	277122.6875	246331.2778	233366.4737	221698.15	184748.4583	177358.52	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262906	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	739428	369714	246476	184857	147885.6	123238	105632.5714	92428.5	82158.66667	73942.8	67220.72727	61619	56879.07692	52816.28571	49295.2	46214.25	41079.33333	38917.26316	36971.4	30809.5	29577.12	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262907	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	266898	133449	88966	66724.5	53379.6	44483	38128.28571	33362.25	29655.33333	26689.8	24263.45455	22241.5	20530.61538	19064.14286	17793.2	16681.125	14827.66667	14047.26316	13344.9	11120.75	10675.92	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262908	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	325225	162612.5	108408.3333	81306.25	65045	54204.16667	46460.71429	40653.125	36136.11111	32522.5	29565.90909	27102.08333	25017.30769	23230.35714	21681.66667	20326.5625	18068.05556	17117.10526	16261.25	13551.04167	13009	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262909	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	453515	226757.5	151171.6667	113378.75	90703	75585.83333	64787.85714	56689.375	50390.55556	45351.5	41228.63636	37792.91667	34885.76923	32393.92857	30234.33333	28344.6875	25195.27778	23869.21053	22675.75	18896.45833	18140.6	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262910	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	44178	22089	14726	11044.5	8835.6	7363	6311.142857	5522.25	4908.666667	4417.8	4016.181818	3681.5	3398.307692	3155.571429	2945.2	2761.125	2454.333333	2325.157895	2208.9	1840.75	1767.12	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262911	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262912	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	731941	365970.5	243980.3333	182985.25	146388.2	121990.1667	104563	91492.625	81326.77778	73194.1	66540.09091	60995.08333	56303.15385	52281.5	48796.06667	45746.3125	40663.38889	38523.21053	36597.05	30497.54167	29277.64	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262913	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	334561	167280.5	111520.3333	83640.25	66912.2	55760.16667	47794.42857	41820.125	37173.44444	33456.1	30414.63636	27880.08333	25735.46154	23897.21429	22304.06667	20910.0625	18586.72222	17608.47368	16728.05	13940.04167	13382.44	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262914	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	1154369	577184.5	384789.6667	288592.25	230873.8	192394.8333	164909.8571	144296.125	128263.2222	115436.9	104942.6364	96197.41667	88797.61538	82454.92857	76957.93333	72148.0625	64131.61111	60756.26316	57718.45	48098.70833	46174.76	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262915	CHOYP_SODM.2.2|m.62945	HHQTYVNNLNVAEEK	HHQTYVNNLNVAEEK	330187	165093.5	110062.3333	82546.75	66037.4	55031.16667	47169.57143	41273.375	36687.44444	33018.7	30017	27515.58333	25399	23584.78571	22012.46667	20636.6875	18343.72222	17378.26316	16509.35	13757.79167	13207.48	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262916	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	16844802	8422401	5614934	4211200.5	3368960.4	2807467	2406400.286	2105600.25	1871644.667	1684480.2	1531345.636	1403733.5	1295754	1203200.143	1122986.8	1052800.125	935822.3333	886568.5263	842240.1	701866.75	673792.08	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262917	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	9577870	4788935	3192623.333	2394467.5	1915574	1596311.667	1368267.143	1197233.75	1064207.778	957787	870715.4545	798155.8333	736759.2308	684133.5714	638524.6667	598616.875	532103.8889	504098.4211	478893.5	399077.9167	383114.8	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262918	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	2469855	1234927.5	823285	617463.75	493971	411642.5	352836.4286	308731.875	274428.3333	246985.5	224532.2727	205821.25	189988.8462	176418.2143	164657	154365.9375	137214.1667	129992.3684	123492.75	102910.625	98794.2	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262919	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	3889258	1944629	1296419.333	972314.5	777851.6	648209.6667	555608.2857	486157.25	432139.7778	388925.8	353568.9091	324104.8333	299173.6923	277804.1429	259283.8667	243078.625	216069.8889	204697.7895	194462.9	162052.4167	155570.32	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262920	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	2241474	1120737	747158	560368.5	448294.8	373579	320210.5714	280184.25	249052.6667	224147.4	203770.3636	186789.5	172421.0769	160105.2857	149431.6	140092.125	124526.3333	117972.3158	112073.7	93394.75	89658.96	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262921	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	1187721	593860.5	395907	296930.25	237544.2	197953.5	169674.4286	148465.125	131969	118772.1	107974.6364	98976.75	91363.15385	84837.21429	79181.4	74232.5625	65984.5	62511.63158	59386.05	49488.375	47508.84	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262922	CHOYP_SODM.2.2|m.62945	IIQLQAAIR	IIQLQAAIR	406529	203264.5	135509.6667	101632.25	81305.8	67754.83333	58075.57143	50816.125	45169.88889	40652.9	36957.18182	33877.41667	31271.46154	29037.78571	27101.93333	25408.0625	22584.94444	21396.26316	20326.45	16938.70833	16261.16	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262923	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	1151867	575933.5	383955.6667	287966.75	230373.4	191977.8333	164552.4286	143983.375	127985.2222	115186.7	104715.1818	95988.91667	88605.15385	82276.21429	76791.13333	71991.6875	63992.61111	60624.57895	57593.35	47994.45833	46074.68	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262924	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	1014686	507343	338228.6667	253671.5	202937.2	169114.3333	144955.1429	126835.75	112742.8889	101468.6	92244.18182	84557.16667	78052.76923	72477.57143	67645.73333	63417.875	56371.44444	53404.52632	50734.3	42278.58333	40587.44	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262925	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	1213097	606548.5	404365.6667	303274.25	242619.4	202182.8333	173299.5714	151637.125	134788.5556	121309.7	110281.5455	101091.4167	93315.15385	86649.78571	80873.13333	75818.5625	67394.27778	63847.21053	60654.85	50545.70833	48523.88	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262926	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262927	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262928	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262929	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262930	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262931	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262932	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262933	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262934	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262935	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262936	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
262937	CHOYP_SODM.2.2|m.62945	NVRPDYVNAIWHIIDWK	NVRPDYVNAIWHIIDWK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P04179	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176
267022	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267023	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267024	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267025	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267026	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267027	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267028	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267029	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267030	CHOYP_STIP1.1.2|m.12856	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267031	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267032	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267033	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267034	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267035	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267036	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	22335	11167.5	7445	5583.75	4467	3722.5	3190.714286	2791.875	2481.666667	2233.5	2030.454545	1861.25	1718.076923	1595.357143	1489	1395.9375	1240.833333	1175.526316	1116.75	930.625	893.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267037	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267038	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	20417	10208.5	6805.666667	5104.25	4083.4	3402.833333	2916.714286	2552.125	2268.555556	2041.7	1856.090909	1701.416667	1570.538462	1458.357143	1361.133333	1276.0625	1134.277778	1074.578947	1020.85	850.7083333	816.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267039	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267040	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267041	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267042	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267043	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267044	CHOYP_STIP1.1.2|m.12856	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267045	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267046	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267047	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267048	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	409205	204602.5	136401.6667	102301.25	81841	68200.83333	58457.85714	51150.625	45467.22222	40920.5	37200.45455	34100.41667	31477.30769	29228.92857	27280.33333	25575.3125	22733.61111	21537.10526	20460.25	17050.20833	16368.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267049	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	741404	370702	247134.6667	185351	148280.8	123567.3333	105914.8571	92675.5	82378.22222	74140.4	67400.36364	61783.66667	57031.07692	52957.42857	49426.93333	46337.75	41189.11111	39021.26316	37070.2	30891.83333	29656.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267050	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	134625	67312.5	44875	33656.25	26925	22437.5	19232.14286	16828.125	14958.33333	13462.5	12238.63636	11218.75	10355.76923	9616.071429	8975	8414.0625	7479.166667	7085.526316	6731.25	5609.375	5385	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267051	CHOYP_STIP1.1.2|m.12856	DNHVLYSNR	DNHVLYSNR	62572	31286	20857.33333	15643	12514.4	10428.66667	8938.857143	7821.5	6952.444444	6257.2	5688.363636	5214.333333	4813.230769	4469.428571	4171.466667	3910.75	3476.222222	3293.263158	3128.6	2607.166667	2502.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267052	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	7652375	3826187.5	2550791.667	1913093.75	1530475	1275395.833	1093196.429	956546.875	850263.8889	765237.5	695670.4545	637697.9167	588644.2308	546598.2143	510158.3333	478273.4375	425131.9444	402756.5789	382618.75	318848.9583	306095	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267053	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	4119514	2059757	1373171.333	1029878.5	823902.8	686585.6667	588502	514939.25	457723.7778	411951.4	374501.2727	343292.8333	316885.6923	294251	274634.2667	257469.625	228861.8889	216816.5263	205975.7	171646.4167	164780.56	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267054	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	2620941	1310470.5	873647	655235.25	524188.2	436823.5	374420.1429	327617.625	291215.6667	262094.1	238267.3636	218411.75	201610.8462	187210.0714	174729.4	163808.8125	145607.8333	137944.2632	131047.05	109205.875	104837.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267055	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	791530	395765	263843.3333	197882.5	158306	131921.6667	113075.7143	98941.25	87947.77778	79153	71957.27273	65960.83333	60886.92308	56537.85714	52768.66667	49470.625	43973.88889	41659.47368	39576.5	32980.41667	31661.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267056	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	848584	424292	282861.3333	212146	169716.8	141430.6667	121226.2857	106073	94287.11111	84858.4	77144	70715.33333	65275.69231	60613.14286	56572.26667	53036.5	47143.55556	44662.31579	42429.2	35357.66667	33943.36	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267057	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	2952872	1476436	984290.6667	738218	590574.4	492145.3333	421838.8571	369109	328096.8889	295287.2	268442.9091	246072.6667	227144	210919.4286	196858.1333	184554.5	164048.4444	155414.3158	147643.6	123036.3333	118114.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267058	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	32633	16316.5	10877.66667	8158.25	6526.6	5438.833333	4661.857143	4079.125	3625.888889	3263.3	2966.636364	2719.416667	2510.230769	2330.928571	2175.533333	2039.5625	1812.944444	1717.526316	1631.65	1359.708333	1305.32	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267059	CHOYP_STIP1.1.2|m.12856	AIQLNPEWAK	AIQLNPEWAK	535948	267974	178649.3333	133987	107189.6	89324.66667	76564	66993.5	59549.77778	53594.8	48722.54545	44662.33333	41226.76923	38282	35729.86667	33496.75	29774.88889	28207.78947	26797.4	22331.16667	21437.92	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267060	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	1017622	508811	339207.3333	254405.5	203524.4	169603.6667	145374.5714	127202.75	113069.1111	101762.2	92511.09091	84801.83333	78278.61538	72687.28571	67841.46667	63601.375	56534.55556	53559.05263	50881.1	42400.91667	40704.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267061	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267062	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	1256534	628267	418844.6667	314133.5	251306.8	209422.3333	179504.8571	157066.75	139614.8889	125653.4	114230.3636	104711.1667	96656.46154	89752.42857	83768.93333	78533.375	69807.44444	66133.36842	62826.7	52355.58333	50261.36	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267063	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267064	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267065	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267066	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267067	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267068	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267069	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267070	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267071	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	53704	26852	17901.33333	13426	10740.8	8950.666667	7672	6713	5967.111111	5370.4	4882.181818	4475.333333	4131.076923	3836	3580.266667	3356.5	2983.555556	2826.526316	2685.2	2237.666667	2148.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267072	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	64604	32302	21534.66667	16151	12920.8	10767.33333	9229.142857	8075.5	7178.222222	6460.4	5873.090909	5383.666667	4969.538462	4614.571429	4306.933333	4037.75	3589.111111	3400.210526	3230.2	2691.833333	2584.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267073	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	49848	24924	16616	12462	9969.6	8308	7121.142857	6231	5538.666667	4984.8	4531.636364	4154	3834.461538	3560.571429	3323.2	3115.5	2769.333333	2623.578947	2492.4	2077	1993.92	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267074	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267075	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	114800	57400	38266.66667	28700	22960	19133.33333	16400	14350	12755.55556	11480	10436.36364	9566.666667	8830.769231	8200	7653.333333	7175	6377.777778	6042.105263	5740	4783.333333	4592	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267076	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	218836	109418	72945.33333	54709	43767.2	36472.66667	31262.28571	27354.5	24315.11111	21883.6	19894.18182	18236.33333	16833.53846	15631.14286	14589.06667	13677.25	12157.55556	11517.68421	10941.8	9118.166667	8753.44	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267077	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267078	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267079	CHOYP_STIP1.1.2|m.12856	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267080	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267081	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267082	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267083	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	206942	103471	68980.66667	51735.5	41388.4	34490.33333	29563.14286	25867.75	22993.55556	20694.2	18812.90909	17245.16667	15918.61538	14781.57143	13796.13333	12933.875	11496.77778	10891.68421	10347.1	8622.583333	8277.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267084	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	299540	149770	99846.66667	74885	59908	49923.33333	42791.42857	37442.5	33282.22222	29954	27230.90909	24961.66667	23041.53846	21395.71429	19969.33333	18721.25	16641.11111	15765.26316	14977	12480.83333	11981.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267085	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	210264	105132	70088	52566	42052.8	35044	30037.71429	26283	23362.66667	21026.4	19114.90909	17522	16174.15385	15018.85714	14017.6	13141.5	11681.33333	11066.52632	10513.2	8761	8410.56	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267086	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	106385	53192.5	35461.66667	26596.25	21277	17730.83333	15197.85714	13298.125	11820.55556	10638.5	9671.363636	8865.416667	8183.461538	7598.928571	7092.333333	6649.0625	5910.277778	5599.210526	5319.25	4432.708333	4255.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267087	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	23425	11712.5	7808.333333	5856.25	4685	3904.166667	3346.428571	2928.125	2602.777778	2342.5	2129.545455	1952.083333	1801.923077	1673.214286	1561.666667	1464.0625	1301.388889	1232.894737	1171.25	976.0416667	937	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267088	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	74249	37124.5	24749.66667	18562.25	14849.8	12374.83333	10607	9281.125	8249.888889	7424.9	6749.909091	6187.416667	5711.461538	5303.5	4949.933333	4640.5625	4124.944444	3907.842105	3712.45	3093.708333	2969.96	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267089	CHOYP_STIP1.1.2|m.12856	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267090	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267091	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	2679328	1339664	893109.3333	669832	535865.6	446554.6667	382761.1429	334916	297703.1111	267932.8	243575.2727	223277.3333	206102.1538	191380.5714	178621.8667	167458	148851.5556	141017.2632	133966.4	111638.6667	107173.12	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267092	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267093	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267094	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267095	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267096	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267097	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267098	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267099	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267100	CHOYP_STIP1.1.2|m.12856	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267101	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	10562221	5281110.5	3520740.333	2640555.25	2112444.2	1760370.167	1508888.714	1320277.625	1173580.111	1056222.1	960201.9091	880185.0833	812478.5385	754444.3571	704148.0667	660138.8125	586790.0556	555906.3684	528111.05	440092.5417	422488.84	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267102	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	6578883	3289441.5	2192961	1644720.75	1315776.6	1096480.5	939840.4286	822360.375	730987	657888.3	598080.2727	548240.25	506067.9231	469920.2143	438592.2	411180.1875	365493.5	346257	328944.15	274120.125	263155.32	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267103	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	3793890	1896945	1264630	948472.5	758778	632315	541984.2857	474236.25	421543.3333	379389	344899.0909	316157.5	291837.6923	270992.1429	252926	237118.125	210771.6667	199678.4211	189694.5	158078.75	151755.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267104	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	900739	450369.5	300246.3333	225184.75	180147.8	150123.1667	128677	112592.375	100082.1111	90073.9	81885.36364	75061.58333	69287.61538	64338.5	60049.26667	56296.1875	50041.05556	47407.31579	45036.95	37530.79167	36029.56	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267105	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	1682405	841202.5	560801.6667	420601.25	336481	280400.8333	240343.5714	210300.625	186933.8889	168240.5	152945.9091	140200.4167	129415.7692	120171.7857	112160.3333	105150.3125	93466.94444	88547.63158	84120.25	70100.20833	67296.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267106	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	3962970	1981485	1320990	990742.5	792594	660495	566138.5714	495371.25	440330	396297	360270	330247.5	304843.8462	283069.2857	264198	247685.625	220165	208577.3684	198148.5	165123.75	158518.8	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267107	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	282065	141032.5	94021.66667	70516.25	56413	47010.83333	40295	35258.125	31340.55556	28206.5	25642.27273	23505.41667	21697.30769	20147.5	18804.33333	17629.0625	15670.27778	14845.52632	14103.25	11752.70833	11282.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267108	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	133637	66818.5	44545.66667	33409.25	26727.4	22272.83333	19091	16704.625	14848.55556	13363.7	12148.81818	11136.41667	10279.76923	9545.5	8909.133333	8352.3125	7424.277778	7033.526316	6681.85	5568.208333	5345.48	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267109	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267110	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	280029	140014.5	93343	70007.25	56005.8	46671.5	40004.14286	35003.625	31114.33333	28002.9	25457.18182	23335.75	21540.69231	20002.07143	18668.6	17501.8125	15557.16667	14738.36842	14001.45	11667.875	11201.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267111	CHOYP_STIP1.1.2|m.12856	ALEIDPNSEEAQK	ALEIDPNSEEAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267112	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	2331422	1165711	777140.6667	582855.5	466284.4	388570.3333	333060.2857	291427.75	259046.8889	233142.2	211947.4545	194285.1667	179340.1538	166530.1429	155428.1333	145713.875	129523.4444	122706.4211	116571.1	97142.58333	93256.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267113	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	1420143	710071.5	473381	355035.75	284028.6	236690.5	202877.5714	177517.875	157793.6667	142014.3	129103.9091	118345.25	109241.7692	101438.7857	94676.2	88758.9375	78896.83333	74744.36842	71007.15	59172.625	56805.72	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267114	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	774837	387418.5	258279	193709.25	154967.4	129139.5	110691	96854.625	86093	77483.7	70439.72727	64569.75	59602.84615	55345.5	51655.8	48427.3125	43046.5	40780.89474	38741.85	32284.875	30993.48	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267115	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	101141	50570.5	33713.66667	25285.25	20228.2	16856.83333	14448.71429	12642.625	11237.88889	10114.1	9194.636364	8428.416667	7780.076923	7224.357143	6742.733333	6321.3125	5618.944444	5323.210526	5057.05	4214.208333	4045.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267116	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	581360	290680	193786.6667	145340	116272	96893.33333	83051.42857	72670	64595.55556	58136	52850.90909	48446.66667	44720	41525.71429	38757.33333	36335	32297.77778	30597.89474	29068	24223.33333	23254.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267117	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267118	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267119	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267120	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267121	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	1103065	551532.5	367688.3333	275766.25	220613	183844.1667	157580.7143	137883.125	122562.7778	110306.5	100278.6364	91922.08333	84851.15385	78790.35714	73537.66667	68941.5625	61281.38889	58056.05263	55153.25	45961.04167	44122.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267122	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267123	CHOYP_STIP1.1.2|m.12856	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267124	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	8705361	4352680.5	2901787	2176340.25	1741072.2	1450893.5	1243623	1088170.125	967262.3333	870536.1	791396.4545	725446.75	669643.1538	621811.5	580357.4	544085.0625	483631.1667	458176.8947	435268.05	362723.375	348214.44	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267125	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	6190366	3095183	2063455.333	1547591.5	1238073.2	1031727.667	884338	773795.75	687818.4444	619036.6	562760.5455	515863.8333	476182	442169	412691.0667	386897.875	343909.2222	325808.7368	309518.3	257931.9167	247614.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267126	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	3605231	1802615.5	1201743.667	901307.75	721046.2	600871.8333	515033	450653.875	400581.2222	360523.1	327748.2727	300435.9167	277325.4615	257516.5	240348.7333	225326.9375	200290.6111	189749	180261.55	150217.9583	144209.24	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267127	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267128	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	415153	207576.5	138384.3333	103788.25	83030.6	69192.16667	59307.57143	51894.125	46128.11111	41515.3	37741.18182	34596.08333	31934.84615	29653.78571	27676.86667	25947.0625	23064.05556	21850.15789	20757.65	17298.04167	16606.12	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267129	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267130	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	185891	92945.5	61963.66667	46472.75	37178.2	30981.83333	26555.85714	23236.375	20654.55556	18589.1	16899.18182	15490.91667	14299.30769	13277.92857	12392.73333	11618.1875	10327.27778	9783.736842	9294.55	7745.458333	7435.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267131	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	1165103	582551.5	388367.6667	291275.75	233020.6	194183.8333	166443.2857	145637.875	129455.8889	116510.3	105918.4545	97091.91667	89623.30769	83221.64286	77673.53333	72818.9375	64727.94444	61321.21053	58255.15	48545.95833	46604.12	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267132	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	1002368	501184	334122.6667	250592	200473.6	167061.3333	143195.4286	125296	111374.2222	100236.8	91124.36364	83530.66667	77105.23077	71597.71429	66824.53333	62648	55687.11111	52756.21053	50118.4	41765.33333	40094.72	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267133	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	557243	278621.5	185747.6667	139310.75	111448.6	92873.83333	79606.14286	69655.375	61915.88889	55724.3	50658.45455	46436.91667	42864.84615	39803.07143	37149.53333	34827.6875	30957.94444	29328.57895	27862.15	23218.45833	22289.72	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267134	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	1125999	562999.5	375333	281499.75	225199.8	187666.5	160857	140749.875	125111	112599.9	102363.5455	93833.25	86615.30769	80428.5	75066.6	70374.9375	62555.5	59263.10526	56299.95	46916.625	45039.96	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267135	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	430892	215446	143630.6667	107723	86178.4	71815.33333	61556	53861.5	47876.88889	43089.2	39172	35907.66667	33145.53846	30778	28726.13333	26930.75	23938.44444	22678.52632	21544.6	17953.83333	17235.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267136	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267137	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	3053292	1526646	1017764	763323	610658.4	508882	436184.5714	381661.5	339254.6667	305329.2	277572	254441	234868.6154	218092.2857	203552.8	190830.75	169627.3333	160699.5789	152664.6	127220.5	122131.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267138	CHOYP_STIP1.1.2|m.12856	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267139	CHOYP_STIP1.1.2|m.12856	LILEQMQK	LILEQMQK	9326025	4663012.5	3108675	2331506.25	1865205	1554337.5	1332289.286	1165753.125	1036225	932602.5	847820.4545	777168.75	717386.5385	666144.6429	621735	582876.5625	518112.5	490843.4211	466301.25	388584.375	373041	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267140	CHOYP_STIP1.1.2|m.12856	LILEQMQK	LILEQMQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267141	CHOYP_STIP1.1.2|m.12856	LILEQMQK	LILEQMQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267142	CHOYP_STIP1.1.2|m.12856	LILEQMQK	LILEQMQK	742576	371288	247525.3333	185644	148515.2	123762.6667	106082.2857	92822	82508.44444	74257.6	67506.90909	61881.33333	57121.23077	53041.14286	49505.06667	46411	41254.22222	39082.94737	37128.8	30940.66667	29703.04	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267143	CHOYP_STIP1.1.2|m.12856	LILEQMQK	LILEQMQK	312985	156492.5	104328.3333	78246.25	62597	52164.16667	44712.14286	39123.125	34776.11111	31298.5	28453.18182	26082.08333	24075.76923	22356.07143	20865.66667	19561.5625	17388.05556	16472.89474	15649.25	13041.04167	12519.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267144	CHOYP_STIP1.1.2|m.12856	LILEQMQK	LILEQMQK	296455	148227.5	98818.33333	74113.75	59291	49409.16667	42350.71429	37056.875	32939.44444	29645.5	26950.45455	24704.58333	22804.23077	21175.35714	19763.66667	18528.4375	16469.72222	15602.89474	14822.75	12352.29167	11858.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267244	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267245	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267246	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267247	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267248	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267249	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267250	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267251	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267252	CHOYP_STIP1.2.2|m.54723	IQGNEALNQQK	IQGNEALNQQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267253	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267254	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267255	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267256	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267257	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267258	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	22335	11167.5	7445	5583.75	4467	3722.5	3190.714286	2791.875	2481.666667	2233.5	2030.454545	1861.25	1718.076923	1595.357143	1489	1395.9375	1240.833333	1175.526316	1116.75	930.625	893.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267259	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267260	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	20417	10208.5	6805.666667	5104.25	4083.4	3402.833333	2916.714286	2552.125	2268.555556	2041.7	1856.090909	1701.416667	1570.538462	1458.357143	1361.133333	1276.0625	1134.277778	1074.578947	1020.85	850.7083333	816.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267261	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267262	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267263	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267264	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267265	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267266	CHOYP_STIP1.2.2|m.54723	YQEAIEHYTAAIDLDK	YQEAIEHYTAAIDLDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267267	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267268	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267269	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267270	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	409205	204602.5	136401.6667	102301.25	81841	68200.83333	58457.85714	51150.625	45467.22222	40920.5	37200.45455	34100.41667	31477.30769	29228.92857	27280.33333	25575.3125	22733.61111	21537.10526	20460.25	17050.20833	16368.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267271	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	741404	370702	247134.6667	185351	148280.8	123567.3333	105914.8571	92675.5	82378.22222	74140.4	67400.36364	61783.66667	57031.07692	52957.42857	49426.93333	46337.75	41189.11111	39021.26316	37070.2	30891.83333	29656.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267272	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	134625	67312.5	44875	33656.25	26925	22437.5	19232.14286	16828.125	14958.33333	13462.5	12238.63636	11218.75	10355.76923	9616.071429	8975	8414.0625	7479.166667	7085.526316	6731.25	5609.375	5385	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267273	CHOYP_STIP1.2.2|m.54723	DNHVLYSNR	DNHVLYSNR	62572	31286	20857.33333	15643	12514.4	10428.66667	8938.857143	7821.5	6952.444444	6257.2	5688.363636	5214.333333	4813.230769	4469.428571	4171.466667	3910.75	3476.222222	3293.263158	3128.6	2607.166667	2502.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267274	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	7652375	3826187.5	2550791.667	1913093.75	1530475	1275395.833	1093196.429	956546.875	850263.8889	765237.5	695670.4545	637697.9167	588644.2308	546598.2143	510158.3333	478273.4375	425131.9444	402756.5789	382618.75	318848.9583	306095	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267275	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	4119514	2059757	1373171.333	1029878.5	823902.8	686585.6667	588502	514939.25	457723.7778	411951.4	374501.2727	343292.8333	316885.6923	294251	274634.2667	257469.625	228861.8889	216816.5263	205975.7	171646.4167	164780.56	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267276	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	2620941	1310470.5	873647	655235.25	524188.2	436823.5	374420.1429	327617.625	291215.6667	262094.1	238267.3636	218411.75	201610.8462	187210.0714	174729.4	163808.8125	145607.8333	137944.2632	131047.05	109205.875	104837.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267277	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	791530	395765	263843.3333	197882.5	158306	131921.6667	113075.7143	98941.25	87947.77778	79153	71957.27273	65960.83333	60886.92308	56537.85714	52768.66667	49470.625	43973.88889	41659.47368	39576.5	32980.41667	31661.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267278	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	848584	424292	282861.3333	212146	169716.8	141430.6667	121226.2857	106073	94287.11111	84858.4	77144	70715.33333	65275.69231	60613.14286	56572.26667	53036.5	47143.55556	44662.31579	42429.2	35357.66667	33943.36	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267279	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	2952872	1476436	984290.6667	738218	590574.4	492145.3333	421838.8571	369109	328096.8889	295287.2	268442.9091	246072.6667	227144	210919.4286	196858.1333	184554.5	164048.4444	155414.3158	147643.6	123036.3333	118114.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267280	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	32633	16316.5	10877.66667	8158.25	6526.6	5438.833333	4661.857143	4079.125	3625.888889	3263.3	2966.636364	2719.416667	2510.230769	2330.928571	2175.533333	2039.5625	1812.944444	1717.526316	1631.65	1359.708333	1305.32	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267281	CHOYP_STIP1.2.2|m.54723	AIQLNPEWAK	AIQLNPEWAK	535948	267974	178649.3333	133987	107189.6	89324.66667	76564	66993.5	59549.77778	53594.8	48722.54545	44662.33333	41226.76923	38282	35729.86667	33496.75	29774.88889	28207.78947	26797.4	22331.16667	21437.92	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267282	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	1017622	508811	339207.3333	254405.5	203524.4	169603.6667	145374.5714	127202.75	113069.1111	101762.2	92511.09091	84801.83333	78278.61538	72687.28571	67841.46667	63601.375	56534.55556	53559.05263	50881.1	42400.91667	40704.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267283	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267284	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	1256534	628267	418844.6667	314133.5	251306.8	209422.3333	179504.8571	157066.75	139614.8889	125653.4	114230.3636	104711.1667	96656.46154	89752.42857	83768.93333	78533.375	69807.44444	66133.36842	62826.7	52355.58333	50261.36	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267285	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267286	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267287	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267288	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267289	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267290	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267291	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267292	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267293	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	53704	26852	17901.33333	13426	10740.8	8950.666667	7672	6713	5967.111111	5370.4	4882.181818	4475.333333	4131.076923	3836	3580.266667	3356.5	2983.555556	2826.526316	2685.2	2237.666667	2148.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267294	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	64604	32302	21534.66667	16151	12920.8	10767.33333	9229.142857	8075.5	7178.222222	6460.4	5873.090909	5383.666667	4969.538462	4614.571429	4306.933333	4037.75	3589.111111	3400.210526	3230.2	2691.833333	2584.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267295	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	49848	24924	16616	12462	9969.6	8308	7121.142857	6231	5538.666667	4984.8	4531.636364	4154	3834.461538	3560.571429	3323.2	3115.5	2769.333333	2623.578947	2492.4	2077	1993.92	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267296	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267297	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	114800	57400	38266.66667	28700	22960	19133.33333	16400	14350	12755.55556	11480	10436.36364	9566.666667	8830.769231	8200	7653.333333	7175	6377.777778	6042.105263	5740	4783.333333	4592	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267298	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	218836	109418	72945.33333	54709	43767.2	36472.66667	31262.28571	27354.5	24315.11111	21883.6	19894.18182	18236.33333	16833.53846	15631.14286	14589.06667	13677.25	12157.55556	11517.68421	10941.8	9118.166667	8753.44	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267299	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267300	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267301	CHOYP_STIP1.2.2|m.54723	SHLTGPGNSQPISSPFAAPDMMAK	SHLTGPGNSQPISSPFAAPDMMAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267302	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267303	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267304	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267305	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	206942	103471	68980.66667	51735.5	41388.4	34490.33333	29563.14286	25867.75	22993.55556	20694.2	18812.90909	17245.16667	15918.61538	14781.57143	13796.13333	12933.875	11496.77778	10891.68421	10347.1	8622.583333	8277.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267306	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	299540	149770	99846.66667	74885	59908	49923.33333	42791.42857	37442.5	33282.22222	29954	27230.90909	24961.66667	23041.53846	21395.71429	19969.33333	18721.25	16641.11111	15765.26316	14977	12480.83333	11981.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267307	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	210264	105132	70088	52566	42052.8	35044	30037.71429	26283	23362.66667	21026.4	19114.90909	17522	16174.15385	15018.85714	14017.6	13141.5	11681.33333	11066.52632	10513.2	8761	8410.56	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267308	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	106385	53192.5	35461.66667	26596.25	21277	17730.83333	15197.85714	13298.125	11820.55556	10638.5	9671.363636	8865.416667	8183.461538	7598.928571	7092.333333	6649.0625	5910.277778	5599.210526	5319.25	4432.708333	4255.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267309	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	23425	11712.5	7808.333333	5856.25	4685	3904.166667	3346.428571	2928.125	2602.777778	2342.5	2129.545455	1952.083333	1801.923077	1673.214286	1561.666667	1464.0625	1301.388889	1232.894737	1171.25	976.0416667	937	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267310	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	74249	37124.5	24749.66667	18562.25	14849.8	12374.83333	10607	9281.125	8249.888889	7424.9	6749.909091	6187.416667	5711.461538	5303.5	4949.933333	4640.5625	4124.944444	3907.842105	3712.45	3093.708333	2969.96	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267311	CHOYP_STIP1.2.2|m.54723	AAVYFEQENYDK	AAVYFEQENYDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267312	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267313	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	2679328	1339664	893109.3333	669832	535865.6	446554.6667	382761.1429	334916	297703.1111	267932.8	243575.2727	223277.3333	206102.1538	191380.5714	178621.8667	167458	148851.5556	141017.2632	133966.4	111638.6667	107173.12	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267314	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267315	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267316	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267317	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267318	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267319	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267320	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267321	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267322	CHOYP_STIP1.2.2|m.54723	LAYVNPELALEEK	LAYVNPELALEEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267323	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	10562221	5281110.5	3520740.333	2640555.25	2112444.2	1760370.167	1508888.714	1320277.625	1173580.111	1056222.1	960201.9091	880185.0833	812478.5385	754444.3571	704148.0667	660138.8125	586790.0556	555906.3684	528111.05	440092.5417	422488.84	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267324	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	6578883	3289441.5	2192961	1644720.75	1315776.6	1096480.5	939840.4286	822360.375	730987	657888.3	598080.2727	548240.25	506067.9231	469920.2143	438592.2	411180.1875	365493.5	346257	328944.15	274120.125	263155.32	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267325	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	3793890	1896945	1264630	948472.5	758778	632315	541984.2857	474236.25	421543.3333	379389	344899.0909	316157.5	291837.6923	270992.1429	252926	237118.125	210771.6667	199678.4211	189694.5	158078.75	151755.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267326	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	900739	450369.5	300246.3333	225184.75	180147.8	150123.1667	128677	112592.375	100082.1111	90073.9	81885.36364	75061.58333	69287.61538	64338.5	60049.26667	56296.1875	50041.05556	47407.31579	45036.95	37530.79167	36029.56	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267327	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	1682405	841202.5	560801.6667	420601.25	336481	280400.8333	240343.5714	210300.625	186933.8889	168240.5	152945.9091	140200.4167	129415.7692	120171.7857	112160.3333	105150.3125	93466.94444	88547.63158	84120.25	70100.20833	67296.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267328	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	3962970	1981485	1320990	990742.5	792594	660495	566138.5714	495371.25	440330	396297	360270	330247.5	304843.8462	283069.2857	264198	247685.625	220165	208577.3684	198148.5	165123.75	158518.8	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267329	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	282065	141032.5	94021.66667	70516.25	56413	47010.83333	40295	35258.125	31340.55556	28206.5	25642.27273	23505.41667	21697.30769	20147.5	18804.33333	17629.0625	15670.27778	14845.52632	14103.25	11752.70833	11282.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267330	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	133637	66818.5	44545.66667	33409.25	26727.4	22272.83333	19091	16704.625	14848.55556	13363.7	12148.81818	11136.41667	10279.76923	9545.5	8909.133333	8352.3125	7424.277778	7033.526316	6681.85	5568.208333	5345.48	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267331	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267332	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	280029	140014.5	93343	70007.25	56005.8	46671.5	40004.14286	35003.625	31114.33333	28002.9	25457.18182	23335.75	21540.69231	20002.07143	18668.6	17501.8125	15557.16667	14738.36842	14001.45	11667.875	11201.16	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267333	CHOYP_STIP1.2.2|m.54723	ALEIDPNSEEAQK	ALEIDPNSEEAQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267334	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	2331422	1165711	777140.6667	582855.5	466284.4	388570.3333	333060.2857	291427.75	259046.8889	233142.2	211947.4545	194285.1667	179340.1538	166530.1429	155428.1333	145713.875	129523.4444	122706.4211	116571.1	97142.58333	93256.88	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267335	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	1420143	710071.5	473381	355035.75	284028.6	236690.5	202877.5714	177517.875	157793.6667	142014.3	129103.9091	118345.25	109241.7692	101438.7857	94676.2	88758.9375	78896.83333	74744.36842	71007.15	59172.625	56805.72	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267336	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	774837	387418.5	258279	193709.25	154967.4	129139.5	110691	96854.625	86093	77483.7	70439.72727	64569.75	59602.84615	55345.5	51655.8	48427.3125	43046.5	40780.89474	38741.85	32284.875	30993.48	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267337	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	101141	50570.5	33713.66667	25285.25	20228.2	16856.83333	14448.71429	12642.625	11237.88889	10114.1	9194.636364	8428.416667	7780.076923	7224.357143	6742.733333	6321.3125	5618.944444	5323.210526	5057.05	4214.208333	4045.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267338	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	581360	290680	193786.6667	145340	116272	96893.33333	83051.42857	72670	64595.55556	58136	52850.90909	48446.66667	44720	41525.71429	38757.33333	36335	32297.77778	30597.89474	29068	24223.33333	23254.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267339	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267340	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267341	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267342	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267343	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	1103065	551532.5	367688.3333	275766.25	220613	183844.1667	157580.7143	137883.125	122562.7778	110306.5	100278.6364	91922.08333	84851.15385	78790.35714	73537.66667	68941.5625	61281.38889	58056.05263	55153.25	45961.04167	44122.6	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267344	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267345	CHOYP_STIP1.2.2|m.54723	DAMMAEGNDPEAVR	DAMMAEGNDPEAVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267346	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	8705361	4352680.5	2901787	2176340.25	1741072.2	1450893.5	1243623	1088170.125	967262.3333	870536.1	791396.4545	725446.75	669643.1538	621811.5	580357.4	544085.0625	483631.1667	458176.8947	435268.05	362723.375	348214.44	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267347	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	6190366	3095183	2063455.333	1547591.5	1238073.2	1031727.667	884338	773795.75	687818.4444	619036.6	562760.5455	515863.8333	476182	442169	412691.0667	386897.875	343909.2222	325808.7368	309518.3	257931.9167	247614.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267348	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	3605231	1802615.5	1201743.667	901307.75	721046.2	600871.8333	515033	450653.875	400581.2222	360523.1	327748.2727	300435.9167	277325.4615	257516.5	240348.7333	225326.9375	200290.6111	189749	180261.55	150217.9583	144209.24	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267349	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267350	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	415153	207576.5	138384.3333	103788.25	83030.6	69192.16667	59307.57143	51894.125	46128.11111	41515.3	37741.18182	34596.08333	31934.84615	29653.78571	27676.86667	25947.0625	23064.05556	21850.15789	20757.65	17298.04167	16606.12	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267351	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267352	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	185891	92945.5	61963.66667	46472.75	37178.2	30981.83333	26555.85714	23236.375	20654.55556	18589.1	16899.18182	15490.91667	14299.30769	13277.92857	12392.73333	11618.1875	10327.27778	9783.736842	9294.55	7745.458333	7435.64	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267353	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	1165103	582551.5	388367.6667	291275.75	233020.6	194183.8333	166443.2857	145637.875	129455.8889	116510.3	105918.4545	97091.91667	89623.30769	83221.64286	77673.53333	72818.9375	64727.94444	61321.21053	58255.15	48545.95833	46604.12	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267354	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	1002368	501184	334122.6667	250592	200473.6	167061.3333	143195.4286	125296	111374.2222	100236.8	91124.36364	83530.66667	77105.23077	71597.71429	66824.53333	62648	55687.11111	52756.21053	50118.4	41765.33333	40094.72	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267355	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	557243	278621.5	185747.6667	139310.75	111448.6	92873.83333	79606.14286	69655.375	61915.88889	55724.3	50658.45455	46436.91667	42864.84615	39803.07143	37149.53333	34827.6875	30957.94444	29328.57895	27862.15	23218.45833	22289.72	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267356	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	1125999	562999.5	375333	281499.75	225199.8	187666.5	160857	140749.875	125111	112599.9	102363.5455	93833.25	86615.30769	80428.5	75066.6	70374.9375	62555.5	59263.10526	56299.95	46916.625	45039.96	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267357	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	430892	215446	143630.6667	107723	86178.4	71815.33333	61556	53861.5	47876.88889	43089.2	39172	35907.66667	33145.53846	30778	28726.13333	26930.75	23938.44444	22678.52632	21544.6	17953.83333	17235.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267358	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267359	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	3053292	1526646	1017764	763323	610658.4	508882	436184.5714	381661.5	339254.6667	305329.2	277572	254441	234868.6154	218092.2857	203552.8	190830.75	169627.3333	160699.5789	152664.6	127220.5	122131.68	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267360	CHOYP_STIP1.2.2|m.54723	AMGDPEVQAILNDPAMR	AMGDPEVQAILNDPAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267361	CHOYP_STIP1.2.2|m.54723	LILEQMQK	LILEQMQK	9326025	4663012.5	3108675	2331506.25	1865205	1554337.5	1332289.286	1165753.125	1036225	932602.5	847820.4545	777168.75	717386.5385	666144.6429	621735	582876.5625	518112.5	490843.4211	466301.25	388584.375	373041	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267362	CHOYP_STIP1.2.2|m.54723	LILEQMQK	LILEQMQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267363	CHOYP_STIP1.2.2|m.54723	LILEQMQK	LILEQMQK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267364	CHOYP_STIP1.2.2|m.54723	LILEQMQK	LILEQMQK	742576	371288	247525.3333	185644	148515.2	123762.6667	106082.2857	92822	82508.44444	74257.6	67506.90909	61881.33333	57121.23077	53041.14286	49505.06667	46411	41254.22222	39082.94737	37128.8	30940.66667	29703.04	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267365	CHOYP_STIP1.2.2|m.54723	LILEQMQK	LILEQMQK	312985	156492.5	104328.3333	78246.25	62597	52164.16667	44712.14286	39123.125	34776.11111	31298.5	28453.18182	26082.08333	24075.76923	22356.07143	20865.66667	19561.5625	17388.05556	16472.89474	15649.25	13041.04167	12519.4	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267366	CHOYP_STIP1.2.2|m.54723	LILEQMQK	LILEQMQK	296455	148227.5	98818.33333	74113.75	59291	49409.16667	42350.71429	37056.875	32939.44444	29645.5	26950.45455	24704.58333	22804.23077	21175.35714	19763.66667	18528.4375	16469.72222	15602.89474	14822.75	12352.29167	11858.2	P31948	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822
267367	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267368	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	1115063	557531.5	371687.6667	278765.75	223012.6	185843.8333	159294.7143	139382.875	123895.8889	111506.3	101369.3636	92921.91667	85774.07692	79647.35714	74337.53333	69691.4375	61947.94444	58687.52632	55753.15	46460.95833	44602.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267369	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	244234	122117	81411.33333	61058.5	48846.8	40705.66667	34890.57143	30529.25	27137.11111	24423.4	22203.09091	20352.83333	18787.23077	17445.28571	16282.26667	15264.625	13568.55556	12854.42105	12211.7	10176.41667	9769.36	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267370	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267371	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267372	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	92966	46483	30988.66667	23241.5	18593.2	15494.33333	13280.85714	11620.75	10329.55556	9296.6	8451.454545	7747.166667	7151.230769	6640.428571	6197.733333	5810.375	5164.777778	4892.947368	4648.3	3873.583333	3718.64	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267373	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267374	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	28463	14231.5	9487.666667	7115.75	5692.6	4743.833333	4066.142857	3557.875	3162.555556	2846.3	2587.545455	2371.916667	2189.461538	2033.071429	1897.533333	1778.9375	1581.277778	1498.052632	1423.15	1185.958333	1138.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267375	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	47176	23588	15725.33333	11794	9435.2	7862.666667	6739.428571	5897	5241.777778	4717.6	4288.727273	3931.333333	3628.923077	3369.714286	3145.066667	2948.5	2620.888889	2482.947368	2358.8	1965.666667	1887.04	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267376	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267377	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267378	CHOYP_STK24.1.1|m.13301	AGAFSENDIAIILR	AGAFSENDIAIILR	138902	69451	46300.66667	34725.5	27780.4	23150.33333	19843.14286	17362.75	15433.55556	13890.2	12627.45455	11575.16667	10684.76923	9921.571429	9260.133333	8681.375	7716.777778	7310.631579	6945.1	5787.583333	5556.08	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267379	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267380	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267381	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267382	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	248663	124331.5	82887.66667	62165.75	49732.6	41443.83333	35523.28571	31082.875	27629.22222	24866.3	22605.72727	20721.91667	19127.92308	17761.64286	16577.53333	15541.4375	13814.61111	13087.52632	12433.15	10360.95833	9946.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267383	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267384	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	1459421	729710.5	486473.6667	364855.25	291884.2	243236.8333	208488.7143	182427.625	162157.8889	145942.1	132674.6364	121618.4167	112263.1538	104244.3571	97294.73333	91213.8125	81078.94444	76811.63158	72971.05	60809.20833	58376.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267385	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267386	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	113038	56519	37679.33333	28259.5	22607.6	18839.66667	16148.28571	14129.75	12559.77778	11303.8	10276.18182	9419.833333	8695.230769	8074.142857	7535.866667	7064.875	6279.888889	5949.368421	5651.9	4709.916667	4521.52	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267387	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	288075	144037.5	96025	72018.75	57615	48012.5	41153.57143	36009.375	32008.33333	28807.5	26188.63636	24006.25	22159.61538	20576.78571	19205	18004.6875	16004.16667	15161.84211	14403.75	12003.125	11523	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267388	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267389	CHOYP_STK24.1.1|m.13301	AANVLLSEMGDVK	AANVLLSEMGDVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267390	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267391	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267392	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267393	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267394	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267395	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267396	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267397	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	146483	73241.5	48827.66667	36620.75	29296.6	24413.83333	20926.14286	18310.375	16275.88889	14648.3	13316.63636	12206.91667	11267.92308	10463.07143	9765.533333	9155.1875	8137.944444	7709.631579	7324.15	6103.458333	5859.32	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267398	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267399	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267400	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267401	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267402	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267403	CHOYP_STK24.1.1|m.13301	LADFGVAGQLTNTTNK	LADFGVAGQLTNTTNK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267404	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	7580018	3790009	2526672.667	1895004.5	1516003.6	1263336.333	1082859.714	947502.25	842224.2222	758001.8	689092.5455	631668.1667	583078.3077	541429.8571	505334.5333	473751.125	421112.1111	398948.3158	379000.9	315834.0833	303200.72	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267405	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	3302721	1651360.5	1100907	825680.25	660544.2	550453.5	471817.2857	412840.125	366969	330272.1	300247.3636	275226.75	254055.4615	235908.6429	220181.4	206420.0625	183484.5	173827.4211	165136.05	137613.375	132108.84	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267406	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	1709365	854682.5	569788.3333	427341.25	341873	284894.1667	244195	213670.625	189929.4444	170936.5	155396.8182	142447.0833	131489.6154	122097.5	113957.6667	106835.3125	94964.72222	89966.57895	85468.25	71223.54167	68374.6	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267407	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267408	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267409	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267410	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267411	CHOYP_STK24.1.1|m.13301	TTYLQELIDK	TTYLQELIDK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9Z2W1	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	GO:0000139; GO:0004702; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168
267501	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267502	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	1770956	885478	590318.6667	442739	354191.2	295159.3333	252993.7143	221369.5	196772.8889	177095.6	160996	147579.6667	136227.3846	126496.8571	118063.7333	110684.75	98386.44444	93208.21053	88547.8	73789.83333	70838.24	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267503	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267504	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267505	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	523011	261505.5	174337	130752.75	104602.2	87168.5	74715.85714	65376.375	58112.33333	52301.1	47546.45455	43584.25	40231.61538	37357.92857	34867.4	32688.1875	29056.16667	27526.89474	26150.55	21792.125	20920.44	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267506	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	460439	230219.5	153479.6667	115109.75	92087.8	76739.83333	65777	57554.875	51159.88889	46043.9	41858.09091	38369.91667	35418.38462	32888.5	30695.93333	28777.4375	25579.94444	24233.63158	23021.95	19184.95833	18417.56	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267507	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267508	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	258628	129314	86209.33333	64657	51725.6	43104.66667	36946.85714	32328.5	28736.44444	25862.8	23511.63636	21552.33333	19894.46154	18473.42857	17241.86667	16164.25	14368.22222	13612	12931.4	10776.16667	10345.12	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
267509	CHOYP_STK39.1.1|m.44512	EMVEAGLVNGK	EMVEAGLVNGK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q9UEW8	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of rubidium ion transmembrane transporter activity [GO:2000687]; negative regulation of rubidium ion transport [GO:2000681]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of potassium ion transport [GO:0043268]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of ion homeostasis [GO:2000021]; response to stress [GO:0006950]; signal transduction by protein phosphorylation [GO:0023014]	GO:0001933; GO:0004674; GO:0004702; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006950; GO:0008217; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0023014; GO:0035556; GO:0043268; GO:0050727; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:2000021; GO:2000681; GO:2000687
281301	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	64887388	32443694	21629129.33	16221847	12977477.6	10814564.67	9269626.857	8110923.5	7209709.778	6488738.8	5898853.455	5407282.333	4991337.538	4634813.429	4325825.867	4055461.75	3604854.889	3415125.684	3244369.4	2703641.167	2595495.52	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281302	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	33299940	16649970	11099980	8324985	6659988	5549990	4757134.286	4162492.5	3699993.333	3329994	3027267.273	2774995	2561533.846	2378567.143	2219996	2081246.25	1849996.667	1752628.421	1664997	1387497.5	1331997.6	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281303	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	24262528	12131264	8087509.333	6065632	4852505.6	4043754.667	3466075.429	3032816	2695836.444	2426252.8	2205684.364	2021877.333	1866348.308	1733037.714	1617501.867	1516408	1347918.222	1276975.158	1213126.4	1010938.667	970501.12	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281304	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281305	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281306	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281307	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281308	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281309	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281310	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281311	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281312	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281313	CHOYP_TPR.2.2|m.46877	SIQDGESSSLTTQLR	SIQDGESSSLTTQLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281314	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	448132	224066	149377.3333	112033	89626.4	74688.66667	64018.85714	56016.5	49792.44444	44813.2	40739.27273	37344.33333	34471.69231	32009.42857	29875.46667	28008.25	24896.22222	23585.89474	22406.6	18672.16667	17925.28	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281315	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281316	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	554824	277412	184941.3333	138706	110964.8	92470.66667	79260.57143	69353	61647.11111	55482.4	50438.54545	46235.33333	42678.76923	39630.28571	36988.26667	34676.5	30823.55556	29201.26316	27741.2	23117.66667	22192.96	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281317	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281318	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281319	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281320	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281321	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281322	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281323	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281324	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281325	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281326	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281327	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281328	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281329	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281330	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281331	CHOYP_TPR.2.2|m.46877	TSQSMLMANLQSIQNTLEHSER	TSQSMLMANLQSIQNTLEHSER	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281332	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	1087370	543685	362456.6667	271842.5	217474	181228.3333	155338.5714	135921.25	120818.8889	108737	98851.81818	90614.16667	83643.84615	77669.28571	72491.33333	67960.625	60409.44444	57230	54368.5	45307.08333	43494.8	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281333	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281334	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281335	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281336	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281337	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	117823	58911.5	39274.33333	29455.75	23564.6	19637.16667	16831.85714	14727.875	13091.44444	11782.3	10711.18182	9818.583333	9063.307692	8415.928571	7854.866667	7363.9375	6545.722222	6201.210526	5891.15	4909.291667	4712.92	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281338	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281339	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281340	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281341	CHOYP_TPR.2.2|m.46877	LQQELEEAVSTR	LQQELEEAVSTR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281342	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281343	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281344	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281345	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281346	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	27419	13709.5	9139.666667	6854.75	5483.8	4569.833333	3917	3427.375	3046.555556	2741.9	2492.636364	2284.916667	2109.153846	1958.5	1827.933333	1713.6875	1523.277778	1443.105263	1370.95	1142.458333	1096.76	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281347	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281348	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	100067	50033.5	33355.66667	25016.75	20013.4	16677.83333	14295.28571	12508.375	11118.55556	10006.7	9097	8338.916667	7697.461538	7147.642857	6671.133333	6254.1875	5559.277778	5266.684211	5003.35	4169.458333	4002.68	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281349	CHOYP_TPR.2.2|m.46877	MSNDVMTIQR	MSNDVMTIQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281350	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	7381604	3690802	2460534.667	1845401	1476320.8	1230267.333	1054514.857	922700.5	820178.2222	738160.4	671054.9091	615133.6667	567815.6923	527257.4286	492106.9333	461350.25	410089.1111	388505.4737	369080.2	307566.8333	295264.16	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281351	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	3241356	1620678	1080452	810339	648271.2	540226	463050.8571	405169.5	360150.6667	324135.6	294668.7273	270113	249335.0769	231525.4286	216090.4	202584.75	180075.3333	170597.6842	162067.8	135056.5	129654.24	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281352	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	1168904	584452	389634.6667	292226	233780.8	194817.3333	166986.2857	146113	129878.2222	116890.4	106264	97408.66667	89915.69231	83493.14286	77926.93333	73056.5	64939.11111	61521.26316	58445.2	48704.33333	46756.16	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281353	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281354	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	607905	303952.5	202635	151976.25	121581	101317.5	86843.57143	75988.125	67545	60790.5	55264.09091	50658.75	46761.92308	43421.78571	40527	37994.0625	33772.5	31995	30395.25	25329.375	24316.2	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281355	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	97066	48533	32355.33333	24266.5	19413.2	16177.66667	13866.57143	12133.25	10785.11111	9706.6	8824.181818	8088.833333	7466.615385	6933.285714	6471.066667	6066.625	5392.555556	5108.736842	4853.3	4044.416667	3882.64	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281356	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	25782	12891	8594	6445.5	5156.4	4297	3683.142857	3222.75	2864.666667	2578.2	2343.818182	2148.5	1983.230769	1841.571429	1718.8	1611.375	1432.333333	1356.947368	1289.1	1074.25	1031.28	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281357	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	56082	28041	18694	14020.5	11216.4	9347	8011.714286	7010.25	6231.333333	5608.2	5098.363636	4673.5	4314	4005.857143	3738.8	3505.125	3115.666667	2951.684211	2804.1	2336.75	2243.28	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281358	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281359	CHOYP_TPR.2.2|m.46877	LADVSFDEDTAR	LADVSFDEDTAR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281360	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	636554	318277	212184.6667	159138.5	127310.8	106092.3333	90936.28571	79569.25	70728.22222	63655.4	57868.54545	53046.16667	48965.69231	45468.14286	42436.93333	39784.625	35364.11111	33502.84211	31827.7	26523.08333	25462.16	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281361	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281362	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281363	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281364	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	64436	32218	21478.66667	16109	12887.2	10739.33333	9205.142857	8054.5	7159.555556	6443.6	5857.818182	5369.666667	4956.615385	4602.571429	4295.733333	4027.25	3579.777778	3391.368421	3221.8	2684.833333	2577.44	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281365	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	55755	27877.5	18585	13938.75	11151	9292.5	7965	6969.375	6195	5575.5	5068.636364	4646.25	4288.846154	3982.5	3717	3484.6875	3097.5	2934.473684	2787.75	2323.125	2230.2	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281366	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	75633	37816.5	25211	18908.25	15126.6	12605.5	10804.71429	9454.125	8403.666667	7563.3	6875.727273	6302.75	5817.923077	5402.357143	5042.2	4727.0625	4201.833333	3980.684211	3781.65	3151.375	3025.32	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281367	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	42830	21415	14276.66667	10707.5	8566	7138.333333	6118.571429	5353.75	4758.888889	4283	3893.636364	3569.166667	3294.615385	3059.285714	2855.333333	2676.875	2379.444444	2254.210526	2141.5	1784.583333	1713.2	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281368	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	20374	10187	6791.333333	5093.5	4074.8	3395.666667	2910.571429	2546.75	2263.777778	2037.4	1852.181818	1697.833333	1567.230769	1455.285714	1358.266667	1273.375	1131.888889	1072.315789	1018.7	848.9166667	814.96	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281369	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281370	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281371	CHOYP_TPR.2.2|m.46877	TQLIQIQQENTQLK	TQLIQIQQENTQLK	13918	6959	4639.333333	3479.5	2783.6	2319.666667	1988.285714	1739.75	1546.444444	1391.8	1265.272727	1159.833333	1070.615385	994.1428571	927.8666667	869.875	773.2222222	732.5263158	695.9	579.9166667	556.72	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281372	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281373	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281374	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281375	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281376	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281377	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281378	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	394957	197478.5	131652.3333	98739.25	78991.4	65826.16667	56422.42857	49369.625	43884.11111	39495.7	35905.18182	32913.08333	30381.30769	28211.21429	26330.46667	24684.8125	21942.05556	20787.21053	19747.85	16456.54167	15798.28	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281379	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	16323	8161.5	5441	4080.75	3264.6	2720.5	2331.857143	2040.375	1813.666667	1632.3	1483.909091	1360.25	1255.615385	1165.928571	1088.2	1020.1875	906.8333333	859.1052632	816.15	680.125	652.92	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281380	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281381	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281382	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	15262	7631	5087.333333	3815.5	3052.4	2543.666667	2180.285714	1907.75	1695.777778	1526.2	1387.454545	1271.833333	1174	1090.142857	1017.466667	953.875	847.8888889	803.2631579	763.1	635.9166667	610.48	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281383	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281384	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281385	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281386	CHOYP_TPR.2.2|m.46877	LSSSEQPTGASEEAESR	LSSSEQPTGASEEAESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	F1MA98	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	Tpr	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; MAPK import into nucleus [GO:0000189]; mitotic nuclear division [GO:0007067]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	GO:0000122; GO:0000189; GO:0000776; GO:0003682; GO:0003729; GO:0005487; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006611; GO:0006999; GO:0007067; GO:0007094; GO:0010965; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673
281429	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281430	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281431	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281432	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281433	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281434	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281435	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281436	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	57422	28711	19140.66667	14355.5	11484.4	9570.333333	8203.142857	7177.75	6380.222222	5742.2	5220.181818	4785.166667	4417.076923	4101.571429	3828.133333	3588.875	3190.111111	3022.210526	2871.1	2392.583333	2296.88	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281437	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281438	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281439	CHOYP_TRAP1.1.1|m.60651	TFTIQDTGIGMTK	TFTIQDTGIGMTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281440	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	1012591	506295.5	337530.3333	253147.75	202518.2	168765.1667	144655.8571	126573.875	112510.1111	101259.1	92053.72727	84382.58333	77891.61538	72327.92857	67506.06667	63286.9375	56255.05556	53294.26316	50629.55	42191.29167	40503.64	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281441	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281442	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281443	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281444	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281445	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	162210	81105	54070	40552.5	32442	27035	23172.85714	20276.25	18023.33333	16221	14746.36364	13517.5	12477.69231	11586.42857	10814	10138.125	9011.666667	8537.368421	8110.5	6758.75	6488.4	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281446	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	69550	34775	23183.33333	17387.5	13910	11591.66667	9935.714286	8693.75	7727.777778	6955	6322.727273	5795.833333	5350	4967.857143	4636.666667	4346.875	3863.888889	3660.526316	3477.5	2897.916667	2782	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281447	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281448	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281449	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281450	CHOYP_TRAP1.1.1|m.60651	ANIVQPLWMMDPK	ANIVQPLWMMDPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281451	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	2567551	1283775.5	855850.3333	641887.75	513510.2	427925.1667	366793	320943.875	285283.4444	256755.1	233413.7273	213962.5833	197503.9231	183396.5	171170.0667	160471.9375	142641.7222	135134.2632	128377.55	106981.2917	102702.04	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281452	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	1791970	895985	597323.3333	447992.5	358394	298661.6667	255995.7143	223996.25	199107.7778	179197	162906.3636	149330.8333	137843.8462	127997.8571	119464.6667	111998.125	99553.88889	94314.21053	89598.5	74665.41667	71678.8	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281453	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	1027983	513991.5	342661	256995.75	205596.6	171330.5	146854.7143	128497.875	114220.3333	102798.3	93453	85665.25	79075.61538	73427.35714	68532.2	64248.9375	57110.16667	54104.36842	51399.15	42832.625	41119.32	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281454	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	150318	75159	50106	37579.5	30063.6	25053	21474	18789.75	16702	15031.8	13665.27273	12526.5	11562.92308	10737	10021.2	9394.875	8351	7911.473684	7515.9	6263.25	6012.72	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281455	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281456	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	56445	28222.5	18815	14111.25	11289	9407.5	8063.571429	7055.625	6271.666667	5644.5	5131.363636	4703.75	4341.923077	4031.785714	3763	3527.8125	3135.833333	2970.789474	2822.25	2351.875	2257.8	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281457	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	279790	139895	93263.33333	69947.5	55958	46631.66667	39970	34973.75	31087.77778	27979	25435.45455	23315.83333	21522.30769	19985	18652.66667	17486.875	15543.88889	14725.78947	13989.5	11657.91667	11191.6	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281458	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	285734	142867	95244.66667	71433.5	57146.8	47622.33333	40819.14286	35716.75	31748.22222	28573.4	25975.81818	23811.16667	21979.53846	20409.57143	19048.93333	17858.375	15874.11111	15038.63158	14286.7	11905.58333	11429.36	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281459	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281460	CHOYP_TRAP1.1.1|m.60651	SITDDMHEEFYR	SITDDMHEEFYR	236615	118307.5	78871.66667	59153.75	47323	39435.83333	33802.14286	29576.875	26290.55556	23661.5	21510.45455	19717.91667	18201.15385	16901.07143	15774.33333	14788.4375	13145.27778	12453.42105	11830.75	9858.958333	9464.6	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281461	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281462	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281463	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281464	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	4393975	2196987.5	1464658.333	1098493.75	878795	732329.1667	627710.7143	549246.875	488219.4444	439397.5	399452.2727	366164.5833	337998.0769	313855.3571	292931.6667	274623.4375	244109.7222	231261.8421	219698.75	183082.2917	175759	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281465	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	4337723	2168861.5	1445907.667	1084430.75	867544.6	722953.8333	619674.7143	542215.375	481969.2222	433772.3	394338.4545	361476.9167	333671	309837.3571	289181.5333	271107.6875	240984.6111	228301.2105	216886.15	180738.4583	173508.92	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281466	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	1902385	951192.5	634128.3333	475596.25	380477	317064.1667	271769.2857	237798.125	211376.1111	190238.5	172944.0909	158532.0833	146337.3077	135884.6429	126825.6667	118899.0625	105688.0556	100125.5263	95119.25	79266.04167	76095.4	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281467	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	4885845	2442922.5	1628615	1221461.25	977169	814307.5	697977.8571	610730.625	542871.6667	488584.5	444167.7273	407153.75	375834.2308	348988.9286	325723	305365.3125	271435.8333	257149.7368	244292.25	203576.875	195433.8	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281468	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	5748341	2874170.5	1916113.667	1437085.25	1149668.2	958056.8333	821191.5714	718542.625	638704.5556	574834.1	522576.4545	479028.4167	442180.0769	410595.7857	383222.7333	359271.3125	319352.2778	302544.2632	287417.05	239514.2083	229933.64	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281469	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	15453536	7726768	5151178.667	3863384	3090707.2	2575589.333	2207648	1931692	1717059.556	1545353.6	1404866.909	1287794.667	1188733.538	1103824	1030235.733	965846	858529.7778	813344	772676.8	643897.3333	618141.44	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281470	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	585205	292602.5	195068.3333	146301.25	117041	97534.16667	83600.71429	73150.625	65022.77778	58520.5	53200.45455	48767.08333	45015.76923	41800.35714	39013.66667	36575.3125	32511.38889	30800.26316	29260.25	24383.54167	23408.2	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281471	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	1079081	539540.5	359693.6667	269770.25	215816.2	179846.8333	154154.4286	134885.125	119897.8889	107908.1	98098.27273	89923.41667	83006.23077	77077.21429	71938.73333	67442.5625	59948.94444	56793.73684	53954.05	44961.70833	43163.24	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281472	CHOYP_TRAP1.1.1|m.60651	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR	819544	409772	273181.3333	204886	163908.8	136590.6667	117077.7143	102443	91060.44444	81954.4	74504	68295.33333	63041.84615	58538.85714	54636.26667	51221.5	45530.22222	43133.89474	40977.2	34147.66667	32781.76	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281473	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	8281395	4140697.5	2760465	2070348.75	1656279	1380232.5	1183056.429	1035174.375	920155	828139.5	752854.0909	690116.25	637030.3846	591528.2143	552093	517587.1875	460077.5	435862.8947	414069.75	345058.125	331255.8	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281474	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	9258079	4629039.5	3086026.333	2314519.75	1851615.8	1543013.167	1322582.714	1157259.875	1028675.444	925807.9	841643.5455	771506.5833	712159.9231	661291.3571	617205.2667	578629.9375	514337.7222	487267.3158	462903.95	385753.2917	370323.16	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281475	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	7960982	3980491	2653660.667	1990245.5	1592196.4	1326830.333	1137283.143	995122.75	884553.5556	796098.2	723725.6364	663415.1667	612383.2308	568641.5714	530732.1333	497561.375	442276.7778	418999.0526	398049.1	331707.5833	318439.28	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281476	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281477	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281478	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281479	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281480	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281481	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281482	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281483	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281484	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281485	CHOYP_TRAP1.1.1|m.60651	TAPGELIGLDEYADR	TAPGELIGLDEYADR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281486	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281487	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	5246711	2623355.5	1748903.667	1311677.75	1049342.2	874451.8333	749530.1429	655838.875	582967.8889	524671.1	476973.7273	437225.9167	403593.1538	374765.0714	349780.7333	327919.4375	291483.9444	276142.6842	262335.55	218612.9583	209868.44	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281488	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	1258578	629289	419526	314644.5	251715.6	209763	179796.8571	157322.25	139842	125857.8	114416.1818	104881.5	96813.69231	89898.42857	83905.2	78661.125	69921	66240.94737	62928.9	52440.75	50343.12	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281489	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	999524	499762	333174.6667	249881	199904.8	166587.3333	142789.1429	124940.5	111058.2222	99952.4	90865.81818	83293.66667	76886.46154	71394.57143	66634.93333	62470.25	55529.11111	52606.52632	49976.2	41646.83333	39980.96	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281490	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	859370	429685	286456.6667	214842.5	171874	143228.3333	122767.1429	107421.25	95485.55556	85937	78124.54545	71614.16667	66105.38462	61383.57143	57291.33333	53710.625	47742.77778	45230	42968.5	35807.08333	34374.8	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281491	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	1240418	620209	413472.6667	310104.5	248083.6	206736.3333	177202.5714	155052.25	137824.2222	124041.8	112765.2727	103368.1667	95416.76923	88601.28571	82694.53333	77526.125	68912.11111	65285.15789	62020.9	51684.08333	49616.72	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281492	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	162677	81338.5	54225.66667	40669.25	32535.4	27112.83333	23239.57143	20334.625	18075.22222	16267.7	14788.81818	13556.41667	12513.61538	11619.78571	10845.13333	10167.3125	9037.611111	8561.947368	8133.85	6778.208333	6507.08	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281493	CHOYP_TRAP1.1.1|m.60651	DIFYLSAPNR	DIFYLSAPNR	62477	31238.5	20825.66667	15619.25	12495.4	10412.83333	8925.285714	7809.625	6941.888889	6247.7	5679.727273	5206.416667	4805.923077	4462.642857	4165.133333	3904.8125	3470.944444	3288.263158	3123.85	2603.208333	2499.08	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281494	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	588942	294471	196314	147235.5	117788.4	98157	84134.57143	73617.75	65438	58894.2	53540.18182	49078.5	45303.23077	42067.28571	39262.8	36808.875	32719	30996.94737	29447.1	24539.25	23557.68	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281495	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281496	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	153069	76534.5	51023	38267.25	30613.8	25511.5	21867	19133.625	17007.66667	15306.9	13915.36364	12755.75	11774.53846	10933.5	10204.6	9566.8125	8503.833333	8056.263158	7653.45	6377.875	6122.76	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281497	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281498	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281499	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281500	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281501	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281502	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	52969	26484.5	17656.33333	13242.25	10593.8	8828.166667	7567	6621.125	5885.444444	5296.9	4815.363636	4414.083333	4074.538462	3783.5	3531.266667	3310.5625	2942.722222	2787.842105	2648.45	2207.041667	2118.76	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281503	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281504	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281505	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281506	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	197349	98674.5	65783	49337.25	39469.8	32891.5	28192.71429	24668.625	21927.66667	19734.9	17940.81818	16445.75	15180.69231	14096.35714	13156.6	12334.3125	10963.83333	10386.78947	9867.45	8222.875	7893.96	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
281507	CHOYP_TRAP1.1.1|m.60651	LLQPTLEINPSHPLIK	LLQPTLEINPSHPLIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5XHZ0	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751
284308	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284309	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284310	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284311	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	50530	25265	16843.33333	12632.5	10106	8421.666667	7218.571429	6316.25	5614.444444	5053	4593.636364	4210.833333	3886.923077	3609.285714	3368.666667	3158.125	2807.222222	2659.473684	2526.5	2105.416667	2021.2	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284312	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284313	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	689010	344505	229670	172252.5	137802	114835	98430	86126.25	76556.66667	68901	62637.27273	57417.5	53000.76923	49215	45934	43063.125	38278.33333	36263.68421	34450.5	28708.75	27560.4	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284314	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	434642	217321	144880.6667	108660.5	86928.4	72440.33333	62091.71429	54330.25	48293.55556	43464.2	39512.90909	36220.16667	33434	31045.85714	28976.13333	27165.125	24146.77778	22875.89474	21732.1	18110.08333	17385.68	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284315	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284316	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	302870	151435	100956.6667	75717.5	60574	50478.33333	43267.14286	37858.75	33652.22222	30287	27533.63636	25239.16667	23297.69231	21633.57143	20191.33333	18929.375	16826.11111	15940.52632	15143.5	12619.58333	12114.8	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284317	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284318	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284319	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
284320	CHOYP_TVAG_007510.2.2|m.64163	IGQAVFTLANETESR	IGQAVFTLANETESR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P85120	Daple-like protein (Coiled-coil domain-containing protein 88C-like) (Dvl-associating protein with a high frequency of leucine residues-like) (xDal)	ccdc88c dal	"activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; dorsal/ventral axis specification [GO:0009950]; establishment of planar polarity [GO:0001736]; stress-activated protein kinase signaling cascade [GO:0031098]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	GO:0001736; GO:0005737; GO:0007257; GO:0009950; GO:0030165; GO:0031098; GO:0060070; GO:0060071
285698	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	4849074	2424537	1616358	1212268.5	969814.8	808179	692724.8571	606134.25	538786	484907.4	440824.9091	404089.5	373005.6923	346362.4286	323271.6	303067.125	269393	255214.4211	242453.7	202044.75	193962.96	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285699	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	3622185	1811092.5	1207395	905546.25	724437	603697.5	517455	452773.125	402465	362218.5	329289.5455	301848.75	278629.6154	258727.5	241479	226386.5625	201232.5	190641.3158	181109.25	150924.375	144887.4	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285700	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	1552035	776017.5	517345	388008.75	310407	258672.5	221719.2857	194004.375	172448.3333	155203.5	141094.0909	129336.25	119387.3077	110859.6429	103469	97002.1875	86224.16667	81686.05263	77601.75	64668.125	62081.4	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285701	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	20356	10178	6785.333333	5089	4071.2	3392.666667	2908	2544.5	2261.777778	2035.6	1850.545455	1696.333333	1565.846154	1454	1357.066667	1272.25	1130.888889	1071.368421	1017.8	848.1666667	814.24	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285702	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	161800	80900	53933.33333	40450	32360	26966.66667	23114.28571	20225	17977.77778	16180	14709.09091	13483.33333	12446.15385	11557.14286	10786.66667	10112.5	8988.888889	8515.789474	8090	6741.666667	6472	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285703	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	125094	62547	41698	31273.5	25018.8	20849	17870.57143	15636.75	13899.33333	12509.4	11372.18182	10424.5	9622.615385	8935.285714	8339.6	7818.375	6949.666667	6583.894737	6254.7	5212.25	5003.76	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285704	CHOYP_TXD12.1.1|m.18602	GWGDDIEWK	GWGDDIEWK	132308	66154	44102.66667	33077	26461.6	22051.33333	18901.14286	16538.5	14700.88889	13230.8	12028	11025.66667	10177.53846	9450.571429	8820.533333	8269.25	7350.444444	6963.578947	6615.4	5512.833333	5292.32	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285705	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	5853318	2926659	1951106	1463329.5	1170663.6	975553	836188.2857	731664.75	650368.6667	585331.8	532119.8182	487776.5	450255.2308	418094.1429	390221.2	365832.375	325184.3333	308069.3684	292665.9	243888.25	234132.72	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285706	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285707	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	2156646	1078323	718882	539161.5	431329.2	359441	308092.2857	269580.75	239627.3333	215664.6	196058.7273	179720.5	165895.8462	154046.1429	143776.4	134790.375	119813.6667	113507.6842	107832.3	89860.25	86265.84	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285708	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	572271	286135.5	190757	143067.75	114454.2	95378.5	81753	71533.875	63585.66667	57227.1	52024.63636	47689.25	44020.84615	40876.5	38151.4	35766.9375	31792.83333	30119.52632	28613.55	23844.625	22890.84	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285709	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285710	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	1394913	697456.5	464971	348728.25	278982.6	232485.5	199273.2857	174364.125	154990.3333	139491.3	126810.2727	116242.75	107301	99636.64286	92994.2	87182.0625	77495.16667	73416.47368	69745.65	58121.375	55796.52	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285711	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285712	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285713	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	59312	29656	19770.66667	14828	11862.4	9885.333333	8473.142857	7414	6590.222222	5931.2	5392	4942.666667	4562.461538	4236.571429	3954.133333	3707	3295.111111	3121.684211	2965.6	2471.333333	2372.48	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285714	CHOYP_TXD12.1.1|m.18602	EFYNVGGHDEYK	EFYNVGGHDEYK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285715	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285716	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285717	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285718	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285719	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	275583	137791.5	91861	68895.75	55116.6	45930.5	39369	34447.875	30620.33333	27558.3	25053	22965.25	21198.69231	19684.5	18372.2	17223.9375	15310.16667	14504.36842	13779.15	11482.625	11023.32	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285720	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	279054	139527	93018	69763.5	55810.8	46509	39864.85714	34881.75	31006	27905.4	25368.54545	23254.5	21465.69231	19932.42857	18603.6	17440.875	15503	14687.05263	13952.7	11627.25	11162.16	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285721	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285722	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285723	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	89633	44816.5	29877.66667	22408.25	17926.6	14938.83333	12804.71429	11204.125	9959.222222	8963.3	8148.454545	7469.416667	6894.846154	6402.357143	5975.533333	5602.0625	4979.611111	4717.526316	4481.65	3734.708333	3585.32	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285724	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	358891	179445.5	119630.3333	89722.75	71778.2	59815.16667	51270.14286	44861.375	39876.77778	35889.1	32626.45455	29907.58333	27607	25635.07143	23926.06667	22430.6875	19938.38889	18889	17944.55	14953.79167	14355.64	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285725	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	84368	42184	28122.66667	21092	16873.6	14061.33333	12052.57143	10546	9374.222222	8436.8	7669.818182	7030.666667	6489.846154	6026.285714	5624.533333	5273	4687.111111	4440.421053	4218.4	3515.333333	3374.72	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285726	CHOYP_TXD12.1.1|m.18602	YYYFSPDLIVETMK	YYYFSPDLIVETMK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q5E936	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	TXNDC12	cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	GO:0005788; GO:0015037; GO:0019153; GO:0045454; GO:1902236
285727	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	16852640	8426320	5617546.667	4213160	3370528	2808773.333	2407520	2106580	1872515.556	1685264	1532058.182	1404386.667	1296356.923	1203760	1123509.333	1053290	936257.7778	886981.0526	842632	702193.3333	674105.6	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285728	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	9180593	4590296.5	3060197.667	2295148.25	1836118.6	1530098.833	1311513.286	1147574.125	1020065.889	918059.3	834599.3636	765049.4167	706199.4615	655756.6429	612039.5333	573787.0625	510032.9444	483189.1053	459029.65	382524.7083	367223.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285729	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	2449362	1224681	816454	612340.5	489872.4	408227	349908.8571	306170.25	272151.3333	244936.2	222669.2727	204113.5	188412.4615	174954.4286	163290.8	153085.125	136075.6667	128913.7895	122468.1	102056.75	97974.48	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285730	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	1343539	671769.5	447846.3333	335884.75	268707.8	223923.1667	191934.1429	167942.375	149282.1111	134353.9	122139.9091	111961.5833	103349.1538	95967.07143	89569.26667	83971.1875	74641.05556	70712.57895	67176.95	55980.79167	53741.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285731	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	3196861	1598430.5	1065620.333	799215.25	639372.2	532810.1667	456694.4286	399607.625	355206.7778	319686.1	290623.7273	266405.0833	245912.3846	228347.2143	213124.0667	199803.8125	177603.3889	168255.8421	159843.05	133202.5417	127874.44	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285732	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	715289	357644.5	238429.6667	178822.25	143057.8	119214.8333	102184.1429	89411.125	79476.55556	71528.9	65026.27273	59607.41667	55022.23077	51092.07143	47685.93333	44705.5625	39738.27778	37646.78947	35764.45	29803.70833	28611.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285733	CHOYP_TXND3.1.4|m.3505	ADTIDALEK	ADTIDALEK	174598	87299	58199.33333	43649.5	34919.6	29099.66667	24942.57143	21824.75	19399.77778	17459.8	15872.54545	14549.83333	13430.61538	12471.28571	11639.86667	10912.375	9699.888889	9189.368421	8729.9	7274.916667	6983.92	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285734	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	8846982	4423491	2948994	2211745.5	1769396.4	1474497	1263854.571	1105872.75	982998	884698.2	804271.0909	737248.5	680537.0769	631927.2857	589798.8	552936.375	491499	465630.6316	442349.1	368624.25	353879.28	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285735	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285736	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285737	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	83969	41984.5	27989.66667	20992.25	16793.8	13994.83333	11995.57143	10496.125	9329.888889	8396.9	7633.545455	6997.416667	6459.153846	5997.785714	5597.933333	5248.0625	4664.944444	4419.421053	4198.45	3498.708333	3358.76	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285738	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285739	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	214866	107433	71622	53716.5	42973.2	35811	30695.14286	26858.25	23874	21486.6	19533.27273	17905.5	16528.15385	15347.57143	14324.4	13429.125	11937	11308.73684	10743.3	8952.75	8594.64	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285740	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	356302	178151	118767.3333	89075.5	71260.4	59383.66667	50900.28571	44537.75	39589.11111	35630.2	32391.09091	29691.83333	27407.84615	25450.14286	23753.46667	22268.875	19794.55556	18752.73684	17815.1	14845.91667	14252.08	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285741	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	35857	17928.5	11952.33333	8964.25	7171.4	5976.166667	5122.428571	4482.125	3984.111111	3585.7	3259.727273	2988.083333	2758.230769	2561.214286	2390.466667	2241.0625	1992.055556	1887.210526	1792.85	1494.041667	1434.28	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285742	CHOYP_TXND3.1.4|m.3505	TITEQLQQEHK	TITEQLQQEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285743	CHOYP_TXND3.1.4|m.3505	HLTEEEVR	HLTEEEVR	6067589	3033794.5	2022529.667	1516897.25	1213517.8	1011264.833	866798.4286	758448.625	674176.5556	606758.9	551599	505632.4167	466737.6154	433399.2143	404505.9333	379224.3125	337088.2778	319346.7895	303379.45	252816.2083	242703.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285744	CHOYP_TXND3.1.4|m.3505	HLTEEEVR	HLTEEEVR	4556415	2278207.5	1518805	1139103.75	911283	759402.5	650916.4286	569551.875	506268.3333	455641.5	414219.5455	379701.25	350493.4615	325458.2143	303761	284775.9375	253134.1667	239811.3158	227820.75	189850.625	182256.6	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285745	CHOYP_TXND3.1.4|m.3505	HLTEEEVR	HLTEEEVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285746	CHOYP_TXND3.1.4|m.3505	HLTEEEVR	HLTEEEVR	47818	23909	15939.33333	11954.5	9563.6	7969.666667	6831.142857	5977.25	5313.111111	4781.8	4347.090909	3984.833333	3678.307692	3415.571429	3187.866667	2988.625	2656.555556	2516.736842	2390.9	1992.416667	1912.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285747	CHOYP_TXND3.1.4|m.3505	HLTEEEVR	HLTEEEVR	169825	84912.5	56608.33333	42456.25	33965	28304.16667	24260.71429	21228.125	18869.44444	16982.5	15438.63636	14152.08333	13063.46154	12130.35714	11321.66667	10614.0625	9434.722222	8938.157895	8491.25	7076.041667	6793	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285748	CHOYP_TXND3.1.4|m.3505	HLTEEEVR	HLTEEEVR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285749	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285750	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285751	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	2062439	1031219.5	687479.6667	515609.75	412487.8	343739.8333	294634.1429	257804.875	229159.8889	206243.9	187494.4545	171869.9167	158649.1538	147317.0714	137495.9333	128902.4375	114579.9444	108549.4211	103121.95	85934.95833	82497.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285752	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	2112823	1056411.5	704274.3333	528205.75	422564.6	352137.1667	301831.8571	264102.875	234758.1111	211282.3	192074.8182	176068.5833	162524.8462	150915.9286	140854.8667	132051.4375	117379.0556	111201.2105	105641.15	88034.29167	84512.92	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285753	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	657769	328884.5	219256.3333	164442.25	131553.8	109628.1667	93967	82221.125	73085.44444	65776.9	59797.18182	54814.08333	50597.61538	46983.5	43851.26667	41110.5625	36542.72222	34619.42105	32888.45	27407.04167	26310.76	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285754	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	191689	95844.5	63896.33333	47922.25	38337.8	31948.16667	27384.14286	23961.125	21298.77778	19168.9	17426.27273	15974.08333	14745.30769	13692.07143	12779.26667	11980.5625	10649.38889	10088.89474	9584.45	7987.041667	7667.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285755	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	425671	212835.5	141890.3333	106417.75	85134.2	70945.16667	60810.14286	53208.875	47296.77778	42567.1	38697.36364	35472.58333	32743.92308	30405.07143	28378.06667	26604.4375	23648.38889	22403.73684	21283.55	17736.29167	17026.84	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285756	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285757	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285758	CHOYP_TXND3.1.4|m.3505	DLIGPTAVEEAK	DLIGPTAVEEAK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285759	CHOYP_TXND3.1.4|m.3505	EAKPESLR	EAKPESLR	9497316	4748658	3165772	2374329	1899463.2	1582886	1356759.429	1187164.5	1055257.333	949731.6	863392.3636	791443	730562.7692	678379.7143	633154.4	593582.25	527628.6667	499858.7368	474865.8	395721.5	379892.64	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285760	CHOYP_TXND3.1.4|m.3505	EAKPESLR	EAKPESLR	6643760	3321880	2214586.667	1660940	1328752	1107293.333	949108.5714	830470	738195.5556	664376	603978.1818	553646.6667	511058.4615	474554.2857	442917.3333	415235	369097.7778	349671.5789	332188	276823.3333	265750.4	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285761	CHOYP_TXND3.1.4|m.3505	EAKPESLR	EAKPESLR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285762	CHOYP_TXND3.1.4|m.3505	EAKPESLR	EAKPESLR	6288863	3144431.5	2096287.667	1572215.75	1257772.6	1048143.833	898409	786107.875	698762.5556	628886.3	571714.8182	524071.9167	483758.6923	449204.5	419257.5333	393053.9375	349381.2778	330992.7895	314443.15	262035.9583	251554.52	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285763	CHOYP_TXND3.1.4|m.3505	EAKPESLR	EAKPESLR	159201	79600.5	53067	39800.25	31840.2	26533.5	22743	19900.125	17689	15920.1	14472.81818	13266.75	12246.23077	11371.5	10613.4	9950.0625	8844.5	8379	7960.05	6633.375	6368.04	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285764	CHOYP_TXND3.1.4|m.3505	EAKPESLR	EAKPESLR	413125	206562.5	137708.3333	103281.25	82625	68854.16667	59017.85714	51640.625	45902.77778	41312.5	37556.81818	34427.08333	31778.84615	29508.92857	27541.66667	25820.3125	22951.38889	21743.42105	20656.25	17213.54167	16525	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285765	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	5958156	2979078	1986052	1489539	1191631.2	993026	851165.1429	744769.5	662017.3333	595815.6	541650.5455	496513	458319.6923	425582.5714	397210.4	372384.75	331008.6667	313587.1579	297907.8	248256.5	238326.24	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285766	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	4413218	2206609	1471072.667	1103304.5	882643.6	735536.3333	630459.7143	551652.25	490357.5556	441321.8	401201.6364	367768.1667	339478.3077	315229.8571	294214.5333	275826.125	245178.7778	232274.6316	220660.9	183884.0833	176528.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285767	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285768	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285769	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285770	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285771	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	705893	352946.5	235297.6667	176473.25	141178.6	117648.8333	100841.8571	88236.625	78432.55556	70589.3	64172.09091	58824.41667	54299.46154	50420.92857	47059.53333	44118.3125	39216.27778	37152.26316	35294.65	29412.20833	28235.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285772	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285773	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	116787	58393.5	38929	29196.75	23357.4	19464.5	16683.85714	14598.375	12976.33333	11678.7	10617	9732.25	8983.615385	8341.928571	7785.8	7299.1875	6488.166667	6146.684211	5839.35	4866.125	4671.48	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285774	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	141264	70632	47088	35316	28252.8	23544	20180.57143	17658	15696	14126.4	12842.18182	11772	10866.46154	10090.28571	9417.6	8829	7848	7434.947368	7063.2	5886	5650.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285775	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285776	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285777	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285778	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285779	CHOYP_TXND3.1.4|m.3505	TFMNALHGSSSEDMAMR	TFMNALHGSSSEDMAMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285780	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285781	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	21739348	10869674	7246449.333	5434837	4347869.6	3623224.667	3105621.143	2717418.5	2415483.111	2173934.8	1976304.364	1811612.333	1672257.538	1552810.571	1449289.867	1358709.25	1207741.556	1144176.211	1086967.4	905806.1667	869573.92	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285782	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	15048925	7524462.5	5016308.333	3762231.25	3009785	2508154.167	2149846.429	1881115.625	1672102.778	1504892.5	1368084.091	1254077.083	1157609.615	1074923.214	1003261.667	940557.8125	836051.3889	792048.6842	752446.25	627038.5417	601957	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285783	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285784	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285785	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285786	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285787	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285788	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285789	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285790	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285791	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285792	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285793	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285794	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285795	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285796	CHOYP_TXND3.1.4|m.3505	ELAFFFPDYVAPPAEGKPK	ELAFFFPDYVAPPAEGKPK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285797	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285798	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285799	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285800	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	1542267	771133.5	514089	385566.75	308453.4	257044.5	220323.8571	192783.375	171363	154226.7	140206.0909	128522.25	118635.9231	110161.9286	102817.8	96391.6875	85681.5	81171.94737	77113.35	64261.125	61690.68	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285801	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	1512877	756438.5	504292.3333	378219.25	302575.4	252146.1667	216125.2857	189109.625	168097.4444	151287.7	137534.2727	126073.0833	116375.1538	108062.6429	100858.4667	94554.8125	84048.72222	79625.10526	75643.85	63036.54167	60515.08	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285802	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	465688	232844	155229.3333	116422	93137.6	77614.66667	66526.85714	58211	51743.11111	46568.8	42335.27273	38807.33333	35822.15385	33263.42857	31045.86667	29105.5	25871.55556	24509.89474	23284.4	19403.66667	18627.52	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285803	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	394616	197308	131538.6667	98654	78923.2	65769.33333	56373.71429	49327	43846.22222	39461.6	35874.18182	32884.66667	30355.07692	28186.85714	26307.73333	24663.5	21923.11111	20769.26316	19730.8	16442.33333	15784.64	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285804	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285805	CHOYP_TXND3.1.4|m.3505	TLALIRPDAFK	TLALIRPDAFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285806	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	1683754	841877	561251.3333	420938.5	336750.8	280625.6667	240536.2857	210469.25	187083.7778	168375.4	153068.5455	140312.8333	129519.5385	120268.1429	112250.2667	105234.625	93541.88889	88618.63158	84187.7	70156.41667	67350.16	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285807	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	1645182	822591	548394	411295.5	329036.4	274197	235026	205647.75	182798	164518.2	149562	137098.5	126552.4615	117513	109678.8	102823.875	91399	86588.52632	82259.1	68549.25	65807.28	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285808	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	721403	360701.5	240467.6667	180350.75	144280.6	120233.8333	103057.5714	90175.375	80155.88889	72140.3	65582.09091	60116.91667	55492.53846	51528.78571	48093.53333	45087.6875	40077.94444	37968.57895	36070.15	30058.45833	28856.12	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285809	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	88929	44464.5	29643	22232.25	17785.8	14821.5	12704.14286	11116.125	9881	8892.9	8084.454545	7410.75	6840.692308	6352.071429	5928.6	5558.0625	4940.5	4680.473684	4446.45	3705.375	3557.16	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285810	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	354918	177459	118306	88729.5	70983.6	59153	50702.57143	44364.75	39435.33333	35491.8	32265.27273	29576.5	27301.38462	25351.28571	23661.2	22182.375	19717.66667	18679.89474	17745.9	14788.25	14196.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285811	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	292890	146445	97630	73222.5	58578	48815	41841.42857	36611.25	32543.33333	29289	26626.36364	24407.5	22530	20920.71429	19526	18305.625	16271.66667	15415.26316	14644.5	12203.75	11715.6	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285812	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	123367	61683.5	41122.33333	30841.75	24673.4	20561.16667	17623.85714	15420.875	13707.44444	12336.7	11215.18182	10280.58333	9489.769231	8811.928571	8224.466667	7710.4375	6853.722222	6493	6168.35	5140.291667	4934.68	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285813	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	155104	77552	51701.33333	38776	31020.8	25850.66667	22157.71429	19388	17233.77778	15510.4	14100.36364	12925.33333	11931.07692	11078.85714	10340.26667	9694	8616.888889	8163.368421	7755.2	6462.666667	6204.16	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285814	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285815	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	43758	21879	14586	10939.5	8751.6	7293	6251.142857	5469.75	4862	4375.8	3978	3646.5	3366	3125.571429	2917.2	2734.875	2431	2303.052632	2187.9	1823.25	1750.32	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285816	CHOYP_TXND3.1.4|m.3505	EDILATISEAGFK	EDILATISEAGFK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285817	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	24860006	12430003	8286668.667	6215001.5	4972001.2	4143334.333	3551429.429	3107500.75	2762222.889	2486000.6	2260000.545	2071667.167	1912308.154	1775714.714	1657333.733	1553750.375	1381111.444	1308421.368	1243000.3	1035833.583	994400.24	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285818	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	17362048	8681024	5787349.333	4340512	3472409.6	2893674.667	2480292.571	2170256	1929116.444	1736204.8	1578368	1446837.333	1335542.154	1240146.286	1157469.867	1085128	964558.2222	913792	868102.4	723418.6667	694481.92	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285819	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	7667537	3833768.5	2555845.667	1916884.25	1533507.4	1277922.833	1095362.429	958442.125	851948.5556	766753.7	697048.8182	638961.4167	589810.5385	547681.2143	511169.1333	479221.0625	425974.2778	403554.5789	383376.85	319480.7083	306701.48	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285820	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	2844655	1422327.5	948218.3333	711163.75	568931	474109.1667	406379.2857	355581.875	316072.7778	284465.5	258605	237054.5833	218819.6154	203189.6429	189643.6667	177790.9375	158036.3889	149718.6842	142232.75	118527.2917	113786.2	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285821	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	6162206	3081103	2054068.667	1540551.5	1232441.2	1027034.333	880315.1429	770275.75	684689.5556	616220.6	560200.5455	513517.1667	474015.8462	440157.5714	410813.7333	385137.875	342344.7778	324326.6316	308110.3	256758.5833	246488.24	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285822	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	4027793	2013896.5	1342597.667	1006948.25	805558.6	671298.8333	575399	503474.125	447532.5556	402779.3	366163	335649.4167	309830.2308	287699.5	268519.5333	251737.0625	223766.2778	211989.1053	201389.65	167824.7083	161111.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285823	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	2059732	1029866	686577.3333	514933	411946.4	343288.6667	294247.4286	257466.5	228859.1111	205973.2	187248.3636	171644.3333	158440.9231	147123.7143	137315.4667	128733.25	114429.5556	108406.9474	102986.6	85822.16667	82389.28	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285824	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	1493264	746632	497754.6667	373316	298652.8	248877.3333	213323.4286	186658	165918.2222	149326.4	135751.2727	124438.6667	114866.4615	106661.7143	99550.93333	93329	82959.11111	78592.84211	74663.2	62219.33333	59730.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285825	CHOYP_TXND3.1.4|m.3505	GQDYFEELITR	GQDYFEELITR	943287	471643.5	314429	235821.75	188657.4	157214.5	134755.2857	117910.875	104809.6667	94328.7	85753.36364	78607.25	72560.53846	67377.64286	62885.8	58955.4375	52404.83333	49646.68421	47164.35	39303.625	37731.48	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285826	CHOYP_TXND3.1.4|m.3505	EDAITGWR	EDAITGWR	14953834	7476917	4984611.333	3738458.5	2990766.8	2492305.667	2136262	1869229.25	1661537.111	1495383.4	1359439.455	1246152.833	1150294.923	1068131	996922.2667	934614.625	830768.5556	787043.8947	747691.7	623076.4167	598153.36	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285827	CHOYP_TXND3.1.4|m.3505	EDAITGWR	EDAITGWR	9758446	4879223	3252815.333	2439611.5	1951689.2	1626407.667	1394063.714	1219805.75	1084271.778	975844.6	887131.4545	813203.8333	750649.6923	697031.8571	650563.0667	609902.875	542135.8889	513602.4211	487922.3	406601.9167	390337.84	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285828	CHOYP_TXND3.1.4|m.3505	EDAITGWR	EDAITGWR	9086920	4543460	3028973.333	2271730	1817384	1514486.667	1298131.429	1135865	1009657.778	908692	826083.6364	757243.3333	698993.8462	649065.7143	605794.6667	567932.5	504828.8889	478258.9474	454346	378621.6667	363476.8	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285829	CHOYP_TXND3.1.4|m.3505	EDAITGWR	EDAITGWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285830	CHOYP_TXND3.1.4|m.3505	EDAITGWR	EDAITGWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285831	CHOYP_TXND3.1.4|m.3505	EDAITGWR	EDAITGWR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285832	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285833	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285834	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285835	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	843017	421508.5	281005.6667	210754.25	168603.4	140502.8333	120431	105377.125	93668.55556	84301.7	76637.90909	70251.41667	64847.46154	60215.5	56201.13333	52688.5625	46834.27778	44369.31579	42150.85	35125.70833	33720.68	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285836	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285837	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285838	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	18306	9153	6102	4576.5	3661.2	3051	2615.142857	2288.25	2034	1830.6	1664.181818	1525.5	1408.153846	1307.571429	1220.4	1144.125	1017	963.4736842	915.3	762.75	732.24	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285839	CHOYP_TXND3.1.4|m.3505	HMLGPTEVEK	HMLGPTEVEK	205183	102591.5	68394.33333	51295.75	41036.6	34197.16667	29311.85714	25647.875	22798.11111	20518.3	18653	17098.58333	15783.30769	14655.92857	13678.86667	12823.9375	11399.05556	10799.10526	10259.15	8549.291667	8207.32	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285840	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285841	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285842	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285843	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	1320266	660133	440088.6667	330066.5	264053.2	220044.3333	188609.4286	165033.25	146696.2222	132026.6	120024.1818	110022.1667	101558.9231	94304.71429	88017.73333	82516.625	73348.11111	69487.68421	66013.3	55011.08333	52810.64	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285844	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	2204536	1102268	734845.3333	551134	440907.2	367422.6667	314933.7143	275567	244948.4444	220453.6	200412.3636	183711.3333	169579.6923	157466.8571	146969.0667	137783.5	122474.2222	116028.2105	110226.8	91855.66667	88181.44	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285845	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	2389010	1194505	796336.6667	597252.5	477802	398168.3333	341287.1429	298626.25	265445.5556	238901	217182.7273	199084.1667	183770	170643.5714	159267.3333	149313.125	132722.7778	125737.3684	119450.5	99542.08333	95560.4	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285846	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	1387252	693626	462417.3333	346813	277450.4	231208.6667	198178.8571	173406.5	154139.1111	138725.2	126113.8182	115604.3333	106711.6923	99089.42857	92483.46667	86703.25	77069.55556	73013.26316	69362.6	57802.16667	55490.08	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285847	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	1317943	658971.5	439314.3333	329485.75	263588.6	219657.1667	188277.5714	164742.875	146438.1111	131794.3	119813	109828.5833	101380.2308	94138.78571	87862.86667	82371.4375	73219.05556	69365.42105	65897.15	54914.29167	52717.72	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285848	CHOYP_TXND3.1.4|m.3505	ELAEEFYAEHK	ELAEEFYAEHK	476838	238419	158946	119209.5	95367.6	79473	68119.71429	59604.75	52982	47683.8	43348.90909	39736.5	36679.84615	34059.85714	31789.2	29802.375	26491	25096.73684	23841.9	19868.25	19073.52	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285849	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285850	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285851	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	85339	42669.5	28446.33333	21334.75	17067.8	14223.16667	12191.28571	10667.375	9482.111111	8533.9	7758.090909	7111.583333	6564.538462	6095.642857	5689.266667	5333.6875	4741.055556	4491.526316	4266.95	3555.791667	3413.56	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285852	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285853	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285854	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285855	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285856	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285857	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285858	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285859	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285860	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285861	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285862	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285863	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285864	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285865	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285866	CHOYP_TXND3.1.4|m.3505	EYYDDLVEHMTSGPTYIMVLSR	EYYDDLVEHMTSGPTYIMVLSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285867	CHOYP_TXND3.1.4|m.3505	EDAVQGWR	EDAVQGWR	15698633	7849316.5	5232877.667	3924658.25	3139726.6	2616438.833	2242661.857	1962329.125	1744292.556	1569863.3	1427148.455	1308219.417	1207587.154	1121330.929	1046575.533	981164.5625	872146.2778	826243.8421	784931.65	654109.7083	627945.32	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285868	CHOYP_TXND3.1.4|m.3505	EDAVQGWR	EDAVQGWR	4192067	2096033.5	1397355.667	1048016.75	838413.4	698677.8333	598866.7143	524008.375	465785.2222	419206.7	381097	349338.9167	322466.6923	299433.3571	279471.1333	262004.1875	232892.6111	220635.1053	209603.35	174669.4583	167682.68	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285869	CHOYP_TXND3.1.4|m.3505	EDAVQGWR	EDAVQGWR	1095299	547649.5	365099.6667	273824.75	219059.8	182549.8333	156471.2857	136912.375	121699.8889	109529.9	99572.63636	91274.91667	84253.76923	78235.64286	73019.93333	68456.1875	60849.94444	57647.31579	54764.95	45637.45833	43811.96	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285870	CHOYP_TXND3.1.4|m.3505	EDAVQGWR	EDAVQGWR	476128	238064	158709.3333	119032	95225.6	79354.66667	68018.28571	59516	52903.11111	47612.8	43284.36364	39677.33333	36625.23077	34009.14286	31741.86667	29758	26451.55556	25059.36842	23806.4	19838.66667	19045.12	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285871	CHOYP_TXND3.1.4|m.3505	EDAVQGWR	EDAVQGWR	2009849	1004924.5	669949.6667	502462.25	401969.8	334974.8333	287121.2857	251231.125	223316.5556	200984.9	182713.5455	167487.4167	154603.7692	143560.6429	133989.9333	125615.5625	111658.2778	105781.5263	100492.45	83743.70833	80393.96	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285872	CHOYP_TXND3.1.4|m.3505	EDAVQGWR	EDAVQGWR	1205574	602787	401858	301393.5	241114.8	200929	172224.8571	150696.75	133952.6667	120557.4	109597.6364	100464.5	92736.46154	86112.42857	80371.6	75348.375	66976.33333	63451.26316	60278.7	50232.25	48222.96	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285873	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	13309505	6654752.5	4436501.667	3327376.25	2661901	2218250.833	1901357.857	1663688.125	1478833.889	1330950.5	1209955	1109125.417	1023808.077	950678.9286	887300.3333	831844.0625	739416.9444	700500.2632	665475.25	554562.7083	532380.2	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285874	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	6974050	3487025	2324683.333	1743512.5	1394810	1162341.667	996292.8571	871756.25	774894.4444	697405	634004.5455	581170.8333	536465.3846	498146.4286	464936.6667	435878.125	387447.2222	367055.2632	348702.5	290585.4167	278962	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285875	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285876	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	2839638	1419819	946546	709909.5	567927.6	473273	405662.5714	354954.75	315515.3333	283963.8	258148.9091	236636.5	218433.6923	202831.2857	189309.2	177477.375	157757.6667	149454.6316	141981.9	118318.25	113585.52	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285877	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	1014650	507325	338216.6667	253662.5	202930	169108.3333	144950	126831.25	112738.8889	101465	92240.90909	84554.16667	78050	72475	67643.33333	63415.625	56369.44444	53402.63158	50732.5	42277.08333	40586	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285878	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285879	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285880	CHOYP_TXND3.1.4|m.3505	QVIGPTDPEK	QVIGPTDPEK	2322327	1161163.5	774109	580581.75	464465.4	387054.5	331761	290290.875	258036.3333	232232.7	211120.6364	193527.25	178640.5385	165880.5	154821.8	145145.4375	129018.1667	122227.7368	116116.35	96763.625	92893.08	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285881	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285882	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	819753	409876.5	273251	204938.25	163950.6	136625.5	117107.5714	102469.125	91083.66667	81975.3	74523	68312.75	63057.92308	58553.78571	54650.2	51234.5625	45541.83333	43144.89474	40987.65	34156.375	32790.12	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285883	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	386377	193188.5	128792.3333	96594.25	77275.4	64396.16667	55196.71429	48297.125	42930.77778	38637.7	35125.18182	32198.08333	29721.30769	27598.35714	25758.46667	24148.5625	21465.38889	20335.63158	19318.85	16099.04167	15455.08	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285884	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285885	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285886	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285887	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285888	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	52654	26327	17551.33333	13163.5	10530.8	8775.666667	7522	6581.75	5850.444444	5265.4	4786.727273	4387.833333	4050.307692	3761	3510.266667	3290.875	2925.222222	2771.263158	2632.7	2193.916667	2106.16	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285889	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	104266	52133	34755.33333	26066.5	20853.2	17377.66667	14895.14286	13033.25	11585.11111	10426.6	9478.727273	8688.833333	8020.461538	7447.571429	6951.066667	6516.625	5792.555556	5487.684211	5213.3	4344.416667	4170.64	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285890	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285891	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285892	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285893	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285894	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285895	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285896	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285897	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285898	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285899	CHOYP_TXND3.1.4|m.3505	NILQNAVHGSSTAEHADVTVK	NILQNAVHGSSTAEHADVTVK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285900	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285901	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285902	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285903	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285904	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	122742	61371	40914	30685.5	24548.4	20457	17534.57143	15342.75	13638	12274.2	11158.36364	10228.5	9441.692308	8767.285714	8182.8	7671.375	6819	6460.105263	6137.1	5114.25	4909.68	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285905	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	23632	11816	7877.333333	5908	4726.4	3938.666667	3376	2954	2625.777778	2363.2	2148.363636	1969.333333	1817.846154	1688	1575.466667	1477	1312.888889	1243.789474	1181.6	984.6666667	945.28	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285906	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285907	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285908	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	19369	9684.5	6456.333333	4842.25	3873.8	3228.166667	2767	2421.125	2152.111111	1936.9	1760.818182	1614.083333	1489.923077	1383.5	1291.266667	1210.5625	1076.055556	1019.421053	968.45	807.0416667	774.76	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
285909	CHOYP_TXND3.1.4|m.3505	IFAEDVPEQQEK	IFAEDVPEQQEK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q95YJ5	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	GO:0004550; GO:0005622; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454; GO:1902176
287787	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	977096832	488548416	325698944	244274208	195419366.4	162849472	139585261.7	122137104	108566314.7	97709683.2	88826984.73	81424736	75161294.77	69792630.86	65139788.8	61068552	54283157.33	51426149.05	48854841.6	40712368	39083873.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287788	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	591583168	295791584	197194389.3	147895792	118316633.6	98597194.67	84511881.14	73947896	65731463.11	59158316.8	53780288	49298597.33	45506397.54	42255940.57	39438877.87	36973948	32865731.56	31135956.21	29579158.4	24649298.67	23663326.72	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287789	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	246532256	123266128	82177418.67	61633064	49306451.2	41088709.33	35218893.71	30816532	27392472.89	24653225.6	22412023.27	20544354.67	18964019.69	17609446.86	16435483.73	15408266	13696236.44	12975381.89	12326612.8	10272177.33	9861290.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287790	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	53643948	26821974	17881316	13410987	10728789.6	8940658	7663421.143	6705493.5	5960438.667	5364394.8	4876722.545	4470329	4126457.538	3831710.571	3576263.2	3352746.75	2980219.333	2823365.684	2682197.4	2235164.5	2145757.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287791	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	24872264	12436132	8290754.667	6218066	4974452.8	4145377.333	3553180.571	3109033	2763584.889	2487226.4	2261114.909	2072688.667	1913251.077	1776590.286	1658150.933	1554516.5	1381792.444	1309066.526	1243613.2	1036344.333	994890.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287792	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	32144684	16072342	10714894.67	8036171	6428936.8	5357447.333	4592097.714	4018085.5	3571631.556	3214468.4	2922244	2678723.667	2472668	2296048.857	2142978.933	2009042.75	1785815.778	1691825.474	1607234.2	1339361.833	1285787.36	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287793	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	30837662	15418831	10279220.67	7709415.5	6167532.4	5139610.333	4405380.286	3854707.75	3426406.889	3083766.2	2803423.818	2569805.167	2372127.846	2202690.143	2055844.133	1927353.875	1713203.444	1623034.842	1541883.1	1284902.583	1233506.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287794	CHOYP_UBP37.1.1|m.15559	VHGSIEMHQR	VHGSIEMHQR	11772739	5886369.5	3924246.333	2943184.75	2354547.8	1962123.167	1681819.857	1471592.375	1308082.111	1177273.9	1070249	981061.5833	905595.3077	840909.9286	784849.2667	735796.1875	654041.0556	619617.8421	588636.95	490530.7917	470909.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287795	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287796	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287797	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287798	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287799	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287800	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287801	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287802	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287803	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287804	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287805	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287806	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287807	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
287808	CHOYP_UBP37.1.1|m.15559	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
288010	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	728529	364264.5	242843	182132.25	145705.8	121421.5	104075.5714	91066.125	80947.66667	72852.9	66229.90909	60710.75	56040.69231	52037.78571	48568.6	45533.0625	40473.83333	38343.63158	36426.45	30355.375	29141.16	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288011	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288012	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288013	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288014	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288015	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288016	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288017	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288018	CHOYP_UBQL4.1.1|m.37426	DGDTLAQHGIK	DGDTLAQHGIK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288019	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	5836386	2918193	1945462	1459096.5	1167277.2	972731	833769.4286	729548.25	648487.3333	583638.6	530580.5455	486365.5	448952.7692	416884.7143	389092.4	364774.125	324243.6667	307178.2105	291819.3	243182.75	233455.44	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288020	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	1970456	985228	656818.6667	492614	394091.2	328409.3333	281493.7143	246307	218939.5556	197045.6	179132.3636	164204.6667	151573.5385	140746.8571	131363.7333	123153.5	109469.7778	103708.2105	98522.8	82102.33333	78818.24	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288021	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	1332317	666158.5	444105.6667	333079.25	266463.4	222052.8333	190331	166539.625	148035.2222	133231.7	121119.7273	111026.4167	102485.9231	95165.5	88821.13333	83269.8125	74017.61111	70121.94737	66615.85	55513.20833	53292.68	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288022	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	817792	408896	272597.3333	204448	163558.4	136298.6667	116827.4286	102224	90865.77778	81779.2	74344.72727	68149.33333	62907.07692	58413.71429	54519.46667	51112	45432.88889	43041.68421	40889.6	34074.66667	32711.68	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288023	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	570493	285246.5	190164.3333	142623.25	114098.6	95082.16667	81499	71311.625	63388.11111	57049.3	51863	47541.08333	43884.07692	40749.5	38032.86667	35655.8125	31694.05556	30025.94737	28524.65	23770.54167	22819.72	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288024	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	1558181	779090.5	519393.6667	389545.25	311636.2	259696.8333	222597.2857	194772.625	173131.2222	155818.1	141652.8182	129848.4167	119860.0769	111298.6429	103878.7333	97386.3125	86565.61111	82009.52632	77909.05	64924.20833	62327.24	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288025	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	26518	13259	8839.333333	6629.5	5303.6	4419.666667	3788.285714	3314.75	2946.444444	2651.8	2410.727273	2209.833333	2039.846154	1894.142857	1767.866667	1657.375	1473.222222	1395.684211	1325.9	1104.916667	1060.72	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288026	CHOYP_UBQL4.1.1|m.37426	EMMANPDLMR	EMMANPDLMR	403934	201967	134644.6667	100983.5	80786.8	67322.33333	57704.85714	50491.75	44881.55556	40393.4	36721.27273	33661.16667	31071.84615	28852.42857	26928.93333	25245.875	22440.77778	21259.68421	20196.7	16830.58333	16157.36	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288027	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	5891415	2945707.5	1963805	1472853.75	1178283	981902.5	841630.7143	736426.875	654601.6667	589141.5	535583.1818	490951.25	453185.7692	420815.3571	392761	368213.4375	327300.8333	310074.4737	294570.75	245475.625	235656.6	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288028	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	2740335	1370167.5	913445	685083.75	548067	456722.5	391476.4286	342541.875	304481.6667	274033.5	249121.3636	228361.25	210795	195738.2143	182689	171270.9375	152240.8333	144228.1579	137016.75	114180.625	109613.4	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288029	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	629288	314644	209762.6667	157322	125857.6	104881.3333	89898.28571	78661	69920.88889	62928.8	57208	52440.66667	48406.76923	44949.14286	41952.53333	39330.5	34960.44444	33120.42105	31464.4	26220.33333	25171.52	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288030	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	1288398	644199	429466	322099.5	257679.6	214733	184056.8571	161049.75	143155.3333	128839.8	117127.0909	107366.5	99107.53846	92028.42857	85893.2	80524.875	71577.66667	67810.42105	64419.9	53683.25	51535.92	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288031	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	553856	276928	184618.6667	138464	110771.2	92309.33333	79122.28571	69232	61539.55556	55385.6	50350.54545	46154.66667	42604.30769	39561.14286	36923.73333	34616	30769.77778	29150.31579	27692.8	23077.33333	22154.24	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288032	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	154569	77284.5	51523	38642.25	30913.8	25761.5	22081.28571	19321.125	17174.33333	15456.9	14051.72727	12880.75	11889.92308	11040.64286	10304.6	9660.5625	8587.166667	8135.210526	7728.45	6440.375	6182.76	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288033	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	595652	297826	198550.6667	148913	119130.4	99275.33333	85093.14286	74456.5	66183.55556	59565.2	54150.18182	49637.66667	45819.38462	42546.57143	39710.13333	37228.25	33091.77778	31350.10526	29782.6	24818.83333	23826.08	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288034	CHOYP_UBQL4.1.1|m.37426	QMITSNPQMR	QMITSNPQMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288035	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288036	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	2009109	1004554.5	669703	502277.25	401821.8	334851.5	287015.5714	251138.625	223234.3333	200910.9	182646.2727	167425.75	154546.8462	143507.7857	133940.6	125569.3125	111617.1667	105742.5789	100455.45	83712.875	80364.36	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288037	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	345235	172617.5	115078.3333	86308.75	69047	57539.16667	49319.28571	43154.375	38359.44444	34523.5	31385	28769.58333	26556.53846	24659.64286	23015.66667	21577.1875	19179.72222	18170.26316	17261.75	14384.79167	13809.4	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288038	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	56127	28063.5	18709	14031.75	11225.4	9354.5	8018.142857	7015.875	6236.333333	5612.7	5102.454545	4677.25	4317.461538	4009.071429	3741.8	3507.9375	3118.166667	2954.052632	2806.35	2338.625	2245.08	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288039	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	429239	214619.5	143079.6667	107309.75	85847.8	71539.83333	61319.85714	53654.875	47693.22222	42923.9	39021.72727	35769.91667	33018.38462	30659.92857	28615.93333	26827.4375	23846.61111	22591.52632	21461.95	17884.95833	17169.56	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288040	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	193459	96729.5	64486.33333	48364.75	38691.8	32243.16667	27637	24182.375	21495.44444	19345.9	17587.18182	16121.58333	14881.46154	13818.5	12897.26667	12091.1875	10747.72222	10182.05263	9672.95	8060.791667	7738.36	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288041	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	83658	41829	27886	20914.5	16731.6	13943	11951.14286	10457.25	9295.333333	8365.8	7605.272727	6971.5	6435.230769	5975.571429	5577.2	5228.625	4647.666667	4403.052632	4182.9	3485.75	3346.32	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288042	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	96572	48286	32190.66667	24143	19314.4	16095.33333	13796	12071.5	10730.22222	9657.2	8779.272727	8047.666667	7428.615385	6898	6438.133333	6035.75	5365.111111	5082.736842	4828.6	4023.833333	3862.88	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288043	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	129643	64821.5	43214.33333	32410.75	25928.6	21607.16667	18520.42857	16205.375	14404.77778	12964.3	11785.72727	10803.58333	9972.538462	9260.214286	8642.866667	8102.6875	7202.388889	6823.315789	6482.15	5401.791667	5185.72	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288044	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288045	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288046	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288047	CHOYP_UBQL4.1.1|m.37426	NPEISHMLNNPELMR	NPEISHMLNNPELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288048	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	4334348	2167174	1444782.667	1083587	866869.6	722391.3333	619192.5714	541793.5	481594.2222	433434.8	394031.6364	361195.6667	333411.3846	309596.2857	288956.5333	270896.75	240797.1111	228123.5789	216717.4	180597.8333	173373.92	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288049	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288050	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288051	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	2193356	1096678	731118.6667	548339	438671.2	365559.3333	313336.5714	274169.5	243706.2222	219335.6	199396	182779.6667	168719.6923	156668.2857	146223.7333	137084.75	121853.1111	115439.7895	109667.8	91389.83333	87734.24	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288052	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	1653620	826810	551206.6667	413405	330724	275603.3333	236231.4286	206702.5	183735.5556	165362	150329.0909	137801.6667	127201.5385	118115.7143	110241.3333	103351.25	91867.77778	87032.63158	82681	68900.83333	66144.8	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288053	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	1163043	581521.5	387681	290760.75	232608.6	193840.5	166149	145380.375	129227	116304.3	105731.1818	96920.25	89464.84615	83074.5	77536.2	72690.1875	64613.5	61212.78947	58152.15	48460.125	46521.72	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288054	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	429776	214888	143258.6667	107444	85955.2	71629.33333	61396.57143	53722	47752.88889	42977.6	39070.54545	35814.66667	33059.69231	30698.28571	28651.73333	26861	23876.44444	22619.78947	21488.8	17907.33333	17191.04	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288055	CHOYP_UBQL4.1.1|m.37426	NPAMLQELMR	NPAMLQELMR	188607	94303.5	62869	47151.75	37721.4	31434.5	26943.85714	23575.875	20956.33333	18860.7	17146.09091	15717.25	14508.23077	13471.92857	12573.8	11787.9375	10478.16667	9926.684211	9430.35	7858.625	7544.28	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288056	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	4411495	2205747.5	1470498.333	1102873.75	882299	735249.1667	630213.5714	551436.875	490166.1111	441149.5	401045	367624.5833	339345.7692	315106.7857	294099.6667	275718.4375	245083.0556	232183.9474	220574.75	183812.2917	176459.8	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288057	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	6215217	3107608.5	2071739	1553804.25	1243043.4	1035869.5	887888.1429	776902.125	690579.6667	621521.7	565019.7273	517934.75	478093.6154	443944.0714	414347.8	388451.0625	345289.8333	327116.6842	310760.85	258967.375	248608.68	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288058	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	2204731	1102365.5	734910.3333	551182.75	440946.2	367455.1667	314961.5714	275591.375	244970.1111	220473.1	200430.0909	183727.5833	169594.6923	157480.7857	146982.0667	137795.6875	122485.0556	116038.4737	110236.55	91863.79167	88189.24	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288059	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288060	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288061	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	442211	221105.5	147403.6667	110552.75	88442.2	73701.83333	63173	55276.375	49134.55556	44221.1	40201	36850.91667	34016.23077	31586.5	29480.73333	27638.1875	24567.27778	23274.26316	22110.55	18425.45833	17688.44	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288062	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	550508	275254	183502.6667	137627	110101.6	91751.33333	78644	68813.5	61167.55556	55050.8	50046.18182	45875.66667	42346.76923	39322	36700.53333	34406.75	30583.77778	28974.10526	27525.4	22937.83333	22020.32	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288063	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	236440	118220	78813.33333	59110	47288	39406.66667	33777.14286	29555	26271.11111	23644	21494.54545	19703.33333	18187.69231	16888.57143	15762.66667	14777.5	13135.55556	12444.21053	11822	9851.666667	9457.6	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288064	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	6467490	3233745	2155830	1616872.5	1293498	1077915	923927.1429	808436.25	718610	646749	587953.6364	538957.5	497499.2308	461963.5714	431166	404218.125	359305	340394.2105	323374.5	269478.75	258699.6	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288065	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	96125	48062.5	32041.66667	24031.25	19225	16020.83333	13732.14286	12015.625	10680.55556	9612.5	8738.636364	8010.416667	7394.230769	6866.071429	6408.333333	6007.8125	5340.277778	5059.210526	4806.25	4005.208333	3845	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288066	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288067	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288068	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288069	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288070	CHOYP_UBQL4.1.1|m.37426	AMSNLESIPGGFNALQR	AMSNLESIPGGFNALQR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288071	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	998262	499131	332754	249565.5	199652.4	166377	142608.8571	124782.75	110918	99826.2	90751.09091	83188.5	76789.38462	71304.42857	66550.8	62391.375	55459	52540.10526	49913.1	41594.25	39930.48	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288072	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288073	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288074	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	134825	67412.5	44941.66667	33706.25	26965	22470.83333	19260.71429	16853.125	14980.55556	13482.5	12256.81818	11235.41667	10371.15385	9630.357143	8988.333333	8426.5625	7490.277778	7096.052632	6741.25	5617.708333	5393	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288075	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	84612	42306	28204	21153	16922.4	14102	12087.42857	10576.5	9401.333333	8461.2	7692	7051	6508.615385	6043.714286	5640.8	5288.25	4700.666667	4453.263158	4230.6	3525.5	3384.48	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288076	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	94290	47145	31430	23572.5	18858	15715	13470	11786.25	10476.66667	9429	8571.818182	7857.5	7253.076923	6735	6286	5893.125	5238.333333	4962.631579	4714.5	3928.75	3771.6	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288077	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	375410	187705	125136.6667	93852.5	75082	62568.33333	53630	46926.25	41712.22222	37541	34128.18182	31284.16667	28877.69231	26815	25027.33333	23463.125	20856.11111	19758.42105	18770.5	15642.08333	15016.4	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288078	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	51840	25920	17280	12960	10368	8640	7405.714286	6480	5760	5184	4712.727273	4320	3987.692308	3702.857143	3456	3240	2880	2728.421053	2592	2160	2073.6	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288079	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	188859	94429.5	62953	47214.75	37771.8	31476.5	26979.85714	23607.375	20984.33333	18885.9	17169	15738.25	14527.61538	13489.92857	12590.6	11803.6875	10492.16667	9939.947368	9442.95	7869.125	7554.36	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288080	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	16781	8390.5	5593.666667	4195.25	3356.2	2796.833333	2397.285714	2097.625	1864.555556	1678.1	1525.545455	1398.416667	1290.846154	1198.642857	1118.733333	1048.8125	932.2777778	883.2105263	839.05	699.2083333	671.24	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288081	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288082	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
288083	CHOYP_UBQL4.1.1|m.37426	ALQATLGDVNAAIDR	ALQATLGDVNAAIDR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q8R317	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; macroautophagy [GO:0016236]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome assembly [GO:2000785]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005886; GO:0016235; GO:0016236; GO:0019215; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0043234; GO:0048471; GO:0071456; GO:0097352; GO:1901097; GO:1901340; GO:1902175; GO:1903071; GO:2000785
291230	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291231	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	1977132	988566	659044	494283	395426.4	329522	282447.4286	247141.5	219681.3333	197713.2	179739.2727	164761	152087.0769	141223.7143	131808.8	123570.75	109840.6667	104059.5789	98856.6	82380.5	79085.28	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291232	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	321726	160863	107242	80431.5	64345.2	53621	45960.85714	40215.75	35747.33333	32172.6	29247.81818	26810.5	24748.15385	22980.42857	21448.4	20107.875	17873.66667	16932.94737	16086.3	13405.25	12869.04	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291233	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	474959	237479.5	158319.6667	118739.75	94991.8	79159.83333	67851.28571	59369.875	52773.22222	47495.9	43178.09091	39579.91667	36535.30769	33925.64286	31663.93333	29684.9375	26386.61111	24997.84211	23747.95	19789.95833	18998.36	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291234	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291235	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	35465	17732.5	11821.66667	8866.25	7093	5910.833333	5066.428571	4433.125	3940.555556	3546.5	3224.090909	2955.416667	2728.076923	2533.214286	2364.333333	2216.5625	1970.277778	1866.578947	1773.25	1477.708333	1418.6	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291236	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291237	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	58499	29249.5	19499.66667	14624.75	11699.8	9749.833333	8357	7312.375	6499.888889	5849.9	5318.090909	4874.916667	4499.923077	4178.5	3899.933333	3656.1875	3249.944444	3078.894737	2924.95	2437.458333	2339.96	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291238	CHOYP_WFS1.1.1|m.25462	IGVSWLIEASK	IGVSWLIEASK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291239	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	2515328	1257664	838442.6667	628832	503065.6	419221.3333	359332.5714	314416	279480.8889	251532.8	228666.1818	209610.6667	193486.7692	179666.2857	167688.5333	157208	139740.4444	132385.6842	125766.4	104805.3333	100613.12	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291240	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	1113902	556951	371300.6667	278475.5	222780.4	185650.3333	159128.8571	139237.75	123766.8889	111390.2	101263.8182	92825.16667	85684.76923	79564.42857	74260.13333	69618.875	61883.44444	58626.42105	55695.1	46412.58333	44556.08	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291241	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	554644	277322	184881.3333	138661	110928.8	92440.66667	79234.85714	69330.5	61627.11111	55464.4	50422.18182	46220.33333	42664.92308	39617.42857	36976.26667	34665.25	30813.55556	29191.78947	27732.2	23110.16667	22185.76	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291242	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	723937	361968.5	241312.3333	180984.25	144787.4	120656.1667	103419.5714	90492.125	80437.44444	72393.7	65812.45455	60328.08333	55687.46154	51709.78571	48262.46667	45246.0625	40218.72222	38101.94737	36196.85	30164.04167	28957.48	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291243	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	675131	337565.5	225043.6667	168782.75	135026.2	112521.8333	96447.28571	84391.375	75014.55556	67513.1	61375.54545	56260.91667	51933.15385	48223.64286	45008.73333	42195.6875	37507.27778	35533.21053	33756.55	28130.45833	27005.24	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291244	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	36496	18248	12165.33333	9124	7299.2	6082.666667	5213.714286	4562	4055.111111	3649.6	3317.818182	3041.333333	2807.384615	2606.857143	2433.066667	2281	2027.555556	1920.842105	1824.8	1520.666667	1459.84	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291245	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	243792	121896	81264	60948	48758.4	40632	34827.42857	30474	27088	24379.2	22162.90909	20316	18753.23077	17413.71429	16252.8	15237	13544	12831.15789	12189.6	10158	9751.68	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291246	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	112234	56117	37411.33333	28058.5	22446.8	18705.66667	16033.42857	14029.25	12470.44444	11223.4	10203.09091	9352.833333	8633.384615	8016.714286	7482.266667	7014.625	6235.222222	5907.052632	5611.7	4676.416667	4489.36	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291247	CHOYP_WFS1.1.1|m.25462	NMFQAINGTHR	NMFQAINGTHR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291248	CHOYP_WFS1.1.1|m.25462	EGLDFVMR	EGLDFVMR	1040983	520491.5	346994.3333	260245.75	208196.6	173497.1667	148711.8571	130122.875	115664.7778	104098.3	94634.81818	86748.58333	80075.61538	74355.92857	69398.86667	65061.4375	57832.38889	54788.57895	52049.15	43374.29167	41639.32	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291249	CHOYP_WFS1.1.1|m.25462	EGLDFVMR	EGLDFVMR	166683	83341.5	55561	41670.75	33336.6	27780.5	23811.85714	20835.375	18520.33333	16668.3	15153	13890.25	12821.76923	11905.92857	11112.2	10417.6875	9260.166667	8772.789474	8334.15	6945.125	6667.32	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291250	CHOYP_WFS1.1.1|m.25462	EGLDFVMR	EGLDFVMR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291251	CHOYP_WFS1.1.1|m.25462	EGLDFVMR	EGLDFVMR	415172	207586	138390.6667	103793	83034.4	69195.33333	59310.28571	51896.5	46130.22222	41517.2	37742.90909	34597.66667	31936.30769	29655.14286	27678.13333	25948.25	23065.11111	21851.15789	20758.6	17298.83333	16606.88	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291252	CHOYP_WFS1.1.1|m.25462	EGLDFVMR	EGLDFVMR	310585	155292.5	103528.3333	77646.25	62117	51764.16667	44369.28571	38823.125	34509.44444	31058.5	28235	25882.08333	23891.15385	22184.64286	20705.66667	19411.5625	17254.72222	16346.57895	15529.25	12941.04167	12423.4	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291253	CHOYP_WFS1.1.1|m.25462	EGLDFVMR	EGLDFVMR	310191	155095.5	103397	77547.75	62038.2	51698.5	44313	38773.875	34465.66667	31019.1	28199.18182	25849.25	23860.84615	22156.5	20679.4	19386.9375	17232.83333	16325.84211	15509.55	12924.625	12407.64	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291254	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291255	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291256	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291257	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291258	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	801097	400548.5	267032.3333	200274.25	160219.4	133516.1667	114442.4286	100137.125	89010.77778	80109.7	72827	66758.08333	61622.84615	57221.21429	53406.46667	50068.5625	44505.38889	42163	40054.85	33379.04167	32043.88	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291259	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291260	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291261	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291262	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	42796	21398	14265.33333	10699	8559.2	7132.666667	6113.714286	5349.5	4755.111111	4279.6	3890.545455	3566.333333	3292	3056.857143	2853.066667	2674.75	2377.555556	2252.421053	2139.8	1783.166667	1711.84	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291263	CHOYP_WFS1.1.1|m.25462	TYNVGVDVEQTK	TYNVGVDVEQTK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P56695	Wolframin	Wfs1	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675
291625	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291626	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	2317142	1158571	772380.6667	579285.5	463428.4	386190.3333	331020.2857	289642.75	257460.2222	231714.2	210649.2727	193095.1667	178241.6923	165510.1429	154476.1333	144821.375	128730.1111	121954.8421	115857.1	96547.58333	92685.68	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291627	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	1200417	600208.5	400139	300104.25	240083.4	200069.5	171488.1429	150052.125	133379.6667	120041.7	109128.8182	100034.75	92339.76923	85744.07143	80027.8	75026.0625	66689.83333	63179.84211	60020.85	50017.375	48016.68	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291628	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291629	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291630	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	444608	222304	148202.6667	111152	88921.6	74101.33333	63515.42857	55576	49400.88889	44460.8	40418.90909	37050.66667	34200.61538	31757.71429	29640.53333	27788	24700.44444	23400.42105	22230.4	18525.33333	17784.32	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291631	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291632	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291633	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291634	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	129122	64561	43040.66667	32280.5	25824.4	21520.33333	18446	16140.25	14346.88889	12912.2	11738.36364	10760.16667	9932.461538	9223	8608.133333	8070.125	7173.444444	6795.894737	6456.1	5380.083333	5164.88	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291635	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	59769	29884.5	19923	14942.25	11953.8	9961.5	8538.428571	7471.125	6641	5976.9	5433.545455	4980.75	4597.615385	4269.214286	3984.6	3735.5625	3320.5	3145.736842	2988.45	2490.375	2390.76	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291636	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291637	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	55254	27627	18418	13813.5	11050.8	9209	7893.428571	6906.75	6139.333333	5525.4	5023.090909	4604.5	4250.307692	3946.714286	3683.6	3453.375	3069.666667	2908.105263	2762.7	2302.25	2210.16	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
291638	CHOYP_YAHB.1.1|m.25422	IMIAMDGSEYSEGALK	IMIAMDGSEYSEGALK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P42297	Universal stress protein YxiE (USP YxiE)	yxiE BSU39250 N17E	response to stress [GO:0006950]	GO:0006950
293780	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293781	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	3026602	1513301	1008867.333	756650.5	605320.4	504433.6667	432371.7143	378325.25	336289.1111	302660.2	275145.6364	252216.8333	232815.5385	216185.8571	201773.4667	189162.625	168144.5556	159294.8421	151330.1	126108.4167	121064.08	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293782	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293783	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	267849	133924.5	89283	66962.25	53569.8	44641.5	38264.14286	33481.125	29761	26784.9	24349.90909	22320.75	20603.76923	19132.07143	17856.6	16740.5625	14880.5	14097.31579	13392.45	11160.375	10713.96	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293784	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	594944	297472	198314.6667	148736	118988.8	99157.33333	84992	74368	66104.88889	59494.4	54085.81818	49578.66667	45764.92308	42496	39662.93333	37184	33052.44444	31312.84211	29747.2	24789.33333	23797.76	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293785	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	2618190	1309095	872730	654547.5	523638	436365	374027.1429	327273.75	290910	261819	238017.2727	218182.5	201399.2308	187013.5714	174546	163636.875	145455	137799.4737	130909.5	109091.25	104727.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293786	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	1651690	825845	550563.3333	412922.5	330338	275281.6667	235955.7143	206461.25	183521.1111	165169	150153.6364	137640.8333	127053.0769	117977.8571	110112.6667	103230.625	91760.55556	86931.05263	82584.5	68820.41667	66067.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293787	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	1536667	768333.5	512222.3333	384166.75	307333.4	256111.1667	219523.8571	192083.375	170740.7778	153666.7	139697	128055.5833	118205.1538	109761.9286	102444.4667	96041.6875	85370.38889	80877.21053	76833.35	64027.79167	61466.68	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293788	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	495840	247920	165280	123960	99168	82640	70834.28571	61980	55093.33333	49584	45076.36364	41320	38141.53846	35417.14286	33056	30990	27546.66667	26096.84211	24792	20660	19833.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293789	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	364449	182224.5	121483	91112.25	72889.8	60741.5	52064.14286	45556.125	40494.33333	36444.9	33131.72727	30370.75	28034.53846	26032.07143	24296.6	22778.0625	20247.16667	19181.52632	18222.45	15185.375	14577.96	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293790	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	1099049	549524.5	366349.6667	274762.25	219809.8	183174.8333	157007	137381.125	122116.5556	109904.9	99913.54545	91587.41667	84542.23077	78503.5	73269.93333	68690.5625	61058.27778	57844.68421	54952.45	45793.70833	43961.96	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293791	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	752761	376380.5	250920.3333	188190.25	150552.2	125460.1667	107537.2857	94095.125	83640.11111	75276.1	68432.81818	62730.08333	57904.69231	53768.64286	50184.06667	47047.5625	41820.05556	39619	37638.05	31365.04167	30110.44	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293792	CHOYP_contig_012079|m.13840	AATDLNADMIVMGSR	AATDLNADMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293793	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293794	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	3026602	1513301	1008867.333	756650.5	605320.4	504433.6667	432371.7143	378325.25	336289.1111	302660.2	275145.6364	252216.8333	232815.5385	216185.8571	201773.4667	189162.625	168144.5556	159294.8421	151330.1	126108.4167	121064.08	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293795	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293796	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	267849	133924.5	89283	66962.25	53569.8	44641.5	38264.14286	33481.125	29761	26784.9	24349.90909	22320.75	20603.76923	19132.07143	17856.6	16740.5625	14880.5	14097.31579	13392.45	11160.375	10713.96	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293797	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	594944	297472	198314.6667	148736	118988.8	99157.33333	84992	74368	66104.88889	59494.4	54085.81818	49578.66667	45764.92308	42496	39662.93333	37184	33052.44444	31312.84211	29747.2	24789.33333	23797.76	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293798	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	2618190	1309095	872730	654547.5	523638	436365	374027.1429	327273.75	290910	261819	238017.2727	218182.5	201399.2308	187013.5714	174546	163636.875	145455	137799.4737	130909.5	109091.25	104727.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293799	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	1651690	825845	550563.3333	412922.5	330338	275281.6667	235955.7143	206461.25	183521.1111	165169	150153.6364	137640.8333	127053.0769	117977.8571	110112.6667	103230.625	91760.55556	86931.05263	82584.5	68820.41667	66067.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293800	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	1536667	768333.5	512222.3333	384166.75	307333.4	256111.1667	219523.8571	192083.375	170740.7778	153666.7	139697	128055.5833	118205.1538	109761.9286	102444.4667	96041.6875	85370.38889	80877.21053	76833.35	64027.79167	61466.68	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293801	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	495840	247920	165280	123960	99168	82640	70834.28571	61980	55093.33333	49584	45076.36364	41320	38141.53846	35417.14286	33056	30990	27546.66667	26096.84211	24792	20660	19833.6	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293802	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	364449	182224.5	121483	91112.25	72889.8	60741.5	52064.14286	45556.125	40494.33333	36444.9	33131.72727	30370.75	28034.53846	26032.07143	24296.6	22778.0625	20247.16667	19181.52632	18222.45	15185.375	14577.96	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293803	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	1099049	549524.5	366349.6667	274762.25	219809.8	183174.8333	157007	137381.125	122116.5556	109904.9	99913.54545	91587.41667	84542.23077	78503.5	73269.93333	68690.5625	61058.27778	57844.68421	54952.45	45793.70833	43961.96	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293804	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	752761	376380.5	250920.3333	188190.25	150552.2	125460.1667	107537.2857	94095.125	83640.11111	75276.1	68432.81818	62730.08333	57904.69231	53768.64286	50184.06667	47047.5625	41820.05556	39619	37638.05	31365.04167	30110.44	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
293805	CHOYP_contig_012079|m.13839	AATDLNADMIVMGSR	AATDLNADMIVMGSR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P74897	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	0	response to stress [GO:0006950]	GO:0006950
301280	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301281	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301282	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301283	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301284	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301285	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301286	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301287	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301288	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301289	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301290	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301291	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301292	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
301293	CHOYP_contig_043877|m.50699	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303280	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303281	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303282	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303283	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303284	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303285	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303286	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303287	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303288	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303289	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303290	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303291	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303292	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303293	CHOYP_contig_048898|m.58002	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303820	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	977096832	488548416	325698944	244274208	195419366.4	162849472	139585261.7	122137104	108566314.7	97709683.2	88826984.73	81424736	75161294.77	69792630.86	65139788.8	61068552	54283157.33	51426149.05	48854841.6	40712368	39083873.28	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303821	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	591583168	295791584	197194389.3	147895792	118316633.6	98597194.67	84511881.14	73947896	65731463.11	59158316.8	53780288	49298597.33	45506397.54	42255940.57	39438877.87	36973948	32865731.56	31135956.21	29579158.4	24649298.67	23663326.72	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303822	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	246532256	123266128	82177418.67	61633064	49306451.2	41088709.33	35218893.71	30816532	27392472.89	24653225.6	22412023.27	20544354.67	18964019.69	17609446.86	16435483.73	15408266	13696236.44	12975381.89	12326612.8	10272177.33	9861290.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303823	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	53643948	26821974	17881316	13410987	10728789.6	8940658	7663421.143	6705493.5	5960438.667	5364394.8	4876722.545	4470329	4126457.538	3831710.571	3576263.2	3352746.75	2980219.333	2823365.684	2682197.4	2235164.5	2145757.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303824	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	24872264	12436132	8290754.667	6218066	4974452.8	4145377.333	3553180.571	3109033	2763584.889	2487226.4	2261114.909	2072688.667	1913251.077	1776590.286	1658150.933	1554516.5	1381792.444	1309066.526	1243613.2	1036344.333	994890.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303825	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	32144684	16072342	10714894.67	8036171	6428936.8	5357447.333	4592097.714	4018085.5	3571631.556	3214468.4	2922244	2678723.667	2472668	2296048.857	2142978.933	2009042.75	1785815.778	1691825.474	1607234.2	1339361.833	1285787.36	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303826	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	30837662	15418831	10279220.67	7709415.5	6167532.4	5139610.333	4405380.286	3854707.75	3426406.889	3083766.2	2803423.818	2569805.167	2372127.846	2202690.143	2055844.133	1927353.875	1713203.444	1623034.842	1541883.1	1284902.583	1233506.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303827	CHOYP_contig_050645|m.60289	VHGSIEMHQR	VHGSIEMHQR	11772739	5886369.5	3924246.333	2943184.75	2354547.8	1962123.167	1681819.857	1471592.375	1308082.111	1177273.9	1070249	981061.5833	905595.3077	840909.9286	784849.2667	735796.1875	654041.0556	619617.8421	588636.95	490530.7917	470909.56	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303828	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	2025939456	1012969728	675313152	506484864	405187891.2	337656576	289419922.3	253242432	225104384	202593945.6	184176314.2	168828288	155841496.6	144709961.1	135062630.4	126621216	112552192	106628392.4	101296972.8	84414144	81037578.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303829	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1967468544	983734272	655822848	491867136	393493708.8	327911424	281066934.9	245933568	218607616	196746854.4	178860776.7	163955712	151343734.2	140533467.4	131164569.6	122966784	109303808	103550976	98373427.2	81977856	78698741.76	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303830	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	1054602112	527301056	351534037.3	263650528	210920422.4	175767018.7	150657444.6	131825264	117178012.4	105460211.2	95872919.27	87883509.33	81123239.38	75328722.29	70306807.47	65912632	58589006.22	55505374.32	52730105.6	43941754.67	42184084.48	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303831	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303832	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	19887506	9943753	6629168.667	4971876.5	3977501.2	3314584.333	2841072.286	2485938.25	2209722.889	1988750.6	1807955.091	1657292.167	1529808.154	1420536.143	1325833.733	1242969.125	1104861.444	1046710.842	994375.3	828646.0833	795500.24	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303833	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	90940648	45470324	30313549.33	22735162	18188129.6	15156774.67	12991521.14	11367581	10104516.44	9094064.8	8267331.636	7578387.333	6995434.462	6495760.571	6062709.867	5683790.5	5052258.222	4786349.895	4547032.4	3789193.667	3637625.92	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303834	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	72638120	36319060	24212706.67	18159530	14527624	12106353.33	10376874.29	9079765	8070902.222	7263812	6603465.455	6053176.667	5587547.692	5188437.143	4842541.333	4539882.5	4035451.111	3823058.947	3631906	3026588.333	2905524.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303835	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	221866960	110933480	73955653.33	55466740	44373392	36977826.67	31695280	27733370	24651884.44	22186696	20169723.64	18488913.33	17066689.23	15847640	14791130.67	13866685	12325942.22	11677208.42	11093348	9244456.667	8874678.4	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303836	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	60944620	30472310	20314873.33	15236155	12188924	10157436.67	8706374.286	7618077.5	6771624.444	6094462	5540420	5078718.333	4688047.692	4353187.143	4062974.667	3809038.75	3385812.222	3207611.579	3047231	2539359.167	2437784.8	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303837	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	124344752	62172376	41448250.67	31086188	24868950.4	20724125.33	17763536	15543094	13816083.56	12434475.2	11304068.36	10362062.67	9564980.923	8881768	8289650.133	7771547	6908041.778	6544460.632	6217237.6	5181031.333	4973790.08	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303838	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	52997516	26498758	17665838.67	13249379	10599503.2	8832919.333	7571073.714	6624689.5	5888612.889	5299751.6	4817956	4416459.667	4076732	3785536.857	3533167.733	3312344.75	2944306.444	2789342.947	2649875.8	2208229.833	2119900.64	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303839	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	140312080	70156040	46770693.33	35078020	28062416	23385346.67	20044582.86	17539010	15590231.11	14031208	12755643.64	11692673.33	10793236.92	10022291.43	9354138.667	8769505	7795115.556	7384846.316	7015604	5846336.667	5612483.2	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303840	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	4771942	2385971	1590647.333	1192985.5	954388.4	795323.6667	681706	596492.75	530215.7778	477194.2	433812.9091	397661.8333	367072.4615	340853	318129.4667	298246.375	265107.8889	251154.8421	238597.1	198830.9167	190877.68	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062
303841	CHOYP_contig_050645|m.60289	TFDWLTIGHTDGILGR	TFDWLTIGHTDGILGR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Q08420	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062